PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Martens-Habbena, W; Berube, PM; Urakawa, H; de la Torre, JR; Stahl, DA				Martens-Habbena, Willm; Berube, Paul M.; Urakawa, Hidetoshi; de la Torre, Jose R.; Stahl, David A.			Ammonia oxidation kinetics determine niche separation of nitrifying Archaea and Bacteria	NATURE			English	Article							OXIDIZING BACTERIA; NITROSOMONAS-EUROPAEA; MARINE; NITROGEN; OCEAN; GROWTH; WATER; STARVATION; NUTRIENTS; PHYTOPLANKTON	The discovery of ammonia oxidation by mesophilic and thermophilic Crenarchaeota and the widespread distribution of these organisms in marine and terrestrial environments indicated an important role for them in the global nitrogen cycle(1-7). However, very little is known about their physiology or their contribution to nitrification(8). Here we report oligotrophic ammonia oxidation kinetics and cellular characteristics of the mesophilic crenarchaeon 'Candidatus Nitrosopumilus maritimus' strain SCM1. Unlike characterized ammonia-oxidizing bacteria, SCM1 is adapted to life under extreme nutrient limitation, sustaining high specific oxidation rates at ammonium concentrations found in open oceans. Its half-saturation constant (K-m = 133 nM total ammonium) and substrate threshold (<= 10 nM) closely resemble kinetics of in situ nitrification in marine systems(9,10) and directly link ammonia-oxidizing Archaea to oligotrophic nitrification. The remarkably high specific affinity for reduced nitrogen (68,700 l per g cells per h) of SCM1 suggests that Nitrosopumilus-like ammonia-oxidizing Archaea could successfully compete with heterotrophic bacterio-plankton and phytoplankton. Together these findings support the hypothesis that nitrification is more prevalent in the marine nitrogen cycle than accounted for in current biogeochemical models(11).	[Martens-Habbena, Willm; Berube, Paul M.; Urakawa, Hidetoshi; de la Torre, Jose R.; Stahl, David A.] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle	Martens-Habbena, W (corresponding author), Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98105 USA.	willmmh@u.washington.edu; dastahl@u.washington.edu	Urakawa, Hidetoshi/B-1337-2013; de la Torre, Jose R/H-2081-2012; Martens-Habbena, Willm/AAK-1372-2021; Martens-Habbena, Willm/I-7656-2013	Urakawa, Hidetoshi/0000-0003-3748-6027; de la Torre, Jose R/0000-0002-9553-6048; Martens-Habbena, Willm/0000-0002-8495-9125; Martens-Habbena, Willm/0000-0002-8495-9125; Berube, Paul/0000-0001-5598-6602	NSF [MCB-0604448, OCE-0623174]	NSF(National Science Foundation (NSF))	We thank A. M. Gee for technical assistance and C. B. Walker, K. C. Costa, S. Flagan, D. K. Button, M. G. Klotz, L. Bakken, S. Sandfest, M. Konneke, K. L. Hillesland and L. H. Larsen for discussions. This work was supported by NSF award MCB-0604448 to D. A. S. and J. R. T. and by NSF award OCE-0623174 to A. E. Ingalls, D. A. S. and A. H. Devol.	Agogue H, 2008, NATURE, V456, P788, DOI 10.1038/nature07535; Berube PM, 2007, J BACTERIOL, V189, P3935, DOI 10.1128/JB.01861-06; Bollmann A, 2005, APPL ENVIRON MICROB, V71, P1276, DOI 10.1128/AEM.71.3.1276-1282.2005; Bollmann A, 2002, APPL ENVIRON MICROB, V68, P4751, DOI 10.1128/AEM.68.10.4751-4757.2002; BUTTON DK, 1985, MICROBIOL REV, V49, P270, DOI 10.1128/MMBR.49.3.270-297.1985; Button DK, 1998, MICROBIOL MOL BIOL R, V62, P636, DOI 10.1128/MMBR.62.3.636-645.1998; Button DK, 1998, APPL ENVIRON MICROB, V64, P4467; CLEGG SL, 1995, GEOCHIM COSMOCHIM AC, V59, P2403, DOI 10.1016/0016-7037(95)00135-2; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; EPPLEY RW, 1974, J PHYCOL, V10, P15, DOI 10.1111/j.0022-3646.1974.00015.x; EPPLEY RW, 1969, LIMNOL OCEANOGR, V14, P912, DOI 10.4319/lo.1969.14.6.0912; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Freitag TE, 2006, ENVIRON MICROBIOL, V8, P684, DOI 10.1111/j.1462-2920.2005.00947.x; GLOVER HE, 1985, ARCH MICROBIOL, V142, P45, DOI 10.1007/BF00409235; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Gundersen JK, 1998, LIMNOL OCEANOGR, V43, P1932; HASHIMOTO LK, 1983, DEEP-SEA RES, V30, P575, DOI 10.1016/0198-0149(83)90037-7; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Jiang QQ, 1999, FEMS MICROBIOL ECOL, V30, P171, DOI 10.1111/j.1574-6941.1999.tb00646.x; KARL DM, 1984, NATURE, V309, P54, DOI 10.1038/309054a0; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; KEEN GA, 1987, ARCH MICROBIOL, V147, P73, DOI 10.1007/BF00492908; Kirchman DL, 2007, LIMNOL OCEANOGR, V52, P495, DOI 10.4319/lo.2007.52.2.0495; KIRCHMAN DL, 1994, MICROBIAL ECOL, V28, P255, DOI 10.1007/BF00166816; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Laanbroek HJ, 1995, ADV MICROB ECOL, V14, P275; LEE S, 1987, APPL ENVIRON MICROB, V53, P1298, DOI 10.1128/AEM.53.6.1298-1303.1987; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Loureiro S, 2009, J PLANKTON RES, V31, P399, DOI 10.1093/plankt/fbn122; Lunau M, 2005, ENVIRON MICROBIOL, V7, P961, DOI 10.1111/j.1462-2920.2005.00767.x; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; OLSON RJ, 1981, J MAR RES, V39, P203; Ouverney CC, 2000, APPL ENVIRON MICROB, V66, P4829, DOI 10.1128/AEM.66.11.4829-4833.2000; Phillips CJ, 1999, APPL ENVIRON MICROB, V65, P779; PROSSER J. I., 1989, ADV MICROBIAL PHYSL, P125; Prosser JI, 2008, ENVIRON MICROBIOL, V10, P2931, DOI 10.1111/j.1462-2920.2008.01775.x; Reay DS, 1999, APPL ENVIRON MICROB, V65, P2577; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Stark JM, 1996, SOIL BIOL BIOCHEM, V28, P1307, DOI 10.1016/S0038-0717(96)00133-2; STEHR G, 1995, FEMS MICROBIOL ECOL, V17, P177, DOI 10.1016/0168-6496(95)00022-3; Stickland JDH, 1972, PRACTICAL HDB SEAWAT; SUWA Y, 1994, WATER RES, V28, P1523, DOI 10.1016/0043-1354(94)90218-6; SUZUKI I, 1974, J BACTERIOL, V120, P556, DOI 10.1128/JB.120.1.556-558.1974; Ward B. B., 1986, Special Publications of the Society for General Microbiology, V20, P157; WARD BB, 1984, CONT SHELF RES, V3, P383, DOI 10.1016/0278-4343(84)90018-9; WARD BB, 1990, MICROBIAL ECOL, V19, P211, DOI 10.1007/BF02017166; WARD BB, 1987, ARCH MICROBIOL, V147, P126, DOI 10.1007/BF00415273; Watson S. W., 1965, LIMNOL OCEANOGR, V10, pR274, DOI DOI 10.4319/LO.1965.10.SUPPL2.R274; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Yool A, 2007, NATURE, V447, P999, DOI 10.1038/nature05885	53	1096	1172	29	725	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					976	U234		10.1038/nature08465	http://dx.doi.org/10.1038/nature08465			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19794413				2022-12-24	WOS:000270817700046
J	Millar, M				Millar, Michael			Should we screen low risk patients for meticillin resistant Staphylococcus aureus?	BRITISH MEDICAL JOURNAL			English	Editorial Material							ACTIVE SURVEILLANCE CULTURES; MRSA; INFECTION; PREVENTION; ORGANISMS		Barts & London NHS Trust, Dept Infect, London E1 2ES, England	Barts Health NHS Trust	Millar, M (corresponding author), Barts & London NHS Trust, Dept Infect, London E1 2ES, England.	michael.millar@bartsandthelondon.nhs.uk						Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; *BRIGHT SUSS U HOS, MRSA SCREEN FREQ ASK; Coia JE, 2006, J HOSP INFECT, V63, pS1, DOI 10.1016/j.jhin.2006.01.001; *DEP HLTH, 2001, REF GUID CONT EX TRE; *DEP HLTH, TEMPL PAT LEAFL MRSA; Department of Health, 2008, IMP ASS SCREEN EL PA; Department of Health, NHS ENGL OP FRAM 200; Diekema DJ, 2007, CLIN INFECT DIS, V44, P1101, DOI 10.1086/512820; Edmond M, 2008, PUBLIC HEALTH ETH-UK, V1, P235, DOI 10.1093/phe/phn014; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Humphreys H, 2009, CLIN MICROBIOL INFEC, V15, P120, DOI 10.1111/j.1469-0691.2009.02699.x; Kluytmans J, 2009, BMJ-BRIT MED J, V338, P532; McGinigle KL, 2008, CLIN INFECT DIS, V46, P1717, DOI 10.1086/587901; Mill J. S., 1989, LIBERTY OTHER ESSAYS; Millar M, 2008, J HOSP INFECT, V69, P1, DOI 10.1016/j.jhin.2008.01.035; National Audit Office, 2009, RED HEALTHC ASS INF; *NETH HLTH COUNC, 2006, MRSA POL NETH; *NUFF COUNC BIOETH, 2007, PUBL HLTH ETH ISS; Santos RP, 2008, CLIN INFECT DIS, V47, P110, DOI 10.1086/588789; United Nations Environment Programme, 1992, RIO DECL ENV DEV; Weber SG, 2007, AM J INFECT CONTROL, V35, P73, DOI 10.1016/j.ajic.2007.01.001; Wenzel RP, 2008, INFECT CONT HOSP EP, V29, P1012, DOI 10.1086/593120; Wolk DM, 2009, J CLIN MICROBIOL, V47, P758, DOI 10.1128/JCM.01714-08; 1999, SAVING LIVES OUR HLT	24	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 8	2009	339								b4035	10.1136/bmj.b4035	http://dx.doi.org/10.1136/bmj.b4035			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505TH	19815584				2022-12-24	WOS:000270719300004
J	Hu, DY; Hou, LH; Zhang, LJ; Xu, X				Hu, Dongyu; Hou, Lianhai; Zhang, Lijun; Xu, Xing			A pre-Archaeopteryx troodontid theropod from China with long feathers on the metatarsus	NATURE			English	Article							4-WINGED DINOSAURS; ORIGIN; MANIRAPTORAN	The early evolution of the major groups of derived non-avialan theropods is still not well understood, mainly because of their poor fossil record in the Jurassic. A well-known result of this problemis the 'temporal paradox' argument that is sometimes made against the theropod hypothesis of avian origins(1). Here we report on an exceptionally well-preserved small theropod specimen collected from the earliest Late Jurassic Tiaojishan Formation of western Liaoning, China(2). The specimen is referable to the Troodontidae, which are among the theropods most closely related to birds. This new find refutes the 'temporal paradox'(1) and provides significant information on the temporal framework of theropod divergence. Furthermore, the extensive feathering of this specimen, particularly the attachment of long pennaceous feathers to the pes, sheds new light on the early evolution of feathers and demonstrates the complex distribution of skeletal and integumentary features close to the dinosaur-bird transition.	[Hu, Dongyu; Hou, Lianhai; Zhang, Lijun; Xu, Xing] Shenyang Normal Univ, Inst Paleontol, Shenyang 110034, Peoples R China; [Hou, Lianhai; Xu, Xing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Zhang, Lijun] Shenyang Inst Geol & Mineral Resources, Shenyang 110032, Peoples R China	Shenyang Normal University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Xu, X (corresponding author), Shenyang Normal Univ, Inst Paleontol, 253 N Huanghe St, Shenyang 110034, Peoples R China.	hudongyu@synu.edu.cn; xingxu@vip.sina.com			Education Bureau of Liaoning Province [20060805, 2008S214]; Special Fund of Shenyang Normal University; X. X. from the Chinese Academy of Sciences; National Natural Science Foundation of China; Major Basic Research Projects of the Ministry of Science and Technology, China	Education Bureau of Liaoning Province; Special Fund of Shenyang Normal University; X. X. from the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Basic Research Projects of the Ministry of Science and Technology, China	We thank S. Zheng for help with the fieldwork, T. Yu for preparing the specimen, C. Sullivan for editing and commenting on the manuscript, G. Sun, P. Cheng and F. Jin for discussions and comments, and J. Huang for Supplementary Fig. 4i. The fieldwork was supported by grants from the Education Bureau of Liaoning Province ( numbers 20060805 and 2008S214) and the Special Fund of Shenyang Normal University. This study was also supported by grants to X. X. from the Chinese Academy of Sciences, the National Natural Science Foundation of China, and Major Basic Research Projects of the Ministry of Science and Technology, China.	Chure Daniel J., 1994, Brigham Young University Geology Studies, V40, P11; Currie P.J., 1987, Journal of Vertebrate Paleontology, V7, P72; EVANS SE, 1985, SHADOW DINOSAURS, P303; Feduccia A, 2002, AUK, V119, P1187, DOI 10.1642/0004-8038(2002)119[1187:BADSAT]2.0.CO;2; JENSEN JA, 1989, J PALEONTOL, V63, P364, DOI 10.1017/S0022336000019533; Longrich N, 2006, PALEOBIOLOGY, V32, P417, DOI 10.1666/04014.1; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P184; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Makovicky PJ, 2003, AM MUS NOVIT, P1; Norell MA, 2004, DINOSAURIA, 2ND EDITION, P196; Padian K, 2003, BIOSCIENCE, V53, P450; Sawyer RH, 2003, J EXP ZOOL PART B, V298B, P57, DOI 10.1002/jez.b.26; WEIDENSAUL S, 1995, RAPTORS BIRDS PREY; Wellnhofer P, 2008, ARCHAEOPTERYX URVOGE; Xu K., 2003, JURASSIC SYSTEM N CH, VVII; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Xu X, 2005, NATURE, V438, pE3, DOI 10.1038/nature04355; Xu X, 2004, NATURE, V431, P838, DOI 10.1038/nature02898; Xu X, 2001, J VERTEBR PALEONTOL, V21, P477, DOI 10.1671/0272-4634(2001)021[0477:ANTFTL]2.0.CO;2; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589; Xu Xing, 2004, Vertebrata Palasiatica, V42, P111; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; Zhang FC, 2004, NATURE, V431, P925, DOI 10.1038/431925a; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447	25	251	277	3	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					640	643		10.1038/nature08322	http://dx.doi.org/10.1038/nature08322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19794491				2022-12-24	WOS:000270302600038
J	Torii, M; Hashimoto-Torii, K; Levitt, P; Rakic, P				Torii, Masaaki; Hashimoto-Torii, Kazue; Levitt, Pat; Rakic, Pasko			Integration of neuronal clones in the radial cortical columns by EphA and ephrin-A signalling	NATURE			English	Article							DEVELOPING CEREBRAL-CORTEX; NEURAL PRECURSORS; DIPHTHERIA-TOXIN; CELL-MIGRATION; EXPRESSION; NEOCORTEX; BRAIN; PROGENITORS; RECEPTORS; REPRESENTATION	The cerebral cortex is a laminated sheet of neurons composed of the arrays of intersecting radial columns(1-3). During development, excitatory projection neurons originating from the proliferative units at the ventricular surface of the embryonic cerebral vesicles migrate along elongated radial glial fibres(4) to form a cellular infrastructure of radial (vertical) ontogenetic columns in the overlaying cortical plate(5). However, a subpopulation of these clonally related neurons also undergoes a short lateral shift and transfers from their parental to the neighbouring radial glial fibres(6), and intermixes with neurons originating from neighbouring proliferative units(5,7). This columnar organization acts as the primary information processing unit in the cortex(1,8,9). The molecular mechanisms, role and significance of this lateral dispersion for cortical development are not understood. Here we show that an Eph receptor A (EphA) and ephrin A (Efna) signalling-dependent shift in the allocation of clonally related neurons is essential for the proper assembly of cortical columns. In contrast to the relatively uniform labelling of the developing cortical plate by various molecular markers and retrograde tracers in wild-type mice, we found alternating labelling of columnar compartments in Efna knockout mice that are caused by impaired lateral dispersion of migrating neurons rather than by altered cell production or death. Furthermore, in utero electroporation showed that lateral dispersion depends on the expression levels of EphAs and ephrin-As during neuronal migration. This so far unrecognized mechanism for lateral neuronal dispersion seems to be essential for the proper intermixing of neuronal types in the cortical columns, which, when disrupted, might contribute to neuropsychiatric disorders associated with abnormal columnar organization(8,10).	[Torii, Masaaki; Hashimoto-Torii, Kazue; Rakic, Pasko] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Torii, Masaaki; Hashimoto-Torii, Kazue; Rakic, Pasko] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Torii, Masaaki; Levitt, Pat] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Torii, Masaaki; Levitt, Pat] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA	Yale University; Yale University; University of Southern California; University of Southern California	Rakic, P (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	masaaki.torii@yale.edu; pasko.rakic@yale.edu			NARSAD Young Investigator Award; Kavli Institute for Neuroscience at Yale; National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038296, R01NS014841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023999, R01DA022785] Funding Source: NIH RePORTER	NARSAD Young Investigator Award(NARSAD); Kavli Institute for Neuroscience at Yale; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to T. Cutforth, D. A. Feldheim, J. G. Flanagan, J. Frisen, F. H. Gage, N. Y. Ip, K. Kohno, L. F. Kromer, C. Redies, J. L. R. Rubenstein and T. Saito for providing materials. We also thank M. R. Sarkisian and A. Bonnin for helpful comments, and M. Pappy, J. Bao, C. Anderson and S. Ellis for technical assistance. This work was supported by the NARSAD Young Investigator Award ( M. T.), the Kavli Institute for Neuroscience at Yale ( P. R.) and the National Institutes of Health ( P. L. and P. R.)	Ang ESBC, 2003, J NEUROSCI, V23, P5805; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bonnin A, 2007, NAT NEUROSCI, V10, P588, DOI 10.1038/nn1896; Buxhoeveden DP, 2002, BRAIN, V125, P935, DOI 10.1093/brain/awf110; Cang JH, 2005, NEURON, V48, P577, DOI 10.1016/j.neuron.2005.10.026; Casanova MF, 2008, NEUROSCIENTIST, V14, P101, DOI 10.1177/1073858407309091; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cholfin JA, 2007, P NATL ACAD SCI USA, V104, P7652, DOI 10.1073/pnas.0702225104; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gal JS, 2006, J NEUROSCI, V26, P1045, DOI 10.1523/JNEUROSCI.4499-05.2006; Gamble JA, 2005, J NEUROSCI, V25, P3142, DOI 10.1523/JNEUROSCI.4759-04.2005; Ge WH, 2006, P NATL ACAD SCI USA, V103, P1319, DOI 10.1073/pnas.0510419103; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; GOLDMANRAKIC PS, 1987, HDB PHYSL NERVOUS SY, P373; Grove EA, 1998, DEVELOPMENT, V125, P2315; Haydar TF, 1999, BRAIN RES PROTOC, V4, P425, DOI 10.1016/S1385-299X(99)00033-1; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Jones EG, 2000, P NATL ACAD SCI USA, V97, P5019, DOI 10.1073/pnas.97.10.5019; Kimura Y, 2007, J BIOCHEM, V142, P105, DOI 10.1093/jb/mvm115; MAXWELL IH, 1986, CANCER RES, V46, P4660; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Passante L, 2008, DEVELOPMENT, V135, P3281, DOI 10.1242/dev.024778; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1974, NATURE, V250, P31, DOI 10.1038/250031a0; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sanada K, 2004, NEURON, V42, P197, DOI 10.1016/S0896-6273(04)00222-3; SORIANO E, 1995, P NATL ACAD SCI USA, V92, P11676, DOI 10.1073/pnas.92.25.11676; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; SZENTAGOTHAI J, 1978, PROC R SOC SER B-BIO, V201, P219, DOI 10.1098/rspb.1978.0043; Tabata H, 2003, J NEUROSCI, V23, P9996; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; Torii M, 2005, NEURON, V48, P563, DOI 10.1016/j.neuron.2005.09.021; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; Walkenhorst J, 2000, MOL CELL NEUROSCI, V16, P365, DOI 10.1006/mcne.2000.0878; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722	45	109	109	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					524	U86		10.1038/nature08362	http://dx.doi.org/10.1038/nature08362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19759535	Green Accepted			2022-12-24	WOS:000270082900040
J	Wiedemann, N; van der Laan, M; Pfanner, N				Wiedemann, Nils; van der Laan, Martin; Pfanner, Nikolaus			SnapShot: Import and Sorting of Mitochondrial Proteins	CELL			English	Editorial Material							INTERMEMBRANE SPACE; MEMBRANE INSERTION		[Wiedemann, Nils; van der Laan, Martin; Pfanner, Nikolaus] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany	University of Freiburg	Wiedemann, N (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany.		Pfanner, Nikolaus/AAV-7878-2021	van der Laan, Martin/0000-0003-0789-9912; Wiedemann, Nils/0000-0001-8305-6728				Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; D'Silva PR, 2008, MOL BIOL CELL, V19, P424, DOI 10.1091/mbc.E07-08-0748; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; van der Laan M, 2006, CURR BIOL, V16, P2271, DOI 10.1016/j.cub.2006.10.025	10	4	4	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 21	2009	138	4					808	U7		10.1016/j.cell.2009.08.004	http://dx.doi.org/10.1016/j.cell.2009.08.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703404	Bronze			2022-12-24	WOS:000269156100022
J	Chan, AT; Ogino, S; Fuchs, CS				Chan, Andrew T.; Ogino, Shuji; Fuchs, Charles S.			Aspirin Use and Survival After Diagnosis of Colorectal Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Digestive Disease Week/110th Annual Meeting of the American-Gastroenterological-Association	MAY 30-JUN 04, 2009	Chicago, IL	Amer Gastroenterol Assoc			CYCLOOXYGENASE-2 GENE-EXPRESSION; FOOD FREQUENCY QUESTIONNAIRE; MALE HEALTH-PROFESSIONALS; NATIONAL DEATH INDEX; COLON-CANCER; LIVER METASTASIS; RANDOMIZED-TRIAL; UP-REGULATION; HEMATOGENOUS METASTASIS; SELECTIVE-INHIBITION	Context Aspirin reduces risk of colorectal neoplasia in randomized trials and inhibits tumor growth and metastases in animal models. However, the influence of aspirin on survival after diagnosis of colorectal cancer is unknown. Objective To examine the association between aspirin use after colorectal cancer diagnosis on colorectal cancer-specific and overall survival. Design, Setting, and Participants Prospective cohort study of 1279 men and women diagnosed with stage I, II, or III colorectal cancer. Participants were enrolled in 2 nationwide health professional cohorts in 1980 and 1986 prior to diagnosis and followed up through June 1, 2008. Main Outcome Measure Colorectal cancer-specific and overall mortality. Results After a median follow-up of 11.8 years, there were 193 total deaths (35%) and 81 colorectal cancer-specific deaths (15%) among 549 participants who regularly used aspirin after colorectal cancer diagnosis, compared with 287 total deaths (39%) and 141 colorectal cancer-specific deaths (19%) among 730 participants who did not use aspirin. Compared with nonusers, participants who regularly used aspirin after diagnosis experienced a multivariate hazard ratio (HR) for colorectal cancer-specific mortality of 0.71 (95% confidence interval [CI], 0.53-0.95) and for overall mortality of 0.79 ( 95% CI, 0.65-0.97). Among 719 participants who did not use aspirin before diagnosis, aspirin use initiated after diagnosis was associated with a multivariate HR for colorectal cancer-specific mortality of 0.53 ( 95% CI, 0.33-0.86). Among 459 participants with colorectal cancers that were accessible for immunohistochemical assessment, the effect of aspirin differed significantly according to cyclooxygenase 2 (COX-2) expression (P for interaction = .04). Regular aspirin use after diagnosis was associated with a lower risk of colorectal cancer-specific mortality among participants in whom primary tumors overexpressed COX-2 ( multivariate HR, 0.39; 95% CI, 0.20-0.76), whereas aspirin use was not associated with lower risk among those with primary tumors with weak or absent expression ( multivariate HR, 1.22; 95% CI, 0.36-4.18). Conclusion Regular aspirin use after the diagnosis of colorectal cancer is associated with lower risk of colorectal cancer-specific and overall mortality, especially among individuals with tumors that overexpress COX-2. JAMA. 2009; 302(6):649-659 www.jama.com	[Chan, Andrew T.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Ogino, Shuji] Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ogino, Shuji; Fuchs, Charles S.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Chan, Andrew T.; Fuchs, Charles S.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Chan, AT (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, 55 Fruit St,GRJ 722, Boston, MA 02114 USA.	achan@partners.org	Chan, Andrew T/P-8293-2014	Chan, Andrew T/0000-0001-7284-6767; Ogino, Shuji/0000-0002-3909-2323	NATIONAL CANCER INSTITUTE [R01CA137178, P01CA087969, R01CA118553, K07CA122826, K07CA107412, P50CA127003, P01CA055075] Funding Source: NIH RePORTER; NCI NIH HHS [K07 CA107412, CA87969, P01 CA055075-110002, P01 CA055075, K07 CA107412-05, P01 CA087969, R01 CA118553, CA137178, P01 CA055075-18, P50 CA127003, R01 CA137178, K07 CA122826, CA122826, CA107412, P50 CA127003-03, R01 CA137178-01A1, CA127003, CA118553, R01 CA118553-03, CA55075] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arber N, 2008, CANCER EPIDEM BIOMAR, V17, P1852, DOI 10.1158/1055-9965.EPI-08-0167; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Baron JA, 2006, GASTROENTEROLOGY, V131, P1674, DOI 10.1053/j.gastro.2006.08.079; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Buchanan FG, 2004, GASTROENTEROLOGY, V127, P1391, DOI 10.1053/j.gastro.2004.07.025; Chan AT, 2008, GASTROENTEROLOGY, V134, P21, DOI 10.1053/j.gastro.2007.09.035; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chan AT, 2004, ANN INTERN MED, V140, P157, DOI 10.7326/0003-4819-140-3-200402030-00006; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; Chen WS, 2001, INT J CANCER, V91, P894, DOI 10.1002/1097-0215(200102)9999:9999<894::AID-IJC1146>3.3.CO;2-R; Cianchi F, 2001, GASTROENTEROLOGY, V121, P1339, DOI 10.1053/gast.2001.29691; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Dube C, 2007, ANN INTERN MED, V146, P365, DOI 10.7326/0003-4819-146-5-200703060-00009; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Fuchs C, 2005, J CLIN ONCOL, V23, p253S; Fux R, 2005, CLIN CANCER RES, V11, P4754, DOI 10.1158/1078-0432.CCR-04-2586; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; Goel A, 2003, CLIN CANCER RES, V9, P383; Greene FL, 2002, AJCC CANC STAGING HD; Gum PA, 2001, JAMA-J AM MED ASSOC, V286, P1187, DOI 10.1001/jama.286.10.1187; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Joo YE, 2002, J GASTROINTEST CANC, V31, P147, DOI 10.1385/IJGC:31:1-3:147; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Lin J, 2005, BIOCHEM PHARMACOL, V70, P658, DOI 10.1016/j.bcp.2005.05.028; Logan RFA, 2008, GASTROENTEROLOGY, V134, P29, DOI 10.1053/j.gastro.2007.10.014; LUNDHOLM K, 1994, CANCER RES, V54, P5602; MANSON JE, 1991, JAMA-J AM MED ASSOC, V266, P521, DOI 10.1001/jama.266.4.521; Markowitz SD, 2007, NEW ENGL J MED, V356, P2195, DOI 10.1056/NEJMe078044; Martinez ME, 2003, P NATL ACAD SCI USA, V100, P7859, DOI 10.1073/pnas.1332465100; Masunaga R, 2000, CLIN CANCER RES, V6, P4064; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3527, DOI 10.1200/JCO.2006.06.0855; Ogino S, 2006, MODERN PATHOL, V19, P59, DOI 10.1038/modpathol.3800482; Ogino S, 2008, CLIN CANCER RES, V14, P8221, DOI 10.1158/1078-0432.CCR-08-1841; Petersen S, 2002, ANTICANCER RES, V22, P1225; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rimm EB, 1992, AM J EPIDEMIOL, V135, P1127, DOI [DOI 10.1093/OXFORDJOURNALS.AJE.A116211, DOI 10.1093/OXFORDJOUMALS.AJE.A116211]; Rosner B., 2000, FUNDAMENTALS BIOSTAT; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Schwenger P, 1997, P NATL ACAD SCI USA, V94, P2869, DOI 10.1073/pnas.94.7.2869; Sheehan KM, 1999, JAMA-J AM MED ASSOC, V282, P1254, DOI 10.1001/jama.282.13.1254; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Sheng HM, 1997, J CLIN INVEST, V99, P2254, DOI 10.1172/JCI119400; Soumaoro LT, 2004, CLIN CANCER RES, V10, P8465, DOI 10.1158/1078-0432.CCR-04-0653; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Tomozawa S, 1999, BRIT J CANCER, V81, P1274, DOI 10.1038/sj.bjc.6694262; Tomozawa S, 2000, BRIT J CANCER, V83, P324, DOI 10.1054/bjoc.2000.1270; Trifan OC, 2002, CANCER RES, V62, P5778; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Uchida K, 2005, CLIN CANCER RES, V11, P3363, DOI 10.1158/1078-0432.CCR-04-1650; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Williams CS, 2000, CANCER RES, V60, P6045; Williams CS, 2000, J CLIN INVEST, V105, P1589, DOI 10.1172/JCI9621; Williams CS, 2001, NEOPLASIA, V3, P428, DOI 10.1038/sj.neo.7900177; Yamac D, 2005, PATHOL RES PRACT, V201, P497, DOI 10.1016/j.prp.2005.04.006; Yamauchi T, 2003, ANTICANCER RES, V23, P245; Yao M, 2005, CLIN CANCER RES, V11, P1618, DOI 10.1158/1078-0432.CCR-04-1696; Yao M, 2003, CANCER RES, V63, P586; Yao M, 2004, BRIT J CANCER, V90, P712, DOI 10.1038/sj.bjc.6601489; Zhang H, 2002, AM J GASTROENTEROL, V97, P1037	66	423	443	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 12	2009	302	6					649	659		10.1001/jama.2009.1112	http://dx.doi.org/10.1001/jama.2009.1112			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	481ZI	19671906	Green Accepted, Bronze			2022-12-24	WOS:000268852300023
J	Salahudeen, AA; Thompson, JW; Ruiz, JC; Ma, HW; Kinch, LN; Li, QM; Grishin, NV; Bruick, RK				Salahudeen, Ameen A.; Thompson, Joel W.; Ruiz, Julio C.; Ma, He-Wen; Kinch, Lisa N.; Li, Qiming; Grishin, Nick V.; Bruick, Richard K.			An E3 Ligase Possessing an Iron-Responsive Hemerythrin Domain Is a Regulator of Iron Homeostasis	SCIENCE			English	Article							DEPENDENT DEGRADATION; MOLECULAR CONTROL; BINDING PROTEIN; IRP2; UBIQUITINATION; RNA	Cellular iron homeostasis is maintained by the coordinate posttranscriptional regulation of genes responsible for iron uptake, release, use, and storage through the actions of the iron regulatory proteins IRP1 and IRP2. However, the manner in which iron levels are sensed to affect IRP2 activity is poorly understood. We found that an E3 ubiquitin ligase complex containing the FBXL5 protein targets IRP2 for proteasomal degradation. The stability of FBXL5 itself was regulated, accumulating under iron-and oxygen-replete conditions and degraded upon iron depletion. FBXL5 contains an iron-and oxygen-binding hemerythrin domain that acted as a ligand-dependent regulatory switch mediating FBXL5's differential stability. These observations suggest a mechanistic link between iron sensing via the FBXL5 hemerythrin domain, IRP2 regulation, and cellular responses to maintain mammalian iron homeostasis.	[Salahudeen, Ameen A.; Thompson, Joel W.; Ruiz, Julio C.; Ma, He-Wen; Kinch, Lisa N.; Li, Qiming; Grishin, Nick V.; Bruick, Richard K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Bruick, RK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	richard.bruick@utsouthwestern.edu		Kinch, Lisa/0000-0003-3041-2615; Thompson, Joel/0000-0002-5131-3248; A Salahudeen, Ameen/0000-0001-9037-3481	Burroughs Wellcome Fund; Robert A. Welch Foundation; Texas Advanced Research Program; NIH [CA115962, C06 RR 15437-01]; NATIONAL CANCER INSTITUTE [R01CA115962] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015437] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Robert A. Welch Foundation(The Welch Foundation); Texas Advanced Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank R. Eisenstein for IRP1 reagents and helpful discussions; Z. Chen for SCF expression plasmids; W. Gao for K0-GST-Ubiquitin and helpful discussions; M. Brown and J. Goldstein for E2 expression constructs; K. Gardner and F. Correa for assistance with circular dichroism; the UTSW HTS facility for assistance with siRNA screening; and L. Wang, G. Pineda, S. Laxman, X. Du, and J. Wang for helpful discussions. R. K. B. is the Michael L. Rosenberg Scholar in Medical Research and was supported by the Burroughs Wellcome Fund, the Robert A. Welch Foundation, the Texas Advanced Research Program, and NIH grant CA115962. This investigation was conducted in a facility constructed with support from the Research Facilities Improvement Program (grant C06 RR 15437-01) from the NIH National Center for Research Resources.	Beutler E, 2006, ANNU REV MED, V57, P331, DOI 10.1146/annurev.med.57.121304.131310; Bourdon E, 2003, BLOOD CELL MOL DIS, V31, P247, DOI 10.1016/S1079-9796(03)00161-X; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; Fillebeen C, 2003, MOL CELL BIOL, V23, P6973, DOI 10.1128/MCB.23.19.6973-6981.2003; French CE, 2008, FEMS MICROBIOL LETT, V279, P131, DOI 10.1111/j.1574-6968.2007.01011.x; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; KOELLER DM, 1989, P NATL ACAD SCI USA, V86, P3574, DOI 10.1073/pnas.86.10.3574; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Somers DE, 2009, TRENDS PLANT SCI, V14, P206, DOI 10.1016/j.tplants.2009.01.003; STENKAMP RE, 1994, CHEM REV, V94, P715, DOI 10.1021/cr00027a008; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wrighting DM, 2008, CURR TOP DEV BIOL, V82, P141, DOI 10.1016/S0070-2153(07)00006-3; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952; ZHANG JH, 1991, BIOCHEMISTRY-US, V30, P583, DOI 10.1021/bi00216a037; Zhang N, 2007, BIOCHEM BIOPH RES CO, V359, P34, DOI 10.1016/j.bbrc.2007.05.068; Zumbrennen KB, 2008, BBA-MOL CELL RES, V1783, P246, DOI 10.1016/j.bbamcr.2007.07.010	26	274	289	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					722	726		10.1126/science.1176326	http://dx.doi.org/10.1126/science.1176326			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19762597	Green Accepted, Green Submitted			2022-12-24	WOS:000271233200036
J	Jara, P; Hierro, L; Martinez-Fernandez, P; Alvarez-Doforno, R; Yanez, F; Diaz, MC; Camarena, C; De la Vega, A; Frauca, E; Munoz-Bartolo, G; Lopez-Santamaria, M; Larrauri, J; Alvarez, L				Jara, Paloma; Hierro, Loreto; Martinez-Fernandez, Pilar; Alvarez-Doforno, Rita; Yanez, Francisca; Diaz, Maria C.; Camarena, Carmen; De la Vega, Angela; Frauca, Esteban; Munoz-Bartolo, Gema; Lopez-Santamaria, Manuel; Larrauri, Javier; Alvarez, Luis			Brief Report: Recurrence of Bile Salt Export Pump Deficiency after Liver Transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; RECEPTOR; HEPATOCYTES; EXPRESSION; TRANSPORT; CHILDREN; SISTER; MICE; IGG	Severe bile salt export pump (BSEP) deficiency is a hereditary cholestatic condition that starts in infancy and leads to end-stage liver disease. Three children who underwent orthotopic liver transplantation for severe BSEP deficiency had post-transplantation episodes of cholestatic dysfunction that mimicked the original disease. Remission of all episodes was achieved by intensifying the immunosuppressive regimen. The phenotypic recurrence of the disease correlated with the presence of circulating high-titer antibodies against BSEP that inhibit transport by BSEP in vitro. When administered to rats, these antibodies targeted the bile canaliculi and impaired bile acid secretion.	[Alvarez, Luis] La Paz Univ Hosp, FIBHULP, Res Unit, Madrid 28046, Spain; [Jara, Paloma; Hierro, Loreto; Diaz, Maria C.; Camarena, Carmen; De la Vega, Angela; Frauca, Esteban; Munoz-Bartolo, Gema] La Paz Univ Hosp, Pediat Liver Serv, Madrid 28046, Spain; [Alvarez-Doforno, Rita; Yanez, Francisca] La Paz Univ Hosp, Serv Immunol, Madrid 28046, Spain; [Larrauri, Javier] La Paz Univ Hosp, Dept Pathol, Madrid 28046, Spain; [Lopez-Santamaria, Manuel] La Paz Univ Hosp, Dept Pediat Surg, Madrid 28046, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz	Alvarez, L (corresponding author), La Paz Univ Hosp, FIBHULP, Res Unit, Paseo La Castellana 261, Madrid 28046, Spain.	luisalvarez.hulp@salud.madrid.org		Hierro, Loreto/0000-0002-6173-4716; Jara Vega, Paloma/0000-0002-4669-7929	Fondo de Investigaciones Sanitarias [05/2373]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	Supported by a grant from the Fondo de Investigaciones Sanitarias (05/2373).	Alissa FT, 2008, J PEDIATR GASTR NUTR, V46, P241, DOI 10.1097/MPG.0b013e3181596060; Alvarez L, 2004, HUM MOL GENET, V13, P2451, DOI 10.1093/hmg/ddh261; Balistreri WF, 1999, SCHIFFS DIS LIVER, P1357; BITTNER RE, 1995, NEW ENGL J MED, V333, P732, DOI 10.1056/NEJM199509143331114; BLUMBERG RS, 1995, J CLIN INVEST, V95, P2397, DOI 10.1172/JCI117934; Bull LN, 1997, HEPATOLOGY, V26, P155; Byrne JA, 2002, GASTROENTEROLOGY, V123, P1649, DOI 10.1053/gast.2002.36591; Kashtan CE, 2006, PEDIATR TRANSPLANT, V10, P651, DOI 10.1111/j.1399-3046.2006.00528.x; Knisely AS, 2006, HEPATOLOGY, V44, P478, DOI 10.1002/hep.21287; Lam P, 2005, BIOCHEMISTRY-US, V44, P12598, DOI 10.1021/bi050943e; Migliazza L, 2000, J PEDIATR SURG, V35, P5, DOI 10.1016/S0022-3468(00)80066-4; Noe J, 2002, GASTROENTEROLOGY, V123, P1659, DOI 10.1053/gast.2002.36587; Stieger B, 2007, PFLUG ARCH EUR J PHY, V453, P611, DOI 10.1007/s00424-006-0152-8; Strautnieks SS, 2008, GASTROENTEROLOGY, V134, P1203, DOI 10.1053/j.gastro.2008.01.038; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; TALALAY PAUL, 1960, METHODS BIOCHEM ANAL, V8, P119; Telleman P, 2000, IMMUNOLOGY, V100, P245, DOI 10.1046/j.1365-2567.2000.00034.x; Thompson R, 2001, SEMIN LIVER DIS, V21, P545, DOI 10.1055/s-2001-19038; Tiao G, 2007, LIVER DISEASE IN CHILDREN, 3RD EDITION, P975, DOI 10.1017/CBO9780511547409.043; Wang RX, 2001, P NATL ACAD SCI USA, V98, P2011, DOI 10.1073/pnas.031465498; WHITINGTON PF, 1994, J PEDIATR GASTR NUTR, V18, P134, DOI 10.1097/00005176-199402000-00003	21	74	75	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2009	361	14					1359	1367		10.1056/NEJMoa0901075	http://dx.doi.org/10.1056/NEJMoa0901075			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500KZ	19797282				2022-12-24	WOS:000270300000010
J	Bermejo, R; Capra, T; Gonzalez-Huici, V; Fachinetti, D; Cocito, A; Natoli, G; Katou, Y; Mori, H; Kurokawa, K; Shirahige, K; Foiani, M				Bermejo, Rodrigo; Capra, Thelma; Gonzalez-Huici, Victor; Fachinetti, Daniele; Cocito, Andrea; Natoli, Gioacchino; Katou, Yuki; Mori, Hiroshi; Kurokawa, Ken; Shirahige, Katsuhiko; Foiani, Marco			Genome-Organizing Factors Top2 and Hmo1 Prevent Chromosome Fragility at Sites of S phase Transcription	CELL			English	Article							DNA TOPOISOMERASE-II; RIBOSOMAL-PROTEIN GENES; SACCHAROMYCES-CEREVISIAE; REPLICATION FORKS; BOX PROTEIN; HMG-BOX; CHROMATIN; RNA; BINDING; PROGRESSION	Specialized topoisomerases solve the topological constraints arising when replication forks encounter transcription. We have investigated the contribution of Top2 in S phase transcription. Specifically in S phase, Top2 binds intergenic regions close to transcribed genes. The Top2-bound loci exhibit low nucleosome density and accumulate gamma H2A when Top2 is defective. These intergenic loci associate with the HMG protein Hmo1 throughout the cell cycle and are refractory to the histone variant Htz1. In top2 mutants, Hmo1 is deleterious and accumulates at pericentromeric regions in G2/M. Our data indicate that Top2 is dispensable for transcription and that Hmo1 and Top2 bind in the proximity of genes transcribed in S phase suppressing chromosome fragility at the M-G1 transition. We propose that an Hmo1-dependent epigenetic signature together with Top2 mediate an S phase architectural pathway to preserve genome integrity.	[Foiani, Marco] Univ Milan, DSBB, I-20122 Milan, Italy; [Natoli, Gioacchino] IFOM IEO Campus, European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Katou, Yuki; Mori, Hiroshi; Kurokawa, Ken; Shirahige, Katsuhiko] Tokyo Inst Technol, Lab Genome Struct & Funct, Div Gene Res, Ctr Biol Resources & Informat,Midori Ku, Yokohama, Kanagawa 2268501, Japan	University of Milan; IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); Tokyo Institute of Technology		marco.foiani@ifom-ieo-campus.it	Shingakujyutsu, Kurokawaken/G-1378-2011; Natoli, gioacchino/ABB-8679-2020; Capra, Thelma/AAN-4064-2020; Bermejo, Rodrigo/AAG-7830-2019; Natoli, gioacchino/J-2100-2018; Foiani, Marco/M-8234-2014; Bermejo, Rodrigo/S-2445-2019; Bermejo, Rodrigo/K-6613-2014; Gonzalez-Huici, Victor/ABB-4680-2020	Foiani, Marco/0000-0003-4795-834X; Bermejo, Rodrigo/0000-0002-2692-7045; Mori, Hiroshi/0000-0003-0806-7704; Gonzalez Huici, Victor/0000-0002-6977-1060; Natoli, Gioacchino/0000-0003-0711-2411; Shirahige, Katsuhiko/0000-0002-7862-1144; Fachinetti, Daniele/0000-0002-8795-6771	Italian Association for Cancer Research; Telethon-Italy, European Community (GENICA); Italian Ministry of Health; EMBO and Marie Curie fellowships; MEXT, Japan	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Telethon-Italy, European Community (GENICA)(European CommissionFondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy); EMBO and Marie Curie fellowships(European Commission); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank A. Verreault for antibodies, D. Branzei, Y. Doksani, M. Bianchi (HSR), and all members of our laboratories for discussions. We thank R. Jossen, M. Saponaro, A. Colosio, and the COGENTECH microarray facility staff for technical advice and support. Work in M.F.'s laboratory is supported by grants from Italian Association for Cancer Research, Telethon-Italy, European Community (GENICA), and Italian Ministry of Health. V. G.-H. was supported by EMBO and Marie Curie fellowships. K. S. is supported by a grant of the Genome Network Project and Grant-in-Aid for Scientific Research (S) from the MEXT, Japan. Y. K. is a GCOE research associate.	Agresti A, 2003, CURR OPIN GENET DEV, V13, P170, DOI 10.1016/S0959-437X(03)00023-6; Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Berger AB, 2007, MOL CELL BIOL, V27, P8015, DOI 10.1128/MCB.01102-07; Bermejo R, 2008, GENE DEV, V22, P2297, DOI 10.1101/gad.1719308; Bermejo R, 2007, GENE DEV, V21, P1921, DOI 10.1101/gad.432107; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; BLASQUEZ VC, 1989, GENOME, V31, P503, DOI 10.1139/g89-098; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; BRILL SJ, 1988, CELL, V54, P403, DOI 10.1016/0092-8674(88)90203-6; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; COCKERILL PN, 1986, CELL, V44, P273, DOI 10.1016/0092-8674(86)90761-0; Collins I, 2001, MOL CELL BIOL, V21, P8437, DOI 10.1128/MCB.21.24.8437-8451.2001; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DINARDO S, 1984, P NATL ACAD SCI-BIOL, V81, P2616, DOI 10.1073/pnas.81.9.2616; EARNSHAW WC, 1985, J CELL BIOL, V100, P1716, DOI 10.1083/jcb.100.5.1716; Elvazova ER, 2009, J MOL BIOL, V386, P929, DOI 10.1016/j.jmb.2008.12.022; Gadal O, 2002, EMBO J, V21, P5498, DOI 10.1093/emboj/cdf539; Gaillard Claire, 2000, BMC Biochemistry, V1, P1; Gasser R, 1996, J MOL BIOL, V258, P224, DOI 10.1006/jmbi.1996.0245; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hall DB, 2006, MOL CELL BIOL, V26, P3672, DOI 10.1128/MCB.26.9.3672-3679.2006; HOLM C, 1989, MOL CELL BIOL, V9, P159, DOI 10.1128/MCB.9.1.159; HUGHES EN, 1992, J BIOL CHEM, V267, P13520; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kamau E, 2004, J BIOL CHEM, V279, P55234, DOI 10.1074/jbc.M409459200; Kasahara K, 2007, MOL CELL BIOL, V27, P6686, DOI 10.1128/MCB.00876-07; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Katou Y, 2006, METHOD ENZYMOL, V409, P389, DOI 10.1016/S0076-6879(05)09023-3; Lemaitre JM, 2005, CELL, V123, P787, DOI 10.1016/j.cell.2005.08.045; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Lengronne A, 2001, NUCLEIC ACIDS RES, V29, P1433, DOI 10.1093/nar/29.7.1433; Li TK, 1999, GENE DEV, V13, P1553, DOI 10.1101/gad.13.12.1553; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lopes M, 2003, MOL CELL, V12, P1499, DOI 10.1016/S1097-2765(03)00473-8; Lu J, 1996, J BIOL CHEM, V271, P33678, DOI 10.1074/jbc.271.52.33678; Lucas I, 2001, EMBO J, V20, P6509, DOI 10.1093/emboj/20.22.6509; Lydall D, 2005, DNA REPAIR, V4, P1195, DOI 10.1016/j.dnarep.2005.06.007; Mankouri HW, 2006, MOL BIOL CELL, V17, P4473, DOI 10.1091/mbc.E06-06-0516; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; Myung K, 2002, P NATL ACAD SCI USA, V99, P4500, DOI 10.1073/pnas.062702199; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Postow L, 2001, P NATL ACAD SCI USA, V98, P8219, DOI 10.1073/pnas.111006998; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; SAITOH Y, 1994, CELL, V76, P609, DOI 10.1016/0092-8674(94)90502-9; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Schmidt KH, 2006, P NATL ACAD SCI USA, V103, P18196, DOI 10.1073/pnas.0608566103; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Scholes DT, 2001, GENETICS, V159, P1449; Sikdar N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000290; Smith S, 2005, DNA REPAIR, V4, P606, DOI 10.1016/j.dnarep.2005.01.004; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; SPELL RM, 1994, MOL CELL BIOL, V14, P1465, DOI 10.1128/MCB.14.2.1465; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; Stros M, 2000, J BIOL CHEM, V275, P35699, DOI 10.1074/jbc.M007167200; Stros M, 2007, NUCLEIC ACIDS RES, V35, P5001, DOI 10.1093/nar/gkm525; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Torres JZ, 2004, GENE DEV, V18, P498, DOI 10.1101/gad.1154704; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Vidanes GM, 2005, CELL, V121, P973, DOI 10.1016/j.cell.2005.06.013; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang XD, 2008, GENE DEV, V22, P2426, DOI 10.1101/gad.487508; Warsi TH, 2008, MOL BIOL CELL, V19, P4421, DOI 10.1091/mbc.E08-05-0547; Yeh E, 2008, CURR BIOL, V18, P81, DOI 10.1016/j.cub.2007.12.019; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x; ZLATANOVA J S, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P211; Zlatanova J, 2008, STRUCTURE, V16, P166, DOI 10.1016/j.str.2007.12.008	85	90	91	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					870	884		10.1016/j.cell.2009.06.022	http://dx.doi.org/10.1016/j.cell.2009.06.022			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737516	Bronze			2022-12-24	WOS:000269564600014
J	Boland, MJ; Hazen, JL; Nazor, KL; Rodriguez, AR; Gifford, W; Martin, G; Kupriyanov, S; Baldwin, KK				Boland, Michael J.; Hazen, Jennifer L.; Nazor, Kristopher L.; Rodriguez, Alberto R.; Gifford, Wesley; Martin, Greg; Kupriyanov, Sergey; Baldwin, Kristin K.			Adult mice generated from induced pluripotent stem cells	NATURE			English	Article							TETRAPLOID CELLS; FIBROBLASTS; EXPRESSION; INDUCTION; NEURONS	Recent landmark experiments have shown that transient overexpression of a small number of transcription factors can reprogram differentiated cells into induced pluripotent stem (iPS) cells that resemble embryonic stem (ES) cells(1-7). These iPS cells hold great promise for medicine because they have the potential to generate patient-specific cell types for cell replacement therapy and produce in vitro models of disease, without requiring embryonic tissues or oocytes(8-10). Although current iPS cell lines resemble ES cells, they have not passed the most stringent test of pluripotency by generating full-term or adult mice in tetraploid complementation assays(3,11), raising questions as to whether they are sufficiently potent to generate all of the cell types in an organism. Whether this difference between iPS and ES cells reflects intrinsic limitations of direct reprogramming is not known. Here we report fertile adult mice derived entirely from iPS cells that we generated by inducible genetic reprogramming of mouse embryonic fibroblasts. Producing adult mice derived entirely from a reprogrammed fibroblast shows that all features of a differentiated cell can be restored to an embryonic level of pluripotency without exposure to unknown ooplasmic factors. Comparing these fully pluripotent iPS cell lines to less developmentally potent lines may reveal molecular markers of different pluripotent states. Furthermore, mice derived entirely from iPS cells will provide a new resource to assess the functional and genomic stability of cells and tissues derived from iPS cells, which is important to validate their utility in cell replacement therapy and research applications.	[Boland, Michael J.; Hazen, Jennifer L.; Nazor, Kristopher L.; Baldwin, Kristin K.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Rodriguez, Alberto R.; Martin, Greg; Kupriyanov, Sergey] Scripps Res Inst, Mouse Genet Core Facil, La Jolla, CA 92037 USA; [Gifford, Wesley] Univ Calif San Diego, Med Scientist Training Program, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego	Baldwin, KK (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	kitnazor@scripps.edu; kbaldwin@scripps.edu		Baldwin, Kristin/0000-0002-6137-030X; Boland, Michael/0000-0001-5649-9603	Pew Scholars Award; California Institute of Regenerative Medicine; Whitehall Foundation; O'Keefe Foundation; Shapiro Family Foundation	Pew Scholars Award; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Whitehall Foundation; O'Keefe Foundation; Shapiro Family Foundation	We wish to thank S. Carlson for help with animal husbandry, K. Spencer for help with imaging, and D. Trajkovic for help with histology. We thank G. Joyce, U. Mueller, L. Stowers, A. Patapoutian and A. Maximov for critical reading of the manuscript. We thank M. Mayford for the gift of rtTAM2.2, A. Maximov for the lentiviral vector backbones, and members of A. Kralli's laboratory for assistance with qPCR. We thank R. Axel for supporting the generation of the Pcdh21/Cre mouse strain, which was a gift. This work was supported by a Pew Scholars Award (K. K. B.) and grants from the California Institute of Regenerative Medicine, the Whitehall Foundation, the O'Keefe Foundation, and the Shapiro Family Foundation.	Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Eakin GS, 2005, DEV BIOL, V288, P150, DOI 10.1016/j.ydbio.2005.09.028; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Eggan K, 2003, METHOD ENZYMOL, V365, P25; Eggan K, 2006, PRIN PRACT, P41; Go WY, 2002, J GENE MED, V4, P258, DOI 10.1002/jgm.271; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MacKay GE, 2005, MECH DEVELOP, V122, P1266, DOI 10.1016/j.mod.2005.09.001; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nagai Y, 2005, GENESIS, V43, P12, DOI 10.1002/gene.20146; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A, 2003, MANIPULATING MOUSE E, P453; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	32	335	360	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					91	U94		10.1038/nature08310	http://dx.doi.org/10.1038/nature08310			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19672243				2022-12-24	WOS:000269478800036
J	Lynch, MF; Blanton, EM; Bulens, S; Polyak, C; Vojdani, J; Stevenson, J; Medalla, F; Barzilay, E; Joyce, K; Barrett, T; Mintz, ED				Lynch, Michael F.; Blanton, Elizabeth M.; Bulens, Sandra; Polyak, Christina; Vojdani, Jazmin; Stevenson, Jennifer; Medalla, Felicia; Barzilay, Ezra; Joyce, Kevin; Barrett, Timothy; Mintz, Eric Daniel			Typhoid Fever in the United States, 1999-2006	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESISTANT SALMONELLA-TYPHI; ENTERICA SEROTYPE TYPHI; ANTIMICROBIAL-RESISTANCE; DRUG-RESISTANCE; INFECTIONS; COUNTRIES; BURDEN; TRAVEL; INDIA	Context Typhoid fever in the United States has increasingly been due to infection with antimicrobial-resistant Salmonella ser Typhi. National surveillance for typhoid fever can inform prevention and treatment recommendations. Objective To assess trends in infections with antimicrobial-resistant S Typhi. Design Cross-sectional, laboratory-based surveillance study. Setting and Participants We reviewed data from 1999-2006 for 1902 persons with typhoid fever who had epidemiologic information submitted to the Centers for Disease Control and Prevention (CDC) and 2016 S Typhi isolates sent by participating public health laboratories to the National Antimicrobial Resistance Monitoring System Laboratory at the CDC for antimicrobial susceptibility testing. Main Outcome Measures Proportion of S Typhi isolates demonstrating resistance to 14 antimicrobial agents and patient risk factors for antimicrobial-resistant infections. Results Patient median age was 22 years (range, <1-90 years); 1295 (73%) were hospitalized and 3 (0.2%) died. Foreign travel within 30 days of illness was reported by 1439 (79%). Only 58 travelers (5%) had received typhoid vaccine. Two hundred seventy-two (13%) of 2016 isolates tested were resistant to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole (multidrug-resistant S Typhi [MDRST]); 758 (38%) were resistant to nalidixic acid (nalidixic acid-resistant S Typhi [NARST]) and 734 NARST isolates (97%) had decreased susceptibility to ciprofloxacin. The proportion of NARST increased from 19% in 1999 to 54% in 2006. Five ciprofloxacin-resistant isolates were identified. Patients with resistant infections were more likely to report travel to the Indian subcontinent: 85% of patients infected with MDRST and 94% with NARST traveled to the Indian subcontinent, while 44% of those with susceptible infections did (MDRST odds ratio, 7.5; 95% confidence interval, 4.1-13.8; NARST odds ratio, 20.4; 95% confidence interval, 12.4-33.9). Conclusion Infection with antimicrobial-resistant S Typhi strains among US patients with typhoid fever is associated with travel to the Indian subcontinent, and an increasing proportion of these infections are due to S Typhi strains with decreased susceptibility to fluoroquinolones. JAMA. 2009; 302(8): 859-865	[Lynch, Michael F.; Blanton, Elizabeth M.; Bulens, Sandra; Polyak, Christina; Vojdani, Jazmin; Stevenson, Jennifer; Medalla, Felicia; Barzilay, Ezra; Mintz, Eric Daniel] Ctr Dis Control & Prevent, Natl Ctr Zoonot Vectorborne & Enter Dis, Enter Dis Epidemiol Branch, Atlanta, GA 30341 USA; [Joyce, Kevin; Barrett, Timothy] Ctr Dis Control & Prevent, Natl Ctr Zoonot Vectorborne & Enter Dis, Enter Dis Lab Branch, Atlanta, GA 30341 USA; [Barrett, Timothy] Ctr Dis Control & Prevent, Natl Ctr Zoonot Vectorborne & Enter Dis, Div Foodborne Bacterial & Mycot Dis, Atlanta, GA 30341 USA; [Barrett, Timothy] Ctr Dis Control & Prevent, Natl Ctr Zoonot Vectorborne & Enter Dis, Off Chief Sci Officer, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Lynch, MF (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Zoonot Vectorborne & Enter Dis, Enter Dis Epidemiol Branch, 4770 Buford Hwy,MS F-22, Atlanta, GA 30341 USA.	mlynch1@cdc.gov		Duque, Jazmin/0000-0003-3484-276X				Ackers ML, 2000, JAMA-J AM MED ASSOC, V283, P2668, DOI 10.1001/jama.283.20.2668; [Anonymous], REV CHILENA INFECTOL; Atkins BL, 1998, JAMA-J AM MED ASSOC, V279, P579, DOI 10.1001/jama.279.8.579; AVASIA S, 2004, 53 ANN EP INT SERV C; Baggett HC, 2009, J TRAVEL MED, V16, P112, DOI 10.1111/j.1708-8305.2008.00284.x; Bhutta ZA, 1996, ARCH DIS CHILD, V75, P214, DOI 10.1136/adc.75.3.214; BUTLER T, 1985, REV INFECT DIS, V7, P244; *CLSI, 2006, M100S16 CLSI S; Crump JA, 2008, EPIDEMIOL INFECT, V136, P436, DOI 10.1017/S0950268807009338; Crump JA, 2003, CLIN INFECT DIS, V37, P75, DOI 10.1086/375602; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2008, ANTIMICROB AGENTS CH, V52, P1278, DOI 10.1128/AAC.01509-07; Cutler D, 2005, DEMOGRAPHY, V42, P1, DOI 10.1353/dem.2005.0002; Katz DJ, 2002, J INFECT DIS, V186, P234, DOI 10.1086/341208; McNabb Scott J N, 2008, MMWR Morb Mortal Wkly Rep, V55, P1; Mermin JH, 1998, ARCH INTERN MED, V158, P633, DOI 10.1001/archinte.158.6.633; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Rowe B, 1997, CLIN INFECT DIS, V24, pS106, DOI 10.1093/clinids/24.Supplement_1.S106; RYAN CA, 1989, REV INFECT DIS, V11, P1; Steinberg EB, 2004, CLIN INFECT DIS, V39, P186, DOI 10.1086/421945; THANAWALLA J. K., 1956, INDIAN JOUR PEDIATRICS, V23, P421; Threlfall EJ, 2008, EMERG INFECT DIS, V14, P860, DOI 10.3201/eid1405.071184; Threlfall EJ, 1999, LANCET, V353, P1590, DOI 10.1016/S0140-6736(99)01001-6; THRELFALL EJ, 1992, EUR J CLIN MICROBIOL, V11, P990, DOI 10.1007/BF01967788	25	126	134	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 26	2009	302	8					859	865		10.1001/jama.2009.1229	http://dx.doi.org/10.1001/jama.2009.1229			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487GN	19706859	Bronze			2022-12-24	WOS:000269260100019
J	Nanda, A; Chen, MH; Braccioforte, MH; Moran, BJ; D'Amico, AV				Nanda, Akash; Chen, Ming-Hui; Braccioforte, Michelle H.; Moran, Brian J.; D'Amico, Anthony V.			Hormonal Therapy Use for Prostate Cancer and Mortality in Men With Coronary Artery Disease-Induced Congestive Heart Failure or Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANDROGEN-DEPRIVATION THERAPY; EXTERNAL-BEAM RADIOTHERAPY; RADIATION-THERAPY; DEFINITIVE RADIOTHERAPY; CARDIOVASCULAR-DISEASE; BODY-COMPOSITION; SUPPRESSION; SURVIVAL; BRACHYTHERAPY; MANAGEMENT	Context Hormonal therapy (HT) when added to radiation therapy (RT) for treating unfavorable-risk prostate cancer leads to an increase in survival except possibly in men with moderate to severe comorbidity. However, it is unknown which comorbid conditions eliminate this survival benefit. Objective To assess whether neoadjuvant HT use affects the risk of all-cause mortality in men with prostate cancer and coronary artery disease (CAD)-induced congestive heart failure (CHF) or myocardial infarction (MI), CAD risk factors, or no comorbidity. Design, Setting, and Patients A total of 5077 men (median age, 69.5 years) with localized or locally advanced prostate cancer were consecutively treated with or without a median of 4 months of neoadjuvant HT followed by RT at a suburban cancer center between 1997 and 2006 and were followed up until July 1, 2008. Cox regression multivariable analyses were performed assessing whether neoadjuvant HT use affected the risk of all-cause mortality, adjusting for age, year and type of RT, treatment propensity score, and known prostate cancer prognostic factors in each comorbidity group. Main Outcome Measure Risk of all-cause mortality. Results Neoadjuvant HT use was not associated with an increased risk of all-cause mortality in men with no comorbidity (9.6% vs 6.7%, adjusted hazard ratio [HR], 0.97; 95% confidence interval [CI], 0.72-1.32; P=.86) or a single CAD risk factor (10.7% vs 7.0%, adjusted HR, 1.04; 95% CI, 0.75-1.43; P=.82) after median follow-ups of 5.0 and 4.4 years, respectively. However, for men with CAD-induced CHF or MI, after a median follow-up of 5.1 years, neoadjuvant HT use was significantly associated with an increased risk of all-cause mortality (26.3% vs 11.2%, adjusted HR, 1.96; 95% CI, 1.04-3.71; P=.04). Conclusion Neoadjuvant HT use is significantly associated with an increased risk of all-cause mortality among men with a history of CAD-induced CHF or MI but not among men with no comorbidity or a single CAD risk factor. JAMA. 2009; 302(8): 866-873	[Nanda, Akash] Brigham & Womens Hosp, Harvard Radiat Oncol Program, Dana Farber Canc Inst, Boston, MA 02115 USA; [D'Amico, Anthony V.] Brigham & Womens Hosp, Dept Radiat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Chen, Ming-Hui] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA; [Braccioforte, Michelle H.; Moran, Brian J.] Prostate Canc Fdn Chicago, Westmont, IL USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; University of Connecticut	Nanda, A (corresponding author), Brigham & Womens Hosp, Harvard Radiat Oncol Program, Dana Farber Canc Inst, 75 Francis St,ASB1 L2, Boston, MA 02115 USA.	ananda@partners.org						Agresti A, 2002, WILEY SERIES PROBABI; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; [Anonymous], 1979, Circulation, V59, P607; Ansell BJ, 1999, JAMA-J AM MED ASSOC, V282, P2051, DOI 10.1001/jama.282.21.2051; Beyer DC, 2005, INT J RADIAT ONCOL, V61, P1299, DOI 10.1016/j.ijrobp.2004.08.024; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; Braga-Basaria M, 2006, J CLIN ONCOL, V24, P3979, DOI 10.1200/JCO.2006.05.9741; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CUPPLES LA, 1995, STAT MED, V14, P1731, DOI 10.1002/sim.4780141603; D'Amico AV, 2008, JAMA-J AM MED ASSOC, V299, P289, DOI 10.1001/jama.299.3.289; D'Amico AV, 2007, J CLIN ONCOL, V25, P2420, DOI 10.1200/JCO.2006.09.3369; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; Denham JW, 2005, LANCET ONCOL, V6, P841, DOI 10.1016/S1470-2045(05)70348-X; Gavin JR, 1997, DIABETES CARE, V20, P1183; Genuth S, 2003, DIABETES CARE, V26, P3160; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hollander M, 1973, NONPARAMETRIC STAT M; Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; Klein JP, 2003, SURVIVAL ANAL; Lee H, 2005, CANCER-AM CANCER SOC, V104, P1633, DOI 10.1002/cncr.21381; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Merrick GS, 2006, INT J RADIAT ONCOL, V65, P669, DOI 10.1016/j.ijrobp.2006.01.030; Nag S, 1999, INT J RADIAT ONCOL, V44, P789, DOI 10.1016/S0360-3016(99)00069-3; Newgard CD, 2004, ACAD EMERG MED, V11, P953, DOI 10.1197/j.aem.2004.02.530; Piccirillo JF, 2004, JAMA-J AM MED ASSOC, V291, P2441, DOI 10.1001/jama.291.20.2441; Pilepich MV, 2001, INT J RADIAT ONCOL, V50, P1243, DOI 10.1016/S0360-3016(01)01579-6; Pilepich MV, 2005, INT J RADIAT ONCOL, V61, P1285, DOI 10.1016/j.ijrobp.2004.08.047; Potters L, 2000, J CLIN ONCOL, V18, P1187, DOI 10.1200/JCO.2000.18.6.1187; Sesso HD, 2001, CIRCULATION, V104, P393, DOI 10.1161/hc2901.093115; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Smith MR, 2008, UROLOGY, V71, P318, DOI 10.1016/j.urology.2007.08.035; Smith MR, 2002, J CLIN ENDOCR METAB, V87, P599, DOI 10.1210/jc.87.2.599; Stock RG, 2006, INT J RADIAT ONCOL, V64, P810, DOI 10.1016/j.ijrobp.2005.09.005; Sylvester JE, 2007, INT J RADIAT ONCOL, V67, P57, DOI 10.1016/j.ijrobp.2006.07.1382; Tsai HK, 2007, J NATL CANCER I, V99, P1516, DOI 10.1093/jnci/djm168; Walsh PC, 2007, NEW ENGL J MED, V357, P2696, DOI 10.1056/NEJMcp0706784; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zelefsky MJ, 2008, BRACHYTHERAPY, V7, P1, DOI 10.1016/j.brachy.2007.12.002; Zelefsky MJ, 2007, INT J RADIAT ONCOL, V67, P65, DOI 10.1016/j.ijrobp.2006.08.030; 1997, ARCH INTERN MED, V157, P2413	46	219	227	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 26	2009	302	8					866	873		10.1001/jama.2009.1137	http://dx.doi.org/10.1001/jama.2009.1137			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487GN	19706860	Bronze			2022-12-24	WOS:000269260100020
J	Moore, M; Yuen, HM; Dunn, N; Mullee, MA; Maskell, J; Kendrick, T				Moore, Michael; Yuen, Ho Ming; Dunn, Nick; Mullee, Mark A.; Maskell, Joe; Kendrick, Tony			Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; TRENDS; DEPRESSION; UK; PREVALENCE; GUIDELINES	Objective To explore the reasons behind the recent increase in antidepressant prescribing in the United Kingdom. Design Detailed retrospective analysis of data on general practitioner consultations and antidepressant prescribing. Data source Data were obtained from the general practice research database, which contains linked anonymised records of over 3 million patients registered in the UK. Data were extracted for all new incident cases of depression between 1993 and 2005. Review methods Detailed analysis of general practitioner consultations and antidepressant prescribing was restricted to 170 practices that were contributing data for the full duration of the study. Results In total, 189 851 people within the general practice research database experienced their first episode of depression between 1993 and 2005, of whom 150 825 (79.4%) received a prescription for antidepressants in the first year of diagnosis. This proportion remained stable across all the years examined. The incidence of new cases of depression rose in young women but fell slightly in other groups such that overall incidence increased then declined slightly (men: 7.83 cases per 1000 patient years in 1993 to 5.97 in 2005, women: 15.83 cases per 1000 patient years in 1993 to 10.06 in 2005). Antidepressant prescribing nearly doubled during the study period-the average number of prescriptions issued per patient increased from 2.8 in 1993 to 5.6 in 2004. The majority of antidepressant prescriptions were given as long term treatment or as intermittent treatment to patients with multiple episodes of depression. Conclusions The rise in antidepressant prescribing is mainly explained by small changes in the proportion of patients receiving long term treatment. Previous clinical guidelines have focused on antidepressant initiation and appropriate targeting of antidepressants. To address the costly rise in antidepressant prescribing, future research and guidance needs to concentrate on appropriate long term prescribing for depression and regular review of medication.	[Moore, Michael; Kendrick, Tony] Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England; [Dunn, Nick] Univ Southampton, Div Med Educ, Sch Med, Southampton SO16 7PX, Hants, England; [Yuen, Ho Ming; Mullee, Mark A.; Maskell, Joe] Univ Southampton, Southampton SO16 6YD, Hants, England	University of Southampton; University of Southampton; University of Southampton	Moore, M (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England.	mvm198@soton.ac.uk	Moore, Michael/C-3447-2011; Kendrick, Tony/H-8558-2014	Moore, Michael/0000-0002-5127-4509; Kendrick, Tony/0000-0003-1618-9381				Anderson IM, 2008, J PSYCHOPHARMACOL, V22, P343, DOI 10.1177/0269881107088441; Cruickshank Gillian, 2008, Ment Health Fam Med, V5, P105; Dunn RL, 1999, J PSYCHOPHARMACOL, V13, P136, DOI 10.1177/026988119901300204; Helgason T, 2004, BRIT J PSYCHIAT, V184, P157, DOI 10.1192/bjp.184.2.157; Hemels MEH, 2002, ANN PHARMACOTHER, V36, P1375, DOI 10.1345/aph.1A331; Hunot Vivien M, 2007, Prim Care Companion J Clin Psychiatry, V9, P91; Hyde J, 2005, BRIT J GEN PRACT, V55, P846; Hyde J, 2005, BRIT J GEN PRACT, V55, P755; Kendrick T, 2005, BRIT J GEN PRACT, V55, P280; KENDRICK T, 2009, BRIT MED J, V339, P750; Leydon GM, 2007, FAM PRACT, V24, P570, DOI 10.1093/fampra/cmm069; McManus P, 2000, MED J AUSTRALIA, V173, P458, DOI 10.5694/j.1326-5377.2000.tb139294.x; Middleton N, 2001, J PUBLIC HEALTH MED, V23, P262, DOI 10.1093/pubmed/23.4.262; Munoz-Arroyo R, 2006, BRIT J GEN PRACT, V56, P423; *NAT I CLIN EXC, 2004, CLIN GUID NAT I CLIN, V23; *NHS EMPL BMA, 2006, REV GMS CONTR 2006 7; Olfson M, 2002, JAMA-J AM MED ASSOC, V287, P203, DOI 10.1001/jama.287.2.203; Petty DR, 2006, AGE AGEING, V35, P523, DOI 10.1093/ageing/afl023; Pincus HA, 1998, JAMA-J AM MED ASSOC, V279, P526, DOI 10.1001/jama.279.7.526; *PRESCR PRIC AUTH, 2007, PRESCR REV DRUGS US; Raymond CB, 2007, PSYCHIAT SERV, V58, P79, DOI 10.1176/appi.ps.58.1.79-a; REID I, 2009, PRESCRIBER, V20, P18; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; 2006, PHARMAC, V24	24	170	170	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 15	2009	339								b3999	10.1136/bmj.b3999	http://dx.doi.org/10.1136/bmj.b3999			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508DQ	19833707	Green Accepted, Green Published, hybrid			2022-12-24	WOS:000270908300002
J	Wang, XQ; Tsai, JW; Imai, JH; Lian, WN; Vallee, RB; Shi, SH				Wang, Xiaoqun; Tsai, Jin-Wu; Imai, Janice H.; Lian, Wei-Nan; Vallee, Richard B.; Shi, Song-Hai			Asymmetric centrosome inheritance maintains neural progenitors in the neocortex	NATURE			English	Article							RADIAL GLIAL-CELLS; STEM-CELL; NEURONAL MIGRATION; SPINDLE ORIENTATION; CORTICAL-NEURONS; DIVISION; CYCLE; CENTRIOLES; MOTHER; NINEIN	Asymmetric divisions of radial glia progenitors produce self-renewing radial glia and differentiating cells simultaneously in the ventricular zone (VZ) of the developing neocortex. Whereas differentiating cells leave the VZ to constitute the future neocortex, renewing radial glia progenitors stay in the VZ for subsequent divisions. The differential behaviour of progenitors and their differentiating progeny is essential for neocortical development; however, the mechanisms that ensure these behavioural differences are unclear. Here we show that asymmetric centrosome inheritance regulates the differential behaviour of renewing progenitors and their differentiating progeny in the embryonic mouse neocortex. Centrosome duplication in dividing radial glia progenitors generates a pair of centrosomes with differently aged mother centrioles. During peak phases of neurogenesis, the centrosome retaining the old mother centriole stays in the VZ and is preferentially inherited by radial glia progenitors, whereas the centrosome containing the new mother centriole mostly leaves the VZ and is largely associated with differentiating cells. Removal of ninein, a mature centriole-specific protein, disrupts the asymmetric segregation and inheritance of the centrosome and causes premature depletion of progenitors from the VZ. These results indicate that preferential inheritance of the centrosome with the mature older mother centriole is required for maintaining radial glia progenitors in the developing mammalian neocortex.	[Wang, Xiaoqun; Imai, Janice H.; Shi, Song-Hai] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10021 USA; [Tsai, Jin-Wu; Lian, Wei-Nan; Vallee, Richard B.] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Tsai, Jin-Wu; Lian, Wei-Nan; Vallee, Richard B.] Columbia Univ, Dept Cell Biol, New York, NY 10032 USA; [Imai, Janice H.; Shi, Song-Hai] Weill Cornell Med Coll, BCMB Allied Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Columbia University; Columbia University; Cornell University	Shi, SH (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA.	shis@mskcc.org		Tsai, Jin-Wu/0000-0003-0135-759X	March of Dimes Birth Defects Foundation; Whitehall Foundation; Dana Foundation; Autism Speaks Foundation; Klingenstein Foundation; NARSAD; NIH; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024681] Funding Source: NIH RePORTER	March of Dimes Birth Defects Foundation(March of Dimes); Whitehall Foundation; Dana Foundation; Autism Speaks Foundation; Klingenstein Foundation(Klingenstein Philanthropies); NARSAD(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. Hall, A. L. Joyner, K. V. Anderson, J. Kaltschmidt, B. M. Tsou, Y. Chin and L. A. McDowell for comments on the manuscript; members of the Shi laboratory for discussions; A. K. Hadjantonakis for human centrin 1 cDNA; M. Bornens for EGFP-Nin (mouse) and Nin truncation mutant plasmids; Y.-R. Hong for EGFP-Nin (human) plasmid; A. Miyawaki for pCS21-Kaede plasmid; and H. Zhong, K. Svoboda and R. Tsien for DsRedexpress and mPlum cDNA constructs. Wethank C. T. Anderson and T. Stearns for sharing unpublished data. This work is supported by grants from March of Dimes Birth Defects Foundation, Whitehall Foundation, Dana Foundation, Autism Speaks Foundation, Klingenstein Foundation, NARSAD (to S.-H. S.) and NIH (to S.-H. S. and R. B. V.).	Anderson CT, 2009, CURR BIOL, V19, P1498, DOI 10.1016/j.cub.2009.07.034; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Bornens M, 2002, CURR BIOL, V12, pR71, DOI 10.1016/S0960-9822(01)00678-9; BoucksonCastaing V, 1996, J CELL SCI, V109, P179; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Cabernard C, 2007, CURR BIOL, V17, pR465, DOI 10.1016/j.cub.2007.04.016; Cai L, 1997, J NEUROSCI, V17, P2079; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Chretien D, 1997, J STRUCT BIOL, V120, P117, DOI 10.1006/jsbi.1997.3928; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; Delattre M, 2004, J CELL SCI, V117, P1619, DOI 10.1242/jcs.01128; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Fuentealba LC, 2008, P NATL ACAD SCI USA, V105, P7732, DOI 10.1073/pnas.0803027105; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; HINDS JW, 1971, Z ZELLFORSCH MIK ANA, V115, P226, DOI 10.1007/BF00391127; Lambert JD, 2002, NATURE, V420, P682, DOI 10.1038/nature01241; LANGE BMH, 1995, J CELL BIOL, V130, P919, DOI 10.1083/jcb.130.4.919; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mogensen MM, 2000, J CELL SCI, V113, P3013; Nakagawa Y, 2001, MOL BIOL CELL, V12, P1687, DOI 10.1091/mbc.12.6.1687; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Ou YY, 2002, J CELL SCI, V115, P1825; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Preble AM, 2000, CURR TOP DEV BIOL, V49, P207; Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244; Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021; Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Spradling AC, 2007, SCIENCE, V315, P469, DOI 10.1126/science.1138237; Stevens NR, 2007, CURR BIOL, V17, P1498, DOI 10.1016/j.cub.2007.07.060; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; Wigley WC, 1999, J CELL BIOL, V145, P481; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Yamashita YM, 2008, J CELL BIOL, V180, P261, DOI 10.1083/jcb.200707083; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910	50	324	328	3	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					947	U206		10.1038/nature08435	http://dx.doi.org/10.1038/nature08435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829375	Green Accepted			2022-12-24	WOS:000270817700040
J	Wright, SW				Wright, Scott W.			Oh, to Live in an Age When Men Had Breasts ...	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												swright@faegre.com						American Cancer Society, BREAST CANC FACTS FI; Contractor KB, 2008, WORLD J SURG ONCOL, V6, DOI 10.1186/1477-7819-6-58; Giordano SH, 2004, CANCER, V101, P51, DOI 10.1002/cncr.20312	3	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 14	2009	302	14					1511	1512		10.1001/jama.2009.1402	http://dx.doi.org/10.1001/jama.2009.1402			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505UA	19826013				2022-12-24	WOS:000270721800001
J	Chan, CM; Zhou, C; Huang, RH				Chan, Chio Mui; Zhou, Chun; Huang, Raven H.			Reconstituting Bacterial RNA Repair and Modification in Vitro	SCIENCE			English	Article							PLANT MICRORNA BIOGENESIS; CYTOTOXIC RIBONUCLEASE; METHYLTRANSFERASE; GERMLINE; ENZYME; HEN1		[Chan, Chio Mui; Zhou, Chun; Huang, Raven H.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Huang, Raven H.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Huang, RH (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	huang@uiuc.edu		zhou, chun/0000-0002-9257-468X	NSF [MCB-0920966]	NSF(National Science Foundation (NSF))	We thank C. Wraight, D. Shapiro, and C. Vanderpool for critical reading of the manuscript; T. Thiel (University of Missouri St. Louis) and C. Hayes (University of California Santa Barbara) for materials; and X. Chen (University of California Riverside) for inspiration. Supported by NSF grant MCB-0920966.	Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Keppetipola N, 2007, NUCLEIC ACIDS RES, V35, P3624, DOI 10.1093/nar/gkm110; Martins A, 2005, RNA, V11, P1271, DOI 10.1261/rna.2690505; Ogawa T, 1999, SCIENCE, V283, P2097, DOI 10.1126/science.283.5410.2097; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Tkaczuk KL, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-6; Tomita K, 2000, P NATL ACAD SCI USA, V97, P8278, DOI 10.1073/pnas.140213797; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130	9	51	52	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					247	247		10.1126/science.1179480	http://dx.doi.org/10.1126/science.1179480			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815768				2022-12-24	WOS:000270599500032
J	Bray, PS; Anderson, KB				Bray, P. Sargent; Anderson, Ken B.			Identification of Carboniferous (320 Million Years Old) Class Ic Amber	SCIENCE			English	Article							NATURAL RESINS; GEOSPHERE; PYROLYSIS; CONIFERS; FATE; COAL	The presence of amber, the fossil form of the resins produced by many types of higher plants, has been reported from many localities in Mesozoic and Cenozoic rocks. We have found Class I (polylabdanoid) amber in Carboniferous sediments dating to similar to 320 million years ago. This result demonstrates that preconifer gymnosperms evolved the biosynthetic mechanisms to produce complex polyterpenoid resins earlier than previously believed and that the biosynthetic pathways leading to the types of polylabdanoid resins that are now typically found in conifers and those now typically found in angiosperms had already diverged by the Carboniferous.	[Bray, P. Sargent; Anderson, Ken B.] So Illinois Univ, Dept Geol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Anderson, KB (corresponding author), So Illinois Univ, Dept Geol, Carbondale, IL 62901 USA.	kanderson@geo.siu.edu						Anderson KB, 1995, ACS SYM SER, V617, P105; Anderson KB, 2006, GEOCHEM T, V7, P1, DOI 10.1186/1467-4866-7-2; ANDERSON KB, 1991, ANAL CHEM, V63, P2901, DOI 10.1021/ac00024a019; Bray PS, 2008, GEOCHEM T, V9, DOI 10.1186/1467-4866-9-3; Crelling JC, 1998, INT J COAL GEOL, V37, P55, DOI 10.1016/S0166-5162(98)00021-4; Jehlicka J, 2004, J RAMAN SPECTROSC, V35, P761, DOI 10.1002/jrs.1191; Langenheim J.H., 2003, PLANT RESINS; MURCHISON DG, 1966, ADV CHEM SER, V55, P307; NIP M, 1992, ENERG FUEL, V6, P125, DOI 10.1021/ef00032a003; Otto A, 2001, BOT REV, V67, P141, DOI 10.1007/BF02858076; POINAR GO, 1993, SCIENCE, V259, P222, DOI 10.1126/science.259.5092.222; Trapp S, 2001, ANNU REV PLANT PHYS, V52, P689, DOI 10.1146/annurev.arplant.52.1.689; vanBergen PF, 1995, ACS SYM SER, V617, P149	13	70	77	4	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					132	134		10.1126/science.1177539	http://dx.doi.org/10.1126/science.1177539			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797659				2022-12-24	WOS:000270355600052
J	Stark, JR; Mucci, L; Rothman, KJ; Adami, HO				Stark, Jennifer R.; Mucci, Lorelei; Rothman, Kenneth J.; Adami, Hans-Olov			Screening for prostate cancer remains controversial	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SOJOURN TIME; MORTALITY; ANTIGEN; TRENDS; OVERDIAGNOSIS; MEN		[Mucci, Lorelei; Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Mucci, Lorelei] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab,Dept Med, Boston, MA 02115 USA; [Rothman, Kenneth J.] Res Triangle Inst, RTI Hlth Solut, Res Triangle Pk, NC 27709 USA; [Rothman, Kenneth J.] Boston Univ, Med Ctr, Dept Epidemiol, Boston, MA USA; [Rothman, Kenneth J.] Boston Univ, Med Ctr, Dept Med, Boston, MA USA; [Mucci, Lorelei; Adami, Hans-Olov] Dana Farber Harvard Canc Ctr, Boston, MA USA; [Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Research Triangle Institute; Boston University; Boston University; Harvard University; Dana-Farber Cancer Institute; Karolinska Institutet		stark@hsph.harvard.edu	Rider, Jennifer/T-1272-2019; Rider, Jennifer/A-5371-2011	Rider, Jennifer/0000-0002-2637-6036; Rothman, Kenneth/0000-0003-2398-1705				Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; *AM UR ASS, 2009, EARL DET PROST CANC; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; Collin SM, 2008, LANCET ONCOL, V9, P445, DOI 10.1016/S1470-2045(08)70104-9; DeFrances CJ, 2008, 2006 NATL HOSP DISCH; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Farwell WR, 2007, ARCH INTERN MED, V167, P2497, DOI 10.1001/archinte.167.22.2497; Federman D G, 1999, Eff Clin Pract, V2, P152; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; Hussain S, 2008, BJU INT, V101, P547, DOI 10.1111/j.1464-410X.2007.07338.x; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; Kvale R, 2007, JNCI-J NATL CANCER I, V99, P1881, DOI 10.1093/jnci/djm249; Lamplugh M, 2006, ANN ROY COLL SURG, V88, P284, DOI 10.1308/003588406X98685; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pashayan N, 2009, BRIT J CANCER, V100, P1198, DOI 10.1038/sj.bjc.6604973; SAKR WA, 1994, IN VIVO, V8, P439; Scales CD, 2008, CANCER-AM CANCER SOC, V113, P1315, DOI 10.1002/cncr.23667; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Shen Y, 2001, J CLIN ONCOL, V19, P3490, DOI 10.1200/JCO.2001.19.15.3490; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66; Wilt TJ, 2008, ANN INTERN MED, V148, P435, DOI 10.7326/0003-4819-148-6-200803180-00209	22	33	34	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2009	339								b3601	10.1136/bmj.b3601	http://dx.doi.org/10.1136/bmj.b3601			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	499OG	19778971				2022-12-24	WOS:000270231800004
J	Sansonetti, PJ; Medzhitov, R				Sansonetti, Philippe J.; Medzhitov, Ruslan			Learning Tolerance while Fighting Ignorance	CELL			English	Article							INTESTINAL IMMUNE HOMEOSTASIS; NF-KAPPA-B; EPITHELIAL-CELLS; INNATE IMMUNITY; GENE-EXPRESSION; INFLAMMATION; GUT; DISEASE; MICROBIOTA; BACTERIA	Research on microbe-host interactions focuses principally on pathogens, yet our immune system must deal with the huge number of beneficial commensal bacteria in our gut. It is becoming clear that the host immune system must reach a delicate balance between destroying dangerous bacterial pathogens while preserving the beneficial gut microbiota.	[Sansonetti, Philippe J.] Inst Pasteur, Unite Pathogenie Microbienne Mol, F-75724 Paris 15, France; [Sansonetti, Philippe J.] Coll France, F-75231 Paris 05, France; [Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Medzhitov, Ruslan] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06510 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; College de France; Howard Hughes Medical Institute; Yale University; Yale University	Sansonetti, PJ (corresponding author), Inst Pasteur, Unite Pathogenie Microbienne Mol, F-75724 Paris 15, France.	psanson@pasteur.fr			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	P.J.S. is a foreign scholar of the Howard Hughes Medical Institute. The authors thank members of their respective groups for invaluable discussions.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Arseneau Kristen O, 2007, Curr Gastroenterol Rep, V9, P508, DOI 10.1007/s11894-007-0067-3; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; Coats SR, 2007, CELL MICROBIOL, V9, P1191, DOI 10.1111/j.1462-5822.2006.00859.x; Collier-Hyams LS, 2005, J IMMUNOL, V175, P4194, DOI 10.4049/jimmunol.175.7.4194; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Fujiya M, 2007, CELL HOST MICROBE, V1, P299, DOI 10.1016/j.chom.2007.05.004; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Hoffmann JC, 2002, PATHOBIOLOGY, V70, P121, DOI 10.1159/000068143; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kravchenko VV, 2008, SCIENCE, V321, P259, DOI 10.1126/science.1156499; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Moal VLL, 2006, CLIN MICROBIOL REV, V19, P315, DOI 10.1128/CMR.19.2.315-337.2006; Munford RS, 2006, PLOS PATHOG, V2, P467, DOI 10.1371/journal.ppat.0020067; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nuding S, 2007, GUT, V56, P1240, DOI 10.1136/gut.2006.118646; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Sperandio B, 2008, J EXP MED, V205, P1121, DOI 10.1084/jem.20071698; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Swidsinski A, 2005, WORLD J GASTROENTERO, V11, P1131, DOI 10.3748/wjg.v11.i8.1131; Tien MT, 2006, J IMMUNOL, V176, P1228, DOI 10.4049/jimmunol.176.2.1228; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590	33	108	116	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					416	420		10.1016/j.cell.2009.07.024	http://dx.doi.org/10.1016/j.cell.2009.07.024			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665961	Bronze			2022-12-24	WOS:000268771900003
J	Hancock, K; Veguilla, V; Lu, XH; Zhong, WM; Butler, EN; Sun, H; Liu, F; Dong, LB; DeVos, JR; Gargiullo, PM; Brammer, TL; Cox, NJ; Tumpey, TM; Katz, JM				Hancock, Kathy; Veguilla, Vic; Lu, Xiuhua; Zhong, Weimin; Butler, Ebonee N.; Sun, Hong; Liu, Feng; Dong, Libo; DeVos, Joshua R.; Gargiullo, Paul M.; Brammer, T. Lynnette; Cox, Nancy J.; Tumpey, Terrence M.; Katz, Jacqueline M.			Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEUTRALIZING ANTIBODIES; VACCINE; IMMUNITY; HUMANS; ORIGIN; H5N1; VOLUNTEERS; INFECTION; SERUM; AGE	Background: A new pandemic influenza A (H1N1) virus has emerged, causing illness globally, primarily in younger age groups. To assess the level of preexisting immunity in humans and to evaluate seasonal vaccine strategies, we measured the antibody response to the pandemic virus resulting from previous influenza infection or vaccination in different age groups. Methods: Using a microneutralization assay, we measured cross-reactive antibodies to pandemic H1N1 virus (2009 H1N1) in stored serum samples from persons who either donated blood or were vaccinated with recent seasonal or 1976 swine influenza vaccines. Results: A total of 4 of 107 persons (4%) who were born after 1980 had preexisting cross-reactive antibody titers of 40 or more against 2009 H1N1, whereas 39 of 115 persons (34%) born before 1950 had titers of 80 or more. Vaccination with seasonal trivalent inactivated influenza vaccines resulted in an increase in the level of cross-reactive antibody to 2009 H1N1 by a factor of four or more in none of 55 children between the ages of 6 months and 9 years, in 12 to 22% of 231 adults between the ages of 18 and 64 years, and in 5% or less of 113 adults 60 years of age or older. Seasonal vaccines that were formulated with adjuvant did not further enhance cross-reactive antibody responses. Vaccination with the A/New Jersey/1976 swine influenza vaccine substantially boosted cross-reactive antibodies to 2009 H1N1 in adults. Conclusions: Vaccination with recent seasonal nonadjuvanted or adjuvanted influenza vaccines induced little or no cross-reactive antibody response to 2009 H1N1 in any age group. Persons under the age of 30 years had little evidence of cross-reactive antibodies to the pandemic virus. However, a proportion of older adults had preexisting cross-reactive antibodies. N Engl J Med 2009;361:1945-52.	[DeVos, Joshua R.] Ctr Dis Control & Prevent, Div Global AIDS, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Hancock, Kathy; Veguilla, Vic; Lu, Xiuhua; Zhong, Weimin; Butler, Ebonee N.; Sun, Hong; Liu, Feng; Dong, Libo; Gargiullo, Paul M.; Brammer, T. Lynnette; Cox, Nancy J.; Tumpey, Terrence M.; Katz, Jacqueline M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Katz, JM (corresponding author), CDC, Influenza Div, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd, Atlanta, GA 30333 USA.	jkatz@cdc.gov			GlaxoSmithKline; Juvaris BioTherapeutics	GlaxoSmithKline(GlaxoSmithKline); Juvaris BioTherapeutics	Dr. Hancock reports receiving research support from GlaxoSmithKline and Juvaris BioTherapeutics; Dr. Lu, research support from Juvaris BioTherapeutics; and Dr. Katz, research support from GlaxoSmithKline. No other conflict of interest relevant to this article was reported.	CUNEOCROVARI P, 1976, B I SIEROTER MILAN, V55, P463; DAVENPORT FM, 1953, J EXP MED, V98, P641, DOI 10.1084/jem.98.6.641; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Dowdle Walter R., 1997, Journal of Infectious Diseases, V176, pS69, DOI 10.1086/514180; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kendal AP, 1982, CONCEPTS PROCEDURES; Leroux-Roels I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001665; MARINE WM, 1973, POSTGRAD MED J, V49, P164, DOI 10.1136/pgmj.49.569.164; MASSICOT J, 1977, J INFECT DIS, V136, pS472, DOI 10.1093/infdis/136.Supplement_3.S472; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Newman AP, 2008, EMERG INFECT DIS, V14, P1470, DOI 10.3201/eid1409.080305; *NOV SWIN OR INFL, 2009, NEW ENGL J MED, V361, P102; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Rimmelzwaan GF, 2008, VACCINE, V26, pD41, DOI 10.1016/j.vaccine.2008.07.043; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06; Sencer DJ, 2006, EMERG INFECT DIS, V12, P29; Shinde V, 2009, NEW ENGL J MED, V361, P102; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Shope RE, 1936, J EXP MED, V63, P669, DOI 10.1084/jem.63.5.669; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948; Stephenson I, 2008, NEW ENGL J MED, V359, P1631, DOI 10.1056/NEJMc0805274; Taubenberger JK, 2001, PHILOS T ROY SOC B, V356, P1829, DOI 10.1098/rstb.2001.1020; Tumpey TM, 2004, P NATL ACAD SCI USA, V101, P3166, DOI 10.1073/pnas.0308391100; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; 2009, MMWR MORB MORTAL WKL, V58, P521	29	1009	1057	3	104	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2009	361	20					1945	1952		10.1056/NEJMoa0906453	http://dx.doi.org/10.1056/NEJMoa0906453			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518AI	19745214				2022-12-24	WOS:000271660500008
J	Gao, YG; Selmer, M; Dunham, CM; Weixlbaumer, A; Kelley, AC; Ramakrishnan, V				Gao, Yong-Gui; Selmer, Maria; Dunham, Christine M.; Weixlbaumer, Albert; Kelley, Ann C.; Ramakrishnan, V.			The Structure of the Ribosome with Elongation Factor G Trapped in the Posttranslocational State	SCIENCE			English	Article							LARGE CONFORMATIONAL-CHANGES; ACID-BINDING SITE; FUSIDIC ACID; TRANSFER-RNA; 70S RIBOSOME; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; EF-G; GTPASE ACTIVATION; MESSENGER-RNA	Elongation factor G (EF-G) is a guanosine triphosphatase (GTPase) that plays a crucial role in the translocation of transfer RNAs (tRNAs) and messenger RNA (mRNA) during translation by the ribosome. We report a crystal structure refined to 3.6 angstrom resolution of the ribosome trapped with EF-G in the posttranslocational state using the antibiotic fusidic acid. Fusidic acid traps EF-G in a conformation intermediate between the guanosine triphosphate and guanosine diphosphate forms. The interaction of EF-G with ribosomal elements implicated in stimulating catalysis, such as the L10-L12 stalk and the L11 region, and of domain IV of EF-G with the tRNA at the peptidyl-tRNA binding site (P site) and with mRNA shed light on the role of these elements in EF-G function. The stabilization of the mobile stalks of the ribosome also results in a more complete description of its structure.	[Gao, Yong-Gui; Selmer, Maria; Dunham, Christine M.; Weixlbaumer, Albert; Kelley, Ann C.; Ramakrishnan, V.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk	Gao, Yong Gui/A-2187-2011; Gao, Yonggui/A-9473-2015; Weixlbaumer, Albert/P-3587-2016; Weixlbaumer, Albert/AAI-8474-2021	Gao, Yonggui/0000-0001-7298-0835; Weixlbaumer, Albert/0000-0001-9635-3844; Weixlbaumer, Albert/0000-0001-9635-3844; Ramakrishnan, V/0000-0002-4699-2194; Selmer, Maria/0000-0001-9079-2774	U.K. Medical Research Council; Wellcome Trust; Agouron Institute; Louis-Jeantet Foundation; MRC [MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_U105184332] Funding Source: researchfish	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Louis-Jeantet Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C. Schulze-Briese, M. Fuchs, and M. Wang for help with data collection at the Swiss Light Source; J. Frank for coordinates of the ratcheted ribosome obtained from modeling into cryo-EM maps; J. Hentschel for help with crystallization trials; M. Schmeing and R. Voorhees for help with data collection, making figures, and critical feedback; and C. Neubauer and L. Ng for useful discussions. V. R. was supported by the U. K. Medical Research Council, a Wellcome Trust program grant, and awards from the Agouron Institute and the Louis-Jeantet Foundation. Coordinates for the structure have been deposited in the Protein Data Bank as four split entries with codes 2wri, 2wrj, 2wrk, and 2wrl.	AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Al-Karadaghi S, 1996, STRUCTURE, V4, P555, DOI 10.1016/S0969-2126(96)00061-5; BODLEY JW, 1970, J BIOL CHEM, V245, P5662; Cameron DM, 2004, J BACTERIOL, V186, P5819, DOI 10.1128/JB.186.17.5819-5825.2004; Cameron DM, 2002, J MOL BIOL, V319, P27, DOI 10.1016/S0022-2836(02)00235-8; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Datta PP, 2005, MOL CELL, V20, P723, DOI 10.1016/j.molcel.2005.10.028; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Ermolenko DN, 2007, NAT STRUCT MOL BIOL, V14, P493, DOI 10.1038/nsmb1243; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Hansson S, 2005, J MOL BIOL, V348, P939, DOI 10.1016/j.jmb.2005.02.066; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; JOHANSON U, 1994, GENE, V143, P55, DOI 10.1016/0378-1119(94)90604-1; Jorgensen R, 2003, NAT STRUCT BIOL, V10, P379, DOI 10.1038/nsb923; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; Martemyanov KA, 2000, J BIOL CHEM, V275, P35820, DOI 10.1074/jbc.M002656200; Martemyanov KA, 1998, FEBS LETT, V434, P205, DOI 10.1016/S0014-5793(98)00982-X; Martemyanov KA, 2001, J BIOL CHEM, V276, P28774, DOI 10.1074/jbc.M102023200; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; MURRAY IA, 1995, J MOL BIOL, V254, P993, DOI 10.1006/jmbi.1995.0671; Nagaev I, 2001, MOL MICROBIOL, V40, P433, DOI 10.1046/j.1365-2958.2001.02389.x; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pan DL, 2007, MOL CELL, V25, P519, DOI 10.1016/j.molcel.2007.01.014; Peske F, 2004, J MOL BIOL, V343, P1183, DOI 10.1016/j.jmb.2004.08.097; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Rodnina MV, 1999, P NATL ACAD SCI USA, V96, P9586, DOI 10.1073/pnas.96.17.9586; Savelsbergh A, 2000, J MOL BIOL, V300, P951, DOI 10.1006/jmbi.2000.3886; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; SCHMEING TM, 2009, SCIENCE         1015, DOI DOI 10.1126/SCIENCE.1179700; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Seo HS, 2006, BIOCHEMISTRY-US, V45, P2504, DOI 10.1021/bi0516677; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Vogeley L, 2001, J BIOL CHEM, V276, P17149, DOI 10.1074/jbc.M100017200; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Zunszain PA, 2008, J MOL BIOL, V381, P394, DOI 10.1016/j.jmb.2008.06.016	46	376	384	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					694	699		10.1126/science.1179709	http://dx.doi.org/10.1126/science.1179709			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19833919	Green Accepted			2022-12-24	WOS:000271233200028
J	Brownell, KD; Farley, T; Willett, WC; Popkin, BM; Chaloupka, FJ; Thompson, JW; Ludwig, DS				Brownell, Kelly D.; Farley, Thomas; Willett, Walter C.; Popkin, Barry M.; Chaloupka, Frank J.; Thompson, Joseph W.; Ludwig, David S.			The Public Health and Economic Benefits of Taxing Sugar-Sweetened Beverages	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SOFT DRINK CONSUMPTION; ENERGY-INTAKE; WEIGHT-GAIN; FOOD-INTAKE; CHILDHOOD OBESITY; BODY-WEIGHT; ADOLESCENTS; TAXES; PREVENTION; APPETITE		[Brownell, Kelly D.] Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT 06520 USA; [Farley, Thomas] Dept Hlth & Mental Hyg, New York, NY USA; [Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ludwig, David S.] Childrens Hosp, Optimal Weight Life Program, Boston, MA 02115 USA; [Ludwig, David S.] Harvard Univ, Sch Med, Boston, MA USA; [Popkin, Barry M.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Popkin, Barry M.] Univ N Carolina, Interdisciplinary Obes Ctr, Chapel Hill, NC USA; [Chaloupka, Frank J.] Univ Illinois, Dept Econ, Chicago, IL 60680 USA; [Chaloupka, Frank J.] Univ Illinois, Ctr Hlth Policy, Chicago, IL 60680 USA; [Thompson, Joseph W.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Thompson, Joseph W.] Surgeon Generals Off, Little Rock, AR USA	Yale University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Arkansas System; University of Arkansas Medical Sciences	Brownell, KD (corresponding author), Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT 06520 USA.		Popkin, Barry/T-6633-2019	Ludwig, David/0000-0003-3307-8544; popkin, barry/0000-0001-9495-9324	NCI NIH HHS [R01 CA121152-05, R01 CA121152, R01-CA121152] Funding Source: Medline; NIDDK NIH HHS [P30 DK040561-14, P30 DK040561] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA121152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albala C, 2008, AM J CLIN NUTR, V88, P605, DOI 10.1093/ajcn/88.3.605; ANDREYEVA T, AM J PUBLIC IN PRESS; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Barquera S, 2008, J NUTR, V138, P2454, DOI 10.3945/jn.108.092163; Brownell K. D., 1994, NY TIMES, pA29; Brownell KD, 2005, J HEALTH POLIT POLIC, V30, P955, DOI 10.1215/03616878-30-5-955; Brownell KD, 2009, NEW ENGL J MED, V360, P1805, DOI 10.1056/NEJMp0902392; Brownell KD, 2009, MILBANK Q, V87, P259, DOI 10.1111/j.1468-0009.2009.00555.x; Cawley J, 2004, AM J PREV MED, V27, P117, DOI 10.1016/j.amepre.2004.06.012; CHALOUPKA FJ, CIGARETTE E IN PRESS; DECASTRO JM, 1993, PHYSIOL BEHAV, V53, P1133, DOI 10.1016/0031-9384(93)90370-U; Duffey KJ, 2007, OBESITY, V15, P2739, DOI 10.1038/oby.2007.326; Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Flood JE, 2006, J AM DIET ASSOC, V106, P1984, DOI 10.1016/j.jada.2006.09.005; Forshee RA, 2009, AM J CLIN NUTR, V89, P441, DOI 10.3945/ajcn.2008.27217; Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140; HAKIM D, 2009, NY TIMES        0301; Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6; Jacobson MF, 2000, AM J PUBLIC HEALTH, V90, P854, DOI 10.2105/AJPH.90.6.854; James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE; James J, 2004, BRIT MED J, V328, P1236; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2009, AM J CLIN NUTR, V89, P438, DOI 10.3945/ajcn.2008.26980; Mattes RD, 2009, AM J CLIN NUTR, V89, P1, DOI 10.3945/ajcn.2008.26792; Montonen J, 2007, J NUTR, V137, P1447, DOI 10.1093/jn/137.6.1447; Mourao DM, 2007, INT J OBESITY, V31, P1688, DOI 10.1038/sj.ijo.0803667; Palmer JR, 2008, ARCH INTERN MED, V168, P1487, DOI 10.1001/archinte.168.14.1487; Powell LM, 2009, MILBANK Q, V87, P229, DOI 10.1111/j.1468-0009.2009.00554.x; Raben A, 2002, AM J CLIN NUTR, V76, P721, DOI 10.1093/ajcn/76.4.721; *RUDD CTR FOOD POL, REV CALC SOFT DRINK; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Sichieri R, 2009, PUBLIC HEALTH NUTR, V12, P197, DOI 10.1017/S1368980008002644; TORDOFF MG, 1990, AM J CLIN NUTR, V51, P963, DOI 10.1093/ajcn/51.6.963; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Yoshida M, 2007, J NUTR, V137, P2121, DOI 10.1093/jn/137.9.2121	39	479	489	4	162	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2009	361	16					1599	1605		10.1056/NEJMhpr0905723	http://dx.doi.org/10.1056/NEJMhpr0905723			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	506LT	19759377	Green Accepted, Green Published			2022-12-24	WOS:000270777000017
J	Rothschild, JM; Keohane, CA; Rogers, S; Gardner, R; Lipsitz, SR; Salzberg, CA; Yu, T; Yoon, CS; Williams, DH; Wien, MF; Czeisler, CA; Bates, DW; Landrigan, CP				Rothschild, Jeffrey M.; Keohane, Carol A.; Rogers, Selwyn; Gardner, Roxane; Lipsitz, Stuart R.; Salzberg, Claudia A.; Yu, Tony; Yoon, Catherine S.; Williams, Deborah H.; Wien, Matt F.; Czeisler, Charles A.; Bates, David W.; Landrigan, Christopher P.			Risks of Complications by Attending Physicians After Performing Nighttime Procedures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PATIENT SAFETY; WORK HOURS; CARE; IMPACT; RESIDENTS; EDUCATION; SURGEONS; QUALITY; EVENTS; ERRORS	Context Few data exist on the relationships between experienced physicians' work hours and sleep, and patient safety. Objective To determine if sleep opportunities for attending surgeons and obstetricians/gynecologists are associated with the risk of complications. Design, Setting, and Patients Matched retrospective cohort study of procedures performed from January 1999 through June 2008 by attending physicians (86 surgeons and 134 obstetricians/gynecologists) who had been in the hospital performing another procedure involving adult patients for at least part of the preceding night (12 AM-6 AM, postnighttime procedures). Sleep opportunity was calculated as the time between end of the overnight procedure and start of the first procedure the following day. Matched control procedures included as many as 5 procedures of the same type performed by the same physician on days without preceding overnight procedures. Complications were identified and classified by a blinded 3-step process that included administrative screening, medical record reviews, and clinician ratings. Main Outcome Measures Rates of complications in postnighttime procedures as compared with controls; rates of complications in postnighttime procedures among physicians with more than 6-hour sleep opportunities vs those with sleep opportunities of 6 hours or less. Results A total of 919 surgical and 957 obstetrical postnighttime procedures were matched with 3552 and 3945 control procedures, respectively. Complications occurred in 101 postnighttime procedures (5.4%) and 365 control procedures (4.9%) (odds ratio, 1.09; 95% confidence interval [CI], 0.84-1.41). Complications occurred in 82 of 1317 postnighttime procedures with sleep opportunities of 6 hours or less (6.2%) vs 19 of 559 postnighttime procedures with sleep opportunities of more than 6 hours (3.4%) (odds ratio, 1.72; 95% CI, 1.02-2.89). Postnighttime procedures completed after working more than than 12 hours (n=958) compared with 12 hours or less (n=918) had nonsignificantly higher complication rates (6.5% vs 4.3%; odds ratio, 1.47; 95% CI, 0.96-2.27). Conclusion Overall, procedures performed the day after attending physicians worked overnight were not associated with significantly increased complication rates, although there was an increased rate of complications among postnighttime surgical procedures performed by physicians with sleep opportunities of less than 6 hours. JAMA. 2009; 302(14): 1565-1572	[Rothschild, Jeffrey M.; Keohane, Carol A.; Lipsitz, Stuart R.; Salzberg, Claudia A.; Yu, Tony; Yoon, Catherine S.; Williams, Deborah H.; Wien, Matt F.; Bates, David W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gen Med & Primary Care, Boston, MA 02115 USA; [Czeisler, Charles A.; Landrigan, Christopher P.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Sleep Med, Boston, MA 02115 USA; [Rogers, Selwyn] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA; [Gardner, Roxane] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Obstet & Gynecol, Boston, MA 02115 USA; [Lipsitz, Stuart R.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Landrigan, Christopher P.] Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital	Rothschild, JM (corresponding author), Brigham & Womens Hosp, Div Gen Med, 1620 Tremont St, Boston, MA 02120 USA.	jrothschild@partners.org	Bates, David/AAE-7283-2019	Landrigan, Christopher/0000-0001-8386-4100	Rx Foundation, Cambridge, Massachusetts	Rx Foundation, Cambridge, Massachusetts	This study was supported by a grant from the Rx Foundation, Cambridge, Massachusetts.	Agency for Healthcare Research and Quality, 2003, AHRQ QUAL IND GUID P; American College of Obstetricians and Gynecologists, 2006, Obstet Gynecol, V107, P429; Ayas NT, 2006, JAMA-J AM MED ASSOC, V296, P1055, DOI 10.1001/jama.296.9.1055; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Buchler P, 2003, SURGERY, V134, P3, DOI 10.1067/msy.2003.161; Dijk DJ, 2000, CHRONOBIOL INT, V17, P285, DOI 10.1081/CBI-100101049; Ellman PI, 2004, ANN THORAC SURG, V78, P906, DOI 10.1016/j.athoracsur.2004.04.006; Fletcher KE, 2004, ANN INTERN MED, V141, P851, DOI 10.7326/0003-4819-141-11-200412070-00009; Forster AJ, 2006, OBSTET GYNECOL, V108, P1073, DOI 10.1097/01.AOG.0000242565.28432.7c; Gaba DM, 2002, NEW ENGL J MED, V347, P1249, DOI 10.1056/NEJMsa020846; Gawande AA, 2003, SURGERY, V133, P614, DOI 10.1067/msy.2003.169; Hutter MM, 2006, ANN SURG, V243, P864, DOI 10.1097/01.sla.0000220042.48310.66; Hyman NH, 2009, ARCH SURG-CHICAGO, V144, P7, DOI 10.1001/archsurg.2008.518; *I MED COMM OPT GA, 2008, RES DUT HOURS ENH SL; IEZZONI LI, 1994, MED CARE, V32, P700, DOI 10.1097/00005650-199407000-00004; Karson AS, 1999, J EVAL CLIN PRACT, V5, P23, DOI 10.1046/j.1365-2753.1999.00158.x; Landrigan CP, 2007, JT COMM J QUAL PATIE, V33, P19, DOI 10.1016/S1553-7250(07)33110-3; Landrigan CP, 2006, JAMA-J AM MED ASSOC, V296, P1063, DOI 10.1001/jama.296.9.1063; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Lydon-Rochelle M, 2000, JAMA-J AM MED ASSOC, V283, P2411, DOI 10.1001/jama.283.18.2411; Maa J, 2007, J AM COLL SURGEONS, V205, P704, DOI 10.1016/j.jamcollsurg.2007.05.008; Makary MA, 2006, ANN SURG, V243, P628, DOI 10.1097/01.sla.0000216410.74062.0f; Mann S, 2006, JT COMM J QUAL PATIE, V32, P497, DOI 10.1016/S1553-7250(06)32065-X; Pape HC, 2009, PATIENT SAF SURG, V3, DOI 10.1186/1754-9493-3-3; Rogers AE, 2004, HEALTH AFFAIR, V23, P202, DOI 10.1377/hlthaff.23.4.202; Romano PS, 2005, OBSTET GYNECOL, V106, P717, DOI 10.1097/01.AOG.0000179552.36108.6d; Sachs BP, 2005, JAMA-J AM MED ASSOC, V294, P833, DOI 10.1001/jama.294.7.833; Vincent C, 2004, ANN SURG, V239, P475, DOI 10.1097/01.sla.0000118753.22830.41; Weinstein L, 2003, AM J OBSTET GYNECOL, V188, P310, DOI 10.1067/mob.2003.133; Weissman JS, 2007, MED CARE, V45, P448, DOI 10.1097/01.mlr.0000257231.86368.09; WOFLINGER R, 1993, J STAT COMPUT SIM, V48, P233, DOI DOI 10.1080/00949659308811554	33	169	172	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 14	2009	302	14					1565	1572		10.1001/jama.2009.1423	http://dx.doi.org/10.1001/jama.2009.1423			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505UA	19826026	Bronze			2022-12-24	WOS:000270721800025
J	Cicalese, A; Bonizzi, G; Pasi, CE; Faretta, M; Ronzoni, S; Giulini, B; Brisken, C; Minucci, S; Di Fiore, PP; Pelicci, PG				Cicalese, Angelo; Bonizzi, Giuseppina; Pasi, Cristina E.; Faretta, Mario; Ronzoni, Simona; Giulini, Barbara; Brisken, Cathrin; Minucci, Saverio; Di Fiore, Pier Paolo; Pelicci, Pier Giuseppe			The Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem Cells	CELL			English	Article							IN-VIVO; MOUSE; RESTORATION; CANCER; MODEL; GLAND; MICE; ACTIVATION; PATHWAY	Stem-like cells may be integral to the development and maintenance of human cancers. Direct proof is still lacking, mainly because of our poor understanding of the biological differences between normal and cancer stem cells (SCs). Using the ErbB2 transgenic model of breast cancer, we found that self-renewing divisions of cancer SCs are more frequent than their normal counterparts, unlimited and symmetric, thus contributing to increasing numbers of SCs in tumoral tissues. SCs with targeted mutation of the tumor suppressor p53 possess the same self-renewal properties as cancer SCs, and their number increases progressively in the p53 null premalignant mammary gland. Pharmacological reactivation of p53 correlates with restoration of asymmetric divisions in cancer SCs and tumor growth reduction, without significant effects on additional cancer cells. These data demonstrate that p53 regulates polarity of cell division in mammary SCs and suggest that loss of p53 favors symmetric divisions of cancer SCs, contributing to tumor growth.	[Cicalese, Angelo; Bonizzi, Giuseppina; Pasi, Cristina E.; Faretta, Mario; Ronzoni, Simona; Giulini, Barbara; Minucci, Saverio; Di Fiore, Pier Paolo; Pelicci, Pier Giuseppe] IEO, Dept Expt Oncol, I-20139 Milan, Italy; [Di Fiore, Pier Paolo] Fdn Ist FIRC Oncol Mol IFOM, I-20139 Milan, Italy; [Brisken, Cathrin] Swiss Inst Expt Canc Res, Natl Ctr Competence Res Mol Oncol, Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Minucci, Saverio; Di Fiore, Pier Paolo; Pelicci, Pier Giuseppe] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20122 Milan, Italy	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; IRCCS Istituti Fisioterapici Ospitalieri (IFO); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of Milan	Di Fiore, PP (corresponding author), IEO, Dept Expt Oncol, IFOM IEO Campus,Via Adamello 16, I-20139 Milan, Italy.	pierpaolo.difiore@ifom-ieo-campus.it; piergiuseppe.pelicci@ifom-ieo-campus.it	Ronzoni, Simona/AAQ-1669-2020; Bonizzi, Giuseppina/AAD-9042-2022; Faretta, Mario/H-8946-2012; Di Fiore, Pier Paolo/K-2130-2012; Minucci, Saverio/J-9669-2012; Pelicci, Pier Giuseppe/AAL-6572-2020	Faretta, Mario/0000-0003-1678-5781; Di Fiore, Pier Paolo/0000-0002-2252-0950; Brisken, Cathrin/0000-0002-6857-3230	Associazione Italiana per la Ricerca Contro il Cancro; Cariplo Foundation; European Commission (EPITRON and GENICA); Swiss Bridge and Vollaro Foundations; Monzino Foundation; American Italian Cancer Foundation	Associazione Italiana per la Ricerca Contro il Cancro(Fondazione AIRC per la ricerca sul cancro); Cariplo Foundation(Fondazione Cariplo); European Commission (EPITRON and GENICA)(European CommissionEuropean Commission Joint Research Centre); Swiss Bridge and Vollaro Foundations; Monzino Foundation; American Italian Cancer Foundation	We thank R. Orecchia, B. Amati, S. Pece, and D. Tosoni for helpful discussions; A. Brozzi for statistical analysis; I. Muradore for FACS analysis; C. Saccomani for cell sorting; M. Capillo, D. Sardella, and A. Gobbi for help with mice; F. Della Valle, S. Pesce, M. Minora, and M. Scanarini for technical assistance; G. Viale and G. Mazzarol for histopathological analysis; and P. Dalton for editing the manuscript. This study was supported by grants from the Associazione Italiana per la Ricerca Contro il Cancro and the Cariplo Foundation to P. G. P and P. P. D. F., the European Commission (EPITRON and GENICA), the Swiss Bridge and Vollaro Foundations to P. G. P., and the Monzino Foundation to P. P. D. F. G. B. is a fellow of the American Italian Cancer Foundation.	Bonnefoix T, 1996, J IMMUNOL METHODS, V194, P113, DOI 10.1016/0022-1759(96)00077-4; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; DANIEL CW, 1968, P NATL ACAD SCI USA, V61, P53, DOI 10.1073/pnas.61.1.53; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gatza CE, 2008, DEV BIOL, V313, P130, DOI 10.1016/j.ydbio.2007.10.004; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Jerry DJ, 2000, ONCOGENE, V19, P1052, DOI 10.1038/sj.onc.1203270; Jerry DJ, 1998, ONCOGENE, V17, P2305, DOI 10.1038/sj.onc.1202157; Kise N, 2001, TETRAHEDRON LETT, V42, P2365, DOI 10.1016/S0040-4039(01)00178-2; Kuperwasser C, 2000, AM J PATHOL, V157, P2151, DOI 10.1016/S0002-9440(10)64853-5; Lanzkron SM, 1999, BLOOD, V93, P1916, DOI 10.1182/blood.V93.6.1916.406k15_1916_1921; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Rambhatla L., 2001, J BIOMED BIOTECHNOL, V1, P28, DOI DOI 10.1155/S1110724301000079; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Trichopoulos D, 2008, INT J CANCER, V122, P481, DOI 10.1002/ijc.23303; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhang M, 2006, CURR OPIN GENET DEV, V16, P60, DOI 10.1016/j.gde.2005.12.008; Zheng L, 2004, CELL RES, V14, P497, DOI 10.1038/sj.cr.7290253	29	532	553	0	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1083	1095		10.1016/j.cell.2009.06.048	http://dx.doi.org/10.1016/j.cell.2009.06.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766563	Bronze, Green Submitted			2022-12-24	WOS:000269923200010
J	Zofall, M; Fischer, T; Zhang, K; Zhou, M; Cui, BW; Veenstra, TD; Grewal, SIS				Zofall, Martin; Fischer, Tamas; Zhang, Ke; Zhou, Ming; Cui, Bowen; Veenstra, Timothy D.; Grewal, Shiv I. S.			Histone H2A.Z cooperates with RNAi and heterochromatin factors to suppress antisense RNAs	NATURE			English	Article							FISSION YEAST; QUALITY CONTROL; NONCODING RNAS; VARIANT; TRANSCRIPTION; CHROMATIN; GENOME; DROSOPHILA; COMPLEX; EXOSOME	Eukaryotic transcriptomes are characterized by widespread transcription of noncoding and antisense RNAs(1-3), which is linked to key chromosomal processes, such as chromatin remodelling, gene regulation and heterochromatin assembly(4-7). However, these transcripts can be deleterious, and their accumulation is suppressed by several mechanisms including degradation by the nuclear exosome(8,9). The mechanisms by which cells differentiate coding RNAs from transcripts targeted for degradation are not clear. Here we show that the variant histone H2A.Z, which is loaded preferentially at the 5' ends of genes by the Swr1 complex containing a JmjC domain protein, mediates suppression of antisense transcripts in the fission yeast Schizosaccharomyces pombe genome. H2A.Z is partially redundant in this regard with the Clr4 (known as SUV39H in mammals)-containing heterochromatin silencing complex that is also distributed at euchromatic loci, and with RNA interference component Argonaute (Ago1). Loss of Clr4 or Ago1 alone has little effect on antisense transcript levels, but cells lacking either of these factors and H2A.Z show markedly increased levels of antisense RNAs that are normally degraded by the exosome. These analyses suggest that as well as performing other functions, H2A.Z is a component of a genome indexing mechanism that cooperates with heterochromatin and RNAi factors to suppress read-through antisense transcripts.	[Zofall, Martin; Fischer, Tamas; Zhang, Ke; Cui, Bowen; Grewal, Shiv I. S.] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Zhou, Ming; Veenstra, Timothy D.] NCI Frederick, SAIC Frederick Inc, Lab Prote & Analyt Technol, Adv Technol Program, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Grewal, SIS (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov	Fischer, Tamas/A-7729-2016; Cui, Bowen/F-1038-2011	Fischer, Tamas/0000-0002-7996-4042; 	National Institutes of Health [N01-CO-12400]; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011208, ZIABC010523] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Acknowledgements We thank K. Noma for strain constructions, D. McPheeters for the run-on protocol, M. Lichten, F. Reyes-Turcu, E. Bartlett and H. Cam for comments on the manuscript, P. Fitzgerald for designing microarrays, and D. Venzon for advice with data analyses. This research was supported by the Intramural Research Program, and under Contract N01-CO-12400 of the National Institutes of Health, National Cancer Institute.	Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; CARR AM, 1994, MOL GEN GENET, V245, P628, DOI 10.1007/BF00282226; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rangasamy D, 2004, NAT STRUCT MOL BIOL, V11, P650, DOI 10.1038/nsmb786; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Shevchenko A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r167; Swaminathan J, 2005, GENE DEV, V19, P65, DOI 10.1101/gad.1259105; Wagner EJ, 2007, MOL CELL, V28, P692, DOI 10.1016/j.molcel.2007.10.009; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	30	114	115	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 17	2009	461	7262					419	U120		10.1038/nature08321	http://dx.doi.org/10.1038/nature08321			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19693008	Green Accepted			2022-12-24	WOS:000269828100045
J	Sada, A; Suzuki, A; Suzuki, H; Saga, Y				Sada, Aiko; Suzuki, Atsushi; Suzuki, Hitomi; Saga, Yumiko			The RNA-Binding Protein NANOS2 Is Required to Maintain Murine Spermatogonial Stem Cells	SCIENCE			English	Article							SELF-RENEWAL; GERM-CELLS; DIFFERENTIATION; SPERMATOGENESIS; CONSERVATION; MAINTENANCE; PLZF	Stem cells give rise to differentiated cell types but also preserve their undifferentiated state through cell self-renewal. With the use of transgenic mice, we found that the RNA-binding protein NANOS2 is essential for maintaining spermatogonial stem cells. Lineage-tracing analyses revealed that undifferentiated spermatogonia expressing Nanos2 self-renew and generate the entire spermatogenic cell lineage. Conditional disruption of postnatal Nanos2 depleted spermatogonial stem cell reserves, whereas mouse testes in which Nanos2 had been overexpressed accumulated spermatogonia with undifferentiated, stem cell-like properties. Thus, NANOS2 is a key stem cell regulator that is expressed in self-renewing spermatogonial stem cells and maintains the stem cell state during murine spermatogenesis.	[Sada, Aiko; Saga, Yumiko] SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Suzuki, Atsushi] Yokohama Natl Univ, Interdisciplinary Res Ctr, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Suzuki, Hitomi; Saga, Yumiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Saga, Yumiko] Natl Inst Genet, Div Mammalian Dev, Mishima, Shizuoka 4118540, Japan	Graduate University for Advanced Studies - Japan; Yokohama National University; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Saga, Y (corresponding author), SOKENDAI, Dept Genet, 1111 Yata, Mishima, Shizuoka 4118540, Japan.	ysaga@lab.nig.ac.jp	Sada, Aiko/B-1176-2019	Sada, Aiko/0000-0002-0984-4280	Ministry of Education, Culture, Sports, Science and Technology of Japan; Research Fellowships of the Japan Society	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Fellowships of the Japan Society	We thank Y. Nishimune for the TRA98 antibody; S. Chuma and N. Nakatsuji for the SCP3 antibody; S. Yoshida for the Ngn3-EGFP and Ngn3-Cre transgenic mice; S. Evans for the MER-Cre-MER construct; and T. Shinohara, R. Behringer, and Y. Hiromi for critical reading of the manuscript. This study was supported in part by the Genome Network Project of the Ministry of Education, Culture, Sports, Science and Technology of Japan and by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists to A. S.	Atchison FW, 2003, BIOL REPROD, V69, P1989, DOI 10.1095/biolreprod.103.020859; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; De Rooij DG, 2000, J ANDROL, V21, P776; Draper BW, 2007, DEV BIOL, V305, P589, DOI 10.1016/j.ydbio.2007.03.007; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; Jaruzelska J, 2003, DEV GENES EVOL, V213, P120, DOI 10.1007/s00427-003-0303-2; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Mochizuki K, 2000, DEV GENES EVOL, V210, P591, DOI 10.1007/s004270000105; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; YOSHIDA S, 2007, ANN N Y ACAD SCI, P73902	18	211	232	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1394	1398		10.1126/science.1172645	http://dx.doi.org/10.1126/science.1172645			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745153	Green Submitted			2022-12-24	WOS:000269699100039
J	Rothman, SM; Rothman, DJ				Rothman, Sheila M.; Rothman, David J.			Marketing HPV Vaccine Implications for Adolescent Health and Medical Professionalism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; TYPE-16	The new vaccine against 4 types of human papillomavirus (HPV), Gardasil, like other immunizations appears to be a cost-effective intervention with the potential to enhance both adolescent health and the quality of their adult lives. However, the messages and the methods by which the vaccine was marketed present important challenges to physician practice and medical professionalism. By making the vaccine's target disease cervical cancer, the sexual transmission of HPV was minimized, the threat of cervical cancer to adolescents was maximized, and the subpopulations most at risk practically ignored. The vaccine manufacturer also provided educational grants to professional medical associations (PMAs) concerned with adolescent and women's health and oncology. The funding encouraged many PMAs to create educational programs and product-specific speakers' bureaus to promote vaccine use. However, much of the material did not address the full complexity of the issues surrounding the vaccine and did not provide balanced recommendations on risks and benefits. As important and appropriate as it is for PMAs to advocate for vaccination as a public good, their recommendations must be consistent with appropriate and cost-effective use. JAMA. 2009; 302(7):781-786 www.jama.com	[Rothman, Sheila M.] Mailman Sch Publ Hlth, New York, NY USA		Rothman, SM (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Soc & Med, 630 W 168th St,PH 15-25, New York, NY 10023 USA.	smr4@columbia.edu			Pew Charitable Trusts	Pew Charitable Trusts	This work was funded by the Pew Charitable Trusts.	Allen A, 2007, VACCINE CONTROVERSIA; *AM COLL HLTH ASS, HPV VACC TOOLK; *AM COLL HLTH ASS, VACC PREV DIS ADV CO; *AM COLL HLTH ASS, AM COLL HLTH ASS VOI; *AM COLL HLTH ASS, ACHA YEAR REV; *AM COLL HLTH ASS, FREE WEBC HPV VACC U; [Anonymous], 1991, MMWR Recomm Rep, V40, P1; AULT KA, EXPANDING BENEFITS H; Baden LR, 2007, NEW ENGL J MED, V356, P1990, DOI 10.1056/NEJMe078088; BOCK P, 2007, SEATTLE TIMES   1005; CARREYROU J, 2007, WALL STREET J   0416, pA1; *CDC, 1988, MMWR-MORBID MORTAL W, V37, P341; *CDCP, 1982, MMWR-MORBID MORTAL W, V31, P317; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P549; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P563; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P1100; Centers for Disease Control (CDC), 1988, MMWR Morb Mortal Wkly Rep, V37, P351; CRUM CP, 1984, NEW ENGL J MED, V310, P880, DOI 10.1056/NEJM198404053101403; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; FREED GL, 1994, PEDIATRICS, V93, P747; Freeman H, 2005, EXCESS CERVICAL CANC; Gostin LO, 2007, JAMA-J AM MED ASSOC, V297, P1921, DOI 10.1001/jama.297.17.1921; Haug CJ, 2008, NEW ENGL J MED, V359, P861, DOI 10.1056/NEJMe0804638; HERSKOVITS B, 2007, PHARM EXEC, V27, P58; *I MED PROF, HPV VACC SOURC; Karlan BY, 2006, GYNECOL ONCOL, V102, P1, DOI 10.1016/j.ygyno.2006.05.004; KAUFMAN M, 2006, WASHINGTON POST 0609; Kim JJ, 2008, NEW ENGL J MED, V359, P821, DOI 10.1056/NEJMsa0707052; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Lawrence RS, 2009, ADOLESCENT HEALTH SERVICES: MISSING OPPORTUNITIES, P194; *MERCK, 2007 ANN REV DRIV GR; *NAT BOARD PROF TE, 1997, STAT LOC ACT SUPP NA, P1; Orenstein WA, 2005, HEALTH AFFAIR, V24, P599, DOI 10.1377/hlthaff.24.3.599; Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9; Rothman DJ, 2009, JAMA-J AM MED ASSOC, V301, P1367, DOI 10.1001/jama.2009.407; Runowicz CD, 2002, GYNECOL ONCOL, V84, P357, DOI 10.1006/gyno.2001.6421; Sawaya GF, 2007, NEW ENGL J MED, V356, P1991, DOI 10.1056/NEJMe078060; SHARFSTEIN J, 2000, AM PROSPECT, V11, P15; *SOC GYN ONC, CORP SPONS OPP; *SOC GYN ONC, HIST SGO OR SOC; *SOC GYN ONC, FAQ CERV CANC VACC; *SOC GYN ONC, RAIS AW GYN CANC PHY; *SOC GYN ONC, HPV CERV CANC VACC S; *SOC GYN ONC, ED RES PAN; SPITZER M, 2006, COMMUNICATION   0317; Spitzer Mark, 2007, J Low Genit Tract Dis, V11, P133, DOI 10.1097/LGT.0b013e31805d8cea; *US FDA, 2006, FDA LIC NEW VACC PRE; Vetter KM, 2007, J WOMENS HEALTH, V16, P1258, DOI 10.1089/jwh.2007.0493; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	50	75	76	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	2009	302	7					781	786		10.1001/jama.2009.1179	http://dx.doi.org/10.1001/jama.2009.1179			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484UT	19690311				2022-12-24	WOS:000269073800027
J	May, C; Montori, VM; Mair, FS				May, Carl; Montori, Victor M.; Mair, Frances S.			We need minimally disruptive medicine	BRITISH MEDICAL JOURNAL			English	Editorial Material							DIABETES-MELLITUS; HELPING PATIENTS; PRIMARY-CARE; ADHERENCE; HEALTH; MEDICATION; MORTALITY		[May, Carl] Univ Newcastle, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England; [Montori, Victor M.] Mayo Clin, UK Knowledge & Encounter Res Unit, Rochester, MN USA; [Mair, Frances S.] Univ Glasgow, Sect Gen Practice & Primary Care, Glasgow, Lanark, Scotland	Newcastle University - UK; Mayo Clinic; University of Glasgow	May, C (corresponding author), Univ Newcastle, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England.	c.r.may@ncl.ac.uk	May, Carl/A-8502-2011	Montori, Victor/0000-0003-0595-2898; May, Carl/0000-0002-0451-2690; Mair, Frances/0000-0001-9780-1135				ARMSTRONG D, 1982, PROBLEM MED KNOWLEDG; Baker RM, 2006, SOC SCI MED, V63, P2341, DOI 10.1016/j.socscimed.2006.06.007; Barber N, 2004, QUAL SAF HEALTH CARE, V13, P172, DOI 10.1136/qshc.2003.005926; Charmaz K, 2006, GOOD DAYS BAD DAYS S; DeJesus E, 2009, JAIDS-J ACQ IMM DEF, V51, P163, DOI 10.1097/QAI.0b013e3181a572cf; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Gately C, 2007, SOC SCI MED, V65, P934, DOI 10.1016/j.socscimed.2007.04.018; Golin CE, 1996, DIABETES CARE, V19, P1153, DOI 10.2337/diacare.19.10.1153; Greene JA, 2004, SOC HIST MED, V17, P327, DOI 10.1093/shm/17.3.327; Haynes RB, 2002, JAMA-J AM MED ASSOC, V288, P2880, DOI 10.1001/jama.288.22.2880; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; May C, 2006, SOC SCI MED, V62, P1022, DOI 10.1016/j.socscimed.2005.07.003; May C, 2009, SOCIOLOGY, V43, P535, DOI 10.1177/0038038509103208; Rasmussen JN, 2007, JAMA-J AM MED ASSOC, V297, P177, DOI 10.1001/jama.297.2.177; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Wens J, 2008, DIABETES RES CLIN PR, V79, P377, DOI 10.1016/j.diabres.2007.06.006; Weymiller AJ, 2007, ARCH INTERN MED, V167, P1076, DOI 10.1001/archinte.167.10.1076; *WHO, 2003, INF SHEET FACTS REL; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	19	380	383	2	24	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2009	339								b2803	10.1136/bmj.b2803	http://dx.doi.org/10.1136/bmj.b2803			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485YH	19671932				2022-12-24	WOS:000269161800001
J	Lee, YS; Kennedy, WD; Yin, YW				Lee, Young-Sam; Kennedy, W. Dexter; Yin, Y. Whitney			Structural Insight into Processive Human Mitochondrial DNA Synthesis and Disease-Related Polymerase Mutations	CELL			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; ACCESSORY SUBUNIT; ESCHERICHIA-COLI; AUTOSOMAL-DOMINANT; W748S MUTATION; GAMMA; PURIFICATION; REPLICATION; PROTEIN; POLG	Human mitochondrial DNA polymerase (Pol gamma) is the sole replicase in mitochondria. Pol gamma is vulnerable to nonselective antiretroviral drugs and is increasingly associated with mutations found in patients with mitochondriopathies. We determined crystal structures of the human heterotrimeric Pol gamma holoenzyme and, separately, a variant of its processivity factor, Pol gamma B. The holoenzyme structure reveals an unexpected assembly of the mitochondrial DNA replicase where the catalytic subunit Pol gamma A interacts with its processivity factor primarily via a domain that is absent in all other DNA polymerases. This domain provides a structural module for supporting both the intrinsic processivity of the catalytic subunit alone and the enhanced processivity of holoenzyme. The Pol gamma structure also provides a context for interpreting the phenotypes of disease-related mutations in the polymerase and establishes a foundation for understanding the molecular basis of toxicity of anti-retroviral drugs targeting HIV reverse transcriptase.	[Lee, Young-Sam; Kennedy, W. Dexter; Yin, Y. Whitney] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Yin, Y. Whitney] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Yin, YW (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	whitney.yin@mail.utexas.edu			National Institutes of Health (NIH) [GM044613, GM083703]; Department of Energy [DE-AC02-06CH11357]; Welch Foundation [F-1592]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044613, R01GM083703] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Molineux for his insight, helpful discussions, and critical comments on the manuscript and K. Johnson for his long-term support, help in initiating the crystallography of Pol gamma, and financial support through the National Institutes of Health (NIH; GM044613). We thank D. Bogenhagen, W. Copeland, and all members of the Y.W.Y. lab for helpful discussion. We are grateful for excellent technical support from S. Ginell and the staff at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source, which is supported by the Department of Energy under contract DE-AC02-06CH11357. The research was supported by grants from the Welch Foundation (F-1592) and NIH (GM083703) to Y.W.Y.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bellizzi JJ, 1999, STRUCTURE, V7, pR263, DOI 10.1016/S0969-2126(00)80020-9; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8; Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424; Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200; Chinnery P.F., 2007, NEUROMUSCULAR DISORD, V18, P259; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073; Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; Fersht A., 1985, ENZYME STRUCTURE MEC; Gleghorn ML, 2008, MOL CELL, V32, P707, DOI 10.1016/j.molcel.2008.11.010; Graves SW, 1998, BIOCHEMISTRY-US, V37, P6050, DOI 10.1021/bi972685u; Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805; Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; HORI K, 1979, J BIOL CHEM, V254, P1591; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; HUBER HE, 1987, J BIOL CHEM, V262, P16224; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Johnson AA, 2001, J BIOL CHEM, V276, P38097; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Klarmann GJ, 2007, BIOCHEMISTRY-US, V46, P2118, DOI 10.1021/bi061772w; Kohler JJ, 2007, ENVIRON MOL MUTAGEN, V48, P166, DOI 10.1002/em.20223; Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278; Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4; Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303; Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196; MCHENRY C, 1977, J BIOL CHEM, V252, P6478; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PETRUSKA J, 1986, P NATL ACAD SCI USA, V83, P1559, DOI 10.1073/pnas.83.6.1559; SARAFIANOS SG, 1995, J BIOL CHEM, V270, P19729, DOI 10.1074/jbc.270.34.19729; TABOR S, 1987, J BIOL CHEM, V262, P16212; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WERNETTE CM, 1986, J BIOL CHEM, V261, P4764; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200; Yakubovskaya E, 2007, EMBO J, V26, P4283, DOI 10.1038/sj.emboj.7601843; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259	52	149	153	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					312	324		10.1016/j.cell.2009.07.050	http://dx.doi.org/10.1016/j.cell.2009.07.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837034	Green Accepted, Bronze			2022-12-24	WOS:000270857500015
J	Steinbrook, R				Steinbrook, Robert			Drug Shortages and Public Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Lauer MS, 2009, NEW ENGL J MED, V361, P841, DOI 10.1056/NEJMp0904735; National Research Council Committee on Medical Isotope Production Without Highly Enriched Uranium, 2009, MED IS PROD HIGHL EN	3	25	26	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2009	361	16					1525	1527		10.1056/NEJMp0906922	http://dx.doi.org/10.1056/NEJMp0906922			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	506LT	19828529				2022-12-24	WOS:000270777000003
J	Ji, JF; Shi, J; Budhu, A; Yu, ZP; Forgues, M; Roessler, S; Ambs, S; Chen, YD; Meltzer, PS; Croce, CM; Qin, LX; Man, K; Lo, CM; Lee, J; Ng, IOL; Fan, J; Tang, ZY; Sun, HC; Wang, XW				Ji, Junfang; Shi, Jiong; Budhu, Anuradha; Yu, Zhipeng; Forgues, Marshonna; Roessler, Stephanie; Ambs, Stefan; Chen, Yidong; Meltzer, Paul S.; Croce, Carlo M.; Qin, Lun-Xiu; Man, Kwan; Lo, Chung-Mau; Lee, Joyce; Ng, Irene O. L.; Fan, Jia; Tang, Zhao-You; Sun, Hui-Chuan; Wang, Xin Wei			MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATOCELLULAR-CARCINOMA; GENDER; PROFILES; INTERLEUKIN-6; RECURRENCE; PROGNOSIS; SIGNATURE; RESECTION; FEMALE	Background Hepatocellular carcinoma is a common and aggressive cancer that occurs mainly in men. We examined microRNA expression patterns, survival, and response to interferon alfa in both men and women with the disease. Methods We analyzed three independent cohorts that included a total of 455 patients with hepatocellular carcinoma who had undergone radical tumor resection between 1999 and 2003. MicroRNA-expression profiling was performed in a cohort of 241 patients with hepatocellular carcinoma to identify tumor-related microRNAs and determine their association with survival in men and women. In addition, to validate our findings, we used quantitative reverse-transcriptase-polymerase-chain-reaction assays to measure microRNAs and assess their association with survival and response to therapy with interferon alfa in 214 patients from two independent, prospective, randomized, controlled trials of adjuvant interferon therapy. Results In patients with hepatocellular carcinoma, the expression of miR-26a and miR-26b in nontumor liver tissue was higher in women than in men. Tumors had reduced levels of miR-26 expression, as compared with paired noncancerous tissues, which indicated that the level of miR-26 expression was also associated with hepatocellular carcinoma. Moreover, tumors with reduced miR-26 expression had a distinct transcriptomic pattern, and analyses of gene networks revealed that activation of signaling pathways between nuclear factor kappa B and interleukin-6 might play a role in tumor development. Patients whose tumors had low miR-26 expression had shorter overall survival but a better response to interferon therapy than did patients whose tumors had high expression of the microRNA. Conclusions The expression patterns of microRNAs in liver tissue differ between men and women with hepatocellular carcinoma. The miR-26 expression status of such patients is associated with survival and response to adjuvant therapy with interferon alfa.	[Ji, Junfang; Shi, Jiong; Budhu, Anuradha; Yu, Zhipeng; Forgues, Marshonna; Roessler, Stephanie; Wang, Xin Wei] NCI, Liver Carcinogenesis Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Ambs, Stefan] NCI, Breast & Prostate Unit, Human Carcinogenesis Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Chen, Yidong; Meltzer, Paul S.] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Shi, Jiong; Qin, Lun-Xiu; Fan, Jia; Tang, Zhao-You; Sun, Hui-Chuan] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Shi, Jiong; Qin, Lun-Xiu; Fan, Jia; Tang, Zhao-You; Sun, Hui-Chuan] Fudan Univ, Liver Canc Inst, Shanghai 200433, Peoples R China; [Croce, Carlo M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Man, Kwan; Lo, Chung-Mau] Univ Hong Kong, Dept Surg, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Lee, Joyce; Ng, Irene O. L.] Univ Hong Kong, Dept Pathol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fudan University; Fudan University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Hong Kong; University of Hong Kong	Wang, XW (corresponding author), NCI, Liver Carcinogenesis Sect, Ctr Canc Res, NIH, 37 Convent Dr,Bldg 37,Rm 3044A, Bethesda, MD 20892 USA.	sun.huichuan@zs-hospital.sh.cn; xw3u@nih.gov	Wang, Xin Wei/B-6162-2009; Roessler, Stephanie/J-8432-2019; Fan, Jia/C-6689-2017; Young, Richard A/F-6495-2012	Wang, Xin Wei/0000-0001-9735-606X; Roessler, Stephanie/0000-0002-5333-5942; Young, Richard A/0000-0001-8855-8647; Sun, Hui-Chuan/0000-0003-3761-7058; Ambs, Stefan/0000-0001-7651-9309; Ng, Irene Oi-lin/0000-0001-7532-2029	Intramural Research Program of the Center for Cancer Research of the National Cancer Institute [Z01-BC 010313, Z01-BC 010876]; NATIONAL CANCER INSTITUTE [Z01BC010876, Z01BC010313, ZIABC011091, ZIABC010886] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Cancer Research of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by grants (Z01-BC 010313 and Z01-BC 010876) from the Intramural Research Program of the Center for Cancer Research of the National Cancer Institute.	Ashizawa Tatsuto, 2005, Gastric Cancer, V8, P124, DOI 10.1007/s10120-005-0315-x; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Clavien PA, 2007, ANN SURG, V245, P843, DOI 10.1097/SLA.0b013e31805d0788; Dohmen K, 2003, J GASTROEN HEPATOL, V18, P267, DOI 10.1046/j.1440-1746.2003.02936.x; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ghebranious N, 1998, HEPATOLOGY, V27, P383, DOI 10.1002/hep.510270211; Kim JW, 2004, HEPATOLOGY, V39, P518, DOI 10.1002/hep.20053; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lo CM, 2007, ANN SURG, V245, P831, DOI 10.1097/01.sla.0000245829.00977.45; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Nakatani T, 2001, JPN J CANCER RES, V92, P249, DOI 10.1111/j.1349-7006.2001.tb01089.x; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; NG IOL, 1995, CANCER, V75, P18, DOI 10.1002/1097-0142(19950101)75:1<18::AID-CNCR2820750105>3.0.CO;2-#; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Porta C, 2008, ANN ONCOL, V19, P353, DOI 10.1093/annonc/mdm448; Rogers AB, 2007, CANCER RES, V67, P11536, DOI 10.1158/0008-5472.CAN-07-1479; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Sun HC, 2006, J CANCER RES CLIN, V132, P458, DOI 10.1007/s00432-006-0091-y; Tangkijvanich P, 2004, WORLD J GASTROENTERO, V10, P1547, DOI 10.3748/wjg.v10.i11.1547; Thyrell L, 2007, EXP CELL RES, V313, P4015, DOI 10.1016/j.yexcr.2007.08.007; Wands J, 2007, NEW ENGL J MED, V357, P1974, DOI 10.1056/NEJMcibr075652; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	25	656	739	1	93	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2009	361	15					1437	1447		10.1056/NEJMoa0901282	http://dx.doi.org/10.1056/NEJMoa0901282			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503MU	19812400	Green Accepted, Green Published			2022-12-24	WOS:000270540000005
J	Patel, K; Wells, K				Patel, Kavita; Wells, Kenneth			Applying Health Care Reform Principles to Mental Health and Substance Abuse Services	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wells, Kenneth] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA; [Patel, Kavita] White House, Off Publ Engagement & Intergovt Affairs, Washington, DC USA; [Wells, Kenneth] Univ Calif Los Angeles, David Geffen Sch Med, Jane & Terry Semel Inst Neurosci & Human Behav, Dept Psychiat, Los Angeles, CA 90095 USA; [Wells, Kenneth] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biobehav Sci, Los Angeles, CA 90095 USA; [Wells, Kenneth] RAND Hlth Program, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RAND Corporation	Wells, K (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, 10920 Wilshire Blvd,Ste 300, Los Angeles, CA 90024 USA.	kwells@mednet.ucla.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078853, P30MH082760] Funding Source: NIH RePORTER; NIMH NIH HHS [1P30MH082760-01, R01 MH078853-02, R01 MH078853, P30 MH082760] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Committee on Crossing the Quality Chasm Adaptation to Mental Health Addictive Disorders, 2006, IMPR QUAL HLTH CAR M; Frank R. G., 2006, BETTER NOT WELL MENT; Frank RG, 2007, ANNU REV PUBL HEALTH, V28, P303, DOI 10.1146/annurev.publhealth.28.021406.144029; Office of the Surgeon General, 2019, SURG GEN ADV MAR US; Patel KK, 2006, HEALTH AFFAIR, V25, P681, DOI 10.1377/hlthaff.25.3.681; *US DEP HHS, PREV MENT DIS; *US DEP HHS, PROGR CAMP	7	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 7	2009	302	13					1463	1464		10.1001/jama.2009.1446	http://dx.doi.org/10.1001/jama.2009.1446			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	503CL	19809029	Green Accepted			2022-12-24	WOS:000270509600023
J	van Wolfswinkel, JC; Claycomb, JM; Batista, PJ; Mello, CC; Berezikov, E; Ketting, RF				van Wolfswinkel, Josien C.; Claycomb, Julie M.; Batista, Pedro J.; Mello, Craig C.; Berezikov, Eugene; Ketting, Rene F.			CDE-1 Affects Chromosome Segregation through Uridylation of CSR-1-Bound siRNAs	CELL			English	Article							CYTOPLASMIC POLY(A) POLYMERASE; C-ELEGANS; CAENORHABDITIS-ELEGANS; RNA INTERFERENCE; FISSION YEAST; GERM-LINE; SCHIZOSACCHAROMYCES-POMBE; GENE-EXPRESSION; HETEROCHROMATIN; PROTEIN	We have studied the function of a conserved germline-specific nucleotidyltransferase protein, CDE-1, in RNAi and chromosome segregation in C. elegans. CDE-1 localizes specifically to mitotic chromosomes in embryos. This localization requires the RdRP EGO-1, which physically interacts with CDE-1, and the Argonaute protein CSR-1. We found that CDE-1 is required for the uridylation of CSR-1 bound siRNAs, and that in the absence of CDE-1 these siRNAs accumulate to inappropriate levels, accompanied by defects in both meiotic and mitotic chromosome segregation. Elevated siRNA levels are associated with erroneous gene silencing, most likely through the inappropriate loading of CSR-1 siRNAs into other Argonaute proteins. We propose a model in which CDE-1 restricts specific EGO-1-generated siRNAs to the CSR-1 mediated, chromosome associated RNAi pathway, thus separating it from other endogenous RNAi pathways. The conserved nature of CDE-1 suggests that similar sorting mechanisms may operate in other animals, including mammals.	[van Wolfswinkel, Josien C.; Berezikov, Eugene; Ketting, Rene F.] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [van Wolfswinkel, Josien C.; Berezikov, Eugene; Ketting, Rene F.] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [van Wolfswinkel, Josien C.] Univ Utrecht, Dept Biomol Mass Spectrometry, NL-3584 CT Utrecht, Netherlands; [Claycomb, Julie M.; Batista, Pedro J.; Mello, Craig C.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Batista, Pedro J.] Gulbenkian PhD Programme Biomed, P-2780156 Oeiras, Portugal; [Mello, Craig C.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Ketting, RF (corresponding author), Hubrecht Inst KNAW, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	r.ketting@hubrecht.eu	Berezikov, Eugene/D-3363-2013; Batista, Pedro J/K-5303-2012	Berezikov, Eugene/0000-0002-1145-2884; Claycomb, Julie/0000-0003-3132-5206; Ketting, Rene/0000-0001-6161-5621	Developmental Studies Hybridoma Bank (DSHB) [OIC104]; National Proteomics Centre, the European Union Sixth Framework Program Integrated Project SIROCCO [LSHG-CT-2006-037900]; Netherlands Organisation for Scientific Research; European Union Seventh Framework Program [202819]	Developmental Studies Hybridoma Bank (DSHB); National Proteomics Centre, the European Union Sixth Framework Program Integrated Project SIROCCO; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union Seventh Framework Program(European Commission)	We thank Abby Dernburg and members of her lab for protocols, reagents and support concerning the immunostainings and microscopy. We thank Alex Dammermann, Karen Oegema, Reto Gassmann, and Arshad Desai for antibodies and transgenic strains. Several strains were generously provided by the Caenorhabditis Genetics Center (CGC), by Shohei Mitani of the Japanese National Bioresources Project for C. elegans and Hendrik Korswagen. PGL-1 antibody (OIC104) was provided by the Developmental Studies Hybridoma Bank (DSHB). This work was supported by the National Proteomics Centre, the European Union Sixth Framework Program Integrated Project SIROCCO (Grant LSHG-CT-2006-037900), VIDI fellowships from the Netherlands Organisation for Scientific Research (NWO; R.F.K. and E.B.) and an ERC Starting Grant from the Ideas Program of the European Union Seventh Framework Program (R.F.K.; Grant 202819).	ALBERTSON DG, 1982, CHROMOSOMA, V86, P409, DOI 10.1007/BF00292267; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Crittenden SL, 2003, PHILOS T ROY SOC B, V358, P1359, DOI 10.1098/rstb.2003.1333; DEMBURG AF, 2001, J CELL BIOL, V153, pF33; Ekwall K, 2004, CHROMOSOME RES, V12, P535, DOI 10.1023/B:CHRO.0000036584.40567.e5; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Gassmann R, 2008, GENE DEV, V22, P2385, DOI 10.1101/gad.1687508; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Kwak JE, 2007, RNA, V13, P860, DOI 10.1261/rna.514007; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Maddox PS, 2004, CHROMOSOME RES, V12, P641, DOI 10.1023/B:CHRO.0000036588.42225.2f; MAIDA Y, 2009, NATURE; Martienssen RA, 2005, TRENDS GENET, V21, P450, DOI 10.1016/j.tig.2005.06.005; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Moore LL, 1999, J CELL BIOL, V147, P471, DOI 10.1083/jcb.147.3.471; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Olsen A, 2006, SCIENCE, V312, P1381, DOI 10.1126/science.1124981; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; RISSLAND OS, 2009, NAT STRUCT MOL BIOL; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Schmid M, 2009, GENE DEV, V23, P824, DOI 10.1101/gad.494009; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Stear JH, 2002, GENE DEV, V16, P1498, DOI 10.1101/gad.989102; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; Win TZ, 2006, MOL CELL BIOL, V26, P4435, DOI 10.1128/MCB.02205-05; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	51	136	139	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					135	148		10.1016/j.cell.2009.09.012	http://dx.doi.org/10.1016/j.cell.2009.09.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804759	Bronze			2022-12-24	WOS:000270388600022
J	Zhang, FJ; Dou, ZH; Ma, Y; Zhao, Y; Liu, ZF; Bulterys, M; Chen, RY				Zhang, Fujie; Dou, Zhihui; Ma, Ye; Zhao, Yan; Liu, Zhongfu; Bulterys, Marc; Chen, Ray Y.			Five-Year Outcomes of the China National Free Antiretroviral Treatment Program	ANNALS OF INTERNAL MEDICINE			English	Article							HIV-INFECTED PATIENTS; CD4 CELL COUNT; RESOURCE-LIMITED SETTINGS; SUB-SAHARAN AFRICA; VIRAL LOAD; SCALE-UP; TREATMENT FAILURE; EARLY MORTALITY; 1ST YEAR; THERAPY	Background: China's National Free Antiretroviral Treatment Program began in 2002 and, by August 2008, included more than 52 000 patients. Objective: To report 5-year outcomes on adult mortality and immunologic treatment failure rates and risk factors. Design: Open cohort analysis of a prospectively collected, observational database. Setting: China. Patients: All patients in the national treatment database from June 2002 to August 2008. Patients were excluded if they had not started triple therapy or had missing treatment regimen information. Intervention: Antiretroviral therapy according to Chinese national treatment guidelines. Measurements: Mortality rate and immunologic treatment failure rate, according to World Health Organization criteria. Results: Of 52 191 patients, 48 785 were included. Median age was 38 years, 58% were men, 53% were infected through plasma or blood, and the median baseline CD4 cell count was 0.118 x 10(9) cells/L. Mortality was greatest during the first 3 months of treatment (22.6 deaths per 100 person-years) but decreased to a steady rate of 4 to 5 deaths per 100 person-years after 6 months and maintained this rate over the subsequent 4.5 years. The strongest mortality risk factors were a baseline CD4 cell count less than 0.050 x 10(9) cells/L (adjusted hazard ratio [HR] compared with a count >= 0.200 x 10(9) cells/L, 3.3 [95% CI, 2.9 to 3.8]) and having 4 to 5 baseline symptom categories (adjusted HR compared with no baseline symptom categories, 3.4 [CI, 2.9 to 4.0]). Treatment failure was determined among 31 070 patients with 1 or more follow-up CD4 cell counts. Overall, treatment failed for 25% of patients (12.0 treatment failures per 100 person-years), with the cumulative treatment failure rate increasing to 50% at 5 years. Limitation: Immunologic treatment failure does not necessarily correlate well with virologic treatment failure. Conclusion: The National Free Antiretroviral Treatment Program reduced mortality among adult patients in China with AIDS to rates similar to those of other low-or middle-income countries. A cumulative immunologic treatment failure rate of 50% after 5 years, due to the limited availability of second-line regimens, is of great concern.	[Zhang, Fujie] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing 100050, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Zhang, FJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, 27 Nanwei Rd, Beijing 100050, Peoples R China.	treatment@chinaaids.cn	Chen, Ray/T-5102-2019; Chen, Ray/GRJ-6736-2022	Chen, Ray/0000-0001-6344-1442	AIDS preventionand treatment of the China Ministry of Health [WA-2006-03]; U. S. National Institutes of Health [U2R TW006918, R03 TW008203]; U. S. Centers for Disease Control and Prevention Global AIDS Program to the Chinese Center for Disease Control and Prevention [1U2GPS001188-01]; FOGARTY INTERNATIONAL CENTER [R03TW008203, U2RTW006918] Funding Source: NIH RePORTER	AIDS preventionand treatment of the China Ministry of Health; U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Centers for Disease Control and Prevention Global AIDS Program to the Chinese Center for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	By the applied research program on AIDS preventionand treatment of the China Ministry of Health ( grant WA-2006-03), the U. S. National Institutes of Health ( grants U2R TW006918 and R03 TW008203), and a cooperative agreement from the U. S. Centers for Disease Control and Prevention Global AIDS Program to the Chinese Center for Disease Control and Prevention ( grant 1U2GPS001188-01).	Barth RE, 2008, EUR J CLIN MICROBIOL, V27, P977, DOI 10.1007/s10096-008-0534-2; Bartlett JG, 2008, J INFECT DIS, V197, pS250, DOI 10.1086/533417; BASENERO A, 2007, 4 INT AIDS SOC C HIV; Bisson GP, 2006, AIDS, V20, P1613, DOI 10.1097/01.aids.0000238407.00874.dc; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; *CHIN CTR DIS CONT, 2005, CHIN FREE ART MAN; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Corey DM, 2007, JAIDS-J ACQ IMM DEF, V44, P451, DOI 10.1097/QAI.0b013e31802f8512; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Ferradini L, 2007, AIDS, V21, P2293, DOI 10.1097/QAD.0b013e32828cc8b7; Grinszten B, 2007, JAIDS-J ACQ IMM DEF, V45, P515, DOI 10.1097/QAI.0b013e3180decb6a; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; HOSSEINIPOUR M, 2007, 4 INT AIDS SOC C HIV; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Laurent C, 2005, JAIDS-J ACQ IMM DEF, V38, P14, DOI 10.1097/00126334-200501010-00003; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; MA Y, 2009, INT J EPIDEMIOL 0625; Madec Y, 2007, AIDS, V21, P351, DOI 10.1097/QAD.0b013e328012c54f; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Moore DM, 2008, LANCET, V371, P1396, DOI 10.1016/S0140-6736(08)60607-8; Moore DM, 2006, JAIDS-J ACQ IMM DEF, V43, P436, DOI 10.1097/01.qai.0000243105.80393.42; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Sherer R, 2008, HEALTH AFFAIR, V27, P1140, DOI 10.1377/hlthaff.27.4.1140; State Council AIDS Working Committee Office and UN Theme Group on AIDS in China, 2007, JOINT ASS HIV AIDS P; Sterne JAC, 2007, JAIDS-J ACQ IMM DEF, V46, P607, DOI 10.1097/QAI.0b013e31815b7dba; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Van der Borght SF, 2009, ANTIVIR THER, V14, P63; Wang L, 2009, JAIDS-J ACQ IMM DEF, V50, P414, DOI 10.1097/QAI.0b013e3181958530; World Health Organization, 2006, ANT THER HIV INF AD; Zhang F., 2005, CHINA FREE ART MANUA; Zhang FJ, 2008, CLIN INFECT DIS, V47, P825, DOI 10.1086/590945; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhou J, 2007, HIV MED, V8, P8, DOI 10.1111/j.1468-1293.2007.00417.x	48	205	293	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2009	151	4					241	W52		10.7326/0003-4819-151-4-200908180-00006	http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484IW	19687491				2022-12-24	WOS:000269038900003
J	Gurwitz, D; Fortier, I; Lunshof, JE; Knoppers, BM				Gurwitz, David; Fortier, Isabel; Lunshof, Jeantine E.; Knoppers, Bartha Maria			Children and Population Biobanks	SCIENCE			English	Editorial Material							GENETIC PRIVACY; RESOURCE; SCIENCE		[Gurwitz, David] Tel Aviv Univ, Natl Lab Genet Israeli Populat, Dept Human Mol Genet & Biochem, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Fortier, Isabel] P3G, Montreal, PQ H3V 1A2, Canada; [Lunshof, Jeantine E.] Maastricht Univ, European Ctr Publ Hlth Genom, NL-6200 MD Maastricht, Netherlands; [Lunshof, Jeantine E.] Maastricht Univ, Fac Hlth Med & Life Sci, NL-6200 MD Maastricht, Netherlands; [Lunshof, Jeantine E.] Vrije Univ Amsterdam, Dept Mol Cell Physiol, NL-1081 HV Amsterdam, Netherlands; [Knoppers, Bartha Maria] McGill Univ, Dept Human Genet, Fac Med, Ctr Genom & Policy, Montreal, PQ H3A 1A4, Canada	Tel Aviv University; Sackler Faculty of Medicine; Maastricht University; Maastricht University; Vrije Universiteit Amsterdam; McGill University	Gurwitz, D (corresponding author), Tel Aviv Univ, Natl Lab Genet Israeli Populat, Dept Human Mol Genet & Biochem, Sackler Fac Med, IL-69978 Tel Aviv, Israel.	gurwitz@post.tau.ac.il	Gurwitz, David/E-7642-2013	Gurwitz, David/0000-0002-9363-1869; Lunshof, Jeantine E/0000-0002-5630-7947				Asslaber Martin, 2007, Briefings in Functional Genomics & Proteomics, V6, P193, DOI 10.1093/bfgp/elm023; Borry P, 2009, NAT REV GENET, V10, P8, DOI 10.1038/nrg2501; Couzin J, 2008, SCIENCE, V321, P1278, DOI 10.1126/science.321.5894.1278; Couzin-Frankel J, 2009, SCIENCE, V324, P166, DOI 10.1126/science.324.5924.166; Glantz LH, 1998, AM J LAW MED, V24, P213; Goldenberg AJ, 2009, J PEDIATR-US, V155, P578, DOI 10.1016/j.jpeds.2009.04.034; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Kaiser J, 2006, SCIENCE, V312, P1584; Knoppers BM, 2008, EUR J HUM GENET, V16, P664, DOI 10.1038/ejhg.2008.55; Kohane IS, 2005, NEW ENGL J MED, V353, P2074, DOI 10.1056/NEJMsb051220; Lunshof JE, 2008, NAT REV GENET, V9, P406, DOI 10.1038/nrg2360; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Palmer LJ, 2007, LANCET, V369, P1980, DOI 10.1016/S0140-6736(07)60924-6; Ronningen KS, 2006, EUR J EPIDEMIOL, V21, P619, DOI 10.1007/s10654-006-9041-x; Samuel J, 2008, GENEDIT, V6, P1; Yuille M, 2008, BRIEF BIOINFORM, V9, P14, DOI 10.1093/bib/bbm050	16	70	70	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 14	2009	325	5942					818	819		10.1126/science.1173284	http://dx.doi.org/10.1126/science.1173284			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AK	19679798	Green Published			2022-12-24	WOS:000269242400027
J	Beaugerie, L; Brousse, N; Bouvier, AM; Colombel, JF; Lemann, M; Cosnes, J; Hebuterne, X; Cortot, A; Bouhnik, Y; Gendre, JP; Simon, T; Maynadie, M; Hermine, O; Faivre, J; Carrat, F				Beaugerie, Laurent; Brousse, Nicole; Bouvier, Anne Marie; Colombel, Jean Frederic; Lemann, Marc; Cosnes, Jacques; Hebuterne, Xavier; Cortot, Antoine; Bouhnik, Yoram; Gendre, Jean Pierre; Simon, Tabassome; Maynadie, Marc; Hermine, Olivier; Faivre, Jean; Carrat, Fabrice		CESAME Study Grp	Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study	LANCET			English	Article							SOLID-ORGAN TRANSPLANTATION; CROHNS-DISEASE; INCREASED RISK; LYMPHOMA RISK; AZATHIOPRINE; MAINTENANCE; CANCER; METHOTREXATE; METAANALYSIS; INFLIXIMAB	Background Reports of an increased risk of lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease are controversial. We assessed this risk in a prospective observational cohort study. Methods 19486 patients with inflammatory bowel disease, of whom 11759 (60.3%) had Crohn's disease and 7727 (39.7%) had ulcerative colitis or unclassified inflammatory bowel disease, were enrolled in a nationwide French cohort by 680 gastroenterologists, who reported details of immunosuppressive therapy during the observation period, cases of cancer, and deaths. The risk of lymphoproliferative disorder was assessed according to thiopurine exposure. Median follow-up was 35 months (IQR 29-40). Findings At baseline, 5867 (30.1%) of patients were receiving, 2809 (14.4%) had discontinued, and 10810 (55.5%) had never received thiopurines. 23 new cases of lymphoproliferative disorder were diagnosed, consisting of one case of Hodgkin's lymphoma and 22 cases of non-Hodgkin lymphoproliferative disorder. The incidence rates of lymphoproliferative disorder were 0.90 per 1000 (95% CI 0.50-1.49) patient-years in those receiving, 0.20/1000 (0.02-0.72) patient-years in those who had discontinued, and 0.26/1000 (0.10-0.57) patient-years in those who had never received thiopurines (p=0.0054). The multivariate-adjusted hazard ratio of lymphoproliferative disorder between patients receiving thiopurines and those who had never received the drugs was 5.28 (2.01-13.9, p=0.0007). Most cases associated with thiopurine exposure matched the pathological range of post-transplant disease. Interpretation Patients receiving thiopurines for inflammatory bowel disease have an increased risk of developing lymphoproliferative disorders.	[Beaugerie, Laurent] Univ Paris 06, Serv Gastroenterol & Nutr, Hop St Antoine, Dept Gastroenterol,AP HP, F-75571 Paris 12, France; [Simon, Tabassome] Univ Paris 06, Dept Pharmacol, Hop St Antoine, AP HP, F-75571 Paris 12, France; [Simon, Tabassome] Univ Paris 06, URCEST, Hop St Antoine, AP HP, F-75571 Paris 12, France; [Carrat, Fabrice] Univ Paris 06, Unit Publ Hlth, Hop St Antoine, AP HP, F-75571 Paris 12, France; [Carrat, Fabrice] Univ Paris 06, INSERM, Hop St Antoine, AP HP,UMR S 707, F-75571 Paris 12, France; [Brousse, Nicole] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Dept Pathol, Paris, France; [Hermine, Olivier] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Dept Haematol, Paris, France; [Hermine, Olivier] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Ctr Reference Mastocytoses, Paris, France; [Bouvier, Anne Marie; Faivre, Jean] Univ Bourgogne, CHU Dijon, Registre Bourguignon Canc Digestifs, Dijon, France; [Maynadie, Marc] Univ Bourgogne, CHU Dijon, Registre Hemopathies Malignes Cote Or, EA4184, Dijon, France; [Colombel, Jean Frederic; Cortot, Antoine] CHU Lille, Dept Hepatogastroenterol, F-59037 Lille, France; [Lemann, Marc] Univ Paris 07, Dept Gastroenterol, Hop St Louis, AP HP, Paris, France; [Bouhnik, Yoram] Univ Paris 07, Dept Gastroenterol, Hop Beaujon, AP HP, Paris, France; [Hebuterne, Xavier] Univ Nice Sophia Antipolis, Dept Gastroenterol, CHU Nice, INSERM ERI 21, Nice, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Beaugerie, L (corresponding author), Univ Paris 06, Serv Gastroenterol & Nutr, Hop St Antoine, Dept Gastroenterol,AP HP, F-75571 Paris 12, France.	laurent.beaugerie@sat.aphp.fr	CORTOT, ANTOINE/I-7739-2016; gottrand, frederic F/G-7370-2015; Bourreille, Arnaud/K-2398-2015; Michaud, Laurent/S-2041-2018; Desreumaux, Pierre F/R-6877-2018; NANCEY, STEPHANE/Y-5093-2019; Carrat, Fabrice/AAU-8480-2020; Bouvier, Anne-Marie/GLU-3915-2022; BOUVIER, Anne-Marie/R-6600-2017; Hermine, Olivier/Q-7072-2018; CORTOT, Antoine/I-5796-2015; Maynadié, Marc/E-6271-2010	CORTOT, ANTOINE/0000-0002-1067-8996; gottrand, frederic F/0000-0002-5290-0436; Michaud, Laurent/0000-0002-5020-1367; Desreumaux, Pierre F/0000-0002-6127-5281; NANCEY, STEPHANE/0000-0003-2088-1442; Carrat, Fabrice/0000-0002-8672-7918; Bouvier, Anne-Marie/0000-0001-9070-1027; Hugot, Jean-Pierre/0000-0002-8446-6056; GARGOT, Dany/0000-0002-7369-9532; Siproudhis, laurent/0000-0002-2575-6790; Hermine, Olivier/0000-0003-2574-3874; Savoye, Guillaume/0000-0002-9200-2067; MION, Francois/0000-0002-2908-1591; SIMON, Tabassome/0000-0002-4550-0450; FLOURIE, bernard/0000-0002-3300-0299; Thiefin, Gerard/0000-0002-8626-8352; CHRISTIDIS, Christos/0000-0002-7565-0134; Ganne-Carrie, Nathalie/0000-0002-7351-5027; BENAMOUZIG, ROBERT/0000-0003-1952-6830; peyrin-biroulet, laurent/0000-0003-2536-6618	Programme Hospitalier de Recherche Clinique National [AOM05157]; Association Francois Aupetit; Delegation Interregionale de la Recherche Clinique Ile de France-Assistance Publique Hopitaux de Paris; Ligue contre le Cancer; Fonds de Recherche de la Societe Nationale Francaise de Gastro-enterologie	Programme Hospitalier de Recherche Clinique National; Association Francois Aupetit; Delegation Interregionale de la Recherche Clinique Ile de France-Assistance Publique Hopitaux de Paris; Ligue contre le Cancer(Ligue nationale contre le cancer); Fonds de Recherche de la Societe Nationale Francaise de Gastro-enterologie	Supported by grants from Programme Hospitalier de Recherche Clinique National (AOM05157), Association Francois Aupetit, Delegation Interregionale de la Recherche Clinique Ile de France-Assistance Publique Hopitaux de Paris (AP-HP), Ligue contre le Cancer, and Fonds de Recherche de la Societe Nationale Francaise de Gastro-enterologie. We thank Roger Salamon for his independent review of the study design.	Armitage P., 2001, STAT METHODS MED RES; Askling J, 2005, GUT, V54, P617, DOI 10.1136/gut.2004.051771; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Caillard S, 2006, AM J TRANSPLANT, V6, P2735, DOI 10.1111/j.1600-6143.2006.01540.x; Cosnes J, 2005, GUT, V54, P237, DOI 10.1136/gut.2004.045294; Dayharsh GA, 2002, GASTROENTEROLOGY, V122, P72, DOI 10.1053/gast.2002.30328; DHaens G, 1997, GASTROENTEROLOGY, V112, P1475, DOI 10.1016/S0016-5085(97)70027-1; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Feagan BG, 2000, NEW ENGL J MED, V342, P1627, DOI 10.1056/NEJM200006013422202; Jess T, 2005, AM J GASTROENTEROL, V100, P2724, DOI 10.1111/j.1572-0241.2005.00287.x; Jones JL, 2007, INFLAMM BOWEL DIS, V13, P1299, DOI 10.1002/ibd.20211; Kandiel A, 2005, GUT, V54, P1121, DOI 10.1136/gut.2004.049460; KINLEN LJ, 1979, BRIT MED J, V2, P1461, DOI 10.1136/bmj.2.6203.1461; LAW CG, 1992, STAT MED, V11, P1569, DOI 10.1002/sim.4780111204; Lewis JD, 2000, GASTROENTEROLOGY, V118, P1018, DOI 10.1016/S0016-5085(00)70353-2; Lewis JD, 2001, GASTROENTEROLOGY, V121, P1080, DOI 10.1053/gast.2001.28703; Lichtenstein GR, 2006, GASTROENTEROLOGY, V130, P940, DOI 10.1053/j.gastro.2006.01.048; Mariette X, 2002, BLOOD, V99, P3909, DOI 10.1182/blood.V99.11.3909; Masunaga Y, 2007, ANN PHARMACOTHER, V41, P21, DOI 10.1345/aph.1H219; Opelz G, 2004, AM J TRANSPLANT, V4, P222, DOI 10.1046/j.1600-6143.2003.00325.x; Pearson DC, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000067; POSTHUMA EFM, 1995, GUT, V36, P311, DOI 10.1136/gut.36.2.311; Rezk SA, 2007, HUM PATHOL, V38, P1293, DOI 10.1016/j.humpath.2007.05.020; Rutgeerts P, 2004, GASTROENTEROLOGY, V126, P402, DOI 10.1053/j.gastro.2003.11.014; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Seksik P, 2009, INFLAMM BOWEL DIS, V15, P734, DOI 10.1002/ibd.20828; Swerdlow SH, 2008, WHO CLASSIFICATION T, P343; Takakuwa T, 2008, LEUKEMIA, V22, P620, DOI 10.1038/sj.leu.2405059; Taylor AL, 2005, CRIT REV ONCOL HEMAT, V56, P23, DOI 10.1016/j.critrevonc.2005.03.012; Timmer A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000478.pub2; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052	32	751	775	0	45	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2009	374	9701					1617	1625		10.1016/S0140-6736(09)61302-7	http://dx.doi.org/10.1016/S0140-6736(09)61302-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518EZ	19837455				2022-12-24	WOS:000271674600035
J	Kim, JJ; Ortendahl, J; Goldie, SJ				Kim, Jane J.; Ortendahl, Jesse; Goldie, Sue J.			Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							HPV TYPE-DISTRIBUTION; HEALTH-CARE; ECONOMIC-EVALUATION; SOCIETY GUIDELINE; PARTICLE VACCINE; FOLLOW-UP; DNA; PREVALENCE; WORLDWIDE; NEOPLASIA	Background: Women older than 30 years are the main beneficiaries of improved cervical cancer screening with human papillomavirus (HPV) DNA testing. The role of vaccination against HPV types 16 and 18, which is recommended routinely for preadolescent girls, is unclear in this age group. Objective: To assess the health and economic outcomes of HPV vaccination in older U. S. women. Design: Cost-effectiveness analysis with an empirically calibrated model. Data Sources: Published literature. Target Population: U.S. women aged 35 to 45 years. Time Horizon: Lifetime. Perspective: Societal. Intervention: HPV vaccination added to screening strategies that differ by test (cytology or HPV DNA testing), frequency, and start age versus screening alone. Outcome Measures: Incremental cost-effectiveness ratios (2006 U.S. dollars per quality-adjusted life-year [QALY] gained). Results of Base-Case Analysis: In the context of annual or biennial screening, HPV vaccination of women aged 35 to 45 years ranged from $116 950 to $272 350 per QALY for cytology with HPV DNA testing for triage of equivocal results and from $193 690 to $381 590 per QALY for combined cytology and HPV DNA testing, depending on age and screening frequency. Results of Sensitivity Analysis: The probability of HPV vaccination being cost-effective for women aged 35 to 45 years was 0% with annual or biennial screening and less than 5% with triennial screening, at thresholds considered good value for money. Limitation: The natural history of the disease and the efficacy of the vaccine in older women are uncertain. Conclusion: Given currently available information, the effectiveness of HPV vaccination for women older than 30 years who are screened seems to be small. Compared with current screening that uses sensitive HPV DNA testing, HPV vaccination is associated with less attractive cost-effectiveness ratios in this population than those for other, well-accepted interventions in the United States.	[Kim, Jane J.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Kim, JJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, 718 Huntington Ave,2nd Floor, Boston, MA 02115 USA.	jkim@hsph.harvard.edu		Ortendahl, Jesse/0000-0003-0911-340X	National Cancer Institute [R01 CA93435]; Centers for Disease Control and Prevention; American Cancer Society; Bill and Melinda Gates Foundation [30505]; NATIONAL CANCER INSTITUTE [R01CA093435] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); American Cancer Society(American Cancer Society); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute (R01 CA93435), the Centers for Disease Control and Prevention, and the American Cancer Society, and also the Bill and Melinda Gates Foundation (30505) for related work in developing countries.	American College of Obstetricians and Gynecologists, 2003, Int J Gynaecol Obstet, V83, P237; Arbyn M, 2008, OBSTET GYNECOL, V111, P167, DOI 10.1097/01.AOG.0000296488.85807.b3; Barr E, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.001; Cantor SB, 2006, MED DECIS MAKING, V26, P265, DOI 10.1177/027298906288679; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; Clifford GM, 2005, CANCER EPIDEM BIOMAR, V14, P1157, DOI 10.1158/1055-9965.EPI-04-0812; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; *CTR MED MED SERV, 2005, 2006 CLIN LAB FEE SC; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; Eltoum IA, 2007, CANCER CYTOPATHOL, V111, P34, DOI 10.1002/cncr.22487; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Franco EL, 2006, VACCINE, V24, P171, DOI 10.1016/j.vaccine.2006.05.061; French KM, 2007, BRIT J CANCER, V96, P514, DOI 10.1038/sj.bjc.6603575; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Gold MR, 1996, COST EFFECTIVENESS H; Goldhaber-Fiebert Jeremy D, 2007, Popul Health Metr, V5, P11, DOI 10.1186/1478-7954-5-11; Goldhaber-Fiebert JD, 2008, JNCI-J NATL CANCER I, V100, P308, DOI 10.1093/jnci/djn019; Goldie SJ, 2004, OBSTET GYNECOL, V103, P619, DOI 10.1097/01.AOG.0000120143.50098.c7; Goldie SJ, 2004, JNCI-J NATL CANCER I, V96, P604, DOI 10.1093/jnci/djh104; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Huang ES, 2007, HEALTH SERV RES, V42, P2174, DOI 10.1111/j.1475-6773.2007.00734.x; HUANG ES, 2007, HEALTH SERV RES, V42, P2294; Insinga RP, 2004, CANCER EPIDEM BIOMAR, V13, P355; Iskedjian M, 2004, VACCINE, V22, P4215, DOI 10.1016/j.vaccine.2004.04.025; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Kim JJ, 2008, NEW ENGL J MED, V359, P821, DOI 10.1056/NEJMsa0707052; Kim JJ, 2007, AM J EPIDEMIOL, V166, P137, DOI 10.1093/aje/kwm086; King JT, 2005, MED DECIS MAKING, V25, P667, DOI 10.1177/0272989X05282640; Kulasingam SL, 2006, JNCI-J NATL CANCER I, V98, P92, DOI 10.1093/jnci/djj009; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; Losina E, 2009, ARCH INTERN MED, V169, P1113, DOI 10.1001/archinternmed.2009.136; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Munoz N, 2009, LANCET, V373, P1949, DOI 10.1016/S0140-6736(09)60691-7; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Paavonen J, 2008, CURR MED RES OPIN, V24, P1623, DOI 10.1185/03007990802068151; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Parkin DM, 2005, CANC INCIDENCE 5 CON, VI-VIII; RIES LAG, 2004, SURVEILLANCE EPIDEMI; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; Saslow D, 2007, CA-CANCER J CLIN, V57, P7, DOI 10.3322/canjclin.57.1.7; Schwarz TF, 2009, VACCINE, V27, P581, DOI 10.1016/j.vaccine.2008.10.088; Shireman TI, 2001, INT J TECHNOL ASSESS, V17, P146, DOI 10.1017/S0266462301104137; SHIROIWA T, 2009, HLTH EC; Skinner SR, 2008, MED J AUSTRALIA, V188, P238, DOI 10.5694/j.1326-5377.2008.tb01593.x; Steinbrook R, 2009, NEW ENGL J MED, V360, P1057, DOI 10.1056/NEJMp0900665; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Taira AV, 2004, EMERG INFECT DIS, V10, P1915, DOI 10.3201/eid1011.040222; *US BUR LAB STAT, 2009, CONS PRIC IND MED CA; *US CDCP, 1999, HIV COUNS TEST SYST; *US CDCP, 2008, HPV VACC INF YOUNG W; Villa L, 2007, LANCET, V369, P1861, DOI 10.1016/S0140-6736(07)60852-6; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Wallace LA, 2005, VACCINE, V23, P5624, DOI 10.1016/j.vaccine.2005.06.034; Winkelmayer WC, 2002, MED DECIS MAKING, V22, P417, DOI 10.1177/027298902236927; Wong JB, 2009, ANN INTERN MED, V150, P274, DOI 10.7326/0003-4819-150-4-200902170-00010; Wright TC, 2004, OBSTET GYNECOL, V103, P304, DOI 10.1097/01.AOG.0000109426.82624.f8	61	70	70	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2009	151	8					538	U45		10.7326/0003-4819-151-8-200910200-00007	http://dx.doi.org/10.7326/0003-4819-151-8-200910200-00007			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514HY	19841455	Green Accepted			2022-12-24	WOS:000271386200003
J	Shin, JH; Dawson, VL; Dawson, TM				Shin, Joo-Ho; Dawson, Valina L.; Dawson, Ted M.			SnapShot: Pathogenesis of Parkinson's Disease	CELL			English	Editorial Material									[Shin, Joo-Ho] Johns Hopkins Univ, Sch Med, NeuroRegenerat Program, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Stem Cell Program, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Shin, JH (corresponding author), Johns Hopkins Univ, Sch Med, NeuroRegenerat Program, Baltimore, MD 21205 USA.		Dawson, Valina/Y-9757-2019; Shin, Joo-Ho/P-1417-2018	Dawson, Valina/0000-0002-2915-3970	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377] Funding Source: NIH RePORTER; NINDS NIH HHS [P50 NS038377] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abeliovich A, 2007, NATURE, V448, P759, DOI 10.1038/448759a; Gasser T, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001148; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Gupta A, 2008, ANN NEUROL, V64, pS3, DOI 10.1002/ana.21573; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lim KL, 2009, BBA-MOL BASIS DIS, V1792, P604, DOI 10.1016/j.bbadis.2008.10.005; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7	7	13	13	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 16	2009	139	2							440.e1	10.1016/j.cell.2009.09.026	http://dx.doi.org/10.1016/j.cell.2009.09.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837042	Bronze			2022-12-24	WOS:000270857500025
J	Yi, MS; Hong, N; Hong, YH				Yi, Meisheng; Hong, Ni; Hong, Yunhan			Generation of Medaka Fish Haploid Embryonic Stem Cells	SCIENCE			English	Article							ORYZIAS-LATIPES; DROSOPHILA-MELANOGASTER; MOUSE EMBRYOS; LINES; DIFFERENTIATION; ESTABLISHMENT; BIOLOGY; BLASTOCYSTS; DERIVATION; EXPRESSION	Haploid embryonic stem (ES) cells combine haploidy and pluripotency, enabling direct genetic analyses of recessive phenotypes in vertebrate cells. Haploid cells have been elusive for culture, due to their inferior growth and genomic instability. Here, we generated gynogenetic medaka embryos and obtained three haploid ES cell lines that retained pluripotency and competitive growth. Upon nuclear transfer into unfertilized oocytes, the haploid ES cells, even after genetic engineering, generated viable offspring capable of germline transmission. Hence, haploid medaka ES cells stably maintain normal growth, pluripotency, and genomic integrity. Mosaic oocytes created by combining a mitotic nucleus and a meiotic nucleus can generate fertile fish offspring. Haploid ES cells may offer a yeast-like system for analyzing recessive phenotypes in numerous cell lineages of vertebrates in vitro.	[Yi, Meisheng; Hong, Ni; Hong, Yunhan] Natl Univ Singapore, Dept Biol Sci, Singapore 119260, Singapore	National University of Singapore	Hong, YH (corresponding author), Natl Univ Singapore, Dept Biol Sci, 10 Kent Ridge Crescent, Singapore 119260, Singapore.	dbshyh@nus.edu.sg	Hong, Ni/Y-6114-2018; Test Account, SLB-WOS/E-5790-2010; Hong, Yunhan/D-4197-2009	Hong, Ni/0000-0002-9404-3110; 	Biomedical Research Council of Singapore [R-05-1-21-19-404, R-08-1-21-19-585, SBIC-SSCC C-002-2007]; Ministry of Education of Singapore [R-154-000-285-112]; National University of Singapore; Lee Hiok Kwee donation [R-154-000-153-720]	Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Education of Singapore(Ministry of Education, Singapore); National University of Singapore(National University of Singapore); Lee Hiok Kwee donation	Supported by the Biomedical Research Council of Singapore (R-05-1-21-19-404, R-08-1-21-19-585 and SBIC-SSCC C-002-2007), the Ministry of Education of Singapore (R-154-000-285-112), the National University of Singapore, and the Lee Hiok Kwee donation (R-154-000-153-720). We thank J. Deng for fish breeding.	Araki K, 2001, DEV GROWTH DIFFER, V43, P591; Bejar J, 2003, DEVELOPMENT, V130, P6545, DOI 10.1242/dev.00872; BOTSTEIN D, 1988, SCIENCE, V240, P1439, DOI 10.1126/science.3287619; DEBEC A, 1984, EXP CELL RES, V151, P236, DOI 10.1016/0014-4827(84)90371-9; DEBEC A, 1978, NATURE, V274, P255, DOI 10.1038/274255a0; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FREED J J, 1970, Proceedings of the National Academy of Sciences of the United States of America, V65, P337, DOI 10.1073/pnas.65.2.337; Hong YH, 1998, DEV GENES EVOL, V208, P595, DOI 10.1007/s004270050220; Hong YH, 1998, P NATL ACAD SCI USA, V95, P3679, DOI 10.1073/pnas.95.7.3679; Hong YH, 2004, P NATL ACAD SCI USA, V101, P8011, DOI 10.1073/pnas.0308668101; Hong YH, 1996, MECH DEVELOP, V60, P33, DOI 10.1016/S0925-4773(96)00596-5; Hong Yunhan, 2006, V329, P3; KAUFMAN MH, 1983, J EMBRYOL EXP MORPH, V73, P249; Kobayashi D, 2006, DEV GROWTH DIFFER, V48, P283, DOI 10.1111/j.1440-169x.2006.00870.x; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Mai QY, 2007, CELL RES, V17, P1008, DOI 10.1038/cr.2007.102; Otto SP, 2008, CURR BIOL, V18, pR1121, DOI 10.1016/j.cub.2008.09.039; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; UWA H, 1981, P JPN ACAD B-PHYS, V57, P39, DOI 10.2183/pjab.57.39; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659; Yanagimachi R, 2005, REPROD BIOMED ONLINE, V10, P247, DOI 10.1016/S1472-6483(10)60947-9	24	141	173	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					430	433		10.1126/science.1175151	http://dx.doi.org/10.1126/science.1175151			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833967				2022-12-24	WOS:000270818600054
J	Issigonis, M; Tulina, N; de Cuevas, M; Brawley, C; Sandler, L; Matunis, E				Issigonis, Melanie; Tulina, Natalia; de Cuevas, Margaret; Brawley, Crista; Sandler, Laurel; Matunis, Erika			JAK-STAT Signal Inhibition Regulates Competition in the Drosophila Testis Stem Cell Niche	SCIENCE			English	Article							SELF-RENEWAL; JAK/STAT PATHWAY; SOMATIC CONTROL; PROTEIN; CANCER; RECEPTOR	Adult stem cells often reside in local microenvironments, or niches. Although niches can contain multiple types of stem cells, the coordinate regulation of stem cell behavior is poorly understood. In the Drosophila testis, Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling is directly required for maintenance of the resident germline and somatic stem cells. We found that the JAK-STAT signaling target and inhibitor Suppressor of cytokine signaling 36E (SOCS36E) is required for germline stem cell maintenance. SOCS36E suppresses JAK-STAT signaling specifically in the somatic stem cells, preventing them from displacing neighboring germline stem cells in a manner that depends on the adhesion protein integrin. Thus, in niches housing multiple stem cell types, negative feedback loops can modulate signaling, preventing one stem cell population from outcompeting the other.	[Issigonis, Melanie; Tulina, Natalia; de Cuevas, Margaret; Brawley, Crista; Sandler, Laurel; Matunis, Erika] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Matunis, E (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St, Baltimore, MD 21205 USA.	matunis@jhmi.edu	de Cuevas, Margaret/GXV-8365-2022		NIH [RO1HD40307]; Basil O'Connor/March of Dimes [5-FY02-285]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052937, R01HD040307] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basil O'Connor/March of Dimes(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the Bloomington Stock Center, Developmental Studies Hybridoma Bank, and members of the fly community for reagents; M. Sepanski for electron microscopy; M. Gold for inverse polymerase chain reaction; B. Ohlstein, M. Wawersik, and M. Matunis for helpful comments; and J. Leatherman and S. DiNardo for sharing unpublished data. This work was supported by NIH grant RO1HD40307 ( to E. M.) and Basil O'Connor/March of Dimes grant 5-FY02-285 ( to M. C.). The authors have no conflicts of interest.	Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Callus BA, 2002, ONCOGENE, V21, P4812, DOI 10.1038/sj.onc.1205618; Chen HW, 2002, GENE DEV, V16, P388, DOI 10.1101/gad.955202; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Ghiglione C, 2002, DEVELOPMENT, V129, P5437, DOI 10.1242/dev.00116; Gonzalez-Reyes A, 2003, J CELL SCI, V116, P949, DOI 10.1242/jcs.00310; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Karsten P, 2002, MECH DEVELOP, V117, P343, DOI 10.1016/S0925-4773(02)00216-2; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Leeman RJ, 2006, EXPERT OPIN BIOL TH, V6, P231, DOI 10.1517/14712598.6.3.231; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nystul TG, 2006, CURR OPIN GENET DEV, V16, P463, DOI 10.1016/j.gde.2006.08.003; Pontier SM, 2009, J CELL SCI, V122, P207, DOI 10.1242/jcs.040394; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sarkar A, 2007, CURR BIOL, V17, P1253, DOI 10.1016/j.cub.2007.06.048; Terry NA, 2006, DEV BIOL, V294, P246, DOI 10.1016/j.ydbio.2006.02.048; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173; Wawersik M, 2005, NATURE, V436, P563, DOI 10.1038/nature03849	27	119	123	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					153	156		10.1126/science.1176817	http://dx.doi.org/10.1126/science.1176817			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797664	Green Accepted			2022-12-24	WOS:000270355600059
J	Ludvigsson, JF; Montgomery, SM; Ekbom, A; Brandt, L; Granath, F				Ludvigsson, Jonas F.; Montgomery, Scott M.; Ekbom, Anders; Brandt, Lena; Granath, Fredrik			Small-Intestinal Histopathology and Mortality Risk in Celiac Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POPULATION-BASED COHORT; C-REACTIVE PROTEIN; TISSUE TRANSGLUTAMINASE; GLUTEN SENSITIVITY; INFLAMMATION; DIAGNOSIS; INDIVIDUALS; MALIGNANCY; SMOKING; PEOPLE	Context Studies of mortality in celiac disease have not taken small-intestinal pathology into account. Objective To examine mortality in celiac disease according to small-intestinal histopathology. Design, Setting, and Patients Retrospective cohort study. We collected data from duodenal/jejunal biopsies taken between July 1969 and February 2008 on celiac disease (Marsh stage 3: villous atrophy; n=29 096 individuals) and inflammation (Marsh stage 1-2; n=13 306) from all 28 pathology departments in Sweden. A third cohort consisted of individuals with latent celiac disease from 8 university hospitals (n=3719). Latent celiac disease was defined as positive celiac disease serology in individuals with normal mucosa (Marsh stage 0). Through linkage with the Swedish Total Population Register, we estimated the risk of death through August 31, 2008, compared with age-and sex-matched controls from the general population. Main Outcome Measure All-cause mortality. Results There were 3049 deaths among patients with celiac disease, 2967 with inflammation, and 183 with latent celiac disease. We found an increased hazard ratio (HR) for death in celiac disease (HR, 1.39; 95% confidence interval [CI], 1.33-1.45; median follow-up, 8.8 years), inflammation (HR, 1.72; 95% CI, 1.64-1.79; median follow-up, 7.2 years), and latent celiac disease (HR, 1.35; 95% CI, 1.14-1.58; median follow-up, 6.7 years). The absolute mortality rate was 10.4 (95% CI, 10.0-10.8) per 1000 person-years in celiac disease, 25.9 (95% CI, 25.0-26.8) in inflammation, and 6.7 (95% CI, 5.7-7.6) in latent celiac disease. Excess mortality was 2.9 per 1000 person-years in celiac disease, 10.8 in inflammation, and 1.7 in latent celiac disease. This risk increase was also seen in children. Excluding the first year of follow-up, HRs decreased somewhat. Conclusion Risk of death among patients with celiac disease, inflammation, or latent celiac disease is modestly increased. JAMA. 2009; 302(11): 1171-1178	[Ludvigsson, Jonas F.] Orebro Univ Hosp, Dept Pediat, S-70185 Orebro, Sweden; [Montgomery, Scott M.] Orebro Univ Hosp, Clin Res Ctr, S-70185 Orebro, Sweden; [Ludvigsson, Jonas F.; Montgomery, Scott M.; Ekbom, Anders; Brandt, Lena; Granath, Fredrik] Karolinska Inst, Clin Epidemiol Unit, Dept Med, Stockholm, Sweden; [Montgomery, Scott M.] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, Charing Cross Hosp, London, England	Orebro University; Orebro University; Karolinska Institutet; Imperial College London	Ludvigsson, JF (corresponding author), Orebro Univ Hosp, Dept Pediat, S-70185 Orebro, Sweden.	jonasludvigsson@yahoo.com	Ludvigsson, Jonas F/A-8560-2012; Montgomery, Scott/AAN-2546-2020	Ludvigsson, Jonas F/0000-0003-1024-5602; Montgomery, Scott/0000-0001-6328-5494	Orebro University Hospital; Swedish Society of Medicine; Swedish Research Council; Sven Jerring Foundation; Orebro Society of Medicine; Karolinska Institutet; Clas Groschinsky Foundation; Juhlin Foundation; Majblomman Foundation; Uppsala-Orebro Regional Research Council; Swedish Celiac Society	Orebro University Hospital; Swedish Society of Medicine; Swedish Research Council(Swedish Research CouncilEuropean Commission); Sven Jerring Foundation; Orebro Society of Medicine; Karolinska Institutet(Karolinska Institutet); Clas Groschinsky Foundation; Juhlin Foundation; Majblomman Foundation; Uppsala-Orebro Regional Research Council; Swedish Celiac Society	Funding/Support: Dr Ludvigsson was supported by a grant from the Orebro University Hospital. This project was supported by a grant from the Swedish Society of Medicine, the Swedish Research Council, the Sven Jerring Foundation, the Orebro Society of Medicine, the Karolinska Institutet, the Clas Groschinsky Foundation, the Juhlin Foundation, the Majblomman Foundation, Uppsala-Orebro Regional Research Council, and the Swedish Celiac Society.	Anderson LA, 2007, WORLD J GASTROENTERO, V13, P146, DOI 10.3748/wjg.v13.i1.146; [Anonymous], 2005, GASTROENTEROLOGY, V128, pS1, DOI 10.1053/j.gastro.2005.02.007; BURGINWOLFF A, 1991, ARCH DIS CHILD, V66, P941, DOI 10.1136/adc.66.8.941; COLLIN P, 1994, GUT, V35, P1215, DOI 10.1136/gut.35.9.1215; Corrao G, 2001, LANCET, V358, P356, DOI 10.1016/S0140-6736(01)05554-4; Cottone M, 1999, DIGEST DIS SCI, V44, P2538, DOI 10.1023/A:1026655609906; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Dickson BC, 2006, J CLIN PATHOL, V59, P1008, DOI 10.1136/jcp.2005.035345; Dieterich W, 1998, GASTROENTEROLOGY, V115, P1317, DOI 10.1016/S0016-5085(98)70007-1; Erlinger TP, 2004, JAMA-J AM MED ASSOC, V291, P585, DOI 10.1001/jama.291.5.585; Hill PG, 2008, ALIMENT PHARM THER, V27, P572, DOI 10.1111/j.1365-2036.2008.03609.x; Johannesson I, 2002, TOTAL POPULATION REG; Lee SK, 2003, GASTROINTEST ENDOSC, V57, P187, DOI 10.1067/mge.2003.54; LOGAN RFA, 1989, GASTROENTEROLOGY, V97, P265, DOI 10.1016/0016-5085(89)90060-7; Ludvigsson JF, 2005, CLIN GASTROENTEROL H, V3, P869, DOI 10.1016/S1542-3565(05)00414-3; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Ludvigsson JF, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-57; Ludvigsson JF, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-19; Mahadeva S, 2002, J CLIN PATHOL, V55, P424, DOI 10.1136/jcp.55.6.424; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Metzger MH, 2006, EUR J EPIDEMIOL, V21, P359, DOI 10.1007/s10654-006-9002-4; NIELSEN OH, 1985, SCAND J GASTROENTERO, V20, P13, DOI 10.3109/00365528509089626; PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207; Peters U, 2003, ARCH INTERN MED, V163, P1566, DOI 10.1001/archinte.163.13.1566; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004; Snook JA, 1996, GUT, V39, P60, DOI 10.1136/gut.39.1.60; Solaymani-Dodaran M, 2007, AM J GASTROENTEROL, V102, P864, DOI 10.1111/j.1572-0241.2007.01111.x; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; Viljamaa M, 2006, DIGEST LIVER DIS, V38, P374, DOI 10.1016/j.dld.2006.03.002; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C; West J, 2003, GUT, V52, P960, DOI 10.1136/gut.52.7.960; Westin M, 2004, HEALTH POLICY, V68, P333, DOI 10.1016/j.healthpol.2003.10.008	34	277	279	1	23	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	2009	302	11					1171	1178		10.1001/jama.2009.1320	http://dx.doi.org/10.1001/jama.2009.1320			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494FR	19755695				2022-12-24	WOS:000269797600026
J	Xia, ZP; Sun, LJ; Chen, X; Pineda, G; Jiang, XM; Adhikari, A; Zeng, WW; Chen, ZJ				Xia, Zong-Ping; Sun, Lijun; Chen, Xiang; Pineda, Gabriel; Jiang, Xiaomo; Adhikari, Anirban; Zeng, Wenwen; Chen, Zhijian J.			Direct activation of protein kinases by unanchored polyubiquitin chains	NATURE			English	Article							NF-KAPPA-B; UBIQUITIN-CONJUGATING ENZYME; LYS63-LINKED POLYUBIQUITINATION; BINDING; NEMO; TRAF6; TAK1; IL-1; IKK; AUTOUBIQUITINATION	TRAF6 is a ubiquitin ligase that is essential for the activation of NF-kappa B and MAP kinases in several signalling pathways, including those emanating from the interleukin 1 and Toll-like receptors(1-3). TRAF6 functions together with a ubiquitin-conjugating enzyme complex consisting of UBC13 (also known as UBE2N) and UEV1A (UBE2V1) to catalyse Lys 63-linked polyubiquitination, which activates the TAK1 (also known as MAP3K7) kinase complex(4,5). TAK1 in turn phosphorylates and activates I kappa B kinase (IKK), leading to the activation of NF-kappa B. Although several proteins are known to be polyubiquitinated in the IL1R and Toll-like receptor pathways, it is not clear whether ubiquitination of any of these proteins is important for TAK1 or IKK activation. By reconstituting TAK1 activation in vitro using purified proteins, here we show that free Lys 63 polyubiquitin chains, which are not conjugated to any target protein, directly activate TAK1 by binding to the ubiquitin receptor TAB2 (also known as MAP3K7IP2). This binding leads to autophosphorylation and activation of TAK1. Furthermore, we found that unanchored polyubiquitin chains synthesized by TRAF6 and UBCH5C (also known as UBE2D3) activate the IKK complex. Disassembly of the polyubiquitin chains by deubiquitination enzymes prevented TAK1 and IKK activation. These results indicate that unanchored polyubiquitin chains directly activate TAK1 and IKK, suggesting a new mechanism of protein kinase regulation.	[Xia, Zong-Ping; Sun, Lijun; Chen, Xiang; Pineda, Gabriel; Jiang, Xiaomo; Adhikari, Anirban; Zeng, Wenwen; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Sun, Lijun; Chen, Xiang; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	Zhijian.Chen@UTSouthwestern.edu	Sun, Lijun/ABD-4470-2021; Zeng, Wenwen/D-7276-2017; Chen, Zhijian/C-6039-2012	Zeng, Wenwen/0000-0001-8544-3318; Chen, Zhijian/0000-0002-8475-8251	National Institute of Health [RO1-AI09919, RO1-GM63692]; Robert Welch Foundation [I-1389]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060919, F32AI009919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063692] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch Foundation(The Welch Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C.-K. Ea for generating the HEK293 cell line stably expressing the TAP-tagged TAK1, J. Ashwell for the bacterial GST-Ub2 and GST-Ub3 expression plasmids, A. Garcia-Sastre for the expression vector encoding the viral OTU enzyme, CCHFV-L(1-169), and X. Li for the IRAK1-deficient HEK293 cells line. Wealso thank B. Skaug for critically reading the manuscript. This work was supported by grants from the National Institute of Health (RO1-AI09919 and RO1-GM63692) and the Robert Welch Foundation (I-1389). Z. J. C. is an Investigator of the Howard Hughes Medical Institute.	Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Courtois G, 2008, CELL MOL LIFE SCI, V65, P1123, DOI 10.1007/s00018-007-7465-4; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; HAYSTEAD CMM, 1993, EUR J BIOCHEM, V214, P459, DOI 10.1111/j.1432-1033.1993.tb17942.x; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Inoue J, 2007, ADV EXP MED BIOL, V597, P72; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Krappmann D, 2005, EMBO REP, V6, P321, DOI 10.1038/sj.embor.7400380; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Li XX, 1999, MOL CELL BIOL, V19, P4643; Petroski MD, 2007, J BIOL CHEM, V282, P29936, DOI 10.1074/jbc.M703911200; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; You JX, 1999, BIOTECHNIQUES, V27, P950, DOI 10.2144/99275st01; Zhang F, 2001, J BIOL CHEM, V276, P24946, DOI 10.1074/jbc.M102108200	30	408	433	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					114	U125		10.1038/nature08247	http://dx.doi.org/10.1038/nature08247			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19675569	Green Accepted			2022-12-24	WOS:000269478800041
J	Sessler, DI				Sessler, Daniel I.			New surgical thermal management guidelines	LANCET			English	Editorial Material							WOUND-INFECTION; NORMOTHERMIA; HYPOTHERMIA		Cleveland Clin, Dept Outcomes Res, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Sessler, DI (corresponding author), Cleveland Clin, Dept Outcomes Res, Cleveland, OH 44195 USA.	DS@OR.org	Sessler, Daniel/D-3504-2011	Sessler, Daniel/0000-0001-9932-3077				Centers for Medicare and Medicaid Services, 2009, PHYS QUAL REP IN; Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Lenhardt R, 1997, ANESTHESIOLOGY, V87, P1318, DOI 10.1097/00000542-199712000-00009; Melling AC, 2001, LANCET, V358, P876, DOI 10.1016/S0140-6736(01)06071-8; *QUAL NET, 2009, SURG CAR IMPR PROJ D; Rajagopalan S, 2008, ANESTHESIOLOGY, V108, P71, DOI 10.1097/01.anes.0000296719.73450.52; Sessler DI, 2008, ANESTHESIOLOGY, V109, P318, DOI 10.1097/ALN.0b013e31817f6d76; Sessler DI, 2000, ANESTHESIOLOGY, V92, P578, DOI 10.1097/00000542-200002000-00042	9	21	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2009	374	9695					1049	1050		10.1016/S0140-6736(09)61686-X	http://dx.doi.org/10.1016/S0140-6736(09)61686-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	501HA	19782858				2022-12-24	WOS:000270370900010
J	Blaha, G; Stanley, RE; Steitz, TA				Blaha, Gregor; Stanley, Robin E.; Steitz, Thomas A.			Formation of the First Peptide Bond: The Structure of EF-P Bound to the 70S Ribosome	SCIENCE			English	Article							TRANSLATION INITIATION COMPLEX; ELONGATION-FACTOR-P; ESCHERICHIA-COLI; TRANSFER-RNA; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; HYPUSINE MODIFICATION; GENE-PRODUCT; FACTOR 5A; L1 STALK	Elongation factor P (EF-P) is an essential protein that stimulates the formation of the first peptide bond in protein synthesis. Here we report the crystal structure of EF-P bound to the Thermus thermophilus 70S ribosome along with the initiator transfer RNA N-formyl-methionyl-tRNA(i) (fMet-tRNA(i)(fMet)) and a short piece of messenger RNA (mRNA) at a resolution of 3.5 angstroms. EF-P binds to a site located between the binding site for the peptidyl tRNA (P site) and the exiting tRNA (E site). It spans both ribosomal subunits with its amino terminal domain positioned adjacent to the aminoacyl acceptor stem and its carboxyl terminal domain positioned next to the anticodon stem-loop of the P site-bound initiator tRNA. Domain II of EF-P interacts with the ribosomal protein L1, which results in the largest movement of the L1 stalk that has been observed in the absence of ratcheting of the ribosomal subunits. EF-P facilitates the proper positioning of the fMet-tRNA(i)(fMet) for the formation of the first peptide bond during translation initiation.	[Blaha, Gregor; Stanley, Robin E.; Steitz, Thomas A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	thomas.steitz@yale.edu	Stanley, Robin E/C-7128-2019; Steitz, Thomas A./C-6559-2009; Stanley, Robin/M-3008-2019	Stanley, Robin E/0000-0002-2106-3102; Stanley, Robin/0000-0002-2106-3102	NIH [GM22778]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM22778 (to T.A.S.). The coordinates for both copies of the 70S in the asymmetric unit have been deposited in the Research Collaboratory for Structural Bioinformatics Protein Data Bank with accession numbers 3HUW, 3HUX, 3HUY, and 3HUZ. T.A.S. owns stock in and is on the advisory board of Rib-X Pharmaceuticals, Inc., which does structure-based drug design targeted at the ribosome.	Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; AN G, 1980, CAN J BIOCHEM CELL B, V58, P1312, DOI 10.1139/o80-177; Aoki H, 1997, BIOCHIMIE, V79, P7, DOI 10.1016/S0300-9084(97)87619-5; Aoki H, 1997, J BIOL CHEM, V272, P32254, DOI 10.1074/jbc.272.51.32254; Aoki H, 2008, FEBS J, V275, P671, DOI 10.1111/j.1742-4658.2007.06228.x; BENNE R, 1978, J BIOL CHEM, V253, P3070; Brochier C, 2004, GENE, V330, P169, DOI 10.1016/j.gene.2004.01.018; COLE JR, 1987, J MOL BIOL, V198, P383, DOI 10.1016/0022-2836(87)90288-9; Connell SR, 2008, NAT STRUCT MOL BIOL, V15, P910, DOI 10.1038/nsmb.1469; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; Dorner S, 2006, NAT STRUCT MOL BIOL, V13, P234, DOI 10.1038/nsmb1060; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Ganoza MC, 2002, MICROBIOL MOL BIOL R, V66, P460, DOI 10.1128/MMBR.66.3.460-485.2002; Ganoza MC, 2000, BIOL CHEM, V381, P553, DOI 10.1515/BC.2000.071; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; Hanawa-Suetsugu K, 2004, P NATL ACAD SCI USA, V101, P9595, DOI 10.1073/pnas.0308667101; HERSHEY JWB, 1990, BIOCHIM BIOPHYS ACTA, V1050, P160, DOI 10.1016/0167-4781(90)90159-Y; Jao DLE, 2006, J CELL BIOCHEM, V97, P583, DOI 10.1002/jcb.20658; Korostelev A, 2007, TRENDS BIOCHEM SCI, V32, P434, DOI 10.1016/j.tibs.2007.08.002; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P224, DOI 10.1073/pnas.95.1.224; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Maguire BA, 2005, MOL CELL, V20, P427, DOI 10.1016/j.molcel.2005.09.009; MOORE VG, 1975, P NATL ACAD SCI USA, V72, P844, DOI 10.1073/pnas.72.3.844; Newton DT, 1999, J BIOL CHEM, V274, P22143, DOI 10.1074/jbc.274.32.22143; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; SANDER G, 1983, J BIOL CHEM, V258, P98; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; SELMER M, 1935, SCIENCE, V313, P2006, DOI DOI 10.1126/SCIENCE.1131127; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Simonetti A, 2009, CELL MOL LIFE SCI, V66, P423, DOI 10.1007/s00018-008-8416-4; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; SUBRAMANIAN AR, 1980, EUR J BIOCHEM, V112, P425, DOI 10.1111/j.1432-1033.1980.tb07222.x; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Wower IK, 1998, J BIOL CHEM, V273, P19847, DOI 10.1074/jbc.273.31.19847; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zanelli CF, 2007, AMINO ACIDS, V33, P351, DOI 10.1007/s00726-007-0533-0	40	155	159	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					966	970		10.1126/science.1175800	http://dx.doi.org/10.1126/science.1175800			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19696344	Green Accepted			2022-12-24	WOS:000269242800038
J	Rick, TC; Erlandson, JM				Rick, Torben C.; Erlandson, Jon M.			Coastal Exploitation	SCIENCE			English	Editorial Material							SOUTH-AFRICA; ECOSYSTEMS; MIDDLE		[Rick, Torben C.] Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Archaeobiol Program, Washington, DC 20013 USA; [Erlandson, Jon M.] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Erlandson, Jon M.] Univ Oregon, Museum Nat & Cultural Hist, Eugene, OR 97403 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of Oregon; University of Oregon	Rick, TC (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Archaeobiol Program, Washington, DC 20013 USA.	rickt@si.edu; jerland@uoregon.edu		Rick, Torben/0000-0002-8254-5885; Erlandson, Jon/0000-0002-4705-4319				Bourque BJ, 2008, HUMAN IMPACTS ON ANCIENT MARINE ECOSYSTEMS: A GLOBAL PERSPECTIVE, P165; Corbett DG, 2008, HUMAN IMPACTS ON ANCIENT MARINE ECOSYSTEMS: A GLOBAL PERSPECTIVE, P43; Erlandson J., 2005, P 6 CAL ISL C; Grayson DK, 2001, J WORLD PREHIST, V15, P1, DOI 10.1023/A:1011165119141; Hames R, 2007, ANNU REV ANTHROPOL, V36, P177, DOI 10.1146/annurev.anthro.35.081705.123321; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; Lyman RL, 2006, EVOL ANTHROPOL, V15, P11, DOI 10.1002/evan.20083; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Martin Paul S., 2005, TWILIGHT MAMMOTHS IC; Steele TE, 2008, ARCHAEOFAUNA, V17, P63; Stiner MC, 2001, P NATL ACAD SCI USA, V98, P6993, DOI 10.1073/pnas.121176198; Voorhies B, 2004, COASTAL COLLECTORS H; Williams J., 2006, CLAM GARDENS ABORIGI	14	52	54	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					952	953		10.1126/science.1178539	http://dx.doi.org/10.1126/science.1178539			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AN	19696338				2022-12-24	WOS:000269242800030
J	Slade, BA; Leidel, L; Vellozzi, C; Woo, EJ; Hua, W; Sutherland, A; Izurieta, HS; Ball, R; Miller, N; Braun, MM; Markowitz, LE; Iskander, J				Slade, Barbara A.; Leidel, Laura; Vellozzi, Claudia; Woo, Emily Jane; Hua, Wei; Sutherland, Andrea; Izurieta, Hector S.; Ball, Robert; Miller, Nancy; Braun, M. Miles; Markowitz, Lauri E.; Iskander, John			Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUILLAIN-BARRE-SYNDROME; SYNCOPE; SYSTEM	Context In June 2006, the Food and Drug Administration licensed the quadrivalent human papillomavirus (types 6, 11, 16, and 18) recombinant vaccine (qHPV) in the United States for use in females aged 9 to 26 years; the Advisory Committee on Immunization Practices then recommended qHPV for routine vaccination of girls aged 11 to 12 years. Objective To summarize reports to the Vaccine Adverse Event Reporting System (VAERS) following receipt of qHPV. Design, Setting, and Participants Review and describe adverse events following immunization (AEFIs) reported to VAERS, a national, voluntary, passive surveillance system, from June 1, 2006, through December 31, 2008. Additional analyses were performed for some AEFIs in prelicensure trials, those of unusual severity, or those that had received public attention. Statistical data mining, including proportional reporting ratios (PRRs) and empirical Bayesian geometric mean methods, were used to detect disproportionality in reporting. Main Outcome Measures Numbers of reported AEFIs, reporting rates (reports per 100 000 doses of distributed vaccine or per person-years at risk), and comparisons with expected background rates. Results VAERS received 12 424 reports of AEFIs following qHPV distribution, a rate of 53.9 reports per 100 000 doses distributed. A total of 772 reports (6.2% of all reports) described serious AEFIs, including 32 reports of death. The reporting rates per 100 000 qHPV doses distributed were 8.2 for syncope; 7.5 for local site reactions; 6.8 for dizziness; 5.0 for nausea; 4.1 for headache; 3.1 for hypersensitivity reactions; 2.6 for urticaria; 0.2 for venous thromboembolic events, autoimmune disorders, and Guillain-Barre syndrome; 0.1 for anaphylaxis and death; 0.04 for transverse myelitis and pancreatitis; and 0.009 for motor neuron disease. Disproportional reporting of syncope and venous thromboembolic events was noted with data mining methods. Conclusions Most of the AEFI rates were not greater than the background rates compared with other vaccines, but there was disproportional reporting of syncope and venous thromboembolic events. The significance of these findings must be tempered with the limitations (possible underreporting) of a passive reporting system. JAMA. 2009;302(7):750-757	[Slade, Barbara A.; Leidel, Laura; Vellozzi, Claudia; Markowitz, Lauri E.; Iskander, John] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Woo, Emily Jane; Hua, Wei; Sutherland, Andrea; Izurieta, Hector S.; Ball, Robert; Miller, Nancy; Braun, M. Miles] US FDA, Washington, DC 20204 USA	Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA)	Slade, BA (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop D-26, Atlanta, GA 30333 USA.	bfs9@cdc.gov			CDC; FDA	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); FDA(United States Department of Health & Human Services)	The study was implemented by the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA). The only funds used were from CDC and FDA budgets. This study had no external sponsors.	Almenoff JS, 2007, CLIN PHARMACOL THER, V82, P157, DOI 10.1038/sj.clpt.6100258; [Anonymous], MED DICT REGULATORY; [Anonymous], 2005, GUID IND GOOD PHARM; Block SL, 2006, PEDIATRICS, V118, P2135, DOI 10.1542/peds.2006-0461; Bosch F Xavier, 2003, J Natl Cancer Inst Monogr, P3; Braun MM, 1997, ARCH PEDIAT ADOL MED, V151, P255, DOI 10.1001/archpedi.1997.02170400041007; CHEN RT, 1994, VACCINE, V12, P542, DOI 10.1016/0264-410X(94)90315-8; Chen RT, 1997, PEDIATRICS, V99, P765, DOI 10.1542/peds.99.6.765; Davis RL, 2005, EPIDEMIOLOGY, V16, P336, DOI 10.1097/01.ede.0000155506.05636.a4; DuMouchel W, 1999, AM STAT, V53, P177, DOI 10.2307/2686093; Ehresman K., 1999, Morbidity and Mortality Weekly Report, V48, P577; EVANS S, 2002, PHARMACOVIGILANCE, P273; Evans SJW, 2001, PHARMACOEPIDEM DR S, V10, P483, DOI 10.1002/pds.677; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; *FOOD DRUG ADM, GRAD HUM PAP QUADR T; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Gomes MPV, 2004, ARCH INTERN MED, V164, P1965, DOI 10.1001/archinte.164.18.1965; Healthcare Cost and Utilization Project, HEALTHC COST UT PROJ; LIN JTY, 1982, ANN NEUROL, V11, P525, DOI 10.1002/ana.410110513; PICKERING LK, 2006, RED BOOK 2006 REPORT; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; RODDY SM, 1983, PEDIATRICS, V72, P715; Ruggeberg JU, 2007, VACCINE, V25, P5675, DOI 10.1016/j.vaccine.2007.02.064; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; SCHONBERGER LB, 1981, ANN NEUROL, V9, P31, DOI 10.1002/ana.410090707; Sutherland A., 2008, Morbidity and Mortality Weekly Report, V57, P457; Szarfman A, 2002, DRUG SAFETY, V25, P381, DOI 10.2165/00002018-200225060-00001; Varricchio F, 2004, PEDIATR INFECT DIS J, V23, P287, DOI 10.1097/00006454-200404000-00002; Villa L, 2007, LANCET, V369, P1861, DOI 10.1016/S0140-6736(07)60852-6; Weber J.C.P., 1984, ADV INFLAMMAT RES, V6, P1; Woo E. J., 2006, Morbidity and Mortality Weekly Report, V55, P1120; Woo EJ, 2005, ARCH PEDIAT ADOL MED, V159, P1083, DOI 10.1001/archpedi.159.11.1083; Zhou Weigong, 2003, MMWR Surveill Summ, V52, P1	33	314	335	7	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	2009	302	7					750	757		10.1001/jama.2009.1201	http://dx.doi.org/10.1001/jama.2009.1201			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484UT	19690307	Bronze			2022-12-24	WOS:000269073800023
J	Sweet, M				Sweet, Melissa			Pandemic flu Pandemic lessons from Australia	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	10	10	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2009	339								b3317	10.1136/bmj.b3317	http://dx.doi.org/10.1136/bmj.b3317			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486RZ	19690003				2022-12-24	WOS:000269216700016
J	Yu, C; Feng, W; Wei, ZY; Miyanoiri, Y; Wen, WY; Zhao, YX; Zhang, MJ				Yu, Cong; Feng, Wei; Wei, Zhiyi; Miyanoiri, Yohei; Wen, Wenyu; Zhao, Yanxiang; Zhang, Mingjie			Myosin VI Undergoes Cargo-Mediated Dimerization	CELL			English	Article							UNCONVENTIONAL MYOSINS; CELLULAR FUNCTIONS; PROCESSIVE MOTOR; ORGANIZATION; DISABLED-2; BINDING; DOMAIN; KINESIN; MODEL; TRANSPORT	Myosin VI is the only known molecular motor that moves toward the minus ends of actin filaments; thus, it plays unique roles in diverse cellular processes. The processive walking of myosin VI on actin filaments requires dimerization of the motor, but the protein can also function as a nonprocessive monomer. The molecular mechanism governing the monomer-dimer conversion is not clear. We report the high-resolution NMR structure of the cargo-free myosin VI cargo-binding domain (CBD) and show that it is a stable monomer in solution. The myosin VI CBD binds to a fragment of the clathrin-coated vesicle adaptor Dab2 with a high affinity, and the X-ray structure of the myosin VI CBD in complex with Dab2 reveals that the motor undergoes a cargo-binding-mediated dimerization. The cargo-binding-induced dimerization may represent a general paradigm for the regulation of processivity for myosin VI as well as other myosins, including myosin VII and myosin X.	[Yu, Cong; Feng, Wei; Wei, Zhiyi; Miyanoiri, Yohei; Wen, Wenyu; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Dept Biochem, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China; [Zhao, Yanxiang] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong Polytechnic University	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Mol Neurosci Ctr, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	Wei, Zhiyi/N-9995-2019; yu, cong/V-5140-2018; Wei, Zhiyi/B-5001-2010; , 余聪/AAK-9457-2020; Wei, Zhiyi/C-4315-2014; FENG, WEI/C-8966-2012	Wei, Zhiyi/0000-0002-4446-6502; yu, cong/0000-0003-2912-6347; Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; Zhao, Yanxiang/0000-0002-9408-9979; Zhang, Mingjie/0000-0001-9404-0190; Miyanoiri, Yohei/0000-0001-6889-5160	Research Grants Council of Hong Kong [HKUST6419/05M, 6442/06M, 663407, 663808, CA07/08.SC01, AoE/B-15/01-II, 660708, PolyU5641/08M]; Hong Kong Jockey Club	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Hong Kong Jockey Club	We thank Anthony Zhang for critical reading of the manuscript and Joanne Chan for technical help. This work was supported by grants from the Research Grants Council of Hong Kong to M. Z. (HKUST6419/05M, 6442/06M, 663407, 663808, CA07/08.SC01, and AoE/B-15/01-II), W. F. (660708), and Y.Z. (PolyU5641/08M). The NMR spectrometers used in this work were purchased with funds donated to the Biotechnology Research Institute by the Hong Kong Jockey Club.	Altman D, 2007, PLOS BIOL, V5, P1712, DOI 10.1371/journal.pbio.0050210; Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767; Au JSY, 2007, J CELL BIOL, V177, P103, DOI 10.1083/jcb.200608126; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker JP, 1997, J MOL BIOL, V272, P523, DOI 10.1006/jmbi.1997.1232; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryant Z, 2007, P NATL ACAD SCI USA, V104, P772, DOI 10.1073/pnas.0610144104; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Buss F, 2004, ANNU REV CELL DEV BI, V20, P649, DOI 10.1146/annurev.cellbio.20.012103.094243; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Buss F, 2008, BIOCHEM BIOPH RES CO, V369, P165, DOI 10.1016/j.bbrc.2007.11.150; Dance AL, 2004, TRAFFIC, V5, P798, DOI 10.1111/j.1600-0854.2004.00224.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fazili Z, 1999, ONCOGENE, V18, P3104, DOI 10.1038/sj.onc.1202649; Feng W, 2004, NAT STRUCT MOL BIOL, V11, P475, DOI 10.1038/nsmb751; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Geisbrecht ER, 2002, NAT CELL BIOL, V4, P616, DOI 10.1038/ncb830; Hasson T, 1996, GENOMICS, V36, P431, DOI 10.1006/geno.1996.0488; HASSON T, 1994, J CELL BIOL, V127, P425, DOI 10.1083/jcb.127.2.425; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Inoue A, 2002, BIOCHEM BIOPH RES CO, V292, P300, DOI 10.1006/bbrc.2002.6636; Kay LE, 1997, CURR OPIN STRUC BIOL, V7, P722, DOI 10.1016/S0959-440X(97)80084-X; KELLERMAN KA, 1992, J CELL BIOL, V119, P823, DOI 10.1083/jcb.119.4.823; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; Maddugoda MP, 2007, J CELL BIOL, V178, P529, DOI 10.1083/jcb.200612042; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Menetrey J, 2008, EMBO J, V27, P244, DOI 10.1038/sj.emboj.7601937; Menetrey J, 2007, CELL, V131, P300, DOI 10.1016/j.cell.2007.08.027; MERMALL V, 1994, NATURE, V369, P560, DOI 10.1038/369560a0; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Nicholls A., 1992, GRASP GRAPHICAL REPR; O'Connell CB, 2007, BBA-MOL CELL RES, V1773, P615, DOI 10.1016/j.bbamcr.2006.06.012; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rodriguez OC, 2000, TRENDS CELL BIOL, V10, P307, DOI 10.1016/S0962-8924(00)01797-9; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Seiler C, 2004, DEV BIOL, V272, P328, DOI 10.1016/j.ydbio.2004.05.004; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Sweeney HL, 2007, CURR OPIN CELL BIOL, V19, P57, DOI 10.1016/j.ceb.2006.12.005; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Wu HJ, 2002, J BIOL CHEM, V277, P30928, DOI 10.1074/jbc.M203735200; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yang Y, 2006, P NATL ACAD SCI USA, V103, P5746, DOI 10.1073/pnas.0509935103	62	97	99	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					537	548		10.1016/j.cell.2009.05.030	http://dx.doi.org/10.1016/j.cell.2009.05.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665975	Bronze			2022-12-24	WOS:000268771900018
J	Cole, BL; Harris, RW				Cole, Barry L.; Harris, Ross W.			Caution: coloured medication and the colour blind	LANCET			English	Editorial Material							VISION		[Cole, Barry L.; Harris, Ross W.] Univ Melbourne, Victorian Coll Optometry, Melbourne, Vic 3053, Australia	University of Melbourne	Cole, BL (corresponding author), Univ Melbourne, Victorian Coll Optometry, Corner Cardigan & Keppel St, Melbourne, Vic 3053, Australia.	bcole@vco.org.au		Mishra, Arun Kumar/0000-0001-6096-8097				Cole BL, 2006, OPTOMETRY VISION SCI, V83, P879, DOI 10.1097/01.opx.0000249974.22205.2a; STEWARD JM, 1989, OPTOMETRY VISION SCI, V66, P288, DOI 10.1097/00006324-198905000-00006	2	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2009	374	9691					720	720		10.1016/S0140-6736(09)60313-5	http://dx.doi.org/10.1016/S0140-6736(09)60313-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	489LV	19716964				2022-12-24	WOS:000269422500028
J	Esserman, L; Shieh, Y; Thompson, I				Esserman, Laura; Shieh, Yiwey; Thompson, Ian			Rethinking Screening for Breast Cancer and Prostate Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARCINOMA IN-SITU; UNITED-STATES; ACTIVE SURVEILLANCE; ADJUVANT THERAPY; SEATTLE AREA; RISK; MORTALITY; PREVENTION; WOMEN; MAMMOGRAPHY	After 20 years of screening for breast and prostate cancer, several observations can be made. First, the incidence of these cancers increased after the introduction of screening but has never returned to prescreening levels. Second, the increase in the relative fraction of early stage cancers has increased. Third, the incidence of regional cancers has not decreased at a commensurate rate. One possible explanation is that screening may be increasing the burden of low-risk cancers without significantly reducing the burden of more aggressively growing cancers and therefore not resulting in the anticipated reduction in cancer mortality. To reduce morbidity and mortality from prostate cancer and breast cancer, new approaches for screening, early detection, and prevention for both diseases should be considered. JAMA. 2009;302(15):1685-1692	[Esserman, Laura] Univ Calif San Francisco, Carol Franc Buck Canc Ctr, Dept Surg & Radiol, San Francisco, CA 94115 USA; [Shieh, Yiwey] Univ Calif San Francisco, Sch Med, San Francisco, CA 94115 USA; [Thompson, Ian] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Health San Antonio	Esserman, L (corresponding author), Univ Calif San Francisco, Carol Franc Buck Canc Ctr, Dept Surg & Radiol, 1600 Divisadero St,Box 1710, San Francisco, CA 94115 USA.	laura.esserman@ucsfmedctr.org		Shieh, Yiwey/0000-0002-0159-7748	 [U01CA111234];  [U01CA086402]; NATIONAL CANCER INSTITUTE [U01CA111234, U01CA086402] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This article grew out of collaboration initiated within the Early Detection Research Network and was supported by grants U01CA111234 and U01CA086402.	Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; *ATHENA BREAST HLT, 2009, ATHENA BREAST HLTH N; Bach PB, 2007, JAMA-J AM MED ASSOC, V297, P953, DOI 10.1001/jama.297.9.953; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; Burnside E, 2001, Clin Breast Cancer, V2, P145, DOI 10.3816/CBC.2001.n.019; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Chen SN, 2006, J CLIN ONCOL, V24, P863, DOI 10.1200/JCO.2005.03.6772; Cooperberg MR, 2004, J UROLOGY, V171, P1393, DOI 10.1097/01.ju.0000107247.81471.06; Cuzick J, 2007, JNCI-J NATL CANCER I, V99, P272, DOI 10.1093/jnci/djk049; Dall'Era MA, 2008, CANCER-AM CANCER SOC, V112, P1650, DOI 10.1002/cncr.23373; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Ernster VL, 2002, J NATL CANCER I, V94, P1546; Ernster VL, 1996, JAMA-J AM MED ASSOC, V275, P913, DOI 10.1001/jama.275.12.913; ESSERMAN LJ, 2009, J CLIN ONCOL S, V27; FRIDLAND J, 2008, AM SOC CLIN ONC 2008; Garwood ER, 2009, ANN SURG, V249, P26, DOI 10.1097/SLA.0b013e31818e41a7; Gotzsche PC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub2; Gotzsche PC, 2006, COCHRANE DB SYST REV; Grove AS, 2005, JAMA-J AM MED ASSOC, V294, P490, DOI 10.1001/jama.294.4.490; Hartmann LC, 2005, NEW ENGL J MED, V353, P229, DOI 10.1056/NEJMoa044383; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Hwang ES, 2004, ANN SURG ONCOL, V11, p37S, DOI 10.1007/BF02524794; IKEDA DM, 1992, AM J ROENTGENOL, V159, P287, DOI 10.2214/ajr.159.2.1632342; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; JOENSUU H, 1995, J CLIN ONCOL, V13, P62, DOI 10.1200/JCO.1995.13.1.62; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Klotz L, 2008, WORLD J UROL, V26, P437, DOI 10.1007/s00345-008-0330-8; Li CI, 2005, CANCER EPIDEM BIOMAR, V14, P1008, DOI 10.1158/1055-9965.EPI-04-0849; Lin C, 2009, J CLIN ONCOL, V27; Logothetis CJ, 2008, CANCER PREV RES, V1, P151, DOI 10.1158/1940-6207.CAPR-08-0085; Lu-Yao G, 2002, BMJ-BRIT MED J, V325, P740, DOI 10.1136/bmj.325.7367.740; Lu-Yao G, 2008, J GEN INTERN MED, V23, P1809, DOI 10.1007/s11606-008-0785-8; Lucia MS, 2008, CANCER PREV RES, V1, P167, DOI 10.1158/1940-6207.CAPR-08-0078; LUYAO GL, 1994, LANCET, V343, P251, DOI 10.1016/S0140-6736(94)91109-6; *NAT BREAST SCREEN, 2008, SAV LIV SCREEN; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Oliver S, 2000, LANCET, V355, P1788, DOI 10.1016/S0140-6736(00)02269-8; Olivotto IA, 2005, J CLIN ONCOL, V23, P2716, DOI 10.1200/JCO.2005.06.178; Ozanne EM, 2004, CANCER EPIDEM BIOMAR, V13, P2043; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Redman MW, 2008, CANCER PREV RES, V1, P174, DOI 10.1158/1940-6207.CAPR-08-0092; Ries L MD, 2008, SEER CANC STAT REV 1; Schilling FH, 2003, CANCER LETT, V197, P19, DOI 10.1016/S0304-3835(03)00077-6; Schrag D, 2000, JAMA-J AM MED ASSOC, V283, P617, DOI 10.1001/jama.283.5.617; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; SEIDMAN H, 1985, CA-CANCER J CLIN, V35, P36, DOI 10.3322/canjclin.35.1.36; Shao YH, 2009, JNCI-J NATL CANCER I, V101, P1280, DOI 10.1093/jnci/djp262; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; Smith-Bindman R, 2003, JAMA-J AM MED ASSOC, V290, P2129, DOI 10.1001/jama.290.16.2129; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208; Thompson IM, 2008, J UROLOGY, V180, P1219, DOI 10.1016/j.juro.2008.07.089; Thompson IM, 2008, UROLOGY, V71, P854, DOI 10.1016/j.urology.2008.01.025; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; van't Veer LJ, 2009, J CLIN ONCOL, V27; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Weaver DL, 2006, CANCER, V106, P732, DOI 10.1002/cncr.21652; Weir HK, 2003, JNCI-J NATL CANCER I, V95, P1276, DOI 10.1093/jnci/djg040; Welch HG, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b1425; Welch HG, 2004, SHOULD I BE TESTED C; Wilt T J, 1997, Oncology (Williston Park), V11, P1133; WINAWER SJ, 1977, JAMA-J AM MED ASSOC, V238, P2014, DOI 10.1001/jama.238.19.2014; Woods WG, 2002, NEW ENGL J MED, V346, P1041, DOI 10.1056/NEJMoa012387; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311	71	395	404	1	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 21	2009	302	15					1685	1692		10.1001/jama.2009.1498	http://dx.doi.org/10.1001/jama.2009.1498			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508NX	19843904				2022-12-24	WOS:000270941200024
J	Hennessy, BT; Coleman, RL; Markman, M				Hennessy, Bryan T.; Coleman, Robert L.; Markman, Maurie			Ovarian cancer	LANCET			English	Review							GYNECOLOGIC-ONCOLOGY-GROUP; PHASE-III TRIAL; PEGYLATED LIPOSOMAL DOXORUBICIN; INTRAVENOUS CISPLATIN PLUS; RANDOMIZED CLINICAL-TRIAL; SINGLE-AGENT CARBOPLATIN; STAGE-III; 1ST-LINE TREATMENT; INTRAPERITONEAL CHEMOTHERAPY; INTERGROUP TRIAL	The standard initial management of epithelial ovarian cancer consists of surgical staging, operative tumour debulking including total abdominal hysterectomy and bilateral salpingo-oophorectomy, and administration of six cycles of intravenous chemotherapy with carboplatin and paclitaxel. Extensive and largely retrospective experience has shown that optimum surgical debulking to leave residual tumour deposits that are less than 1 cm in size is associated with improved patient outcomes. However, 75% of patients present with advanced (stage III or IV) disease and, although more than 80% of these women benefit from first-line therapy, tumour recurrence occurs in almost all these patients at a median of 15 months from diagnosis. Second-line treatments can improve survival and quality of life but are not curative. Advances in screening and understanding of molecular pathogenesis of ovarian cancer and development of novel targeted therapies (eg, bevacizumab) and practical intraperitoneal techniques for drug delivery are most likely to improve patient outcomes.	[Hennessy, Bryan T.; Markman, Maurie] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Med Oncol, Houston, TX 77030 USA; [Coleman, Robert L.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Markman, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gynecol Med Oncol, Houston, TX 77030 USA.	mmarkman@mdanderson.org	yang, xiao-jun/B-1927-2009; FALANDRY, Claire/H-6055-2012; Coleman, Robert/E-4346-2019	FALANDRY, Claire/0000-0001-7267-4723; Hennessy, Bryan/0000-0002-7871-6477				Aabo K, 1998, BRIT J CANCER, V78, P1479, DOI 10.1038/bjc.1998.710; Alberts DS, 1996, NEW ENGL J MED, V335, P1950, DOI 10.1056/NEJM199612263352603; Aletti GD, 2006, GYNECOL ONCOL, V100, P283, DOI 10.1016/j.ygyno.2005.08.027; American College of Obstetricians and Gynecologists, 2009, OBSTET GYNECOL, V113, P957, DOI DOI 10.1097/AOG.0B013E3181A106D4; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Badgwell D, 2007, DIS MARKERS, V23, P397, DOI 10.1155/2007/309382; Bast RC, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.3500; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1; Berek J, 2009, J CLIN ONCOL, V27, P418, DOI 10.1200/JCO.2008.17.8400; Berek JS, 2004, J CLIN ONCOL, V22, P3507, DOI 10.1200/JCO.2004.09.016; Berry DA, 2002, J CLIN ONCOL, V20, P2701, DOI 10.1200/JCO.2002.05.121; BERTELSEN K, 1993, GYNECOL ONCOL, V49, P30, DOI 10.1006/gyno.1993.1081; BESSETTE AR, 2008, IGCS BIENN M P BANGK; Bookman MA, 2006, J CLIN ONCOL, V24, p256S; Bookman MA, 2003, J CLIN ONCOL, V21, P283, DOI 10.1200/JCO.2003.10.104; Breidenbach M, 2005, GENE THER, V12, P187, DOI 10.1038/sj.gt.3302404; Brewster WR, 2005, NAT CLIN PRACT ONCOL, V2, P286, DOI 10.1038/ncponc0198; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; Burger RA, 2007, J CLIN ONCOL, V25, P5165, DOI 10.1200/JCO.2007.11.5345; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; *CAN RES UK, CANCSTAT INC UK; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chen SN, 2006, J CLIN ONCOL, V24, P863, DOI 10.1200/JCO.2005.03.6772; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Cheng WJ, 2005, NAT MED, V11, P531, DOI 10.1038/nm1230; Cliby W, 2004, GYNECOL ONCOL, V94, P655, DOI 10.1016/j.ygyno.2004.04.032; Collinson FJ, 2008, EXPERT REV ANTICANC, V8, P21, DOI 10.1586/14737140.8.1.21; CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P717; Crum CP, 2007, CLIN MED RES, V5, P35, DOI 10.3121/cmr.2007.702; De Placido S, 2004, J CLIN ONCOL, V22, P2635, DOI 10.1200/JCO.2004.09.088; DELCAMPO JM, 1994, GYNECOL ONCOL, V53, P27, DOI 10.1006/gyno.1994.1082; du Bois A, 2005, ANN ONCOL, V16, P7, DOI 10.1093/annonc/mdi961; du Bois A, 2003, JNCI-J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; Eisenkop SM, 2006, GYNECOL ONCOL, V103, P329, DOI 10.1016/j.ygyno.2006.07.004; Eisenkop SM, 2001, GYNECOL ONCOL, V82, P489, DOI 10.1006/gyno.2001.6312; Elit L, 2004, CANCER, V101, P1926, DOI 10.1002/cncr.20595; Elit L, 2007, CANCER-AM CANCER SOC, V109, P692, DOI 10.1002/cncr.22466; Fader AN, 2007, J CLIN ONCOL, V25, P2873, DOI 10.1200/JCO.2007.11.0932; FATHALLA MF, 1971, LANCET, V2, P163; Ferrandina G, 2008, J CLIN ONCOL, V26, P890, DOI 10.1200/JCO.2007.13.6606; Fong PC, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.5510; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Friedman GD, 2005, FAM PRACT, V22, P548, DOI 10.1093/fampra/cmi044; Garcia M, 2007, GLOBAL CANC FACTS FI; Gordon AN, 2001, J CLIN ONCOL, V19, P3312, DOI 10.1200/JCO.2001.19.14.3312; Gore M, 1998, J CLIN ONCOL, V16, P2426, DOI 10.1200/JCO.1998.16.7.2426; Gore M, 2006, J CLIN ONCOL, V24, P4528, DOI 10.1200/JCO.2006.06.0376; HAKES TB, 1992, GYNECOL ONCOL, V45, P284, DOI 10.1016/0090-8258(92)90305-3; Hall GD, 2004, BRIT J CANCER, V91, P621, DOI 10.1038/sj.bjc.6602037; HANKINSON SE, 1993, JAMA-J AM MED ASSOC, V270, P2813, DOI 10.1001/jama.270.23.2813; Harter P, 2006, ANN SURG ONCOL, V13, P1702, DOI 10.1245/s10434-006-9058-0; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; Hellstrom I, 2003, CANCER RES, V63, P3695; Hennessy BT, 2006, INT J BIOCHEM CELL B, V38, P1450, DOI 10.1016/j.biocel.2006.01.009; Hennessy BT, 2008, ADV EXP MED BIOL, V617, P23, DOI 10.1007/978-0-387-69080-3_3; Herzog TJ, 2006, GYNECOL ONCOL, V102, P218, DOI 10.1016/j.ygyno.2005.12.001; Hess LM, 2007, INT J GYNECOL CANCER, V17, P561, DOI 10.1111/j.1525-1438.2006.00846.x; Hirte H, 2006, GYNECOL ONCOL, V102, P300, DOI 10.1016/j.ygyno.2005.12.020; HOLGUIN T, 1986, GYNECOL ONCOL, V25, P128, DOI 10.1016/0090-8258(86)90074-0; Kamikihara T, 2005, INT J CANCER, V115, P690, DOI 10.1002/ijc.20971; Kodama Shoji, 1999, International Journal of Clinical Oncology, V4, P90, DOI 10.1007/s101470050033; Lambert HE, 1997, ANN ONCOL, V8, P327, DOI 10.1023/A:1008256431090; Markman M, 2006, J CLIN ONCOL, V24, P988, DOI 10.1200/JCO.2005.05.2456; Markman M, 2001, J CLIN ONCOL, V19, P1001, DOI 10.1200/JCO.2001.19.4.1001; Markman M, 2003, J CLIN ONCOL, V21, P2460, DOI 10.1200/JCO.2003.07.013; Markman M, 2008, DRUGS, V68, P771, DOI 10.2165/00003495-200868060-00004; Markman M, 2009, GYNECOL ONCOL, V113, P4, DOI 10.1016/j.ygyno.2008.12.022; MCGUIRE WP, 1995, J CLIN ONCOL, V13, P1589, DOI 10.1200/JCO.1995.13.7.1589; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Merritt WM, 2008, J NATL CANCER I, V100, P359, DOI 10.1093/jnci/djn024; Mobus V, 2007, J CLIN ONCOL, V25, P4187, DOI 10.1200/JCO.2006.09.7527; Monk BJ, 2008, ANN ONCOL, V19, P2; Morris CR, 2008, GYNECOL ONCOL, V108, P207, DOI 10.1016/j.ygyno.2007.09.026; Muggia FM, 2000, J CLIN ONCOL, V18, P106, DOI 10.1200/JCO.2000.18.1.106; Mutch DG, 2007, J CLIN ONCOL, V25, P2811, DOI 10.1200/JCO.2006.09.6735; National Cancer Institute, NCI ISS CLIN ANN PRE; NCCN, 2008, NCCN CLIN PRACT GUID; Neijt JP, 2000, J CLIN ONCOL, V18, P3084, DOI 10.1200/JCO.2000.18.17.3084; Nicholson S, 1998, ONCOL REP, V5, P223; Nossov V, 2008, AM J OBSTET GYNECOL, V199, P215, DOI 10.1016/j.ajog.2008.04.009; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Panici PB, 2005, JNCI-J NATL CANCER I, V97, P560, DOI 10.1093/jnci/dji102; Parmar MKB, 2003, LANCET, V361, P2099; Parmar MKB, 2002, LANCET, V360, P505; Paulsen T, 2006, INT J GYNECOL CANCER, V16, P11, DOI 10.1111/j.1525-1438.2006.00319.x; Pecorelli S, 2009, J CLIN ONCOL, V27, P4642, DOI 10.1200/JCO.2009.21.9691; Pfisterer J, 2006, J CLIN ONCOL, V24, P4699, DOI 10.1200/JCO.2006.06.0913; Pfisterer J, 2006, JNCI-J NATL CANCER I, V98, P1036, DOI 10.1093/jnci/djj296; Piccart MJ, 2000, JNCI-J NATL CANCER I, V92, P699, DOI 10.1093/jnci/92.9.699; Polverino G, 2005, GYNECOL ONCOL, V99, P343, DOI 10.1016/j.ygyno.2005.06.008; PUJADALAURAINE E, 2009, J CLIN ONCOL S, V27; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Rodriguez-Burford C, 2002, CLIN CANCER RES, V8, P202; Rose PG, 2004, NEW ENGL J MED, V351, P2489, DOI 10.1056/NEJMoa041125; Rustin GJ, 2009, J CLIN ONCOL, V27, DOI 10.1200/jco.2009.27.18_suppl.1; Sandercock J, 2002, BRIT J CANCER, V87, P815, DOI 10.1038/sj.bjc.6600567; Saygili U, 2002, J SURG ONCOL, V81, P132, DOI 10.1002/jso.10124; Schilder RJ, 2007, J CLIN ONCOL, V25; Schumer ST, 2003, J CLIN ONCOL, V21, P1180, DOI 10.1200/JCO.2003.10.019; Sehouli J, 2008, J CLIN ONCOL, V26, P3176, DOI 10.1200/JCO.2007.15.1258; Shaaban A, 2009, CLIN OBSTET GYNECOL, V52, P73, DOI 10.1097/GRF.0b013e3181961625; Shaw P. A., 1999, Modern Pathology, V12, p124A; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Silverberg S G, 1989, Curr Top Pathol, V78, P85; Skirnisdottir I, 2007, INT J GYNECOL CANCER, V17, P1231, DOI 10.1111/j.1525-1438.2007.00928.x; Smith DI, 2002, CYTOMETRY, V47, P60, DOI 10.1002/cyto.10042; Sorbe B, 2003, INT J GYNECOL CANCER, V13, P278, DOI 10.1046/j.1525-1438.2003.13193.x; Spriggs DR, 2007, J CLIN ONCOL, V25, P4466, DOI 10.1200/JCO.2006.10.3846; Suzuki S, 2000, CANCER RES, V60, P5382; Timmerman D, 2005, J CLIN ONCOL, V23, P8794, DOI 10.1200/JCO.2005.01.7632; Timmerman D, 2000, ULTRASOUND OBST GYN, V16, P500, DOI 10.1046/j.1469-0705.2000.00287.x; Trimbos JB, 2003, JNCI-J NATL CANCER I, V95, P105; Trimbos JB, 2003, JNCI-J NATL CANCER I, V95, P113, DOI 10.1093/jnci/95.2.113; Valentin L, 2006, GYNECOL ONCOL, V102, P41, DOI 10.1016/j.ygyno.2005.11.015; van Nagell JR, 1999, CURR OPIN OBSTET GYN, V11, P45, DOI 10.1097/00001703-199901000-00009; VANDERBURG MEL, 1995, NEW ENGL J MED, V332, P629, DOI 10.1056/NEJM199503093321002; Varia MA, 2003, J CLIN ONCOL, V21, P2849, DOI 10.1200/JCO.2003.11.018; Vasey PA, 2004, JNCI-J NATL CANCER I, V96, P1682, DOI 10.1093/jnci/djh323; Vergote I, 2001, LANCET, V357, P176, DOI 10.1016/S0140-6736(00)03590-X; Vernooij F, 2007, GYNECOL ONCOL, V105, P801, DOI 10.1016/j.ygyno.2007.02.030; Walker JL, 2009, GYNECOL ONCOL, V112, P439, DOI 10.1016/j.ygyno.2009.01.007; YOUNG RC, 1983, JAMA-J AM MED ASSOC, V250, P3072, DOI 10.1001/jama.250.22.3072; YOUNG RC, 1990, NEW ENGL J MED, V322, P1021, DOI 10.1056/NEJM199004123221501; Zeimet AG, 2003, LANCET ONCOL, V4, P415, DOI 10.1016/S1470-2045(03)01139-2	130	509	526	2	77	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2009	374	9698					1371	1382		10.1016/S0140-6736(09)61338-6	http://dx.doi.org/10.1016/S0140-6736(09)61338-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MW	19793610				2022-12-24	WOS:000271254600033
J	Pagani, MR; Oishi, K; Gelb, BD; Zhong, Y				Pagani, Mario R.; Oishi, Kimihiko; Gelb, Bruce D.; Zhong, Yi			The Phosphatase SHP2 Regulates the Spacing Effect for Long-Term Memory Induction	CELL			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SYNAPTIC PLASTICITY; NOONAN-SYNDROME; ENCODING VARIABILITY; DISTRIBUTED PRACTICE; CONSOLIDATED MEMORY; MUTANT DROSOPHILA; KINASE; PTPN11; MUTATIONS	A property of long-term memory (LTM) induction is the requirement for repeated training sessions spaced over time. This augmentation of memory formation with spaced resting intervals is called the spacing effect. We now show that in Drosophila, the duration of resting intervals required for inducing LTM is regulated by activity levels of the protein tyrosine phosphatase corkscrew (CSW). Overexpression of wild-type CSW in mushroom body neurons shortens the inter-trial interval required for LTM induction, whereas overexpression of constitutively active CSW proteins prolongs these resting intervals. These gain-of-function csw mutations are associated with a clinical condition of mental retardation. Biochemical analysis reveals that LTM-inducing training regimens generate repetitive waves of CSW-dependent MAPK activation, the length of which appears to define the duration of the resting interval. Constitutively active CSW proteins prolong the resting interval by altering the MAPK inactivation cycle. We thus provide insight into the molecular basis of the spacing effect.	[Pagani, Mario R.; Zhong, Yi] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Oishi, Kimihiko; Gelb, Bruce D.] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Oishi, Kimihiko; Gelb, Bruce D.] Mt Sinai Sch Med, Dept Genet, New York, NY 10029 USA; [Oishi, Kimihiko; Gelb, Bruce D.] Mt Sinai Sch Med, Dept Genom Sci, New York, NY 10029 USA; [Oishi, Kimihiko; Gelb, Bruce D.] Mt Sinai Sch Med, Ctr Mol Cardiol, New York, NY 10029 USA	Cold Spring Harbor Laboratory; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Zhong, Y (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	zhongyi@cshl.edu		Oishi, Kimihiko/0000-0001-9446-8912; Zhong, Yi/0000-0001-7810-9899; Zhong, Yi/0000-0002-7927-5976	National Institutes of Health (NIH) [5R01 DC05784-05A1, HL71207]; Dept. of Army [W81XWH-05-1-0142]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005784] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Army; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank L. Rela, Y. Wang, J. Dubnau, and the Zhong's lab for discussion on the experiments, S. Yichun for gal80ts; gal4 lines, L. Perkins for csw hypomorphic lines and antibody, and J. Beshel for comments on the manuscript. This work was supported by grants to Y.Z. from the National Institutes of Health (NIH) 5R01 DC05784-05A1 and Dept. of Army W81XWH-05-1-0142 and to B. D. G. from NIH (HL71207). B. D. G. is an inventor on U. S. Patent 7,335,469 entitled "Methods for diagnosing Noonan syndrome.'' He and his institution receive royalties for genetic testing of PTPN11 for Noonan syndrome.	Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Appleton-Knapp SL, 2005, J CONSUM RES, V32, P266, DOI 10.1086/432236; Beck CDO, 2000, J NEUROSCI, V20, P2944; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; BJORK RA, 1970, J VERB LEARN VERB BE, V9, P567, DOI 10.1016/S0022-5371(70)80103-7; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cammarota M, 2008, BEHAV BRAIN RES, V195, P120, DOI 10.1016/j.bbr.2007.11.029; CAREW TJ, 1972, SCIENCE, V175, P451, DOI 10.1126/science.175.4020.451; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DEZAZZO J, 1995, TRENDS NEUROSCI, V18, P212, DOI 10.1016/0166-2236(95)93905-D; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Ebbinghaus H., 1885, MEMORY CONTRIBUTION; ESTES WK, 1955, PSYCHOL REV, V62, P369, DOI 10.1037/h0046888; FISHMAN EJ, 1968, J EDUC PSYCHOL, V59, P290, DOI 10.1037/h0020055; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FREEMAN RM, 1992, P NATL ACAD SCI USA, V89, P11239, DOI 10.1073/pnas.89.23.11239; Ge XC, 2004, P NATL ACAD SCI USA, V101, P10172, DOI 10.1073/pnas.0403497101; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Gerber B, 1998, NEUROBIOL LEARN MEM, V69, P71, DOI 10.1006/nlme.1997.3801; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; Hintzman D. L., 1974, THEORIES COGNITIVE P, P77; Ho IS, 2007, J NEUROSCI, V27, P6852, DOI 10.1523/JNEUROSCI.0933-07.2007; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; IZAWA C, 1967, J EXP PSYCHOL, V75, P194, DOI 10.1037/h0024971; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kontaridis MI, 2004, MOL CELL BIOL, V24, P5340, DOI 10.1128/MCB.24.12.5340-5352.2004; LANDAUER TK, 1969, PSYCHOL REV, V76, P82, DOI 10.1037/h0026746; Lee T, 1999, DEVELOPMENT, V126, P4065; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; Maroun CR, 2000, MOL CELL BIOL, V20, P8513, DOI 10.1128/MCB.20.22.8513-8525.2000; MARTIN E, 1968, PSYCHOL REV, V75, P421, DOI 10.1037/h0026301; Mayford M, 2007, CURR OPIN NEUROBIOL, V17, P313, DOI 10.1016/j.conb.2007.05.001; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; NOONAN JA, 1968, AM J DIS CHILD, V116, P373, DOI 10.1001/archpedi.1968.02100020377005; Oishi K, 2006, HUM MOL GENET, V15, P543, DOI 10.1093/hmg/ddi471; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Perkins LA, 1996, DEV BIOL, V180, P63, DOI 10.1006/dbio.1996.0285; Philips GT, 2007, J NEUROSCI, V27, P13701, DOI 10.1523/JNEUROSCI.4262-07.2007; Purcell AL, 2003, TRENDS NEUROSCI, V26, P625, DOI 10.1016/j.tins.2003.09.005; QUINN WG, 1976, NATURE, V262, P576, DOI 10.1038/262576a0; Sutton MA, 2002, LEARN MEMORY, V9, P29, DOI 10.1101/lm.44802; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; WICKELGREN WA, 1970, MODELS MEMORY; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030	54	114	114	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					186	198		10.1016/j.cell.2009.08.033	http://dx.doi.org/10.1016/j.cell.2009.08.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804763	Green Accepted, Bronze			2022-12-24	WOS:000270388600026
J	Rose, J; Hawthorn, RL; Watts, B; Singer, ME				Rose, Johnie; Hawthorn, Rachael L.; Watts, Brook; Singer, Mendel E.			Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ORAL CHOLERA VACCINE; 1ST 2 YEARS; LATIN-AMERICAN; DOUBLE-BLIND; CHILDREN; EFFICACY; INFANTS; DISEASE; GASTROENTERITIS; DIARRHEA	Objectives To examine the public health impact of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in a birth cohort in India, and to estimate the cost effectiveness and affordability of such a programme. Design Decision analytical Markov model encompassing all direct medical costs. Infection risk and severity depended on age, number of previous infections, and vaccination history; probabilities of use of inpatient and outpatient health services depended on symptom severity. Data sources Published clinical, epidemiological, and economic data. When possible, parameter estimates were based on data specific for India. Population Simulated Indian birth cohort followed for five years. Main outcome measures Decrease in rotavirus gastroenteritis episodes (non-severe and severe), deaths, outpatient visits, and admission to hospital; incremental cost effectiveness ratio of vaccination expressed as net cost in 2007 rupees per life year saved. Results In the base case, vaccination prevented 28 943 (29.7%) symptomatic episodes, 6981 (38.2%) severe episodes, 164 deaths (41.0%), 7178 (33.3%) outpatient visits, and 812 (34.3%) admissions to hospital per 100 000 children. Vaccination cost 8023 rupees ( about 100 pound, (sic)113, $165) per life year saved, less than India's per capita gross domestic product, a common criterion for cost effectiveness. The net programme cost would be equivalent to 11.6% of the 2006-7 budget of the Indian Department of Health and Family Welfare. Model results were most sensitive to variations in access to outpatient care for those with severe symptoms. If this parameter was increased to its upper limit, the incremental cost effectiveness ratio for vaccination still fell between one and three times the per capita gross domestic product, meeting the World Health Organization's criterion for "cost effective" interventions. Uncertainty analysis indicated a 94.7% probability that vaccination would be cost effective according to a criterion of one times per capita gross domestic product per life year saved, and a 97.8% probability that it would be cost effective according to a criterion of three times per capita gross domestic product. Conclusions Across a wide range of assumptions, mass RIX4414 vaccination in India would probably prevent substantial morbidity and mortality at a cost per life year saved below typical thresholds of cost effectiveness. The opportunity costs of such a programme in this or similar settings, however, should be weighed up carefully.	[Rose, Johnie; Singer, Mendel E.] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Div Hlth Serv Res & Policy, Cleveland, OH 44106 USA; [Watts, Brook] Louis Stokes Cleveland Vet Affairs Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Rose, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Div Hlth Serv Res & Policy, 10900 Euclid Ave,WG-57, Cleveland, OH 44106 USA.	johnie.rose@case.edu	Singer, Mendel/S-8775-2019; /AAB-7864-2021; /AHA-3700-2022	/0000-0001-7458-9303; /0000-0001-7458-9303; Singer, Mendel/0000-0002-3331-3340	US Department of Health and Human Services Agency for Healthcare Research and Quality	US Department of Health and Human Services Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	JR and RLH received support from a US Department of Health and Human Services Agency for Healthcare Research and Quality institutional training grant. No other direct funding was received for this study.	Angel J, 2007, NAT REV MICROBIOL, V5, P529, DOI 10.1038/nrmicro1692; [Anonymous], 2005, GUID EST EC BURD DIA; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Bahl R, 2005, J INFECT DIS, V192, pS114, DOI 10.1086/431497; Banerjee I, 2006, J CLIN MICROBIOL, V44, P2468, DOI 10.1128/JCM.01882-05; BLACK RE, 1989, AM J EPIDEMIOL, V129, P785, DOI 10.1093/oxfordjournals.aje.a115193; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; *CIA, 2008, WORLF FACTB; Clark HF, 1996, J INFECT DIS, V174, pS73, DOI 10.1093/infdis/174.Supplement_1.S73; CLEMENS JD, 1987, J INFECT DIS, V155, P79, DOI 10.1093/infdis/155.1.79; Cortese Margaret M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Dayan GH, 2001, VACCINE, V19, P4204, DOI 10.1016/S0264-410X(01)00160-8; De Vos B, 2009, PEDIATR INFECT DIS J, V28, P261, DOI 10.1097/INF.0b013e3181907177; De Wals P, 2004, VACCINE, V22, P1233, DOI 10.1016/j.vaccine.2003.09.022; Del Rio RA, 2006, HEPATOLOGY, V44, P1598, DOI 10.1002/hep.21409; Dennehy PH, 2008, CLIN MICROBIOL REV, V21, P198, DOI 10.1128/CMR.00029-07; Dennehy PH, 2007, VACCINE, V25, P3137, DOI 10.1016/j.vaccine.2007.01.102; DEZOYSA I, 1985, B WORLD HEALTH ORGAN, V63, P569; Fischer TK, 2005, J INFECT DIS, V192, P1720, DOI 10.1086/497339; Fischer TK, 2002, J INFECT DIS, V186, P593, DOI 10.1086/342294; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; GEORGESCOURBOT MC, 1991, RES VIROLOGY, V142, P405, DOI 10.1016/0923-2516(91)90008-Q; Glass RI, 2005, J INFECT DIS, V192, pS160, DOI 10.1086/431504; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; Global Advisory Committee on Vaccine Safety, 2008, WKLY EPIDEMIOL REC, V84, P37; HANLON P, 1987, LANCET, V1, P1342; *IND NAT INF CTR, 2007, UN BUDG 2007 2008; *IND PRWIRE, 2006, IND MICR NAT INV PLA; Isakbaeva ET, 2007, VACCINE, V25, P373, DOI 10.1016/j.vaccine.2006.07.029; Jaffe S, 2005, SCIENTIST, V19, P37; Jain Vivek, 2001, Indian Journal of Pediatrics, V68, P855, DOI 10.1007/BF02762113; JOHN TJ, 1976, BRIT MED J, V1, P812, DOI 10.1136/bmj.1.6013.812; Kim SY, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-29; Kotecha Prakash V, 2008, Indian J Community Med, V33, P9, DOI 10.4103/0970-0218.39235; Lahiri S, 2005, AM J IND MED, V48, P503, DOI 10.1002/ajim.20222; LANATA CF, 1989, J INFECT DIS, V159, P452, DOI 10.1093/infdis/159.3.452; LINHARES AC, 1989, EPIDEMIOL INFECT, V102, P129, DOI 10.1017/S0950268800029769; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; LOPEZ P, 2006, 24 ANN M EUR SOC INF; Madhavi Y, 2006, CURR SCI INDIA, V90, P1465; Mendelsohn AS, 2008, TROP MED INT HEALTH, V13, P934, DOI 10.1111/j.1365-3156.2008.02094.x; Minor PD, 2004, NAT REV MICROBIOL, V2, P473, DOI 10.1038/nrmicro906; Mrukowicz J, 2008, J PEDIATR GASTR NUTR, V46, pS32, DOI 10.1097/MPG.0b013e31816f79b0; Naghipour M, 2008, VACCINE, V26, P3236, DOI 10.1016/j.vaccine.2008.04.004; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parashar UD, 2006, SCIENCE, V312, P851, DOI 10.1126/science.1128827; Patel Archana B, 2003, Cost Eff Resour Alloc, V1, P7, DOI 10.1186/1478-7547-1-7; *PATH, 2006, P 7 INT S ROT ROT VA; Podewils LJ, 2005, J INFECT DIS, V192, pS133, DOI 10.1086/431513; Qadri F, 2007, VACCINE, V25, P231, DOI 10.1016/j.vaccine.2006.08.031; Rheingans RD, 2007, REV PANAM SALUD PUBL, V21, P205, DOI 10.1590/S1020-49892007000300003; Richie E, 2000, VACCINE, V18, P2399, DOI 10.1016/S0264-410X(00)00006-2; RODRIGUEZ WJ, 1987, PEDIATR INFECT DIS J, V6, P170, DOI 10.1097/00006454-198702000-00006; Rose J, 2008, PHARMACOECONOMICS, V26, P185, DOI 10.2165/00019053-200826030-00003; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; Samajdar S, 2008, J CLIN VIROL, V43, P334, DOI 10.1016/j.jcv.2008.07.007; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Sharma S, 2008, J CLIN MICROBIOL, V46, P1343, DOI 10.1128/JCM.02358-07; SIMHON A, 1985, J INFECT DIS, V152, P1134, DOI 10.1093/infdis/152.6.1134; Sisk JE, 2003, ANN INTERN MED, V138, P960, DOI 10.7326/0003-4819-138-12-200306170-00007; STEELE AD, 2008, VACCINE         0908; Thiry N, 2009, INT J TECHNOL ASSESS, V25, P161, DOI 10.1017/S0266462309090217; *USAID MICR PROGR, 2005, DIARRH TREATM GUID I; Valencia-Mendoza A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-103; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; WHO, 2009, WKLY EPIDEMIOL REC, V84, P213; *WHO, 2008, IMM PROF IND; *WHO, 2006, LIF TABL WHO MEMB ST; World Bank, 2008, WORLD BANK COUNTRY, P1, DOI 10.1596/978-0-8213-7462-7; World Health Organisation, 2009, EST ROT DEATHS CHILD; World Health Organization, 2007, Wkly Epidemiol Rec, V82, P285; World Health Organization, 2001, NAT BURD DIS STUD PR; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Zahn M, 2006, PEDIATR ANN, V35, P23, DOI 10.3928/0090-4481-20060101-10; ZAKI AM, 1986, AM J TROP MED HYG, V35, P1013, DOI 10.4269/ajtmh.1986.35.1013; Zaman K, 2009, VACCINE, V27, P1333, DOI 10.1016/j.vaccine.2008.12.059	79	38	38	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2009	339								b3653	10.1136/bmj.b3653	http://dx.doi.org/10.1136/bmj.b3653			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	499OH	19783581	Green Published, hybrid			2022-12-24	WOS:000270231900002
J	Kiendler-Scharr, A; Wildt, J; Dal Maso, M; Hohaus, T; Kleist, E; Mentel, TF; Tillmann, R; Uerlings, R; Schurr, U; Wahner, A				Kiendler-Scharr, Astrid; Wildt, Juergen; Dal Maso, Miikka; Hohaus, Thorsten; Kleist, Einhard; Mentel, Thomas F.; Tillmann, Ralf; Uerlings, Ricarda; Schurr, Uli; Wahner, Andreas			New particle formation in forests inhibited by isoprene emissions	NATURE			English	Article							ORGANIC AEROSOL; NATURAL AEROSOL; SULFURIC-ACID; OXIDATION; IMPACT; RATES; MODEL	It has been suggested that volatile organic compounds (VOCs) are involved in organic aerosol formation, which in turn affects radiative forcing and climate(1). The most abundant VOCs emitted by terrestrial vegetation are isoprene and its derivatives, such as monoterpenes and sesquiterpenes(2). New particle formation in boreal regions is related to monoterpene emissions(3) and causes an estimated negative radiative forcing(4) of about -0.2 to -0.9 W m(-2). The annual variation in aerosol growth rates during particle nucleation events correlates with the seasonality of monoterpene emissions of the local vegetation, with a maximum during summer(5). The frequency of nucleation events peaks, however, in spring and autumn(5). Here we present evidence from simulation experiments conducted in a plant chamber that isoprene can significantly inhibit new particle formation. The process leading to the observed decrease in particle number concentration is linked to the high reactivity of isoprene with the hydroxyl radical (OH). The suppression is stronger with higher concentrations of isoprene, but with little dependence on the specific VOC mixture emitted by trees. A parameterization of the observed suppression factor as a function of isoprene concentration suggests that the number of new particles produced depends on the OH concentration and VOCs involved in the production of new particles undergo three to four steps of oxidation by OH. Our measurements simulate conditions that are typical for forested regions and may explain the observed seasonality in the frequency of aerosol nucleation events, with a lower number of nucleation events during summer compared to autumn and spring(5). Biogenic emissions of isoprene are controlled by temperature and light(2), and if the relative isoprene abundance of biogenic VOC emissions increases in response to climate change or land use change, the new particle formation potential may decrease, thus damping the aerosol negative radiative forcing effect.	[Kiendler-Scharr, Astrid; Dal Maso, Miikka; Hohaus, Thorsten; Mentel, Thomas F.; Tillmann, Ralf; Wahner, Andreas] Forschungszentrum Julich, Inst ICG 2, D-52425 Julich, Germany; [Wildt, Juergen; Kleist, Einhard; Uerlings, Ricarda; Schurr, Uli] Forschungszentrum Julich, Inst ICG 3, D-52425 Julich, Germany; [Dal Maso, Miikka] Univ Helsinki, Dept Phys, Helsinki 00014, Finland	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; University of Helsinki	Kiendler-Scharr, A (corresponding author), Forschungszentrum Julich, Inst ICG 2, Postfach 1913, D-52425 Julich, Germany.	a.kiendler-scharr@fz-juelich.de	Dal Maso, Miikka/A-7980-2008; Mentel, Thomas F/A-3576-2011; Tillmann, Ralf/I-9203-2012; Tillmann, Ralf/AAM-5619-2021; Schurr, Ulrich/AAA-3158-2022; Wahner, Andreas/J-4129-2012; Kiendler-Scharr, Astrid/E-8439-2011; Hohaus, Thorsten/N-5507-2015	Dal Maso, Miikka/0000-0003-3040-3612; Mentel, Thomas F/0000-0003-0810-3541; Tillmann, Ralf/0000-0003-0648-6622; Tillmann, Ralf/0000-0003-0648-6622; Wahner, Andreas/0000-0001-8948-1928; Kiendler-Scharr, Astrid/0000-0003-3166-2253; Hohaus, Thorsten/0000-0001-5722-6244	European Commission [036833-2]	European Commission(European CommissionEuropean Commission Joint Research Centre)	We gratefully acknowledge support by the European Commission (IP-EUCAARI, contract number 036833-2).	Berndt T, 2005, SCIENCE, V307, P698, DOI 10.1126/science.1104054; Bloss C, 2005, ATMOS CHEM PHYS, V5, P641, DOI 10.5194/acp-5-641-2005; Goldstein AH, 2007, ENVIRON SCI TECHNOL, V41, P1514, DOI 10.1021/es072476p; Greenberg JP, 1999, ATMOS ENVIRON, V33, P855, DOI 10.1016/S1352-2310(98)00302-1; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Guenther A, 2006, ATMOS CHEM PHYS, V6, P3181, DOI 10.5194/acp-6-3181-2006; Hakola H, 2003, ATMOS ENVIRON, V37, P1623, DOI 10.1016/S1352-2310(03)00014-1; Heiden AC, 2003, J ATMOS CHEM, V45, P143, DOI 10.1023/A:1024069605420; Kanakidou M, 2005, ATMOS CHEM PHYS, V5, P1053, DOI 10.5194/acp-5-1053-2005; KASHCHIEV D, 1982, J CHEM PHYS, V76, P5098, DOI 10.1063/1.442808; Kellomaki S, 2001, GLOBAL CHANGE BIOL, V7, P531, DOI 10.1046/j.1365-2486.2001.00414.x; Kerminen VM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023130; Kesselmeier J, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000267; Kulmala M, 2004, ATMOS CHEM PHYS, V4, P557, DOI 10.5194/acp-4-557-2004; Kulmala M, 2004, J AEROSOL SCI, V35, P143, DOI 10.1016/j.jaerosci.2003.10.003; Laaksonen A, 2008, ATMOS CHEM PHYS, V8, P2657, DOI 10.5194/acp-8-2657-2008; Lathiere J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024164; Lathiere J, 2006, ATMOS CHEM PHYS, V6, P2129, DOI 10.5194/acp-6-2129-2006; Lindfors V, 2000, ATMOS ENVIRON, V34, P4983, DOI 10.1016/S1352-2310(00)00223-5; Lindfors Virpi, 2000, Boreal Environment Research, V5, P95; Mentel TF, 2009, ATMOS CHEM PHYS, V9, P4387, DOI 10.5194/acp-9-4387-2009; Riipinen I, 2007, ATMOS CHEM PHYS, V7, P1899, DOI 10.5194/acp-7-1899-2007; Sharkey TD, 2008, ANN BOT-LONDON, V101, P5, DOI 10.1093/aob/mcm240; Tsigaridis K, 2003, ATMOS CHEM PHYS, V3, P1849, DOI 10.5194/acp-3-1849-2003; Tunved P, 2008, TELLUS B, V60, P473, DOI [10.1111/j.1600-0889.2008.00363.x, 10.3402/tellusb.v60i4.16938]; Tunved P, 2006, SCIENCE, V312, P261, DOI 10.1126/science.1123052; Weber RJ, 1996, CHEM ENG COMMUN, V151, P53, DOI 10.1080/00986449608936541; WENT FW, 1960, NATURE, V187, P641, DOI 10.1038/187641a0; Wiedinmyer C, 2006, EARTH INTERACT, V10, DOI 10.1175/EI174.1	29	190	197	5	192	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					381	384		10.1038/nature08292	http://dx.doi.org/10.1038/nature08292			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19759617	Green Published			2022-12-24	WOS:000269828100036
J	Weintraub, NL				Weintraub, Neal L.			Understanding Abdominal Aortic Aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OXIDATIVE STRESS		[Weintraub, Neal L.] Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH 45221 USA; [Weintraub, Neal L.] Univ Cincinnati, Coll Med, VA Med Ctr, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Weintraub, NL (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH 45221 USA.			Weintraub, Neal/0000-0002-5138-3705	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076684] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL076684] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Dobrin PB, 1996, ANN NY ACAD SCI, V800, P74, DOI 10.1111/j.1749-6632.1996.tb33300.x; Miller FJ, 2002, ARTERIOSCL THROM VAS, V22, P560, DOI 10.1161/01.ATV.0000013778.72404.30; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958	5	113	116	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2009	361	11					1114	1116		10.1056/NEJMcibr0905244	http://dx.doi.org/10.1056/NEJMcibr0905244			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492LP	19741234	Green Accepted			2022-12-24	WOS:000269659400019
J	Lam, FC; Law, A; Wykes, W				Lam, Fook Chang; Law, Allison; Wykes, William			Practice 10-Minute Consultation Herpes zoster ophthalmicus	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lam, Fook Chang; Wykes, William] So Gen Hosp, Dept Ophthalmol, Glasgow G51 4TF, Lanark, Scotland; [Law, Allison] Southbank Surg, Kirkintilloch G66 1NH, Scotland	University of Glasgow	Lam, FC (corresponding author), So Gen Hosp, Dept Ophthalmol, Glasgow G51 4TF, Lanark, Scotland.	fook_chang@hotmail.com							0	7	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 13	2009	339								b2624	10.1136/bmj.b2624	http://dx.doi.org/10.1136/bmj.b2624			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485YK	19679612				2022-12-24	WOS:000269162100001
J	Katz, MH				Katz, Mitchell H.			Structural Interventions for Addressing Chronic Health Problems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICAL-ACTIVITY; PUBLIC-HEALTH		San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA	San Francisco Department of Public Health	Katz, MH (corresponding author), San Francisco Dept Publ Hlth, 101 Grove St,Room 308, San Francisco, CA 94102 USA.	Mitch.Katz@sfdph.org						Blankenship KM, 2006, J URBAN HEALTH, V83, P59, DOI 10.1007/s11524-005-9007-4; Eckel RH, 2005, JAMA-J AM MED ASSOC, V293, P96, DOI 10.1001/jama.293.1.96; Frieden TR, 2008, INT J EPIDEMIOL, V37, P966, DOI 10.1093/ije/dyn108; King AC, 1998, AM J PREV MED, V15, P316, DOI 10.1016/S0749-3797(98)00085-3; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Moulton AD, 2009, AM J PUBLIC HEALTH, V99, P17, DOI 10.2105/AJPH.2007.130278; National Center for Health Marketing Centers for Disease Control and Prevention, GUID COMM PREV SERV; Rigotti NA, 2002, NEW ENGL J MED, V346, P506, DOI 10.1056/NEJMcp012279; Sallis JF, 1998, AM J PREV MED, V15, P379, DOI 10.1016/S0749-3797(98)00076-2; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350	10	19	20	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 12	2009	302	6					683	685		10.1001/jama.2009.1147	http://dx.doi.org/10.1001/jama.2009.1147			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481ZI	19671911				2022-12-24	WOS:000268852300029
J	Wardlaw, T; Salama, P; Brocklehurst, C; Chopra, M; Mason, E				Wardlaw, Tessa; Salama, Peter; Brocklehurst, Clarissa; Chopra, Mickey; Mason, Elizabeth			Diarrhoea: why children are still dying and what can be done	LANCET			English	Editorial Material									[Wardlaw, Tessa] UNICEF, Div Policy & Practice, New York, NY 10017 USA; [Salama, Peter] UNICEF, Harare, Zimbabwe; [Brocklehurst, Clarissa; Chopra, Mickey] UNICEF, Programme Div, New York, NY 10017 USA; [Mason, Elizabeth] WHO, Dept Child & Adolescent Hlth & Dev, CH-1211 Geneva, Switzerland	UNICEF; UNICEF; University of Geneva; World Health Organization	Wardlaw, T (corresponding author), UNICEF, Div Policy & Practice, New York, NY 10017 USA.	twardlaw@unicef.org						[Anonymous], 2009, DIARRH WHY CHILDR AR; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Editorial, 1978, LANCET, V312, P300; Kar K., 2005, SUBSIDY SELF RESPECT; PINTO CB, INT MATERNA IN PRESS; Rudan I, 2007, LANCET INFECT DIS, V7, P56, DOI 10.1016/S1473-3099(06)70687-9; UNICEF WHO, 2004, JOINT STAT CLIN MAN; Walker CLF, 2009, B WORLD HEALTH ORGAN, V87, P780, DOI 10.2471/BLT.08.058990; WHO, 2009, WKLY EPIDEMIOL REC, V84, P213; WHO, 2008, SAF WAT BETT HLTH; World Health Organisation, 2009, EST ROT DEATHS CHILD; World Health Organization, 2008, GLOB BURD DIS 2004 U; You D, 2010, LANCET, V375, P100, DOI 10.1016/S0140-6736(09)61601-9	13	125	132	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 13	2010	375	9718					870	872		10.1016/S0140-6736(09)61798-0	http://dx.doi.org/10.1016/S0140-6736(09)61798-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	574NA	19833382				2022-12-24	WOS:000275995300006
J	Zhang, Q; Davis, JC; Lamborn, IT; Freeman, AF; Jing, H; Favreau, AJ; Matthews, HF; Davis, J; Turner, ML; Uzel, G; Holland, SM; Su, HC				Zhang, Qian; Davis, Jeremiah C.; Lamborn, Ian T.; Freeman, Alexandra F.; Jing, Huie; Favreau, Amanda J.; Matthews, Helen F.; Davis, Joie; Turner, Maria L.; Uzel, Gulbu; Holland, Steven M.; Su, Helen C.			Combined Immunodeficiency Associated with DOCK8 Mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPER-IGE SYNDROME; T-CELL IMMUNODEFICIENCY; STAT3 MUTATIONS; DIFFERENTIATION; DEFICIENCIES; ACTIVATOR; DELETION; DISEASES; EGRESS; FAMILY	BACKGROUND Recurrent sinopulmonary and cutaneous viral infections with elevated serum levels of IgE are features of some variants of combined immunodeficiency. The genetic causes of these variants are unknown. METHODS We collected longitudinal clinical data on 11 patients from eight families who had recurrent sinopulmonary and cutaneous viral infections. We performed comparative genomic hybridization arrays and targeted gene sequencing. Variants with predicted loss-of-expression mutations were confirmed by means of a quantitative reverse-transcriptase-polymerase-chain-reaction assay and immunoblotting. We evaluated the number and function of lymphocytes with the use of in vitro assays and flow cytometry. RESULTS Patients had recurrent otitis media, sinusitis, and pneumonias; recurrent Staphylococcus aureus skin infections with otitis externa; recurrent, severe herpes simplex virus or herpes zoster infections; extensive and persistent infections with molluscum contagiosum; and human papillomavirus infections. Most patients had severe atopy with anaphylaxis; several had squamous-cell carcinomas, and one had T-cell lymphoma-leukemia. Elevated serum IgE levels, hypereosinophilia, low numbers of T cells and B cells, low serum IgM levels, and variable IgG antibody responses were common. Expansion in vitro of activated CD8 T cells was impaired. Novel homozygous or compound heterozygous deletions and point mutations in the gene encoding the dedicator of cytokinesis 8 protein (DOCK8) led to the absence of DOCK8 protein in lymphocytes. CONCLUSIONS Autosomal recessive DOCK8 deficiency is associated with a novel variant of combined immunodeficiency.	[Su, Helen C.] NIAID, NIH, Host Def Lab, Bethesda, MD 20892 USA; [Freeman, Alexandra F.; Davis, Joie; Uzel, Gulbu; Holland, Steven M.] NIAID, Lab Clin Infect Dis, Bethesda, MD 20892 USA; [Favreau, Amanda J.] NIAID, Res Technol Branch, Bethesda, MD 20892 USA; [Matthews, Helen F.] NIAID, Immunol Lab, Bethesda, MD 20892 USA; [Davis, Jeremiah C.] Howard Hughes Med Inst, Bethesda, MD 20817 USA; [Turner, Maria L.] NCI, Dermatol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Su, HC (corresponding author), NIAID, NIH, Host Def Lab, CRC 5W3940,MSC 1456, Bethesda, MD 20892 USA.	hsu@niaid.nih.gov	Su, Helen C/H-9541-2015	Su, Helen C/0000-0002-5582-9110; Zhang, Qian/0000-0002-9040-3289	National Institutes of Health; National Institute of Allergy and Infectious Diseases; National Cancer Institute; Howard Hughes Medical Institute-National Institutes of Health Research Scholar Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001059, ZIAAI000646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute-National Institutes of Health Research Scholar Program(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Intramural Research Program of the National Institutes of Health, the National Institute of Allergy and Infectious Diseases, and the National Cancer Institute, and by a grant from the Howard Hughes Medical Institute-National Institutes of Health Research Scholar Program ( to Mr. Davis). Sequencing was performed by the Genomics Unit of the Rocky Mountain Laboratories Research Technologies Section of the National Institute of Allergy and Infectious Diseases.	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Brito-Babapulle F, 2003, BRIT J HAEMATOL, V121, P203, DOI 10.1046/j.1365-2141.2003.04195.x; Bustamante J, 2008, IMMUNOL ALLERGY CLIN, V28, P235, DOI 10.1016/j.iac.2008.01.009; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; CUSTER JW, 2009, HARRIET LANE HDB MAN; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; Fischer A, 2007, IMMUNITY, V27, P835, DOI 10.1016/j.immuni.2007.11.012; Freeman AF, 2008, IMMUNOL ALLERGY CLIN, V28, P277, DOI 10.1016/j.iac.2008.01.005; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Griggs BL, 2008, GENOMICS, V91, P195, DOI 10.1016/j.ygeno.2007.10.011; Grimbacher B, 1999, AM J HUM GENET, V65, P735, DOI 10.1086/302547; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Idbaih A, 2008, J NEURO-ONCOL, V90, P133, DOI 10.1007/s11060-008-9644-z; Kalman L, 2004, GENET MED, V6, P16, DOI 10.1097/01.GIM.0000105752.80592.A3; Kawai T, 2009, CURR OPIN HEMATOL, V16, P20, DOI 10.1097/MOH.0b013e32831ac557; Lei JY, 2000, AM J DERMATOPATH, V22, P524, DOI 10.1097/00000372-200012000-00008; Liston A, 2008, NAT REV IMMUNOL, V8, P545, DOI 10.1038/nri2336; MARKERT ML, 1987, J CLIN IMMUNOL, V7, P389, DOI 10.1007/BF00917017; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Nombela-Arrieta C, 2007, J EXP MED, V204, P497, DOI 10.1084/jem.20061780; Ozcan E, 2008, J ALLERGY CLIN IMMUN, V122, P1054, DOI 10.1016/j.jaci.2008.10.023; Pignata C, 1996, AM J MED GENET, V65, P167, DOI 10.1002/(SICI)1096-8628(19961016)65:2<167::AID-AJMG17>3.0.CO;2-O; PRAWER SE, 1977, ARCH DERMATOL, V113, P495, DOI 10.1001/archderm.113.4.495; Renner ED, 2004, J PEDIATR-US, V144, P93, DOI 10.1016/S0022-3476(03)00449-9; Renner ED, 2008, J ALLERGY CLIN IMMUN, V122, P181, DOI 10.1016/j.jaci.2008.04.037; Ruusala A, 2004, FEBS LETT, V572, P159, DOI 10.1016/j.febslet.2004.06.095; Sanui T, 2003, IMMUNITY, V19, P119, DOI 10.1016/S1074-7613(03)00169-9; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; Takahashi K, 2006, INT J ONCOL, V28, P321; Tanaka Y, 2007, NAT IMMUNOL, V8, P1067, DOI 10.1038/ni1506; van der Burg M, 2006, J CLIN INVEST, V116, P137, DOI 10.1172/JCI26121; van der Burg M, 2009, J CLIN INVEST, V119, P91, DOI 10.1172/JCI37141; Vinci G, 2007, MOL HUM REPROD, V13, P685, DOI 10.1093/molehr/gam045; Woellner C, 2007, IMMUNITY, V26, P535, DOI 10.1016/j.immuni.2007.05.007	39	485	499	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2009	361	21					2046	2055		10.1056/NEJMoa0905506	http://dx.doi.org/10.1056/NEJMoa0905506			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521DA	19776401	Green Accepted			2022-12-24	WOS:000271898600009
J	Engelberg, AB; Kesselheim, AS; Avorn, J				Engelberg, Alfred B.; Kesselheim, Aaron S.; Avorn, Jerry			Balancing Innovation, Access, and Profits -- Market Exclusivity for Biologics.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Engelberg, Alfred B.] Engelberg Fdn, Palm Beach, FL 33480 USA; [Kesselheim, Aaron S.; Avorn, Jerry] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Kesselheim, Aaron S.; Avorn, Jerry] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Engelberg, AB (corresponding author), Engelberg Fdn, Palm Beach, FL 33480 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Dudzinski DM, 2008, NEW ENGL J MED, V358, P843, DOI 10.1056/NEJMhle0706973; Engelberg A., 1999, IDEA, V39, P389; *FED TRAD COMM, 2009, FOLL ON BIOL DRUG CO; SYRE S, 2009, BOSTON GLOBE    0821	4	48	49	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2009	361	20					1917	1919		10.1056/NEJMp0908496	http://dx.doi.org/10.1056/NEJMp0908496			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	518AI	19828525				2022-12-24	WOS:000271660500001
J	Higgins, MJ; Graham, SJH				Higgins, Matthew J.; Graham, Stuart J. H.			Balancing Innovation and Access: Patent Challenges Tip the Scales	SCIENCE			English	Editorial Material							RESEARCH-AND-DEVELOPMENT; PHARMACEUTICAL-INDUSTRY; PRICE-COMPETITION; DRUGS		[Higgins, Matthew J.; Graham, Stuart J. H.] Georgia Inst Technol, Coll Management, Atlanta, GA 30308 USA; [Graham, Stuart J. H.] Univ Calif Berkeley, Sch Law, Berkeley Ctr Law & Technol, Berkeley, CA 94720 USA	University System of Georgia; Georgia Institute of Technology; University of California System; University of California Berkeley	Higgins, MJ (corresponding author), Georgia Inst Technol, Coll Management, Atlanta, GA 30308 USA.	matt.higgins@mgt.gatech.edu						*AM INT PROP LAW A, 2007, REP EC SURV 2007; [Anonymous], 2000, PROTECTING THEIR INT; Arrow K. J, 1962, RATE DIRECTION INVEN, P609, DOI DOI 10.1515/9781400879762-024; Berndt ER, 2007, HEALTH AFFAIR, V26, P790, DOI 10.1377/hlthaff.26.3.790; Cockburn IM, 2006, INNOV POLICY ECON, V7, P1; Congressional Budget Office, 1998, INCR COMP GEN DRUGS; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; *FED TRAD COMM, 2002, GEN ENTR PRIOR PAT E; Federal Trade Commission, 2009, AUTH GEN INT REP AUTH GEN INT REP; *FOOD DRUG ADM, 2009, OR BOOK APPR DRUG PR; GLASS G, 2009, PARAGRAPH 4 REPORT A; Grabowski H, 2002, J INT ECON LAW, V5, P849, DOI 10.1093/jiel/5.4.849; Grabowski H, 2007, PHARMACEUTICAL INNOVATION: INCENTIVES, COMPETITION, AND COST-BENEFIT ANALYSIS IN INTERNATIONAL PERSPECTIVE, P153, DOI 10.1017/CBO9780511618871.009; Grabowski HG, 2007, MANAG DECIS ECON, V28, P491, DOI 10.1002/mde.1356; GRABOWSKI HG, 1992, J LAW ECON, V35, P331, DOI 10.1086/467257; Graham S. J. H., 2008, TIMING NEW DRUG INTR; Groetken Troy A., 2008, NW J TECHNOL INTELL, V6, P331; Higgins MJ, 2006, J FINANC ECON, V80, P351, DOI 10.1016/j.jfineco.2005.04.004; Hughes B, 2008, NAT REV DRUG DISCOV, V7; Kapczynski A., 2005, BERKELEY TECHNOLOGY, V20, P1031; Lichtenberg FR, 2001, HEALTH AFFAIR, V20, P241, DOI 10.1377/hlthaff.20.5.241; Lichtenberg Frank R, 2005, Int J Health Care Finance Econ, V5, P47, DOI 10.1007/s10754-005-6601-7; *MERCK CO, 2008, 2008 ANN REP MERCK C; *NAT AC SCI ENG I, 2007, RIS GATH STORM EN EM; *PHARM RES MAN AM, 2009, 2009 ANN REP PHRMA, P14; *PHRMA, 2009, IND PROF 2009, P54; RICHWINE L, 2009, REUTERS         0625; Saha A, 2006, INT J ECON BUS, V13, P15, DOI 10.1080/13571510500519905; Scherer FM, 2001, HEALTH AFFAIR, V20, P216, DOI 10.1377/hlthaff.20.5.216; *TEV PHARM IND LTD, 2007, FORM 20 F; Vernon John A., 2002, REGULATION, V25, P22; Wood AJJ, 2006, NEW ENGL J MED, V355, P618, DOI 10.1056/NEJMsb055203; 2004, OFFICIAL J L, V136, P34	33	55	55	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					370	371		10.1126/science.1176116	http://dx.doi.org/10.1126/science.1176116			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	506ZM	19833944				2022-12-24	WOS:000270818600029
J	Doyle, Y; McKee, M; Rechel, B; Grundy, E				Doyle, Yvonne; McKee, Martin; Rechel, Bernd; Grundy, Emily			Meeting the challenge of population ageing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICAL-ACTIVITY; OLDER-ADULTS; DEMENTIA; PATTERNS; DISEASE; TIME; RISK		[Doyle, Yvonne] NHS SE Coast, Horley RH6 7DE, Surrey, England; [McKee, Martin; Rechel, Bernd; Grundy, Emily] London Sch Hyg & Trop Med, London, England	University of London; London School of Hygiene & Tropical Medicine	Doyle, Y (corresponding author), NHS SE Coast, Horley RH6 7DE, Surrey, England.	yvonne.doyle@southeastcoast.nhs.uk	Mckee, Martin/E-6673-2018; Grundy, Emily/AAC-3260-2019; McKee, Marc D/E-2187-2011	Mckee, Martin/0000-0002-0121-9683; Grundy, Emily/0000-0002-9633-1116; McKee, Marc D/0000-0001-8349-965X; Rechel, Bernd/0000-0001-8020-3956				Albertini M, 2007, J EUR SOC POLICY, V17, P319, DOI 10.1177/0958928707081068; Angevaren M, 2008, COCHRANE DATABASE SY; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; *ASS PUBL HLTH OBS, IND PUBL HLTH REG 9; Attias-Donfut Claudine, 2005, Eur J Ageing, V2, P161, DOI 10.1007/s10433-005-0008-7; Clarke P, 2009, MATURITAS, V64, P14, DOI 10.1016/j.maturitas.2009.07.011; Coley N, 2008, EPIDEMIOL REV, V30, P35, DOI 10.1093/epirev/mxn010; Daatland SO, 2003, AGEING SOC, V23, P537, DOI 10.1017/S0144686X03001272; *EUR COMM EUR COUN, 2009, JOINT REP SOC PROT S; *FLASH EUR, 2009, INT SOL; Flicker L, 2009, MATURITAS, V63, P319, DOI 10.1016/j.maturitas.2009.06.008; GRUBER J, 1999, EBRI ISSUE BRIEF, V209, P1; Grundy E, 2001, ENVIRON PLANN A, V33, P685, DOI 10.1068/a33165; Grundy E, 2005, BRIT J SOCIOL, V56, P233, DOI 10.1111/j.1468-4446.2005.00057.x; Harbers M., 2008, OLD AGE DEPENDENCY R; *HM GOV, 2009, BUILD SOC ALL AG; Humphrey A., 2003, FACTORS AFFECTING LA; *IUS LAB, 2006, RES AG DISCR SURV; Jagger C, 2008, LANCET, V372, P2124, DOI 10.1016/S0140-6736(08)61594-9; Kapteyn A, 2004, LABOUR ECON, V11, P293, DOI 10.1016/j.labeco.2003.08.001; Kenny GP, 2008, AM J IND MED, V51, P610, DOI 10.1002/ajim.20600; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Libby P, 2006, AM J CLIN NUTR, V83, p456S; LUND T, 2004, EUR J AGEING, V2, P275; LUPTON MK, 2009, INT J GERIATR P 0520; Mayhew L., 2009, INCREASING LONGEVITY; Naegele G., 2006, EUROPEAN FDN IMPROVE; Nolte E, 2008, CARING PEOPLE CHRONI; *OECD, ANN LAB FORC STAT; Oliveira Martins J., 2005, IMPACT AGEING DEMAND; Oxley H., 2009, POLICIES HLTH AGEING; Rechel B., 2010, CAN HLTH SYSTEMS RES; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; United Nations, 2002, SOC POL DEV AG 2 WOR; Varraso R, 2007, AM J CLIN NUTR, V86, P488, DOI 10.1093/ajcn/86.2.488; 2009, DAILY TELEGRAPH 0818; 2007, TIMES           0625	37	49	49	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 5	2009	339								b3926	10.1136/bmj.b3926	http://dx.doi.org/10.1136/bmj.b3926			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505TE	19805472	Green Accepted			2022-12-24	WOS:000270718700002
J	Vanacore, R; Ham, AJL; Voehler, M; Sanders, CR; Conrads, TP; Veenstra, TD; Sharpless, KB; Dawson, PE; Hudson, BG				Vanacore, Roberto; Ham, Amy-Joan L.; Voehler, Markus; Sanders, Charles R.; Conrads, Thomas P.; Veenstra, Timothy D.; Sharpless, K. Barry; Dawson, Philip E.; Hudson, Billy G.			A Sulfilimine Bond Identified in Collagen IV	SCIENCE			English	Article							BASEMENT-MEMBRANE COLLAGEN; COVALENT CROSS-LINK; CRYSTAL-STRUCTURE; IMMUNE PRIVILEGE; STRUCTURAL BASIS; METHIONINE; DOMAIN; STABILIZATION; AUTOANTIGEN; INTEGRINS	Collagen IV networks are ancient proteins of basement membranes that underlie epithelia in metazoa from sponge to human. The networks provide structural integrity to tissues and serve as ligands for integrin cell-surface receptors. They are assembled by oligomerization of triple-helical protomers and are covalently crosslinked, a key reinforcement that stabilizes networks. We used Fourier-transform ion cyclotron resonance mass spectrometry and nuclear magnetic resonance spectroscopy to show that a sulfilimine bond (-S=N-) crosslinks hydroxylysine-211 and methionine-93 of adjoining protomers, a bond not previously found in biomolecules. This bond, the nitrogen analog of a sulfoxide, appears to have arisen at the divergence of sponge and cnidaria, an adaptation of the extracellular matrix in response to mechanical stress in metazoan evolution.	[Vanacore, Roberto; Hudson, Billy G.] Vanderbilt Univ, Dept Med, Div Nephrol, Nashville, TN 37232 USA; [Vanacore, Roberto; Hudson, Billy G.] Vanderbilt Univ, Ctr Matrix Biol, Nashville, TN 37232 USA; [Ham, Amy-Joan L.; Sanders, Charles R.; Hudson, Billy G.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Voehler, Markus] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA; [Conrads, Thomas P.; Veenstra, Timothy D.] NCI, Lab Prote & Analyt Technol, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21702 USA; [Sharpless, K. Barry; Dawson, Philip E.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Sharpless, K. Barry; Dawson, Philip E.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Dawson, Philip E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Vanacore, R (corresponding author), Vanderbilt Univ, Dept Med, Div Nephrol, Nashville, TN 37232 USA.	roberto.vanacore@vanderbilt.edu; billy.hudson@vanderbilt.edu	Vanacore, Roberto/AAD-6399-2020; Vanacore, Roberto/C-9763-2012	Vanacore, Roberto/0000-0002-2886-0606; Vanacore, Roberto/0000-0002-2886-0606; Hudson, Billy/0000-0002-5420-4100	NIH [DK065123, DK18381, DC007416, GM059380]; W. M. Keck Foundation; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018381, P01DK065123, R37DK018381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007416] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. Liebler for facilitating the initial contact with T. D. Veenstra from SAIC-Frederick, Incorporated, and C. Bolm (Aachen University, Germany) for helpful discussions. The technical assistance of P. Todd and M. Rafi is greatly appreciated. We would also like to thank S. Hill and H. McDonald, from the Proteomics Laboratory at the Mass Spectrometry Research Center of Vanderbilt University, for their assistance with the Orbitrap-LTQ (Therme Electron, San Jose, CA) instrument. This work was supported in part by NIH grants DK065123 and DK18381 (to B. G. H.), DC007416 (C. R. S.), and GM059380 (P. E. D.); the W. M. Keck Foundation (K. B. S.); and the Skaggs Institute for Chemical Biology (K. B. S.). R. V. and B. G. H. have filed a provisional patent (1 June 2009) on the potential enzyme system that catalyses the sulfilimine bond formation and that may be involved in pathophysiological processes.	Aouacheria A, 2006, MOL BIOL EVOL, V23, P2288, DOI 10.1093/molbev/msl100; Borza DB, 2005, J BIOL CHEM, V280, P27147, DOI 10.1074/jbc.M504050200; COPE AC, 1949, J AM CHEM SOC, V71, P3929, DOI 10.1021/ja01180a014; GILCHRIST TL, 1977, CHEM REV, V77, P409, DOI 10.1021/cr60307a005; GLASS RS, 1976, J AM CHEM SOC, V98, P965, DOI 10.1021/ja00420a016; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JOHNSON CR, 1972, TETRAHEDRON LETT, V6, P501; Khoshnoodi J, 2006, J BIOL CHEM, V281, P6058, DOI 10.1074/jbc.M506555200; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; KOVAL IV, 1990, USP KHIM+, V59, P1409; Lagerwerf FM, 1996, RAPID COMMUN MASS SP, V10, P1905, DOI 10.1002/(SICI)1097-0231(199612)10:15<1905::AID-RCM755>3.0.CO;2-9; LAMBETH DO, 1979, J ORG CHEM, V44, P263; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Reid GE, 2004, J PROTEOME RES, V3, P751, DOI 10.1021/pr0499646; SIEBOLD B, 1988, EUR J BIOCHEM, V176, P617, DOI 10.1111/j.1432-1033.1988.tb14321.x; Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200; Than ME, 2005, BIOL CHEM, V386, P759, DOI 10.1515/BC.2005.089; Than ME, 2002, P NATL ACAD SCI USA, V99, P6607, DOI 10.1073/pnas.062183499; Thorner PS, 1996, J BIOL CHEM, V271, P13821, DOI 10.1074/jbc.271.23.13821; Vanacore RM, 2005, J BIOL CHEM, V280, P29300, DOI 10.1074/jbc.M502752200; Vanacore RM, 2004, J BIOL CHEM, V279, P44723, DOI 10.1074/jbc.M406344200; Vanacore RM, 2008, J BIOL CHEM, V283, P22737, DOI 10.1074/jbc.M803451200; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; WEBER S, 1984, EUR J BIOCHEM, V139, P401, DOI 10.1111/j.1432-1033.1984.tb08019.x; YURCHENCO PD, 1984, BIOCHEMISTRY-US, V23, P1839, DOI 10.1021/bi00303a040	30	150	154	5	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 4	2009	325	5945					1230	1234		10.1126/science.1176811	http://dx.doi.org/10.1126/science.1176811			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729652	Green Accepted			2022-12-24	WOS:000269523200033
J	Sprague, BL; Trentham-Dietz, A				Sprague, Brian L.; Trentham-Dietz, Amy			Prevalence of Breast Carcinoma In Situ in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CANCER; RISK		[Sprague, Brian L.; Trentham-Dietz, Amy] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sprague, BL (corresponding author), Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI 53706 USA.	bsprague@wisc.edu			NATIONAL CANCER INSTITUTE [R01CA067264] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA067264-12, R01 CA067264, CA67264] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Capocaccia R, 1997, STAT MED, V16, P425, DOI 10.1002/(SICI)1097-0258(19970228)16:4<425::AID-SIM414>3.0.CO;2-Z; Gail MH, 1999, BIOMETRICS, V55, P1137, DOI 10.1111/j.0006-341X.1999.01137.x; Rakovitch E, 2003, BREAST CANCER RES TR, V77, P285, DOI 10.1023/A:1021853302033; Ries L, 1975, SEER CANC STAT REV; SEER, SEER STAT DAT; Warnberg F, 2000, LANCET, V355, P724, DOI 10.1016/S0140-6736(99)03703-4	6	17	17	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 26	2009	302	8					846	848						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487GN	19706857	Green Accepted			2022-12-24	WOS:000269260100017
J	Califf, RM				Califf, Robert M.		Global Collaborative Cardiovasc Re	Key issues for global cardiovascular medicine	LANCET			English	Editorial Material									[Califf, Robert M.; Global Collaborative Cardiovasc Re] Duke Univ, Med Ctr, Duke Translat Med Inst, Durham, NC 27710 USA	Duke University	Califf, RM (corresponding author), Duke Univ, Med Ctr, Duke Translat Med Inst, Durham, NC 27710 USA.	robert.califf@duke.edu						Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Mark DB, 2007, EUR HEART J, V28, P2678, DOI 10.1093/eurheartj/ehm411; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205	3	5	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 15	2009	374	9689					508	510		10.1016/S0140-6736(09)61470-7	http://dx.doi.org/10.1016/S0140-6736(09)61470-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	484BX	19683629				2022-12-24	WOS:000269019400007
J	Thomsen, RW; Schoonen, WM; Farkas, DK; Riis, A; Jacobsen, J; Fryzek, JP; Sorensen, HT				Thomsen, Reimar W.; Schoonen, W. Marieke; Farkas, Dora K.; Riis, Anders; Jacobsen, Jacob; Fryzek, Jon P.; Sorensen, Henrik Toft			Risk for Hospital Contact With Infection in Patients With Splenectomy A Population-Based Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY-CARE; MORTALITY; BACTEREMIA; PROPHYLAXIS; PNEUMONIA; SEPSIS; ADULTS	Background: Splenectomy has been associated with increased risk for infection. Objective: To assess the magnitude and duration of risk for hospital contact with infection associated with splenectomy. Design: Population-based cohort study. Setting: Denmark. Patients: All 3812 persons in Denmark who underwent splenectomy from 1996 to 2005. Splenectomized patients were matched to 3 comparison cohorts: the general population, appendectomized patients, and unsplenectomized patients with indications for splenectomy. Measurements: Relative risks were assessed for hospital contact involving any infection, pneumonia, and microbiologically confirmed bacteremia among 3812 splenectomized patients and their matched comparisons, during different follow-up periods and after regression analysis for confounder adjustment. Results: The adjusted relative risk for any hospital contact with infection was highest within 90 days of splenectomy: 10.2% vs. 0.6% among general population comparisons (adjusted odds ratio, 18.1 [95% CI, 14.8 to 22.1]) and 10.2% vs. 4.2% among appendectomized patients (adjusted odds ratio, 2.4 [ CI, 2.1 to 2.8]). The hazard of infection was 4.6-fold (CI, 3.8 to 5.5) higher in splenectomized patients than in general population comparisons from 91 to 365 days after splenectomy and 2.5 times (CI, 2.2 to 2.8) higher more than 365 days after splenectomy. The risks were similar for pneumonia and were higher for bacteremia. Markedly increased risks were also found when compared with those of appendectomized patients. Modest increases in infection risk were seen with splenectomy matched-indication comparisons (adjusted 90-day odds ratio, 1.7 [CI, 1.5 to 2.1]; hazard ratios, 1.5 [CI, 1.2 to 1.8] from 91 to 365 days after splenectomy and 1.2 [CI, 1.1 to 1.4] beyond 365 days after splenectomy). Relative risks for infection were highest in patients who had splenectomy because of hematologic disorders. Limitation: Increased surveillance among splenectomized patients may have affected the findings. Conclusion: Splenectomy is associated with increased long-term risk for infections involving hospital contact.	[Thomsen, Reimar W.] Aarhus Univ Hosp, Aalborg Hosp, Sci & Innovat Ctr, Dept Clin Epidemiol, DK-9000 Aalborg, Denmark; [Schoonen, W. Marieke] Amgen Inc, Uxbridge UB8 1DH, Middx, England; [Farkas, Dora K.; Riis, Anders; Jacobsen, Jacob; Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus, Denmark; [Fryzek, Jon P.] Amgen Inc, Thousand Oaks, CA 91360 USA	Aalborg University; Aalborg University Hospital; Aarhus University; Amgen; Amgen Limited; Aarhus University; Amgen	Thomsen, RW (corresponding author), Aarhus Univ Hosp, Aalborg Hosp, Sci & Innovat Ctr, Dept Clin Epidemiol, Sondre Skovvej 15, DK-9000 Aalborg, Denmark.	thomsen@rn.dk; hts@dce.au.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Thomsen, Reimar/0000-0001-9135-3474; Riis, Anders Hammerich/0000-0002-6684-4068	Amgen; Clinical Epidemiological Research Founddation at Aarhus University; Karen Elise Jensens Foundation	Amgen(Amgen); Clinical Epidemiological Research Founddation at Aarhus University; Karen Elise Jensens Foundation	Grant Support: By Amgen, the Clinical Epidemiological Research Founddation at Aarhus University, and the Karen Elise Jensens Foundation.	Andersen TF, 1999, DAN MED BULL, V46, P263; BIRGENS HS, 2003, BENIGNE HAEMATOLOGIS; Bisharat N, 2001, J INFECTION, V43, P182, DOI 10.1053/jinf.2001.0904; Cadili A, 2008, AM J MED, V121, P371, DOI 10.1016/j.amjmed.2008.02.014; CHAPLIN DD, 2003, FUNDAMENTAL IMMUNOLO, P419; CULLINGFORD GL, 1991, BRIT J SURG, V78, P716, DOI 10.1002/bjs.1800780626; DEODHAR HA, 1993, BRIT MED J, V307, P1408, DOI 10.1136/bmj.307.6916.1408; Ejstrud P, 1997, EUR J SURG, V163, P733; Ejstrud P, 2000, SCAND J INFECT DIS, V32, P521, DOI 10.1080/003655400458811; Ernstrom F, 1998, Ugeskr Laeger, V160, P2887; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; GORDON S, 2003, FUNDAMENTAL IMMUNOLO, P482; KINNERSLEY P, 1993, BRIT MED J, V307, P1398, DOI 10.1136/bmj.307.6916.1398; Kornum JB, 2007, DIABETES CARE, V30, P2251, DOI 10.2337/dc06-2417; Kyaw MH, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.07.044; Kyaw MH, 2002, J CLIN PATHOL, V55, P472, DOI 10.1136/jcp.55.6.472; MELLEMKJAER L, 1995, CANCER, V75, P577, DOI 10.1002/1097-0142(19950115)75:2<577::AID-CNCR2820750222>3.0.CO;2-K; Newland A, 2005, BRIT MED J, V331, P417, DOI 10.1136/bmj.331.7514.417; Sampath S, 2007, AM J SURG, V193, P580, DOI 10.1016/j.amjsurg.2007.02.002; Schneeweiss S, 2007, J CLIN EPIDEMIOL, V60, P397, DOI 10.1016/j.jclinepi.2006.07.011; Schonheyder Henrik C, 2007, Ugeskr Laeger, V169, P4175; SCHWARTZ PE, 1982, JAMA-J AM MED ASSOC, V248, P2279, DOI 10.1001/jama.248.18.2279; Sogaard M, 2008, J AM GERIATR SOC, V56, P1593, DOI 10.1111/j.1532-5415.2008.01855.x; Sorensen HT, 1996, INT J EPIDEMIOL, V25, P435, DOI 10.1093/ije/25.2.435; *STAT SER I, EPI NEWS NAT SURV CO; Thomsen RW, 2006, J INTERN MED, V259, P410, DOI 10.1111/j.1365-2796.2006.01629.x; Thomsen RW, 2006, CRIT CARE MED, V34, P1080, DOI 10.1097/01.CCM.0000207345.92928.E4; Waghorn DJ, 2001, J CLIN PATHOL, V54, P214, DOI 10.1136/jcp.54.3.214; Wiseman J, 2006, AM SURGEON, V72, P947	29	105	110	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2009	151	8					546	U56		10.7326/0003-4819-151-8-200910200-00008	http://dx.doi.org/10.7326/0003-4819-151-8-200910200-00008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514HY	19841456				2022-12-24	WOS:000271386200004
J	Haralson, RH; Zuckerman, JD				Haralson, Robert H., III; Zuckerman, Joseph D.			Prevalence, Health Care Expenditures, and Orthopedic Surgery Workforce for Musculoskeletal Conditions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Zuckerman, Joseph D.] NYU, Dept Orthopaed Surg, Hosp Joint Dis, New York, NY 10003 USA; [Haralson, Robert H., III; Zuckerman, Joseph D.] Amer Acad Orthopaed Surg, Rosemont, IL USA	New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC	Zuckerman, JD (corresponding author), NYU, Dept Orthopaed Surg, Hosp Joint Dis, 301 E 17th St,Room 1402, New York, NY 10003 USA.	joseph.zuckerman@nyumc.org						*AM AC ORTH SURG, 2008, BURD MUS DIS US; *DEP RES SCI AFF A, 2006, ORTH SURG CENS; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; McNeil JM, 2001, JAMA-J AM MED ASSOC, V285, P1571; *NAT CTR HLTH STAT, NAT HLTH INT SURV AD; *NAT OST FDN, NAT OST FDN FAST FAC; *NAT OST FDN, 2000, AM BON HLTH STAT OST	7	31	31	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 14	2009	302	14					1586	1587		10.1001/jama.2009.1489	http://dx.doi.org/10.1001/jama.2009.1489			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505UA	19826031				2022-12-24	WOS:000270721800030
J	Weiss, LA; Arking, DE				Weiss, Lauren A.; Arking, Dan E.		Johns Hopkins & Autism Consortium	A genome-wide linkage and association scan reveals novel loci for autism	NATURE			English	Article							SPECTRUM DISORDERS; WILLIAMS-SYNDROME; GENETIC VARIANT; COMMON DISEASES; EXPRESSION; GTF2IRD1; DEFICITS; MARKERS; CNTNAP2; CORTEX	Although autism is a highly heritable neurodevelopmental disorder, attempts to identify specific susceptibility genes have thus far met with limited success(1). Genome-wide association studies using half a million or more markers, particularly those with very large sample sizes achieved through meta-analysis, have shown great success in mapping genes for other complex genetic traits. Consequently, we initiated a linkage and association mapping study using half a million genome-wide single nucleotide polymorphisms (SNPs) in a common set of 1,031 multiplex autism families ( 1,553 affected offspring). We identified regions of suggestive and significant linkage on chromosomes 6q27 and 20p13, respectively. Initial analysis did not yield genome-wide significant associations; however, genotyping of top hits in additional families revealed an SNP on chromosome 5p15 ( between SEMA5A and TAS2R1) that was significantly associated with autism (P = 2 x 10(-7)). We also demonstrated that expression of SEMA5A is reduced in brains from autistic patients, further implicating SEMA5A as an autism susceptibility gene. The linkage regions reported here provide targets for rare variation screening whereas the discovery of a single novel association demonstrates the action of common variants.	[Weiss, Lauren A.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Weiss, Lauren A.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Weiss, Lauren A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Arking, Dan E.] Johns Hopkins Univ, Ctr Complex Dis Genom, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johns Hopkins University	Weiss, LA (corresponding author), Univ Calif San Francisco, Dept Psychiat, Inst Human Genet, Ctr Neurobiol & Psychiat, San Francisco, CA 94143 USA.		Leboyer, Marion/AAW-3648-2021; Pickles, Andrew/A-9625-2011; Bailey, Anthony/J-2860-2014; Pinto, Dalila/C-4218-2016; Oliveira, Guiomar/AAF-3911-2021; Altshuler, David M/A-4476-2009; Monaco, Anthony P/A-4495-2010; Battaglia, Agatino/AAG-1406-2020; Betancur, Catalina/K-3791-2017; Sutcliffe, James S/C-1348-2012; Paterson, Andrew/AAQ-7511-2020; Haines, Jonathan/C-3374-2012; Tansey, Katherine E/B-1033-2013; Munir, Kerim/D-6910-2015; Fombonne, Eric/M-4893-2018; Morrow, Eric/J-2767-2013; Vicente, Astrid/F-8692-2014; Paterson, Andrew D/A-4088-2011; Scherer, Stephen W./B-3785-2013	Leboyer, Marion/0000-0001-5473-3697; Pickles, Andrew/0000-0003-1283-0346; Bailey, Anthony/0000-0003-4257-972X; Pinto, Dalila/0000-0002-8769-0846; Oliveira, Guiomar/0000-0002-7049-1277; Altshuler, David M/0000-0002-7250-4107; Monaco, Anthony P/0000-0001-7480-3197; Battaglia, Agatino/0000-0002-7128-7606; Betancur, Catalina/0000-0002-3327-4804; Sutcliffe, James S/0000-0001-5200-6007; Paterson, Andrew/0000-0002-9169-118X; Haines, Jonathan/0000-0002-4351-4728; Tansey, Katherine E/0000-0002-9663-3376; Munir, Kerim/0000-0002-2404-1806; Fombonne, Eric/0000-0002-8605-3538; Morrow, Eric/0000-0003-3430-3520; Vicente, Astrid/0000-0001-7134-8037; Paterson, Andrew D/0000-0002-9169-118X; Scherer, Stephen W./0000-0002-8326-1999; Ennis, Sean/0000-0002-4330-1386; Dawson, Geraldine/0000-0003-1410-2764; Mottron, Laurent/0000-0001-5668-5422; Yaspan, Brian/0000-0002-3787-2510; McNeil, Kirsty/0000-0003-0437-3608; Guter, Stephen/0000-0002-4476-2045; Gill, Michael/0000-0003-0206-5337; Freitag, Christine Margarete/0000-0001-9676-4782; Wassink, Thomas/0000-0002-0952-8333; Bolte, Sven/0000-0002-4579-4970; Sheffield, Val/0000-0002-6282-0835; MAESTRINI, ELENA/0000-0001-5924-3179; Holm, Ingrid/0000-0003-4712-8821; Gallagher, Louise/0000-0001-9462-2836; Liu, Xiao-Qing/0000-0002-4034-5156; R Magalhaes, Tiago/0000-0002-5528-2119; Stevens, Christine/0000-0002-2621-2234; Correia, Catarina/0000-0001-5481-2010; Green, Jonathan/0000-0002-0143-181X; Lamb, Janine/0000-0002-7248-0539; Joseph, Robert/0000-0001-6879-0254; Green, Andrew/0000-0002-1077-7417; Anney, Richard/0000-0002-6083-407X; Buxbaum, Joseph/0000-0001-8898-8313; Wijsman, Ellen/0000-0002-2725-6669; Nurnberger, John/0000-0002-7674-1767; Oliveira, Guiomar Goncalves/0000-0003-4031-3880; Estes, Annette/0000-0003-2687-4155; West, Andrew/0000-0002-3034-4061	National Center for Research Resources [U54 RR020278]; National Institutes of Mental Health [MH60007, MH081754]; Simons Foundation; Autism Consortium of Boston; NIMH [1R01 MH083565, 1K23MH080954]; Nancy Lurie Marks ( NLM) Family Foundation; National Institute of Health [MH52708, MH39437, MH00219, MH00980, MH6454, MH61009, MH55135, MH55284, HD055782, NS042165]; National Health Medical Research Council [0034328]; Scottish Rite; Spunk Fund, Inc.; Rebecca and Solomon Baker Fund; APEX Foundation; National Alliance for Research in Schizophrenia and Affective Disorders ( NARSAD),; Nancy Pritzker Laboratory; Cure Autism Now Foundation; Fundacao Calouste Gulbenkian; INSERM, Fondation de France, Fondation Orange; Fondation pour la Recherche Medicale; Swedish Science Council; The Seaver Foundation; The Children's Medical & Research Foundation; Our Lady's Children's Hospital, Crumlin, Ireland; The Medical Research Council ( MRC); MRC [G0601030] Funding Source: UKRI; Medical Research Council [G0601030] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055748, P50HD055782] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060007, R01MH052708, K23MH080954, R01MH083565, R01MH081754, R10MH055135, R01MH055284, R10MH055284, R01MH064547, P01MH039437, K05MH000219, R01MH055135, R01MH061009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042165] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; Autism Consortium of Boston; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Nancy Lurie Marks ( NLM) Family Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Scottish Rite; Spunk Fund, Inc.; Rebecca and Solomon Baker Fund; APEX Foundation; National Alliance for Research in Schizophrenia and Affective Disorders ( NARSAD),(NARSAD); Nancy Pritzker Laboratory; Cure Autism Now Foundation; Fundacao Calouste Gulbenkian(European Commission); INSERM, Fondation de France, Fondation Orange(Institut National de la Sante et de la Recherche Medicale (Inserm)Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Swedish Science Council; The Seaver Foundation; The Children's Medical & Research Foundation; Our Lady's Children's Hospital, Crumlin, Ireland; The Medical Research Council ( MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Autism Genome Project ( AGP) work was supported by the following grants: ( 1) The Hilibrand Foundation ( Principal Investigaor Joachim F. Hallmayer); ( 2) Autism Speaks ( for the AGP); ( 3) grants from the National Institutes of Health (NIH) MH61009 ( James S. Sutcliffe), MH55135 ( Susan E. Folstein), MH55284 ( Joseph Piven), HD055782 ( Ellen M. Wijsman), NS042165 (Joachim F. Hallmayer); ( 4) Fundacao para a Ciencia e Tecnologia (POCTI/39636/ESP/2001) Fundacao Calouste Gulbenkian ( Astrid Vincente); ( 5) INSERM, Fondation de France, Fondation Orange, Fondation pour la Recherche Medicale ( Catalina Betancur, Marion Leboyer), and the Swedish Science Council ( Christopher Gillberg); ( 6) The Seaver Foundation ( Joseph D. Buxbaum); ( 7) The Children's Medical & Research Foundation ( CMRF), Our Lady's Children's Hospital, Crumlin, Ireland (Sean Ennis); ( 8) The Medical Research Council ( MRC) ( Anthony P. Monaco, Anthony J. Bailey). Fresh-frozen brain tissue samples were obtained through the Autism Tissue Program and the Harvard Brain Bank.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Auranen M, 2002, AM J HUM GENET, V71, P777, DOI 10.1086/342720; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; Bhangale TR, 2008, NAT GENET, V40, P841, DOI 10.1038/ng.180; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell DB, 2007, ANN NEUROL, V62, P243, DOI 10.1002/ana.21180; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Di Rienzo A, 2006, CURR OPIN GENET DEV, V16, P630, DOI 10.1016/j.gde.2006.10.002; Edelmann L, 2007, J MED GENET, V44, P136, DOI 10.1136/jmg.2006.044537; Gaffrey MS, 2007, NEUROPSYCHOLOGIA, V45, P1672, DOI 10.1016/j.neuropsychologia.2007.01.008; Gauthier J, 2006, MOL PSYCHIATR, V11, P206, DOI 10.1038/sj.mp.4001756; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; LANDA R, 1992, PSYCHOL MED, V22, P245, DOI 10.1017/S0033291700032918; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mattila ML, 2007, J AM ACAD CHILD PSY, V46, P636, DOI 10.1097/chi.0b013e318033ff42; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Melin M, 2006, NEUROPSYCHOBIOLOGY, V54, P64, DOI 10.1159/000096040; Mitchell AA, 2003, AM J HUM GENET, V72, P598, DOI 10.1086/368203; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tyrer P., 1988, PERSONALITY DISORDER; van Hagen JM, 2007, NEUROBIOL DIS, V26, P112, DOI 10.1016/j.nbd.2006.12.009; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wechsler D., 1991, WISC 3 WECHSLER INTE; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; World Health Organization (WHO), 1993, ICD 10 CLASS MENT BE; Zafeiriou DI, 2007, BRAIN DEV-JPN, V29, P257, DOI 10.1016/j.braindev.2006.09.003	42	458	478	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 8	2009	461	7265					802	U62		10.1038/nature08490	http://dx.doi.org/10.1038/nature08490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19812673	Green Submitted, Green Accepted			2022-12-24	WOS:000270547500038
J	Williams, RS; Dodson, GE; Limbo, O; Yamada, Y; Williams, JS; Guenther, G; Classen, S; Glover, JNM; Iwasaki, H; Russell, P; Tainer, JA				Williams, R. Scott; Dodson, Gerald E.; Limbo, Oliver; Yamada, Yoshiki; Williams, Jessica S.; Guenther, Grant; Classen, Scott; Glover, J. N. Mark; Iwasaki, Hiroshi; Russell, Paul; Tainer, John A.			Nbs1 Flexibly Tethers Ctp1 and Mre11-Rad50 to Coordinate DNA Double-Strand Break Processing and Repair	CELL			English	Article							PHOSPHOPEPTIDE RECOGNITION; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; SCATTERING SAXS; DAMAGE-RESPONSE; ATM ACTIVATION; BRCT REPEATS; FHA DOMAIN; COMPLEX; MDC1	The Nijmegen breakage syndrome 1 (Nbs1) subunit of the Mre11-Rad50-Nbs1 (MRN) complex protects genome integrity by coordinating double-strand break (DSB) repair and checkpoint signaling through undefined interactions with ATM, MDC1, and Sae2/Ctp1/CtIP. Here, fission yeast and human Nbs1 structures defined by X-ray crystallography and small angle X-ray scattering (SAXS) reveal Nbs1 cardinal features: fused, extended, FHA-BRCT1-BRCT2 domains flexibly linked to C-terminal Mre11- and ATM-binding motifs. Genetic, biochemical, and structural analyses of an Nbs1-Ctp1 complex show Nbs1 recruits phosphorylated Ctp1 to DSBs via binding of the Nbs1 FHA domain to a Ctp1 pThr- Asp motif. Nbs1 structures further identify an extensive FHA-BRCT interface, a bipartite MDC1-binding scaffold, an extended conformational switch, and the molecular consequences associated with cancer predisposing Nijmegen breakage syndrome mutations. Tethering of Ctp1 to a flexible Nbs1 arm suggests a mechanism for restricting DNA end processing and homologous recombination activities of Sae2/Ctp1/CtIP to the immediate vicinity of DSBs.	[Williams, R. Scott; Dodson, Gerald E.; Limbo, Oliver; Yamada, Yoshiki; Williams, Jessica S.; Guenther, Grant; Russell, Paul; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Dodson, Gerald E.; Limbo, Oliver; Yamada, Yoshiki; Williams, Jessica S.; Russell, Paul] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Williams, R. Scott; Guenther, Grant; Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Classen, Scott; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Mol Biol, Div Life Sci, Berkeley, CA 94720 USA; [Glover, J. N. Mark] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Iwasaki, Hiroshi] Yokohama City Univ, Int Grad Sch Arts & Sci, Div Mol & Cellular Biol, Kanagawa 2300045, Japan	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Alberta; Yokohama City University	Russell, P (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,MB4, La Jolla, CA 92037 USA.	prussell@scripps.edu; jat@scripps.edu	Classen, Scott/AAY-8176-2020; Tainer, John/GWQ-4878-2022; Iwasaki, Hiroshi/Y-7946-2018; Williams, R Scott/A-6059-2015	Tainer, John/0000-0003-1659-2429; Iwasaki, Hiroshi/0000-0002-0153-6873; Limbo, Oliver/0000-0003-1686-1414; Williams, R Scott/0000-0002-4610-8397	Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; National Cancer Institute [CA117638, CA92584, CA77325]; SIBYLS beamline [BL12.3.1]; United States Department of Energy program Integrated Diffraction Analysis Technologies [DE-AC02-05CH11231]; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [R01CA117638, R01CA077325, P01CA092584] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); SIBYLS beamline; United States Department of Energy program Integrated Diffraction Analysis Technologies(United States Department of Energy (DOE)); Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Fellowship support was provided to R. S. W. (Canadian Institutes of Health Research, the Alberta Heritage Foundation for Medical Research, and the Skaggs Institute for Chemical Biology), G.E.D. (National Institutes of Health National Research Service Award), and Y.Y. (The Uehara Memorial Foundation). Work on Mre11 complex and Ctp1 in the authors' laboratories is supported by National Cancer Institute grants CA117638, CA92584, and CA77325. SIBYLS beamline (BL12.3.1) efforts at the Advanced Light Source of Lawrence Berkeley National Laboratory are supported by United States Department of Energy program Integrated Diffraction Analysis Technologies (for integrating crystallography and X-ray scattering) under contract number DE-AC02-05CH11231. We thank SIBYLS staff G. Hura and M. Hammel for expert SAXS data collection assistance, B. Chapados, C. Chahwan for discussions, and E. Getzoff and G. Williams for comments.	Akamatsu Y, 2008, MOL CELL BIOL, V28, P3639, DOI 10.1128/MCB.01828-07; Bernstein NK, 2005, MOL CELL, V17, P657, DOI 10.1016/j.molcel.2005.02.012; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Chen PL, 2005, MOL CELL BIOL, V25, P3535, DOI 10.1128/MCB.25.9.3535-3542.2005; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Digweed M, 2004, DNA REPAIR, V3, P1207, DOI 10.1016/j.dnarep.2004.03.004; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hartsuiker E, 2009, MOL CELL, V33, P117, DOI 10.1016/j.molcel.2008.11.021; Heikkinen K, 2006, CARCINOGENESIS, V27, P1593, DOI 10.1093/carcin/bgi360; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kruger L, 2007, CARCINOGENESIS, V28, P107, DOI 10.1093/carcin/bgl126; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lloyd J, 2009, CELL, V139, P100, DOI 10.1016/j.cell.2009.07.043; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Palmbos PL, 2008, GENETICS, V180, P1809, DOI 10.1534/genetics.108.095539; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Seemanova E, 2006, J MED GENET, V43, P218, DOI 10.1136/jmg.2005.035287; Shima H, 2005, GENETICS, V170, P71, DOI 10.1534/genetics.104.037580; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Wu LM, 2008, P NATL ACAD SCI USA, V105, P11200, DOI 10.1073/pnas.0802885105; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	54	240	244	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					87	99		10.1016/j.cell.2009.07.033	http://dx.doi.org/10.1016/j.cell.2009.07.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804755	Green Accepted, Bronze			2022-12-24	WOS:000270388600018
J	Gunnell, D; Irvine, D; Wise, L; Davies, C; Martin, RM				Gunnell, D.; Irvine, D.; Wise, L.; Davies, C.; Martin, R. M.			Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database	BRITISH MEDICAL JOURNAL			English	Article							SUSTAINED-RELEASE BUPROPION; RANDOMIZED CONTROLLED-TRIAL; RECEPTOR PARTIAL AGONIST; SMOKING-CESSATION; DEPENDENCE; PLACEBO; RISK	Objective To determine whether varenicline, a recently licensed smoking cessation product, is associated with an increased risk of suicide and suicidal behaviour compared with alternative treatments bupropion and nicotine replacement therapy. Design Cohort study nested within the General Practice Research Database. Setting Primary care in the United Kingdom. Participants 80 660 men and women aged 18-95 years were prescribed a new course of a smoking cessation product between 1 September 2006 and 31 May 2008; the initial drugs prescribed during follow-up were nicotine replacement products (n=63 265), varenicline (n=10 973), and bupropion (n=6422). Main outcome measures Primary outcomes were fatal and non-fatal self harm, secondary outcomes were suicidal thoughts and depression, all investigated with Cox's proportional hazards models. Results There was no clear evidence that varenicline was associated with an increased risk of fatal (n=2) or non-fatal (n=166) self harm, although a twofold increased risk cannot be ruled out on the basis of the upper limit of the 95% confidence interval. Compared with nicotine replacement products, the hazard ratio for self harm among people prescribed varenicline was 1.12 (95% CI 0.67 to 1.88), and it was 1.17 (0.59 to 2.32) for people prescribed bupropion. There was no evidence that varenicline was associated with an increased risk of depression (n=2244) (hazard ratio 0.88 (0.77 to 1.00)) or suicidal thoughts (n=37) (1.43 (0.53 to 3.85)). Conclusion Although a twofold increased risk of self harm with varenicline cannot be ruled out, these findings provide some reassurance concerning its association with suicidal behaviour.	[Gunnell, D.; Martin, R. M.] Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England; [Irvine, D.; Wise, L.; Davies, C.] Med & Healthcare Prod Regulatory Agcy, London SW8 5NQ, England	University of Bristol; The Medicines & Healthcare Products Regulatory Agency	Gunnell, D (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England.	d.j.gunnell@bristol.ac.uk	Gunnell, David/ABE-6653-2020	Gunnell, David/0000-0002-0829-6470; Martin, Richard/0000-0002-7992-7719	Medicines and Healthcare Products Regulatory Agency (MHRA); ESRC [ES/G007543/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish	Medicines and Healthcare Products Regulatory Agency (MHRA); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Small grant from the Medicines and Healthcare Products Regulatory Agency (MHRA).	Boden JM, 2008, PSYCHOL MED, V38, P433, DOI 10.1017/S0033291707001547; Cahill K, 2009, DRUG SAFETY, V32, P119, DOI 10.2165/00002018-200932020-00005; Farrell M, 2001, BRIT J PSYCHIAT, V179, P432, DOI 10.1192/bjp.179.5.432; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Gunnell D, 2004, BRIT J PSYCHIAT, V185, P385, DOI 10.1192/bjp.185.5.385; Hays JT, 2008, NEW ENGL J MED, V359, P2018, DOI 10.1056/NEJMct0800146; Hemmingsson T, 2003, INT J EPIDEMIOL, V32, P1000, DOI 10.1093/ije/dyg203; Hughes JR, 2008, DRUG ALCOHOL DEPEN, V98, P169, DOI 10.1016/j.drugalcdep.2008.06.003; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Leistikow BN, 1999, PREV MED, V28, P255, DOI 10.1006/pmed.1998.0412; Lewis G, 1998, BMJ-BRIT MED J, V317, P1283, DOI 10.1136/bmj.317.7168.1283; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; Medicines and Healthcare Products Regulatory Agency (MHRA), 2007, DRUG SAFETY UPDATE, V1, P12; Miller M, 2000, AM J PUBLIC HEALTH, V90, P768, DOI 10.2105/AJPH.90.5.768; *OFF NAT STAT, IND DEPR UK SIM DIFF; Patterson F, 2009, BIOL PSYCHIAT, V65, P144, DOI 10.1016/j.biopsych.2008.08.028; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419	18	144	151	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 1	2009	339								b3805	10.1136/bmj.b3805	http://dx.doi.org/10.1136/bmj.b3805			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502LB	19797344	Green Published, hybrid			2022-12-24	WOS:000270460000004
J	Martin, RE; Marchetti, RV; Cowan, AI; Howitt, SM; Broer, S; Kirk, K				Martin, Rowena E.; Marchetti, Rosa V.; Cowan, Anna I.; Howitt, Susan M.; Broeer, Stefan; Kirk, Kiaran			Chloroquine Transport via the Malaria Parasite's Chloroquine Resistance Transporter	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; DIGESTIVE VACUOLE; PFCRT MUTATIONS; PH; EFFLUX; MECHANISM; AGENTS	The emergence and spread of chloroquine-resistant Plasmodium falciparum malaria parasites has been a disaster for world health. Resistance is conferred by mutations in the Chloroquine Resistance Transporter (PfCRT), an integral membrane protein localized to the parasite's internal digestive vacuole. These mutations result in a marked reduction in the accumulation of chloroquine (CQ) by the parasite. However, the mechanism by which this occurs is unclear. We expressed both wild-type and resistant forms of PfCRT at the surface of Xenopus laevis oocytes. The resistant form of PfCRT transported CQ, whereas the wild-type protein did not. CQ transport via the mutant PfCRT was inhibited by CQ analogs and by the resistance-reverser verapamil. Thus, CQ resistance is due to direct transport of the drug via mutant PfCRT.	[Martin, Rowena E.; Marchetti, Rosa V.; Howitt, Susan M.; Broeer, Stefan; Kirk, Kiaran] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Cowan, Anna I.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 0200, Australia	Australian National University; Australian National University; John Curtin School of Medical Research	Martin, RE (corresponding author), Australian Natl Univ, Res Sch Biol, GPO Box 4, Canberra, ACT 0200, Australia.	rowena.martin@anu.edu.au	Howitt, Susan M/C-9308-2009; Kirk, Kiaran/C-8299-2009; Martin, Rowena E/C-9992-2009; Broer, Stefan/A-1286-2008	Howitt, Susan M/0000-0002-2192-2317; Kirk, Kiaran/0000-0002-5613-2622; Martin, Rowena E/0000-0001-7408-5295; Broer, Stefan/0000-0002-8040-1634; Cowan, Anna/0000-0002-5681-6610	Australian National Health and Medical Research Council (NHMRC) [471472, 520320]; Australian Research Council [DP0559433]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	We thank J. Abbey, R. Summers, E. Baker, and R. Slatyer for technical assistance. This work was supported by the Australian National Health and Medical Research Council (NHMRC) (grant 471472) and the Australian Research Council (grant DP0559433). R. E. M. was supported by an NHMRC Australian Biomedical Fellowship (fellowship 520320).	Bennett TN, 2004, MOL BIOCHEM PARASIT, V133, P99, DOI 10.1016/j.molbiopara.2003.09.008; Bray PG, 2006, MOL MICROBIOL, V62, P238, DOI 10.1111/j.1365-2958.2006.05368.x; Bray PG, 2005, MOL MICROBIOL, V56, P323, DOI 10.1111/j.1365-2958.2005.04556.x; Cortazzo P, 2002, BIOCHEM BIOPH RES CO, V293, P537, DOI 10.1016/S0006-291X(02)00226-7; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FITCH CD, 1969, P NATL ACAD SCI USA, V64, P1181, DOI 10.1073/pnas.64.4.1181; Hayward R, 2006, J CELL SCI, V119, P1016, DOI 10.1242/jcs.02795; Johnson DJ, 2004, MOL CELL, V15, P867, DOI 10.1016/j.molcel.2004.09.012; Klonis N, 2007, BIOCHEM J, V407, P343, DOI 10.1042/BJ20070934; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; KROGSTAD DJ, 1987, SCIENCE, V238, P1283, DOI 10.1126/science.3317830; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; Lakshmanan V, 2005, EMBO J, V24, P2294, DOI 10.1038/sj.emboj.7600681; Lehane AM, 2008, ANTIMICROB AGENTS CH, V52, P4374, DOI 10.1128/AAC.00666-08; Martin RE, 2004, MOL BIOL EVOL, V21, P1938, DOI 10.1093/molbev/msh205; Naude B, 2005, J BIOL CHEM, V280, P25596, DOI 10.1074/jbc.M503227200; Sanchez CP, 2007, MOL MICROBIOL, V64, P407, DOI 10.1111/j.1365-2958.2007.05664.x; Sanchez CP, 2005, BIOCHEMISTRY-US, V44, P9862, DOI 10.1021/bi050061f; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; van Schalkwyk DA, 2006, DRUG RESIST UPDATE, V9, P211, DOI 10.1016/j.drup.2006.09.002; Wagner CA, 2000, CELL PHYSIOL BIOCHEM, V10, P1, DOI 10.1159/000016341	21	214	221	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 25	2009	325	5948					1680	1682		10.1126/science.1175667	http://dx.doi.org/10.1126/science.1175667			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779197				2022-12-24	WOS:000270131800043
J	Watson, DA; Su, MJ; Teverovskiy, G; Zhang, Y; Garcia-Fortanet, J; Kinzel, T; Buchwald, SL				Watson, Donald A.; Su, Mingjuan; Teverovskiy, Georgiy; Zhang, Yong; Garcia-Fortanet, Jorge; Kinzel, Tom; Buchwald, Stephen L.			Formation of ArF from LPdAr(F): Catalytic Conversion of Aryl Triflates to Aryl Fluorides	SCIENCE			English	Article							F REDUCTIVE ELIMINATION; FLUORINATION; COMPLEXES; CARBON; PALLADIUM(II); ROUTE; SALTS; STEP; CL	Despite increasing pharmaceutical importance, fluorinated aromatic organic molecules remain difficult to synthesize. Present methods require either harsh reaction conditions or highly specialized reagents, making the preparation of complex fluoroarenes challenging. Thus, the development of general methods for their preparation that overcome the limitations of those techniques currently in use is of great interest. We have prepared [LPd(II)Ar(F)] complexes, where L is a biaryl monophosphine ligand and Ar is an aryl group, and identified conditions under which reductive elimination occurs to form an Ar-F bond. On the basis of these results, we have developed a catalytic process that converts aryl bromides and aryl triflates into the corresponding fluorinated arenes by using simple fluoride salts. We expect this method to allow the introduction of fluorine atoms into advanced, highly functionalized intermediates.	[Watson, Donald A.; Su, Mingjuan; Teverovskiy, Georgiy; Zhang, Yong; Garcia-Fortanet, Jorge; Kinzel, Tom; Buchwald, Stephen L.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Buchwald, SL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	sbuchwal@mit.edu			NIH [GM46059]; Merck; Nippon Chemical; Boehringer Ingelheim; BASF; Singapore-MIT Alliance; Spanish Ministerio de Educacion y Ciencia; Alexander von Humboldt Foundation; NSF [CHE 9808061, DBI 9729592]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046059, R37GM046059] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck(Merck & Company); Nippon Chemical; Boehringer Ingelheim(Boehringer Ingelheim); BASF(BASF); Singapore-MIT Alliance(Singapore-MIT Alliance for Research & Technology Centre (SMART)); Spanish Ministerio de Educacion y Ciencia(Spanish Government); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the NIH for financial support of this project (grant GM46059) and Merck, Nippon Chemical, Boehringer Ingelheim, and BASF for gifts of chemicals and additional funds. M. S. thanks the Singapore-MIT Alliance for a graduate fellowship. J. G.-F. thanks the Spanish Ministerio de Educacion y Ciencia for a postdoctoral fellowship. T. K. thanks the Alexander von Humboldt Foundation for a Feodor Lynen postdoctoral fellowship. The Varian NMR instrument used was supported by the NSF (grants CHE 9808061 and DBI 9729592). We also thank P. Muller for obtaining the crystal structure of 4. Cambridge Crystallographic Data Centre (CCDC) 741377 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from the CCDC via www.ccdc.cam.ac.uk/data_request/cif. A patent application has been filed by MIT covering portions of this work with S. L. B., D. A. W., M. S., and G. T. as co-inventors.	Ametamey SM, 2008, CHEM REV, V108, P1501, DOI 10.1021/cr0782426; ANGELINI G, 1985, J FLUORINE CHEM, V27, P177, DOI 10.1016/S0022-1139(00)84987-8; Ball ND, 2009, J AM CHEM SOC, V131, P3796, DOI 10.1021/ja8054595; Balz G, 1927, BER DTSCH CHEM GES, V60, P1186, DOI 10.1002/cber.19270600539; Bohm HJ, 2004, CHEMBIOCHEM, V5, P637, DOI 10.1002/cbic.200301023; FINGER GC, 1956, J AM CHEM SOC, V78, P6034, DOI 10.1021/ja01604a022; Fors BP, 2008, J AM CHEM SOC, V130, P13552, DOI 10.1021/ja8055358; Furuya T, 2008, J AM CHEM SOC, V130, P10060, DOI 10.1021/ja803187x; Furuya T, 2008, ANGEW CHEM INT EDIT, V47, P5993, DOI 10.1002/anie.200802164; Furuya T, 2009, J AM CHEM SOC, V131, P1662, DOI 10.1021/ja8086664; Gerebtzoff G, 2004, CHEMBIOCHEM, V5, P676, DOI 10.1002/cbic.200400017; Grushin VV, 2008, ORGANOMETALLICS, V27, P4825, DOI 10.1021/om800520e; Grushin VV, 2007, ORGANOMETALLICS, V26, P4997, DOI 10.1021/om700469k; Grushin VV, 2004, J AM CHEM SOC, V126, P3068, DOI 10.1021/ja049844z; Grushin VV, 2002, CHEM-EUR J, V8, P1006, DOI 10.1002/1521-3765(20020301)8:5<1006::AID-CHEM1006>3.0.CO;2-M; GRUSHIN VV, 2007, Patent No. 7202388; Hull KL, 2006, J AM CHEM SOC, V128, P7134, DOI 10.1021/ja061943k; Jeschke P, 2004, CHEMBIOCHEM, V5, P570, DOI 10.1002/cbic.200300833; Kaspi AW, 2008, INORG CHEM, V47, P5, DOI 10.1021/ic701722f; Macgregor SA, 2005, J AM CHEM SOC, V127, P15304, DOI 10.1021/ja054506z; Mann G, 1998, J AM CHEM SOC, V120, P9205, DOI 10.1021/ja981428p; Marshall WJ, 2004, ORGANOMETALLICS, V23, P2343, DOI 10.1021/om049813c; Marshall WJ, 2003, ORGANOMETALLICS, V22, P555, DOI 10.1021/om020838q; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Pan Y, 1999, J ORGANOMET CHEM, V577, P257, DOI 10.1016/S0022-328X(98)01071-7; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; PIKE VW, 1995, J CHEM SOC CHEM COMM, P2215, DOI 10.1039/C39950002215; Ross TL, 2007, J AM CHEM SOC, V129, P8018, DOI 10.1021/ja066850h; Roy AH, 2001, J AM CHEM SOC, V123, P1232, DOI 10.1021/ja0034592; Sun H, 2006, ANGEW CHEM INT EDIT, V45, P2720, DOI 10.1002/anie.200504555; Wang XS, 2009, J AM CHEM SOC, V131, P7520, DOI 10.1021/ja901352k; Withbroe GJ, 2008, ORG PROCESS RES DEV, V12, P480, DOI 10.1021/op7002858; Yandulov DV, 2007, J AM CHEM SOC, V129, P1342, DOI 10.1021/ja066930l	33	494	510	2	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1661	1664		10.1126/science.1178239	http://dx.doi.org/10.1126/science.1178239			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	498II	19679769	Green Submitted, Green Accepted			2022-12-24	WOS:000270131800037
J	Yan, Y; Sabharwal, P; Rao, M; Sockanathan, S				Yan, Ye; Sabharwal, Priyanka; Rao, Meenakshi; Sockanathan, Shanthini			The Antioxidant Enzyme Prdx1 Controls Neuronal Differentiation by Thiol-Redox-Dependent Activation of GDE2	CELL			English	Article							GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE; TRYPAREDOXIN PEROXIDASE; MEMBRANE-PROTEIN; SPINAL-CORD; IN-VIVO; PEROXIREDOXIN; CELLS; SPECIFICATION; OLIG2; NEUROGENESIS	The six-transmembrane protein GDE2 controls the onset and progression of spinal motor neuron differentiation through extracellular glycerophosphodiester phosphodiesterase metabolism. Although this process is likely to be tightly regulated, the relevant mechanisms that modulate its activity are unknown. Here we show that the antioxidant scavenger peroxiredoxin1 (Prdx1) interacts with GDE2, and that loss of Prdx1 causes motor neuron deficits analogous to GDE2 ablation. Prdx1 cooperates with GDE2 to drive motor neuron differentiation, and this synergy requires Prdx1 thiol-dependent catalysis. Prdx1 activates GDE2 through reduction of an intramolecular disulfide bond that bridges its intracellular N- and C-terminal domains. GDE2 variants incapable of disulfide bond formation acquire independence from Prdx1 and are potent inducers of motor neuron differentiation. These findings define Prdx1 as a pivotal regulator of GDE2 activity and suggest roles for coupled thiol-redox-dependent cascades in controlling neuronal differentiation in the spinal cord.	[Yan, Ye; Sabharwal, Priyanka; Rao, Meenakshi; Sockanathan, Shanthini] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Sockanathan, S (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssockan1@jhmi.edu	Sabharwal, Priyanka/AAA-3303-2019	Sabharwal, Priyanka/0000-0002-2099-1994	National Institute of Neurological Disorders and Stroke; Muscular Dystrophy Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046336, R56NS046336] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Lawson for technical help; B. Selvakumar for advice; J. Rotty for help in initial candidate screens; M. Goulding, T. M. Jessell, L. Pevny, and B. Novitch for antibodies; E. Prochownik and Y. F. Shi for Prdx1 null animals; C. H. Lee, G. Periz, L. M. Wang, and B. Q. Zhuang for discussions; and A. L. Kolodkin, G. Periz, W. Watson, and P. F. Worley for critical reading and comments on the manuscript. This work was funded by the National Institute of Neurological Disorders and Stroke and the Muscular Dystrophy Association.	Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Bertram John S., 2000, Molecular Aspects of Medicine, V21, P167, DOI 10.1016/S0098-2997(00)00007-8; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; Flohe L, 2002, ARCH BIOCHEM BIOPHYS, V397, P324, DOI 10.1006/abbi.2001.2688; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Hollyday M, 2001, INT J DEV NEUROSCI, V19, P161, DOI 10.1016/S0736-5748(00)00093-9; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kintner C, 2002, J NEUROSCI, V22, P639, DOI 10.1523/JNEUROSCI.22-03-00639.2002; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Megason SG, 2002, DEVELOPMENT, V129, P2087; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Montemartini M, 1999, EUR J BIOCHEM, V264, P516, DOI 10.1046/j.1432-1327.1999.00656.x; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Nogusa Y, 2004, GENE, V337, P173, DOI 10.1016/j.gene.2004.04.026; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Paget MSB, 2003, ANNU REV GENET, V37, P91, DOI 10.1146/annurev.genet.37.110801.142538; Rao M, 2004, DEV DYNAM, V231, P592, DOI 10.1002/dvdy.20161; Rao M, 2005, SCIENCE, V309, P2212, DOI 10.1126/science.1117156; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Ritz D, 2001, SCIENCE, V294, P158, DOI 10.1126/science.1063143; Santelli E, 2004, PROTEINS, V56, P167, DOI 10.1002/prot.20120; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yanaka N, 2003, J BIOL CHEM, V278, P43595, DOI 10.1074/jbc.M302867200; Yanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P1811, DOI 10.1271/bbb.70062; Yanaka N, 2007, FEBS LETT, V581, P712, DOI 10.1016/j.febslet.2007.01.035; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; Zheng B, 2003, P NATL ACAD SCI USA, V100, P1745, DOI 10.1073/pnas.0337605100	37	84	91	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1209	1221		10.1016/j.cell.2009.06.042	http://dx.doi.org/10.1016/j.cell.2009.06.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766572	Bronze, Green Accepted			2022-12-24	WOS:000269923200020
J	Stern, AM; Markel, H				Stern, Alexandra Minna; Markel, Howard			What Mexico Taught the World About Pandemic Influenza Preparedness and Community Mitigation Strategies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							US CITIES; INTERVENTIONS		[Markel, Howard] Univ Michigan, Sch Med, Ctr Hist Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Markel, H (corresponding author), Univ Michigan, Sch Med, Ctr Hist Med, 102 Observ 0725,100 SMI, Ann Arbor, MI 48109 USA.	howard@umich.edu						BOOTH W, 2009, WASHINGTON POST 0511; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Kelso JK, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-117; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; MASSIEU JFR, 1989, AM HLTH ORG SCI PUBL, V509, P372; *PRES CALD IN REUN, 2009, LECC APR INFL A H1N1; ZUCKERMANN L, 2009, NEXOS, V31, P24	9	26	27	3	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	2009	302	11					1221	1222		10.1001/jama.2009.1367	http://dx.doi.org/10.1001/jama.2009.1367			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494FR	19755702				2022-12-24	WOS:000269797600033
J	Wang, LG; Sigworth, FJ				Wang, Liguo; Sigworth, Fred J.			Structure of the BK potassium channel in a lipid membrane from electron cryomicroscopy	NATURE			English	Article							DEPENDENT K+ CHANNEL; HIGH-CONDUCTANCE; VOLTAGE SENSOR; CRYO-EM; STREPTAVIDIN; ENVIRONMENT; REFINEMENT; ACTIVATION; MECHANISM; PROTEINS	A long-sought goal in structural biology has been the imaging of membrane proteins in their membrane environments. This goal has been achieved with electron crystallography(1) in those special cases where a protein forms highly ordered arrays in lipid bilayers. It has also been achieved by NMR methods(1) in proteins up to 50 kilodaltons (kDa) in size, although milligram quantities of protein and isotopic labelling are required. For structural analysis of large soluble proteins in microgram quantities, an increasingly powerful method that does not require crystallization is single-particle reconstruction from electron microscopy of cryogenically cooled samples (electron cryomicroscopy (cryo-EM))(2). Here we report the first single-particle cryo-EM study of a membrane protein, the human large-conductance calcium-and voltage-activated potassium channel(3) (BK), in a lipid environment. The new method is called random spherically constrained (RSC) single-particle reconstruction. BK channels, members of the six-transmembrane segment (6TM) ion channel family, were reconstituted at low density into lipid vesicles (liposomes), and their function was verified by a potassium flux assay. Vesicles were also frozen in vitreous ice and imaged in an electron microscope. From images of 8,400 individual protein particles, a three-dimensional (3D) reconstruction of the BK channel and its membrane environment was obtained at a resolution of 1.7-2.0 nm. Not requiring the formation of crystals, the RSC approach promises to be useful in the structural study of many other membrane proteins as well.	[Wang, Liguo; Sigworth, Fred J.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Sigworth, FJ (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	fred.sigworth@yale.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021501] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR014739-01, S10 RR014739-018020] Funding Source: Medline; NIGMS NIH HHS [P01 GM062580, P01 GM062580-080007, P01 GM062580-06A10007, P01 GM062580-070007] Funding Source: Medline; NINDS NIH HHS [R01 NS021501-19, R01 NS021501-19S1, R01 NS021501-22, R01 NS021501, R01 NS021501-23, R01 NS021501-24, R01 NS021501-21, R01 NS021501-20] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bingham JP, 2006, BIOCONJUGATE CHEM, V17, P689, DOI 10.1021/bc060002u; Chanda B, 1999, BBA-BIOMEMBRANES, V1416, P92, DOI 10.1016/S0005-2736(98)00217-X; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; Fodor AA, 2006, J GEN PHYSIOL, V127, P755, DOI 10.1085/jgp.200509419; Fodor AA, 2009, ANNU REV PHYSIOL, V71, P19, DOI 10.1146/annurev.physiol.010908.163124; Frank J, 2006, 3 DIMENSIONAL ELECT; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; GRIGORIEFF N, 1995, J MOL BIOL, V254, P404, DOI 10.1006/jmbi.1995.0627; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Jiang QX, 2001, J STRUCT BIOL, V133, P119, DOI 10.1006/jsbi.2001.4376; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Liu G, 2008, J GEN PHYSIOL, V131, P537, DOI 10.1085/jgp.200809968; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MILLER C, 1987, J GEN PHYSIOL, V90, P427, DOI 10.1085/jgp.90.3.427; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raunser S, 2009, ANNU REV BIOPHYS, V38, P89, DOI 10.1146/annurev.biophys.050708.133649; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Stewart A, 2004, ULTRAMICROSCOPY, V102, P67, DOI 10.1016/j.ultramic.2004.08.008; Wang LG, 2008, J STRUCT BIOL, V164, P190, DOI 10.1016/j.jsb.2008.07.008; Wang LG, 2006, P NATL ACAD SCI USA, V103, P18528, DOI 10.1073/pnas.0608714103; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Zhang Z, 2006, J NEUROSCI, V26, P11833, DOI 10.1523/JNEUROSCI.3812-06.2006	30	148	153	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					292	U177		10.1038/nature08291	http://dx.doi.org/10.1038/nature08291			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19718020	Green Accepted			2022-12-24	WOS:000269654600050
J	Zhang, J; Fonovic, M; Suyama, K; Bogyo, M; Scott, MP				Zhang, Jun; Fonovic, Marko; Suyama, Kaye; Bogyo, Matthew; Scott, Matthew P.			Rab35 Controls Actin Bundling by Recruiting Fascin as an Effector Protein	SCIENCE			English	Article							DROSOPHILA BRISTLES; SHORT FILAMENTS; CYTOKINESIS; EXPRESSION; SHAPE	Actin filaments are key components of the eukaryotic cytoskeleton that provide mechanical structure and generate forces during cell shape changes, growth, and migration. Actin filaments are dynamically assembled into higher-order structures at specified locations to regulate diverse functions. The Rab family of small guanosine triphosphatases is evolutionarily conserved and mediates intracellular vesicle trafficking. We found that Rab35 regulates the assembly of actin filaments during bristle development in Drosophila and filopodia formation in cultured cells. These effects were mediated by the actin-bundling protein fascin, which directly associated with active Rab35. Targeting Rab35 to the outer mitochondrial membrane triggered actin recruitment, demonstrating a role for an intracellular trafficking protein in localized actin assembly.	[Zhang, Jun; Suyama, Kaye; Scott, Matthew P.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Zhang, Jun; Suyama, Kaye; Scott, Matthew P.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Zhang, Jun; Suyama, Kaye; Scott, Matthew P.] Stanford Univ, Dept Biol Engn, Sch Med, Stanford, CA 94305 USA; [Zhang, Jun; Suyama, Kaye; Scott, Matthew P.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Fonovic, Marko; Bogyo, Matthew] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Fonovic, Marko; Bogyo, Matthew] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Fonovic, Marko] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, Ljubljana 1000, Slovenia	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Scott, MP (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	mscott@stanford.edu	Fonović, Marko/X-9957-2019	Fonovic, Marko/0000-0002-8375-6713; Bogyo, Matthew/0000-0003-3753-4412	Jane Coffin Childs Memorial Fund for Medical Research fellowship; NIH National Technology Center for Networks and NIH Pathway [U54 RR020843]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund for Medical Research fellowship; NIH National Technology Center for Networks and NIH Pathway; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank M. Fish for DNA injections; X. Huang, E. Bustamante, and C. Gauthier for help with initial experiments; Scott lab members for valuable discussion and comments; the Stanford Cell Sciences Imaging Facility for assistance with scanning electron microscopy studies; and S. Pfeffer, A. Ghabrial, and R. Rohatgi for critical reading and comments on the manuscript. Supported by a Jane Coffin Childs Memorial Fund for Medical Research fellowship (J. Z.) and by the NIH National Technology Center for Networks and NIH Pathway grant U54 RR020843 (M.F. and M.B.). The research reported here was supported by the Howard Hughes Medical Institute. M. P. S. is an Investigator of the HHMI.	Adams JC, 1999, MOL BIOL CELL, V10, P4177, DOI 10.1091/mbc.10.12.4177; Bakshi NA, 2007, ARCH PATHOL LAB MED, V131, P742; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; CANT K, 1994, J CELL BIOL, V125, P369, DOI 10.1083/jcb.125.2.369; Chevallier J, 2009, FEBS LETT, V583, P1096, DOI 10.1016/j.febslet.2009.03.012; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Christoforidis S, 2001, METHOD ENZYMOL, V329, P120; De Arcangelis A, 2004, GENE EXPR PATTERNS, V4, P637, DOI 10.1016/j.modgep.2004.04.012; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Guild GM, 2003, J CELL BIOL, V162, P1069, DOI 10.1083/jcb.200305143; Kostopoulou E, 2008, HISTOL HISTOPATHOL, V23, P935, DOI 10.14670/HH-23.935; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; MOOSEKER MS, 1983, CELL, V35, P11, DOI 10.1016/0092-8674(83)90202-7; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Pfeffer S, 2005, BIOCHEM SOC T, V33, P627, DOI 10.1042/BST0330627; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Tilney LG, 2003, MOL BIOL CELL, V14, P3953, DOI 10.1091/mbc.E03-03-0158; Tilney LG, 1996, J CELL BIOL, V135, P1291, DOI 10.1083/jcb.135.5.1291; TILNEY LG, 1995, J CELL BIOL, V130, P629, DOI 10.1083/jcb.130.3.629; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Walseng E, 2008, J BIOL CHEM, V283, P14717, DOI 10.1074/jbc.M801070200; Zhang H, 2006, J CLIN PATHOL, V59, P958, DOI 10.1136/jcp.2005.032730; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761	25	103	107	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1250	1254		10.1126/science.1174921	http://dx.doi.org/10.1126/science.1174921			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729655				2022-12-24	WOS:000269523200039
J	Singer, DE; Chang, YC; Fang, MC; Borowsky, LH; Pomernacki, NK; Udaltsova, N; Go, AS				Singer, Daniel E.; Chang, Yuchiao; Fang, Margaret C.; Borowsky, Leila H.; Pomernacki, Niela K.; Udaltsova, Natalla; Go, Alan S.			The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation	ANNALS OF INTERNAL MEDICINE			English	Article							CLOPIDOGREL PLUS ASPIRIN; ORAL ANTICOAGULATION; VASCULAR EVENTS; RISK STRATIFICATION; STROKE PREVENTION; THERAPY; THROMBOEMBOLISM; IRBESARTAN; INTENSITY; SCHEMES	Background: Guidelines recommend warfarin use in patients with atrial fibrillation solely on the basis of risk for ischemic stroke without antithrombotic therapy. These guidelines rely on ischemic stroke rates observed in older trials and do not explicitly account for increased risk for hemorrhage. Objective: To quantify the net clinical benefit of warfarin therapy in a cohort of patients with atrial fibrillation. Design: Mixed retrospective and prospective cohort study of patients with atrial fibrillation between 1996 and 2003. Setting: An integrated health care delivery system. Patients: 13 559 adults with nonvalvular atrial fibrillation. Measurements: Warfarin exposure, patient characteristics, CHADS(2) score ( 1 point for each of congestive heart failure, hypertension, age, and diabetes and 2 points for stroke), and outcome events were ascertained from health plan records and databases. Net clinical benefit was defined as the annual rate of ischemic strokes and systemic emboli prevented by warfarin minus intracranial hemorrhages attributable to warfarin, multiplied by an impact weight. The base-case impact weight was 1.5, reflecting the greater clinical impact of intracranial hemorrhage versus thromboembolism. Results: Patients accumulated more than 66 000 person-years of follow-up. The adjusted net clinical benefit of warfarin for the cohort overall was 0.68% per year (95% CI, 0.34% to 0.87%). Adjusted net clinical benefit was greatest for patients with a history of ischemic stroke (2.48% per year [ CI, 0.75% to 4.22%]) and for those 85 years or older (2.34% per year [ CI, 1.29% to 3.30%]). The net clinical benefit of warfarin increased from essentially zero in CHADS(2) stroke risk categories 0 and 1 to 2.22% per year ( CI, 0.58% to 3.75%) in CHADS(2) categories 4 to 6. The patterns of results were preserved when weighting factors for intracranial hemorrhage of 1.0 and 2.0 were used. Limitations: Residual confounding is a possibility. Some outcome events were probably missed by the screening algorithm or when medical records were unavailable. Conclusion: Expected net clinical benefit of warfarin therapy is highest among patients with the highest untreated risk for stroke, which includes the oldest age category. Risk assessment that incorporates both risk for thromboembolism and risk for intracranial hemorrhage provides a more quantitatively informed basis for the decision on antithrombotic therapy in patients with atrial fibrillation.	[Singer, Daniel E.] Massachusetts Gen Hosp, Clin Epidemiol Unit, Boston, MA 02114 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Kaiser Permanente No Calif, Oakland, CA 94612 USA	Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; Kaiser Permanente	Singer, DE (corresponding author), Massachusetts Gen Hosp, Clin Epidemiol Unit, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	dsinger@partners.org	White, Howard D/A-7034-2009; Go, Alan S./AAE-7745-2019		National Institute on Aging [R01 AG15478, K23 AG28978]; National Heart, Lung, and Blood Institute [U19 HL091179]; Massachusetts General Hospital; National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U19HL091179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015478, K23AG028978] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Massachusetts General Hospital(General Electric); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging; National Heart, Lung, and Blood Institute; and Massachusetts General Hospital.; By the National Institute on Aging (R01 AG15478); the National Heart, Lung, and Blood Institute (U19 HL091179); and the Eliot B. and Edith C. Shoolman fund of the Massachusetts General Hospital. Dr. Fang's efforts were also partially supported by the National Institute on Aging (K23 AG28978).	Albers GW, 2003, LANCET, V362, P1691; Arima H, 2005, STROKE, V36, P2164, DOI 10.1161/01.STR.0000181115.59173.42; Bousser MG, 2008, LANCET, V371, P315, DOI 10.1016/S0140-6736(08)60168-3; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000; Efron B., 1994, INTRO BOOTSTRAP; Fang MC, 2008, J AM COLL CARDIOL, V51, P810, DOI 10.1016/j.jacc.2007.09.065; Fang MC, 2007, AM J MED, V120, P700, DOI 10.1016/j.amjmed.2006.07.034; Fang MC, 2005, CIRCULATION, V112, P1687, DOI 10.1161/CIRCULATIONAHA.105.553438; Fuster V, 2006, EUROPACE, V8, P651, DOI 10.1093/europace/eul097; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gladstone DJ, 2009, STROKE, V40, P235, DOI 10.1161/STROKEAHA.108.516344; GLASZIOU PP, 1995, BMJ-BRIT MED J, V311, P1356, DOI 10.1136/bmj.311.7016.1356; Go AS, 2003, JAMA-J AM MED ASSOC, V290, P2685, DOI 10.1001/jama.290.20.2685; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; HART RG, 2009, STROKE; Healey JS, 2008, STROKE, V39, P1482, DOI 10.1161/STROKEAHA.107.500199; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Korn E. L., 1999, ANAL HLTH SURVEYS; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Miettinen O S, 1983, Stat Med, V2, P267, DOI 10.1002/sim.4780020222; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Singer DE, 2008, CHEST, V133, p546S, DOI 10.1378/chest.08-0678; Stokes ME, 2000, CATEGORICAL DATA ANA; van Walraven C, 2002, JAMA-J AM MED ASSOC, V288, P2441, DOI 10.1001/jama.288.19.2441; Warlow C, 2003, LANCET, V362, P1211, DOI 10.1016/S0140-6736(03)14544-8	28	496	508	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2009	151	5					297	U16		10.7326/0003-4819-151-5-200909010-00003	http://dx.doi.org/10.7326/0003-4819-151-5-200909010-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492KB	19721017	Green Accepted			2022-12-24	WOS:000269653100001
J	Juurlink, DN; Gomes, T; Lipscombe, LL; Austin, PC; Hux, JE; Mamdani, MM				Juurlink, David N.; Gomes, Tara; Lipscombe, Lorraine L.; Austin, Peter C.; Hux, Janet E.; Mamdani, Muhammad M.			Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONGESTIVE-HEART-FAILURE; ACUTE MYOCARDIAL-INFARCTION; TYPE-2 DIABETES-MELLITUS; ACTIVATED-RECEPTOR-GAMMA; ADMINISTRATIVE DATA; GLYCEMIC CONTROL; PULMONARY-EDEMA; TERM RISK; THIAZOLIDINEDIONES; METAANALYSIS	Objective To compare the risk of acute myocardial infarction, heart failure, and death in patients with type 2 diabetes treated with rosiglitazone and pioglitazone. Design Retrospective cohort study. Setting Ontario, Canada. Participants Outpatients aged 66 years and older who were started on rosiglitazone or pioglitazone between 1 April 2002 and 31 March 2008. Main outcome measure Composite of death or hospital admission for either acute myocardial infarction or heart failure. In a secondary analysis, each outcome was also examined individually. Results 39 736 patients who started on either pioglitazone or rosiglitazone were identified. During the six year study period, the composite outcome was reached in 895 (5.3%) of patients taking pioglitazone and 1563 (6.9%) of patients taking rosiglitazone. After extensive adjustment for demographic and clinical factors and drug doses, pioglitazone treated patients had a lower risk of developing the primary outcome than did patients treated with rosiglitazone (adjusted hazard ratio 0.83, 95% confidence interval 0.76 to 0.90). Secondary analyses revealed a lower risk of death (adjusted hazard ratio 0.86, 0.75 to 0.98) and heart failure (0.77, 0.69 to 0.87) with pioglitazone but no significant difference in the risk of acute myocardial infarction (0.95, 0.81 to 1.11). One additional composite outcome would be predicted to occur annually for every 93 patients treated with rosiglitazone rather than pioglitazone. Conclusions Among older patients with diabetes, pioglitazone is associated with a significantly lower risk of heart failure and death than is rosiglitazone. Given that rosiglitazone lacks a distinct clinical advantage over pioglitazone, continued use of rosiglitazone may not be justified.	[Juurlink, David N.; Hux, Janet E.] Sunnybrook Hlth Sci Ctr, Dept Med, Div Clin Pharmacol & Toxicol, Toronto, ON M4N 3M5, Canada; [Juurlink, David N.; Hux, Janet E.; Mamdani, Muhammad M.] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; [Juurlink, David N.] Univ Toronto, Dept Pediat, Toronto, ON M5S 1A1, Canada; [Juurlink, David N.; Austin, Peter C.; Hux, Janet E.; Mamdani, Muhammad M.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5S 1A1, Canada; [Juurlink, David N.; Gomes, Tara; Lipscombe, Lorraine L.; Austin, Peter C.; Hux, Janet E.; Mamdani, Muhammad M.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Lipscombe, Lorraine L.] Womens Coll Hosp, Toronto, ON M5S 1B2, Canada; [Austin, Peter C.] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON M5S 1A1, Canada; [Mamdani, Muhammad M.] St Michaels Hosp, Appl Hlth Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Hospital for Sick Children (SickKids); Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Juurlink, DN (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Med, Div Clin Pharmacol & Toxicol, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	dnj@ices.on.ca		Gomes, Tara/0000-0002-1468-1965; Austin, Peter/0000-0003-3337-233X; Lipscombe, Lorraine/0000-0001-7412-7993	Ontario Ministry of Health and Long Term Care; Canadian Institutes for Health Research; Heart and Stroke Foundation of Ontario; Canadian Diabetes Association	Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Diabetes Association	This project was supported by a grant from the Ontario Ministry of Health and Long Term Care, which had no role in the design, analysis, writing, or interpretation of the study. DNJ is supported by a new investigator award from the Canadian Institutes for Health Research. PCA is supported by a career investigator award from the Heart and Stroke Foundation of Ontario. LLL is supported by a clinician scientist award from the Canadian Diabetes Association and Canadian Institutes for Health Research.	Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; AUSTIN PC, 2009, J CLIN EPIDEMIO 0218; Boyle PJ, 2002, CLIN THER, V24, P378, DOI 10.1016/S0149-2918(02)85040-8; Diamond GA, 2007, NEW ENGL J MED, V357, P938; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Gerrits CM, 2007, PHARMACOEPIDEM DR S, V16, P1065, DOI 10.1002/pds.1470; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; Guan YF, 2005, NAT MED, V11, P861, DOI 10.1038/nm1278; Haffner SM, 1999, DIABETES CARE, V22, P562, DOI 10.2337/diacare.22.4.562; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Jamieson A, 2004, MAYO CLIN PROC, V79, P571, DOI 10.4065/79.4.571; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Karter AJ, 2005, DIABETIC MED, V22, P986, DOI 10.1111/j.1464-5491.2005.01704.x; Kermani A, 2003, MAYO CLIN PROC, V78, P1088, DOI 10.4065/78.9.1088; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Mamdani M, 2003, ARCH INTERN MED, V163, P481, DOI 10.1001/archinte.163.4.481; Margolis DJ, 2008, PHARMACOEPIDEM DR S, V17, P753, DOI 10.1002/pds.1630; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Pfutzner A, 2005, J AM COLL CARDIOL, V45, P1925, DOI 10.1016/j.jacc.2005.03.041; Psaty BM, 2007, NEW ENGL J MED, V357, P67, DOI 10.1056/NEJMe078116; Rosen CJ, 2007, NEW ENGL J MED, V357, P844, DOI 10.1056/NEJMp078167; Shah BR, 2008, DIABETIC MED, V25, P871, DOI 10.1111/j.1464-5491.2008.02462.x; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; Solomon DH, 2007, JAMA-J AM MED ASSOC, V298, P1216, DOI 10.1001/jama.298.10.1216; Stafylas PC, 2009, INT J CARDIOL, V131, P298, DOI 10.1016/j.ijcard.2008.06.005; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Young PW, 1998, J PHARMACOL EXP THER, V284, P751; Zhang H, 2005, P NATL ACAD SCI USA, V102, P9406, DOI 10.1073/pnas.0501744102; Zinn A, 2008, CLIN CARDIOL, V31, P397, DOI 10.1002/clc.20312	35	116	117	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2009	339								b2942	10.1136/bmj.b2942	http://dx.doi.org/10.1136/bmj.b2942			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486RZ	19690342	Green Published, Green Submitted, hybrid			2022-12-24	WOS:000269216700004
J	Califf, RM; Harrington, RA; Blazing, MA				Califf, Robert M.; Harrington, Robert A.; Blazing, Michael A.			Premature Release of Data from Clinical Trials of Ezetimibe	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SIMVASTATIN		[Califf, Robert M.] Duke Translat Med Inst, Durham, NC USA; [Harrington, Robert A.; Blazing, Michael A.] Duke Clin Res Inst, Durham, NC USA	Duke University; Duke University	Califf, RM (corresponding author), Duke Translat Med Inst, Durham, NC USA.							Baigent C, 2003, KIDNEY INT, V63, pS207, DOI 10.1046/j.1523-1755.63.s84.4.x; Casas JP, 2008, J INTERN MED, V264, P295, DOI 10.1111/j.1365-2796.2008.02015.x; Clader JW, 2004, J MED CHEM, V47, P1, DOI 10.1021/jm030283g; *CLINICALTRIALS GO, NCT00202878 CLINICAL; DeMets David L, 2004, Clin Trials, V1, P525, DOI 10.1191/1740774504cn54oa; *DIV MET END DRUG, 1990, GUID CLIN EV LIP ALT; Fleming TR, 2008, NEW ENGL J MED, V359, P1400, DOI 10.1056/NEJMe0807372; Meng C Q, 2001, Curr Opin Investig Drugs, V2, P389; Peto R, 2008, NEW ENGL J MED, V359, P1357, DOI 10.1056/NEJMsa0806603; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Rossebo AB, 2007, AM J CARDIOL, V99, P970, DOI 10.1016/j.amjcard.2006.10.064; Sager PT, 2003, AM J CARDIOL, V92, P1414, DOI 10.1016/j.amjcard.2003.08.048; Taylor AJ, 2008, CIRC-CARDIOVASC QUAL, V1, P54, DOI 10.1161/CIRCOUTCOMES.108.811901; Wood AJJ, 2009, NEW ENGL J MED, V360, P824, DOI 10.1056/NEJMsr0806582	15	23	26	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2009	361	7					712	717		10.1056/NEJMsr0900910	http://dx.doi.org/10.1056/NEJMsr0900910			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482JX	19675335	Bronze			2022-12-24	WOS:000268884100015
J	Scarmeas, N; Luchsinger, JA; Schupf, N; Brickman, AM; Cosentino, S; Tang, MX; Stern, Y				Scarmeas, Nikolaos; Luchsinger, Jose A.; Schupf, Nicole; Brickman, Adam M.; Cosentino, Stephanie; Tang, Ming X.; Stern, Yaakov			Physical Activity, Diet, and Risk of Alzheimer Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDITERRANEAN DIET; GROWTH-FACTOR; COGNITIVE IMPAIRMENT; LEISURE ACTIVITIES; OLDER-ADULTS; LATE-LIFE; DEMENTIA; EXERCISE; BRAIN; POPULATION	Context Both higher adherence to a Mediterranean-type diet and more physical activity have been independently associated with lower Alzheimer disease ( AD) risk but their combined association has not been investigated. Objective To investigate the combined association of diet and physical activity with AD risk. Design, Setting, and Patients Prospective cohort study of 2 cohorts comprising 1880 community-dwelling elders without dementia living in New York, New York, with both diet and physical activity information available. Standardized neurological and neuropsychological measures were administered approximately every 1.5 years from 1992 through 2006. Adherence to a Mediterranean-type diet (scale of 0-9; trichotomized into low, middle, or high; and dichotomized into low or high) and physical activity (sum of weekly participation in various physical activities, weighted by the type of physical activity [light, moderate, vigorous]; trichotomized into no physical activity, some, or much; and dichotomized into low or high), separately and combined, were the main predictors in Cox models. Models were adjusted for cohort, age, sex, ethnicity, education, apolipoprotein E genotype, caloric intake, body mass index, smoking status, depression, leisure activities, a comorbidity index, and baseline Clinical Dementia Rating score. Main Outcome Measure Time to incident AD. Results A total of 282 incident AD cases occurred during a mean (SD) of 5.4 (3.3) years of follow-up. When considered simultaneously, both Mediterranean-type diet adherence (compared with low diet score, hazard ratio [HR] for middle diet score was 0.98 [95% confidence interval {CI}, 0.72-1.33]; the HR for high diet score was 0.60 [95% CI, 0.42-0.87]; P=.008 for trend) and physical activity (compared with no physical activity, the HR for some physical activity was 0.75 [95% CI, 0.54-1.04]; the HR for much physical activity was 0.67 [95% CI, 0.47-0.95]; P=.03 for trend) were associated with lower AD risk. Compared with individuals neither adhering to the diet nor participating in physical activity (low diet score and no physical activity; absolute AD risk of 19%), those both adhering to the diet and participating in physical activity (high diet score and high physical activity) had a lower risk of AD (absolute risk, 12%; HR, 0.65 [95% CI, 0.44-0.96]; P=.03 for trend). Conclusion In this study, both higher Mediterranean-type diet adherence and higher physical activity were independently associated with reduced risk for AD. JAMA. 2009; 302(6):627-637 www.jama.com	[Scarmeas, Nikolaos; Luchsinger, Jose A.; Schupf, Nicole; Brickman, Adam M.; Cosentino, Stephanie; Stern, Yaakov] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Scarmeas, Nikolaos; Schupf, Nicole; Brickman, Adam M.; Cosentino, Stephanie; Tang, Ming X.; Stern, Yaakov] Columbia Univ, Med Ctr, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; [Scarmeas, Nikolaos; Brickman, Adam M.; Cosentino, Stephanie; Stern, Yaakov] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Luchsinger, Jose A.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Scarmeas, N (corresponding author), Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, 622 W 168th St,19th Floor, New York, NY 10032 USA.	ns257@columbia.edu	Scarmeas, Nikolaos/AAD-2512-2020; Scarmeas, Nikolaos/AAD-2517-2020	Scarmeas, Nikolaos/0000-0001-6453-8908; Scarmeas, Nikolaos/0000-0001-6453-8908; Stern, Yaakov/0000-0001-7542-3241; Luchsinger, Jose/0000-0002-5886-3648	National Institute on Aging [AG028506, P01AG07232]; NATIONAL INSTITUTE ON AGING [P50AG008702, R01AG037212, R01AG028506, P01AG007232] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by National Institute on Aging grants AG028506 and P01AG07232.	Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; BLOMSTRAND E, 1989, ACTA PHYSIOL SCAND, V136, P473, DOI 10.1111/j.1748-1716.1989.tb08689.x; Borst SE, 2002, J AM GERIATR SOC, V50, P884, DOI 10.1046/j.1532-5415.2002.50215.x; Botto LD, 2001, AM J EPIDEMIOL, V153, P1016, DOI 10.1093/aje/153.10.1016; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314; Forbes D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub2; FORDYCE DE, 1991, BEHAV BRAIN RES, V43, P115, DOI 10.1016/S0166-4328(05)80061-0; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Hakim AA, 1998, NEW ENGL J MED, V338, P94, DOI 10.1056/NEJM199801083380204; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Luchsinger JA, 2004, J AM GERIATR SOC, V52, P540, DOI 10.1111/j.1532-5415.2004.52159.x; Luchsinger JA, 2003, ARCH NEUROL-CHICAGO, V60, P203, DOI 10.1001/archneur.60.2.203; Luchsinger JA, 2007, CURR NEUROL NEUROSCI, V7, P366, DOI 10.1007/s11910-007-0057-8; Middleton LE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003124; MILLER DJ, 1994, MED SCI SPORT EXER, V26, P376; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/S0006-8993(96)00273-9; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Podewils LJ, 2005, AM J EPIDEMIOL, V161, P639, DOI 10.1093/aje/kwi092; Reuben DB, 2003, J AM GERIATR SOC, V51, P1125, DOI 10.1046/j.1532-5415.2003.51380.x; ROGERS RL, 1990, J AM GERIATR SOC, V38, P123, DOI 10.1111/j.1532-5415.1990.tb03472.x; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; SALLIS JF, 1993, MED SCI SPORT EXER, V25, P99, DOI 10.1249/00005768-199301000-00014; Scarmeas N, 2006, J NEUROL NEUROSUR PS, V77, P308, DOI 10.1136/jnnp.2005.072306; Scarmeas N, 2005, NEUROLOGY, V64, P1696, DOI 10.1212/01.WNL.0000162054.15428.E9; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Scarmeas N, 2005, ARCH NEUROL-CHICAGO, V62, P1601, DOI 10.1001/archneur.62.10.1601; Scarmeas N, 2007, NEUROLOGY, V69, P1084, DOI 10.1212/01.wnl.0000277320.50685.7c; Scarmeas N, 2009, ARCH NEUROL-CHICAGO, V66, P216, DOI 10.1001/archneurol.2008.536; Scarmeas N, 2006, ANN NEUROL, V59, P912, DOI 10.1002/ana.20854; Scarmeas N, 2006, ARCH NEUROL-CHICAGO, V63, P1709, DOI 10.1001/archneur.63.12.noc60109; STERN Y, 1992, ARCH NEUROL-CHICAGO, V49, P453, DOI 10.1001/archneur.1992.00530290035009; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Wang L, 2006, ARCH INTERN MED, V166, P1115, DOI 10.1001/archinte.166.10.1115; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742	50	587	609	2	118	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 12	2009	302	6					627	637		10.1001/jama.2009.1144	http://dx.doi.org/10.1001/jama.2009.1144			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481ZI	19671904	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000268852300021
J	Armstrong, L; Orr, V				Armstrong, Lawrence; Orr, Valerie			Picture Quiz Seizures in a 9 month old girl	BRITISH MEDICAL JOURNAL			English	Editorial Material							TUBEROUS SCLEROSIS COMPLEX; INFANTILE SPASMS; RANDOMIZED-TRIAL; EPILEPSY; VIGABATRIN; RHABDOMYOMA; MANAGEMENT; OUTCOMES; CHILDREN; AUTISM		[Armstrong, Lawrence; Orr, Valerie] Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland	University of Glasgow	Armstrong, L (corresponding author), Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland.	lawrence.armstrong@nhs.net						Asano E, 2001, NEUROLOGY, V57, P1269, DOI 10.1212/WNL.57.7.1269; Bader RS, 2003, J PEDIATR-US, V143, P620, DOI 10.1067/S0022-3476(03)00494-3; Bolton PF, 1997, LANCET, V349, P392, DOI 10.1016/S0140-6736(97)80012-8; Chiron C, 1997, EPILEPSY RES, V26, P389, DOI 10.1016/S0920-1211(96)01006-6; Goh S, 2005, NEUROLOGY, V65, P235, DOI 10.1212/01.wnl.0000168908.78118.99; Hancock E, 1999, J CHILD NEUROL, V14, P71, DOI 10.1177/088307389901400201; Jansen FE, 2007, EPILEPSIA, V48, P1477, DOI 10.1111/j.1528-1167.2007.01117.x; Joinson C, 2003, PSYCHOL MED, V33, P335, DOI 10.1017/S0033291702007092; Krueger Darcy A, 2008, Paediatr Drugs, V10, P299, DOI 10.2165/00148581-200810050-00004; Lux AL, 2005, LANCET NEUROL, V4, P712, DOI 10.1016/S1474-4422(05)70199-X; MUHLER EG, 1994, BRIT HEART J, V72, P584; O'Callaghan FJK, 2004, ARCH DIS CHILD, V89, P530, DOI 10.1136/adc.2003.026815; Osborne JP, 2008, ARCH DIS CHILD, V93, P728, DOI 10.1136/adc.2006.094938; Pulsifer MB, 2007, EPILEPSY BEHAV, V10, P402, DOI 10.1016/j.yebeh.2007.02.004; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; Sancak O, 2005, EUR J HUM GENET, V13, P731, DOI 10.1038/sj.ejhg.5201402; SMYTHE JF, 1990, AM J CARDIOL, V66, P1247, DOI 10.1016/0002-9149(90)91109-J; Stafstrom CE, 2003, NUTR NEUROSCI, V6, P67, DOI 10.1080/1028415031000084427; Webb DW, 1996, DEV MED CHILD NEUROL, V38, P146; Wong V, 2006, J CHILD NEUROL, V21, P199, DOI 10.2310/7010.2006.00046; Yoong M, 2009, ARCH DIS CHILDHOOD-E, V94, P1, DOI 10.1136/adc.2007.134049	21	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 21	2009	339								b4133	10.1136/bmj.b4133	http://dx.doi.org/10.1136/bmj.b4133			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510PL	19846480				2022-12-24	WOS:000271102300002
J	Sozou, PD; Sheldon, S; Hartshorne, GM				Sozou, Peter D.; Sheldon, Sally; Hartshorne, Geraldine M.			Personal View Withdrawal of consent by sperm donors	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sozou, Peter D.] Univ London London Sch Econ & Polit Sci, Ctr Philosophy Nat & Social Sci, London WC2A 2AE, England; [Sheldon, Sally] Univ Kent, Canterbury CT2 7NZ, Kent, England; [Sozou, Peter D.] Warwick Med Sch, Clin Sci Res Inst, Coventry, W Midlands, England	University of London; London School Economics & Political Science; University of Kent; University of Warwick	Sozou, PD (corresponding author), Univ London London Sch Econ & Polit Sci, Ctr Philosophy Nat & Social Sci, Houghton St, London WC2A 2AE, England.	p.sozou@lse.ac.uk		Sheldon, Sally/0000-0001-5472-9655	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 20	2009	339								b4297	10.1136/bmj.b4297	http://dx.doi.org/10.1136/bmj.b4297			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	510PJ	19843562				2022-12-24	WOS:000271102100006
J	Rappuoli, R; Del Giudice, G; Nabel, GJ; Osterhaus, ADME; Robinson, R; Salisbury, D; Stohr, K; Treanor, JJ				Rappuoli, Rino; Del Giudice, Giuseppe; Nabel, Gary J.; Osterhaus, Albert D. M. E.; Robinson, Robin; Salisbury, David; Stoehr, Klaus; Treanor, John J.			Rethinking Influenza	SCIENCE			English	Editorial Material							H5N1 VACCINE; TRIAL		[Rappuoli, Rino; Del Giudice, Giuseppe] Novartis Vaccines & Diagnost Srl, I-53100 Siena, Italy; [Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Osterhaus, Albert D. M. E.] Erasmus Univ, NL-3015E Rotterdam, Netherlands; [Robinson, Robin] US Dept Hlth & Human Serv HHS, Washington, DC 20201 USA; [Salisbury, David] WHO, SAGE, CH-1211 Geneva 27, Switzerland; [Stoehr, Klaus] Novartis Vaccines & Diagnost Inc, Cambridge, MA 02139 USA; [Treanor, John J.] Univ Rochester, Rochester, NY 14642 USA	Novartis; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Erasmus University Rotterdam; Sage Group; World Health Organization; Novartis; University of Rochester	Rappuoli, R (corresponding author), Novartis Vaccines & Diagnost Srl, I-53100 Siena, Italy.	rino.rappuoli@novartis.com		Osterhaus, Albert/0000-0002-6074-1172				Brooks WA, 2007, EMERG INFECT DIS, V13, P1507, DOI 10.3201/eid1310.070368; CLARK TW, 2009, N ENGL J MED, P144; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; GREENBERG HR, 2009, N ENGL J MED, P144; International Atomic Energy Agency, 2009, INT REACT PRESS VESS, P144; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; *WHO, 2009, UPD H1N1 PAND SEAS V, P144; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	10	14	14	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 2	2009	326	5949					50	50		10.1126/science.1179475	http://dx.doi.org/10.1126/science.1179475			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797644				2022-12-24	WOS:000270355600025
J	Sepulveda, J; Wendler, JE; Summons, RE; Hinrichs, KU				Sepulveda, Julio; Wendler, Jens E.; Summons, Roger E.; Hinrichs, Kai-Uwe			Rapid Resurgence of Marine Productivity After the Cretaceous-Paleogene Mass Extinction	SCIENCE			English	Article							TERTIARY BOUNDARY; STEVNS-KLINT; IMPACT EVENT; DENMARK; CONSEQUENCES; RECOVERY; DECREASE; ISOTOPE; OCEAN	The course of the biotic recovery after the impact-related disruption of photosynthesis and mass extinction event at the Cretaceous-Paleogene boundary has been intensely debated. The resurgence of marine primary production in the aftermath remains poorly constrained because of the paucity of fossil records tracing primary producers that lack skeletons. Here we present a high-resolution record of geochemical variation in the remarkably thick Fiskeler (also known as the Fish Clay) boundary layer at Kulstirenden, Denmark. Converging evidence from the stable isotopes of carbon and nitrogen and abundances of algal steranes and bacterial hopanes indicates that algal primary productivity was strongly reduced for only a brief period of possibly less than a century after the impact, followed by a rapid resurgence of carbon fixation and ecological reorganization.	[Sepulveda, Julio; Hinrichs, Kai-Uwe] Univ Bremen, Organ Geochem Grp, D-28334 Bremen, Germany; [Sepulveda, Julio; Hinrichs, Kai-Uwe] Univ Bremen, Int Grad Coll Proxies Earth Hist EUROPROX, D-28334 Bremen, Germany; [Wendler, Jens E.] Univ Bremen, Dept Geosci, Res Grp Geochronol Basin Anal, D-28334 Bremen, Germany; [Summons, Roger E.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	University of Bremen; University of Bremen; University of Bremen; Massachusetts Institute of Technology (MIT)	Sepulveda, J (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 45 Carleton St E25-623, Cambridge, MA 02139 USA.	juliosep@mit.edu	Sepulveda, Julio/K-8908-2013; Hinrichs, Kai-Uwe/C-7675-2009; Sepúlveda, Julio/AAC-9956-2020; Summons, Roger Everett/AAL-3789-2020; Sepúlveda, Julio/K-6268-2017	Hinrichs, Kai-Uwe/0000-0002-0739-9291; Sepúlveda, Julio/0000-0002-8251-6937; Sepúlveda, Julio/0000-0002-8251-6937	Deutsche Forschungsgemeinschaft through the European Graduate College EUROPROX; MARUM; NASA (Astrobiology Institute, Exobiology Program); Hanse-Wissenschaftskolleg; Alexander von Humboldt-Stiftung	Deutsche Forschungsgemeinschaft through the European Graduate College EUROPROX(German Research Foundation (DFG)); MARUM; NASA (Astrobiology Institute, Exobiology Program)(National Aeronautics & Space Administration (NASA)); Hanse-Wissenschaftskolleg; Alexander von Humboldt-Stiftung(Alexander von Humboldt Foundation)	This research was funded by the Deutsche Forschungsgemeinschaft through the European Graduate College EUROPROX and MARUM, and NASA (Astrobiology Institute, Exobiology Program). We thank X. Prieto, C. Colonero, L. Sherman, J. Salacup, H. Buschhoff, M. Segl, U. Beckert, P. Simundic, C. Gonzalez, A. Kelly, B. Schmincke, M. Milling-Goldbach, and A. Skorokhod for their laboratory and/or logistic assistance. R. E. S. acknowledges the Hanse-Wissenschaftskolleg and the Alexander von Humboldt-Stiftung. J. S. acknowledges EUROPROX for supporting his doctoral studies and a research visit to MIT.	ALTABET MA, 1994, GLOBAL BIOGEOCHEM CY, V8, P103, DOI 10.1029/93GB03396; ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; Arinobu T, 1999, GEOLOGY, V27, P723, DOI 10.1130/0091-7613(1999)027<0723:SOPPAH>2.3.CO;2; Brinkhuis H, 1998, PALAEOGEOGR PALAEOCL, V141, P67, DOI 10.1016/S0031-0182(98)00004-2; Cao CQ, 2009, EARTH PLANET SC LETT, V281, P188, DOI 10.1016/j.epsl.2009.02.012; D'Hondt S, 2005, ANNU REV ECOL EVOL S, V36, P295, DOI 10.1146/annurev.ecolsys.35.021103.105715; D'Hondt S, 1998, SCIENCE, V282, P276, DOI 10.1126/science.282.5387.276; Hart MB, 2004, J GEOL SOC LONDON, V161, P885, DOI 10.1144/0016-764903-071; HOLLANDER DJ, 1993, PALAEOGEOGR PALAEOCL, V104, P229, DOI 10.1016/0031-0182(93)90134-5; HOLLIS CJ, 1995, GEOLOGY, V23, P835, DOI 10.1130/0091-7613(1995)023<0835:SPBITE>2.3.CO;2; HSU KJ, 1982, SCIENCE, V216, P249, DOI 10.1126/science.216.4543.249; Kaiho K, 1999, PALEOCEANOGRAPHY, V14, P511, DOI 10.1029/1999PA900022; Keller G, 1996, PALAEOGEOGR PALAEOCL, V119, P221, DOI 10.1016/0031-0182(95)00009-7; KELLER G, 1993, GEOL SOC AM BULL, V105, P979, DOI 10.1130/0016-7606(1993)105<0979:GMESSA>2.3.CO;2; Knoll Andrew H., 2007, P133; Kring DA, 2007, PALAEOGEOGR PALAEOCL, V255, P4, DOI 10.1016/j.palaeo.2007.02.037; Kuypers MMM, 2004, GEOLOGY, V32, P853, DOI 10.1130/G20458.1; LAWS EA, 1995, GEOCHIM COSMOCHIM AC, V59, P1131, DOI 10.1016/0016-7037(95)00030-4; Medlin LK, 2008, MAR MICROPALEONTOL, V67, P69, DOI 10.1016/j.marmicro.2007.08.007; Mita H, 1999, GEOCHEM J, V33, P285, DOI 10.2343/geochemj.33.285; Mukhopadhyay S, 2001, SCIENCE, V291, P1952, DOI 10.1126/science.291.5510.1952; Pope KO, 1997, J GEOPHYS RES-PLANET, V102, P21645, DOI 10.1029/97JE01743; Rashid H, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001240; SCHMITZ B, 1988, GEOCHIM COSMOCHIM AC, V52, P229, DOI 10.1016/0016-7037(88)90072-5; SCHMITZ B, 1992, PALAEOGEOGR PALAEOCL, V96, P233, DOI 10.1016/0031-0182(92)90104-D; Sheehan Peter M., 1996, Geological Society of America Special Paper, V307, P477; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; Surlyk F, 2006, B GEOL SOC DENMARK, V54, P1; Wendler J, 2002, GEOL SOC AM SPEC PAP, V356, P265	29	82	84	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					129	132		10.1126/science.1176233	http://dx.doi.org/10.1126/science.1176233			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797658				2022-12-24	WOS:000270355600051
J	White, TD; Ambrose, SH; Suwa, G; Su, DF; DeGusta, D; Bernor, RL; Boisserie, JR; Brunet, M; Delson, E; Frost, S; Garcia, N; Giaourtsakis, IX; Haile-Selassie, Y; Howell, FC; Lehmann, T; Likius, A; Pehlevan, C; Saegusa, H; Semprebon, G; Teaford, M; Vrba, E				White, Tim D.; Ambrose, Stanley H.; Suwa, Gen; Su, Denise F.; DeGusta, David; Bernor, Raymond L.; Boisserie, Jean-Renaud; Brunet, Michel; Delson, Eric; Frost, Stephen; Garcia, Nuria; Giaourtsakis, Ioannis X.; Haile-Selassie, Yohannes; Howell, F. Clark; Lehmann, Thomas; Likius, Andossa; Pehlevan, Cesur; Saegusa, Haruo; Semprebon, Gina; Teaford, Mark; Vrba, Elisabeth			Macrovertebrate Paleontology and the Pliocene Habitat of Ardipithecus ramidus	SCIENCE			English	Article							INFERRING PALEOHABITATS; FUNCTIONAL-MORPHOLOGY; PATTERNS; MAMMALS; GONA; AFAR	A diverse assemblage of large mammals is spatially and stratigraphically associated with Ardipithecus ramidus at Aramis. The most common species are tragelaphine antelope and colobine monkeys. Analyses of their postcranial remains situate them in a closed habitat. Assessment of dental mesowear, microwear, and stable isotopes from these and a wider range of abundant associated larger mammals indicates that the local habitat at Aramis was predominantly woodland. The Ar. ramidus enamel isotope values indicate a minimal C-4 vegetation component in its diet (plants using the C-4 photosynthetic pathway), which is consistent with predominantly forest/woodland feeding. Although the Early Pliocene Afar included a range of environments, and the local environment at Aramis and its vicinity ranged from forests to wooded grasslands, the integration of available physical and biological evidence establishes Ar. ramidus as a denizen of the closed habitats along this continuum.	[White, Tim D.; Howell, F. Clark] Univ Calif Berkeley, Human Evolut Res Ctr, Berkeley, CA 94720 USA; [White, Tim D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Ambrose, Stanley H.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [Suwa, Gen] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; [Su, Denise F.] Bryn Mawr Coll, Dept Anthropol, Bryn Mawr, PA 19010 USA; [DeGusta, David] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA; [Bernor, Raymond L.] Natl Sci Fdn, Sedimentary Geol & Paleobiol Program, Arlington, VA 22230 USA; [Bernor, Raymond L.] Howard Univ, Coll Med, Dept Anat, Lab Evolutionary Biol, Washington, DC 20059 USA; [Boisserie, Jean-Renaud] Museum Natl Hist Nat, CNRS, UMR 5143, USM 0203, F-75231 Paris 05, France; [Boisserie, Jean-Renaud] Univ Poitiers, CNRS, UMR 6046, Inst Paleoprimatol & Paleontol Humaine Evolut & P, F-86022 Poitiers, France; [Brunet, Michel] Coll France, Chaire Paleontol Humaine, F-75231 Paris 05, France; [Delson, Eric] CUNY Herbert H Lehman Coll, Dept Anthropol, Bronx, NY 10468 USA; [Delson, Eric] Amer Museum Nat Hist, Dept Vertebrate Paleontol, New York, NY 10024 USA; [Frost, Stephen] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Garcia, Nuria] Univ Complutense Madrid, Dept Paleontol, Madrid 28029, Spain; [Garcia, Nuria] ISCIII, Ctr Evoluc & Comportamiento Humanos, Madrid 28029, Spain; [Giaourtsakis, Ioannis X.] Univ Munich, Dept Geo & Environm Sci, Sect Paleontol, D-80333 Munich, Germany; [Haile-Selassie, Yohannes] Cleveland Museum Nat Hist, Dept Phys Anthropol, Cleveland, OH 44106 USA; [Howell, F. Clark] Univ Calif Berkeley, Dept Anthropol, Berkeley, CA 94720 USA; [Lehmann, Thomas] Senckenberg Forschungsinst, D-60325 Frankfurt, Germany; [Likius, Andossa] Univ NDjamena, Dept Paleontol, Ndjamena, Chad; [Pehlevan, Cesur] Yuzuncu Yil Univ, Dept Anthropol, Fac Sci & Letters, TR-65080 Zeve Yerlesimi, Van, Turkey; [Saegusa, Haruo] Hyogo Med Univ, Inst Nat & Environm Sci, Yayoigaoka, Sanda 6691546, Japan; [Semprebon, Gina] Bay Path Coll, Longmeadow, MA 01106 USA; [Teaford, Mark] Johns Hopkins Univ, Sch Med, Ctr Funct Anat & Evolut, Baltimore, MD 21205 USA; [Vrba, Elisabeth] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Illinois System; University of Illinois Urbana-Champaign; University of Tokyo; Bryn Mawr College; Stanford University; National Science Foundation (NSF); Howard University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; UDICE-French Research Universities; PSL Research University Paris; College de France; City University of New York (CUNY) System; Lehman College (CUNY); American Museum of Natural History (AMNH); University of Oregon; Complutense University of Madrid; Instituto de Salud Carlos III; University of Munich; Cleveland Museum of Natural History; University of California System; University of California Berkeley; Senckenberg Gesellschaft fur Naturforschung (SGN); Yuzuncu Yil University; University of Hyogo; Johns Hopkins University; Yale University	White, TD (corresponding author), Univ Calif Berkeley, Human Evolut Res Ctr, 3101 Valley Life Sci Bldg, Berkeley, CA 94720 USA.	timwhite@berkeley.edu	Lund, Laura/H-7335-2012	Delson, Eric/0000-0002-4062-7567; Giaourtsakis, Ioannis/0000-0003-0519-7642	NSF [SBR-82-10897, 93-18698, 9512534, 96-32389, 99-10344, 03-21893]; Japan Society for the Promotion of Science;  [SBR 98-71480]	NSF(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	Supported by NSF (grants SBR-82-10897, 93-18698, 9512534, 96-32389, 99-10344, and 03-21893 HOMINID-RHOI; and grant SBR 98-71480 for mass spectrometry instrumentation at the Environmental Isotope Paleobiogeochemistry Laboratory) and the Japan Society for the Promotion of Science (G. S. and H. S.). We thank L. Bach, H. Gilbert, and K. Brudvik for illustrations; the Ministry of Tourism and Culture, the Authority for Research and Conservation of the Cultural Heritage, and the National Museum of Ethiopia for permissions and facilitation; and the Afar Regional Government, the Afar people of the Middle Awash, and many other field workers for contributing directly to the data.	AMBROSE SH, 1986, OECOLOGIA, V69, P395, DOI 10.1007/BF00377062; ANDREWS P, 1979, BIOL J LINN SOC, V11, P177, DOI 10.1111/j.1095-8312.1979.tb00034.x; Andrews P, 1999, HUMAN EVOLUT SER, P282; Benefit BR, 1999, HUMAN EVOLUT SER, P172; Bobe R, 2006, J ARID ENVIRON, V66, P564, DOI 10.1016/j.jaridenv.2006.01.010; Bobe R, 2001, PALEOBIOLOGY, V27, P1, DOI 10.1666/0094-8373(2001)027<0001:ROABTP>2.0.CO;2; Carter ML, 2001, THESIS U CHICAGO; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; DeGusta D, 2005, J ARCHAEOL SCI, V32, P1099, DOI 10.1016/j.jas.2005.02.010; DeGusta D, 2003, J ARCHAEOL SCI, V30, P1009, DOI 10.1016/S0305-4403(02)00286-8; Elton S, 2002, FOLIA PRIMATOL, V73, P252, DOI 10.1159/000067457; Fleagle J.G., 1976, YB PHYS ANTHR, V20, P440, DOI [10.1002/ajpa.1330460211, DOI 10.1002/AJPA.1330460211]; Fortelius Mikael, 2000, American Museum Novitates, V3301, P1, DOI 10.1206/0003-0082(2000)301<0001:FCOUMU>2.0.CO;2; Frost Stephen R., 2001, American Museum Novitates, V3350, P1, DOI 10.1206/0003-0082(2001)350<0001:NEPCMP>2.0.CO;2; Haile-Selassie Y, 2004, GEOBIOS-LYON, V37, P536, DOI 10.1016/j.geobios.2003.03.012; Hespenheide H.A., 1973, Annual Rev Ecol Syst, V4, P213, DOI 10.1146/annurev.es.04.110173.001241; Hlusko Leslea J., 2007, Kirtlandia, V56, P163; Kovarovic K, 2002, J HUM EVOL, V43, P395, DOI 10.1006/jhev.2002.0580; KRENTZ HB, 1993, THEROPITHECUS, P383, DOI 10.1017/CBO9780511565540.015; Leakey M, 1999, HUMAN EVOLUT SER, P271; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; Levin NE, 2008, GEOL SOC AM SPEC PAP, V446, P215, DOI 10.1130/2008.2446(10); Louchart A, 2009, SCIENCE, V326, DOI 10.1126/science.1175823; Oates John F., 1994, P45; Quade J, 2008, GEOL SOC AM SPEC PAP, V446, P1, DOI 10.1130/2008.2446(01); Reed KE, 2008, J HUM EVOL, V54, P743, DOI 10.1016/j.jhevol.2007.08.013; Shipman P., 1988, P343; Sikes Nancy E., 1995, Evolutionary Anthropology, V4, P155, DOI 10.1002/evan.1360040504; Sorkin B, 2006, HIST BIOL, V18, P375, DOI 10.1080/08912960600618073; Sponheimer M, 2006, J HUM EVOL, V51, P128, DOI 10.1016/j.jhevol.2006.02.002; Sponheimer Matt, 2007, P555, DOI 10.1007/978-3-540-33761-4_18; SU DF, 2005, THESIS NEW YORK U; Suwa G, 2003, J VERTEBR PALEONTOL, V23, P901, DOI 10.1671/2469-15; van der Merwe NJ, 2008, S AFR J SCI, V104, P153; Vrba E.S., 1980, P247; WHITE F, 1983, VEGETATION AFRICA NA, V20; White T.D., 1988, P449; White TD, 2006, NATURE, V440, P883, DOI 10.1038/nature04629; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; WoldeGabriel G, 2009, SCIENCE, V326, DOI 10.1126/science.1175817	41	192	197	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					87	93		10.1126/science.1175822	http://dx.doi.org/10.1126/science.1175822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	501CA	19810193	Green Published			2022-12-24	WOS:000270355600041
J	Clarke, R; Emberson, J; Fletcher, A; Breeze, E; Marmot, M; Shipley, MJ				Clarke, Robert; Emberson, Jonathan; Fletcher, Astrid; Breeze, Elizabeth; Marmot, Michael; Shipley, Martin J.			Life expectancy in relation to cardiovascular risk factors: 38 year follow-up of 19 000 men in the Whitehall study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEART-DISEASE MORTALITY; CIVIL-SERVANTS; RE-SURVEY; DECLINE; AGE; CHOLESTEROL; POPULATION; SMOKING; TRENDS	Objective To assess life expectancy in relation to cardiovascular risk factors recorded in middle age. Design Prospective cohort study. Setting Men employed in the civil service in London, England. Participants 18 863 men examined at entry in 1967-70 and followed for 38 years, of whom 13 501 died and 4811 were re-examined in 1997. Main outcome measures Life expectancy estimated in relation to fifths and dichotomous categories of risk factors (smoking, "low" or "high" blood pressure (>= 140 mm Hg), and "low" or "high" cholesterol (>= 5 mmol/l)), and a risk score from these risk factors. Results At entry, 42% of the men were current smokers, 39% had high blood pressure, and 51% had high cholesterol. At the re-examination, about two thirds of the previously "current" smokers had quit smoking shortly after entry and the mean differences in levels of those with high and low levels of blood pressure and cholesterol were attenuated by two thirds. Compared with men without any baseline risk factors, the presence of all three risk factors at entry was associated with a 10 year shorter life expectancy from age 50 (23.7 v 33.3 years). Compared with men in the lowest 5% of a risk score based on smoking, diabetes, employment grade, and continuous levels of blood pressure, cholesterol concentration, and body mass index (BMI), men in the highest 5% had a 15 year shorter life expectancy from age 50 (20.2 v 35. 4 years). Conclusion Despite substantial changes in these risk factors over time, baseline differences in risk factors were associated with 10 to 15 year shorter life expectancy from age 50.	[Clarke, Robert; Emberson, Jonathan] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Clarke, Robert; Emberson, Jonathan] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford OX3 7LF, England; [Fletcher, Astrid] London Sch Hyg & Trop Med, London WC1E 6HT, England; [Breeze, Elizabeth; Marmot, Michael; Shipley, Martin J.] UCL, Sch Med, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Medical School	Clarke, R (corresponding author), Univ Oxford, Clin Trial Serv Unit, Richard Doll Bldg, Oxford OX3 7LF, England.	robert.clarke@ctsu.ox.ac.uk	Breeze, Elizabeth/AAK-4927-2021; Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419; Emberson, Jonathan/0000-0001-7792-9422	British Heart Foundation; Medical Research Council; MM; MRC [MC_U137686857] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G0100222, G19/35, G8802774, MC_U137686857] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MM; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Whitehall study was supported by the British Heart Foundation and Medical Research Council. JE and MJS are supported by the British Heart Foundation and MM by a MRC research professorship. All of the analyses were carried out independently of the sources of support.	ALLENDER S, 2006, CORONARY HEART DIS S; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; *CHOL TREATM TRIAL, 2006, LANCET, V366, P1267; Clarke R, 1998, J EPIDEMIOL COMMUN H, V52, P364, DOI 10.1136/jech.52.6.364; Clarke R, 2000, J CARDIOVASC RISK, V7, P251; Clarke R, 2007, ARCH INTERN MED, V167, P1373, DOI 10.1001/archinte.167.13.1373; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Driver JA, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2467; Emberson J, 2004, EUR HEART J, V25, P484, DOI 10.1016/j.ehj.2003.11.012; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; Kivimaki M, 2008, OBESITY, V16, P1926, DOI 10.1038/oby.2008.322; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; *NAT STAT, 2007, IN LIF EXP 65 UK; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; OFLAHERTY M, 2003, HLTH STAT Q, V18, P5; REID DD, 1974, LANCET, V1, P469; ROSE G, 1977, LANCET, V1, P105; Rose G., 1992, STRATEGY PREVENTIVE; SMITH GD, 1991, ANN NUTR METAB, V35, P53, DOI 10.1159/000177678; Turnbull F, 2003, LANCET, V362, P1527; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Yates LB, 2008, ARCH INTERN MED, V168, P284, DOI 10.1001/archinternmed.2007.77	26	66	70	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2009	339								b3513	10.1136/bmj.b3513	http://dx.doi.org/10.1136/bmj.b3513			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496RU	19762417	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-24	WOS:000269994900002
J	Hait, NC; Allegood, J; Maceyka, M; Strub, GM; Harikumar, KB; Singh, SK; Luo, C; Marmorstein, R; Kordula, T; Milstien, S; Spiegel, S				Hait, Nitai C.; Allegood, Jeremy; Maceyka, Michael; Strub, Graham M.; Harikumar, Kuzhuvelil B.; Singh, Sandeep K.; Luo, Cheng; Marmorstein, Ronen; Kordula, Tomasz; Milstien, Sheldon; Spiegel, Sarah			Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate	SCIENCE			English	Article							MEDIATED PHOSPHORYLATION; DEACETYLASE INHIBITORS; SPHINGOSINE-KINASE-2; ACTIVATION; FAMILY	The pleiotropic lipid mediator sphingosine-1-phosphate (S1P) can act intracellularly independently of its cell surface receptors through unknown mechanisms. Sphingosine kinase 2 (SphK2), one of the isoenzymes that generates S1P, was associated with histone H3 and produced S1P that regulated histone acetylation. S1P specifically bound to the histone deacetylases HDAC1 and HDAC2 and inhibited their enzymatic activity, preventing the removal of acetyl groups from lysine residues within histone tails. SphK2 associated with HDAC1 and HDAC2 in repressor complexes and was selectively enriched at the promoters of the genes encoding the cyclin-dependent kinase inhibitor p21 or the transcriptional regulator c-fos, where it enhanced local histone H3 acetylation and transcription. Thus, HDACs are direct intracellular targets of S1P and link nuclear S1P to epigenetic regulation of gene expression.	[Hait, Nitai C.; Allegood, Jeremy; Maceyka, Michael; Strub, Graham M.; Harikumar, Kuzhuvelil B.; Singh, Sandeep K.; Kordula, Tomasz; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Hait, Nitai C.; Allegood, Jeremy; Maceyka, Michael; Strub, Graham M.; Harikumar, Kuzhuvelil B.; Singh, Sandeep K.; Kordula, Tomasz; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23298 USA; [Luo, Cheng; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Luo, Cheng; Marmorstein, Ronen] Univ Penn, Wistar Inst, Philadelphia, PA 19104 USA; [Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Milstien, Sheldon] NIMH, NIH, Bethesda, MD 20892 USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Pennsylvania; The Wistar Institute; University of Pennsylvania; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	sspiegel@vcu.edu	Maceyka, Michael/B-9277-2008; Harikumar, Kuzhuvelil/AAC-2407-2020	Harikumar, Kuzhuvelil/0000-0002-1763-4179	NIH [R37GM043880, R01CA61774]; National Research Service Award [F30NSO58008]; NIMH Intramural Research Program; NATIONAL CANCER INSTITUTE [R01CA061774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043880, R01GM060293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS058008] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the NIH R37GM043880 and R01CA61774 (S. S.). G. S. was supported by National Research Service Award F30NSO58008. S. M. was supported by the NIMH Intramural Research Program.	Albi E, 2008, BIOCHEM J, V410, P381, DOI 10.1042/BJ20070758; Chun J, 2006, CURR PHARM DESIGN, V12, P161, DOI 10.2174/138161206775193109; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; COCCO L, 1980, BIOCHEM BIOPH RES CO, V96, P890, DOI 10.1016/0006-291X(80)91439-4; Ding G, 2007, J BIOL CHEM, V282, P27493, DOI 10.1074/jbc.M701641200; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hait NC, 2007, J BIOL CHEM, V282, P12058, DOI 10.1074/jbc.M609559200; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Mitra P, 2007, METHOD ENZYMOL, V434, P257, DOI 10.1016/S0076-6879(07)34014-7; O'Donnell A, 2008, MOL CELL, V29, P780, DOI 10.1016/j.molcel.2008.01.019; Sankala HM, 2007, CANCER RES, V67, P10466, DOI 10.1158/0008-5472.CAN-07-2090; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	21	695	728	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1254	1257		10.1126/science.1176709	http://dx.doi.org/10.1126/science.1176709			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729656	Green Accepted			2022-12-24	WOS:000269523200040
J	Lake, JA				Lake, James A.			Evidence for an early prokaryotic endosymbiosis	NATURE			English	Article							HORIZONTAL GENE-TRANSFER; SYMBIOBACTERIUM-THERMOPHILUM; COMMUNITY STRUCTURE; GENOME SEQUENCE; EARLY EVOLUTION; LIFE; TREE; ROOT; BACTERIUM; DEPENDS	Endosymbioses have dramatically altered eukaryotic life, but are thought to have negligibly affected prokaryotic evolution. Here, by analysing the flows of protein families, I present evidence that the double-membrane, Gram-negative prokaryotes were formed as the result of a symbiosis between an ancient actinobacterium and an ancient clostridium. The resulting taxon has been extraordinarily successful, and has profoundly altered the evolution of life by providing endosymbionts necessary for the emergence of eukaryotes and by generating Earth's oxygen atmosphere. Their double-membrane architecture and the observed genome flows into them suggest a common evolutionary mechanism for their origin: an endosymbiosis between a clostridium and actinobacterium.	[Lake, James A.] Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Los Angeles, CA 90095 USA; [Lake, James A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Lake, James A.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Lake, James A.] Univ Calif Los Angeles, UCLA Astrobiol Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lake, JA (corresponding author), Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Los Angeles, CA 90095 USA.	lake@mbi.ucla.edu			NSF; UCLA NASA Astrobiology Institute	NSF(National Science Foundation (NSF)); UCLA NASA Astrobiology Institute	I thank C. Herbold, R. Skophammer, A. Norman and J. Servin for advice and help. This work was supported by grants from the NSF and the UCLA NASA Astrobiology Institute to J. A. L.	Archibald JM, 2002, TRENDS GENET, V18, P577, DOI 10.1016/S0168-9525(02)02777-4; BOONE DR, 1989, APPL ENVIRON MICROB, V55, P1735, DOI 10.1128/AEM.55.7.1735-1741.1989; BOONE DR, 2001, BERGEYS MANUAL SYSTE, V1; Bowler C, 2009, NATURE, V459, P180, DOI 10.1038/nature08056; Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118; DeLong EF, 2009, NATURE, V459, P200, DOI 10.1038/nature08059; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Fischer WW, 2008, NATURE, V455, P1051, DOI 10.1038/4551051a; Frostl JM, 2000, ARCH MICROBIOL, V174, P50, DOI 10.1007/s002030000172; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Garritya G. M., 2001, BERGEYS MANUAL SYSTE, P119, DOI DOI 10.1002/9781118960608.BM00031; GEST H, 1983, ARCH MICROBIOL, V136, P11, DOI 10.1007/BF00415602; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; HILARIO E, 1993, BIOSYSTEMS, V31, P111, DOI 10.1016/0303-2647(93)90038-E; Jain R, 2003, MOL BIOL EVOL, V20, P1598, DOI 10.1093/molbev/msg154; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jain R, 2002, THEOR POPUL BIOL, V61, P489, DOI 10.1006/tpbi.2002.1596; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; LAKE JA, 1995, P NATL ACAD SCI USA, V92, P9662, DOI 10.1073/pnas.92.21.9662; Lake JA, 2004, MOL BIOL EVOL, V21, P681, DOI 10.1093/molbev/msh061; LAKE JA, 1994, P NATL ACAD SCI USA, V91, P2880, DOI 10.1073/pnas.91.8.2880; Lake JA, 2008, MOL BIOL EVOL, V25, P1677, DOI 10.1093/molbev/msn117; Lake JA, 2007, MOL BIOL EVOL, V24, P130, DOI 10.1093/molbev/msl140; Lake JA, 2008, SYST BIOL, V57, P835, DOI 10.1080/10635150802555933; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Margulis L., 1993, SYMBIOSIS CELL EVOLU; MARGULIS L, GENOMES FLU IN PRESS; Margulis L, 1970, ORIGIN EUKARYOTIC CE; Martin W, 2004, NATURE, V431, P134, DOI 10.1038/431134a; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; McInerney JO, 2007, SCIENCE, V318, P1390, DOI 10.1126/science.1151657; Ohno M, 2000, INT J SYST EVOL MICR, V50, P1829, DOI 10.1099/00207713-50-5-1829; Overmann J, 2002, ARCH MICROBIOL, V177, P201, DOI 10.1007/s00203-001-0377-z; Poole A, 1999, BIOESSAYS, V21, P880, DOI 10.1002/(SICI)1521-1878(199910)21:10<880::AID-BIES11>3.0.CO;2-P; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; Raymond J, 2002, SCIENCE, V298, P1616, DOI 10.1126/science.1075558; Rivera MC, 2004, NATURE, V431, P152, DOI 10.1038/nature02848; Servin JA, 2008, MOL BIOL EVOL, V25, P1, DOI 10.1093/molbev/msm249; Skophammer RG, 2007, MOL BIOL EVOL, V24, P1761, DOI 10.1093/molbev/msm096; Skophammer RG, 2006, MOL BIOL EVOL, V23, P1648, DOI 10.1093/molbev/msl046; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; Stanier R., 1976, MICROBIAL WORLD; Syvanen M, 1998, HORIZONTAL GENE TRAN; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Ueda K, 2004, NUCLEIC ACIDS RES, V32, P4937, DOI 10.1093/nar/gkh830; Ventura GT, 2007, P NATL ACAD SCI USA, V104, P14260, DOI 10.1073/pnas.0610903104; von Dohlen CD, 2001, NATURE, V412, P433, DOI 10.1038/35086563; Wanner G, 2008, J BACTERIOL, V190, P3721, DOI 10.1128/JB.00027-08; Wilkinson M, 2007, TRENDS ECOL EVOL, V22, P114, DOI 10.1016/j.tree.2007.01.002; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065	51	43	46	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					967	971		10.1038/nature08183	http://dx.doi.org/10.1038/nature08183			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19693078				2022-12-24	WOS:000269085500025
J	Rosove, MH; Grody, WW				Rosove, Michael H.; Grody, Wayne W.			Should We Be Applying Warfarin Pharmacogenetics to Clinical Practice? No, Not Now	ANNALS OF INTERNAL MEDICINE			English	Article							COAGULATION-FACTOR; CYP2C9 GENOTYPE; BLEEDING RISK; VKORC1 GENE; ANTICOAGULATION; POLYMORPHISMS; RESISTANCE; ASSOCIATION; SENSITIVITY; THERAPY	The U. S. Food and Drug Administration modified warfarin labeling in 2007 to suggest, but not mandate, pharmacogenetic testing. Genetic analysis is now commercially available. However, results predict only one third of all dosing variation, the value of testing in reducing bleeding and thrombosis rates remains unproved, and cost-effectiveness is not established. Careful consideration of clinical factors that influence dosing, conscientious prothrombin time monitoring, and sage dosage adjustment remain paramount in warfarin management. Further study is required before routine warfarin pharmacogenetic testing can be recommended.	[Rosove, Michael H.; Grody, Wayne W.] Univ Calif Los Angeles, Los Angeles, CA USA	University of California System; University of California Los Angeles	Rosove, MH (corresponding author), 100 UCLA Med Plaza,Suite 550, Los Angeles, CA 90095 USA.	mrosove@mednet.ucla.edu						Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; *AM COLL CHEST PHY, 2008, CHEST, V133, pS160; Aquilante CL, 2006, CLIN PHARMACOL THER, V79, P291, DOI 10.1016/j.clpt.2005.11.011; Caraco Y, 2008, CLIN PHARMACOL THER, V83, P460, DOI 10.1038/sj.clpt.6100316; *COUM GEN INV, 2007, CIRCULATION, V116, P2563; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; Eckman MH, 2009, ANN INTERN MED, V150, P73, DOI 10.7326/0003-4819-150-2-200901200-00005; Gage BF, 2008, J THROMB THROMBOLYS, V25, P45, DOI 10.1007/s11239-007-0104-y; Harrington DJ, 2005, THROMB HAEMOSTASIS, V93, P23, DOI 10.1160/TH04-08-0540; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690; Hillman MA, 2005, CLIN MED RES, V3, P137, DOI 10.3121/cmr.3.3.137; Kaminsky LS, 1997, PHARMACOL THERAPEUT, V73, P67, DOI 10.1016/S0163-7258(96)00140-4; Kangelaris KN, 2009, J GEN INTERN MED, V24, P656, DOI 10.1007/s11606-009-0949-1; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Krynetskiy E, 2007, J PHARMACOL EXP THER, V322, P427, DOI 10.1124/jpet.106.117952; Limdi N, 2008, CLIN PHARMACOL THER, V83, P312, DOI 10.1038/sj.clpt.6100290; Linder MW, 2001, CLIN CHIM ACTA, V308, P9, DOI 10.1016/S0009-8981(01)00420-X; Loebstein R, 2007, BLOOD, V109, P2477, DOI 10.1182/blood-2006-08-038984; Margaglione M, 2000, THROMB HAEMOSTASIS, V84, P775; Millican EA, 2007, BLOOD, V110, P1511, DOI 10.1182/blood-2007-01-069609; POLLACK A, 2008, NY TIMES        1230; Reitsma PH, 2005, PLOS MED, V2, P996, DOI 10.1371/journal.pmed.0020312; Rettie AE, 2006, BRIT J CLIN PHARMACO, V62, P617, DOI 10.1111/j.1365-2125.2006.02688.x; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Sanderson S, 2005, GENET MED, V7, P97, DOI 10.1097/01.GIM.0000153664.65759.CF; Schwarz UI, 2008, NEW ENGL J MED, V358, P999, DOI 10.1056/NEJMoa0708078; Taube J, 2000, BLOOD, V96, P1816, DOI 10.1182/blood.V96.5.1816.h8001816_1816_1819; Wadelius M, 2007, HUM GENET, V121, P23, DOI 10.1007/s00439-006-0260-8; Wadelius M, 2009, BLOOD, V113, P784, DOI 10.1182/blood-2008-04-149070; Wen MS, 2008, CLIN PHARMACOL THER, V84, P83, DOI 10.1038/sj.clpt.6100453	31	32	32	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 18	2009	151	4					270	W95		10.7326/0003-4819-151-4-200908180-00009	http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484IW	19687493				2022-12-24	WOS:000269038900007
J	Schwartz, LM; Woloshin, S				Schwartz, Lisa M.; Woloshin, Steven			Lost in Transmission - FDA Drug Information That Never Reaches Clinicians	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRIALS		[Schwartz, Lisa M.] Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA; VA Med Ctr, VA Outcomes Grp, White River Jct, VT USA	Dartmouth College; VA Outcomes Group	Schwartz, LM (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA.							*DRUGS FDA, APPR HIST NDA 021223; *DRUGS FDA, APPR HIST NDA 021782; *DRUGS FDA, APPR HIST NDA 021476; Major P, 2001, J CLIN ONCOL, V19, P558, DOI 10.1200/JCO.2001.19.2.558; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106	5	33	33	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2009	361	18					1717	1720		10.1056/NEJMp0907708	http://dx.doi.org/10.1056/NEJMp0907708			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	511RY	19846841				2022-12-24	WOS:000271185600001
J	Herbert, SP; Huisken, J; Kim, TN; Feldman, ME; Houseman, BT; Wang, RA; Shokat, KM; Stainier, DYR				Herbert, Shane P.; Huisken, Jan; Kim, Tyson N.; Feldman, Morri E.; Houseman, Benjamin T.; Wang, Rong A.; Shokat, Kevan M.; Stainier, Didier Y. R.			Arterial-Venous Segregation by Selective Cell Sprouting: An Alternative Mode of Blood Vessel Formation	SCIENCE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; VASCULAR MORPHOGENESIS; NOTCH; P110-ALPHA; ANGIOGENESIS; EPHRINB2; HEDGEHOG; SUBUNIT; PATHWAY; ROLES	Blood vessels form de novo (vasculogenesis) or upon sprouting of capillaries from preexisting vessels (angiogenesis). With high-resolution imaging of zebrafish vascular development, we uncovered a third mode of blood vessel formation whereby the first embryonic artery and vein, two unconnected blood vessels, arise from a common precursor vessel. The first embryonic vein formed by selective sprouting of progenitor cells from the precursor vessel, followed by vessel segregation. These processes were regulated by the ligand EphrinB2 and its receptor EphB4, which are expressed in arterial-fated and venous-fated progenitors, respectively, and interact to orient the direction of progenitor migration. Thus, directional control of progenitor migration drives arterial-venous segregation and generation of separate parallel vessels from a single precursor vessel, a process essential for vascular development.	[Herbert, Shane P.; Huisken, Jan; Stainier, Didier Y. R.] Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94158 USA; [Herbert, Shane P.; Huisken, Jan; Stainier, Didier Y. R.] Univ Calif San Francisco, Dept Genet, San Francisco, CA 94158 USA; [Herbert, Shane P.; Huisken, Jan; Stainier, Didier Y. R.] Univ Calif San Francisco, Cardiovasc Res Inst, Program Human Genet, San Francisco, CA 94158 USA; [Herbert, Shane P.] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds LS2 9JT, W Yorkshire, England; [Herbert, Shane P.] Univ Leeds, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Kim, Tyson N.; Wang, Rong A.] Univ Calif San Francisco, Dept Surg, Div Vasc Surg, Lab Accelerated Vasc Res, San Francisco, CA 94143 USA; [Feldman, Morri E.] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94158 USA; [Houseman, Benjamin T.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Houseman, Benjamin T.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Leeds; University of Leeds; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94158 USA.	Didier.Stainier@ucsf.edu	Huisken, Jan/B-2472-2009	Huisken, Jan/0000-0001-7250-3756; Herbert, Shane/0000-0003-2517-1845; Stainier, Didier/0000-0002-0382-0026; Kim, Tyson/0000-0002-5275-6614	Wellcome Trust; Human Frontier Science Program Organization; Cardiovascular Research Institute fellowship; NIH [HL54737]; Packard Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075033, R01HL054737] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontier Science Program Organization(Human Frontier Science Program); Cardiovascular Research Institute fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Foundation(The David & Lucile Packard Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. E. Cooke, S. Schulte-Merker, and H. Okamoto for reagents and D. Shin, P. Gut, and S. Woo for critical reading of the manuscript. S. P. H. is a Wellcome Trust Sir Henry Wellcome postdoctoral fellow. J. H. was supported by the Human Frontier Science Program Organization and is supported by a Cardiovascular Research Institute fellowship. This study was supported in part by grants from the NIH (HL54737) and Packard Foundation to D. Y. R. S.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X; Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Kim YH, 2008, DEVELOPMENT, V135, P3755, DOI 10.1242/dev.022475; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Lin FJ, 2007, EMBO REP, V8, P920, DOI 10.1038/sj.embor.7401076; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Pendeville H, 2008, DEV BIOL, V317, P405, DOI 10.1016/j.ydbio.2008.01.028; Sato T, 2007, J NEUROSCI, V27, P5271, DOI 10.1523/JNEUROSCI.0883-07.2007; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Sly LM, 2009, BLOOD, V113, P2945, DOI 10.1182/blood-2008-06-166082; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Ueki K, 2002, P NATL ACAD SCI USA, V99, P419, DOI 10.1073/pnas.012581799; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599	26	227	235	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					294	298		10.1126/science.1178577	http://dx.doi.org/10.1126/science.1178577			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815777	Green Accepted			2022-12-24	WOS:000270599500044
J	Stafford, RS; Wagner, TH; Lavori, PW				Stafford, Randall S.; Wagner, Todd H.; Lavori, Philip W.			New, but Not Improved? Incorporating Comparative-Effectiveness Information into FDA Labeling	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Stafford, Randall S.] Stanford Univ, Stanford Prevent Res Ctr, Palo Alto, CA 94304 USA; [Wagner, Todd H.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Wagner, Todd H.; Lavori, Philip W.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Stafford, RS (corresponding author), Stanford Univ, Stanford Prevent Res Ctr, Palo Alto, CA 94304 USA.		; Stafford, Randall/F-3974-2017	Wagner, Todd/0000-0001-7625-3504; Stafford, Randall/0000-0003-1805-1271	NHLBI NIH HHS [K24 HL086703] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL086703] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2001, GUID IND E 10 CHOIC; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Hamburg MA, 2009, NEW ENGL J MED, V360, P2493, DOI 10.1056/NEJMp0903764; Schuber S, 2006, ANN INTERN MED, V145, P448, DOI 10.7326/0003-4819-145-6-200609190-00008; Sisko A, 2009, HEALTH AFFAIR, V28, pW346, DOI 10.1377/hlthaff.28.2.w346	5	57	58	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2009	361	13					1230	1233		10.1056/NEJMp0906490	http://dx.doi.org/10.1056/NEJMp0906490			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	497RN	19675326				2022-12-24	WOS:000270078700003
J	Bleichert, F; Gagnon, KT; Brown, BA; Maxwell, ES; Leschziner, AE; Unger, VM; Baserga, SJ				Bleichert, Franziska; Gagnon, Keith T.; Brown, Bernard A., II; Maxwell, E. Stuart; Leschziner, Andres E.; Unger, Vinzenz M.; Baserga, Susan J.			A Dimeric Structure for Archaeal Box C/D Small Ribonucleoproteins	SCIENCE			English	Article							SMALL NUCLEOLAR RNAS; HUMAN TELOMERASE; RIBOSE METHYLATION; CORE PROTEIN; COMPLEX; HOMOLOGS; BINDING; DOMAIN; RNPS	Methylation of ribosomal RNA ( rRNA) is required for optimal protein synthesis. Multiple 2'-O-ribose methylations are carried out by box C/D guide ribonucleoproteins [small ribonucleoproteins (sRNPs) and small nucleolar ribonucleoproteins (snoRNPs)], which are conserved from archaea to eukaryotes. Methylation is dictated by base pairing between the specific guide RNA component of the sRNP or snoRNP and the target rRNA. We determined the structure of a reconstituted and catalytically active box C/D sRNP from the archaeon Methanocaldococcus jannaschii by single-particle electron microscopy. We found that archaeal box C/D sRNPs unexpectedly formed a dimeric structure with an alternative organization of their RNA and protein components that challenges the conventional view of their architecture. Mutational analysis demonstrated that this di-sRNP structure was relevant for the enzymatic function of archaeal box C/D sRNPs.	[Bleichert, Franziska; Baserga, Susan J.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Gagnon, Keith T.; Brown, Bernard A., II; Maxwell, E. Stuart] N Carolina State Univ, Dept Biol Mol & Struct, Raleigh, NC 27695 USA; [Leschziner, Andres E.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Unger, Vinzenz M.; Baserga, Susan J.] Yale Univ, Dept Mol Biophys & Biochem, Sch Med, New Haven, CT 06520 USA; [Baserga, Susan J.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	Yale University; University of North Carolina; North Carolina State University; Harvard University; Yale University; Yale University	Baserga, SJ (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06520 USA.	susan.baserga@yale.edu		Leschziner, Andres/0000-0002-7732-7023	NIH [RR19895, R01GM69699, R01GM52581]; Boehringer Ingelheim Fonds Ph. D. scholarship; NSF [MCB0543741]; EMDB [EMD-1636]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069699, R01GM052581] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds Ph. D. scholarship(Boehringer Ingelheim); NSF(National Science Foundation (NSF)); EMDB; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Golas, P. Moore, K. Reinisch, J. Steitz, T. Steitz, H. Wang, and S. Wolin for helpful discussion and/or critical reading of the manuscript, and the Yale University Biomedical High Performance Computing Center ( supported by NIH grant RR19895). This work was supported by a Boehringer Ingelheim Fonds Ph. D. scholarship ( F. B.), NIH grants R01GM69699 ( B. A. B.) and R01GM52581 ( S. J. B.), and NSF grant MCB0543741 ( E. S. M.). The EM map has been deposited into EMDB ( accession code EMD-1636).	Aittaleb M, 2003, NAT STRUCT BIOL, V10, P256, DOI 10.1038/nsb905; Beattie TL, 2001, MOL CELL BIOL, V21, P6151, DOI 10.1128/MCB.21.18.6151-6160.2001; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Fouche N, 2006, BIOCHEMISTRY-US, V45, P9624, DOI 10.1021/bi060313s; Gaspin C, 2000, J MOL BIOL, V297, P895, DOI 10.1006/jmbi.2000.3593; HODNETT JL, 1968, J BIOL CHEM, V243, P6334; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kiss-Laszlo Z, 1998, EMBO J, V17, P797, DOI 10.1093/emboj/17.3.797; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Kuhn JF, 2002, NUCLEIC ACIDS RES, V30, P931, DOI 10.1093/nar/30.4.931; Liang XH, 2007, MOL CELL, V28, P965, DOI 10.1016/j.molcel.2007.10.012; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; Omer AD, 2000, SCIENCE, V288, P517, DOI 10.1126/science.288.5465.517; Omer AD, 2002, P NATL ACAD SCI USA, V99, P5289, DOI 10.1073/pnas.082101999; Oruganti S, 2007, J MOL BIOL, V371, P1141, DOI 10.1016/j.jmb.2007.06.029; Prescott J, 1997, GENE DEV, V11, P2790, DOI 10.1101/gad.11.21.2790; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Rashid R, 2003, J MOL BIOL, V333, P295, DOI 10.1016/j.jmb.2003.08.012; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; Stark H, 2006, ANNU REV BIOPH BIOM, V35, P435, DOI 10.1146/annurev.biophys.35.040405.101953; Suryadi J, 2005, BIOCHEMISTRY-US, V44, P9657, DOI 10.1021/bi050568q; Tran EJ, 2003, EMBO J, V22, P3930, DOI 10.1093/emboj/cdg368; Wenz C, 2001, EMBO J, V20, P3526, DOI 10.1093/emboj/20.13.3526; Zhang XX, 2006, RNA, V12, P1092, DOI 10.1261/rna.2230106	24	47	47	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1384	1387		10.1126/science.1176099	http://dx.doi.org/10.1126/science.1176099			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745151	Green Accepted			2022-12-24	WOS:000269699100036
J	Koshiba-Takeuchi, K; Mori, AD; Kaynak, BL; Cebra-Thomas, J; Sukonnik, T; Georges, RO; Latham, S; Beck, L; Henkelman, RM; Black, BL; Olson, EN; Wade, J; Takeuchi, JK; Nemer, M; Gilbert, SF; Bruneau, BG				Koshiba-Takeuchi, Kazuko; Mori, Alessandro D.; Kaynak, Bogac L.; Cebra-Thomas, Judith; Sukonnik, Tatyana; Georges, Romain O.; Latham, Stephany; Beck, Laural; Henkelman, R. Mark; Black, Brian L.; Olson, Eric N.; Wade, Juli; Takeuchi, Jun K.; Nemer, Mona; Gilbert, Scott F.; Bruneau, Benoit G.			Reptilian heart development and the molecular basis of cardiac chamber evolution	NATURE			English	Article							VENTRICULAR SEPTUM; TBX5; EXPRESSION; PHYLOGENY; TURTLE; GROWTH; ROLES	The emergence of terrestrial life witnessed the need for more sophisticated circulatory systems. This has evolved in birds, mammals and crocodilians into complete septation of the heart into left and right sides, allowing separate pulmonary and systemic circulatory systems, a key requirement for the evolution of endothermy(1-3). However, the evolution of the amniote heart is poorly understood. Reptilian hearts have been the subject of debate in the context of the evolution of cardiac septation: do they possess a single ventricular chamber or two incompletely septated ventricles(4-7)? Here we examine heart development in the red-eared slider turtle, Trachemys scripta elegans (a chelonian), and the green anole, Anolis carolinensis (a squamate), focusing on gene expression in the developing ventricles. Both reptiles initially form a ventricular chamber that homogenously expresses the T-box transcription factor gene Tbx5. In contrast, in birds and mammals, Tbx5 is restricted to left ventricle precursors(8,9). In later stages, Tbx5 expression in the turtle (but not anole) heart is gradually restricted to a distinct left ventricle, forming a left-right gradient. This suggests that Tbx5 expression was refined during evolution to pattern the ventricles. In support of this hypothesis, we show that loss of Tbx5 in the mouse ventricle results in a single chamber lacking distinct identity, indicating a requirement for Tbx5 in septation. Importantly, misexpression of Tbx5 throughout the developing myocardium to mimic the reptilian expression pattern also results in a single mispatterned ventricular chamber lacking septation. Thus ventricular septation is established by a steep and correctly positioned Tbx5 gradient. Our findings provide a molecular mechanism for the evolution of the amniote ventricle, and support the concept that altered expression of developmental regulators is a key mechanism of vertebrate evolution.	[Koshiba-Takeuchi, Kazuko; Mori, Alessandro D.; Kaynak, Bogac L.; Sukonnik, Tatyana; Bruneau, Benoit G.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Koshiba-Takeuchi, Kazuko; Mori, Alessandro D.; Kaynak, Bogac L.; Sukonnik, Tatyana; Black, Brian L.; Bruneau, Benoit G.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Koshiba-Takeuchi, Kazuko; Mori, Alessandro D.; Kaynak, Bogac L.; Sukonnik, Tatyana; Bruneau, Benoit G.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Koshiba-Takeuchi, Kazuko; Takeuchi, Jun K.] Tokyo Inst Technol, Div Cardiovasc Res, Global Edge Inst, Yokohama, Kanagawa 2268503, Japan; [Mori, Alessandro D.; Bruneau, Benoit G.] Hosp Sick Children, Program Stem Cell & Dev Biol, Toronto, ON M5G 1X8, Canada; [Mori, Alessandro D.; Bruneau, Benoit G.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Cebra-Thomas, Judith] Millersville Univ Pennsylvania, Dept Biol, Millersville, PA 17551 USA; [Georges, Romain O.; Nemer, Mona] Univ Montreal, Programme Biol Mol, Inst Rech Clin Montreal, Montreal, PQ H3C 3J7, Canada; [Latham, Stephany; Beck, Laural; Wade, Juli] Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA; [Latham, Stephany; Beck, Laural; Wade, Juli] Michigan State Univ, Program Neurosci, E Lansing, MI 48824 USA; [Henkelman, R. Mark] Hosp Sick Children, Mouse Imaging Ctr, Toronto, ON M5G 1X8, Canada; [Henkelman, R. Mark] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Black, Brian L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Nemer, Mona] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Gilbert, Scott F.] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Tokyo Institute of Technology; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Pennsylvania State System of Higher Education (PASSHE); Millersville University of Pennsylvania; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Michigan State University; Michigan State University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Ottawa; Swarthmore College	Bruneau, BG (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.	bbruneau@gladstone.ucsf.edu	wade, juli/F-4993-2012; HENKELMAN, MARK/W-6847-2019	Kaynak, Bogac/0000-0002-6946-9603; Bruneau, Benoit/0000-0002-0804-7597; Black, Brian/0000-0002-6664-8913	March of Dimes Birth Defects Foundation; J. David Gladstone Institutes; William H. Younger; National Institutes of Health [P01HL089707]; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Richard Lewar Centre for Excellence; University of Toronto; Ontario Graduate Scholarship; Fumi Yamamura Memorial Foundation; MEXT; Sumitomo Foundation and Nakajima Foundation; Canada Research Chair in Imaging; Heart and Stroke foundation of Canada and the Canadian Institutes for Health Research; National Science Foundation [RUI-0748508, IOS-0742833]; National Institutes of Health/National Center for Research Resources [C06 RR018928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL089707, R01HL064658] Funding Source: NIH RePORTER	March of Dimes Birth Defects Foundation(March of Dimes); J. David Gladstone Institutes(University of California System); William H. Younger; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Heart and Stroke Richard Lewar Centre for Excellence; University of Toronto(University of Toronto); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Fumi Yamamura Memorial Foundation; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation and Nakajima Foundation; Canada Research Chair in Imaging(Canada Research Chairs); Heart and Stroke foundation of Canada and the Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Acknowledgements We thank J. N. Wylie and L. Davidson for technical assistance, M. Harris and J. Fallon for alligator embryos, T. Sanger and J. Gibson-Brown for unpublished data on Anolis staging, T. Ogura for chick Tbx5 and Tbx20 probes, and G. Howard and S. Ordway for editorial assistance. This work was funded in part by the March of Dimes Birth Defects Foundation (B. G. B.), the J. David Gladstone Institutes (B. G. B.), William H. Younger Jr (B. G. B.); a National Institutes of Health program project grant (P01HL089707 to B. G. B., B. L. B.); scholarships from the Natural Sciences and Engineering Research Council of Canada, the Heart and Stroke Richard Lewar Centre for Excellence, University of Toronto, and Ontario Graduate Scholarship (A. D. M.); the Fumi Yamamura Memorial Foundation for Female Natural Scientists and Grants-in-Aid for Scientific Research (C) (K. K.-T.), MEXT's program for young independent researchers (K. K.-T., J. K. T.), Sumitomo Foundation and Nakajima Foundation (J. K. T.), a Canada Research Chair in Imaging (R. M. H.), the Heart and Stroke foundation of Canada and the Canadian Institutes for Health Research (M. N.), and grants from the National Science Foundation (RUI-0748508 to S. F. G., J. C.-T. and IOS-0742833 to J. W.). Funding for the J. David Gladstone Institutes from a National Institutes of Health/National Center for Research Resources grant (C06 RR018928) is also acknowledged.	Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Bruneau BG, 1999, DEV BIOL, V211, P100, DOI 10.1006/dbio.1999.9298; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Farmer CG, 1999, ANNU REV PHYSIOL, V61, P573, DOI 10.1146/annurev.physiol.61.1.573; Farrel A.P., 1998, BIOL REPTILIA, V19, P375; Georges R, 2008, MOL CELL BIOL, V28, P4052, DOI 10.1128/MCB.02100-07; Greenbaum E, 2002, J MORPHOL, V254, P272, DOI 10.1002/jmor.10036; Greil A., 1903, MORPH JB, V31, P123; Hedges SB, 1999, SCIENCE, V283, P998, DOI 10.1126/science.283.5404.998; Hicks JW, 2002, NEWS PHYSIOL SCI, V17, P241, DOI 10.1152/nips.01397.2002; Hillenius WJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1019, DOI 10.1086/425185; HOLMES EB, 1975, J MORPHOL, V147, P209, DOI 10.1002/jmor.1051470207; Horb ME, 1999, DEVELOPMENT, V126, P1739; Koshiba-Takeuchi K, 2006, NAT GENET, V38, P175, DOI 10.1038/ng1707; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lyson T, 2009, EVOL DEV, V11, P133, DOI 10.1111/j.1525-142X.2009.00325.x; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Mori AD, 2006, DEV BIOL, V297, P566, DOI 10.1016/j.ydbio.2006.05.023; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Rieppel O, 1999, SCIENCE, V283, P945, DOI 10.1126/science.283.5404.945; Sanger TJ, 2008, J MORPHOL, V269, P129, DOI 10.1002/jmor.10563; Seymour RS, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1051, DOI 10.1086/422766; Shedlock AM, 2007, P NATL ACAD SCI USA, V104, P2767, DOI 10.1073/pnas.0606204104; Stennard FA, 2005, DEVELOPMENT, V132, P4897, DOI 10.1242/dev.02099; Takeuchi JK, 2003, DEVELOPMENT, V130, P5953, DOI 10.1242/dev.00797; Trajanovska S, 2008, GEN COMP ENDOCR, V156, P339, DOI 10.1016/j.ygcen.2008.01.013; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; WEBB GJW, 1979, J MORPHOL, V161, P221, DOI 10.1002/jmor.1051610209	30	98	99	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					95	U99		10.1038/nature08324	http://dx.doi.org/10.1038/nature08324			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19727199	Green Accepted, Green Submitted			2022-12-24	WOS:000269478800037
J	Panesar, SS; Cleary, K; Bhandari, M; Sheikh, A				Panesar, Sukhmeet S.; Cleary, Kevin; Bhandari, Mohit; Sheikh, Aziz			To cement or not in hip fracture surgery?	LANCET			English	Editorial Material									[Panesar, Sukhmeet S.; Cleary, Kevin] Natl Patient Safety Agcy, London W1T 5HD, England; [Bhandari, Mohit] McMaster Univ, Hamilton, ON, Canada; [Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	McMaster University; University of Edinburgh	Panesar, SS (corresponding author), Natl Patient Safety Agcy, London W1T 5HD, England.	sukhmeet.panesar@npsa.nhs.uk	Sheikh, Aziz/D-2818-2009; Bhandari, Mohit/AAQ-1675-2021	Sheikh, Aziz/0000-0001-7022-3056; 				Ahn J, 2008, CLIN ORTHOP RELAT R, V466, P2513, DOI 10.1007/s11999-008-0368-3; Donaldson AJ, 2009, BRIT J ANAESTH, V102, P12, DOI 10.1093/bja/aen328; DONALDSON L, 2008, STATE PUBLIC HLTH AN; Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148; Haleem S, 2008, INJURY, V39, P1157, DOI 10.1016/j.injury.2008.03.022; *NAT JOINT REG, 2007, NAT JOINT REG 4 ANN; *NAT PAT SAF AG, 2009, RAP RESP REP MIT SUR; *NIH CLIN EXC, 2000, HIP DIS REPL PROTH S; ORSINI EC, 1987, J BONE JOINT SURG AM, V69A, P822, DOI 10.2106/00004623-198769060-00005; PARKER MJ, 2006, COCHRANE DB SYST REV, V2; PARVIZI J, 1999, CLIN ORTHOP RELAT R, V369, P39; Sierra RJ, 2009, J ARTHROPLASTY, V24, P325, DOI 10.1016/j.arth.2008.01.301	12	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2009	374	9695					1047	1049		10.1016/S0140-6736(09)61685-8	http://dx.doi.org/10.1016/S0140-6736(09)61685-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501HA	19782857				2022-12-24	WOS:000270370900009
J	Verheugt, FWA				Verheugt, Freek W. A.			Who is ineligible for warfarin in atrial fibrillation?	LANCET			English	Editorial Material							ST-SEGMENT ELEVATION; MYOCARDIAL-INFARCTION; CONTROLLED-TRIAL; CLOPIDOGREL; ASPIRIN; THERAPY; STROKE		Onze Lieve Vrouw Hosp, Dept Cardiol, NL-1091 AC Amsterdam, Netherlands	Onze Lieve Vrouwe Gasthuis Hospital	Verheugt, FWA (corresponding author), Onze Lieve Vrouw Hosp, Dept Cardiol, NL-1091 AC Amsterdam, Netherlands.	f.w.a.verheugt@olvg.nl	Verheugt, F.W.A./H-8105-2014					Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Lip GYH, 2002, BRIT MED J, V325, P1022, DOI 10.1136/bmj.325.7371.1022; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Verheugt FWA, 2003, LANCET, V362, P1686, DOI 10.1016/S0140-6736(03)14880-5; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; Yusuf S, 2001, NEW ENGL J MED, V345, P494	9	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2009	374	9689					510	511		10.1016/S0140-6736(09)61471-9	http://dx.doi.org/10.1016/S0140-6736(09)61471-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484BX	19683630				2022-12-24	WOS:000269019400008
J	Lloyd, J; Chapman, JR; Clapperton, JA; Haire, LF; Hartsuiker, E; Li, JJ; Carr, AM; Jackson, SP; Smerdon, SJ				Lloyd, Janette; Chapman, J. Ross; Clapperton, Julie A.; Haire, Lesley F.; Hartsuiker, Edgar; Li, Jiejin; Carr, Antony M.; Jackson, Stephen P.; Smerdon, Stephen J.			A Supramodular FHA/BRCT-Repeat Architecture Mediates Nbs1 Adaptor Function in Response to DNA Damage	CELL			English	Article							NIJMEGEN-BREAKAGE-SYNDROME; DOUBLE-STRAND BREAKS; FORKHEAD-ASSOCIATED DOMAIN; SCHIZOSACCHAROMYCES-POMBE; FHA DOMAIN; CHROMATIN RETENTION; TUMOR-SUPPRESSOR; FOCUS FORMATION; MRE11 COMPLEX; BRCT DOMAIN	The Mre11/Rad50/Nbs1 protein complex plays central enzymatic and signaling roles in the DNA-damage response. Nuclease (Mre11) and scaffolding (Rad50) components of MRN have been extensively characterized, but the molecular basis of Nbs1 function has remained elusive. Here, we present a 2.3A crystal structure of the N-terminal region of fission yeast Nbs1, revealing an unusual but conserved architecture in which the FHA- and BRCT-repeat domains structurally coalesce. We demonstrate that diphosphorylated pSer-Asp-pThr-Asp motifs, recently identified as multicopy docking sites within Mdc1, are evolutionarily conserved Nbs1 binding targets. Furthermore, we show that similar phosphomotifs within Ctp1, the fission yeast ortholog of human CtIP, promote interactions with the Nbs1 FHA domain that are necessary for Ctp1-dependent resistance to DNA damage. Finally, we establish that human Nbs1 interactions with Mdc1 occur through both its FHA- and BRCT-repeat domains, suggesting how their structural and functional interdependence underpins Nbs1 adaptor functions in the DNA-damage response.	[Chapman, J. Ross; Jackson, Stephen P.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Chapman, J. Ross; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Lloyd, Janette; Clapperton, Julie A.; Haire, Lesley F.; Li, Jiejin; Smerdon, Stephen J.] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England; [Hartsuiker, Edgar; Carr, Antony M.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Cambridge; University of Cambridge; MRC National Institute for Medical Research; University of Sussex	Jackson, SP (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk; stephen.smerdon@nimr.mrc.ac.uk	Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014; Chapman, J Ross/C-7973-2012; Li, Jiejin/G-4980-2010	Jackson, Stephen Philip/0000-0001-9317-7937; Li, Jiejin/0000-0003-1525-7768; Hartsuiker, Edgar/0000-0002-7257-6389; Carr, Antony Michael/0000-0002-2028-2389; Chapman, Ross/0000-0002-6477-4254; Smerdon, Stephen/0000-0001-5688-8465	Cancer Research UK [C20600/A6620]; Medical Research Council program [G0600233]; Cancer Research UK; European Union [LSHG-CT-2005-512113]; Genomic Instability in Cancer and Precancer, GENICA [HEALTH-F2-2007-201630]; Medical Research Council, UK; Diamond Light Source, UK; MRC [G0600233, MC_U117584228, G0001129] Funding Source: UKRI; Medical Research Council [G0001129, MC_U117584228, G0600233] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council program(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); European Union(European Commission); Genomic Instability in Cancer and Precancer, GENICA; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diamond Light Source, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank H. Iwasaki for the kind gift of reagents, P. Walker for invaluable assistance with X-ray data collection, and K. Rittinger for advice on ITC measurements and are grateful for support from the NIMR large-scale laboratory. E. H. is supported by Cancer Research UK grant C20600/A6620, and T. C. acknowledges funding by Medical Research Council program grant G0600233. Research in the S.P.J. laboratory is supported by grants from Cancer Research UK, the European Union (Integrated Project DNA repair, LSHG-CT-2005-512113, and Genomic Instability in Cancer and Precancer, GENICA, HEALTH-F2-2007-201630), and core infrastructure funding from Cancer Research UK and the Wellcome Trust. S.J.S. is grateful to the Medical Research Council, UK, for continuing support and to Diamond Light Source, UK, for synchrotron access and beamline support.	Akamatsu Y, 2008, MOL CELL BIOL, V28, P3639, DOI 10.1128/MCB.01828-07; Becker E, 2006, BIOINFORMATICS, V22, P1289, DOI 10.1093/bioinformatics/btl075; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cerosaletti KM, 2003, J BIOL CHEM, V278, P21944, DOI 10.1074/jbc.M211689200; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Derbyshire DJ, 2002, EMBO J, V21, P3863, DOI 10.1093/emboj/cdf383; Desai-Mehta A, 2001, MOL CELL BIOL, V21, P2184, DOI 10.1128/MCB.21.6.2184-2191.2001; Difilippantonio S, 2007, CELL CYCLE, V6, P2366, DOI 10.4161/cc.6.19.4758; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Giglione C, 2004, CELL MOL LIFE SCI, V61, P1455, DOI 10.1007/s00018-004-3466-8; Joo WS, 2002, GENE DEV, V16, P583, DOI 10.1101/gad.959202; Kobayashi J, 2002, CURR BIOL, V12, P1846, DOI 10.1016/S0960-9822(02)01259-9; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Martinez A, 2008, PROTEOMICS, V8, P2809, DOI 10.1002/pmic.200701191; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Matsuura S, 1998, NAT GENET, V19, P179, DOI 10.1038/549; Matsuzaki K, 2008, GENETICS, V179, P213, DOI 10.1534/genetics.107.079236; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; Palmbos PL, 2008, GENETICS, V180, P1809, DOI 10.1534/genetics.108.095539; Riches LC, 2008, MUTAGENESIS, V23, P331, DOI 10.1093/mutage/gen039; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Suga M, 2005, YEAST, V22, P799, DOI 10.1002/yea.1247; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Watson AT, 2008, GENE, V407, P63, DOI 10.1016/j.gene.2007.09.024; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Wu LM, 2008, P NATL ACAD SCI USA, V105, P11200, DOI 10.1073/pnas.0802885105; Xu C, 2008, J MOL BIOL, V381, P361, DOI 10.1016/j.jmb.2008.05.087; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	44	130	132	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					100	111		10.1016/j.cell.2009.07.043	http://dx.doi.org/10.1016/j.cell.2009.07.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804756	Green Accepted, Bronze			2022-12-24	WOS:000270388600019
J	Katzourakis, A; Gifford, RJ; Tristem, M; Gilbert, MTP; Pybus, OG				Katzourakis, Aris; Gifford, Robert J.; Tristem, Michael; Gilbert, M. Thomas P.; Pybus, Oliver G.			Macroevolution of Complex Retroviruses	SCIENCE			English	Article							MAMMALS		[Katzourakis, Aris; Gifford, Robert J.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Katzourakis, Aris] Univ Oxford, Inst Emergent Infect, Oxford OX1 3PS, England; [Tristem, Michael] Univ London Imperial Coll Sci Technol & Med, Div Biol, London SL5 7PY, England; [Gilbert, M. Thomas P.] Univ Copenhagen, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark	University of Oxford; University of Oxford; Imperial College London; University of Copenhagen	Katzourakis, A (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	aris.katzourakis@zoo.ox.ac.uk; robert.gifford@zoo.ox.ac.uk	Gilbert, Marcus TP/A-8936-2013; Pybus, Oliver G/B-2640-2012	Gilbert, Marcus TP/0000-0002-5805-7195; Pybus, Oliver G/0000-0002-8797-2667; Gifford, Robert/0000-0003-4028-9884; Katzourakis, Aris/0000-0003-3328-6204	James Martin 21st Century School; Danish Natural Science Research Council; Royal Society	James Martin 21st Century School; Danish Natural Science Research Council(Danish Natural Science Research Council); Royal Society(Royal Society of London)	We thank the Washington University St. Louis Genome Sequencing Center for the C. hoffmanni genome assembly; B. Voirin, A. Hedayat, and the University of Copenhagen Zoological Museum for xenarthran tissue samples; and R. Blakey for tectonic maps. A. K. was funded by the James Martin 21st Century School, M. T. P. G. by the Danish Natural Science Research Council, and O. G. P. by the Royal Society. GenBank accession numbers are GQ169506 to GQ169527.	Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Delsuc F, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-11; Holmes EC, 2003, J VIROL, V77, P3893, DOI 10.1128/JVI.77.7.3893-3897.2003; Huchon D, 2000, P ROY SOC B-BIOL SCI, V267, P393, DOI 10.1098/rspb.2000.1014; Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341; Weiss RA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-67; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704	7	122	123	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 18	2009	325	5947					1512	1512		10.1126/science.1174149	http://dx.doi.org/10.1126/science.1174149			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762636				2022-12-24	WOS:000269887900029
J	Walpole, M; Almond, REA; Besancon, C; Butchart, SHM; Campbell-Lendrum, D; Carr, GM; Collen, B; Collette, L; Davidson, NC; Dulloo, E; Fazel, AM; Galloway, JN; Gill, M; Goverse, T; Hockings, M; Leaman, DJ; Morgan, DHW; Revenga, C; Rickwood, CJ; Schutyser, F; Simons, S; Stattersfield, AJ; Tyrrell, TD; Vie, JC; Zimsky, M				Walpole, Matt; Almond, Rosamunde E. A.; Besancon, Charles; Butchart, Stuart H. M.; Campbell-Lendrum, Diarmid; Carr, Genevieve M.; Collen, Ben; Collette, Linda; Davidson, Nick C.; Dulloo, Ehsan; Fazel, Asghar M.; Galloway, James N.; Gill, Michael; Goverse, Tessa; Hockings, Marc; Leaman, Danna J.; Morgan, David H. W.; Revenga, Carmen; Rickwood, Carrie J.; Schutyser, Frederik; Simons, Sarah; Stattersfield, Alison J.; Tyrrell, Tristan D.; Vie, Jean-Christophe; Zimsky, Mark			Tracking Progress Toward the 2010 Biodiversity Target and Beyond	SCIENCE			English	Editorial Material							LIVING PLANET INDEX		[Campbell-Lendrum, Diarmid] WHO, Global Environm Change Publ Hlth & Environm, Geneva, Switzerland; [Collen, Ben] Zool Soc London, Inst Zool, London, England; [Galloway, James N.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Hockings, Marc] Univ Queensland, Sch Integrat Syst, Brisbane, Qld 4072, Australia; [Leaman, Danna J.] IUCN SSC, Med Plant Specialist Grp, Gland, Switzerland; [Revenga, Carmen] Nature Conservancy, Arlington, VA USA; [Vie, Jean-Christophe] IUCN, Species Programme, Gland, Switzerland	World Health Organization; Zoological Society of London; University of Virginia; University of Queensland; Nature Conservancy		matt.walpole@unep-wcmc.org	Collen, Ben/D-5055-2011; Butchart, Stuart/AAJ-1852-2021; Leaman, Danna/AAN-7510-2020; Hockings, Marc/A-1283-2007; Butchart, Stuart HM/Y-2711-2018; Davidson, Nicholas/AAA-9921-2019; Galloway, James N/C-2769-2013; Collen, Ben/F-2543-2016	Butchart, Stuart/0000-0002-1140-4049; Hockings, Marc/0000-0003-4419-8963; Davidson, Nicholas/0000-0002-2466-0658; Galloway, James N/0000-0001-7676-8698; Collen, Ben/0000-0003-2564-4243; Collette, Laurence/0000-0003-2518-7281				Baillie JEM, 2008, CONSERV LETT, V1, P18, DOI 10.1111/j.1755-263X.2008.00009.x; Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; CARR GM, 2007, WATER QUALITY INDEX; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Convention on Biological Diversity (CBD), 2006, GLOB BIOD OUTL; *FAO, 2006, GLOB FOR RES ASS 200; GOLDFINGER EBS, 2008, ECOLOGICAL FOOTPRINT; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Loh J, 2005, PHILOS T R SOC B, V360, P289, DOI 10.1098/rstb.2004.1584; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; Scholes RJ, 2008, SCIENCE, V321, P1044, DOI 10.1126/science.1162055; UNEP-WCMC, 2008, STAT WORLDS PROT AR	14	152	162	1	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 18	2009	325	5947					1503	1504		10.1126/science.1175466	http://dx.doi.org/10.1126/science.1175466			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	495JS	19762630				2022-12-24	WOS:000269887900023
J	Sing, A; Pannell, D; Karaiskakis, A; Sturgeon, K; Djabali, M; Ellis, J; Lipshitz, HD; Cordes, SP				Sing, Angela; Pannell, Dylan; Karaiskakis, Angelo; Sturgeon, Kendra; Djabali, Malek; Ellis, James; Lipshitz, Howard D.; Cordes, Sabine P.			A Vertebrate Polycomb Response Element Governs Segmentation of the Posterior Hindbrain	CELL			English	Article							EMBRYONIC STEM-CELLS; H3 LYSINE-27 METHYLATION; DNA-BINDING PROTEIN; DROSOPHILA-MELANOGASTER; TARGET GENES; METHYLTRANSFERASE ACTIVITY; DEVELOPMENTAL REGULATORS; TRANSCRIPTION FACTOR; BITHORAX COMPLEX; UBX GENE	Chromatin remodeling by Polycomb group (PcG) and trithorax group (trxG) proteins regulates gene expression in all metazoans. Two major complexes, Polycomb repressive complexes 1 and 2 (PRC1 and PRC2), are thought to mediate PcG-dependent repression in flies and mammals. In Drosophila, PcG/trxG protein complexes are recruited by PcG/trxG response elements (PREs). However, it has been unclear how PcG/trxG are recuited in vertebrates. Here we have identified a vertebrate PRE, PRE-kr, that regulates expression of the mouse MafB/Kreisler gene. PRE-kr recruits PcG proteins in flies and mouse F9 cells and represses gene expression in a PcG/trxG-dependent manner. PRC1 and 2 bind to a minimal PRE-kr region, which can recruit stable PRC1 binding but only weak PRC2 binding when introduced ectopically, suggesting that PRC1 and 2 have different binding requirements. Thus, we provide evidence that similar to invertebrates, PREs act as entry sites for PcG/trxG chromatin remodeling in vertebrates.	[Sing, Angela; Sturgeon, Kendra; Cordes, Sabine P.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Pannell, Dylan; Karaiskakis, Angelo; Ellis, James; Lipshitz, Howard D.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Sing, Angela; Pannell, Dylan; Karaiskakis, Angelo; Sturgeon, Kendra; Ellis, James; Lipshitz, Howard D.; Cordes, Sabine P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Djabali, Malek] CNRS, INSERM, Ctr Immunol, F-13288 Marseille 9, France	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Cordes, SP (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	cordes@lunenfeld.ca	Ellis, James/F-4789-2011; Cordes, Sabine P/A-5423-2012	Ellis, James/0000-0002-4400-0091; Lipshitz, Howard/0000-0002-7372-4419	CIHR [14312]	CIHR(Canadian Institutes of Health Research (CIHR))	We thank Renato Paro for PC and PH antibodies, G. Cavalli for the immuno-FISH protocol, Sandra Tondat and the Samuel Lunenfeld Research Institute Transgenic facility for transgenic mice, and Eddy Rubin for help with sequence analysis. We would also like to thank Dragana Vukasovic and Lori Nelson for administrative assistance. This work was funded by CIHR grant # 14312 to S. P. C.	ARTZT K, 1973, P NATL ACAD SCI USA, V70, P2988, DOI 10.1073/pnas.70.10.2988; Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Beisel C, 2007, P NATL ACAD SCI USA, V104, P16615, DOI 10.1073/pnas.0701538104; Bel-Vialar S, 2000, DEV BIOL, V224, P238, DOI 10.1006/dbio.2000.9791; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; Courel M, 2008, DEV DYNAM, V237, P1232, DOI 10.1002/dvdy.21516; Crosby MA, 1999, MOL CELL BIOL, V19, P1159; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; FROHMAN MA, 1993, DEVELOPMENT, V117, P925; Gavalas A, 1998, DEVELOPMENT, V125, P1123; Gee H, 2008, NATURE, V453, P999, DOI 10.1038/453999a; Gellon G, 1997, DEVELOPMENT, V124, P3321; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Giudicelli F, 2003, DEV BIOL, V253, P150, DOI 10.1006/dbio.2002.0864; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; GUTHRIE S, 1991, DEVELOPMENT, V112, P221; Hauenschild A, 2008, PLOS BIOL, V6, P2130, DOI 10.1371/journal.pbio.0060261; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Huang DH, 2002, MOL CELL BIOL, V22, P6261, DOI 10.1128/MCB.22.17.6261-6271.2002; John RM, 2001, DEV BIOL, V236, P387, DOI 10.1006/dbio.2001.0327; Kahn TG, 2006, J BIOL CHEM, V281, P29064, DOI 10.1074/jbc.M605430200; Karakuzu O, 2009, DEVELOPMENT, V136, P943, DOI 10.1242/dev.029363; Kim FA, 2005, MECH DEVELOP, V122, P1300, DOI 10.1016/j.mod.2005.08.001; King IFG, 2002, MOL CELL BIOL, V22, P7919, DOI 10.1128/MCB.22.22.7919-7928.2002; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lavrov S, 2004, METH MOL B, V247, P289; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Lyko F, 1997, NAT GENET, V16, P171, DOI 10.1038/ng0697-171; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mihaly J, 1998, MOL CELL, V1, P1065, DOI 10.1016/S1097-2765(00)80107-0; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Rivkin E, 2008, GENESIS, V46, P119, DOI 10.1002/dvg.20371; Rusch DB, 2000, GENETICS, V156, P183; Sadl VS, 2003, DEV DYNAM, V227, P134, DOI 10.1002/dvdy.10279; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; SIMON J, 1993, DEV BIOL, V158, P131, DOI 10.1006/dbio.1993.1174; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Swaminathan J, 2005, GENE DEV, V19, P65, DOI 10.1101/gad.1259105; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; WIJNHOLDS J, 1995, DEV BIOL, V171, P73, DOI 10.1006/dbio.1995.1261; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021	71	188	200	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					885	897		10.1016/j.cell.2009.08.020	http://dx.doi.org/10.1016/j.cell.2009.08.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737517	Bronze			2022-12-24	WOS:000269564600015
J	Yan, D; Wu, ZL; Chisholm, AD; Jin, YS				Yan, Dong; Wu, Zilu; Chisholm, Andrew D.; Jin, Yishi			The DLK-1 Kinase Promotes mRNA Stability and Local Translation in C. elegans Synapses and Axon Regeneration	CELL			English	Article							ZIPPER-BEARING KINASE; TRANSCRIPTION FACTOR; PROTEIN-SYNTHESIS; GENE-EXPRESSION; LOCALIZATION; RPM-1; IDENTIFICATION; GROWTH; C/EBP; TRANSPORT	Growth cone guidance and synaptic plasticity involve dynamic local changes in proteins at axons and dendrites. The Dual-Leucine zipper Kinase MAPKKK (DLK) has been previously implicated in synaptogenesis and axon outgrowth in C. elegans and other animals. Here we show that in C. elegans DLK-1 regulates not only proper synapse formation and axon morphology but also axon regeneration by influencing mRNA stability. DLK-1 kinase signals via a MAPKAP kinase, MAK-2, to stabilize the mRNA encoding CEBP-1, a bZip protein related to CCAAT/enhancer-binding proteins, via its 3'UTR. Inappropriate upregulation of cebp-1 in adult neurons disrupts synapses and axon morphology. CEBP-1 and the DLK-1 pathway are essential for axon regeneration after laser axotomy in adult neurons, and axotomy induces translation of CEBP-1 in axons. Our findings identify the DLK-1 pathway as a regulator of mRNA stability in synapse formation and maintenance and also in adult axon regeneration.	[Yan, Dong; Wu, Zilu; Chisholm, Andrew D.; Jin, Yishi] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Chisholm, Andrew D.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Jin, Yishi] Univ Calif San Diego, Dept Cellular & Mol Med, Sch Med, La Jolla, CA 92093 USA; [Yan, Dong; Wu, Zilu; Jin, Yishi] Howard Hughes Med Inst, Chevy Chase, MD USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute	Jin, YS (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	yijin@ucsd.edu		Chisholm, Andrew/0000-0001-5091-0537; Jin, Yishi/0000-0002-9371-9860	NIH [NS35546, NS57317]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057317, R01NS035546, R56NS057317] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH R01 awards NS35546 to Y. J. and NS57317 to A. D. C. D. Y. and Z.W. are associates and Y. J. is an Investigator of the Howard Hughes Medical Institute.	Abrams B, 2008, DEV DYNAM, V237, P630, DOI 10.1002/dvdy.21446; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; BERNARDI A, 1972, P NATL ACAD SCI USA, V69, P3033, DOI 10.1073/pnas.69.10.3033; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; BRENNER S, 1974, GENETICS, V77, P71; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Ch'ng' Q, 2003, GENETICS, V164, P1355; Chalfie M, 1995, PROG BRAIN RES, V105, P179; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; Clark SG, 2003, DEVELOPMENT, V130, P3781, DOI 10.1242/dev.00571; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Di Giovanni S, 2004, FASEB J, V18, P153, DOI 10.1096/fj.04-2694fje; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Giuditta A, 2002, TRENDS NEUROSCI, V25, P400, DOI 10.1016/S0166-2236(02)02188-4; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Harris KD, 2008, TRENDS NEUROSCI, V31, P130, DOI 10.1016/j.tins.2007.12.002; Herdegen T, 1997, TRENDS NEUROSCI, V20, P227, DOI 10.1016/S0166-2236(96)01000-4; HOLZMAN LB, 1994, J BIOL CHEM, V269, P30808; Hu JY, 2004, J NEUROSCI, V24, P9933, DOI 10.1523/JNEUROSCI.3329-04.2004; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; KIM J, 1993, P NATL ACAD SCI USA, V90, P4513, DOI 10.1073/pnas.90.10.4513; Korneev Sergei, 1997, Invertebrate Neuroscience, V3, P185, DOI 10.1007/BF02480373; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lyles V, 2006, NEURON, V49, P349, DOI 10.1016/j.neuron.2005.12.029; Mata M, 1996, J BIOL CHEM, V271, P16888, DOI 10.1074/jbc.271.28.16888; Nadeau S, 2005, MOL CELL NEUROSCI, V29, P525, DOI 10.1016/j.mcn.2005.04.004; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Nedelec S, 2004, P NATL ACAD SCI USA, V101, P10815, DOI 10.1073/pnas.0403824101; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Roche FK, 2009, J NEUROSCI, V29, P638, DOI 10.1523/JNEUROSCI.3845-08.2009; SANFORD T, 1983, J BIOL CHEM, V258, P2804; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; STEWARD O, 1982, J NEUROSCI, V2, P284; Sung YJ, 2001, J NEUROBIOL, V47, P67, DOI 10.1002/neu.1016; Sutton MA, 2005, J NEUROBIOL, V64, P116, DOI 10.1002/neu.20152; Wang DO, 2009, SCIENCE, V324, P1536, DOI 10.1126/science.1173205; Wang WL, 2007, DEV NEUROBIOL, V67, P1166, DOI 10.1002/dneu.20511; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Wu Z, 2007, P NATL ACAD SCI USA, V104, P15132, DOI 10.1073/pnas.0707001104; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhou HM, 2001, J NEUROSCI, V21, P3749, DOI 10.1523/JNEUROSCI.21-11-03749.2001	61	252	267	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					1005	1018		10.1016/j.cell.2009.06.023	http://dx.doi.org/10.1016/j.cell.2009.06.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737525	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000269564600024
J	Yao, CK; Lin, YQ; Ly, CV; Ohyama, T; Haueter, CM; Moiseenkova-Bell, VY; Wensel, TG; Bellen, HJ				Yao, Chi-Kuang; Lin, Yong Qi; Ly, Cindy V.; Ohyama, Tomoko; Haueter, Claire M.; Moiseenkova-Bell, Vera Y.; Wensel, Theodore G.; Bellen, Hugo J.			A Synaptic Vesicle-Associated Ca2+ Channel Promotes Endocytosis and Couples Exocytosis to Endocytosis	CELL			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; CALCIUM-DEPENDENCE; ENDOPHILIN; MEMBRANE; RELEASE; SYNAPTOJANIN; SELECTIVITY; PERMEATION; SUPPRESSOR; MUTATIONS	Synaptic vesicle (SV) exo- and endocytosis are tightly coupled to sustain neurotransmission in presynaptic terminals, and both are regulated by Ca2+. Ca2+ influx triggered by voltage-gated Ca2+ channels is necessary for SV fusion. However, extracellular Ca2+ has also been shown to be required for endocytosis. The intracellular Ca2+ levels (<1 mu M) that trigger endocytosis are typically much lower than those (>10 mu M) needed to induce exocytosis, and endocytosis is inhibited when the Ca2+ level exceeds 1 mu M. Here, we identify and characterize a transmembrane protein associated with SVs that, upon SV fusion, localizes at periactive zones. Loss of Flower results in impaired intracellular resting Ca2+ levels and impaired endocytosis. Flower multimerizes and is able to form a channel to control Ca2+ influx. We propose that Flower functions as a Ca2+ channel to regulate synaptic endocytosis and hence couples exo- with endocytosis.	[Yao, Chi-Kuang; Lin, Yong Qi; Haueter, Claire M.; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Ly, Cindy V.; Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Ohyama, Tomoko; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Moiseenkova-Bell, Vera Y.; Wensel, Theodore G.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Bellen, HJ (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, 1 Baylor Plaza, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu	Yao, Chi-Kuang/Y-9325-2019	Yao, Chi-Kuang/0000-0003-0977-4347; Bellen, Hugo/0000-0001-5992-5989; Ohyama, Tomoko/0000-0003-1697-1138; Wensel, Theodore/0000-0003-3518-9352	National Institute of Neurological Disease [F30NS056520]; Baylor College of Medicine Intellectual and Developmental Disabilities Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS056520] Funding Source: NIH RePORTER	National Institute of Neurological Disease; Baylor College of Medicine Intellectual and Developmental Disabilities Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Yuchun He, Hongling Pan, Yu Cao, and Zhihua Wang for technical assistance. We thank Ben Tobe, Julie Vargas, and Frank T. Horrigan for helping with the 45 Ca<SUP>2+</SUP> experiments. We thank Karen L. Schulze, Christian Rosenmund, Huda Zoghbi, Patrik Verstreken, Robin Hiesinger, Paul Pfaffinger, Ellen Lumpkin, Mingshan Xue, and Nikos Giagtzoglou for comments and discussions, and the Bloomington Stock Center and the Developmental Studies Hybridoma Bank for reagents. C. V. L. was supported by a National Research Service Award from the National Institute of Neurological Disease (F30NS056520). Confocal microscopy was supported by the Baylor College of Medicine Intellectual and Developmental Disabilities Research Center. H. J. B. is an investigator of the Howard Hughes Medical Institute.	ADLER EM, 1991, J NEUROSCI, V11, P1496; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Cousin MA, 1998, NEUROSCI LETT, V253, P1, DOI 10.1016/S0304-3940(98)00610-7; Cousin MA, 2000, J NEUROSCI, V20, P949, DOI 10.1523/JNEUROSCI.20-03-00949.2000; Cousin MA, 2000, MOL NEUROBIOL, V22, P115, DOI 10.1385/MN:22:1-3:115; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Fabian-Fine R, 2003, J NEUROSCI, V23, P10732; Farkas R, 1998, IN VITRO CELL DEV-AN, V34, P813; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Guatimosim C, 1998, J NEUROCHEM, V70, P2477; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HENKEL AW, 1995, NEUROPHARMACOLOGY, V34, P1397, DOI 10.1016/0028-3908(95)00126-Q; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Koh TW, 2007, J CELL BIOL, V178, P309, DOI 10.1083/jcb.200701030; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Kuromi H, 2004, NEURON, V41, P101, DOI 10.1016/S0896-6273(03)00815-8; Kuromi H, 2002, NEURON, V35, P333, DOI 10.1016/S0896-6273(02)00777-8; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Lisman JE, 2007, NAT REV NEUROSCI, V8, P597, DOI 10.1038/nrn2191; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Macleod GT, 2004, J NEUROSCI, V24, P2496, DOI 10.1523/JNEUROSCI.5372-03.2004; Macleod GT, 2002, J NEUROPHYSIOL, V88, P2659, DOI 10.1152/jn.00515.2002; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Neale EA, 1999, J CELL BIOL, V147, P1249, DOI 10.1083/jcb.147.6.1249; Ohkura M, 2005, ANAL CHEM, V77, P5861, DOI 10.1021/ac0506837; Ohyama T, 2007, J CELL BIOL, V179, P1481, DOI 10.1083/jcb.200710061; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; PETROVICH TZ, 1993, GENETICS, V133, P955; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sather WA, 2003, ANNU REV PHYSIOL, V65, P133, DOI 10.1146/annurev.physiol.65.092101.142345; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Stowers RS, 1999, GENETICS, V152, P1631; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Xiong J, 2002, J NEUROSCI, V22, P10761; Zefirov AL, 2006, NEUROSCIENCE, V143, P905, DOI 10.1016/j.neuroscience.2006.08.025; Zhai RG, 2003, P NATL ACAD SCI USA, V100, P10860, DOI 10.1073/pnas.1832753100; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	59	102	104	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					947	960		10.1016/j.cell.2009.06.033	http://dx.doi.org/10.1016/j.cell.2009.06.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737521	Green Accepted, Bronze			2022-12-24	WOS:000269564600020
J	Guydosh, NR; Block, SM				Guydosh, Nicholas R.; Block, Steven M.			Direct observation of the binding state of the kinesin head to the microtubule	NATURE			English	Article							OPTICAL FORCE CLAMP; HAND-OVER-HAND; SINGLE-MOLECULE; ATP; RESOLUTION; MECHANISM; STRAIN; STEPS; CYCLE	The dimeric motor protein kinesin-1 converts chemical energy from ATP hydrolysis into mechanical work used to transport cargo along microtubules(1,2). Cargo attached to the kinesin stalk moves processively in 8-nm increments(3) as its twin motor domains (heads) carry out an asymmetric, 'hand-over-hand' walk(4-7). The extent of individual head interactions with the microtubule during stepping, however, remains controversial(4,8-14). A major experimental limitation has been the lack of a means to monitor the attachment of an individual head to the microtubule during movement, necessitating indirect approaches. Here we report the development of a single-molecule assay that can directly report head binding in a walking kinesin molecule, and show that only a single head is bound to the microtubule between steps at low ATP concentrations. A bead was linked to one of the two kinesin heads by means of a short DNA tether and used to apply rapidly alternating hindering and assisting loads with an optical trap. The time-dependent difference between forwards and backwards displacements of the bead alternated between two discrete values during stepping, corresponding to those intervals when the linked head adopted a bound or an unbound state. The linked head could only rebind the microtubule once ATP had become bound to its partner head.	[Block, Steven M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Block, Steven M.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Guydosh, Nicholas R.] Stanford Univ, Biophys Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Block, SM (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	sblock@stanford.edu	Guydosh, Nicholas/AFQ-5807-2022	Guydosh, Nicholas/0000-0001-7116-326X	US National Institutes of Health [GM51453]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051453] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Dunn, B. Choi and W. Hwang for advice on labelling kinesin; S. Gilbert for advice on expressing kinesin; and B. Gutierrez-Medina, C. Sindelar, C. Perez and K. Frieda for comments on the manuscript. This work was supported by grant GM51453 from the US National Institutes of Health.	Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Asenjo AB, 2009, P NATL ACAD SCI USA, V106, P5657, DOI 10.1073/pnas.0808355106; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Crevel I, 1999, EMBO J, V18, P5863, DOI 10.1093/emboj/18.21.5863; DELANO WL, 2002, PYMOL MOL VIEWER VER; FEHR AN, BIOPHYS J IN PRESS; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hackney DD, 2005, P NATL ACAD SCI USA, V102, P18338, DOI 10.1073/pnas.0505288102; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Kawaguchi K, 2003, BIOPHYS J, V84, P1103, DOI 10.1016/S0006-3495(03)74926-1; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; Mandelkow E, 1999, CURR OPIN CELL BIOL, V11, P34, DOI 10.1016/S0955-0674(99)80005-2; Mori T, 2007, NATURE, V450, P750, DOI 10.1038/nature06346; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Sablin EP, 2004, J BIOL CHEM, V279, P15707, DOI 10.1074/jbc.R300036200; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Taniguchi Y, 2005, NAT CHEM BIOL, V1, P342, DOI 10.1038/nchembio741; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018	31	80	80	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					125	U137		10.1038/nature08259	http://dx.doi.org/10.1038/nature08259			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19693012	Green Accepted			2022-12-24	WOS:000269478800043
J	McLachlan, G				McLachlan, Greta			Taking the spice out of legal smoking mixtures	LANCET			English	Editorial Material									Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	McLachlan, G (corresponding author), Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England.	ugm3gmcm@leeds.ac.uk						[Anonymous], 2009, CONS MAJ CANN AG; Burley B., 2008, BBC NEWSBEAT    1007; European Monitoring Centre for Drugs and Drug Addiction, 2009, ACT NEW DRUGS BRIEF; MANN N, 2009, GUERNSEY PRESS  0407; ROSS K, 2009, LONDON PAPER    0812	5	20	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2009	374	9690					600	600		10.1016/S0140-6736(09)61507-5	http://dx.doi.org/10.1016/S0140-6736(09)61507-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486TU	19699999				2022-12-24	WOS:000269222600011
J	Houghton, FJ; Chew, PL; Lodeho, S; Goud, B; Gleeson, PA				Houghton, Fiona J.; Chew, Pau Ling; Lodeho, Sylvain; Goud, Bruno; Gleeson, Paul A.			The Localization of the Golgin GCC185 Is Independent of Rab6A/A ' and Arl1	CELL			English	Article							COILED-COIL PROTEINS; GRIP-DOMAIN PROTEINS; TRANS-GOLGI; MOLECULAR CHARACTERIZATION; EARLY/RECYCLING ENDOSOMES; MEMBRANE TRAFFICKING; RETROGRADE TRANSPORT; STRUCTURAL BASIS; NETWORK GOLGIN; BINDING-SITES	Mammalian golgins of the trans-Golgi network (TGN) are small G protein effectors that are required for membrane transport and contain a Golgi targeting C-terminal GRIP domain. The localization of two TGN golgins, p230/golgin-245 and golgin-97, is mediated by the small GTPase Arl1, whereas recruitment of the TGN golgin GCC185 is controversial. Recently, GCC185 was proposed to localize to the Golgi by the co-operation of two small GTPases, Rab6A/A' and Arl1 (Burguete et al., 2008), a model based predominantly on in vitro interactions. Here we demonstrate that Golgi recruitment of endogenous GCC185 does not involve Rab6A/A' and Arl1. We find minimal colocalization between Rab6A/A' and endogenous GCC185 on Golgi membranes and failed to detect an interaction between Rab6A/A' and C-terminal domains of GCC185 by yeast two-hybrid analyses. Moreover, depletion of both Rab6A/A' and Arl1 also had no effect on the localization of endogenous GCC185 or the isolated GRIP domain of GCC185.	[Houghton, Fiona J.; Chew, Pau Ling; Gleeson, Paul A.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Houghton, Fiona J.; Chew, Pau Ling; Gleeson, Paul A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Lodeho, Sylvain; Goud, Bruno] CNRS, Inst Curie, UMR144, F-75005 Paris, France	University of Melbourne; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Gleeson, PA (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia.	pgleeson@unimelb.edu.au	Goud, Bruno/GWC-4807-2022	HOUGHTON, FIONA/0000-0002-4420-2953; Gleeson, Paul/0000-0002-5336-6503	Australian Research Council	Australian Research Council(Australian Research Council)	We gratefully thank Florence Jollivet, Institut Curie, for expert technical support. This work was supported by funding from the Australian Research Council.	Barr FA, 1999, CURR BIOL, V9, P381, DOI 10.1016/S0960-9822(99)80167-5; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Derby MC, 2004, J CELL SCI, V117, P5865, DOI 10.1242/jcs.01497; Derby MC, 2007, INT REV CYTOL, V261, P47, DOI 10.1016/S0074-7696(07)61002-X; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Erlich R, 1996, J BIOL CHEM, V271, P8328, DOI 10.1074/jbc.271.14.8328; Fritzler MJ, 1995, J BIOL CHEM, V270, P31262, DOI 10.1074/jbc.270.52.31262; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gleeson PA, 2004, TRAFFIC, V5, P315, DOI 10.1111/j.1398-9219.2004.00182.x; Gleeson PA, 1996, J CELL SCI, V109, P2811; Griffith KJ, 1997, ARTHRITIS RHEUM, V40, P1693, DOI 10.1002/art.1780400920; Hayes GL, 2009, MOL BIOL CELL, V20, P209, DOI 10.1091/mbc.E08-07-0740; Jackson CL, 2003, CURR BIOL, V13, pR174, DOI 10.1016/S0960-9822(03)00116-7; Janoueix-Lerosey I, 2000, METHODS, V20, P399, DOI 10.1006/meth.2000.0952; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; Kjer-Nielsen L, 1999, J CELL SCI, V112, P1645; KOOY J, 1992, J BIOL CHEM, V267, P20255; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; Lieu ZZ, 2007, MOL BIOL CELL, V18, P4979, DOI 10.1091/mbc.E07-06-0622; Lock JG, 2005, TRAFFIC, V6, P1142, DOI 10.1111/j.1600-0854.2005.00349.x; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Luke MR, 2005, BIOCHEM J, V388, P835, DOI 10.1042/BJ20041810; Luke MR, 2003, J BIOL CHEM, V278, P4216, DOI 10.1074/jbc.M210387200; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Munro S, 1999, CURR BIOL, V9, P377, DOI 10.1016/S0960-9822(99)80166-3; Opdam FJM, 2000, J CELL SCI, V113, P2725; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Panic B, 2003, CURR BIOL, V13, P405, DOI 10.1016/S0960-9822(03)00091-5; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; Setty SRG, 2003, CURR BIOL, V13, P401, DOI 10.1016/S0960-9822(03)00089-7; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Sinka R, 2008, J CELL BIOL, V183, P607, DOI 10.1083/jcb.200808018; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Wu MS, 2004, NAT STRUCT MOL BIOL, V11, P86, DOI 10.1038/nsmb714	38	33	35	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					787	794		10.1016/j.cell.2009.05.048	http://dx.doi.org/10.1016/j.cell.2009.05.048			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703403	Bronze			2022-12-24	WOS:000269156100019
J	Parks, AR; Li, ZP; Shi, QJ; Owens, RM; Jin, MM; Peters, JE				Parks, Adam R.; Li, Zaoping; Shi, Qiaojuan; Owens, Roisin M.; Jin, Moonsoo M.; Peters, Joseph E.			Transposition into Replicating DNA Occurs through Interaction with the Processivity Factor	CELL			English	Article							BETA-SLIDING-CLAMP; POLYMERASE-III HOLOENZYME; TN7 TRANSPOSITION; MISMATCH-REPAIR; DELTA-SUBUNIT; PROTEIN; RECOGNITION; COMPLEX; BINDING; MOTIF	The bacterial transposon Tn7 directs transposition into actively replicating DNA by a mechanism involving the transposon-encoded protein TnsE. Here we show that TnsE physically and functionally interacts with the processivity factor of the DNA replication machinery in vivo and in vitro. Our work establishes an in vitro TnsABC+E transposition reaction reconstituted from purified proteins and target DNA structures. Using the in vitro reaction we confirm that the processivity factor specifically reorders TnsE-mediated transposition events on target DNAs in a way that matches the bias with active DNA replication in vivo. The TnsE interaction with an essential and conserved component of the replication machinery, and a DNA structure reveals a mechanism by which Tn7, and probably other elements, selects target sites associated with DNA replication.	[Parks, Adam R.; Li, Zaoping; Shi, Qiaojuan; Peters, Joseph E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Owens, Roisin M.; Jin, Moonsoo M.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA	Cornell University; Cornell University	Peters, JE (corresponding author), NCI, Ctr Canc Res, Frederick, MD 21702 USA.	jep48@cornell.edu	Peters, Joseph/P-7130-2019; Jin, Moonsoo/D-6128-2011; Owens, Roisin/O-4371-2019	Peters, Joseph/0000-0001-8309-3297; Owens, Roisin/0000-0001-7856-2108	National Institutes of Health [R01 GM069508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM069508. We thank Mark Sutton and Bik Tye for strains and plasmids and helpful discussions. We also thank Eric Alani, Bik Tye, Jeff Roberts, and the members of the Peters laboratory for comments on the manuscript.	AMBERG DC, 2006, COLD SPRING HARBOR P, DOI DOI 10.1101/PDB.PROT4158; BAINTON RJ, 1993, CELL, V72, P931, DOI 10.1016/0092-8674(93)90581-A; Beuning PJ, 2006, MOL MICROBIOL, V59, P460, DOI 10.1111/j.1365-2958.2005.04959.x; BIACORE I, 1997, BIAEVALUATION SOFTWA; Biery MC, 2000, NUCLEIC ACIDS RES, V28, P1067, DOI 10.1093/nar/28.5.1067; Bordi C, 2008, APPL ENVIRON MICROB, V74, P3419, DOI 10.1128/AEM.00476-08; Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; CHEN J, 1992, GENETICS, V130, P665; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Craig Nancy L., 2002, P423; CRAIG NL, 2002, MOBILE DNA, V2; DALLMANN HG, 1995, J BIOL CHEM, V270, P29563, DOI 10.1074/jbc.270.49.29563; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; de Saro FJL, 2001, P NATL ACAD SCI USA, V98, P8376, DOI 10.1073/pnas.121009498; de Saro FL, 2004, PHILOS T R SOC B, V359, P25, DOI 10.1098/rstb.2003.1361; Einarson Margret B, 2007, CSH Protoc, V2007, DOI [10.1101/pdb.prot4758, 10.1101/pdb.prot4759]; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; Garsin DA, 2004, J BACTERIOL, V186, P7280, DOI 10.1128/JB.186.21.7280-7289.2004; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Golemis E.A., 2002, PROTEIN PROTEIN INTE; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; KELMAN Z, 1995, GENE, V166, P177, DOI 10.1016/0378-1119(95)00556-7; Kelman Z, 1995, METHOD ENZYMOL, V262, P430; Kuduvalli PN, 2001, EMBO J, V20, P924, DOI 10.1093/emboj/20.4.924; KUZMINOV A, 1995, BIOESSAYS, V17, P733, DOI 10.1002/bies.950170810; Laurence TA, 2008, J BIOL CHEM, V283, P22895, DOI 10.1074/jbc.M800174200; Leu FP, 2000, J BIOL CHEM, V275, P34609, DOI 10.1074/jbc.M005495200; Leu FP, 2001, J BIOL CHEM, V276, P47185, DOI 10.1074/jbc.M106780200; Liachko I, 2005, GENETICS, V171, P503, DOI 10.1534/genetics.105.042333; de Saro FJL, 2006, J BIOL CHEM, V281, P14340, DOI 10.1074/jbc.M601264200; Maul RW, 2007, MOL MICROBIOL, V65, P811, DOI 10.1111/j.1365-2958.2007.05828.x; MCKOWN RL, 1988, J BACTERIOL, V170, P352, DOI 10.1128/jb.170.1.352-358.1988; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Parks AR, 2007, J BACTERIOL, V189, P2170, DOI 10.1128/JB.01536-06; Parks AR, 2009, PLASMID, V61, P1, DOI 10.1016/j.plasmid.2008.09.008; Peters J.E., 2007, METHODS GEN MOL MICR, P735; Peters JE, 2001, GENE DEV, V15, P737, DOI 10.1101/gad.870201; Peters JE, 2001, NAT REV MOL CELL BIO, V2, P806, DOI 10.1038/35099006; Peters JE, 2000, MOL CELL, V6, P573, DOI 10.1016/S1097-2765(00)00056-3; Rao JE, 2000, P NATL ACAD SCI USA, V97, P3936, DOI 10.1073/pnas.080061497; Rao JE, 2001, J MOL BIOL, V307, P1161, DOI 10.1006/jmbi.2001.4553; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Seringhaus M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl184; SHAFFERMAN A, 1982, J MOL BIOL, V161, P57, DOI 10.1016/0022-2836(82)90278-9; Sharp PL, 1998, EMBO J, V17, P5822, DOI 10.1093/emboj/17.19.5822; Shi QJ, 2008, GENETICS, V179, P1237, DOI 10.1534/genetics.108.088161; Simmons LA, 2008, MOL CELL, V29, P291, DOI 10.1016/j.molcel.2007.10.036; Stellwagen AE, 1997, GENETICS, V145, P573; Stellwagen AE, 1998, TRENDS BIOCHEM SCI, V23, P486, DOI 10.1016/S0968-0004(98)01325-5; Stellwagen AE, 2001, J MOL BIOL, V305, P633, DOI 10.1006/jmbi.2000.4317; Sutton MD, 2004, J BACTERIOL, V186, P6738, DOI 10.1128/JB.186.20.6738-6748.2004; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang HX, 2001, MOL BIOTECHNOL, V19, P133, DOI 10.1385/MB:19:2:133; Warbrick E, 1998, NUCLEIC ACIDS RES, V26, P3925, DOI 10.1093/nar/26.17.3925; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Wijffels G, 2004, BIOCHEMISTRY-US, V43, P5661, DOI 10.1021/bi036229j; Wilkins B, 1993, BACTERIAL CONJUGATIO, P105; Wolkow CA, 1996, GENE DEV, V10, P2145, DOI 10.1101/gad.10.17.2145	62	45	46	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					685	695		10.1016/j.cell.2009.06.011	http://dx.doi.org/10.1016/j.cell.2009.06.011			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703395	Green Accepted, Bronze			2022-12-24	WOS:000269156100011
J	Dekel, N				Dekel, Nava			Master Regulators of Female Fertility	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CELLS		Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Dekel, N (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.		DEKEL, NAVA/R-8817-2019					Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Sela-Abramovich S, 2005, ENDOCRINOLOGY, V146, P1236, DOI 10.1210/en.2004-1006; Su YQ, 2002, ENDOCRINOLOGY, V143, P2221, DOI 10.1210/en.143.6.2221	3	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2009	361	7					718	719		10.1056/NEJMcibr0904558	http://dx.doi.org/10.1056/NEJMcibr0904558			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482JX	19675336				2022-12-24	WOS:000268884100016
J	Vashisht, AA; Zumbrennen, KB; Huang, XH; Powers, DN; Durazo, A; Sun, DH; Bhaskaran, N; Persson, A; Uhlen, M; Sangfelt, O; Spruck, C; Leibold, EA; Wohlschlegel, JA				Vashisht, Ajay A.; Zumbrennen, Kimberly B.; Huang, Xinhua; Powers, David N.; Durazo, Armando; Sun, Dahui; Bhaskaran, Nimesh; Persson, Anja; Uhlen, Mathias; Sangfelt, Olle; Spruck, Charles; Leibold, Elizabeth A.; Wohlschlegel, James A.			Control of Iron Homeostasis by an Iron-Regulated Ubiquitin Ligase	SCIENCE			English	Article							PROTEIN IDENTIFICATION TECHNOLOGY; ELEMENT-BINDING PROTEIN; DEGRADATION; IRP2; PROTEASOME; PATHWAY; OXYGEN	Eukaryotic cells require iron for survival and have developed regulatory mechanisms for maintaining appropriate intracellular iron concentrations. The degradation of iron regulatory protein 2 (IRP2) in iron-replete cells is a key event in this pathway, but the E3 ubiquitin ligase responsible for its proteolysis has remained elusive. We found that a SKP1-CUL1-FBXL5 ubiquitin ligase protein complex associates with and promotes the iron-dependent ubiquitination and degradation of IRP2. The F-box substrate adaptor protein FBXL5 was degraded upon iron and oxygen depletion in a process that required an iron-binding hemerythrin-like domain in its N terminus. Thus, iron homeostasis is regulated by a proteolytic pathway that couples IRP2 degradation to intracellular iron levels through the stability and activity of FBXL5.	[Vashisht, Ajay A.; Huang, Xinhua; Powers, David N.; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Zumbrennen, Kimberly B.; Leibold, Elizabeth A.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Zumbrennen, Kimberly B.; Leibold, Elizabeth A.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Durazo, Armando] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Sun, Dahui; Spruck, Charles] Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA; [Bhaskaran, Nimesh; Sangfelt, Olle] Karolinska Hosp, Dept Pathol & Oncol, Canc Ctr Karolinska, SE-17176 Stockholm, Sweden; [Persson, Anja; Uhlen, Mathias] Royal Inst Technol AlbaNova, Dept Prote, Sch Biotechnol, SE-10691 Stockholm, Sweden	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; Karolinska Institutet; Karolinska University Hospital; Royal Institute of Technology	Wohlschlegel, JA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	jwohl@mednet.ucla.edu	Uhlen, Mathias/AAV-8746-2021; Uhlen, Mathias/B-3262-2016	Uhlen, Mathias/0000-0002-4858-8056	NIH [GM45201]; Swedish Cancer Society; Swedish Children Cancer Foundation; Swedish Research Council; Cancer Society in Stockholm; Knut and Alice Wallenberg Foundation; Stein-Oppenheimer Foundation; Jonsson Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045201, R01GM089778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Cancer Society(Swedish Cancer Society); Swedish Children Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer Society in Stockholm; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Stein-Oppenheimer Foundation; Jonsson Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from NIH (GM45201 to E. A. L), the Swedish Cancer Society (N.B. and O.S.), the Swedish Children Cancer Foundation (O.S.), the Swedish Research Council (O.S.), the Cancer Society in Stockholm (O.S.), the Knut and Alice Wallenberg Foundation (A. P. and M. U.), the Stein-Oppenheimer Foundation (J.A.W.), and the Jonsson Comprehensive Cancer Center (J.A.W.). We thank D. Lim for graphic support.	Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; GUO B, 1994, J BIOL CHEM, V269, P24252; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; STENKAMP RE, 1994, CHEM REV, V94, P715, DOI 10.1021/cr00027a008; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; Wang J, 2007, MOL CELL BIOL, V27, P2423, DOI 10.1128/MCB.01111-06; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952; Zumbrennen KB, 2008, BBA-MOL CELL RES, V1783, P246, DOI 10.1016/j.bbamcr.2007.07.010	21	290	307	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					718	721		10.1126/science.1176333	http://dx.doi.org/10.1126/science.1176333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19762596	Green Accepted			2022-12-24	WOS:000271233200035
J	Yang, Y; Sugimoto, JD; Halloran, ME; Basta, NE; Chao, DL; Matrajt, L; Potter, G; Kenah, E; Longini, IM				Yang, Yang; Sugimoto, Jonathan D.; Halloran, M. Elizabeth; Basta, Nicole E.; Chao, Dennis L.; Matrajt, Laura; Potter, Gail; Kenah, Eben; Longini, Ira M., Jr.			The Transmissibility and Control of Pandemic Influenza A (H1N1) Virus	SCIENCE			English	Article							MITIGATION STRATEGIES; UNITED-STATES; COMMUNITY; MODEL; PARAMETERS; HOUSEHOLD	Pandemic influenza A (H1N1) 2009 (pandemic H1N1) is spreading throughout the planet. It has become the dominant strain in the Southern Hemisphere, where the influenza season has now ended. Here, on the basis of reported case clusters in the United States, we estimated the household secondary attack rate for pandemic H1N1 to be 27.3% [95% confidence interval (CI) from 12.2% to 50.5%]. From a school outbreak, we estimated that a typical schoolchild infects 2.4 (95% CI from 1.8 to 3.2) other children within the school. We estimated the basic reproductive number, R-0, to range from 1.3 to 1.7 and the generation interval to range from 2.6 to 3.2 days. We used a simulation model to evaluate the effectiveness of vaccination strategies in the United States for fall 2009. If a vaccine were available soon enough, vaccination of children, followed by adults, reaching 70% overall coverage, in addition to high-risk and essential workforce groups, could mitigate a severe epidemic.	[Yang, Yang; Sugimoto, Jonathan D.; Halloran, M. Elizabeth; Basta, Nicole E.; Chao, Dennis L.; Kenah, Eben; Longini, Ira M., Jr.] Fred Hutchinson Canc Res Ctr, Ctr Stat & Quantitat Infect Dis, Seattle, WA 98109 USA; [Yang, Yang; Sugimoto, Jonathan D.; Halloran, M. Elizabeth; Basta, Nicole E.; Chao, Dennis L.; Kenah, Eben; Longini, Ira M., Jr.] Univ Washington, Seattle, WA 98109 USA; [Sugimoto, Jonathan D.; Basta, Nicole E.] Univ Washington, Dept Epidemiol, Sch Publ Hlth, Seattle, WA 98195 USA; [Halloran, M. Elizabeth; Kenah, Eben; Longini, Ira M., Jr.] Univ Washington, Dept Biostat, Sch Publ Hlth, Seattle, WA 98195 USA; [Matrajt, Laura] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Potter, Gail] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Kenah, Eben] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Longini, IM (corresponding author), Fred Hutchinson Canc Res Ctr, Ctr Stat & Quantitat Infect Dis, Seattle, WA 98109 USA.	longini@scharp.org	Basta, Nicole/B-4157-2013; Matrajt, Laura/AAV-5216-2020	Chao, Dennis/0000-0002-8253-6321; Sugimoto, Jonathan/0000-0002-1761-328X; Yang, Yang/0000-0003-0428-5480	National Institute of General Medical Sciences MIDAS [U01-GM070749]; National Institute of Allergy and Infectious Diseases [R01-AI32042]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070749] Funding Source: NIH RePORTER	National Institute of General Medical Sciences MIDAS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by the National Institute of General Medical Sciences MIDAS grant U01-GM070749 and the National Institute of Allergy and Infectious Diseases grant R01-AI32042.	Basta NE, 2009, AM J EPIDEMIOL, V170, P679, DOI 10.1093/aje/kwp237; Basta NE, 2008, AM J EPIDEMIOL, V168, P1343, DOI 10.1093/aje/kwn259; BRIAND S, 2009, WHO STRAT ADV GROUP; *CDCP, 2009, FLUVIEW 2008 2009 IN; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P435, DOI DOI 10.1007/S00134-010-2021-3; Chan M., 2009, WORLD NOW START 2009; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Chowell G, 2007, MATH BIOSCI ENG, V4, P457, DOI 10.3934/mbe.2007.4.457; DUNN FL, 1959, AM J HYG, V70, P351, DOI 10.1093/oxfordjournals.aje.a120083; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; GLEZEN WP, 1982, AM J EPIDEMIOL, V116, P589, DOI 10.1093/oxfordjournals.aje.a113441; Grais R F, 2004, Health Care Manag Sci, V7, P127, DOI 10.1023/B:HCMS.0000020652.38181.da; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Halloran ME, 2006, SCIENCE, V311, P615, DOI 10.1126/science.1122143; *KS DEP HLTH ENV, 2009, SWIN INFL NEWS C 29; *KS DEP HLTH ENV, 2009, KDHE REP 2 CAS SWIN; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; LONGINI IM, 1978, MATH BIOSCI, V38, P141, DOI 10.1016/0025-5564(78)90023-8; LONGINI IM, 1982, BIOMETRICS, V38, P115, DOI 10.2307/2530294; LONGINI IM, 1986, MATH BIOSCI, V82, P19, DOI 10.1016/0025-5564(86)90003-9; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; *NAT I ALL INF DIS, 2009, CLIN TRIALS 2009 H1N; *NY CIT DEP HLTH M, 2009, ST FRANC PREP UPD SW; ROBINSON R, 2009, ADV COMM IMM PRACT A; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Sander B, 2009, VALUE HEALTH, V12, P226, DOI 10.1111/j.1524-4733.2008.00437.x; *WHO, 2009, NOV INFL A H1N1 UPD; *WORLD HLTH ORG, 2009, PROD AV PAND INFL H1; Yang Y, 2007, EMERG INFECT DIS, V13, P1348, DOI 10.3201/eid1309.070111; Yang Y, 2007, COMPUT STAT DATA AN, V51, P6582, DOI 10.1016/j.csda.2007.03.007	35	398	420	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					729	733		10.1126/science.1177373	http://dx.doi.org/10.1126/science.1177373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19745114	Green Accepted			2022-12-24	WOS:000271233200038
J	Bao, SQ; Tang, FC; Li, XH; Hayashi, K; Gillich, A; Lao, KQ; Surani, MA				Bao, Siqin; Tang, Fuchou; Li, Xihe; Hayashi, Katsuhiko; Gillich, Astrid; Lao, Kaiqin; Surani, M. Azim			Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem cells	NATURE			English	Article							X-CHROMOSOME; GERM-CELLS; MOUSE; METHYLATION; HETEROGENEITY; ESTABLISHMENT; STATES; LINES	The pluripotent state, which is first established in the primitive ectoderm cells of blastocysts, is lost progressively and irreversibly during subsequent development(1). For example, development of post-implantation epiblast cells from primitive ectoderm involves significant transcriptional and epigenetic changes, including DNA methylation and X chromosome inactivation(2), which create a robust epigenetic barrier and prevent their reversion to a primitive-ectoderm-like state. Epiblast cells are refractory to leukaemia inhibitory factor (LIF)-STAT3 signalling, but they respond to activin/basic fibroblast growth factor to form self-renewing epiblast stem cells (EpiSCs), which exhibit essential properties of epiblast cells(3,4) and that differ from embryonic stem (ES) cells derived from primitive ectoderm(5). Here we show reprogramming of advanced epiblast cells fromembryonic day 5.5-7.5mouseembryos with uniform expression of N-cadherin and inactive X chromosome to ES-cell-like cells (rESCs) in response to LIF-STAT3 signalling. Cultured epiblast cells overcome the epigenetic barrier progressively as they proceed with the erasure of key properties of epiblast cells, resulting in DNA demethylation, X reactivation and expression of E-cadherin. The accompanying changes in the transcriptome result in a loss of phenotypic and epigenetic memory of epiblast cells. Using this approach, we report reversion of established EpiSCs to rESCs. Moreover, unlike epiblast and EpiSCs, rESCs contribute to somatic tissues and germ cells in chimaeras. Further studies may reveal how signalling-induced epigenetic reprogramming may promote reacquisition of pluripotency.	[Bao, Siqin; Tang, Fuchou; Hayashi, Katsuhiko; Gillich, Astrid; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Li, Xihe] Inner Mongolia Univ, Mengniu RB CO Ltd, Coll Life Sci, Hohhot 010021, Inner Mongolia, Peoples R China; [Lao, Kaiqin] Appl Biosyst Inc, Mol Cell Biol, Foster City, CA 94404 USA	University of Cambridge; Inner Mongolia University; Thermo Fisher Scientific; Applied Biosystems	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	a.surani@gurdon.cam.ac.uk		Bao, Siqin/0000-0002-9582-3194; Surani, Azim/0000-0002-8640-4318	Wellcome Trust; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C. Lee for assistance. This work was supported by grants from the Wellcome Trust to M. A. S.	Bao SQ, 2005, EMBO REP, V6, P748, DOI 10.1038/sj.embor.7400461; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Lopes SMCD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040030; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; Hayashi K, 2009, CELL STEM CELL, V4, P493, DOI 10.1016/j.stem.2009.05.007; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Rathjen J, 2003, BIOL REPROD, V69, P1863, DOI 10.1095/biolreprod.103.017384; Shovlin TC, 2008, DEV BIOL, V313, P674, DOI 10.1016/j.ydbio.2007.11.007; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Surani MA, 2008, COLD SH Q B, V73, P9, DOI 10.1101/sqb.2008.73.015; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; TAKAGI N, 1982, CHROMOSOMA, V85, P275, DOI 10.1007/BF00294971; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Yeom YI, 1996, DEVELOPMENT, V122, P881	31	295	307	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 29	2009	461	7268					1292	1295		10.1038/nature08534	http://dx.doi.org/10.1038/nature08534			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19816418	Green Accepted			2022-12-24	WOS:000271190800051
J	Clark, RN				Clark, Roger N.			Detection of Adsorbed Water and Hydroxyl on the Moon	SCIENCE			English	Article							LUNAR POLES; ICE; HYDROGEN; INTERIOR; SURFACE	Data from the Visual and Infrared Mapping Spectrometer (VIMS) on Cassini during its flyby of the Moon in 1999 show a broad absorption at 3 micrometers due to adsorbed water and near 2.8 micrometers attributed to hydroxyl in the sunlit surface on the Moon. The amounts of water indicated in the spectra depend on the type of mixing and the grain sizes in the rocks and soils but could be 10 to 1000 parts per million and locally higher. Water in the polar regions may be water that has migrated to the colder environments there. Trace hydroxyl is observed in the anorthositic highlands at lower latitudes.	US Geol Survey, Denver, CO 80227 USA	United States Department of the Interior; United States Geological Survey	Clark, RN (corresponding author), US Geol Survey, Mail Stop 964,Box 25046 Fed Ctr, Denver, CO 80227 USA.	rclark@usgs.gov			NASA Cassini VIMS	NASA Cassini VIMS	This research was funded by NASA Cassini VIMS under contract to the U. S. Geological Survey; R. C. is a VIMS team member.	ARNOLD JR, 1979, J GEOPHYS RES, V84, P5659, DOI 10.1029/JB084iB10p05659; Brown RH, 2004, SPACE SCI REV, V115, P111, DOI 10.1007/s11214-004-1453-x; Canup RM, 2004, ANNU REV ASTRON ASTR, V42, P441, DOI 10.1146/annurev.astro.41.082201.113457; CLARK R, 2009, LUNAR PLANET SCI, V40; Clark R. N., 2007, US GEOLOGICAL SURVEY, V231; CLARK RN, 1979, ICARUS, V40, P94, DOI 10.1016/0019-1035(79)90056-3; Farmer V. C., 1974, INFRARED SPECTRA MIN; Feldman WC, 2000, J GEOPHYS RES-PLANET, V105, P4175, DOI 10.1029/1999JE001129; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Feldman WC, 2001, J GEOPHYS RES-PLANET, V106, P23231, DOI 10.1029/2000JE001444; Hapke B., 1993, THEORY REFLECTANCE E; HESS PC, 1995, EARTH PLANET SC LETT, V134, P501, DOI 10.1016/0012-821X(95)00138-3; HOOD LL, 2000, ORIGIN EARTH MOON, P397; Lucey P, 2006, REV MINERAL GEOCHEM, V60, P83, DOI 10.2138/rmg.2006.60.2; Noble SK, 2007, ICARUS, V192, P629, DOI 10.1016/j.icarus.2007.07.021; Pieters CM, 2009, SCIENCE, V326, P568, DOI 10.1126/science.1178658; Saal AE, 2008, NATURE, V454, P192, DOI 10.1038/nature07047; Starukhina LV, 2000, ICARUS, V147, P585, DOI 10.1006/icar.2000.6476; Sunshine JM, 2009, SCIENCE, V326, P565, DOI 10.1126/science.1179788; Urey H.C., 1952, PLANETS THEIR ORIGIN, DOI [10.1063/1.3067687, DOI 10.1063/1.3067687]; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033	21	257	269	5	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 23	2009	326	5952					562	564		10.1126/science.1178105	http://dx.doi.org/10.1126/science.1178105			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19779152	Green Published			2022-12-24	WOS:000271019400038
J	Belle, MDC; Diekman, CO; Forger, DB; Piggins, HD				Belle, Mino D. C.; Diekman, Casey O.; Forger, Daniel B.; Piggins, Hugh D.			Daily Electrical Silencing in the Mammalian Circadian Clock	SCIENCE			English	Article							SUPRACHIASMATIC NUCLEUS NEURONS; PACEMAKER; ELECTROPHYSIOLOGY; EXCITABILITY; RHYTHMICITY; DYNAMICS; PER1	Neurons in the brain's suprachiasmatic nuclei (SCNs), which control the timing of daily rhythms, are thought to encode time of day by changing their firing frequency, with high rates during the day and lower rates at night. Some SCN neurons express a key clock gene, period 1 (per1). We found that during the day, neurons containing per1 sustain an electrically excited state and do not fire, whereas non-per1 neurons show the previously reported daily variation in firing activity. Using a combined experimental and theoretical approach, we explain how ionic currents lead to the unusual electrophysiological behaviors of per1 cells, which unlike other mammalian brain cells can survive and function at depolarized states.	[Belle, Mino D. C.; Piggins, Hugh D.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Diekman, Casey O.] Univ Michigan, Dept Ind & Operat Engn, Ann Arbor, MI 48109 USA; [Forger, Daniel B.] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; [Diekman, Casey O.; Forger, Daniel B.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Manchester; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Piggins, HD (corresponding author), Univ Manchester, Fac Life Sci, AV Hill Bldg, Manchester M13 9PT, Lancs, England.	hugh.d.piggins@manchester.ac.uk	Forger, Daniel/C-5552-2015; Belle, Mino/AAV-6093-2020	Forger, Daniel/0000-0001-7581-4031; Belle, Mino/0000-0002-4917-957X; Piggins, Hugh/0000-0003-2555-9858	Biotechnology and Biological Sciences Research Council [BB/E00511X]; NSF; Air Force Office of Scientific Research Young Investigator [FA 9550-08-01-0076]; BBSRC [BB/E00511X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E00511X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research Young Investigator(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank D. McMahon, Vanderbilt University, for providing us with the per1::2dGFP mice and R. Lucas and R. Baines, University of Manchester, C. Diniz Behn, University of Michigan, and D. Paydarfar, University of Massachusetts Medical School, for their critical reading of the manuscript. This work was funded by a project grant from the Biotechnology and Biological Sciences Research Council awarded to H. D. P. (BB/E00511X). M. D. C. B. is a Research Associate. C. O. D. is a NSF Graduate Research Fellow. D. B. F. is an Air Force Office of Scientific Research Young Investigator (FA 9550-08-01-0076).	Brown TM, 2007, PROG NEUROBIOL, V82, P229, DOI 10.1016/j.pneurobio.2007.05.002; Cao G, 2008, J NEUROSCI, V28, P6493, DOI 10.1523/JNEUROSCI.1503-08.2008; Cutler DJ, 2003, EUR J NEUROSCI, V17, P197, DOI 10.1046/j.1460-9568.2003.02425.x; GILLETTE MU, 1995, CIBA F SYMP, V183, P134; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Herbison AE, 2008, ENDOCRINOLOGY, V149, P3598, DOI 10.1210/en.2007-1631; Hughes ATL, 2008, J NEUROCHEM, V106, P1646, DOI 10.1111/j.1471-4159.2008.05520.x; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; Irwin RP, 2007, J NEUROSCI, V27, P11748, DOI 10.1523/JNEUROSCI.1840-07.2007; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Jackson AC, 2004, J NEUROSCI, V24, P7985, DOI 10.1523/JNEUROSCI.2146-04.2004; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kuhlman SJ, 2003, J NEUROSCI, V23, P1441, DOI 10.1523/JNEUROSCI.23-04-01441.2003; MICHEL S, 1993, SCIENCE, V259, P239, DOI 10.1126/science.8421785; Mrugala M, 2000, AM J PHYSIOL-REG I, V278, pR987, DOI 10.1152/ajpregu.2000.278.4.R987; Paydarfar D, 2006, J NEUROPHYSIOL, V96, P3338, DOI 10.1152/jn.00486.2006; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; Pitts GR, 2006, BRAIN RES, V1071, P54, DOI 10.1016/j.brainres.2005.11.078; RINZEL J, 1998, METHODS NEURONAL MOD, P251; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Sim CK, 2007, J BIOL RHYTHM, V22, P445, DOI 10.1177/0748730407306041; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Vansteensel MJ, 2003, CURR BIOL, V13, P1538, DOI 10.1016/S0960-9822(03)00560-8; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287	24	126	129	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					281	284		10.1126/science.1169657	http://dx.doi.org/10.1126/science.1169657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815775				2022-12-24	WOS:000270599500041
J	Matsuno, M; Compagnon, V; Schoch, GA; Schmitt, M; Debayle, D; Bassard, JE; Pollet, B; Hehn, A; Heintz, D; Ullmann, P; Lapierre, C; Bernier, F; Ehlting, J; Werck-Reichhart, D				Matsuno, Michiyo; Compagnon, Vincent; Schoch, Guillaume A.; Schmitt, Martine; Debayle, Delphine; Bassard, Jean-Etienne; Pollet, Brigitte; Hehn, Alain; Heintz, Dimitri; Ullmann, Pascaline; Lapierre, Catherine; Bernier, Francois; Ehlting, Juergen; Werck-Reichhart, Daniele			Evolution of a Novel Phenolic Pathway for Pollen Development	SCIENCE			English	Article							DETECTING POSITIVE SELECTION; ARABIDOPSIS-THALIANA; REPRODUCTIVE PROTEINS; CYTOCHROME P4502C8; PLANT-GROWTH; LIKELIHOOD; ACID; ACYLTRANSFERASE; ACCUMULATION; SPERMIDINES	Metabolic plasticity, which largely relies on the creation of new genes, is an essential feature of plant adaptation and speciation and has led to the evolution of large gene families. A typical example is provided by the diversification of the cytochrome P450 enzymes in plants. We describe here a retroposition, neofunctionalization, and duplication sequence that, via selective and local amino acid replacement, led to the evolution of a novel phenolic pathway in Brassicaceae. This pathway involves a cascade of six successive hydroxylations by two partially redundant cytochromes P450, leading to the formation of N-1,N-5-di(hydroxyferuloyl)-N-10-sinapoylspermidine, a major pollen constituent and so-far-overlooked player in phenylpropanoid metabolism. This example shows how positive Darwinian selection can favor structured clusters of nonsynonymous substitutions that are needed for the transition of enzymes to new functions.	[Matsuno, Michiyo; Compagnon, Vincent; Debayle, Delphine; Bassard, Jean-Etienne; Heintz, Dimitri; Ullmann, Pascaline; Bernier, Francois; Werck-Reichhart, Daniele] Univ Strasbourg, CNRS, Inst Biol Mol Plantes, UPR2357, F-67083 Strasbourg, France; [Schoch, Guillaume A.] F Hoffmann La Roche & Co Ltd, Discovery Technol, Pharma Res, CH-4070 Basel, Switzerland; [Schmitt, Martine] Fac Pharm Strasbourg, CNRS, Inst Gilbert Laustriat LC1, UMR ULP 7175, F-67401 Illkirch Graffenstaden, France; [Pollet, Brigitte; Lapierre, Catherine] AgroParisTech, UMR Chim Biol AgroParisTech INRA 206, F-78850 Thiverval Grignon, France; [Hehn, Alain] Nancy Univ, UMR, INRA Agron & Environm, F-54505 Vandoeuvre Les Nancy, France; [Ehlting, Juergen] Univ Victoria, Ctr Forest Biol, Victoria, BC V8W 3N5, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Novartis; Roche Holding; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Lorraine; University of Victoria	Werck-Reichhart, D (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol Plantes, UPR2357, 28 Rue Goethe, F-67083 Strasbourg, France.	daniele.werck@ibmp-ulp.u-strasbg.fr	Bassard, Jean-Etienne/AAH-1680-2019; Lapierre, Catherine/AAD-9209-2020; Bernier, Francois/AAP-2174-2020; WERCK-REICHHART, Danièle/U-3713-2019; Schmitt, Martine/B-5878-2016; Bernier, Francois/V-7150-2018	Bassard, Jean-Etienne/0000-0002-7937-8027; WERCK-REICHHART, Danièle/0000-0003-2869-4262; Schmitt, Martine/0000-0002-8723-9502; Lapierre, Catherine/0000-0002-6757-1524; Ehlting, Jurgen/0000-0003-2302-696X; Hehn, Alain/0000-0003-4507-8031	Human Frontier Science program; Natural Sciences and Engineering Council of Canada	Human Frontier Science program(Human Frontier Science Program); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank J. J. Bourguignon, M. Legrand, E Grienenberger, D. Banner, and S. J. Perlman for helpful advice; D. Nelson for naming P450s; and N. Abdulrazzak for his contribution. M. M. and J. E. are grateful for funding of European Marie Curie actions; D. W.-R., M. M., V. C., and J.-E. B. acknowledge support from the Human Frontier Science program; and J. E. acknowledges support from the Natural Sciences and Engineering Council of Canada.	Abdulrazzak N, 2006, PLANT PHYSIOL, V140, P30, DOI 10.1104/pp.105.069690; Besseau S, 2007, PLANT CELL, V19, P148, DOI 10.1105/tpc.106.044495; Bienz S, 2005, NAT PROD REP, V22, P647, DOI 10.1039/b413742f; Clark NL, 2006, REPRODUCTION, V131, P11, DOI 10.1530/rep.1.00357; Cona A, 2006, TRENDS PLANT SCI, V11, P80, DOI 10.1016/j.tplants.2005.12.009; Ehlting J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-47; Fellenberg C, 2008, PLANT J, V56, P132, DOI 10.1111/j.1365-313X.2008.03576.x; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Franke R, 2002, PLANT J, V30, P33, DOI 10.1046/j.1365-313X.2002.01266.x; Grienenberger E, 2009, PLANT J, V58, P246, DOI 10.1111/j.1365-313X.2008.03773.x; Jain M, 2008, FUNCT INTEGR GENOMIC, V8, P69, DOI 10.1007/s10142-007-0052-9; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; KAKKAR RK, 1993, PHYTOCHEMISTRY, V33, P1281, DOI 10.1016/0031-9422(93)85076-4; Luo J, 2009, PLANT CELL, V21, P318, DOI 10.1105/tpc.108.063511; MARTINTANGUY J, 1982, PHYTOCHEMISTRY, V21, P1939, DOI 10.1016/0031-9422(82)83019-7; MEURERGRIMES B, 1995, BRITTONIA, V47, P130, DOI 10.2307/2806952; Meyer K, 1996, P NATL ACAD SCI USA, V93, P6869, DOI 10.1073/pnas.93.14.6869; Morant M, 2007, PLANT MOL BIOL, V63, P1, DOI 10.1007/s11103-006-9028-8; Pacini E, 2005, FLORA, V200, P399, DOI 10.1016/j.flora.2005.02.006; Paquette SM, 2000, DNA CELL BIOL, V19, P307, DOI 10.1089/10445490050021221; Schoch G, 2001, J BIOL CHEM, V276, P36566, DOI 10.1074/jbc.M104047200; Schoch GA, 2004, J BIOL CHEM, V279, P9497, DOI 10.1074/jbc.M312516200; Schoch GA, 2008, J BIOL CHEM, V283, P17227, DOI 10.1074/jbc.M802180200; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Walters D, 2001, FEMS MICROBIOL LETT, V201, P255, DOI 10.1111/j.1574-6968.2001.tb10765.x; Wang W, 2006, PLANT CELL, V18, P1791, DOI 10.1105/tpc.106.041905; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zamble A, 2006, CHEM BIODIVERS, V3, P982, DOI 10.1002/cbdv.200690107; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	30	119	122	3	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1688	1692		10.1126/science.1174095	http://dx.doi.org/10.1126/science.1174095			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779199				2022-12-24	WOS:000270131800046
J	Wald, R; Quinn, RR; Luo, J; Li, P; Scales, DC; Mamdani, MM; Ray, JG				Wald, Ron; Quinn, Robert R.; Luo, Jin; Li, Ping; Scales, Damon C.; Mamdani, Muhammad M.; Ray, Joel G.		Univ Toronto Acute Kidney Injury R	Chronic Dialysis and Death Among Survivors of Acute Kidney Injury Requiring Dialysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; REPLACEMENT THERAPY; HOSPITALIZED-PATIENTS; ELDERLY-PATIENTS; RECOVERY; OUTCOMES; RISK; EPIDEMIOLOGY	Context Severe acute kidney injury among hospitalized patients often necessitates initiation of short-term dialysis. Little is known about the long-term outcome of those who survive to hospital discharge. Objective To assess the risk of chronic dialysis and all-cause mortality in individuals who experience an episode of acute kidney injury requiring dialysis. Design, Setting, and Participants We conducted a population-based cohort study of all adult patients in Ontario, Canada, with acute kidney injury who required in-hospital dialysis and survived free of dialysis for at least 30 days after discharge between July 1, 1996, and December 31, 2006. These individuals were matched with patients without acute kidney injury or dialysis during their index hospitalization. Matching was by age plus or minus 5 years, sex, history of chronic kidney disease, receipt of mechanical ventilation during the index hospitalization, and a propensity score for developing acute kidney injury requiring dialysis. Patients were followed up until March 31, 2007. Main Outcome Measures The primary end point was the need for chronic dialysis and the secondary outcome was all-cause mortality. Results We identified 3769 adults with acute kidney injury requiring in-hospital dialysis and 13 598 matched controls. The mean age was 62 years and median follow-up was 3 years. The incidence rate of chronic dialysis was 2.63 per 100 personyears among individuals with acute kidney injury requiring dialysis, and 0.91 per 100 person-years among control participants (adjusted hazard ratio, 3.23; 95% confidence interval, 2.70-3.86). All-cause mortality rates were 10.10 and 10.85 per 100 person-years, respectively (adjusted hazard ratio, 0.95; 95% confidence interval, 0.891.02). Conclusions Acute kidney injury necessitating in-hospital dialysis was associated with an increased risk of chronic dialysis but not all-cause mortality. JAMA. 2009; 302(11): 1179-1185	[Wald, Ron] St Michaels Hosp, Div Nephrol, Toronto, ON M5C 2T2, Canada; [Ray, Joel G.] St Michaels Hosp, Div Gen Internal Med, Toronto, ON M5C 2T2, Canada; [Wald, Ron; Mamdani, Muhammad M.; Ray, Joel G.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Wald, Ron; Scales, Damon C.; Mamdani, Muhammad M.; Ray, Joel G.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Quinn, Robert R.] Sunnybrook Hlth Sci Ctr, Div Nephrol, Toronto, ON M4N 3M5, Canada; [Scales, Damon C.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Luo, Jin; Li, Ping; Scales, Damon C.; Mamdani, Muhammad M.; Ray, Joel G.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Mamdani, Muhammad M.] King Saud Univ, Fac Med, Riyadh, Saudi Arabia	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; King Saud University	Wald, R (corresponding author), St Michaels Hosp, Div Nephrol, 61 Queen St E,9-140, Toronto, ON M5C 2T2, Canada.	waldr@smh.toronto.on.ca	Li, Ping/GYV-4914-2022; Lapinsky, Stephen/C-4624-2015; Quinn, Robert R/E-7017-2011	Lapinsky, Stephen/0000-0002-6930-0306; Friedrich, Jan/0000-0001-7248-2350	Ontario Ministry of Health and Long-Term Care; University of Toronto Faculty of Medicine; Canadian Institutes of Health Research New Investigator Award; Canadian Institutes of Health Research; Amgen; Canadian Institutes of Health Research Institute of Health Services and Policy Research Fellowship	Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); University of Toronto Faculty of Medicine(University of Toronto); Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Amgen(Amgen); Canadian Institutes of Health Research Institute of Health Services and Policy Research Fellowship(Canadian Institutes of Health Research (CIHR))	Funding/Support: This study was supported by the Institute for Clinical Evaluative Sciences, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care; and a New Staff Dean's Grant from the University of Toronto Faculty of Medicine. Dr Scales reports support from a Canadian Institutes of Health Research New Investigator Award. Dr Wald reports receipt of an RCT Mentoring Program Award from the Canadian Institutes of Health Research and an unrestricted grant from Amgen. Dr Quinn reports support from a Canadian Institutes of Health Research Institute of Health Services and Policy Research Fellowship. Dr Ray reports support from a Canadian Institutes of Health Research New Investigator Award.	Ahlstrom A, 2005, INTENS CARE MED, V31, P1222, DOI 10.1007/s00134-005-2681-6; Bagshaw SM, 2005, CRIT CARE, V9, pR700, DOI 10.1186/cc3879; Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Brivet FG, 1996, CRIT CARE MED, V24, P192, DOI 10.1097/00003246-199602000-00003; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; de Mendonca A, 2000, INTENS CARE MED, V26, P915, DOI 10.1007/s001340051281; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Liangos O, 2006, CLIN J AM SOC NEPHRO, V1, P43, DOI 10.2215/CJN.00220605; McCarthy JT, 1996, MAYO CLIN PROC, V71, P117, DOI 10.4065/71.2.117; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; Metnitz PGH, 2002, CRIT CARE MED, V30, P2051, DOI 10.1097/00003246-200209000-00016; Morgera S, 2002, AM J KIDNEY DIS, V40, P275, DOI 10.1053/ajkd.2002.34505; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Redelmeier DA, 2005, BRIT MED J, V331, P932, DOI 10.1136/bmj.38603.746944.3A; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Scales DC, 2006, J CLIN EPIDEMIOL, V59, P802, DOI 10.1016/j.jclinepi.2005.11.015; Schiffl H, 2006, NEPHROL DIAL TRANSPL, V21, P1248, DOI 10.1093/ndt/gfk069; Schiffl H, 2008, NEPHROL DIAL TRANSPL, V23, P2235, DOI 10.1093/ndt/gfn182; Silvester W, 2001, CRIT CARE MED, V29, P1910, DOI 10.1097/00003246-200110000-00010; Spurgeon KR, 2005, AM J PHYSIOL-RENAL, V288, pF568, DOI 10.1152/ajprenal.00330.2004; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073	25	519	540	1	19	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	2009	302	11					1179	1185		10.1001/jama.2009.1322	http://dx.doi.org/10.1001/jama.2009.1322			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494FR	19755696	Bronze			2022-12-24	WOS:000269797600027
J	Alston, JM; Beddow, JM; Pardey, PG				Alston, Julian M.; Beddow, Jason M.; Pardey, Philip G.			Agricultural Research, Productivity, and Food Prices in the Long Run	SCIENCE			English	Editorial Material									[Beddow, Jason M.; Pardey, Philip G.] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Beddow, Jason M.; Pardey, Philip G.] Univ Minnesota, InSTePP Ctr, St Paul, MN 55108 USA; [Alston, Julian M.] Univ Calif Davis, Dept Agr & Resource Econ, Davis, CA 95616 USA; [Alston, Julian M.] Univ Calif Davis, Robert Mondavi Inst Ctr Wine Econ, Davis, CA 95616 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Davis; University of California System; University of California Davis	Pardey, PG (corresponding author), Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA.	ppardey@umn.edu						Alston J.M., 2000, META ANAL RATES RETU; EVENSON RE, 1979, SCIENCE, V205, P1101, DOI 10.1126/science.205.4411.1101; EVENSON RE, 2002, HDB AGR EC A, V1, pCH11; Fan SG, 1997, J DEV ECON, V53, P115, DOI 10.1016/S0304-3878(97)00005-9; *FAO, 2008, HUNG RIS SOAR PRIC 7; *FAO, FAOSTAT PROD IND; Food and Agricultural Organisation of the United Nations (FAO), FAOSTAT DAT; JAMES JS, 2008, 0801 INSTEPP; Macours K, 2002, ECON DEV CULT CHANGE, V50, P365, DOI 10.1086/322883; Pardey P.G., 2006, AGR R D DEV WORLD TO; Ruttan V.W., 1982, AGR RES POLICY; *USDA, MAN CLASS AGR FOR RE; *USDA, CRIS DAT FIL; *USDA, INV AGR RES	14	229	233	3	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1209	1210		10.1126/science.1170451	http://dx.doi.org/10.1126/science.1170451			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	490RY	19729642				2022-12-24	WOS:000269523200022
J	Fazel, R; Krumholz, HM; Wang, YF; Ross, JS; Chen, J; Ting, HH; Shah, ND; Nasir, K; Einstein, AJ; Nallamothu, BK				Fazel, Reza; Krumholz, Harlan M.; Wang, Yongfei; Ross, Joseph S.; Chen, Jersey; Ting, Henry H.; Shah, Nilay D.; Nasir, Khurram; Einstein, Andrew J.; Nallamothu, Brahmajee K.			Exposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPUTED-TOMOGRAPHY; UNITED-STATES; PATIENT; RISKS; ANGIOGRAPHY; PROTECTION; RADIOLOGY; CANCER; PHYSICIAN; AWARENESS	Background: The growing use of imaging procedures in the United States has raised concerns about exposure to low-dose ionizing radiation in the general population. Methods: We identified 952,420 nonelderly adults (between 18 and 64 years of age) in five health care markets across the United States between January 1, 2005, and December 31, 2007. Utilization data were used to estimate cumulative effective doses of radiation from imaging procedures and to calculate population-based rates of exposure, with annual effective doses defined as low (lessthan/equal 3 mSv), moderate (>3 to 20 mSv), high (>20 to 50 mSv), or very high (>50 mSv). Results: During the study period, 655,613 enrollees (68.8%) underwent at least one imaging procedure associated with radiation exposure. The mean (+/-SD) cumulative effective dose from imaging procedures was 2.4+/-6.0 mSv per enrollee per year; however, a wide distribution was noted, with a median effective dose of 0.1 mSv per enrollee per year (interquartile range, 0.0 to 1.7). Overall, moderate effective doses of radiation were incurred in 193.8 enrollees per 1000 per year, whereas high and very high doses were incurred in 18.6 and 1.9 enrollees per 1000 per year, respectively. In general, cumulative effective doses of radiation from imaging procedures increased with advancing age and were higher in women than in men. Computed tomographic and nuclear imaging accounted for 75.4% of the cumulative effective dose, with 81.8% of the total administered in outpatient settings. Conclusions: Imaging procedures are an important source of exposure to ionizing radiation in the United States and can result in high cumulative effective doses of radiation. N Engl J Med 2009;361:849-57.	[Fazel, Reza] Emory Univ, Div Cardiol, Sch Med, Dept Med, Atlanta, GA 30306 USA; [Krumholz, Harlan M.; Wang, Yongfei; Chen, Jersey] Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, Dept Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Ross, Joseph S.] Columbia Univ, Med Ctr, Mt Sinai Sch Med, New York, NY USA; [Ross, Joseph S.] Columbia Univ, Med Ctr, James J Peters Vet Affairs Med Ctr, New York, NY USA; Columbia Univ, Med Ctr, Dept Med, Div Cardiol, New York, NY USA; Columbia Univ, Med Ctr, Dept Radiol, New York, NY USA; [Einstein, Andrew J.] New York Presbyterian Hosp, New York, NY USA; [Ting, Henry H.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Shah, Nilay D.] Hlth Care Policy & Res, Rochester, MN USA; [Nasir, Khurram] Johns Hopkins Ciccarone Prevent Cardiol Ctr, Baltimore, MD USA; [Nasir, Khurram] Boston Med Ctr, Dept Internal Med, Boston, MA USA; [Nallamothu, Brahmajee K.] Vet Affairs Ann Arbor Hlth Serv Res & Dev Ctr Exc, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA	Emory University; Yale University; Yale University; Yale University; Yale University; Columbia University; Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine; Boston Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Fazel, R (corresponding author), Emory Univ, Div Cardiol, Sch Med, Dept Med, Bldg A,Suite 1-N,1256 Briarcliff Rd NE, Atlanta, GA 30306 USA.	rfazel@emory.edu	, Harlan/AAI-2875-2020; Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789; Fazel, Reza/0000-0002-9102-6155; Ross, Joseph/0000-0002-9218-3320	NCRR NIH HHS [5 KL2 RR024157, KL2 RR024157] Funding Source: Medline; NIA NIH HHS [K08 AG032886, K08 AG032886-01] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Administration of Radioactive Substances Advisory Committee, 2014, ARSAC NOT GUID GOOD; [Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; BEEBE MDJ, 2006, CPT 2007 STANDARD ED; Bhargavan M, 2005, RADIOLOGY, V234, P824, DOI 10.1148/radiol.2343031536; Brenner DJ, 2008, BRIT J RADIOL, V81, P521, DOI 10.1259/bjr/22942198; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Brenner DJ, 2004, RADIOLOGY, V231, P440, DOI 10.1148/radiol.2312030880; Buls N, 2003, HEALTH PHYS, V85, P165, DOI 10.1097/00004032-200308000-00005; Dietze G, 2009, BRIT J RADIOL, V82, P348, DOI 10.1259/bjr/91937653; Einstein AJ, 2007, CIRCULATION, V116, P1290, DOI 10.1161/CIRCULATIONAHA.107.688101; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Einstein AJ, 2009, JAMA-J AM MED ASSOC, V301, P545, DOI 10.1001/jama.2009.53; Gerber TC, 2009, CIRCULATION, V119, P1056, DOI 10.1161/CIRCULATIONAHA.108.191650; Goske Marilyn J, 2008, J Am Coll Radiol, V5, P1200, DOI 10.1016/j.jacr.2008.06.007; Hausleiter J, 2009, JAMA-J AM MED ASSOC, V301, P500, DOI 10.1001/jama.2009.54; Henzlova MJ, 2009, J NUCL CARDIOL, V16, P331, DOI DOI 10.1007/S12350-009-9062-4; ICRP, 1996, ANN ICRP, V26, P1; *IMV MED INF DIV, 2005, IMV 2005 NUCL MED CE; Jacob K, 2004, CLIN RADIOL, V59, P928, DOI 10.1016/j.crad.2004.04.020; Kailasnath P, 2001, Cardiol Rev, V9, P160, DOI 10.1097/00045415-200105000-00009; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; Martin CJ, 2007, BRIT J RADIOL, V80, P639, DOI 10.1259/bjr/25922439; Martin CJ, 2008, RADIAT PROT DOSIM, V128, P1, DOI 10.1093/rpd/ncm425; McCollough CH, 2008, HEALTH PHYS, V95, P508, DOI 10.1097/01.HP.0000326343.35884.03; Menzel H. G, 2009, BRIT J RADIOL, V81, p[521, 976]; Mettler FA, 2008, HEALTH PHYS, V95, P502, DOI 10.1097/01.HP.0000326333.42287.a2; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; National Research Council, 2006, HLTH RISKS EXP LOW L, P141; NCRP, 2009, J RADIOLOGICAL PROTE, V29; *NEXT, 2007, CRCPD PUBL E, V72; Perisinakis K, 2005, J AM COLL CARDIOL, V46, P2335, DOI 10.1016/j.jacc.2005.01.070; Perisinakis K, 2001, CIRCULATION, V104, P58, DOI 10.1161/hc2601.091710; Prasad KN, 2004, BRIT J RADIOL, V77, P97, DOI 10.1259/bjr/88081058; Quinn AD, 1997, BRIT J RADIOL, V70, P102, DOI 10.1259/bjr.70.829.9059306; Shiralkar S, 2003, BRIT MED J, V327, P371, DOI 10.1136/bmj.327.7411.371; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491; United Nations, 2000, SOURC EFF ION RAD, V1; Wennberg JE, 2004, BMJ-BRIT MED J, V328, P607, DOI 10.1136/bmj.328.7440.607; Wrixon AD, 2008, J RADIOL PROT, V28, P161, DOI 10.1088/0952-4746/28/2/R02; 1996, ANN ICRP, V27, P61	41	980	1007	1	93	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2009	361	9					849	857		10.1056/NEJMoa0901249	http://dx.doi.org/10.1056/NEJMoa0901249			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487XV	19710483	Green Accepted			2022-12-24	WOS:000269312700005
J	Shuldiner, AR; O'Connell, JR; Bliden, KP; Gandhi, A; Ryan, K; Horenstein, RB; Damcott, CM; Pakyz, R; Tantry, US; Gibson, Q; Pollin, TI; Post, W; Parsa, A; Mitchell, BD; Faraday, N; Herzog, W; Gurbel, PA				Shuldiner, Alan R.; O'Connell, Jeffrey R.; Bliden, Kevin P.; Gandhi, Amish; Ryan, Kathleen; Horenstein, Richard B.; Damcott, Coleen M.; Pakyz, Ruth; Tantry, Udaya S.; Gibson, Quince; Pollin, Toni I.; Post, Wendy; Parsa, Afshin; Mitchell, Braxton D.; Faraday, Nauder; Herzog, William; Gurbel, Paul A.			Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; ACTIVE METABOLITE; HEALTHY-SUBJECTS; CYP2C19 POLYMORPHISM; STENT THROMBOSIS; PHARMACOKINETICS; PHARMACODYNAMICS; RESISTANCE; PRASUGREL	Context Clopidogrel therapy improves cardiovascular outcomes in patients with acute coronary syndromes and following percutaneous coronary intervention by inhibiting adenosine diphosphate (ADP)-dependent platelet activation. However, nonresponsiveness is widely recognized and is related to recurrent ischemic events. Objective To identify gene variants that influence clopidogrel response. Design, Setting, and Participants In the Pharmacogenomics of Antiplatelet Intervention (PAPI) Study (2006-2008), we administered clopidogrel for 7 days to 429 healthy Amish persons and measured response by ex vivo platelet aggregometry. A genome-wide association study was performed followed by genotyping the loss-of-function cytochrome P450 (CYP) 2C19*2 variant (rs4244285). Findings in the PAPI Study were extended by examining the relation of CYP2C19*2 genotype to platelet function and cardiovascular outcomes in an independent sample of 227 patients undergoing percutaneous coronary intervention. Main Outcome Measure ADP-stimulated platelet aggregation in response to clopidogrel treatment and cardiovascular events. Results Platelet response to clopidogrel was highly heritable (h(2)=0.73; P<.001). Thirteen single-nucleotide polymorphisms on chromosome 10q24 within the CYP2C18-CYP2C19-CYP2C9-CYP2C8 cluster were associated with diminished clopidogrel response, with a high degree of statistical significance (P=1.5 x 10(-13) for rs12777823, additive model). The rs12777823 polymorphism was in strong linkage disequilibrium with the CYP2C19*2 variant, and was associated with diminished clopidogrel response, accounting for 12% of the variation in platelet aggregation to ADP (P=4.3 x 10(-11)). The relation between CYP2C19*2 genotype and platelet aggregation was replicated in clopidogrel-treated patients undergoing coronary intervention (P=.02). Furthermore, patients with the CYP2C19*2 variant were more likely (20.9% vs 10.0%) to have a cardiovascular ischemic event or death during 1 year of follow-up (hazard ratio, 2.42; 95% confidence interval, 1.18-4.99; P=.02). Conclusion CYP2C19*2 genotype was associated with diminished platelet response to clopidogrel treatment and poorer cardiovascular outcomes. JAMA. 2009; 302(8): 849-858	[Shuldiner, Alan R.; O'Connell, Jeffrey R.; Gandhi, Amish; Ryan, Kathleen; Horenstein, Richard B.; Damcott, Coleen M.; Pakyz, Ruth; Gibson, Quince; Pollin, Toni I.; Mitchell, Braxton D.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Dept Med, Baltimore, MD 21201 USA; [Parsa, Afshin] Univ Maryland, Sch Med, Div Nephrol, Dept Med, Baltimore, MD 21201 USA; [Shuldiner, Alan R.] Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Baltimore, MD 21218 USA; [Bliden, Kevin P.; Tantry, Udaya S.; Herzog, William; Gurbel, Paul A.] Sinai Hosp, Sinai Ctr Thrombosis Res, Baltimore, MD 21215 USA; [Post, Wendy; Herzog, William] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Faraday, Nauder] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Sinai Center Thrombosis Research; Sinai Hospital of Baltimore; Johns Hopkins University; Johns Hopkins University	Shuldiner, AR (corresponding author), Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Dept Med, 660 W Redwood St,Room 494, Baltimore, MD 21201 USA.	ashuldin@medicine.umaryland.edu	Mitchell, Braxton/CAF-0876-2022	Mitchell, Braxton/0000-0003-4920-4744; Shuldiner, Alan/0000-0001-9921-4305	National Institutes of Health [NIH U01 GM074518, U01 HL084756]; Clinical Nutrition Research Unit of Maryland [P30 DK072488]; University of Maryland General Clinical Research Center [M01 RR 16500]; Baltimore Veterans Administration Geriatric Research and Education Clinical Center; Sinai Hospital of Baltimore; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR016500] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488, P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Nutrition Research Unit of Maryland; University of Maryland General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Baltimore Veterans Administration Geriatric Research and Education Clinical Center; Sinai Hospital of Baltimore; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding/Support: This study was supported by National Institutes of Health grants NIH U01 GM074518 and U01 HL084756, the Clinical Nutrition Research Unit of Maryland (P30 DK072488), the University of Maryland General Clinical Research Center (M01 RR 16500), the Baltimore Veterans Administration Geriatric Research and Education Clinical Center, and Sinai Hospital of Baltimore.	Agarwala R, 1998, GENOME RES, V8, P211, DOI 10.1101/gr.8.3.211; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Angiolillo DJ, 2007, THROMB HAEMOSTASIS, V98, P707, DOI 10.1160/TH07-08-0518; Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]; Applegate RJ, 2008, AM J CARDIOL, V102, P683, DOI 10.1016/j.amjcard.2008.04.050; Bliden KP, 2007, J AM COLL CARDIOL, V49, P657, DOI 10.1016/j.jacc.2006.10.050; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Brandt JT, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.010; Buonamici P, 2007, J AM COLL CARDIOL, V49, P2312, DOI 10.1016/j.jacc.2007.01.094; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Farid NA, 2008, PHARMACOTHERAPY, V28, P1483, DOI 10.1592/phco.28.12.1483; Fontana P, 2007, J THROMB HAEMOST, V5, P2153, DOI 10.1111/j.1538-7836.2007.02722.x; Frere C, 2008, AM J CARDIOL, V101, P1088, DOI 10.1016/j.amjcard.2007.11.065; Gilard M, 2006, J THROMB HAEMOST, V4, P2508, DOI 10.1111/j.1538-7836.2006.02162.x; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1820, DOI 10.1016/j.jacc.2005.07.041; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Gurbel PA, 2008, J AM COLL CARDIOL, V51, P261, DOI 10.1016/j.jacc.2007.07.090; Gurbel PA, 2007, THROMB RES, V120, P311, DOI 10.1016/j.thromres.2006.08.012; Gurbel PA, 2006, NAT CLIN PRACT CARD, V3, P387, DOI 10.1038/ncpcardio0602; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Kim KA, 2008, CLIN PHARMACOL THER, V84, P236, DOI 10.1038/clpt.2008.20; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Lau WC, 2004, CIRCULATION, V109, P166, DOI 10.1161/01.CIR.0000112378.09325.F9; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; Luo HR, 2006, CLIN PHARMACOL THER, V80, P33, DOI 10.1016/j.clpt.2006.03.003; Malek LA, 2008, CIRC J, V72, P1165, DOI 10.1253/circj.72.1165; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Savi P, 2000, THROMB HAEMOSTASIS, V84, P891, DOI 10.1055/s-0037-1614133; Siller-Matula JM, 2008, J AM COLL CARDIOL, V52, P1557, DOI 10.1016/j.jacc.2008.07.055; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Small DS, 2008, CURR MED RES OPIN, V24, P2251, DOI 10.1185/03007990802205985; Takahashi M, 2008, J PHARMACEUT BIOMED, V48, P1219, DOI 10.1016/j.jpba.2008.08.020; Takakubo F, 1996, PHARMACOGENETICS, V6, P265, DOI 10.1097/00008571-199606000-00011; Tcheng JE, 2000, LANCET, V356, P2037; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Umemura K, 2008, J THROMB HAEMOST, V6, P1439, DOI 10.1111/j.1538-7836.2008.03050.x; Wallentin L, 2008, EUR HEART J, V29, P21, DOI 10.1093/eurheartj/ehm545; Xiao ZS, 1997, J PHARMACOL EXP THER, V281, P604	41	1090	1166	6	96	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 26	2009	302	8					849	858		10.1001/jama.2009.1232	http://dx.doi.org/10.1001/jama.2009.1232			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487GN	19706858	Green Accepted			2022-12-24	WOS:000269260100018
J	Ramalho-Santos, M				Ramalho-Santos, Miguel			iPS Cells: Insights into Basic Biology	CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; GENERATION	The discovery that adult somatic cells can be induced to become pluripotent by overexpression of a few key transcription factors provides an exciting new window into the basic biology of pluripotency and differentiation.	[Ramalho-Santos, Miguel] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Ob Gyn, San Francisco, CA 94143 USA; [Ramalho-Santos, Miguel] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ramalho-Santos, M (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Ob Gyn, San Francisco, CA 94143 USA.	mrsantos@diabetes.ucsf.edu	Ramalho-Santos, Miguel/L-9092-2018	Ramalho-Santos, Miguel/0000-0003-0177-5556	NIH; California Institute; Juvenile Diabetes Research Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004698] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	I thank the Santos lab, R. Blelloch, J. Ramalho-Santos, M. Conti, B. Bruneau, J. Reiter, and S. Fisher for helpful comments and M. Grskovic for help with the figure. M. R.-S. is funded by an NIH Director's New Innovator Award, the California Institute for Regenerative Medicine, and the Juvenile Diabetes Research Foundation.	Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	15	20	22	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					616	618		10.1016/j.cell.2009.08.012	http://dx.doi.org/10.1016/j.cell.2009.08.012			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703387	Green Accepted, Bronze			2022-12-24	WOS:000269156100002
J	Dinarina, A; Pugieux, C; Corral, MM; Loose, M; Spatz, J; Karsenti, E; Nedelec, F				Dinarina, Ana; Pugieux, Celine; Corral, Maria Mora; Loose, Martin; Spatz, Joachim; Karsenti, Eric; Nedelec, Francois			Chromatin Shapes the Mitotic Spindle	CELL			English	Article							XENOPUS EGG EXTRACTS; POLYMERIZATION DYNAMICS; CHROMOSOME ALIGNMENT; SELF-ORGANIZATION; MICROTUBULE FLUX; IN-VITRO; CENTROSOME; METAPHASE; PROTEIN; CYCLIN	In animal and plant cells, mitotic chromatin locally generates microtubules that self-organize into a mitotic spindle, and its dimensions and bipolar symmetry are essential for accurate chromosome segregation. By immobilizing microscopic chromatin-coated beads on slide surfaces using a microprinting technique, we have examined the effect of chromatin on the dimensions and symmetry of spindles in Xenopus laevis cytoplasmic extracts. While circular spots with diameters around 14-18 mu m trigger bipolar spindle formation, larger spots generate an incorrect number of poles. We also examined lines of chromatin with various dimensions. Their length determined the number of poles that formed, with a 6 x 18 mu m rectangular patch generating normal spindle morphology. Around longer lines, multiple poles formed and the structures were disorganized. While lines thinner than 10 mu m generated symmetric structures, thicker lines induced the formation of asymmetric structures where all microtubules are on the same side of the line. Our results show that chromatin defines spindle shape and orientation. For a video summary of this article, see the Paper-Flick file available with the online Supplemental Data.	[Dinarina, Ana; Pugieux, Celine; Corral, Maria Mora; Loose, Martin; Karsenti, Eric; Nedelec, Francois] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; [Spatz, Joachim] Univ Heidelberg, Dept Biophys Chem, D-69120 Heidelberg, Germany; [Spatz, Joachim] MPI Met Res, D-70569 Stuttgart, Germany	European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg	Nedelec, F (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany.	nedelec@embl.de	Nedelec, Francois/AAC-1673-2019; Spatz, Joachim P/A-1107-2017; Nedelec, Francois J/H-3317-2011	Nedelec, Francois/0000-0002-8141-5288; Spatz, Joachim P/0000-0003-3419-9807; Nedelec, Francois J/0000-0002-8141-5288; Loose, Martin/0000-0001-7309-9724	EU [LSHG-CT-2004-503568]; Spanish ministry of education; EU-STREP active BioMics; Center for Modeling and Simulation in the Biosciences; Volkswagenstiftung, and Human Frontier Science Program [RGY84]	EU(European Commission); Spanish ministry of education(Spanish Government); EU-STREP active BioMics; Center for Modeling and Simulation in the Biosciences; Volkswagenstiftung, and Human Frontier Science Program(Volkswagen)	A. D. and C. P. performed the experiments. M. M. C. established the chromatin patterning technique. M. L. developed the microfluidic chambers. M. M. C. obtained the initial results with M. L. J. S. and colleagues advised with microfabrication and offered access to the necessary facilities. E. K. contributed expertise with X. laevis egg extracts and bead assays and helped supervise the project. F. N. wrote the Matlab functions and analyzed the results with A. D. and C. P. He conceived and directed the research. F. N., A. D., and C. P. wrote the article with help from E. K. and M. L.; We thank C. Roduit, M. Kaksonen, R. Loughlin, T. Surrey, and J. Ward for critically reading the manuscript and Z. Gueroui for discussions. We used the Advanced Light Microscopy Facility and the animal facility at the European Molecular Biology Laboratory. We thank K. Crnokic, M. Caudron, S. Kandels-Lewis, S. Ruf ( egg extracts), J. Ulmer and A. Lindner (microcontact printing), A. Wunsche ( image acquisition), S. Laffont, M. Etzrodt, and N. Charuttini for help with the assay development. This work was supported by EU contract LSHG-CT-2004-503568 ComBio, the Spanish ministry of education ( M. M. C.), and EU-STREP active BioMics ( A. D.). Research in the Nedelec lab is funded by the Center for Modeling and Simulation in the Biosciences (http://www.bioms.de), the Volkswagenstiftung, and Human Frontier Science Program grant RGY84.	Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Athale CA, 2008, SCIENCE, V322, P1243, DOI 10.1126/science.1161820; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Bornens M, 2007, ADV EXP MED BIOL, V607, P119; Bringmann H, 2004, SCIENCE, V303, P1519, DOI 10.1126/science.1094838; Brown KS, 2007, J CELL BIOL, V176, P765, DOI 10.1083/jcb.200610043; Burbank KS, 2007, CURR BIOL, V17, P1373, DOI 10.1016/j.cub.2007.07.058; Clausen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000244; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1998, J CELL BIOL, V141, P703, DOI 10.1083/jcb.141.3.703; Dogterom M, 1996, J CELL BIOL, V133, P125, DOI 10.1083/jcb.133.1.125; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Gaetz J, 2006, NAT CELL BIOL, V8, P924, DOI 10.1038/ncb1455; Gatlin JC, 2009, CURR BIOL, V19, P287, DOI 10.1016/j.cub.2009.01.055; Gehmlich K, 2004, EMBO REP, V5, P97, DOI 10.1038/sj.embor.7400046; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; KARSENTI E, 1984, J CELL BIOL, V99, pS47, DOI 10.1083/jcb.99.1.47s; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Lloyd C, 2006, NAT REV MOL CELL BIO, V7, P147, DOI 10.1038/nrm1831; Mahoney NM, 2006, CURR BIOL, V16, P564, DOI 10.1016/j.cub.2006.01.053; Maresca Thomas J., 2006, V322, P459; Matthies HJG, 1996, J CELL BIOL, V134, P455, DOI 10.1083/jcb.134.2.455; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; THIEBAUD CH, 1977, CHROMOSOMA, V59, P253, DOI 10.1007/BF00292781; Tokai-Nishizumi N, 2005, MOL BIOL CELL, V16, P5455, DOI 10.1091/mbc.E05-03-0244; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Wickstead B, 2007, TRAFFIC, V8, P1708, DOI 10.1111/j.1600-0854.2007.00646.x; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Wuhr M, 2008, CURR BIOL, V18, P1256, DOI 10.1016/j.cub.2008.07.092	41	69	69	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					502	513		10.1016/j.cell.2009.05.027	http://dx.doi.org/10.1016/j.cell.2009.05.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665972	Bronze			2022-12-24	WOS:000268771900015
J	Davies, A; Jones, D; Bailey, M; Beca, J; Bellomo, R; Blackwell, N; Forrest, P; Gattas, D; Granger, E; Herkes, R; Jackson, A; McGuinness, S; Nair, P; Pellegrino, V; Pettila, V; Plunkett, B; Pye, R; Torzillo, P; Webb, S; Wilson, M; Ziegenfuss, M				Davies, Andrew; Jones, Daryl; Bailey, Michael; Beca, John; Bellomo, Rinaldo; Blackwell, Nikki; Forrest, Paul; Gattas, David; Granger, Emily; Herkes, Robert; Jackson, Andrew; McGuinness, Shay; Nair, Priya; Pellegrino, Vincent; Pettilae, Ville; Plunkett, Brian; Pye, Roger; Torzillo, Paul; Webb, Steve; Wilson, Michael; Ziegenfuss, Marc		ANZ ECMO Influenza Investigators	Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LIFE-SUPPORT; A H1N1; PREGNANCY; FAILURE	Context The novel influenza A(H1N1) pandemic affected Australia and New Zealand during the 2009 southern hemisphere winter. It caused an epidemic of critical illness and some patients developed severe acute respiratory distress syndrome (ARDS) and were treated with extracorporeal membrane oxygenation (ECMO). Objectives To describe the characteristics of all patients with 2009 influenza A(H1N1) associated ARDS treated with ECMO and to report incidence, resource utilization, and patient outcomes. Design, Setting, and Patients An observational study of all patients (n=68) with 2009 influenza A(H1N1)-associated ARDS treated with ECMO in 15 intensive care units (ICUs) in Australia and New Zealand between June 1 and August 31, 2009. Main Outcome Measures Incidence, clinical features, degree of pulmonary dysfunction, technical characteristics, duration of ECMO, complications, and survival. Results Sixty-eight patients with severe influenza-associated ARDS were treated with ECMO, of whom 61 had either confirmed 2009 influenza A(H1N1) (n=53) or influenza A not subtyped (n=8), representing an incidence rate of 2.6 ECMO cases per million population. An additional 133 patients with influenza A received mechanical ventilation but no ECMO in the same ICUs. The 68 patients who received ECMO had a median (interquartile range [IQR]) age of 34.4 (26.6-43.1) years and 34 patients (50%) were men. Before ECMO, patients had severe respiratory failure despite advanced mechanical ventilatory support with a median (IQR) PaO(2)/fraction of inspired oxygen (FIO(2)) ratio of 56 (48-63), positive end-expiratory pressure of 18 (15-20) cm H(2)O, and an acute lung injury score of 3.8 (3.5-4.0). The median (IQR) duration of ECMO support was 10 (7-15) days. At the time of reporting, 48 of the 68 patients (71%; 95% confidence interval [CI], 60%-82%) had survived to ICU discharge, of whom 32 had survived to hospital discharge and 16 remained as hospital inpatients. Fourteen patients (21%; 95% CI, 11%-30%) had died and 6 remained in the ICU, 2 of whom were still receiving ECMO. Conclusions During June to August 2009 in Australia and New Zealand, the ICUs at regional referral centers provided mechanical ventilation for many patients with 2009 influenza A(H1N1) -associated respiratory failure, one-third of whom received ECMO. These ECMO-treated patients were often young adults with severe hypoxemia and had a 21% mortality rate at the end of the study period. JAMA. 2009;302(17):1888-1895	[Davies, Andrew] Alfred Hosp, Intens Care Unit, Melbourne, Vic 3004, Australia; [Davies, Andrew; Jones, Daryl; Bailey, Michael; Bellomo, Rinaldo; Pettilae, Ville] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia; [Jones, Daryl; Bellomo, Rinaldo] Austin Hosp, Melbourne, Vic 3084, Australia; [Beca, John; McGuinness, Shay] Auckland City Hosp, Auckland, New Zealand; [Blackwell, Nikki; Ziegenfuss, Marc] Prince Charles Hosp, Brisbane, Qld 4032, Australia; [Forrest, Paul; Gattas, David; Herkes, Robert; Plunkett, Brian; Torzillo, Paul; Wilson, Michael] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Granger, Emily; Jackson, Andrew; Nair, Priya; Pye, Roger] St Vincents Hosp, Sydney, NSW 2010, Australia; [Webb, Steve] Univ Western Australia, Royal Perth Hosp, Perth, WA 6009, Australia; [Webb, Steve] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Webb, Steve] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Auckland City Hospital; Prince Charles Hospital; University of Sydney; St Vincents Hospital Sydney; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia	Davies, A (corresponding author), Alfred Hosp, Intens Care Unit, Commercial Rd, Melbourne, Vic 3004, Australia.	a.davies@alfred.org.au	Bailey, Michael J/A-4499-2012; Joyce, Christopher/B-7437-2013; Gattas, David/AAN-9668-2020; blackwell, nikki/H-4222-2013	Bailey, Michael J/0000-0002-5551-1401; Gattas, David/0000-0002-9282-7093; Micallef, Sharon/0000-0002-8496-2324; McGuinness, Shay/0000-0003-0620-4787; Ziegenfuss, Marc/0000-0002-1488-2994; Rajbhandari, Dorrilyn/0000-0001-8883-0428; Bellomo, Rinaldo/0000-0002-1650-8939; Whitehead, Christina/0000-0003-4561-7082				[Anonymous], WORLDWIDE H1N1 SWINE; *AUSRT DEP HLTH AG, PAND H1N1 2009 UPD B; *AUSTR DEP HLTH AG, PAND H1N1 2009 UPD B; *AUSTR DEP HLTH AG, AUSTR NAT INFL SURV; Australian Bureau of Statistics, AUSTR DEM STAT; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; CHOW AW, 1992, CLIN INFECT DIS, V15, pS62, DOI 10.1093/clind/15.Supplement_1.S62; Conrad SA, 2005, ASAIO J, V51, P4, DOI 10.1097/01.mat.0000151922.67540.E9; Cunningham JA, 2006, OBSTET GYNECOL, V108, P792, DOI 10.1097/01.AOG.0000209184.33709.ec; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Hemmila MR, 2004, ANN SURG, V240, P595, DOI 10.1097/01.sla.0000141159.90676.2d; King PT, 2000, LANCET, V356, P45, DOI 10.1016/S0140-6736(00)02438-7; Linden VB, 2009, ACTA ANAESTH SCAND, V53, P489, DOI 10.1111/j.1399-6576.2008.01808.x; LUM ME, 2009, MED J AUSTRALIA, V191, P1; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; *NZ MIN HLTH, PAND INFL H1N1 09 SW; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Peek GJ, 1997, CHEST, V112, P759, DOI 10.1378/chest.112.3.759; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; *STAT NZ, POP IND; Webb SAR, 2009, CRIT CARE RESUSC, V11, P170; WHO, INFL LIK ILLN US MEX	22	1113	1169	4	154	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 4	2009	302	17					1888	1895		10.1001/jama.2009.1535	http://dx.doi.org/10.1001/jama.2009.1535			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514DU	19822628	Bronze			2022-12-24	WOS:000271375300020
J	Dippold, HC; Ng, MM; Farber-Katz, SE; Lee, SK; Kerr, ML; Peterman, MC; Sim, R; Wiharto, PA; Galbraith, KA; Madhavarapu, S; Fuchs, GJ; Meerloo, T; Farquhar, MG; Zhou, HL; Field, SJ				Dippold, Holly C.; Ng, Michelle M.; Farber-Katz, Suzette E.; Lee, Sun-Kyung; Kerr, Monica L.; Peterman, Marshall C.; Sim, Ronald; Wiharto, Patricia A.; Galbraith, Kenneth A.; Madhavarapu, Swetha; Fuchs, Greg J.; Meerloo, Timo; Farquhar, Marilyn G.; Zhou, Huilin; Field, Seth J.			GOLPH3 Bridges Phosphatidylinositol-4-Phosphate and Actomyosin to Stretch and Shape the Golgi to Promote Budding	CELL			English	Article							PDZ-CONTAINING MYOSIN; ACTIN DYNAMICS; TRANSPORT; COMPLEX; BINDING; LOCALIZATION; TRAFFICKING; SECRETION; PROTEINS; CELLS	Golgi membranes, from yeast to humans, are uniquely enriched in phosphatidylinositol-4-phosphate (PtdIns(4)P), although the role of this lipid remains poorly understood. Using a proteomic lipid-binding screen, we identify the Golgi protein GOLPH3 (also called GPP34, GMx33, MIDAS, or yeast Vps74p) as a PtdIns(4)P-binding protein that depends on PtdIns(4)P for its Golgi localization. We further show that GOLPH3 binds the unconventional myosin MYO18A, thus connecting the Golgi to F-actin. We demonstrate that this linkage is necessary for normal Golgi trafficking and morphology. The evidence suggests that GOLPH3 binds to PtdIns(4) P-rich trans-Golgi membranes and MYO18A conveying a tensile force required for efficient tubule and vesicle formation. Consequently, this tensile force stretches the Golgi into the extended ribbon observed by fluorescence microscopy and the familiar flattened form observed by electron microscopy.	[Dippold, Holly C.; Ng, Michelle M.; Farber-Katz, Suzette E.; Lee, Sun-Kyung; Peterman, Marshall C.; Sim, Ronald; Wiharto, Patricia A.; Galbraith, Kenneth A.; Field, Seth J.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Fuchs, Greg J.; Zhou, Huilin] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Meerloo, Timo; Farquhar, Marilyn G.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kerr, Monica L.; Madhavarapu, Swetha] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA	University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Beth Israel Deaconess Medical Center	Field, SJ (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA.	sjfield@ucsd.edu		Field, Seth/0000-0002-8893-4806; Zhou, Huilin/0000-0002-1350-4430	NIDDK Postdoctoral Training Grant; American Cancer Society Fellowship; Burroughs Wellcome Fund; V Foundation; NIH New Innovator Award; NATIONAL CANCER INSTITUTE [R01CA138676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK065108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080469] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004265] Funding Source: NIH RePORTER	NIDDK Postdoctoral Training Grant; American Cancer Society Fellowship(American Cancer Society); Burroughs Wellcome Fund(Burroughs Wellcome Fund); V Foundation; NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Cantley, S. Emr, G. Rosenfeld, and C. Min for helpful advice, reagents, and support. We thank R. Tsien, P. Mayinger, J. Lippincott-Schwartz, V. Malhotra, O. Ohara, and Z. Chroneos for generous gifts of reagents. We thank K. Messer of the UCSD-Moores Cancer Center for help with statistical analyses. We acknowledge the following support: M.M.N. by NIDDK Postdoctoral Training Grant and American Cancer Society Fellowship; S.E.F.-K. by NIDDK Pre-Doctoral Training Grant; and S. J. F. by the Burroughs Wellcome Fund, the V Foundation, NIDDK, and NIH New Innovator Award.	Allan VJ, 2002, NAT CELL BIOL, V4, pE236, DOI 10.1038/ncb1002-e236; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Barr FA, 1996, SEMIN CELL DEV BIOL, V7, P505, DOI 10.1006/scdb.1996.0063; Beh CT, 2001, GENETICS, V157, P1117; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; COOPER MS, 1990, CELL, V61, P135, DOI 10.1016/0092-8674(90)90221-Y; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; DAVIDSON MW, 2004, MOL EXPRESSIONS CELL; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Finger FP, 1998, J CELL BIOL, V142, P609, DOI 10.1083/jcb.142.3.609; Furusawa T, 2000, BIOCHEM BIOPH RES CO, V270, P67, DOI 10.1006/bbrc.2000.2377; Giussani P, 2008, BBA-MOL CELL BIOL L, V1781, P40, DOI 10.1016/j.bbalip.2007.11.002; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hirschberg K, 2000, METHOD ENZYMOL, V327, P69, DOI 10.1016/S0076-6879(00)27268-6; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Isogawa Y, 2005, BIOCHEMISTRY-US, V44, P6190, DOI 10.1021/bi0475931; KRISTEN U, 1983, EUR J CELL BIOL, V29, P262; Lazaro-Dieguez F, 2007, FEBS LETT, V581, P3875, DOI 10.1016/j.febslet.2007.07.015; Lazaro-Dieguez F, 2006, CELL MOTIL CYTOSKEL, V63, P778, DOI 10.1002/cm.20161; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Mori K, 2005, BIOCHEM BIOPH RES CO, V326, P491, DOI 10.1016/j.bbrc.2004.11.058; Mori K, 2003, J BIOCHEM, V133, P405, DOI 10.1093/jb/mvg053; Nakagawa T, 1996, J BIOL CHEM, V271, P12088, DOI 10.1074/jbc.271.20.12088; Nakashima-Kamimura N, 2005, J CELL SCI, V118, P5357, DOI 10.1242/jcs.02645; Oka T, 2005, J BIOL CHEM, V280, P32736, DOI 10.1074/jbc.M505558200; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Puthenveedu MA, 2005, CURR OPIN CELL BIOL, V17, P369, DOI 10.1016/j.ceb.2005.06.006; Raychaudhuri S, 2006, BIOCHEM SOC T, V34, P359, DOI 10.1042/BST0340359; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; ROGALSKI AA, 1984, J CELL BIOL, V99, P1092, DOI 10.1083/jcb.99.3.1092; Rohde HM, 2003, J BIOL CHEM, V278, P52689, DOI 10.1074/jbc.M307983200; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Snyder CM, 2006, MOL BIOL CELL, V17, P511, DOI 10.1091/mbc.E05-07-0682; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Varnai P, 2007, PFLUG ARCH EUR J PHY, V455, P69, DOI 10.1007/s00424-007-0270-y; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wong K, 1997, J BIOL CHEM, V272, P13236, DOI 10.1074/jbc.272.20.13236; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x; Yoshino A, 2005, J CELL SCI, V118, P2279, DOI 10.1242/jcs.02358; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	61	280	299	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					337	351		10.1016/j.cell.2009.07.052	http://dx.doi.org/10.1016/j.cell.2009.07.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837035	Green Accepted, Bronze			2022-12-24	WOS:000270857500017
J	Vakulin, A; Baulk, SD; Catcheside, PG; Antic, NA; van den Heuvel, CJ; Dorrian, J; McEvoy, RD				Vakulin, Andrew; Baulk, Stuart D.; Catcheside, Peter G.; Antic, Nick A.; van den Heuvel, Cameron J.; Dorrian, Jillian; McEvoy, R. Doug			Effects of Alcohol and Sleep Restriction on Simulated Driving Performance in Untreated Patients With Obstructive Sleep Apnea	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-DOSE ALCOHOL; DAYTIME SLEEPINESS; RISK-FACTORS; DEPRIVATION; IMPAIRMENT; FATIGUE; ADULTS; MEN; ASSOCIATION; WAKEFULNESS	Background: Because of previous sleep disturbance and sleep hypoxia, patients with obstructive sleep apnea (OSA) might be more vulnerable to the effects of alcohol and sleep restriction than healthy persons. Objective: To compare the effects of sleep restriction and alcohol on driving simulator performance in patients with OSA and age-matched control participants. Design: Driving simulator assessments in 2 groups under 3 different conditions presented in random order. Setting: Adelaide Institute for Sleep Health, Sleep Laboratory, Adelaide, Australia. Participants: 38 untreated patients with OSA and 20 control participants. Measurements: Steering deviation, crashes, and braking reaction time. Intervention: Unrestricted sleep, sleep restricted to a maximum of 4 hours, and ingestion of an amount of 40% vodka calculated to achieve a blood alcohol level of 0.05 g/dL. Results: Patients with OSA demonstrated increased steering deviation compared with control participants (mean, 50.5 cm [95% CI, 46.1 to 54.9 cm] in the OSA group and 38.4 cm [CI, 32.4 to 44.4 cm] in the control group; P < 0.01) and significantly greater steering deterioration over time (group by time interaction, P = 0.02). The increase in steering deviation after sleep restriction and alcohol was approximately 40% greater in patients with OSA than in control participants (group by condition interaction, P = 0.04). Patients with OSA crashed more frequently than control participants (1 vs. 24 participants; odds ratio [OR], 25.4; P = 0.03) and crashed more frequently after sleep restriction (OR, 4.0; P < 0.01) and alcohol consumption (OR, 2.3; P = 0.02) than after normal sleep. In patients with OSA, prolonged eye closure (>2 seconds) and microsleeps (>2 seconds of theta activity on electroencephalography) were significant crash predictors (OR, 19.2 and 7.2, respectively; P < 0.01). Braking reaction time was slower after sleep restriction than after normal sleep (mean, 1.39 [SD, 0.06] seconds vs. 1.22 [SD, 0.04] seconds; P < 0.01) but not after alcohol consumption. No group differences were found. Limitation: Simulated driving was assessed rather than on-road driving. Conclusion: Patients with OSA are more vulnerable than healthy persons to the effects of alcohol consumption and sleep restriction on various driving performance variables.	[Vakulin, Andrew] Univ Adelaide, Adelaide Inst Sleep Hlth, Repatriat Gen Hosp, Adelaide, SA 5041, Australia; Univ S Australia, Ctr Sleep Res, Adelaide, SA 5001, Australia; Flinders Univ S Australia, Park, Australia	Flinders University South Australia; University of Adelaide; University of South Australia; Flinders University South Australia	Vakulin, A (corresponding author), Univ Adelaide, Adelaide Inst Sleep Hlth, Repatriat Gen Hosp, Daws Rd,Daw Pk, Adelaide, SA 5041, Australia.	andrew.vakulin@health.sa.gov.au	McEvoy, Doug/ABB-8052-2020; Dorrian, Jillian/C-1339-2010; van den Heuvel, Cameron J./E-1993-2012; Dorrian, Jillian/K-6496-2019; Vakulin, Andrew/Q-3360-2019	Dorrian, Jillian/0000-0002-6485-1643; van den Heuvel, Cameron J./0000-0001-7264-4655; Vakulin, Andrew/0000-0002-3919-1313; Catcheside, Peter/0000-0002-9372-6788	Australian National Health and Medical Research Council [390400]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	By the Australian National Health and Medical Research Council (project grant 390400).	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Ayalon L, 2006, NEUROIMAGE, V31, P1817, DOI 10.1016/j.neuroimage.2006.02.042; Banks S, 2004, SLEEP, V27, P1063, DOI 10.1093/sleep/27.6.1063; Barrett PR, 2004, HUM PSYCHOPHARM CLIN, V19, P421, DOI 10.1002/hup.601; BEARPARK H, 1995, AM J RESP CRIT CARE, V151, P1459, DOI 10.1164/ajrccm.151.5.7735600; BEDARD MA, 1993, J CLIN EXP NEUROPSYC, V15, P330, DOI 10.1080/01688639308402567; Beebe DW, 2003, SLEEP, V26, P298, DOI 10.1093/sleep/26.3.298; Beebe DW, 2002, J SLEEP RES, V11, P1, DOI 10.1046/j.1365-2869.2002.00289.x; Berry JG, 2007, ADDICTION, V102, P1399, DOI 10.1111/j.1360-0443.2007.01893.x; CROW KA, 1989, HUMAN METABOLISM ALC, V1; Desai AV, 2006, J CLIN SLEEP MED, V2, P63; Drummond SPA, 2005, PSYCHIAT RES-NEUROIM, V140, P211, DOI 10.1016/j.pscychresns.2005.06.007; Drummond SPA, 1999, NEUROREPORT, V10, P3745, DOI 10.1097/00001756-199912160-00004; Drummond SPA, 2001, J SLEEP RES, V10, P85, DOI 10.1046/j.1365-2869.2001.00245.x; Eckert Danny J, 2008, Proc Am Thorac Soc, V5, P144, DOI 10.1513/pats.200707-114MG; Engleman H, 1999, SLEEP MED REV, V3, P59, DOI 10.1016/S1087-0792(99)90014-X; Flemons WW, 2004, AM J RESP CRIT CARE, V169, P668, DOI 10.1164/rccm.200308-1124PP; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; George CFP, 1996, AM J RESP CRIT CARE, V154, P175, DOI 10.1164/ajrccm.154.1.8680676; George CFP, 2002, AM J RESP CRIT CARE, V165, P746, DOI 10.1164/ajrccm.165.6.2107112; Gozal D, 2001, J NEUROSCI, V21, P2442, DOI 10.1523/JNEUROSCI.21-07-02442.2001; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Howard ME, 2007, SLEEP, V30, P1334, DOI 10.1093/sleep/30.10.1334; Howard ME, 2004, AM J RESP CRIT CARE, V170, P1014, DOI 10.1164/rccm.200312-1782oc; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Juniper M, 2000, EUR RESPIR J, V15, P590, DOI 10.1034/j.1399-3003.2000.15.27.x; Kamba M, 2001, J NEUROL NEUROSUR PS, V71, P334, DOI 10.1136/jnnp.71.3.334; Kapur Vishesh, 2002, Sleep Breath, V6, P49, DOI 10.1055/s-2002-32318; Kotterba S, 1998, J NEUROL SCI, V159, P45, DOI 10.1016/S0022-510X(98)00131-2; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Moselhy HF, 2001, ALCOHOL ALCOHOLISM, V36, P357, DOI 10.1093/alcalc/36.5.357; *NAT SLEEP FDN, 2008, SLEEP AM POLL; O'Donoghue FJ, 2005, AM J RESP CRIT CARE, V171, P1185, DOI 10.1164/rccm.200406-738OC; Philip P, 2005, SLEEP, V28, P1511, DOI 10.1093/sleep/28.12.1511; Philip P, 2003, SLEEP, V26, P277, DOI 10.1093/sleep/26.3.277; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Risser MR, 2000, SLEEP, V23, P393; Sassani A, 2004, SLEEP, V27, P453, DOI 10.1093/sleep/27.3.453; Stockwell TR, 2002, MED J AUSTRALIA, V176, P91, DOI 10.5694/j.1326-5377.2002.tb04308.x; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Thiffault P, 2003, ACCIDENT ANAL PREV, V35, P381, DOI 10.1016/S0001-4575(02)00014-3; Thomas RJ, 2005, J APPL PHYSIOL, V98, P2226, DOI 10.1152/japplphysiol.01225.2004; Turkington PM, 2001, THORAX, V56, P800, DOI 10.1136/thorax.56.10.800; Vakulin A, 2007, SLEEP, V30, P1327, DOI 10.1093/sleep/30.10.1327; Veasey SC, 2004, SLEEP, V27, P194, DOI 10.1093/sleep/27.2.194; Vgontzas AN, 1998, ARCH INTERN MED, V158, P1333, DOI 10.1001/archinte.158.12.1333; Weaver Terri E, 2008, Proc Am Thorac Soc, V5, P173, DOI 10.1513/pats.200708-119MG; Wong KKH, 2008, J SLEEP RES, V17, P322, DOI 10.1111/j.1365-2869.2008.00665.x; Young T, 1997, SLEEP, V20, P608, DOI 10.1093/sleep/20.8.608; Young T, 2004, JAMA-J AM MED ASSOC, V291, P2013, DOI 10.1001/jama.291.16.2013; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	54	61	62	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2009	151	7					447	W145		10.7326/0003-4819-151-7-200910060-00005	http://dx.doi.org/10.7326/0003-4819-151-7-200910060-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502OT	19805768				2022-12-24	WOS:000270470500002
J	Balazs, AC; Epstein, IR				Balazs, Anna C.; Epstein, Irving R.			Emergent or Just Complex?	SCIENCE			English	Editorial Material							LIFE; ORIGIN; GUIDE; CELLS		[Balazs, Anna C.] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA; [Epstein, Irving R.] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; [Epstein, Irving R.] Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brandeis University; Brandeis University	Balazs, AC (corresponding author), Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA.	balazs@pitt.edu; epstein@brandeis.edu		Balazs, Anna/0000-0002-5555-2692				Barish RD, 2009, P NATL ACAD SCI USA, V106, P6054, DOI 10.1073/pnas.0808736106; Dayal P, 2009, LANGMUIR, V25, P4298, DOI 10.1021/la900051b; Deamer DW, 2008, NATURE, V454, P37, DOI 10.1038/454037a; Gandhi N, 2007, J THEOR BIOL, V249, P58, DOI 10.1016/j.jtbi.2007.07.004; GARDNER M, 1970, SCI AM, V223, P120, DOI 10.1038/scientificamerican1070-120; Hud NV, 2007, CHEM BIODIVERS, V4, P768, DOI 10.1002/cbdv.200790063; Kiss IZ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046204; Leunissen ME, 2009, SOFT MATTER, V5, P2422, DOI 10.1039/b817679e; Norris V, 2007, ORIGINS LIFE EVOL B, V37, P429, DOI 10.1007/s11084-007-9088-z; Pizzarello S, 2007, CHEM BIODIVERS, V4, P680, DOI 10.1002/cbdv.200790058; Pooley CM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228103; Rasmussen S, 2004, SCIENCE, V303, P963, DOI 10.1126/science.1093669; Snezhko A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.118103; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Taylor AF, 2009, SCIENCE, V323, P614, DOI 10.1126/science.1166253; *U AL, 2009, EM CHEM SYST 2 0; Vanag VK, 2003, P NATL ACAD SCI USA, V100, P14635, DOI 10.1073/pnas.2534816100; Wolfram S., 2002, NEW KIND SCI	18	24	24	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 25	2009	325	5948					1632	1634		10.1126/science.1178323	http://dx.doi.org/10.1126/science.1178323			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779180				2022-12-24	WOS:000270131800024
J	Walker, B; Barrett, S; Polasky, S; Galaz, V; Folke, C; Engstrom, G; Ackerman, F; Arrow, K; Carpenter, S; Chopra, K; Daily, G; Ehrlich, P; Hughes, T; Kautsky, N; Levin, S; Maler, KG; Shogren, J; Vincent, J; Xepapadeas, T; de Zeeuw, A				Walker, Brian; Barrett, Scott; Polasky, Stephen; Galaz, Victor; Folke, Carl; Engstrom, Gustav; Ackerman, Frank; Arrow, Ken; Carpenter, Stephen; Chopra, Kanchan; Daily, Gretchen; Ehrlich, Paul; Hughes, Terry; Kautsky, Nils; Levin, Simon; Maler, Karl-Goran; Shogren, Jason; Vincent, Jeff; Xepapadeas, Tasos; de Zeeuw, Aart			Looming Global-Scale Failures and Missing Institutions	SCIENCE			English	Editorial Material									[Walker, Brian] CSIRO, Canberra, ACT 2601, Australia; [Walker, Brian; Galaz, Victor; Folke, Carl; Maler, Karl-Goran] Stockholm Univ, Stockholm Resilience Ctr, SE-10691 Stockholm, Sweden; [Barrett, Scott] Columbia Univ, Earth Inst, New York, NY 10027 USA; [Barrett, Scott] Columbia Univ, Sch Int & Publ Affairs, New York, NY 10027 USA; [Polasky, Stephen; Folke, Carl; Engstrom, Gustav; Maler, Karl-Goran; de Zeeuw, Aart] Royal Swedish Acad Sci, Beijer Inst Ecol Econ, SE-10405 Stockholm, Sweden; [Polasky, Stephen] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Ackerman, Frank] Stockholm Environm Inst, SE-10691 Stockholm, Sweden; [Engstrom, Gustav] Lund Univ, Dept Econ, SE-22180 Lund, Sweden; [Ackerman, Frank] Tufts Univ, Medford, MA 02155 USA; [Arrow, Ken] Stanford Univ, Dept Econ, Stanford, CA 94305 USA; [Carpenter, Stephen] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Chopra, Kanchan] Inst Econ Growth, Delhi 110007, India; [Daily, Gretchen; Ehrlich, Paul] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Hughes, Terry] James Cook Univ, Ctr Excellence Coral Reef Studies, ARC, Townsville, Qld 4811, Australia; [Kautsky, Nils] Stockholm Univ, Dept Syst Ecol, SE-10691 Stockholm, Sweden; [Levin, Simon] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Shogren, Jason] Univ Wyoming, Dept Econ & Finance, Laramie, WY 82071 USA; [Vincent, Jeff] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Xepapadeas, Tasos] Athens Univ Econ & Business, Dept Int & European Econ Studies, GR-10434 Athens, Greece; [de Zeeuw, Aart] Tilburg Univ, NL-5000 LE Tilburg, Netherlands	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Stockholm University; Columbia University; Columbia University; Royal Swedish Academy of Sciences; Beijer Institute of Ecological Economics; University of Minnesota System; University of Minnesota Twin Cities; Stockholm Environment Institute; Lund University; Tufts University; Stanford University; University of Wisconsin System; University of Wisconsin Madison; Stanford University; James Cook University; Stockholm University; Princeton University; University of Wyoming; Duke University; Athens University of Economics & Business; Tilburg University	Walker, B (corresponding author), CSIRO, Canberra, ACT 2601, Australia.	brian.walker@csiro.au	Hughes, Terry P/L-4721-2013; Polasky, Stephen/AAC-5341-2019; Shogren, Jason/B-9771-2017; Levin, Simon A/J-1218-2014; Shogren, Jason/N-8193-2019; Walker, Brian H/F-2386-2011; Folke, Carl/Z-1545-2019; Carpenter, Stephen/AAQ-6404-2020; Xepapadeas, Anastasios/ABH-3240-2020	Hughes, Terry P/0000-0002-5257-5063; Shogren, Jason/0000-0003-3757-959X; Levin, Simon A/0000-0002-8216-5639; Shogren, Jason/0000-0003-3757-959X; Folke, Carl/0000-0002-4050-3281; Galaz, Victor/0000-0002-7303-8849				Barrett S, 2007, WHY COOPERATE INCENT; BASU K, 2008, CONTESTED COMMONS CO, P229; Cash DW, 2003, P NATL ACAD SCI USA, V100, P8086, DOI 10.1073/pnas.1231332100; DeSombre Elizabeth R., 2000, DOMESTIC SOURCES INT; Ehrlich PR, 2005, SCIENCE, V309, P562, DOI 10.1126/science.1113028; Evans G, 2002, FOREIGN AFF, V81, P99, DOI 10.2307/20033347; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Gehring T, 2008, INSTITUTIONS AND ENVIRONMENTAL CHANGE: PRINCIPAL FINDINGS, APPLICATIONS, AND RESEARCH FRONTIERS, P187; Inomata Tadanori, 2008, MANAGEMENT REV ENV G; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING; LAWRENCE RZ, 2003, CRIMES PUNISHMENTS R; PATTERSON E, 2003, ASIL INSIGHT; Sandler T., 2004, GLOBAL COLLECTIVE AC; Thaler R.H., 2021, NUDGE FINAL EDITION	14	242	255	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 11	2009	325	5946					1345	1346		10.1126/science.1175325	http://dx.doi.org/10.1126/science.1175325			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	492YO	19745137				2022-12-24	WOS:000269699100020
J	Unger, EF				Unger, Ellis F.			Weighing Benefits and Risks -- The FDA's Review of Prasugrel.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACUTE CORONARY SYNDROMES		US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Unger, EF (corresponding author), US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]; Food and Drug Administration, FDA APPR DRUG PROD; *FOOD DRUG ADM CTR, PRAS RED CARD EV PAT; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	4	74	75	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2009	361	10					942	945		10.1056/NEJMp0907122	http://dx.doi.org/10.1056/NEJMp0907122			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490EI	19726770				2022-12-24	WOS:000269480400003
J	Berger, JS; Elliott, L; Gallup, D; Roe, M; Granger, CB; Armstrong, PW; Simes, RJ; White, HD; Van de Werf, F; Topol, EJ; Hochman, JS; Newby, LK; Harrington, RA; Califf, RM; Becker, RC; Douglas, PS				Berger, Jeffrey S.; Elliott, Laine; Gallup, Dianne; Roe, Matthew; Granger, Christopher B.; Armstrong, Paul W.; Simes, R. John; White, Harvey D.; Van de Werf, Frans; Topol, Eric J.; Hochman, Judith S.; Newby, L. Kristin; Harrington, Robert A.; Califf, Robert M.; Becker, Richard C.; Douglas, Pamela S.			Sex Differences in Mortality Following Acute Coronary Syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CLINICAL PRESENTATION; INTERNATIONAL TRIAL; GENDER-DIFFERENCES; DIABETES-MELLITUS; 30-DAY MORTALITY; PLAQUE EROSION; RISK-FACTORS; WOMEN; MEN	Context Conflicting information exists about whether sex differences modulate short-term mortality following acute coronary syndromes (ACS). Objectives To investigate the relationship between sex and 30-day mortality in ACS, and to determine whether this relationship was modified by clinical syndrome or coronary anatomy using a large database across the spectrum of ACS and adjusting for potentially confounding clinical covariates. Design, Setting, and Participants A convenience sample of patients pooled from 11 independent, international, randomized ACS clinical trials between 1993 and 2006 whose databases are maintained at the Duke Clinical Research Institute, Durham, North Carolina. Of 136 247 patients, 38 048 (28%) were women; 102 004 (26% women) with ST-segment elevation myocardial infarction (STEMI), 14 466 (29% women) with non-STEMI (NSTEMI), and 19 777 (40% women) with unstable angina. Main Outcome Measure Thirty-day mortality following ACS. Results Thirty-day mortality was 9.6% in women and 5.3% in men (odds ratio [OR], 1.91; 95% confidence interval [CI], 1.83-2.00). After multivariable adjustment, mortality was not significantly different between women and men (adjusted OR, 1.06; 95% CI, 0.99-1.15). A significant sex by type of ACS interaction was demonstrated (P<.001). In STEMI, 30-day mortality was higher among women (adjusted OR, 1.15; 95% CI, 1.06-1.24), whereas in NSTEMI (adjusted OR, 0.77; 95% CI, 0.63-0.95) and unstable angina, mortality was lower among women (adjusted OR, 0.55; 95% CI, 0.43-0.70). In a cohort of 35 128 patients with angiographic data, women more often had nonobstructive (15% vs 8%) and less often had 2-vessel (25% vs 28%) and 3-vessel (23% vs 26%) coronary disease, regardless of ACS type. After additional adjustment for angiographic disease severity, 30-day mortality among women was not significantly different than men, regardless of ACS type. The relationship between sex and 30-day mortality was similar across the levels of angiographic disease severity (P for interaction=.70). Conclusions Sex-based differences existed in 30-day mortality among patients with ACS and vary depending on clinical presentation. However, these differences appear to be largely explained by clinical differences at presentation and severity of angiographically documented disease. JAMA. 2009; 302(8): 874-882	[Berger, Jeffrey S.] NYU, Sch Med, Leon H Charney Div Cardiol, Dept Med, New York, NY 10016 USA; [Elliott, Laine; Gallup, Dianne] Duke Clin Res Inst, Dept Biostat & Bioinformat, Durham, NC USA; [Califf, Robert M.] Duke Translat Med Inst, Durham, NC USA; [Armstrong, Paul W.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Simes, R. John] Univ Sydney, Sydney, NSW 2006, Australia; [White, Harvey D.] Auckland City Hosp, Auckland, New Zealand; [Van de Werf, Frans] Univ Hosp Gasthuisberg, B-3000 Leuven, Belgium; [Topol, Eric J.] Scripps Translat Res Inst, La Jolla, CA USA; [Topol, Eric J.] Scripps Clin, La Jolla, CA 92037 USA	New York University; Duke University; Duke University; University of Alberta; University of Sydney; Auckland City Hospital; KU Leuven; University Hospital Leuven; Scripps Research Institute	Berger, JS (corresponding author), NYU, Sch Med, Leon H Charney Div Cardiol, Dept Med, 530 1st Ave,Skirball 9R, New York, NY 10016 USA.	jeffrey.berger@nyumc.org	Granger, Christopher B/D-3458-2014; Simes, Robert John/P-1497-2014	Granger, Christopher B/0000-0002-0045-3291; Douglas, Pamela/0000-0001-9876-4049; Topol, Eric/0000-0002-1478-4729; Hochman, Judith/0000-0002-5889-5981; Armstrong, Paul/0000-0002-0460-3445; Berger, Jeffrey/0000-0001-8216-4647; Van de Werf, Frans/0000-0001-9479-7767	American Heart Association [0775074N]; Duke Clinical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL079896] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Duke Clinical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding/Support: This study was partly funded by an American Heart Association Fellow to Faculty Award 0775074N (Dr Berger). The statistical portion of the manuscript was funded by the Duke Clinical Research Institute.	ABBOTT RD, 1988, JAMA-J AM MED ASSOC, V260, P3456, DOI 10.1001/jama.260.23.3456; Arbustini E, 1999, HEART, V82, P269, DOI 10.1136/hrt.82.3.269; Blomkalns AL, 2005, J AM COLL CARDIOL, V45, P832, DOI 10.1016/j.jacc.2004.11.055; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Boersma E, 2002, LANCET, V359, P189, DOI 10.1016/S0140-6736(02)07442-1; Burke AP, 1998, CIRCULATION, V97, P2110, DOI 10.1161/01.CIR.97.21.2110; CALIFF RM, 1989, JAMA-J AM MED ASSOC, V261, P2077, DOI 10.1001/jama.261.14.2077; Chang WC, 2003, ARCH INTERN MED, V163, P2476, DOI 10.1001/archinte.163.20.2476; CHARNEY R, 1993, AM HEART J, V126, P937, DOI 10.1016/0002-8703(93)90710-Q; Chua TP, 2000, INT J CARDIOL, V72, P281, DOI 10.1016/S0167-5273(99)00204-1; DEUTSCH E, 1990, CIRCULATION, V82, P2044, DOI 10.1161/01.CIR.82.6.2044; DONAHUE RP, 1993, J CLIN EPIDEMIOL, V46, P245, DOI 10.1016/0895-4356(93)90072-9; Dotevall A, 2005, DIABETIC MED, V22, P1542, DOI 10.1111/j.1464-5491.2005.01696.x; FARB A, 1995, CIRCULATION, V92, P1701, DOI 10.1161/01.CIR.92.7.1701; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; FUSTER V, 1995, AM J CARDIOL, V76, pC24, DOI 10.1016/S0002-9149(99)80467-6; Gan SC, 2000, NEW ENGL J MED, V343, P8, DOI 10.1056/NEJM200007063430102; GOLDBERG RJ, 1993, CIRCULATION, V87, P1947, DOI 10.1161/01.CIR.87.6.1947; Gottlieb S, 2000, CIRCULATION, V102, P2484, DOI 10.1161/01.CIR.102.20.2484; HLATKY MA, 1988, J AM COLL CARDIOL, V11, P237, DOI 10.1016/0735-1097(88)90086-1; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Hochman JS, 1997, J AM COLL CARDIOL, V30, P141, DOI 10.1016/S0735-1097(97)00107-1; JOHANSSON S, 1984, EUR HEART J, V5, P374, DOI 10.1093/oxfordjournals.eurheartj.a061671; Kleiman NS, 2000, CIRCULATION, V101, P751, DOI 10.1161/01.CIR.101.7.751; KOSTIS JB, 1994, CIRCULATION, V90, P1715, DOI 10.1161/01.CIR.90.4.1715; KRUMHOLZ HM, 1992, ANN INTERN MED, V116, P785, DOI 10.7326/0003-4819-116-10-785; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; MAYNARD C, 1992, ARCH INTERN MED, V152, P972, DOI 10.1001/archinte.152.5.972; Moliterno DJ, 2000, AM HEART J, V139, P563, DOI 10.1016/S0002-8703(00)90031-0; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Naslund U, 1999, EUR HEART J, V20, P771, DOI 10.1053/euhj.1998.1351; Nicholls SJ, 2006, J AM COLL CARDIOL, V47, P1967, DOI 10.1016/j.jacc.2005.12.058; NICOL D, 2004, ACM T MODEL COMPUT S, V14, P1; Oe K, 2002, CIRC J, V66, P435, DOI 10.1253/circj.66.435; Reynolds HR, 2007, ARCH INTERN MED, V167, P2054, DOI 10.1001/archinte.167.19.2054; Roger VL, 2000, JAMA-J AM MED ASSOC, V283, P646, DOI 10.1001/jama.283.5.646; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Rosengren A, 2004, EUR HEART J, V25, P663, DOI 10.1016/j.ehj.2004.02.023; Simoons ML, 2001, LANCET, V357, P1915; Topol E, 1997, NEW ENGL J MED, V337, P1118; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Topol E, 1998, CIRCULATION, V97, P2386; Topol EJ, 1996, NEW ENGL J MED, V335, P775; Vaccarino V, 2000, AM J EPIDEMIOL, V152, P965, DOI 10.1093/aje/152.10.965; Vaccarino V, 1996, J AM GERIATR SOC, V44, P1174, DOI 10.1111/j.1532-5415.1996.tb01366.x; VACCARINO V, 1995, CIRCULATION, V91, P1861, DOI 10.1161/01.CIR.91.6.1861; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Van de Werf F, 1999, LANCET, V354, P716, DOI 10.1016/S0140-6736(99)07403-6; Van de Werf F, 2001, LANCET, V358, P605; Wallentin L, 2003, CIRCULATION, V108, P135, DOI 10.1161/01.CIR.0000081659.72985.A8; Weaver WD, 1996, JAMA-J AM MED ASSOC, V275, P777, DOI 10.1001/jama.275.10.777; White HD, 2001, LANCET, V358, P1855; Woodfield SL, 1997, J AM COLL CARDIOL, V29, P35, DOI 10.1016/S0735-1097(96)00449-4; Yellon DM, 2000, CIRC RES, V87, P543, DOI 10.1161/01.RES.87.7.543	54	364	374	2	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 26	2009	302	8					874	882		10.1001/jama.2009.1227	http://dx.doi.org/10.1001/jama.2009.1227			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487GN	19706861	Green Accepted			2022-12-24	WOS:000269260100021
J	Krumholz, HM; Wang, Y; Chen, J; Drye, EE; Spertus, JA; Ross, JS; Curtis, JP; Nallamothu, BK; Lichtman, JH; Havranek, EP; Masoudi, FA; Radford, MJ; Han, LF; Rapp, MT; Straube, BM; Normand, SLT				Krumholz, Harlan M.; Wang, Yun; Chen, Jersey; Drye, Elizabeth E.; Spertus, John A.; Ross, Joseph S.; Curtis, Jeptha P.; Nallamothu, Brahmajee K.; Lichtman, Judith H.; Havranek, Edward P.; Masoudi, Frederick A.; Radford, Martha J.; Han, Lein F.; Rapp, Michael T.; Straube, Barry M.; Normand, Sharon-Lise T.			Reduction in Acute Myocardial Infarction Mortality in the United States Risk-Standardized Mortality Rates From 1995-2006	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-CARE; NATIONAL REGISTRY; HOSPITAL MORTALITY; TRENDS; MEDICARE; IMPROVEMENT; ELEVATION; COMMUNITY; OUTCOMES; PROGRAM	Context During the last 2 decades, health care professional, consumer, and payer organizations have sought to improve outcomes for patients hospitalized with acute myocardial infarction (AMI). However, little has been reported about improvements in hospital short-term mortality rates or reductions in between-hospital variation in short-term mortality rates. Objective To estimate hospital-level 30-day risk-standardized mortality rates (RSMRs) for patients discharged with AMI. Design, Setting, and Patients Observational study using administrative data and a validated risk model to evaluate 3 195 672 discharges in 2 755 370 patients discharged from nonfederal acute care hospitals in the United States between January 1, 1995, and December 31, 2006. Patients were 65 years or older (mean, 78 years) and had at least a 12-month history of fee-for-service enrollment prior to the index hospitalization. Patients discharged alive within 1 day of an admission not against medical advice were excluded, because it is unlikely that these patients had sustained an AMI. Main Outcome Measure Hospital-specific 30-day all-cause RSMR. Results At the patient level, the odds of dying within 30 days of admission if treated at a hospital 1 SD above the national average relative to that if treated at a hospital 1 SD below the national average were 1.63 (95% CI, 1.60-1.65) in 1995 and 1.56 (95% CI, 1.53-1.60) in 2006. In terms of hospital-specific RSMRs, a decrease from 18.8% in 1995 to 15.8% in 2006 was observed (odds ratio, 0.76; 95% CI, 0.75-0.77). A reduction in between-hospital heterogeneity in the RSMRs was also observed: the coefficient of variation decreased from 11.2% in 1995 to 10.8%, the interquartile range from 2.8% to 2.1%, and the between-hospital variance from 4.4% to 2.9%. Conclusion Between 1995 and 2006, the risk-standardized hospital mortality rate for Medicare patients discharged with AMI showed a significant decrease, as did between-hospital variation. JAMA. 2009;302(7):767-773	[Krumholz, Harlan M.; Wang, Yun; Chen, Jersey; Drye, Elizabeth E.; Curtis, Jeptha P.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Hlth Policy & Adm, Sch Publ Hlth, New Haven, CT 06510 USA; [Lichtman, Judith H.] Yale Univ, Sch Med, Sect Chron Dis Epidemiol, Sch Publ Hlth, New Haven, CT 06510 USA; [Krumholz, Harlan M.; Wang, Yun] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Spertus, John A.] Univ Missouri Kansas City, Sch Med, Kansas City, MO USA; [Spertus, John A.] Mid Amer Heart Inst, Kansas City, MO USA; [Ross, Joseph S.] Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY USA; [Ross, Joseph S.] James J Peters VA Med Ctr, Ctr Geriatr Res Educ & Clin, Bronx, NY USA; [Ross, Joseph S.] Hlth Serv Res Enhancement Award Program, Bronx, NY USA; [Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, Hlth Serv Res & Dev Ctr Excellence, Ann Arbor VA Med Ctr, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, Div Cardiovasc Dis, Dept Internal Med, Ann Arbor, MI USA; [Havranek, Edward P.; Masoudi, Frederick A.] Univ Colorado, Hlth Sci Ctr, Denver, CO USA; [Havranek, Edward P.; Masoudi, Frederick A.] Denver Hlth Med Ctr, Denver, CO USA; [Radford, Martha J.] NYU, Sch Med, New York, NY USA; [Han, Lein F.; Rapp, Michael T.; Straube, Barry M.] Ctr Medicare, Baltimore, MD USA; [Han, Lein F.; Rapp, Michael T.; Straube, Barry M.] Ctr Medicaid Serv, Baltimore, MD USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Yale University; Yale University; Yale University; Yale University; Yale University; University of Missouri System; University of Missouri Kansas City; Saint Luke's Mid America Heart Institute; Icahn School of Medicine at Mount Sinai; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Denver Health Medical Center; New York University; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Sect Cardiovasc Med, 1 Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	Masoudi, Frederick/Q-7467-2019; Spertus, John/ABD-3075-2021; , Harlan/AAI-2875-2020	Normand, Sharon-Lise/0000-0001-7027-4769; Ross, Joseph/0000-0002-9218-3320; Radford, Martha/0000-0001-7503-9557	Centers for Medicare & Medicaid Services (CMS); US Department of Health and Human Services;  [HHSM-500-2005-CO001C]; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	Centers for Medicare & Medicaid Services (CMS); US Department of Health and Human Services; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The analyses on which this article is based were performed under contract HHSM-500-2005-CO001C, "Utilization and Quality Control Quality Improvement Organization for the State (commonwealth) of Colorado," funded by the Centers for Medicare & Medicaid Services (CMS), an agency of the US Department of Health and Human Services.	Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Goldberg RJ, 1999, J AM COLL CARDIOL, V33, P1533, DOI 10.1016/S0735-1097(99)00040-6; Gunnar R M, 1990, Circulation, V82, P664; JENCKS SF, 1992, JAMA-J AM MED ASSOC, V268, P900, DOI 10.1001/jama.268.7.900; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; KRUMHOLZ HM, 1995, CIRCULATION, V92, P2841, DOI 10.1161/01.CIR.92.10.2841; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Lewis WR, 2008, ARCH INTERN MED, V168, P1813, DOI 10.1001/archinte.168.16.1813; Masoudi FA, 2006, CIRCULATION, V114, P2806, DOI 10.1161/CIRCULATIONAHA.106.611707; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Myerson M, 2009, CIRCULATION, V119, P503, DOI 10.1161/CIRCULATIONAHA.107.693879; Peterson ED, 2008, AM HEART J, V156, P1045, DOI 10.1016/j.ahj.2008.07.028; Roger VL, 2006, CIRCULATION, V114, P790, DOI 10.1161/CIRCULATIONAHA.106.627505; Rogers WJ, 2008, AM HEART J, V156, P1026, DOI 10.1016/j.ahj.2008.07.030; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Shah Rahman, 2006, Crit Pathw Cardiol, V5, P160, DOI 10.1097/01.hpc.0000234779.87257.ad	21	205	211	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	2009	302	7					767	773		10.1001/jama.2009.1178	http://dx.doi.org/10.1001/jama.2009.1178			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484UT	19690309	Green Accepted, Bronze			2022-12-24	WOS:000269073800025
J	Wheeler, R				Wheeler, Robert			Personal View Priority patients in a pandemonium	BRITISH MEDICAL JOURNAL			English	Editorial Material									Southampton Univ Hosp Trust, Southampton, Hants, England	University of Southampton; University Hospital Southampton NHS Foundation Trust	Wheeler, R (corresponding author), Southampton Univ Hosp Trust, Southampton, Hants, England.	robert.wheeler@suht.swest.nhs.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 19	2009	339								b3321	10.1136/bmj.b3321	http://dx.doi.org/10.1136/bmj.b3321			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486SB	19692444				2022-12-24	WOS:000269216900007
J	Kim, K; Sato, K; Shibuya, M; Zeiger, DM; Butcher, RA; Ragains, JR; Clardy, J; Touhara, K; Sengupta, P				Kim, Kyuhyung; Sato, Koji; Shibuya, Mayumi; Zeiger, Danna M.; Butcher, Rebecca A.; Ragains, Justin R.; Clardy, Jon; Touhara, Kazushige; Sengupta, Piali			Two Chemoreceptors Mediate Developmental Effects of Dauer Pheromone in C-elegans	SCIENCE			English	Article							RECEPTOR GENE-EXPRESSION; GUANYLYL CYCLASE DAF-11; CAENORHABDITIS-ELEGANS; LARVAL DEVELOPMENT; SIGNALING PATHWAY; BRAIN; ACTS	Intraspecific chemical communication is mediated by signals called pheromones. Caenorhabditis elegans secretes a mixture of small molecules (collectively termed dauer pheromone) that regulates entry into the alternate dauer larval stage and also modulates adult behavior via as yet unknown receptors. Here, we identify two heterotrimeric GTP-binding protein (G protein)-coupled receptors (GPCRs) that mediate dauer formation in response to a subset of dauer pheromone components. The SRBC-64 and SRBC-66 GPCRs are members of the large Caenorhabditis-specific SRBC subfamily and are expressed in the ASK chemosensory neurons, which are required for pheromone-induced dauer formation. Expression of both, but not each receptor alone, confers pheromone-mediated effects on heterologous cells. Identification of dauer pheromone receptors will allow a better understanding of the signaling cascades that transduce the context-dependent effects of ecologically important chemic al signals.	[Kim, Kyuhyung; Shibuya, Mayumi; Zeiger, Danna M.; Sengupta, Piali] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Kim, Kyuhyung; Shibuya, Mayumi; Zeiger, Danna M.; Sengupta, Piali] Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Sato, Koji; Touhara, Kazushige] Univ Tokyo, Dept Integrated Biosci, Chiba 2778562, Japan; [Butcher, Rebecca A.; Ragains, Justin R.; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Brandeis University; Brandeis University; University of Tokyo; Harvard University; Harvard Medical School	Sengupta, P (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.	sengupta@brandeis.edu		xing zhi, zuo teng/0000-0001-6198-6406	NSF [IOS 0542372]; NIH [R01 GM56223, P30 NS45713, R01 CA24487, F32 GM077943]; Ministry of Education, Science, Sports, and Culture, Japan; NATIONAL CANCER INSTITUTE [R01CA024487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056223, F32GM077943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045713] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to E. Macosko, C. Bargmann, J. Thomas, and R. Shingai for advice, assistance, and reagents. We thank the Caenorhabditis Genetics Center and S. Mitani for strains, members of the Sengupta lab and P. Garrity for discussion, and C. Li for critical comments. This work was supported by NSF ( IOS 0542372 to P. S.), NIH (R01 GM56223 to P. S., P30 NS45713, R01 CA24487 to J. C., and F32 GM077943 to R. A. B.), and the Ministry of Education, Science, Sports, and Culture, Japan ( K. T.).	Alaux C, 2009, GENES BRAIN BEHAV, V8, P309, DOI 10.1111/j.1601-183X.2009.00480.x; Alewijnse AE, 1997, FEBS LETT, V419, P171, DOI 10.1016/S0014-5793(97)01440-3; [Anonymous], 2014, PHEROMONES ANIMAL BE; Birnby DA, 2000, GENETICS, V155, P85; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Butcher RA, 2008, P NATL ACAD SCI USA, V105, P14288, DOI 10.1073/pnas.0806676105; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Dowell P, 2005, ANNU REV BIOCHEM, V74, P515, DOI 10.1146/annurev.biochem.73.011303.074027; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Grus WE, 2008, MOL BIOL EVOL, V25, P1593, DOI 10.1093/molbev/msn107; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Murakami M, 2001, MECH DEVELOP, V109, P27, DOI 10.1016/S0925-4773(01)00507-X; Nolan KM, 2002, GENE DEV, V16, P3061, DOI 10.1101/gad.1027702; Peckol EL, 2001, P NATL ACAD SCI USA, V98, P11032, DOI 10.1073/pnas.191352498; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Thomas JH, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-42; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Zwaal RR, 1997, GENETICS, V145, P715	26	144	157	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					994	998		10.1126/science.1176331	http://dx.doi.org/10.1126/science.1176331			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19797623	Green Accepted			2022-12-24	WOS:000271712300040
J	Domian, IJ; Chiravuri, M; van der Meer, P; Feinberg, AW; Shi, X; Shao, Y; Wu, SM; Parker, KK; Chien, KR				Domian, Ibrahim J.; Chiravuri, Murali; van der Meer, Peter; Feinberg, Adam W.; Shi, Xi; Shao, Ying; Wu, Sean M.; Parker, Kevin Kit; Chien, Kenneth R.			Generation of Functional Ventricular Heart Muscle from Mouse Ventricular Progenitor Cells	SCIENCE			English	Article							SMOOTH-MUSCLE; ISL1; DIFFERENTIATION; TRANSCRIPTION; EXPRESSION; MEF2C	The mammalian heart is formed from distinct sets of first and second heart field (FHF and SHF, respectively) progenitors. Although multipotent progenitors have previously been shown to give rise to cardiomyocytes, smooth muscle, and endothelial cells, the mechanism governing the generation of large numbers of differentiated progeny remains poorly understood. We have employed a two-colored fluorescent reporter system to isolate FHF and SHF progenitors from developing mouse embryos and embryonic stem cells. Genome-wide profiling of coding and noncoding transcripts revealed distinct molecular signatures of these progenitor populations. We further identify a committed ventricular progenitor cell in the Islet 1 lineage that is capable of limited in vitro expansion, differentiation, and assembly into functional ventricular muscle tissue, representing a combination of tissue engineering and stem cell biology.	[Domian, Ibrahim J.; Chiravuri, Murali; van der Meer, Peter; Shi, Xi; Shao, Ying; Wu, Sean M.; Chien, Kenneth R.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Domian, Ibrahim J.; Wu, Sean M.; Parker, Kevin Kit; Chien, Kenneth R.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [van der Meer, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands; [Feinberg, Adam W.; Parker, Kevin Kit] Harvard Univ, Sch Engn & Appl Sci, Dis Biophys Grp, Cambridge, MA 02138 USA; [Parker, Kevin Kit] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Chien, Kenneth R.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; University of Groningen; Harvard University; Harvard University; Harvard University	Chien, KR (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charles River Plaza,CPZN 3200,185 Cambridge St, Boston, MA 02114 USA.	krchien@partners.org	Feinberg, Adam W/A-7103-2009; Feinberg, Adam W/AAM-8547-2020	Feinberg, Adam W/0000-0003-3338-5456; Feinberg, Adam W/0000-0003-3338-5456; Wu, Sean/0000-0002-0000-3821	NHLBI NIH HHS [K08 HL081086-01, K08 HL091209, R01 HL079126, K08 HL081086, T32 HL002807, R01 HL079126-01A1] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079126, K08HL081086, K08HL091209] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Blanco MJ, 2007, DEVELOPMENT, V134, P4073, DOI 10.1242/dev.006858; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Dodou E, 2003, MECH DEVELOP, V120, P1021, DOI 10.1016/S0925-4773(03)00178-3; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lien CL, 1999, DEVELOPMENT, V126, P75; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Mori AD, 2006, DEV BIOL, V297, P566, DOI 10.1016/j.ydbio.2006.05.023; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	21	161	170	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					426	429		10.1126/science.1177350	http://dx.doi.org/10.1126/science.1177350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833966	Green Accepted, Green Submitted			2022-12-24	WOS:000270818600053
J	Varga, V; Leduc, C; Bormuth, V; Diez, S; Howard, J				Varga, Vladimir; Leduc, Cecile; Bormuth, Volker; Diez, Stefan; Howard, Jonathon			Kinesin-8 Motors Act Cooperatively to Mediate Length-Dependent Microtubule Depolymerization	CELL			English	Article							FISSION YEAST; CHROMOSOME CONGRESSION; CARGO MOVEMENT; DEPOLYMERASE; PROTEIN; CELLS; MOLECULES; DYNAMICS; SPINDLE; KIF18A	Motor proteins in the kinesin-8 family depolymerize microtubules in a length-dependent manner that may be crucial for controlling the length of organelles such as the mitotic spindle. We used single-molecule microscopy to understand the mechanism of length-dependent depolymerization by the budding yeast kinesin-8, Kip3p. We found that after binding at a random position on a microtubule and walking to the plus end, an individual Kip3p molecule pauses there until an incoming Kip3p molecule bumps it off. Kip3p dissociation is accompanied by removal of just one or two tubulin dimers (on average). Such a cooperative mechanism leads to a depolymerization rate that is proportional to the flux of motors to the microtubule end and accounts for the length dependence of depolymerization. This type of feedback between length and disassembly may serve as a model for understanding how an ensemble of molecules can measure and control polymer length.	[Varga, Vladimir; Leduc, Cecile; Bormuth, Volker; Diez, Stefan; Howard, Jonathon] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Howard, J (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	howard@mpi-cbg.de	Howard, Jonathon/J-7492-2016; Howard, Jonathon/D-4229-2011; Leduc, Cécile/AGB-1431-2022; Leduc, Cecile/AAC-1998-2019; Diez, Stefan/E-8172-2010	Howard, Jonathon/0000-0003-0086-1196; Howard, Jonathon/0000-0003-0086-1196; Leduc, Cécile/0000-0002-1806-4120; Diez, Stefan/0000-0002-0750-8515; Varga, Vladimir/0000-0002-0384-1281	German Ministry of Science and Education [03 N 8712]; Max Planck Society; Gottlieb Daimler and Karl Benz Foundation; Boehringer Ingelheim Fonds	German Ministry of Science and Education; Max Planck Society(Max Planck Society); Gottlieb Daimler and Karl Benz Foundation; Boehringer Ingelheim Fonds(Boehringer Ingelheim)	We thank Frauke Hussmann and Burkhard Rammner for structural insights into the Kip3p motor domain, Felix Ruhnow for tracking software, and Regine Hartmann, Corina Brauer, and Jan Ribbe for help with proteinexpression. We thank members of the Howard and Diez labs and Erik Schaeffer and Jonne Helenius for comments on an earlier draft of this manuscript. We acknowledge financial support by the German Ministry of Science and Education ( grant 03 N 8712) and the Max Planck Society. C. L. was supported by the Gottlieb Daimler and Karl Benz Foundation and V. B. by a fellowship from the Boehringer Ingelheim Fonds.	Cooper JR, 2009, CURR OPIN CELL BIOL, V21, P68, DOI 10.1016/j.ceb.2009.01.005; Crevenna AH, 2008, BIOPHYS J, V95, P5216, DOI 10.1529/biophysj.108.132449; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Grissom PM, 2009, MOL BIOL CELL, V20, P963, DOI 10.1091/mbc.E08-09-0979; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howard J., 2001, MECH MOTOR PROTEINS; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; Leduc C, 2007, P NATL ACAD SCI USA, V104, P10847, DOI 10.1073/pnas.0701B64104; Marshall WF, 2005, MOL BIOL CELL, V16, P270, DOI 10.1091/mbc.E04-07-0586; Marshall WF, 2004, ANNU REV CELL DEV BI, V20, P677, DOI 10.1146/annurev.cellbio.20.012103.094437; Mayr MI, 2007, CURR BIOL, V17, P488, DOI 10.1016/j.cub.2007.02.036; Moores CA, 2002, MOL CELL, V9, P903, DOI 10.1016/S1097-2765(02)00503-8; Rogers KR, 2001, EMBO J, V20, P5101, DOI 10.1093/emboj/20.18.5101; Seitz A, 2006, EMBO J, V25, P267, DOI 10.1038/sj.emboj.7600937; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; TAYLOR DL, 1980, NATURE, V284, P405, DOI 10.1038/284405a0; Tischer C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.5; TYSON CB, 1979, J BACTERIOL, V138, P92, DOI 10.1128/JB.138.1.92-98.1979; Unsworth A, 2008, MOL BIOL CELL, V19, P5104, DOI 10.1091/mbc.E08-02-0224; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; WADSWORTH P, 1983, J CELL BIOL, V97, P1249, DOI 10.1083/jcb.97.4.1249	29	205	206	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1174	1183		10.1016/j.cell.2009.07.032	http://dx.doi.org/10.1016/j.cell.2009.07.032			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766569	Bronze			2022-12-24	WOS:000269923200017
J	Fine, B; Hodakoski, C; Koujak, S; Su, T; Saal, LH; Maurer, M; Hopkins, B; Keniry, M; Sulis, ML; Mense, S; Hibshoosh, H; Parsons, R				Fine, Barry; Hodakoski, Cindy; Koujak, Susan; Su, Tao; Saal, Lao H.; Maurer, Matthew; Hopkins, Benjamin; Keniry, Megan; Sulis, Maria Luisa; Mense, Sarah; Hibshoosh, Hanina; Parsons, Ramon			Activation of the PI3K Pathway in Cancer Through Inhibition of PTEN by Exchange Factor P-REX2a	SCIENCE			English	Article							BREAST-CANCER; GENETIC ALTERATIONS; TUMOR-SUPPRESSOR; PROSTATE-CANCER; RAC; CELLS; PHOSPHATASE; MUTATIONS	PTEN (phosphatase and tensin homolog on chromosome 10) is a tumor suppressor whose cellular regulation remains incompletely understood. We identified phosphatidylinositol 3,4,5-trisphosphate RAC exchanger 2a (P-REX2a) as a PTEN-interacting protein. P-REX2a mRNA was more abundant in human cancer cells and significantly increased in tumors with wild-type PTEN that expressed an activated mutant of PIK3CA encoding the p110 subunit of phosphoinositide 3-kinase subunit alpha (PI3K alpha). P-REX2a inhibited PTEN lipid phosphatase activity and stimulated the PI3K pathway only in the presence of PTEN. P-REX2a stimulated cell growth and cooperated with a PIK3CA mutant to promote growth factor-independent proliferation and transformation. Depletion of P-REX2a reduced amounts of phosphorylated AKT and growth in human cell lines with intact PTEN. Thus, P-REX2a is a component of the PI3K pathway that can antagonize PTEN in cancer cells.	[Fine, Barry; Hodakoski, Cindy; Koujak, Susan; Su, Tao; Saal, Lao H.; Maurer, Matthew; Hopkins, Benjamin; Keniry, Megan; Sulis, Maria Luisa; Mense, Sarah; Hibshoosh, Hanina; Parsons, Ramon] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Fine, Barry; Hodakoski, Cindy; Koujak, Susan; Su, Tao; Saal, Lao H.; Maurer, Matthew; Hopkins, Benjamin; Keniry, Megan; Sulis, Maria Luisa; Mense, Sarah; Hibshoosh, Hanina; Parsons, Ramon] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Su, Tao; Hibshoosh, Hanina; Parsons, Ramon] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Sulis, Maria Luisa] Columbia Univ, Med Ctr, Div Pediat Oncol, New York, NY 10032 USA; [Maurer, Matthew; Parsons, Ramon] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Parsons, R (corresponding author), Columbia Univ, Inst Canc Genet, 1130 St Nicholas Ave, New York, NY 10032 USA.	rep15@columbia.edu	Saal, Lao H/A-2919-2011; Su, Tao/T-4411-2019; Califano, Andrea/F-7239-2012	Saal, Lao H/0000-0002-0815-1896; Su, Tao/0000-0002-9148-6127; Parsons, Ramon/0000-0002-6656-3514	NIH Medical Scientist Training Program; NCI [CA097403]; Avon Foundation; Octoberwoman Foundation; Adele Meyer Fund; NATIONAL CANCER INSTITUTE [P01CA097403, R01CA082783] Funding Source: NIH RePORTER	NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Avon Foundation; Octoberwoman Foundation; Adele Meyer Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. Zhang and the Herbert Irving Comprehensive Cancer Center Proteomics Shared Resource, M. Li, W. Gu, V. Seshan, S. Voronov, G. DiPaolo, R. Baer, J. Settleman, K. Kinzler, A. Hall, N. Leslie, C. P. Downes, and the members of the Parsons laboratory for technical assistance or critical reading. B. F. is supported by the NIH Medical Scientist Training Program. Supported by NCI CA097403, the Avon Foundation, Octoberwoman Foundation, and the Adele Meyer Fund.	Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; BIECHE I, 1995, GENE CHROMOSOME CANC, V14, P227, DOI 10.1002/gcc.2870140402; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Donald S, 2004, FEBS LETT, V572, P172, DOI 10.1016/j.febslet.2004.06.096; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Fejzo MS, 1998, GENE CHROMOSOME CANC, V22, P105; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; McConnachie G, 2003, BIOCHEM J, V371, P947, DOI 10.1042/BJ20021848; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Rosenfeldt H, 2004, FEBS LETT, V572, P167, DOI 10.1016/j.febslet.2004.06.097; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sun JS, 2007, PROSTATE, V67, P692, DOI 10.1002/pros.20543; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Yu ZB, 2002, J BIOL CHEM, V277, P40247, DOI 10.1074/jbc.M207608200	23	162	167	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1261	1265		10.1126/science.1173569	http://dx.doi.org/10.1126/science.1173569			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729658	Green Accepted			2022-12-24	WOS:000269523200042
J	Lurie, N				Lurie, Nicole			H1N1 Influenza, Public Health Preparedness, and Health Care Reform.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lurie, Nicole] RAND Hlth, Arlington, VA USA	RAND Corporation	Lurie, N (corresponding author), RAND Hlth, Arlington, VA USA.							Keim M., 2006, DISASTER MED, P164; Kessler RC, 2007, J GEN INTERN MED, V22, P1225, DOI 10.1007/s11606-007-0294-1; LACEY M, 2009, NY TIMES        0430; Oster A, 2003, MED CARE, V41, P198, DOI 10.1097/00005650-200302000-00002	4	21	22	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2009	361	9					843	845		10.1056/NEJMp0905330	http://dx.doi.org/10.1056/NEJMp0905330			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	487XV	19710481				2022-12-24	WOS:000269312700002
J	Casino, P; Rubio, V; Marina, A				Casino, Patricia; Rubio, Vicente; Marina, Alberto			Structural Insight into Partner Specificity and Phosphoryl Transfer in Two-Component Signal Transduction	CELL			English	Article							HISTIDINE KINASE ENVZ; RESPONSE REGULATOR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; SELENOMETHIONYL PROTEINS; MOLECULAR RECOGNITION; PHOSPHATASE-ACTIVITY; DOMAIN; SENSOR; COMPLEX	The chief mechanism used by bacteria for sensing their environment is based on two conserved proteins: a sensor histidine kinase (HK) and an effector response regulator (RR). The signal transduction process involves highly conserved domains of both proteins that mediate autokinase, phospho-transfer, and phosphatase activities whose output is a finely tuned RR phosphorylation level. Here, we report the structure of the complex between the entire cytoplasmic portion of Thermotoga maritima class I HK853 and its cognate, RR468, as well as the structure of the isolated RR468, both free and BeF3- bound. Our results provide insight into partner specificity in two-component systems, recognition of the phosphorylation state of each partner, and the catalytic mechanism of the phosphatase reaction. Biochemical analysis shows that the HK853-catalyzed autokinase reaction proceeds by a cis autophosphorylation mechanism within the HK subunit. The results suggest a model for the signal transduction mechanism in two-component systems.	[Marina, Alberto] CSIC, IBV, Valencia 46010, Spain; CIBERER, Valencia 46010, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Marina, A (corresponding author), CSIC, IBV, Jaume Roig 11, Valencia 46010, Spain.	amarina@ibv.csic.es	Rubio, Vicente/K-7919-2014; Marina, Alberto/H-6264-2011; Casino, Patricia/ABE-5756-2020; CASINO, PATRICIA/L-1579-2014	Rubio, Vicente/0000-0001-8124-1196; Marina, Alberto/0000-0002-1334-5273; Casino, Patricia/0000-0002-2144-188X; CASINO, PATRICIA/0000-0002-2144-188X	European Union; Spanish Ministry of Science [BIO2005-0153, BIO2008-04592, BFU2008-05021]	European Union(European Commission); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	We thank W. A. Hendrickson (Columbia University, New York) for sparking this work, A.J. Fernandez and M. Lopez-Redondo (IBV-CSIC) for experimental help, I. Fita (Instituto de Biologia Molecular de Barcelona-Consejo Superior de Investigaciones Cientificas [IBMB-CSIC]), S. Ramon, A. Alt, and L. Sevilla (IBV-CSIC) for critical reading the manuscript, the European Synchrotron Radiation Facility (ESRF) personnel at BM16, BM30A, and ID14-3 beamlines for help with data collection, the European Union and ESRF for support for synchrotron use, and the Spanish Ministry of Science for grants BIO2005-0153, BIO2008-04592, and BFU2008-05021.	ATKINSON MR, 1992, J BACTERIOL, V174, P4538, DOI 10.1128/JB.174.14.4538-4548.1992; Bick MJ, 2009, J MOL BIOL, V386, P163, DOI 10.1016/j.jmb.2008.12.006; Brandon L, 2000, MOL MICROBIOL, V38, P1086, DOI 10.1046/j.1365-2958.2000.02219.x; Cai SJ, 2003, J MOL BIOL, V328, P409, DOI 10.1016/S0022-2836(03)00275-4; Casino P, 2007, BBA-PROTEINS PROTEOM, V1774, P603, DOI 10.1016/j.bbapap.2007.02.005; Depardieu F, 2003, MOL MICROBIOL, V50, P1069, DOI 10.1046/j.1365-2958.2003.03771.x; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Dutta R, 1999, MOL MICROBIOL, V34, P633, DOI 10.1046/j.1365-2958.1999.01646.x; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hsing WH, 1998, J BACTERIOL, V180, P4538, DOI 10.1128/JB.180.17.4538-4546.1998; Hsing WH, 1997, J BACTERIOL, V179, P3729, DOI 10.1128/jb.179.11.3729-3735.1997; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lee SY, 2001, J BIOL CHEM, V276, P16425, DOI 10.1074/jbc.M101002200; Lewis RJ, 1999, J MOL BIOL, V294, P9, DOI 10.1006/jmbi.1999.3261; LUKAT GS, 1991, J BIOL CHEM, V266, P8348; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; Mildvan AS, 1997, PROTEINS, V29, P401, DOI 10.1002/(SICI)1097-0134(199712)29:4<401::AID-PROT1>3.3.CO;2-#; NINFA EG, 1993, J BACTERIOL, V175, P7024, DOI 10.1128/jb.175.21.7024-7032.1993; Qin L, 2003, J BACTERIOL, V185, P3429, DOI 10.1128/JB.185.11.3429-3435.2003; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Ruiz D, 2008, MICROBIOL-SGM, V154, P3002, DOI 10.1099/mic.0.2008/020677-0; Russo F D, 1993, Trends Microbiol, V1, P306, DOI 10.1016/0966-842X(93)90007-E; Saito K, 2003, MOL MICROBIOL, V48, P373, DOI 10.1046/j.1365-2958.2003.03446.x; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tao W, 2002, MOL MICROBIOL, V43, P459, DOI 10.1046/j.1365-2958.2002.02757.x; Tomomori C, 1999, NAT STRUCT BIOL, V6, P729; Tzeng YL, 1997, J MOL BIOL, V272, P200, DOI 10.1006/jmbi.1997.1226; Varughese KI, 2006, J BACTERIOL, V188, P4970, DOI 10.1128/JB.00160-06; Yamada S, 2006, J MOL BIOL, V362, P123, DOI 10.1016/j.jmb.2006.07.012; YANG Y, 1991, P NATL ACAD SCI USA, V88, P11057, DOI 10.1073/pnas.88.24.11057; Yoshida T, 2002, MOL MICROBIOL, V46, P1283, DOI 10.1046/j.1365-2958.2002.03240.x; Zapf J, 2000, STRUCTURE, V8, P851, DOI 10.1016/S0969-2126(00)00174-X; Zapf J, 1998, BIOCHEMISTRY-US, V37, P7725, DOI 10.1021/bi9729615; Zhu Y, 2000, P NATL ACAD SCI USA, V97, P7808, DOI 10.1073/pnas.97.14.7808	36	286	292	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					325	336		10.1016/j.cell.2009.08.032	http://dx.doi.org/10.1016/j.cell.2009.08.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19800110	Bronze			2022-12-24	WOS:000270857500016
J	Filippone, M; Bonetto, G; Cherubin, E; Carraro, S; Baraldi, E				Filippone, Marco; Bonetto, Gea; Cherubin, Emanuele; Carraro, Silvia; Baraldi, Eugenio			Childhood Course of Lung Function in Survivors of Bronchopulmonary Dysplasia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							INFANCY; AGE		[Filippone, Marco; Bonetto, Gea; Cherubin, Emanuele; Carraro, Silvia; Baraldi, Eugenio] Univ Padua, Sch Med, Dept Pediat, Padua, Italy	University of Padua	Filippone, M (corresponding author), Univ Padua, Sch Med, Dept Pediat, Padua, Italy.	baraldi@pediatria.unipd.it	baraldi, eugenio/AAC-5233-2022	BARALDI, EUGENIO/0000-0002-1829-3652				Baraldi E, 1997, AM J RESP CRIT CARE, V155, P149, DOI 10.1164/ajrccm.155.1.9001304; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Filippone M, 2003, LANCET, V361, P753, DOI 10.1016/S0140-6736(03)12633-5; Hoo AF, 2002, AM J RESP CRIT CARE, V165, P1084, DOI 10.1164/ajrccm.165.8.2103035; Stanojevic S, 2008, AM J RESP CRIT CARE, V177, P253, DOI 10.1164/rccm.200708-1248OC; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8	6	57	57	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 7	2009	302	13					1418	1420		10.1001/jama.2009.1419	http://dx.doi.org/10.1001/jama.2009.1419			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503CL	19809022				2022-12-24	WOS:000270509600013
J	Zid, BM; Rogers, AN; Katewa, SD; Vargas, MA; Kolipinski, MC; Lu, TA; Benzer, S; Kapahi, P				Zid, Brian M.; Rogers, Aric N.; Katewa, Subhash D.; Vargas, Misha A.; Kolipinski, Marysia C.; Lu, Tony Au; Benzer, Seymour; Kapahi, Pankaj			4E-BP Extends Lifespan upon Dietary Restriction by Enhancing Mitochondrial Activity in Drosophila	CELL			English	Article							CAENORHABDITIS-ELEGANS; MESSENGER-RNAS; SIGNALING PATHWAY; GENE-EXPRESSION; FACTOR EIF-4E; CELL-GROWTH; TRANSLATION; EXTENSION; CANCER; TOR	Dietary restriction (DR) extends lifespan in multiple species. To examine the mechanisms of lifespan extension upon DR, we assayed genome-wide translational changes in Drosophila. A number of nuclear encoded mitochondrial genes, including those in Complex I and IV of the electron transport chain, showed increased ribosomal loading and enhanced overall activity upon DR. We found that various mitochondrial genes possessed shorter and less structured 5'UTRs, which were important for their enhanced mRNA translation. The translational repressor 4E-BP, the eukaryotic translation initiation factor 4E binding protein, was upregulated upon DR and mediated DR dependent changes in mitochondrial activity and lifespan extension. Inhibition of individual mitochondrial subunits from Complex I and IV diminished the lifespan extension obtained upon DR, reflecting the importance of enhanced mitochondrial function during DR. Our results imply that translational regulation of nuclear-encoded mitochondrial gene expression by 4E-BP plays an important role in lifespan extension upon DR. For a video summary of this article, see the PaperFlick file with the Supplemental Data available online.	[Rogers, Aric N.; Katewa, Subhash D.; Vargas, Misha A.; Kolipinski, Marysia C.; Kapahi, Pankaj] Buck Inst Age Res, Novato, CA 94945 USA; [Zid, Brian M.; Lu, Tony Au; Benzer, Seymour] CALTECH, Pasadena, CA 91125 USA	Buck Institute for Research on Aging; California Institute of Technology	Zid, BM (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	zid@fas.harvard.edu; pkapahi@buckinstitute.org	Rogers, Aric/AAH-2748-2019	Rogers, Aric/0000-0002-6149-6842; Zid, Brian/0000-0003-1876-2479	National Institutes of Health [RL1AAG032113, 1R21AG028241-01]; Ellison Medical Foundation; American Foundation; Hillblom foundation; Nathan Shock Startup; Reta Haynes Family Foundation; Millard and Muriel Jacobs Genetics and Genomics Laboratory at California Institute of Technology; NATIONAL INSTITUTE ON AGING [RL1AG032113, R21AG028241, P30AG025708, T32AG000266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); American Foundation; Hillblom foundation; Nathan Shock Startup; Reta Haynes Family Foundation; Millard and Muriel Jacobs Genetics and Genomics Laboratory at California Institute of Technology; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This manuscript is dedicated to the memory of Seymour Benzer, who passed away in the interim between research and publication of the manuscript. We thank David Nicholls, Martin Brand, Judith Campisi, Gordon Lithgow, Nagendra Yadav, Paul Sternberg, Eric Schwarz, Eimear Kenny, and members of the Kapahi and Benzer Labs, for helpful discussions. We would also like to thank the Kimbrell, Lasko, Sonenberg, Tijan, Tower, and Hafen labs for donation of strains and antibodies. This work was funded by grants from the National Institutes of Health (S. B.), a T32 NIH training grant fellowship (A. R.), grants from the Ellison Medical Foundation, American Foundation for aging research, Hillblom foundation, a Nathan Shock Startup award, a gift from the Harold J. and Reta Haynes Family Foundation, and the NIH (RL1AAG032113, 1R21AG028241-01) ( P. K.). The microarray work was supported by the Millard and Muriel Jacobs Genetics and Genomics Laboratory at California Institute of Technology.	Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen D, 2007, AGING CELL, V6, P525, DOI 10.1111/j.1474-9726.2007.00305.x; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Ford D, 2007, EXP GERONTOL, V42, P483, DOI 10.1016/j.exger.2007.01.004; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Giannakou ME, 2008, AGING CELL, V7, P187, DOI 10.1111/j.1474-9726.2007.00362.x; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Henderson ST, 2006, J GERONTOL A-BIOL, V61, P444, DOI 10.1093/gerona/61.5.444; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; JOSHIBARVE S, 1992, J BIOL CHEM, V267, P21038; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; KAPAHI P, 2004, SCI AGING KNOWLEDGE, pPE34; Katewa SD, 2007, INSECT BIOCHEM MOLEC, V37, P213, DOI 10.1016/j.ibmb.2006.11.002; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Lachance PED, 2002, MOL CELL BIOL, V22, P1656, DOI 10.1128/MCB.22.6.1656-1663.2002; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lewis E.B., 1960, DROS INFORM SERV, V34, P117, DOI DOI 10.1101/PDB.REC081414; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Magwere T, 2006, J GERONTOL A-BIOL, V61, P36, DOI 10.1093/gerona/61.1.36; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Mair W, 2004, EXP GERONTOL, V39, P1011, DOI 10.1016/j.exger.2004.03.018; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; Min KJ, 2008, AGING CELL, V7, P199, DOI 10.1111/j.1474-9726.2008.00373.x; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Nusbaum TJ, 1999, J GERONTOL A-BIOL, V54, pB192, DOI 10.1093/gerona/54.5.B192; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Petroulakis E, 2006, BRIT J CANCER, V94, P195, DOI 10.1038/sj.bjc.6602902; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Shantz LM, 1996, CANCER RES, V56, P3265; Sonenberg N, 2000, TRANSLATIONAL CONTRO; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; WARBURG O, 1956, SCIENCE, V124, P269; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zong Q, 1999, P NATL ACAD SCI USA, V96, P10632, DOI 10.1073/pnas.96.19.10632	59	386	403	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					149	160		10.1016/j.cell.2009.07.034	http://dx.doi.org/10.1016/j.cell.2009.07.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804760	Green Accepted, Bronze			2022-12-24	WOS:000270388600023
J	Aarestrup, K; Okland, F; Hansen, MM; Righton, D; Gargan, P; Castonguay, M; Bernatchez, L; Howey, P; Sparholt, H; Pedersen, MI; McKinley, RS				Aarestrup, Kim; Okland, Finn; Hansen, Michael M.; Righton, David; Gargan, Patrik; Castonguay, Martin; Bernatchez, Louis; Howey, Paul; Sparholt, Henrik; Pedersen, Michael I.; McKinley, Robert S.			Oceanic Spawning Migration of the European Eel (Anguilla anguilla)	SCIENCE			English	Article									[Aarestrup, Kim; Hansen, Michael M.; McKinley, Robert S.] Tech Univ Denmark, Natl Inst Aquat Resources, DK-8600 Silkeborg, Denmark; [Okland, Finn] Norwegian Inst Nat Res NINA, NO-7485 Trondheim, Norway; [Righton, David] CEFAS, Lowestoft NR33 0HT, Suffolk, England; [Gargan, Patrik] CFB, Dublin, Ireland; [Castonguay, Martin] Fisheries & Oceans Canada DFO, Inst Maurice Lamontagne, Mont Joli, PQ G5H 3Z4, Canada; [Bernatchez, Louis] Univ Laval, IBIS, Quebec City, PQ G1V 0A6, Canada; [Howey, Paul] Microwave Telemetry Inc, Columbia, MD 21045 USA; [Sparholt, Henrik] ICES, DK-1553 Copenhagen V, Denmark; [McKinley, Robert S.] Univ British Columbia, W Vancouver, BC V7V 1N6, Canada	Technical University of Denmark; Norwegian Institute Nature Research; Centre for Environment Fisheries & Aquaculture Science; Fisheries & Oceans Canada; Laval University; University of British Columbia	Aarestrup, K (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources, Vejlsovej 39, DK-8600 Silkeborg, Denmark.	kaa@aqua.dtu.dk	Hansen, Michael/I-5979-2013; Pedersen, Michael Ingemann/AAJ-8755-2021; Righton, David/D-6140-2013; Hansen, Michael M./Z-5047-2019; Aarestrup, Kim/AAK-9155-2021	Hansen, Michael/0000-0001-5372-4828; Pedersen, Michael Ingemann/0000-0002-3030-0704; Hansen, Michael M./0000-0001-5372-4828; Aarestrup, Kim/0000-0001-8521-6270; Righton, David/0000-0001-8643-3672; Bernatchez, Louis/0000-0002-8085-9709				Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; BOETIUS INGE, 1967, MEDD DANMARKS FISKERI HAVUNDERSOGELSER, V4, P339; FRICKE H, 1995, NATURWISSENSCHAFTEN, V82, P32, DOI 10.1007/s001140050136; IWASA Y, 1982, AM NAT, V120, P171, DOI 10.1086/283980; Jellyman D, 2005, MAR ECOL PROG SER, V286, P261, DOI 10.3354/meps286261; Tesch F.-W., 2003, EEL, P1	6	223	226	5	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1660	1660		10.1126/science.1178120	http://dx.doi.org/10.1126/science.1178120			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779192				2022-12-24	WOS:000270131800036
J	Owusu-Ansah, E; Banerjee, U				Owusu-Ansah, Edward; Banerjee, Utpal			Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation	NATURE			English	Article							OXIDATIVE STRESS; FEEDBACK-REGULATION; SIGNALING CENTER; CELL; JNK; INSULIN; GROWTH; BLOOD; FOXO; ACTIVATION	Reactive oxygen species (ROS), produced during various electron transfer reactions in vivo, are generally considered to be deleterious to cells(1). In the mammalian haematopoietic system, haematopoietic stem cells contain low levels of ROS. However, unexpectedly, the common myeloid progenitors (CMPs) produce significantly increased levels of ROS2. The functional significance of this difference in ROS level in the two progenitor types remains unresolved(2,3). Here we show that Drosophila multipotent haematopoietic progenitors, which are largely akin to the mammalian myeloid progenitors(4), display increased levels of ROS under in vivo physiological conditions, which are downregulated on differentiation. Scavenging the ROS from these haematopoietic progenitors by using in vivo genetic tools retards their differentiation into mature blood cells. Conversely, increasing the haematopoietic progenitor ROS beyond their basal level triggers precocious differentiation into all three mature blood cell types found in Drosophila, through a signalling pathway that involves JNK and FoxO activation as well as Polycomb downregulation. We conclude that the developmentally regulated, moderately high ROS level in the progenitor population sensitizes them to differentiation, and establishes a signalling role for ROS in the regulation of haematopoietic cell fate. Our results lead to a model that could be extended to reveal a probable signalling role for ROS in the differentiation of CMPs in mammalian haematopoietic development and oxidative stress response.	[Owusu-Ansah, Edward; Banerjee, Utpal] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Banerjee, U (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu			US National Institutes of Health [R01HL067395]; T32 institutional postdoctoral fellowship [T32-HL069766]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067395, T32HL069766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057291] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 institutional postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank I. Ando and H. Muller for antibodies, and E. Hafen, A. Martinez- Arias, F. Missirlis, S. Noselli, R. Paro, S Sinenko, the National Institute of Genetics Fly Stock Center ( Japan) and the Bloomington Stock Center for fly stocks. We acknowledge M. Kulkarni and C. Pitsouli of the Perrimon laboratory for technical assistance. Owing to space limitations, we apologize to our colleagues whose work is not referenced. This study was supported by US National Institutes of Health grant R01HL067395 to U. B. and a T32 institutional postdoctoral fellowship T32-HL069766 to E. O.-A.	BRAND AH, 1993, DEVELOPMENT, V118, P401; Bruckner K, 2004, DEV CELL, V7, P73, DOI 10.1016/j.devcel.2004.06.007; Coffer PJ, 2007, NAT CELL BIOL, V9, P251, DOI 10.1038/ncb0307-251; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Harvey KF, 2008, J CELL BIOL, V180, P691, DOI 10.1083/jcb.200710100; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Missirlis F, 2003, BIOL CHEM, V384, P463, DOI 10.1515/BC.2003.052; Owusu-Ansah E., 2008, NATURE PROTOCOLS, DOI [10.1038/nprot.2008.23, DOI 10.1038/NPROT.2008.23]; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Takeda S, 2008, SCIENCE, V319, P1241, DOI 10.1126/science.1152505; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202	26	540	563	5	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					537	U109		10.1038/nature08313	http://dx.doi.org/10.1038/nature08313			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19727075	Green Submitted, Green Accepted			2022-12-24	WOS:000270082900043
J	Cermeno, P; Falkowski, PG				Cermeno, Pedro; Falkowski, Paul G.			Controls on Diatom Biogeography in the Ocean	SCIENCE			English	Article							MOLECULAR EVIDENCE; DIVERSITY; POPULATIONS; DISPERSAL	The extent to which the spatial distribution of marine planktonic microbes is controlled by local environmental selection or dispersal is poorly understood. Our ability to separate the effects of these two biogeographic controls is limited by the enormous environmental variability both in space and through time. To circumvent this limitation, we analyzed fossil diatom assemblages over the past similar to 1.5 million years from the world oceans and show that these eukaryotic microbes are not limited by dispersal. The lack of dispersal limitation in marine diatoms suggests that the biodiversity at the microbial level fundamentally differs from that of macroscopic animals and plants for which geographic isolation is a common component of speciation.	[Cermeno, Pedro; Falkowski, Paul G.] Rutgers State Univ, Environm Biophys & Mol Ecol Program, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Falkowski, Paul G.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Cermeno, P (corresponding author), Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Spain.	pedro@uvigo.es; falko@marine.rutgers.edu		Cermeno, Pedro/0000-0002-3902-3475	Marie Curie International Fellowship	Marie Curie International Fellowship(European Commission)	We thank all the people who contributed to the collection and management of data and C. de Vargas, J. Grassle, M. Katz, and P. Morin for comments on the manuscript. The Neptune database is hosted by Chronos (www.chronos.org). This work was supported by a Marie Curie International Fellowship within the 6th European Community framework Program (P.C.).	Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; De Vargas C, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P271; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; DiMichele WA, 2004, ANNU REV ECOL EVOL S, V35, P285, DOI 10.1146/annurev.ecolsys.35.120202.110110; Fenchel T, 2006, PHILOS T R SOC B, V361, P1965, DOI 10.1098/rstb.2006.1924; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Hedlund B.P., 2004, MICROBIAL DIVERSITY, P225, DOI DOI 10.1128/9781555817770.CH22; Hubbell Stephen P., 2001, V32, pi; Kooistra WHCF, 2008, PROTIST, V159, P177, DOI 10.1016/j.protis.2007.09.004; Lee WJ, 1998, PROTIST, V149, P229, DOI 10.1016/S1434-4610(98)70031-8; Lomolino MV, 2006, BIOGEOGRAPHY; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; Norris RD, 1999, RECONSTRUCTING OCEAN HISTORY, P173; Sexton PF, 2008, GEOLOGY, V36, P899, DOI 10.1130/G25232A.1; Slapeta J, 2006, MOL BIOL EVOL, V23, P23, DOI 10.1093/molbev/msj001; Soininen J, 2004, ECOGRAPHY, V27, P330, DOI 10.1111/j.0906-7590.2004.03749.x; Spencer-Cervato Cinzia, 1999, Palaeontologia Electronica, V2, pUnpaginated; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Telford RJ, 2006, SCIENCE, V312, P1015, DOI 10.1126/science.1125669; Vanormelingen P, 2008, BIODIVERS CONSERV, V17, P393, DOI 10.1007/s10531-007-9257-4; Vyverman W, 2007, ECOLOGY, V88, P1924, DOI 10.1890/06-1564.1; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909	26	110	111	4	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1539	1541		10.1126/science.1174159	http://dx.doi.org/10.1126/science.1174159			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762642				2022-12-24	WOS:000269887900039
J	Yamada, T				Yamada, Tadataka			Poverty, Wealth, and Access to Pandemic Influenza Vaccines.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA	Bill & Melinda Gates Foundation	Yamada, T (corresponding author), Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA.								0	30	32	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2009	361	12					1129	1131		10.1056/NEJMp0906972	http://dx.doi.org/10.1056/NEJMp0906972			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	494QA	19675324				2022-12-24	WOS:000269828000001
J	Morrow, M; Jagsi, R; Alderman, AK; Griggs, JJ; Hawley, ST; Hamilton, AS; Graff, JJ; Katz, SJ				Morrow, Monica; Jagsi, Reshma; Alderman, Amy K.; Griggs, Jennifer J.; Hawley, Sarah T.; Hamilton, Ann S.; Graff, John J.; Katz, Steven J.			Surgeon Recommendations and Receipt of Mastectomy for Treatment of Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREOPERATIVE CHEMOTHERAPY; CONSERVING SURGERY; INFORMED DECISION; LOCAL THERAPY; WOMEN; OUTCOMES; TRENDS; TRIAL; RATES; MRI	Context There is concern that mastectomy is overused in the United States. Objectives To evaluate the association of patient-reported initial recommendations by surgeons and those given when a second opinion was sought with receipt of initial mastectomy; and to assess the use of mastectomy after attempted breast-conserving surgery (BCS). Design, Setting, and Patients A survey of women aged 20 to 79 years with intraductal or stage I and II breast cancer diagnosed between June 2005 and February 2007 and reported to the National Cancer Institute's Surveillance, Epidemiology, and End Results registries for the metropolitan areas of Los Angeles, California, and Detroit, Michigan. Patients were identified using rapid case ascertainment, and Latinas and blacks were oversampled. Of 3133 patients sent surveys, 2290 responded (73.1%). A mailed survey was completed by 96.5% of respondents and 3.5% completed a telephone survey. The final sample included 1984 female patients (502 Latinas, 529 blacks, and 953 non-Hispanic white or other). Main Outcome Measures The rate of initial mastectomy and the perceived reason for its use (surgeon recommendation, patient driven, medical contraindication) and the rate of mastectomy after attempted BCS. Results Of the 1984 patients, 1468 had BCS as an initial surgical therapy (75.4%) and 460 had initial mastectomy, including 13.4% following surgeon recommendation and 8.8% based on patient preference. Approximately 20% of patients (n=378) sought a second opinion; this was more common for those patients advised by their initial surgeon to undergo mastectomy (33.4%) than for those advised to have BCS (15.6%) or for those not receiving a recommendation for one procedure over another (21.2%) (P<.001). Discordance in treatment recommendations between surgeons occurred in 12.1% (n=43) of second opinions and did not differ on the basis of patient race/ethnicity, education, or geographic site. Among the 1459 women for whom BCS was attempted, additional surgery was required in 37.9% of patients, including 358 with reexcision (26.0%) and 167 with mastectomy (11.9%). Mastectomy was most common in patients with stage II cancer (P<.001). Conclusion Breast-conserving surgery was recommended by surgeons and attempted in the majority of patients evaluated, with surgeon recommendation, patient decision, and failure of BCS all contributing to the mastectomy rate. JAMA. 2009; 302(14): 1551-1556	[Morrow, Monica] Mem Sloan Kettering Canc Ctr, Breast Surg Serv, New York, NY 10065 USA; [Jagsi, Reshma; Alderman, Amy K.; Griggs, Jennifer J.; Hawley, Sarah T.; Katz, Steven J.] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Hamilton, Ann S.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Graff, John J.] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI USA	Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan; University of Southern California; Barbara Ann Karmanos Cancer Institute; Wayne State University	Morrow, M (corresponding author), Mem Sloan Kettering Canc Ctr, Breast Surg Serv, 1275 York Ave, New York, NY 10065 USA.	morrowm@mskcc.org	KATZ, STEVEN/ABH-8886-2020	Jagsi, Reshma/0000-0001-6562-1228	National Cancer Institute [R01 CA109696, R01 CA088370, K05CA111340, N01-PC-35139, N01-PC-35145]; American Cancer Society [MRSG-09-145-01];  [N01-PC-54404]; NATIONAL CANCER INSTITUTE [K05CA111340, R01CA109696, R55CA054404, R01CA088370, R01CA054404] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP000807] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded by grants R01 CA109696 and R01 CA088370 from the National Cancer Institute to the University of Michigan. Dr Katz was supported by an Established Investigator Award in Cancer Prevention, Control, Behavioral, and Population Sciences Research from the National Cancer Institute (K05CA111340). Dr Jagsi is supported by Mentored Research Scholar grant MRSG-09-145-01 from the American Cancer Society. The collection of Los Angeles County cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code 103885. The National Cancer Institute's Surveillance, Epidemiology, and End Results Program under contract N01-PC-35139 was awarded to the University of Southern California. Contract N01-PC-54404 and agreement 1U58DP00807-01 were awarded to the Public Health Institute. The collection of metropolitan Detroit cancer incidence data was supported by the National Cancer Institute's Surveillance, Epidemiology, and End Results Program under contract N01-PC-35145.	[Anonymous], 2007, J AM COLL SURGEONS, V205, P362, DOI 10.1016/j.jamcollurg.2007.02.057; [Anonymous], 1978, MAIL TELEPHONE SURVE; *AV FDN BREAST CTR, QUAL CORN; Bleicher RJ, 2009, J AM COLL SURGEONS, V209, P180, DOI 10.1016/j.jamcollsurg.2009.04.010; *CED SIN MED CTR, MEAS QUAL CAR SAUL J; Collins ED, 2009, J CLIN ONCOL, V27, P519, DOI 10.1200/JCO.2008.16.6215; Drew PJ, 2009, CANCER RES, V69, p75S; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; Fagerlin A, 2006, PATIENT EDUC COUNS, V64, P303, DOI 10.1016/j.pec.2006.03.010; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Grobmyer SR, 2008, J AM COLL SURGEONS, V206, P1045, DOI 10.1016/j.jamcollsurg.2007.12.039; Hamilton AS, 2009, CANCER EPIDEM BIOMAR, V18, P2022, DOI 10.1158/1055-9965.EPI-09-0238; Hawley ST, 2009, JNCI-J NATL CANCER I, V101, P1337, DOI 10.1093/jnci/djp271; Katipamula R, 2009, J CLIN ONCOL, V27, P4082, DOI 10.1200/JCO.2008.19.4225; Katz IR, 2007, INFORM TECHNOL LIBR, V26, P3, DOI 10.6017/ital.v26i3.3271; Katz SJ, 2005, CANCER, V104, P1854, DOI 10.1002/cncr.21396; Katz SJ, 2005, J CLIN ONCOL, V23, P5526, DOI 10.1200/JCO.2005.06.217; Katz SJ, 2005, J CLIN ONCOL, V23, P3001, DOI 10.1200/JCO.2005.04.028; Lee MC, 2009, BREAST J, V15, P34, DOI 10.1111/j.1524-4741.2008.00668.x; Locker GY, 2004, CANCER-AM CANCER SOC, V101, P735, DOI 10.1002/cncr.20435; Mandelblatt J, 2006, J CLIN ONCOL, V24, P4908, DOI 10.1200/JCO.2006.07.1159; MORROW M, 2008, J CLIN ONCOL, V26, P629; Nattinger AB, 1996, MED CARE, V34, P479, DOI 10.1097/00005650-199605000-00009; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; *STATACORP, 2007, STATA REF MAN REL 10; Taghian A, 2005, ANN SURG, V241, P629, DOI 10.1097/01.sla.0000157272.04803.1b; Tuttle TM, 2007, J CLIN ONCOL, V25, P5203, DOI 10.1200/JCO.2007.12.3141; *U VIRG HLTH SYST, BREAST CANC PAG; van der Hage JA, 2001, J CLIN ONCOL, V19, P4224, DOI 10.1200/JCO.2001.19.22.4224; Wright MJ, 2007, J AM COLL SURGEONS, V204, P541, DOI 10.1016/j.jamcollsurg.2007.01.031	30	254	259	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 14	2009	302	14					1551	1556		10.1001/jama.2009.1450	http://dx.doi.org/10.1001/jama.2009.1450			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505UA	19826024	Bronze, Green Accepted			2022-12-24	WOS:000270721800023
J	Jiang, DW; Zhao, LL; Clapham, DE				Jiang, Dawei; Zhao, Linlin; Clapham, David E.			Genome-Wide RNAi Screen Identifies Letm1 as a Mitochondrial Ca2+/H+ Antiporter	SCIENCE			English	Article							WOLF-HIRSCHHORN-SYNDROME; PERMEABILITY TRANSITION; CRYSTAL-STRUCTURE; CELL-DEATH; CALCIUM; TRANSPORTER; CHANNEL; CORA	Mitochondria are integral components of cellular calcium (Ca2+) signaling. Calcium stimulates mitochondrial adenosine 5'-triphosphate production, but can also initiate apoptosis. In turn, cytoplasmic Ca2+ concentrations are regulated by mitochondria. Although several transporter and ion-channel mechanisms have been measured in mitochondria, the molecules that govern Ca2+ movement across the inner mitochondrial membrane are unknown. We searched for genes that regulate mitochondrial Ca2+ and H+ concentrations using a genome-wide Drosophila RNA interference (RNAi) screen. The mammalian homolog of one Drosophila gene identified in the screen, Letm1, was found to specifically mediate coupled Ca2+/H+ exchange. RNAi knockdown, overexpression, and liposome reconstitution of the purified Letm1 protein demonstrate that Letm1 is a mitochondrial Ca2+/H+ antiporter.	[Clapham, David E.] Childrens Hosp Boston, Manton Ctr Orphan Dis, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Clapham, DE (corresponding author), Childrens Hosp Boston, Manton Ctr Orphan Dis, Howard Hughes Med Inst, Dept Cardiol, Enders Bldg 1309,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428	Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	We thank B. Mathey-Prevot, N. Ramadan, M. Booker, and staff at the Drosophila RNAi Screening Center for assistance with the screen; A. Miyawaki for pericam; R. Tsien for CherryFP; T. Schwarz for the PMK33 vector; R. Kaplan for advice on the proteoliposome study; D. Baker for assistance with Robetta; and G. Krapivinsky, Y. Kirichok, and J. Jin for discussions. D. J. is a recipient of fellowship awards from the Canadian Institutes of Health Research and the Alberta Heritage Foundation for Medical Research.	Bergemann AD, 2005, TRENDS GENET, V21, P188, DOI 10.1016/j.tig.2005.01.008; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Brookes PS, 2008, NAT CELL BIOL, V10, P1235, DOI 10.1038/ncb1108-1235; Demaurex N, 2009, BBA-BIOENERGETICS, V1787, P1383, DOI 10.1016/j.bbabio.2008.12.012; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147; GUNTER KK, 1994, J BIOENERG BIOMEMBR, V26, P471, DOI 10.1007/BF00762732; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hasegawa A, 2007, HUM MOL GENET, V16, P2061, DOI 10.1093/hmg/ddm154; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Nicholls DG, 2008, BBA-BIOENERGETICS, V1777, P550, DOI 10.1016/j.bbabio.2008.03.014; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Piao L, 2009, CANCER RES, V69, P3397, DOI 10.1158/0008-5472.CAN-08-3235; Ramadan N, 2007, NAT PROTOC, V2, P2245, DOI 10.1038/nprot.2007.250; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Schindl R, 2007, BIOPHYS J, V93, P3872, DOI 10.1529/biophysj.107.112318; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Tamai S, 2008, J CELL SCI, V121, P2588, DOI 10.1242/jcs.026625; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556	23	379	383	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 2	2009	326	5949					144	147		10.1126/science.1175145	http://dx.doi.org/10.1126/science.1175145			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797662	Green Accepted			2022-12-24	WOS:000270355600056
J	Fisher, CE				Fisher, Carl Erik			Manipulation and the Match	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIRECTORS; PROGRAM					cf2141@columbia.edu						Anderson, 2000, Curr Surg, V57, P460, DOI 10.1016/S0149-7944(00)00309-3; Anderson KD, 1999, AM J SURG, V177, P237, DOI 10.1016/S0002-9610(99)00019-7; Carek PJ, 2000, FAM MED, V32, P258; Miller FH, 2003, JAMA-J AM MED ASSOC, V289, P913, DOI 10.1001/jama.289.7.913; Opel D, 2007, PEDIATRICS, V120, pE826, DOI 10.1542/peds.2006-3189; Roth AE, 2003, JAMA-J AM MED ASSOC, V289, P909, DOI 10.1001/jama.289.7.909; Shetty SK, 2006, ACAD RADIOL, V13, P121, DOI 10.1016/j.acra.2005.09.085	7	15	15	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	2009	302	12					1266	1267		10.1001/jama.2009.1388	http://dx.doi.org/10.1001/jama.2009.1388			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497AR	19773557				2022-12-24	WOS:000270026000001
J	Young, JQ; Wachter, RM				Young, John Q.; Wachter, Robert M.			Academic Year-End Transfers of Outpatients From Outgoing to Incoming Residents An Unaddressed Patient Safety Issue	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SIGN-OUT; CARE; COMMUNICATION; CONSEQUENCES; STRATEGIES		[Young, John Q.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Wachter, Robert M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Young, JQ (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	jqyoung@lppi.ucsf.edu	Young, John Q./L-5916-2019	Young, John Q./0000-0003-2219-5657	NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH060482] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arora V, 2005, QUAL SAF HEALTH CARE, V14, P401, DOI 10.1136/qshc.2005.015107; Arora V, 2006, JT COMM J QUAL PATIE, V32, P646, DOI 10.1016/S1553-7250(06)32084-3; Arora VM, 2008, MED CLIN N AM, V92, P315, DOI 10.1016/j.mcna.2007.11.002; Boockvar K, 2004, ARCH INTERN MED, V164, P545, DOI 10.1001/archinte.164.5.545; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Horwitz LI, 2008, ARCH INTERN MED, V168, P1755, DOI 10.1001/archinte.168.16.1755; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Mischoulon D, 2000, ACAD PSYCHIATR, V24, P156, DOI 10.1176/appi.ap.24.3.156; Patterson ES, 2004, INT J QUAL HEALTH C, V16, P125, DOI 10.1093/intqhc/mzh026; Roy MJ, 2003, J GEN INTERN MED, V18, P364, DOI 10.1046/j.1525-1497.2003.20747.x; Salsberg E, 2008, JAMA-J AM MED ASSOC, V300, P1174, DOI 10.1001/jama.300.10.1174; Scalise D, 2006, HOSP HEALTH NETWORK, V80, P40; Sinha M, 2007, ACAD EMERG MED, V14, P192, DOI 10.1197/j.aem.2006.09.048; Vidyarthi AR, 2006, J HOSP MED, V1, P257, DOI 10.1002/jhm.103; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487	15	35	35	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	2009	302	12					1327	1329		10.1001/jama.2009.1399	http://dx.doi.org/10.1001/jama.2009.1399			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	497AR	19773568				2022-12-24	WOS:000270026000015
J	Coombes, R				Coombes, Rebecca			Climate Change Population: the forgotten priority	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Coombes, R (corresponding author), BMJ, London WC1H 9JR, England.	rcoombes@bmjgroup.com						*UN DEP EC SOC AFF, 2008, WORLD CONTR US 2007; United Nations Population Fund, 2008, STAT WORLD POP 2008	2	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2009	339								b3750	10.1136/bmj.b3750	http://dx.doi.org/10.1136/bmj.b3750			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496RT	19759080				2022-12-24	WOS:000269994800010
J	Heitmann, BL; Frederiksen, P				Heitmann, Berit L.; Frederiksen, Peder			Thigh circumference and risk of heart disease and premature death: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALL-CAUSE MORTALITY; BODY-MASS INDEX; FAT-FREE MASS; FOLLOW-UP; DANISH POPULATION; HIP CIRCUMFERENCE; PHYSICAL-ACTIVITY; STRENGTH; MUSCLE; ASSOCIATIONS	Objective To examine associations between thigh circumference and incident cardiovascular disease and coronary heart disease and total mortality. Design Prospective observational cohort study with Cox proportional hazards model and restricted cubic splines. Setting Random subset of adults in Denmark. Participants 1436 men and 1380 women participating in the Danish MONICA project, examined in 1987-8 for height, weight, and thigh, hip, and waist circumference, and body composition by impedance. Main outcome measures 10 year incidence of cardiovascular and coronary heart disease and 12.5 years of follow-up for total death. Results A small thigh circumference was associated with an increased risk of cardiovascular and coronary heart diseases and total mortality in both men and women. A threshold effect for thigh circumference was evident, with greatly increased risk of premature death below around 60 cm. Above the threshold there seemed to be no additional benefit of having larger thighs in either sex. These findings were independent of abdominal and general obesity, lifestyle, and cardiovascular risk factors such as blood pressure and lipid concentration. Conclusion A low thigh circumference seems to be associated with an increased risk of developing heart disease or premature death. The adverse effects of small thighs might be related to too little muscle mass in the region. The measure of thigh circumference might be a relevant anthropometric measure to help general practitioners in early identification of individuals at an increased risk of premature morbidity and mortality.	[Heitmann, Berit L.; Frederiksen, Peder] Copenhagen Univ Hosp, Inst Prevent Med, Res Unit Dietary Studies, DK-1357 Copenhagen K, Denmark; [Heitmann, Berit L.] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark	University of Copenhagen; University of Copenhagen	Heitmann, BL (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Res Unit Dietary Studies, Ostre Sogade 20, DK-1357 Copenhagen K, Denmark.	blh@ipm.regionh.dk		Heitmann, Berit Lilienthal/0000-0002-6809-4504	Danish Medical Research Council	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Danish Medical Research Council. Both researchers were independent of the funding agency.	Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; Bigaard J, 2004, INT J OBESITY, V28, P741, DOI 10.1038/sj.ijo.0802635; Brotman DJ, 2003, CIRCULATION, V108, pE61, DOI 10.1161/01.CIR.0000086784.14560.C3; Evans WJ, 1996, GERIATRICS, V51, P46; Goodpaster BH, 2008, J APPL PHYSIOL, V105, P1498, DOI 10.1152/japplphysiol.90425.2008; GRIMBY G, 1979, MUSCLE METABOLISM EX, P469; Heitmann BL, 2004, OBES RES, V12, P482, DOI 10.1038/oby.2004.54; HEITMANN BL, 1991, INT J OBESITY, V15, P535; HEITMANN BL, 1990, INT J OBESITY, V14, P789; Heitmann BL, 2000, INT J OBESITY, V24, P33, DOI 10.1038/sj.ijo.0801082; Hippe M, 1999, J EPIDEMIOL COMMUN H, V53, P269, DOI 10.1136/jech.53.5.269; JENSEN KH, 1991, GASTROENTEROLOGY, V100, P790, DOI 10.1016/0016-5085(91)80027-7; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Lissner L, 2001, OBES RES, V9, P644, DOI 10.1038/oby.2001.85; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; MCCARTNEY N, 1995, J GERONTOL A-BIOL, V50, pB97, DOI 10.1093/gerona/50A.2.B97; McCarty MF, 2003, MED HYPOTHESES, V61, P173, DOI 10.1016/S0306-9877(02)00238-4; MILLER JP, 1994, J APPL PHYSIOL, V77, P1122, DOI 10.1152/jappl.1994.77.3.1122; Olsen DB, 2005, J PHYSIOL-LONDON, V565, P555, DOI 10.1113/jphysiol.2004.081356; R Development Core Team, 2005, R LANG ENV STAT COMP; Sacchetti M, 2005, DIABETOLOGIA, V48, P938, DOI 10.1007/s00125-005-1727-1; Snijder MB, 2004, DIABETES CARE, V27, P372, DOI 10.2337/diacare.27.2.372; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; Tanko LB, 2004, CIRCULATION, V110, P2246, DOI 10.1161/01.CIR.0000144470.55149.E5; Therneau TM, 2000, MODELING SURVIVAL DA; WAALER HT, 1988, ACTA MED SCAND, V713, P17; World Health Organization, 1989, 123 EURICPNUT WHO; Zhu SK, 2003, ANN EPIDEMIOL, V13, P286, DOI 10.1016/S1047-2797(02)00417-9	28	119	120	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2009	339								b3292	10.1136/bmj.b3292	http://dx.doi.org/10.1136/bmj.b3292			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491CI	19729416	Green Published, hybrid			2022-12-24	WOS:000269554100002
J	Downward, J				Downward, Julian			Finding the Weakness in Cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ONCOGENE; THERAPY		Canc Res UK London Res Inst, London, England	Cancer Research UK	Downward, J (corresponding author), Canc Res UK London Res Inst, London, England.		Downward, Julian/A-3251-2012	Downward, Julian/0000-0002-2331-4729				Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017	4	5	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2009	361	9					922	924		10.1056/NEJMcibr0905242	http://dx.doi.org/10.1056/NEJMcibr0905242			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487XV	19710492				2022-12-24	WOS:000269312700015
J	Jefferson, T; Jones, M; Doshi, P; Del Mar, C				Jefferson, Tom; Jones, Mark; Doshi, Peter; Del Mar, Chris			Possible harms of oseltarnivir-a call for urgent action	LANCET			English	Editorial Material							OSELTAMIVIR		[Del Mar, Chris] Bond Univ, Fac Med & Hlth Sci, Gold Coast, Qld 4229, Australia; [Jefferson, Tom] Cochrane Acute Resp Infect Grp, Anguillara Sabazia, Italy; [Jones, Mark] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Doshi, Peter] MIT, Cambridge, MA 02139 USA	Bond University; University of Queensland; Massachusetts Institute of Technology (MIT)	Del Mar, C (corresponding author), Bond Univ, Fac Med & Hlth Sci, Gold Coast, Qld 4229, Australia.	cdelmar@bond.edu.au	Del Mar, Chris/B-1136-2008; Jones, Mark/I-2720-2016	Del Mar, Chris/0000-0003-3821-8163; Jones, Mark/0000-0001-6858-9710				Hama R., 2008, INT J RISK SAF MED, V20, P5, DOI [DOI 10.3233/JRS-2008-0431, 10.3233/JRS-2008-0431]; Jefferson TO, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001265.pub2; Nicholson K G, 1992, Semin Respir Infect, V7, P26; Ortiz JR, 2008, EMERG INFECT DIS, V14, P1280, DOI 10.3201/eid1408.080074; Shun-Shin M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3172; *US FDA, 2009, ADV EV REP SYST AERS; Yorifuji T, 2009, EPIDEMIOLOGY, V20, P188, DOI 10.1097/EDE.0b013e318190e73f	7	26	26	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2009	374	9698					1312	1313		10.1016/S0140-6736(09)61804-3	http://dx.doi.org/10.1016/S0140-6736(09)61804-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	512MW	19837238	Green Submitted			2022-12-24	WOS:000271254600009
J	Pagel, C; Lewycka, S; Colbourn, T; Mwansambo, C; Meguid, T; Chiudzu, G; Utley, M; Costello, AML				Pagel, Christina; Lewycka, Sonia; Colbourn, Tim; Mwansambo, Charles; Meguid, Tarek; Chiudzu, Grace; Utley, Martin; Costello, Anthony M. L.			Estimation of potential effects of improved community-based drug provision, to augment health-facility strengthening, on maternal mortality due to post-partum haemorrhage and sepsis in sub-Saharan Africa: an equity-effectiveness model	LANCET			English	Article							CHILD UNDERNUTRITION; MANAGEMENT; SURVIVAL; STRATEGIES; MALARIA; INTERVENTIONS; MISOPROSTOL; PREVENTION; PNEUMONIA; COUNTRIES	Background Maternal mortality in Africa has changed little since 1990. We developed a mathematical model with the aim to assess whether improved community-based access to life-saving drugs, to augment a core programme of health-facility strengthening, could reduce maternal mortality due to post-partum haemorrhage or sepsis. Methods We developed a mathematical model by considering the key events leading to maternal death from post-partum haemorrhage or sepsis after delivery. With parameter estimates from published work of occurrence of post-partum haemorrhage and sepsis, case fatality and the effectiveness of drugs, we used this model to estimate the effect of three potential packages of interventions: 1) health-facility strengthening; 2) health-facility strengthening combined with improved drug provision via antenatal-care appointments and community health workers; and 3) all interventions in package two combined with improved community-based drug provision via female volunteers in villages. The model was applied to Malawi and sub-Saharan Africa. Findings In the implementation of the model, the lowest risk deliveries were those in health facilities. With the model we estimated that of 2860 maternal deaths from post-partum haemorrhage or sepsis per year in Malawi, intervention package one could prevent 210 (7%) deaths, package two 720 (25%) deaths, and package three 1020 (36%) deaths. In sub-Saharan Africa, we estimated that of 182 000 of such maternal deaths per year, these three packages could prevent 21300 (12%), 43 800 (24%), and 59 000 (32%) deaths, respectively. The estimated effect of community-based drug provision was greatest for the poorest women. Interpretation Community provision of misoprostol and antibiotics to reduce maternal deaths from post-partum haemorrhage and sepsis could be a highly effective addition to health-facility strengthening in Africa. Investigation of such interventions is urgently needed to establish the risks, benefits, and challenges of widespread implementation. Funding Institute of Child Health and Faculty of Mathematical and Physical Sciences, University College London, and a donation from John and Ann-Margaret Walton.	[Pagel, Christina; Utley, Martin] UCL, Clin Operat Res Unit, Dept Math, London WC1H 0BT, England; [Lewycka, Sonia; Colbourn, Tim; Costello, Anthony M. L.] UCL, Ctr Int Hlth & Dev, Inst Child Hlth, London WC1H 0BT, England; [Meguid, Tarek; Chiudzu, Grace] Kamuzu Cent Hosp, Dept Obstet & Gynaecol, Lilongwe, Malawi; [Meguid, Tarek; Chiudzu, Grace] Bwaila Hosp, Lilongwe, Malawi; [Lewycka, Sonia; Colbourn, Tim; Mwansambo, Charles] Univ Malawi, Kamuzu Cent Hosp, Dept Paediat, Parent & Child Hlth Initiat, Lilongwe, Malawi	University of London; University College London; University of London; University College London; University of Malawi	Pagel, C (corresponding author), UCL, Clin Operat Res Unit, Dept Math, 4 Taviton St, London WC1H 0BT, England.	c.pagel@ucl.ac.uk	Colbourn, Tim/AAE-6645-2019; Lewycka, Sonia/J-1234-2019; Lewycka, Sonia/G-4698-2012	Colbourn, Tim/0000-0002-6917-6552; Lewycka, Sonia/0000-0002-5923-9468; Pagel, Christina/0000-0002-2857-1628; Utley, Martin/0000-0001-9928-1516	Institute of Child Health; Dean of the Faculty of Mathematical and Physical Sciences; The Health Foundation; UK Department for International Development; UK Department of Health Policy Research Programme	Institute of Child Health; Dean of the Faculty of Mathematical and Physical Sciences; The Health Foundation; UK Department for International Development; UK Department of Health Policy Research Programme	This study was funded jointly by the Institute of Child Health and the Dean of the Faculty of Mathematical and Physical Sciences (Richard Catlow) at University College London; and John and Ann-Margaret Walton contributed a generous donation. The Health Foundation and the UK Department for International Development provided funding support via salary provision for TC and SL. The Clinical Operational Research Unit (MU) receives funding from the UK Department of Health Policy Research Programme. We thank Wronique Fihppi for her valuable input.	AbouZahr C, 2003, BRIT MED BULL, V67, P13, DOI 10.1093/bmb/ldg014; Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; Alfirevic Z, 2007, INT J GYNECOL OBSTET, V99, pS198, DOI 10.1016/j.ijgo.2007.09.012; BANG AT, 1994, B WORLD HEALTH ORGAN, V72, P897; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Collin Simon M, 2007, BMC Pregnancy Childbirth, V7, P6, DOI 10.1186/1471-2393-7-6; Costello A, 2004, BMJ-BRIT MED J, V329, P1166, DOI 10.1136/bmj.329.7475.1166; Das LK, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-75; Derman RJ, 2006, LANCET, V368, P1248, DOI 10.1016/S0140-6736(06)69522-6; Elmardi KA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-39; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Geller SE, 2006, INT J GYNECOL OBSTET, V92, P202, DOI 10.1016/j.ijgo.2005.12.009; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Hadi A, 2003, B WORLD HEALTH ORGAN, V81, P183; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Hofmeyr GJ, 2008, BEST PRACT RES CL OB, V22, P1025, DOI 10.1016/j.bpobgyn.2008.08.005; Holloway KA, 2009, TROP MED INT HEALTH, V14, P101, DOI 10.1111/j.1365-3156.2008.02191.x; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kidney E, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-2; Koblinsky MA, 1999, B WORLD HEALTH ORGAN, V77, P399; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Lilford RJ, 1998, BMJ-BRIT MED J, V317, P405; Maine D, 1997, INT J GYNECOL OBSTET, V59, pS23, DOI 10.1016/S0020-7292(97)00144-6; Maine D, 1997, INT J GYNECOL OBSTET, V59, pS259, DOI 10.1016/S0020-7292(97)00174-4; *MED SANS FRONT, 2008, FULL PRESCR BETT MAL; Okech BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004050; Prata N, 2009, HEALTH POLICY, V89, P131, DOI 10.1016/j.healthpol.2008.05.007; RAIBHANDARI S, 2006, INT J GYNECOL OBS S2, V94, pS143; Rasmussen Z, 2000, INT J TUBERC LUNG D, V4, P807; Ross JS, 2004, AM J PUBLIC HEALTH, V94, P1174, DOI 10.2105/AJPH.94.7.1174; SANGHVI H, PREVENTING PPH HOMEB; Sebitloane HM, 2008, BEST PRACT RES CL OB, V22, P489, DOI 10.1016/j.bpobgyn.2007.11.003; Wagstaff A, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P181; WHO, 1996, WHOFHEMSM9411	37	51	52	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2009	374	9699					1441	1448		10.1016/S0140-6736(09)61566-X	http://dx.doi.org/10.1016/S0140-6736(09)61566-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MZ	19783291				2022-12-24	WOS:000271255000033
J	Wald, HS				Wald, Hedy S.			Separation Anxiety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												hedy_wald@brown.edu							0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 7	2009	302	13					1403	1404		10.1001/jama.2009.1339	http://dx.doi.org/10.1001/jama.2009.1339			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503CL	19809014				2022-12-24	WOS:000270509600001
J	Moriniere, J; Rousseaux, S; Steuerwald, U; Soler-Lopez, M; Curtet, S; Vitte, AL; Govin, J; Gaucher, J; Sadoul, K; Hart, DJ; Krijgsveld, J; Khochbin, S; Muller, CW; Petosa, C				Moriniere, Jeanne; Rousseaux, Sophie; Steuerwald, Ulrich; Soler-Lopez, Montserrat; Curtet, Sandrine; Vitte, Anne-Laure; Govin, Jerome; Gaucher, Jonathan; Sadoul, Karin; Hart, Darren J.; Krijgsveld, Jeroen; Khochbin, Saadi; Mueller, Christoph W.; Petosa, Carlo			Cooperative binding of two acetylation marks on a histone tail by a single bromodomain	NATURE			English	Article							CHROMATIN MODIFICATIONS; MITOTIC CHROMOSOMES; RECOGNITION; PROTEINS; BRDT; CBP; H4	A key step in many chromatin-related processes is the recognition of histone post-translational modifications by effector modules such as bromodomains and chromo-like domains of the Royal family(1,2). Whereas effector-mediated recognition of single post-translational modifications is well characterized(3), how the cell achieves combinatorial readout of histones bearing multiple modifications is poorly understood. One mechanism involves multivalent binding by linked effector modules(4). For example, the tandem bromodomains of human TATA-binding protein-associated factor-1 (TAF1) bind better to a diacetylated histone H4 tail than to monoacetylated tails, a cooperative effect attributed to each bromodomain engaging one acetyl-lysine mark(5). Here we report a distinct mechanism of combinatorial readout for the mouse TAF1 homologue Brdt, a testis-specific member of the BET protein family(6). Brdt associates with hyperacetylated histone H4 (ref. 7) and is implicated in the marked chromatin remodelling that follows histone hyperacetylation during spermiogenesis, the stage of spermatogenesis in which post-meiotic germ cells mature into fully differentiated sperm(7-10). Notably, we find that a single bromodomain (BD1) of Brdt is responsible for selectively recognizing histone H4 tails bearing two or more acetylation marks. The crystal structure of BD1 bound to a diacetylated H4 tail shows how two acetyl-lysine residues cooperate to interact with one binding pocket. Structure-based mutagenesis that reduces the selectivity of BD1 towards diacetylated tails destabilizes the association of Brdt with acetylated chromatin in vivo. Structural analysis suggests that other chromatin-associated proteins may be capable of a similar mode of ligand recognition, including yeast Bdf1, human TAF1 and human CBP/p300 (also known as CREBBP and EP300, respectively). Our findings describe a new mechanism for the combinatorial readout of histone modifications in which a single effector module engages two marks on a histone tail as a composite binding epitope.	[Steuerwald, Ulrich; Krijgsveld, Jeroen; Mueller, Christoph W.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Moriniere, Jeanne; Soler-Lopez, Montserrat; Hart, Darren J.] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; [Moriniere, Jeanne; Soler-Lopez, Montserrat; Hart, Darren J.] Univ Grenoble 1, CNRS, EMBL, Unit Virus Host Cell Interact,UMI 3265, F-38042 Grenoble 9, France; [Rousseaux, Sophie; Curtet, Sandrine; Vitte, Anne-Laure; Govin, Jerome; Gaucher, Jonathan; Sadoul, Karin; Khochbin, Saadi] Univ Grenoble 1, INSERM, U823, Inst Albert Bonniot, F-38700 Grenoble, France; [Petosa, Carlo] Univ Grenoble 1, CNRS, CEA, Inst Biol Struct Jean Pierre Ebel,UMR 5075, F-38027 Grenoble 1, France	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Muller, CW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	christoph.mueller@embl.de	Sadoul, Karin/N-2649-2013; Khochbin, Saadi/M-8090-2013; CURTET, Sandrine/N-3517-2013; Govin, Jerome/B-2326-2014; CURTET, Sandrine/E-8217-2019; GAUCHER, Jonathan/AGD-9327-2022; Müller, Christoph W/I-7420-2012; Rousseaux, Sophie/G-1697-2013; Krijgsveld, Jeroen/F-5974-2011; Hart, Darren/C-4858-2015	Sadoul, Karin/0000-0001-7174-5016; Khochbin, Saadi/0000-0002-0455-0857; Govin, Jerome/0000-0001-5511-6965; CURTET, Sandrine/0000-0002-9419-8868; GAUCHER, Jonathan/0000-0002-1654-8009; Müller, Christoph W/0000-0003-2176-8337; Rousseaux, Sophie/0000-0001-5246-5350; Petosa, Carlo/0000-0002-9975-1167; Hart, Darren/0000-0002-3502-2002; Krijgsveld, Jeroen/0000-0001-7549-9326	Rhone-Alpes region; EU; ANRS/Fondation de France AIJC; CNRS ATIP programmes	Rhone-Alpes region(Region Auvergne-Rhone-Alpes); EU(European Commission); ANRS/Fondation de France AIJC(ANRS); CNRS ATIP programmes	We thank the ESRF and EMBL staff for beamline assistance, the Partnership for Structural Biology (PSB) for access to technical platforms, M. Jamin for MALLS experiments, G. Natrajan and V. Rybin for help with ITC, C. Soucier for help with FRAP, D. Panne and C. Clapier for comments on the manuscript, and S. Cusack for critical support. Work in the S. K. laboratory was supported by ANR blanche 'EpiSperm' and 'Empreinte', INCa and 'ARECA' ( ARC) research programmes. J. Ga. was supported by a Ph. D. fellowship from the Rhone-Alpes region. J. M. was supported by an 'E-STAR' fellowship funded by EU FP6. C. P. acknowledges support from the ANRS/Fondation de France AIJC and CNRS ATIP programmes.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Crowley TE, 2002, MOL ENDOCRINOL, V16, P1727, DOI 10.1210/me.2001-0353; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Florence B, 2001, FRONT BIOSCI-LANDMRK, V6, pD1008, DOI 10.2741/Florence; Govin J, 2004, EUR J BIOCHEM, V271, P3459, DOI 10.1111/j.1432-1033.2004.04266.x; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Pivot-Pajot C, 2003, MOL CELL BIOL, V23, P5354, DOI 10.1128/MCB.23.15.5354-5365.2003; Polesskaya A, 2001, MOL CELL BIOL, V21, P5312, DOI 10.1128/MCB.21.16.5312-5320.2001; Rousseaux S, 2005, GENE, V345, P139, DOI 10.1016/j.gene.2004.12.004; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Shang EY, 2007, DEVELOPMENT, V134, P3507, DOI 10.1242/dev.004481; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Toyama R, 2008, DEV DYNAM, V237, P1636, DOI 10.1002/dvdy.21576; Wei LL, 2008, BIOCHEM BIOPH RES CO, V368, P279, DOI 10.1016/j.bbrc.2008.01.071	28	322	347	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					664	U112		10.1038/nature08397	http://dx.doi.org/10.1038/nature08397			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19794495				2022-12-24	WOS:000270302600043
J	Trimbuch, T; Beed, P; Vogt, J; Schuchmann, S; Maier, N; Kintscher, M; Breustedt, J; Schuelke, M; Streu, N; Kieselmann, O; Brunk, I; Laube, G; Strauss, U; Battefeld, A; Wende, H; Birchmeier, C; Wiese, S; Sendtner, M; Kawabe, H; Kishimoto-Suga, M; Brose, N; Baumgart, J; Geist, B; Aoki, J; Savaskan, NE; Brauer, AU; Chun, J; Ninnemann, O; Schmitz, D; Nitsch, R				Trimbuch, Thorsten; Beed, Prateep; Vogt, Johannes; Schuchmann, Sebastian; Maier, Nikolaus; Kintscher, Michael; Breustedt, Joerg; Schuelke, Markus; Streu, Nora; Kieselmann, Olga; Brunk, Irene; Laube, Gregor; Strauss, Ulf; Battefeld, Arne; Wende, Hagen; Birchmeier, Carmen; Wiese, Stefan; Sendtner, Michael; Kawabe, Hiroshi; Kishimoto-Suga, Mika; Brose, Nils; Baumgart, Jan; Geist, Beate; Aoki, Junken; Savaskan, Nic E.; Braeuer, Anja U.; Chun, Jerold; Ninnemann, Olaf; Schmitz, Dietmar; Nitsch, Robert			Synaptic PRG-1 Modulates Excitatory Transmission via Lipid Phosphate-Mediated Signaling	CELL			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; POSTSYNAPTIC DENSITY PROTEINS; LYSOPHOSPHATIDIC ACID; SPHINGOSINE 1-PHOSPHATE; RAT-BRAIN; IDENTIFICATION; EXPRESSION; PLASTICITY; COMPLEXES; NEURONS	Plasticity related gene-1 (PRG-1) is a brain-specific membrane protein related to lipid phosphate phosphatases, which acts in the hippocampus specifically at the excitatory synapse terminating on glutamatergic neurons. Deletion of prg-1 in mice leads to epileptic seizures and augmentation of EPSCs, but not IPSCs. In utero electroporation of PRG-1 into deficient animals revealed that PRG-1 modulates excitation at the synaptic junction. Mutation of the extracellular domain of PRG-1 crucial for its interaction with lysophosphatidic acid (LPA) abolished the ability to prevent hyperexcitability. As LPA application in vitro induced hyperexcitability in wild-type but not in LPA(2) receptor-deficient animals, and uptake of phospholipids is reduced in PRG-1-deficient neurons, we assessed PRG-1/LPA(2) receptor deficient animals, and found that the pathophysiology observed in the PRG-1-deficient mice was fully reverted. Thus, we propose PRG-1 as an important player in the modulatory control of hippocampal excitability dependent on presynaptic LPA(2) receptor signaling.	[Trimbuch, Thorsten; Vogt, Johannes; Kintscher, Michael; Streu, Nora; Kieselmann, Olga; Strauss, Ulf; Battefeld, Arne; Baumgart, Jan; Geist, Beate; Savaskan, Nic E.; Braeuer, Anja U.; Ninnemann, Olaf; Nitsch, Robert] Charite, Inst Cell Biol & Neurobiol & NeuroCure, D-10117 Berlin, Germany; [Beed, Prateep; Schuchmann, Sebastian; Maier, Nikolaus; Kintscher, Michael; Breustedt, Joerg; Schmitz, Dietmar] Charite, Neurosci Res Ctr & NeuroCure, D-10117 Berlin, Germany; [Schuelke, Markus] Charite, Dept Neuropediat, D-10117 Berlin, Germany; [Schuelke, Markus] Charite, NeuroCure Clin Res Ctr, D-10117 Berlin, Germany; [Brunk, Irene; Laube, Gregor] Charite, Inst Integrat Neuroanat, D-10117 Berlin, Germany; [Wende, Hagen; Birchmeier, Carmen] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Wiese, Stefan; Sendtner, Michael] Univ Wurzburg, Inst Clin Neurobiol, D-97078 Wurzburg, Germany; [Kawabe, Hiroshi; Kishimoto-Suga, Mika; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Chun, Jerold] Scripps Res Inst, La Jolla, CA 92037 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wurzburg; Max Planck Society; Tohoku University; Scripps Research Institute	Nitsch, R (corresponding author), Charite, Inst Cell Biol & Neurobiol & NeuroCure, Charitepl 1, D-10117 Berlin, Germany.	robert.nitsch@charite.de	Sendtner, Michael/J-1542-2012; Chun, Jerold/Y-4670-2019; Bräuer, Anja/N-3692-2019; Vogt, Johannes/O-4289-2019; Kawabe, Hiroshi/U-7325-2018; Braeuer, Anja/K-8339-2013; Sendtner, Michael/M-8137-2014; Maier, Nikolaus/CAF-2990-2022; Maier, Nikolaus/CAH-9008-2022; Nitsch, Robert/AAI-9129-2021; Vogt, Johannes/K-2278-2015; Strauss, Ulf/I-4146-2012; Savaskan, Nicolai/D-2923-2018	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974; Maier, Nikolaus/0000-0001-5203-0736; Schuelke, Markus/0000-0003-2824-3891; Vogt, Johannes/0000-0003-2439-8247; Brunk, Irene/0000-0002-2668-7002; Battefeld, Arne/0000-0003-1777-4523; Schmitz, Dietmar/0000-0003-2741-5241; Kawabe, Hiroshi/0000-0001-5650-8696; Aoki, Junken/0000-0001-9435-1896; Strauss, Ulf/0000-0002-1534-6624; Baumgart, Jan/0000-0003-1996-4267; Trimbuch, Thorsten/0000-0001-7512-8955; Savaskan, Nicolai/0000-0003-1348-094X; Wende, Hagen/0000-0002-9168-8095; Kintscher, Michael/0000-0003-2355-1369	NIMH NIH HHS [MH51699, R01 MH051699] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051699, R29MH051699] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anliker B, 2004, SEMIN CELL DEV BIOL, V15, P457, DOI 10.1016/j.semcdb.2004.05.005; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Ben-Ari Y, 2006, EPILEPTIC DISORD, V8, P91; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brandt N, 2007, EMBO J, V26, P2371, DOI 10.1038/sj.emboj.7601680; Brauer AU, 2003, NAT NEUROSCI, V6, P572, DOI 10.1038/nn1052; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Contos JJA, 2000, MOL PHARMACOL, V58, P1188, DOI 10.1124/mol.58.6.1188; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Contos JJA, 2000, GENOMICS, V64, P155, DOI 10.1006/geno.2000.6122; COTMAN CW, 1972, J CELL BIOL, V55, P696, DOI 10.1083/jcb.55.3.696; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; FUKUSHIMA N, 2001, LPA RECEPTORS PROSTA, V64, P21; Hermansson M, 2005, J NEUROCHEM, V95, P609, DOI 10.1111/j.1471-4159.2005.03376.x; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; Krauss A, 2007, J NEUROCHEM, V103, P679, DOI 10.1111/j.1471-4159.2007.04770.x; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; MacLennan AJ, 2001, EUR J NEUROSCI, V14, P203, DOI 10.1046/j.0953-816x.2001.01634.x; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; McDermott MI, 2004, NAT NEUROSCI, V7, P789, DOI 10.1038/nn0804-789a; Milstien S, 2007, ACTA PAEDIATR, V96, P40, DOI 10.1111/j.1651-2227.2007.00206.x; Mokin M, 2006, J NEUROSCI METH, V157, P218, DOI 10.1016/j.jneumeth.2006.04.016; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Neuwald AF, 1997, PROTEIN SCI, V6, P1764, DOI 10.1002/pro.5560060817; Pan CY, 2007, J NEUROCHEM, V102, P944, DOI 10.1111/j.1471-4159.2007.04584.x; Peeva GP, 2006, EUR J NEUROSCI, V24, P2152, DOI 10.1111/j.1460-9568.2006.05091.x; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Pyne S, 2005, BIOCHEM SOC T, V33, P1370, DOI 10.1042/BST0331370; Renault AD, 2004, SCIENCE, V305, P1963, DOI 10.1126/science.1102421; Roberts RZ, 2000, BBA-MOL CELL BIOL L, V1487, P33, DOI 10.1016/S1388-1981(00)00081-0; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Sassoe-Pognetto M, 2000, EUR J NEUROSCI, V12, P2205, DOI 10.1046/j.1460-9568.2000.00106.x; Savaskan NE, 2004, EUR J NEUROSCI, V19, P212, DOI 10.1046/j.1460-9568.2003.03078.x; Shida D, 2004, LAB INVEST, V84, P1352, DOI 10.1038/labinvest.3700146; Sigal YJ, 2005, BIOCHEM J, V387, P281, DOI 10.1042/BJ20041771; Sigal YJ, 2007, J CELL SCI, V120, P340, DOI 10.1242/jcs.03335; Spiegel S, 2002, TRENDS CELL BIOL, V12, P236, DOI 10.1016/S0962-8924(02)02277-8; Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Todd AE, 2002, STRUCTURE, V10, P1435, DOI 10.1016/S0969-2126(02)00861-4; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Wouterlood FG, 2003, J NEUROSCI METH, V128, P129, DOI 10.1016/S0165-0270(03)00171-7; Ye XQ, 2002, NEUROREPORT, V13, P2169, DOI 10.1097/00001756-200212030-00002; Zhang QX, 2000, BIOCHEM J, V345, P181, DOI 10.1042/0264-6021:3450181	47	99	109	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1222	1235		10.1016/j.cell.2009.06.050	http://dx.doi.org/10.1016/j.cell.2009.06.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766573	Green Accepted, Bronze			2022-12-24	WOS:000269923200021
J	Gabor, NM; Zhong, ZH; Bosnick, K; Park, J; McEuen, PL				Gabor, Nathaniel M.; Zhong, Zhaohui; Bosnick, Ken; Park, Jiwoong; McEuen, Paul L.			Extremely Efficient Multiple Electron-Hole Pair Generation in Carbon Nanotube Photodiodes	SCIENCE			English	Article							SILICON NANOWIRES; SOLAR-CELLS; EMISSION; EXCITONS	We observed highly efficient generation of electron-hole pairs due to impact excitation in single-walled carbon nanotube p-n junction photodiodes. Optical excitation into the second electronic subband E-22 leads to striking photocurrent steps in the device I-V-SD characteristics that occur at voltage intervals of the band-gap energy E-GAP/e. Spatially and spectrally resolved photocurrent combined with temperature-dependent studies suggest that these steps result from efficient generation of multiple electron-hole pairs from a single hot E-22 carrier. This process is both of fundamental interest and relevant for applications in future ultra-efficient photovoltaic devices.	[Gabor, Nathaniel M.; McEuen, Paul L.] Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; [Zhong, Zhaohui; McEuen, Paul L.] Cornell Univ, Ctr Nanoscale Syst, Ithaca, NY 14853 USA; [Park, Jiwoong] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Bosnick, Ken] Natl Res Council Canada, Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada	Cornell University; Cornell University; Cornell University; National Research Council Canada	Gabor, NM (corresponding author), Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA.	nmg32@cornell.edu	Park, Jiwoong/C-2327-2013	Gabor, Nathaniel/0000-0002-0351-2787; Bosnick, Kenneth/0000-0002-4928-0264	NSF through the Center for Nanoscale Systems; Microelectronics Advanced Research Corporation Focused Research Center on Materials, Structures, and Devices	NSF through the Center for Nanoscale Systems; Microelectronics Advanced Research Corporation Focused Research Center on Materials, Structures, and Devices	We thank R. Ilic and J. Kinder for useful discussions. This work was supported by the NSF through the Center for Nanoscale Systems and by the Microelectronics Advanced Research Corporation Focused Research Center on Materials, Structures, and Devices. Sample fabrication was performed at the Cornell Nanoscale Science and Technology Facility, a National Nanotechnology Infrastructure Network node, funded by NSF.	[Anonymous], 1981, PHYS SEMICONDUCTOR D; Avouris P, 2007, NAT NANOTECHNOL, V2, P605, DOI 10.1038/nnano.2007.300; Bosnick K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2360895; Chen J, 2005, SCIENCE, V310, P1171, DOI 10.1126/science.1119177; Ellingson RJ, 2005, NANO LETT, V5, P865, DOI 10.1021/nl0502672; Hayden O, 2006, NAT MATER, V5, P352, DOI 10.1038/nmat1635; KIM J, 2008, APPL PHYS LETT, V92; Lee JU, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2010598; Lee JU, 2004, APPL PHYS LETT, V85, P145, DOI 10.1063/1.1769595; Liao A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.256804; Manzoni C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.207401; Marty L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.136803; Misewich JA, 2003, SCIENCE, V300, P783, DOI 10.1126/science.1081294; Park JY, 2004, NANO LETT, V4, P517, DOI 10.1021/nl035258c; Perebeinos V, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.121410; Pop E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.155505; Saito R., 1998, PHYS PROPERTIES CARB; Schaller RD, 2005, NAT PHYS, V1, P189, DOI 10.1038/nphys151; Schaller RD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.186601; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Tian BZ, 2007, NATURE, V449, P885, DOI 10.1038/nature06181; Yang C, 2006, NANO LETT, V6, P2929, DOI 10.1021/nl062314b; Yao Z, 2000, PHYS REV LETT, V84, P2941, DOI 10.1103/PhysRevLett.84.2941	23	379	389	2	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1367	1371		10.1126/science.1176112	http://dx.doi.org/10.1126/science.1176112			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745146				2022-12-24	WOS:000269699100031
J	Rousseau, P				Rousseau, Paul			The Other Person	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												palliativedoctor@aol.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 26	2009	302	8					832	832		10.1001/jama.2009.1263	http://dx.doi.org/10.1001/jama.2009.1263			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487GN	19706850				2022-12-24	WOS:000269260100001
J	Osborn, KJ; Haddock, SHD; Pleijel, F; Madin, LP; Rouse, GW				Osborn, Karen J.; Haddock, Steven H. D.; Pleijel, Fredrik; Madin, Laurence P.; Rouse, Greg W.			Deep-Sea, Swimming Worms with Luminescent "Bombs"	SCIENCE			English	Article									[Osborn, Karen J.; Rouse, Greg W.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Haddock, Steven H. D.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Pleijel, Fredrik] Univ Gothenburg, Dept Marine Ecol Tjarno, SE-45296 Stromstad, Sweden; [Madin, Laurence P.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Monterey Bay Aquarium Research Institute; University of Gothenburg; Woods Hole Oceanographic Institution	Osborn, KJ (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	kjosborn@ucsd.edu	Rouse, Gregory/AAW-1494-2021; Rouse, Greg W/F-2611-2010; Osborn, Karen/E-9222-2011	Rouse, Gregory/0000-0001-9036-9263; Rouse, Greg W/0000-0001-9036-9263; Osborn, Karen/0000-0002-4226-9257	Scripps Institution of Oceanography; University of California; David and Lucile Packard Foundation; National Oceanic and Atmospheric Administration; WHOI; National Geographic Society	Scripps Institution of Oceanography(University of California System); University of California(University of California System); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); WHOI; National Geographic Society(National Geographic Society)	Research supported by Scripps Institution of Oceanography, University of California Presidents Postdoctoral Fellowship, David and Lucile Packard Foundation, National Oceanic and Atmospheric Administration, WHOI, and the National Geographic Society	Bush SL, 2009, BIOL BULL-US, V216, P7, DOI 10.1086/BBLv216n1p7; Deheyn D, 2000, J MAR BIOL ASSOC UK, V80, P179, DOI 10.1017/S0025315499001733; Osborn KJ, 2008, MOL PHYLOGENET EVOL, V49, P386, DOI 10.1016/j.ympev.2008.05.042	3	44	47	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 21	2009	325	5943					964	964		10.1126/science.1172488	http://dx.doi.org/10.1126/science.1172488			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19696343				2022-12-24	WOS:000269242800036
J	Sunshine, JM; Farnham, TL; Feaga, LM; Groussin, O; Merlin, F; Milliken, RE; A'Hearn, MF				Sunshine, Jessica M.; Farnham, Tony L.; Feaga, Lori M.; Groussin, Olivier; Merlin, Frederic; Milliken, Ralph E.; A'Hearn, Michael F.			Temporal and Spatial Variability of Lunar Hydration As Observed by the Deep Impact Spacecraft	SCIENCE			English	Article							SPECTRAL PROPERTIES; WATER; MONTMORILLONITE; MIXTURES; MINERALS	The Moon is generally anhydrous, yet the Deep Impact spacecraft found the entire surface to be hydrated during some portions of the day. Hydroxyl (OH) and water (H2O) absorptions in the near infrared were strongest near the North Pole and are consistent with <0.5 weight percent H2O. Hydration varied with temperature, rather than cumulative solar radiation, but no inherent absorptivity differences with composition were observed. However, comparisons between data collected 1 week (a quarter lunar day) apart show a dynamic process with diurnal changes in hydration that were greater for mare basalts (similar to 70%) than for highlands (similar to 50%). This hydration loss and return to a steady state occurred entirely between local morning and evening, requiring a ready daytime source of water-group ions, which is consistent with a solar wind origin.	[Sunshine, Jessica M.; Farnham, Tony L.; Feaga, Lori M.; Merlin, Frederic; A'Hearn, Michael F.] Univ Maryland, College Pk, MD 20742 USA; [Groussin, Olivier] Lab Astrophys Marseille, F-13388 Marseille, France; [Milliken, Ralph E.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University System of Maryland; University of Maryland College Park; UDICE-French Research Universities; Aix-Marseille Universite; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Sunshine, JM (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	jess@astro.umd.edu	Callahan, Charles D/L-1641-2013	Feaga, Lori/0000-0002-4230-6759; Sunshine, Jessica/0000-0002-9413-8785	NASA Discovery Program [NNM07AA99C, NNG06GJ31G]	NASA Discovery Program(National Aeronautics & Space Administration (NASA))	EPOXI, the Deep Impact extended mission, is supported by the NASA Discovery Program under contract NNM07AA99C to the University of Maryland. The Deep Impact spacecraft and HRI-IR instrument were built by Ball Aerospace. We gratefully acknowledge the efforts and support of the EPOXI project team at the Jet Propulsion Laboratory in acquiring the data presented here and the continuing work of members of the EPOXI science team in improving the instrument calibration. Laboratory spectra of lunar soils were acquired with the NASA/Keck RELAB, a multi-user facility supported by NASA grant NNG06GJ31G. We also thank R. Clark for discussions on the spectral interpretations of the 3-mm feature and L. McFadden for comments that improved this manuscript.	BISHOP JL, 1994, CLAY CLAY MINER, V42, P702, DOI 10.1346/CCMN.1994.0420606; CLARK RN, 1983, J GEOPHYS RES, V88, P635, DOI 10.1029/JB088iB12p10635; CLARK RN, 1984, J GEOPHYS RES, V89, P6341, DOI 10.1029/JB089iB07p06341; Clark RN, 2009, SCIENCE, V326, P562, DOI 10.1126/science.1178105; Crider DH, 2002, ADV SPACE RES, V30, P1869, DOI 10.1016/S0273-1177(02)00493-3; Farmer V.C., 1974, INFRARED SPECTRA MIN, V4; GLOECKLER G, 2008, EOS T AGU, V89; Groussin O, 2007, ICARUS, V187, P16, DOI 10.1016/j.icarus.2006.08.030; Hampton DL, 2005, SPACE SCI REV, V117, P43, DOI 10.1007/s11214-005-3390-8; HAPKE B, 1983, THEORY REFLECTANCE E; Jouglet D, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002846; Milliken RE, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002853; Milliken RE, 2007, ICARUS, V189, P550, DOI 10.1016/j.icarus.2007.02.017; MILLIKEN RE, 2006, THESIS BROWN U; Pieters CM, 2009, SCIENCE, V326, P568, DOI 10.1126/science.1178658; Rivkin AS, 2003, METEORIT PLANET SCI, V38, P1383, DOI 10.1111/j.1945-5100.2003.tb00321.x; SINTON WM, 1967, ICARUS, V6, P222, DOI 10.1016/0019-1035(67)90018-8	17	289	300	4	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					565	568		10.1126/science.1179788	http://dx.doi.org/10.1126/science.1179788			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19779149				2022-12-24	WOS:000271019400039
J	Fujita, M; Maeda, Y; Ra, M; Yamaguchi, Y; Taguchi, R; Kinoshita, T				Fujita, Morihisa; Maeda, Yusuke; Ra, Moonjin; Yamaguchi, Yoshiki; Taguchi, Ryo; Kinoshita, Taroh			GPI Glycan Remodeling by PGAP5 Regulates Transport of GPI-Anchored Proteins from the ER to the Golgi	CELL			English	Article							COPII-COATED VESICLES; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; INOSITOL DEACYLATION; RECYCLING PATHWAY; MDCK CELLS; GLYCOSYLPHOSPHATIDYLINOSITOL; YEAST; MEMBRANE	Many eukaryotic proteins are attached to the cell surface via glycosylphosphatidylinositol (GPI) anchors. How GPI-anchored proteins (GPI-APs) are trafficked from the endoplasmic reticulum (ER) to the cell surface is poorly understood, but the GPI moiety has been postulated to function as a signal for sorting and transport. Here, we established mutant cells that were selectively defective in transport of GPI-APs from the ER to the Golgi. We identified a responsible gene, designated PGAP5 (post-GPI-attachment to proteins 5). PGAP5 belongs to a dimetal-containing phosphoesterase family and catalyzed the remodeling of the glycan moiety on GPI-APs. PGAP5 catalytic activity is a prerequisite for the efficient exit of GPI-APs from the ER. Our data demonstrate that GPI glycan acts as an ER-exit signal and suggest that glycan remodeling mediated by PGAP5 regulates GPI-AP transport in the early secretory pathway.	[Fujita, Morihisa; Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Maeda, Yusuke; Kinoshita, Taroh] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Ra, Moonjin; Taguchi, Ryo] Univ Tokyo, Grad Sch Med, Tokyo 1130033, Japan; [Yamaguchi, Yoshiki] RIKEN ASI, Struct Glycobiol Team, Saitama 3510198, Japan; [Fujita, Morihisa; Taguchi, Ryo; Kinoshita, Taroh] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama 3320012, Japan	Osaka University; Osaka University; University of Tokyo; RIKEN; Japan Science & Technology Agency (JST)	Kinoshita, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tkinoshi@biken.osaka-u.ac.jp	Fujita, Morihisa/AAM-4142-2020; Kinoshita, Taroh/C-7353-2009; ra, moonjin/AAK-3816-2021; Yamaguchi, Yoshiki/N-5246-2015	Yamaguchi, Yoshiki/0000-0003-0100-5439	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Osaka University Global COE program	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Osaka University Global COE program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We are grateful to Yasu Morita for critical reading and helpful discussion. We thank Ikuo Wada for plasmids, Felix Wieland and Irene Schulz for antibodies, Keiko Kinoshita, Noriyuki Kanzawa, Satoshi Takida, and Fumiko Mori for technical help, Kohjiro Nakamura for cell sorting, Katsuichiro Komatsu for homology modeling, Tadashi Satoh, Shinya Hanashima, and Masaki Kato for evaluation of 3D structural model, Yoshiko Murakami and Tamotsu Yoshimori for helpful discussion, and Yoshifumi Jigami for initial support of this work. This work was supported by grants from Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology of Japan. M.F. was supported by the Osaka University Global COE program.	Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Baumann NA, 2000, J BIOL CHEM, V275, P7378, DOI 10.1074/jbc.275.10.7378; Belden WJ, 2001, MOL BIOL CELL, V12, P957, DOI 10.1091/mbc.12.4.957; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Benachour A, 1999, J BIOL CHEM, V274, P15251, DOI 10.1074/jbc.274.21.15251; Bosson R, 2006, MOL BIOL CELL, V17, P2636, DOI 10.1091/mbc.E06-02-0104; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Ferguson M. A., 2008, ESSENTIALS GLYCOBIOL, P143; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Fujita M, 2006, MOL BIOL CELL, V17, P834, DOI 10.1091/mbc.E05-05-0443; Fujita M, 2008, BBA-GEN SUBJECTS, V1780, P410, DOI 10.1016/j.bbagen.2007.08.009; Fujita M, 2006, MOL BIOL CELL, V17, P5253, DOI 10.1091/mbc.E06-08-0715; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Guddat LW, 1999, STRUCT FOLD DES, V7, P757, DOI 10.1016/S0969-2126(99)80100-2; Haass FA, 2007, P NATL ACAD SCI USA, V104, P18079, DOI 10.1073/pnas.0708765104; HARTWELL LH, 1970, P NATL ACAD SCI USA, V66, P352, DOI 10.1073/pnas.66.2.352; Hauri HP, 2000, J CELL SCI, V113, P587; HIROSE S, 1992, J BIOL CHEM, V267, P16968; Kaiser C, 2000, P NATL ACAD SCI USA, V97, P3783, DOI 10.1073/pnas.97.8.3783; Klumperman J, 1998, J CELL SCI, V111, P3411; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; Losev E, 2008, MOL CELL BIOL, V28, P3336, DOI 10.1128/MCB.00567-07; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; Malkus P, 2002, J CELL BIOL, V159, P915, DOI 10.1083/jcb.200208074; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; McDowell MA, 1998, BIOCHEM J, V335, P681, DOI 10.1042/bj3350681; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X; Nagaya H, 2008, J CELL BIOL, V180, P129, DOI 10.1083/jcb.200704078; Ogata K, 2000, J MOL GRAPH MODEL, V18, P258, DOI 10.1016/S1093-3263(00)00037-1; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Paidhungat M, 1998, GENETICS, V148, P1787; Paladino S, 2006, J CELL BIOL, V172, P1023, DOI 10.1083/jcb.200507116; Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; Shishioh N, 2005, J BIOL CHEM, V280, P9728, DOI 10.1074/jbc.M413755200; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sipos G, 1997, EMBO J, V16, P3494, DOI 10.1093/emboj/16.12.3494; TAGUCHI R, 1994, BIOCHEMISTRY-US, V33, P1017, DOI 10.1021/bi00170a021; Takida S, 2008, BIOCHEM J, V409, P555, DOI 10.1042/BJ20070234; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200; Tashima Y, 2006, MOL BIOL CELL, V17, P1410, DOI 10.1091/mbc.E05-11-1005; Tavassoli K, 1997, HUM GENET, V100, P508, DOI 10.1007/s004390050543	48	100	104	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					352	365		10.1016/j.cell.2009.08.040	http://dx.doi.org/10.1016/j.cell.2009.08.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837036	Bronze			2022-12-24	WOS:000270857500018
J	Jack, A				Jack, Andrew			Pandemic Flu Flu's unexpected bonus	BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	Andrew.Jack@ft.com		Jack, Andrew/0000-0001-9679-2898				JACK A, 2009, FINANCIAL TIMES 0906; JACK A, 2009, FINANCIAL TIMES 0720; JACK A, 2009, FINANCIAL TIMES 0729; Roche, 2009, TAM MED BRIEF; Schwartz Nelson D., 2005, CNN MONEY 1031	5	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 18	2009	339								b3811	10.1136/bmj.b3811	http://dx.doi.org/10.1136/bmj.b3811			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496RV	19767343				2022-12-24	WOS:000269995000008
J	Eggleston, KN; Shah, ND; Smith, SA; Wagie, AE; Williams, AR; Grossman, JH; Berndt, ER; Long, KH; Banerjee, R; Newhouse, JP				Eggleston, Karen N.; Shah, Nilay D.; Smith, Steven A.; Wagie, Amy E.; Williams, Arthur R.; Grossman, Jerome H.; Berndt, Ernst R.; Long, Kirsten Hall; Banerjee, Ritesh; Newhouse, Joseph P.			The Net Value of Health Care for Patients With Type 2 Diabetes, 1997 to 2005	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; UKPDS RISK ENGINE; GLYCEMIC CONTROL; COSTS; ILLNESSES; MELLITUS; IMPACT; MODEL; LIFE	Background: The net economic value of increased health care spending remains unclear, especially for chronic diseases. Objective: To assess the net value of health care for patients with type 2 diabetes. Design: Economic analysis of observational cohort data. Setting: Mayo Clinic, Rochester, Minnesota, a not-for-profit integrated health care delivery system. Patients: 613 patients with type 2 diabetes. Measurements: Changes in inflation-adjusted annual health care spending and in health status between 1997 and 2005 (with health status defined as 10-year cardiovascular risk), holding age and diabetes duration constant across the observation period ("modifiable risk"), and simulated outcomes for all diabetes complications based on the UKPDS (United Kingdom Perspective Diabetes Study) Outcomes Model. Net value was estimated as the present discounted monetary value of improved survival and avoided treatment spending for coronary heart disease minus the increase in annual spending per patient. Results: Assuming that 1 life-year is worth $200 000 and accounting for changes in modifiable cardiovascular risk, the net value of changes in health care for patients with type 2 diabetes was $10 911 per patient (95% CI, -$8480 to $33 402) between 1997 and 2005, a positive dollar value that suggests the value of health care has improved despite increased spending. A second approach based on diabetes complications yielded a net value of $6931 per patient (CI, -$186 901 to $211 980). Limitation: The patient population was homogeneous and small, and the wide CIs of the estimates are compatible with a decrease as well as an increase in value. Conclusion: The economic value of improvements in health status for patients with type 2 diabetes seems to exceed or equal increases in health care spending, suggesting that those increases were worth the extra cost. However, the possibility that society is getting less value for its money could not be statistically excluded, and there is opportunity to improve the value of diabetes-related health care.	Harvard Univ, Dept Hlth Care Policy, Sch Med, Boston, MA 02115 USA; Stanford Univ, Shorenstein Asia Pacific Res Ctr, Stanford, CA 94305 USA; Mayo Clin, Rochester, MN USA; Childrens Mercy Hosp & Clin, Kansas City, MO USA; Univ Missouri, Sch Med, Kansas City, MO 64108 USA; Harvard Univ, Kennedy Sch, Cambridge, MA 02138 USA; MIT, Cambridge, MA 02139 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Stanford University; Mayo Clinic; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard T.H. Chan School of Public Health	Newhouse, JP (corresponding author), Harvard Univ, Dept Hlth Care Policy, Sch Med, 180 Longwood Ave, Boston, MA 02115 USA.	newhouse@hcp.med.harvard.edu	Newhouse, Joseph/AAD-9763-2019; Smith, Steven/HDM-9496-2022; Newhouse, Joseph/AGJ-5632-2022					Alexander GC, 2008, ARCH INTERN MED, V168, P2088, DOI 10.1001/archinte.168.19.2088; Beaulieu N, 2006, FORUM HLTH EC POLICY, V9, P1, DOI [DOI 10.2202/1558-9544.1072], 10.2202/1558-9544.1072, DOI 10.2202/1558-9544.1072]; Berndt ER, 2002, J HEALTH ECON, V21, P373, DOI 10.1016/S0167-6296(01)00132-1; Berndt ER, 2000, HANDB ECON, V17, P119; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Brown JB, 1999, DIABETES CARE, V22, P1116, DOI 10.2337/diacare.22.7.1116; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Cutler DM, 1998, Q J ECON, V113, P991, DOI 10.1162/003355398555801; Fireman B, 2004, HEALTH AFFAIR, V23, P63, DOI 10.1377/hlthaff.23.6.63; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gold MR, 1996, COST EFFECTIVENESS H; Gorman CA, 2000, COMPUT METH PROG BIO, V62, P127, DOI 10.1016/S0169-2607(99)00054-1; Grossman J., 2008, INNOVATORS PRESCRIPT; HAHN RA, 1992, JAMA-J AM MED ASSOC, V267, P268, DOI 10.1001/jama.267.2.268; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Huang ES, 2007, HEALTH SERV RES, V42, P2174, DOI 10.1111/j.1475-6773.2007.00734.x; HUANG ES, 2007, HEALTH SERV RES, V42, P2294; Kupersmith J, 2007, HEALTH AFFAIR, V26, pW156, DOI 10.1377/hlthaff.26.2.w156; Lee JD, 2004, CURR MED RES OPIN, V20, P765, DOI 10.1185/030079904125003539; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Montori VM, 2009, ANN INTERN MED, V150, P803, DOI 10.7326/0003-4819-150-11-200906020-00008; Montori VM, 2002, DIABETES CARE, V25, P1952, DOI 10.2337/diacare.25.11.1952; Nathan DM, 2007, NEW ENGL J MED, V356, P437, DOI 10.1056/NEJMp068294; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Petersen M, 2003, DIABETES CARE, V26, P917; Rosen AB, 2007, HEALTH AFFAIR, V26, P111, DOI 10.1377/hlthaff.26.1.111; Rubin RJ, 1998, J CLIN ENDOCR METAB, V83, P2635, DOI 10.1210/jc.83.8.2635; SCITOVSKY AA, 1985, MED CARE, V23, P1345, DOI 10.1097/00005650-198512000-00004; Scitovsky AA, 1967, AM ECON REV, V57, P1182; Shapiro I, 2001, STUD INCOME, V62, P411; Song SH, 2004, DIABETIC MED, V21, P238, DOI 10.1111/j.1464-5491.2004.01116.x; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257; Wagner EH, 2001, JAMA-J AM MED ASSOC, V285, P182, DOI 10.1001/jama.285.2.182; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	37	23	23	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2009	151	6					386	W127		10.7326/0003-4819-151-6-200909150-00003	http://dx.doi.org/10.7326/0003-4819-151-6-200909150-00003			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	501OB	19755364				2022-12-24	WOS:000270390100003
J	Fortuna, RJ; Robbins, BW; Halterman, JS				Fortuna, Robert J.; Robbins, Brett W.; Halterman, Jill S.			Ambulatory Care Among Young Adults in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							CONTROLLED-TRIAL; MEDICAL-CARE; HEALTH; ADOLESCENTS; SERVICES; UNINSURANCE; DELIVERY; BEHAVIOR; VISITS; RISK	Background: Young adults are the most likely age group to be uninsured and have the highest prevalence of substance abuse, motor vehicle accidents, and sexually transmitted diseases, yet little is known about their use of ambulatory care. Objective: To characterize ambulatory care of young adults. Design: Cross-sectional data from the National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey. Setting: Community and hospital-based clinics. Patients: Nonpregnant young adults age 20 to 29 years. Measurements: Ambulatory care utilization, types of visits, and preventive care. Results: Insured young adults had more visits (2.16 [95% CI, 2.14 to 2.19] annual visits per capita) than those without insurance (0.59 [CI, 0.54 to 0.67] annual visits per capita). Young men utilized ambulatory medical care less than adolescents age 15 to 19 years or older adults age 30 to 39 years (1.10, 1.65, and 1.73 annual visits per capita, respectively) and had lower rates of utilization than young women (1.10 vs. 2.31 annual visits per capita). Young black and Hispanic men had considerably fewer annual visits per capita (0.75 and 0.65, respectively) than did young white men (1.21). Young men had nearly one half the preventive care visits compared with male adolescents or older men (0.11, 0.24, and 0.19 annual visits per capita, respectively) and less than one quarter the visits compared with young women (0.11 vs. 0.48 annual visits per capita). Only 30.6% of visits by young adults included any preventive counseling, and few encounters included counseling directed toward injury prevention (2.4%), mental health (4.1%), or sexually transmitted diseases (2.7%). Limitation: School-based clinics were not included, and counseling may be underreported. Conclusion: Young adults use less ambulatory medical care relative to other groups and infrequently receive preventive care directed at the greatest threats to their health. Efforts to ensure appropriate preventive care are needed.	[Fortuna, Robert J.] Univ Rochester, Sch Med & Dent, Ctr Primary Care, Rochester, NY 14609 USA; Univ Rochester, Sch Med & Dent, Strong Childrens Res Ctr, Rochester, NY 14609 USA	University of Rochester; University of Rochester	Fortuna, RJ (corresponding author), Univ Rochester, Sch Med & Dent, Ctr Primary Care, 913 Culver Rd, Rochester, NY 14609 USA.	Robert_Fortuna@urmc.rochester.edu			Center for Primary Care	Center for Primary Care	The authors thank the Center for Primary Care at the University of Rochester School of Medicine and Dentistry for support of this project.	American Academy of Pediatrics, 2008, BRIGHT FUT GUID HLTH; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; BIEN TH, 1993, ADDICTION, V88, P315, DOI 10.1111/j.1360-0443.1993.tb00820.x; Callahan ST, 2005, PEDIATRICS, V116, P88, DOI 10.1542/peds.2004-1449; Callahan ST, 2004, PEDIATRICS, V113, P291, DOI 10.1542/peds.113.2.291; *CDCP, 2008, SEX TRANSM DIS SURV; ELSTER A, 2004, GUIDELINES ADOLESCEN; Gilchrist VJ, 2004, MED CARE, V42, P276, DOI 10.1097/01.mlr.0000114916.95639.af; HIBBARD JH, 1986, WOMEN HEALTH, V11, P21, DOI 10.1300/J013v11n02_03; *I CLIN SYST IMPR, PREV SERV CHILDR AD; Johnston BD, 2002, PEDIATRICS, V110, P267, DOI 10.1542/peds.110.2.267; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Klein JD, 2001, ARCH PEDIAT ADOL MED, V155, P597, DOI 10.1001/archpedi.155.5.597; Kriss Jennifer L, 2008, Issue Brief (Commonw Fund), V38, P1; Ma J, 2005, J ADOLESCENT HEALTH, V37, P434, DOI 10.1016/j.jadohealth.2005.07.012; Marcell AV, 2002, J ADOLESCENT HEALTH, V30, P35, DOI 10.1016/S1054-139X(01)00319-6; *NAT CTR HLTH STAT, US ULT CLUST MOD NAM; *NAT CTR HLTH STAT, PROT 2003 05 NAT AMB; National Center for Health Statistics, NCHS PUBL US DAT FIL; Ortega-Sanchez R, 2004, PREV MED, V38, P219, DOI 10.1016/j.ypmed.2003.09.042; Ozer E, 2003, J ADOLESCENT HEALTH, V32, P132, DOI 10.1016/S1054-139X(02)00638-9; Park MJ, 2008, J ADOLESCENT HEALTH, V42, P329, DOI 10.1016/j.jadohealth.2008.01.008; Park MJ, 2006, J ADOLESCENT HEALTH, V39, P305, DOI 10.1016/j.jadohealth.2006.04.017; Rand CM, 2005, J ADOLESCENT HEALTH, V37, P87, DOI 10.1016/j.jadohealth.2005.02.008; Rand CM, 2007, ARCH PEDIAT ADOL MED, V161, P252, DOI 10.1001/archpedi.161.3.252; *ROCH COMM WID CLI, 2007, PREV CAR AD AG 19 YE; Stein RJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.5.e66; *SUBST AB MENT HLT, 2008, NSDUH REP TREATM YEA; Substance Abuse and Mental Health Services Administration Office of Applied Studies, 2008, NSDUH SERIES H; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; *US BUR CENS POP D, MONTHL POP EST US; *US BUR CENS POP D, CENS 2000 BRIEFS SPE; VERBRUGGE LM, 1982, PUBLIC HEALTH REP, V97, P417; Ziv A, 1999, PEDIATRICS, V104, P35, DOI 10.1542/peds.104.1.35	34	89	89	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2009	151	6					379	W119		10.7326/0003-4819-151-6-200909150-00002	http://dx.doi.org/10.7326/0003-4819-151-6-200909150-00002			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	501OB	19755363				2022-12-24	WOS:000270390100002
J	Yang, J; Zhang, ZG; Roe, SM; Marshall, CJ; Barford, D				Yang, Jing; Zhang, Ziguo; Roe, S. Mark; Marshall, Christopher J.; Barford, David			Activation of Rho GTPases by DOCK Exchange Factors Is Mediated by a Nucleotide Sensor	SCIENCE			English	Article							STRUCTURAL BASIS; CDC42; PROTEINS; GEF; BINDING; DOMAIN; RAC; MEMBRANE; ZIZIMIN1; CRYSTAL	Activation of Rho guanosine triphosphatases (GTPases) to the guanine triphosphate (GTP)-bound state is a critical event in their regulation of the cytoskeleton and cell signaling. Members of the DOCK family of guanine nucleotide exchange factors (GEFs) are important activators of Rho GTPases, but the mechanism of activation by their catalytic DHR2 domain is unknown. Through structural analysis of DOCK9-Cdc42 complexes, we identify a nucleotide sensor within the alpha 10 helix of the DHR2 domain that contributes to release of guanine diphosphate (GDP) and then to discharge of the activated GTP-bound Cdc42. Magnesium exclusion, a critical factor in promoting GDP release, is mediated by a conserved valine residue within this sensor, whereas binding of GTP-Mg2+ to the nucleotide-free complex results in magnesium-inducing displacement of the sensor to stimulate discharge of Cdc42-GTP. These studies identify an unusual mechanism of GDP release and define the complete GEF catalytic cycle from GDP dissociation followed by GTP binding and discharge of the activated GTPase.	[Yang, Jing; Zhang, Ziguo; Roe, S. Mark; Barford, David] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; [Marshall, Christopher J.] Inst Canc Res, Chester Beatty Labs, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Barford, D (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	David.Barford@icr.ac.uk		Zhang, Ziguo/0000-0002-7268-9631; Roe, Mark/0000-0002-7371-9855	Cancer Research-UK; Gibb Life Fellow of Cancer Resesarch-UK; Diamond Light Source	Cancer Research-UK(Cancer Research UK); Gibb Life Fellow of Cancer Resesarch-UK; Diamond Light Source	This work was funded by grants from Cancer Research-UK to D. B. and C. J. M. C. J. M. is a Gibb Life Fellow of Cancer Resesarch-UK, and work was carried out with the support of the Diamond Light Source. We thank staff at the European Synchrotron Radiation Facility for help with data collection, T. Bunney for advice and reagents, and D. Komander for discussions. Accession numbers for coordinates and structure factors are 2wm9, 2wm9sf, 2wmn, 2wmnsf, 2wmo, and 2wmosf for the DOCK9DHR2-Cdc42 complex and -GDP and -GTP complexes, respectively.	Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Gadea G, 2008, CURR BIOL, V18, P1456, DOI 10.1016/j.cub.2008.08.053; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kobayashi S, 2001, BIOCHEM J, V354, P73, DOI 10.1042/0264-6021:3540073; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Meller N, 2004, J BIOL CHEM, V279, P37470, DOI 10.1074/jbc.M404535200; Miyamoto Y, 2007, EXP CELL RES, V313, P791, DOI 10.1016/j.yexcr.2006.11.017; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Phillips MJ, 2008, J BIOL CHEM, V283, P14153, DOI 10.1074/jbc.M706271200; REINSTEIN J, 1991, J BIOL CHEM, V266, P17700; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rossman KL, 2002, J BIOL CHEM, V277, P50893, DOI 10.1074/jbc.M208580200; Rudolph MG, 1999, PROTEIN SCI, V8, P778; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014	28	91	94	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1398	1402		10.1126/science.1174468	http://dx.doi.org/10.1126/science.1174468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745154				2022-12-24	WOS:000269699100040
J	Coulombe, F; Behr, MA				Coulombe, Francois; Behr, Marcel A.			Crohn's disease as an immune deficiency?	LANCET			English	Editorial Material									[Coulombe, Francois; Behr, Marcel A.] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3G 1A4, Canada	McGill University	Behr, MA (corresponding author), McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3G 1A4, Canada.	marcel.behr@mcgill.ca						Behr MA, 2006, INFLAMM BOWEL DIS, V12, P1000, DOI 10.1097/01.mib.0000228183.70197.dd; Coulombe F, 2009, J EXP MED, V206, P1709, DOI 10.1084/jem.20081779; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; Park JH, 2007, CYTOKINE, V39, P32, DOI 10.1016/j.cyto.2007.07.123; SEGAL AW, 1976, LANCET, V2, P219; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233	8	20	20	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2009	374	9692					769	770		10.1016/S0140-6736(09)61576-2	http://dx.doi.org/10.1016/S0140-6736(09)61576-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492QU	19733770				2022-12-24	WOS:000269675000010
J	Leslie, WD; O'Donnell, S; Jean, S; Lagace, C; Walsh, P; Bancej, C; Morin, S; Hanley, DA; Papaioannou, A				Leslie, William D.; O'Donnell, Siobhan; Jean, Sonia; Lagace, Claudia; Walsh, Peter; Bancej, Christina; Morin, Suzanne; Hanley, David A.; Papaioannou, Alexandra		Osteoporosis Surveillance Expert W	Trends in Hip Fracture Rates in Canada	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OSTEOPOROSIS CARE GAP; QUALITY-OF-LIFE; UNITED-STATES; FRAGILITY FRACTURES; RISK-FACTORS; OLDER MEN; WOMEN; METAANALYSIS; COMMUNITY; MORTALITY	Context Hip fractures are a public health concern because they are associated with significant morbidity, excess mortality, and the majority of the costs directly attributable to osteoporosis. Objective To examine trends in hip fracture rates in Canada. Design, Setting, and Patients Ecologic trend study using nationwide hospitalization data for 1985 to 2005 from a database at the Canadian Institute for Health Information. Data for all patients with a hospitalization for which the primary reason was a hip fracture (570 872 hospitalizations) were analyzed. Main Outcome Measures Age-specific and age-standardized hip fracture rates. Results There was a decrease in age-specific hip fracture rates (all P for trend <.001). Over the 21-year period of the study, age-adjusted hip fracture rates decreased by 31.8% in females (from 118.6 to 80.9 fractures per 100 000 person-years) and by 25.0% in males (from 68.2 to 51.1 fractures per 100 000 person-years). Joinpoint regression analysis identified a change in the linear slope around 1996. For the overall population, the average age-adjusted annual percentage decrease in hip fracture rates was 1.2% (95% confidence interval, 1.0%-1.3%) per year from 1985 to 1996 and 2.4% (95% confidence interval, 2.1%-2.6%) per year from 1996 to 2005 (P<.001 for difference in slopes). Similar changes were seen in both females and males with greater slope reductions after 1996 (P<.001 for difference in slopes for each sex). Conclusions Age-standardized rates of hip fracture have steadily declined in Canada since 1985 and more rapidly during the later study period. The factors primarily responsible for the earlier reduction in hip fractures are unknown. JAMA. 2009; 302(8): 883-889	[Leslie, William D.] Univ Manitoba, Dept Med, Winnipeg, MB R2H 2A6, Canada; [O'Donnell, Siobhan; Lagace, Claudia; Walsh, Peter; Bancej, Christina] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Jean, Sonia] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [Morin, Suzanne] McGill Univ, Montreal, PQ, Canada; [Hanley, David A.] Univ Calgary, Calgary, AB, Canada; [Papaioannou, Alexandra] McMaster Univ, Hamilton, ON, Canada	University of Manitoba; Public Health Agency of Canada; Institut national de sante publique du Quebec (INSPQ); McGill University; University of Calgary; McMaster University	Leslie, WD (corresponding author), Univ Manitoba, Dept Med C5121, 409 Tache Ave, Winnipeg, MB R2H 2A6, Canada.	bleslie@sbgh.mb.ca		Leslie, William/0000-0002-1056-1691; Morin, Suzanne/0000-0002-4317-492X; Kendler, David/0000-0001-7679-3965				Adachi JD, 2001, OSTEOPOROSIS INT, V12, P903, DOI 10.1007/s001980170017; Berry SD, 2007, ARCH INTERN MED, V167, P1971, DOI 10.1001/archinte.167.18.1971; Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; Browner WS, 1996, ARCH INTERN MED, V156, P1521, DOI 10.1001/archinte.156.14.1521; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Chapurlat RD, 2003, OSTEOPOROSIS INT, V14, P130, DOI 10.1007/s00198-002-1327-6; CHENG N, 2008, CAN FAM PHYSICIAN, V54, pE1; Cheng N, 2008, CAN FAM PHYSICIAN, V54, P1140; Chevalley T, 2007, BONE, V40, P1284, DOI 10.1016/j.bone.2006.12.063; Couris CM, 2007, BONE, V41, P896, DOI 10.1016/j.bone.2007.06.020; Feldstein AC, 2005, OSTEOPOROSIS INT, V16, P953, DOI 10.1007/s00198-005-1950-0; Gates S, 2008, BRIT MED J, V336, P130, DOI 10.1136/bmj.39412.525243.BE; Gehlbach SH, 2007, OSTEOPOROSIS INT, V18, P585, DOI 10.1007/s00198-006-0281-0; Giangregorio L, 2006, SEMIN ARTHRITIS RHEU, V35, P293, DOI 10.1016/j.semarthrit.2005.11.001; GILMORE J, 82F0077XIE STAT CAN; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; Hallberg I, 2004, OSTEOPOROSIS INT, V15, P834, DOI 10.1007/s00198-004-1622-5; Hannan EL, 2001, JAMA-J AM MED ASSOC, V285, P2736, DOI 10.1001/jama.285.21.2736; Icks A, 2008, OSTEOPOROSIS INT, V19, P1139, DOI 10.1007/s00198-007-0534-6; Jaglal SB, 2005, J BONE MINER RES, V20, P898, DOI 10.1359/JBMR.041231; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P155, DOI 10.1007/s00198-004-1640-3; Kannus P, 2006, J BONE MINER RES, V21, P1836, DOI 10.1359/JBMR.060815; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Lippuner K, 2005, OSTEOPOROSIS INT, V16, pS8, DOI 10.1007/s00198-004-1696-0; Melton LJ, 2007, J BONE MINER RES, V22, P1096, DOI 10.1359/JBMR.070323; Melton LJ, 1996, PUBLIC HEALTH REP, V111, P146; Melton LJ, 2003, ENDOCRIN METAB CLIN, V32, P1, DOI 10.1016/S0889-8529(02)00061-0; Nichols HB, 2006, AM J EPIDEMIOL, V164, P1003, DOI 10.1093/aje/kwj282; Papaioannou A, 2008, OSTEOPOROSIS INT, V19, P581, DOI 10.1007/s00198-007-0483-0; RICHARDS J, 1989, SOC SCI MED, V28, P175; Ryg P, 2009, J BONE MINER RES, V24, P1299, DOI [10.1359/JBMR.090207, 10.1359/jbmr.090207]; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; Zingmond DS, 2004, OSTEOPOROSIS INT, V15, P603, DOI 10.1007/s00198-004-1592-7	35	248	256	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 26	2009	302	8					883	889		10.1001/jama.2009.1231	http://dx.doi.org/10.1001/jama.2009.1231			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487GN	19706862	Bronze			2022-12-24	WOS:000269260100022
J	Betts, TR				Betts, Timothy R.			Is rate more important than rhythm in treating atrial fibrillation? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ELECTRICAL CARDIOVERSION RACE; QUALITY-OF-LIFE; MANAGEMENT AFFIRM; RANDOMIZED-TRIAL; STRATEGIES; AMIODARONE; ABLATION		John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England	University of Oxford	Betts, TR (corresponding author), John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England.	EP.doctors@orh.nhs.uk	Mitchell, Andrew/AFQ-7844-2022	Mitchell, Andrew/0000-0002-5386-9645				Betts TR, 2008, EUROPACE, V10, P425, DOI 10.1093/europace/eun063; Carlsson J, 2003, J AM COLL CARDIOL, V41, P1690, DOI 10.1016/S0735-1097(03)00332-2; Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11; Curtis AB, 2005, AM HEART J, V149, P645, DOI 10.1016/j.ahj.2004.09.038; Fetsch T, 2004, EUR HEART J, V25, P1385, DOI 10.1016/j.ehj.2004.04.015; Gronefeld GC, 2003, EUR HEART J, V24, P1430, DOI 10.1016/S0195-668X(03)00261-6; Hagens VE, 2004, EUR HEART J, V25, P1542, DOI 10.1016/j.ehj.2004.06.020; Hagens VE, 2004, J AM COLL CARDIOL, V43, P241, DOI 10.1016/j.jacc.2003.08.037; Hohnloser SH, 2000, LANCET, V356, P1789, DOI 10.1016/S0140-6736(00)03230-X; Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; Kumana CR, 2005, BRIT J CLIN PHARMACO, V60, P347, DOI 10.1111/j.1365-2125.2005.02449.x; Lubitz SA, 2008, BMJ-BRIT MED J, V336, P819, DOI 10.1136/bmj.39513.555150.BE; Marshall DA, 2004, ANN INTERN MED, V141, P653, DOI 10.7326/0003-4819-141-9-200411020-00005; Opolski G, 2004, CHEST, V126, P476, DOI 10.1378/chest.126.2.476; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Vorperian VR, 1997, J AM COLL CARDIOL, V30, P791, DOI 10.1016/S0735-1097(97)00220-9; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	19	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2009	339								b3173	10.1136/bmj.b3173	http://dx.doi.org/10.1136/bmj.b3173			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486SE	19700508				2022-12-24	WOS:000269217200007
J	Picotti, P; Bodenmiller, B; Mueller, LN; Domon, B; Aebersold, R				Picotti, Paola; Bodenmiller, Bernd; Mueller, Lukas N.; Domon, Bruno; Aebersold, Ruedi			Full Dynamic Range Proteome Analysis of S. cerevisiae by Targeted Proteomics	CELL			English	Article							MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; GLYCOLYTIC-ENZYMES; YEAST; QUANTIFICATION; EXPRESSION; PEPTIDES; IDENTIFICATION; PROTEINS; RESOURCE	The rise of systems biology implied a growing demand for highly sensitive techniques for the fast and consistent detection and quantification of target sets of proteins across multiple samples. This is only partly achieved by classical mass spectrometry or affinity-based methods. We applied a targeted proteomics approach based on selected reaction monitoring (SRM) to detect and quantify proteins expressed to a concentration below 50 copies/cell in total S. cerevisiae digests. The detection range can be extended to single-digit copies/cell and to proteins undetected by classical methods. We illustrate the power of the technique by the consistent and fast measurement of a network of proteins spanning the entire abundance range over a growth time course of S. cerevisiae transiting through a series of metabolic phases. We therefore demonstrate the potential of SRM-based proteomics to provide assays for the measurement of any set of proteins of interest in yeast at high-throughput and quantitative accuracy.	[Picotti, Paola; Bodenmiller, Bernd; Mueller, Lukas N.; Domon, Bruno; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Inst Syst Biol, Seattle, WA 98103 USA; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Institute for Systems Biology (ISB); University of Zurich	Aebersold, R (corresponding author), ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.	aebersold@imsb.biol.ethz.ch			ETH Zurich; Swiss National Science Foundation; National Heart, Lung, and Blood Institute; National Institutes of Health [HV-28179]; SystemsX.ch; Swiss initiative; Boehringer Ingelheim Fonds; Marie Curie Intra-European fellowship; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028179] Funding Source: NIH RePORTER	ETH Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SystemsX.ch; Swiss initiative; Boehringer Ingelheim Fonds(Boehringer Ingelheim); Marie Curie Intra-European fellowship(European Commission); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge Holger Wenschuh (JPT Peptide Technologies), Marko Jovanovic, Vinzenz Lange, Sarah Maria Fendt, Nichole King, and Matthias Heinemann for insightful discussions. We are also grateful to Roeland Costenoble and Uwe Sauer for providing <SUP>15</SUP>N- labeled S. cerevisiae cells. This project has been funded in part by ETH Zurich; the Swiss National Science Foundation, with Federal funds from the National Heart, Lung, and Blood Institute; the National Institutes of Health, under contract No. N01-HV-28179; and SystemsX.ch, the Swiss initiative for systems biology. B.B. is the recipient of a fellowship from the Boehringer Ingelheim Fonds. P.P. is the recipient of a Marie Curie Intra-European fellowship.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; Brunner E, 2007, NAT BIOTECHNOL, V25, P576, DOI 10.1038/nbt1300; Chen EI, 2006, MOL CELL PROTEOMICS, V5, P53, DOI 10.1074/mcp.T500013-MCP200; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; de Godoy LMF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r50; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DESIDERIO DM, 1983, BIOMED MASS SPECTROM, V10, P471, DOI 10.1002/bms.1200100806; Deutsch EW, 2008, EMBO REP, V9, P429, DOI 10.1038/embor.2008.56; Domon B, 2004, J PROTEOME RES, V3, P253, DOI 10.1021/pr034082c; ENTIAN KD, 1980, MOL GEN GENET, V177, P345, DOI 10.1007/BF00267449; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Haurie V, 2004, PROTEOMICS, V4, P364, DOI 10.1002/pmic.200300564; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Kuster B, 2005, NAT REV MOL CELL BIO, V6, P577, DOI 10.1038/nrm1683; Lange V, 2008, MOL CELL PROTEOMICS, V7, P1489, DOI 10.1074/mcp.M800032-MCP200; MacQueen J, 1967, P 5 BERKELEY S MATH, V1, DOI DOI 10.1007/S11665-016-2173-6; MACQUEEN J, 1967, U CALIFORNIA PRESS, P5; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Malmstrom J, 2006, J PROTEOME RES, V5, P2241, DOI 10.1021/pr0600632; Pawlak M, 2002, PROTEOMICS, V2, P383, DOI 10.1002/1615-9861(200204)2:4<383::AID-PROT383>3.0.CO;2-E; Picotti P, 2008, NAT METHODS, V5, P913, DOI 10.1038/nmeth1108-913; Picotti P, 2007, MOL CELL PROTEOMICS, V6, P1589, DOI 10.1074/mcp.M700029-MCP200; POLAKIS ES, 1965, BIOCHEM J, V97, P284, DOI 10.1042/bj0970284; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Stahl-Zeng J, 2007, MOL CELL PROTEOMICS, V6, P1809, DOI 10.1074/mcp.M700132-MCP200; Taussig MJ, 2007, NAT METHODS, V4, P13, DOI 10.1038/nmeth0107-13; Uhlen M, 2008, BIOTECHNIQUES, V44, P649, DOI 10.2144/000112803; Wenschuh H, 2000, BIOPOLYMERS, V55, P188, DOI 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104	36	604	620	1	136	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					795	806		10.1016/j.cell.2009.05.051	http://dx.doi.org/10.1016/j.cell.2009.05.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19664813	Green Accepted, Bronze			2022-12-24	WOS:000269156100020
J	Vecchi, C; Montosi, G; Zhang, KZ; Lamberti, I; Duncan, SA; Kaufman, RJ; Pietrangelo, A				Vecchi, Chiara; Montosi, Giuliana; Zhang, Kezhong; Lamberti, Igor; Duncan, Stephen A.; Kaufman, Randal J.; Pietrangelo, Antonello			ER Stress Controls Iron Metabolism Through Induction of Hepcidin	SCIENCE			English	Article							UNFOLDED PROTEIN RESPONSE; ANTIMICROBIAL PEPTIDE; IN-VIVO; EXPRESSION; HEMOCHROMATOSIS; TRANSCRIPTION; INFLAMMATION; STAT3; LIVER	Hepcidin is a peptide hormone that is secreted by the liver and controls body iron homeostasis. Hepcidin overproduction causes anemia of inflammation, whereas its deficiency leads to hemochromatosis. Inflammation and iron are known extracellular stimuli for hepcidin expression. We found that endoplasmic reticulum (ER) stress also induces hepcidin expression and causes hypoferremia and spleen iron sequestration in mice. CREBH (cyclic AMP response element-binding protein H), an ER stress-activated transcription factor, binds to and transactivates the hepcidin promoter. Hepcidin induction in response to exogenously administered toxins or accumulation of unfolded protein in the ER is defective in CREBH knockout mice, indicating a role for CREBH in ER stress-regulated hepcidin expression. The regulation of hepcidin by ER stress links the intracellular response involved in protein quality control to innate immunity and iron homeostasis.	[Vecchi, Chiara; Montosi, Giuliana; Lamberti, Igor; Pietrangelo, Antonello] Univ Hosp Policlin Modena, Dept Internal Med, Ctr Hemochromatosis, Modena, Italy; [Zhang, Kezhong] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Duncan, Stephen A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Kaufman, Randal J.] Univ Michigan, Howard Hughes Med Inst, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.] Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Med Ctr, Ann Arbor, MI 48109 USA	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Wayne State University; Medical College of Wisconsin; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Pietrangelo, A (corresponding author), Univ Hosp Policlin Modena, Dept Internal Med, Ctr Hemochromatosis, Modena, Italy.	antonello.pietrangelo@unimore.it	Vecchi, Chiara/C-1552-2014; Pietrangelo, Antonello/K-1517-2016	Pietrangelo, Antonello/0000-0002-7411-935X; Zhang, Kezhong/0000-0002-6062-235X; Duncan, Stephen/0000-0002-2507-7827; VECCHI, Chiara/0000-0001-7761-4922	European Union [EUROIRON Ct.2006-037296]; NIH [DK42394, HL52173, PO1 HL057346]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057346, R01HL052173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042394, R37DK042394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH089782] Funding Source: NIH RePORTER	European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by European Union grant EUROIRON Ct.2006-037296 (A.P.) and NIH grants DK42394, HL52173, and PO1 HL057346 R.J.K.). R.J.K. is an Investigator of the Howard Hughes Medical Institute.	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; CARTWRIGHT G. E., 1966, SEMINARS HEMATOL, V3, P351; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Flanagan JM, 2007, BLOOD CELL MOL DIS, V38, P253, DOI 10.1016/j.bcmd.2007.01.004; Ganz T, 2006, CURR TOP MICROBIOL, V306, P183; HURST HC, 1995, PROTEIN PROFILE, V2, P105; Miao HZ, 2004, BLOOD, V103, P3412, DOI 10.1182/blood-2003-10-3591; Muckenthaler M, 2003, NAT GENET, V34, P102, DOI 10.1038/ng1152; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	21	231	239	4	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					877	880		10.1126/science.1176639	http://dx.doi.org/10.1126/science.1176639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AK	19679815	Green Accepted			2022-12-24	WOS:000269242400047
J	Shen, YJ; Tenney, AP; Busch, SA; Horn, KP; Cuascut, FX; Liu, K; He, ZG; Silver, J; Flanagan, JG				Shen, Yingjie; Tenney, Alan P.; Busch, Sarah A.; Horn, Kevin P.; Cuascut, Fernando X.; Liu, Kai; He, Zhigang; Silver, Jerry; Flanagan, John G.			PTP sigma Is a Receptor for Chondroitin Sulfate Proteoglycan, an Inhibitor of Neural Regeneration	SCIENCE			English	Article							TYROSINE-PHOSPHATASE-SIGMA; SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; GLIAL SCAR; AXONAL REGENERATION; FUNCTIONAL RECOVERY; IN-VIVO; GROWTH; CNS; LAR	Chondroitin sulfate proteoglycans (CSPGs) present a barrier to axon regeneration. However, no specific receptor for the inhibitory effect of CSPGs has been identified. We showed that a transmembrane protein tyrosine phosphatase, PTP sigma, binds with high affinity to neural CSPGs. Binding involves the chondroitin sulfate chains and a specific site on the first immunoglobulin-like domain of PTP sigma. In culture, PTP sigma(-/-) neurons show reduced inhibition by CSPG. A PTP sigma fusion protein probe can detect cognate ligands that are up-regulated specifically at neural lesion sites. After spinal cord injury, PTP sigma gene disruption enhanced the ability of axons to penetrate regions containing CSPG. These results indicate that PTP sigma can act as a receptor for CSPGs and may provide new therapeutic approaches to neural regeneration.	[Shen, Yingjie; Tenney, Alan P.; Flanagan, John G.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Shen, Yingjie; Tenney, Alan P.; Flanagan, John G.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Busch, Sarah A.; Horn, Kevin P.; Cuascut, Fernando X.; Silver, Jerry] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA; [Liu, Kai; He, Zhigang] Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Case Western Reserve University; Harvard University; Boston Children's Hospital; Harvard Medical School	Flanagan, JG (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	flanagan@hms.harvard.edu	Flanagan, John/AAM-2995-2020	Horn, Kevin/0000-0002-8799-6941	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD029417] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS025713, R01NS025713] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY011559] Funding Source: Medline; NICHD NIH HHS [R37 HD029417] Funding Source: Medline; NINDS NIH HHS [R01 NS025713, R37 NS025713, R37 NS025713-22] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Asher RA, 2000, J NEUROSCI, V20, P2427; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Cafferty WBJ, 2008, J NEUROSCI, V28, P11998, DOI 10.1523/JNEUROSCI.3877-08.2008; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Chagnon MJ, 2004, BIOCHEM CELL BIOL, V82, P664, DOI 10.1139/O04-120; Chan CCM, 2007, GLIA, V55, P369, DOI 10.1002/glia.20466; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Domeniconi M, 2005, J NEUROL SCI, V233, P43, DOI 10.1016/j.jns.2005.03.023; Elchebly M, 1999, NAT GENET, V21, P330, DOI 10.1038/6859; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; FRY EJ, 2009, GLIA, DOI DOI 10.1002/GLIA.20934; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Haworth K, 1998, MOL CELL NEUROSCI, V12, P93, DOI 10.1006/mcne.1998.0707; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; Lu P, 2008, EXP NEUROL, V209, P313, DOI 10.1016/j.expneurol.2007.08.004; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; McLean J, 2002, J NEUROSCI, V22, P5481; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Sapieha PS, 2005, MOL CELL NEUROSCI, V28, P625, DOI 10.1016/j.mcn.2004.10.011; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Tester NJ, 2008, EXP NEUROL, V209, P483, DOI 10.1016/j.expneurol.2007.07.019; Thompson KM, 2003, MOL CELL NEUROSCI, V23, P681, DOI 10.1016/S1044-7431(03)00120-9; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	35	479	502	4	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					592	596		10.1126/science.1178310	http://dx.doi.org/10.1126/science.1178310			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19833921	Green Accepted			2022-12-24	WOS:000271019400047
J	Psaty, BM; Prentice, RL				Psaty, Bruce M.; Prentice, Ross L.			Variation in Event Rates in Trials of Patients With Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GLUCOSE CONTROL		[Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; [Prentice, Ross L.] Univ Washington, Div Publ Hlth Sci, Fred Hutchinson Canc Res Ctr, Seattle, WA 98101 USA; [Prentice, Ross L.] Univ Washington, Dept Biostat, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Grp Hlth, Grp Hlth Res Inst, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu			NATIONAL CANCER INSTITUTE [P01CA053996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074745, U01HL080295, R01HL085251, R01HL080295, R01HL087652] Funding Source: NIH RePORTER; NCI NIH HHS [CA53996] Funding Source: Medline; NHLBI NIH HHS [HL74745, HL087652, HL085251, HL080295] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*ARIC, ARIC INC TABL; Chambless LE, 2002, AM J EPIDEMIOL, V155, P38, DOI 10.1093/aje/155.1.38; Davis BR, 2009, NEW ENGL J MED, V360, P1148; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Prentice RL, 2009, JNCI-J NATL CANCER I, V101, P216, DOI 10.1093/jnci/djn515	10	17	17	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 21	2009	302	15					1698	1700		10.1001/jama.2009.1497	http://dx.doi.org/10.1001/jama.2009.1497			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508NX	19843906				2022-12-24	WOS:000270941200027
J	Dekas, AE; Poretsky, RS; Orphan, VJ				Dekas, Anne E.; Poretsky, Rachel S.; Orphan, Victoria J.			Deep-Sea Archaea Fix and Share Nitrogen in Methane-Consuming Microbial Consortia	SCIENCE			English	Article							ANAEROBIC OXIDATION; FIXATION; EVOLUTION; SEDIMENTS; BIOGEOCHEMISTRY; BACTERIA; DIVERSE; CARBON; FISH	Nitrogen-fixing (diazotrophic) microorganisms regulate productivity in diverse ecosystems; however, the identities of diazotrophs are unknown in many oceanic environments. Using single-cell-resolution nanometer secondary ion mass spectrometry images of (15)N incorporation, we showed that deep-sea anaerobic methane-oxidizing archaea fix N(2), as well as structurally similar CN(-), and share the products with sulfate-reducing bacterial symbionts. These archaeal/bacterial consortia are already recognized as the major sink of methane in benthic ecosystems, and we now identify them as a source of bioavailable nitrogen as well. The archaea maintain their methane oxidation rates while fixing N(2) but reduce their growth, probably in compensation for the energetic burden of diazotrophy. This finding extends the demonstrated lower limits of respiratory energy capable of fueling N(2) fixation and reveals a link between the global carbon, nitrogen, and sulfur cycles.	[Dekas, Anne E.; Poretsky, Rachel S.; Orphan, Victoria J.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Dekas, AE (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	dekas@gps.caltech.edu; vorphan@gps.caltech.edu	Orphan, Victoria/AAS-5989-2020; Orphan, Victoria J/K-1002-2014	Orphan, Victoria/0000-0002-5374-6178; Orphan, Victoria J/0000-0002-5374-6178	NSF [MCB-0348492]; Gordon and Betty Moore Foundation; NSF Graduate Research Fellowship	NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF Graduate Research Fellowship(National Science Foundation (NSF))	We thank C. House, A. Schmitt, K. McKeegan, Y. Guan, J. Eiler, and L. Remusat for assistance with the ion microprobe data collection; S. Joye, M. Boyles, M. Walton, J. Howard, N. Dalleska, O. Mason, A. Green, P. Tavormina, S. Goffredi, C. Gammon, and the shipboard party and crew of the R/V Atlantis and DSSV Alvin for support in the field and laboratory; and J. Howard, W. Fischer, J. Amend, C. Anderson, D. Fike, D. Sigman, V. Rich, J. Bailey, D. Newman, J. Grotzinger, T. Hoehler, J. Delacruz, and three anonymous reviewers for helpful suggestions regarding this manuscript. Funding was provided by NSF (grant MCB-0348492), the Gordon and Betty Moore Foundation, and an NSF Graduate Research Fellowship (A. E. D.). The Caltech Center for Microanalysis and nanoSIMS 50L are funded by the Gordon and Betty Moore Foundation, and the University of California Los Angeles ion microprobe is partially supported by the NSF Instrumentation and Facilities Program.	Behrens S, 2008, APPL ENVIRON MICROB, V74, P3143, DOI 10.1128/AEM.00191-08; Berman-Frank I, 2003, RES MICROBIOL, V154, P157, DOI 10.1016/S0923-2508(03)00029-9; BROOKS JM, 1987, SCIENCE, V238, P1138, DOI 10.1126/science.238.4830.1138; Buckley DH, 2008, SOIL BIOL BIOCHEM, V40, P1272, DOI 10.1016/j.soilbio.2007.05.006; Chien YT, 2000, J BACTERIOL, V182, P3247, DOI 10.1128/JB.182.11.3247-3253.2000; Codispoti LA, 2007, BIOGEOSCIENCES, V4, P233, DOI 10.5194/bg-4-233-2007; Dang HY, 2009, APPL ENVIRON MICROB, V75, P2238, DOI 10.1128/AEM.02556-08; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Fulweiler RW, 2007, NATURE, V448, P180, DOI 10.1038/nature05963; Horner-Devine MC, 2008, SCIENCE, V320, P757, DOI 10.1126/science.1147012; Joye SB, 2004, CHEM GEOL, V205, P219, DOI 10.1016/j.chemgeo.2003.12.019; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Kessler PS, 2001, J BACTERIOL, V183, P882, DOI 10.1128/JB.183.3.882-889.2001; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Leigh JA, 2000, PROKARYOTIC NITROGEN FIXATION, P657; Liu Jong-Kaing, 1997, Proceedings of the National Science Council Republic of China Part B Life Sciences, V21, P37; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; Mehta MP, 2006, SCIENCE, V314, P1783, DOI 10.1126/science.1134772; MURRAY PA, 1984, NATURE, V312, P284, DOI 10.1038/312284a0; Orphan VJ, 2009, ENVIRON MICROBIOL, V11, P1777, DOI 10.1111/j.1462-2920.2009.01903.x; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Pernthaler A, 2008, P NATL ACAD SCI USA, V105, P7052, DOI 10.1073/pnas.0711303105; Raymond J, 2005, REV MINERAL GEOCHEM, V59, P211, DOI 10.2138/rmg.2005.59.9; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; SILVER WS, 1973, J THEOR BIOL, V40, P1, DOI 10.1016/0022-5193(73)90160-4; Strous M, 2004, ANNU REV MICROBIOL, V58, P99, DOI 10.1146/annurev.micro.58.030603.123605; Udvardi MK, 1997, ANNU REV PLANT PHYS, V48, P493, DOI 10.1146/annurev.arplant.48.1.493; Young JPW, 2005, GENOMES AND GENOMICS OF NITROGEN-FIXING ORGANISMS, P221; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x	29	222	234	8	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 16	2009	326	5951					422	426		10.1126/science.1178223	http://dx.doi.org/10.1126/science.1178223			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833965	Green Accepted			2022-12-24	WOS:000270818600052
J	Wu, MV; Manoli, DS; Fraser, EJ; Coats, JK; Tollkuhn, J; Honda, SI; Harada, N; Shah, NM				Wu, Melody V.; Manoli, Devanand S.; Fraser, Eleanor J.; Coats, Jennifer K.; Tollkuhn, Jessica; Honda, Shin-Ichiro; Harada, Nobuhiro; Shah, Nirao M.			Estrogen Masculinizes Neural Pathways and Sex-Specific Behaviors	CELL			English	Article							STRIA TERMINALIS; BED NUCLEUS; VENTROMEDIAL NUCLEUS; ANDROGEN RECEPTOR; MICE LACKING; REPRODUCTIVE BEHAVIORS; INTERMALE AGGRESSION; MATING-BEHAVIOR; MEDIAL NUCLEUS; MESSENGER-RNA	Sex hormones are essential for neural circuit development and sex-specific behaviors. Male behaviors require both testosterone and estrogen, but it is unclear how the two hormonal pathways intersect. Circulating testosterone activates the androgen receptor (AR) and is also converted into estrogen in the brain via aromatase. We demonstrate extensive sexual dimorphism in the number and projections of aromatase-expressing neurons. The masculinization of these cells is independent of AR but can be induced in females by either testosterone or estrogen, indicating a role for aromatase in sexual differentiation of these neurons. We provide evidence suggesting that aromatase is also important in activating male-specific aggression and urine marking because these behaviors can be elicited by testosterone in males mutant for AR and in females subjected to neonatal estrogen exposure. Our results suggest that aromatization of testosterone into estrogen is important for the development and activation of neural circuits that control male territorial behaviors.	[Wu, Melody V.; Coats, Jennifer K.; Shah, Nirao M.] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA; [Fraser, Eleanor J.; Shah, Nirao M.] Univ Calif San Francisco, Genet Program, San Francisco, CA 94158 USA; [Tollkuhn, Jessica; Shah, Nirao M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Manoli, Devanand S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Shah, Nirao M.] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94158 USA; [Honda, Shin-Ichiro; Harada, Nobuhiro] Fujita Hlth Univ, Sch Med, Aichi, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Fujita Health University	Shah, NM (corresponding author), Univ Calif San Francisco, Program Neurosci, MC 2722, San Francisco, CA 94158 USA.	nms@ucsf.edu		Manoli, Devanand/0000-0002-7238-2330; Tollkuhn, Jessica/0000-0001-5991-7620; Wu, Melody/0000-0002-5246-2659	Genentech Graduate Fellowships; National Science Foundation Graduate Research Fellowship; National Institutes of Health Institutional Training Grant; National Institutes of Health [R01]; Biomedical Sciences, UCSF Program for Breakthrough Biomedical Research; McKnight Foundation for Neuroscience; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049488] Funding Source: NIH RePORTER	Genentech Graduate Fellowships; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health Institutional Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Sciences, UCSF Program for Breakthrough Biomedical Research; McKnight Foundation for Neuroscience; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Barberini for software programming; C. Cheung for technical assistance with ISH; D. Lubahn for providing us with aromatase<SUP>-/+</SUP> animals; V. Mandiyan, L. Crothers, and C. Carey for technical assistance; P. Ohara for assistance with stereology; and R. Axel, T. Clandinin, H. Ingraham, D. Julius, S. Lomvardas, and Shah lab members for critical discussions and comments on the manuscript. This work was supported by Genentech Graduate Fellowships (M.V.W., J.K.C.); National Science Foundation Graduate Research Fellowship (E.J.F.); Achievement Rewards for College Scientists Scholarship (J.K.C.); National Institutes of Health Institutional Training Grant (J.T.); National Institutes of Health (R01), Career Awards in the Biomedical Sciences, UCSF Program for Breakthrough Biomedical Research, Edward Mallinckrodt, Jr. Foundation, and McKnight Foundation for Neuroscience (N.M.S.).	ALBERT DJ, 1984, NEUROSCI BIOBEHAV R, V8, P5, DOI 10.1016/0149-7634(84)90017-4; AlShamma HA, 1996, J NEUROBIOL, V29, P91, DOI 10.1002/(SICI)1097-4695(199601)29:1<91::AID-NEU7>3.0.CO;2-2; Amateau SK, 2004, ENDOCRINOLOGY, V145, P2906, DOI 10.1210/en.2003-1363; Arai Y, 1996, NEUROSCI RES, V25, P403; Arnold AP, 2003, ANN NY ACAD SCI, V1007, P176, DOI 10.1196/annals.1286.018; BAUM MJ, 1974, HORM BEHAV, V5, P175, DOI 10.1016/0018-506X(74)90042-7; BAYER SA, 1980, J COMP NEUROL, V194, P845, DOI 10.1002/cne.901940409; BEACH FA, 1976, HORM BEHAV, V7, P105, DOI 10.1016/0018-506X(76)90008-8; BEEMAN EA, 1947, PHYSIOL ZOOL, V20, P373, DOI 10.1086/physzool.20.4.30151969; Bodo C, 2006, ENDOCRINOLOGY, V147, P415, DOI 10.1210/en.2005-0834; Burns-Cusato M, 2004, PHYSIOL BEHAV, V83, P217, DOI 10.1016/j.physbeh.2004.08.015; Byne W, 2006, MT SINAI J MED, V73, P950; CANTERAS NS, 1995, J COMP NEUROL, V360, P213, DOI 10.1002/cne.903600203; CHAREST NJ, 1991, MOL ENDOCRINOL, V5, P573, DOI 10.1210/mend-5-4-573; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; DESJARDINS C, 1973, SCIENCE, V182, P939, DOI 10.1126/science.182.4115.939; Dong HW, 2004, J COMP NEUROL, V471, P396, DOI 10.1002/cne.20002; EDWARDS DA, 1971, HORM BEHAV, V2, P49, DOI 10.1016/0018-506X(71)90037-7; FINNEY HC, 1976, HORM BEHAV, V7, P391, DOI 10.1016/0018-506X(76)90010-6; Gotsiridze T, 2007, DEV NEUROBIOL, V67, P355, DOI 10.1002/dneu.20353; Goy R. W., 1980, SEXUAL DIFFERENTIATI; HARADA N, 1992, ENDOCRINOLOGY, V131, P2306, DOI 10.1210/en.131.5.2306; HINES M, 1992, BRAIN RES, V579, P321, DOI 10.1016/0006-8993(92)90068-K; Hines M, 2006, EUR J ENDOCRINOL, V155, pS115, DOI 10.1530/eje.1.02236; Honda S, 1998, BIOCHEM BIOPH RES CO, V252, P445, DOI 10.1006/bbrc.1998.9672; Juntti SA, 2008, HORM BEHAV, V53, P627, DOI 10.1016/j.yhbeh.2007.12.012; Jyotika J, 2007, DEV NEUROBIOL, V67, P1511, DOI 10.1002/dneu.20525; KIMURA T, 1985, HORM BEHAV, V19, P64, DOI 10.1016/0018-506X(85)90006-6; Kondo Y, 1998, BEHAV BRAIN RES, V91, P213; Liu YC, 1997, J NEUROSCI, V17, P5245; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; MATSUMOTO A, 1986, NEUROSCI LETT, V68, P165, DOI 10.1016/0304-3940(86)90135-7; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; Miczek KA, 2001, BEHAV BRAIN RES, V125, P167, DOI 10.1016/S0166-4328(01)00298-4; MILLHOUSE OE, 1973, BRAIN RES, V55, P89, DOI 10.1016/0006-8993(73)90490-3; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Morris JA, 2008, J COMP NEUROL, V506, P851, DOI 10.1002/cne.21536; Musatov S, 2007, P NATL ACAD SCI USA, V104, P2501, DOI 10.1073/pnas.0610787104; Musatov S, 2006, P NATL ACAD SCI USA, V103, P10456, DOI 10.1073/pnas.0603045103; NAFTOLIN F, 1975, J STEROID BIOCHEM, V6, P993, DOI 10.1016/0022-4731(75)90340-4; Ogawa S, 1999, P NATL ACAD SCI USA, V96, P12887, DOI 10.1073/pnas.96.22.12887; Ogawa S, 2004, ANN NY ACAD SCI, V1036, P257, DOI 10.1196/annals.1330.016; Ogawa S, 2000, P NATL ACAD SCI USA, V97, P14737, DOI 10.1073/pnas.250473597; OHNO S, 1974, CELL, V3, P235, DOI 10.1016/0092-8674(74)90137-8; Perez SE, 2003, DEV BRAIN RES, V145, P117, DOI 10.1016/S0165-3806(03)00223-2; PETERS PJ, 1972, PHYSIOL BEHAV, V8, P265, DOI 10.1016/0031-9384(72)90371-X; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; RALLS K, 1971, SCIENCE, V171, P443, DOI 10.1126/science.171.3970.443; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rissman EF, 1997, HORM BEHAV, V31, P232, DOI 10.1006/hbeh.1997.1390; Roselli CE, 1998, BIOL REPROD, V58, P79, DOI 10.1095/biolreprod58.1.79; ROSELLI CE, 1987, ENDOCRINOLOGY, V121, P2205, DOI 10.1210/endo-121-6-2205; Sato T, 2004, P NATL ACAD SCI USA, V101, P1673, DOI 10.1073/pnas.0305303101; Scordalakes EM, 2004, GENES BRAIN BEHAV, V3, P20, DOI 10.1111/j.1601-183X.2004.00036.x; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; SIMERLY RB, 1988, J COMP NEUROL, V270, P209, DOI 10.1002/cne.902700205; SIMON NG, 1984, PHYSIOL BEHAV, V33, P379, DOI 10.1016/0031-9384(84)90157-4; Spors H, 2007, NEURON, V55, P689, DOI 10.1016/j.neuron.2007.08.016; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Toda K, 2001, J ENDOCRINOL, V168, P217, DOI 10.1677/joe.0.1680217; VALE JR, 1973, DEV PSYCHOBIOL, V6, P319, DOI 10.1002/dev.420060405; Varoqueaux F, 1999, ANAT EMBRYOL, V199, P249, DOI 10.1007/s004290050226; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Wagner CK, 1996, J COMP NEUROL, V370, P71; WALLIS CJ, 1975, J ENDOCRINOL, V66, P257, DOI 10.1677/joe.0.0660257; WHALEN RE, 1963, SCIENCE, V141, P273, DOI 10.1126/science.141.3577.273	67	267	271	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					61	72		10.1016/j.cell.2009.07.036	http://dx.doi.org/10.1016/j.cell.2009.07.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804754	Green Accepted, Bronze			2022-12-24	WOS:000270388600016
J	Strong, A; Chisholm, S; Miller, C; Cullen, J				Strong, Aaron; Chisholm, Sallie; Miller, Charles; Cullen, John			Ocean fertilization: time to move on	NATURE			English	Editorial Material									[Strong, Aaron; Chisholm, Sallie] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Strong, Aaron] Tufts Univ, Fletcher Sch Law & Diplomacy, Medford, MA 02155 USA; [Miller, Charles] Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Cullen, John] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada	Massachusetts Institute of Technology (MIT); Tufts University; Oregon State University; Dalhousie University	Strong, A (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	chisholm@mit.edu	Cuillen, John/AAE-1371-2019; Cullen, John J/B-6105-2008	Cuillen, John/0000-0002-7740-0999; Cullen, John J/0000-0002-7740-0999; Chisholm, Sallie/0000-0003-1480-2445					0	58	58	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					347	348		10.1038/461347a	http://dx.doi.org/10.1038/461347a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	494QB	19759603				2022-12-24	WOS:000269828100021
J	Chan, PS; Nichol, G; Krumholz, HM; Spertus, JA; Jones, PG; Peterson, ED; Rathore, SS; Nallamothu, BK				Chan, Paul S.; Nichol, Graham; Krumholz, Harlan M.; Spertus, John A.; Jones, Philip G.; Peterson, Eric D.; Rathore, Saif S.; Nallamothu, Brahmajee K.		Amer Heart Assoc NRCPR Investigato	Racial Differences in Survival After In-Hospital Cardiac Arrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMERICAN-HEART-ASSOCIATION; EUROPEAN RESUSCITATION COUNCIL; HEALTH-CARE PROFESSIONALS; INTERNATIONAL LIAISON COMMITTEE; ADVANCED LIFE-SUPPORT; RECOMMENDED GUIDELINES; STROKE FOUNDATION; CARDIOPULMONARY-RESUSCITATION; UTSTEIN STYLE; TASK-FORCE	Context Racial differences in survival have not been previously studied after in-hospital cardiac arrest, an event for which access to care is not likely to influence treatment. Objectives To estimate racial differences in survival for patients with in-hospital cardiac arrests and examine the association of sociodemographic and clinical factors and the admitting hospital with racial differences in survival. Design, Setting, and Patients Cohort study of 10 011 patients with cardiac arrests due to ventricular fibrillation or pulseless ventricular tachycardia enrolled between January 1, 2000, and February 29, 2008, at 274 hospitals within the National Registry of Cardiopulmonary Resuscitation. Main Outcome Measures Survival to hospital discharge; successful resuscitation from initial arrest and postresuscitation survival (secondary outcome measures). Results Included were 1883 black patients (18.8%) and 8128 white patients (81.2%). Rates of survival to discharge were lower for black patients (25.2%) than for white patients (37.4%) (unadjusted relative rate [RR], 0.73; 95% confidence interval [CI], 0.67-0.79). Unadjusted racial differences narrowed after adjusting for patient characteristics (adjusted RR, 0.81 [95% CI, 0.75-0.88]; P<.001) and diminished further after additional adjustment for hospital site (adjusted RR, 0.89 [95% CI, 0.82-0.96]; P=.002). Lower rates of survival to discharge for blacks reflected lower rates of both successful resuscitation (55.8% vs 67.4% for whites; unadjusted RR, 0.84 [95% CI, 0.81-0.88]) and postresuscitation survival (45.2% vs 55.5% for whites; unadjusted RR, 0.85 [95% CI, 0.79-0.91]). Adjustment for the hospital site at which patients received care explained a substantial portion of the racial differences in successful resuscitation (adjusted RR, 0.92 [95% CI, 0.88-0.96]; P<.001) and eliminated the racial differences in postresuscitation survival (adjusted RR, 0.99 [95% CI, 0.92-1.06]; P=.68). Conclusions Black patients with in-hospital cardiac arrest were significantly less likely to survive to discharge than white patients, with lower rates of survival during both the immediate resuscitation and postresuscitation periods. Much of the racial difference was associated with the hospital center in which black patients received care. JAMA. 2009; 302(11): 1195-1201	[Chan, Paul S.; Spertus, John A.; Jones, Philip G.] St Lukes Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Nichol, Graham] Univ Washington, Dept Med, Clin Trial Ctr, Seattle, WA USA; [Nichol, Graham] Univ Washington, Dept Biostat, Clin Trial Ctr, Seattle, WA 98195 USA; [Nichol, Graham] Harborview Ctr Prehosp Emergency Care, Seattle, WA USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT USA; [Krumholz, Harlan M.; Rathore, Saif S.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.; Rathore, Saif S.] Yale Univ, Sch Med, Sect Hlth Policy & Adm, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Nallamothu, Brahmajee K.] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.] VA Ann Arbor Hlth Serv, Res & Develop Ctr Excellence, Ann Arbor, MI USA	Saint Luke's Mid America Heart Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harborview Medical Center; Yale University; Yale University; Yale University; Yale University; Yale University; Duke University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Chan, PS (corresponding author), St Lukes Mid Amer Heart Inst, 5th Floor,4401 Wornall Rd, Kansas City, MO 64111 USA.	pchan@cc-pc.com	, Harlan/AAI-2875-2020; Spertus, John/ABD-3075-2021; Peterson, Eric David/ABF-5033-2021; Nichol, Graham/Z-4996-2019		American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding/Support: The American Heart Association provided funding for the collection and management of the data and reviewed and approved the final manuscript.	Barnato AE, 2008, AM J RESP CRIT CARE, V177, P279, DOI 10.1164/rccm.200703-480OC; Barnato AE, 2006, HEALTH SERV RES, V41, P2219, DOI 10.1111/j.1475-6773.2006.00598.x; Carr BG, 2009, RESUSCITATION, V80, P30, DOI 10.1016/j.resuscitation.2008.09.001; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; Cummins RO, 1997, ANN EMERG MED, V29, P647, DOI 10.1016/S0196-0644(97)70255-5; Cummins RO, 1997, CIRCULATION, V95, P2213, DOI 10.1161/01.CIR.95.8.2213; Degenholtz HB, 2002, J AM GERIATR SOC, V50, P378, DOI 10.1046/j.1532-5415.2002.50073.x; Epstein AM, 2000, NEW ENGL J MED, V343, P1537, DOI 10.1056/NEJM200011233432106; ESCARCE JJ, 1993, AM J PUBLIC HEALTH, V83, P948, DOI 10.2105/AJPH.83.7.948; Ewy GA, 2000, J AM COLL CARDIOL, V35, P830; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Hernandez AF, 2007, JAMA-J AM MED ASSOC, V298, P1525, DOI 10.1001/jama.298.13.1525; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; JENNETT B, 1975, LANCET, V1, P480; Jha AK, 2005, NEW ENGL J MED, V353, P683, DOI 10.1056/NEJMsa050672; KNAUS WA, 1993, ANN INTERN MED, V118, P753, DOI 10.7326/0003-4819-118-10-199305150-00001; Kressin NR, 2001, ANN INTERN MED, V135, P352, DOI 10.7326/0003-4819-135-5-200109040-00012; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; *R DEV COR TEAM, R FDN STAT COMP V R; Rathore SS, 2004, ANN INTERN MED, V141, P635, DOI 10.7326/0003-4819-141-8-200410190-00011; Schneider EC, 2001, ANN INTERN MED, V135, P328, DOI 10.7326/0003-4819-135-5-200109040-00009; Shepardson LB, 1999, J GEN INTERN MED, V14, P15, DOI 10.1046/j.1525-1497.1999.00275.x; Vaccarino V, 2005, NEW ENGL J MED, V353, P671, DOI 10.1056/NEJMsa032214; WENGER NS, 1995, ARCH INTERN MED, V155, P2056, DOI 10.1001/archinte.155.19.2056; ZARITSKY A, 1995, RESUSCITATION, V30, P95, DOI 10.1016/0300-9572(95)00884-V; ZARITSKY A, 1995, CIRCULATION, V92, P2006, DOI 10.1161/01.CIR.92.7.2006; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	31	121	122	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	2009	302	11					1195	1201		10.1001/jama.2009.1340	http://dx.doi.org/10.1001/jama.2009.1340			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	494FR	19755698	Bronze, Green Accepted			2022-12-24	WOS:000269797600029
J	Suzuki, M; Saruwatari, K; Kogure, T; Yamamoto, Y; Nishimura, T; Kato, T; Nagasawa, H				Suzuki, Michio; Saruwatari, Kazuko; Kogure, Toshihiro; Yamamoto, Yuya; Nishimura, Tatsuya; Kato, Takashi; Nagasawa, Hiromichi			An Acidic Matrix Protein, Pif, Is a Key Macromolecule for Nacre Formation	SCIENCE			English	Article							CHITIN-BINDING PROTEINS; ORGANIC MATRIX; SHELL FORMATION; MOLLUSK SHELLS; EVOLUTION; INVERTEBRATES; CARBONATE; DOMAINS	The mollusk shell is a hard tissue consisting of calcium carbonate crystals and an organic matrix. The nacre of the shell is characterized by a stacked compartment structure with a uniformly oriented c axis of aragonite crystals in each compartment. Using a calcium carbonate-binding assay, we identified an acidic matrix protein, Pif, in the pearl oyster Pinctada fucata that specifically binds to aragonite crystals. The Pif complementary DNA (cDNA) encoded a precursor protein, which was posttranslationally cleaved to produce Pif 97 and Pif 80. The results from immunolocalization, a knockdown experiment that used RNA interference, and in vitro calcium carbonate crystallization studies strongly indicate that Pif regulates nacre formation.	[Suzuki, Michio; Nagasawa, Hiromichi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Saruwatari, Kazuko; Kogure, Toshihiro] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Yamamoto, Yuya; Nishimura, Tatsuya; Kato, Takashi] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Nagasawa, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	anagahi@mail.ecc.u-tokyo.ac.jp	Kato, Takashi/Q-8050-2016; Kogure, Toshihiro/K-7857-2015; Nishimura, Tatsuya/A-3013-2013	Kato, Takashi/0000-0002-0571-0883; Kogure, Toshihiro/0000-0002-3494-8989; Nishimura, Tatsuya/0000-0002-8416-4007	Japan Society for the Promotion of Science (JSPS) [17GS0311]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to M. Hayashi and H. Aoki of the Fisheries Research Institute, Mie Prefecture, Japan, for a kind gift of live pearl oysters and to S. Akera and E. Okamoto of Tasaki Shinju Co. for providing us Japanese pearl oyster shells. We are also grateful to H. Kagi of the Geochemical Laboratory, Graduate School of Science, the University of Tokyo, Japan, for measuring Raman spectra and to H. Tanaka of Okutama Kogyo Co. for a kind gift of aragonite crystals. We also thank V. Jayasankar of the Japan International Research Center for Agricultural Sciences for critical reading of this manuscript. This work was supported by a Grant-in-Aid for Scientific Research (17GS0311) from the Japan Society for the Promotion of Science (JSPS). M. S. was supported by a Research Fellowship of JSPS for young scientists.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; BROOKS R, 1950, PHILOS T R SOC S-A, V243, P145, DOI 10.1098/rsta.1950.0016; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; Dauphin Y, 2008, ANAL BIOANAL CHEM, V390, P1659, DOI 10.1007/s00216-008-1860-z; Elvin CM, 1996, J BIOL CHEM, V271, P8925, DOI 10.1074/jbc.271.15.8925; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548; Kato T, 2000, CHEM LETT, P186, DOI 10.1246/cl.2000.186; Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372; Mann S., 2002, BIOMINERALIZATION; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Oaki K, 2005, ANGEW CHEM INT EDIT, V44, P6571, DOI 10.1002/anie.200500338; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Saruwatari K, 2009, BIOMATERIALS, V30, P3028, DOI 10.1016/j.biomaterials.2009.03.011; Shen ZC, 1999, J MOL EVOL, V48, P341, DOI 10.1007/PL00006478; Suetake T, 2000, J BIOL CHEM, V275, P17929, DOI 10.1074/jbc.C000184200; Sugawara A, 2006, J POLYM SCI POL CHEM, V44, P5153, DOI 10.1002/pola.21604; Tuckwell D, 1999, BIOCHEM SOC T, V27, P835, DOI 10.1042/bst0270835; WATABE N, 1960, NATURE, V188, P334, DOI 10.1038/188334a0; WATABE N, 1965, J ULTRA MOL STRUCT R, V12, P351, DOI 10.1016/S0022-5320(65)80104-6; WEINER S, 1991, TRENDS BIOCHEM SCI, V16, P252, DOI 10.1016/0968-0004(91)90098-G; WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259	25	503	527	10	300	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1388	1390		10.1126/science.1173793	http://dx.doi.org/10.1126/science.1173793			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19679771				2022-12-24	WOS:000269699100037
J	Price, LC				Price, Laura Claire			Personal View Should I have an H1N1 flu vaccination after Guillain-Barre syndrome?	BRITISH MEDICAL JOURNAL			English	Editorial Material							INFLUENZA VACCINATION; UNITED-KINGDOM; IMMUNIZATION; ASSOCIATION; VACCINES; ADULTS; STATES					lauracprice@hotmail.com						Evans D, 2009, J INFECT DIS, V200, P321, DOI 10.1086/603560; Geier MR, 2003, CLIN IMMUNOL, V107, P116, DOI 10.1016/S1521-6616(03)00046-9; Haber P, 2004, JAMA-J AM MED ASSOC, V292, P2478, DOI 10.1001/jama.292.20.2478; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 1999, J NEUROIMMUNOL, V100, P74, DOI 10.1016/S0165-5728(99)00195-2; Hughes RA, 2006, ARCH INTERN MED, V166, P1301, DOI 10.1001/archinte.166.12.1301; HURWITZ ES, 1981, NEW ENGL J MED, V304, P1557, DOI 10.1056/NEJM198106253042601; Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110; Juurlink DN, 2006, ARCH INTERN MED, V166, P2217, DOI 10.1001/archinte.166.20.2217; KAPLAN JE, 1982, JAMA-J AM MED ASSOC, V248, P698, DOI 10.1001/jama.248.6.698; Kuitwaard K, 2009, J PERIPHER NERV SYST, V14, P81; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; Marwick Charles, 2003, BMJ, V326, P620; Pritchard J, 2002, J NEUROL NEUROSUR PS, V73, P348, DOI 10.1136/jnnp.73.3.348; ROSCELLI JD, 1991, AM J EPIDEMIOL, V133, P952, DOI 10.1093/oxfordjournals.aje.a115974; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Sivadon-Tardy V, 2009, CLIN INFECT DIS, V48, P48, DOI 10.1086/594124; Stowe J, 2009, AM J EPIDEMIOL, V169, P382, DOI 10.1093/aje/kwn310; Tam CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000344; Vellozzi C, 2009, VACCINE, V27, P2114, DOI 10.1016/j.vaccine.2009.01.125	20	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 9	2009	339								b3577	10.1136/bmj.b3577	http://dx.doi.org/10.1136/bmj.b3577			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	493RD	19740925				2022-12-24	WOS:000269754700004
J	Federoff, HJ; Gostin, LO				Federoff, Howard J.; Gostin, Lawrence O.			Evolving From Reductionism to Holism Is There a Future for Systems Medicine?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GENOMEWIDE ASSOCIATION; DISEASE; BIOLOGY		[Federoff, Howard J.] Georgetown Univ, Med Ctr, Washington, DC 20057 USA; [Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global & Hlth Law, Washington, DC USA	Georgetown University; Georgetown University	Federoff, HJ (corresponding author), Georgetown Univ, Med Ctr, Bldg D,4000 Reservoir Rd NW, Washington, DC 20057 USA.	hjf8@georgetown.edu						Burja AM, 2003, TRENDS BIOTECHNOL, V21, P504, DOI 10.1016/j.tibtech.2003.08.008; Clayton EW, 2003, NEW ENGL J MED, V349, P562, DOI 10.1056/NEJMra012577; Flexner A., 1910, MEDICAL ED US CANADA; Gostin LO, 2009, JAMA-J AM MED ASSOC, V301, P1373, DOI 10.1001/jama.2009.424; GOTTLIEB S, 2000, BRIT MED J, V321, pD1040; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Pollard HB, 2000, ANAT REC, V259; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Yuan JS, 2008, TRENDS PLANT SCI, V13, P165, DOI 10.1016/j.tplants.2008.02.003	10	58	61	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 2	2009	302	9					994	996		10.1001/jama.2009.1264	http://dx.doi.org/10.1001/jama.2009.1264			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489TF	19724047				2022-12-24	WOS:000269444900025
J	Richards, H				Richards, Helen			Personal View We must defend personal continuity in primary care	BRITISH MEDICAL JOURNAL			English	Editorial Material												Helen.cowan3@btinternet.com						2007, BRIT MED J, V335, P941	1	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 6	2009	339								b3923	10.1136/bmj.b3923	http://dx.doi.org/10.1136/bmj.b3923			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	505TF	19808748				2022-12-24	WOS:000270719100005
J	Sachs, JD; Baillie, JEM; Sutherland, WJ; Armsworth, PR; Ash, N; Beddington, J; Blackburn, TM; Collen, B; Gardiner, B; Gaston, KJ; Godfray, HCJ; Green, RE; Harvey, PH; House, B; Knapp, S; Kumpel, NF; Macdonald, DW; Mace, GM; Mallet, J; Matthews, A; May, RM; Petchey, O; Purvis, A; Roe, D; Safi, K; Turner, K; Walpole, M; Watson, R; Jones, KE				Sachs, Jeffrey D.; Baillie, Jonathan E. M.; Sutherland, William J.; Armsworth, Paul R.; Ash, Neville; Beddington, John; Blackburn, Tim M.; Collen, Ben; Gardiner, Barry; Gaston, Kevin J.; Godfray, H. Charles J.; Green, Rhys E.; Harvey, Paul H.; House, Brett; Knapp, Sandra; Kuempel, Noelle F.; Macdonald, David W.; Mace, Georgina M.; Mallet, James; Matthews, Adam; May, Robert M.; Petchey, Owen; Purvis, Andy; Roe, Dilys; Safi, Kamran; Turner, Kerry; Walpole, Matt; Watson, Robert; Jones, Kate E.			Biodiversity Conservation and the Millennium Development Goals	SCIENCE			English	Editorial Material									[Baillie, Jonathan E. M.; Blackburn, Tim M.; Collen, Ben; Harvey, Paul H.; Kuempel, Noelle F.; Safi, Kamran; Jones, Kate E.] Zool Soc London, London, England; [Sachs, Jeffrey D.; House, Brett] Columbia Univ, New York, NY 10027 USA; [Sutherland, William J.; Green, Rhys E.] Univ Cambridge, Cambridge CB2 1TN, England; [Armsworth, Paul R.; Gaston, Kevin J.; Petchey, Owen] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England; [Ash, Neville] IUCN, Gland, Switzerland; [Beddington, John; Mace, Georgina M.; Purvis, Andy] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Godfray, H. Charles J.; Harvey, Paul H.; Macdonald, David W.; May, Robert M.] Univ Oxford, Oxford OX1 2JD, England; [Knapp, Sandra] Nat Hist Museum London, London, England; [Mallet, James] UCL, London WC1E 6BT, England; [Matthews, Adam] GLOBE Int, London, England; [Roe, Dilys] Int Inst Environm & Dev, London, England; [Turner, Kerry; Watson, Robert] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Watson, Robert] Dept Environm Food & Rural Affairs, London, England; [Gardiner, Barry] House Commons, London, England	Zoological Society of London; Columbia University; University of Cambridge; University of Sheffield; Imperial College London; University of Oxford; Natural History Museum London; University of London; University College London; University of East Anglia	Jones, KE (corresponding author), Zool Soc London, London, England.	kate.jones@ioz.ac.uk	Knapp, Sandra/A-4856-2011; Sutherland, William/B-1291-2013; Mace, Georgina M/I-3072-2016; Collen, Ben/D-5055-2011; mallet, james L.B./B-5114-2008; Blackburn, Tim M/A-7685-2011; Jones, Kate E/G-4768-2010; Safi, Kamran/B-2079-2008; Petchey, Owen/D-8851-2011; Purvis, Andy/A-7529-2008; Blackburn, Tim/AAC-3144-2019; Jones, Kate/Y-3317-2019; Collen, Ben/F-2543-2016	Knapp, Sandra/0000-0001-7698-3945; Mace, Georgina M/0000-0001-8965-5211; Jones, Kate E/0000-0001-5231-3293; Safi, Kamran/0000-0002-8418-6759; Petchey, Owen/0000-0002-7724-1633; Purvis, Andy/0000-0002-8609-6204; Blackburn, Tim/0000-0003-0152-2663; Jones, Kate/0000-0001-5231-3293; Collen, Ben/0000-0003-2564-4243; Sutherland, William/0000-0002-6498-0437; Roe, Dilys/0000-0002-6547-6427; Mallet, James/0000-0002-3370-0367; Armsworth, Paul/0000-0003-0918-0573				Adams W.M., 2007, CONSERV SOC, V5, P147, DOI DOI 10.2307/26392879; Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; DAO MQ, 2008, J STUD EC ECONOMETR, V32, P47; DASGUPTA P, 2003, HDB ENV EC ENV DEGRA, P192; Dasgupta S, 2002, J ECON PERSPECT, V16, P147, DOI 10.1257/0895330027157; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; MACE GM, 2005, MILLENNIUM ECOSYSTEM, V1, pCH4; Sachs J. D., 2005, END POVERTY EC POSSI; Strassburg B, 2009, GLOBAL ENVIRON CHANG, V19, P265, DOI 10.1016/j.gloenvcha.2008.11.004; UN Millennium Project, 2005, INV DEV PRACT PLAN A; Walpole M, 2009, SCIENCE, V325, P1503, DOI 10.1126/science.1175466; POVERTY MAPS	15	182	185	9	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1502	1503		10.1126/science.1175035	http://dx.doi.org/10.1126/science.1175035			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	495JS	19762629				2022-12-24	WOS:000269887900022
J	Doshi, P				Doshi, Peter			Calibrated response to emerging infections	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									MIT, Program Hist Anthropol & Sci, Technol & Society, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Doshi, P (corresponding author), MIT, Program Hist Anthropol & Sci, Technol & Society, 77 Massachusetts Avenue, Cambridge, MA 02139 USA.	pnd@mit.edu						[Anonymous], 2009, Wkly Epidemiol Rec, V84, P197; BARRY JM, 2005, TIME; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chan M., 2009, INFLUENZA A H1N1; CHAN M, 2009, TRANS STATEMENT; CHAN M, 2009, WORLD BETTER PREPARE; COHEN E, 2009, WHEN PANDEMIC ISNT; Doshi P, 2008, AM J PUBLIC HEALTH, V98, P939, DOI 10.2105/AJPH.2007.119933; Fineberg HV, 2009, SCIENCE, V324, P987, DOI 10.1126/science.1176297; FOLLIN P, 2009, VARIETY RESP VIR; *GOV CANADA, H1N1 FLU VIRUS; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Lipsitch M, 2009, NEW ENGL J MED, V361, P112, DOI 10.1056/NEJMp0904380; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; PARK M, 2009, WALKING WELL FLOOD; *PUB HLTH AGCY CAN, 2006, HIGHLIGHTS CANADIAN; *US CDCP, 2009, FLUVIEW; *US CDCP, EMERG INFECT INFL; *US DHHS, 2009, HHS DECLARES PUBL; *US DHHS, 2005, INFL PAND HOW THEY; *US DHHS, 2007, PANDEMIC FLU BASICS; *US DHHS, 2009, H1N1 FLU UPDATE; *WHO, 2009, TRANS PRESS CONF; *WHO, PADEMIC PREPARED; *WHO, 2005, TEN THINGS NEED KNOW; *WHO, 2005, WHO GLOB PREPARE	26	16	18	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2009	339								b3471	10.1136/bmj.b3471	http://dx.doi.org/10.1136/bmj.b3471			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	493RE	19729419	Green Submitted, Green Published			2022-12-24	WOS:000269754800004
J	Gnecco, E				Gnecco, Enrico			NANOTECHNOLOGY A gentle jackhammer	NATURE			English	Editorial Material									Univ Basel, Dept Phys, Natl Ctr Competence Res Nanoscale Sci, CH-4056 Basel, Switzerland	University of Basel	Gnecco, E (corresponding author), Univ Basel, Dept Phys, Natl Ctr Competence Res Nanoscale Sci, Klingelbergstr 82, CH-4056 Basel, Switzerland.	enrico.gnecco@unibas.ch	Gnecco, Enrico/H-5419-2013	Gnecco, Enrico/0000-0002-3053-923X				Erdemir A., 2007, SUPERLUBRICITY; Gnecco E, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/2/025501; Knoll A, 2006, MICROELECTRON ENG, V83, P1692, DOI 10.1016/j.mee.2006.01.206; LANTZ MA, 2009, NATURE; Schirmeisen A, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.245403; Socoliuc A, 2006, SCIENCE, V313, P207, DOI 10.1126/science.1125874	6	4	4	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 10	2009	461	7261					178	179		10.1038/461178a	http://dx.doi.org/10.1038/461178a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19741691				2022-12-24	WOS:000269654600024
J	Cook, AG; Fukuhara, N; Jinek, M; Conti, E				Cook, Atlanta G.; Fukuhara, Noemi; Jinek, Martin; Conti, Elena			Structures of the tRNA export factor in the nuclear and cytosolic states	NATURE			English	Article							PHENYLALANINE TRANSFER-RNA; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; TRANSPORT; COMPLEX; PROTEIN; RECEPTOR; IDENTIFICATION; TRANSLOCATION; CRM1	Transfer RNAs are among the most ubiquitous molecules in cells, central to decoding information from messenger RNAs on translating ribosomes. In eukaryotic cells, tRNAs are actively transported from their site of synthesis in the nucleus to their site of function in the cytosol. This is mediated by a dedicated nucleo-cytoplasmic transport factor of the karyopherin-beta family (Xpot, also known as Los1 in Saccharomyces cerevisiae). Here we report the 3.2 angstrom resolution structure of Schizosaccharomyces pombe Xpot in complex with tRNA and RanGTP, and the 3.1 angstrom structure of unbound Xpot, revealing both nuclear and cytosolic snapshots of this transport factor. Xpot undergoes a large conformational change on binding cargo, wrapping around the tRNA and, in particular, binding to the tRNA 59 and 39 ends. The binding mode explains how Xpot can recognize all mature tRNAs in the cell and yet distinguish them from those that have not been properly processed, thus coupling tRNA export to quality control.	[Cook, Atlanta G.; Conti, Elena] MPI Biochem, D-82152 Martinsried, Germany; [Fukuhara, Noemi; Jinek, Martin; Conti, Elena] EMBL, D-69117 Heidelberg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL)	Conti, E (corresponding author), MPI Biochem, Am Klopferspitz 18, D-82152 Martinsried, Germany.	conti@biochem.mpg.de	Cook, Atlanta/A-8641-2015; Jinek, Martin/E-6621-2011	Cook, Atlanta/0000-0003-2087-9772; Jinek, Martin/0000-0002-7601-210X; Conti, Elena/0000-0003-1254-5588	Max Planck Gesellschaft; European Molecular Biology Laboratory (EMBL); Sonderforschungsbereich SFB646; Deutsche Forschungsgemeinschaft (DFG); EU [LSHG-CT-2005-512028]	Max Planck Gesellschaft(Max Planck Society); European Molecular Biology Laboratory (EMBL); Sonderforschungsbereich SFB646(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EU(European Commission)	We would like to thank P. Brick for comments and critical reading of the manuscript. We also thank P. Reichelt and J. Ebert for technical assistance, S. Kuersten and I. Mattaj at the initial phase of the project, K. Valer-Saldana, S. Pleyer and J. Basquin of the MPI-Martinsried crystallization facility and the staff at the Swiss Light Source (Villigen, Switzerland) for assistance during data collection. We would like to thank C. Vonrhein (Global Phasing) for optimising the phase calculations of unbound Xpot with SHARP. This study was supported by the Max Planck Gesellschaft, the European Molecular Biology Laboratory (EMBL), the Sonderforschungsbereich SFB646 and the Gottfried Wilhelm Leibniz Program of the Deutsche Forschungsgemeinschaft (DFG), the EU grant 3D Repertoire contract number LSHG-CT-2005-512028.	Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Arts GJ, 1998, EMBO J, V17, P7430, DOI 10.1093/emboj/17.24.7430; Arts GJ, 1998, CURR BIOL, V8, P305, DOI 10.1016/S0960-9822(98)70130-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BJORK GR, 1987, ANNU REV BIOCHEM, V56, P263, DOI 10.1146/annurev.bi.56.070187.001403; BLOOMFIELD VA, 1999, NUCL ACIDS STRUCTURE, P298; Broennimann C, 2006, J SYNCHROTRON RADIAT, V13, P120, DOI 10.1107/S0909049505038665; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calado A, 2002, EMBO J, V21, P6216, DOI 10.1093/emboj/cdf620; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cook A, 2005, MOL CELL, V18, P355, DOI 10.1016/j.molcel.2005.03.021; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dong XH, 2009, NAT STRUCT MOL BIOL, V16, P558, DOI 10.1038/nsmb.1586; Doublie S, 1996, FEBS LETT, V384, P219, DOI 10.1016/0014-5793(96)00316-X; Elad N, 2009, CURR OPIN STRUC BIOL, V19, P226, DOI 10.1016/j.sbi.2009.02.009; Fukuhara N, 2004, J BIOL CHEM, V279, P2176, DOI 10.1074/jbc.M309112200; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Iwata-Reuyl D, 2008, CURR OPIN CHEM BIOL, V12, P126, DOI 10.1016/j.cbpa.2008.01.041; JONES TA, 1990, CRYSTALLOGRAPHIC MOD, P189; Jovine L, 2000, J MOL BIOL, V301, P401, DOI 10.1006/jmbi.2000.3950; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kuersten S, 2002, MOL CELL BIOL, V22, P5708, DOI 10.1128/MCB.22.16.5708-5720.2002; Kutay U, 1998, MOL CELL, V1, P359, DOI 10.1016/S1097-2765(00)80036-2; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lim RYH, 2008, HISTOCHEM CELL BIOL, V129, P105, DOI 10.1007/s00418-007-0371-x; Lipowsky G, 1999, RNA, V5, P539, DOI 10.1017/S1355838299982134; Lund E, 1998, SCIENCE, V282, P2082, DOI 10.1126/science.282.5396.2082; Madrid AS, 2006, CHROMOSOMA, V115, P98, DOI 10.1007/s00412-005-0043-3; Marvin MC, 2009, RNA BIOL, V6, P40, DOI 10.4161/rna.6.1.7566; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; MORAS D, 1992, TRENDS BIOCHEM SCI, V17, P159, DOI 10.1016/0968-0004(92)90326-5; Peters R, 2009, BIOESSAYS, V31, P466, DOI 10.1002/bies.200800159; Rodriguez MS, 2004, BIOL CELL, V96, P639, DOI 10.1016/j.biolcel.2004.04.014; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Shibata S, 2006, NUCLEIC ACIDS RES, V34, P4711, DOI 10.1093/nar/gkl663; Spath B, 2007, CELL MOL LIFE SCI, V64, P2404, DOI 10.1007/s00018-007-7160-5; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; WALKER PA, 1994, BIO-TECHNOL, V12, P601, DOI 10.1038/nbt0694-601; Xiong Y, 2006, CURR OPIN STRUC BIOL, V16, P12, DOI 10.1016/j.sbi.2005.12.001; ZASLOFF M, 1983, P NATL ACAD SCI-BIOL, V80, P6436, DOI 10.1073/pnas.80.21.6436	53	91	93	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					60	U60		10.1038/nature08394	http://dx.doi.org/10.1038/nature08394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19680239				2022-12-24	WOS:000269478800029
J	Regalbuto, JR				Regalbuto, John R.			Cellulosic Biofuels-Got Gasoline?	SCIENCE			English	Editorial Material							SOLID BIOMASS; HYDROCARBONS		Natl Sci Fdn, Arlington, VA 22230 USA	National Science Foundation (NSF)	Regalbuto, JR (corresponding author), Natl Sci Fdn, 4201 Wilson Blvd, Arlington, VA 22230 USA.	jregalbu@nsf.gov						Carlson TR, 2008, CHEMSUSCHEM, V1, P397, DOI 10.1002/cssc.200800018; Chheda JN, 2007, ANGEW CHEM INT EDIT, V46, P7164, DOI 10.1002/anie.200604274; CONNOR PO, COMMUNICATION; CORTRIGHT R, 2009, COMMUNICATION   0408; Dauenhauer PJ, 2007, ANGEW CHEM INT EDIT, V46, P5864, DOI 10.1002/anie.200701238; GOODFELLOW R, 2009, COMMUNICATION   0414; Huber GW, 2009, SCI AM, V301, P52, DOI 10.1038/scientificamerican0709-52; JENSEN A, COMMUNICATION; JONIETZ E, 2007, TECHNOL REV     1109; Kunkes EL, 2008, SCIENCE, V322, P417, DOI 10.1126/science.1159210; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; National Renewable Energy Laboratory, 1998, LOOK BACK US DEP EN; U.S. National Science Foundation, 2008, BREAK CHEM ENG BARR; United States Department of Energy (US DOE), 2005, BIOM FEEDST BIOEN BI; US-DOE, 2006, BREAK BIOL BARR CELL; *VIR EN SYST WHIT, 2008, PROD CONV LIQ FUELS; [No title captured]	17	224	234	2	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					822	824		10.1126/science.1174581	http://dx.doi.org/10.1126/science.1174581			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AK	19679801				2022-12-24	WOS:000269242400030
J	He, J; Gu, D; Chen, J; Wu, X; Kelly, TN; Huang, JF; Chen, JC; Chen, CS; Bazzano, LA; Reynolds, K; Whelton, PK; Klag, MJ				He, Jiang; Gu, Dongfeng; Chen, Jing; Wu, Xigui; Kelly, Tanika N.; Huang, Jian-feng; Chen, Ji-chun; Chen, Chung-Shiuan; Bazzano, Lydia A.; Reynolds, Kristi; Whelton, Paul K.; Klag, Michael J.			Premature deaths attributable to blood pressure in China: a prospective cohort study	LANCET			English	Article							JOINT NATIONAL COMMITTEE; CARDIOVASCULAR-DISEASE; GLOBAL BURDEN; HYPERTENSION; HEALTH; PREVALENCE; RISK; ADULTS; PREHYPERTENSION; POPULATION	Background Hypertension is a major global-health challenge because of its high prevalence and concomitant risks of cardiovascular disease. We estimated premature deaths attributable to increased blood pressure in China. Methods We did a prospective cohort study in a nationally representative sample of 169871 Chinese adults aged 40 years and older. Blood pressure and other risk factors were measured at a baseline examination in 1991 and follow-up assessment was done in 1999-2000. Premature death was defined as mortality before age 72 years in men and 75 years in women, which were the average life expectancies in China in 2005. We calculated the numbers of total and premature deaths attributable to blood pressure using population-attributable risk, mortality; and the population size of China in 2005. Findings Hypertension and prehypertension were significantly associated with increased all-cause and cardiovascular mortality (p<0.0001). We estimated that in 2005, 2.33 million (95% CI 2.21-2.45) cardiovascular deaths were attributable to increased blood pressure in China: 2.11 million (2.03-2.20) in adults with hypertension and 0.22 million (0.19-0.25) in adults with prehypertension. Additionally, 1.27 million (1.18-1.36) premature cardiovascular deaths were attributable to raised blood pressure in China: 1.15 million (1.08-1.22) in adults with hypertension and 0.12 million (0.10-0.14) in adults with prehypertension. Most blood pressure-related deaths were caused by cerebrovascular diseases: 1.86 million (1.76-1.96) total deaths and 1.08 million (1.00-1.15) premature deaths. Interpretation Increased blood pressure is the leading preventable risk factor for premature mortality in the Chinese general population. Prevention and control of this condition should receive top public-health priority in China.	[He, Jiang; Kelly, Tanika N.; Chen, Chung-Shiuan; Bazzano, Lydia A.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; [He, Jiang; Chen, Jing; Bazzano, Lydia A.] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [He, Jiang; Chen, Jing; Bazzano, Lydia A.] Tulane Univ, Sch Med, Tulane Hypertens & Renal Ctr Excellence, New Orleans, LA 70112 USA; [Gu, Dongfeng; Wu, Xigui; Huang, Jian-feng; Chen, Ji-chun] Cardiovasc Inst, Dept Evidence Based Med, Beijing, Peoples R China; [Gu, Dongfeng; Wu, Xigui; Huang, Jian-feng; Chen, Ji-chun] Chinese Acad Med Sci, Fu Wai Hosp, Beijing 100037, Peoples R China; [Gu, Dongfeng; Wu, Xigui; Huang, Jian-feng; Chen, Ji-chun] Peking Union Med Coll, Beijing 100021, Peoples R China; [Gu, Dongfeng; Wu, Xigui; Huang, Jian-feng; Chen, Ji-chun] Natl Cardiovasc Ctr, Beijing, Peoples R China; [Reynolds, Kristi] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA USA; [Whelton, Paul K.] Loyola Univ Med Ctr, Maywood, IL 60153 USA; [Klag, Michael J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Tulane University; Tulane University; Tulane University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Kaiser Permanente; Loyola University Chicago; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	He, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA.	jhe@tulane.edu	Reynolds, Kristi/AAN-1434-2021; He, Jiang/AAF-5303-2020	Reynolds, Kristi/0000-0001-7619-1649; He, Jiang/0000-0002-8286-9652	American Heart Association (USA); National Heart, Lung, and Blood Institute, National institutes of Health (USA); Ministry of Health (China); Ministry of Science and Technology (China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072507] Funding Source: NIH RePORTER	American Heart Association (USA)(American Heart Association); National Heart, Lung, and Blood Institute, National institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ministry of Health (China); Ministry of Science and Technology (China)(Ministry of Science and Technology, China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	American Heart Association (USA); National Heart, Lung, and Blood Institute, National institutes of Health (USA); Ministry of Health (China); and Ministry of Science and Technology (China).	*ATH RISK COMM STU, 1997, MAN 3 SURV COMP PROC; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Choi KM, 2006, J HYPERTENS, V24, P1515, DOI 10.1097/01.hjh.0000239286.02389.0f; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; FROHLICH ED, 1988, CIRCULATION, V77, pA502; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Gu DF, 2008, AM J HYPERTENS, V21, P265, DOI 10.1038/ajh.2007.59; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hsia J, 2007, CIRCULATION, V115, P855, DOI 10.1161/CIRCULATIONAHA.106.656850; INGRAM DD, 1994, VITAL HLTH STAT 2, V121, P1; KAHN HA, 1989, STAT METHODS EPIDEMI, P73; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kelly TN, 2008, CIRCULATION, V118, P1558, DOI 10.1161/CIRCULATIONAHA.107.723593; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Martiniuk ALC, 2007, J HYPERTENS, V25, P73, DOI 10.1097/HJH.0b013e328010775f; *MIN HLTH PEOPL RE, 2001, HLTH STAT INF CHIN 2; Perkovic V, 2007, HYPERTENSION, V50, P991, DOI 10.1161/HYPERTENSIONAHA.107.095497; Rao C, 2007, INT J EPIDEMIOL, V36, P642, DOI 10.1093/ije/dym003; Rodgers A, 2004, PLOS MED, V1, P44, DOI 10.1371/journal.pmed.0010027; United Nations, 2000, UN MILL DECL GEN ASS; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; Whelton PK, 2002, JAMA-J AM MED ASSOC, V288, P1882, DOI 10.1001/jama.288.15.1882; WHELTON PK, 2004, CLIN TRIALS CARDIOVA, P282; *WHO, 2006, LIF TABL CHIN; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z; Wu YF, 2006, CIRCULATION, V114, P2217, DOI 10.1161/CIRCULATIONAHA.105.607499; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166	33	176	215	1	35	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2009	374	9703					1765	1772		10.1016/S0140-6736(09)61199-5	http://dx.doi.org/10.1016/S0140-6736(09)61199-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525ID	19811816				2022-12-24	WOS:000272207700025
J	Dawson, MA; Bannister, AJ; Gottgens, B; Foster, SD; Bartke, T; Green, AR; Kouzarides, T				Dawson, Mark A.; Bannister, Andrew J.; Goettgens, Berthold; Foster, Samuel D.; Bartke, Till; Green, Anthony R.; Kouzarides, Tony			JAK2 phosphorylates histone H3Y41 and excludes HP1 alpha from chromatin	NATURE			English	Article							DNA-REPLICATION; LYSINE 9; H3; MUTATIONS; PROTEIN; CELLS; HP1; METHYLATION; ACTIVATION; THERAPY	Activation of Janus kinase 2 (JAK2) by chromosomal translocations or point mutations is a frequent event in haematological malignancies(1-6). JAK2 is a non-receptor tyrosine kinase that regulates several cellular processes by inducing cytoplasmic signalling cascades. Here we show that human JAK2 is present in the nucleus of haematopoietic cells and directly phosphorylates Tyr 41 (Y41) on histone H3. Heterochromatin protein 1 alpha (HP1 alpha), but not HP1 beta, specifically binds to this region of H3 through its chromo-shadow domain. Phosphorylation of H3Y41 by JAK2 prevents this binding. Inhibition of JAK2 activity in human leukaemic cells decreases both the expression of the haematopoietic oncogene lmo2 and the phosphorylation of H3Y41 at its promoter, while simultaneously increasing the binding of HP1a at the same site. These results identify a previously unrecognized nuclear role for JAK2 in the phosphorylation of H3Y41 and reveal a direct mechanistic link between two genes, jak2 and lmo2, involved in normal haematopoiesis and leukaemia(1-9).	[Dawson, Mark A.; Goettgens, Berthold; Foster, Samuel D.; Green, Anthony R.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Dawson, Mark A.; Goettgens, Berthold; Foster, Samuel D.; Green, Anthony R.] Univ Cambridge, Dept Haematol, Cambridge CB2 0XY, England; [Dawson, Mark A.; Green, Anthony R.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England; [Bannister, Andrew J.; Bartke, Till; Kouzarides, Tony] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Bannister, Andrew J.; Bartke, Till; Kouzarides, Tony] Univ Cambridge, Dept Pathol, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge	Green, AR (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	arg1000@cam.ac.uk; t.kouzarides@gurdon.cam.ac.uk	Dawson, Mark A/B-9317-2017	Dawson, Mark A/0000-0002-5464-5029; Foster, Samuel/0000-0001-5375-7080; Green, Anthony/0000-0002-9795-0218; Bannister, Andrew/0000-0002-6312-4436; Kouzarides, Tony/0000-0002-8918-4162	General Sir John Monash Foundation; Cambridge Commonwealth Trust; Raymond and Beverly Sackler; UK Leukaemia Research Fund; Wellcome Trust; Leukemia & Lymphoma Society of America; National Institute for Health Research Cambridge Biomedical Research Centre; Leukaemia Research Fund; Cancer Research UK; Medical Research Council; 6th Research Framework Programme of the European Union ( Epitron, HEROIC and SMARTER).; Medical Research Council [G0800784, G0800784B, G0300723B] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI	General Sir John Monash Foundation; Cambridge Commonwealth Trust; Raymond and Beverly Sackler; UK Leukaemia Research Fund; Wellcome Trust(Wellcome Trust); Leukemia & Lymphoma Society of America(Leukemia and Lymphoma Society); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Leukaemia Research Fund; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); 6th Research Framework Programme of the European Union ( Epitron, HEROIC and SMARTER).; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. Flicek, S. Wilder, B. Huntly, S. J. Dawson and all the members of the A. R. G., B. G. and T. K. laboratories, in particular P. Hurd, B. Xhemalce, E. J. Baxter and P. Beer, for helpful discussions; A. Wood for sharing unpublished data; and J. LeQuesne for help with image analysis. This work was supported by PhD fellowship grants to M. A. D. from the General Sir John Monash Foundation, the Cambridge Commonwealth Trust and Raymond and Beverly Sackler. The Green ( A. R. G.) laboratory is funded by the UK Leukaemia Research Fund, the Wellcome Trust, the Leukemia & Lymphoma Society of America and the National Institute for Health Research Cambridge Biomedical Research Centre. The Gottgens ( B. G.) laboratory is funded by the Leukaemia Research Fund, Cancer Research UK, the Leukemia & Lymphoma Society of America and a Medical Research Council studentship to S. D. F. The Kouzarides ( T. K.) laboratory is funded by grants from Cancer Research UK and the 6th Research Framework Programme of the European Union ( Epitron, HEROIC and SMARTER).	Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bercovich D, 2008, LANCET, V372, P1484, DOI 10.1016/S0140-6736(08)61341-0; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Cummings WJ, 2007, PLOS BIOL, V5, P2145, DOI 10.1371/journal.pbio.0050246; Donaldson IJ, 2005, BIOINFORMATICS, V21, P3058, DOI 10.1093/bioinformatics/bti461; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Ferreira H, 2007, MOL CELL BIOL, V27, P4037, DOI 10.1128/MCB.02229-06; Krude T, 2000, J BIOL CHEM, V275, P13699, DOI 10.1074/jbc.275.18.13699; Krude T, 1999, EXP CELL RES, V247, P148, DOI 10.1006/excr.1998.4342; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Ma ACH, 2007, BLOOD, V110, P1824, DOI 10.1182/blood-2007-03-078287; McCormack MP, 2004, NEW ENGL J MED, V350, P913, DOI 10.1056/NEJMra032207; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Panteleeva I, 2007, EMBO J, V26, P3616, DOI 10.1038/sj.emboj.7601789; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; Plo I, 2008, BLOOD, V112, P1402, DOI 10.1182/blood-2008-01-134114; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Shi S, 2006, NAT GENET, V38, P1071, DOI 10.1038/ng1860; SQUIRES MS, 2007, BLOOD, V110; Walz C, 2006, J BIOL CHEM, V281, P18177, DOI 10.1074/jbc.M600064200; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; Wood AD, 2009, BLOOD, V114, P1820, DOI 10.1182/blood-2009-02-206573; Xie SH, 2001, ONCOGENE, V20, P6188, DOI 10.1038/sj.onc.1204834; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Zhao R, 2008, NEW ENGL J MED, V359, P2778, DOI 10.1056/NEJMoa0804953	33	66	67	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					819	U79		10.1038/nature08448	http://dx.doi.org/10.1038/nature08448			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19783980	Green Accepted			2022-12-24	WOS:000270547500041
J	Huang, Y; Ji, LJ; Huang, QC; Vassylyev, DG; Chen, XM; Ma, JB				Huang, Ying; Ji, Lijuan; Huang, Qichen; Vassylyev, Dmitry G.; Chen, Xuemei; Ma, Jin-Biao			Structural insights into mechanisms of the small RNA methyltransferase HEN1	NATURE			English	Article							SMALL INTERFERING RNA; PIWI-INTERACTING RNAS; 3'-END RECOGNITION; MICRORNA; METHYLATION; PROTEIN; HOMOLOG; FAMILY; LA; 2'-O-METHYLATION	RNA silencing is a conserved regulatory mechanism in fungi, plants and animals that regulates gene expression and defence against viruses and transgenes(1). Small silencing RNAs of similar to 20-30 nucleotides and their associated effector proteins, the Argonaute family proteins, are the central components in RNA silencing(2). A subset of small RNAs, such as microRNAs and small interfering RNAs (siRNAs) in plants, Piwi-interacting RNAs in animals and siRNAs in Drosophila, requires an additional crucial step for their maturation; that is, 2'-O-methylation on the 39 terminal nucleotide(3-6). A conserved S-adenosyl-L-methionine-dependent RNA methyltransferase, HUA ENHANCER 1 (HEN1), and its homologues are responsible for this specific modification(3-5,7,8). Here we report the 3.1 angstrom crystal structure of full-length HEN1 from Arabidopsis in complex with a 22-nucleotide small RNA duplex and cofactor product S-adenosyl-L-homocysteine. Highly cooperative recognition of the small RNA substrate by multiple RNA binding domains and the methyltransferase domain in HEN1 measures the length of the RNA duplex and determines the substrate specificity. Metal ion coordination by both 2' and 3' hydroxyls on the 3'-terminal nucleotide and four invariant residues in the active site of the methyltransferase domain suggests a novel Mg2+-dependent 2'-O-methylation mechanism.	[Huang, Ying; Huang, Qichen; Vassylyev, Dmitry G.; Ma, Jin-Biao] Univ Alabama Birmingham, Dept Biochem, Birmingham, AL 35294 USA; [Huang, Ying; Huang, Qichen; Vassylyev, Dmitry G.; Ma, Jin-Biao] Univ Alabama Birmingham, Sch Med, Dept Mol Genet, Birmingham, AL 35294 USA; [Huang, Ying; Huang, Qichen; Vassylyev, Dmitry G.; Ma, Jin-Biao] Univ Alabama Birmingham, Sch Dent, Birmingham, AL 35294 USA; [Ji, Lijuan; Chen, Xuemei] Univ Calif Riverside, Dept Bot & Plant Sci, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Ma, Jin-Biao] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Riverside; University of Alabama System; University of Alabama Birmingham	Ma, JB (corresponding author), Univ Alabama Birmingham, Dept Biochem, Birmingham, AL 35294 USA.	jma@biochemistry.uab.edu	Huang, Ying/AFM-0838-2022; Vassylyev, Dmitry/A-9005-2008; Ji, Lijuan/C-4919-2012	Huang, Ying/0000-0002-2806-2874; Ji, Lijuan/0000-0003-0678-6131; Chen, Xuemei/0000-0002-5209-1157	V Foundation for Cancer Research; National Science Foundation [MCB-0718029]; National Institutes of Health [R01 GM074252, R01 GM074840]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074252, R01GM061146, R01GM074840] Funding Source: NIH RePORTER	V Foundation for Cancer Research; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Sergiy for assistance with the in- house X- ray generator operation, and the staff at Advanced Photon Source beamlines 19ID and 23ID, Argonne National Laboratory, for help with data collection. We thank T. Townes and H. Wang for critical reading of the manuscript. This work was supported by a start-up fund ( to J.- B. M.) and partly by a grant from the V Foundation for Cancer Research ( to J.- B. M.) and a grant from the National Science Foundation (MCB-0718029 to X. C.). D. G. V. is supported by grants from National Institutes of Health (R01 GM074252 and R01 GM074840).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen XM, 2002, DEVELOPMENT, V129, P1085; Curry S, 2006, TRENDS BIOCHEM SCI, V31, P303, DOI 10.1016/j.tibs.2006.04.008; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Kirino Y, 2007, RNA, V13, P1397, DOI 10.1261/rna.659307; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Kurth HM, 2009, RNA, V15, P675, DOI 10.1261/rna.1455509; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Maraia RJ, 2006, MOL CELL, V21, P149, DOI 10.1016/j.molcel.2006.01.004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; STUMP WT, 1995, RNA, V1, P55; Teplova M, 2006, MOL CELL, V21, P75, DOI 10.1016/j.molcel.2005.10.027; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Tkaczuk KL, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-6; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292; Yang ZY, 2007, METHOD ENZYMOL, V427, P139, DOI 10.1016/S0076-6879(07)27008-9; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Yu B, 2006, FEBS LETT, V580, P3117, DOI 10.1016/j.febslet.2006.04.063	38	96	102	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					823	U86		10.1038/nature08433	http://dx.doi.org/10.1038/nature08433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19812675	Green Accepted			2022-12-24	WOS:000270547500042
J	Sukkar, E				Sukkar, Elizabeth			International Aid The cost of donated drugs	BRITISH MEDICAL JOURNAL			English	Editorial Material												Elizabeth.Sukkar@informa.com						Hogerzeil HV, 1997, BRIT MED J, V314, P737, DOI 10.1136/bmj.314.7082.737; Pharmaciens Sans Frontieres, 2005, IOP C SERIES EARTH E; WHO, 1999, GUID SAF DISP UNW PH; World Health Organization, 1999, GUID DRUG DON	4	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 2	2009	339								b3830	10.1136/bmj.b3830	http://dx.doi.org/10.1136/bmj.b3830			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502LD	19801381				2022-12-24	WOS:000270460200001
J	Guo, JH; Cheng, P; Yuan, HY; Liu, Y				Guo, Jinhu; Cheng, Ping; Yuan, Haiyan; Liu, Yi			The Exosome Regulates Circadian Gene Expression in a Posttranscriptional Negative Feedback Loop	CELL			English	Article							RNA-BINDING PROTEIN; CLOCK-CONTROLLED GENES; MESSENGER-RNA; NEUROSPORA-CRASSA; MULTIPLE OSCILLATORS; LIGHT RESPONSES; PHOSPHORYLATION; FREQUENCY; TRANSCRIPTION; RHYTHMS	The eukaryotic circadian oscillators consist of autoregulatory negative feedback loops. However, little is known about the role of posttranscriptional regulation of RNA in circadian oscillators. In the Neurospora circadian negative feedback loop, FRQ and FRH form the FFC complex that represses frq transcription. Here, we show that FFC also binds frq RNA and interacts with the exosome to regulate frq RNA decay. Consequently, frq RNA is robustly rhythmic as it is more stable when FRQ levels are low. Silencing of RRP44, the catalytic subunit of the exosome, elevates frq RNA levels and impairs clock function. In addition, rrp44 is a clock-controlled gene and a direct target of the WHITE COLLAR complex, and RRP44 controls the circadian expression of some ccgs. Taken together, these results suggest that FFC and the exosome are part of a posttranscriptional negative feedback loop that regulates frq transcript levels and the circadian output pathway.	[Guo, Jinhu; Cheng, Ping; Yuan, Haiyan; Liu, Yi] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Liu, Y (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	yi.liu@utsouthwestern.edu			National Institutes of Health; Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Guocun Huang for technical assistance and Chi-Tai Tang for critical comments. We thank Jay Dunlap for providing the luciferase-containing plasmid. This research was supported by grants from National Institutes of Health and Welch Foundation to Y. L.	Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; BellPedersen D, 1996, P NATL ACAD SCI USA, V93, P13096, DOI 10.1073/pnas.93.23.13096; BellPedersen D, 1996, MOL CELL BIOL, V16, P513; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Buttner K, 2006, MOL MICROBIOL, V61, P1372, DOI 10.1111/j.1365-2958.2006.05331.x; Cha J, 2008, EMBO J, V27, P3246, DOI 10.1038/emboj.2008.245; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Cheng P, 2002, MOL CELL BIOL, V22, P517, DOI 10.1128/MCB.22.2.517-524.2002; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; Correa A, 2003, P NATL ACAD SCI USA, V100, P13597, DOI 10.1073/pnas.2233734100; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Das B, 2003, MOL CELL BIOL, V23, P5502, DOI 10.1128/MCB.23.16.5502-5515.2003; de Paula RM, 2007, COLD SPRING HARB SYM, V72, P345, DOI 10.1101/sqb.2007.72.002; Dunlap JC, 2006, J BIOL CHEM, V281, P28489, DOI 10.1074/jbc.R600018200; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Garbarino-Pico E, 2007, COLD SH Q B, V72, P145, DOI 10.1101/sqb.2007.72.022; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gooch VD, 2008, EUKARYOT CELL, V7, P28, DOI 10.1128/EC.00257-07; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2005, J BIOL CHEM, V280, P17526, DOI 10.1074/jbc.M414010200; Heintzen C, 1997, P NATL ACAD SCI USA, V94, P8515, DOI 10.1073/pnas.94.16.8515; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Huang GC, 2007, GENE DEV, V21, P3283, DOI 10.1101/gad.1610207; Kojima S, 2007, P NATL ACAD SCI USA, V104, P1859, DOI 10.1073/pnas.0607567104; Kwak E, 2006, J BIOL CHEM, V281, P19100, DOI 10.1074/jbc.M511927200; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lewis ZA, 2002, MOL MICROBIOL, V45, P917, DOI 10.1046/j.1365-2958.2002.03074.x; Lidder P, 2005, PLANT PHYSIOL, V138, P2374, DOI 10.1104/pp.105.060368; Liu Y, 2006, EUKARYOT CELL, V5, P1184, DOI 10.1128/EC.00133-06; Lorentzen E, 2006, CELL, V125, P651, DOI 10.1016/j.cell.2006.05.002; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Maiti M, 2007, GENE DEV, V21, P590, DOI 10.1101/gad.1497607; Newby LM, 1996, J NEUROBIOL, V31, P117, DOI 10.1002/(SICI)1097-4695(199609)31:1<117::AID-NEU10>3.0.CO;2-I; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Nowrousian M, 2003, GENETICS, V164, P923; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Schneider C, 2007, MOL CELL, V27, P324, DOI 10.1016/j.molcel.2007.06.006; Sehgal A, 2004, MOL BIOL CIRCADIAN R; Shinohara ML, 1998, J BIOL CHEM, V273, P446, DOI 10.1074/jbc.273.1.446; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Staiger D, 2003, PLANT J, V33, P361, DOI 10.1046/j.1365-313X.2003.01629.x; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	54	78	82	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1236	1246		10.1016/j.cell.2009.06.043	http://dx.doi.org/10.1016/j.cell.2009.06.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19747717	Bronze, Green Accepted			2022-12-24	WOS:000269923200022
J	Alvarado, D; Klein, DE; Lemmon, MA				Alvarado, Diego; Klein, Daryl E.; Lemmon, Mark A.			ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor	NATURE			English	Article							EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; REGION; REVEALS; SYSTEM; HER2; CONFORMATION; ACTIVATION; HERCEPTIN; COMPLEX	The orphan receptor tyrosine kinase ErbB2 ( also known as HER2 or Neu) transforms cells when overexpressed(1), and it is an important therapeutic target in human cancer(2,3). Structural studies(4,5) have suggested that the oncogenic (and ligand-independent) signalling properties of ErbB2 result from the absence of a key intramolecular 'tether' in the extracellular region that autoinhibits other human ErbB receptors, including the epidermal growth factor (EGF) receptor(6). Although ErbB2 is unique among the four human ErbB receptors(6,7), here we show that it is the closest structural relative of the single EGF receptor family member in Drosophila melanogaster (dEGFR). Genetic and biochemical data show that dEGFR is tightly regulated by growth factor ligands(8), yet a crystal structure shows that it, too, lacks the intramolecular tether seen in human EGFR, ErbB3 and ErbB4. Instead, a distinct set of autoinhibitory interdomain interactions hold unliganded dEGFR in an inactive state. All of these interactions are maintained (and even extended) in ErbB2, arguing against the suggestion that ErbB2 lacks autoinhibition. We therefore suggest that normal and pathogenic ErbB2 signalling may be regulated by ligands in the same way as dEGFR. Our findings have important implications for ErbB2 regulation in human cancer, and for developing therapeutic approaches that target novel aspects of this orphan receptor.	[Alvarado, Diego; Klein, Daryl E.; Lemmon, Mark A.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania	Lemmon, MA (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, 809C Stellar Chance Labs,422 Curie Blvd, Philadelphia, PA 19104 USA.	mlemmon@mail.med.upenn.edu	Garzon-Alvarado, Diego/AAD-6607-2019	Lemmon, Mark/0000-0002-3379-5319; Klein, Daryl/0000-0002-7188-0450	National Cancer Institute; National Institute of General Medical Science; NIH; US Army Breast Cancer Research Program; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA079992, R01CA125432] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army Breast Cancer Research Program(United States Department of Defense); Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Lemmon and Ferguson laboratories, K. Ferguson, G. Van Duyne, C. Abrams and J. Shorter for advice and comments on the manuscript; Z. Bu for assistance with collecting SAXS data; and R. Gillilan of MacCHESS for help with SAXS data collection and processing at CHESS beamline G1. Crystallographic results were obtained in research conducted at the GM/CA Collaborative Access Team at the Advanced Photon Source ( APS), supported with funds from the National Cancer Institute and National Institute of General Medical Science. This study was supported by grants from the NIH ( to M. A. L.). D. E. K. was supported by a Predoctoral fellowship from the US Army Breast Cancer Research Program. D. A. was supported by an NIH Postdoctoral Training Grant and a Postdoctoral Fellowship from the Damon Runyon Cancer Research Foundation.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berger MB, 2004, FEBS LETT, V569, P332, DOI 10.1016/j.febslet.2004.06.014; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Brennan PJ, 2000, ONCOGENE, V19, P6093, DOI 10.1038/sj.onc.1203967; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Carraway KL, 2003, BIOESSAYS, V25, P66, DOI 10.1002/bies.10201; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; CLIFFORD R, 1994, GENETICS, V137, P531; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson KM, 2000, EMBO J, V19, P4632, DOI 10.1093/emboj/19.17.4632; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; HORAN T, 1995, J BIOL CHEM, V270, P24604, DOI 10.1074/jbc.270.41.24604; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Klein DE, 2008, NATURE, V453, P1271, DOI 10.1038/nature06978; Klein DE, 2004, NATURE, V430, P1040, DOI 10.1038/nature02840; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Mattoon D, 2004, P NATL ACAD SCI USA, V101, P923, DOI 10.1073/pnas.0307286101; Miura GI, 2006, DEV CELL, V10, P167, DOI 10.1016/j.devcel.2005.11.017; Moasser MM, 2007, ONCOGENE, V26, P6577, DOI 10.1038/sj.onc.1210478; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penuel E, 2002, J BIOL CHEM, V277, P28468, DOI 10.1074/jbc.M202510200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Walker F, 2004, J BIOL CHEM, V279, P22387, DOI 10.1074/jbc.M401244200; Wehrman TS, 2006, P NATL ACAD SCI USA, V103, P19063, DOI 10.1073/pnas.0605218103; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wriggers W, 2001, J STRUCT BIOL, V133, P193, DOI 10.1006/jsbi.2000.4350	43	63	66	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					287	U172		10.1038/nature08297	http://dx.doi.org/10.1038/nature08297			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19718021	Green Accepted			2022-12-24	WOS:000269654600049
J	Zheng, JP; Birktoft, JJ; Chen, Y; Wang, T; Sha, RJ; Constantinou, PE; Ginell, SL; Mao, CD; Seeman, NC				Zheng, Jianping; Birktoft, Jens J.; Chen, Yi; Wang, Tong; Sha, Ruojie; Constantinou, Pamela E.; Ginell, Stephan L.; Mao, Chengde; Seeman, Nadrian C.			From molecular to macroscopic via the rational design of a self-assembled 3D DNA crystal	NATURE			English	Article							NUCLEIC-ACID JUNCTIONS; HOLLIDAY JUNCTION; CRYSTALLIZATION; SUBSTRATE; TRIANGLES	We live in a macroscopic three-dimensional (3D) world, but our best description of the structure of matter is at the atomic and molecular scale. Understanding the relationship between the two scales requires a bridge from the molecular world to the macroscopic world. Connecting these two domains with atomic precision is a central goal of the natural sciences, but it requires high spatial control of the 3D structure of matter(1). The simplest practical route to producing precisely designed 3D macroscopic objects is to form a crystalline arrangement by self-assembly, because such a periodic array has only conceptually simple requirements: a motif that has a robust 3D structure, dominant affinity interactions between parts of the motif when it self-associates, and predictable structures for these affinity interactions. Fulfilling these three criteria to produce a 3D periodic system is not easy, but should readily be achieved with well-structured branched DNA motifs tailed by sticky ends(2). Complementary sticky ends associate with each other preferentially and assume the well-known B-DNA structure when they do so(3); the helically repeating nature of DNA facilitates the construction of a periodic array. It is essential that the directions of propagation associated with the sticky ends do not share the same plane, but extend to form a 3D arrangement of matter. Here we report the crystal structure at 4 angstrom resolution of a designed, self-assembled, 3D crystal based on the DNA tensegrity triangle(4). The data demonstrate clearly that it is possible to design and self-assemble a well-ordered macromolecular 3D crystalline lattice with precise control.	[Zheng, Jianping; Birktoft, Jens J.; Wang, Tong; Sha, Ruojie; Constantinou, Pamela E.; Seeman, Nadrian C.] NYU, Dept Chem, New York, NY 10003 USA; [Chen, Yi; Mao, Chengde] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Ginell, Stephan L.] Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA	New York University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Energy (DOE); Argonne National Laboratory	Seeman, NC (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.	mao@purdue.edu; ned.seeman@nyu.edu	Mao, Chengde/GPP-1546-2022; Chen, Yi/D-7943-2013	Chen, Yi/0000-0002-2310-1416	National Institute of General Medical Sciences; National Science Foundation [CCF-0622093]; Army Research Office; Office of Naval Research; W. M. Keck Foundation; NIH [1R21EB007472]; US Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB007472] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Army Research Office; Office of Naval Research(Office of Naval Research); W. M. Keck Foundation(W.M. Keck Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research has been supported by grants to N. C. S. from the National Institute of General Medical Sciences, the National Science Foundation, the Army Research Office, the Office of Naval Research and the W. M. Keck Foundation. It has also been supported by NSF grant CCF-0622093 and NIH grant 1R21EB007472 to C. M. We thank W. Sherman for assistance in establishing the likely structural features of tensegrity triangles. We thank R. Sweet, M. Allaire, H. Robinson, A. Saxena and A. Heroux at the BNL-NSLS at beamlines X6A and X25 of the National Synchrotron Light Source. BNL-NSLS is supported principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy, and from the National Center for Research Resources of the National Institutes of Health. The use of the 19ID beamline at the Structural Biology Center/Advanced Photon Source is supported by the US Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Birac JJ, 2006, J MOL GRAPH MODEL, V25, P470, DOI 10.1016/j.jmgm.2006.03.005; Ding B, 2006, SCIENCE, V314, P1583, DOI 10.1126/science.1131372; Eichman BF, 2000, P NATL ACAD SCI USA, V97, P3971, DOI 10.1073/pnas.97.8.3971; Furukawa H, 2008, J AM CHEM SOC, V130, P11650, DOI 10.1021/ja803783c; Gu HZ, 2009, NAT NANOTECHNOL, V4, P245, DOI [10.1038/nnano.2009.5, 10.1038/NNANO.2009.5]; Kawano M, 2007, J AM CHEM SOC, V129, P15418, DOI 10.1021/ja0752540; Liu D, 2004, J AM CHEM SOC, V126, P2324, DOI 10.1021/ja031754r; Mao CD, 1999, J AM CHEM SOC, V121, P5437, DOI 10.1021/ja9900398; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Paukstelis PJ, 2006, J AM CHEM SOC, V128, P6794, DOI 10.1021/ja061322r; Paukstelis PJ, 2004, CHEM BIOL, V11, P1119, DOI 10.1016/j.chembiol.2004.05.021; Qiu HX, 1997, J MOL BIOL, V267, P881, DOI 10.1006/jmbi.1997.0918; ROBINSON BH, 1987, PROTEIN ENG, V1, P295, DOI 10.1093/protein/1.4.295; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; SEEMAN NC, 1990, J BIOMOL STRUCT DYN, V8, P573, DOI 10.1080/07391102.1990.10507829; SEEMAN NC, 1985, J BIOMOL STRUCT DYN, V3, P11, DOI 10.1080/07391102.1985.10508395; Sha RJ, 2002, BIOCHEMISTRY-US, V41, P5950, DOI 10.1021/bi020001z; Vargason JM, 2001, P NATL ACAD SCI USA, V98, P7265, DOI 10.1073/pnas.121176898; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Zheng JW, 2006, NANO LETT, V6, P1502, DOI 10.1021/nl060994c	24	669	702	18	426	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					74	77		10.1038/nature08274	http://dx.doi.org/10.1038/nature08274			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19727196	Green Accepted			2022-12-24	WOS:000269478800032
J	Li, JX; Timko, MP				Li, Jianxiong; Timko, Michael P.			Gene-for-Gene Resistance in Striga-Cowpea Associations	SCIENCE			English	Article							GESNERIOIDES		[Li, Jianxiong; Timko, Michael P.] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA	University of Virginia	Li, JX (corresponding author), Univ Virginia, Dept Biol, Gilmer Hall, Charlottesville, VA 22903 USA.	mpt9g@virginia.edu			NSF; Kirkhouse Charitable Trust	NSF(National Science Foundation (NSF)); Kirkhouse Charitable Trust	We thank J. Westwood for critical reading and commentary and members of the Timko laboratory for helpful comments and suggestions. Supported by funds from NSF and Kirkhouse Charitable Trust.	Ashfield T, 2004, PLANT CELL, V16, P309, DOI 10.1105/tpc.016725; Botanga CJ, 2006, GENOME, V49, P1351, DOI 10.1139/G06-086; Caplan J, 2008, CELL HOST MICROBE, V3, P126, DOI 10.1016/j.chom.2008.02.010; Ejeta G, 2007, INTEGRATING NEW TECH, P115; Lane J. A., 1997, P81; Ouedraogo JT, 2001, THEOR APPL GENET, V102, P1029, DOI 10.1007/s001220000499; Tameling WIL, 2007, PHYSIOL MOL PLANT P, V71, P126, DOI 10.1016/j.pmpp.2007.12.006; Timko MP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-103	8	64	65	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2009	325	5944					1094	1094		10.1126/science.1174754	http://dx.doi.org/10.1126/science.1174754			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713520				2022-12-24	WOS:000269382300031
J	Sweeney, K; Toy, L; Cornwell, J				Sweeney, Kieran; Toy, Liz; Cornwell, Jocelyn			Practice A patient's journey Mesothelioma	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sweeney, Kieran] Peninsula Med Sch, Exeter EX2 1PU, Devon, England; [Toy, Liz] Royal Devon & Exeter NHS Fdn Trust, Exeter EX2 5DW, Devon, England; [Cornwell, Jocelyn] Kings Fund, Point Care Programme, London, England	University of Exeter; University of Exeter	Sweeney, K (corresponding author), Peninsula Med Sch, Exeter EX2 1PU, Devon, England.	kieran.sweeney@pms.ac.uk							0	17	17	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 14	2009	339								b2862	10.1136/bmj.b2862	http://dx.doi.org/10.1136/bmj.b2862			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485YL	19684101				2022-12-24	WOS:000269162200004
J	Ramadan, MM; El-Desouky, MES				Ramadan, Mahmoud Mohammed; El-Desouky, Mohamed El-Sayed			Esophageal Foreign Body	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ramadan, Mahmoud Mohammed; El-Desouky, Mohamed El-Sayed] Mansoura Univ, Mansoura 35516, Dakahleya, Egypt	Egyptian Knowledge Bank (EKB); Mansoura University	Ramadan, MM (corresponding author), Mansoura Univ, Mansoura 35516, Dakahleya, Egypt.			Ramadan, Mahmoud/0000-0001-8843-0141					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2009	361	7					E11	E11		10.1056/NEJMicm0803473	http://dx.doi.org/10.1056/NEJMicm0803473			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482JX	19675327				2022-12-24	WOS:000268884100011
J	Pasupathy, D; Wood, AM; Pell, JP; Fleming, M; Smith, GCS				Pasupathy, Dharmintra; Wood, Angela M.; Pell, Jill P.; Fleming, Michael; Smith, Gordon C. S.			Rates of and Factors Associated With Delivery-Related Perinatal Death Among Term Infants in Scotland	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	28th Annual Meeting of the Society-for-Maternal-Fetal-Medicine	JAN 28-FEB 02, 2008	Dallas, TX	Soc Maternal Fetal Med (SMFM)			CESAREAN-SECTION; FETAL-DEATH; RISK; MORTALITY; STILLBIRTH; BIRTH; AGE	Context Rates of obstetric intervention in labor, including cesarean delivery, have increased significantly in most developed countries. It is, however, unclear if this has been paralleled by decreased rates of perinatal and neonatal death associated with complications of labor at term. Objectives To determine whether rates of perinatal death at term, either during labor or in the neonatal period, have changed in Scotland during the last 20 years and whether this was associated with a reduction in deaths ascribed to intrapartum anoxia. Design, Setting, and Participants A population-based, retrospective cohort study of linked data from a registry of births ( Scottish Morbidity Record 02) and a registry of perinatal deaths ( Scottish Stillbirth and Infant Death Survey) between 1988 and 2007. Participants included all births of a singleton infant in a cephalic presentation at term (N = 1 012 266), excluding those with perinatal death due to congenital anomaly or antepartum stillbirth. Main Outcome Measure Delivery-related perinatal death, defined as intrapartum stillbirth or neonatal death unrelated to congenital abnormality. These events were also subdivided into those events ascribed to intrapartum anoxia and all other causes. The risk of death was modeled using logistic regression and analyses were adjusted for maternal age, height, parity, socioeconomic deprivation status, gestational age, birth weight percentile, fetal sex, onset of labor, and the annual number of births per hospital. Results During the study period, the risk of delivery-related perinatal death decreased from 8.8 to 5.5 per 10 000 births (unadjusted change, -38%; 95% confidence interval [CI], -51% to -21%). When analyzed by the cause of death, there was a significant decrease in the risk of death ascribed to intrapartum anoxia (5.7 to 3.0 per 10 000 births; unadjusted change, -48%; 95% CI, -62% to -29%), but no significant change in the risk of death ascribed to other causes. When deaths ascribed to intrapartum anoxia were analyzed by the time of death in relation to delivery, the reduction was similar comparing intrapartum stillbirths (2.6 to 1.1 per 10 000 births; unadjusted change, -60%; 95% CI, -75% to -34%) and neonatal deaths (3.1 to 1.9 per 10 000 births; unadjusted change, -38%; 95% CI, -59% to -7%). Adjustment for maternal, fetal, and obstetric factors was without material effect. Conclusion Rates of intrapartum stillbirth and neonatal death at term decreased in Scotland between 1988 and 2007. This decrease was only significant for deaths ascribed to intrapartum anoxia. JAMA. 2009; 302(6):660-668 www.jama.com	[Pasupathy, Dharmintra; Smith, Gordon C. S.] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge CB2 2SW, England; [Wood, Angela M.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 2SW, England; [Pell, Jill P.] Univ Glasgow, Publ Hlth Sect, Glasgow, Lanark, Scotland; [Fleming, Michael] Natl Serv Scotland, Natl Hlth Serv, Informat & Stat Div, Paisley, Renfrew, Scotland; [Smith, Gordon C. S.] Cambridge Comprehens Biomed Res Ctr, Natl Inst Hlth Res, Cambridge, England	University of Cambridge; University of Cambridge; University of Glasgow; NHS Blood & Transplant (NHSBT); NHS National Services Scotland; University of Cambridge	Smith, GCS (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, Rosie Hosp, Cambridge CB2 2SW, England.	gcss2@cam.ac.uk	Pasupathy, Dharmintra/N-9586-2019; Smith, Gordon/A-8070-2008; Wood, Angela/GZA-5762-2022	Pasupathy, Dharmintra/0000-0002-6722-1006; Smith, Gordon/0000-0003-2124-0997; Wood, Angela/0000-0002-7937-304X; fleming, michael/0000-0002-2185-4502; Pell, Jill/0000-0002-8898-7035	MRC [G0600469] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: Medline; Medical Research Council [G0600469] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 1985, LANCET, V2, P436; Bell R, 2004, BJOG-INT J OBSTET GY, V111, P1400, DOI 10.1111/j.1471-0528.2004.00296.x; Bell R, 2004, ARCH DIS CHILD-FETAL, V89, pF531, DOI 10.1136/adc.2003.038414; Cahill AG, 2006, AM J OBSTET GYNECOL, V194, P909, DOI 10.1016/j.ajog.2006.02.031; COLE SK, 1980, PERINATAL AUDIT SURV, P39; Eichenwald EC, 2008, NEW ENGL J MED, V358, P1700, DOI 10.1056/NEJMra0707601; FORBES JF, 1982, J EPIDEMIOL COMMUN H, V36, P282, DOI 10.1136/jech.36.4.282; FRETTS RC, 1992, OBSTET GYNECOL, V79, P35; Glinianaia SV, 2005, J CLIN EPIDEMIOL, V58, P1299, DOI 10.1016/j.jclinepi.2005.03.015; HEY EN, 1986, BRIT J OBSTET GYNAEC, V93, P1213, DOI 10.1111/j.1471-0528.1986.tb07854.x; Little R. J. A., 1987, STAT ANAL MISSING DA; MacDorman Marian F, 2007, Natl Vital Stat Rep, V56, P1; MACFARLANE A, 2000, BIRTH COUNTS STAT PR, V1; MCILWAINE GM, 1985, BRIT J OBSTET GYNAEC, V92, P9, DOI 10.1111/j.1471-0528.1985.tb01041.x; *NAT HLTH SERV SCO, 2001, SCOTT PER INF MORT M; O'Leary CM, 2007, PAEDIATR PERINAT EP, V21, P541, DOI 10.1111/j.1365-3016.2007.00849.x; Pasupathy D, 2009, INT J EPIDEMIOL, V38, P490, DOI 10.1093/ije/dyn225; Rankin J, 2005, PAEDIATR PERINAT EP, V19, P56, DOI 10.1111/j.1365-3016.2004.00625.x; Rietberg CCT, 2005, BJOG-INT J OBSTET GY, V112, P205, DOI 10.1111/j.1471-0528.2004.00317.x; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Smith GCS, 2005, AM J OBSTET GYNECOL, V192, P17, DOI 10.1016/j.ajog.2004.08.014; Smith GCS, 2004, BRIT MED J, V329, P375, DOI 10.1136/bmj.38160.634352.55; Smith GCS, 2003, LANCET, V362, P1779, DOI 10.1016/S0140-6736(03)14896-9; Smith GCS, 2002, JAMA-J AM MED ASSOC, V287, P2684, DOI 10.1001/jama.287.20.2684; Smith GCS, 2002, BRIT MED J, V324, P483; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Stoelhorst GMSJ, 2005, PEDIATRICS, V115, P396, DOI 10.1542/peds.2004-1497; Thornton CM, 1998, BRIT J OBSTET GYNAEC, V105, P18, DOI 10.1111/j.1471-0528.1998.tb09344.x; Walsh CA, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.018; WHITFIELD CR, 1986, BRIT J OBSTET GYNAEC, V93, P694, DOI 10.1111/j.1471-0528.1986.tb08054.x	30	34	34	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 12	2009	302	6					660	668		10.1001/jama.2009.1111	http://dx.doi.org/10.1001/jama.2009.1111			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	481ZI	19671907	Bronze			2022-12-24	WOS:000268852300024
J	Kostrewa, D; Zeller, ME; Armache, KJ; Seizl, M; Leike, K; Thomm, M; Cramer, P				Kostrewa, Dirk; Zeller, Mirijam E.; Armache, Karim-Jean; Seizl, Martin; Leike, Kristin; Thomm, Michael; Cramer, Patrick			RNA polymerase II-TFIIB structure and mechanism of transcription initiation	NATURE			English	Article							START SITE SELECTION; N-TERMINAL REGION; PREINITIATION COMPLEX; ANGSTROM RESOLUTION; ELONGATION COMPLEX; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; ZINC RIBBON; YEAST; DNA	To initiate gene transcription, RNA polymerase II (Pol II) requires the transcription factor IIB (B). Here we present the crystal structure of the complete Pol II-B complex at 4.3 angstrom resolution, and complementary functional data. The results indicate the mechanism of transcription initiation, including the transition to RNA elongation. Promoter DNA is positioned over the Pol II active centre cleft with the 'B-core' domain that binds the wall at the end of the cleft. DNA is then opened with the help of the 'B-linker' that binds the Pol II rudder and clamp coiled-coil at the edge of the cleft. The DNA template strand slips into the cleft and is scanned for the transcription start site with the help of the 'B-reader' that approaches the active site. Synthesis of the RNA chain and rewinding of upstream DNA displace the B-reader and B-linker, respectively, to trigger B release and elongation complex formation.	[Kostrewa, Dirk; Armache, Karim-Jean; Seizl, Martin; Leike, Kristin; Cramer, Patrick] Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany; [Kostrewa, Dirk; Armache, Karim-Jean; Seizl, Martin; Leike, Kristin; Cramer, Patrick] Univ Munich, Dept Chem & Biochem, CIPSM, D-81377 Munich, Germany; [Zeller, Mirijam E.; Thomm, Michael] Univ Regensburg, Inst Biochem Genet & Mikrobiol, D-93053 Regensburg, Germany	University of Munich; University of Munich; University of Regensburg	Cramer, P (corresponding author), Univ Munich, Gene Ctr Munich, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@lmb.uni-muenchen.de			Deutsche Forschungsgemeinschaft; Sonderforschungsbereich [SFB646]; Transregio 5; Forschergruppe 'Regulation und Mechanismen der Ribosomen-Biogenese'; Nanosystems Initiative Munich (NIM); Ernst-Jung-Stiftung; Fonds der chemischen Industrie; Boehringer-Ingelheim-Fonds and Elitenetzwerk Bayern; DFG Forschergruppe 'Regulation und Mechanismen der Ribosomenbiogenese'	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich(German Research Foundation (DFG)); Transregio 5; Forschergruppe 'Regulation und Mechanismen der Ribosomen-Biogenese'; Nanosystems Initiative Munich (NIM); Ernst-Jung-Stiftung; Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Boehringer-Ingelheim-Fonds and Elitenetzwerk Bayern; DFG Forschergruppe 'Regulation und Mechanismen der Ribosomenbiogenese'(German Research Foundation (DFG))	P. C. was supported by the Deutsche Forschungsgemeinschaft, the Sonderforschungsbereich SFB646, the Transregio 5, the Forschergruppe 'Regulation und Mechanismen der Ribosomen-Biogenese', the Nanosystems Initiative Munich (NIM), the Ernst-Jung-Stiftung, and the Fonds der chemischen Industrie. M. S. was supported by the Boehringer-Ingelheim-Fonds and Elitenetzwerk Bayern. Part of this work was performed at the ESRF at Grenoble, France, and at the Swiss Light Source (SLS) at the Paul Scherrer Institut, Villigen, Switzerland. M. T. and M.E.Z. were supported by the DFG Forschergruppe 'Regulation und Mechanismen der Ribosomenbiogenese'. We thank members of the Cramer laboratory, in particular E. Lehmann and K. Maier, and members of the Thomm laboratory, in particular P. Decartes, W. Forster and F. Hirchaud. We thank K. Romer and the Romer-Stiftung for support.	Andrecka J, 2009, NUCLEIC ACIDS RES, V37, P5803, DOI 10.1093/nar/gkp601; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Bangur CS, 1997, MOL CELL BIOL, V17, P6784, DOI 10.1128/MCB.17.12.6784; Bartlett MS, 2004, J BIOL CHEM, V279, P5894, DOI 10.1074/jbc.M311429200; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Chen BS, 2004, MOL CELL BIOL, V24, P3983, DOI 10.1128/MCB.24.9.3983-3991.2004; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Cho EJ, 1999, J BIOL CHEM, V274, P25807, DOI 10.1074/jbc.274.36.25807; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Cramer P, 2002, BIOESSAYS, V24, P724, DOI 10.1002/bies.10127; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Faitar SL, 2001, MOL CELL BIOL, V21, P4427, DOI 10.1128/MCB.21.14.4427-4440.2001; Geszvain K, 2004, J MOL BIOL, V343, P569, DOI 10.1016/j.jmb.2004.08.063; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; Kassavetis GA, 2001, EMBO J, V20, P2823, DOI 10.1093/emboj/20.11.2823; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kuehner JN, 2008, MOL CELL, V31, P201, DOI 10.1016/j.molcel.2008.05.018; Kuehner JN, 2006, J BIOL CHEM, V281, P14119, DOI 10.1074/jbc.M601937200; Kusser AG, 2008, J MOL BIOL, V376, P303, DOI 10.1016/j.jmb.2007.08.066; Kuznedelov K, 2002, EMBO J, V21, P1369, DOI 10.1093/emboj/21.6.1369; Kwapisz M, 2008, EMBO J, V27, P2411, DOI 10.1038/emboj.2008.165; LI Y, 1994, SCIENCE, V263, P805, DOI 10.1126/science.8303296; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Naji S, 2008, NUCLEIC ACIDS RES, V36, P676, DOI 10.1093/nar/gkm1086; Naji S, 2007, J BIOL CHEM, V282, P11047, DOI 10.1074/jbc.M611674200; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Pardee TS, 1998, J BIOL CHEM, V273, P17859, DOI 10.1074/jbc.273.28.17859; PINTO I, 1994, J BIOL CHEM, V269, P30569; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Renfrow MB, 2004, J BIOL CHEM, V279, P2825, DOI 10.1074/jbc.M311433200; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; SEVERINOV K, 1994, J BIOL CHEM, V269, P20826; Thiebaut M, 2008, MOL CELL, V31, P671, DOI 10.1016/j.molcel.2008.08.010; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Werner F, 2005, MOL CELL BIOL, V25, P8344, DOI 10.1128/MCB.25.18.8344-8355.2005; Young BA, 2004, SCIENCE, V303, P1382, DOI 10.1126/science.1092462; Zhang DY, 2002, NUCLEIC ACIDS RES, V30, P3078, DOI 10.1093/nar/gkf422; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583; Zhu WL, 1996, NAT STRUCT BIOL, V3, P122, DOI 10.1038/nsb0296-122	50	224	228	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					323	330		10.1038/nature08548	http://dx.doi.org/10.1038/nature08548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19820686				2022-12-24	WOS:000271899300038
J	Albert, NM; Yancy, CW; Liang, L; Zhao, X; Hernandez, AF; Peterson, ED; Cannon, CP; Fonarow, GC				Albert, Nancy M.; Yancy, Clyde W.; Liang, Li; Zhao, Xin; Hernandez, Adrian F.; Peterson, Eric D.; Cannon, Christopher P.; Fonarow, Gregg C.			Use of Aldosterone Antagonists in Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RENAL-INSUFFICIENCY; SPIRONOLACTONE; HYPERKALEMIA; GUIDELINES; DYSFUNCTION; ASSOCIATION; MANAGEMENT; POTASSIUM; DIAGNOSIS; UPDATE	Context Aldosterone antagonists are recommended for patients with moderate to severe heart failure (HF) and systolic dysfunction. Prior studies suggest underuse of aldosterone antagonists in eligible patients as well as overuse in settings in which therapy may be harmful. Objective To examine aldosterone antagonist prescription based on HF management guideline criteria, investigator-defined appropriateness criteria, and trends over time in patients hospitalized with heart failure. Design, Setting, and Patients Observational analysis of 43 625 patients admitted with HF and discharged home from 241 hospitals participating in the Get With The Guidelines-HF quality improvement registry between January 2005 and December 2007. Main Outcome Measures Prescription and predictors of use of aldosterone antagonists, based on guideline criteria. Results Among 12 565 patients eligible for aldosterone antagonist therapy, 4087 (32.5%) received an aldosterone antagonist at discharge, and treatment increased modestly from 28% to 34% over the study period. There was also wide variation in aldosterone antagonist use among hospitals (0%-90.6%). Aldosterone antagonist use in eligible patients was associated with younger age (adjusted odds ratio [OR], 0.85; 95% confidence interval [CI], 0.82-0.88), African American race/ethnicity (adjusted OR, 1.17; 95% CI, 1.04-1.32), lower systolic blood pressure (adjusted OR, 0.94; 95% CI, 0.92-0.95), history of implantable cardioverter-defibrillator use (adjusted OR, 1.51; 95% CI, 1.34-1.69), depression (adjusted OR, 1.15; 95% CI, 1.01-1.30), alcohol use (adjusted OR, 1.23; 95% CI, 1.02-1.50), and pacemaker implantation (adjusted OR, 1.21; 95% CI, 1.06-1.38), and with having no history of renal insufficiency (adjusted OR, 0.85; 95% CI, 0.75-0.96). Applying serum creatinine and potassium appropriateness criteria, inappropriate and potentially inappropriate use of aldosterone antagonist therapy was low and did not change over the 3-year study period. Conclusions Less than one-third of eligible patients hospitalized for HF and participating in a quality improvement registry received HF guideline-recommended aldosterone antagonist therapy. Use of aldosterone antagonist therapy among patients with documented contraindications was low. JAMA. 2009;302(15):1658-1665	[Albert, Nancy M.] Cleveland Clin, Nursing Inst, Cleveland, OH 44106 USA; [Albert, Nancy M.] Cleveland Clin, Kaufman Ctr Heart Failure, Cleveland, OH 44106 USA; [Yancy, Clyde W.] Baylor Univ, Med Ctr, Baylor Heart & Vasc Inst, Dallas, TX USA; [Liang, Li; Zhao, Xin; Hernandez, Adrian F.; Peterson, Eric D.] Duke Clin Res Inst, Durham, NC USA; [Cannon, Christopher P.] Brigham & Womens Hosp, TIMI Study Grp, Boston, MA 02115 USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Baylor University; Baylor University Medical Center; Duke University; Harvard University; Brigham & Women's Hospital; University of California System; University of California Los Angeles	Albert, NM (corresponding author), 9500 Euclid Ave,Mail Code J3-4, Cleveland, OH 44195 USA.	albertn@ccf.org	Hernandez, Adrian F/A-7818-2016; Peterson, Eric David/ABF-5033-2021; Cannon, Christopher P/AAY-7644-2020; Fonarow, Gregg C/D-5988-2014	Hernandez, Adrian F/0000-0003-3387-9616; Cannon, Christopher P/0000-0003-4596-2791; Fonarow, Gregg C/0000-0002-3192-8093	American Heart Association; GlaxoSmithKline; Medtronic	American Heart Association(American Heart Association); GlaxoSmithKline(GlaxoSmithKline); Medtronic(Medtronic)	The Get With The GuidelinesHeart Failure program is sponsored by the American Heart Association and receives funding in part from GlaxoSmithKline and Medtronic.	Bozkurt B, 2003, J AM COLL CARDIOL, V41, P211, DOI 10.1016/S0735-1097(02)02694-3; Erhardt L, 2008, EUR J HEART FAIL, V10, P1020, DOI 10.1016/j.ejheart.2008.08.001; Ezekowitz JA, 2009, EUR HEART J, V30, P469, DOI 10.1093/eurheartj/ehn543; Fonarow GC, 2008, CIRC-HEART FAIL, V1, P98, DOI 10.1161/CIRCHEARTFAILURE.108.772228; Hernandez AF, 2007, JAMA-J AM MED ASSOC, V298, P1525, DOI 10.1001/jama.298.13.1525; Hu YW, 2002, ANESTH ANALG, V95, P39, DOI 10.1097/00000539-200207000-00006; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hunt SA, 2005, J AM COLL CARDIOL, V46, P1116, DOI [DOI 10.1016/j.jacc.2005.08.023, DOI 10.1016/J.JACC.2005.08.023]; HUNT SA, 2006, CIRCULATION, V113, pE684; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Krantz MJ, 2008, AM J CARDIOL, V102, P1693, DOI 10.1016/j.amjcard.2008.08.015; LaBresh Kenneth A, 2003, Jt Comm J Qual Saf, V29, P539; Masoudi FA, 2005, CIRCULATION, V112, P39, DOI 10.1161/CIRCULATIONAHA.104.527549; Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193; Palmer BF, 2004, NEW ENGL J MED, V351, P585, DOI 10.1056/NEJMra035279; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Raebel MA, 2007, ANN PHARMACOTHER, V41, P193, DOI 10.1345/aph.1H520; Saito M, 2005, J CLIN PHARM THER, V30, P603, DOI 10.1111/j.1365-2710.2005.00694.x; Shah KB, 2005, J AM COLL CARDIOL, V46, P845, DOI 10.1016/j.jacc.2005.06.010; Smaha LA, 2004, AM HEART J, V148, pS46, DOI 10.1016/j.ahj.2004.09.015; Svensson M, 2004, J CARD FAIL, V10, P297, DOI 10.1016/j.cardfail.2003.10.012; Tamirisa KP, 2004, AM HEART J, V148, P971, DOI 10.1016/j.ahj.2004.10.005; Williams EM, 2006, CLIN CARDIOL, V29, P149, DOI 10.1002/clc.4960290405; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	25	203	206	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 21	2009	302	15					1658	1665		10.1001/jama.2009.1493	http://dx.doi.org/10.1001/jama.2009.1493			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508NX	19843900	Bronze			2022-12-24	WOS:000270941200020
J	Bodenheimer, T; Berry-Millett, R				Bodenheimer, Thomas; Berry-Millett, Rachel			Follow the Money - Controlling Expenditures by Improving Care for Patients Needing Costly Services	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CONTROLLED-TRIAL		[Bodenheimer, Thomas; Berry-Millett, Rachel] Univ Calif San Francisco, Sch Med, Dept Family & Community Med, Ctr Excellence Primary Care, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bodenheimer, T (corresponding author), Univ Calif San Francisco, Sch Med, Dept Family & Community Med, Ctr Excellence Primary Care, San Francisco, CA 94143 USA.							Anderson G, 2007, CHRONIC CONDITIONS M; BODENHEIMER T, 2009, CARE MANAGE IN PRESS; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Leff B, 2009, AM J MANAG CARE, V15, P555; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x	5	96	98	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2009	361	16					1521	1523		10.1056/NEJMp0907185	http://dx.doi.org/10.1056/NEJMp0907185			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	506LT	19797277				2022-12-24	WOS:000270777000001
J	Lange, A; Wickstrom, SA; Jakobson, M; Zent, R; Sainio, K; Fassler, R				Lange, Anika; Wickstroem, Sara A.; Jakobson, Madis; Zent, Roy; Sainio, Kirsi; Faessler, Reinhard			Integrin-linked kinase is an adaptor with essential functions during mouse development	NATURE			English	Article							HAIR FOLLICLE MORPHOGENESIS; NEUROTROPHIC FACTOR; PROTEIN-KINASE; CELL-ADHESION; ILK; ACTIN; INACTIVATION; CYTOSKELETON; EXPRESSION; PARVIN	The development of multicellular organisms requires integrin-mediated interactions between cells and their extracellular environment. Integrin binding to extracellular matrix catalyses assembly of multiprotein complexes, which transduce mechanical and chemical signals that regulate many aspects of cell physiology(1,2). Integrin-linked kinase (Ilk) is a multifunctional protein that binds beta-integrin cytoplasmic domains and regulates actin dynamics by recruiting actin binding regulatory proteins such as alpha-and beta-parvin(3). Ilk has also been shown to possess serine/threonine kinase activity(4) and to phosphorylate signalling proteins such as Akt1 and glycogen synthase kinase 3 beta (Gsk3 beta) in mammalian cells(5); however, these functions have been shown by genetic studies(6,7) not to occur in flies and worms. Here we show that mice carrying point mutations in the proposed autophosphorylation site of the putative kinase domain and in the pleckstrin homology domain are normal. In contrast, mice with point mutations in the conserved lysine residue of the potential ATP-binding site of the kinase domain, which mediates Ilk binding to alpha-parvin, die owing to renal agenesis. Similar renal defects occur in alpha-parvin-null mice. Thus, we provide genetic evidence that the kinase activity of Ilk is dispensable for mammalian development; however, an interaction between Ilk and alpha-parvin is critical for kidney development.	[Lange, Anika; Wickstroem, Sara A.; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Jakobson, Madis; Sainio, Kirsi] Univ Helsinki, Inst Biomed Med Biochem & Dev Biol, FIN-00014 Helsinki, Finland; [Zent, Roy] Vanderbilt Univ Sch Med, Dept Med, Div Nephrol, Nashville, TN 37232 USA; [Zent, Roy] Vet Affairs Hosp, Nashville, TN 37232 USA	Max Planck Society; University of Helsinki; Vanderbilt University	Fassler, R (corresponding author), Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany.	Faessler@biochem.mpg.de		Wickstrom, Sara/0000-0001-6383-6292	Sigrid Juselius Foundation; Academy of Finland; Finnish Cultural Foundation; NIDDK [DK065123, DK075594, DK65123]; AHA; Department of Veterans Affairs; Austrian Science Funds [SFB021]; Max Planck Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK065123, R01DK075594] Funding Source: NIH RePORTER	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHA(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); Austrian Science Funds(Austrian Science Fund (FWF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Bosl and M. Moser for help with the generation of the mutant mice, E. Montanez for help with the analysis of the alpha-parvin-null mice, M. Grzejszczyk and S. Bach for technical assistance, O. Kudlacek for help with initial vector construction, M. Aumailley (Univ. Cologne) for laminin322, A. A. Noegel (Univ. Cologne) for alpha-parvin cDNA, A. Miettinen (Univ. Helsinki) for the brush border antibody, and R. Bottcher for careful reading of the manuscript. This work was supported by the Sigrid Juselius Foundation (to S. A. W. and M. J.), the Academy of Finland (to S. A. W., M. J. and K. S.), the Finnish Cultural Foundation (to S. A. W.), NIDDK DK065123, DK075594, DK65123, an AHA established investigator award and a Merit award from the Department of Veterans Affairs (to R. Z.), the Austrian Science Funds (grant SFB021) and the Max Planck Society (to R. F.).	Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Brodbeck S, 2004, PEDIATR NEPHROL, V19, P249, DOI 10.1007/s00467-003-1374-z; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Chu HY, 2006, MOL CELL BIOL, V26, P1817, DOI 10.1128/MCB.26.5.1817-1825.2006; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Filipenko NR, 2005, ONCOGENE, V24, P5837, DOI 10.1038/sj.onc.1208737; Grashoff C, 2003, EMBO REP, V4, P432, DOI 10.1038/sj.embor.embor801; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kuure S, 2005, MECH DEVELOP, V122, P765, DOI 10.1016/j.mod.2005.03.006; Kuure S, 2007, J AM SOC NEPHROL, V18, P1130, DOI 10.1681/ASN.2006111206; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Li SH, 2005, J CELL SCI, V118, P2913, DOI 10.1242/jcs.02422; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; Lu HZ, 2006, CIRCULATION, V114, P2271, DOI 10.1161/CIRCULATIONAHA.106.642330; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Maeshima A, 2007, J AM SOC NEPHROL, V18, P3147, DOI 10.1681/ASN.2007060642; MONTANEZ E, EMBO J IN PRESS; Nakrieko KA, 2008, MOL BIOL CELL, V19, P1462, DOI 10.1091/mbc.E07-06-0526; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Postel R, 2008, DEV BIOL, V318, P92, DOI 10.1016/j.ydbio.2008.03.024; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sainio K, 1997, DEVELOPMENT, V124, P4077; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007	33	100	101	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					1002	U269		10.1038/nature08468	http://dx.doi.org/10.1038/nature08468			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829382				2022-12-24	WOS:000270817700052
J	Rudick, RA; Trapp, BD				Rudick, Richard A.; Trapp, Bruce D.			Gray-Matter Injury in Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rudick, Richard A.] Cleveland Clin, Neurol Inst, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA; [Trapp, Bruce D.] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Rudick, RA (corresponding author), Cleveland Clin, Neurol Inst, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA.							Derfuss T, 2009, P NATL ACAD SCI USA, V106, P8302, DOI 10.1073/pnas.0901496106; FISHER E, 2008, ANN NEUROL, V282, P106; Fisniku LK, 2008, ANN NEUROL, V64, P247, DOI 10.1002/ana.21423; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Tiberio M, 2005, NEUROLOGY, V64, P1001, DOI 10.1212/01.WNL.0000154526.22878.30	5	48	50	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2009	361	15					1505	1506		10.1056/NEJMcibr0905482	http://dx.doi.org/10.1056/NEJMcibr0905482			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503MU	19812410				2022-12-24	WOS:000270540000017
J	Kim, JB; Greber, B; Arauzo-Bravo, MJ; Meyer, J; Park, KI; Zaehres, H; Scholer, HR				Kim, Jeong Beom; Greber, Boris; Arauzo-Bravo, Marcos J.; Meyer, Johann; Park, Kook In; Zaehres, Holm; Schoeler, Hans R.			Direct reprogramming of human neural stem cells by OCT4	NATURE			English	Article							HUMAN FIBROBLASTS; GENERATION; MOUSE; PLURIPOTENCY; INDUCTION; MYC	Induced pluripotent stem (iPS) cells have been generated from mouse and human somatic cells by ectopic expression of four transcription factors (OCT4 (also called POU5F1), SOX2, c-Myc and KLF4)(1-7). We previously reported that Oct4 alone is sufficient to reprogram directly adult mouse neural stem cells to iPS cells(8). Here we report the generation of one-factor human iPS cells from human fetal neural stem cells (one-factor (1F) human NiPS cells) by ectopic expression of OCT4 alone. One-factor human NiPS cells resemble human embryonic stem cells in global gene expression profiles, epigenetic status, as well as pluripotency in vitro and in vivo. These findings demonstrate that the transcription factor OCT4 is sufficient to reprogram human neural stem cells to pluripotency. One-factor iPS cell generation will advance the field further towards understanding reprogramming and generating patient-specific pluripotent stem cells.	[Kim, Jeong Beom; Greber, Boris; Arauzo-Bravo, Marcos J.; Zaehres, Holm; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, NRW, Germany; [Meyer, Johann] Hannover Med Sch, Dept Expt Hematol, D-30625 Hannover, Germany; [Park, Kook In] Yonsei Univ, Coll Med, Dept Pediat, Project Med Sci BK21, Seoul 120752, South Korea	Max Planck Society; Hannover Medical School; Yonsei University; Yonsei University Health System	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, NRW, Germany.	office@mpi-muenster.mpg.de	Marcos, Arauzo-Bravo/A-1706-2011; , HS/AAB-4434-2019	Marcos, Arauzo-Bravo/0000-0002-3264-464X; , HS/0000-0003-2643-5136; Greber, Boris/0000-0002-9404-7293; Kim, Jeong Beom/0000-0001-6230-8826	German Federal Ministry of Education and Research BMBF [01GN0811]; Deutsche Forschungsgemeinschaft DFG [SCHO 340/4-1]	German Federal Ministry of Education and Research BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	We thank B. Schafer for histology, T. Kitamura for the pMX retroviral vector and A. Malapetsas and S. Kolsch for editing. This work has been supported, in part, by a grant from the German Federal Ministry of Education and Research BMBF 01GN0811 and in part by a grant by the Deutsche Forschungsgemeinschaft DFG SCHO 340/4-1.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Widera D, 2009, STEM CELLS, V27, P1899, DOI 10.1002/stem.104; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaehres H, 2006, METHOD ENZYMOL, V420, P49, DOI 10.1016/S0076-6879(06)20004-1	25	506	565	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					649	U93		10.1038/nature08436	http://dx.doi.org/10.1038/nature08436			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19718018				2022-12-24	WOS:000270302600040
J	Lu-Yao, GL; Albertsen, PC; Moore, DF; Shih, WC; Lin, Y; DiPaola, RS; Barry, MJ; Zietman, A; O'Leary, M; Walker-Corkery, E; Yao, SL				Lu-Yao, Grace L.; Albertsen, Peter C.; Moore, Dirk F.; Shih, Weichung; Lin, Yong; DiPaola, Robert S.; Barry, Michael J.; Zietman, Anthony; O'Leary, Michael; Walker-Corkery, Elizabeth; Yao, Siu-Long			Outcomes of Localized Prostate Cancer Following Conservative Management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACTIVE SURVEILLANCE; RADICAL PROSTATECTOMY; ANDROGEN-DEPRIVATION; SURVIVAL; MEN; TRENDS; RISK; INTERVENTION; DEATH	Context Most newly diagnosed prostate cancers are clinically localized, and major treatment options include surgery, radiation, or conservative management. Although conservative management can be a reasonable choice, there is little contemporary prostate-specific antigen (PSA)-era data on outcomes with this approach. Objective To evaluate the outcomes of clinically localized prostate cancer managed without initial attempted curative therapy in the PSA era. Design, Setting, and Participants A population-based cohort study of men aged 65 years or older when they were diagnosed (1992-2002) with stage T1 or T2 prostate cancer and whose cases were managed without surgery or radiation for 6 months after diagnosis. Living in areas covered by the Surveillance, Epidemiology, and End Results (SEER) program, the men were followed up for a median of 8.3 years (through December 31, 2007). Competing risk analyses were performed to assess outcomes. Main Outcome Measures Ten-year overall survival, cancer-specific survival, and major cancer related interventions. Results Among men who were a median age of 78 years at cancer diagnosis, 10-year prostate cancer-specific mortality was 8.3%(95% confidence interval [CI], 4.2%-12.8%) formen with well-differentiated tumors; 9.1%(95% CI, 8.3%-10.1%) for those with moderately differentiated tumors, and 25.6% (95% CI, 23.7%-28.3%) for those with poorly differentiated tumors. The corresponding 10-year risks of dying of competing causes were 59.8%(95% CI, 53.2%-67.8%), 57.2%(95% CI, 52.6%-63.9%), and 56.5%(95% CI, 53.6%-58.8%), respectively. Ten-year disease-specific mortality for men aged 66 to 74 years diagnosed with moderately differentiated disease was 60% to 74% lower than earlier studies: 6%(95% CI, 4%-8%) in the contemporary PSA era (1992-2002) compared with results of previous studies(15%-23%) in earlier eras (1949-1992). Improved survival was also observed in poorly differentiated disease. The use of chemotherapy (1.6%) or major interventions for spinal cord compression (0.9%) was uncommon. Conclusions Results following conservative management of clinically localized prostate cancer diagnosed from 1992 through 2002 are better than outcomes among patients diagnosed in the 1970s and 1980s. This may be due, in part, to additional lead time, overdiagnosis related to PSA testing, grade migration, or advances in medical care. JAMA. 2009; 302(11): 1202-1209	[Lu-Yao, Grace L.; Moore, Dirk F.; Shih, Weichung; Lin, Yong; DiPaola, Robert S.; Yao, Siu-Long] Univ Med & Dent New Jersey, Canc Inst New Jersey, Piscataway, NJ 08854 USA; [Lu-Yao, Grace L.; DiPaola, Robert S.; Yao, Siu-Long] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Piscataway, NJ 08854 USA; [Moore, Dirk F.; Shih, Weichung; Lin, Yong] Univ Med & Dent New Jersey, Sch Publ Hlth, Dept Biostat, Piscataway, NJ 08854 USA; [Albertsen, Peter C.] Univ Connecticut, Dept Surg Oncol, Farmington, CT USA; [Lu-Yao, Grace L.; DiPaola, Robert S.] Massachusetts Gen Hosp, Dean & Betty Gallo Prostate Canc Ctr, Boston, MA 02114 USA; [Barry, Michael J.; Walker-Corkery, Elizabeth] Massachusetts Gen Hosp, Med Practices Evaluat Ctr, Boston, MA 02114 USA; [Zietman, Anthony] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [O'Leary, Michael] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Yao, Siu-Long] Schering Plough Res Inst, Kenilworth, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Connecticut; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Merck & Company; Schering-Plough Research Institute	Lu-Yao, GL (corresponding author), 195 Little Albany St,Room 5534, New Brunswick, NJ USA.	luyaogr@umdnj.edu		Lu-Yao, Grace/0000-0002-6017-9175	US Army Medical Research Acquisition Activity, Fort Detrick, MD [DAMD17-01-10755]; Department of Defense award [W81XWG-05-1-0235]; Ohl Foundation [R01 CA116399]; National Cancer Institute [CA-72720-10]; NATIONAL CANCER INSTITUTE [P30CA072720, R01CA116399] Funding Source: NIH RePORTER	US Army Medical Research Acquisition Activity, Fort Detrick, MD; Department of Defense award(United States Department of Defense); Ohl Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding/Support: The study was supported by the following grants and awards: award DAMD17-01-10755 from the US Army Medical Research Acquisition Activity, Fort Detrick, MD, Department of Defense award W81XWG-05-1-0235, Ohl Foundation, and grants R01 CA116399 and CINJ core grant CA-72720-10 from the National Cancer Institute.	ADOLFSSON J, 1993, CANCER-AM CANCER SOC, V72, P310, DOI 10.1002/1097-0142(19930715)72:2<310::AID-CNCR2820720203>3.0.CO;2-T; ADOLFSSON J, 1992, BRIT J UROL, V69, P183, DOI 10.1111/j.1464-410X.1992.tb15493.x; Albertsen PC, 2005, J NATL CANCER I, V97, P1248, DOI 10.1093/jnci/dji248; Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Albertsen PC, 2000, J UROLOGY, V163, P519, DOI 10.1016/S0022-5347(05)67915-3; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Carter HB, 2007, J UROLOGY, V178, P2359, DOI 10.1016/j.juro.2007.08.039; CHODAK GW, 1994, NEW ENGL J MED, V330, P242, DOI 10.1056/NEJM199401273300403; Cooperberg MR, 2007, J UROLOGY, V178, pS14, DOI 10.1016/j.juro.2007.03.135; Cooperberg MR, 2003, J NATL CANCER I, V95, P981, DOI 10.1093/jnci/95.13.981; Cooperberg MR, 2004, J UROLOGY, V171, P1393, DOI 10.1097/01.ju.0000107247.81471.06; Dall'Era MA, 2008, CANCER-AM CANCER SOC, V112, P1650, DOI 10.1002/cncr.23373; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Efron B., 1994, INTRO BOOTSTRAP; Hardie C, 2005, BJU INT, V95, P956, DOI 10.1111/j.1464-410X.2005.05446.x; Jani AB, 2008, AM J CLIN ONCOL-CANC, V31, P375, DOI 10.1097/COC.0b013e3181637384; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; JOHANSSON JE, 1992, JAMA-J AM MED ASSOC, V267, P2191, DOI 10.1001/jama.267.16.2191; Johansson JE, 1997, JAMA-J AM MED ASSOC, V277, P467, DOI 10.1001/jama.277.6.467; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; Kattan MW, 2008, CANCER, V112, P69, DOI 10.1002/cncr.23106; Kawakami J, 2006, CANCER, V106, P1708, DOI 10.1002/cncr.21799; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Klotz L, 2008, SEMIN RADIAT ONCOL, V18, P2, DOI 10.1016/j.semradonc.2007.09.001; LuYao GL, 1997, LANCET, V349, P906, DOI 10.1016/S0140-6736(96)09380-4; MULLER HG, 1994, BIOMETRICS, V50, P61, DOI 10.2307/2533197; OLEYNICK JU, 2006, AM SOC CLIN ONC ANN; Patel MI, 2004, J UROLOGY, V171, P1520, DOI 10.1097/01.ju.0000118224.54949.78; Penson DF, 2001, J NATL CANCER I, V93, P1822, DOI 10.1093/jnci/93.23.1822; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Ries LAG, 2007, SEER CANC STAT REV 1; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Virnig BA, 2002, MED CARE, V40, P49; Walsh PC, 2007, NEW ENGL J MED, V357, P2696, DOI 10.1056/NEJMcp0706784; Warlick C, 2006, JNCI-J NATL CANCER I, V98, P355, DOI 10.1093/jnci/djj072; Warren JL, 2002, MED CARE, V40, P3; Warren JL, 2002, MED CARE, V40, P55; Wilt TJ, 2008, ANN INTERN MED, V148, P888, DOI 10.7326/0003-4819-148-11-200806030-00023; Wilt TJ, 2008, ANN INTERN MED, V148, P435, DOI 10.7326/0003-4819-148-6-200803180-00209; Wilt TJ, 2009, CONTEMP CLIN TRIALS, V30, P81, DOI 10.1016/j.cct.2008.08.002	40	291	302	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	2009	302	11					1202	1209		10.1001/jama.2009.1348	http://dx.doi.org/10.1001/jama.2009.1348			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494FR	19755699	Green Accepted			2022-12-24	WOS:000269797600030
J	Ulbrich, C; Diepholz, M; Bassler, J; Kressler, D; Pertschy, B; Galani, K; Bottcher, B; Hurt, E				Ulbrich, Cornelia; Diepholz, Meikel; Bassler, Jochen; Kressler, Dieter; Pertschy, Brigitte; Galani, Kyriaki; Boettcher, Bettina; Hurt, Ed			Mechanochemical Removal of Ribosome Biogenesis Factors from Nascent 60S Ribosomal Subunits	CELL			English	Article							NUCLEAR EXPORT; STRUCTURAL BASIS; PRE-RIBOSOME; AAA-ATPASE; RNA; BINDING; PROTEIN; NUCLEOLUS; DYNEIN; MATURATION	The dynein-related AAA ATPase Rea1 is a preribosomal factor that triggers an unknown maturation step in 60S subunit biogenesis. Using electron microscopy, we show that Rea1's motor domain is docked to the pre-60S particle and its tail-like structure, harboring a metal ion-dependent adhesion site (MIDAS), protrudes from the preribosome. Typically, integrins utilize a MIDAS to bind extracellular ligands, an interaction that is strengthened under applied tensile force. Likewise, the Rea1 MIDAS binds the preribosomal factor Rsa4, which is located on the pre-60S subunit at a site that is contacted by the flexible Rea1 tail. The MIDAS-Rsa4 interaction is essential for ATP-dependent dissociation of a group of non-ribosomal factors from the pre-60S particle. Thus, Rea1 aligns with its interacting partners on the preribosome to effect a necessary step on the path to the export-competent 60S subunit.	[Diepholz, Meikel; Galani, Kyriaki; Boettcher, Bettina] EMBL, D-69117 Heidelberg, Germany; [Ulbrich, Cornelia; Bassler, Jochen; Kressler, Dieter; Pertschy, Brigitte; Galani, Kyriaki; Hurt, Ed] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; [Boettcher, Bettina] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland	European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; University of Edinburgh	Bottcher, B (corresponding author), EMBL, Meyerhofstr 1, D-69117 Heidelberg, Germany.	bettina.boettcher@ed.ac.uk; ed.hurt@bzh.uni-heidelberg.de	Ed Hurt, Dr./AAE-8874-2019; Kressler, Dieter/C-2218-2012; Bottcher, Bettina/E-9397-2010; Baßler, Jochen/AAC-5336-2021	Ed Hurt, Dr./0000-0002-4535-8255; Bottcher, Bettina/0000-0002-7962-4849; Baßler, Jochen/0000-0002-7441-7867; Pertschy, Brigitte/0000-0003-3558-0191; Kressler, Dieter/0000-0003-4855-3563	Welcome Trust [WT 087658]; FP6 Marie Curie Action for Early-Stage-Training [MEST-CT-2004-504640]; Deutsche Forschungsgemeinschaft [Hu363/9-2]; Fonds der Chemischen Industrie;  [LSHG-CT-2005-512028]	Welcome Trust(Wellcome Trust); FP6 Marie Curie Action for Early-Stage-Training(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); 	The excellent technical help of Martina Kallas and Claire Batisse is gratefully acknowledged. We thank Drs. M. Remacha, H. Tschochner, M. FromontRacine, A. W. Johnson, M. Seedorf, B. Stillman, and J. Warner for antibodies. B. B. was supported by the EU-grant '3D repertoire (LSHG-CT-2005-512028) and by the Welcome Trust (WT 087658). M. D. was supported by an E-STAR project (FP6 Marie Curie Action for Early-Stage-Training, MEST-CT-2004-504640). E. H. and J. B. are recipients of grants from the Deutsche Forschungsgemeinschaft (Hu363/9-2) and Fonds der Chemischen Industrie.	Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bassler J, 2006, J BIOL CHEM, V281, P24737, DOI 10.1074/jbc.M604261200; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Chantha SC, 2007, PLANTA, V225, P1107, DOI 10.1007/s00425-006-0420-z; Craig D, 2004, STRUCTURE, V12, P2049, DOI 10.1016/j.str.2004.09.009; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Gadal O, 2002, J CELL BIOL, V157, P941, DOI 10.1083/jcb.200111039; Galani K, 2004, J BIOL CHEM, V279, P55411, DOI 10.1074/jbc.M406876200; Garbarino JE, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-18; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Kressler D, 2008, J CELL BIOL, V181, P935, DOI 10.1083/jcb.200801181; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200; Nissan TA, 2004, MOL CELL, V15, P295, DOI 10.1016/j.molcel.2004.06.033; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Pertschy B, 2007, MOL CELL BIOL, V27, P6581, DOI 10.1128/MCB.00668-07; Puig O, 1998, YEAST, V14, P1139; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Strasser K, 2000, J CELL BIOL, V150, P695, DOI 10.1083/jcb.150.4.695; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013	36	115	119	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					911	922		10.1016/j.cell.2009.06.045	http://dx.doi.org/10.1016/j.cell.2009.06.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737519	Green Submitted, Bronze			2022-12-24	WOS:000269564600017
J	Down, C; Chappell, A				Down, Chantelle; Chappell, Anna			A Patient's Journey Childhood asthma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												apldj@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2009	339								b2889	10.1136/bmj.b2889	http://dx.doi.org/10.1136/bmj.b2889			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	491CG	19723712				2022-12-24	WOS:000269553900006
J	Dominguez-Cherit, G; Lapinsky, SE; Macias, AE; Pinto, R; Espinosa-Perez, L; de la Torre, A; Poblano-Morales, M; Baltazar-Torres, JA; Bautista, E; Martinez, A; Martinez, MA; Rivero, E; Valdez, R; Ruiz-Palacios, G; Hernandez, M; Stewart, TE; Fowler, RA				Dominguez-Cherit, Guillermo; Lapinsky, Stephen E.; Macias, Alejandro E.; Pinto, Ruxandra; Espinosa-Perez, Lourdes; de la Torre, Alethse; Poblano-Morales, Manuel; Baltazar-Torres, Jose A.; Bautista, Edgar; Martinez, Abril; Martinez, Marco A.; Rivero, Eduardo; Valdez, Rafael; Ruiz-Palacios, Guillermo; Hernandez, Martin; Stewart, Thomas E.; Fowler, Robert A.			Critically Ill Patients With 2009 Influenza A(H1N1) in Mexico	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							H5N1; MORTALITY; DISEASE	Context In March 2009, novel 2009 influenza A(H1N1) was first reported in the southwestern United States and Mexico. The population and health care system in Mexico City experienced the first and greatest early burden of critical illness. Objective To describe baseline characteristics, treatment, and outcomes of consecutive critically ill patients in Mexico hospitals that treated the majority of such patients with confirmed, probable, or suspected 2009 influenza A(H1N1). Design, Setting, and Patients Observational study of 58 critically ill patients with 2009 influenza A(H1N1) at 6 hospitals between March 24 and June 1, 2009. Demographic data, symptoms, comorbid conditions, illness progression, treatments, and clinical outcomes were collected using a piloted case report form. Main Outcome Measures The primary outcome measure was mortality. Secondary outcomes included rate of 2009 influenza (A) H1N1-related critical illness and mechanical ventilation as well as intensive care unit (ICU) and hospital length of stay. Results Critical illness occurred in 58 of 899 patients (6.5%) admitted to the hospital with confirmed, probable, or suspected 2009 influenza (A) H1N1. Patients were young (median, 44.0 [range, 10-83] years); all presented with fever and all but 1 with respiratory symptoms. Few patients had comorbid respiratory disorders, but 21 (36%) were obese. Time from hospital to ICU admission was short (median, 1 day [inter-quartile range {IQR}, 0-3 days]), and all patients but 2 received mechanical ventilation for severe acute respiratory distress syndrome and refractory hypoxemia (median day 1 ratio of PaO2 to fraction of inspired oxygen, 83 [IQR, 59-145] mm Hg). By 60 days, 24 patients had died (41.4%; 95% confidence interval, 28.9%-55.0%). Patients who died had greater initial severity of illness, worse hypoxemia, higher creatine kinase levels, higher creatinine levels, and ongoing organ dysfunction. After adjusting for a reduced opportunity of patients dying early to receive neuraminidase inhibitors, neuraminidase inhibitor treatment (vs no treatment) was associated with improved survival (odds ratio, 8.5; 95% confidence interval, 1.2-62.8). Conclusion Critical illness from 2009 influenza A(H1N1) in Mexico occurred in young individuals, was associated with severe acute respiratory distress syndrome and shock, and had a high case-fatality rate. JAMA. 2009;302(17):1880-1887	[Pinto, Ruxandra; Fowler, Robert A.] Sunnybrook Hlth Sci Ctr, Toronto, ON M5N 3M5, Canada; [Dominguez-Cherit, Guillermo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Div Pulm & Crit Care, Mexico City, DF, Mexico; [Macias, Alejandro E.; de la Torre, Alethse] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Hosp Epidemiol Dept, Mexico City, DF, Mexico; [Ruiz-Palacios, Guillermo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Mexico City, DF, Mexico; [Rivero, Eduardo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Crit Care Med, Mexico City, DF, Mexico; [Lapinsky, Stephen E.; Pinto, Ruxandra] Univ Toronto, Dept Med, Toronto, ON, Canada; [Lapinsky, Stephen E.; Pinto, Ruxandra; Stewart, Thomas E.; Fowler, Robert A.] Univ Toronto, Interdepartmental Div Crit Care Med, Toronto, ON, Canada; [Espinosa-Perez, Lourdes] Inst Tecnol Estud Super Monterrey, Sch Med, Monterrey, Mexico; Univ Trondheim, Toronto, ON, Canada; [Poblano-Morales, Manuel] Hosp Juarez Mexico, Mexico City, DF, Mexico; [Baltazar-Torres, Jose A.] IMSS, Hosp Especialidades Ctr Med La Raza, Mexico City, DF, Mexico; [Bautista, Edgar] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Martinez, Abril; Martinez, Marco A.] Hosp Gen Dr Manuel Gea Gonzalez, Dept Internal Med, Mexico City, DF, Mexico; [Valdez, Rafael] Hosp Gen Dr Manuel Gea Gonzalez, Infect Dis Hosp, Mexico City, DF, Mexico; [Hernandez, Martin] Hosp San Jose Tec Monterrey, Monterrey, Mexico; [Stewart, Thomas E.] Univ Toronto, Mt Sinai Hosp, Univ Hlth Network, Dept Med & Anaesthesia, Toronto, ON M5G 1X5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; University of Toronto; University of Toronto; Tecnologico de Monterrey; Instituto Mexicano del Seguro Social; Tecnologico de Monterrey; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University Health Network Toronto	Fowler, RA (corresponding author), Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave D478, Toronto, ON M5N 3M5, Canada.	rob.fowler@sunnybrook.ca	Macías, Alejandro Molina/HHS-2363-2022; Lapinsky, Stephen/C-4624-2015; Ruiz-Palacios, Guillermo/GYQ-5462-2022	Lapinsky, Stephen/0000-0002-6930-0306; Dominguez-Cherit, Guillermo/0000-0003-1403-4415; BALTAZAR-TORRES, JOSE ANGEL/0000-0002-2360-7986; Macias, Alejandro/0000-0002-6573-4350				Abe M, 2006, CLIN NEPHROL, V66, P166; *AM THOR SOC, 2009, AM THOR SOC 2009 INT; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453; Arabi Y, 2007, CRIT CARE MED, V35, P1397, DOI 10.1097/01.CCM.0000262940.34596.4B; *CAN CRIT CAR TRIA, INFL REL RES IN; *CAN CRIT CAR TRIA, SOC CRIT CAR MED H1N; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; *CDCP, INT GUID CAS DEF BE; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Central Intelligence Agency, WORLD FACTB FIELD LI; Christian MD, 2006, CAN MED ASSOC J, V175, P1377, DOI 10.1503/cmaj.060911; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Fowler RA, 2003, JAMA-J AM MED ASSOC, V290, P367, DOI 10.1001/jama.290.3.367; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Gruber PC, 2006, INTENS CARE MED, V32, P823, DOI 10.1007/s00134-006-0148-z; Kerr JR, 2009, J CLIN PATHOL, V62, P577, DOI 10.1136/jcp.2009.067710; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Li FCK, 2008, J EPIDEMIOL COMMUN H, V62, P555, DOI 10.1136/jech.2007.064030; Martinez Guerra M L, 1973, Prensa Med Mex, V38, P1; *MEX SCR SAL, GRAF DEF DESCR PREL; *MEX SECR SAL, SIT ACT EP; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; O'Brien JM, 2006, CRIT CARE MED, V34, P738, DOI 10.1097/01.CCM.0000202207.87891.FC; Oliveira Eduardo C, 2003, J Intensive Care Med, V18, P80, DOI 10.1177/0885066602250368; Phua J, 2009, AM J RESP CRIT CARE, V179, P220, DOI 10.1164/rccm.200805-722OC; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Public Health Agency of Canada, CAS DEF NAT SURV H1N; SIMON NM, 1970, J AMER MED ASSOC, V212, P1704, DOI 10.1001/jama.212.10.1704; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; *WHO, 2009, GLOB AL RESP GAR PAN; *WHO, 2009, INFL A H1N1 UPD 32; WHO (World Health Organization), 2011, GLOB AL RESP GAR INF; World Health Organization, WHO GLOB INF BMI OV; World Health Organization. Global alert and response (GAR), GLOB AL RESP GAR PAN	35	660	707	0	56	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 4	2009	302	17					1880	1887		10.1001/jama.2009.1536	http://dx.doi.org/10.1001/jama.2009.1536			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514DU	19822626	Bronze			2022-12-24	WOS:000271375300019
J	Roy, HK; Bianchi, LK				Roy, Hemant K.; Bianchi, Laura K.			Differences in Colon Adenomas and Carcinomas Among Women and Men Potential Clinical Implications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COLORECTAL-CANCER; COLONOSCOPY; NEOPLASIA; ESTROGEN; AGE		[Roy, Hemant K.] NorthShore Univ HealthSyst, Dept Internal Med, Evanston, IL 60201 USA; Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA	NorthShore University Health System; University of Chicago	Roy, HK (corresponding author), NorthShore Univ HealthSyst, Dept Internal Med, 1001 Univ Pl, Evanston, IL 60201 USA.	hroy@northshore.org	Roy, Hemant/AAC-9096-2020		NCI NIH HHS [R21 CA140936, U01 CA111257-04, R21CA140936, U01CA111257, U01 CA111257-02, R21CA141112, U01 CA111257, R21 CA141112, R21 CA140936-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA141112, U01CA111257, R21CA140936] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Brenner H, 2007, BRIT J CANCER, V96, P828, DOI 10.1038/sj.bjc.6603628; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kennelly R, 2008, LANCET ONCOL, V9, P385, DOI 10.1016/S1470-2045(08)70100-1; Nguyen SP, 2009, CLIN GASTROENTEROL H, V7, P676, DOI 10.1016/j.cgh.2009.01.008; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Zisman AL, 2006, ARCH INTERN MED, V166, P629, DOI 10.1001/archinte.166.6.629	10	29	30	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 21	2009	302	15					1696	1697		10.1001/jama.2009.1499	http://dx.doi.org/10.1001/jama.2009.1499			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508NX	19843905	Green Accepted			2022-12-24	WOS:000270941200026
J	Williams, TN; Uyoga, S; Macharia, A; Ndila, C; McAuley, CF; Opi, DH; Mwarumba, S; Makani, J; Komba, A; Ndiritu, MN; Sharif, SK; Marsh, K; Berkley, JA; Scott, JAG				Williams, Thomas N.; Uyoga, Sophie; Macharia, Alex; Ndila, Carolyne; McAuley, Charlotte F.; Opi, Daniel H.; Mwarumba, Salim; Makani, Julie; Komba, Albert; Ndiritu, Moses N.; Sharif, Shahnaaz K.; Marsh, Kevin; Berkley, James A.; Scott, J. Anthony G.			Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study	LANCET			English	Article							INFLUENZAE TYPE-B; PNEUMOCOCCAL-POLYSACCHARIDE IMMUNIZATION; ACUTE BACTERIAL-MENINGITIS; CONJUGATE VACCINE; ANTIBIOTIC-RESISTANCE; KILIFI DISTRICT; DISEASE; INFECTION; MALARIA; AFRICA	Background in sub-Saharan Africa, more than 90% of children with sickle-cell anaemia die before the diagnosis can be made. The causes of death are poorly documented, but bacterial sepsis is probably important. We examined the risk of invasive bacterial diseases in children with sickle-cell anaemia. Methods This study was undertaken in a rural area on the coast of Kenya, with a case-control approach. We undertook blood cultures on all children younger than 14 years who were admitted from within a defined study area to Kilifi District Hospital between Aug 1, 1998, and March 31, 2008; those with bacteraemia were defined as cases. We used two sets of controls: children recruited by random sampling in the same area into several studies undertaken between Sept 1, 1998, and Nov 30, 2005; and those born consecutively within the area between May 1, 2006, and April 30, 2008. Cases and controls were tested for sickle-cell anaemia retrospectively. Findings We detected 2157 episodes of bacteraemia in 38 441 admissions (6%). 1749 of these children with bacteraemia (81%) were typed for sickle-cell anaemia, of whom 108 (6%) were positive as were 89 of 13 492 controls (1%). The organisms most commonly isolated from children with sickle-cell anaemia were Streptococcus pneumoniae (44/108 isolates; 41%), non-typhi Salmonella species (19/108; 18%), Haemophilus influenzae type b (13/108; 12%), Acinetobacter species (seven of 108; 7%), and Escherichia coli (seven of 108; 7%). The age-adjusted odds ratio for bacteraemia in children with sickle-cell anaemia was 26.3 (95% CI 14.5-47.6), with the strongest associations for S pneumoniae (33.0, 17.4-62.8), non-typhi Salmonella species (35.5, 16.4-76.8), and H influenzae type b (28.1, 12.0-65.9). Interpretation The organisms causing bacteraemia in African children with sickle-cell anaemia are the same as those in developed countries. introduction of conjugate vaccines against S pneumoniae and H influenzae into the childhood immunisation schedules of African countries could substantially affect survival of children with sickle-cell anaemia.	[Williams, Thomas N.] KEMRI Wellcome Trust Programme, Ctr Geog Med Res Coast, Kilifi, Kenya; [Williams, Thomas N.; Marsh, Kevin; Berkley, James A.; Scott, J. Anthony G.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Williams, Thomas N.; McAuley, Charlotte F.] Univ Oxford, Dept Paediat, Oxford, England; [Williams, Thomas N.; Scott, J. Anthony G.] INDEPTH Network Demog Surveillance Sites, Accra, Ghana; [Makani, Julie; Komba, Albert] Muhimbili Univ Coll Hlth Sci, Dar Es Salaam, Tanzania; [Sharif, Shahnaaz K.] Minist Hlth, Nairobi, Kenya	University of Oxford; University of Oxford; INDEPTH Network; Muhimbili University of Health & Allied Sciences	Williams, TN (corresponding author), KEMRI Wellcome Trust Programme, Ctr Geog Med Res Coast, POB 230, Kilifi, Kenya.	twilliams@kilifi.kemri-wellcome.org	Makani, Julie/E-8525-2017; Makani, Julie/N-9370-2013	Makani, Julie/0000-0002-4801-6250; Makani, Julie/0000-0002-4801-6250; Berkley, James/0000-0002-1236-849X; Uyoga, Sophie/0000-0003-1746-7873	Kenya Medical Research Institute (KEMRI); Wellcome Trust, UK [076934, 072064, 077092, 083579, 081835]; EU; Bill & Melinda Gates Foundation	Kenya Medical Research Institute (KEMRI); Wellcome Trust, UK(Wellcome Trust); EU(European Commission); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This study was supported by the Kenya Medical Research Institute (KEMRI) and the Wellcome Trust, UK. TNW is supported by the Wellcome Trust (grant number 076934), the EU Network 6 BioMalpar Consortium, and the MalariaGen Consortium funded by the Bill & Melinda Gates Foundation. JM (grant number 072064), KM (grant number 077092), JAB (grant number 083579), and JAGS (grant number 081835) are supported by the Wellcome Trust, UK. We thank the patients and staff of Kilifi District Hospital and the KEM RI/Wellcome Trust Centre for their support with this study; Emily Orori, Adan Mohammed, Metrine Tendwa, and Johnstone Makale for laboratory support; Hussein Kivugo, Emmanuel Mabibo, Gideon Nyutu, and other members of the Genetics Team for field work and data management; and David Weatherall, Bob Snow, Charles Newton, and Kathryn Maitland for helpful comments on earlier drafts. This paper is published with the permission of the Director of the Kenya Medical Research Institute (KEMRI).	Adamkiewicz TV, 2003, J PEDIATR-US, V143, P438, DOI 10.1067/S0022-3476(03)00331-7; Aken'ova Y. A., 1998, Central African Journal of Medicine, V44, P102; AKINYANJU O, 1987, ANN TROP PAEDIATR, V7, P181, DOI 10.1080/02724936.1987.11748503; Akuse RM, 1996, J TROP PEDIATRICS, V42, P318, DOI 10.1093/tropej/42.6.318; AMMANN AJ, 1977, NEW ENGL J MED, V297, P897, DOI 10.1056/NEJM197710272971701; BARRETTCONNOR E, 1971, MEDICINE, V50, P97, DOI 10.1097/00005792-197103000-00002; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2001, LANCET, V357, P1753, DOI 10.1016/S0140-6736(00)04897-2; Cowgill KD, 2006, JAMA-J AM MED ASSOC, V296, P671, DOI 10.1001/jama.296.6.671; DIGGS L. W., 1967, CLIN ORTHOP RELATED RES, V52, P119, DOI 10.1097/00003086-196700520-00011; EECKELS R, 1967, NATURE, V216, P382, DOI 10.1038/216382a0; GILL FM, 1995, BLOOD, V86, P776, DOI 10.1182/blood.V86.2.776.bloodjournal862776; Goldblatt D, 1996, ARCH DIS CHILD, V75, P159, DOI 10.1136/adc.75.2.159; HODGES FJ, 1951, YB RADIOLOGY, P89; JOHN AB, 1984, BRIT MED J, V288, P1567, DOI 10.1136/bmj.288.6430.1567; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kizito ME, 2007, ARCH DIS CHILD, V92, P21, DOI 10.1136/adc.2005.088807; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; MOLINEAUX L, 1979, ANN TROP MED PARASIT, V73, P301, DOI 10.1080/00034983.1979.11687263; Mwangi I, 2002, PEDIATR INFECT DIS J, V21, P1042, DOI 10.1097/00006454-200211000-00013; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Ndiritu M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-132; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; OKUONGHAE HO, 1993, ANN TROP PAEDIATR, V13, P55, DOI 10.1080/02724936.1993.11747625; OVERTURF GD, 1982, AM J PEDIAT HEMATOL, V4, P25; POWARS D, 1983, PEDIATRICS, V71, P927; ROBINSON MG, 1966, NEW ENGL J MED, V274, P1006, DOI 10.1056/NEJM196605052741806; RUBIN LG, 1992, AM J DIS CHILD, V146, P340, DOI 10.1001/archpedi.1992.02160150080026; Serjeant GR, 2005, BRIT MED J, V330, P432, DOI 10.1136/bmj.330.7489.432; SMITH W S, 1953, Ohio State Med J, V49, P692; VANDEPITTE J, 1953, Ann Soc Belg Med Trop (1920), V33, P511; Waterfall CM, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.23.e119; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; Wright J, 1997, J PEDIATR-US, V130, P394, DOI 10.1016/S0022-3476(97)70201-4; ZARKOWSKY HS, 1986, J PEDIATR-US, V109, P579, DOI 10.1016/S0022-3476(86)80216-5	36	161	161	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 17	2009	374	9698					1364	1370		10.1016/S0140-6736(09)61374-X	http://dx.doi.org/10.1016/S0140-6736(09)61374-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MW	19747721	Green Accepted, Green Published			2022-12-24	WOS:000271254600032
J	Tachibana, M; Sparman, M; Sritanaudomchai, H; Ma, H; Clepper, L; Woodward, J; Li, Y; Ramsey, C; Kolotushkina, O; Mitalipov, S				Tachibana, Masahito; Sparman, Michelle; Sritanaudomchai, Hathaitip; Ma, Hong; Clepper, Lisa; Woodward, Joy; Li, Ying; Ramsey, Cathy; Kolotushkina, Olena; Mitalipov, Shoukhrat			Mitochondrial gene replacement in primate offspring and embryonic stem cells	NATURE			English	Article							NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; DNA MUTATIONS; OOPLASMIC TRANSPLANTATION; GENOTYPE SEGREGATION; NUCLEAR TRANSFER; HUMAN OOCYTES; DONOR OOCYTE; DYSFUNCTION; MTDNA	Mitochondria are found in all eukaryotic cells and contain their own genome (mitochondrial DNA or mtDNA). Unlike the nuclear genome, which is derived from both the egg and sperm at fertilization, the mtDNA in the embryo is derived almost exclusively from the egg; that is, it is of maternal origin. Mutations in mtDNA contribute to a diverse range of currently incurable human diseases and disorders. To establish preclinical models for new therapeutic approaches, we demonstrate here that the mitochondrial genome can be efficiently replaced in mature non-human primate oocytes (Macaca mulatta) by spindle-chromosomal complex transfer from one egg to an enucleated, mitochondrial-replete egg. The reconstructed oocytes with the mitochondrial replacement were capable of supporting normal fertilization, embryo development and produced healthy offspring. Genetic analysis confirmed that nuclear DNA in the three infants born so far originated from the spindle donors whereas mtDNA came from the cytoplast donors. No contribution of spindle donor mtDNA was detected in offspring. Spindle replacement is shown here as an efficient protocol replacing the full complement of mitochondria in newly generated embryonic stem cell lines. This approach may offer a reproductive option to prevent mtDNA disease transmission in affected families.	[Tachibana, Masahito; Sparman, Michelle; Sritanaudomchai, Hathaitip; Ma, Hong; Clepper, Lisa; Woodward, Joy; Li, Ying; Ramsey, Cathy; Kolotushkina, Olena; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Beaverton, OR 97006 USA; [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Beaverton, OR 97006 USA; [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Beaverton, OR 97006 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA.	mitalipo@ohsu.edu			Oregon National Primate Research Center; Oregon Stem Cell Center; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057121] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD047675] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR013632, P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044330] Funding Source: NIH RePORTER	Oregon National Primate Research Center; Oregon Stem Cell Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge the Division of Animal Resources, Surgical Team, Endocrine Technology Core, Imaging & Morphology Core and Molecular & Cellular Biology Core at the Oregon National Primate Research Center for providing expertise and services that contributed to this project. We are grateful to W. Sanger and M. Nelson for karyotyping services, C. Penedo for microsatellite analysis and S. Wong for providing Sendai virus. We thank J. Hennebold, R. Stouffer and D. Wolf for consulting, helpful discussions and critical reading of the manuscript. This study was supported by start-up funds from Oregon National Primate Research Center, Oregon Stem Cell Center and grants from the National Institutes of Health.	Barritt JA, 2001, HUM REPROD, V16, P513, DOI 10.1093/humrep/16.3.513; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Brenner CA, 2000, FERTIL STERIL, V74, P573, DOI 10.1016/S0015-0282(00)00681-6; Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7; Cohen J, 1998, MOL HUM REPROD, V4, P269, DOI 10.1093/molehr/4.3.269; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Keating DJ, 2008, J NEUROCHEM, V104, P298, DOI 10.1111/j.1471-4159.2007.04997.x; Lanzendorf SE, 1999, FERTIL STERIL, V71, P575, DOI 10.1016/S0015-0282(98)00504-4; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959; Meirelles FV, 1998, GENETICS, V148, P877; Meirelles FV, 1997, GENETICS, V145, P445; Mitalipov SM, 2007, HUM REPROD, V22, P2232, DOI 10.1093/humrep/dem136; Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6; Poulton J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b94; Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016; Roberts RM, 1999, AM J MED GENET, V87, P265, DOI 10.1002/(SICI)1096-8628(19991126)87:3<265::AID-AJMG14>3.0.CO;2-S; Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Solano A, 2001, SALUD PUBLICA MEXICO, V43, P151, DOI 10.1590/S0036-36342001000200010; Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Takeuchi T, 2005, BIOL REPROD, V72, P584, DOI 10.1095/biolreprod.104.032391; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Tsuboniwa N, 2001, HUM GENE THER, V12, P469, DOI 10.1089/104303401300042366; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wilding M, 2001, HUM REPROD, V16, P909, DOI 10.1093/humrep/16.5.909; Wolf DP, 2004, BIOL REPROD, V71, P486, DOI 10.1095/biolreprod.103.025932; ZEVIANI M, 1988, NEUROLOGY, V38, P1339	35	379	399	0	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					367	372		10.1038/nature08368	http://dx.doi.org/10.1038/nature08368			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19710649	Green Accepted			2022-12-24	WOS:000269828100033
J	Connor, A; Tomson, C				Connor, Andrew; Tomson, Charlie			Uncertainties Page Should statins be prescribed for primary prevention of cardiovascular disease in patients with chronic kidney disease?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OUTCOMES; EVENTS; METAANALYSIS; TRIALS		[Connor, Andrew] Dorset Cty Hosp, Dept Renal Med, Dorchester DT1 2JY, England; [Tomson, Charlie] Southmead Hosp, Richard Bright Renal Unit, Bristol BS10 5NB, Avon, England	Southmead Hospital	Connor, A (corresponding author), 3 Hope Terrace, Martinstown DT2 9JN, North Ireland.	andrewconnor1974@hotmail.co.uk		Tomson, Charles/0000-0002-0224-8726				Baigent C, 2000, LANCET, V356, P147, DOI 10.1016/S0140-6736(00)02456-9; Baigent C, 2003, KIDNEY INT, V63, pS207, DOI 10.1046/j.1523-1755.63.s84.4.x; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Coca SG, 2006, JAMA-J AM MED ASSOC, V296, P1377, DOI 10.1001/jama.296.11.1377; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Fellstrom B, 2007, KIDNEY BLOOD PRESS R, V30, P314, DOI 10.1159/000106803; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Keough-Ryan TM, 2005, AM J KIDNEY DIS, V46, P845, DOI 10.1053/j.ajkd.2005.07.043; *NAT I HLTH CLIN E, 2008, CLIN GUID NAT I HLTH, V73; Navaneethan SD, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007784; *REN ASS, GUID COMPL CKD; Strippoli GFM, 2008, BMJ-BRIT MED J, V336, P645, DOI 10.1136/bmj.39472.580984.AE; Tonelli M, 2004, CIRCULATION, V110, P1557, DOI 10.1161/01.CIR.0000143892.84582.60; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545	16	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 20	2009	339								b2949	10.1136/bmj.b2949	http://dx.doi.org/10.1136/bmj.b2949			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486SC	19696089				2022-12-24	WOS:000269217000005
J	Fonarow, GC; Peterson, ED				Fonarow, Gregg C.; Peterson, Eric D.			Heart Failure Performance Measures and Outcomes Real or Illusory Gains	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY-OF-CARE; US HOSPITALS; MORTALITY		[Fonarow, Gregg C.] Ronald Reagan UCLA Med Ctr, Los Angeles, CA USA; [Peterson, Eric D.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Peterson, Eric D.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Ronald Reagan UCLA Medical Center; Duke University; Duke University	Fonarow, GC (corresponding author), Ahmanson UCLA Cardiomyopathy Ctr, 10833 LeConte Ave,Room 47-123 CHS, Los Angeles, CA 90095 USA.	gfonarow@mednet.ucla.edu	Fonarow, Gregg C/D-5988-2014; Peterson, Eric David/ABF-5033-2021	Fonarow, Gregg C/0000-0002-3192-8093; 				Curtis LH, 2008, ARCH INTERN MED, V168, P2481, DOI 10.1001/archinte.168.22.2481; Fonarow GC, 2005, ARCH INTERN MED, V165, P1469, DOI 10.1001/archinte.165.13.1469; Fonarow GC, 2007, JAMA-J AM MED ASSOC, V297, P61, DOI 10.1001/jama.297.1.61; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; *JOINT COMM ACCR H, COMPR REV DEV TEST N; *JOINT COMM ACCR H, JOINT COMM ANN REP Q; Krumholz HM, 2008, CIRCULATION, V118, P1394, DOI 10.1161/CIRCULATIONAHA.108.804880; *US DEP HHS, FIND COMP HOSP; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778	10	75	76	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	2009	302	7					792	794		10.1001/jama.2009.1180	http://dx.doi.org/10.1001/jama.2009.1180			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484UT	19690314				2022-12-24	WOS:000269073800030
J	Sudore, RL				Sudore, Rebecca L.			Can We Agree to Disagree?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rsucsf@yahoo.com	Sudore, Rebecca/AAF-1635-2021						0	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 21	2009	302	15					1629	1630		10.1001/jama.2009.1422	http://dx.doi.org/10.1001/jama.2009.1422			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508NX	19843890				2022-12-24	WOS:000270941200001
J	Benton, R				Benton, Richard			EPPENDORF WINNER Evolution and Revolution in Odor Detection	SCIENCE			English	Editorial Material							MEMBRANE TOPOLOGY; DROSOPHILA; RECEPTORS; SENSITIVITY; CHANNELS; SMELL		Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	University of Lausanne	Benton, R (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	richard.benton@unil.ch						Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2006, CELL MOL LIFE SCI, V63, P1579, DOI 10.1007/s00018-006-6130-7; Benton R, 2007, TRENDS NEUROSCI, V30, P512, DOI 10.1016/j.tins.2007.07.004; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906	13	9	10	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 16	2009	326	5951					382	383		10.1126/science.1181998	http://dx.doi.org/10.1126/science.1181998			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833953				2022-12-24	WOS:000270818600038
J	Junge, HJ; Yang, S; Burton, JB; Paes, K; Shu, X; French, DM; Costa, M; Rice, DS; Ye, WL				Junge, Harald J.; Yang, Stacey; Burton, Jeremy B.; Paes, Kim; Shu, Xiao; French, Dorothy M.; Costa, Mike; Rice, Dennis S.; Ye, Weilan			TSPAN12 Regulates Retinal Vascular Development by Promoting Norrin- but Not Wnt-Induced FZD4/beta-Catenin Signaling	CELL			English	Article							FAMILIAL EXUDATIVE VITREORETINOPATHY; CATENIN PATHWAY; DISEASE GENE; ANGIOGENESIS; MUTATIONS; EXPRESSION; RECEPTORS; EVOLUTION; OLIGOMERS; ACTIVATE	Mutations in the genes encoding the Wnt receptor Frizzled-4 (FZD4), coreceptor LRP5, or the ligand Norrin disrupt retinal vascular development and cause ophthalmic diseases. Although Norrin is structurally unrelated to Wnts, it binds FZD4 and activates the canonical Wnt pathway. Here we show that the tetraspanin Tspan12 is expressed in the retinal vasculature, and loss of Tspan12 phenocopies defects seen in Fzd4, Lrp5, and Norrin mutant mice. In addition, Tspan12 genetically interacts with Norrin or Lrp5. Overexpressed TSPAN12 associates with the Norrin-receptor complex and significantly increases Norrin/beta-catenin but not Wnt/beta-catenin signaling, whereas Tspan12 siRNA abolishes transcriptional responses to Norrin but not Wnt3A in retinal endothelial cells. Signaling defects caused by Norrin or FZD4 mutations that are predicted to impair receptor multimerization are rescued by overexpression of TSPAN12. Our data indicate that Norrin multimers and TSPAN12 cooperatively promote multimerization of FZD4 and its associated proteins to elicit physiological levels of signaling.	[Junge, Harald J.; Yang, Stacey; Burton, Jeremy B.; Shu, Xiao; Ye, Weilan] Genentech Inc, Tumor Biol & Angiogenesis Dept, San Francisco, CA 94080 USA; [French, Dorothy M.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Costa, Mike] Genentech Inc, Dept Canc Targets, San Francisco, CA 94080 USA; [Paes, Kim; Rice, Dennis S.] Lexicon Pharmaceut Inc, Dept Ophthalmol, The Woodlands, TX 77381 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Lexicon Pharmaceuticals	Ye, WL (corresponding author), Genentech Inc, Tumor Biol & Angiogenesis Dept, 1 DNA Way, San Francisco, CA 94080 USA.	loni@gene.com		JUNGE, HARALD/0000-0003-2458-6010; Ye, Weilan/0000-0002-6219-3982				BERGER W, 2001, METABOLIC MOL BASES, P5977; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Figueroa DJ, 2000, J HISTOCHEM CYTOCHEM, V48, P1357, DOI 10.1177/002215540004801006; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Hartzer MK, 1999, BRAIN RES BULL, V49, P355, DOI 10.1016/S0361-9230(99)00071-4; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; ISASHIKI Y, 1995, BRIT J OPHTHALMOL, V79, P703, DOI 10.1136/bjo.79.7.703; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Luhmann UFO, 2005, INVEST OPHTH VIS SCI, V46, P3372, DOI 10.1167/iovs.05-0174; Perez-Vilar J, 1997, J BIOL CHEM, V272, P33410, DOI 10.1074/jbc.272.52.33410; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Rehm HL, 2002, J NEUROSCI, V22, P4286, DOI 10.1523/JNEUROSCI.22-11-04286.2002; Serru V, 2000, BBA-PROTEIN STRUCT M, V1478, P159, DOI 10.1016/S0167-4838(00)00022-4; Smallwood PM, 2007, J BIOL CHEM, V282, P4057, DOI 10.1074/jbc.M609618200; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Toomes C, 2005, BRIT J OPHTHALMOL, V89, P194, DOI 10.1136/bjo.2004.042507; Toomes C, 2004, INVEST OPHTH VIS SCI, V45, P2083, DOI 10.1167/iovs.03-1044; van Amerongen R, 2006, TRENDS GENET, V22, P678, DOI 10.1016/j.tig.2006.10.001; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Wang YS, 2001, J NEUROSCI, V21, P4761, DOI 10.1523/JNEUROSCI.21-13-04761.2001; Warden Scott M, 2007, Semin Ophthalmol, V22, P211, DOI 10.1080/08820530701745124; Xia CH, 2008, HUM MOL GENET, V17, P1605, DOI 10.1093/hmg/ddn047; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8	33	248	269	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					299	311		10.1016/j.cell.2009.07.048	http://dx.doi.org/10.1016/j.cell.2009.07.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837033	Bronze			2022-12-24	WOS:000270857500014
J	Korkut, C; Ataman, B; Ramachandran, P; Ashley, J; Barria, R; Gherbesi, N; Budnik, V				Korkut, Ceren; Ataman, Bulent; Ramachandran, Preethi; Ashley, James; Barria, Romina; Gherbesi, Norberto; Budnik, Vivian			Trans-Synaptic Transmission of Vesicular Wnt Signals through Evi/Wntless	CELL			English	Article							SYNAPSE DEVELOPMENT; WINGLESS; REQUIRES; SECRETION; EXOSOMES; GENE; TRAFFICKING; MORPHOGENS; PATHWAYS; PROTEINS	Wnts play pivotal roles during development and in the mature nervous system. However, the mechanism by which Wnts traffic between cells has remained elusive. Here we demonstrate a mechanism of Wnt transmission through release of exosome-like vesicles containing the Wnt-binding protein Evenness Interrupted/Wntless/Sprinter (Evi/Wls/Srt). We show that at the Drosophila larval neuromuscular junction (NMJ), presynaptic vesicular release of Evi is required for the secretion of the Wnt, Wingless (Wg). We also show that Evi acts cell-autonomously in the postsynaptic Wnt-receiving cell to target dGRIP, a Wg-receptor-interacting protein, to postsynaptic sites. Upon Evi loss of function, dGRIP is not properly targeted to synaptic sites, interfering with postsynaptic Wnt signal transduction. These findings uncover a previously unknown cellular mechanism by which a secreted Wnt is transported across synapses by Evi-containing vesicles and reveal trafficking functions of Evi in both the Wnt-producing and the Wnt-receiving cells.	[Korkut, Ceren; Ataman, Bulent; Ramachandran, Preethi; Ashley, James; Barria, Romina; Gherbesi, Norberto; Budnik, Vivian] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Budnik, V (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01655 USA.	vivian.budnik@umassmed.edu		Tezer, Ceren/0000-0001-9276-3264; Ashley, James/0000-0002-6693-1014	NIH [RO1 MH070000]; Diabetes Endocrinology Research Center [DK32520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070000] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrinology Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Drs. Marc Freeman, Michael Francis, and Motojiro Yoshihara as well as members of the Budnik lab for helpful comments and critical discussion on the manuscript. We especially thank John Nunnari for great help with immunoelectron microscopy, Yuly Fuentes for providing the images with UAS-LacZ-NLS, and Dr. Sean Speese for help with the qPCR. We also thank Dr. Michael Boutros for providing the evi<SUP>2</SUP> and Evi-EGFP fly lines as well as the Evi-EGFP and Wg plasmids for studies in S2 cells. This work was supported by NIH grant RO1 MH070000 to V. B. Core resources supported by the Diabetes Endocrinology Research Center grant DK32520 were also used. This paper is dedicated to Susan Cumberledge (3/5/1956-7/28/2008).	Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Baeg GH, 2001, DEVELOPMENT, V128, P87; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Franco B, 2004, J NEUROSCI, V24, P6573, DOI 10.1523/JNEUROSCI.1580-04.2004; Gagliardi M, 2008, TRAFFIC, V9, P1, DOI 10.1111/j.1600-0854.2007.00662.x; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Lu B, 1997, REV NEUROSCIENCE, V8, P1; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; Marques G, 2005, J NEUROBIOL, V64, P417, DOI 10.1002/neu.20165; Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051; Mendoza-Topaz C, 2008, J NEUROSCI, V28, P304, DOI 10.1523/JNEUROSCI.4395-07.2008; Miech C, 2008, J NEUROSCI, V28, P10875, DOI 10.1523/JNEUROSCI.0164-08.2008; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pan CL, 2008, DEV CELL, V14, P132, DOI 10.1016/j.devcel.2007.12.001; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Sanyal S, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-20; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; SIEGFRIED E, 1994, BIOESSAYS, V16, P395, DOI 10.1002/bies.950160607; Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.003; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200; Zhao CJ, 2005, DEVELOPMENT, V132, P2917, DOI 10.1242/dev.01871	41	309	317	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					393	404		10.1016/j.cell.2009.07.051	http://dx.doi.org/10.1016/j.cell.2009.07.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837038	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000270857500021
J	Zuend, SJ; Coughlin, MP; Lalonde, MP; Jacobsen, EN				Zuend, Stephan J.; Coughlin, Matthew P.; Lalonde, Mathieu P.; Jacobsen, Eric N.			Scaleable catalytic asymmetric Strecker syntheses of unnatural alpha-amino acids	NATURE			English	Article							HEPATITIS-C-VIRUS; IMINES; ADDITIONS; CYANIDE; AGENTS	alpha-Amino acids are the building blocks of proteins and are widely used as components of medicinally active molecules and chiral catalysts(1-5). Efficient chemo-enzymatic methods for the synthesis of enantioenriched alpha-amino acids have been developed, but it is still a challenge to obtain non-naturalamino acids(6,7). Alkene hydrogenation is broadly useful for the enantioselective catalytic synthesis of many classes of amino acids(8,9), but it is not possible to obtain zeta-amino acids bearing aryl or quaternary alkyl alpha-substituents using this method. The Strecker synthesis-the reaction of an imine or imine equivalent with hydrogen cyanide, followed by nitrile hydrolysis-is an especially versatile chemical method for the synthesis of racemic alpha-amino acids(10,11). Asymmetric Strecker syntheses using stoichiometric amounts of a chiral reagent have been applied successfully on gram-to-kilogram scales, yielding enantiomerically enriched alpha-amino acids(12-14). In principle, Strecker syntheses employing sub-stoichiometric quantities of a chiral reagent could provide a practical alternative to these approaches, but the reported catalytic asymmetric methods have seen limited use on preparative scales (more than a gram)(15,16). The limited utility of existing catalytic methods may be due to several important factors, including the relatively complex and precious nature of the catalysts and the requisite use of hazardous cyanide sources. Here we report a new catalytic asymmetric method for the syntheses of highly enantiomerically enriched non-natural amino acids using a simple chiral amido-thiourea catalyst to control the key hydrocyanation step. This catalyst is robust, without sensitive functional groups, so it is compatible with aqueous cyanide salts, which are safer and easier to handle than other cyanide sources; this makes the method adaptable to large-scale synthesis. We have used this new method to obtain enantiopure amino acids that are not readily prepared by enzymatic methods or by chemical hydrogenation.	[Zuend, Stephan J.; Coughlin, Matthew P.; Lalonde, Mathieu P.; Jacobsen, Eric N.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University	Jacobsen, EN (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	jacobsen@chemistry.harvard.edu			NIH; American Chemical Society and Roche; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM069721, R37GM043214] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Chemical Society and Roche; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH, and through fellowships from the American Chemical Society and Roche (to S. J. Z.) and the Natural Sciences and Engineering Research Council of Canada (to M. P. L.).	Anderson JC, 2004, TETRAHEDRON, V60, P2327, DOI 10.1016/j.tet.2004.01.021; Arasappan A, 2007, TETRAHEDRON LETT, V48, P6343, DOI 10.1016/j.tetlet.2007.07.002; Belanger E, 2009, ORG LETT, V11, P2201, DOI 10.1021/ol9005618; Bhat S. V., 2005, CHEM NATURAL PRODUCT, P317; BLOCK RJ, 1946, CHEM REV, V38, P501, DOI 10.1021/cr60121a004; Bommarius AS, 2001, CHIMIA, V55, P50; Breuer M, 2004, ANGEW CHEM INT EDIT, V43, P788, DOI 10.1002/anie.200300599; Corey EJ, 1999, ORG LETT, V1, P157, DOI 10.1021/ol990623l; Davie EAC, 2007, CHEM REV, V107, P5759, DOI 10.1021/cr068377w; Doyle AG, 2007, CHEM REV, V107, P5713, DOI 10.1021/cr068373r; Frisch M., 2016, GAUSSIAN 16 REVISION; Groger H, 2003, CHEM REV, V103, P2795, DOI 10.1021/cr020038p; HARADA K, 1963, NATURE, V200, P1201, DOI 10.1038/2001201a0; Helmchen G, 2000, ACCOUNTS CHEM RES, V33, P336, DOI 10.1021/ar9900865; KNOWLES WS, 1983, ACCOUNTS CHEM RES, V16, P106, DOI 10.1021/ar00087a006; Krueger CA, 1999, J AM CHEM SOC, V121, P4284, DOI 10.1021/ja9840605; Kuethe JT, 2007, J ORG CHEM, V72, P7469, DOI 10.1021/jo7012862; MAI K, 1986, J ORG CHEM, V51, P3545, DOI 10.1021/jo00368a030; Merino P, 2009, TETRAHEDRON, V65, P1219, DOI 10.1016/j.tet.2008.11.020; MILLER SL, 1955, J AM CHEM SOC, V77, P2351, DOI 10.1021/ja01614a001; Mita T, 2009, SYNLETT, P1680, DOI 10.1055/s-0029-1217344; Najera C, 2007, CHEM REV, V107, P4584, DOI 10.1021/cr050580o; Ooi T, 2006, J AM CHEM SOC, V128, P2548, DOI 10.1021/ja058066n; Reisman SE, 2008, J AM CHEM SOC, V130, P7198, DOI 10.1021/ja801514m; Shu LH, 2008, ORG PROCESS RES DEV, V12, P298, DOI 10.1021/op700286u; Sigman MS, 2000, ANGEW CHEM INT EDIT, V39, P1279, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1279::AID-ANIE1279>3.0.CO;2-U; Tsantrizos YS, 2008, ACCOUNTS CHEM RES, V41, P1252, DOI 10.1021/ar8000519; Wang L, 2005, ANGEW CHEM INT EDIT, V44, P34, DOI 10.1002/anie.200460627; Wenzel AG, 2003, SYNLETT, P1919; Zuend SJ, 2009, J AM CHEM SOC, V131, P15358, DOI 10.1021/ja9058958	30	258	263	4	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					968	U223		10.1038/nature08484	http://dx.doi.org/10.1038/nature08484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	506ZF	19829379	Green Accepted			2022-12-24	WOS:000270817700044
J	Chain, PSG; Grafham, DV; Fulton, RS; FitzGerald, MG; Hostetler, J; Muzny, D; Ali, J; Birren, B; Bruce, DC; Buhay, C; Cole, JR; Ding, Y; Dugan, S; Field, D; Garrity, GM; Gibbs, R; Graves, T; Han, CS; Harrison, SH; Highlander, S; Hugenholtz, P; Khouri, HM; Kodira, CD; Kolker, E; Kyrpides, NC; Lang, D; Lapidus, A; Malfatti, SA; Markowitz, V; Metha, T; Nelson, KE; Parkhill, J; Pitluck, S; Qin, X; Read, TD; Schmutz, J; Sozhamannan, S; Sterk, P; Strausberg, RL; Sutton, G; Thomson, NR; Tiedje, JM; Weinstock, G; Wollam, A; Detter, JC				Chain, P. S. G.; Grafham, D. V.; Fulton, R. S.; FitzGerald, M. G.; Hostetler, J.; Muzny, D.; Ali, J.; Birren, B.; Bruce, D. C.; Buhay, C.; Cole, J. R.; Ding, Y.; Dugan, S.; Field, D.; Garrity, G. M.; Gibbs, R.; Graves, T.; Han, C. S.; Harrison, S. H.; Highlander, S.; Hugenholtz, P.; Khouri, H. M.; Kodira, C. D.; Kolker, E.; Kyrpides, N. C.; Lang, D.; Lapidus, A.; Malfatti, S. A.; Markowitz, V.; Metha, T.; Nelson, K. E.; Parkhill, J.; Pitluck, S.; Qin, X.; Read, T. D.; Schmutz, J.; Sozhamannan, S.; Sterk, P.; Strausberg, R. L.; Sutton, G.; Thomson, N. R.; Tiedje, J. M.; Weinstock, G.; Wollam, A.; Detter, J. C.		Genomic Stand Consortium; Human Microbiome Project Jumpstart	Genome Project Standards in a New Era of Sequencing	SCIENCE			English	Editorial Material									[Chain, P. S. G.] Lawrence Livermore Natl Lab, Livermore, CA USA; [Chain, P. S. G.; Cole, J. R.; Garrity, G. M.; Harrison, S. H.; Tiedje, J. M.] Michigan State Univ, E Lansing, MI 48824 USA; [Fulton, R. S.; Graves, T.; Weinstock, G.; Wollam, A.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Muzny, D.; Buhay, C.; Ding, Y.; Dugan, S.; Gibbs, R.; Highlander, S.; Qin, X.] Baylor Coll Med, Houston, TX 77030 USA; [Bruce, D. C.; Detter, J. C.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Kolker, E.] Seattle Childrens Hosp & Res Inst, Seattle, WA USA; [Kolker, E.] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Markowitz, V.] Lawrence Berkeley Natl Lab, Berkeley, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Michigan State University; Washington University (WUSTL); Baylor College of Medicine; United States Department of Energy (DOE); Los Alamos National Laboratory; Seattle Children's Hospital; University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory		pchain@lanl.gov; dg1@sanger.ac.uk	Parkhill, Julian/G-4703-2011; Chain, Patrick/O-4140-2019; Read, Timothy/E-6240-2011; Schmutz, Jeremy/N-3173-2013; chain, patrick/B-9777-2013; Kyrpides, Nikos C./A-6305-2014; Lapidus, Alla L/I-4348-2013; Garrity, George M/I-8452-2019; Garrity, George/F-7551-2013; Sozhamannan, Shanmuga/AAN-7809-2020; Sozhamannan, Shanmuga/AGF-2410-2022; Hugenholtz, Philip/AAD-9138-2019; Kolker, Eugene/C-6711-2008; Weinstock, George M/C-6314-2013; Field, Dawn/C-1653-2010; Thomson, Nicholas/P-5988-2014	Parkhill, Julian/0000-0002-7069-5958; Chain, Patrick/0000-0003-3949-3634; Schmutz, Jeremy/0000-0001-8062-9172; Kyrpides, Nikos C./0000-0002-6131-0462; Lapidus, Alla L/0000-0003-0427-8731; Garrity, George M/0000-0002-4465-7034; Garrity, George/0000-0002-4465-7034; Sozhamannan, Shanmuga/0000-0002-6762-7874; Hugenholtz, Philip/0000-0001-5386-7925; Weinstock, George M/0000-0002-2997-4592; Read, Timothy/0000-0001-8966-9680; Thomson, Nicholas/0000-0002-4432-8505; Sterk, Peter/0000-0003-1668-7778; Han, Cliff/0000-0003-1972-0692; Malfatti, Stephanie/0000-0003-4225-9857	NERC [NE/D01252X/1] Funding Source: UKRI; Natural Environment Research Council [NE/D01252X/1] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968, U54HG004973] Funding Source: NIH RePORTER; NHGRI NIH HHS [U54 HG004968, U54 HG004973] Funding Source: Medline	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Blakesley RW, 2004, GENOME RES, V14, P2235, DOI 10.1101/gr.2648404; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; *INT STAND SEQ FID, 2 INT STRAT M HUM GE; Liolios K, 2008, NUCLEIC ACIDS RES, V36, pD475, DOI 10.1093/nar/gkm884	5	282	285	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					236	237		10.1126/science.1180614	http://dx.doi.org/10.1126/science.1180614			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	504EX	19815760	Green Submitted, Green Accepted			2022-12-24	WOS:000270599500024
J	Artal-Sanz, M; Tavernarakis, N				Artal-Sanz, Marta; Tavernarakis, Nektarios			Prohibitin couples diapause signalling to mitochondrial metabolism during ageing in C-elegans	NATURE			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; TRANSCRIPTION FACTOR; REGULATES LONGEVITY; OXIDATIVE STRESS; PROTEINS; KINASE; GENE; SENESCENCE; NUTRITION	Marked alterations in cellular energy metabolism are a universal hallmark of the ageing process(1). The biogenesis and function of mitochondria, the energy-generating organelles in eukaryotic cells, are primary longevity determinants. Genetic or pharmacological manipulations of mitochondrial activity profoundly affect the life-span of diverse organisms(2). However, the molecular mechanisms regulating mitochondrial biogenesis and energy metabolism during ageing are poorly understood. Prohibitins are ubiquitous, evolutionarily conserved proteins, which form a ring-like, high-molecular-mass complex at the inner membrane of mitochondria(3). Here, we show that the mitochondrial prohibitin complex promotes longevity by modulating mitochondrial function and fat metabolism in the nematode Caenorhabditis elegans. We found that prohibitin deficiency shortens the lifespan of otherwise wild-type animals. Notably, knockdown of prohibitin promotes longevity in diapause mutants or under conditions of dietary restriction. In addition, prohibitin deficiency extends the lifespan of animals with compromised mitochondrial function or fat metabolism. Depletion of prohibitin influences ATP levels, animal fat content and mitochondrial proliferation in a genetic-background- and age-specific manner. Together, these findings reveal a novel mechanism regulating mitochondrial biogenesis and function, with opposing effects on energy metabolism, fat utilization and ageing in C. elegans. Prohibitin may have a similar key role in modulating energy metabolism during ageing in mammals.	[Artal-Sanz, Marta; Tavernarakis, Nektarios] Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece		Tavernarakis, N (corresponding author), Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece.	martal@ibv.csic.es; tavernarakis@imbb.forth.gr	Artal-Sanz, Marta/J-6186-2012; Tavernarakis, Nektarios/B-9684-2013	Artal-Sanz, Marta/0000-0003-1126-0492; Tavernarakis, Nektarios/0000-0002-5253-1466	EMBO; European Research Council ( ERC); Marie Curie Fellowships; European Commission [LSHM-CT-2005-19063]	EMBO(European Molecular Biology Organization (EMBO)); European Research Council ( ERC)(European Research Council (ERC)European Commission); Marie Curie Fellowships(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank A. Pasparaki for technical support with experiments. Some nematode strains used in this work were provided by the C. elegans Gene Knockout Project at OMRF (http://www.mutantfactory.ouhsc.edu/), which is part of the International C. elegans Gene Knockout Consortium, the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources ( NCRR), and S. Mitani ( National Bioresource Project) in Japan. We thank A. Fire for plasmid vectors and J. Berden for antibodies. This work was funded by grants from EMBO, the European Research Council ( ERC), the Marie Curie Fellowships Programme and the European Commission Coordination Action ENINET ( contract number LSHM-CT-2005-19063).	Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Back JW, 2002, PROTEIN SCI, V11, P2471, DOI 10.1110/ps.0212602; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; Coates PJ, 2001, EXP CELL RES, V265, P262, DOI 10.1006/excr.2001.5166; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; FRANCIS R, 1995, GENETICS, V139, P579; Gaskova D, 2007, BIOCHEM BIOPH RES CO, V354, P814, DOI 10.1016/j.bbrc.2007.01.073; Gershman B, 2007, PHYSIOL GENOMICS, V29, P24, DOI 10.1152/physiolgenomics.00061.2006; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kampkotter A, 2007, ARCH TOXICOL, V81, P849, DOI 10.1007/s00204-007-0215-4; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Mishra S, 2005, TRENDS MOL MED, V11, P192, DOI 10.1016/j.molmed.2005.02.004; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Rea S, 2003, DEV CELL, V5, P197, DOI 10.1016/S1534-5807(03)00242-9; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Roberts SB, 2006, PHYSIOL REV, V86, P651, DOI 10.1152/physrev.00019.2005; Sanz MA, 2003, J BIOL CHEM, V278, P32091, DOI 10.1074/jbc.M304877200; Schleicher M, 2008, J CELL BIOL, V180, P101, DOI 10.1083/jcb.200706072; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Shaw WM, 2007, CURR BIOL, V17, P1635, DOI 10.1016/j.cub.2007.08.058; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053	34	141	149	3	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					793	U47		10.1038/nature08466	http://dx.doi.org/10.1038/nature08466			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19812672				2022-12-24	WOS:000270547500036
J	Kim, JJ; Goldie, SJ				Kim, Jane J.; Goldie, Sue J.			Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CANCER-SOCIETY GUIDELINE; CERVICAL-CANCER; ECONOMIC-IMPACT; HPV VACCINE; PARTICLE VACCINE; HEALTH-CARE; INFECTION; WOMEN; PREVALENCE; EFFICACY	Objective To assess the cost effectiveness of including preadolescent boys in a routine human papillomavirus (HPV) vaccination programme for preadolescent girls. Design Cost effectiveness analysis from the societal perspective Setting United States. Population Girls and boys aged 12 years. Interventions HPV vaccination of girls alone and of girls and boys in the context of screening for cervical cancer. Main outcome measure Incremental cost effectiveness ratios, expressed as cost per quality adjusted life year (QALY) gained. Results With 75% vaccination coverage and an assumption of complete, lifelong vaccine efficacy, routine HPV vaccination of 12 year old girls was consistently less than $ 50 000 per QALY gained compared with screening alone. Including preadolescent boys in a routine vaccination programme for preadolescent girls resulted in higher costs and benefits and generally had cost effectiveness ratios that exceeded $ 100 000 per QALY across a range of HPV related outcomes, scenarios for cervical cancer screening, and assumptions of vaccine efficacy and duration. Vaccinating both girls and boys fell below a willingness to pay threshold of $ 100 000 per QALY only under scenarios of high, lifelong vaccine efficacy against all HPV related diseases (including other non-cervical cancers and genital warts), or scenarios of lower efficacy with lower coverage or lower vaccine costs. Conclusions Given currently available information, including boys in an HPV vaccination programme generally exceeds conventional thresholds of good value for money, even under favourable conditions of vaccine protection and health benefits. Uncertainty still exists in many areas that can either strengthen or attenuate our findings. As new information emerges, assumptions and analyses will need to be iteratively revised to continue to inform policies for HPV vaccination.	[Kim, Jane J.; Goldie, Sue J.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Kim, JJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, 718 Huntington Ave, Boston, MA 02115 USA.	jkim@hsph.harvard.edu			National Cancer Institute [R01 CA93435]; Centers for Disease Control and Prevention; American Cancer Society; Bill and Melinda Gates Foundation [30505]; NATIONAL CANCER INSTITUTE [R01CA093435] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); American Cancer Society(American Cancer Society); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are supported by grants from the National Cancer Institute (R01 CA93435), the Centers for Disease Control and Prevention, and the American Cancer Society, and by the Bill and Melinda Gates Foundation (30505) for related work in developing countries. The authors' work was independent of the funders, and the funding sources had no involvement in the study design; collection, analysis, or interpretation of data; writing of the report; or the decision to submit the paper for publication.	American College of Obstetricians and Gynecologists, 2003, Int J Gynaecol Obstet, V83, P237; [Anonymous], [No title captured]; Barnaby N, 2007, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2007/07/017; Barnett D, 2009, HEALTH AFFAIR, V28, P600, DOI 10.1377/hlthaff.28.2.600; Bishai D, 2000, ARCH OTOLARYNGOL, V126, P935, DOI 10.1001/archotol.126.8.935; Boot HJ, 2007, VACCINE, V25, P6245, DOI 10.1016/j.vaccine.2007.05.061; Brisson M, 2007, VACCINE, V25, P5399, DOI 10.1016/j.vaccine.2007.04.086; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Dasbach EJ, 2006, EPIDEMIOL REV, V28, P88, DOI 10.1093/epirev/mxj006; DERKAY CS, 1995, ARCH OTOLARYNGOL, V121, P1386; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; Eltoum IA, 2007, CANCER CYTOPATHOL, V111, P34, DOI 10.1002/cncr.22487; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Franceschi S, 2002, BRIT J CANCER, V86, P705, DOI 10.1038/sj.bjc.6600194; Franco EL, 2006, VACCINE, V24, P171, DOI 10.1016/j.vaccine.2006.05.061; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; GIULIANO AR, 2008, EFFICACY QUADRIVALEN; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; Gold MR, 1996, COST EFFECTIVENESS H; Goldhaber-Fiebert JD, 2008, JNCI-J NATL CANCER I, V100, P308, DOI 10.1093/jnci/djn019; Goldie SJ, 2004, OBSTET GYNECOL, V103, P619, DOI 10.1097/01.AOG.0000120143.50098.c7; Goldie SJ, 2004, JNCI-J NATL CANCER I, V96, P604, DOI 10.1093/jnci/djh104; Goldie SJ, 2007, VACCINE, V25, P6257, DOI 10.1016/j.vaccine.2007.05.058; Hamilton Brady E, 2006, Natl Vital Stat Rep, V55, P1; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Haug C, 2009, JAMA-J AM MED ASSOC, V302, P795, DOI 10.1001/jama.2009.1215; Hu D, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.03.064; Insinga RP, 2004, CANCER EPIDEM BIOMAR, V13, P355; Insinga RP, 2003, CLIN INFECT DIS, V36, P1397, DOI 10.1086/375074; *INT UN CANC, 1966, CANC NIC 5 CONT, V1; Iskedjian M, 2004, VACCINE, V22, P4215, DOI 10.1016/j.vaccine.2004.04.025; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Kim JJ, 2007, BRIT J CANCER, V97, P1322, DOI 10.1038/sj.bjc.6604023; Kim JJ, 2008, VACCINE, V26, pK76, DOI 10.1016/j.vaccine.2008.06.009; Kim JJ, 2008, NEW ENGL J MED, V359, P821, DOI 10.1056/NEJMsa0707052; Kim JJ, 2007, AM J EPIDEMIOL, V166, P137, DOI 10.1093/aje/kwm086; Kulasingam SL, 2003, JAMA-J AM MED ASSOC, V290, P781, DOI 10.1001/jama.290.6.781; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; Marra F, 2009, PHARMACOECONOMICS, V27, P127, DOI 10.2165/00019053-200927020-00004; Mennini FS, 2009, GYNECOL ONCOL, V112, P370, DOI 10.1016/j.ygyno.2008.09.031; MITKA M, 2008, JAMA, V300, P1290; Mosher William D, 2005, Adv Data, P1; *NAT CANC I, 2005, SURV EP END RES SEER; Newall AT, 2007, LANCET INFECT DIS, V7, P289, DOI 10.1016/S1473-3099(07)70083-X; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; PALEFSKY J, 2008, EFFICACY QUADRIVALEN; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Rowhani-Rahbar A, 2009, VACCINE, V27, P5612, DOI 10.1016/j.vaccine.2009.07.027; Sanders GD, 2003, EMERG INFECT DIS, V9, P37; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; Saslow D, 2007, CA-CANCER J CLIN, V57, P7, DOI 10.3322/canjclin.57.1.7; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Slade BA, 2009, JAMA-J AM MED ASSOC, V302, P750, DOI 10.1001/jama.2009.1201; Steinbrook R, 2009, NEW ENGL J MED, V360, P1057, DOI 10.1056/NEJMp0900665; Taira AV, 2004, EMERG INFECT DIS, V10, P1915, DOI 10.3201/eid1011.040222; *US CDCP, 1999, HIV COUNS TEST SYST; *US CDCP, 2007, MMWR-MORBID MORTAL W, V56, P885; *US CDCP, 2008, MMWR-MORBID MORTAL W, V57, P1100; *US CDCP, 2009, HPV VACC INF YOUNG W; Villa L, 2007, LANCET, V369, P1861, DOI 10.1016/S0140-6736(07)60852-6; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Wallace LA, 2005, VACCINE, V23, P5624, DOI 10.1016/j.vaccine.2005.06.034; Watson M, 2008, CANCER-AM CANCER SOC, V113, P2841, DOI 10.1002/cncr.23758; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P346, DOI 10.1016/j.ajog.2007.07.047	71	158	161	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2009	339								b3884	10.1136/bmj.b3884	http://dx.doi.org/10.1136/bmj.b3884			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505TH	19815582	Green Published, hybrid			2022-12-24	WOS:000270719300002
J	Lahn, BT; Ebenstein, L				Lahn, Bruce T.; Ebenstein, Lanny			Let's celebrate human genetic diversity	NATURE			English	Editorial Material							SELECTION; GENOME		[Lahn, Bruce T.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Ebenstein, Lanny] Univ Calif Santa Barbara, Dept Econ, Santa Barbara, CA 93106 USA	University of Chicago; University of California System; University of California Santa Barbara	Lahn, BT (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	blahn@bsd.uchicago.edu						de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; KAMIN LJ, 1984, NOT OUR GENES BIOL I; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Peregrine Peter N., 2009, ANCIENT HUMAN MIGRAT; Phan VH, 2009, EXPERT OPIN DRUG MET, V5, P243, DOI [10.1517/17425250902800153, 10.1517/17425250902800153 ]; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rose S, 2009, NATURE, V457, P786, DOI 10.1038/457786a; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Zhu XF, 2008, ADV GENET, V60, P547, DOI 10.1016/S0065-2660(07)00419-1	15	15	15	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 8	2009	461	7265					726	728		10.1038/461726a	http://dx.doi.org/10.1038/461726a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	503OR	19812654				2022-12-24	WOS:000270547500017
J	West, CP; Tan, AD; Habermann, TM; Sloan, JA; Shanafelt, TD				West, Colin P.; Tan, Angelina D.; Habermann, Thomas M.; Sloan, Jeff A.; Shanafelt, Tait D.			Association of Resident Fatigue and Distress With Perceived Medical Errors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EPWORTH SLEEPINESS SCALE; ADVERSE EVENTS; DAYTIME SLEEPINESS; INTENSIVE-CARE; WORK HOURS; BURNOUT; MISTAKES; INTERNS; EMPATHY; CANCER	Context Fatigue and distress have been separately shown to be associated with medical errors. The contribution of each factor when assessed simultaneously is unknown. Objective To determine the association of fatigue and distress with self-perceived major medical errors among resident physicians using validated metrics. Design, Setting, and Participants Prospective longitudinal cohort study of categorical and preliminary internal medicine residents at Mayo Clinic, Rochester, Minnesota. Data were provided by 380 of 430 eligible residents (88.3%). Participants began training from 2003 to 2008 and completed surveys quarterly through February 2009. Surveys included self-assessment of medical errors, linear analog self-assessment of overall quality of life (QOL) and fatigue, the Maslach Burnout Inventory, the PRIME-MD depression screening instrument, and the Epworth Sleepiness Scale. Main Outcome Measures Frequency of self-perceived, self-defined major medical errors was recorded. Associations of fatigue, QOL, burnout, and symptoms of depression with a subsequently reported major medical error were determined using generalized estimating equations for repeated measures. Results The mean response rate to individual surveys was 67.5%. Of the 356 participants providing error data (93.7%), 139 (39%) reported making at least 1 major medical error during the study period. In univariate analyses, there was an association of subsequent self-reported error with the Epworth Sleepiness Scale score (odds ratio [OR], 1.10 per unit increase; 95% confidence interval [CI], 1.03-1.16; P = .002) and fatigue score (OR, 1.14 per unit increase; 95% CI, 1.08-1.21; P < .001). Subsequent error was also associated with burnout (ORs per 1-unit change: depersonalization OR, 1.09; 95% CI, 1.05-1.12; P < .001; emotional exhaustion OR, 1.06; 95% CI, 1.04-1.08; P < .001; lower personal accomplishment OR, 0.94; 95% CI, 0.92-0.97; P < .001), a positive depression screen (OR, 2.56; 95% CI, 1.76-3.72; P < .001), and overall QOL (OR, 0.84 per unit increase; 95% CI, 0.79-0.91; P < .001). Fatigue and distress variables remained statistically significant when modeled together with little change in the point estimates of effect. Sleepiness and distress, when modeled together, showed little change in point estimates of effect, but sleepiness no longer had a statistically significant association with errors when adjusted for burnout or depression. Conclusion Among internal medicine residents, higher levels of fatigue and distress are independently associated with self-perceived medical errors. JAMA. 2009;302(12):1294-1300	[West, Colin P.] Mayo Clin, Div Gen Internal Med, Rochester, MN 55905 USA; [West, Colin P.; Tan, Angelina D.; Sloan, Jeff A.] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN 55905 USA; [West, Colin P.; Habermann, Thomas M.; Shanafelt, Tait D.] Mayo Clin, Dept Med, Rochester, MN 55905 USA; [Habermann, Thomas M.; Shanafelt, Tait D.] Mayo Clin, Div Hematol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	West, CP (corresponding author), Mayo Clin, Div Gen Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	west.colin@mayo.edu			Mayo Clinic Department of Medicine Program on Physician Well-being	Mayo Clinic Department of Medicine Program on Physician Well-being	This work was supported by the Mayo Clinic Department of Medicine Program on Physician Well-being.	Agency for Healthcare Research and Quality, MAK HLTH CAR SAF CRI; Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Barger LK, 2006, PLOS MED, V3, P2440, DOI 10.1371/journal.pmed.0030487; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Gaba DM, 2002, NEW ENGL J MED, V347, P1249, DOI 10.1056/NEJMsa020846; Gander P, 2007, OCCUP ENVIRON MED, V64, P733, DOI 10.1136/oem.2006.030916; Gopal R, 2005, ARCH INTERN MED, V165, P2595, DOI 10.1001/archinte.165.22.2595; Gudex C, 1996, QUAL LIFE RES, V5, P521, DOI 10.1007/BF00439226; Handel DA, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-136; Institute of Medicine, 2008, RES DUT HOURS ENH SL; Jagsi R, 2005, ARCH INTERN MED, V165, P2607, DOI 10.1001/archinte.165.22.2607; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; LIANG KY, 1986, BIOMETRIKA, V73, P1; Lockley SW, 2007, JT COMM J QUAL PATIE, V33, P7, DOI 10.1016/S1553-7250(07)33109-7; Maslach C., 1996, MASLACH BURNOUT INVE; MIZRAHI T, 1984, SOC SCI MED, V19, P135, DOI 10.1016/0277-9536(84)90280-6; Nuckols TK, 2009, NEW ENGL J MED, V360, P2202, DOI 10.1056/NEJMsa0810251; ONEIL AC, 1993, ANN INTERN MED, V119, P370, DOI 10.7326/0003-4819-119-5-199309010-00004; Philibert I, 2002, JAMA-J AM MED ASSOC, V288, P1112, DOI 10.1001/jama.288.9.1112; Pigeon WR, 2003, J PSYCHOSOM RES, V54, P61, DOI 10.1016/S0022-3999(02)00542-1; Rosen IM, 2006, ACAD MED, V81, P82, DOI 10.1097/00001888-200601000-00020; Rothschild JM, 2005, CRIT CARE MED, V33, P1694, DOI 10.1097/01.CCM.0000171609.91035.BD; Rummans TA, 2006, J CLIN ONCOL, V24, P635, DOI 10.1200/JCO.2006.06.209; Shanafelt TD, 2005, ONCOLOGY-BASEL, V68, P23, DOI 10.1159/000084519; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Shen JH, 2006, SLEEP MED REV, V10, P63, DOI 10.1016/j.smrv.2005.05.004; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Thomas NK, 2004, JAMA-J AM MED ASSOC, V292, P2880, DOI 10.1001/jama.292.23.2880; Weingart SN, 2001, J GEN INTERN MED, V16, P809, DOI 10.1046/j.1525-1497.2001.10231.x; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Williams JW, 2002, JAMA-J AM MED ASSOC, V287, P1160, DOI 10.1001/jama.287.9.1160; WU AW, 1991, JAMA-J AM MED ASSOC, V265, P2089, DOI 10.1001/jama.265.16.2089; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	40	589	600	1	42	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	2009	302	12					1294	1300		10.1001/jama.2009.1389	http://dx.doi.org/10.1001/jama.2009.1389			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497AR	19773564	Bronze			2022-12-24	WOS:000270026000011
J	Sohmen, D; Harms, JM; Schlunzen, F; Wilson, DN				Sohmen, Daniel; Harms, Joerg M.; Schluenzen, Frank; Wilson, Daniel N.			SnapShot: Antibiotic Inhibition of Protein Synthesis I	CELL			English	Editorial Material							RIBOSOME		[Sohmen, Daniel; Wilson, Daniel N.] Univ Munich, D-80539 Munich, Germany; [Harms, Joerg M.] Univ Hamburg, MPSD, Hamburg, Germany; [Schluenzen, Frank] DESY, D-2000 Hamburg, Germany; [Wilson, Daniel N.] CiPS M, Munich, Germany	University of Munich; University of Hamburg; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Sohmen, D (corresponding author), Univ Munich, Marchioninistr 15, D-80539 Munich, Germany.		Schluenzen, Frank/P-9177-2019; Schluenzen, Frank/H-6274-2014; Harms, Joerg/K-8786-2012; Wilson, Daniel/AAE-8504-2019	Schluenzen, Frank/0000-0003-2849-0542; Schluenzen, Frank/0000-0003-2849-0542; Harms, Joerg/0000-0002-9442-8264; Wilson, Daniel/0000-0003-3816-3828				Moore PB, 2003, ANNU REV BIOCHEM, V72, P813, DOI 10.1146/annurev.biochem.72.110601.135450; Polacek N, 2005, CRIT REV BIOCHEM MOL, V40, P285, DOI 10.1080/10409230500326334; Spahn CMT, 1996, J MOL MED, V74, P423, DOI 10.1007/s001090050044; Sutcliffe JA, 2005, CURR OPIN MICROBIOL, V8, P534, DOI 10.1016/j.mib.2005.08.004; Tenson T, 2006, MOL MICROBIOL, V59, P1664, DOI 10.1111/j.1365-2958.2006.05063.x; Wilson D. N., 2004, PROTEIN SYNTHESIS RI, P449; Yonath A, 2005, ANNU REV BIOCHEM, V74, P649, DOI 10.1146/annurev.biochem.74.082803.133130	7	25	25	3	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 18	2009	138	6					1248	A1248		10.1016/j.cell.2009.08.001	http://dx.doi.org/10.1016/j.cell.2009.08.001			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766574	Bronze			2022-12-24	WOS:000269923200024
J	Wiley, LF; Gostin, LO				Wiley, Lindsay F.; Gostin, Lawrence O.			The International Response to Climate Change An Agenda for Global Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global & Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global & Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Wiley, Lindsay/0000-0001-7918-329X				BALS C, 2008, POZNAN COPENHAGEN CL; Bates B.C., 2008, CLIMATE CHANGE WATER; Beggs PJ, 2005, ENVIRON HEALTH PERSP, V113, P915, DOI 10.1289/ehp.7724; Brown, 2008, PLAN B 3 0; CONFALONIERI U, 2007, CLIMATE CHANGE 2007, P291; Gostin LO, 2007, JAMA-J AM MED ASSOC, V298, P89, DOI 10.1001/jama.298.1.89; HARMELING S, 2008, MAKING ADAPTATION FU; MAX A, 2009, HUFFINGTON POST 0329; NEIRA M, 2009, WORLD CONSERV, V1, P24; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Takacs D., 2009, HASTINGS WNWJ ENV L, V15, P39; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; *UN FAO, EN AGR CONTR CLIM CH; WOOD P, 2008, CLIMATE DILEMMA	14	14	15	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	2009	302	11					1218	1220		10.1001/jama.2009.1381	http://dx.doi.org/10.1001/jama.2009.1381			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494FR	19755701				2022-12-24	WOS:000269797600032
J	Yang, WL; Wang, J; Chan, CH; Lee, SW; Campos, AD; Lamothe, B; Hur, L; Grabiner, BC; Lin, X; Darnay, BG; Lin, HK				Yang, Wei-Lei; Wang, Jing; Chan, Chia-Hsin; Lee, Szu-Wei; Campos, Alejandro D.; Lamothe, Betty; Hur, Lana; Grabiner, Brian C.; Lin, Xin; Darnay, Bryant G.; Lin, Hui-Kuan			The E3 Ligase TRAF6 Regulates Akt Ubiquitination and Activation	SCIENCE			English	Article							HUMAN CANCER; PH DOMAIN; PATHWAY; MDM2; SURVIVAL; RECEPTOR	Akt signaling plays a central role in many biological functions, such as cell proliferation and apoptosis. Because Akt (also known as protein kinase B) resides primarily in the cytosol, it is not known how these signaling molecules are recruited to the plasma membrane and subsequently activated by growth factor stimuli. We found that the protein kinase Akt undergoes lysine-63 chain ubiquitination, which is important for Akt membrane localization and phosphorylation. TRAF6 was found to be a direct E3 ligase for Akt and was essential for Akt ubiquitination, membrane recruitment, and phosphorylation upon growth-factor stimulation. The human cancer-associated Akt mutant displayed an increase in Akt ubiquitination, in turn contributing to the enhancement of Akt membrane localization and phosphorylation. Thus, Akt ubiquitination is an important step for oncogenic Akt activation.	[Yang, Wei-Lei; Wang, Jing; Chan, Chia-Hsin; Lee, Szu-Wei; Grabiner, Brian C.; Lin, Xin; Lin, Hui-Kuan] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Yang, Wei-Lei; Lee, Szu-Wei; Grabiner, Brian C.; Lin, Xin; Lin, Hui-Kuan] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Campos, Alejandro D.; Lamothe, Betty; Hur, Lana; Darnay, Bryant G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Lin, HK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	hklin@mdanderson.org	Chan, Chia-Hsin/AAT-7782-2020; Yang, Wei-Lei/E-2598-2012; 高, 雨莉/HGU-8187-2022	Chan, Chia-Hsin/0000-0001-8506-7500	M. D. Anderson Trust Scholar Fund; NATIONAL CANCER INSTITUTE [R01CA149321] Funding Source: NIH RePORTER	M. D. Anderson Trust Scholar Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. C. Hung, D. Bohmann, M. Eiliers, A. M. Weissman, S. Lipkowitz, J. L. Wrana, X. Yang, W. C. Yeh, and T. Mak for reagents; M. C. Hung, D. Sarbassov, and M. H. Lee for insightful comments and suggestions; H. Li and S. Zhang for their technical support and sharing reagents; Z. Han for assistance in confocal microscopy; and V. M. Mohlere and T. Locke for their critical reading and editing of our manuscript. This work was supported by the M. D. Anderson Trust Scholar Fund to H.K.L.	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nishimura M, 2005, BIOL PHARM BULL, V28, P886, DOI 10.1248/bpb.28.886; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rong SB, 2001, J MED CHEM, V44, P898, DOI 10.1021/jm000493i; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yu HG, 2008, INT J CANCER, V122, P433, DOI 10.1002/ijc.23049; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	21	422	450	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2009	325	5944					1134	1138		10.1126/science.1175065	http://dx.doi.org/10.1126/science.1175065			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713527	Green Accepted			2022-12-24	WOS:000269382300043
J	Dando, M				Dando, Malcolm			Biologists napping while work militarized	NATURE			English	Editorial Material									Univ Bradford, Wellcome Trust Project Bldg Sustainable Capac Dua, Dept Peace Studies, Bradford BD7 1DP, W Yorkshire, England	University of Bradford	Dando, M (corresponding author), Univ Bradford, Wellcome Trust Project Bldg Sustainable Capac Dua, Dept Peace Studies, Richmond Rd, Bradford BD7 1DP, W Yorkshire, England.	mrdando@bradford.ac.uk						*CHEM COMM, 1959, 32 M 5 MARCH 1959; HESS L, 2007, P 4 EUR S NONL WEAP; Lakoski J. M., 2000, ADVANTAGES LIMITATIO; Petro James B, 2003, Biosecur Bioterror, V1, P161, DOI 10.1089/153871303769201815; WHITBRED G, 2006, OFFENSIVE USE CHEM T	5	11	11	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 20	2009	460	7258					950	951		10.1038/460950a	http://dx.doi.org/10.1038/460950a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19693065	Bronze			2022-12-24	WOS:000269085500015
J	Ford, AC; Talley, NJ				Ford, Alexander C.; Talley, Nicholas J.			Does Helicobacter pylori really cause duodenal ulcers? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PEPTIC-ULCER; GASTRIC-CANCER; DISEASE; ERADICATION; INFECTION; COHORT; ACID		[Ford, Alexander C.] St James Univ Hosp, Acad Dept Med, Leeds LS9 7TF, W Yorkshire, England; [Talley, Nicholas J.] Mayo Clin Florida, Dept Med, Jacksonville, FL 32224 USA; [Talley, Nicholas J.] Univ Sydney, Dept Med, Nepean Hosp, Sydney, NSW 2006, Australia	Saint James's University Hospital; Mayo Clinic; Nepean Hospital; University of Sydney	Ford, AC (corresponding author), St James Univ Hosp, Acad Dept Med, Leeds LS9 7TF, W Yorkshire, England.	alexf12399@yahoo.com	Talley, Nicholas J/D-5399-2013; Ford, Alexander/K-5491-2012	Talley, Nicholas J/0000-0003-2537-3092; Ford, Alexander/0000-0001-6371-4359				Agha A, 2005, SCAND J GASTROENTERO, V40, P523, DOI 10.1080/00365520510012280; BANATVALA N, 1993, J INFECT DIS, V168, P219, DOI 10.1093/infdis/168.1.219; BARON JH, 1969, GUT, V10, P637, DOI 10.1136/gut.10.8.637; El-Serag HB, 1998, GUT, V43, P327, DOI 10.1136/gut.43.3.327; Ford AC, 2005, GASTROENTEROLOGY, V129, P1910, DOI 10.1053/j.gastro.2005.09.016; Ford AC, 2004, AM J GASTROENTEROL, V99, P1833, DOI 10.1111/j.1572-0241.2004.40014.x; Harvey RF, 2002, QJM-INT J MED, V95, P519, DOI 10.1093/qjmed/95.8.519; Iijima K, 2000, GUT, V46, P20, DOI 10.1136/gut.46.1.20; Leung WK, 1999, AM J GASTROENTEROL, V94, P2881, DOI 10.1111/j.1572-0241.1999.01431.x; MARSHALL BJ, 1985, MED J AUSTRALIA, V142, P436, DOI 10.5694/j.1326-5377.1985.tb113443.x; Moayyedi P, 2008, GASTROENTEROLOGY, V134, pA631; Ohkusa T, 2003, GUT, V52, P797, DOI 10.1136/gut.52.6.797; Rosenstock S, 2003, GUT, V52, P186, DOI 10.1136/gut.52.2.186; Schultze V, 1998, SCAND J GASTROENTERO, V33, P137, DOI 10.1080/00365529850166851; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347	15	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2009	339								b2784	10.1136/bmj.b2784	http://dx.doi.org/10.1136/bmj.b2784			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485YL	19684098				2022-12-24	WOS:000269162200001
J	Lefevre, F; Forget, F				Lefevre, Franck; Forget, Francois			Observed variations of methane on Mars unexplained by known atmospheric chemistry and physics	NATURE			English	Article							MARTIAN DUST DEVILS; INTERANNUAL VARIABILITY; OXIDANT ENHANCEMENT; STORMS; ORIGIN; LIFE	The detection of methane on Mars(1-3) has revived the possibility of past or extant life on this planet, despite the fact that an abiogenic origin is thought to be equally plausible(4). An intriguing aspect of the recent observations of methane on Mars is that methane concentrations appear to be locally enhanced and change with the seasons(3). However, methane has a photochemical lifetime of several centuries, and is therefore expected to have a spatially uniform distribution on the planet(5). Here we use a global climate model of Mars with coupled chemistry(6-8) to examine the implications of the recently observed variations of Martian methane for our understanding of the chemistry of methane. We find that photochemistry as currently understood does not produce measurable variations in methane concentrations, even in the case of a current, local and episodic methane release. In contrast, we find that the condensation-sublimation cycle of Mars' carbon dioxide atmosphere can generate large-scale methane variations differing from those observed. In order to reproduce local methane enhancements similar to those recently reported(3), we show that an atmospheric lifetime of less than 200 days is necessary, even if a local source of methane is only active around the time of the observation itself. This implies an unidentified methane loss process that is 600 times faster than predicted by standard photochemistry. The existence of such a fast loss in the Martian atmosphere is difficult to reconcile with the observed distribution of other trace gas species. In the case of a destruction mechanism only active at the surface of Mars, destruction of methane must occur with an even shorter timescale of the order of similar to 1 hour to explain the observations. If recent observations of spatial and temporal variations of methane are confirmed, this would suggest an extraordinarily harsh environment for the survival of organics on the planet.	[Lefevre, Franck] Univ Paris 06, CNRS, LATMOS, F-75005 Paris, France; [Forget, Francois] Univ Paris 06, CNRS, Meteorol Dynam Lab, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Lefevre, F (corresponding author), Univ Paris 06, CNRS, LATMOS, F-75005 Paris, France.	franck.lefevre@upmc.fr			CNRS; ESA; CNES	CNRS(Centre National de la Recherche Scientifique (CNRS)); ESA(European Space Agency); CNES(Centre National D'etudes Spatiales)	The LMD Martian global climate model has been developed with the support of CNRS, ESA and CNES. We thank R. M. Haberle and F. Montmessin for their contributions to an early phase of this work, as well as P.- Y. Meslin and R. Wordsworth for discussions.	Atreya SK, 2007, PLANET SPACE SCI, V55, P358, DOI 10.1016/j.pss.2006.02.005; Atreya SK, 2006, ASTROBIOLOGY, V6, P439, DOI 10.1089/ast.2006.6.439; Clancy RT, 2004, ICARUS, V168, P116, DOI 10.1016/j.icarus.2003.12.003; Davila AF, 2008, EARTH PLANET SC LETT, V272, P456, DOI 10.1016/j.epsl.2008.05.015; Delory GT, 2006, ASTROBIOLOGY, V6, P451, DOI 10.1089/ast.2006.6.451; Farrell WM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027210; Forget F, 1999, J GEOPHYS RES-PLANET, V104, P24155, DOI 10.1029/1999JE001025; FORGET F, 2008, 3 WORKSH MARS MOD OB; Formisano V, 2004, SCIENCE, V306, P1758, DOI 10.1126/science.1101732; Geminale A, 2008, PLANET SPACE SCI, V56, P1194, DOI 10.1016/j.pss.2008.03.004; GOUGH RV, 2009, 40 LUN PLAN SCI C; Hurowitz JA, 2007, EARTH PLANET SC LETT, V255, P41, DOI 10.1016/j.epsl.2006.12.004; Keir RS, 2005, DEEP-SEA RES PT I, V52, P1043, DOI 10.1016/j.dsr.2004.12.006; Kok JF, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036691; Krashnopolsky VA, 2004, ICARUS, V172, P537, DOI 10.1016/j.icarus.2004.07.004; Krasnopolsky VA, 2006, ICARUS, V180, P359, DOI 10.1016/j.icarus.2005.10.015; Lefevre F, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002268; Lefevre F, 2008, NATURE, V454, P971, DOI 10.1038/nature07116; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Melnik O, 1998, J GEOPHYS RES-SPACE, V103, P29107, DOI 10.1029/98JA01954; Montabone L, 2005, ADV SPACE RES-SERIES, V36, P2146, DOI 10.1016/j.asr.2005.07.047; MUMMA M, 2008, 3 WORKSH MARS MOD OB; Mumma MJ, 2009, SCIENCE, V323, P1041, DOI 10.1126/science.1165243; Sander S. P., 2006, JPL PUBLICATION; Smith MD, 2004, ICARUS, V167, P148, DOI 10.1016/j.icarus.2003.09.010; Smith MD, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003288; Sprague AL, 2004, SCIENCE, V306, P1364, DOI 10.1126/science.1098496; SPRAGUE AL, 2007, J GEOPHYS RES-PLANET, V112; Summers ME, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015377; Wong AS, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002003	30	172	172	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					720	723		10.1038/nature08228	http://dx.doi.org/10.1038/nature08228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19661912				2022-12-24	WOS:000268670300034
J	Schmeing, TM; Voorhees, RM; Kelley, AC; Gao, YG; Murphy, FV; Weir, JR; Ramakrishnan, V				Schmeing, T. Martin; Voorhees, Rebecca M.; Kelley, Ann C.; Gao, Yong-Gui; Murphy, Frank V., IV; Weir, John R.; Ramakrishnan, V.			The Crystal Structure of the Ribosome Bound to EF-Tu and Aminoacyl-tRNA	SCIENCE			English	Article							ELONGATION-FACTOR TU; GTPASE ACTIVATION; ESCHERICHIA-COLI; ACTIVE-ROLE; CROSS-LINK; SELECTION; HYDROLYSIS; BINDING; COMPLEX; RECOGNITION	The ribosome selects a correct transfer RNA (tRNA) for each amino acid added to the polypeptide chain, as directed by messenger RNA. Aminoacyl-tRNA is delivered to the ribosome by elongation factor Tu (EF-Tu), which hydrolyzes guanosine triphosphate (GTP) and releases tRNA in response to codon recognition. The signaling pathway that leads to GTP hydrolysis upon codon recognition is critical to accurate decoding. Here we present the crystal structure of the ribosome complexed with EF-Tu and aminoacyl-tRNA, refined to 3.6 angstrom resolution. The structure reveals details of the tRNA distortion that allows aminoacyl-tRNA to interact simultaneously with the decoding center of the 30S subunit and EF-Tu at the factor binding site. A series of conformational changes in EF-Tu and aminoacyl-tRNA suggests a communication pathway between the decoding center and the guanosine triphosphatase center of EF-Tu.	[Schmeing, T. Martin; Voorhees, Rebecca M.; Kelley, Ann C.; Gao, Yong-Gui; Murphy, Frank V., IV; Weir, John R.; Ramakrishnan, V.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	ramakr@mrc-lmb.cam.ac.uk	Weir, John R./AAF-5435-2020; Gao, Yonggui/A-9473-2015; Gao, Yong Gui/A-2187-2011	Weir, John R./0000-0002-6904-0284; Gao, Yonggui/0000-0001-7298-0835; Ramakrishnan, V/0000-0002-4699-2194; VOORHEES, REBECCA/0000-0003-1640-2293	Medical Research Council U. K.; Wellcome Trust; Agouron Institute; Louis-Jeantet Foundation; Gates-Cambridge scholarship; Human Frontiers Science Program Organization and Emmanuel College, University of Cambridge; MRC [MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_U105184332] Funding Source: researchfish	Medical Research Council U. K.(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Agouron Institute(Pfizer); Louis-Jeantet Foundation; Gates-Cambridge scholarship; Human Frontiers Science Program Organization and Emmanuel College, University of Cambridge(University of Cambridge); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. M. Babu and P. Lukavski for help with data analysis, G. Leonard and S. Brockhauser for their guidance and advice with data collection at the European Synchrotron Light Source beamline ID14.4, C. Schulze-Briese and A. Pauluhn for help with initial diffraction studies performed at the Swiss Light Source, and L. Ulisko for preparation of additional images. This work was supported by the Medical Research Council U. K., the Wellcome Trust, the Agouron Institute, and the Louis-Jeantet Foundation. R. M. V. is the recipient of a Gates-Cambridge scholarship; T. M. S. received support from the Human Frontiers Science Program Organization and Emmanuel College, University of Cambridge; and V. R. holds stock options and is on the Scientific Advisory Board of Rib-X Pharmaceuticals, a company dedicated to making antibiotics that target the ribosome. The structure has been deposited at the Protein Data Bank with accession codes 2WRN, 2WRO, 2WRQ, and 2WRR.	BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; BILGIN N, 1994, J MOL BIOL, V235, P813, DOI 10.1006/jmbi.1994.1041; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; FAVRE A, 1975, NUCLEIC ACIDS RES, V2, P1421, DOI 10.1093/nar/2.8.1421; Gregory ST, 2009, RNA, V15, P208, DOI 10.1261/rna.1355709; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; HIRSH D, 1970, NATURE, V228, P57, DOI 10.1038/228057a0; Knudsen C, 2001, J BIOL CHEM, V276, P22183, DOI 10.1074/jbc.M102186200; Kothe U, 2006, BIOCHEMISTRY-US, V45, P12767, DOI 10.1021/bi061192z; Lee TH, 2007, P NATL ACAD SCI USA, V104, P13661, DOI 10.1073/pnas.0705988104; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Piepenburg O, 2000, BIOCHEMISTRY-US, V39, P1734, DOI 10.1021/bi992331y; Rodnina MV, 2009, P NATL ACAD SCI USA, V106, P969, DOI 10.1073/pnas.0812576106; Rodnina MV, 1996, J BIOL CHEM, V271, P646, DOI 10.1074/jbc.271.2.646; RODNINA MV, 1994, BIOCHEMISTRY-US, V33, P12267, DOI 10.1021/bi00206a033; RUUSALA T, 1982, EMBO J, V1, P741, DOI 10.1002/j.1460-2075.1982.tb01240.x; Saarma U, 1997, J MOL BIOL, V272, P327, DOI 10.1006/jmbi.1997.1254; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; SCHULTZ DW, 1994, J MOL BIOL, V235, P1381, DOI 10.1006/jmbi.1994.1095; SELMER M, 1935, SCIENCE, V313, P2006, DOI DOI 10.1126/SCIENCE.1131127; SMITH D, 1989, J MOL BIOL, V206, P503, DOI 10.1016/0022-2836(89)90497-X; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; SWART GWM, 1987, BIOCHEMISTRY-US, V26, P2047, DOI 10.1021/bi00381a038; THOMPSON RC, 1977, P NATL ACAD SCI USA, V74, P198, DOI 10.1073/pnas.74.1.198; VACHER J, 1979, J MOL BIOL, V129, P287; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Vogeley L, 2001, J BIOL CHEM, V276, P17149, DOI 10.1074/jbc.M100017200; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Vorstenbosch E, 1996, EMBO J, V15, P6766, DOI 10.1002/j.1460-2075.1996.tb01066.x; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Zeidler W, 1996, EUR J BIOCHEM, V239, P265, DOI 10.1111/j.1432-1033.1996.0265u.x	43	390	397	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					688	694		10.1126/science.1179700	http://dx.doi.org/10.1126/science.1179700			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19833920	Green Accepted			2022-12-24	WOS:000271233200027
J	Krajbich, I; Camerer, C; Ledyard, J; Rangel, A				Krajbich, Ian; Camerer, Colin; Ledyard, John; Rangel, Antonio			Using Neural Measures of Economic Value to Solve the Public Goods Free-Rider Problem	SCIENCE			English	Article							HUMAN BRAIN; PUNISHMENT; MECHANISMS; CORTEX	Every social group needs to decide when to provide public goods and how to allocate the costs among its members. Ideally, this decision would maximize the group's net benefits while also ensuring that every individual's benefit is greater than the cost he or she has to pay. Unfortunately, the economic theory of mechanism design has shown that this ideal solution is not feasible when the group leadership does not know the values of the individual group members for the public good. We show that this impossibility result can be overcome in laboratory settings by combining technologies for obtaining neural measures of value ( functional magnetic resonance imaging-based pattern classification) with carefully designed institutions that allocate costs based on both reported and neurally measured values.	[Camerer, Colin; Rangel, Antonio] CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA; [Krajbich, Ian; Camerer, Colin; Ledyard, John; Rangel, Antonio] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Rangel, A (corresponding author), CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA.	rangel@hss.caltech.edu			NSF-Integrative Graduate Education and Research Traineeship Program; Gordon and Betty Moore Foundation; Human Frontier Science Program	NSF-Integrative Graduate Education and Research Traineeship Program(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Human Frontier Science Program(Human Frontier Science Program)	Financial support from NSF-Integrative Graduate Education and Research Traineeship Program ( I. K.), Gordon and Betty Moore Foundation ( C. F. C., A. R.), and Human Frontier Science Program ( C. F. C.) is gratefully acknowledged.	ABREU D, 1992, ECONOMETRICA, V60, P1439, DOI 10.2307/2951529; CHEN Y, 2004, HDB EXPT EC; Diamantaras D., 2009, TOOLBOX EC DESIGN; Falkinger J, 2000, AM ECON REV, V90, P247, DOI 10.1257/aer.90.1.247; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Gailmard S, 2005, J PUBLIC ECON, V89, P1361, DOI 10.1016/j.jpubeco.2003.04.002; GIBBARD A, 1973, ECONOMETRICA, V41, P587, DOI 10.2307/1914083; GREEN J, 1977, ECONOMETRICA, V45, P427, DOI 10.2307/1911219; GROVES T, 1977, ECONOMETRICA, V45, P783, DOI 10.2307/1912672; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Ledyard J., 1995, HDB EXPT EC; Lindahl E., 1919, GERECHTIGKEIT BESTEU; Maskin E, 1999, REV ECON STUD, V66, P23, DOI 10.1111/1467-937X.00076; MOULIN H, 1994, REV ECON STUD, V61, P305, DOI 10.2307/2297983; Myerson R.B., 2008, NEW PALGRAVE DICT EC; O'Toole AJ, 2007, J COGNITIVE NEUROSCI, V19, P1735, DOI 10.1162/jocn.2007.19.11.1735; Pessoa L, 2007, CEREB CORTEX, V17, P691, DOI 10.1093/cercor/bhk020; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Samuelson PA, 1954, REV ECON STAT, V36, P387, DOI 10.2307/1925895; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; Smith Adam, 1776, INQUIRY NATURE CAUSE	25	44	45	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					596	599		10.1126/science.1177302	http://dx.doi.org/10.1126/science.1177302			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509LN	19745115				2022-12-24	WOS:000271019400048
J	Wang, YL; Juranek, S; Li, HT; Sheng, G; Wardle, GS; Tuschl, T; Patel, DJ				Wang, Yanli; Juranek, Stefan; Li, Haitao; Sheng, Gang; Wardle, Greg S.; Tuschl, Thomas; Patel, Dinshaw J.			Nucleation, propagation and cleavage of target RNAs in Ago silencing complexes	NATURE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; RECOGNITION; ARGONAUTE; DNA; MESSENGER; RISC; MECHANISMS; SLICER; INTERFERENCE	The slicer activity of the RNA-induced silencing complex resides within its Argonaute (Ago) component, in which the PIWI domain provides the catalytic residues governing guide-strand mediated site-specific cleavage of target RNA. Here we report on structures of ternary complexes of Thermus thermophilus Ago catalytic mutants with 5'-phosphorylated 21-nucleotide guide DNA and complementary target RNAs of 12, 15 and 19 nucleotides in length, which define the molecular basis for Mg2+-facilitated site-specific cleavage of the target. We observe pivot-like domain movements within the Ago scaffold on proceeding from nucleation to propagation steps of guide-target duplex formation, with duplex zippering beyond one turn of the helix requiring the release of the 3'-end of the guide from the PAZ pocket. Cleavage assays on targets of various lengths supported this model, and sugar-phosphate-backbone-modified target strands showed the importance of structural and catalytic divalent metal ions observed in the crystal structures.	[Wang, Yanli; Li, Haitao; Sheng, Gang; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Juranek, Stefan; Wardle, Greg S.; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Rockefeller University	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	ttuschl@mail.rockefeller.edu; pateld@mskcc.org	Li, Haitao/B-2668-2012; wang, yanli/G-3306-2010	Li, Haitao/0000-0001-6741-293X; Wang, Yanli/0000-0002-5969-1745	National Institutes of Health (NIH); Starr Foundation; Howard Hughes Medical Institute (HHMI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068476] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported by funds from the National Institutes of Health (NIH) and the Starr Foundation to D. J. P., and from the NIH, Starr Foundation and the Howard Hughes Medical Institute (HHMI) to T. T. We would like to thank the staff of NE-CAT beam lines at the Advanced Photon Source (APS), Argonne National Laboratory, and the X-29 beamline at the Brookhaven National Laboratory, supported by the US Department of Energy, for assistance with data collection. We thank Z. Wang for assistance with X-ray data collection at the APS.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGERS PMJ, 1978, P NATL ACAD SCI USA, V75, P4798, DOI 10.1073/pnas.75.10.4798; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Freier SM, 1997, NUCLEIC ACIDS RES, V25, P4429, DOI 10.1093/nar/25.22.4429; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Patel DJ, 2006, COLD SPRING HARB SYM, V71, P81, DOI 10.1101/sqb.2006.71.053; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Thorogood H, 1996, J BIOL CHEM, V271, P8855, DOI 10.1074/jbc.271.15.8855; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tonelli M, 2003, BIOPHYS J, V85, P2525, DOI 10.1016/S0006-3495(03)74675-X; Turner DH, 1996, CURR OPIN STRUC BIOL, V6, P299, DOI 10.1016/S0959-440X(96)80047-9; Verma S, 1998, ANNU REV BIOCHEM, V67, P99, DOI 10.1146/annurev.biochem.67.1.99; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	48	371	414	3	87	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					754	U3		10.1038/nature08434	http://dx.doi.org/10.1038/nature08434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19812667	Green Accepted			2022-12-24	WOS:000270547500028
J	Aathavan, K; Politzer, AT; Kaplan, A; Moffitt, JR; Chemla, YR; Grimes, S; Jardine, PJ; Anderson, DL; Bustamante, C				Aathavan, K.; Politzer, Adam T.; Kaplan, Ariel; Moffitt, Jeffrey R.; Chemla, Yann R.; Grimes, Shelley; Jardine, Paul J.; Anderson, Dwight L.; Bustamante, Carlos			Substrate interactions and promiscuity in a viral DNA packaging motor	NATURE			English	Article							ATP HYDROLYSIS; PORTAL MOTOR; TRANSLOCATION; HELICASE; MECHANISM; BACKBONE; TRACKING	The ASCE (additional strand, conserved E) superfamily of proteins consists of structurally similar ATPases associated with diverse cellular activities involving metabolism and transport of proteins and nucleic acids in all forms of life(1). A subset of these enzymes consists of multimeric ringed pumps responsible for DNA transport in processes including genome packaging in adenoviruses, herpesviruses, poxviruses and tailed bacteriophages(2). Although their mechanism of mechanochemical conversion is beginning to be understood(3), little is known about how these motors engage their nucleic acid substrates. Questions remain as to whether the motors contact a single DNA element, such as a phosphate or a base, or whether contacts are distributed over several parts of the DNA. Furthermore, the role of these contacts in the mechanochemical cycle is unknown. Here we use the genome packaging motor of the Bacillus subtilis bacteriophage phi 29 (ref. 4) to address these questions. The full mechanochemical cycle of the motor, in which the ATPase is a pentameric-ring(5) of gene product 16 (gp16), involves two phases-an ATP-loading dwell followed by a translocation burst of four 2.5-base-pair (bp) steps(6) triggered by hydrolysis product release(7). By challenging the motor with a variety of modified DNA substrates, we show that during the dwell phase important contacts are made with adjacent phosphates every 10-bp on the 5'-3' strand in the direction of packaging. As well as providing stable, long-lived contacts, these phosphate interactions also regulate the chemical cycle. In contrast, during the burst phase, we find that DNA translocation is driven against large forces by extensive contacts, some of which are not specific to the chemical moieties of DNA. Such promiscuous, nonspecific contacts may reflect common translocase-substrate interactions for both the nucleic acid and protein translocases of the ASCE superfamily(1).	[Aathavan, K.; Politzer, Adam T.; Bustamante, Carlos] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Aathavan, K.; Politzer, Adam T.; Kaplan, Ariel; Moffitt, Jeffrey R.; Chemla, Yann R.; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Kaplan, Ariel; Bustamante, Carlos] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Kaplan, Ariel; Moffitt, Jeffrey R.; Chemla, Yann R.; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Grimes, Shelley; Jardine, Paul J.; Anderson, Dwight L.] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Grimes, Shelley; Jardine, Paul J.; Anderson, Dwight L.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Anderson, Dwight L.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu	Kaplan, Ariel/F-3657-2010	Kaplan, Ariel/0000-0002-9731-6962; Jardine, Paul/0000-0002-1090-0550; Chemla, Yann/0000-0001-9167-0234; Bustamante, Carlos/0000-0002-2970-0073	Burroughs Wellcome Fund; NIH Molecular Biophysics Training Grant; Human Frontier Science Program Cross-Disciplinary Fellowship; NSF Graduate Research Fellowship; Burroughs Wellcome Fund Career Award; National Institutes of Health ( NIH) [GM-071552, DE-003606, GM-059604]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE003606, R37DE003606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059604, R01GM071552] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH Molecular Biophysics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Cross-Disciplinary Fellowship(Human Frontier Science Program); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); National Institutes of Health ( NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. L. Hetherington, M. Kopaczynska, A. Spakowitz and J. M. Berger for critical discussions, and D. Reid, M. T. Couvillon and N. L. S. Chavez for preliminary work leading to this publication. K. A. acknowledges the PMMB fellowship through the Burroughs Wellcome Fund, A. T. P. the NIH Molecular Biophysics Training Grant, A. K. the Human Frontier Science Program Cross-Disciplinary Fellowship, J. R. M. the NSF Graduate Research Fellowship, and Y. R. C. the Burroughs Wellcome Fund Career Award at the Scientific Interface for funding. This research was supported in part by the National Institutes of Health ( NIH) grants GM-071552, DE-003606 and GM-059604. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; AGRESTI A, 2003, CATEGORICAL DATA ANA, pCH5; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; BURROUGHS AM, 2007, COMP GENOMICS EVOLUT, P48; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Dillingham MS, 1999, NUCLEIC ACIDS RES, V27, P3310, DOI 10.1093/nar/27.16.3310; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Eoff RL, 2005, BIOCHEMISTRY-US, V44, P666, DOI 10.1021/bi0484926; Grimes S, 2002, ADV VIRUS RES, V58, P255, DOI 10.1016/S0065-3527(02)58007-6; Hopfner KP, 2007, CURR OPIN STRUC BIOL, V17, P87, DOI 10.1016/j.sbi.2006.11.003; HOWARD J, 2001, MECH MOTOR PROTEINS, P62; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Kawaoka J, 2004, NAT STRUCT MOL BIOL, V11, P526, DOI 10.1038/nsmb771; Lewis JR, 2006, J USABILITY STUD, V1, P136; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Moll WD, 2005, J MOL BIOL, V351, P100, DOI 10.1016/j.jmb.2005.05.038; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Oram M, 2008, J MOL BIOL, V381, P61, DOI 10.1016/j.jmb.2008.05.074; PEARSON RK, 1988, GENETICS, V118, P5; Rickgauer JP, 2008, BIOPHYS J, V94, P159, DOI 10.1529/biophysj.107.104612; SENGUPTA DJ, 1992, SCIENCE, V256, P1656, DOI 10.1126/science.256.5064.1656; Shen JP, 2005, P NATL ACAD SCI USA, V102, P11248, DOI 10.1073/pnas.0409646102; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Stanley LK, 2006, EMBO J, V25, P2230, DOI 10.1038/sj.emboj.7601104; STRAUSS JK, 1994, SCIENCE, V266, P1829, DOI 10.1126/science.7997878; Thiviyanathan V, 2002, BIOCHEMISTRY-US, V41, P827, DOI 10.1021/bi011551k	30	88	88	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					669	U118		10.1038/nature08443	http://dx.doi.org/10.1038/nature08443			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19794496	Green Accepted			2022-12-24	WOS:000270302600044
J	Lam, H; Oh, DC; Cava, F; Takacs, CN; Clardy, J; de Pedro, MA; Waldor, MK				Lam, Hubert; Oh, Dong-Chan; Cava, Felipe; Takacs, Constantin N.; Clardy, Jon; de Pedro, Miguel A.; Waldor, Matthew K.			D-Amino Acids Govern Stationary Phase Cell Wall Remodeling in Bacteria	SCIENCE			English	Article							ESCHERICHIA-COLI; BACILLUS-SUBTILIS; PEPTIDOGLYCAN; GROWTH	In all known organisms, amino acids are predominantly thought to be synthesized and used as their L-enantiomers. Here, we found that bacteria produce diverse D-amino acids as well, which accumulate at millimolar concentrations in supernatants of stationary phase cultures. In Vibrio cholerae, a dedicated racemase produced D-Met and D-Leu, whereas Bacillus subtilis generated D-Tyr and D-Phe. These unusual D-amino acids appear to modulate synthesis of peptidoglycan, a strong and elastic polymer that serves as the stress-bearing component of the bacterial cell wall. D-Amino acids influenced peptidoglycan composition, amount, and strength, both by means of their incorporation into the polymer and by regulating enzymes that synthesize and modify it. Thus, synthesis of D-amino acids may be a common strategy for bacteria to adapt to changing environmental conditions.	[Lam, Hubert; Cava, Felipe; Takacs, Constantin N.; Waldor, Matthew K.] Harvard Univ, Brigham & Womens Hosp, Channing Lab, Sch Med, Boston, MA 02115 USA; [Lam, Hubert; Cava, Felipe; Takacs, Constantin N.; Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Oh, Dong-Chan; Clardy, Jon] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [de Pedro, Miguel A.] Cient Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa Consejo Super Invest, Fac Ciencias, Madrid 28049, Spain	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Waldor, MK (corresponding author), Harvard Univ, Brigham & Womens Hosp, Channing Lab, Sch Med, Boston, MA 02115 USA.	mwaldor@rics.bwh.harvard.edu	Cava, Felipe/L-2082-2017	Cava, Felipe/0000-0001-5995-718X; Waldor, Matthew/0000-0003-1843-7000	Howard Hughes Medical Institute (HHMI); NIH [AI-R37-42347, CA24487, GM086258]; Ministry of Education and Science, Spain (MEC) [BFU2006-04574]; Fundacion Ramon Areces; Jane Coffin Childs Fellowship; MEC Fellowship; HHMI Exceptional Research Opportunities (EXROP); NATIONAL CANCER INSTITUTE [R01CA024487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086258] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education and Science, Spain (MEC)(Spanish Government); Fundacion Ramon Areces; Jane Coffin Childs Fellowship; MEC Fellowship(German Research Foundation (DFG)); HHMI Exceptional Research Opportunities (EXROP)(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Davis, C. Jacobs-Wagner, and D. Rudner for insightful comments on the manuscript. This work was supported by Howard Hughes Medical Institute (HHMI); NIH AI-R37-42347 ( M. K. W.) and CA24487 and GM086258 ( J. C.); Ministry of Education and Science, Spain (MEC) BFU2006-04574 and Fundacion Ramon Areces (M. A. P.); Jane Coffin Childs Fellowship ( H. L.); MEC Fellowship ( F. C.); and HHMI Exceptional Research Opportunities (EXROP) ( C.N.T.).	Anfora AT, 2007, INFECT IMMUN, V75, P5298, DOI 10.1128/IAI.00652-07; CAPARROS M, 1992, J BACTERIOL, V174, P5549; CHAMPNEY WS, 1970, J BACTERIOL, V104, P107, DOI 10.1128/JB.104.1.107-116.1970; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; LARK C, 1959, CAN J MICROBIOL, V5, P369, DOI 10.1139/m59-046; OConnor KA, 1997, MOL MICROBIOL, V24, P839, DOI 10.1046/j.1365-2958.1997.3931757.x; Tiyanont K, 2006, P NATL ACAD SCI USA, V103, P11033, DOI 10.1073/pnas.0600829103; TSURUOKA T, 1985, EUR J BIOCHEM, V151, P209, DOI 10.1111/j.1432-1033.1985.tb09089.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Yoshimura T, 2003, J BIOSCI BIOENG, V96, P103, DOI 10.1016/S1389-1723(03)90111-3	10	404	417	5	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1552	1555		10.1126/science.1178123	http://dx.doi.org/10.1126/science.1178123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762646	Green Accepted			2022-12-24	WOS:000269887900043
J	Fasano, A				Fasano, Alessio			Should we screen for coeliac disease? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							POPULATION; DIAGNOSIS		[Fasano, Alessio] Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Fasano, Alessio] Univ Maryland, Sch Med, Ctr Celiac Res, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Fasano, A (corresponding author), Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA.	afasano@mbrc.umaryland.edu	Fasano, Alessio/K-5486-2016	Fasano, Alessio/0000-0002-2134-0261				Anderson LA, 2007, WORLD J GASTROENTERO, V13, P146, DOI 10.3748/wjg.v13.i1.146; Caicedo R. A., 2008, Frontiers in celiac disease, P107, DOI 10.1159/000128665; Catassi C., 2008, Frontiers in celiac disease, P23, DOI 10.1159/000128610; Catassi C, 2008, CURR OPIN GASTROEN, V24, P687, DOI 10.1097/MOG.0b013e32830edc1e; Catassi C, 2007, AM J GASTROENTEROL, V102, P1454, DOI 10.1111/j.1572-0241.2007.01173.x; *EUR OBS HLTH SYST, 2006, POL BRIEF SCREEN EUR; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; Gasbarrini G, 2008, DIGEST DIS, V26, P121, DOI 10.1159/000116769; Green Peter H R, 2008, J Insur Med, V40, P218; Green PHR, 2001, AM J GASTROENTEROL, V96, P126, DOI 10.1111/j.1572-0241.2001.03462.x; Guandalini S, 2008, CURR OPIN GASTROEN, V24, P707, DOI 10.1097/MOG.0b013e32830f4527; Mearin ML, 2005, BEST PRACT RES CL GA, V19, P441, DOI 10.1016/j.bpg.2005.02.004; Shamir R, 2006, MED DECIS MAKING, V26, P282, DOI 10.1177/0272989X06289012; Sollid LM, 2009, MUCOSAL IMMUNOL, V2, P3, DOI 10.1038/mi.2008.74; Stern M., 2008, Frontiers in celiac disease, P114, DOI 10.1159/000128671	15	28	28	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 17	2009	339								b3592	10.1136/bmj.b3592	http://dx.doi.org/10.1136/bmj.b3592			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496RU	19762413				2022-12-24	WOS:000269994900005
J	Mateja, A; Szlachcic, A; Downing, ME; Dobosz, M; Mariappan, M; Hegde, RS; Keenan, RJ				Mateja, Agnieszka; Szlachcic, Anna; Downing, Maureen E.; Dobosz, Malgorzata; Mariappan, Malaiyalam; Hegde, Ramanujan S.; Keenan, Robert J.			The structural basis of tail-anchored membrane protein recognition by Get3	NATURE			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; ARSA-ATPASE; CRYSTALLOGRAPHIC STRUCTURE; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SIGNAL; PARTICLE; INSERTION; BINDING	Targeting of newly synthesized membrane proteins to the endoplasmic reticulum is an essential cellular process. Most membrane proteins are recognized and targeted co-translationally by the signal recognition particle. However, nearly 5% of membrane proteins are 'tail-anchored' by a single carboxy-terminal transmembrane domain that cannot access the co-translational pathway. Instead, tail-anchored proteins are targeted post-translationally by a conserved ATPase termed Get3. The mechanistic basis for tail-anchored protein recognition or targeting by Get3 is not known. Here we present crystal structures of yeast Get3 in 'open' (nucleotide-free) and 'closed' (ADP center dot AlF4--bound) dimer states. In the closed state, the dimer interface of Get3 contains an enormous hydrophobic groove implicated by mutational analyses in tail-anchored protein binding. In the open state, Get3 undergoes a striking rearrangement that disrupts the groove and shields its hydrophobic surfaces. These data provide a molecular mechanism for nucleotide-regulated binding and release of tail-anchored proteins during their membrane targeting by Get3.	[Mateja, Agnieszka; Szlachcic, Anna; Downing, Maureen E.; Dobosz, Malgorzata; Keenan, Robert J.] Univ Chicago, Dept Biochem & Mol Biol, Gordon Ctr Integrat Sci, Chicago, IL 60637 USA; [Mariappan, Malaiyalam; Hegde, Ramanujan S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Szlachcic, Anna] Univ Wroclaw, Fac Biotechnol, Dept Prot Engn, PL-50137 Wroclaw, Poland; [Dobosz, Malgorzata] Jagiellonian Univ, Fac Chem, PL-30060 Krakow, Poland	University of Chicago; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Wroclaw; Jagiellonian University	Keenan, RJ (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, Gordon Ctr Integrat Sci, Room W238,920 E 57th St, Chicago, IL 60637 USA.	bkeenan@uchicago.edu	mariappan, malaiyalam/K-9024-2012	Keenan, Robert/0000-0003-1466-0889; Hegde, Ramanujan/0000-0001-8338-852X; Dobosz-Bartoszek, Malgorzata/0000-0001-7773-596X; Szlachcic, Anna/0000-0003-0574-1476	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Edward Mallinckrodt, Jr. Foundation; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086487] Funding Source: NIH RePORTER	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Edward Mallinckrodt, Jr. Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data were collected at beamlines 21-IDG and 23-IDD at the Advanced Photon Source (APS), Argonne National Laboratory, and we thank the beamline staff for support. Use of the APS was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. We thank B. Glick and R. Strack for reagents and advice, X. Li for assay characterization, and A. Shiau and T. Steck for comments on the manuscript. This work was supported by a grant from the Edward Mallinckrodt, Jr. Foundation (to R. J. K.) and by the Intramural Research Program of the National Institutes of Health (to R. S. H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Freymann DM, 1997, NATURE, V385, P361, DOI 10.1038/385361a0; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; Hayashi I, 2001, EMBO J, V20, P1819, DOI 10.1093/emboj/20.8.1819; Horie C, 2002, MOL BIOL CELL, V13, P1615, DOI 10.1091/mbc.01-12-0570; Jiang Y, 2005, J BIOL CHEM, V280, P9921, DOI 10.1074/jbc.M413391200; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Kiianitsa K, 2003, ANAL BIOCHEM, V321, P266, DOI 10.1016/S0003-2697(03)00461-5; Kurdi-Haidar B, 1998, J BIOL CHEM, V273, P22173, DOI 10.1074/jbc.273.35.22173; KurdiHaidar B, 1996, GENOMICS, V36, P486, DOI 10.1006/geno.1996.0494; Kuroda R, 1998, J BIOL CHEM, V273, P31097, DOI 10.1074/jbc.273.47.31097; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Metz J, 2006, J BIOL CHEM, V281, P410, DOI 10.1074/jbc.M507481200; Montoya G, 1997, NATURE, V385, P365, DOI 10.1038/385365a0; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rosen BP, 1999, BBA-BIOMEMBRANES, V1461, P207, DOI 10.1016/S0005-2736(99)00159-5; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VOGEL G, 1976, BIOCHEMISTRY-US, V15, P208, DOI 10.1021/bi00646a032; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Zhou TQ, 2000, EMBO J, V19, P4838, DOI 10.1093/emboj/19.17.4838; Zhou TQ, 2001, J BIOL CHEM, V276, P30414, DOI 10.1074/jbc.M103671200	40	131	133	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					361	U58		10.1038/nature08319	http://dx.doi.org/10.1038/nature08319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19675567	Green Accepted			2022-12-24	WOS:000269828100032
J	Kumar, R; St John, J; Devendra, D				Kumar, Raekha; St John, Joan; Devendra, Devasenan			10-Minute Consultation Hirsutism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kumar, Raekha; Devendra, Devasenan] Cent Middlesex Hosp, Jeffrey Kelson Diabet Ctr, Imperial Coll Sch Med, London NW10 7NS, England; [St John, Joan] Law Med Practice Grp, Wembley HA9 6QQ, Middx, England	Imperial College London	Devendra, D (corresponding author), Cent Middlesex Hosp, Jeffrey Kelson Diabet Ctr, Imperial Coll Sch Med, London NW10 7NS, England.	d.devendra@imperial.ac.uk							0	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2009	339								b3090	10.1136/bmj.b3090	http://dx.doi.org/10.1136/bmj.b3090			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489AZ	19717498				2022-12-24	WOS:000269393200001
J	Salvage, AV; Quinn, B				Salvage, Ann V.; Quinn, Barry			Practice A Patient's Journey Cancer and chemotherapy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Quinn, Barry] Univ London St Georges Hosp, London SW17 0QT, England	St Georges University London	Quinn, B (corresponding author), Univ London St Georges Hosp, London SW17 0QT, England.	barry.quinn@stgeorges.nhs.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2009	339								b2875	10.1136/bmj.b2875	http://dx.doi.org/10.1136/bmj.b2875			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489AP	19703923				2022-12-24	WOS:000269392100001
J	Okie, S				Okie, Susan			Multinational Medicines - Ensuring Drug Quality in an Era of Global Manufacturing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												susan.okie@verizon.net						Government Accountability Office, 2008, GOV ACC OFF PUBL; *I SAF MED PRACT, 2009, QUARTERWATCH 2008 QU	2	13	14	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 20	2009	361	8					737	740		10.1056/NEJMp0903870	http://dx.doi.org/10.1056/NEJMp0903870			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484WX	19692686				2022-12-24	WOS:000269081200001
J	Grijalva, CG; Nuorti, JP; Griffin, MR				Grijalva, Carlos G.; Nuorti, J. Pekka; Griffin, Marie R.			Antibiotic Prescription Rates for Acute Respiratory Tract Infections in US Ambulatory Settings	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; ACUTE OTITIS-MEDIA; COMMUNITY-ACQUIRED PNEUMONIA; HEALTH-CARE UTILIZATION; UNITED-STATES; STREPTOCOCCUS-PNEUMONIAE; CHILDHOOD IMMUNIZATION; CHANGING EPIDEMIOLOGY; DISEASES-SOCIETY; YOUNG-CHILDREN	Context During the 1990s, antibiotic prescriptions for acute respiratory tract infection (ARTI) decreased in the United States. The sustainability of those changes is unknown. Objective To assess trends in antibiotic prescriptions for ARTI. Design, Setting, and Participants The National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey data (1995-2006) were used to examine trends in antibiotic prescription rates by antibiotic indication and class. Annual survey data and census denominators were combined in 2-year intervals for rate calculations. Main Outcome Measures National annual visit rates and antibiotic prescription rates for ARTI, including otitis media (OM) and non-ARTI. Results Among children younger than 5 years, annual ARTI visit rates decreased by 17% (95% confidence interval [CI], 9%-24%), from 1883 per 1000 population in 1995-1996 to 1560 per 1000 population in 2005-2006, primarily due to a 33% (95% CI, 22%-43%) decrease in OM visit rates (950 to 634 per 1000 population, respectively). This decrease was accompanied by a 36% (95% CI, 26%-45%) decrease in ARTI-associated antibiotic prescriptions (1216 to 779 per 1000 population). Among persons aged 5 years or older, ARTI visit rates remained stable but associated antibiotic prescription rates decreased by 18% (95% CI, 6%-29%), from 178 to 146 per 1000 population. Antibiotic prescription rates for non-OM ARTI for which antibiotics are rarely indicated decreased by 41% (95% CI, 22%-55%) and 24% (95% CI, 10%-37%) among persons younger than 5 years and 5 years or older, respectively. Overall, ARTI-associated prescription rates for penicillin, cephalosporin, and sulfonamide/tetracycline decreased. Prescription rates for azithromycin increased and it became the most commonly prescribed macrolide for ARTI and OM (10% of OM visits). Among adults, quinolone prescriptions increased. Conclusions Overall antibiotic prescription rates for ARTI decreased, associated with fewer OM visits in children younger than 5 years and with fewer prescriptions for ARTI for which antibiotics are rarely indicated. However, prescription rates for broad-spectrum antibiotics increased significantly. JAMA. 2009;302(7):758-766	[Grijalva, Carlos G.; Griffin, Marie R.] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37232 USA; [Griffin, Marie R.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Nuorti, J. Pekka] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Vanderbilt University; Vanderbilt University; Centers for Disease Control & Prevention - USA	Grijalva, CG (corresponding author), Vanderbilt Univ, Sch Med, Dept Prevent Med, 1500 21st Ave,Ste 2600, Nashville, TN 37232 USA.	carlos.grijalva@vanderbilt.edu		Grijalva, Carlos/0000-0002-2329-7797	MedImmune; Pfizer; Centers for Disease Control and Prevention (CDC) [TS-1392, TS-1454, K01 CI000163]; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES [K01IP000163] Funding Source: NIH RePORTER	MedImmune(AstraZenecaMedimmune); Pfizer(Pfizer); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Drs Grijalva and Griffin reported receiving lecture fees and negotiating potential research support from Wyeth. Dr Griffin reported receiving grant support from MedImmune and Pfizer. Dr Nuorti reported no disclosures.; This study was funded by the Centers for Disease Control and Prevention (CDC) through Cooperative Agreements with the Association for Prevention Teaching and Research (TS-1392 and TS-1454). Dr Grijalva is supported by a CDC career development award (K01 CI000163).	Besser RE, 2003, ANN INTERN MED, V138, P605, DOI 10.7326/0003-4819-138-7-200304010-00020; Black S, 2008, CLIN INFECT DIS, V47, P485, DOI 10.1086/590002; Centers for Disease Control and Prevention, ACT BACT COR SURV AB; Centers for Disease Control and Prevention, GET SMART KNOW ANT W; CHANCEY S, 2008, 6 INT S PNEUM PNEUM; Cosby JL, 2007, LANCET INFECT DIS, V7, P749, DOI 10.1016/S1473-3099(07)70263-3; Dagan R, 2009, J INFECT DIS, V199, P776, DOI 10.1086/597044; Doern GV, 2006, MED CLIN N AM, V90, P1109, DOI 10.1016/j.mcna.2006.07.010; Dowell SF, 1998, AM FAM PHYSICIAN, V58, P1335; Dowell SF, 1998, AM FAM PHYSICIAN, V58, P1113; Dowell SF, 1998, PEDIATRICS, V101, P163; Dowell SF, 1998, AM FAM PHYSICIAN, V58, P1345; Felmingham D, 2002, J ANTIMICROB CHEMOTH, V50, P25, DOI 10.1093/jac/dkf808; Finkelstein JA, 2005, PEDIATRICS, V115, P1466, DOI 10.1542/peds.2004-1473; Finkelstein JA, 2003, PEDIATRICS, V112, P620, DOI 10.1542/peds.112.3.620; Finkelstein JA, 2008, PEDIATRICS, V121, pE15, DOI 10.1542/peds.2007-0819; Gonzales R, 2008, MED CARE, V46, P597, DOI 10.1097/MLR.0b013e3181653d2e; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Grijalva CG, 2006, PEDIATRICS, V118, P865, DOI 10.1542/peds.2006-0492; Halasa NB, 2002, PEDIATR INFECT DIS J, V21, P1023, DOI 10.1097/00006454-200211000-00009; Healthy People 2010, 2010, HLTH PEOPLE 2010; Hyde TB, 2001, JAMA-J AM MED ASSOC, V286, P1857, DOI 10.1001/jama.286.15.1857; Jacobs RF, 2000, PEDIATR INFECT DIS J, V19, P938, DOI 10.1097/00006454-200009000-00038; Karchmer AW, 2004, CLIN INFECT DIS, V39, pS142, DOI 10.1086/421352; Klugman KP, 2005, EMERG INFECT DIS, V11, P802, DOI 10.3201/eid1106.050147; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lacapa R, 2008, CLIN INFECT DIS, V47, P476, DOI 10.1086/590001; Lieberman JM, 2003, PEDIATR INFECT DIS J, V22, P1143, DOI 10.1097/01.inf.0000101851.57263.63; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Linder JA, 2005, PHARMACOEPIDEM DR S, V14, P531, DOI 10.1002/pds.1067; Linder JA, 2005, AM J MED, V118, P259, DOI 10.1016/j.amjmed.2004.09.015; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; McCaig LF, 2002, JAMA-J AM MED ASSOC, V287, P3096, DOI 10.1001/jama.287.23.3096; McCaig LF, 2003, EMERG INFECT DIS, V9, P432; McKenna S, 2001, Can J Infect Dis, V12, P218; McWilliams DB, 2008, ARCH PEDIAT ADOL MED, V162, P151, DOI 10.1001/archpediatrics.2007.30; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; *NAT CTR HLTH STAT, AMB HLTH CAR DAT NHA; National Center for Health Statistics, 2011, AMB HLTH CAR DAT NAM; NIEDERMAN MS, 1993, AM REV RESPIR DIS, V148, P1418, DOI 10.1164/ajrccm/148.5.1418; Panpanich R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001954.pub3; Poehling KA, 2007, PEDIATRICS, V119, P707, DOI 10.1542/peds.2006-2138; Roumie CL, 2005, J GEN INTERN MED, V20, P697, DOI 10.1111/j.1525-1497.2005.0148.x; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Steinman MA, 2003, JAMA-J AM MED ASSOC, V289, P719, DOI 10.1001/jama.289.6.719; Steinman MA, 2003, ANN INTERN MED, V138, P525, DOI 10.7326/0003-4819-138-7-200304010-00008; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; *US BUR CENS, POP EST DAT SETS; Vernacchio L, 2007, PEDIATRICS, V120, P281, DOI 10.1542/peds.2006-3601; von Gottberg A, 2008, LANCET, V371, P1108, DOI 10.1016/S0140-6736(08)60350-5; Weissman Jennifer, 2004, Semin Pediatr Infect Dis, V15, P41, DOI 10.1053/j.spid.2004.01.004; Zhou FJ, 2008, PEDIATRICS, V121, P253, DOI 10.1542/peds.2007-0619; Zhou FJ, 2007, ARCH PEDIAT ADOL MED, V161, P1162, DOI 10.1001/archpedi.161.12.1162	53	369	379	2	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 19	2009	302	7					758	766		10.1001/jama.2009.1163	http://dx.doi.org/10.1001/jama.2009.1163			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484UT	19690308	Green Accepted, Bronze			2022-12-24	WOS:000269073800024
J	Haller, G; Myles, PS; Taffe, P; Perneger, TV; Wu, CL				Haller, Guy; Myles, Paul S.; Taffe, Patrick; Perneger, Thomas V.; Wu, Christopher L.			Rate of undesirable events at beginning of academic year: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CREW RESOURCE-MANAGEMENT; INTENSIVE-CARE-UNIT; LENGTH-OF-STAY; ADVERSE EVENTS; JULY PHENOMENON; PATIENT SAFETY; ERRORS; QUALITY; ANESTHESIA; RESIDENTS	Objective To determine whether an increase in the rate of undesirable events occurs after care provided by trainees at the beginning of the academic year. Design Retrospective cohort study using administrative and patient record data. Setting University affiliated hospital in Melbourne, Australia. Participants 19 560 patients having an anaesthetic procedure carried out by first to fifth year trainees starting work for the first time at the hospital over a period of five years (1995-2000). Main outcome measures Absolute event rates, absolute rate reduction, and rate ratios of undesirable events. Results The rate of undesirable events was higher at the beginning of the academic year compared with the rest of the year (absolute event rate 137 v 107 per 1000 patient hours, relative rate reduction 28%, P<0.001). The overall adjusted rate ratio for undesirable events was 1.40, 95% confidence interval 1.24 to 1.58. This excess risk was seen for all residents, regardless of their level of seniority. The excess risk decreased progressively after the first month, and the trend disappeared fully after the fourth month of the year (rate ratio for fourth month 1.21, 0.93 to 1.57). The most important decreases were for central and peripheral nerve injuries (relative difference 82%), inadequate oxygenation of the patient (66%), vomiting/aspiration in theatre (53%), and technical failures of tracheal tube placement (49%). Conclusions The rate of undesirable events was greater among trainees at the beginning of the academic year regardless of their level of clinical experience. This suggests that several additional factors, such as knowledge of the working environment, teamwork, and communication, may contribute to the increase.	[Haller, Guy] Univ Geneva, Univ Hosp Geneva, Dept Anaesthesia Pharmacol & Intens Care, CH-1211 Geneva, Switzerland; [Myles, Paul S.] Monash Univ, Dept Anaesthesia & Perioperat Med, Alfred Hosp, Prahran, Vic 3181, Australia; [Taffe, Patrick] Univ Lausanne, Inst Social & Prevent Med, CH-1005 Lausanne, Switzerland; [Perneger, Thomas V.] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland; [Wu, Christopher L.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	University of Geneva; Florey Institute of Neuroscience & Mental Health; Monash University; University of Lausanne; University of Geneva; Johns Hopkins University	Haller, G (corresponding author), Univ Geneva, Univ Hosp Geneva, Dept Anaesthesia Pharmacol & Intens Care, CH-1211 Geneva, Switzerland.	Guy.Haller@hcuge.ch	Myles, Paul/AAU-9524-2020; Taffé, Patrick/AAW-2701-2020; Wu, Christopher/AAH-5389-2020	Myles, Paul/0000-0002-3324-5456; Taffe, Patrick/0000-0002-2049-6651; Wu, Christopher/0000-0002-4484-0787; haller, guy/0000-0001-7367-7029	University of Geneva (Switzerland)	University of Geneva (Switzerland)	This research was supported by a University of Geneva (Switzerland) postgraduate research scholarship awarded to GH. The sponsor had no role in study design; data collection, analysis, and interpretation; or publication of results. The researchers were all independent from the funder.	Abeysekera A, 2005, ANAESTHESIA, V60, P220, DOI 10.1111/j.1365-2044.2005.04123.x; *AM SOC AN, 2008, ASA STAND GUID STAT; Andrews LB, 1997, LANCET, V349, P309, DOI 10.1016/S0140-6736(96)08268-2; *ANZCA, 2006, PROF STAND ANZCA, V6; AYLIN P, 1994, BRIT MED J, V309, P1690, DOI 10.1136/bmj.309.6970.1690; Baldwin DC, 2008, J INTERPROF CARE, V22, P573, DOI 10.1080/13561820802364740; Barry WA, 2003, J GEN INTERN MED, V18, P639, DOI 10.1046/j.1525-1497.2003.20605.x; Barzansky B, 2008, JAMA-J AM MED ASSOC, V300, P1221, DOI 10.1001/jama.300.10.1221; BELL BM, 1993, JAMA-J AM MED ASSOC, V269, P403, DOI 10.1001/jama.269.3.403; Booth JG, 2003, STAT MODEL, V3, P179, DOI 10.1191/1471082X03st058oa; BUCHWALD D, 1989, ARCH INTERN MED, V149, P765, DOI 10.1001/archinte.149.4.765; Claridge JA, 2001, SURGERY, V130, P346, DOI 10.1067/msy.2001.116670; Cosgrove CM, 2002, ANN ROY COLL SURG, V84, P344, DOI 10.1308/003588402760452691; Cruess SR, 2004, TEACH LEARN MED, V16, P74, DOI 10.1207/s15328015tlm1601_15; Dhaliwal AS, 2008, AM J SURG, V196, P720, DOI 10.1016/j.amjsurg.2008.07.005; Dunn EJ, 2007, JT COMM J QUAL PATIE, V33, P317, DOI 10.1016/S1553-7250(07)33036-5; Englesbe MJ, 2007, ANN SURG, V246, P456, DOI 10.1097/SLA.0b013e31814855f2; Epstein RM, 2002, JAMA-J AM MED ASSOC, V287, P226, DOI 10.1001/jama.287.2.226; Finkielman JD, 2004, CRIT CARE MED, V32, P1161, DOI 10.1097/01.CCM.0000126151.56590.99; Ford AA, 2007, J PERINATOL, V27, P73, DOI 10.1038/sj.jp.7211635; FRESS EW, 2004, LONGITUDINAL PANEL D; Gawande A., 2002, COMPLICATIONS SURG N; Haller G, 2005, ANESTHESIOLOGY, V103, P1121, DOI 10.1097/00000542-200512010-00004; Haller G, 2008, INT J QUAL HEALTH C, V20, P254, DOI 10.1093/intqhc/mzn018; Haller G, 2007, J AM MED INFORM ASSN, V14, P175, DOI 10.1197/jamia.M2196; Institute of Medicine, 2004, PATIENT SAFETY ACHIE; Issenberg SB, 1999, JAMA-J AM MED ASSOC, V282, P861, DOI 10.1001/jama.282.9.861; Jagsi R, 2005, ARCH INTERN MED, V165, P2607, DOI 10.1001/archinte.165.22.2607; Kluger MT, 1999, ANAESTHESIA, V54, P19, DOI 10.1046/j.1365-2044.1999.00642.x; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Kopacz DJ, 2002, REGION ANESTH PAIN M, V27, P9, DOI 10.1053/rapm.2002.29715; Lesar TS, 1997, JAMA-J AM MED ASSOC, V277, P312, DOI 10.1001/jama.277.4.312; MARSHALL JB, 1995, GASTROINTEST ENDOSC, V42, P287, DOI 10.1016/S0016-5107(95)70123-0; Mellin-Olsen J, 2007, EUR J ANAESTH, V24, P479, DOI 10.1017/S0265021507000324; Michel P, 2004, BRIT MED J, V328, P199, DOI 10.1136/bmj.328.7433.199; Norman J, 1996, J CLIN MONITOR, V12, P91; *ORG EC COOP DEV, OECD HLTH DAT 2008; Parke B, 2008, INT J AVIAT PSYCHOL, V18, P72, DOI 10.1080/10508410701749464; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Prystowsky JB, 2002, SURGERY, V132, P663, DOI 10.1067/msy.2002.127550; RICH EC, 1990, JAMA-J AM MED ASSOC, V263, P953; Rogers SO, 2006, SURGERY, V140, P25, DOI 10.1016/j.surg.2006.01.008; RUNCIMAN WB, 1993, ANAESTH INTENS CARE, V21, P506, DOI 10.1177/0310057X9302100506; SEE WA, 1993, JAMA-J AM MED ASSOC, V270, P2689, DOI 10.1001/jama.270.22.2689; SHNIDER SM, 1963, ANESTHESIOLOGY, V24, P11, DOI 10.1097/00000542-196301000-00002; Shulkin D J, 1995, Am J Med Qual, V10, P14, DOI 10.1177/0885713X9501000104; Smith ER, 2006, J NEUROSURG, V105, P169, DOI 10.3171/ped.2006.105.3.169; Volpp KGM, 2003, NEW ENGL J MED, V348, P851, DOI 10.1056/NEJMsb021667; *WHO, 2000, ICD 10 AM INT STAT C	50	83	84	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2009	339								b3974	10.1136/bmj.b3974	http://dx.doi.org/10.1136/bmj.b3974			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508DO	19826176	hybrid, Green Published, Green Submitted			2022-12-24	WOS:000270908100003
J	Blandin, SA; Wang-Sattler, R; Lamacchia, M; Gagneur, J; Lycett, G; Ning, Y; Levashina, EA; Steinmetz, LM				Blandin, Stephanie A.; Wang-Sattler, Rui; Lamacchia, Marina; Gagneur, Julien; Lycett, Gareth; Ning, Ye; Levashina, Elena A.; Steinmetz, Lars M.			Dissecting the Genetic Basis of Resistance to Malaria Parasites in Anopheles gambiae	SCIENCE			English	Article							COMPLEMENT-LIKE PROTEIN; QUANTITATIVE TRAIT LOCI; MELANIZATION RESPONSE; PLASMODIUM-BERGHEI; MOSQUITO; TEP1	The ability of Anopheles gambiae mosquitoes to transmit Plasmodium parasites is highly variable between individuals. However, the genetic basis of this variability has remained unknown. We combined genome-wide mapping and reciprocal allele-specific RNA interference (rasRNAi) to identify the genomic locus that confers resistance to malaria parasites and demonstrated that polymorphisms in a single gene encoding the antiparasitic thioester-containing protein 1 (TEP1) explain a substantial part of the variability in parasite killing. The link between TEP1 alleles and resistance to malaria may offer new tools for controlling malaria transmission. The successful application of rasRNAi in Anopheles suggests that it could also be applied to other organisms where RNAi is feasible to dissect complex phenotypes to the level of individual quantitative trait alleles.	[Blandin, Stephanie A.; Wang-Sattler, Rui; Gagneur, Julien; Lycett, Gareth; Ning, Ye; Steinmetz, Lars M.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Blandin, Stephanie A.; Lamacchia, Marina; Levashina, Elena A.] INSERM, CNRS, UPR9022, U963, F-67084 Strasbourg, France; [Wang-Sattler, Rui] Helmholtz Zentrum Munchen, Inst Epidemiol, D-85764 Munich, Germany	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Steinmetz, LM (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	larsms@embl.de	Wang-Sattler, Rui/B-5354-2014; Blandin, Stephanie/I-2786-2016; Blandin, Stephanie/ABH-2267-2021	Wang-Sattler, Rui/0000-0002-8794-8229; Blandin, Stephanie/0000-0003-4566-1200; Blandin, Stephanie/0000-0003-4566-1200; Levashina, Elena/0000-0003-4605-906X; Lycett, Gareth/0000-0002-2422-053X; Steinmetz, Lars/0000-0002-3962-2865; Gagneur, Julien/0000-0002-8924-8365	NIH; Deutsche Forschungsgemeinschaft; CNRS; INSERM; European Molecular Biology Organization (EMBO) Young Investigators Program; European Commission Network of Excellence "BioMalPar"; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068717] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Molecular Biology Organization (EMBO) Young Investigators Program(European Molecular Biology Organization (EMBO)); European Commission Network of Excellence "BioMalPar"; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Cohuet for sharing sequencing information, R. Carmouche and J. Luis from the EMBL Genecore facility for support with genotyping, R. Bourgon for advice on statistical analyses, A. Budd for suggestions on the phylogenetic analysis, D. Doherty and J. Soichot for help with breeding mosquitoes, and E. Marois and C. Ramakrishnan for comments on the manuscript. We acknowledge the support of F. Kafatos, in whose laboratory this work was initially carried out. This work was supported by grants from NIH and the Deutsche Forschungsgemeinschaft ( L. M. S.), CNRS and INSERM ( E. A. L. and S. A. B), the European Molecular Biology Organization (EMBO) Young Investigators Program ( E. A. L.), and the European Commission Network of Excellence "BioMalPar" ( E. A. L.). S. A. B. received a postdoctoral fellowship from EMBO. E. A. L. is an international Howard Hughes Medical Institute research scholar. EMBL Nucleotide Sequence Database accession numbers for TEP1 alleles sequenced in this report are as follows: FN431782 to FN431785.	Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin SA, 2008, CELL HOST MICROBE, V3, P364, DOI 10.1016/j.chom.2008.05.007; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Gorman MJ, 1997, AM J TROP MED HYG, V56, P446, DOI 10.4269/ajtmh.1997.56.446; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; Obbard DJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-274; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Shiao SH, 2006, PLOS PATHOG, V2, P1152, DOI 10.1371/journal.ppat.0020133; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; VERNICK KD, 1995, EXP PARASITOL, V80, P583, DOI 10.1006/expr.1995.1074; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862; Zheng LB, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-16; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	21	80	84	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					147	150		10.1126/science.1175241	http://dx.doi.org/10.1126/science.1175241			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797663	Green Accepted			2022-12-24	WOS:000270355600057
J	Sinha, M; Watanabe, S; Johnson, A; Moazed, D; Peterson, CL				Sinha, Manisha; Watanabe, Shinya; Johnson, Aaron; Moazed, Danesh; Peterson, Craig L.			Recombinational Repair within Heterochromatin Requires ATP-Dependent Chromatin Remodeling	CELL			English	Article							DOUBLE-STRAND BREAK; POSITION-EFFECT VARIEGATION; SACCHAROMYCES-CEREVISIAE; SILENT CHROMATIN; DNA-DAMAGE; TELOMERIC HETEROCHROMATIN; NUCLEOSOME COMPLEX; FISSION YEAST; HISTONE H3; IN-VITRO	Heterochromatin plays a key role in protection of chromosome integrity by suppressing homologous recombination. In Saccharomyces cerevisiae, Sir2p, Sir3p, and Sir4p are structural components of heterochromatin found at telomeres and the silent mating-type loci. Here we have investigated whether incorporation of Sir proteins into minichromosomes regulates early steps of recombinational repair in vitro. We find that addition of Sir3p to a nucleosomal substrate is sufficient to eliminate yRad51p-catalyzed formation of joints, and that this repression is enhanced by Sir2p/Sir4p. Importantly, Sir-mediated repression requires histone residues that are critical for silencing in vivo. Moreover, we demonstrate that the SWI/SNF chromatin-remodeling enzyme facilitates joint formation by evicting Sir3p, thereby promoting subsequent Rad54p-dependent formation of a strand invasion product. These results suggest that recombinational repair in the context of heterochromatin presents additional constraints that can be overcome by ATP-dependent chromatin-remodeling enzymes.	[Sinha, Manisha; Watanabe, Shinya; Peterson, Craig L.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Sinha, Manisha] Univ Massachusetts, Sch Med, Interdisciplinary Grad Program, Worcester, MA 01605 USA; [Johnson, Aaron; Moazed, Danesh] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Moazed, Danesh] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Peterson, CL (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	craig.peterson@umassmed.edu			National Institutes of Health [GM54096, GM061641]; a Ruth L. Kirschstein National Research Service Award; National Institute of General Medical Sciences [F32 GM078799]; Howard Hughes Medical Institute investigator; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054096, F32GM078799, R37GM049650, R01GM061641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); a Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute investigator(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Anthony Imbalzano (UMMS) for antibody to the FLAG epitope and Blaine Bartholomew ( University of. S. Illinois) for providing the strain harboring the RSC2-TAP allele. We apologize to those colleagues whose work we were unable to cite due to space restrictions. This work was supported by grants from the National Institutes of Health to C. L. P. (GM54096) and to D. M. (GM061641) and by a Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship through the National Institute of General Medical Sciences to A. J. (F32 GM078799). D. M. is a Howard Hughes Medical Institute investigator.	ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Barton AB, 2008, GENETICS, V179, P1221, DOI 10.1534/genetics.107.083493; Bruno M, 2003, MOL CELL, V12, P1599, DOI 10.1016/S1097-2765(03)00499-4; Buchberger JR, 2008, MOL CELL BIOL, V28, P6903, DOI 10.1128/MCB.01210-08; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Chaban Y, 2008, NAT STRUCT MOL BIOL, V15, P1272, DOI 10.1038/nsmb.1524; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Dechassa ML, 2008, MOL CELL BIOL, V28, P6010, DOI 10.1128/MCB.00693-08; Georgel PT, 2001, P NATL ACAD SCI USA, V98, P8584, DOI 10.1073/pnas.151258798; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Ikeda K, 1999, MOL CELL BIOL, V19, P855; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jaco I, 2008, J CELL BIOL, V181, P885, DOI 10.1083/jcb.200803042; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Logie C, 1999, METHOD ENZYMOL, V304, P726; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LOO S, 1994, SCIENCE, V264, P1768, DOI 10.1126/science.8209257; Luger K, 1999, METH MOL B, V119, P1; Martino F, 2009, MOL CELL, V33, P323, DOI 10.1016/j.molcel.2009.01.009; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; Osley MA, 2007, MUTAT RES-FUND MOL M, V618, P65, DOI 10.1016/j.mrfmmm.2006.07.011; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; PASSARGE E, 1979, AM J HUM GENET, V31, P106; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; RIDDLES PW, 1985, J BIOL CHEM, V260, P165; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Savitsky M, 2002, MOL CELL BIOL, V22, P3204, DOI 10.1128/MCB.22.9.3204-3218.2002; Schmuckli-Maurer J, 1999, MOL GEN GENET, V260, P551, DOI 10.1007/s004380050928; Sinha M, 2008, MOL CELL, V30, P803, DOI 10.1016/j.molcel.2008.04.015; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; Solinger JA, 2001, J MOL BIOL, V307, P1207, DOI 10.1006/jmbi.2001.4555; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Tsukuda T, 2009, DNA REPAIR, V8, P360, DOI 10.1016/j.dnarep.2008.11.014; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Westphal T, 2002, GENETICS, V160, P609; White SA, 2008, CURR TOP MICROBIOL, V320, P157; Wolner B, 2005, J BIOL CHEM, V280, P10855, DOI 10.1074/jbc.M414388200; Zaitseva EM, 1999, J BIOL CHEM, V274, P2907, DOI 10.1074/jbc.274.5.2907; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025; Zou S, 1996, GENE DEV, V10, P634, DOI 10.1101/gad.10.5.634	54	61	61	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1109	1121		10.1016/j.cell.2009.07.013	http://dx.doi.org/10.1016/j.cell.2009.07.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766565	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000269923200012
J	Jackson, CE; Solomon, SD; Gerstein, HC; Zetterstrand, S; Olofsson, B; Michelson, EL; Granger, CB; Swedberg, K; Pfeffer, MA; Yusuf, S; McMurray, JJV				Jackson, Colette E.; Solomon, Scott D.; Gerstein, Hertzel C.; Zetterstrand, Sofia; Olofsson, Bertil; Michelson, Eric L.; Granger, Christopher B.; Swedberg, Karl; Pfeffer, Marc A.; Yusuf, Salim; McMurray, John J. V.		CHARM Investigators Comm	Albuminuria in chronic heart failure: prevalence and prognostic importance	LANCET			English	Article							CARDIOVASCULAR RISK; RENAL-FUNCTION; CLINICAL PROTEINURIA; BROAD-SPECTRUM; MORTALITY; MICROALBUMINURIA; MORBIDITY; DISEASE; CANDESARTAN; EVENTS	Background Increased excretion of albumin in urine might be a marker of the various pathophysiological changes that arise in patients with heart failure. Therefore our aim was to assess the prevalence and prognostic value of a spot urinary albumin to creatinine ratio (UACR) in patients with heart failure. Methods UACR was measured at baseline and during follow-up of 2310 patients in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Programme. The prevalence of microalbuminuria and macroalbuminuria, and the predictive value of UACR for the primary composite outcome of each CHARM study-ie, death from cardiovascular causes or admission to hospital with worsening heart failure-and death from any cause were assessed. Findings 1349 (58%) patients had a normal UACR 704 (30%) had microalbuminuria, and 257 (11%) had macroalbuminuria. The prevalence of increased UACR was similar in patients with reduced and preserved left ventricular ejection fractions. Patients with an increased UACR were older, had more cardiovascular comorbidity, worse renal function, and a higher prevalence of diabetes mellitus than did those with normoalbuminuria. However, a high prevalence of increased UACR was still noted among patients without diabetes, hypertension, or renal dysfunction. Elevated UACR was associated with increased risk of the composite outcome and death even after adjustment for other prognostic variables including renal function, diabetes, and haemoglobin A(1c). The adjusted hazard ratio (HR) for the composite outcome in patients with microalbuminuria versus normoalbuminuria was 1.43 (95% CI 1.21-1.69; p<0.0001) and for macroalbuminuria versus normoalbuminuria was 1.75 (1.39-2.20; p<0.0001). The adjusted values for death were 1.62 (1.32-1.99; p<0.0001) for microalbuminuria versus normoalbuminuria, and 1.76 (1.32-2.35; p=0.0001) for macroalbuminuria versus normoalbuminuria. Treatment with candesartan did not reduce or prevent the development of excessive excretion of urinary albumin. Interpretation Increased UACR is a powerful and independent predictor of prognosis in heart failure. Funding AstraZeneca.	[Jackson, Colette E.; McMurray, John J. V.] Univ Glasgow, Cardiovasc Res Ctr, British Heart Fdn, Glasgow G12 8TA, Lanark, Scotland; [Solomon, Scott D.; Pfeffer, Marc A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Gerstein, Hertzel C.; Yusuf, Salim] McMaster Univ & Hamilton Hlth Sci, Dept Med, Hamilton, ON, Canada; [Gerstein, Hertzel C.; Yusuf, Salim] McMaster Univ & Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Zetterstrand, Sofia; Olofsson, Bertil] AstraZeneca Res & Dev, Molndal, Sweden; [Michelson, Eric L.] AstraZeneca, Wilmington, DE USA; [Granger, Christopher B.] Duke Univ, Med Ctr, Durham, NC USA; [Swedberg, Karl] Univ Gothenburg, Sahlgrenska Acad, Dept Emergency & Cardiovasc Med, Gothenburg, Sweden	University of Glasgow; Harvard University; Brigham & Women's Hospital; McMaster University; McMaster University; Population Health Research Institute; AstraZeneca; AstraZeneca; Duke University; University of Gothenburg	McMurray, JJV (corresponding author), Univ Glasgow, Cardiovasc Res Ctr, British Heart Fdn, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	j.mcmurray@bio.gla.ac.uk	Solomon, Scott/I-5789-2013; Granger, Christopher B/D-3458-2014; Gerstein, Hertzel/ABB-8781-2020; mcmurray, John/B-2467-2013; Gerstein, Hertzel C/B-1235-2013; Swedberg, Karl/B-2475-2008	Granger, Christopher B/0000-0002-0045-3291; Gerstein, Hertzel/0000-0001-8072-2836; mcmurray, John/0000-0002-6317-3975; Gerstein, Hertzel C/0000-0001-8072-2836; Yusuf, Salim/0000-0003-4776-5601	AstraZeneca	AstraZeneca(AstraZeneca)	The CHARM Programme was funded by AstraZeneca.	Agewall S, 1997, AM J CARDIOL, V80, P164, DOI 10.1016/S0002-9149(97)00312-3; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Brantsma AH, 2008, NEPHROL DIAL TRANSPL, V23, P3851, DOI 10.1093/ndt/gfn356; Capes SE, 2000, DIABETES CARE, V23, P377, DOI 10.2337/diacare.23.3.377; Chugh Atul, 2007, J Clin Hypertens (Greenwich), V9, P196, DOI 10.1111/j.1524-6175.2007.06445.x; Damman K, 2009, J AM COLL CARDIOL, V53, P582, DOI 10.1016/j.jacc.2008.08.080; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Deckert T, 1996, BRIT MED J, V312, P871; Diercks GFH, 2000, EUR HEART J, V21, P1922, DOI 10.1053/euhj.2000.2248; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gerstein HC, 2008, ARCH INTERN MED, V168, P1699, DOI 10.1001/archinte.168.15.1699; Hillege HL, 2006, CIRCULATION, V113, P671, DOI 10.1161/CIRCULATIONAHA.105.580506; Home P, 2006, DIABETIC MED, V23, P579; Jensen JS, 1997, NEPHROL DIAL TRANSPL, V12, P6; Jose P, 2006, J AM COLL CARDIOL, V47, P1725, DOI 10.1016/j.jacc.2006.01.047; Keane WF, 1999, AM J KIDNEY DIS, V33, P1004, DOI 10.1016/S0272-6386(99)70442-7; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555; Silverberg D, 2004, CURR OPIN NEPHROL HY, V13, P163, DOI 10.1097/00041552-200403000-00004; Smilde TDJ, 2009, CLIN RES CARDIOL, V98, P121, DOI 10.1007/s00392-008-0732-z; Solomon SD, 2007, CIRCULATION, V116, P2687, DOI 10.1161/CIRCULATIONAHA.107.723270; Swedberg K, 1999, J Card Fail, V5, P276, DOI 10.1016/S1071-9164(99)90013-1; Van De Wal RMA, 2005, J CARD FAIL, V11, P602, DOI 10.1016/j.cardfail.2005.05.007; Wachtell K, 2003, ANN INTERN MED, V139, P901, DOI 10.7326/0003-4819-139-11-200312020-00008; WEGRIA R, 1955, J CLIN INVEST, V34, P737, DOI 10.1172/JCI103127; Weir MR, 2007, CLIN J AM SOC NEPHRO, V2, P581, DOI 10.2215/CJN.03190906	30	202	220	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2009	374	9689					543	550		10.1016/S0140-6736(09)61378-7	http://dx.doi.org/10.1016/S0140-6736(09)61378-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	484BX	19683640				2022-12-24	WOS:000269019400022
J	Paukner, A; Suomi, SJ; Visalberghi, E; Ferrari, PF				Paukner, Annika; Suomi, Stephen J.; Visalberghi, Elisabetta; Ferrari, Pier F.			Capuchin Monkeys Display Affiliation Toward Humans Who Imitate Them	SCIENCE			English	Article							MIMICRY; RECOGNITION; SYNCHRONY	During social interactions, humans often unconsciously and unintentionally imitate the behaviors of others, which increases rapport, liking, and empathy between interaction partners. This effect is thought to be an evolutionary adaptation that facilitates group living and may be shared with other primate species. Here, we show that capuchin monkeys, a highly social primate species, prefer human imitators over non-imitators in a variety of ways: The monkeys look longer at imitators, spend more time in proximity to imitators, and choose to interact more frequently with imitators in a token exchange task. These results demonstrate that imitation can promote affiliation in nonhuman primates. Behavior matching that leads to prosocial behaviors toward others may have been one of the mechanisms at the basis of altruistic behavioral tendencies in capuchins and in other primates, including humans.	[Paukner, Annika; Suomi, Stephen J.; Ferrari, Pier F.] Eunice Kennedy Shriver NICHHD, Comparat Ethol Lab, NIH, Anim Ctr, Poolesville, MD 20837 USA; [Visalberghi, Elisabetta] CNR, Ist Sci & Tecnol Cogniz, I-00197 Rome, Italy; [Ferrari, Pier F.] Univ Parma, Dipartimento Biol Evolut & Funz, I-43100 Parma, Italy	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University of Parma	Paukner, A (corresponding author), Eunice Kennedy Shriver NICHHD, Comparat Ethol Lab, NIH, Anim Ctr, POB 529, Poolesville, MD 20837 USA.	pauknera@mail.nih.gov	Ferrari, Pier Francesco/G-5547-2017; Paukner, Annika/ABA-3275-2020	Paukner, Annika/0000-0002-3421-1864; Visalberghi, Elisabetta/0000-0001-7407-5468	Division of Intramural Research; National Institute of Child Health and Human Development; ECT ESF The Evolution of Cooperation and Trading European Science Foundation project SOCCOP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001107] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ECT ESF The Evolution of Cooperation and Trading European Science Foundation project SOCCOP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Division of Intramural Research, National Institute of Child Health and Human Development, and the TECT ESF The Evolution of Cooperation and Trading European Science Foundation project SOCCOP The Social and Mental Dynamics of Cooperation.	Addessi E, 2007, P ROY SOC B-BIOL SCI, V274, P2579, DOI 10.1098/rspb.2007.0726; Agnetta B, 2004, INFANCY, V6, P1, DOI 10.1207/s15327078in0601_1; Agostini I, 2005, AM J PRIMATOL, V65, P335, DOI 10.1002/ajp.20120; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; de Waal F., 2001, APE SUSHI MASTER CUL; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; FRAGASZY DM, 2005, COMPLETE CAPUCHIN; Hattori Y, 2007, ANIM COGN, V10, P141, DOI 10.1007/s10071-006-0049-0; Haun DBM, 2008, CURR BIOL, V18, pR288, DOI 10.1016/j.cub.2008.02.031; HERVE N, 1993, PRIMATES, V34, P227, DOI 10.1007/BF02381395; LAFRANCE M, 1979, US SOC PSYCHOL, V42, P66, DOI 10.2307/3033875; Lakin JL, 2003, J NONVERBAL BEHAV, V27, P145, DOI 10.1023/A:1025389814290; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Meltzoff AN., 1998, INTERSUBJECTIVE COMM, P47; Nielsen M, 2005, ANIM COGN, V8, P31, DOI 10.1007/s10071-004-0232-0; Paukner A, 2005, BIOL LETTERS, V1, P219, DOI 10.1098/rsbl.2004.0291; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; van Baaren RB, 2003, J EXP SOC PSYCHOL, V39, P393, DOI 10.1016/S0022-1031(03)00014-3; Visalberghi E, 2002, FROM ANIM ANIMAT, P471; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x	21	127	130	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					880	883		10.1126/science.1176269	http://dx.doi.org/10.1126/science.1176269			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487AK	19679816	Green Accepted			2022-12-24	WOS:000269242400048
J	Feart, C; Samieri, C; Rondeau, V; Amieva, H; Portet, F; Dartigues, JF; Scarmeas, N; Barberger-Gateau, P				Feart, Catherine; Samieri, Cecilia; Rondeau, Virginie; Amieva, Helene; Portet, Florence; Dartigues, Jean-Francois; Scarmeas, Nikolaos; Barberger-Gateau, Pascale			Adherence to a Mediterranean Diet, Cognitive Decline, and Risk of Dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; PATTERNS; HEALTH; ASSOCIATION; POPULATION; 3-CITY; CONSUMPTION; IMPAIRMENT; SYMPTOMS	Context Higher adherence to a Mediterranean-type diet is linked to lower risk for mortality and chronic diseases, but its association with cognitive decline is unclear. Objective To investigate the association of a Mediterranean diet with change in cognitive performance and risk for dementia in elderly French persons. Design, Setting, and Participants Prospective cohort study of 1410 adults (>= 65 years) from Bordeaux, France, included in the Three-City cohort in 20012002 and reexamined at least once over 5 years. Adherence to a Mediterranean diet ( scored as 0 to 9) was computed from a food frequency questionnaire and 24-hour recall. Main Outcome Measures Cognitive performance was assessed on 4 neuropsychological tests: the Mini-Mental State Examination (MMSE), Isaacs Set Test (IST), Benton Visual Retention Test (BVRT), and Free and Cued Selective Reminding Test (FCSRT). Incident cases of dementia (n=99) were validated by an independent expert committee of neurologists. Results Adjusting for age, sex, education, marital status, energy intake, physical activity, depressive symptomatology, taking 5 medications/d or more, apolipoprotein E genotype, cardiovascular risk factors, and stroke, higher Mediterranean diet score was associated with fewer MMSE errors (beta=-0.006; 95% confidence interval [CI], -0.01 to -0.0003; P=.04 for 1 point of the Mediterranean diet score). Performance on the IST, BVRT, or FCSRT over time was not significantly associated with Mediterranean diet adherence. Greater adherence as a categorical variable (score 6-9) was not significantly associated with fewer MMSE errors and better FCSRT scores in the entire cohort, but among individuals who remained free from dementia over 5 years, the association for the highest compared with the lowest group was significant (adjusted for all factors, for MMSE: beta=-0.03; 95% CI, -0.05 to -0.001; P=.04; for FCSRT: beta=0.21; 95% CI, 0.008 to 0.41; P=. 04). Mediterranean diet adherence was not associated with the risk for incident dementia (fully adjusted model: hazard ratio, 1.12; 95% CI, 0.60 to 2.10; P=.72), although power to detect a difference was limited. Conclusions Higher adherence to a Mediterranean diet was associated with slower MMSE cognitive decline but not consistently with other cognitive tests. Higher adherence was not associated with risk for incident dementia. JAMA. 2009; 302(6):638-648 www.jama.com	[Feart, Catherine] Univ Bordeaux 2, INSERM, Equipe Epidemiol Nutr & Comportements Alimentaire, Res Ctr,ISPED Case 11,U897, F-33076 Bordeaux, France; [Portet, Florence] Univ Montpellier I, INSERM, U888, Montpellier, France; [Scarmeas, Nikolaos] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Columbia University	Feart, C (corresponding author), Univ Bordeaux 2, INSERM, Equipe Epidemiol Nutr & Comportements Alimentaire, Res Ctr,ISPED Case 11,U897, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	catherine.feart@isped.u-bordeaux2.fr	Scarmeas, Nikolaos/AAD-2517-2020; Amieva, Helene/E-4850-2014; Amieva, Helene/T-4170-2019; FEART, Catherine/A-3339-2016; Samieri, Cécilia/E-3334-2014; Scarmeas, Nikolaos/AAD-2512-2020; DARTIGUES, Jean François/T-4513-2019; rondeau, virginie/E-4192-2014; Samieri, Cecilia/T-3267-2019; rondeau, virginie/T-9763-2019	Scarmeas, Nikolaos/0000-0001-6453-8908; Amieva, Helene/0000-0002-0119-7242; Samieri, Cécilia/0000-0001-9809-7506; Scarmeas, Nikolaos/0000-0001-6453-8908; rondeau, virginie/0000-0001-7109-4831; Samieri, Cecilia/0000-0001-9809-7506; rondeau, virginie/0000-0001-7109-4831; FEART, Catherine/0000-0002-7959-1610	Institut National de la Sante et de la Recherche Medicale (INSERM); Institut de Sante Publique et Developpement of the Victor Segalen Bordeaux 2 University; Sanofi-Aventis; The Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Regional Governments of Aquitaine and Bourgogne; Fondation de France; Ministry of Research-INSERM Programme; French National Research Agency [ANR-06PNRA-005]; Association France Alzheimer; Aquitaine Regional Government	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut de Sante Publique et Developpement of the Victor Segalen Bordeaux 2 University; Sanofi-Aventis(Sanofi-Aventis); The Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale; Institut de la Longevite; Regional Governments of Aquitaine and Bourgogne(Region Nouvelle-Aquitaine); Fondation de France(Fondation de France); Ministry of Research-INSERM Programme(Institut National de la Sante et de la Recherche Medicale (Inserm)); French National Research Agency(French National Research Agency (ANR)); Association France Alzheimer; Aquitaine Regional Government(Region Nouvelle-Aquitaine)	The Three-City (3C) Study is conducted under a partnership agreement between the Institut National de la Sante et de la Recherche Medicale (INSERM), the Institut de Sante Publique et Developpement of the Victor Segalen Bordeaux 2 University, and Sanofi-Aventis. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The 3C Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, Mutuelle Generale de l'Education Nationale, Institut de la Longevite, Regional Governments of Aquitaine and Bourgogne, Fondation de France, and Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques." Financial support for the 3C-COGINUT project was provided by the French National Research Agency (ANR-06PNRA-005). Dr Feart was funded by Association France Alzheimer; Dr Samieri was funded by Aquitaine Regional Government.	Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; Bach A, 2006, PUBLIC HEALTH NUTR, V9, P132, DOI 10.1079/PHN2005936; Bach-Faig A, 2006, PUBLIC HEALTH NUTR, V9, P1110, DOI 10.1017/S1368980007668499; Barberger-Gateau P, 2007, NEUROLOGY, V69, P1921, DOI 10.1212/01.wnl.0000278116.37320.52; Benton A, 1965, MANUEL APPL TEST RET; BERKMAN LF, 1986, AM J EPIDEMIOL, V124, P372, DOI 10.1093/oxfordjournals.aje.a114408; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Dai J, 2008, AM J CLIN NUTR, V88, P1364, DOI 10.3945/ajcn.2008.26528; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Engelhart MJ, 2002, JAMA-J AM MED ASSOC, V287, P3223, DOI 10.1001/jama.287.24.3223; Feart C, 2007, BRIT J NUTR, V98, P1046, DOI 10.1017/S0007114507756520; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Giugliano D, 2008, CURR OPIN LIPIDOL, V19, P63, DOI 10.1097/MOL.0b013e3282f2fa4d; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; GROBER E, 1988, NEUROLOGY, V38, P900, DOI 10.1212/WNL.38.6.900; ISAACS B, 1973, BRIT J PSYCHIAT, V123, P467, DOI 10.1192/bjp.123.4.467; JacqminGadda H, 1997, AM J EPIDEMIOL, V145, P498; Jacques PF, 2001, AM J CLIN NUTR, V73, P1, DOI 10.1093/ajcn/73.1.1; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Lamarca R, 1998, J GERONTOL A-BIOL, V53, pM337, DOI 10.1093/gerona/53A.5.M337; Letenneur L, 2007, AM J EPIDEMIOL, V165, P1364, DOI 10.1093/aje/kwm036; Luchsinger JA, 2004, LANCET NEUROL, V3, P579, DOI 10.1016/S1474-4422(04)00878-6; Panza F, 2007, EXP GERONTOL, V42, P6, DOI 10.1016/j.exger.2006.09.011; Reynolds E, 2006, LANCET NEUROL, V5, P949, DOI 10.1016/S1474-4422(06)70598-1; Rock CL, 2007, AM J CLIN NUTR, V85, p277S, DOI 10.1093/ajcn/85.1.277S; Samieri C, 2008, J AM DIET ASSOC, V108, P1461, DOI 10.1016/j.jada.2008.06.437; Sanchez-Villegas A, 2006, PUBLIC HEALTH NUTR, V9, P1104, DOI 10.1017/S1368980007668578; Scarmeas N, 2009, ARCH NEUROL-CHICAGO, V66, P216, DOI 10.1001/archneurol.2008.536; Scarmeas N, 2006, ANN NEUROL, V59, P912, DOI 10.1002/ana.20854; SIMERMANN J, 2007, 25 ANN C SOC FRANC N; Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344; Solfrizzi V, 2006, NEUROBIOL AGING, V27, P1694, DOI 10.1016/j.neurobiolaging.2005.09.026; Stampfer MJ, 2005, NEW ENGL J MED, V352, P245, DOI 10.1056/NEJMoa041152; Steele M, 2007, EXP GERONTOL, V42, P28, DOI 10.1016/j.exger.2006.06.002; Tamers SL, 2009, EUR J CLIN NUTR, V63, P11, DOI 10.1038/ejcn.2008.2; Touvier M, 2009, EUR J CLIN NUTR, V63, P39, DOI 10.1038/sj.ejcn.1602907; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S	39	464	472	1	98	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 12	2009	302	6					638	648		10.1001/jama.2009.1146	http://dx.doi.org/10.1001/jama.2009.1146			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481ZI	19671905	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000268852300022
J	Shine, KI; Rogers, B; Goldfrank, LR				Shine, Kenneth I.; Rogers, Bonnie; Goldfrank, Lewis R.			Novel H1N1 Influenza and Respiratory Protection for Health Care Workers.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shine, Kenneth I.] Univ Texas Syst, Austin, TX USA; [Rogers, Bonnie] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA; [Goldfrank, Lewis R.] NYU, Sch Med, New York, NY USA	University of Texas System; University of Texas Austin; University of North Carolina; University of North Carolina Chapel Hill; New York University	Shine, KI (corresponding author), Univ Texas Syst, Austin, TX USA.							*CDCP, 2009, FLU SYMPT SEV INFL S; Institute of Medicine, 2008, PREP INFL PAND PERS; Institute of Medicine, 2009, RESP PROT HEALTHC WO; Oberg T, 2008, AM J INFECT CONTROL, V36, P276, DOI 10.1016/j.ajic.2007.07.008; Radonovich LJ, 2009, JAMA-J AM MED ASSOC, V301, P36, DOI 10.1001/jama.2008.894	5	34	34	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2009	361	19					1823	1825		10.1056/NEJMp0908437	http://dx.doi.org/10.1056/NEJMp0908437			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514OZ	19797278				2022-12-24	WOS:000271405800004
J	Mancuso, K; Hauswirth, WW; Li, QH; Connor, TB; Kuchenbecker, JA; Mauck, MC; Neitz, J; Neitz, M				Mancuso, Katherine; Hauswirth, William W.; Li, Qiuhong; Connor, Thomas B.; Kuchenbecker, James A.; Mauck, Matthew C.; Neitz, Jay; Neitz, Maureen			Gene therapy for red-green colour blindness in adult primates	NATURE			English	Article							MOLECULAR-GENETICS; VISION; EXPRESSION; RETINA; DEFICIENCY; PIGMENTS	Red-green colour blindness, which results from the absence of either the long-(L) or the middle- (M) wavelength-sensitive visual photopigments, is the most common single locus genetic disorder. Here we explore the possibility of curing colour blindness using gene therapy in experiments on adult monkeys that had been colour blind since birth. A third type of cone pigment was added to dichromatic retinas, providing the receptoral basis for trichromatic colour vision. This opened a new avenue to explore the requirements for establishing the neural circuits for a new dimension of colour sensation. Classic visual deprivation experiments(1) have led to the expectation that neural connections established during development would not appropriately process an input that was not present from birth. Therefore, it was believed that the treatment of congenital vision disorders would be ineffective unless administered to the very young. However, here we show that the addition of a third opsin in adult red-green colour deficient primates was sufficient to produce trichromatic colour vision behaviour. Thus, trichromacy can arise from a single addition of a third cone class and it does not require an early developmental process. This provides a positive outlook for the potential of gene therapy to cure adult vision disorders.	[Mancuso, Katherine; Kuchenbecker, James A.; Neitz, Jay; Neitz, Maureen] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Hauswirth, William W.; Li, Qiuhong] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; [Hauswirth, William W.; Li, Qiuhong] Univ Florida, Powell Gene Therapy Ctr, Gainesville, FL 32610 USA; [Connor, Thomas B.; Mauck, Matthew C.] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA	University of Washington; University of Washington Seattle; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Medical College of Wisconsin	Neitz, J (corresponding author), Univ Washington, Dept Ophthalmol, Box 356485,1959 NE Pacific St, Seattle, WA 98195 USA.	jneitz@uw.edu		Neitz, Maureen/0000-0002-5404-3343; Neitz, Jay/0000-0003-3877-6712; hauswirth, william/0000-0002-3244-4947	National Institutes of Health [R01EY016861, R01EY11123]; Research Training Program in Vision Science [T32EY014537]; NEI Core Grants [P30EY01931, P30EY01730, P30EY08571]; Harry J. Heeb Foundation; Posner Foundation; Macular Vision Research Foundation; Foundation Fighting Blindness; Hope for Vision; Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008571, P30EY001931, R01EY011123, R01EY016861, P30EY001730, T32EY014537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Training Program in Vision Science; NEI Core Grants; Harry J. Heeb Foundation; Posner Foundation; Macular Vision Research Foundation; Foundation Fighting Blindness(European Commission); Hope for Vision; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health grants R01EY016861 (M. N.) and R01EY11123 (W. W. H.); Research Training Program in Vision Science Grant T32EY014537; NEI Core Grants for Vision Research P30EY01931, P30EY01730 and P30EY08571; the Harry J. Heeb Foundation, the Posner Foundation, the Macular Vision Research Foundation, the Foundation Fighting Blindness, Hope for Vision, and Research to Prevent Blindness. We would like to thank V. Chiodo, S. Boye, D. Conklyn, P. M. Summerfelt, K. Chmielewski and K. L. Gunther for technical assistance. J. N. is the Bishop Professor in Ophthalmology, M. N. is the Ray Hill Professor in Ophthalmology, and W. W. H. is Rybaczki-Bullard Professor of Ophthalmology.	Bainbridge JW, 2008, GENE THER, V15, P1191, DOI 10.1038/gt.2008.117; Buning H, 2008, J GENE MED, V10, P717, DOI 10.1002/jgm.1205; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; DEVALOIS RL, 1993, VISION RES, V33, P1053, DOI 10.1016/0042-6989(93)90240-W; Jacobs GH, 2007, SCIENCE, V315, P1723, DOI 10.1126/science.1138838; Jacobs GH, 1998, VISION RES, V38, P3307, DOI 10.1016/S0042-6989(97)00405-7; Kuchenbecker JA, 2008, VISUAL NEUROSCI, V25, P301, DOI 10.1017/S0952523808080474; Li QH, 2008, VISION RES, V48, P332, DOI 10.1016/j.visres.2007.07.026; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Makous W, 2007, SCIENCE, V318, DOI 10.1126/science.1146084; Mancuso K, 2007, J OPT SOC AM A, V24, P1411, DOI 10.1364/JOSAA.24.001411; Mancuso K, 2006, VISUAL NEUROSCI, V23, P695, DOI 10.1017/S0952523806233364; Mauck MC, 2008, VISUAL NEUROSCI, V25, P273, DOI 10.1017/S0952523808080577; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NEITZ M, 1991, SCIENCE, V252, P971, DOI 10.1126/science.1903559; REFFIN JP, 1991, COLOUR VISION DEFICI, V10, P69; REGAN BC, 1994, VISION RES, V34, P1279, DOI 10.1016/0042-6989(94)90203-8; Shapley R, 2006, J NEUROPHYSIOL, V95, P587, DOI 10.1152/jn.01054.2005; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	21	213	248	6	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					784	U34		10.1038/nature08401	http://dx.doi.org/10.1038/nature08401			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19759534	Green Accepted			2022-12-24	WOS:000270547500034
J	Ng, PC; Venter, JC; Murray, SS; Levy, S				Ng, Pauline C.; Venter, J. Craig; Murray, Sarah S.; Levy, Samuel			An agenda for personalized medicine	NATURE			English	Editorial Material							ADVERSE DRUG-REACTIONS; CELIAC-DISEASE; RISK-FACTORS; VARIANTS; DATABASE		[Ng, Pauline C.; Venter, J. Craig] J Craig Venter Inst, San Diego, CA 92121 USA; [Murray, Sarah S.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Levy, Samuel] J Craig Venter Inst, Rockville, MD 20850 USA	J. Craig Venter Institute; Scripps Research Institute; J. Craig Venter Institute	Ng, PC (corresponding author), J Craig Venter Inst, Sci Ctr Dr, San Diego, CA 92121 USA.	png@jcvi.org						Adeyemo A, 2010, PUBLIC HEALTH GENOMI, V13, P72, DOI 10.1159/000218711; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Duncan D. E., 2009, EXPT MAN WHAT ONE MA; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5; Heshka JT, 2008, GENET MED, V10, P19, DOI 10.1097/GIM.0b013e31815f524f; Hogarth S, 2008, ANNU REV GENOM HUM G, V9, P161, DOI 10.1146/annurev.genom.9.081307.164319; HSU A, 2008, GUIDELINES VETTING; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Navigenics, 2008, APPL PREV GEN MED CL; *PERS MED COAL, 2008, PERS GEN IND STAND S; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Prainsack B, 2008, NATURE, V456, P34, DOI 10.1038/456034a; Sangkuhl K, 2008, DRUG METAB REV, V40, P539, DOI 10.1080/03602530802413338 ; SINGER E, 2009, TECHNOLOGY REV MIT; Topol EJ, 2007, JAMA-J AM MED ASSOC, V298, P218, DOI 10.1001/jama.298.2.218	23	241	248	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					724	726		10.1038/461724a	http://dx.doi.org/10.1038/461724a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	503OR	19812653				2022-12-24	WOS:000270547500016
J	Gostin, LO				Gostin, Lawrence O.			FDA Regulation of Tobacco Politics, Law, and the Public's Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES		Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Brandt AM, 2008, NEW ENGL J MED, V359, P445, DOI 10.1056/NEJMp0803729; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P524	3	25	25	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 7	2009	302	13					1459	1460		10.1001/jama.2009.1421	http://dx.doi.org/10.1001/jama.2009.1421			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503CL	19809027				2022-12-24	WOS:000270509600021
J	Hart, M; Moots, RJ				Hart, Michael; Moots, Robert J.			A Patient's Journey Behcet's syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Moots, Robert J.] Aintree Univ Hosp NHS Fdn Trust, Aintree Univ Hosp NHS Fdn Trust, Liverpool L9 7AL, Merseyside, England	Aintree University Hospitals NHS Foundation Trust		michaelanddawn@btinternet.com	Moots, Robert/AAM-8091-2020						0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 5	2009	339								b3876	10.1136/bmj.b3876	http://dx.doi.org/10.1136/bmj.b3876			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	505TE	19805471				2022-12-24	WOS:000270718700001
J	Suwa, G; Kono, RT; Simpson, SW; Asfaw, B; Lovejoy, CO; White, TD				Suwa, Gen; Kono, Reiko T.; Simpson, Scott W.; Asfaw, Berhane; Lovejoy, C. Owen; White, Tim D.			Paleobiological Implications of the Ardipithecus ramidus Dentition	SCIENCE			English	Article							MOLAR ENAMEL THICKNESS; PAN-TROGLODYTES; MIDDLE AWASH; TOOTH SIZE; AUSTRALOPITHECUS-AFARENSIS; DISTRIBUTION PATTERNS; CANINE DIMORPHISM; SEXUAL-DIMORPHISM; UPPER MIOCENE; EARLY HOMINID	The Middle Awash Ardipithecus ramidus sample comprises over 145 teeth, including associated maxillary and mandibular sets. These help reveal the earliest stages of human evolution. Ar. ramidus lacks the postcanine megadontia of Australopithecus. Its molars have thinner enamel and are functionally less durable than those of Australopithecus but lack the derived Pan pattern of thin occlusal enamel associated with ripe-fruit frugivory. The Ar. ramidus dental morphology and wear pattern are consistent with a partially terrestrial, omnivorous/frugivorous niche. Analyses show that the ARA-VP-6/500 skeleton is female and that Ar. ramidus was nearly monomorphic in canine size and shape. The canine/lower third premolar complex indicates a reduction of canine size and honing capacity early in hominid evolution, possibly driven by selection targeted on the male upper canine.	[Suwa, Gen] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; [Kono, Reiko T.] Natl Museum Nat & Sci, Dept Anthropol, Shinjuku Ku, Tokyo 1690073, Japan; [Simpson, Scott W.] Case Western Reserve Univ, Sch Med, Dept Anat, Cleveland, OH 44106 USA; [Asfaw, Berhane] Rift Valley Res Serv, Addis Ababa, Ethiopia; [Lovejoy, C. Owen] Kent State Univ, Div Biomed Sci, Dept Anthropol, Kent, OH 44240 USA; [White, Tim D.] Univ Calif Berkeley, Human Evolut Res Ctr, Berkeley, CA 94720 USA; [White, Tim D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of Tokyo; National Museum of Nature and Science; Case Western Reserve University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Suwa, G (corresponding author), Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan.	suwa@um.u-tokyo.ac.jp	, owen/N-7301-2019; Lund, Laura/H-7335-2012; Simpson, Scott/GRS-0081-2022	, owen/0000-0003-0053-4523; 	NSF [8210897, 9318698, 9512534, 9632389, 9727519, 9729060, 9910344, 0321893]; Japan Society for the Promotion of Science [11640708, 11691176, 14540657, 16405016, 16770187, 17207017, 19207019, 19770215, 21255005]	NSF(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	For funding, we thank NSF (grant nos. 8210897, 9318698, 9512534, 9632389, 9727519, 9729060, 9910344, and 0321893 HOMINID-RHOI) and the Japan Society for the Promotion of Science (grant nos. 11640708, 11691176, 14540657, 16405016, 16770187, 17207017, 19207019, 19770215, and 21255005); the Ministry of Tourism and Culture, the Authority for Research and Conservation of the Cultural Heritage, and the National Museum of Ethiopia for permissions and facilitation; the Afar Regional Government, the Afar people of the Middle Awash, and many other field workers for contributing directly to the data; the institutions and staff of National Museum of Ethiopia, National Museums of Kenya, Transvaal Museum South Africa, Cleveland Museum of Natural History, Royal Museum of Central Africa Tervuren, Naturalis Leiden, and the Department of Zoology of the National Museum of Nature and Science (Tokyo) for access to comparative materials; H. Gilbert for graphics work on Fig. 1; D. DeGusta and L. Hlusko for editorial assistance; R. Bernor, L. de Bonis, M. Brunet, M. C. Dean, B. Engesser, F. Guy, E. Heizmann, W. Liu, S. Moya-Sola, M. Plavcan, D. Reid, S. Semaw, and J. F. Thackeray for cooperation with comparative data and fossils; and T. Tanijiri, M. Chubachi, D. Kubo, S. Matsukawa, M. Ozaki, H. Fukase, S. Mizushima, and A. Saso for analytical and graphics assistance.	Brunet M, 2005, NATURE, V434, P752, DOI 10.1038/nature03392; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Campbell CJ, 2008, CAM S BIO EVOL ANTHR, V55, P1, DOI 10.1017/CBO9780511721915; CONROY GC, 1991, AM J PHYS ANTHROPOL, V86, P243, DOI 10.1002/ajpa.1330860212; Cope Dana A., 1993, P211; Dean MC, 2001, AM J PHYS ANTHROPOL, V116, P209, DOI 10.1002/ajpa.1116; DEAN MC, 2001, DENT MORPHOLOGY, P135; Di Fiore A, 2005, INT J PRIMATOL, V26, P1137, DOI 10.1007/s10764-005-6462-4; GINGERICH PD, 1979, AM J PHYS ANTHROPOL, V51, P457, DOI 10.1002/ajpa.1330510318; Grine FE, 2006, J HUM EVOL, V51, P297, DOI 10.1016/j.jhevol.2006.04.004; Haile-Selassie Y, 2004, SCIENCE, V303, P1503, DOI 10.1126/science.1092978; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Haile-Selassie Yohannes, 2009, P159; Hamada Y, 2002, AM J PHYS ANTHROPOL, V118, P268, DOI 10.1002/ajpa.10078; Hamada Y, 1999, PRIMATES, V40, P439, DOI 10.1007/BF02557580; JOHANSON DC, 1974, THESIS U CHICAGO; KELLEY J, 1995, AM J PHYS ANTHROPOL, V96, P365, DOI 10.1002/ajpa.1330960405; Kinzey W.G., 1984, P65; Kono Reiko T., 2008, Bulletin of the National Science Museum Series D (Anthropology), V34, P1; Kono RT, 2004, ANTHROPOL SCI, V112, P121, DOI 10.1537/ase.03106; Kuykendall KL, 1996, AM J PHYS ANTHROPOL, V99, P135, DOI 10.1002/(SICI)1096-8644(199601)99:1<135::AID-AJPA8>3.0.CO;2-#; Leigh SR, 2005, AM J PHYS ANTHROPOL, V127, P296, DOI 10.1002/ajpa.20096; Leigh SR, 1996, AM J PHYS ANTHROPOL, V101, P455, DOI 10.1002/(SICI)1096-8644(199612)101:4<455::AID-AJPA2>3.0.CO;2-V; Leigh SR, 1996, AM J PHYS ANTHROPOL, V99, P43, DOI 10.1002/(SICI)1096-8644(199601)99:1<43::AID-AJPA3>3.0.CO;2-0; Leigh SR, 2008, J HUM EVOL, V55, P75, DOI 10.1016/j.jhevol.2008.01.001; Lovejoy CO, 2009, SCIENCE, V326, P100, DOI 10.1126/science.1175833; Lucas PW, 2008, J ANAT, V212, P486, DOI 10.1111/j.1469-7580.2008.00877.x; MALENKY RK, 1994, AM J PRIMATOL, V32, P1, DOI 10.1002/ajp.1350320102; MCHENRY HM, 1986, J HUM EVOL, V15, P177, DOI 10.1016/S0047-2484(86)80044-6; MCHENRY HM, 1984, AM J PHYS ANTHROPOL, V64, P297, DOI 10.1002/ajpa.1330640312; Pickford M, 2005, ANTHROPOL SCI, V113, P95, DOI 10.1537/ase.04S014; Plavcan J.M., 1990, THESIS DUKE U; Reno PL, 2003, P NATL ACAD SCI USA, V100, P9404, DOI 10.1073/pnas.1133180100; Schwartz GT, 2001, AM J PHYS ANTHROPOL, V115, P269, DOI 10.1002/ajpa.1081; Semaw S, 2005, NATURE, V433, P301, DOI 10.1038/nature03177; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Shields ED, 2005, AM J PHYS ANTHROPOL, V128, P299, DOI 10.1002/ajpa.20110; SIMPSON SW, 1992, AM J PHYS ANTHROPOL, V87, P29, DOI 10.1002/ajpa.1330870104; Smith B. Holly, 1994, Yearbook of Physical Anthropology, V37, P177; Sponheimer M, 2006, J HUM EVOL, V51, P128, DOI 10.1016/j.jhevol.2006.02.002; Suwa G, 2009, SCIENCE, V326, DOI 10.1126/science.1175825; Vinyard CJ, 2005, J HUM EVOL, V49, P241, DOI 10.1016/j.jhevol.2005.04.002; Vogel ER, 2008, J HUM EVOL, V55, P60, DOI 10.1016/j.jhevol.2007.12.005; White TD, 2006, NATURE, V440, P883, DOI 10.1038/nature04629; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; White TD, 2000, AM J PHYS ANTHROPOL, V111, P45, DOI 10.1002/(SICI)1096-8644(200001)111:1<45::AID-AJPA4>3.0.CO;2-I; White TD, 2009, SCIENCE, V326, P87, DOI 10.1126/science.1175822; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802	48	130	135	6	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					94	99		10.1126/science.1175824	http://dx.doi.org/10.1126/science.1175824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	501CA	19810195	Green Published			2022-12-24	WOS:000270355600042
J	Jaddoe, VWV				Jaddoe, Vincent W. V.			Antenatal education programmes: do they work?	LANCET			English	Editorial Material							CHILDBIRTH; RATES		[Jaddoe, Vincent W. V.] Erasmus Univ, Med Ctr, Dept Epidemiol, Generat R Study Grp, NL-3000 CA Rotterdam, Netherlands; [Jaddoe, Vincent W. V.] Erasmus Univ, Med Ctr, Dept Paediat, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Jaddoe, VWV (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol, Generat R Study Grp, NL-3000 CA Rotterdam, Netherlands.	v.jaddoe@erasmusmc.nl						Bergstrom M, 2009, BJOG-INT J OBSTET GY, V116, P1167, DOI 10.1111/j.1471-0528.2009.02144.x; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Cyna Allan M, 2006, BMC Pregnancy Childbirth, V6, P5, DOI 10.1186/1471-2393-6-5; Deave Toity, 2008, BMC Pregnancy Childbirth, V8, P30, DOI 10.1186/1471-2393-8-30; Dick-Read Grantly, 1944, CHILDBIRTH FEAR PRIN; Fabian HM, 2005, ACTA OBSTET GYN SCAN, V84, P436, DOI 10.1111/j.0001-6349.2005.00732.x; Gagnon AJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002869.pub2; Lamaze F., 1958, PAINLESS CHILDBIRTH; Su LL, 2007, BMJ-BRIT MED J, V335, P596, DOI 10.1136/bmj.39279.656343.55	9	17	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2009	374	9693					863	864		10.1016/S0140-6736(09)61610-X	http://dx.doi.org/10.1016/S0140-6736(09)61610-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	496BN	19748386				2022-12-24	WOS:000269943100010
J	Martinez-Hackert, E; Hendrickson, WA				Martinez-Hackert, Erik; Hendrickson, Wayne A.			Promiscuous Substrate Recognition in Folding and Assembly Activities of the Trigger Factor Chaperone	CELL			English	Article							RIBOSOMAL-PROTEIN S7; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; TRANSLATING RIBOSOMES; NASCENT POLYPEPTIDES; ISOMERASE ACTIVITY; FOLDED PROTEIN; DNAK; CHAINS; IDENTIFICATION	Trigger factor (TF) is a molecular chaperone that binds to bacterial ribosomes where it contacts emerging nascent chains, but TF is also abundant free in the cytosol where its activity is less well characterized. In vitro studies show that TF promotes protein refolding. We find here that ribosome-free TF stably associates with and rescues from misfolding a large repertoire of full-length proteins. We identify over 170 members of this cytosolic Escherichia coli TF substrate proteome, including ribosomal protein S7. We analyzed the biochemical properties of a TF: S7 complex from Thermotoga maritima and determined its crystal structure. Thereby, we obtained an atomic-level picture of a promiscuous chaperone in complex with a physiological substrate protein. The structure of the complex reveals the molecular basis of substrate recognition by TF, indicates how TF could accelerate protein folding, and suggests a role for TF in the biogenesis of protein complexes.	[Martinez-Hackert, Erik; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Hendrickson, Wayne A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Hendrickson, WA (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	wayne@convex.hhmi.columbia.edu		Martinez-Hackert, Erik/0000-0002-6182-7023	Lymphoma Society of America; Jane Elissa/Charlotte Meyers Endowment Fund; NIH [GM34102]; National Synchrotron Light Source (NSLS); New York Structural Biology Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034102, R37GM034102] Funding Source: NIH RePORTER	Lymphoma Society of America; Jane Elissa/Charlotte Meyers Endowment Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Synchrotron Light Source (NSLS); New York Structural Biology Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to M. Floer and C. J. Lusty for comments. We thank M. A. Gawinowicz for mass spectrometry; T. Mareeva and Y. Sykulev for Biacore measurements; H. Bernstein, P. Genevaux, C. Georgoplous, and F. U. Hartl for strains; P. Genevaux for anti-TF; G. Boel, R. Gonzales, J. Hunt, and A. Tzagoloff for help with polysome fractionation; M. Babu, A. Emili, and J. Greenblatt for TAP-tag TF data; and N. Belgado, J. Cheung, M. Collins, A. Duran, Q. Fan, G. Gregorio, J. Lidestri, Q. Liu, A. Korkut, A. Marina, C. Min, J. Moore, H. Xie, R. Xu, and Z. Zhang for assistance. This work was supported in part by fellowships from the Leukemia and Lymphoma Society of America (E.M.- H.) and the Jane Elissa/Charlotte Meyers Endowment Fund (E.M.- H.) and by NIH grant GM34102 (W. A. H.). Beamline X4A at the National Synchrotron Light Source (NSLS) is supported by the New York Structural Biology Center.	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Clare DK, 2009, NATURE, V457, P107, DOI 10.1038/nature07479; CROOKE E, 1987, P NATL ACAD SCI USA, V84, P5216, DOI 10.1073/pnas.84.15.5216; CROOKE E, 1988, CELL, V54, P1003, DOI 10.1016/0092-8674(88)90115-8; Davis FP, 2005, BIOINFORMATICS, V21, P1901, DOI 10.1093/bioinformatics/bti277; DEAN D, 1981, CELL, V24, P413, DOI 10.1016/0092-8674(81)90331-7; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; ELLIS RJ, 1994, CURR BIOL, V4, P633; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Fredrick K, 2000, J MOL BIOL, V298, P379, DOI 10.1006/jmbi.2000.3563; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Hage AE, 2004, MOL MICROBIOL, V51, P189, DOI 10.1046/j.1365-2958.2003.03813.x; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hesterkamp T, 1996, P NATL ACAD SCI USA, V93, P4437, DOI 10.1073/pnas.93.9.4437; Hoffmann A, 2006, J BIOL CHEM, V281, P6539, DOI 10.1074/jbc.M512345200; Huang GC, 2000, PROTEIN SCI, V9, P1254, DOI 10.1110/ps.9.6.1254; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kandror O, 1997, P NATL ACAD SCI USA, V94, P4978, DOI 10.1073/pnas.94.10.4978; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; Kramer G, 2004, J BIOL CHEM, V279, P14165, DOI 10.1074/jbc.M313635200; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Lakshmipathy SK, 2007, J BIOL CHEM, V282, P12186, DOI 10.1074/jbc.M609871200; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee HC, 2002, J BIOL CHEM, V277, P43527, DOI 10.1074/jbc.M205950200; Li ZY, 2001, FEBS LETT, V506, P108, DOI 10.1016/S0014-5793(01)02896-4; LILL R, 1988, CELL, V54, P1013, DOI 10.1016/0092-8674(88)90116-X; Liu CP, 2005, J BIOL CHEM, V280, P13315, DOI 10.1074/jbc.M414151200; Liu CP, 2004, BIOCHEM BIOPH RES CO, V313, P509, DOI 10.1016/j.bbrc.2003.11.142; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Maier R, 2003, J MOL BIOL, V326, P585, DOI 10.1016/S0022-2836(02)01427-4; Maier R, 2001, J MOL BIOL, V314, P1181, DOI 10.1006/jmbi.2000.5192; Maisonneuve E, 2008, J BACTERIOL, V190, P887, DOI 10.1128/JB.01603-07; Martinez-Hackert E, 2007, ACTA CRYSTALLOGR D, V63, P536, DOI 10.1107/S090744490700964X; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; Merz F, 2006, J BIOL CHEM, V281, P31963, DOI 10.1074/jbc.M605164200; Patzelt H, 2002, BIOL CHEM, V383, P1611, DOI 10.1515/BC.2002.182; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Raine A, 2006, J BIOL CHEM, V281, P28033, DOI 10.1074/jbc.M605753200; Rutkowska A, 2008, J BIOL CHEM, V283, P4124, DOI 10.1074/jbc.M708294200; Scholz C, 1997, EMBO J, V16, P54, DOI 10.1093/emboj/16.1.54; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; STOLLER G, 1995, EMBO J, V14, P4939, DOI 10.1002/j.1460-2075.1995.tb00177.x; Takagi F, 2003, P NATL ACAD SCI USA, V100, P11367, DOI 10.1073/pnas.1831920100; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Tomic S, 2006, FEBS LETT, V580, P72, DOI 10.1016/j.febslet.2005.11.050; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; Wadell H, 1935, J GEOL, V43, P250, DOI 10.1086/624298	58	113	116	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					923	934		10.1016/j.cell.2009.07.044	http://dx.doi.org/10.1016/j.cell.2009.07.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737520	Bronze, Green Accepted			2022-12-24	WOS:000269564600018
J	Bae, JH; Lew, ED; Yuzawa, S; Tome, F; Lax, I; Schlessinger, J				Bae, Jae Hyun; Lew, Erin Denise; Yuzawa, Satoru; Tome, Francisco; Lax, Irit; Schlessinger, Joseph			The Selectivity of Receptor Tyrosine Kinase Signaling Is Controlled by a Secondary SH2 Domain Binding Site	CELL			English	Article							PHOSPHOLIPASE C-GAMMA-1; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; REQUIREMENT; SPECIFICITY; SUBSTRATE; RESIDUES; PEPTIDE; COMPLEX	SH2 domain-mediated interactions represent a crucial step in transmembrane signaling by receptor tyrosine kinases. SH2 domains recognize phosphotyrosine (pY) in the context of particular sequence motifs in receptor phosphorylation sites. However, the modest binding affinity of SH2 domains to pY containing peptides may not account for and likely represents an oversimplified mechanism for regulation of selectivity of signaling pathways in living cells. Here we describe the crystal structure of the activated tyrosine kinase domain of FGFR1 in complex with a phospholipase C gamma fragment. The structural and biochemical data and experiments with cultured cells show that the selectivity of phospholipase C gamma binding and signaling via activated FGFR1 are determined by interactions between a secondary binding site on an SH2 domain and a region in FGFR1 kinase domain in a phosphorylation independent manner. These experiments reveal a mechanism for how SH2 domain selectivity is regulated in vivo to mediate a specific cellular process.	[Bae, Jae Hyun; Lew, Erin Denise; Yuzawa, Satoru; Tome, Francisco; Lax, Irit; Schlessinger, Joseph] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Schlessinger, J (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	joseph.schlessinger@yale.edu		Yuzawa, Satoru/0000-0002-1031-5781	NIH [R01-AR051448, R01-AR051886, P50-AR054086]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051886, P50AR054086, R01AR051448] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grants R01-AR051448, R01-AR051886, and P50-AR054086 to J. S. We thank Titus Boggon, Mark Lemmon, Kate Ferguson, Benjamin Turk, David Calderwood, Valsan Mandiyan, Ewa Folta-Stogniew, Cristina Furdui, and Steve Hubbard for their advice and support; and members of Brookhaven National Laboratory Beamlines X6, X25, and X29 for their support.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Chattopadhyay A, 1999, J BIOL CHEM, V274, P26091, DOI 10.1074/jbc.274.37.26091; Donaldson LW, 2002, P NATL ACAD SCI USA, V99, P14053, DOI 10.1073/pnas.212518799; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Groesch TD, 2006, J MOL BIOL, V356, P1222, DOI 10.1016/j.jmb.2005.11.095; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Ji QS, 1999, MOL CELL BIOL, V19, P4961; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; LAROSE L, 1995, J BIOL CHEM, V270, P3858, DOI 10.1074/jbc.270.8.3858; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Lax I, 2002, MOL CELL, V10, P709, DOI 10.1016/S1097-2765(02)00689-5; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Liu HH, 2006, ACTA PHYS-CHIM SIN, V22, P868, DOI 10.3866/PKU.WHXB20060720; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PICCIONE E, 1993, BIOCHEMISTRY-US, V32, P3197, DOI 10.1021/bi00064a001; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Poulin B, 2000, J BIOL CHEM, V275, P6411, DOI 10.1074/jbc.275.9.6411; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	34	109	112	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					514	524		10.1016/j.cell.2009.05.028	http://dx.doi.org/10.1016/j.cell.2009.05.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665973	Green Accepted, Bronze			2022-12-24	WOS:000268771900016
J	Pieters, CM; Goswami, JN; Clark, RN; Annadurai, M; Boardman, J; Buratti, B; Combe, JP; Dyar, MD; Green, R; Head, JW; Hibbitts, C; Hicks, M; Isaacson, P; Klima, R; Kramer, G; Kumar, S; Livo, E; Lundeen, S; Malaret, E; McCord, T; Mustard, J; Nettles, J; Petro, N; Runyon, C; Staid, M; Sunshine, J; Taylor, LA; Tompkins, S; Varanasi, P				Pieters, C. M.; Goswami, J. N.; Clark, R. N.; Annadurai, M.; Boardman, J.; Buratti, B.; Combe, J. -P.; Dyar, M. D.; Green, R.; Head, J. W.; Hibbitts, C.; Hicks, M.; Isaacson, P.; Klima, R.; Kramer, G.; Kumar, S.; Livo, E.; Lundeen, S.; Malaret, E.; McCord, T.; Mustard, J.; Nettles, J.; Petro, N.; Runyon, C.; Staid, M.; Sunshine, J.; Taylor, L. A.; Tompkins, S.; Varanasi, P.			Character and Spatial Distribution of OH/H2O on the Surface of the Moon Seen by M-3 on Chandrayaan-1	SCIENCE			English	Article							WATER ICE; EPITHERMAL NEUTRONS; OPTICAL-CONSTANTS; LUNAR PROSPECTOR; HYDROGEN; POLES	The search for water on the surface of the anhydrous Moon had remained an unfulfilled quest for 40 years. However, the Moon Mineralogy Mapper (M-3) on Chandrayaan-1 has recently detected absorption features near 2.8 to 3.0 micrometers on the surface of the Moon. For silicate bodies, such features are typically attributed to hydroxyl- and/or water-bearing materials. On the Moon, the feature is seen as a widely distributed absorption that appears strongest at cooler high latitudes and at several fresh feldspathic craters. The general lack of correlation of this feature in sunlit M-3 data with neutron spectrometer hydrogen abundance data suggests that the formation and retention of hydroxyl and water are ongoing surficial processes. Hydroxyl/water production processes may feed polar cold traps and make the lunar regolith a candidate source of volatiles for human exploration.	[Pieters, C. M.; Head, J. W.; Isaacson, P.; Klima, R.; Mustard, J.; Nettles, J.] Brown Univ, Providence, RI 02912 USA; [Goswami, J. N.] Phys Res Lab, Ahmadabad 380009, Gujarat, India; [Goswami, J. N.; Annadurai, M.] Indian Space Res Org, Bangalore 562140, Karnataka, India; [Clark, R. N.; Livo, E.] US Geol Survey, Denver, CO 80225 USA; [Boardman, J.] Analyt Imaging & Geophys, Boulder, CO 80303 USA; [Buratti, B.; Green, R.; Hicks, M.; Lundeen, S.; Varanasi, P.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Combe, J. -P.; Kramer, G.; McCord, T.] Bear Fight Ctr, Winthrop, WA 98862 USA; [Dyar, M. D.] Mt Holyoke Coll, S Hadley, MA 01075 USA; [Hibbitts, C.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Kumar, S.] Natl Remote Sensing Agcy, Hyderabad, Andhra Pradesh, India; [Malaret, E.] Appl Coherent Technol Corp, Herndon, VA 22070 USA; [Petro, N.] NASA Goddard, Greenbelt, MD 20771 USA; [Runyon, C.] Coll Charleston, Charleston, SC 29424 USA; [Staid, M.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Sunshine, J.] Univ Maryland, College Pk, MD 20742 USA; [Taylor, L. A.] Univ Tennessee, Knoxville, TN 37996 USA; [Tompkins, S.] Def Adv Res Projects Agcy, Arlington, VA 22203 USA	Brown University; Department of Space (DoS), Government of India; Physical Research Laboratory - India; Department of Space (DoS), Government of India; Indian Space Research Organisation (ISRO); United States Department of the Interior; United States Geological Survey; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Mount Holyoke College; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Department of Space (DoS), Government of India; Indian Space Research Organisation (ISRO); National Remote Sensing Centre (NRSC); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; College of Charleston; University System of Maryland; University of Maryland College Park; University of Tennessee System; University of Tennessee Knoxville; United States Department of Defense; Defense Advanced Research Projects Agency (DARPA)	Pieters, CM (corresponding author), Brown Univ, Providence, RI 02912 USA.	carle_pieters@brown.edu	Hibbitts, Charles/B-7787-2016; Petro, Noah E/F-5340-2013	Hibbitts, Charles/0000-0001-9089-4391; Petro, Noah/0000-0003-4676-077X; Sunshine, Jessica/0000-0002-9413-8785; Ahmed, Syed/0000-0001-7001-6030	NASA's Discovery program [NNM05AB26C, NNG06GJ31G]	NASA's Discovery program(National Aeronautics & Space Administration (NASA))	M<SUP>3</SUP> is funded as a Mission of Opportunity under NASA's Discovery program contract NNM05AB26C to Brown University. Lunar reflectance spectra were acquired using the NASA/Keck Reflectance Experiment Laboratory, a multiuser facility supported by NASA grant NNG06GJ31G. A portion of this research was carried out at the JPL, California Institute of Technology, under a contract with NASA. We thank the team of engineers at JPL who designed and built M3 ( led by T. Glavich and M. White) and the Chandrayaan-1 mission operations team ( led by N. S. Hegde, with M3 implementation largely by S. Gomathi), whose mission support has made M3 data possible. The M3 team is honored to be a guest instrument on India's first mission to the Moon.	ARNOLD JR, 1979, J GEOPHYS RES, V84, P5659, DOI 10.1029/JB084iB10p05659; BOARDMAN JW, 2009, 6 EARSEL SIG IS WORK; Burns R. G, 1993, MINERALOGICAL APPL C; CLARK RN, 1979, ICARUS, V40, P94, DOI 10.1016/0019-1035(79)90056-3; Clark RN, 2009, SCIENCE, V326, P562, DOI 10.1126/science.1178105; Crider DH, 2002, ADV SPACE RES, V30, P1869, DOI 10.1016/S0273-1177(02)00493-3; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Feldman WC, 2001, J GEOPHYS RES-PLANET, V106, P23231, DOI 10.1029/2000JE001444; GREEN RO, 2009, 40 LUN PLAN SCI C HO; Johnson JR, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001430; Keller LP, 1997, GEOCHIM COSMOCHIM AC, V61, P2331, DOI 10.1016/S0016-7037(97)00085-9; Lawrence DJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002637; Maurice S, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002208; Noble SK, 2007, ICARUS, V192, P629, DOI 10.1016/j.icarus.2007.07.021; Pieters CM, 2000, METEORIT PLANET SCI, V35, P1101, DOI 10.1111/j.1945-5100.2000.tb01496.x; Seaman SJ, 2006, AM MINERAL, V91, P12, DOI 10.2138/am.2006.1765; Starukhina LV, 2000, ICARUS, V147, P585, DOI 10.1006/icar.2000.6476; Sunshine JM, 2009, SCIENCE, V326, P565, DOI 10.1126/science.1179788; Taylor LA, 2001, J GEOPHYS RES-PLANET, V106, P27985, DOI 10.1029/2000JE001402; Urey H.C., 1952, PLANETS THEIR ORIGIN, DOI [10.1063/1.3067687, DOI 10.1063/1.3067687]; WARREN SG, 1984, APPL OPTICS, V23, P1206, DOI 10.1364/AO.23.001206; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033; WIELICZKA DM, 1989, APPL OPTICS, V28, P1714, DOI 10.1364/AO.28.001714	23	458	485	7	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					568	572		10.1126/science.1178658	http://dx.doi.org/10.1126/science.1178658			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19779151				2022-12-24	WOS:000271019400040
J	Chandrashekar, J; Yarmolinsky, D; von Buchholtz, L; Oka, Y; Sly, W; Ryba, NJP; Zuker, CS				Chandrashekar, Jayaram; Yarmolinsky, David; von Buchholtz, Lars; Oka, Yuki; Sly, William; Ryba, Nicholas J. P.; Zuker, Charles S.			The Taste of Carbonation	SCIENCE			English	Article							CARBONIC-ANHYDRASE; MAMMALIAN SWEET; RECEPTOR-CELLS; ORAL SENSATION; BITTER TASTE; UMAMI TASTE; FAMILY; RAT; ACETAZOLAMIDE; DROSOPHILA	Carbonated beverages are commonly available and immensely popular, but little is known about the cellular and molecular mechanisms underlying the perception of carbonation in the mouth. In mammals, carbonation elicits both somatosensory and chemosensory responses, including activation of taste neurons. We have identified the cellular and molecular substrates for the taste of carbonation. By targeted genetic ablation and the silencing of synapses in defined populations of taste receptor cells, we demonstrated that the sour-sensing cells act as the taste sensors for carbonation, and showed that carbonic anhydrase 4, a glycosylphosphatidylinositol-anchored enzyme, functions as the principal CO2 taste sensor. Together, these studies reveal the basis of the taste of carbonation as well as the contribution of taste cells in the orosensory response to CO2.	[Chandrashekar, Jayaram; Yarmolinsky, David; Oka, Yuki; Zuker, Charles S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Chandrashekar, Jayaram; Yarmolinsky, David; Oka, Yuki; Zuker, Charles S.] Univ Calif San Diego, Dept Neurobiol, La Jolla, CA 92093 USA; [Chandrashekar, Jayaram; Yarmolinsky, David; Oka, Yuki; Zuker, Charles S.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [von Buchholtz, Lars; Ryba, Nicholas J. P.] NIDCR, Bethesda, MD 20892 USA; [Sly, William] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Saint Louis University	Zuker, CS (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	cz2195@columbia.edu		Chandrashekar, jayaram/0000-0001-6412-0114; Oka, Yuki/0000-0003-2686-0677; Ryba, Nicholas/0000-0002-2060-8393	NIH; NIDCR; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank W. Guo and A. Becker for generation and maintenance of mouse lines, M. Hoon for help in the initial phase of this work, E. R. Swenson for a generous gift of benzolamide, M. Goulding for Rosa26-flox-STOP-TeNT mice, A. Waheed for Car4 antibodies, and members of the Zuker laboratory for valuable comments. Supported in part by the intramural research program of the NIH, NIDCR (N.J.P.R.). C.S.Z. is an investigator of the Howard Hughes Medical Institute.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Akiba Y, 2008, GUT, V57, P1654, DOI 10.1136/gut.2007.144378; BOTTGER B, 1996, CHEM SENSES, V21, P580; BROWN D, 1984, BRAIN RES, V324, P346, DOI 10.1016/0006-8993(84)90046-5; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Dahl M, 1997, BRAIN RES, V756, P22, DOI 10.1016/S0006-8993(97)00131-5; Daikoku H, 1999, CHEM SENSES, V24, P255, DOI 10.1093/chemse/24.3.255; Dessirier JM, 2001, CHEM SENSES, V26, P639, DOI 10.1093/chemse/26.6.639; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; GRABER M, 1988, AM J MED, V84, P979, DOI 10.1016/0002-9343(88)90091-5; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; KAWAMURA AA, 1967, OLFACTION TASTE, V2, P431; KOMAI M, 1993, BRAIN RES, V612, P122, DOI 10.1016/0006-8993(93)91652-9; KOMAI M, 1994, OLFACTION TASTE, V11, P92; Lahiri S, 2003, INT J BIOCHEM CELL B, V35, P1413, DOI 10.1016/S1357-2725(03)00050-5; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Lyall V, 2001, AM J PHYSIOL-CELL PH, V281, pC1005, DOI 10.1152/ajpcell.2001.281.3.C1005; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; MILLER LG, 1990, J FAM PRACTICE, V31, P199; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; OKUYAMA T, 1995, ARCH BIOCHEM BIOPHYS, V320, P315, DOI 10.1016/0003-9861(95)90015-2; Shah GN, 2005, P NATL ACAD SCI USA, V102, P16771, DOI 10.1073/pnas.0508449102; Simons CT, 1999, J NEUROSCI, V19, P8134; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Supuran CT, 2008, CURR PHARM DESIGN, V14, P603, DOI 10.2174/138161208783877884; Vullo D, 2005, BIOORG MED CHEM LETT, V15, P971, DOI 10.1016/j.bmcl.2004.12.052; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	38	237	242	4	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					443	445		10.1126/science.1174601	http://dx.doi.org/10.1126/science.1174601			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833970	Green Accepted			2022-12-24	WOS:000270818600058
J	Sohmen, D; Harms, JM; Schlunzen, F; Wilson, DN				Sohmen, Daniel; Harms, Joerg M.; Schluenzen, Frank; Wilson, Daniel N.			SnapShot: Antibiotic Inhibition of Protein Synthesis II	CELL			English	Editorial Material							RIBOSOME		[Sohmen, Daniel; Wilson, Daniel N.] Univ Munich, D-80539 Munich, Germany; [Harms, Joerg M.] Univ Hamburg, MPSD, Hamburg, Germany; [Schluenzen, Frank] DESY, D-2000 Hamburg, Germany; [Wilson, Daniel N.] CiPS M, Munich, Germany	University of Munich; University of Hamburg; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Sohmen, D (corresponding author), Univ Munich, D-80539 Munich, Germany.		Harms, Joerg/K-8786-2012; Schluenzen, Frank/H-6274-2014; Schluenzen, Frank/P-9177-2019; Wilson, Daniel/AAE-8504-2019	Harms, Joerg/0000-0002-9442-8264; Schluenzen, Frank/0000-0003-2849-0542; Schluenzen, Frank/0000-0003-2849-0542; Wilson, Daniel/0000-0003-3816-3828				Moore PB, 2003, ANNU REV BIOCHEM, V72, P813, DOI 10.1146/annurev.biochem.72.110601.135450; Polacek N, 2005, CRIT REV BIOCHEM MOL, V40, P285, DOI 10.1080/10409230500326334; Spahn CMT, 1996, J MOL MED, V74, P423, DOI 10.1007/s001090050044; Sutcliffe JA, 2005, CURR OPIN MICROBIOL, V8, P534, DOI 10.1016/j.mib.2005.08.004; Tenson T, 2006, MOL MICROBIOL, V59, P1664, DOI 10.1111/j.1365-2958.2006.05063.x; Wilson D. N., 2004, PROTEIN SYNTHESIS RI, P449; Yonath A, 2005, ANNU REV BIOCHEM, V74, P649, DOI 10.1146/annurev.biochem.74.082803.133130	7	18	19	2	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 2	2009	139	1							212.e1	10.1016/j.cell.2009.08.009	http://dx.doi.org/10.1016/j.cell.2009.08.009			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804764	Bronze			2022-12-24	WOS:000270388600029
J	Sipkins, DA				Sipkins, Dorothy A.			Rendering the Leukemia Cell Susceptible to Attack	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STEM-CELLS		Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Chicago	Sipkins, DA (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA.							Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; Selleri C, 1996, BLOOD, V87, P4149, DOI 10.1182/blood.V87.10.4149.bloodjournal87104149; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227	5	11	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2009	361	13					1307	1309		10.1056/NEJMcibr0904291	http://dx.doi.org/10.1056/NEJMcibr0904291			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497RN	19776414				2022-12-24	WOS:000270078700015
J	Tamguney, G; Miller, MW; Wolfe, LL; Sirochman, TM; Glidden, DV; Palmer, C; Lemus, A; DeArmond, SJ; Prusiner, SB				Tamgueney, Gueltekin; Miller, Michael W.; Wolfe, Lisa L.; Sirochman, Tracey M.; Glidden, David V.; Palmer, Christina; Lemus, Azucena; DeArmond, Stephen J.; Prusiner, Stanley B.			Asymptomatic deer excrete infectious prions in faeces	NATURE			English	Article							CHRONIC WASTING DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; MULE DEER; TRANSGENIC MICE; ODOCOILEUS-HEMIONUS; INCUBATION-TIME; TRANSMISSION; SCRAPIE; PROTEIN; SHEEP	Infectious prion diseases(1)-scrapie of sheep(2) and chronic wasting disease (CWD) of several species in the deer family(3,4)-are transmitted naturally within affected host populations. Although several possible sources of contagion have been identified in excretions and secretions from symptomatic animals(5-8), the biological importance of these sources in sustaining epidemics remains unclear. Here we show that asymptomatic CWD-infected mule deer (Odocoileus hemionus) excrete CWD prions in their faeces long before they develop clinical signs of prion disease. Intracerebral inoculation of irradiated deer faeces into transgenic mice overexpressing cervid prion protein (PrP) revealed infectivity in 14 of 15 faecal samples collected from five deer at 7-11 months before the onset of neurological disease. Although prion concentrations in deer faeces were considerably lower than in brain tissue from the same deer collected at the end of the disease, the estimated total infectious dose excreted in faeces by an infected deer over the disease course may approximate the total contained in a brain. Prolonged faecal prion excretion by infected deer provides a plausible natural mechanism that might explain the high incidence and efficient horizontal transmission of CWD within deer herds(3,4,9), as well as prion transmission among other susceptible cervids.	[Tamgueney, Gueltekin; Palmer, Christina; DeArmond, Stephen J.; Prusiner, Stanley B.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; [Tamgueney, Gueltekin; Prusiner, Stanley B.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Miller, Michael W.; Wolfe, Lisa L.; Sirochman, Tracey M.] Colorado Div Wildlife, Wildlife Res Lab, Ft Collins, CO 80526 USA; [Glidden, David V.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Lemus, Azucena; DeArmond, Stephen J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Prusiner, SB (corresponding author), Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA.	stanley@ind.ucsf.edu	Tamgüney, Gültekin/T-6333-2019; Glidden, David/AAD-4730-2020	Tamgüney, Gültekin/0000-0002-6933-5154; Glidden, David/0000-0001-5888-1419	Colorado Division of Wildlife; US Department of Defense National Prion Research Program [NP020152]; National Institutes of Health [AG02132]; Hillblom Foundation; NATIONAL INSTITUTE ON AGING [P01AG002132] Funding Source: NIH RePORTER	Colorado Division of Wildlife; US Department of Defense National Prion Research Program(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hillblom Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	G. T. was supported by a fellowship from the Larry L. Hillblom Foundation. This work was supported by the Colorado Division of Wildlife and grants from the US Department of Defense National Prion Research Program (NP020152), the National Institutes of Health (AG02132) and the Hillblom Foundation. We thank P. Lessard and the staff of the Hunters Point animal facility for support with the transgenic animal experiments, K. Giles for screening transgenic animals, A. Serban for antibodies, K. Pomeroy for technical assistance, J. Safar for discussions, H. Nguyen for editorial assistance and B. Williams for insights on CWD transmission.	Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; ARTHUR WJ, 1979, J RANGE MANAGE, V32, P67, DOI 10.2307/3897389; ARTHUR WJ, 1980, J WILDLIFE MANAGE, V44, P750; Baeten LA, 2007, J WILDLIFE DIS, V43, P309, DOI 10.7589/0090-3558-43.2.309; BELLINGERKAWAHARA CG, 1988, VIROLOGY, V164, P537, DOI 10.1016/0042-6822(88)90569-7; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; Cox D. R., 1984, ANAL SURVIVAL DATA; COX DR, 1972, J R STAT SOC B, V187, P220; Detwiler LA, 2003, REV SCI TECH OIE, V22, P121, DOI 10.20506/rst.22.1.1386; Diringer H, 1998, J GEN VIROL, V79, P609, DOI 10.1099/0022-1317-79-3-609; Dougherty R., 1964, TECHNIQUES EXPT VIRO, P169; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Judge J, 2005, AGR ECOSYST ENVIRON, V107, P267, DOI 10.1016/j.agee.2004.10.028; Konold T, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-14; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Miekka SI, 2003, VOX SANG, V84, P36, DOI 10.1046/j.1423-0410.2003.00256.x; Miller MW, 2006, ECOL APPL, V16, P2208, DOI 10.1890/1051-0761(2006)016[2208:DOPDTI]2.0.CO;2; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Muramoto T, 1997, NAT MED, V3, P750, DOI 10.1038/nm0797-750; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 2007, FIELDS VIROLOGY, P3059; Raymond GJ, 2000, EMBO J, V19, P4425, DOI 10.1093/emboj/19.17.4425; Safar JG, 2002, NAT BIOTECHNOL, V20, P1147, DOI 10.1038/nbt748; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Tamguney G, 2009, J GEN VIROL, V90, P1035, DOI 10.1099/vir.0.007500-0; Tamguney G, 2008, J GEN VIROL, V89, P1777, DOI 10.1099/vir.0.2008/001255-0; Tamguney G, 2006, J VIROL, V80, P9104, DOI 10.1128/JVI.00098-06; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; WILLIAMS ES, 2003, EPIDEMIOLOGY CHRONIC; Wolfe LL, 2007, J GEN VIROL, V88, P2078, DOI 10.1099/vir.0.82342-0	41	193	197	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					529	U90		10.1038/nature08289	http://dx.doi.org/10.1038/nature08289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19741608	Green Accepted, Green Submitted			2022-12-24	WOS:000270082900041
J	Kelly, CJ; Mir, FA				Kelly, Christopher J.; Mir, Fraz A.			Economics of biological therapies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FOLLOW-ON BIOLOGICS; DRUGS; NICE		[Mir, Fraz A.] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 0QQ, England; [Kelly, Christopher J.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Kelly, CJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 0QQ, England.	fam31@cam.ac.uk		Kelly, Christopher/0000-0002-1246-844X				Aggarwal S, 2007, NAT BIOTECHNOL, V25, P1097, DOI 10.1038/nbt1007-1097; [Anonymous], 2007, PHARM PRIC REG SCHEM; BERNDT E, 2007, DO AUTHORIZED GENERI; Claxton K, 2008, BMJ-BRIT MED J, V336, P251, DOI 10.1136/bmj.39434.500185.25; Covic A, 2007, INT UROL NEPHROL, V39, P261, DOI 10.1007/s11255-006-9167-5; CROW JM, 2008, CHEM WORLD      0424; *DAT, BIOG 2005 NEW LEV CO; *EUR MED AG, 2006, QUEST ANS REC REF MA; European Medicenes Agency, 2005, GUID SIM BIOL MED PR; *FED TRAD COMM, 2009, EM HLTH CAR ISS; Frank RG, 2007, NEW ENGL J MED, V357, P841, DOI 10.1056/NEJMp078095; Grabowski H, 2006, HEALTH AFFAIR, V25, P1291, DOI 10.1377/hlthaff.25.5.1291; JUDLOWE S, 2008, PROPOSED LEGISLATION; *LA MER BUS INT, TOP 20 BIOL 2007; Muller M, 2006, WIEN KLIN WOCHENSCHR, V118, P508, DOI 10.1007/s00508-006-0670-6; MUNDY A, 2009, WALL STREET J   0225; Raftery J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b67; ROYSTON J, 2008, BIOTECHNOL PROGR, V21, P11; SHAPIRO R, 2008, GENERIC BIOL TREATME; SHENOUDA M, 2008, POLITICAL UPDATE E S; Sikora K, 2007, J ROY SOC MED, V100, P166, DOI 10.1258/jrsm.100.4.166; Sleijfer S, 2009, CLIN PHARMACOL THER, V85, P136, DOI 10.1038/clpt.2008.245; Steinbrook R, 2008, NEW ENGL J MED, V359, P1977, DOI 10.1056/NEJMp0806862; *TUCK BIOG PAN, 2008, CAP MARK PERSP; U. S. Food and Drug Administration, FREQ ASK QUEST THER; *UBS INV BANK EQ R, 2005, INTR PHARM BIOT IND; Webb DJ, 2007, LANCET, V369, P1415, DOI 10.1016/S0140-6736(07)60648-5; Wright E, 2007, CHIM OGGI, V25, P4; YAKATAN S, 2005, BIOEXECUTIVE INT, V1, P2; 2008, PHARMA TIMES    0410; 2009, BBC NEWS        0616; 2009, BIOPHARMA TODAY 0519	32	21	21	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2009	339								b3276	10.1136/bmj.b3276	http://dx.doi.org/10.1136/bmj.b3276			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486SE	19700510				2022-12-24	WOS:000269217200005
J	Manning, A				Manning, Adrian			Personal View Glad to be here	BRITISH MEDICAL JOURNAL			English	Editorial Material												amanning@blueyonder.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 19	2009	339								b3356	10.1136/bmj.b3356	http://dx.doi.org/10.1136/bmj.b3356			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486SB	19692445				2022-12-24	WOS:000269216900006
J	Pipkin, ME; Rao, A				Pipkin, Matthew E.; Rao, Anjana			SnapShot: Effector and Memory T Cell Differentiation	CELL			English	Editorial Material									[Pipkin, Matthew E.; Rao, Anjana] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Pipkin, ME (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.			Pipkin, Matthew/0000-0002-9688-0190	NCI NIH HHS [F32 CA126247-02, F32 CA126247, R01 CA042471] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042471, F32CA126247] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Singh H, 2007, NAT IMMUNOL, V8, P119, DOI 10.1038/ni0207-119; Taniuchi I, 2009, CURR OPIN IMMUNOL, V21, P127, DOI 10.1016/j.coi.2009.03.012; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	9	8	8	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					606	U209	606.e1	10.1016/j.cell.2009.07.020	http://dx.doi.org/10.1016/j.cell.2009.07.020			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665979	Green Accepted, Bronze			2022-12-24	WOS:000268771900024
J	Ji, Q; Luo, ZX; Zhang, XL; Yuan, CX; Xu, L				Ji, Qiang; Luo, Zhe-Xi; Zhang, Xingliao; Yuan, Chong-Xi; Xu, Li			Evolutionary Development of the Middle Ear in Mesozoic Therian Mammals	SCIENCE			English	Article							DIVERSIFICATION; MAMMALIAFORM; CARTILAGE; BEARING; CHINA	The definitive mammalian middle ear (DMME) is defined by the loss of embryonic Meckel's cartilage and disconnection of the middle ear from the mandible in adults. It is a major feature distinguishing living mammals from nonmammalian vertebrates. We report a Cretaceous trechnotherian mammal with an ossified Meckel's cartilage in the adult, showing that homoplastic evolution of the DMME occurred in derived therian mammals, besides the known cases of eutriconodonts. The mandible with ossified Meckel's cartilage appears to be paedomorphic. Reabsorption of embryonic Meckel's cartilage to disconnect the ear ossicles from the mandible is patterned by a network of genes and signaling pathways. This fossil suggests that developmental heterochrony and gene patterning are major mechanisms in homplastic evolution of the DMME.	[Luo, Zhe-Xi] Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA; [Ji, Qiang; Yuan, Chong-Xi] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; [Zhang, Xingliao; Xu, Li] Henan Geol Museum, Zhengzhou 450003, Peoples R China	Chinese Academy of Geological Sciences	Luo, ZX (corresponding author), Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA.	LuoZ@CarnegieMNH.Org	Luo, Zhe-XI/AAU-2263-2021		Ministry of Science and Technology of China (Beijing); NSF (USA); National Natural Science Foundation (China); National Geographic Society; Henan Provincial Government	Ministry of Science and Technology of China (Beijing)(Ministry of Science and Technology, China); NSF (USA)(National Science Foundation (NSF)); National Natural Science Foundation (China)(National Natural Science Foundation of China (NSFC)); National Geographic Society(National Geographic Society); Henan Provincial Government	We thank G. Cui for fossil preparation; M. R. Dawson for improving the manuscript; and R. Asher, Y. Chai, and A. Tucker for discussion. Support from the 973 Project of Ministry of Science and Technology of China (Q. J.); from Institute of Geology of Chinese Academy of Geological Sciences (Beijing) (C.-X. Y.), from NSF (USA), National Natural Science Foundation (China), and National Geographic Society (Z.-X. L.); and from Henan Provincial Government (to Z.-L. Z. and L. X.).	ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; CIFELLI CL, 1999, GEODIVERSITAS, V21, P167; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Kirk EC, 2008, J HUM EVOL, V55, P278, DOI 10.1016/j.jhevol.2008.02.008; Li CK, 2003, CHINESE SCI BULL, V48, P1129, DOI 10.1360/02wd0134; Li G, 2006, NATURE, V439, P195, DOI 10.1038/nature04168; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo ZX, 2007, NATURE, V446, P288, DOI 10.1038/nature05627; Luo ZX, 2005, SCIENCE, V308, P103, DOI 10.1126/science.1108875; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Luo ZX, 2001, SCIENCE, V292, P1535, DOI 10.1126/science.1058476; MAIER W, 1993, MAMMAL PHYLOGENY, V1, P165; Martin T, 2005, J VERTEBR PALEONTOL, V25, P414, DOI 10.1671/0272-4634(2005)025[0414:MADOAP]2.0.CO;2; MENG J, 1995, NATURE, V377, P141, DOI 10.1038/377141a0; Meng J, 2003, ZOOL J LINN SOC-LOND, V138, P431, DOI 10.1046/j.1096-3642.2003.00064.x; Meng J, 2006, NATURE, V444, P889, DOI 10.1038/nature05234; Oka K, 2007, DEV BIOL, V303, P391, DOI 10.1016/j.ydbio.2006.11.025; Rich TH, 2005, SCIENCE, V307, P910, DOI 10.1126/science.1105717; Rougier GW, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)507[1:NJMFPA]2.0.CO;2; Rougier GW, 2003, ACTA GEOL SIN-ENGL, V77, P7; Rowe T, 1996, SCIENCE, V273, P651, DOI 10.1126/science.273.5275.651; Rowe T, 2008, P NATL ACAD SCI USA, V105, P1238, DOI 10.1073/pnas.0706385105; Sanchez-Villagra MR, 2002, J MORPHOL, V251, P219, DOI 10.1002/jmor.1085; SHUM L, 1993, DEVELOPMENT, V118, P903; Sweetman SC, 2008, PALAEONTOLOGY, V51, P1367, DOI 10.1111/j.1475-4983.2008.00816.x; Tsubamoto T, 2004, ACTA PALAEONTOL POL, V49, P329; Tucker AS, 2004, DEVELOPMENT, V131, P1235, DOI 10.1242/dev.01017	29	86	95	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					278	281		10.1126/science.1178501	http://dx.doi.org/10.1126/science.1178501			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815774				2022-12-24	WOS:000270599500040
J	Paroo, Z; Ye, XC; Chen, S; Liu, QH				Paroo, Zain; Ye, Xuecheng; Chen, She; Liu, Qinghua			Phosphorylation of the Human MicroRNA-Generating Complex Mediates MAPK/Erk Signaling	CELL			English	Article							SELF-RENEWAL; POSTTRANSCRIPTIONAL REGULATION; CELL-PROLIFERATION; TUMOR INVASION; NUCLEAR EXPORT; DICER; LET-7; GENE; PATHWAY; MATURATION	MicroRNAs (miRNAs) govern an expanding number of biological and disease processes. Understanding the mechanisms by which the miRNA pathway is regulated, therefore, represents an important area of investigation. We determined that the human miRNA-generating complex is comprised of Dicer and phospho-TRBP isoforms. Phosphorylation of TRBP is mediated by the mitogen-activated protein kinase (MAPK) Erk. Expression of phospho-mimic TRBP and TRBP phosphorylation enhanced miRNA production by increasing stability of the miRNA-generating complex. Mitogenic signaling in response to serum and the tumor promoter PMA was dependent on TRBP phosphorylation. These effects were accompanied by a coordinated increase in levels of growth-promoting miRNA and reduced expression of let-7 tumor suppressor miRNA. Conversely, pharmacological inhibition of MAPK/Erk resulted in an anti-growth miRNA profile. Taken together, these studies indicate that the MAPK/Erk pathway regulates the miRNA machinery and suggest a general principle, wherein signaling systems target the miRNA pathway to achieve biological responses.	[Paroo, Zain; Ye, Xuecheng; Liu, Qinghua] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chen, She] Natl Inst Biol Sci, Beijing 102206, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institute of Biological Sciences, Beijing	Liu, QH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	qinghua.liu@utsouthwestern.edu			National Center for Research Resources; National Institutes of Health [C06-RR15437-01, GM078163, GM084010]; Welch Foundation [I-1608]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084010, R01GM078163] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Dangsheng Li, Yi Liu, Eric Olson, Michael White, and Hongtao Yu for critical reading of the manuscript. We thank Fenghe Du and Drs. Yue Chen, Melanie Cobb, Bryan Cullen, Witold Filipowicz, Eric Olson, Patrick Provost, Ramin Shiekhattar, Bing Su, and Yingming Zhao for providing reagents and assistance in the development of this work. We thank Phi Luong, Andrew Williams, and Drs. Gaya Amarasinghe, Alex Pertsemlidis, Joan Reisch, and Michael White for insightful discussion. This work was conducted in a facility renovated with support from the National Center for Research Resources, National Institutes of Health (C06-RR15437-01) and was supported by the Welch Foundation (I-1608) and National Institutes of Health grants (GM078163 and GM084010) awarded to Q. L.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Chan SP, 2008, RNA, V14, P2104, DOI 10.1261/rna.551208; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Khokhlatchev A, 1997, J BIOL CHEM, V272, P11057; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pardal R, 2005, COLD SH Q B, V70, P177, DOI 10.1101/sqb.2005.70.057; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	63	267	270	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					112	122		10.1016/j.cell.2009.06.044	http://dx.doi.org/10.1016/j.cell.2009.06.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804757	Green Accepted, Bronze			2022-12-24	WOS:000270388600020
J	Ciccone, DN; Su, H; Hevi, S; Gay, F; Lei, H; Bajko, J; Xu, GL; Li, E; Chen, TP				Ciccone, David N.; Su, Hui; Hevi, Sarah; Gay, Frederique; Lei, Hong; Bajko, Jeffrey; Xu, Guoliang; Li, En; Chen, Taiping			KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints	NATURE			English	Article							CONTROLS DNA METHYLATION; CRYSTAL-STRUCTURE; DNMT3L; METHYLTRANSFERASE; MAINTENANCE; GENE; LSD1	Differential DNA methylation of the paternal and maternal alleles regulates the parental origin-specific expression of imprinted genes in mammals(1,2). The methylation imprints are established in male and female germ cells during gametogenesis, and the de novo DNA methyltransferase DNMT3A and its cofactor DNMT3L are required in this process(3-5). However, the mechanisms underlying locus-and parental-specific targeting of the de novo DNA methylation machinery in germline imprinting are poorly understood. Here we show that amine oxidase (flavin-containing) domain 1 (AOF1), a protein related to the lysine demethylase KDM1 (also known as LSD1)(6), functions as a histone H3 lysine 4 (H3K4) demethylase and is required for de novo DNA methylation of some imprinted genes in oocytes. AOF1, now renamed lysine demethylase 1B (KDM1B) following a new nomenclature(7), is highly expressed in growing oocytes where genomic imprints are established. Targeted disruption of the gene encoding KDM1B had no effect on mouse development and oogenesis. However, oocytes from KDM1B-deficient females showed a substantial increase in H3K4 methylation and failed to set up the DNA methylation marks at four out of seven imprinted genes examined. Embryos derived from these oocytes showed biallelic expression or biallelic suppression of the affected genes and died before mid-gestation. Our results suggest that demethylation of H3K4 is critical for establishing the DNA methylation imprints during oogenesis.	[Ciccone, David N.; Su, Hui; Hevi, Sarah; Gay, Frederique; Lei, Hong; Bajko, Jeffrey; Li, En; Chen, Taiping] Novartis Inst Biomed Res, Epigenet Program, Cambridge, MA 02139 USA; [Xu, Guoliang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Novartis; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, TP (corresponding author), Novartis Inst Biomed Res, Epigenet Program, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	taiping.chen@novartis.com						Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen Y, 2006, P NATL ACAD SCI USA, V103, P13956, DOI 10.1073/pnas.0606381103; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Hata K, 2002, DEVELOPMENT, V129, P1983; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Obata Y, 2002, J BIOL CHEM, V277, P5285, DOI 10.1074/jbc.M108586200; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Stavropoulos P, 2006, NAT STRUCT MOL BIOL, V13, P626, DOI 10.1038/nsmb1113; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268	23	351	374	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					415	U115		10.1038/nature08315	http://dx.doi.org/10.1038/nature08315			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19727073				2022-12-24	WOS:000269828100044
J	Smith, CA; Roeszler, KN; Ohnesorg, T; Cummins, DM; Farlie, PG; Doran, TJ; Sinclair, AH				Smith, Craig A.; Roeszler, Kelly N.; Ohnesorg, Thomas; Cummins, David M.; Farlie, Peter G.; Doran, Timothy J.; Sinclair, Andrew H.			The avian Z-linked gene DMRT1 is required for male sex determination in the chicken	NATURE			English	Article							MALE REGULATORY GENE; DM-DOMAIN GENE; CONSERVED SYNTENY; EXPRESSION; CHROMOSOME; EVOLUTION; AROMATASE; EMBRYOS; GONADS; SOX9	Sex in birds is chromosomally based, as in mammals, but the sex chromosomes are different and the mechanism of avian sex determination has been a long-standing mystery(1-3). In the chicken and all other birds, the homogametic sex is male (ZZ) and the heterogametic sex is female (ZW). Two hypotheses have been proposed for the mechanism of avian sex determination. The W ( female) chromosome may carry a dominant-acting ovary determinant(4-6). Alternatively, the dosage of a Z-linked gene may mediate sex determination, two doses being required for male development (ZZ)(7,8). A strong candidate avian sex-determinant under the dosage hypothesis is the conserved Z-linked gene, DMRT1 (doublesex and mab-3-related transcription factor 1)(9-11). Here we used RNA interference (RNAi) to knock down DMRT1 in early chicken embryos. Reduction of DMRT1 protein expression in ovo leads to feminization of the embryonic gonads in genetically male (ZZ) embryos. Affected males show partial sex reversal, characterized by feminization of the gonads. The feminized left gonad shows female-like histology, disorganized testis cords and a decline in the testicular marker, SOX9. The ovarian marker, aromatase, is ectopically activated. The feminized right gonad shows a more variable loss of DMRT1 and ectopic aromatase activation, suggesting differential sensitivity to DMRT1 between left and right gonads. Germ cells also show a female pattern of distribution in the feminized male gonads. These results indicate that DMRT1 is required for testis determination in the chicken. Our data support the Z dosage hypothesis for avian sex determination.	[Smith, Craig A.; Roeszler, Kelly N.; Ohnesorg, Thomas; Farlie, Peter G.; Sinclair, Andrew H.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Smith, Craig A.; Roeszler, Kelly N.; Ohnesorg, Thomas; Farlie, Peter G.; Sinclair, Andrew H.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic 3052, Australia; [Cummins, David M.; Doran, Timothy J.] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic 3220, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Smith, CA (corresponding author), Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia.	craig.smith@mcri.edu.au	Sinclair, Andrew H/A-3598-2010; Doran, Timothy J/B-3824-2011	Sinclair, Andrew H/0000-0003-2741-7992; Doran, Timothy J/0000-0002-9716-5148; Roeszler, Kelly/0000-0002-9809-1507; Ohnesorg, Thomas/0000-0001-9225-8911; Smith, Craig/0000-0002-1670-5545	Australian Research Council (ARC) DP; NH MRC Program	Australian Research Council (ARC) DP(Australian Research Council); NH MRC Program(National Health and Medical Research Council (NHMRC) of Australia)	We thank C. Tabin for providing the RCASBP retroviral vectors, and X.- J. Yang for advice on viral preparation. We also thank M. Clinton and H. Sang for methods of manipulating early chicken embryos, S. White for statistical advice and P. Farmer for the histology. P. Koopman provided comments on the manuscript. This work was supported by an Australian Research Council (ARC) DP grant held by C. A. S. and A. H. S., and an NH& MRC Program grant jointly held by A. H. S.	Arlt D, 2004, P ROY SOC B-BIOL SCI, V271, pS249, DOI 10.1098/rsbl.2003.0155; ELBRECHT A, 1992, SCIENCE, V255, P467, DOI 10.1126/science.1734525; Ellegren H, 2000, TRENDS ECOL EVOL, V15, P188, DOI 10.1016/S0169-5347(00)01821-8; Govoroun MS, 2004, DEV DYNAM, V231, P859, DOI 10.1002/dvdy.20189; Guioli S, 2007, DEVELOPMENT, V134, P4199, DOI 10.1242/dev.010249; Hori T, 2000, MOL BIOL CELL, V11, P3645, DOI 10.1091/mbc.11.10.3645; Ishimaru Y, 2008, DEVELOPMENT, V135, P677, DOI 10.1242/dev.012856; Kent J, 1996, DEVELOPMENT, V122, P2813; Kettlewell JR, 2000, GENESIS, V26, P174, DOI 10.1002/(SICI)1526-968X(200003)26:3<174::AID-GENE2>3.0.CO;2-J; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Mizuno S, 2002, CYTOGENET GENOME RES, V99, P236, DOI 10.1159/000071599; Nanda I, 2008, CYTOGENET GENOME RES, V122, P150, DOI 10.1159/000163092; Nanda I, 1999, NAT GENET, V21, P258, DOI 10.1038/6769; Nanda I, 2000, CYTOGENET CELL GENET, V89, P67, DOI 10.1159/000015567; Ounap K, 2004, AM J MED GENET A, V130A, P415, DOI 10.1002/ajmg.a.30269; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Shan Z, 2000, CYTOGENET CELL GENET, V89, P252, DOI 10.1159/000015626; Shetty S, 2002, CYTOGENET GENOME RES, V99, P245, DOI 10.1159/000071600; Shoemaker C, 2007, DEV DYNAM, V236, P1055, DOI 10.1002/dvdy.21096; Smith CA, 2007, CYTOGENET GENOME RES, V117, P165, DOI 10.1159/000103177; Smith CA, 1999, NATURE, V402, P601, DOI 10.1038/45130; Smith CA, 2004, BIOESSAYS, V26, P120, DOI 10.1002/bies.10400; Smith CA, 2003, BIOL REPROD, V68, P560, DOI 10.1095/biolreprod.102.007294; Smith CA, 2007, SEX DEV, V1, P279, DOI 10.1159/000108934; Smith CA, 2009, DIFFERENTIATION, V77, P473, DOI 10.1016/j.diff.2009.02.001; Smith CA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-72; Wise TG, 2007, ANIM BIOTECHNOL, V18, P153, DOI 10.1080/10495390600867515; Yoshimoto S, 2008, P NATL ACAD SCI USA, V105, P2469, DOI 10.1073/pnas.0712244105; Zhao Y, 2007, DEV GENES EVOL, V217, P119, DOI 10.1007/s00427-006-0117-0	30	558	610	6	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					267	271		10.1038/nature08298	http://dx.doi.org/10.1038/nature08298			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19710650				2022-12-24	WOS:000269654600045
J	Sahin, NT; Pinker, S; Cash, SS; Schomer, D; Halgren, E				Sahin, Ned T.; Pinker, Steven; Cash, Sydney S.; Schomer, Donald; Halgren, Eric			Sequential Processing of Lexical, Grammatical, and Phonological Information Within Broca's Area	SCIENCE			English	Article							WORD FORM AREA; BRAIN; LANGUAGE; MODEL; COMPREHENSION; FREQUENCY; REGION; NOUNS; VERBS; FMRI	Words, grammar, and phonology are linguistically distinct, yet their neural substrates are difficult to distinguish in macroscopic brain regions. We investigated whether they can be separated in time and space at the circuit level using intracranial electrophysiology (ICE), namely by recording local field potentials from populations of neurons using electrodes implanted in language-related brain regions while people read words verbatim or grammatically inflected them (present/past or singular/plural). Neighboring probes within Broca's area revealed distinct neuronal activity for lexical (similar to 200 milliseconds), grammatical (similar to 320 milliseconds), and phonological (similar to 450 milliseconds) processing, identically for nouns and verbs, in a region activated in the same patients and task in functional magnetic resonance imaging. This suggests that a linguistic processing sequence predicted on computational grounds is implemented in the brain in fine-grained spatiotemporally patterned activity.	[Sahin, Ned T.; Halgren, Eric] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92037 USA; [Sahin, Ned T.; Pinker, Steven] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Cash, Sydney S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Schomer, Donald] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	University of California System; University of California San Diego; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center	Sahin, NT (corresponding author), Univ Calif San Diego, Dept Radiol, La Jolla, CA 92037 USA.	sahin@post.harvard.edu	Pinker, Steven/GPX-7942-2022		NIH [NS18741, NS44623, HD18381, T32-MH070328, NCRR P41-RR14075]; Mental Illness and Neuroscience Discovery (MIND) Institute; Sackler Scholars Programme in Psychobiology; Harvard Mind/Brain/Behavior Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018381] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH070328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018741, R01NS044623] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mental Illness and Neuroscience Discovery (MIND) Institute; Sackler Scholars Programme in Psychobiology; Harvard Mind/Brain/Behavior Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grants NS18741 (E. H.), NS44623 (E. H.), HD18381 (S. P.), T32-MH070328 (N. T. S.), NCRR P41-RR14075; and the Mental Illness and Neuroscience Discovery (MIND) Institute (N. T. S.), Sackler Scholars Programme in Psychobiology (N. T. S.), and Harvard Mind/Brain/Behavior Initiative (N. T. S.). We heartily thank the patients. We also thank E. Papavassiliou and J. Wu for access to their patients; S. Narayanan, N. Dehghani, M. T. Wheeler, F. Kampmann, and L. Gruber for assistance with intracranial electrophysiological data; R. Raizada for manuscript suggestions; N. M. Sahin; and two anonymous reviewers whose suggestions and encouragement greatly improved this paper.	Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Bornkessel I, 2006, PSYCHOL REV, V113, P787, DOI 10.1037/0033-295X.113.4.787; Broca P., 1861, B SOC ANAT PARIS, V6, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018; CARAMAZZA A, 1991, NATURE, V349, P788, DOI 10.1038/349788a0; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Friederici AD, 1997, CLIN NEUROSCI, V4, P64; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friederici AD, 2009, TRENDS COGN SCI, V13, P175, DOI 10.1016/j.tics.2009.01.001; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Grodzinsky Y, 2000, BEHAV BRAIN SCI, V23, P1, DOI 10.1017/S0140525X00002399; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P51, DOI 10.1016/0928-4257(94)90093-0; Hauk O, 2004, CLIN NEUROPHYSIOL, V115, P1090, DOI 10.1016/j.clinph.2003.12.020; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Janssen DP, 2002, LANG COGNITIVE PROC, V17, P209, DOI 10.1080/01690960143000182; Joanisse MF, 1999, P NATL ACAD SCI USA, V96, P7592, DOI 10.1073/pnas.96.13.7592; Kaan E, 2002, TRENDS COGN SCI, V6, P350, DOI 10.1016/S1364-6613(02)01947-2; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; MACWHINNEY B, 1991, COGNITION, V40, P121, DOI 10.1016/0010-0277(91)90048-9; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; MCCLELLAND JL, 1979, PSYCHOL REV, V86, P287, DOI 10.1037/0033-295X.86.4.287; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; PINKER S, 1991, SCIENCE, V253, P530, DOI 10.1126/science.1857983; Pinker Steven, 1994, LANGUAGE INSTINCT; PLUNKETT K, 1991, COGNITION, V38, P43, DOI 10.1016/0010-0277(91)90022-V; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Sahin NT, 2006, CORTEX, V42, P540, DOI 10.1016/S0010-9452(08)70394-0; SAHIN NT, 2007, NEUROIMAGE, V36, pS74; Shapiro K, 2003, TRENDS COGN SCI, V7, P201, DOI 10.1016/S1364-6613(03)00060-3; ZURIF EB, 1972, NEUROPSYCHOLOGIA, V10, P405, DOI 10.1016/0028-3932(72)90003-6	31	275	278	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 16	2009	326	5951					445	449		10.1126/science.1174481	http://dx.doi.org/10.1126/science.1174481			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	506ZM	19833971	Green Accepted			2022-12-24	WOS:000270818600059
J	Claycomb, JM; Batista, PJ; Pang, KM; Gu, WF; Vasale, JJ; van Wolfswinkel, JC; Chaves, DA; Shirayama, M; Mitani, S; Ketting, RF; Conte, D; Mello, CC				Claycomb, Julie M.; Batista, Pedro J.; Pang, Ka Ming; Gu, Weifeng; Vasale, Jessica J.; van Wolfswinkel, Josien C.; Chaves, Daniel A.; Shirayama, Masaki; Mitani, Shohei; Ketting, Rene F.; Conte, Darryl, Jr.; Mello, Craig C.			The Argonaute CSR-1 and Its 22G-RNA Cofactors Are Required for Holocentric Chromosome Segregation	CELL			English	Article							DIRECTED RNA-POLYMERASE; GERM-LINE DEVELOPMENT; C-ELEGANS; CAENORHABDITIS-ELEGANS; P-GRANULES; CHROMATIN DIMINUTION; KINETOCHORE FUNCTION; GENE-EXPRESSION; INTERFERENCE; CENTROMERE	RNAi-related pathways regulate diverse processes, from developmental timing to transposon silencing. Here, we show that in C. elegans the Argonaute CSR-1, the RNA-dependent RNA polymerase EGO-1, the Dicer-related helicase DRH-3, and the Tudordomain protein EKL-1 localize to chromosomes and are required for proper chromosome segregation. In the absence of these factors chromosomes fail to align at the metaphase plate and kinetochores do not orient to opposing spindle poles. Surprisingly, the CSR-1-interacting small RNAs (22G-RNAs) are antisense to thousands of germline-expressed protein-coding genes. Nematodes assemble holocentric chromosomes in which continuous kinetochores must span the expressed domains of the genome. We show that CSR-1 interacts with chromatin at target loci but does not downregulate target mRNA or protein levels. Instead, our findings support a model in which CSR-1 complexes target protein-coding domains to promote their proper organization within the holocentric chromosomes of C. elegans.	[Claycomb, Julie M.; Batista, Pedro J.; Pang, Ka Ming; Gu, Weifeng; Vasale, Jessica J.; Chaves, Daniel A.; Shirayama, Masaki; Conte, Darryl, Jr.; Mello, Craig C.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01606 USA; [Mello, Craig C.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Batista, Pedro J.] Gulbenkian PhD Programme Biomed, P-2780156 Oeiras, Portugal; [Chaves, Daniel A.] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; [Mitani, Shohei] Japan Sci & Technol Agcy, CREST, Tokyo 1628666, Japan; [van Wolfswinkel, Josien C.; Ketting, Rene F.] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [van Wolfswinkel, Josien C.; Ketting, Rene F.] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [van Wolfswinkel, Josien C.] Univ Utrecht, Dept Biomol Mass Spectrometry, NL-3584 CA Utrecht, Netherlands	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Universidade de Lisboa; Tokyo Women's Medical University; Japan Science & Technology Agency (JST); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University	Conte, D (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01606 USA.	darryl.conte@umassmed.edu; craig.mello@umassmed.edu	pang, Ka Ming Ming/AAW-4059-2021; Batista, Pedro J/K-5303-2012; pang, ka ming/H-4082-2011	pang, ka ming/0000-0001-7262-3918; Claycomb, Julie/0000-0003-3132-5206; Ketting, Rene/0000-0001-6161-5621	Fundacao para Ciencia e a Tecnologia, Portugal [SFRH/BD/11803/2003, SFRH/BD/17629/2004/H6BM]; NIGMS [GMO58800]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM058800, R01GM058800] Funding Source: NIH RePORTER	Fundacao para Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M. C. was an HHMI fellow of the LSRF. P.J.B. and D. A. C. were supported by predoctoral fellowships from Fundacao para Ciencia e a Tecnologia, Portugal (SFRH/BD/11803/2003 for P.J.B.; and SFRH/BD/17629/2004/H6BM for D.A.C.). C.C.M. is an HHMI investigator. Thanks to K. Hagstrom, J. Carey, and T. Tabuchi for discussion and reagents. Thanks to M. Hammell for bioinformatics assistance and to M. Stoltz and P. Furcinitti for assistance with confocal microscopy. We thank D. Moazed, M. Papamichos-Chronakis, R. Gassman, and A. Desai for discussion. Thanks to A. Ensminger, H.Y. Tsai, and E. Youngman for critical reading of the manuscript. Thanks to the UMMS C. elegans community, the CGC, E. Kittler, and the UMMS CFAR. This work was made possible by grant GMO58800 from the NIGMS.	ALBERTSON DG, 1982, CHROMOSOMA, V86, P409, DOI 10.1007/BF00292267; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Ambros Victor, 2004, Methods Mol Biol, V265, P131; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Carroll CW, 2006, TRENDS CELL BIOL, V16, P70, DOI 10.1016/j.tcb.2005.12.008; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chu DS, 2006, NATURE, V443, P101, DOI 10.1038/nature05050; Csankovszki G, 2009, CURR BIOL, V19, P9, DOI 10.1016/j.cub.2008.12.006; Dernburg AF, 2001, J CELL BIOL, V153, pF33, DOI 10.1083/jcb.153.6.F33; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; GODAY C, 1992, J CELL BIOL, V118, P23, DOI 10.1083/jcb.118.1.23; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Maddox PS, 2004, CHROMOSOME RES, V12, P641, DOI 10.1023/B:CHRO.0000036588.42225.2f; Maine EM, 2005, CURR BIOL, V15, P1972, DOI 10.1016/j.cub.2005.09.049; Meneely PM, 2002, GENETICS, V162, P1169; Mito Y, 2003, MOL BIOL CELL, V14, P2399, DOI 10.1091/mbc.E02-09-0603; Moore LL, 2001, J CELL BIOL, V153, P1199, DOI 10.1083/jcb.153.6.1199; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nagaki K, 2005, PLANT CELL, V17, P1886, DOI 10.1105/tpc.105.032961; Nakamura M, 2007, GENES CELLS, V12, P997, DOI 10.1111/j.1365-2443.2007.01111.x; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; PIMPINELLI S, 1989, TRENDS GENET, V5, P310, DOI 10.1016/0168-9525(89)90114-5; Pitt JN, 2000, DEV BIOL, V219, P315, DOI 10.1006/dbio.2000.9607; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Rocheleau CE, 2008, GENETICS, V178, P1431, DOI 10.1534/genetics.107.084608; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Satzinger H, 2008, NAT REV GENET, V9, P231, DOI 10.1038/nrg2311; Schisa JA, 2001, DEVELOPMENT, V128, P1287; She XY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000624; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; van Wolfswinkel JC, 2009, CELL, V139, P135, DOI 10.1016/j.cell.2009.09.012; Vos LJ, 2006, BIOCHEM CELL BIOL, V84, P619, DOI 10.1139/O06-078; Vought VE, 2005, GENETICS, V170, P1121, DOI 10.1534/genetics.105.042135; Welburn JPI, 2008, DEV CELL, V15, P645, DOI 10.1016/j.devcel.2008.10.011; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; Yao MC, 2005, ANNU REV GENET, V39, P537, DOI 10.1146/annurev.genet.39.073003.095906; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	55	290	294	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					123	134		10.1016/j.cell.2009.09.014	http://dx.doi.org/10.1016/j.cell.2009.09.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804758	Green Accepted, Bronze			2022-12-24	WOS:000270388600021
J	Malik, HS; Henikoff, S				Malik, Harmit S.; Henikoff, Steven			Major Evolutionary Transitions in Centromere Complexity	CELL			English	Review							HISTONE H3 VARIANT; POSITION EFFECT VARIEGATION; FISSION YEAST SCM3; CENP-A CHROMATIN; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; MEIOTIC DRIVE; ROBERTSONIAN TRANSLOCATIONS; TETRAHYMENA-THERMOPHILA; STRUCTURAL DETERMINANTS	Centromeres are chromosomal elements that are both necessary and sufficient for chromosome segregation. However, the puzzlingly broad range in centromere complexity, from simple "point" centromeres to multi-megabase arrays of DNA satellites, has defied explanation. We posit that ancestral centromeres were epigenetically defined and that point centromeres, such as those of budding yeast, have derived from the partitioning elements of selfish plasmids. We further propose that the larger centromere sizes in plants and animals and the rapid evolution of their centromeric proteins is the result of an intense battle for evolutionary dominance due to the asymmetric retention of only one product of female meiosis.	[Malik, Harmit S.; Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Malik, Harmit S.; Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Malik, HS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	hsmalik@fhcrc.org	Malik, Harmit S/I-5591-2019; Malik, Harmit S/E-8519-2012	Malik, Harmit S/0000-0001-6005-0016; Henikoff, Steven/0000-0002-7621-8685	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074108] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM074108-05, R01-GM074108, R01 GM074108] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agudo M, 2000, CHROMOSOMA, V109, P190, DOI 10.1007/s004120050427; Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Alonso A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r148; Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Amor DJ, 2004, P NATL ACAD SCI USA, V101, P6542, DOI 10.1073/pnas.0308637101; Anderson JA, 2009, GENETICS, V181, P177, DOI 10.1534/genetics.108.093807; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Baum M, 2006, P NATL ACAD SCI USA, V103, P14877, DOI 10.1073/pnas.0606958103; Bensasson D, 2008, GENETICS, V178, P2161, DOI 10.1534/genetics.107.083980; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Blaisonneau J, 1997, PLASMID, V38, P202, DOI 10.1006/plas.1997.1315; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; Brar GA, 2008, NAT REV GENET, V9, P899, DOI 10.1038/nrg2454; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Burt A, 2006, GENES CONFLICT BIOL; Cardone MF, 2007, GENOMICS, V90, P35, DOI 10.1016/j.ygeno.2007.01.007; Carone DM, 2009, CHROMOSOMA, V118, P113, DOI 10.1007/s00412-008-0181-5; Cervantes MD, 2006, MOL BIOL CELL, V17, P485, DOI 10.1091/mbc.E05-07-0698; Chow JC, 2007, P NATL ACAD SCI USA, V104, P10104, DOI 10.1073/pnas.0610946104; Chueh AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000354; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Collins KA, 2004, CURR BIOL, V14, P1968, DOI 10.1016/j.cub.2004.10.024; Collins KA, 2007, GENETICS, V175, P513, DOI 10.1534/genetics.106.064410; Colombie N, 2008, DEVELOPMENT, V135, P3239, DOI 10.1242/dev.022624; Cui BW, 2006, MOL CELL BIOL, V26, P4499, DOI 10.1128/MCB.00079-06; Dalai Y, 2007, P NATL ACAD SCI USA, V104, P15974, DOI 10.1073/pnas.0707648104; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Daniel A, 2002, AM J MED GENET, V111, P450, DOI 10.1002/ajmg.10618; Dawe RK, 2006, TRENDS BIOCHEM SCI, V31, P662, DOI 10.1016/j.tibs.2006.10.004; de Villena FPM, 2001, GENETICS, V159, P1179; de Villena FPM, 2001, HUM GENET, V108, P31, DOI 10.1007/s004390000437; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Eaker S, 2001, J CELL SCI, V114, P2953; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Ebersbach G, 2008, CELL, V134, P956, DOI 10.1016/j.cell.2008.07.016; Espelin CW, 2003, MOL BIOL CELL, V14, P4557, DOI 10.1091/mbc.E02-08-0533; Fishman L, 2008, SCIENCE, V322, P1559, DOI 10.1126/science.1161406; Flemming W., 1882, ZELLSUBSTANZ; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Furuyama S, 2007, P NATL ACAD SCI USA, V104, P14706, DOI 10.1073/pnas.0706985104; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; FUTCHER AB, 1988, YEAST, V4, P27, DOI 10.1002/yea.320040104; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Ghosh SK, 2007, P NATL ACAD SCI USA, V104, P13034, DOI 10.1073/pnas.0702996104; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hajra S, 2006, J CELL BIOL, V174, P779, DOI 10.1083/jcb.200603042; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; HEWITT GM, 1976, CHROMOSOMA, V56, P381, DOI 10.1007/BF00292957; Higgins AW, 2005, CHROMOSOME RES, V13, P745, DOI 10.1007/s10577-005-1009-2; Ishii K, 2008, SCIENCE, V321, P1088, DOI 10.1126/science.1158699; Jang JK, 2007, GENETICS, V177, P267, DOI 10.1534/genetics.107.076091; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keith KC, 1999, MOL CELL BIOL, V19, P6130; Ketel C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000400; Lam AL, 2006, P NATL ACAD SCI USA, V103, P4186, DOI 10.1073/pnas.0507947103; Le HD, 2004, CHROMOSOMA, V112, P269, DOI 10.1007/s00412-003-0272-2; Lee HR, 2005, P NATL ACAD SCI USA, V102, P11793, DOI 10.1073/pnas.0503863102; Lermontova I, 2006, PLANT CELL, V18, P2443, DOI 10.1105/tpc.106.043174; Lomiento M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r173; Lundgren M, 2005, CURR OPIN MICROBIOL, V8, P662, DOI 10.1016/j.mib.2005.10.008; Malik HS, 2009, PROG MOL SUBCELL BIO, V48, P33, DOI 10.1007/978-3-642-00182-6_2; Malik HS, 2002, CURR OPIN GENET DEV, V12, P711, DOI 10.1016/S0959-437X(02)00351-9; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; Maruyama S, 2007, PLANT J, V49, P1122, DOI 10.1111/j.1365-313X.2006.03024.x; McKee BD, 1998, GENETICS, V149, P143; MEAD DJ, 1986, MOL GEN GENET, V205, P417, DOI 10.1007/BF00338076; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Metcalfe CJ, 2007, GENETICS, V177, P2507, DOI 10.1534/genetics.107.082313; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Moreno-Moreno O, 2006, NUCLEIC ACIDS RES, V34, P6247, DOI 10.1093/nar/gkl902; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Padmanabhan S, 2008, P NATL ACAD SCI USA, V105, P19797, DOI 10.1073/pnas.0809770105; PALMER DK, 1991, P NATL ACAD SCI USA, V88, P3734, DOI 10.1073/pnas.88.9.3734; Pearson CG, 2004, CURR BIOL, V14, P1962, DOI 10.1016/j.cub.2004.09.086; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; PIMPINELLI S, 1989, TRENDS GENET, V5, P310, DOI 10.1016/0168-9525(89)90114-5; Platero JS, 1999, MOL CELL, V4, P995, DOI 10.1016/S1097-2765(00)80228-2; Rudd MK, 2006, GENOME RES, V16, P88, DOI 10.1101/gr.3810906; Sanchez-Pulido L, 2009, CELL, V137, P1173, DOI 10.1016/j.cell.2009.06.010; Sandman K, 2006, CURR OPIN MICROBIOL, V9, P520, DOI 10.1016/j.mib.2006.08.003; Sanyal K, 2004, P NATL ACAD SCI USA, V101, P11374, DOI 10.1073/pnas.0404318101; SAWAMURA K, 1993, MOL GEN GENET, V239, P441, DOI 10.1007/BF00276943; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Scott-Drew S, 2002, CELL BIOL INT, V26, P393, DOI 10.1006/cbir.2002.0867; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Silva NCE, 2007, J MOL BIOL, V370, P555, DOI 10.1016/j.jmb.2007.04.064; STEINER NC, 1994, CELL, V79, P865, DOI 10.1016/0092-8674(94)90075-2; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Sun XP, 2003, GENOME RES, V13, P182, DOI 10.1101/gr.681703; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Takayama Y, 2008, MOL BIOL CELL, V19, P682, DOI 10.1091/mbc.E07-05-0504; Talbert PB, 2008, KINETOCHORE; Topp CN, 2004, P NATL ACAD SCI USA, V101, P15986, DOI 10.1073/pnas.0407154101; Tyler-Smith C, 1999, AM J HUM GENET, V64, P1440, DOI 10.1086/302380; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Vermaak D, 2002, MOL CELL BIOL, V22, P7553, DOI 10.1128/MCB.22.21.7553-7561.2002; Villasante A, 2007, P NATL ACAD SCI USA, V104, P10542, DOI 10.1073/pnas.0703808104; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Weber SA, 2004, PLOS BIOL, V2, P1340, DOI 10.1371/journal.pbio.0020260; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004; Wignall SM, 2009, NAT CELL BIOL, V11, P839, DOI 10.1038/ncb1891; WILLARD HF, 1990, TRENDS GENET, V6, P410, DOI 10.1016/0168-9525(90)90302-M; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Yan HH, 2008, PLOS BIOL, V6, P2563, DOI 10.1371/journal.pbio.0060286; Zou JW, 2008, J CELL BIOL, V180, P459, DOI 10.1083/jcb.200711031	124	241	247	4	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 18	2009	138	6					1067	1082		10.1016/j.cell.2009.08.036	http://dx.doi.org/10.1016/j.cell.2009.08.036			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766562	Bronze			2022-12-24	WOS:000269923200009
J	Charakida, M; Besler, C; Batuca, JR; Sangle, S; Marques, S; Sousa, M; Wang, GS; Tousoulis, D; Alves, JD; Loukogeorgakis, SP; Mackworth-Young, C; D'Cruz, D; Luscher, T; Landmesser, U; Deanfield, JE				Charakida, Marietta; Besler, Christian; Batuca, Joana R.; Sangle, Shirish; Marques, Susanna; Sousa, Miguel; Wang, Guosu; Tousoulis, Dimitris; Alves, Jose Delgado; Loukogeorgakis, Stavros P.; Mackworth-Young, Charles; D'Cruz, David; Luscher, Thomas; Landmesser, Ulf; Deanfield, John E.			Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIGH-DENSITY-LIPOPROTEIN; INTIMA-MEDIA THICKNESS; AUTOIMMUNE RHEUMATIC-DISEASES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACCELERATED ATHEROSCLEROSIS; ANTIINFLAMMATORY PROPERTIES; PREMATURE ATHEROSCLEROSIS; SERUM PARAOXONASE; CAROTID ARTERIES; OXIDATIVE STRESS	Context Accelerated atherosclerosis has been described in antiphospholipid syndrome, but the vascular abnormalities and the underlying mechanisms remain unclear. Objectives To compare vascular structure and function in patients with positive antiphospholipid antibodies (aPL) with controls and to assess their relationship with paraoxonase activity. Design, Setting, and Participants A cross-sectional study of 77 women with positive antiphospholipid antibodies from a lupus outpatient clinic in London, England (90% of the eligible population) and 77 controls matched on frequency basis for age and cardiovascular risk factors between June 2006 and April 2009. Carotid intima media thickness (CIMT), flow-mediated dilatation, pulse wave velocity, and paraoxonase activity were measured in all patients. Anti-inflammatory and antioxidant properties of high-density lipoprotein (HDL) were examined. Main Outcome Measures CIMT, pulse wave velocity, flow-mediated dilatation, and paraoxonase. Results Women with aPL had greater CIMT and pulse wave velocity compared with controls (mean [SD], 0.75 [0.16] vs 0.64 [0.09] mm; 95% confidence interval [CI],-0.14 to-0.06; P<.001; and 9.2 [1.6] vs 8.5 [1.8] m/s; 95% CI,-1.14 to-0.06; P=.04) and lower flow-mediated dilatation (6.2% [4.1%] vs 9.6% [4.2%]; 95% CI, 2.02%-4.69%; P<.001). Paraoxonase activity was lower in women with aPL vs controls (median [interquartile range], 91.2 [64.3-105.1] vs 103.0 [80.5-111.5] mu mol p-nitrophenol/L/serum/min; 95% CI, 0.004-0.007; P=.005) and was inversely associated with CIMT and pulse wave velocity in women with aPL (standardized beta coefficient=-0.4 and-0.3, respectively; P<.05 for both), but not in the control group. High-density lipoprotein from women with aPL inhibited endothelial nitric oxide production in human aortic endothelial cells, in contrast with controls. The beneficial effects of HDL from women with aPL on vascular cell adhesion molecule 1 expression, superoxide production, and monocyte adhesion following activation of human aortic endothelial cells were largely blunted. Conclusions Compared with controls, women with aPL had greater functional and structural arterial abnormalities, which were associated with lower activity of paraoxonase. In patients with aPL, HDL reduced nitric oxide bioavailability and had impaired anti-inflammatory and antioxidant properties. JAMA. 2009; 302(11): 1210-1217	[Charakida, Marietta; Wang, Guosu; Loukogeorgakis, Stavros P.; Deanfield, John E.] UCL, Inst Child Hlth, Dept Vasc Physiol, London WC1N 1EH, England; [Besler, Christian; Luscher, Thomas; Landmesser, Ulf] Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland; [Batuca, Joana R.; Alves, Jose Delgado] Univ Nova Lisboa, Dept Pharmacol, Lisbon, Portugal; [Sangle, Shirish; Marques, Susanna; Sousa, Miguel; D'Cruz, David] St Thomas Hosp, Rayne Inst, Lupus Res Unit, London SE1 7EH, England; [Tousoulis, Dimitris] Univ Athens, Sch Med, Dept Cardiol, Hippokrat Hosp, GR-11527 Athens, Greece; [Mackworth-Young, Charles] Charing Cross Hosp, Dept Rheumatol, London, England	University of London; University College London; University of Zurich; University Zurich Hospital; Universidade Nova de Lisboa; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Athens Medical School; Hippokration General Hospital; National & Kapodistrian University of Athens; Imperial College London	Charakida, M (corresponding author), UCL, Inst Child Hlth, Dept Vasc Physiol, 34 Great Ormond St, London WC1N 1EH, England.	charakidadoc@gmail.com	Alves, José/AAB-2894-2019	Delgado Alves, Jose/0000-0002-5216-4125; Charakida, Marietta/0000-0003-4214-5059; Deanfield, John/0000-0001-8806-6052; Batuca, Joana/0000-0002-0804-6279	Department of Vascular Physiology; Institute of Child Health, University College London, London, England; Cardiovascular Center, University Hospital Zurich, Zurich, Switzerland; Department of Pharmacology, New University of Lisbon, Lisbon, Portugal	Department of Vascular Physiology; Institute of Child Health, University College London, London, England; Cardiovascular Center, University Hospital Zurich, Zurich, Switzerland; Department of Pharmacology, New University of Lisbon, Lisbon, Portugal	Funding/Support: This study was supported by funds from the Department of Vascular Physiology, The Institute of Child Health, University College London, London, England; Cardiovascular Center, University Hospital Zurich, Zurich, Switzerland; and Department of Pharmacology, New University of Lisbon, Lisbon, Portugal.	Alves JD, 2005, RHEUMATOLOGY, V44, P1238, DOI 10.1093/rheumatology/keh722; Alves JD, 2003, RHEUMATOLOGY, V42, P893, DOI 10.1093/rheumatology/keg248; Ames PRJ, 2006, CLIN DEV IMMUNOL, V13, P1, DOI 10.1080/17402520600554930; Ames PRJ, 2005, ANN RHEUM DIS, V64, P315, DOI 10.1136/ard.2004.023952; Ames PRJ, 2002, LUPUS, V11, P208, DOI 10.1191/0961203302lu165oa; Ansell BJ, 2007, CURR OPIN LIPIDOL, V18, P427, DOI 10.1097/MOL.0b013e3282364a17; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Aviram Michael, 2008, V477, P259, DOI 10.1007/978-1-60327-517-0_20; Batuca JR, 2009, RHEUMATOLOGY, V48, P26, DOI 10.1093/rheumatology/ken397; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Charakida M, 2005, CIRCULATION, V112, P103, DOI 10.1161/CIRCULATIONAHA.104.517144; DELGADO AJ, 2002, ARTHRITIS RHEUM, V46, P2686, DOI DOI 10.1371/JOURNAL.PONE.0186513; Dinu AR, 1998, LUPUS, V7, P355, DOI 10.1191/096120398678920262; Donald AE, 2006, J AM COLL CARDIOL, V48, P1846, DOI 10.1016/j.jacc.2006.07.039; Dropinski Jerzy, 2003, Kardiol Pol, V59, P475; Dropinski Jerzy, 2003, Med Sci Monit, V9, pBR105; Feng H, 2009, CURR OPIN ENDOCRINOL, V16, P156, DOI 10.1097/MED.0b013e32832922fc; Fichtlscherer S, 2004, CIRCULATION, V110, P1926, DOI 10.1161/01.CIR.0000143378.58099.8C; Florentin M, 2008, CURR OPIN CARDIOL, V23, P370, DOI 10.1097/HCO.0b013e3283043806; Gordon PA, 2001, LUPUS, V10, P249, DOI 10.1191/096120301680416922; Hughes G, 2007, CLIN REV ALLERG IMMU, V32, P3, DOI 10.1007/BF02686077; Jara LJ, 2006, AUTOIMMUN REV, V5, P195, DOI 10.1016/j.autrev.2005.06.005; Lambert M, 2000, LUPUS, V9, P299, DOI 10.1191/096120300680198980; LEVY PJ, 1995, ANGIOLOGY, V46, P853, DOI 10.1177/000331979504600914; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Mackworth-Young C, 2006, AUTOIMMUN REV, V5, P70, DOI 10.1016/j.autrev.2005.08.001; Matsuura E, 2006, RHEUM DIS CLIN N AM, V32, P537, DOI 10.1016/j.rdc.2006.05.006; Medina G, 2003, ANN RHEUM DIS, V62, P607, DOI 10.1136/ard.62.7.607; Nicolo D, 2004, CLIN IMMUNOL, V112, P183, DOI 10.1016/j.clim.2004.02.016; Pahor A, 2006, IMMUNOBIOLOGY, V211, P689, DOI 10.1016/j.imbio.2006.01.004; Sherer Y, 2006, NAT CLIN PRACT RHEUM, V2, P99, DOI 10.1038/ncprheum0092; Sherer Y, 2003, IMMUNOBIOLOGY, V207, P13, DOI 10.1078/0171-2985-00212; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Shoenfeld Y, 2005, CIRCULATION, V112, P3337, DOI 10.1161/CIRCULATIONAHA.104.507996; Sorrentino SA, 2007, CIRCULATION, V116, P163, DOI 10.1161/CIRCULATIONAHA.106.684381; Tward A, 2002, CIRCULATION, V106, P484, DOI 10.1161/01.CIR.0000023623.87083.4F; Van Lenten BJ, 2001, CIRCULATION, V103, P2283; Vlachoyiannopoulous PG, 2004, THROMB RES, V114, P509, DOI 10.1016/j.thromres.2004.06.027; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986	39	108	110	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	2009	302	11					1210	1217		10.1001/jama.2009.1346	http://dx.doi.org/10.1001/jama.2009.1346			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494FR	19755700	Bronze			2022-12-24	WOS:000269797600031
J	Yang, GJ; Nagel, DH; Feschotte, C; Hancock, CN; Wessler, SR				Yang, Guojun; Nagel, Dawn Holligan; Feschotte, Cedric; Hancock, C. Nathan; Wessler, Susan R.			Tuned for Transposition: Molecular Determinants Underlying the Hyperactivity of a Stowaway MITE	SCIENCE			English	Article							TRANSPOSABLE ELEMENTS MITES; MARINER-LIKE TRANSPOSASES; RICE; EVOLUTION; GENOME; AMPLIFICATION; MOBILIZATION; COMPLEX; FAMILY	Miniature inverted repeat transposable elements (MITEs) are widespread in eukaryotic genomes, where they can attain high copy numbers despite a lack of coding capacity. However, little is known about how they originate and amplify. We performed a genome-wide screen of functional interactions between Stowaway MITEs and potential transposases in the rice genome and identified a transpositionally active MITE that possesses key properties that enhance transposition. Although not directly related to its autonomous element, the MITE has less affinity for the transposase than does the autonomous element but lacks a motif repressing transposition in the autonomous element. The MITE contains internal sequences that enhance transposition. These findings suggest that MITEs achieve high transposition activity by scavenging transposases encoded by distantly related and self-restrained autonomous elements.	[Yang, Guojun; Nagel, Dawn Holligan; Hancock, C. Nathan; Wessler, Susan R.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Yang, Guojun] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Yang, Guojun] Univ Toronto, Toronto, ON M5S 3G5, Canada; [Feschotte, Cedric] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA	University System of Georgia; University of Georgia; University of Toronto; University Toronto Mississauga; University of Toronto; University of Texas System; University of Texas Arlington	Wessler, SR (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	sue@plantbio.uga.edu	Hancock, Charles/AAA-5249-2020; Feschotte, Cedric/C-4048-2011	, Dawn/0000-0001-8996-3572	NIH; NSF; University of Georgia Research Foundation; University of Toronto	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); University of Georgia Research Foundation; University of Toronto(University of Toronto)	We thank C. F. Weil and D. J. Garfinkel for materials and technical assistance and J. Bennetzen, X. Zhang, and J. Leebens-Mack for discussion and insightful comments. This work was supported by NIH, the NSF Plant Genome Program, the University of Georgia Research Foundation, and the University of Toronto. Sequences for Osmar transposase coding sequences and their nonautonomous elements were deposited in GenBank (accession numbers GQ379705 to GQ379718 and GQ382183).	Auge-Gouillou C, 2005, MOL CELL BIOL, V25, P2861, DOI 10.1128/MCB.25.7.2861-2870.2005; Feschotte C, 2005, NUCLEIC ACIDS RES, V33, P2153, DOI 10.1093/nar/gki509; Feschotte C, 2003, GENETICS, V163, P747; Feschotte C, 2002, P NATL ACAD SCI USA, V99, P280, DOI 10.1073/pnas.022626699; Feschotte C, 2002, MOBILE DNA-UK, P1147, DOI DOI 10.1128/9781555817954.CH50; Hart DL, 1997, ANNU REV GENET, V31, P337, DOI 10.1146/annurev.genet.31.1.337; Jiang N, 2004, CURR OPIN PLANT BIOL, V7, P115, DOI 10.1016/j.pbi.2004.01.004; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Kikuchi K, 2003, NATURE, V421, P167, DOI 10.1038/nature01218; Lampe DJ, 2001, MOL BIOL EVOL, V18, P954, DOI 10.1093/oxfordjournals.molbev.a003896; Menzel G, 2006, CHROMOSOME RES, V14, P831, DOI 10.1007/s10577-006-1090-1; Naito K, 2006, P NATL ACAD SCI USA, V103, P17620, DOI 10.1073/pnas.0605421103; Nakazaki T, 2003, NATURE, V421, P170, DOI 10.1038/nature01219; Piriyapongsa J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000203; Tosi LRO, 2000, NUCLEIC ACIDS RES, V28, P784, DOI 10.1093/nar/28.3.784; WAY JC, 1985, GENETICS, V111, P705; WESSLER SR, 1995, CURR OPIN GENET DEV, V5, P814, DOI 10.1016/0959-437X(95)80016-X; Yang GJ, 2005, PLANT CELL, V17, P1559, DOI 10.1105/tpc.104.030528; Yang GJ, 2006, PLANT CELL, V18, P2469, DOI 10.1105/tpc.106.045906	19	110	116	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1391	1394		10.1126/science.1175688	http://dx.doi.org/10.1126/science.1175688			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745152				2022-12-24	WOS:000269699100038
J	Chiang, SH; Bazuine, M; Lumeng, CN; Geletka, LM; Mowers, J; White, NM; Ma, JT; Zhou, J; Qi, N; Westcott, D; Delproposto, JB; Blackwell, TS; Yull, FE; Saltiel, AR				Chiang, Shian-Huey; Bazuine, Merlijn; Lumeng, Carey N.; Geletka, Lynn M.; Mowers, Jonathan; White, Nicole M.; Ma, Jing-Tyan; Zhou, Jie; Qi, Nathan; Westcott, Dan; Delproposto, Jennifer B.; Blackwell, Timothy S.; Yull, Fiona E.; Saltiel, Alan R.			The Protein Kinase IKK epsilon Regulates Energy Balance in Obese Mice	CELL			English	Article							ADIPOSE-TISSUE MACROPHAGES; INDUCED INSULIN-RESISTANCE; TUMOR-NECROSIS-FACTOR; KAPPA-B; PPAR-GAMMA; ADIPONECTIN RECEPTORS; CHRONIC INFLAMMATION; HEPATIC STEATOSIS; TNF-ALPHA; ACTIVATION	Obesity is associated with chronic low-grade inflammation that negatively impacts insulin sensitivity. Here, we show that high-fat diet can increase NF-kappa B activation in mice, which leads to a sustained elevation in level of I kappa B kinase epsilon (IKK epsilon) in liver, adipocytes, and adipose tissue macrophages. IKK epsilon knockout mice are protected from high-fat diet-induced obesity, chronic inflammation in liver and fat, hepatic steatosis, and whole-body insulin resistance. These mice show increased energy expenditure and thermogenesis via enhanced expression of the uncoupling protein UCP1. They maintain insulin sensitivity in liver and fat, without activation of the proinflammatory JNK pathway. Gene expression analyses indicate that IKK epsilon knockout reduces expression of inflammatory cytokines, and changes expression of certain regulatory proteins and enzymes involved in glucose and lipid metabolism. Thus, IKK epsilon may represent an attractive therapeutic target for obesity, insulin resistance, diabetes, and other complications associated with these disorders.	[Chiang, Shian-Huey; Bazuine, Merlijn; Lumeng, Carey N.; Geletka, Lynn M.; Mowers, Jonathan; White, Nicole M.; Ma, Jing-Tyan; Zhou, Jie; Westcott, Dan; Delproposto, Jennifer B.; Saltiel, Alan R.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Lumeng, Carey N.; Mowers, Jonathan; Delproposto, Jennifer B.; Saltiel, Alan R.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Lumeng, Carey N.; Delproposto, Jennifer B.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Saltiel, Alan R.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ma, Jing-Tyan] Fudan Univ, Inst Genet, Shanghai 200433, Peoples R China; [Blackwell, Timothy S.; Yull, Fiona E.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Blackwell, Timothy S.; Yull, Fiona E.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Blackwell, Timothy S.; Yull, Fiona E.] Vanderbilt Univ, Sch Med, Dept Cell & Mol Biol, Nashville, TN 37232 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Fudan University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Saltiel, AR (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	saltiel@lsi.umich.edu	Saltiel, Alan/L-3632-2019	Saltiel, Alan/0000-0002-9726-9828; White, Nicole/0000-0003-3928-9502; Lumeng, Carey/0000-0003-0303-6204	American Diabetes Association [NIH RO1DK060591]; NIH [DK-078851, HD-028820]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD028820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK078851, R01DK061618, R01DK060591] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Tom Maniatis for the IKK epsilon mice and constructs, and for helpful suggestions during the course of these studies. We also thank Drs. Benjamin Tenoever and Jiandie Lin for helpful discussions. We are grateful to Xiao-ling Peng for maintaining the mouse colony and genotyping. We thank Saltiel lab members for support and suggestions, and we especially thank Dr. Dave Bridges for help on statistical analyses. We also thank UM Microarray Core for their help on microarray data analyses and UM Phenotyping Core for CLAMS study. This research was funded by NIH RO1DK060591 to A. R. S. M. B. was supported by a Mentor-Based Postdoctoral Award from the American Diabetes Association. C. N. L. was supported by NIH DK-078851 and HD-028820.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Eguchi J, 2008, CELL METAB, V7, P86, DOI 10.1016/j.cmet.2007.11.002; FEINGOLD KR, 1992, ENDOCRINOLOGY, V130, P10, DOI 10.1210/en.130.1.10; GREEN A, 1994, ENDOCRINOLOGY, V134, P2581, DOI 10.1210/en.134.6.2581; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kelly LJ, 1998, ENDOCRINOLOGY, V139, P4920, DOI 10.1210/en.139.12.4920; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Koh YK, 2008, J BIOL CHEM, V283, P34896, DOI 10.1074/jbc.M804007200; Laplante M, 2003, DIABETES, V52, P291, DOI 10.2337/diabetes.52.2.291; Lesniewski LA, 2007, NAT MED, V13, P455, DOI 10.1038/nm1550; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Otabe S, 2007, AM J PHYSIOL-ENDOC M, V293, pE210, DOI 10.1152/ajpendo.00645.2006; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Ribon V, 1998, P NATL ACAD SCI USA, V95, P14751, DOI 10.1073/pnas.95.25.14751; Sadikot RT, 2001, AM J RESP CRIT CARE, V164, P873, DOI 10.1164/ajrccm.164.5.2008059; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Thirone ACP, 2006, TRENDS ENDOCRIN MET, V17, P70, DOI 10.1016/j.tem.2006.01.005; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wunderlich FT, 2008, P NATL ACAD SCI USA, V105, P1297, DOI 10.1073/pnas.0707849104; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu J, 2006, DIABETES, V55, P3429, DOI 10.2337/db06-0260; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	53	265	286	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					961	975		10.1016/j.cell.2009.06.046	http://dx.doi.org/10.1016/j.cell.2009.06.046			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737522	Green Accepted, Bronze			2022-12-24	WOS:000269564600021
J	de Wit, H; Walter, AM; Milosevic, I; Gulyas-Kovacs, A; Riedel, D; Sorensen, JB; Verhage, M				de Wit, Heidi; Walter, Alexander M.; Milosevic, Ira; Gulyas-Kovacs, Attila; Riedel, Dietmar; Sorensen, Jakob B.; Verhage, Matthijs			Synaptotagmin-1 Docks Secretory Vesicles to Syntaxin-1/SNAP-25 Acceptor Complexes	CELL			English	Article							MEMBRANE-FUSION; SNARE COMPLEX; T-SNARE; NEUROTRANSMITTER RELEASE; CONFORMATIONAL SWITCH; REGULATED EXOCYTOSIS; SYNAPTIC VESICLES; CHROMAFFIN CELLS; PLASMA-MEMBRANE; C2B DOMAIN	Docking, the initial association of secretory vesicles with the plasma membrane, precedes formation of the SNARE complex, which drives membrane fusion. For many years, the molecular identity of the docked state, and especially the vesicular docking protein, has been unknown, as has the link to SNARE complex assembly. Here, using adrenal chromaffin cells, we identify the vesicular docking partner as synaptotagmin-1, the calcium sensor for exocytosis, and SNAP-25 as an essential plasma membrane docking factor, which, together with the previously known docking factors Munc18-1 and syntaxin, form the minimal docking machinery. Moreover, we show that the requirement for Munc18-1 in docking, but not fusion, can be overcome by stabilizing syntaxin/SNAP-25 acceptor complexes. These findings, together with cross-rescue, double-knockout, and electrophysiological data, lead us to propose that vesicles dock when synaptotagmin-1 binds to syntaxin/SNAP-25 acceptor complexes, whereas Munc18-1 is required for the downstream association of synaptobrevin to form fusogenic SNARE complexes.	[Walter, Alexander M.; Milosevic, Ira; Gulyas-Kovacs, Attila; Sorensen, Jakob B.] Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; [Riedel, Dietmar] Max Planck Inst Biophys Chem, Electron Microscopy Lab, D-37077 Gottingen, Germany; [de Wit, Heidi; Verhage, Matthijs] Vrije Univ Amsterdam, Dept Funct Genom, Ctr Neurogenom & Cognit Res, NL-1081 HV Amsterdam, Netherlands; [de Wit, Heidi; Verhage, Matthijs] VU Med Ctr, NL-1081 HV Amsterdam, Netherlands; [Sorensen, Jakob B.] Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark	Max Planck Society; Max Planck Society; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Copenhagen	Sorensen, JB (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany.	jakobbs@sund.ku.dk; matthijs.verhage@cncr.vu.nl	Cruz e Silva, Odete/AAH-5595-2020; Walter, Alexander M/O-1824-2015	Walter, Alexander M/0000-0001-5646-4750; Sorensen, Jakob/0000-0001-5465-3769; verhage, matthijs/0000-0002-6085-7503	Netherlands Organization for Scientific Research [GpD970-10-036, Pionier/VICI900-01-001, VENI 916-36-043]; NeuroBsik Mouse Phenomics Consortium [BSIK03053]; European Commission [LSHM-CT-2005-019055]; Deutsche Forschungsgemeinschaft [SFB523-B16]; Junior Group Leader Fellowship; Lundbeck Foundation; Lundbeck Foundation [R28-2008-1976] Funding Source: researchfish	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NeuroBsik Mouse Phenomics Consortium; European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Junior Group Leader Fellowship; Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from Netherlands Organization for Scientific Research (GpD970-10-036 and Pionier/VICI900-01-001 to M. V., and VENI 916-36-043 to H. d. W.), the NeuroBsik Mouse Phenomics Consortium (BSIK03053), the European Commission (EU Synapse project, LSHM-CT-2005-019055), the Deutsche Forschungsgemeinschaft (SFB523-B16 to J. B. S.), and a Junior Group Leader Fellowship (to J. B. S.) from the Lundbeck Foundation.	Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chieregatti E, 2002, TRAFFIC, V3, P496, DOI 10.1034/j.1600-0854.2002.30706.x; Dai H, 2007, J MOL BIOL, V367, P848, DOI 10.1016/j.jmb.2007.01.040; de Wit H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000126; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; FASSHAUER D, 1997, J BIOL CHEM, V242, P28036; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fukuda M, 2006, BIOCHEM SOC T, V34, P691, DOI 10.1042/BST0340691; Gaffaney JD, 2008, J BIOL CHEM, V283, P31763, DOI 10.1074/jbc.M803355200; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; Loewen CA, 2006, MOL BIOL CELL, V17, P5211, DOI 10.1091/mbc.E06-07-0622; Lynch KL, 2007, MOL BIOL CELL, V18, P4957, DOI 10.1091/mbc.E07-04-0368; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Medine CN, 2007, J CELL SCI, V120, P4407, DOI 10.1242/jcs.020230; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; NEHER E, 1994, NATURE, V372, P316, DOI 10.1038/372316a0; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Reist NE, 1998, J NEUROSCI, V18, P7662; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Rickman C, 2006, MOL BIOL CELL, V17, P283, DOI 10.1091/mbc.E05-07-0620; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Salem N, 1998, NAT NEUROSCI, V1, P551, DOI 10.1038/2787; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Schonn JS, 2008, P NATL ACAD SCI USA, V105, P3998, DOI 10.1073/pnas.0712373105; Schutz D, 2005, EUR J NEUROSCI, V21, P2419, DOI 10.1111/j.1460-9568.2005.04095.x; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Weimer RM, 2005, CURR TOP DEV BIOL, V65, P83; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Xiao WZ, 2001, NAT STRUCT BIOL, V8, P308, DOI 10.1038/86174; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	58	196	200	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					935	946		10.1016/j.cell.2009.07.027	http://dx.doi.org/10.1016/j.cell.2009.07.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19716167	Green Submitted, Bronze			2022-12-24	WOS:000269564600019
J	Han, D; Lerner, AG; Vande Walle, L; Upton, JP; Xu, WH; Hagen, A; Backes, BJ; Oakes, SA; Papa, FR				Han, Dan; Lerner, Alana G.; Vande Walle, Lieselotte; Upton, John-Paul; Xu, Weihong; Hagen, Andrew; Backes, Bradley J.; Oakes, Scott A.; Papa, Feroz R.			IRE1 alpha Kinase Activation Modes Control Alternate Endoribonuclease Outputs to Determine Divergent Cell Fates	CELL			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; MESSENGER-RNA; TYROSINE KINASE; IRE1 REVEALS; ER STRESS; GENES; LOAD	During endoplasmic reticulum ( ER) stress, homeostatic signaling through the unfolded protein response (UPR) augments ER protein-folding capacity. If homeostasis is not restored, the UPR triggers apoptosis. We found that the ER transmembrane kinase/endoribonuclease (RNase) IRE1 alpha is a key component of this apoptotic switch. ER stress induces IRE1 alpha kinase autophosphorylation, activating the RNase to splice XBP1 mRNA and produce the homeostatic transcription factor XBP1s. Under ER stress-or forced autophosphorylation-IRE1 alpha's RNase also causes endonucleolytic decay of many ER-localized mRNAs, including those encoding chaperones, as early events culminating in apoptosis. Using chemical genetics, we show that kinase inhibitors bypass autophosphorylation to activate the RNase by an alternate mode that enforces XBP1 splicing and averts mRNA decay and apoptosis. Alternate RNase activation by kinase-inhibited IRE1 alpha can be reconstituted in vitro. We propose that divergent cell fates during ER stress hinge on a balance between IRE1 alpha RNase outputs that can be tilted with kinase inhibitors to favor survival.	[Han, Dan; Lerner, Alana G.; Vande Walle, Lieselotte; Hagen, Andrew; Backes, Bradley J.; Papa, Feroz R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Upton, John-Paul; Oakes, Scott A.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Han, Dan; Lerner, Alana G.; Vande Walle, Lieselotte; Hagen, Andrew; Backes, Bradley J.; Papa, Feroz R.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Han, Dan; Lerner, Alana G.; Vande Walle, Lieselotte; Hagen, Andrew; Backes, Bradley J.; Papa, Feroz R.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Xu, Weihong] Stanford Univ, Stanford Genome Technol Ctr, Stanford, CA 94304 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Papa, FR (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	frpapa@medicine.ucsf.edu	Longo, Kenneth A/A-5631-2010; Xu, Weihong/C-4175-2012	Xu, Weihong/0000-0002-3988-3571; Hagen, Andrew/0000-0002-2691-157X; Papa, Feroz/0000-0002-3684-9108	National Institutes of Health [DP2 OD001925, K08 DK065671, RO1 DK080955, K08 A1054650, RO1 CA136577]; NIGMS-IMSD [R25 GM56847]; Howard Hughes Medical Institute Physician-Scientist Early Career Award; Steward Trust Foundation; Sandler Program in Basic Sciences; Burroughs Wellcome Foundation; Hillblom Foundation; Partnership for Cures; NATIONAL CANCER INSTITUTE [R01CA136577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI054650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080955, K08DK065671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056847] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS-IMSD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute Physician-Scientist Early Career Award(Howard Hughes Medical Institute); Steward Trust Foundation; Sandler Program in Basic Sciences; Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Hillblom Foundation; Partnership for Cures; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Ryffel for INS-1/FRT/TO cells, L. Glimcher for Xbp1<SUP>-/-</SUP> MEFs, D. Ron for Ire1 alpha<SUP>-/-</SUP> MEFs, F. Urano for anti-IRE1 alpha antibodies, P. Merksamer for ER and cytosolic GFP vectors, and C. Zhang and K. Shokat for 1NM-PP1. We thank J. Bluestone, D. Ganem, M. Hebrok, D. Sheppard, and members of the Oakes and Papa labs for comments. This work was supported by National Institutes of Health: Director's New Innovator Award DP2 OD001925 ( F. R. P), K08 DK065671 ( F. R. P.), RO1 DK080955 ( F. R. P), K08 A1054650 ( S. A. O.), RO1 CA136577 ( S. A. O.), and NIGMS-IMSD R25 GM56847 ( A. G. L.); a Howard Hughes Medical Institute Physician-Scientist Early Career Award ( S. A. O.); the Steward Trust Foundation ( S. A. O.); the Sandler Program in Basic Sciences ( S. A. O. and F. R. P.); the Burroughs Wellcome Foundation ( F. R. P.); the Hillblom Foundation ( F. R. P.); and the Partnership for Cures ( F. R. P.).	Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Dan H, 2008, BIOCHEM BIOPH RES CO, V365, P777, DOI 10.1016/j.bbrc.2007.11.040; Harding HP, 2001, COLD SPRING HARB SYM, V66, P499, DOI 10.1101/sqb.2001.66.499; Higashio H, 2002, BIOCHEM BIOPH RES CO, V296, P568, DOI 10.1016/S0006-291X(02)00923-3; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Lipson KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001648; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Thomas H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh144; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	31	586	611	4	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					562	575		10.1016/j.cell.2009.07.017	http://dx.doi.org/10.1016/j.cell.2009.07.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665977	Green Accepted, Bronze			2022-12-24	WOS:000268771900020
J	Xia, QY; Guo, YR; Zhang, Z; Li, D; Xuan, ZL; Li, Z; Dai, FY; Li, YR; Cheng, DJ; Li, RQ; Cheng, TC; Jiang, T; Becquet, C; Xu, X; Liu, C; Zha, XF; Fan, W; Lin, Y; Shen, YH; Jiang, L; Jensen, J; Hellmann, I; Tang, S; Zhao, P; Xu, HF; Yu, C; Zhang, GJ; Li, J; Cao, JJ; Liu, SP; He, NJ; Zhou, Y; Liu, H; Zhao, J; Ye, C; Du, ZH; Pan, GQ; Zhao, AC; Shao, HJ; Zeng, W; Wu, P; Li, CF; Pan, MH; Li, JJ; Yin, XY; Li, DW; Wang, J; Zheng, HS; Wang, W; Zhang, XQ; Li, SG; Yang, HM; Lu, C; Nielsen, R; Zhou, ZY; Wang, J; Xiang, ZH; Wang, J				Xia, Qingyou; Guo, Yiran; Zhang, Ze; Li, Dong; Xuan, Zhaoling; Li, Zhuo; Dai, Fangyin; Li, Yingrui; Cheng, Daojun; Li, Ruiqiang; Cheng, Tingcai; Jiang, Tao; Becquet, Celine; Xu, Xun; Liu, Chun; Zha, Xingfu; Fan, Wei; Lin, Ying; Shen, Yihong; Jiang, Lan; Jensen, Jeffrey; Hellmann, Ines; Tang, Si; Zhao, Ping; Xu, Hanfu; Yu, Chang; Zhang, Guojie; Li, Jun; Cao, Jianjun; Liu, Shiping; He, Ningjia; Zhou, Yan; Liu, Hui; Zhao, Jing; Ye, Chen; Du, Zhouhe; Pan, Guoqing; Zhao, Aichun; Shao, Haojing; Zeng, Wei; Wu, Ping; Li, Chunfeng; Pan, Minhui; Li, Jingjing; Yin, Xuyang; Li, Dawei; Wang, Juan; Zheng, Huisong; Wang, Wen; Zhang, Xiuqing; Li, Songgang; Yang, Huanming; Lu, Cheng; Nielsen, Rasmus; Zhou, Zeyang; Wang, Jian; Xiang, Zhonghuai; Wang, Jun			Complete Resequencing of 40 Genomes Reveals Domestication Events and Genes in Silkworm (Bombyx)	SCIENCE			English	Article							FORK HEAD; EXPRESSION; SEQUENCE	A single-base pair resolution silkworm genetic variation map was constructed from 40 domesticated and wild silkworms, each sequenced to approximately threefold coverage, representing 99.88% of the genome. We identified similar to 16 million single-nucleotide polymorphisms, many indels, and structural variations. We find that the domesticated silkworms are clearly genetically differentiated from the wild ones, but they have maintained large levels of genetic variability, suggesting a short domestication event involving a large number of individuals. We also identified signals of selection at 354 candidate genes that may have been important during domestication, some of which have enriched expression in the silk gland, midgut, and testis. These data add to our understanding of the domestication processes and may have applications in devising pest control strategies and advancing the use of silkworms as efficient bioreactors.	[Xia, Qingyou; Zhang, Ze; Li, Dong; Dai, Fangyin; Cheng, Daojun; Cheng, Tingcai; Liu, Chun; Zha, Xingfu; Lin, Ying; Shen, Yihong; Zhao, Ping; Xu, Hanfu; Liu, Shiping; He, Ningjia; Du, Zhouhe; Pan, Guoqing; Zhao, Aichun; Li, Chunfeng; Pan, Minhui; Lu, Cheng; Zhou, Zeyang; Xiang, Zhonghuai] Southwest Univ, Coll Biotechnol, Key Sericultural Lab Agr Minist, Chongqing 400715, Peoples R China; [Xia, Qingyou; Zhang, Ze; Cheng, Tingcai] Chongqing Univ, Inst Agron & Life Sci, Chongqing 400044, Peoples R China; [Guo, Yiran; Li, Dong; Xuan, Zhaoling; Li, Zhuo; Li, Yingrui; Li, Ruiqiang; Jiang, Tao; Xu, Xun; Fan, Wei; Jiang, Lan; Yu, Chang; Zhang, Guojie; Li, Jun; Cao, Jianjun; Zhou, Yan; Liu, Hui; Zhao, Jing; Ye, Chen; Shao, Haojing; Zeng, Wei; Wu, Ping; Li, Jingjing; Yin, Xuyang; Li, Dawei; Wang, Juan; Zheng, Huisong; Wang, Wen; Zhang, Xiuqing; Li, Songgang; Yang, Huanming; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Li, Ruiqiang; Nielsen, Rasmus; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2100 Kbh O, Denmark; [Becquet, Celine; Jensen, Jeffrey; Hellmann, Ines; Tang, Si; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Becquet, Celine; Jensen, Jeffrey; Hellmann, Ines; Tang, Si; Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Zhou, Zeyang] Chongqing Normal Univ, Chongqing 400047, Peoples R China; [Shao, Haojing] S China Univ Technol, Innovat Program Undergrad Students, Guangzhou 510006, Guangdong, Peoples R China	Southwest University - China; Chongqing University; Beijing Genomics Institute (BGI); University of Copenhagen; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Chongqing Normal University; South China University of Technology	Xiang, ZH (corresponding author), Southwest Univ, Coll Biotechnol, Key Sericultural Lab Agr Minist, Chongqing 400715, Peoples R China.	xbxzh@swu.edu.cn; wangj@genomics.org.cn	jiang, lan/C-1077-2009; Tang, Si/D-6633-2018; Zhao, Aichun/T-4308-2018; Zhang, Guojie/B-6188-2014; Liu, Shiping/W-2577-2019; Jiang, Lan/K-6869-2014; Wang, Jun/A-7261-2013; Li, Yingrui/K-1064-2015; Zhang, Guojie/J-7273-2019; jiang, lan/T-3965-2019; Nielsen, Rasmus/D-4405-2009; Yu, Chang/AAE-8538-2019; Guo, Yiran/H-4120-2011; Shao, Haojing/C-5429-2017; Xu, Xun/AAI-6763-2020; Wang, Wen/AAP-9873-2020; Wang, Jun/C-8434-2016; Jensen, Jeffrey/S-1084-2016; Wang, Jun/B-9503-2016	jiang, lan/0000-0003-2008-9631; Zhao, Aichun/0000-0001-6140-0102; Zhang, Guojie/0000-0001-6860-1521; Liu, Shiping/0000-0002-2917-0172; Jiang, Lan/0000-0003-2008-9631; Zhang, Guojie/0000-0001-6860-1521; Nielsen, Rasmus/0000-0003-0513-6591; Shao, Haojing/0000-0002-8806-197X; Xu, Xun/0000-0002-5338-5173; Xia, Qingyou/0000-0002-9263-2886; cheng, tingcai/0000-0002-3862-0817; Wang, Wen/0000-0002-7801-2066; Li, Jun/0000-0001-7218-429X; Tang, Si/0000-0002-1050-8604; Zha, Xingfu/0000-0003-2085-5260; Wang, Jun/0000-0002-8540-8931; LI, Dong/0000-0002-4536-9894; Jensen, Jeffrey/0000-0002-4786-8064; Wang, Jun/0000-0002-2113-5874	Ministry of Science and Technology of China [2005CB121000, 2007CB815700, 2006AA10A117, 2006AA10A118, 2006AA02Z177, 2006AA10A121]; Ministry of Education of China [IRT0750]; Chongqing Municipal Government [B07045]; National Natural Science Foundation of China [30725008, 30890032, 90608010]; International Science and Technology Cooperation Project [0806]; Chinese Academy of Science [GJHZ0701-6]; Danish Platform for Integrative Biology; Danish Natural Science Research Council; Solexa project [272-07-0196]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education of China(Ministry of Education, China); Chongqing Municipal Government; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation Project; Chinese Academy of Science(Chinese Academy of Sciences); Danish Platform for Integrative Biology; Danish Natural Science Research Council(Danish Natural Science Research Council); Solexa project; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank two anonymous referees, L. Goodman, L. Bolund, and K. Kristiansen for providing valuable comments. This work was supported by the Ministry of Science and Technology of China (grants 2005CB121000, 2007CB815700, 2006AA10A117, 2006AA10A118, 2006AA02Z177, and 2006AA10A121), the Ministry of Education of China (Program for Changjiang Scholars and Innovative Research Team in University, grant IRT0750), Chongqing Municipal Government, the 111 Project (grant B07045), the National Natural Science Foundation of China (grants 30725008, 30890032, and 90608010), the International Science and Technology Cooperation Project (grant 0806), the Chinese Academy of Science (grant GJHZ0701-6), the Danish Platform for Integrative Biology, the Ole Romer grant from the Danish Natural Science Research Council, and the Solexa project (grant 272-07-0196). Raw genome data are deposited in the National Center for Biotechnology Information/Short Read archive database with accession number SRA009208; silkworm genetic variations, GROSS information, and microarray data can be found in http://silkworm.swu.edu.cn/silkdb/resequencing.html.	Abrams EW, 2006, DEVELOPMENT, V133, P3517, DOI 10.1242/dev.02525; Baba K, 1999, MOL CELL BIOL, V19, P4405; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Horard B, 1997, MOL CELL BIOL, V17, P1572, DOI 10.1128/MCB.17.3.1572; JIANG YL, 1987, AGR ARCHAEOL, V14, P316; Li MW, 2005, GENOME, V48, P802, DOI 10.1139/g05-053; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li TR, 2003, DEV CELL, V5, P59, DOI 10.1016/S1534-5807(03)00192-8; Liu HJ, 2005, P NATL ACAD SCI USA, V102, P10522, DOI 10.1073/pnas.0500945102; Lu Cheng, 2002, Agricultural Sciences in China, V1, P349; MACH V, 1995, J BIOL CHEM, V270, P9340, DOI 10.1074/jbc.270.16.9340; MAEDA S, 1989, ANNU REV ENTOMOL, V34, P351, DOI 10.1146/annurev.en.34.010189.002031; MAEDA S, 1985, NATURE, V315, P592, DOI 10.1038/315592a0; Marcillac F, 2005, P ROY SOC B-BIOL SCI, V272, P303, DOI 10.1098/rspb.2004.2971; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia Qingyou, 1998, Acta Entomologica Sinica, V41, P32; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; XIANG ZH, 2005, BIOL SERICULTURE; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoshitake N., 1967, J SERICULT SCI JAPAN, V37, P83	26	262	350	16	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					433	436		10.1126/science.1176620	http://dx.doi.org/10.1126/science.1176620			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19713493	Green Accepted			2022-12-24	WOS:000270818600055
J	Levskaya, A; Weiner, OD; Lim, WA; Voigt, CA				Levskaya, Anselm; Weiner, Orion D.; Lim, Wendell A.; Voigt, Christopher A.			Spatiotemporal control of cell signalling using a light-switchable protein interaction	NATURE			English	Article							ACTIN POLYMERIZATION; NEURONAL-ACTIVITY; PHYTOCHROME-B; REMOTE; ACTIVATION; BACTERIA; RECEPTOR; PIF3	Genetically encodable optical reporters, such as green fluorescent protein, have revolutionized the observation and measurement of cellular states. However, the inverse challenge of using light to control precisely cellular behaviour has only recently begun to be addressed; semi-synthetic chromophore-tethered receptors(1) and naturally occurring channel rhodopsins have been used to perturb directly neuronal networks(2,3). The difficulty of engineering light-sensitive proteins remains a significant impediment to the optical control of most cell-biological processes. Here we demonstrate the use of a new genetically encoded light-control system based on an optimized, reversible protein-protein interaction from the phytochrome signalling network of Arabidopsis thaliana. Because protein-protein interactions are one of the most general currencies of cellular information, this system can, in principle, be generically used to control diverse functions. Here we show that this system can be used to translocate target proteins precisely and reversibly to the membrane with micrometre spatial resolution and at the second timescale. We show that light-gated translocation of the upstream activators of Rho-family GTPases, which control the actin cytoskeleton, can be used to precisely reshape and direct the cell morphology of mammalian cells. The light-gated protein-protein interaction that has been optimized here should be useful for the design of diverse light-programmable reagents, potentially enabling a new generation of perturbative, quantitative experiments in cell biology.	[Levskaya, Anselm; Weiner, Orion D.; Lim, Wendell A.; Voigt, Christopher A.] Univ Calif San Francisco, UCB NIH Nanomed Dev Ctr, Cell Prop Lab, San Francisco, CA 94158 USA; [Levskaya, Anselm] Univ Calif San Francisco, Grad Program Biophys, San Francisco, CA 94158 USA; [Levskaya, Anselm; Voigt, Christopher A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Weiner, Orion D.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, UCB NIH Nanomed Dev Ctr, Cell Prop Lab, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu	Weiner, Orion D/F-2576-2011	Weiner, Orion D/0000-0002-1778-6543	NSFGR; NIH [R01 GM084040, GM55040, GM62583, EY016546, NIH AI067699, NSF BES-0547637]; Searles Scholar Award; Packard Fellowship; Howard Hughes Medical Institute; Pew Fellowship; Office of Naval Research; UC-Discovery; SynBERC NSF ERC; NATIONAL EYE INSTITUTE [PN1EY016546, PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067699, R56AI067699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084040, R01GM055040, R01GM062583] Funding Source: NIH RePORTER	NSFGR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searles Scholar Award; Packard Fellowship(The David & Lucile Packard Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Pew Fellowship; Office of Naval Research(Office of Naval Research); UC-Discovery(University of California System); SynBERC NSF ERC; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. El-Sady, J. Tepperman, K. Thorn, G. Kapp and members of the Voigt, Weiner and Lim laboratories for assistance and discussion. We thank Molecular Devices and Photonics Instruments for the loan and customization of a Mosaic spatial light modulator. Data for this study were acquired at the Nikon Imaging Center at UCSF. This work was supported by a NSFGR fellowship (A. L.); NIH R01 GM084040 and Searles Scholar Award.(O. D. W.); Packard Fellowship, the Howard Hughes Medical Institute, and NIH grants GM55040, GM62583 and EY016546 (NIH Roadmap Nanomedicine Development Centers) (W. A. L.); Pew Fellowship, the Office of Naval Research, Packard Fellowship, NIH EY016546, NIH AI067699, NSF BES-0547637, UC-Discovery and the SynBERC NSF ERC (C. A. V.).	Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Castellano F, 1999, CURR BIOL, V9, P351, DOI 10.1016/S0960-9822(99)80161-4; Chen M, 2005, CURR BIOL, V15, P637, DOI 10.1016/j.cub.2005.02.028; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Genoud T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000143; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gorostiza P, 2008, SCIENCE, V322, P395, DOI 10.1126/science.1166022; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Khanna R, 2004, PLANT CELL, V16, P3033, DOI 10.1105/tpc.104.025643; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Leung DW, 2008, P NATL ACAD SCI USA, V105, P12797, DOI 10.1073/pnas.0801232105; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Tyszkiewicz AB, 2008, NAT METHODS, V5, P303, DOI [10.1038/nmeth.1189, 10.1038/NMETH.1189]; Wang S, 2007, NANO LETT, V7, P3859, DOI 10.1021/nl072783t	26	700	728	5	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					997	1001		10.1038/nature08446	http://dx.doi.org/10.1038/nature08446			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19749742	Green Accepted, Green Submitted			2022-12-24	WOS:000270817700051
J	Amit, I; Garber, M; Chevrier, N; Leite, AP; Donner, Y; Eisenhaure, T; Guttman, M; Grenier, JK; Li, WB; Zuk, O; Schubert, LA; Birditt, B; Shay, T; Goren, A; Zhang, XL; Smith, Z; Deering, R; McDonald, RC; Cabili, M; Bernstein, BE; Rinn, JL; Meissner, A; Root, DE; Hacohen, N; Regev, A				Amit, Ido; Garber, Manuel; Chevrier, Nicolas; Leite, Ana Paula; Donner, Yoni; Eisenhaure, Thomas; Guttman, Mitchell; Grenier, Jennifer K.; Li, Weibo; Zuk, Or; Schubert, Lisa A.; Birditt, Brian; Shay, Tal; Goren, Alon; Zhang, Xiaolan; Smith, Zachary; Deering, Raquel; McDonald, Rebecca C.; Cabili, Moran; Bernstein, Bradley E.; Rinn, John L.; Meissner, Alex; Root, David E.; Hacohen, Nir; Regev, Aviv			Unbiased Reconstruction of a Mammalian Transcriptional Network Mediating Pathogen Responses	SCIENCE			English	Article							GENE-EXPRESSION; REGULATORS; INDUCTION; MODULE; RNA	Models of mammalian regulatory networks controlling gene expression have been inferred from genomic data but have largely not been validated. We present an unbiased strategy to systematically perturb candidate regulators and monitor cellular transcriptional responses. We applied this approach to derive regulatory networks that control the transcriptional response of mouse primary dendritic cells to pathogens. Our approach revealed the regulatory functions of 125 transcription factors, chromatin modifiers, and RNA binding proteins, which enabled the construction of a network model consisting of 24 core regulators and 76 fine-tuners that help to explain how pathogen-sensing pathways achieve specificity. This study establishes a broadly applicable, comprehensive, and unbiased approach to reveal the wiring and functions of a regulatory network controlling a major transcriptional response in primary mammalian cells.	[Amit, Ido; Garber, Manuel; Leite, Ana Paula; Donner, Yoni; Guttman, Mitchell; Grenier, Jennifer K.; Zuk, Or; Shay, Tal; Goren, Alon; Zhang, Xiaolan; Smith, Zachary; Cabili, Moran; Bernstein, Bradley E.; Rinn, John L.; Meissner, Alex; Root, David E.; Hacohen, Nir; Regev, Aviv] MIT, Broad Inst, Cambridge, MA 02142 USA; [Amit, Ido; Garber, Manuel; Leite, Ana Paula; Donner, Yoni; Guttman, Mitchell; Grenier, Jennifer K.; Zuk, Or; Shay, Tal; Goren, Alon; Zhang, Xiaolan; Smith, Zachary; Cabili, Moran; Bernstein, Bradley E.; Rinn, John L.; Meissner, Alex; Root, David E.; Hacohen, Nir; Regev, Aviv] Harvard Univ, Cambridge, MA 02142 USA; [Amit, Ido; Chevrier, Nicolas; Eisenhaure, Thomas; Li, Weibo; Deering, Raquel; McDonald, Rebecca C.; Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Amit, Ido; Chevrier, Nicolas; Eisenhaure, Thomas; Li, Weibo; Deering, Raquel; McDonald, Rebecca C.; Bernstein, Bradley E.; Hacohen, Nir] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Amit, Ido; Guttman, Mitchell; Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02142 USA; [Leite, Ana Paula] MIT, Cambridge, MA 02139 USA; [Schubert, Lisa A.; Birditt, Brian] NanoString Technol, Seattle, WA 98109 USA; [Goren, Alon; Bernstein, Bradley E.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Goren, Alon; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Hacohen, N (corresponding author), MIT, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	nhacohen@partners.org	Shay, Tal/J-4028-2016	Shay, Tal/0000-0003-0755-1350; Leite, Ana Paula/0000-0001-5773-3211; Goren, Alon/0000-0001-5669-9357; Rinn, John/0000-0002-7231-7539	American Physicians Fellowship for Medicine in Israel; NIH [R21 AI71060]; Burroughs Wellcome Fund; Sloan Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071060] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958, DP2OD002230] Funding Source: NIH RePORTER	American Physicians Fellowship for Medicine in Israel; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Lander, I. Wapinski, D. Pe'er, N. Friedman, J. Kagan, A. Luster, V. Kuchroo, and A. Citri for discussions and comments; L. Gaffney for assistance with artwork; S. Gupta and the Broad Genetic Analysis Platform for microarray processing; and T. Mikkelsen and the Broad Sequencing Platform for help with the ChIP-seq experiments. Supported by the Human Frontier Science Program Organization and a Claire and Emanuel G. Rosenblatt Award from the American Physicians Fellowship for Medicine in Israel (I. A.); NIH grant R21 AI71060 and the NIH New Innovator Award (N. H.); and a Career Award at the Scientific Interface from the Burroughs Wellcome Fund, an NIH Pioneer Award, and the Sloan Foundation (A. R.). A. R. is an Early Career Scientist of the Howard Hughes Medical Institute and an investigator of the Merkin Foundation for Stem Cell Research at the Broad Institute. Complete microarray data sets are available at the Gene Expression Omnibus (accession no. GSE17721).	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Li B, 2007, BIOCHEM J, V405, P369, DOI 10.1042/BJ20061873; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Pe'er Dana, 2002, Bioinformatics, V18 Suppl 1, pS258; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	28	374	392	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					257	263		10.1126/science.1179050	http://dx.doi.org/10.1126/science.1179050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19729616	Green Accepted, Green Submitted			2022-12-24	WOS:000270599500035
J	Brayard, A; Escarguel, G; Bucher, H; Monnet, C; Bruhwiler, T; Goudemand, N; Galfetti, T; Guex, J				Brayard, Arnaud; Escarguel, Gilles; Bucher, Hugo; Monnet, Claude; Bruehwiler, Thomas; Goudemand, Nicolas; Galfetti, Thomas; Guex, Jean			Good Genes and Good Luck: Ammonoid Diversity and the End-Permian Mass Extinction	SCIENCE			English	Article							FOSSIL RECORD; TAXONOMIC DIVERSITY; CARBON-CYCLE; RECOVERY; DYNAMICS; PERTURBATIONS; ORIGINATION; GRADIENTS; EVOLUTION; VOLCANISM	The end-Permian mass extinction removed more than 80% of marine genera. Ammonoid cephalopods were among the organisms most affected by this crisis. The analysis of a global diversity data set of ammonoid genera covering about 106 million years centered on the Permian-Triassic boundary (PTB) shows that Triassic ammonoids actually reached levels of diversity higher than in the Permian less than 2 million years after the PTB. The data favor a hierarchical rather than logistic model of diversification coupled with a niche incumbency hypothesis. This explosive and nondelayed diversification contrasts with the slow and delayed character of the Triassic biotic recovery as currently illustrated for other, mainly benthic groups such as bivalves and gastropods.	[Brayard, Arnaud] Univ Bourgogne, CNRS, UMR Biogeosci 5561, F-21000 Dijon, France; [Escarguel, Gilles] Univ Lyon 1, PEPS, CNRS, UMR 5125, F-69622 Villeurbanne, France; [Bucher, Hugo; Monnet, Claude; Bruehwiler, Thomas; Goudemand, Nicolas; Galfetti, Thomas] Univ Zurich, Palaontol Inst & Museum, CH-8006 Zurich, Switzerland; [Bucher, Hugo] ETH, Dept Earth Sci, Zurich, Switzerland; [Guex, Jean] Univ Lausanne, Dept Geol & Paleontol, Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Lausanne	Brayard, A (corresponding author), Univ Bourgogne, CNRS, UMR Biogeosci 5561, 6 Blvd Gabriel, F-21000 Dijon, France.	arnaud.brayard@u-bourgogne.fr; gilles.escarguel@univ-lyon1.fr	Monnet, Claude/F-8498-2010; Escarguel, Gilles/C-3297-2011; Brayard, Arnaud/E-4711-2011; Bucher, Hugo F.R./O-2212-2013; Brayard, Arnaud/AAH-3075-2020	Monnet, Claude/0000-0002-0899-8392; Bucher, Hugo F.R./0000-0001-9164-5258; Brayard, Arnaud/0000-0003-1304-6553; Escarguel, Gilles/0000-0003-0985-6369; Goudemand, Nicolas/0000-0002-2956-5852	Swiss NSF project [200020-113554]	Swiss NSF project	This article is a contribution from the team Forme, Evolution, Diversite of the UMR-CNRS 5561 Biogeosciences (A.B.), and from the team Adaptation, Morphologie, Environnement of the UMR-CNRS 5125 PEPS (G.E.). This work was supported by the Swiss NSF project 200020-113554 (H.B.). We thank R. Colwell (University of Connecticut, USA) and E. Fara (University of Burgundy, France) for discussion.	Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Brayard A, 2007, GEOBIOS-LYON, V40, P749, DOI 10.1016/j.geobios.2007.06.002; Brayard A, 2007, LETHAIA, V40, P175, DOI 10.1111/j.1502-3931.2007.00012.x; Brayard A, 2006, PALAEOGEOGR PALAEOCL, V239, P374, DOI 10.1016/j.palaeo.2006.02.003; BUCHER H, 1996, AMMONOID PALEOBIOLOG, P407; Embry AF, 1997, B CAN PETROL GEOL, V45, P415; Erwin DH, 2001, P NATL ACAD SCI USA, V98, P5399, DOI 10.1073/pnas.091092698; Escarguel G, 2008, CR GEOSCI, V340, P602, DOI 10.1016/j.crte.2007.11.005; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Galfetti T, 2007, PALAEOGEOGR PALAEOCL, V243, P394, DOI 10.1016/j.palaeo.2006.08.014; Galfetti T, 2007, EARTH PLANET SC LETT, V258, P593, DOI 10.1016/j.epsl.2007.04.023; Galfetti T, 2007, GEOLOGY, V35, P291, DOI 10.1130/G23117A.1; Hautmann M, 2005, PALAEONTOLOGY, V48, P1131, DOI 10.1111/j.1475-4983.2005.00505.x; Kirchner JW, 2000, NATURE, V404, P177, DOI 10.1038/35004564; KULLMAN J, 2007, GONIAT VERSION 3 5; Lu PJ, 2006, P NATL ACAD SCI USA, V103, P2736, DOI 10.1073/pnas.0511083103; MAURER BA, 1989, PALEOBIOLOGY, V15, P133, DOI 10.1017/S0094837300009325; McGowan AJ, 2004, GEOLOGY, V32, P665, DOI 10.1130/G20462.1; McGowan AJ, 2007, PALAEONTOLOGY, V50, P573, DOI 10.1111/j.1475-4983.2007.00653.x; Orchard MJ, 2007, PALAEOGEOGR PALAEOCL, V252, P93, DOI 10.1016/j.palaeo.2006.11.037; Payne JL, 2004, SCIENCE, V305, P506, DOI 10.1126/science.1097023; Payne JL, 2007, EARTH PLANET SC LETT, V256, P264, DOI 10.1016/j.epsl.2007.01.034; Saunders WB, 2008, PALEOBIOLOGY, V34, P128, DOI 10.1666/07053.1; Schaltegger U, 2008, EARTH PLANET SC LETT, V267, P266, DOI 10.1016/j.epsl.2007.11.031; SEPKOSKI JJ, 1978, PALEOBIOLOGY, V4, P223, DOI 10.1017/S0094837300005972; TOZER ET, 1982, GEOL RUNDSCH, V71, P1077, DOI 10.1007/BF01821119; Tozer ET, 1981, AMMONOIDEA, V18, P65; Villier L, 2004, SCIENCE, V306, P264, DOI 10.1126/science.1102127; WALKER TD, 1984, AM NAT, V124, P887, DOI 10.1086/284322; ZHOU Z., 1996, PERMOPHILES, V29, P52	31	220	229	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 28	2009	325	5944					1118	1121		10.1126/science.1174638	http://dx.doi.org/10.1126/science.1174638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713525				2022-12-24	WOS:000269382300038
J	Lister, R; Pelizzola, M; Dowen, RH; Hawkins, RD; Hon, G; Tonti-Filippini, J; Nery, JR; Lee, L; Ye, Z; Ngo, QM; Edsall, L; Antosiewicz-Bourget, J; Stewart, R; Ruotti, V; Millar, AH; Thomson, JA; Ren, B; Ecker, JR				Lister, Ryan; Pelizzola, Mattia; Dowen, Robert H.; Hawkins, R. David; Hon, Gary; Tonti-Filippini, Julian; Nery, Joseph R.; Lee, Leonard; Ye, Zhen; Ngo, Que-Minh; Edsall, Lee; Antosiewicz-Bourget, Jessica; Stewart, Ron; Ruotti, Victor; Millar, A. Harvey; Thomson, James A.; Ren, Bing; Ecker, Joseph R.			Human DNA methylomes at base resolution show widespread epigenomic differences	NATURE			English	Article							EMBRYONIC STEM-CELLS; MAMMALIAN DEVELOPMENT; ENZYMATIC-PROPERTIES; HISTONE METHYLATION; CPG METHYLATION; HUMAN GENOME; GENE; METHYLTRANSFERASES; BINDING; DNMT3A	DNA cytosine methylation is a central epigenetic modification that has essential roles in cellular processes including genome regulation, development and disease. Here we present the first genome-wide, single-base-resolution maps of methylated cytosines in a mammalian genome, from both human embryonic stem cells and fetal fibroblasts, along with comparative analysis of messenger RNA and small RNA components of the transcriptome, several histone modifications, and sites of DNA-protein interaction for several key regulatory factors. Widespread differences were identified in the composition and patterning of cytosine methylation between the two genomes. Nearly one-quarter of all methylation identified in embryonic stem cells was in a non-CG context, suggesting that embryonic stem cells may use different methylation mechanisms to affect gene regulation. Methylation in non-CG contexts showed enrichment in gene bodies and depletion in protein binding sites and enhancers. Non-CG methylation disappeared upon induced differentiation of the embryonic stem cells, and was restored in induced pluripotent stem cells. We identified hundreds of differentially methylated regions proximal to genes involved in pluripotency and differentiation, and widespread reduced methylation levels in fibroblasts associated with lower transcriptional activity. These reference epigenomes provide a foundation for future studies exploring this key epigenetic modification in human disease and development.	[Lister, Ryan; Pelizzola, Mattia; Dowen, Robert H.; Nery, Joseph R.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Hawkins, R. David; Hon, Gary; Lee, Leonard; Ye, Zhen; Ngo, Que-Minh; Edsall, Lee; Ren, Bing] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Tonti-Filippini, Julian; Millar, A. Harvey] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia; [Antosiewicz-Bourget, Jessica; Stewart, Ron; Ruotti, Victor; Thomson, James A.] Morgridge Inst Res, Madison, WI 53707 USA; [Antosiewicz-Bourget, Jessica; Stewart, Ron; Ruotti, Victor; Thomson, James A.] Genome Ctr Wisconsin, Madison, WI 53706 USA; [Thomson, James A.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Thomson, James A.] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA	Salk Institute; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Western Australia; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ecker, JR (corresponding author), Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ecker@salk.edu	Ecker, Joseph R/B-9144-2008; Hu, Ruogu/B-2203-2008; Lister, Ryan/B-5168-2012; Millar, A. Harvey/A-5452-2008; Nery, Joseph/AAE-8422-2019; Tonti-Filippini, Julian S/L-8020-2018	Ecker, Joseph R/0000-0001-5799-5895; Lister, Ryan/0000-0001-6637-7239; Millar, A. Harvey/0000-0001-9679-1473; Nery, Joseph/0000-0003-0153-5659; Tonti-Filippini, Julian S/0000-0003-3464-0770; Edsall, Lee Elizabeth/0000-0002-0326-2829; Pelizzola, Mattia/0000-0001-6672-9636	Mary K. Chapman Foundation; National Institutes of Health [U01 ES017166, U01 1U01ES017166-01]; Australian Research Council [CE0561495, DP0771156]; Morgridge Institute for Research, Madison, Wisconsin; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	Mary K. Chapman Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); Morgridge Institute for Research, Madison, Wisconsin; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank A. Elwell and A. Hernandez for assistance with sequence library preparation and Illumina sequencing. R. L. is supported by a Human Frontier Science Program Long-term Fellowship. R. D. H. is supported by an American Cancer Society Postdoctoral Fellowship. This work was supported by grants from the following: Mary K. Chapman Foundation, The National Institutes of Health (U01 ES017166 and U01 1U01ES017166-01), the California Institute for Regenerative Medicine (RS1-00292-1), the Australian Research Council Centre of Excellence Program (CE0561495, DP0771156) and Morgridge Institute for Research, Madison, Wisconsin. We thank the NIH Roadmap Reference Epigenome Consortium (http://nihroadmap.nih.gov/epigenomics/referenceepigenomeconsortium.asp) and C. Gunter (Hudson-Alpha Institute) for assistance. This study was carried out as part of the NIH Roadmap Epigenomics Program.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Aoki A, 2001, NUCLEIC ACIDS RES, V29, P3506, DOI 10.1093/nar/29.17.3506; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chan SWL, 2008, TRENDS PLANT SCI, V13, P383, DOI 10.1016/j.tplants.2008.05.001; Clark SJ, 1997, GENE, V195, P67, DOI 10.1016/S0378-1119(97)00164-9; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Ferguson-Smith AC, 2007, NATURE, V449, P148, DOI 10.1038/449148a; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Gowher H, 2001, J MOL BIOL, V309, P1201, DOI 10.1006/jmbi.2001.4710; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kitazawa S, 1999, J BIOL CHEM, V274, P28787, DOI 10.1074/jbc.274.40.28787; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mancini DN, 1999, ONCOGENE, V18, P4108, DOI 10.1038/sj.onc.1202764; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; NICHOLS WW, 1977, SCIENCE, V196, P60, DOI 10.1126/science.841339; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Steinert S, 2004, MOL CELL BIOL, V24, P4571, DOI 10.1128/MCB.24.10.4571-4580.2004; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Villesen Palle, 2004, Retrovirology, V1, P32, DOI 10.1186/1742-4690-1-32; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; WOODCOCK DM, 1987, BIOCHEM BIOPH RES CO, V145, P888, DOI 10.1016/0006-291X(87)91048-5	46	3069	3191	11	526	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					315	322		10.1038/nature08514	http://dx.doi.org/10.1038/nature08514			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19829295	Green Accepted, Green Submitted			2022-12-24	WOS:000271899300037
J	Lartigue, C; Vashee, S; Algire, MA; Chuang, RY; Benders, GA; Ma, L; Noskov, VN; Denisova, EA; Gibson, DG; Assad-Garcia, N; Alperovich, N; Thomas, DW; Merryman, C; Hutchison, CA; Smith, HO; Venter, JC; Glass, JI				Lartigue, Carole; Vashee, Sanjay; Algire, Mikkel A.; Chuang, Ray-Yuan; Benders, Gwynedd A.; Ma, Li; Noskov, Vladimir N.; Denisova, Evgeniya A.; Gibson, Daniel G.; Assad-Garcia, Nacyra; Alperovich, Nina; Thomas, David W.; Merryman, Chuck; Hutchison, Clyde A., III; Smith, Hamilton O.; Venter, J. Craig; Glass, John I.			Creating Bacterial Strains from Genomes That Have Been Cloned and Engineered in Yeast	SCIENCE			English	Article							TRANSFORMATION-ASSOCIATED RECOMBINATION; MYCOPLASMA-GENITALIUM GENOME; MYCOIDES; CLONING	We recently reported the chemical synthesis, assembly, and cloning of a bacterial genome in yeast. To produce a synthetic cell, the genome must be transferred from yeast to a receptive cytoplasm. Here we describe methods to accomplish this. We cloned a Mycoplasma mycoides genome as a yeast centromeric plasmid and then transplanted it into Mycoplasma capricolum to produce a viable M. mycoides cell. While in yeast, the genome was altered by using yeast genetic systems and then transplanted to produce a new strain of M. mycoides. These methods allow the construction of strains that could not be produced with genetic tools available for this bacterium.	[Lartigue, Carole; Vashee, Sanjay; Algire, Mikkel A.; Chuang, Ray-Yuan; Ma, Li; Noskov, Vladimir N.; Denisova, Evgeniya A.; Gibson, Daniel G.; Assad-Garcia, Nacyra; Alperovich, Nina; Thomas, David W.; Merryman, Chuck; Venter, J. Craig; Glass, John I.] J Craig Venter Inst, Rockville, MD 20850 USA; [Benders, Gwynedd A.; Hutchison, Clyde A., III; Smith, Hamilton O.; Venter, J. Craig] J Craig Venter Inst, San Diego, CA 92121 USA	J. Craig Venter Institute; J. Craig Venter Institute	Vashee, S (corresponding author), J Craig Venter Inst, 9704 Med Ctr Dr, Rockville, MD 20850 USA.	svashee@jcvi.org	lartigue, carole/I-1576-2013; Lartigue, Carole/GQP-4896-2022; Glass, John/A-6572-2015	Lartigue, Carole/0000-0001-5550-7579; Glass, John/0000-0002-3784-5301	Synthetic Genomics, Inc. (SGI)	Synthetic Genomics, Inc. (SGI)	We thank R. Roberts for helpful information and the Synthetic Biology team at the J. Craig Venter Institute (JCVI) for critical discussions about the manuscript. This work was supported by Synthetic Genomics, Inc. (SGI). J. C. V. is Chief Executive Officer and Co-Chief Scientific Officer of SGI. H. O. S. is Co-Chief Scientific Officer and on the Board of Directors of SGI. C. A. H. is Chairman of the SGI Scientific Advisory Board. All three of these authors and JCVI hold SGI stock. JCVI has filed patent applications on some of the techniques described in this paper.	BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; DAMASSA AJ, 1983, AM J VET RES, V44, P322; Dedieu-Engelmann L, 2008, COMP IMMUNOL MICROB, V31, P227, DOI 10.1016/j.cimid.2007.07.009; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Janis C, 2005, APPL ENVIRON MICROB, V71, P2888, DOI 10.1128/AEM.71.6.2888-2893.2005; KING KW, 1991, PLASMID, V26, P108, DOI 10.1016/0147-619X(91)90050-7; Kouprina N, 2008, NAT PROTOC, V3, P371, DOI 10.1038/nprot.2008.5; Larionov V, 1997, P NATL ACAD SCI USA, V94, P7384, DOI 10.1073/pnas.94.14.7384; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Manso-Silvan L, 2009, INT J SYST EVOL MICR, V59, P1353, DOI 10.1099/ijs.0.005546-0; Thiaucourt F., 2003, VVolume 114, P147	13	181	207	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1693	1696		10.1126/science.1173759	http://dx.doi.org/10.1126/science.1173759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19696314				2022-12-24	WOS:000270131800047
J	Mirouze, M; Reinders, J; Bucher, E; Nishimura, T; Schneeberger, K; Ossowski, S; Cao, J; Weigel, D; Paszkowski, J; Mathieu, O				Mirouze, Marie; Reinders, Jon; Bucher, Etienne; Nishimura, Taisuke; Schneeberger, Korbinian; Ossowski, Stephan; Cao, Jun; Weigel, Detlef; Paszkowski, Jerzy; Mathieu, Olivier			Selective epigenetic control of retrotransposition in Arabidopsis	NATURE			English	Article							DNA METHYLATION; TRANSPOSABLE ELEMENTS; CPG METHYLATION; GENOME-WIDE; RNA; METHYLTRANSFERASES; MAINTENANCE; STABILITY; EPIGENOME; LYSINE-9	Retrotransposons are mobile genetic elements that populate chromosomes, where the host largely controls their activities(1-3). In plants and mammals, retrotransposons are transcriptionally silenced by DNA methylation(1,4), which in Arabidopsis is propagated at CG dinucleotides by METHYLTRANSFERASE 1 (MET1)(5). In met1 mutants, however, mobilization of retrotransposons is not observed, despite their transcriptional activation(4-6). A post-transcriptional mechanism therefore seems to be preventing retrotransposition. Here we show that a copia-type retrotransposon (Evade, French for 'fugitive') evaded suppression of its movement during inbreeding of hybrid epigenomes consisting of met1-and wild-type-derived chromosomes. Evade (EVD) reinsertions caused a series of developmental mutations that allowed its identification. Genetic testing of host control of the EVD life cycle showed that transcriptional suppression occurred by CG methylation supported by RNA-directed DNA methylation. On transcriptional reactivation, subsequent steps of the EVD cycle were inhibited by plant-specific RNA polymerase IV/V-7,V-8 and the histone methyltransferase KRYPTONITE (KYP). Moreover, genome resequencing demonstrated retrotransposition of EVD but no other potentially active retroelements when this combination of epigenetic mechanisms was compromised. Our results demonstrate that epigenetic control of retrotransposons extends beyond transcriptional suppression and can be individualized for particular elements.	[Mirouze, Marie; Reinders, Jon; Bucher, Etienne; Nishimura, Taisuke; Paszkowski, Jerzy; Mathieu, Olivier] Univ Geneva, Dept Plant Biol, CH-1211 Geneva 4, Switzerland; [Schneeberger, Korbinian; Ossowski, Stephan; Cao, Jun; Weigel, Detlef] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Mathieu, Olivier] Univ Clermont Ferrand 2, CNRS, INSERM, GReD,UMR 6247,U931, F-63177 Clermont Ferrand, France	University of Geneva; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	Paszkowski, J (corresponding author), Univ Geneva, Dept Plant Biol, Sci III,30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	jerzy.paszkowski@unige.ch; olivier.mathieu@univ-bpclermont.fr	Weigel, Detlef/GSJ-0799-2022; Mirouze, Marie/AFL-9387-2022; Weigel, Detlef/AAR-3312-2021; Mathieu, Olivier/AAV-6593-2021; Cao, Jun/E-5422-2012; Weigel, Detlef/C-1418-2008; Mirouze, Marie/AAG-8128-2022; Mirouze, Marie/AFL-8165-2022; Schneeberger, Korbinian/U-6329-2019; Ossowski, Stephan/E-2139-2011; Bucher, Etienne/E-7681-2013	Weigel, Detlef/0000-0002-2114-7963; Mathieu, Olivier/0000-0001-5302-1102; Weigel, Detlef/0000-0002-2114-7963; Mirouze, Marie/0000-0002-0514-1270; Mirouze, Marie/0000-0002-0514-1270; Schneeberger, Korbinian/0000-0002-5512-0443; Ossowski, Stephan/0000-0002-7416-9568; Bucher, Etienne/0000-0002-3114-3763	Swiss National Science Foundation [3100A0-102107]; European Commission [LSHG-CT-2004- 503433]; Targeted Gene Integration in Plants (TAGIP) [018785]; Max Planck Society	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Targeted Gene Integration in Plants (TAGIP); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank all members of the Paszkowski laboratory for discussion; L. Broger, M. Freyre, J. Nicolet, C. Megies and J. Lafleuriel for technical assistance; M. Dapp and X. Zhang for met1/ + drm1/ + drm2/ + cmt3/ + material; C. Lanz for help in preparing the Illumina libraries and running the instruments and P. King and E. Lacombe for critically reading the manuscript. This work was supported by grants from the Swiss National Science Foundation (3100A0-102107), the European Commission through The Epigenome (LSHG-CT-2004- 503433) and Targeted Gene Integration in Plants (TAGIP; 018785) and the Max Planck Society.	Beauregard A, 2008, ANNU REV GENET, V42, P587, DOI 10.1146/annurev.genet.42.110807.091549; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Ding Y, 2007, PLANT CELL, V19, P9, DOI 10.1105/tpc.106.048124; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Kanno T, 2008, NAT GENET, V40, P670, DOI 10.1038/ng.119; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Reinders J, 2008, GENOME RES, V18, P469, DOI 10.1101/gr.7073008; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Zhang X, 2006, COLD SPRING HARB SYM, V71, P439, DOI 10.1101/sqb.2006.71.047; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003	31	235	246	1	53	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					427	U130		10.1038/nature08328	http://dx.doi.org/10.1038/nature08328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19734882				2022-12-24	WOS:000269828100047
J	Barrick, JE; Yu, DS; Yoon, SH; Jeong, H; Oh, TK; Schneider, D; Lenski, RE; Kim, JF				Barrick, Jeffrey E.; Yu, Dong Su; Yoon, Sung Ho; Jeong, Haeyoung; Oh, Tae Kwang; Schneider, Dominique; Lenski, Richard E.; Kim, Jihyun F.			Genome evolution and adaptation in a long-term experiment with Escherichia coli	NATURE			English	Article							POPULATION-GENETICS; PARALLEL CHANGES; MUTATIONS; DIVERGENCE; DYNAMICS; SEQUENCE	The relationship between rates of genomic evolution and organismal adaptation remains uncertain, despite considerable interest. The feasibility of obtaining genome sequences from experimentally evolving populations offers the opportunity to investigate this relationship with new precision. Here we sequence genomes sampled through 40,000 generations from a laboratory population of Escherichia coli. Although adaptation decelerated sharply, genomic evolution was nearly constant for 20,000 generations. Such clock-like regularity is usually viewed as the signature of neutral evolution, but several lines of evidence indicate that almost all of these mutations were beneficial. This same population later evolved an elevated mutation rate and accumulated hundreds of additional mutations dominated by a neutral signature. Thus, the coupling between genomic and adaptive evolution is complex and can be counterintuitive even in a constant environment. In particular, beneficial substitutions were surprisingly uniform over time, whereas neutral substitutions were highly variable.	[Barrick, Jeffrey E.; Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Yu, Dong Su; Yoon, Sung Ho; Jeong, Haeyoung; Oh, Tae Kwang; Kim, Jihyun F.] Korea Res Inst Biosci & Biotechnol, Ind Biotechnol & Bioenergy Res Ctr, Taejon 305806, South Korea; [Yu, Dong Su] Chungnam Natl Univ, Dept Comp Sci & Engn, Taejon 305764, South Korea; [Oh, Tae Kwang] 21C Frontier Microbial Genom & Applicat Ctr, Taejon 305806, South Korea; [Schneider, Dominique] Univ Grenoble 1, CNRS, UMR 5163, Inst Jean Roget,Lab Adaptat & Pathogenie Microorg, F-38042 Grenoble 9, France; [Kim, Jihyun F.] Univ Sci & Technol, Sch Sci, Funct Genom Program, Taejon 305333, South Korea	Michigan State University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Lenski, RE (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	lenski@msu.edu; jfk@kribb.re.kr	Barrick, Jeffrey/A-3046-2012; Schneider, Dominique/M-6019-2014; Kim, Jihyun F./B-6286-2013	Barrick, Jeffrey/0000-0003-0888-7358; Lenski, Richard/0000-0002-1064-8375; Jeong, Haeyoung/0000-0002-4479-4573; Yoon, Sung Ho/0000-0003-0171-944X	DARPA 'Fun Bio' Program; US National Science Foundation; Agence Nationale de la Recherche Programme 'Genomique Microbienne a Grande Echelle, Centre National de la Recherche Scientifique, and Universite Joseph Fourier; Ministry of Education, Science and Technology, Republic of Korea	DARPA 'Fun Bio' Program; US National Science Foundation(National Science Foundation (NSF)); Agence Nationale de la Recherche Programme 'Genomique Microbienne a Grande Echelle, Centre National de la Recherche Scientifique, and Universite Joseph Fourier(French National Research Agency (ANR)); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank collaborators in the Lenski and Schneider laboratories for sharing unpublished data; N. Hajela and J. I. Lee for isolation of genomic DNA; C. T. Brown, C. Epstein, C. H. Lee and J. Plotkin for discussion; N. Hajela, L. Ekunwe and S. Simpson for years of technical assistance with the long-term lines; and W. J. Dittmar for assistance with fluctuation tests. We acknowledge support from the DARPA 'Fun Bio' Program (to R. E. L.); the US National Science Foundation (to J. E. B. and R. E. L.); the Agence Nationale de la Recherche Programme 'Genomique Microbienne a Grande Echelle, Centre National de la Recherche Scientifique, and Universite Joseph Fourier (to D. S.); and the 21C Frontier Microbial Genomics and Applications Center Program, Ministry of Education, Science and Technology, Republic of Korea (to J. F. K.).	Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Buckling A, 2009, NATURE, V457, P824, DOI 10.1038/nature07892; CHARLESWORTH B, 1982, EVOLUTION, V36, P474, DOI 10.1111/j.1558-5646.1982.tb05068.x; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; Cooper VS, 2001, J BACTERIOL, V183, P2834, DOI 10.1128/JB.183.9.2834-2841.2001; Crozat E, 2005, GENETICS, V169, P523, DOI 10.1534/genetics.104.035717; Darwin C., 1859, ORIGIN SPECIES MEANS; de Visser JAGM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-19; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Eldredge N, 2005, PALEOBIOLOGY, V31, P133, DOI 10.1666/0094-8373(2005)031[0133:TDOES]2.0.CO;2; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Fiegna F, 2006, NATURE, V441, P310, DOI 10.1038/nature04677; Fisher R.A., 1930, GENETICAL THEORY NAT; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Gillespie J. H., 1991, CAUSES MOL EVOLUTION; GOULD S J, 1977, Paleobiology, V3, P115; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; Hegreness M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-201; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Kimura MA, 1985, NEUTRAL THEORY MOL E; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lenski R. E., 2004, PLANT BREED REV, V24, P225, DOI DOI 10.1002/9780470650288.CH8; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Orr HA, 2002, EVOLUTION, V56, P1317, DOI 10.1111/j.0014-3820.2002.tb01446.x; Pagel M, 2006, SCIENCE, V314, P119, DOI 10.1126/science.1129647; PAQUIN CE, 1983, NATURE, V306, P368, DOI 10.1038/306368a0; Pelosi L, 2006, GENETICS, V173, P1851, DOI 10.1534/genetics.105.049619; Perfeito L, 2007, SCIENCE, V317, P813, DOI 10.1126/science.1142284; R Development Core Team, 2007, R LANG ENV STAT COMP; Remold SK, 2001, P NATL ACAD SCI USA, V98, P11388, DOI 10.1073/pnas.201140198; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schneider D, 2000, GENETICS, V156, P477; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	50	802	815	3	345	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1243	U74		10.1038/nature08480	http://dx.doi.org/10.1038/nature08480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19838166				2022-12-24	WOS:000271190800040
J	Harvey, CD; Collman, F; Dombeck, DA; Tank, DW				Harvey, Christopher D.; Collman, Forrest; Dombeck, Daniel A.; Tank, David W.			Intracellular dynamics of hippocampal place cells during virtual navigation	NATURE			English	Article							THETA PHASE PRECESSION; BARREL CORTEX; UNIT-ACTIVITY; IN-VIVO; OSCILLATIONS; RECORDINGS; AWAKE; CODE; MECHANISMS; EXPERIENCE	Hippocampal place cells encode spatial information in rate and temporal codes. To examine the mechanisms underlying hippocampal coding, here we measured the intracellular dynamics of place cells by combining in vivo whole-cell recordings with a virtual-reality system. Head-restrained mice, running on a spherical treadmill, interacted with a computer-generated visual environment to perform spatial behaviours. Robust place-cell activity was present during movement along a virtual linear track. From whole-cell recordings, we identified three subthreshold signatures of place fields: an asymmetric ramp-like depolarization of the baseline membrane potential, an increase in the amplitude of intracellular theta oscillations, and a phase precession of the intracellular theta oscillation relative to the extracellularly recorded theta rhythm. These intracellular dynamics underlie the primary features of place-cell rate and temporal codes. The virtual-reality system developed here will enable new experimental approaches to study the neural circuits underlying navigation.	[Harvey, Christopher D.; Collman, Forrest; Dombeck, Daniel A.; Tank, David W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Harvey, Christopher D.; Collman, Forrest; Dombeck, Daniel A.; Tank, David W.] Princeton Univ, Lewis Sigler Inst Integrat Gen, Princeton, NJ 08544 USA; [Harvey, Christopher D.; Collman, Forrest; Dombeck, Daniel A.; Tank, David W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Tank, DW (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	dwtank@princeton.edu		Dombeck, Daniel/0000-0003-2576-5918; Collman, Forrest/0000-0002-0280-7022	NIH [1R01MH083686-01, 5R01MH060651-09]; Helen Hay Whitney Fellowship; Patterson Trust Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060651, R01MH083686] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Fellowship; Patterson Trust Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank E. Chaffin for help with mouse behaviour, J. Carmack and id Software for providing the Quake2 code, A. Shishlov for programming advice, G. Buzsaki, J. Magee, H. Dahmen and D. Markowitz for discussions, and C. Brody, M. Berry and E. Civillico for comments on the manuscript. This work was supported by the NIH (1R01MH083686-01, 5R01MH060651-09), a Helen Hay Whitney Fellowship (to C. D. H.), and a Patterson Trust Fellowship (to D. A. D.).	BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cacucci F, 2007, J NEUROSCI, V27, P7854, DOI 10.1523/JNEUROSCI.1704-07.2007; Chahl JS, 1997, APPL OPTICS, V36, P8275, DOI 10.1364/AO.36.008275; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; GREENE N, 1986, IEEE COMPUT GRAPH, V6, P21, DOI 10.1109/MCG.1986.276658; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Lee AK, 2009, NAT PROTOC, V4, P385, DOI 10.1038/nprot.2009.5; Lengyel M, 2003, HIPPOCAMPUS, V13, P700, DOI 10.1002/hipo.10116; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; SUN LD, 2003, THESIS MIT; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wong AA, 2006, GENES BRAIN BEHAV, V5, P389, DOI 10.1111/j.1601-183X.2005.00173.x; WONG RKS, 1978, BRAIN RES, V159, P385, DOI 10.1016/0006-8993(78)90544-9	43	575	584	5	127	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					941	U196		10.1038/nature08499	http://dx.doi.org/10.1038/nature08499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829374	Green Accepted			2022-12-24	WOS:000270817700039
J	Chatterjee, S; Grosshans, H				Chatterjee, Saibal; Grosshans, Helge			Active turnover modulates mature microRNA activity in Caenorhabditis elegans	NATURE			English	Article							TARGET MESSENGER-RNA; C-ELEGANS; LET-7 MICRORNA; SACCHAROMYCES-CEREVISIAE; HUMAN-CELLS; INTERFERENCE; PURIFICATION; DEGRADATION; MATURATION; PROTEINS	MicroRNAs (miRNAs) constitute a large class of regulatory RNAs that repress target messenger RNAs to control various biological processes(1). Accordingly, miRNA biogenesis is highly regulated, controlled at both transcriptional and post-transcriptional levels(2), and overexpression and underexpression of miRNAs are linked to various human diseases, particularly cancers(1,3). As RNA concentrations are generally a function of biogenesis and turnover, active miRNA degradation might also modulate miRNA accumulation, and the plant 3'-> 5' exonuclease SDN1 has been implicated in miRNA turnover(4). Here we report that degradation of mature miRNAs in the nematode Caenorhabditis elegans, mediated by the 5'-> 3' exoribonuclease XRN-2, affects functional miRNA homeostasis in vivo. We recapitulate XRN-2-dependent miRNA turnover in larval lysates, where processing of precursor-miRNA (pre-miRNA) by Dicer, unannealing of the miRNA duplex and loading of the mature miRNA into the Argonaute protein of the miRNA-induced silencing complex (miRISC) are coupled processes that precede degradation of the mature miRNA. Although Argonaute: miRNA complexes are highly resistant to salt, larval lysate promotes efficient release of the miRNA, exposing it to degradation by XRN-2. Release and degradation can both be blocked by the addition of miRNA target RNA. Our results therefore suggest the presence of an additional layer of regulation of animal miRNA activity that might be important for rapid changes of miRNA expression profiles during developmental transitions and for the maintenance of steady-state concentrations of miRNAs. This pathway might represent a potential target for therapeutic intervention on miRNA expression.	[Chatterjee, Saibal; Grosshans, Helge] Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Grosshans, H (corresponding author), Friedrich Miescher Inst Biomed Res, POB 2543, CH-4002 Basel, Switzerland.	helge.grosshans@fmi.ch	Grosshans, Helge/W-8931-2019	Grosshans, Helge/0000-0002-8169-6905	Marie Curie; EMBO	Marie Curie(European Commission); EMBO(European Molecular Biology Organization (EMBO))	We thank M. Buhler and W. Filipowicz for critical comments on the manuscript; W. Filipowicz for plasmids; C. Mello and F. Slack for C. elegans strains; and A. Esquela-Kerscher for sharing Starfire probes for pre-miRNA detection. S. C. was supported by Marie Curie and EMBO long-term postdoctoral fellowships.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chatterjee S, 2006, J BIOL CHEM, V281, P25270, DOI 10.1074/jbc.M604126200; Chernyakov I, 2008, GENE DEV, V22, P1369, DOI 10.1101/gad.1654308; Ding XC, 2008, CELL CYCLE, V7, P3083, DOI 10.4161/cc.7.19.6778; Ding XC, 2009, EMBO J, V28, P213, DOI 10.1038/emboj.2008.275; Ding XC, 2009, TRENDS BIOTECHNOL, V27, P27, DOI 10.1016/j.tibtech.2008.09.006; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Gy I, 2007, PLANT CELL, V19, P3451, DOI 10.1105/tpc.107.055319; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kolb FA, 2005, METHOD ENZYMOL, V392, P316, DOI 10.1016/S0076-6879(04)92019-8; Lee MH, 2001, GENE DEV, V15, P2408, DOI 10.1101/gad.915901; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; STEVENS A, 1987, NUCLEIC ACIDS RES, V15, P695, DOI 10.1093/nar/15.2.695; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858	37	260	284	3	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					546	U120		10.1038/nature08349	http://dx.doi.org/10.1038/nature08349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19734881				2022-12-24	WOS:000270082900045
J	Gusarov, I; Shatalin, K; Starodubtseva, M; Nudler, E				Gusarov, Ivan; Shatalin, Konstantin; Starodubtseva, Marina; Nudler, Evgeny			Endogenous Nitric Oxide Protects Bacteria Against a Wide Spectrum of Antibiotics	SCIENCE			English	Article							BACILLUS-SUBTILIS; OXIDATIVE STRESS; MECHANISM; PYOCYANINE; SYNTHASES; VIRULENCE; CELLS	Bacterial nitric oxide synthases (bNOS) are present in many Gram-positive species and have been demonstrated to synthesize NO from arginine in vitro and in vivo. However, the physiological role of bNOS remains largely unknown. We show that NO generated by bNOS increases the resistance of bacteria to a broad spectrum of antibiotics, enabling the bacteria to survive and share habitats with antibiotic-producing microorganisms. NO-mediated resistance is achieved through both the chemical modification of toxic compounds and the alleviation of the oxidative stress imposed by many antibiotics. Our results suggest that the inhibition of NOS activity may increase the effectiveness of antimicrobial therapy.	[Gusarov, Ivan; Shatalin, Konstantin; Starodubtseva, Marina; Nudler, Evgeny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	New York University	Nudler, E (corresponding author), NYU, Sch Med, Dept Biochem, 550 1st Ave, New York, NY 10016 USA.	evgeny.nudler@nyumc.org	Gusarov, Ivan/AAJ-6282-2020	Nudler, Evgeny/0000-0002-8811-3071	NIH; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000799] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the NIH Director's Pioneer Award to E. N.	ASAD NR, 1991, J BACTERIOL, V173, P2562, DOI 10.1128/jb.173.8.2562-2568.1991; BARON SS, 1981, ANTIMICROB AGENTS CH, V20, P814, DOI 10.1128/AAC.20.6.814; Bosworth CA, 2009, P NATL ACAD SCI USA, V106, P4671, DOI 10.1073/pnas.0710416106; FISHER SH, 1991, ANNU REV MICROBIOL, V45, P107, DOI 10.1146/annurev.mi.45.100191.000543; Foster MW, 2009, BIOCHEMISTRY-US, V48, P792, DOI 10.1021/bi801813n; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Gusarov I, 2008, J BIOL CHEM, V283, P13140, DOI 10.1074/jbc.M710178200; HASSAN HM, 1980, J BACTERIOL, V141, P156, DOI 10.1128/JB.141.1.156-163.1980; Inaoka T, 1998, J BACTERIOL, V180, P3697, DOI 10.1128/JB.180.14.3697-3703.1998; Inaoka T, 1999, J BACTERIOL, V181, P1939, DOI 10.1128/JB.181.6.1939-1943.1999; Johnson EG, 2008, CHEM BIOL, V15, P43, DOI 10.1016/j.chembiol.2007.11.014; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Lim MH, 2006, NAT CHEM BIOL, V2, P375, DOI 10.1038/nchembio794; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moore CM, 2004, J BACTERIOL, V186, P4655, DOI 10.1128/JB.186.14.4655-4664.2004; Nedospasov A, 2000, P NATL ACAD SCI USA, V97, P13543, DOI 10.1073/pnas.250398197; Pant K, 2002, BIOCHEMISTRY-US, V41, P11071, DOI 10.1021/bi0263715; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Shatalin K, 2008, P NATL ACAD SCI USA, V105, P1009, DOI 10.1073/pnas.0710950105; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Vukomanovic DV, 1997, BIOCHEM J, V322, P25, DOI 10.1042/bj3220025; Wainwright M, 2001, J ANTIMICROB CHEMOTH, V47, P1, DOI 10.1093/jac/47.1.1	24	271	290	6	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1380	1384		10.1126/science.1175439	http://dx.doi.org/10.1126/science.1175439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745150	Green Accepted			2022-12-24	WOS:000269699100035
J	Wu, YI; Frey, D; Lungu, OI; Jaehrig, A; Schlichting, I; Kuhlman, B; Hahn, KM				Wu, Yi I.; Frey, Daniel; Lungu, Oana I.; Jaehrig, Angelika; Schlichting, Ilme; Kuhlman, Brian; Hahn, Klaus M.			A genetically encoded photoactivatable Rac controls the motility of living cells	NATURE			English	Article							LIGHT; BINDING; RHO; DYNAMICS; ACTIVATION; MIGRATION; DOMAINS; SITES	The precise spatio-temporal dynamics of protein activity are often critical in determining cell behaviour, yet for most proteins they remain poorly understood; it remains difficult to manipulate protein activity at precise times and places within living cells. Protein activity has been controlled by light, through protein derivatization with photocleavable moieties(1) or using photoreactive small-molecule ligands(2). However, this requires use of toxic ultraviolet wavelengths, activation is irreversible, and/or cell loading is accomplished via disruption of the cell membrane (for example, through microinjection). Here we have developed a new approach to produce genetically encoded photoactivatable derivatives of Rac1, a key GTPase regulating actin cytoskeletal dynamics in metazoan cells(3,4.) Rac1 mutants were fused to the photoreactive LOV (light oxygen voltage) domain from phototropin(5,6), sterically blocking Rac1 interactions until irradiation unwound a helix linking LOV to Rac1. Photoactivatable Rac1 (PA-Rac1) could be reversibly and repeatedly activated using 458-or 473-nm light to generate precisely localized cell protrusions and ruffling. Localized Rac activation or inactivation was sufficient to produce cell motility and control the direction of cell movement. Myosin was involved in Rac control of directionality but not in Rac-induced protrusion, whereas PAK was required for Rac-induced protrusion. PA-Rac1 was used to elucidate Rac regulation of RhoA in cell motility. Rac and Rho coordinate cytoskeletal behaviours with seconds and submicrometre precision(7,8). Their mutual regulation remains controversial(9), with data indicating that Rac inhibits and/or activates Rho(10,11). Rac was shown to inhibit RhoA in mouse embryonic fibroblasts, with inhibition modulated at protrusions and ruffles. A PA-Rac crystal structure and modelling revealed LOV-Rac interactions that will facilitate extension of this photoactivation approach to other proteins.	[Wu, Yi I.; Lungu, Oana I.; Jaehrig, Angelika; Hahn, Klaus M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Lungu, Oana I.; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Wu, Yi I.; Lungu, Oana I.; Jaehrig, Angelika; Kuhlman, Brian; Hahn, Klaus M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Frey, Daniel; Schlichting, Ilme] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Max Planck Society	Hahn, KM (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	yiwu@med.unc.edu; khahn@med.unc.edu	Schlichting, Ilme/I-1339-2013	Hahn, Klaus/0000-0002-1970-7562	American Heart Association; National Institutes of Health [GM057464, GM64346]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346, R01GM057464, R55GM057464] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful for help and constructs from W. Briggs, K. Moffat, A. Tripathy, G. Bokoch and K. Jacobson. Diffraction data were collected at the Swiss Light Source, beamline X10SA, Paul Scherrer Institute, Villigen, Switzerland. We thank the Dortmund-Heidelberg team for data collection, and A. Pauluhn and M. Fuchs for their support in setting up the beamline. This research was supported by the American Heart Association (Y. I. W.) and the National Institutes of Health (K. M. H. grants GM057464 and GM64346).	Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Fortin DL, 2008, NAT METHODS, V5, P331, DOI [10.1038/NMETH.1187, 10.1038/nmeth.1187]; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Goeldner M, 2005, DYNAMIC STUDIES IN BIOLOGY: PHOTOTRIGGERS, PHOTOSWITCHES AND CAGED BIOMOLECULES, P1, DOI 10.1002/3527605592; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; HODGSON L, CURR PROTOC IN PRESS; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Leung DW, 2008, P NATL ACAD SCI USA, V105, P12797, DOI 10.1073/pnas.0801232105; Moglich A, 2009, J MOL BIOL, V385, P1433, DOI 10.1016/j.jmb.2008.12.017; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Yao XL, 2008, NAT CHEM BIOL, V4, P491, DOI 10.1038/nchembio.99	29	768	792	3	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					104	U111		10.1038/nature08241	http://dx.doi.org/10.1038/nature08241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19693014	Green Accepted, Green Submitted			2022-12-24	WOS:000269478800039
J	Webb, SAR; Pettila, V; Seppelt, I; Bellomo, R; Bailey, M; Cooper, DJ; Cretikos, M; Davies, AR; Finfer, S; Harrigan, PWJ; Hart, GK; Howe, B; Iredell, JR; McArthur, C; Mitchell, I; Morrison, S; Nichol, AD; Paterson, DL; Peake, S; Richards, B; Stephens, D; Turner, A; Yung, M				Webb, Steven A. R.; Pettila, Ville; Seppelt, Ian; Bellomo, Rinaldo; Bailey, Michael; Cooper, David J.; Cretikos, Michelle; Davies, Andrew R.; Finfer, Simon; Harrigan, Peter W. J.; Hart, Graeme K.; Howe, Belinda; Iredell, Jonathan R.; McArthur, Colin; Mitchell, Imogen; Morrison, Siouxzy; Nichol, Alistair D.; Paterson, David L.; Peake, Sandra; Richards, Brent; Stephens, Dianne; Turner, Andrew; Yung, Michael		ANZIC Influenza Investigators	Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MORTALITY	Background: Planning for the treatment of infection with the 2009 pandemic influenza A (H1N1) virus through health care systems in developed countries during winter in the Northern Hemisphere is hampered by a lack of information from similar health care systems. Methods: We conducted an inception-cohort study in all Australian and New Zealand intensive care units (ICUs) during the winter of 2009 in the Southern Hemisphere. We calculated, per million inhabitants, the numbers of ICU admissions, bed-days, and days of mechanical ventilation due to infection with the 2009 H1N1 virus. We collected data on demographic and clinical characteristics of the patients and on treatments and outcomes. Results: From June 1 through August 31, 2009, a total of 722 patients with confirmed infection with the 2009 H1N1 virus (28.7 cases per million inhabitants; 95% confidence interval [CI], 26.5 to 30.8) were admitted to an ICU in Australia or New Zealand. Of the 722 patients, 669 (92.7%) were under 65 years of age and 66 (9.1%) were pregnant women; of the 601 adults for whom data were available, 172 (28.6%) had a body-mass index (the weight in kilograms divided by the square of the height in meters) greater than 35. Patients infected with the 2009 H1N1 virus were in the ICU for a total of 8815 bed-days (350 per million inhabitants). The median duration of treatment in the ICU was 7.0 days (interquartile range, 2.7 to 13.4); 456 of 706 patients (64.6%) with available data underwent mechanical ventilation for a median of 8 days (interquartile range, 4 to 16). The maximum daily occupancy of the ICU was 7.4 beds (95% CI, 6.3 to 8.5) per million inhabitants. As of September 7, 2009, a total of 103 of the 722 patients (14.3%; 95% CI, 11.7 to 16.9) had died, and 114 (15.8%) remained in the hospital. Conclusions: The 2009 H1N1 virus had a substantial effect on ICUs during the winter in Australia and New Zealand. Our data can assist planning for the treatment of patients during the winter in the Northern Hemisphere. N Engl J Med 2009;361:1925-34.	[Webb, Steven A. R.] Royal Perth Hosp, Intens Care Unit, Perth, WA 6000, Australia; [Webb, Steven A. R.] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia; [Webb, Steven A. R.] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Pettila, Ville; Bellomo, Rinaldo; Bailey, Michael; Cooper, David J.; Davies, Andrew R.; Howe, Belinda; Morrison, Siouxzy; Nichol, Alistair D.] Monash Univ, Sch Publ Hlth & Prevent Med, ANZIC Res Ctr, Melbourne, Vic 3004, Australia; [Seppelt, Ian] Univ Sydney, Nepean Hosp, Sydney, NSW 2006, Australia; [Cooper, David J.; Davies, Andrew R.; Nichol, Alistair D.] Alfred Hosp, Melbourne, Vic, Australia; [Cretikos, Michelle] Univ Sydney, New S Wales Dept Hlth, Sydney, NSW 2006, Australia; [Cretikos, Michelle] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Finfer, Simon] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia; [Harrigan, Peter W. J.] John Hunter Hosp, Newcastle, NSW, Australia; [Hart, Graeme K.] ANZIC Soc Ctr Outcome & Resources Evaluat, Melbourne, Vic, Australia; [Iredell, Jonathan R.] Univ Sydney, Ctr Infect Dis & Microbiol, Sydney, NSW 2006, Australia; [Iredell, Jonathan R.] Westmead Hosp, Sydney, NSW, Australia; [McArthur, Colin] Auckland City Hosp, Auckland, New Zealand; [Mitchell, Imogen] Canberra Hosp, Canberra, ACT, Australia; [Mitchell, Imogen] Australian Natl Univ, Canberra, ACT, Australia; [Paterson, David L.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Peake, Sandra] Queen Elizabeth Hosp, Adelaide, SA, Australia; [Richards, Brent] Gold Coast Hosp, Southport, Qld, Australia; [Stephens, Dianne] Royal Darwin Hosp, Darwin, NT, Australia; [Turner, Andrew] Royal Hobart Hosp, Intens Care Unit, Hobart, Tas, Australia; [Yung, Michael] Womens & Childrens Hosp Adelaide, Adelaide, SA, Australia	Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; Monash University; Nepean Hospital; University of Sydney; Florey Institute of Neuroscience & Mental Health; University of Sydney; University of Sydney; University of Sydney; John Hunter Hospital; University of Sydney; University of Sydney; Auckland City Hospital; Australian National University; Canberra Hospital; Australian National University; University of Queensland; Gold Coast University Hospital; Royal Hobart Hospital	Webb, SAR (corresponding author), Royal Perth Hosp, Intens Care Unit, Wellington St, Perth, WA 6000, Australia.	sarwebb@cyllene.uwa.edu.au	Cooper, D. James/G-7961-2013; Paterson, David L/A-9258-2010; blackwell, nikki/H-4222-2013; Presneill, Jeffrey J/B-4894-2012; Bailey, Michael J/A-4499-2012; Long, Debbie/L-2036-2016	Cooper, D. James/0000-0002-5872-9051; Presneill, Jeffrey J/0000-0001-7177-7667; Bailey, Michael J/0000-0002-5551-1401; Long, Debbie/0000-0002-0984-9559; Nichol, Alistair Dualta/0000-0002-4771-5615; Nichol, Alistair/0000-0002-4689-1238; Whitehead, Christina/0000-0003-4561-7082; Rajbhandari, Dorrilyn/0000-0001-8883-0428; Richards, Brent/0000-0003-2613-0308; Micallef, Sharon/0000-0002-8496-2324; Bersten, Andrew/0000-0001-9908-394X; Mitchell, Imogen/0000-0001-6013-4922; Bellomo, Rinaldo/0000-0002-1650-8939; Finfer, Simon/0000-0002-2785-5864; SHEHABI, Yahya/0000-0003-4707-7462; Morrison, Siouxzy/0000-0002-2561-5859; Paterson, David/0000-0003-2079-4437; Stephens, Dianne/0000-0002-3785-6828; /0000-0002-4157-5148	Department of Health and Ageing, Commonwealth Government of Australia; New South Wales Health, Government of New South Wales; Department of Health, Government of Victoria; Australian and New Zealand Intensive Care Research Centre; Australian and New Zealand Intensive Care Society; CSL Limited, Melbourne, Victoria	Department of Health and Ageing, Commonwealth Government of Australia(Australian Government); New South Wales Health, Government of New South Wales; Department of Health, Government of Victoria; Australian and New Zealand Intensive Care Research Centre; Australian and New Zealand Intensive Care Society; CSL Limited, Melbourne, Victoria	Supported by the Department of Health and Ageing, Commonwealth Government of Australia; New South Wales Health, Government of New South Wales; Department of Health, Government of Victoria; the Australian and New Zealand Intensive Care Research Centre; the Australian and New Zealand Intensive Care Society; and an unrestricted grant from CSL Limited, Melbourne, Victoria.	Australian Bureau of Statistics, 2008, 3201 0 POP AG SEX AU; Australian Institute of Health and Welfare, 2008, AUSTR HLTH 2008; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; *CDCP, INT GUID INF CONTR C; *CDCP, 2009 H1N1 FLU INT SI; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Cutler J, 2009, CAN MED ASSOC J, V181, P159, DOI 10.1503/cmaj.090859; Dal Grande E, 2005, AUST NZ J PUBL HEAL, V29, P343, DOI 10.1111/j.1467-842X.2005.tb00205.x; DRENNAN K, 2008, INTENSIVE CARE RESOU; *FLUC ORG, WORLDW H1N1 SWIN FLU; Gatherer D, 2009, J CLIN VIROL, V45, P174, DOI 10.1016/j.jcv.2009.06.004; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; LI G, 2009, J CLIN VIROL    0819; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; *NOV SWIN OR INFL, 2009, NEW ENGL J MED, V361, P102; *STAT NZ, NAT POP EST; Stow PJ, 2006, J CRIT CARE, V21, P133, DOI 10.1016/j.jcrc.2005.11.010; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Webb SAR, 2009, CRIT CARE RESUSC, V11, P170; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8	25	745	770	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2009	361	20					1925	1934		10.1056/NEJMoa0908481	http://dx.doi.org/10.1056/NEJMoa0908481			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518AI	19815860				2022-12-24	WOS:000271660500006
J	Ivanov, II; Atarashi, K; Manel, N; Brodie, EL; Shima, T; Karaoz, U; Wei, DG; Goldfarb, KC; Santee, CA; Lynch, SV; Tanoue, T; Imaoka, A; Itoh, K; Takeda, K; Umesaki, Y; Honda, K; Littman, DR				Ivanov, Ivaylo I.; Atarashi, Koji; Manel, Nicolas; Brodie, Eoin L.; Shima, Tatsuichiro; Karaoz, Ulas; Wei, Dongguang; Goldfarb, Katherine C.; Santee, Clark A.; Lynch, Susan V.; Tanoue, Takeshi; Imaoka, Akemi; Itoh, Kikuji; Takeda, Kiyoshi; Umesaki, Yoshinori; Honda, Kenya; Littman, Dan R.			Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria	CELL			English	Article							MURINE GASTROINTESTINAL-TRACT; MUCOSAL IMMUNE-SYSTEM; T-HELPER-CELLS; AUTOIMMUNE INFLAMMATION; HOST-DEFENSE; TGF-BETA; DIFFERENTIATION; INNATE; MICE; IL-23	The gastrointestinal tract of mammals is inhabited by hundreds of distinct species of commensal microorganisms that exist in a mutualistic relationship with the host. How commensal microbiota influence the host immune system is poorly understood. We show here that colonization of the small intestine of mice with a single commensal microbe, segmented filamentous bacterium (SFB), is sufficient to induce the appearance of CD4(+) T helper cells that produce IL-17 and IL-22 (Th17 cells) in the lamina propria. SFB adhere tightly to the surface of epithelial cells in the terminal ileum of mice with Th17 cells but are absent from mice that have few Th17 cells. Colonization with SFB was correlated with increased expression of genes associated with inflammation and antimicrobial defenses and resulted in enhanced resistance to the intestinal pathogen Citrobacter rodentium. Thus, manipulation of this commensal-regulated pathway may provide new opportunities for enhancing mucosal immunity and treating autoimmune disease.	[Atarashi, Koji; Tanoue, Takeshi; Takeda, Kiyoshi; Honda, Kenya] Osaka Univ, Lab Immune Regulat, Grad Sch Med, WPI Immunol Frontier Res Ctr, Osaka 5650871, Japan; [Ivanov, Ivaylo I.; Manel, Nicolas; Littman, Dan R.] NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol, New York, NY 10016 USA; [Ivanov, Ivaylo I.; Manel, Nicolas; Littman, Dan R.] NYU, Sch Med, Med Skirball Inst, New York, NY 10016 USA; [Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Brodie, Eoin L.; Karaoz, Ulas; Goldfarb, Katherine C.; Santee, Clark A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Ctr Environm Biotechnol, Berkeley, CA 94720 USA; [Wei, Dongguang] Carl Zeiss SMT Inc, Nanotechnol Syst Div, Peabody, MA 01960 USA; [Lynch, Susan V.] Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94143 USA; [Shima, Tatsuichiro; Imaoka, Akemi; Umesaki, Yoshinori] Yakult Cent Inst Microbiol Res, Tokyo 1868650, Japan; [Itoh, Kikuji] Univ Tokyo, Dept Vet Publ Hlth, Bunkyo Ku, Tokyo 1138657, Japan; [Honda, Kenya] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Osaka University; New York University; New York University; Howard Hughes Medical Institute; New York University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Carl Zeiss AG; University of California System; University of California San Francisco; Yakult Honsha Company, Limited; University of Tokyo; Japan Science & Technology Agency (JST)	Honda, K (corresponding author), Osaka Univ, Lab Immune Regulat, Grad Sch Med, WPI Immunol Frontier Res Ctr, 2-2 Yamada Oka, Osaka 5650871, Japan.	honda@ongene.med.osaka-u.ac.jp; littman@saturn.med.nyu.edu	Brodie, Eoin L/A-7853-2008; Takeda, Kiyoshi/C-9331-2009; Lynch, Susan V/B-6272-2009; Honda, Kenya/N-5297-2015; Karaoz, Ulas/J-7093-2014; Atarashi, Koji/I-5363-2014; Manel, Nicolas/E-2128-2011	Brodie, Eoin L/0000-0002-8453-8435; Karaoz, Ulas/0000-0002-8238-6757; Atarashi, Koji/0000-0001-5422-0736; Manel, Nicolas/0000-0002-1481-4430; Takeda, Kiyoshi/0000-0002-1778-6332	Crohn's and Colitis Foundation of America; Cancer Research Institute; Howard Hughes Medical Institute; Helen and Martin Kimmel Center for Biology and Medicine; National Institutes of Health [AI33856]; Ministry of Education, Culture, Sports, Science and Technology; PRESTO; JST; Senri Life Science Foundation; Naito Foundation; United States Department of Energy by the University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK085329, P30DK043351] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; Cancer Research Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Helen and Martin Kimmel Center for Biology and Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO; JST(Japan Science & Technology Agency (JST)); Senri Life Science Foundation; Naito Foundation(Naito Memorial Foundation); United States Department of Energy by the University of California, Lawrence Berkeley National Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Littman laboratory for valuable discussions, Takeshi Egawa and Homer Boushey for their contribution to establishing the collaborative study, and Junichi Nishimura for technical assistance. We also thank Feng-Xia (Alice) Liang and Eric Roth from the New York Univeristy imaging core facility for performing transmission electron microscopy and for preparing samples for scanning electron microscopy. We also thank Jiri Zavadil and Agnes Viale and the genomic core facilities of NYU and Memorial Sloan Ketterring Cancer Center, respectively, for performing the array studies. We thank the staff at the Yakult Central Institute for gnotobiotic handling of the mice. The work was supported by Crohn's and Colitis Foundation of America (I. I. I.) and Cancer Research Institute (N.M.) fellowships and by the Howard Hughes Medical Institute (D. R. L.), the Helen and Martin Kimmel Center for Biology and Medicine (D. R. L.), National Institutes of Health grant AI33856 (D. R. L.), Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (K. H.), PRESTO, JST (K. H.), the Senri Life Science Foundation, and the Naito Foundation (K. H.). Part of this work was performed under the auspices of the United States Department of Energy by the University of California, Lawrence Berkeley National Laboratory, under contract DE-AC02-05CH11231.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Auja SJ, 2007, SEMIN IMMUNOL, V19, P377, DOI 10.1016/j.smim.2007.10.009; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; DAVIS CP, 1974, INFECT IMMUN, V10, P948, DOI 10.1128/IAI.10.4.948-956.1974; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; GARLAND CD, 1982, MICROB ECOL, V8, P181, DOI 10.1007/BF02010451; Gavin M, 2003, CURR OPIN IMMUNOL, V15, P690, DOI 10.1016/j.coi.2003.09.011; Glimcher LH, 2000, GENE DEV, V14, P1693; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; He R, 2006, J IMMUNOL, V177, P4072, DOI 10.4049/jimmunol.177.6.4072; Heczko U, 2000, J INFECT DIS, V181, P1027, DOI 10.1086/315348; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; ITOH K, 1985, LAB ANIM, V19, P111, DOI 10.1258/002367785780942589; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; KLAASEN HLBM, 1993, LAB ANIM-UK, V27, P141, DOI 10.1258/002367793780810441; KLAASEN HLBM, 1993, INFECT IMMUN, V61, P303, DOI 10.1128/IAI.61.1.303-306.1993; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; KOOPMAN JP, 1987, LAB ANIM-UK, V21, P48, DOI 10.1258/002367787780740743; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Miyamoto Y, 2000, INT J SYST EVOL MICR, V50, P145, DOI 10.1099/00207713-50-1-145; Monach Paul A, 2008, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1522s81; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; O'Dell JR, 2006, ARTHRITIS RHEUM-US, V54, P621, DOI 10.1002/art.21620; Rakoff-Nahoum S, 2006, CURR TOP MICROBIOL, V308, P1; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; SEVERIJNEN AJ, 1989, J RHEUMATOL, V16, P1061; Simelyte E, 2003, ANN RHEUM DIS, V62, P976, DOI 10.1136/ard.62.10.976; SNEL J, 1995, INT J SYST BACTERIOL, V45, P780, DOI 10.1099/00207713-45-4-780; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Talham GL, 1999, INFECT IMMUN, V67, P1992; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; UMESAKI Y, 1995, MICROBIOL IMMUNOL, V39, P555, DOI 10.1111/j.1348-0421.1995.tb02242.x; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	65	2961	3106	5	304	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 30	2009	139	3					485	498		10.1016/j.cell.2009.09.033	http://dx.doi.org/10.1016/j.cell.2009.09.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	512ON	19836068	Green Accepted, Bronze			2022-12-24	WOS:000271259600014
J	Carreiras, M; Seghier, ML; Baquero, S; Estevez, A; Lozano, A; Devlin, JT; Price, CJ				Carreiras, Manuel; Seghier, Mohamed L.; Baquero, Silvia; Estevez, Adelina; Lozano, Alfonso; Devlin, Joseph T.; Price, Cathy J.			An anatomical signature for literacy	NATURE			English	Article							BRAIN; MORPHOLOGY; DIFFUSION; DYSLEXIA; CHILDREN; LANGUAGE; SKILLS; INTEGRATION; MECHANISMS; HANDEDNESS	Language is a uniquely human ability that evolved at some point in the roughly 6,000,000 years since human and chimpanzee lines diverged(1,2). Even in the most linguistically impoverished environments, children naturally develop sophisticated language systems(3). In contrast, reading is a learnt skill that does not develop without intensive tuition and practice. Learning to read is likely to involve ontogenic structural brain changes(4-6), but these are nearly impossible to isolate in children owing to concurrent biological, environmental and social maturational changes. In Colombia, guerrillas are re-integrating into mainstream society and learning to read for the first time as adults. This presents a unique opportunity to investigate how literacy changes the brain, without the maturational complications present in children. Here we compare structural brain scans from those who learnt to read as adults (late-literates) with those from a carefully matched set of illiterates. Late-literates had more white matter in the splenium of the corpus callosum and more grey matter in bilateral angular, dorsal occipital, middle temporal, left supramarginal and superior temporal gyri. The importance of these brain regions for skilled reading was investigated in early literates, who learnt to read as children. We found anatomical connections linking the left and right angular and dorsal occipital gyri through the area of the corpus callosum where white matter was higher in late-literates than in illiterates; that reading, relative to object naming, increased the interhemispheric functional connectivity between the left and right angular gyri; and that activation in the left angular gyrus exerts top-down modulation on information flow from the left dorsal occipital gyrus to the left supramarginal gyrus. These findings demonstrate how the regions identified in late-literates interact during reading, relative to object naming, in early literates.	[Carreiras, Manuel] Basque Ctr Cognit Brain & Language, Donostia San Sebastian 20009, Spain; [Carreiras, Manuel] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain; [Carreiras, Manuel] Univ Basque Country, Dept Filol Vasca, Bilbao 48940, Spain; [Carreiras, Manuel; Estevez, Adelina] Univ La Laguna, Tenerife 38055, Spain; [Seghier, Mohamed L.; Price, Cathy J.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England; [Baquero, Silvia; Lozano, Alfonso] Univ Nacl Colombia, Bogota 3165000, Colombia; [Devlin, Joseph T.] UCL, London WC1E 6BT, England	Basque Foundation for Science; University of Basque Country; Universidad de la Laguna; University of London; University College London; Universidad Nacional de Colombia; University of London; University College London	Carreiras, M (corresponding author), Basque Ctr Cognit Brain & Language, Donostia San Sebastian 20009, Spain.	m.carreiras@bcbl.eu; c.price@fil.ion.ucl.ac.uk	Seghier, Mohamed/O-8634-2019; Carreiras, Manuel/D-5267-2009; Seghier, Mohamed L/C-6314-2009	Seghier, Mohamed/0000-0002-1146-8800; Carreiras, Manuel/0000-0001-6726-7613; Seghier, Mohamed L/0000-0002-1146-8800; Baquero Castellanos, Silvia/0000-0003-0503-9556; Basque Center on Cognition, Brain and Language, BCBL./0000-0002-8345-6892; Devlin, Joseph/0000-0001-9737-3070; Estevez, Adelina/0000-0003-3724-1767; Price, Catherine/0000-0001-7448-4835	Spanish Ministry of Education and Science; Wellcome Trust	Spanish Ministry of Education and Science(Spanish Government); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank K. Friston for advice on data analyses and A. Leff, T. Munte and T. Shallice for their help with the presentation of the manuscript. This work was funded by a CONSOLIDER-INGENIO grant from the Spanish Ministry of Education and Science and by the Wellcome Trust.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; BINDER JR, 1992, BRAIN, V115, P1807, DOI 10.1093/brain/115.6.1807; Booth JR, 2004, J COGNITIVE NEUROSCI, V16, P1234, DOI 10.1162/0898929041920496; Brambati SM, 2006, BRAIN RES, V1113, P174, DOI 10.1016/j.brainres.2006.06.099; Carreiras M, 2004, LANG COGNITIVE PROC, V19, P321, DOI 10.1080/01690960344000288; Castro-Caldas A, 1999, EUR J NEUROL, V6, P23, DOI 10.1046/j.1468-1331.1999.610023.x; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; DAMASIO AR, 1983, NEUROLOGY, V33, P1573, DOI 10.1212/WNL.33.12.1573; DEJERINE J., 1892, MEMOIRES SOC BIOL, V4, P61; Dougherty RF, 2007, P NATL ACAD SCI USA, V104, P8556, DOI 10.1073/pnas.0608961104; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Fisher SE, 2006, NAT REV GENET, V7, P9, DOI 10.1038/nrg1747; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hoeft F, 2006, J NEUROSCI, V26, P10700, DOI 10.1523/JNEUROSCI.4931-05.2006; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; LUNDBERG I, 1980, SCAND J PSYCHOL, V21, P159, DOI 10.1111/j.1467-9450.1980.tb00356.x; MORAIS J, 1979, COGNITION, V7, P323, DOI 10.1016/0010-0277(79)90020-9; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; PENACASANOVA J, 1995, PROGRAMA INTEGRADO E; Penny WD, 2004, NEUROIMAGE, V23, pS264, DOI 10.1016/j.neuroimage.2004.07.041; Petersson KM, 2007, EUR J NEUROSCI, V26, P791, DOI 10.1111/j.1460-9568.2007.05701.x; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Price CJ, 2006, NEUROIMAGE, V29, P643, DOI 10.1016/j.neuroimage.2005.07.044; Price CJ, 2005, CURR OPIN NEUROBIOL, V15, P231, DOI 10.1016/j.conb.2005.03.003; Pugh KR, 2001, J COMMUN DISORD, V34, P479, DOI 10.1016/S0021-9924(01)00060-0; Raven J.C., 1938, PROGR MATRICES PERCE; Reis A, 2003, APPL NEUROPSYCHOL, V10, P191, DOI 10.1207/s15324826an1004_1; Reis A, 1997, J INT NEUROPSYCH SOC, V3, P444, DOI 10.1017/S135561779700444X; Robichon F, 1998, BRAIN LANG, V62, P127, DOI 10.1006/brln.1997.1891; Rumsey JM, 1996, BIOL PSYCHIAT, V39, P769, DOI 10.1016/0006-3223(95)00225-1; Senghas A, 2004, SCIENCE, V305, P1779, DOI 10.1126/science.1100199; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Silani G, 2005, BRAIN, V128, P2453, DOI 10.1093/brain/awh579; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Spreen O., 1991, PROFILE TEST RESULTS; Steinbrink C, 2008, NEUROPSYCHOLOGIA, V46, P3170, DOI 10.1016/j.neuropsychologia.2008.07.015; Stephan KE, 2007, J NEUROSCI, V27, P3512, DOI 10.1523/JNEUROSCI.4766-06.2007; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; VEGA FC, 1996, BATERIA EVALUACION P; WAGNER RK, 1987, PSYCHOL BULL, V101, P192, DOI 10.1037/0033-2909.101.2.192; Wechsler D, 1987, WMS R WECHSLER MEMOR; Weiskopf N, 2006, NEUROIMAGE, V33, P493, DOI 10.1016/j.neuroimage.2006.07.029	50	288	294	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					983	U245		10.1038/nature08461	http://dx.doi.org/10.1038/nature08461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829380				2022-12-24	WOS:000270817700048
J	Vos, M; Birkett, PJ; Birch, E; Griffiths, RI; Buckling, A				Vos, Michiel; Birkett, Philip J.; Birch, Elizabeth; Griffiths, Robert I.; Buckling, Angus			Local Adaptation of Bacteriophages to Their Bacterial Hosts in Soil	SCIENCE			English	Article							RESISTANCE		[Vos, Michiel; Birkett, Philip J.; Birch, Elizabeth; Buckling, Angus] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Griffiths, Robert I.] Ctr Ecol & Hydrol, Oxford OX1 35R, England	University of Oxford; UK Centre for Ecology & Hydrology (UKCEH)	Vos, M (corresponding author), Royal Netherlands Acad Arts & Sci NIOO KNAW, Netherlands Inst Ecol, Ctr Terr Ecol, NL-6666 GA Heteren, Netherlands.	michiel.vos@nioo.knaw.nl	Griffiths, Robert/D-5237-2011; Birch, Elizabeth/GXW-2925-2022	Griffiths, Robert/0000-0002-3341-4547; Buckling, Angus/0000-0003-1170-4604	European Research Council; the Royal Society; Netherlands Organisation for Scientific Research (NWO); NERC [NE/E012140/1] Funding Source: UKRI; Natural Environment Research Council [CEH010021, NE/E012140/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); the Royal Society(Royal Society of London); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was funded by the European Research Council, the Royal Society, and a Netherlands Organisation for Scientific Research (NWO) Rubicon grant to M.V.	Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Greischar MA, 2007, ECOL LETT, V10, P418, DOI 10.1111/j.1461-0248.2007.01028.x; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913	7	126	134	0	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 14	2009	325	5942					833	833		10.1126/science.1174173	http://dx.doi.org/10.1126/science.1174173			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AK	19679806				2022-12-24	WOS:000269242400035
J	Betley, JN; Wright, CVE; Kawaguchi, Y; Erdelyi, F; Szabo, G; Jessell, TM; Kaltschmidt, JA				Betley, J. Nicholas; Wright, Christopher V. E.; Kawaguchi, Yoshiya; Erdelyi, Ferenc; Szabo, Gabor; Jessell, Thomas M.; Kaltschmidt, Julia A.			Stringent Specificity in the Construction of a GABAergic Presynaptic Inhibitory Circuit	CELL			English	Article							GAMMA-AMINOBUTYRIC-ACID; MOTOR-NEURONS; INTERNEURON DIVERSITY; MOLECULAR-MECHANISMS; CRITICAL PERIOD; DORSAL-HORN; SYNAPSES; CONNECTIVITY; RECEPTOR; FEATURES	GABAergic interneurons are key elements in neural coding, but the mechanisms that assemble inhibitory circuits remain unclear. In the spinal cord, the transfer of sensory signals to motor neurons is filtered by GABAergic interneurons that act presynaptically to inhibit sensory transmitter release and postsynaptically to inhibit motor neuron excitability. We show here that the connectivity and synaptic differentiation of GABAergic interneurons that mediate presynaptic inhibition is directed by their sensory targets. In the absence of sensory terminals these GABAergic neurons shun other available targets, fail to undergo presynaptic differentiation, and withdraw axons from the ventral spinal cord. A sensory-specific source of brain derived neurotrophic factor induces synaptic expression of the GABA synthetic enzyme GAD65 a defining biochemical feature of this set of interneurons. The organization of a GABAergic circuit that mediates presynaptic inhibition in the mammalian CNS is therefore controlled by a stringent program of sensory recognition and signaling.	[Betley, J. Nicholas; Jessell, Thomas M.; Kaltschmidt, Julia A.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Neurosci, New York, NY 10032 USA; [Betley, J. Nicholas; Jessell, Thomas M.; Kaltschmidt, Julia A.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Wright, Christopher V. E.] Vanderbilt Univ, Program Dev Biol, Dept Cell & Dev Biol, Nashville, TN 37240 USA; [Kawaguchi, Yoshiya] Kyoto Univ, Sch Med, Dept Surg & Surg Basic Sci, Kyoto 606, Japan; [Erdelyi, Ferenc; Szabo, Gabor] Hungarian Acad Sci, Inst Expt Med, Dept Gene Technol & Dev Neurobiol, Budapest, Hungary; [Kaltschmidt, Julia A.] Sloan Kettering Inst, Dev Biol Program, New York, NY 10003 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Vanderbilt University; Kyoto University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Memorial Sloan Kettering Cancer Center	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Neurosci, New York, NY 10032 USA.	tmj1@columbia.edu	Szabo, Gabor/A-5087-2008	Szabo, Gabor/0000-0001-5438-5151	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033245] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01 NS033245-16, R01 NS033245, R01 NS 33245] Funding Source: Medline; PHS HHS [NIH 527975] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome TrustEuropean Commission)		Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; BURRY RW, 1982, BRAIN RES, V247, P1, DOI 10.1016/0006-8993(82)91022-8; CASH S, 1992, J NEUROSCI, V12, P2051; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chen HH, 2002, J NEUROSCI, V22, P3512; Conradi S, 1969, Acta Physiol Scand Suppl, V332, P5; ECCLES JC, 1961, J PHYSIOL-LONDON, V159, P147, DOI 10.1113/jphysiol.1961.sp006798; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Holstein GR, 1999, NEUROSCIENCE, V93, P183, DOI 10.1016/S0306-4522(99)00140-2; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Huang ZJ, 2008, CURR OPIN NEUROBIOL, V18, P77, DOI 10.1016/j.conb.2008.05.008; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Hughes DI, 2005, P NATL ACAD SCI USA, V102, P9038, DOI 10.1073/pnas.0503646102; Jankowska E, 2008, J NEUROSCI, V28, P3615, DOI 10.1523/JNEUROSCI.0466-08.2008; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; Kanaani J, 2002, J CELL BIOL, V158, P1229, DOI 10.1083/jcb.200205053; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; KIDD M, 1962, J ANAT, V96, P179; Kubota Y, 2000, J NEUROSCI, V20, P375, DOI 10.1523/JNEUROSCI.20-01-00375.2000; Li WC, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-17; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Monyer H, 2004, TRENDS NEUROSCI, V27, P90, DOI 10.1016/j.tins.2003.12.008; Ohba S, 2005, CEREB CORTEX, V15, P291, DOI 10.1093/cercor/bhh130; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; PENG HB, 1981, NATURE, V292, P831, DOI 10.1038/292831a0; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Rudomin P, 2009, EXP BRAIN RES, V196, P139, DOI 10.1007/s00221-009-1758-9; SANES DH, 1989, NEURON, V2, P1237, DOI 10.1016/0896-6273(89)90308-5; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shen K, 2004, CURR OPIN NEUROBIOL, V14, P83, DOI 10.1016/j.conb.2004.01.007; Smith TC, 2002, NAT NEUROSCI, V5, P760, DOI 10.1038/nn882; SOTELO C, 1990, J EXP BIOL, V153, P225; Stepanyants A, 2004, NEURON, V43, P251, DOI 10.1016/j.neuron.2004.06.013; Stepien AE, 2008, NEURON, V60, P1, DOI 10.1016/j.neuron.2008.09.030; Stevens CF, 2007, J NEUROPHYSIOL, V98, P3221, DOI 10.1152/jn.00857.2007; Thomson AM, 2002, J NEUROCYTOL, V31, P239, DOI 10.1023/A:1024117908539; Tian N, 1999, P NATL ACAD SCI USA, V96, P12911, DOI 10.1073/pnas.96.22.12911; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; WALBERG F, 1965, EXP NEUROL, V13, P218, DOI 10.1016/0014-4886(65)90111-1; Windhorst U, 1996, PROG NEUROBIOL, V49, P517, DOI 10.1016/0301-0082(96)00023-8	52	148	150	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					161	174		10.1016/j.cell.2009.08.027	http://dx.doi.org/10.1016/j.cell.2009.08.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804761	Green Accepted, Bronze			2022-12-24	WOS:000270388600024
J	Kambris, Z; Cook, PE; Phuc, HK; Sinkins, SP				Kambris, Zakaria; Cook, Peter E.; Phuc, Hoang K.; Sinkins, Steven P.			Immune Activation by Life-Shortening Wolbachia and Reduced Filarial Competence in Mosquitoes	SCIENCE			English	Article							ANOPHELES-GAMBIAE; AEDES-AEGYPTI; DROSOPHILA-MELANOGASTER; ANTIMICROBIAL PEPTIDES; BRUGIA-PAHANGI; PLASMODIUM; COMPLEMENT; INFECTION; SUSCEPTIBILITY; TRANSMISSION	Wolbachia strain wMelPop reduces the longevity of its Drosophila melanogaster host and, when introduced into the mosquito Aedes aegypti, halves its life span. We show that wMelPop induces up-regulation of the mosquito's innate immune system and that its presence inhibits the development of filarial nematodes in the mosquito. These data suggest that wMelPop could be used in the global effort to eliminate lymphatic filariasis and possibly for the control of other mosquito-borne parasites where immune preactivation inhibits their development. The cost of constitutive immune up-regulation may contribute to the life-shortening phenotype.	[Sinkins, Steven P.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Sinkins, SP (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	steven.sinkins@zoo.ox.ac.uk			Wellcome Trust; European Union's Framework Programme F7 [223241]; European Molecular Biology Organization; University of Oxford John Fell Fund	Wellcome Trust(Wellcome TrustEuropean Commission); European Union's Framework Programme F7; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); University of Oxford John Fell Fund	This study was supported by the Wellcome Trust, European Union's Framework Programme F7 award 223241, European Molecular Biology Organization, and University of Oxford John Fell Fund. We thank S. O'Neill for providing us with the wMelPop-infected and cured Ae. aegypti lines PGYP1 and PGYP1. tet; to E. Devaney, for providing Brugia pahangi and Refm Ae. aegypti; to M. Povelones, for assistance identifying Ae. aegypti LRIM genes; and to A. Brown for comments on the manuscript. Microarray data have been submitted to the National Center for Biotechnology Information Gene Expression Omnibus database, accession GSE17469.	Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Bourtzis K, 2000, INSECT MOL BIOL, V9, P635, DOI 10.1046/j.1365-2583.2000.00224.x; Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X; Burkot TR, 2002, ANN TROP MED PARASIT, V96, pS61, DOI 10.1179/000349802125002419; Carballar-Lejarazu R, 2008, CELL MOL LIFE SCI, V65, P3081, DOI 10.1007/s00018-008-8250-8; CHALK R, 1995, EXP PARASITOL, V80, P401, DOI 10.1006/expr.1995.1052; Cook PE, 2008, ADV EXP MED BIOL, V627, P126, DOI 10.1007/978-0-387-78225-6_11; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; GWADZ RW, 1989, INFECT IMMUN, V57, P2628, DOI 10.1128/IAI.57.9.2628-2633.1989; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Kim W, 2004, J MED ENTOMOL, V41, P447, DOI 10.1603/0022-2585-41.3.447; Libert S, 2006, AGING CELL, V5, P533, DOI 10.1111/j.1474-9726.2006.00251.x; Lowenberger CA, 1996, EXP PARASITOL, V83, P191, DOI 10.1006/expr.1996.0066; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; MEEK SR, 1982, ANN TROP MED PARASIT, V76, P347, DOI 10.1080/00034983.1982.11687551; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Rasgon JL, 2003, J MED ENTOMOL, V40, P125, DOI 10.1603/0022-2585-40.2.125; Sinkins SP, 2000, INSECT TRANSGENESIS, P271; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Wachinger M, 1998, J GEN VIROL, V79, P731, DOI 10.1099/0022-1317-79-4-731; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102	27	367	386	1	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					134	136		10.1126/science.1177531	http://dx.doi.org/10.1126/science.1177531			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797660	Green Accepted			2022-12-24	WOS:000270355600053
J	Collombat, P; Xu, XB; Ravassard, P; Sosa-Pineda, B; Dussaud, S; Billestrup, N; Madsen, OD; Serup, P; Heimberg, H; Mansouri, A				Collombat, Patrick; Xu, Xiaobo; Ravassard, Philippe; Sosa-Pineda, Beatriz; Dussaud, Sebastien; Billestrup, Nils; Madsen, Ole D.; Serup, Palle; Heimberg, Harry; Mansouri, Ahmed			The Ectopic Expression of Pax4 in the Mouse Pancreas Converts Progenitor Cells into alpha and Subsequently beta Cells	CELL			English	Article							ENDOCRINE PANCREAS; ADULT PANCREAS; KNOCKOUT MICE; DIFFERENTIATION; GLUCAGON; LINEAGES; GENE; ARX; INACTIVATION; REPLACEMENT	We have previously reported that the loss of Arx and/or Pax4 gene activity leads to a shift in the fate of the different endocrine cell subtypes in the mouse pancreas, without affecting the total endocrine cell numbers. Here, we conditionally and ectopically express Pax4 using different cell-specific promoters and demonstrate that Pax4 forces endocrine precursor cells, as well as mature alpha cells, to adopt a beta cell destiny. This results in a glucagon deficiency that provokes a compensatory and continuous glucagon(+) cell neogenesis requiring the re-expression of the pro-endocrine gene Ngn3. However, the newly formed alpha cells fail to correct the hypoglucagonemia since they subsequently acquire a beta cell phenotype upon Pax4 ectopic expression. Notably, this cycle of neogenesis and redifferentiation caused by ectopic expression of Pax4 in alpha cells is capable of restoring a functional beta cellmass and curing diabetes in animals that have been chemically depleted of beta cells.	[Collombat, Patrick; Mansouri, Ahmed] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany; [Collombat, Patrick; Madsen, Ole D.; Serup, Palle; Heimberg, Harry; Mansouri, Ahmed] Beta Cell Biol Consortium, Nashville, TN 37323 USA; [Collombat, Patrick; Ravassard, Philippe; Madsen, Ole D.; Serup, Palle; Heimberg, Harry] JDRF Ctr Beta Cell Therapy Diabet, B-1090 Brussels, Belgium; [Xu, Xiaobo; Heimberg, Harry] Vrije Univ Brussels, Diabet Res Ctr, B-1090 Brussels, Belgium; [Ravassard, Philippe; Dussaud, Sebastien] Univ Paris 06, CNRS, INSERM,Ctr Rech,Inst Cerveau & Moelle, UMR 7225,UMRS 975,Biotechnol & Biotherapy Lab, FR-75013 Paris, France; [Sosa-Pineda, Beatriz] St Jude Childrens Hosp, Dept Genet Tumor Cell Biol, Memphis, TN 38105 USA; [Dussaud, Sebastien] Univ Paris 06, Fac Med Pitie Salpetriere, Ctr Experimentat Fonct, FR-75013 Paris, France; [Billestrup, Nils] Res Inst, Dept Translat Diabetol, DK-2820 Gentofte, Denmark; [Madsen, Ole D.; Serup, Palle] Res Inst, Dept Dev Biol, DK-2820 Gentofte, Denmark; [Mansouri, Ahmed] Univ Gottingen, Dept Clin Neurophysiol, D-37075 Gottingen, Germany	Max Planck Society; Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; St Jude Children's Research Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Gottingen	Collombat, P (corresponding author), Fac Sci, INSERM, U636, Diabet Genet Team, FR-06108 Nice, France.	collombat@unice.fr; amansou@gwdg.de	Serup, Palle/A-7407-2011; collombat, patrick/P-3741-2019; Madsen, Ole D./A-7415-2011; collombat, patrick/F-4495-2015	Serup, Palle/0000-0002-0858-590X; collombat, patrick/0000-0001-8232-1438; Madsen, Ole D./0000-0002-2753-5203; collombat, patrick/0000-0001-8232-1438; ravassard, philippe/0000-0002-0393-9262; Billestrup, Nils/0000-0002-4968-8067; Dussaud, Sebastien/0000-0002-5365-8338; Heimberg, Harry/0000-0003-1954-7375	Max-Planck Society; Dr. H. Storz and Alte Leipziger Foundation; INSERM; INSERM-Avenir Program; National Fund for Scientific Research-FlanderS [G000609N10]; Juvenile Diabetes Research foundation [26-2008-639]; National Institutes of Health Beta Cell Biology Consortium [U19 DK 072495-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK072495, R01DK060542] Funding Source: NIH RePORTER	Max-Planck Society(Max Planck SocietyFoundation CELLEX); Dr. H. Storz and Alte Leipziger Foundation; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INSERM-Avenir Program(Institut National de la Sante et de la Recherche Medicale (Inserm)); National Fund for Scientific Research-FlanderS(FWO); Juvenile Diabetes Research foundation(Juvenile Diabetes Research Foundation); National Institutes of Health Beta Cell Biology Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are most grateful to J. Hecksher-Sorensen, G. Gradwohl, G. Mellitzer, A. Stoykova, G. Collombat, D. Pipeleers, and P. Gruss for discussion. We are indebted to D. A. Melton, C. V. Wright, P. Herrera, M. Sander, B. Ahren, and L. Kvist for providing us with mice and/or antibodies. We also thank M. Van de Casteele, J. Hald, T. Rabe, S. Niemann-Seyde, T. Mundinger, R. Faubel, O. Jackle, T. Schulz, U. Franke, and S. Schrotter for excellent technical assistance, as well as the biotechnical laboratory crew for their support with the mice. The authors are supported by the Max-Planck Society, the Dr. H. Storz and Alte Leipziger Foundation, the INSERM, the INSERM-Avenir Program, the National Fund for Scientific Research-Flanders (G000609N10), the Juvenile Diabetes Research foundation (26-2008-639), and the National Institutes of Health Beta Cell Biology Consortium (U19 DK 072495-01).	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Ashery-Padan R, 2004, DEV BIOL, V269, P479, DOI 10.1016/j.ydbio.2004.01.040; BLUME N, 1995, J CLIN INVEST, V96, P2227, DOI 10.1172/JCI118278; Brun T, 2004, J CELL BIOL, V167, P1123, DOI 10.1083/jcb.200405148; Collombat P, 2005, DEVELOPMENT, V132, P2969, DOI 10.1242/dev.01870; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Collombat P, 2006, MECH DEVELOP, V123, P501, DOI 10.1016/j.mod.2006.05.006; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dor Y, 2008, CELL, V132, P183, DOI 10.1016/j.cell.2008.01.004; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Grapin-Botton A, 2001, GENE DEV, V15, P444, DOI 10.1101/gad.846001; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Offield MF, 1996, DEVELOPMENT, V122, P983; PETERSSON B, 1963, ACTA ENDOCRINOL-COP, V44, P139; Rosenberg L, 1998, MICROSC RES TECHNIQ, V43, P337, DOI 10.1002/(SICI)1097-0029(19981115)43:4<337::AID-JEMT8>3.0.CO;2-U; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Theis M, 2004, EXP CELL RES, V294, P18, DOI 10.1016/j.yexcr.2003.09.031; Wang Q, 2008, DEV DYNAM, V237, P51, DOI 10.1002/dvdy.21379; Webb GC, 2002, DIABETES, V51, P398, DOI 10.2337/diabetes.51.2.398; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	30	399	427	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					449	462		10.1016/j.cell.2009.05.035	http://dx.doi.org/10.1016/j.cell.2009.05.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665969	Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000268771900011
J	Claridge-Chang, A; Roorda, RD; Vrontou, E; Sjulson, L; Li, HY; Hirsh, J; Miesenbock, G				Claridge-Chang, Adam; Roorda, Robert D.; Vrontou, Eleftheria; Sjulson, Lucas; Li, Haiyan; Hirsh, Jay; Miesenboeck, Gero			Writing Memories with Light-Addressable Reinforcement Circuitry	CELL			English	Article							MUSHROOM BODY NEURONS; DROSOPHILA-MELANOGASTER; ADENYLATE-CYCLASE; OLFACTORY MEMORY; REMOTE-CONTROL; TERM-MEMORY; PREDICTION; OPERANT; PHOTOSTIMULATION; LOCALIZATION	Dopaminergic neurons are thought to drive learning by signaling changes in the expectations of salient events, such as rewards or punishments. Olfactory conditioning in Drosophila requires direct dopamine action on intrinsic mushroom body neurons, the likely storage sites of olfactory memories. Neither the cellular sources of the conditioning dopamine nor its precise postsynaptic targets are known. By optically controlling genetically circumscribed subsets of dopaminergic neurons in the behaving fly, we have mapped the origin of aversive reinforcement signals to the PPL1 cluster of 12 dopaminergic cells. PPL1 projections target restricted domains in the vertical lobes and heel of the mushroom body. Artificially evoked activity in a small number of identifiable cells thus suffices for programming behaviorally meaningful memories. The delineation of core reinforcement circuitry is an essential first step in dissecting the neural mechanisms that compute and represent valuations, store associations, and guide actions.	[Claridge-Chang, Adam; Roorda, Robert D.; Vrontou, Eleftheria; Sjulson, Lucas; Miesenboeck, Gero] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Li, Haiyan; Hirsh, Jay] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA	University of Oxford; University of Virginia	Miesenbock, G (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	gero.miesenboeck@dpag.ox.ac.uk		Miesenboeck, Gero/0000-0003-2940-3228; Claridge-Chang, Adam/0000-0002-4583-3650	Medical Research Council; National Institutes of Health; Office of Naval Research; Dana Foundation; European Molecular Biology Organization; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030601, R01DA017297] Funding Source: NIH RePORTER; Medical Research Council [G0701225, G0700888] Funding Source: researchfish; MRC [G0700888, G0701225] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); Dana Foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Trevor Sharp and Paul Overton for 5-HT measurements, Simon Reeve for experiments on rutabaga mutants, Richard Axel, Michael Bate, Ronald Davis, Andre Fiala, and Scott Waddell for fly strains, and Shankar Srinivas for access to a confocal microscope. This work was supported by grants from the Medical Research Council (G. M.), the National Institutes of Health (G. M. and J. H.), the Office of Naval Research (G. M.), the Dana Foundation (G. M.), and the European Molecular Biology Organization (E. V.).	ABRAMS TW, 1991, J NEUROSCI, V11, P2655; Akalal DBG, 2006, LEARN MEMORY, V13, P659, DOI 10.1101/lm.221206; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BERG HC, 2004, BIOL MED PHYS BIOMED, P1; Brembs B, 2002, SCIENCE, V296, P1706, DOI 10.1126/science.1069434; Brembs B, 2000, LEARN MEMORY, V7, P104, DOI 10.1101/lm.7.2.104; Brembs B, 2008, CURR BIOL, V18, P1168, DOI 10.1016/j.cub.2008.07.041; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; CONNOLLY JB, 1998, DROSOPHILA PRACTICAL, P265; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; DAVID CT, 1979, J EXP BIOL, V82, P389; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Holland J. H., 1986, MACHINE LEARNING ART; Houk JC, 1995, MODELS INFORMATION P, P249; Jennings KA, 2006, J NEUROSCI, V26, P8955, DOI 10.1523/JNEUROSCI.5356-05.2006; JOHNSON WA, 1989, GENE DEV, V3, P676, DOI 10.1101/gad.3.5.676; Kalman R. E, 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kanerva P., 1988, SPARSE DISTRIBUTED M; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; MONTAGUE PR, 1995, NATURE, V377, P725, DOI 10.1038/377725a0; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; SAMUEL AL, 1959, IBM J RES DEV, V3, P211, DOI 10.1147/rd.441.0206; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sjulson L, 2008, CHEM REV, V108, P1588, DOI 10.1021/cr078221b; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Wang YL, 2008, J NEUROSCI, V28, P4368, DOI 10.1523/JNEUROSCI.2958-07.2008; Worgotter F, 2005, NEURAL COMPUT, V17, P245, DOI 10.1162/0899766053011555; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	53	320	322	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					405	415		10.1016/j.cell.2009.08.034	http://dx.doi.org/10.1016/j.cell.2009.08.034			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837039	Green Accepted, Bronze			2022-12-24	WOS:000270857500022
J	Billeter, JC; Atallah, J; Krupp, JJ; Millar, JG; Levine, JD				Billeter, Jean-Christophe; Atallah, Jade; Krupp, Joshua J.; Millar, Jocelyn G.; Levine, Joel D.			Specialized cells tag sexual and species identity in Drosophila melanogaster	NATURE			English	Article							CUTICULAR HYDROCARBONS; BEHAVIORAL-RESPONSES; GENETIC-CONTROL; COURTSHIP; PHEROMONES; SUBGROUP; COMMUNICATION; MALES	Social interactions depend on individuals recognizing each other, and in this context many organisms use chemical signals to indicate species and sex(1). Cuticular hydrocarbon signals are used by insects, including Drosophila melanogaster, to distinguish conspecific individuals from others(1-3). These chemicals also contribute to intraspecific courtship and mating interactions(1-3). However, the possibility that sex and species identification are linked by common chemical signalling mechanisms has not been formally tested. Here we provide direct evidence that a single compound is used to communicate female identity among D. melanogaster, and to define a reproductive isolation barrier between D. melanogaster and sibling species. A transgenic manipulation eliminated cuticular hydrocarbons by ablating the oenocytes, specialized cells required for the expression of these chemical signals. The resulting oenocyte-less (oe(-)) females elicited the normal repertoire of courtship behaviours from males, but were actually preferred over wild-type females by courting males. In addition, wild-type males attempted to copulate with oe(-) males. Thus, flies lacking hydrocarbons are a sexual hyperstimulus. Treatment of virgin females with the aversive male pheromone cis-vaccenyl acetate (cVA) significantly delayed mating of oe(-) females compared to wild-type females. This difference was eliminated when oe(-) females were treated with a blend of cVA and the female aphrodisiac (7Z,11Z)-heptacosadiene (7,11-HD), showing that female aphrodisiac compounds can attenuate the effects of male aversive pheromones. 7,11-HD also was shown to have a crucial role in heterospecific encounters. Specifically, the species barrier was lost because males of other Drosophila species courted oe(-) D. melanogaster females, and D. simulans males consistently mated with them. Treatment of oe(-) females with 7,11-HD restored the species barrier, showing that a single compound can confer species identity. These results identify a common mechanism for sexual and species recognition regulated by cuticular hydrocarbons.	[Billeter, Jean-Christophe; Atallah, Jade; Krupp, Joshua J.; Levine, Joel D.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Millar, Jocelyn G.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of Toronto; University Toronto Mississauga; University of California System; University of California Riverside	Levine, JD (corresponding author), Univ Toronto, Dept Biol, 3359 Mississauga Rd, Mississauga, ON L5L 1C6, Canada.	joel.levine@utoronto.ca	Billeter, Jean-Christophe/G-5399-2012	Billeter, Jean-Christophe/0000-0001-7796-4068; Millar, Jocelyn/0000-0001-7639-9001	Swiss National Science Foundation; Canadian Institutes of Health Research; Canada Research Chair	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	We thank H. Pavlou for help with RNA collection; N. Gompel for sharing fly strains; and A. Dornan, S. Douglas, J. C. Hall, I. Dover, C. Kent, C. Kyriacou, K. Luoto, S. Goodwin, M. Ritchie, J. Schneider and M. Sokolowski for critical comments on the manuscript. J.-C. B. was supported by a fellowship for advanced researcher from the Swiss National Science Foundation. This work was supported by the Canadian Institutes of Health Research and Canada Research Chair grants awarded to J. D. L.	[Anonymous], 2014, PHEROMONES ANIMAL BE; ANTONY C, 1985, J CHEM ECOL, V11, P1617, DOI 10.1007/BF01012116; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; COBB M, 1990, ANIM BEHAV, V39, P1058, DOI 10.1016/S0003-3472(05)80778-X; COBB M, 1985, BEHAVIOUR, V95, P203, DOI 10.1163/156853985X00136; COWLING DE, 1981, ANIM BEHAV, V29, P924, DOI 10.1016/S0003-3472(81)80030-9; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Fan YL, 2003, NATURWISSENSCHAFTEN, V90, P121, DOI 10.1007/s00114-003-0402-y; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Hosken DJ, 2009, ANNU REV ENTOMOL, V54, P361, DOI 10.1146/annurev.ento.54.110807.090608; Imhof M, 1998, MOL ECOL, V7, P915, DOI 10.1046/j.1365-294x.1998.00382.x; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; JALLON JM, 1987, EVOLUTION, V41, P294, DOI 10.1111/j.1558-5646.1987.tb05798.x; Kent C, 2008, CURR BIOL, V18, P1384, DOI 10.1016/j.cub.2008.07.088; Krupp JJ, 2008, CURR BIOL, V18, P1373, DOI 10.1016/j.cub.2008.07.089; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; KYRIACOU CP, 1986, SCIENCE, V232, P494, DOI 10.1126/science.3083506; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; MANE SD, 1983, SCIENCE, V222, P419, DOI 10.1126/science.222.4622.419; Marcillac F, 2005, GENETICS, V171, P1617, DOI 10.1534/genetics.104.033159; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Savarit F, 1999, P NATL ACAD SCI USA, V96, P9015, DOI 10.1073/pnas.96.16.9015; Venken KJT, 2005, NAT REV GENET, V6, P167, DOI 10.1038/nrg1553; WHEELER DA, 1991, SCIENCE, V251, P1082, DOI 10.1126/science.1900131; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131	30	264	266	1	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					987	U250		10.1038/nature08495	http://dx.doi.org/10.1038/nature08495			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829381				2022-12-24	WOS:000270817700049
J	Reilly, LAO; Tai, L; Lee, L; Kruse, EA; Grabow, S; Fairlie, WD; Haynes, NM; Tarlinton, DM; Zhang, JG; Belz, GT; Smyth, MJ; Bouillet, P; Robb, L; Strasser, A				Reilly, Lorraine A. O'; Tai, Lin; Lee, Lily; Kruse, Elizabeth A.; Grabow, Stephanie; Fairlie, W. Douglas; Haynes, Nicole M.; Tarlinton, David M.; Zhang, Jian-Guo; Belz, Gabrielle T.; Smyth, Mark J.; Bouillet, Philippe; Robb, Lorraine; Strasser, Andreas			Membrane-bound Fas ligand only is essential for Fas-induced apoptosis	NATURE			English	Article							AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; DENDRITIC CELLS; DOWN-REGULATION; REGULATORS BIM; IMMUNE-SYSTEM; MICE; GENE; EXPRESSION; DEATH; ACTIVATION	Fas ligand (FasL), an apoptosis-inducing member of the TNF cytokine family, and its receptor Fas are critical for the shutdown of chronic immune responses(1-3) and prevention of autoimmunity(4,5). Accordingly, mutations in their genes cause severe lymphadenopathy and autoimmune disease in mice(6,7) and humans(8,9). FasL function is regulated by deposition in the plasma membrane and metalloprotease-mediated shedding(10,11). Here we generated gene-targeted mice that selectively lack either secreted FasL (sFasL) or membrane-bound FasL (mFasL) to resolve which of these forms is required for cell killing and to explore their hypothesized non-apoptotic activities. Mice lacking sFasL (FasL(Delta s/Delta s)) appeared normal and their T cells readily killed target cells, whereas T cells lacking mFasL (FasL(Delta m/Delta m)) could not kill cells through Fas activation. FasL(Delta m/Delta m) mice developed lymphadenopathy and hypergammaglobulinaemia, similar to FasL(gld/gld) mice, which express a mutant form of FasL that cannot bind Fas, but surprisingly, FasL(Delta m/Delta m) mice (on a C57BL/6 background) succumbed to systemic lupus erythematosus (SLE)-like autoimmune kidney destruction and histiocytic sarcoma, diseases that occur only rarely and much later in FasL(gld/gld) mice. These results demonstrate that mFasL is essential for cytotoxic activity and constitutes the guardian against lymphadenopathy, autoimmunity and cancer, whereas excess sFasL appears to promote autoimmunity and tumorigenesis through nonapoptotic activities.	[Reilly, Lorraine A. O'; Tai, Lin; Lee, Lily; Kruse, Elizabeth A.; Grabow, Stephanie; Fairlie, W. Douglas; Tarlinton, David M.; Zhang, Jian-Guo; Belz, Gabrielle T.; Bouillet, Philippe; Robb, Lorraine; Strasser, Andreas] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Kruse, Elizabeth A.; Grabow, Stephanie] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Haynes, Nicole M.; Smyth, Mark J.] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia	Walter & Eliza Hall Institute; University of Melbourne; Peter Maccallum Cancer Center	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.	strasser@wehi.edu.au	Strasser, Andreas/C-7581-2013; Lee, Lily/GWZ-7968-2022; Smyth, Mark J/H-8709-2014; Fairlie, Walter/M-8401-2015; Belz, Gabrielle T/C-9350-2013; Bouillet, Philippe/E-1241-2013	Strasser, Andreas/0000-0002-5020-4891; Smyth, Mark J/0000-0001-7098-7240; Fairlie, Walter/0000-0002-2498-1160; Belz, Gabrielle T/0000-0002-9660-9587; Bouillet, Philippe/0000-0002-9012-6058; Tarlinton, David/0000-0001-9928-686X	NHMRC [461221, 454569]; IRIISS [361646, 257502]; Victorian State Government; Leukemia and Lymphoma Society [7015]; NIH [CA043540-18, CA80188-6]; JDRF/NHMRC; Association for International Cancer Research; Charles and Sylvia Viertel Charitable Foundation; Leukemia Research Foundation; NATIONAL CANCER INSTITUTE [R01CA043540, R01CA080188] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); IRIISS; Victorian State Government; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF/NHMRC(Juvenile Diabetes Research FoundationNational Health and Medical Research Council (NHMRC) of Australia); Association for International Cancer Research; Charles and Sylvia Viertel Charitable Foundation; Leukemia Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Genentech, in particular A. Ashkenazi and S. Masters, for Fas-Fc fusion proteins. We also thank our colleagues at the Walter and Eliza Hall Institute of Medical Research ( Melbourne), G. Siciliano, N. Iannarella, J. Coughlin for animal care; J. Corbin for automated blood analysis; B. Helbert and C. Young for genotyping; S. Mihajlovic, E. Tsui, A. Hasanein, V. Babo and K. Weston for histological sections; A. Light and K. O'Donnell for help with antibody measurements; and S. Drake for help with cytokine quantification. We also thank J. Melny ( Royal Melbourne Hospital) for measuring anti-DNA antibody levels; A. Banerjee, S. Gerondakis and R. Gugasyan ( Burnet Medical Research Institute, Prahran) for antibodies and advice; J. Silke and L. Wong ( La Trobe University, Bundoora) for TNFa; P. Morgan for assistance with protein purification; and A. Silva and J. Sharkey for help with animal procedures ( Peter MacCallum Cancer Centre). This work was supported in part by the NHMRC ( programme numbers 461221 and 454569, a CJ Martin fellowship to N. M. H. and an RD Wright fellowship to L. A. O'R.). We also acknowledge support from the IRIISS ( grant numbers 361646 and 257502 to P. B.), the Victorian State Government ( an OIS grant), the Leukemia and Lymphoma Society ( SCOR grant number 7015), the NIH ( grant numbers CA043540-18 and CA80188-6), the JDRF/NHMRC, the Association for International Cancer Research, the Charles and Sylvia Viertel Charitable Foundation ( to P. B.) and the Leukemia Research Foundation.	Ahn JH, 2001, J BIOL CHEM, V276, P47100, DOI 10.1074/jbc.M107385200; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; Blott EJ, 2001, J CELL SCI, V114, P2405; Chen JJ, 1998, SCIENCE, V282, P1714, DOI 10.1126/science.282.5394.1714; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Fredrickson TN, 2000, ATLAS MOUSE HEMATOPA; FRITH CH, 1981, J GERONTOL, V36, P534, DOI 10.1093/geronj/36.5.534; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Hohlbaum AM, 2000, J EXP MED, V191, P1209, DOI 10.1084/jem.191.7.1209; Huang DCS, 1999, P NATL ACAD SCI USA, V96, P14871, DOI 10.1073/pnas.96.26.14871; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; Hutcheson J, 2008, IMMUNITY, V28, P206, DOI 10.1016/j.immuni.2007.12.015; Karray S, 2004, J IMMUNOL, V172, P2118, DOI 10.4049/jimmunol.172.4.2118; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; Kono D H, 1999, Curr Dir Autoimmun, V1, P72; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Naik S, 2003, BLOOD, V102, P601, DOI 10.1182/blood-2002-10-3186; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Oliveira JB, 2007, P NATL ACAD SCI USA, V104, P8953, DOI 10.1073/pnas.0702975104; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Phillips JM, 2007, DIABETES, V56, P634, DOI 10.2337/db06-0832; Pileri SA, 2002, HISTOPATHOLOGY, V41, P1, DOI 10.1046/j.1365-2559.2002.01418.x; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Schulte M, 2007, CELL DEATH DIFFER, V14, P1040, DOI 10.1038/sj.cdd.4402101; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Sun M, 2007, J IMMUNOL, V179, P4307, DOI 10.4049/jimmunol.179.7.4307; Suzuki I, 1998, J EXP MED, V187, P123, DOI 10.1084/jem.187.1.123; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Trambas CM, 2003, NAT IMMUNOL, V4, P399, DOI 10.1038/ni0503-399; WATANABE D, 1995, EMBO J, V14, P12, DOI 10.1002/j.1460-2075.1995.tb06970.x; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; Weant AE, 2008, IMMUNITY, V28, P218, DOI 10.1016/j.immuni.2007.12.014; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Xiao S, 2002, J BIOL CHEM, V277, P50907, DOI 10.1074/jbc.M206093200	41	287	302	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					659	U106		10.1038/nature08402	http://dx.doi.org/10.1038/nature08402			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19794494	Green Accepted			2022-12-24	WOS:000270302600042
J	Ho, CH; Lin, SH; Hu, HC; Tsay, YF				Ho, Cheng-Hsun; Lin, Shan-Hua; Hu, Heng-Cheng; Tsay, Yi-Fang			CHL1 Functions as a Nitrate Sensor in Plants	CELL			English	Article							PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; CALCIUM SENSORS; ROOT ARCHITECTURE; TRANSPORTER GENE; ARABIDOPSIS; REVEALS; EXPRESSION; GLUCOSE; NRT1.1	Ions serve as essential nutrients in higher plants and can also act as signaling molecules. Little is known about how plants sense changes in soil nutrient concentrations. Previous studies showed that T101-phosphorylated CHL1 is a high-affinity nitrate transporter, whereas T101-dephosphorylated CHL1 is a low-affinity transporter. In this study, analysis of an uptake- and sensing-decoupled mutant showed that the nitrate transporter CHL1 functions as a nitrate sensor. Primary nitrate responses in CHL1T101D and CHLT101A transgenic plants showed that phosphorylated and dephosphorylated CHL1 lead to a low- and high-level response, respectively. In vitro and in vivo studies showed that, in response to low nitrate concentrations, protein kinase CIPK23 can phosphorylate T101 of CHL1 to maintain a low- level primary response. Thus, CHL1 uses dual-affinity binding and a phosphorylation switch to sense a wide range of nitrate concentrations in the soil, thereby functioning as an ion sensor in higher plants. For a video summary of this article, see the PaperFlick file with the Supplemental Data available online.	[Ho, Cheng-Hsun; Tsay, Yi-Fang] Natl Def Med Ctr, Acad Sinica, Inst Mol Biol, Taiwan Int Grad Program, Taipei, Taiwan; [Ho, Cheng-Hsun; Tsay, Yi-Fang] Natl Def Med Ctr, Acad Sinica, Grad Inst Life Sci, Taiwan Int Grad Program, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; Academia Sinica - Taiwan; National Defense Medical Center	Tsay, YF (corresponding author), Natl Def Med Ctr, Acad Sinica, Inst Mol Biol, Taiwan Int Grad Program, Taipei, Taiwan.	yftsay@gate.sinica.edu.tw	Tsay, Yi-Fang/ABB-3662-2021	Tsay, Yi-Fang/0000-0003-4271-0687; Ho, Cheng-Hsun/0000-0002-0895-1914	Taiwan International Graduate Program; Institute of Molecular Biology, Academia Sinica, Taiwan; National Science Council [96-2628-B-001-017-MY3]	Taiwan International Graduate Program; Institute of Molecular Biology, Academia Sinica, Taiwan(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	We thank the Salk Institute Genomic Analysis Laboratory for the Arabidopsis T-DNA insertion mutants, Dr. Hsou-Min Li for the anti-T110 antibody, Dr. Nigel Crawford for critical reading, Lin-Yun Kuang from Transgenic Plant Core Laboratory for technique help, and Dr. Tom Barkas and Dr. Harry Wilson for English editing. This work was supported by the Taiwan International Graduate Program and grants from the Institute of Molecular Biology, Academia Sinica, Taiwan, and the National Science Council ( NSC 96-2628-B-001-017-MY3).	Alboresi A, 2005, PLANT CELL ENVIRON, V28, P500, DOI 10.1111/j.1365-3040.2005.01292.x; Almagro A, 2008, PLANT CELL, V20, P3289, DOI 10.1105/tpc.107.056788; Batistic O, 2004, PLANTA, V219, P915, DOI 10.1007/s00425-004-1333-3; Castaings L, 2009, PLANT J, V57, P426, DOI 10.1111/j.1365-313X.2008.03695.x; Cheng NH, 2004, J BIOL CHEM, V279, P2922, DOI 10.1074/jbc.M309084200; Cheong YH, 2007, PLANT J, V52, P223, DOI 10.1111/j.1365-313X.2007.03236.x; CRAWFORD NM, 1995, PLANT CELL, V7, P859, DOI 10.1105/tpc.7.7.859; De Angeli A, 2009, PHILOS T R SOC B, V364, P195, DOI 10.1098/rstb.2008.0128; DENG MD, 1989, PLANT PHYSIOL, V91, P304, DOI 10.1104/pp.91.1.304; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Forde BG, 2000, BBA-BIOMEMBRANES, V1465, P219, DOI 10.1016/S0005-2736(00)00140-1; Gong DM, 2004, PLANT PHYSIOL, V134, P919, DOI 10.1104/pp.103.037440; Hu HC, 2009, PLANT J, V57, P264, DOI 10.1111/j.1365-313X.2008.03685.x; Huang NC, 1999, PLANT CELL, V11, P1381, DOI 10.1105/tpc.11.8.1381; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; Li LG, 2006, P NATL ACAD SCI USA, V103, P12625, DOI 10.1073/pnas.0605129103; Li WB, 2007, PLANT PHYSIOL, V143, P425, DOI 10.1104/pp.106.091223; Little DY, 2005, P NATL ACAD SCI USA, V102, P13693, DOI 10.1073/pnas.0504219102; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Liu KH, 1999, PLANT CELL, V11, P865, DOI 10.1105/tpc.11.5.865; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; Munos S, 2004, PLANT CELL, V16, P2433, DOI 10.1105/tpc.104.024380; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; REDINBAUGH MG, 1993, PLANT PHYSIOL, V101, P1249, DOI 10.1104/pp.101.4.1249; REDINBAUGH MG, 1991, PHYSIOL PLANTARUM, V82, P640, DOI 10.1111/j.1399-3054.1991.tb02958.x; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; TSAY YF, 1993, CELL, V72, P705, DOI 10.1016/0092-8674(93)90399-B; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Walch-Liu P, 2005, PHOTOSYNTH RES, V83, P239, DOI 10.1007/s11120-004-2080-9; Walch-Liu P, 2008, PLANT J, V54, P820, DOI 10.1111/j.1365-313X.2008.03443.x; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wang RC, 1998, P NATL ACAD SCI USA, V95, P15134, DOI 10.1073/pnas.95.25.15134; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407	38	818	888	18	271	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1184	1194		10.1016/j.cell.2009.07.004	http://dx.doi.org/10.1016/j.cell.2009.07.004			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766570	Bronze			2022-12-24	WOS:000269923200018
J	Young, J; Walker, SM; Bomphrey, RJ; Taylor, GK; Thomas, ALR				Young, John; Walker, Simon M.; Bomphrey, Richard J.; Taylor, Graham K.; Thomas, Adrian L. R.			Details of Insect Wing Design and Deformation Enhance Aerodynamic Function and Flight Efficiency	SCIENCE			English	Article							LOCUST SCHISTOCERCA-GREGARIA; LEADING-EDGE VORTICES; FLAPPING FLIGHT; DESERT LOCUST; HOVERING FLIGHT; FORCES; PERFORMANCE; MORPHOLOGY; SIMULATION; KINEMATICS	Insect wings are complex structures that deform dramatically in flight. We analyzed the aerodynamic consequences of wing deformation in locusts using a three-dimensional computational fluid dynamics simulation based on detailed wing kinematics. We validated the simulation against smoke visualizations and digital particle image velocimetry on real locusts. We then used the validated model to explore the effects of wing topography and deformation, first by removing camber while keeping the same time-varying twist distribution, and second by removing camber and spanwise twist. The full-fidelity model achieved greater power economy than the uncambered model, which performed better than the untwisted model, showing that the details of insect wing topography and deformation are important aerodynamically. Such details are likely to be important in engineering applications of flapping flight.	[Walker, Simon M.; Bomphrey, Richard J.; Taylor, Graham K.; Thomas, Adrian L. R.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Young, John] Univ New S Wales, Australian Def Force Acad, Sch Informat Technol & Engn, Canberra, ACT 2600, Australia	University of Oxford; Australian Defense Force Academy; University of New South Wales Sydney	Thomas, ALR (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	adrian.thomas@zoo.ox.ac.uk	Young, John/G-5473-2011; Bomphrey, Richard/I-6272-2013; Taylor, Graham/A-5041-2010	Young, John/0000-0002-8671-990X; Bomphrey, Richard/0000-0002-4748-0510; 	Engineering and Physical Sciences Research Council (EPSRC) [GR/S23049/01]; European Research Council ( ERC) [FP7/2007-2013]; ERC [204513]; Merit Allocation Scheme on the National Facility of the Australian National Computing Infrastructure (NCI-NF); Rector of the University of New South Wales at the Australian Defense Force Academy; EPSRC; Research Councils UK Academic Fellow; Royal Society University Research Fellow; EPSRC [EP/H004025/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H004025/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council ( ERC)(European Research Council (ERC)European Commission); ERC(European Research Council (ERC)European Commission); Merit Allocation Scheme on the National Facility of the Australian National Computing Infrastructure (NCI-NF); Rector of the University of New South Wales at the Australian Defense Force Academy; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Research Councils UK Academic Fellow(UK Research & Innovation (UKRI)); Royal Society University Research Fellow(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The research leading to these results has received funding from the Engineering and Physical Sciences Research Council (EPSRC) under grant GR/S23049/01 to A. L. R. T. and from the European Research Council ( ERC) under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 204513 to G. K. T. J. Y. was supported by the Merit Allocation Scheme on the National Facility of the Australian National Computing Infrastructure (NCI-NF) and gratefully acknowledges the Rector of the University of New South Wales at the Australian Defense Force Academy for the award of a sabbatical scholarship to perform this work. R. J. B. holds an EPSRC Career Acceleration Fellowship. G. K. T. is a Research Councils UK Academic Fellow and Royal Society University Research Fellow. We gratefully acknowledge the EPSRC Instrument Loan Pool and thank N. J. Lawson for advice and the loan of equipment for the DPIV measurements.	Aono H, 2008, J EXP BIOL, V211, P239, DOI 10.1242/jeb.008649; Bomphrey RJ, 2006, J R SOC INTERFACE, V3, P311, DOI 10.1098/rsif.2005.0090; Bos FM, 2008, J FLUID MECH, V594, P341, DOI 10.1017/S0022112007009172; Du G, 2008, APPL MATH MECH-ENGL, V29, P731, DOI 10.1007/s10483-008-0605-9; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; Ishihara D, 2009, J EXP BIOL, V212, P1, DOI 10.1242/jeb.020404; Isogai K, 2004, AIAA J, V42, P2053, DOI 10.2514/1.6274; Liu H, 1998, J EXP BIOL, V201, P461; Ramamurti R, 2007, J EXP BIOL, V210, P881, DOI 10.1242/jeb.02704; Shyy W, 2007, AIAA J, V45, P2817, DOI 10.2514/1.33205; Sun M, 2004, J EXP BIOL, V207, P1887, DOI 10.1242/jeb.00969; Thomas ALR, 2004, J EXP BIOL, V207, P4299, DOI 10.1242/jeb.01262; Vandenberghe N, 2004, J FLUID MECH, V506, P147, DOI 10.1017/S0022112004008468; Vanella M, 2009, J EXP BIOL, V212, P95, DOI 10.1242/jeb.016428; Walker SM, 2009, J R SOC INTERFACE, V6, P735, DOI 10.1098/rsif.2008.0435; Walker SM, 2009, J R SOC INTERFACE, V6, P351, DOI 10.1098/rsif.2008.0245; Wang ZJ, 2008, J EXP BIOL, V211, P234, DOI 10.1242/jeb.013797; Wang ZJ, 2004, J EXP BIOL, V207, P449, DOI 10.1242/jeb.00739; Wootton RJ, 2000, J EXP BIOL, V203, P2921; WOOTTON RJ, 1992, ANNU REV ENTOMOL, V37, P113, DOI 10.1146/annurev.en.37.010192.000553; Young J, 2008, AIAA J, V46, P918, DOI 10.2514/1.31610	21	293	300	10	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 18	2009	325	5947					1549	1552		10.1126/science.1175928	http://dx.doi.org/10.1126/science.1175928			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762645	Green Published			2022-12-24	WOS:000269887900042
J	Hong, H; Takahashi, K; Ichisaka, T; Aoi, T; Kanagawa, O; Nakagawa, M; Okita, K; Yamanaka, S				Hong, Hyenjong; Takahashi, Kazutoshi; Ichisaka, Tomoko; Aoi, Takashi; Kanagawa, Osami; Nakagawa, Masato; Okita, Keisuke; Yamanaka, Shinya			Suppression of induced pluripotent stem cell generation by the p53-p21 pathway	NATURE			English	Article							SOMATIC-CELLS; MOUSE; P53; FIBROBLASTS; MYC	Induced pluripotent stem(iPS) cells can be generated from somatic cells by the introduction of Oct3/4 ( also known as Pou5f1), Sox2, Klf4 and c-Myc, in mouse(1-4) and in human(5-8). The efficiency of this process, however, is low(9). Pluripotency can be induced without c-Myc, but with even lower efficiency(10,11). A p53 (also known as TP53 in humans and Trp53 in mice) short-interfering RNA (siRNA) was recently shown to promote human iPS cell generation(12), but the specificity and mechanisms remain to be determined. Here we report that up to 10% of transduced mouse embryonic fibroblasts lacking p53 became iPS cells, even without the Myc retrovirus. The p53 deletion also promoted the induction of integration-free mouse iPS cells with plasmid transfection. Furthermore, in the p53-null background, iPS cells were generated from terminally differentiated T lymphocytes. The suppression of p53 also increased the efficiency of human iPS cell generation. DNA microarray analyses identified 34 p53-regulated genes that are common in mouse and human fibroblasts. Functional analyses of these genes demonstrate that the p53-p21 pathway serves as a barrier not only in tumorigenicity, but also in iPS cell generation.	[Hong, Hyenjong; Takahashi, Kazutoshi; Ichisaka, Tomoko; Aoi, Takashi; Nakagawa, Masato; Okita, Keisuke; Yamanaka, Shinya] Kyoto Univ, Inst Integrated Cell Mat Sci, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan; [Hong, Hyenjong; Nakagawa, Masato; Yamanaka, Shinya] Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto 6068507, Japan; [Ichisaka, Tomoko; Yamanaka, Shinya] Japan Sci & Technol Agcy, Yamanaka iPS Cell Special Project, Kawaguchi, Saitama 3320012, Japan; [Kanagawa, Osami] RIKEN Yokohama Inst, RIKEN Ctr Allergy & Immunol, Lab Autoimmune Regulat, Tsurumi Ku, Kanagawa 2300045, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); RIKEN; University of California System; University of California San Francisco; The J David Gladstone Institutes	Yamanaka, S (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan.	yamanaka@frontier.kyoto-u.ac.jp	Takahashi, Kazutoshi/ABE-5504-2020; Jeong, Wonjun/AAM-5937-2020	Takahashi, Kazutoshi/0000-0002-5329-8395; Okita, Keisuke/0000-0001-5806-1090	Leading Project of MEXT; JSPS and MEXT; Program for Promotion of Fundamental Studies in Health Sciences of NIBIO; Japanese Government ( MEXT); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100406] Funding Source: NIH RePORTER	Leading Project of MEXT; JSPS and MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences of NIBIO(National Institute of Biomedical Innovation); Japanese Government ( MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank D. Srivastava for critical reading of the manuscript; M. Narita, A. Okada, N. Takizawa, H. Miyachi and S. Kitano for technical assistance; and R. Kato, S. Takeshima, Y. Ohtsu and E. Nishikawa for administrative assistance. We also thank Y. Sasai and T. Tada for technical advices, T. Kitamura for Plat- E cells and pMXs retroviral vectors, R. Farese for RF8 ES cells, and B. Weinberg and W. Hahn for shRNA constructs. This study was supported in part by a grant from the Leading Project of MEXT, Grants-in-Aid for Scientific Research of JSPS and MEXT, and a grant from the Program for Promotion of Fundamental Studies in Health Sciences of NIBIO ( to S. Y.). H. H. is a research student under the Japanese Government ( MEXT).	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bowman T, 1996, GENE DEV, V10, P826, DOI 10.1101/gad.10.7.826; Cecchinelli B, 2006, CELL DEATH DIFFER, V13, P1994, DOI 10.1038/sj.cdd.4401933; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Shinmura K, 2007, ONCOGENE, V26, P2939, DOI 10.1038/sj.onc.1210085; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	23	977	1053	5	273	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1132	U95		10.1038/nature08235	http://dx.doi.org/10.1038/nature08235			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19668191	Green Submitted, Green Accepted			2022-12-24	WOS:000269314000039
J	Ma, WZ; Trusina, A; El-Samad, H; Lim, WA; Tang, C				Ma, Wenzhe; Trusina, Ala; El-Samad, Hana; Lim, Wendell A.; Tang, Chao			Defining Network Topologies that Can Achieve Biochemical Adaptation	CELL			English	Article							BACTERIAL CHEMOTAXIS; POSITIVE FEEDBACK; ESCHERICHIA-COLI; ROBUSTNESS; MOTIFS; CELLS; TRANSDUCTION; SENSITIVITY; CALCIUM; DESIGN	Many signaling systems show adaptation-the ability to reset themselves after responding to a stimulus. We computationally searched all possible three-node enzyme network topologies to identify those that could perform adaptation. Only two major core topologies emerge as robust solutions: a negative feedback loop with a buffering node and an incoherent feedforward loop with a proportioner node. Minimal circuits containing these topologies are, within proper regions of parameter space, sufficient to achieve adaptation. Morecomplex circuits that robustly perform adaptation all contain at least one of these topologies at their core. This analysis yields a design table highlighting a finite set of adaptive circuits. Despite the diversity of possible biochemical networks, it may be common to find that only a finite set of core topologies can execute a particular function. These design rules provide a framework for functionally classifying complex natural networks and a manual for engineering networks. For a video summary of this article, see the PaperFlick file with the Supplemental Data available online.	[Ma, Wenzhe; Trusina, Ala; El-Samad, Hana; Lim, Wendell A.; Tang, Chao] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Ma, Wenzhe; Tang, Chao] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Ma, Wenzhe; Trusina, Ala; Tang, Chao] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [El-Samad, Hana; Tang, Chao] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Peking University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu; chao.tang@ucsf.edu	Trusina, Ala/L-6069-2013; Ma, Wenzhe/N-3320-2017; trusina, ala/H-7312-2012	Trusina, Ala/0000-0003-1945-454X; Tang, Chao/0000-0003-1474-3705	National Science Foundation [DMR-0804183]; Ministry of Science and Technology of China; National Natural Science Foundation of China; Howard Hughes Medical Institute; Packard Foundation; NIH; NIH Nano-medicine Development Centers; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040] Funding Source: NIH RePORTER; Division Of Materials Research [0804183] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Packard Foundation(The David & Lucile Packard Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Nano-medicine Development Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank Caleb Bashor, Noah Helman, Morten Kloster, Ilya Nemenman, and Eduardo Sontag for helpful discussions, Angi Chau, Kai-Yeung Lau, Thomas Shimizu, and David Burkhardt for critical reading of the manuscript.W.M. acknowledges the support from the Li Foundation.A.T.acknowledges the support from the Sandler Family Supporting Foundation.This work was supported in part by the National Science Foundation (DMR-0804183) (C.T.), Ministry of Science and Technology of China (C.T.), the National Natural Science Foundation of China (C.T.), the Howard Hughes Medical Institute (W.A.L.), the Packard Foundation (W.A.L.), the NIH (W.A.L.), and the NIH Nano-medicine Development Centers (W.A.L.).	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Behar M, 2007, BIOPHYS J, V93, P806, DOI 10.1529/biophysj.107.107516; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; El-Samad H, 2002, J THEOR BIOL, V214, P17, DOI 10.1006/jtbi.2001.2422; Endres RG, 2006, P NATL ACAD SCI USA, V103, P13040, DOI 10.1073/pnas.0603101103; Francois P, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026009; GOLDBETER A, 1984, J BIOL CHEM, V259, P14441; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; IMAN RL, 1980, LATIN HYPERCUBE SAMP, P77; KIRSCH ML, 1993, J BIOL CHEM, V268, P18610; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; Mello BA, 2003, P NATL ACAD SCI USA, V100, P8223, DOI 10.1073/pnas.1330839100; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Rao CV, 2004, PLOS BIOL, V2, P239, DOI 10.1371/journal.pbio.0020049; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; Yang L, 2006, SYST CONTROL LETT, V55, P329, DOI 10.1016/j.sysconle.2005.08.009; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	28	588	610	8	138	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					760	773		10.1016/j.cell.2009.06.013	http://dx.doi.org/10.1016/j.cell.2009.06.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703401	Green Accepted, Bronze			2022-12-24	WOS:000269156100017
J	Gendrel, M; Rapti, G; Richmond, JE; Bessereau, JL				Gendrel, Marie; Rapti, Georgia; Richmond, Janet E.; Bessereau, Jean-Louis			A secreted complement-control-related protein ensures acetylcholine receptor clustering	NATURE			English	Article							ELEGANS NEUROMUSCULAR-JUNCTION; HIKARU GENKI PROTEIN; CAENORHABDITIS-ELEGANS; C-ELEGANS; LEVAMISOLE RESISTANCE; GLUTAMATE RECEPTORS; DROSOPHILA; SYSTEM; GENES; TRAFFICKING	Efficient neurotransmission at chemical synapses relies on spatial congruence between the presynaptic active zone, where synaptic vesicles fuse, and the postsynaptic differentiation, where neurotransmitter receptors concentrate. Diverse molecular systems have evolved to localize receptors at synapses, but in most cases, they rely on scaffolding proteins localized below the plasma membrane(1-3). A few systems have been suggested to control the synaptic localization of neurotransmitter receptors through extracellular interactions, such as the pentraxins that bind AMPA receptors and trigger their aggregation(4). However, it is not yet clear whether these systems have a central role in the organization of postsynaptic domains in vivo or rather provide modulatory functions(5). Here we describe an extracellular scaffold that is necessary to cluster acetylcholine receptors at neuromuscular junctions in the nematode Caenorhabditis elegans. It involves the ectodomain of the previously identified transmembrane protein LEV-10 (ref. 6) and a novel extracellular protein, LEV-9. LEV-9 is secreted by the muscle cells and localizes at cholinergic neuromuscular junctions. Acetylcholine receptors, LEV-9 and LEV-10 are interdependent for proper synaptic localization and physically interact based on biochemical evidence. Notably, the function of LEV-9 relies on eight complement control protein (CCP) domains. These domains, also called 'sushi domains', are usually found in proteins regulating complement activity in the vertebrate immune system(7). Because the complement system does not exist in protostomes, our results suggest that some of the numerous uncharacterized CCP proteins expressed in the mammalian brain might be directly involved in the organization of the synapse, independently from immune functions.	[Gendrel, Marie; Rapti, Georgia; Bessereau, Jean-Louis] ENS, Dept Biol, F-75005 Paris, France; [Gendrel, Marie; Rapti, Georgia; Bessereau, Jean-Louis] INSERM, U789, F-75005 Paris, France; [Richmond, Janet E.] Univ Illinois, Dept Biol, Chicago, IL 60607 USA	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bessereau, JL (corresponding author), ENS, Dept Biol, F-75005 Paris, France.	jlbesse@biologie.ens.fr	Rapti, Georgia/Q-9345-2019; Bessereau, Jean-Louis/M-2988-2017	Rapti, Georgia/0000-0003-4836-8640; Bessereau, Jean-Louis/0000-0002-3088-7621; Gendrel, Marie/0000-0002-0991-0479	Ministere de la Recherche; Association Francaise contre les Myopathies; Ministere de la Recherche fellow; INSERM Avenir; Agence Nationale de la Recherche [ANR-07-NEURO-032-01]; NIH [RO1 MH073156]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073156] Funding Source: NIH RePORTER	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Ministere de la Recherche fellow; INSERM Avenir(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank E. M. Jorgensen and D. Williams for the lev-9(ox171::Mos1) strain, M. Labouesse for the anti-VHA-5 antibodies, J. Rand for the anti-UNC-17 antibodies, A. Fire for the GFP vectors, the Caenorhabditis Genetic Center and W. R. Schafer for strains, I. Katic, M. Zhen and S. Marty for critical reading of the manuscript, and H. Gendrot and B. Mathieu for technical help. M. G. was supported by a fellowship from the Ministere de la Recherche and by the Association Francaise contre les Myopathies. G. R. is a Ministere de la Recherche fellow. This work was funded by an INSERM Avenir grant, the Agence Nationale de la Recherche (ANR-07-NEURO-032-01) and the Association Francaise contre les Myopathies. J. E. R. was supported by NIH RO1 MH073156.	Arlaud GJ, 2007, MOL IMMUNOL, V44, P3809, DOI 10.1016/j.molimm.2007.06.147; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; Bingle CD, 2008, TRENDS IMMUNOL, V29, P444, DOI 10.1016/j.it.2008.07.001; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Boulin T, 2008, P NATL ACAD SCI USA, V105, P18590, DOI 10.1073/pnas.0806933105; Boulin Thomas, 2006, WormBook, P1, DOI 10.1895/wormbook.1.106.1; BRENNER S, 1974, GENETICS, V77, P71; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Duerr JS, 2001, AM J PHYSIOL-CELL PH, V280, pC1616, DOI 10.1152/ajpcell.2001.280.6.C1616; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Fares H, 2001, GENETICS, V159, P133; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fleming JT, 1997, J NEUROSCI, V17, P5843; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Gally C, 2004, NATURE, V431, P578, DOI 10.1038/nature02893; Gally C, 2003, J NEUROSCI, V23, P2591; Hoshino M, 1999, DEV GENES EVOL, V209, P1, DOI 10.1007/s004270050221; Hoshino M, 1996, DEVELOPMENT, V122, P589; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Kneussel M, 2007, BIOL CELL, V99, P297, DOI 10.1042/BC20060120; LEWIS JA, 1980, GENETICS, V95, P905; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; Nonaka M, 2004, IMMUNOL REV, V198, P203, DOI 10.1111/j.0105-2896.2004.00118.x; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Qian H, 2008, FASEB J, V22, P3247, DOI 10.1096/fj.08-110502; Richmond Janet E, 2006, WormBook, P1, DOI 10.1895/wormbook.1.112.1; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; ROBERT VJ, METHODS IN PRESS, DOI DOI 10.1016/J.YMETH.2009.02.013; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Ruaud AF, 2006, DEVELOPMENT, V133, P2211, DOI 10.1242/dev.02392; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Soares DC, 2005, PROTEIN ENG DES SEL, V18, P379, DOI 10.1093/protein/gzi039; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Williams DC, 2005, GENETICS, V169, P1779, DOI 10.1534/genetics.104.038265; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244	41	80	91	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					992	U258		10.1038/nature08430	http://dx.doi.org/10.1038/nature08430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19794415				2022-12-24	WOS:000270817700050
J	Ng, SB; Turner, EH; Robertson, PD; Flygare, SD; Bigham, AW; Lee, C; Shaffer, T; Wong, M; Bhattacharjee, A; Eichler, EE; Bamshad, M; Nickerson, DA; Shendure, J				Ng, Sarah B.; Turner, Emily H.; Robertson, Peggy D.; Flygare, Steven D.; Bigham, Abigail W.; Lee, Choli; Shaffer, Tristan; Wong, Michelle; Bhattacharjee, Arindam; Eichler, Evan E.; Bamshad, Michael; Nickerson, Deborah A.; Shendure, Jay			Targeted capture and massively parallel sequencing of 12 human exomes	NATURE			English	Article							HUMAN GENOME; EXON CAPTURE; ALLELES; GENE	Genome-wide association studies suggest that common genetic variants explain only a modest fraction of heritable risk for common diseases, raising the question of whether rare variants account for a significant fraction of unexplained heritability(1,2). Although DNA sequencing costs have fallen markedly(3), they remain far from what is necessary for rare and novel variants to be routinely identified at a genome-wide scale in large cohorts. We have therefore sought to develop second-generation methods for targeted sequencing of all protein-coding regions ('exomes'), to reduce costs while enriching for discovery of highly penetrant variants. Here we report on the targeted capture and massively parallel sequencing of the exomes of 12 humans. These include eight HapMap individuals representing three populations(4), and four unrelated individuals with a rare dominantly inherited disorder, Freeman-Sheldon syndrome (FSS)(5). We demonstrate the sensitive and specific identification of rare and common variants in over 300 megabases of coding sequence. Using FSS as a proof-of-concept, we show that candidate genes for Mendelian disorders can be identified by exome sequencing of a small number of unrelated, affected individuals. This strategy may be extendable to diseases with more complex genetics through larger sample sizes and appropriate weighting of non-synonymous variants by predicted functional impact.	[Ng, Sarah B.; Turner, Emily H.; Robertson, Peggy D.; Flygare, Steven D.; Lee, Choli; Shaffer, Tristan; Wong, Michelle; Eichler, Evan E.; Nickerson, Deborah A.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Bigham, Abigail W.; Bamshad, Michael] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Bhattacharjee, Arindam] Agilent Technol, Santa Clara, CA 95051 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Agilent Technologies	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	sarahng@u.washington.edu; shendure@u.washington.edu	Shendure, Jay/AAU-3684-2021	Turner, Emily/0000-0001-9040-9229; Shendure, Jay/0000-0002-1516-1865	National Institutes of Health/National Heart Lung and Blood Institute; National Institutes of Health/National Human Genome Research Institute; National Institutes of Health/National Institute of Child Health and Human Development; Washington Research Foundation; Agency for Science, Technology and Research, Singapore; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094976] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004749] Funding Source: NIH RePORTER	National Institutes of Health/National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health/National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health/National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Washington Research Foundation; Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	For discussions or assistance with genotyping data, we thank P. Green, J. Akey, R. Patwardhan, G. Cooper, J. Kidd, D. Gordon, J. Smith, I. Stanaway and M. Rieder. For assistance with project management, computation, data management and submission, we thank E. Torskey, S. Thompson, T. Amburg, B. McNally, S. Hearsey, M. Shumway and L. Hillier. For Human1M-Duo genotype data on HapMap samples, we thank Illumina. Our work was supported in part by grants from the National Institutes of Health/National Heart Lung and Blood Institute, the National Institutes of Health/National Human Genome Research Institute, National Institutes of Health/National Institute of Child Health and Human Development, and the Washington Research Foundation. S. B. N. is supported by the Agency for Science, Technology and Research, Singapore. E. H. T. and A. W. B. are supported by a training fellowship from the National Institutes of Health/National Human Genome Research Institute. E. E. E. is an investigator of the Howard Hughes Medical Institute.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2008, GENOME RES, V18, P2016, DOI 10.1101/gr.081786.108; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; *NAT CTR BIOT INF, 2009, CONS CDS PROT SET; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Olson M, 2007, NAT METHODS, V4, P891, DOI 10.1038/nmeth1107-891; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yngvadottir B, 2009, AM J HUM GENET, V84, P224, DOI 10.1016/j.ajhg.2009.01.008	30	1414	1560	4	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					272	U153		10.1038/nature08250	http://dx.doi.org/10.1038/nature08250			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19684571	Green Accepted			2022-12-24	WOS:000269654600046
J	Shackleton, M; Quintana, E; Fearon, ER; Morrison, SJ				Shackleton, Mark; Quintana, Elsa; Fearon, Eric R.; Morrison, Sean J.			Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution	CELL			English	Article							ACUTE MYELOID-LEUKEMIA; TUMOR-INITIATING CELLS; BREAST-CANCER; MOUSE MODEL; IDENTIFICATION; PROGENITOR; RESISTANCE; MICE; DIFFERENTIATION; TRANSPLANTATION	The identification and characterization of cancer stem cells might lead to more effective treatments for some cancers by focusing therapy on the most malignant cells. To achieve this goal it will be necessary to determine which cancers follow a cancer stem cell model and which do not, to address technical issues related to tumorigenesis assays, and to test the extent to which cancer cell heterogeneity arises from genetic versus epigenetic differences.	[Shackleton, Mark; Quintana, Elsa; Morrison, Sean J.] Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Fearon, Eric R.; Morrison, Sean J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021; damiani, chiara/R-4256-2016	Morrison, Sean/0000-0003-1587-8329	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; FEARON ER, 1986, NEW ENGL J MED, V315, P15, DOI 10.1056/NEJM198607033150103; Feuring-Buske M, 2003, LEUKEMIA, V17, P760, DOI 10.1038/sj.leu.2402882; ILLMENSEE K, 1976, P NATL ACAD SCI USA, V73, P549, DOI 10.1073/pnas.73.2.549; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kennedy James A, 2007, Science, V318, P1722; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Hare T, 2006, CURR OPIN GENET DEV, V16, P92, DOI 10.1016/j.gde.2005.11.002; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.neu.0000316019.28421.95; Oravecz-Wilson KI, 2009, CANCER CELL, V16, P137, DOI 10.1016/j.ccr.2009.06.007; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shah NP, 2007, J CLIN INVEST, V117, P2562, DOI 10.1172/JCI30890; SIKIC BI, 2008, MOL BASIS CANC, P583; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	39	815	840	2	114	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 4	2009	138	5					822	829		10.1016/j.cell.2009.08.017	http://dx.doi.org/10.1016/j.cell.2009.08.017			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737509	Bronze			2022-12-24	WOS:000269564600007
J	Li, H; Collado, M; Villasante, A; Strati, K; Ortega, S; Canamero, M; Blasco, MA; Serrano, M				Li, Han; Collado, Manuel; Villasante, Aranzazu; Strati, Katerina; Ortega, Sagrario; Canamero, Marta; Blasco, Maria A.; Serrano, Manuel			The Ink4/Arf locus is a barrier for iPS cell reprogramming	NATURE			English	Article							EMBRYONIC STEM-CELLS; HUMAN FIBROBLASTS; DEFINED FACTORS; SOMATIC-CELLS; ONCOGENIC RAS; SENESCENCE; EXPRESSION; PLURIPOTENT; CANCER; INK4A/ARF	The mechanisms involved in the reprogramming of differentiated cells into induced pluripotent stem (iPS) cells by the three transcription factors Oct4 (also known as Pou5f1), Klf4 and Sox2 remain poorly understood1. The Ink4/Arf locus comprises the Cdkn2a Cdkn2b genes encoding three potent tumour suppressors, namely p16 Ink4a, p19 Arf and p15 Ink4b, which are basally expressed in differentiated cells and upregulated by aberrant mitogenic signals(2-4). Here we show that the locus is completely silenced in iPS cells, as well as in embryonic stem (ES) cells, acquiring the epigenetic marks of a bivalent chromatin domain, and retaining the ability to be reactivated after differentiation. Cell culture conditions during reprogramming enhance the expression of the Ink4/Arf locus, further highlighting the importance of silencing the locus to allow proliferation and reprogramming. Indeed, the three factors together repress the Ink4/Arf locus soon after their expression and concomitant with the appearance of the first molecular markers of 'stemness'. This downregulation also occurs in cells carrying the oncoprotein large-T, which functionally inactivates the pathways regulated by the Ink4/Arf locus, thus indicating that the silencing of the locus is intrinsic to reprogramming and not the result of a selective process. Genetic inhibition of the Ink4/Arf locus has a profound positive effect on the efficiency of iPS cell generation, increasing both the kinetics of reprogramming and the number of emerging iPS cell colonies. In murine cells, Arf, rather than Ink4a, is the main barrier to reprogramming by activation of p53 (encoded by Trp53) and p21 (encoded by Cdkn1a); whereas, in human fibroblasts, INK4a is more important than ARF. Furthermore, organismal ageing upregulates the Ink4/Arf locus(2,5) and, accordingly, reprogramming is less efficient in cells from old organisms, but this defect can be rescued by inhibiting the locus with a short hairpin RNA. All together, we conclude that the silencing of Ink4/Arf locus is rate-limiting for reprogramming, and its transient inhibition may significantly improve the generation of iPS cells.	[Li, Han; Collado, Manuel; Villasante, Aranzazu; Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, E-28029 Madrid, Spain; [Strati, Katerina; Blasco, Maria A.] Spanish Natl Canc Res Ctr CNIO, Telomeres & Telomerase Grp, E-28029 Madrid, Spain; [Ortega, Sagrario] Spanish Natl Canc Res Ctr CNIO, Transgen Mice Unit, E-28029 Madrid, Spain; [Canamero, Marta] Spanish Natl Canc Res Ctr CNIO, Comparat Pathol Unit, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Serrano, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, 3 Melchor Fernandez Almagro St, E-28029 Madrid, Spain.	mserrano@cnio.es	/AAI-3238-2021; Serrano, Manuel/H-2634-2015; Collado, Manuel/K-8140-2014; Strati, Katerina/GSN-2131-2022; Blasco, Maria A./M-1694-2014; Villasante, Aranzazu/A-9100-2017	Serrano, Manuel/0000-0001-7177-9312; Collado, Manuel/0000-0002-0330-0880; Strati, Katerina/0000-0002-2332-787X; Blasco, Maria A./0000-0002-4211-233X; Villasante, Aranzazu/0000-0001-7919-9670	Spanish Ministry of Science (MICINN).; 'Ramon y Cajal' contract (MICINN).; Regional Government of Madrid; European Union; European Research Council (ERC),; 'Marcelino Botin' Foundation	Spanish Ministry of Science (MICINN).(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); 'Ramon y Cajal' contract (MICINN).(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Madrid; European Union(European Commission); European Research Council (ERC),(European Research Council (ERC)European Commission); 'Marcelino Botin' Foundation	We thank S. Lowe and R. Agami for reagents. We are grateful to M. Munoz, O. Dominguez, D. Megias and H. Schonthaler. H. L. is the recipient of a 'Juan de la Cierva' contract from the Spanish Ministry of Science (MICINN). M. Co. is the recipient of a 'Ramon y Cajal' contract (MICINN). Work in the laboratory of M. S. is funded by the CNIO and by grants from the MICINN (SAF and CONSOLIDER), the Regional Government of Madrid, the European Union, the European Research Council (ERC), and the 'Marcelino Botin' Foundation.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; Hara E, 1996, MOL CELL BIOL, V16, P859; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Palmero I, 2001, METHOD ENZYMOL, V333, P247; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Savatier P, 1996, ONCOGENE, V12, P309; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2004, EXP GERONTOL, V39, P1751, DOI 10.1016/j.exger.2004.06.025; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Wei WY, 2001, MOL CELL BIOL, V21, P6748, DOI 10.1128/MCB.21.20.6748-6757.2001; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	31	738	767	1	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1136	U101		10.1038/nature08290	http://dx.doi.org/10.1038/nature08290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19668188	Green Accepted			2022-12-24	WOS:000269314000040
J	Zhang, W; Dunkle, JA; Cate, JHD				Zhang, Wen; Dunkle, Jack A.; Cate, Jamie H. D.			Structures of the Ribosome in Intermediate States of Ratcheting	SCIENCE			English	Article							TRANSFER-RNA TRANSLOCATION; MESSENGER-RNA; 70S RIBOSOME; TRANSLATION TERMINATION; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; HYBRID STATE; COMPLEX; MOVEMENT; BINDING	Protein biosynthesis on the ribosome requires repeated cycles of ratcheting, which couples rotation of the two ribosomal subunits with respect to each other, and swiveling of the head domain of the small subunit. However, the molecular basis for how the two ribosomal subunits rearrange contacts with each other during ratcheting while remaining stably associated is not known. Here, we describe x-ray crystal structures of the intact Escherichia coli ribosome, either in the apo-form (3.5 angstrom resolution) or with one (4.0 angstrom resolution) or two (4.0 angstrom resolution) anticodon stem-loop tRNA mimics bound, that reveal intermediate states of intersubunit rotation. In the structures, the interface between the small and large ribosomal subunits rearranges in discrete steps along the ratcheting pathway. Positioning of the head domain of the small subunit is controlled by interactions with the large subunit and with the tRNA bound in the peptidyl-tRNA site. The intermediates observed here provide insight into how tRNAs move into the hybrid state of binding that precedes the final steps of mRNA and tRNA translocation.	[Zhang, Wen; Dunkle, Jack A.; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Zhang, Wen; Dunkle, Jack A.; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zhang, W (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	jcate@lbl.gov	Classen, Scott/AAY-8176-2020; Dunkle, Jack/ABB-9713-2020; ZHANG, WEN/HHS-1997-2022	Dunkle, Jack/0000-0001-6252-0587; ZHANG, WEN/0000-0002-4973-1168	NIH [GM65050]; National Cancer Institute [CA92584]; National Center for Research Resources [RR-15301]; Department of Energy [DE-AC03 76SF00098, DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065050] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH (grant GM65050 to J.H.D.C., National Cancer Institute grant CA92584 for the SIBYLS and 8.3.1 beamlines at the ALS, and National Center for Research Resources grant RR-15301 for the Northeastern Collaborative Access Team beamlines at 24-ID at the APS) and by the Department of Energy (grants DE-AC03 76SF00098 for the 12.3.1 and 8.3.1 beamlines at the ALS and DE-AC02-06CH11357 for the APS).	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Berk V, 2006, P NATL ACAD SCI USA, V103, P15830, DOI 10.1073/pnas.0607541103; Borovinskaya MA, 2007, ACS CHEM BIOL, V2, P545, DOI 10.1021/cb700100n; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Cukras AR, 2005, J MOL BIOL, V349, P47, DOI 10.1016/j.jmb.2005.03.075; Ermolenko DN, 2007, NAT STRUCT MOL BIOL, V14, P493, DOI 10.1038/nsmb1243; Frank J, 2007, P NATL ACAD SCI USA, V104, P19671, DOI 10.1073/pnas.0708517104; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Hoang L, 2004, P NATL ACAD SCI USA, V101, P12439, DOI 10.1073/pnas.0405227101; Horan LH, 2007, P NATL ACAD SCI USA, V104, P4881, DOI 10.1073/pnas.0700762104; Johansen SK, 2006, MOL CELL, V23, P173, DOI 10.1016/j.molcel.2006.05.044; Joseph S, 1998, EMBO J, V17, P3478, DOI 10.1093/emboj/17.12.3478; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; LILL R, 1989, EMBO J, V8, P3933, DOI 10.1002/j.1460-2075.1989.tb08574.x; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Pan DL, 2007, MOL CELL, V25, P519, DOI 10.1016/j.molcel.2007.01.014; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840	28	191	196	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					1014	1017		10.1126/science.1175275	http://dx.doi.org/10.1126/science.1175275			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19696352	Green Accepted			2022-12-24	WOS:000269242800051
J	Lackner, LL; Horner, JS; Nunnari, J				Lackner, Laura L.; Horner, Jennifer S.; Nunnari, Jodi			Mechanistic Analysis of a Dynamin Effector	SCIENCE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; WD REPEAT PROTEIN; MITOCHONDRIAL FISSION; MEMBRANE FISSION; MAMMALIAN-CELLS; DIVISION; DNM1P; AMPHIPHYSIN; MORPHOLOGY; CURVATURE	Dynamin-related proteins (DRPs) can generate forces to remodel membranes. In cells, DRPs require additional proteins [DRP-associated proteins (DAPs)] to conduct their functions. To dissect the mechanistic role of a DAP, we used the yeast mitochondrial division machine as a model, which requires the DRP Dnm1, and two other proteins, Mdv1 and Fis1. Mdv1 played a postmitochondrial targeting role in division by specifically interacting and coassembling with the guanosine triphosphate-bound form of Dnm1. This regulated interaction nucleated and promoted the self-assembly of Dnm1 into helical structures, which drive membrane scission. The nucleation of DRP assembly probably represents a general regulatory strategy for this family of filament-forming proteins, similar to F-actin regulation.	[Lackner, Laura L.; Horner, Jennifer S.; Nunnari, Jodi] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Nunnari, J (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	jmnunnari@ucdavis.edu			NIH [R01GM062942, 1F32GM078749]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097432, F32GM078749, R01GM062942] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.N. is supported by NIH grant R01GM062942. L.L.L. is supported by NIH postdoctoral fellowship 1F32GM078749	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cerveny KL, 2007, DEV CELL, V12, P363, DOI 10.1016/j.devcel.2007.01.017; Cerveny KL, 2001, MOL BIOL CELL, V12, P309, DOI 10.1091/mbc.12.2.309; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fekkes P, 2000, J CELL BIOL, V151, P333, DOI 10.1083/jcb.151.2.333; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Jensen RE, 2000, MICROSC RES TECHNIQ, V51, P573, DOI 10.1002/1097-0029(20001215)51:6<573::AID-JEMT7>3.0.CO;2-2; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Karren MA, 2005, J CELL BIOL, V171, P291, DOI 10.1083/jcb.200506158; Lackner LL, 2009, BBA-MOL BASIS DIS, V1792, P1138, DOI 10.1016/j.bbadis.2008.11.011; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355; Youle RJ, 2005, DEV CELL, V8, P298, DOI 10.1016/j.devcel.2005.02.003	31	102	104	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					874	877		10.1126/science.1176921	http://dx.doi.org/10.1126/science.1176921			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AK	19679814	Green Accepted			2022-12-24	WOS:000269242400046
J	Rinehart, J; Maksimova, YD; Tanis, JE; Stone, KL; Hodson, CA; Zhang, JH; Risinger, M; Pan, WJ; Wu, DQ; Colangelo, CM; Forbush, B; Joiner, CH; Gulcicek, EE; Gallagher, PG; Lifton, RP				Rinehart, Jesse; Maksimova, Yelena D.; Tanis, Jessica E.; Stone, Kathryn L.; Hodson, Caleb A.; Zhang, Junhui; Risinger, Mary; Pan, Weijun; Wu, Dianqing; Colangelo, Christopher M.; Forbush, Biff; Joiner, Clinton H.; Gulcicek, Erol E.; Gallagher, Patrick G.; Lifton, Richard P.			Sites of Regulated Phosphorylation that Control K-Cl Cotransporter Activity	CELL			English	Article							CELL-VOLUME; NA-K-2CL COTRANSPORTER; SIGNALING NETWORKS; HUMAN-ERYTHROCYTES; KCL COTRANSPORT; ION-TRANSPORT; PROTEIN; KCC2; KINASE; NKCC1	Modulation of intracellular chloride concentration ([Cl-](i)) plays a fundamental role in cell volume regulation and neuronal response to GABA. Cl- exit via K-Cl cotransporters (KCCs) is a major determinant of [Cl-](I); however, mechanisms governing KCC activities are poorly understood. We identified two sites in KCC3 that are rapidly dephosphorylated in hypotonic conditions in cultured cells and human red blood cells in parallel with increased transport activity. Alanine substitutions at these sites result in constitutively active cotransport. These sites are highly phosphorylated in plasma membrane KCC3 in isotonic conditions, suggesting that dephosphorylation increases KCC3's intrinsic transport activity. Reduction of WNK1 expression via RNA interference reduces phosphorylation at these sites. Homologous sites are phosphorylated in all human KCCs. KCC2 is partially phosphorylated in neonatal mouse brain and dephosphorylated in parallel with KCC2 activation. These findings provide insight into regulation of [Cl-](i) and have implications for control of cell volume and neuronal function.	[Rinehart, Jesse; Hodson, Caleb A.; Zhang, Junhui; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA; [Maksimova, Yelena D.; Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Tanis, Jessica E.; Forbush, Biff] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Pan, Weijun; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Rinehart, Jesse; Stone, Kathryn L.; Colangelo, Christopher M.; Gulcicek, Erol E.; Lifton, Richard P.] Yale Univ, Yale Natl Heart Lung & Blood Inst, Prote Ctr, New Haven, CT 06511 USA; [Stone, Kathryn L.; Colangelo, Christopher M.; Gulcicek, Erol E.] Yale Univ, Keck Biotechnol Resource Lab, New Haven, CT 06511 USA; [Risinger, Mary; Joiner, Clinton H.] Univ Cincinnati, Coll Med, Div Hematol Oncol, Cincinnati Comprehens Sickle Cell Ctr, Cincinnati, OH 45229 USA; [Risinger, Mary; Joiner, Clinton H.] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Lifton, RP (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA.	richard.lifton@yale.edu		Colangelo, Christopher/0000-0002-0438-1395	National Heart, Lung, and Blood Institute (NHLBI) [N01HV-28186]; National Institute on Drug Abuse [1P30DA018343]; National Center for Research Resources (NCRR) [UL1 RR024139, 1S10RR024617-01, HL65448, DK62039]; Cincinnati Comprehensive Sickle Cell Center [U54HL07087, GM083340]; Leducq Transatlantic Network in Hypertension; Howard Hughes Medical Institute; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028186] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA132317, R01CA139395] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026707, S10RR024617, UL1RR024139] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065448, R01HL080706, U54HL070871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054597, R01GM083340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Cincinnati Comprehensive Sickle Cell Center; Leducq Transatlantic Network in Hypertension; Howard Hughes Medical Institute(Howard Hughes Medical Institute); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Terence Wu, Janet Crawford, Mary LoPresti, and Tom Abbott for their help and Christian Collin-Hansen and Angus Nairn for contributions to development of phosphoproteomics methods. This work was supported by National Heart, Lung, and Blood Institute (NHLBI) Proteomics Center N01HV-28186 and National Institute on Drug Abuse ( NIDA) 1P30DA018343, with instrumentation support from National Center for Research Resources (NCRR) UL1 RR024139 and 1S10RR024617-01 and HL65448 and DK62039 ( P. G. G.); Cincinnati Comprehensive Sickle Cell Center U54HL07087 ( C.H.J.) and GM083340 ( B. F.); and the Leducq Transatlantic Network in Hypertension ( R. P. L.). R. P. L. is an investigator of the Howard Hughes Medical Institute.	Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; ALTAMIRANO AA, 1988, AM J PHYSIOL, V254, pC582, DOI 10.1152/ajpcell.1988.254.4.C582; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; BRUGNARA C, 1987, AM J PHYSIOL, V252, pC269, DOI 10.1152/ajpcell.1987.252.3.C269; BRUGNARA C, 1986, SCIENCE, V232, P388, DOI 10.1126/science.3961486; BRUGNARA C, 1993, BRIT J HAEMATOL, V84, P118, DOI 10.1111/j.1365-2141.1993.tb03034.x; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; de los Heros P, 2006, P NATL ACAD SCI USA, V103, P1976, DOI 10.1073/pnas.0510947103; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; DUNHAM PB, 1980, P NATL ACAD SCI-BIOL, V77, P1711, DOI 10.1073/pnas.77.3.1711; Eaton W A, 1990, Adv Protein Chem, V40, P63, DOI 10.1016/S0065-3233(08)60287-9; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Gagnon KBE, 2007, CELL PHYSIOL BIOCHEM, V20, P131, DOI 10.1159/000104161; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; JENNINGS ML, 1991, J GEN PHYSIOL, V97, P799, DOI 10.1085/jgp.97.4.799; Joiner CH, 2007, BLOOD, V109, P1728, DOI 10.1182/blood-2006-04-018630; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Lew VL, 2005, PHYSIOL REV, V85, P179, DOI 10.1152/physrev.00052.2003; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; LYTLE C, 1992, J BIOL CHEM, V267, P25438; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Rinehart J, 2005, P NATL ACAD SCI USA, V102, P16777, DOI 10.1073/pnas.0508303102; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Shifman MA, 2007, J PROTEOME RES, V6, P4019, DOI 10.1021/pr070325f; Strange K, 2006, PHYSIOLOGY, V21, P61, DOI 10.1152/physiol.00139.2005; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Wagner S, 1997, NATURE, V387, P598, DOI 10.1038/42468; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471	43	211	213	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					525	536		10.1016/j.cell.2009.05.031	http://dx.doi.org/10.1016/j.cell.2009.05.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665974	Bronze, Green Accepted			2022-12-24	WOS:000268771900017
J	Jain, S; Kamimoto, L; Bramley, AM; Schmitz, AM; Benoit, SR; Louie, J; Sugerman, DE; Druckenmiller, JK; Ritger, KA; Chugh, R; Jasuja, S; Deutscher, M; Chen, S; Walker, JD; Duchin, JS; Lett, S; Soliva, S; Wells, EV; Swerdlow, D; Uyeki, TM; Fiore, AE; Olsen, SJ; Fry, AM; Bridges, CB; Finelli, L				Jain, Seema; Kamimoto, Laurie; Bramley, Anna M.; Schmitz, Ann M.; Benoit, Stephen R.; Louie, Janice; Sugerman, David E.; Druckenmiller, Jean K.; Ritger, Kathleen A.; Chugh, Rashmi; Jasuja, Supriya; Deutscher, Meredith; Chen, Sanny; Walker, John D.; Duchin, Jeffrey S.; Lett, Susan; Soliva, Susan; Wells, Eden V.; Swerdlow, David; Uyeki, Timothy M.; Fiore, Anthony E.; Olsen, Sonja J.; Fry, Alicia M.; Bridges, Carolyn B.; Finelli, Lyn		2009 Pandemic Influenza H1N1 Virus	Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREGNANT-WOMEN; VIRUS-INFECTION; CHILDREN; COMPLICATIONS; SURVEILLANCE; ADMISSIONS; CALIFORNIA; MORTALITY; VACCINES; HUMANS	Background: During the spring of 2009, a pandemic influenza A (H1N1) virus emerged and spread globally. We describe the clinical characteristics of patients who were hospitalized with 2009 H1N1 influenza in the United States from April 2009 to mid-June 2009. Methods: Using medical charts, we collected data on 272 patients who were hospitalized for at least 24 hours for influenza-like illness and who tested positive for the 2009 H1N1 virus with the use of a real-time reverse-transcriptase-polymerase-chain-reaction assay. Results: Of the 272 patients we studied, 25% were admitted to an intensive care unit and 7% died. Forty-five percent of the patients were children under the age of 18 years, and 5% were 65 years of age or older. Seventy-three percent of the patients had at least one underlying medical condition; these conditions included asthma; diabetes; heart, lung, and neurologic diseases; and pregnancy. Of the 249 patients who underwent chest radiography on admission, 100 (40%) had findings consistent with pneumonia. Of the 268 patients for whom data were available regarding the use of antiviral drugs, such therapy was initiated in 200 patients (75%) at a median of 3 days after the onset of illness. Data suggest that the use of antiviral drugs was beneficial in hospitalized patients, especially when such therapy was initiated early. Conclusions: During the evaluation period, 2009 H1N1 influenza caused severe illness requiring hospitalization, including pneumonia and death. Nearly three quarters of the patients had one or more underlying medical conditions. Few severe illnesses were reported among persons 65 years of age or older. Patients seemed to benefit from antiviral therapy. N Engl J Med 2009;361:1935-44.	[Jain, Seema; Kamimoto, Laurie; Bramley, Anna M.; Sugerman, David E.; Uyeki, Timothy M.; Fiore, Anthony E.; Olsen, Sonja J.; Fry, Alicia M.; Bridges, Carolyn B.; Finelli, Lyn] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Schmitz, Ann M.] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Natl Ctr Zoonot Vector Borne & Enter Dis, Atlanta, GA 30333 USA; [Benoit, Stephen R.] Ctr Dis Control & Prevent, Div Emergency Preparedness & Response, Natl Ctr Publ Hlth Informat, Atlanta, GA 30333 USA; [Deutscher, Meredith; Chen, Sanny; Swerdlow, David] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA 30333 USA; [Deutscher, Meredith] Ctr Dis Control & Prevent, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Louie, Janice] Calif Dept Publ Hlth, Richmond, CA USA; [Swerdlow, David] San Diego Cty Hlth & Human Serv, San Diego, CA USA; [Druckenmiller, Jean K.] Wisconsin Div Publ Hlth, Madison, WI USA; [Ritger, Kathleen A.] Chicago Dept Publ Hlth, Chicago, IL USA; [Chugh, Rashmi] DuPage Cty Hlth Dept, Wheaton, IL USA; [Jasuja, Supriya] Cook Cty Dept Publ Hlth, Oak Pk, IL USA; [Chen, Sanny] Arizona Dept Publ Hlth, Phoenix, AZ USA; [Walker, John D.] Texas Dept State Hlth Serv, Austin, TX USA; [Duchin, Jeffrey S.] Publ Health Seattle & King Cty, Seattle, WA USA; [Lett, Susan; Soliva, Susan] Massachusetts Dept Hlth, Jamaica Plain, MA USA; [Wells, Eden V.] Michigan Dept Community Hlth, Lansing, MI USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; California Department of Public Health; Chicago Department of Public Health; Texas Department of State Health Services; MDHHS - Michigan Department of Health & Human Services	Jain, S (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,MS A-32, Atlanta, GA 30333 USA.	bwc8@cdc.gov	Finelli, Lyn/AAK-2360-2020; Fiore, Anthony/AAO-8956-2020	Cocoros, Noelle/0000-0001-7090-2761; Meites, Elissa/0000-0002-0077-2591; Kainer, Marion/0000-0001-7678-8744; Read, Robert/0000-0002-4297-6728; Biggerstaff, Matthew/0000-0001-5108-8311	Influenza Division; Office of Workforce and Career Development	Influenza Division; Office of Workforce and Career Development(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported by the Influenza Division and Office of Workforce and Career Development at the CDC.	Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; [Anonymous], UPD INT REC US ANT M; [Anonymous], MMWR MORB MORTAL WKL; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P536; [Anonymous], 2009, HARRIET LANE HDB; CATE TR, 1977, J INFECT DIS, V136, pS518, DOI 10.1093/infdis/136.Supplement_3.S518; Centers for Disease Control and Prevention, FLUVIEW WEEKL INFL S; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; DOLIN R, 1977, J INFECT DIS, V136, pS435, DOI 10.1093/infdis/136.Supplement_3.S435; Finelli L, 2008, PEDIATRICS, V122, P805, DOI 10.1542/peds.2008-1336; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Keren R, 2005, JAMA-J AM MED ASSOC, V294, P2188, DOI 10.1001/jama.294.17.2188; LOURIA DB, 1959, J CLIN INVEST, V38, P213, DOI 10.1172/JCI103789; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Moore DL, 2006, PEDIATRICS, V118, pE610, DOI 10.1542/peds.2005-2744; Neuzil KM, 2003, CLIN INFECT DIS, V37, P201, DOI 10.1086/375604; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Nicholson K G, 1992, Semin Respir Infect, V7, P26; *NOV SWIN OR INFL, 2009, NEW ENGL J MED, V361, P102; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Schrag SJ, 2006, PEDIATR INFECT DIS J, V25, P395, DOI 10.1097/01.inf.0000214988.81379.71; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Walsh EE, 2002, J AM GERIATR SOC, V50, P1498, DOI 10.1046/j.1532-5415.2002.50404.x; World Health Organization, PAND H1N1 2009 UPD 6 PAND H1N1 2009 UPD 6; 2008, MMWR RECOMM REP, V57, P1	34	1278	1375	3	157	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2009	361	20					1935	1944		10.1056/NEJMoa0906695	http://dx.doi.org/10.1056/NEJMoa0906695			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518AI	19815859				2022-12-24	WOS:000271660500007
J	Varga, V; Losonczy, A; Zemelman, BV; Borhegyi, Z; Nyiri, G; Domonkos, A; Hangya, B; Holderith, N; Magee, JC; Freund, TF				Varga, Viktor; Losonczy, Attila; Zemelman, Boris V.; Borhegyi, Zsolt; Nyiri, Gabor; Domonkos, Andor; Hangya, Balazs; Holderith, Noemi; Magee, Jeffrey C.; Freund, Tamas F.			Fast Synaptic Subcortical Control of Hippocampal Circuits	SCIENCE			English	Article							RAPHE NEURONS; MODULATION; DIVERSITY; RESPONSES; CONTAIN; RHYTHM	Cortical information processing is under state-dependent control of subcortical neuromodulatory systems. Although this modulatory effect is thought to be mediated mainly by slow nonsynaptic metabotropic receptors, other mechanisms, such as direct synaptic transmission, are possible. Yet, it is currently unknown if any such form of subcortical control exists. Here, we present direct evidence of a strong, spatiotemporally precise excitatory input from an ascending neuromodulatory center. Selective stimulation of serotonergic median raphe neurons produced a rapid activation of hippocampal interneurons. At the network level, this subcortical drive was manifested as a pattern of effective disynaptic GABAergic inhibition that spread throughout the circuit. This form of subcortical network regulation should be incorporated into current concepts of normal and pathological cortical function.	[Varga, Viktor; Borhegyi, Zsolt; Nyiri, Gabor; Domonkos, Andor; Hangya, Balazs; Holderith, Noemi; Freund, Tamas F.] Inst Expt Med, H-1083 Budapest, Hungary; [Losonczy, Attila; Zemelman, Boris V.; Magee, Jeffrey C.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Howard Hughes Medical Institute	Varga, V (corresponding author), Inst Expt Med, H-1083 Budapest, Hungary.	vargav@koki.hu; losonczya@janelia.hhmi.org	Hangya, Balazs/H-5964-2019; Domonkos, Andor/ABF-8641-2020; Borhegyi, Zsolt/G-2152-2010	Hangya, Balazs/0000-0003-2709-7407; Domonkos, Andor/0000-0002-0007-5948; Borhegyi, Zsolt/0000-0001-5556-8742; Zemelman, Boris/0000-0003-2463-4887; Nyiri, Gabor/0000-0002-4247-0356	NIH [NIH-MH-54671]; Howard Hughes Medical Institute [HHMI55005608]; Hungarian Scientific Research Fund [OTKA K-60927, NKTH-OTKA CNK 77793]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	We thank A. Lee and B. Kocsis for their comments on the manuscript. We thank L. Acsady and B. K. Andrasfalvy for helping to establish the collaboration between V. V. and A. L. We thank B. Shields, K. Lengyel, and G. Goda for technical assistance. V. V. and G. N. were Janos Bolyai Research Fellows. This work was supported by grants from the NIH (NIH-MH-54671), Howard Hughes Medical Institute (HHMI55005608), and Hungarian Scientific Research Fund (OTKA K-60927 and NKTH-OTKA CNK 77793). Author contributions V. V., A. L., J. C. M, and T. F. F. conceived the experiments. V. V. conducted the in vivo physiological experiments with the help of A. D. B. V. Z performed the molecular experiments. A. L. performed the in vitro experiments. Z. B. and G. N performed most of the histological experiments. N. H. performed the in vitro experiments for the specificity of the NBQX effect. V. V. and A. L. analyzed most of the physiological data except firing pattern analysis carried out by B. H. A. L., V. V., B. V. Z., J. C. M., and T. F. F. wrote the paper.	Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; FREUND TF, 1990, P NATL ACAD SCI USA, V87, P8501, DOI 10.1073/pnas.87.21.8501; Gras C, 2002, J NEUROSCI, V22, P5442; Hensler JG, 2006, NEUROSCI BIOBEHAV R, V30, P203, DOI 10.1016/j.neubiorev.2005.06.007; Hirase H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-10-j0003.2001; Jackson J, 2009, SYNAPSE, V63, P31, DOI 10.1002/syn.20581; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Kandel E., 2000, PRINCIPLES NEURAL SC; Kocsis B, 2006, P NATL ACAD SCI USA, V103, P1059, DOI 10.1073/pnas.0508360103; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Moita MAP, 2003, NEURON, V37, P485, DOI 10.1016/S0896-6273(03)00033-3; Mueller N, 2007, MOL PSYCHIATR, V12, P988, DOI 10.1038/sj.mp.4002006; Nitz DA, 1999, LEARN MEMORY, V6, P153; Paz RD, 2008, EUR NEUROPSYCHOPHARM, V18, P773, DOI 10.1016/j.euroneuro.2008.06.005; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Somogyi J, 2004, EUR J NEUROSCI, V19, P552, DOI 10.1111/j.0953-816X.2003.03091.x; Vertes RP, 1999, J COMP NEUROL, V407, P555; VERTES RP, 1981, J NEUROPHYSIOL, V46, P1140, DOI 10.1152/jn.1981.46.5.1140	20	177	178	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					449	453		10.1126/science.1178307	http://dx.doi.org/10.1126/science.1178307			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833972				2022-12-24	WOS:000270818600060
J	Kellermann, V; van Heerwaarden, B; Sgro, CM; Hoffmann, AA				Kellermann, Vanessa; van Heerwaarden, Belinda; Sgro, Carla M.; Hoffmann, Ary A.			Fundamental Evolutionary Limits in Ecological Traits Drive Drosophila Species Distributions	SCIENCE			English	Article							RAIN-FOREST DROSOPHILA; ADDITIVE GENETIC VARIANCE; NATURAL-POPULATIONS; STRESS RESISTANCE; TOLERANCE; DESICCATION; ADAPTATION; VARIABILITY; STARVATION; SELECTION	Species that are habitat specialists make up much of biodiversity, but the evolutionary factors that limit their distributions have rarely been considered. We show that in Drosophila, narrow and wide ranges of desiccation and cold resistance are closely associated with the distributions of specialist and generalist species, respectively. Furthermore, our data show that narrowly distributed tropical species consistently have low means and low genetic variation for these traits as compared with those of widely distributed species after phylogenetic correction. These results are unrelated to levels of neutral variation. Thus, specialist species may simply lack genetic variation in key traits, limiting their ability to adapt to conditions beyond their current range. We predict that such species are likely to be constrained in their evolutionary responses to future climate changes.	[van Heerwaarden, Belinda; Sgro, Carla M.] Monash Univ, Sch Biol Sci, Ctr Environm Stress & Adaptat Res, Melbourne, Vic 3800, Australia; [Hoffmann, Ary A.] Univ Melbourne, Dept Genet, Ctr Environm Stress & Adaptat Res, Dept Zool, Melbourne, Vic 3010, Australia	Monash University; University of Melbourne	Kellermann, V (corresponding author), Univ Melbourne, Dept Genet, Ctr Environm Stress & Adaptat Res, Dept Zool, Melbourne, Vic 3010, Australia.	vanessa.kellermann@biology.au.dk	Sgro, Carla/A-2495-2010; Hoffmann, Ary/C-2961-2011; Hoffmann, Ary/R-2972-2019; van Heerwaarden, Belinda/A-4515-2012; Sgro, Carla M/G-5166-2010; Kellermann, Vanessa/C-3908-2011	Hoffmann, Ary/0000-0001-9497-7645; Kellermann, Vanessa/0000-0002-9859-9642; van Heerwaarden, Belinda/0000-0003-2435-2900	Australian Research Council; Commonwealth Environmental Research Fund	Australian Research Council(Australian Research Council); Commonwealth Environmental Research Fund	We thank the Australian Research Council and the Commonwealth Environmental Research Fund for financial support. We also thank M. Blacket for molecular work; A. Miller for assistance with the phylogenetic analysis; K. Mitchell, C. Doig, T. Kristensen, J. Overgaard, L. Carrington, K. Lein, and X. Du for technical support; and reviewers for constructive comments.	Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Blows MW, 2005, ECOLOGY, V86, P1371, DOI 10.1890/04-1209; BLOWS MW, 1993, EVOLUTION, V47, P1255, DOI 10.1111/j.1558-5646.1993.tb02151.x; BRADSHAW AD, 1991, PHILOS T R SOC B, V333, P289, DOI 10.1098/rstb.1991.0079; Chown SL, 2002, COMP BIOCHEM PHYS B, V131, P587, DOI 10.1016/S1096-4959(02)00017-9; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; FUTUYMA DJ, 1995, EVOLUTION, V49, P797, DOI 10.1111/j.1558-5646.1995.tb02316.x; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gibert P, 2001, EVOLUTION, V55, P1063, DOI 10.1554/0014-3820(2001)055[1063:CCTAMC]2.0.CO;2; Gomez-Valero L, 2007, GENOME RES, V17, P1178, DOI 10.1101/gr.6360207; Harrison PM, 2002, J MOL BIOL, V318, P1155, DOI 10.1016/S0022-2836(02)00109-2; Hoffmann AA, 2003, SCIENCE, V301, P100, DOI 10.1126/science.1084296; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; HOFFMANN AA, 1993, J EVOLUTION BIOL, V6, P643, DOI 10.1046/j.1420-9101.1993.6050643.x; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Kellermann VM, 2006, EVOLUTION, V60, P1104, DOI 10.1554/05-710.1; KIMURA MT, 1994, J NAT HIST, V28, P401, DOI 10.1080/00222939400770181; Kimura MT, 2004, OECOLOGIA, V140, P442, DOI 10.1007/s00442-004-1605-4; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; LANDE R, 1975, GENET RES, V26, P221, DOI 10.1017/S0016672300016037; Matzkin LM, 2009, FUNCT ECOL, V23, P521, DOI 10.1111/j.1365-2435.2008.01533.x; Merila J, 2001, GENETICA, V112, P199, DOI 10.1023/A:1013391806317; PARSONS PA, 1982, EVOL BIOL, V14, P297; van Heerwaarden B, 2008, GENETICS, V179, P2135, DOI 10.1534/genetics.107.082768; van Heerwaarden B, 2009, P ROY SOC B-BIOL SCI, V276, P1517, DOI 10.1098/rspb.2008.1288; vanHerrewege J, 1997, ECOSCIENCE, V4, P151, DOI 10.1080/11956860.1997.11682389	27	321	324	3	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 4	2009	325	5945					1244	1246		10.1126/science.1175443	http://dx.doi.org/10.1126/science.1175443			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729654				2022-12-24	WOS:000269523200037
J	Shimono, Y; Zabala, M; Cho, RW; Lobo, N; Dalerba, P; Qian, DL; Diehn, M; Liu, HP; Panula, SP; Chiao, E; Dirbas, FM; Somlo, G; Pera, RAR; Lao, KQ; Clarke, MF				Shimono, Yohei; Zabala, Maider; Cho, Robert W.; Lobo, Neethan; Dalerba, Piero; Qian, Dalong; Diehn, Maximilian; Liu, Huiping; Panula, Sarita P.; Chiao, Eric; Dirbas, Frederick M.; Somlo, George; Pera, Renee A. Reijo; Lao, Kaiqin; Clarke, Michael F.			Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells	CELL			English	Article							SELF-RENEWAL; MESENCHYMAL TRANSITION; MIR-200 FAMILY; HUMAN TUMORS; EXPRESSION; DICER; IDENTIFICATION; PROLIFERATION; SIGNATURE; MICRORNAS	Human breast tumors contain a breast cancer stem cell (BCSC) population with properties reminiscent of normal stem cells. We found 37 microRNAs that were differentially expressed between human BCSCs and nontumorigenic cancer cells. Three clusters, miR-200c-141, miR-200b-200a-429, and miR-18396-182 were downregulated in human BCSCs, normal human and murine mammary stem/progenitor cells, and embryonal carcinoma cells. Expression of BMI1, a known regulator of stem cell self-renewal, was modulated by miR-200c. miR-200c inhibited the clonal expansion of breast cancer cells and suppressed the growth of embryonal carcinoma cells in vitro. Most importantly, miR-200c strongly suppressed the ability of normal mammary stem cells to form mammary ducts and tumor formation driven by human BCSCs in vivo. The coordinated downregulation of three microRNA clusters and the similar functional regulation of clonal expansion by miR-200c provide a molecular link that connects BCSCs with normal stem cells.	[Shimono, Yohei; Zabala, Maider; Cho, Robert W.; Lobo, Neethan; Dalerba, Piero; Qian, Dalong; Diehn, Maximilian; Liu, Huiping; Panula, Sarita P.; Chiao, Eric; Pera, Renee A. Reijo; Clarke, Michael F.] Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94304 USA; [Dirbas, Frederick M.] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Somlo, George] City Hope Canc Ctr, Duarte, CA 91010 USA; [Lao, Kaiqin] Appl Biosyst Inc, Foster City, CA 94404 USA	Stanford University; Stanford University; City of Hope; Thermo Fisher Scientific; Applied Biosystems	Clarke, MF (corresponding author), Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, 1050 Arastradero Rd, Palo Alto, CA 94304 USA.	mfclarke@stanford.edu	Dalerba, Piero/E-2543-2018	Dalerba, Piero/0000-0002-8815-4981; Shimono, Yohei/0000-0002-6256-4704; Liu, Huiping/0000-0003-4822-7995; Diehn, Maximilian/0000-0003-2032-0581	California Breast Cancer Research Program of the University of California [12FB-0053]; Fundacion Alfonso Martin Escudero; Fulbright; NIH [CA100225, CA104987, CA126524, CA139490]; Breast Cancer Research Foundation; Morton Family Foundation; Ludwig Foundation; NATIONAL CANCER INSTITUTE [R01CA100225, R01CA104987, P01CA139490, U54CA126524] Funding Source: NIH RePORTER	California Breast Cancer Research Program of the University of California; Fundacion Alfonso Martin Escudero; Fulbright; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Morton Family Foundation; Ludwig Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Andy Fire for helpful discussions and advice. We thank Jessica S. Lam for technical assistance. This work was supported by the California Breast Cancer Research Program of the University of California #12FB-0053 to Y. S., by the Fundacion Alfonso Martin Escudero and the Fulbright to M. Z., and by the grants from the NIH (NIH CA100225, CA104987, CA126524, CA139490), the Breast Cancer Research Foundation, the Morton Family Foundation, and the Ludwig Foundation to M. F. C. Also, M. F. C. is a consultant for Oncomed Pharmaceuticals, which is developing therapeutics against cancer stem cells.	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; BRUCE WR, 1963, NATURE, V199, P79, DOI 10.1038/199079a0; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fialkow P J, 1976, Birth Defects Orig Artic Ser, V12, P123; FIALKOW PJ, 1990, VERH DEUT G, V74, P43; FIALKOW PJ, 1976, BIOCHIM BIOPHYS ACTA, V458, P283, DOI 10.1016/0304-419X(76)90003-2; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Iwashita T, 2003, SCIENCE, V301, P972, DOI 10.1126/science.1085649; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morrison SJ, 2002, J IMMUNOL, V168, P635, DOI 10.4049/jimmunol.168.2.635; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pietersen AM, 2008, CURR BIOL, V18, P1094, DOI 10.1016/j.cub.2008.06.070; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tang FC, 2006, NAT PROTOC, V1, P1154, DOI 10.1038/nprot.2006.161; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; WU AM, 1968, J EXP MED, V127, P455, DOI 10.1084/jem.127.3.455; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	52	951	1003	1	119	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					592	603		10.1016/j.cell.2009.07.011	http://dx.doi.org/10.1016/j.cell.2009.07.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665978	Bronze, Green Accepted			2022-12-24	WOS:000268771900022
J	Khare, A; Santorelli, LA; Strassmann, JE; Queller, DC; Kuspa, A; Shaulsky, G				Khare, Anupama; Santorelli, Lorenzo A.; Strassmann, Joan E.; Queller, David C.; Kuspa, Adam; Shaulsky, Gad			Cheater-resistance is not futile	NATURE			English	Article							DICTYOSTELIUM-DISCOIDEUM; SOCIAL AMEBA; COOPERATION; DNA; EVOLUTION; SOCIETIES; RESPONSES; MUTANTS	Cooperative social systems are susceptible to cheating by individuals that reap the benefits of cooperation without incurring the costs(1). There are various theoretical mechanisms for the repression of cheating(2) and many have been tested experimentally. One possibility that has not been tested rigorously is the evolution of mutations that confer resistance to cheating. Here we show that the presence of a cheater in a population of randomly mutated social amoebae can select for cheater-resistance. Furthermore, we show that this cheater-resistance can be a noble strategy because the resister strain does not necessarily exploit other strains. Thus, the evolution of resisters may be instrumental in preserving cooperative behaviour in the face of cheating.	[Khare, Anupama; Santorelli, Lorenzo A.; Kuspa, Adam; Shaulsky, Gad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Santorelli, Lorenzo A.; Strassmann, Joan E.; Queller, David C.; Kuspa, Adam; Shaulsky, Gad] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA; [Kuspa, Adam] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Rice University; Baylor College of Medicine	Shaulsky, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	gadi@bcm.edu	Khare, Anupama/N-9220-2018	Khare, Anupama/0000-0003-1231-670X; Shaulsky, Gad/0000-0002-0532-0551; Santorelli, Lorenzo/0000-0002-8392-801X; Kuspa, Adam/0000-0002-9156-149X; Strassmann, Joan/0000-0003-0638-8440	National Science Foundation; Cullen Foundation	National Science Foundation(National Science Foundation (NSF)); Cullen Foundation	This work was supported by a grant from the National Science Foundation. A. Khare was supported by a pre-doctoral fellowship from the Cullen Foundation.	CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Ennis HL, 2000, P NATL ACAD SCI USA, V97, P3292, DOI 10.1073/pnas.050005097; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fiegna F, 2006, NATURE, V441, P310, DOI 10.1038/nature04677; Foster KR, 2004, NATURE, V431, P693, DOI 10.1038/nature02894; Gilbert OM, 2007, P NATL ACAD SCI USA, V104, P8913, DOI 10.1073/pnas.0702723104; Greig D, 2004, P ROYAL SOC B S, V271, P25, DOI [DOI 10.1098/RSBL.2003.0083), 10.1098/rsbl.2003.0083]; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Huang EY, 2006, DEVELOPMENT, V133, P449, DOI 10.1242/dev.02240; Katoh M, 2006, EUKARYOT CELL, V5, P18, DOI 10.1128/EC.5.1.18-25.2006; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; KNECHT DA, 1986, MOL CELL BIOL, V6, P3973, DOI 10.1128/MCB.6.11.3973; KUSPA A, 1992, P NATL ACAD SCI USA, V89, P8803, DOI 10.1073/pnas.89.18.8803; Marques JT, 2007, TRENDS GENET, V23, P359, DOI 10.1016/j.tig.2007.04.004; Mehdiabadi NJ, 2006, NATURE, V442, P881, DOI 10.1038/442881a; Ostrowski EA, 2008, PLOS BIOL, V6, P2376, DOI 10.1371/journal.pbio.0060287; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Santorelli LA, 2008, NATURE, V451, P1107, DOI 10.1038/nature06558; Shaulsky G, 1996, P NATL ACAD SCI USA, V93, P15260, DOI 10.1073/pnas.93.26.15260; Smith J. M., 1997, MAJOR TRANSITIONS EV; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; VOLLRATH D, 1988, P NATL ACAD SCI USA, V85, P6027, DOI 10.1073/pnas.85.16.6027; Vulic M, 2001, GENETICS, V158, P519	26	50	51	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					980	U240		10.1038/nature08472	http://dx.doi.org/10.1038/nature08472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19794414				2022-12-24	WOS:000270817700047
J	Lovejoy, CO; Suwa, G; Simpson, SW; Matternes, JH; White, TD				Lovejoy, C. Owen; Suwa, Gen; Simpson, Scott W.; Matternes, Jay H.; White, Tim D.			The Great Divides: Ardipithecus ramidus Reveals the Postcrania of Our Last Common Ancestors with African Apes	SCIENCE			English	Article							NATURAL-HISTORY; BODY-WEIGHT; HUMAN GAIT; MIOCENE; HOMINID; HUMANS; ORIGINS; FEMUR; NACHOLAPITHECUS; ADAPTATIONS	Genomic comparisons have established the chimpanzee and bonobo as our closest living relatives. However, the intricacies of gene regulation and expression caution against the use of these extant apes in deducing the anatomical structure of the last common ancestor that we shared with them. Evidence for this structure must therefore be sought from the fossil record. Until now, that record has provided few relevant data because available fossils were too recent or too incomplete. Evidence from Ardipithecus ramidus now suggests that the last common ancestor lacked the hand, foot, pelvic, vertebral, and limb structures and proportions specialized for suspension, vertical climbing, and knuckle-walking among extant African apes. If this hypothesis is correct, each extant African ape genus must have independently acquired these specializations from more generalized ancestors who still practiced careful arboreal climbing and bridging. African apes and hominids acquired advanced orthogrady in parallel. Hominoid spinal invagination is an embryogenetic mechanism that reoriented the shoulder girdle more laterally. It was unaccompanied by substantial lumbar spine abbreviation, an adaptation restricted to vertical climbing and/ or suspension. The specialized locomotor anatomies and behaviors of chimpanzees and gorillas therefore constitute poor models for the origin and evolution of human bipedality.	[Lovejoy, C. Owen] Kent State Univ, Sch Biomed Sci, Dept Anthropol, Kent, OH 44242 USA; [Suwa, Gen] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; [Simpson, Scott W.] Case Western Reserve Univ, Sch Med, Dept Anat, Cleveland, OH 44106 USA; [White, Tim D.] Univ Calif Berkeley, Human Evolut Res Ctr, Berkeley, CA 94720 USA; [White, Tim D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of Tokyo; Case Western Reserve University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Lovejoy, CO (corresponding author), Kent State Univ, Sch Biomed Sci, Dept Anthropol, Kent, OH 44242 USA.	olovejoy@aol.com; suwa@um.u-tokyo.ac.jp	Simpson, Scott/GRS-0081-2022; , owen/N-7301-2019	, owen/0000-0003-0053-4523	U. S. National Science Foundation; Japan Society for the Promotion of Science	U. S. National Science Foundation(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	For funding, we thank the U. S. National Science Foundation and the Japan Society for the Promotion of Science. We thank the Ministry of Tourism and Culture, the Authority for Research and Conservation of the Cultural Heritage, and the National Museum of Ethiopia for permissions and facilitation. We thank the Afar Regional Government, the Afar people of the Middle Awash, and many other field workers for contributing directly to the data. We thank the following institutions and staff for access to comparative materials: National Museum of Ethiopia; National Museums of Kenya; Transvaal Museum South Africa; Cleveland Museum of Natural History; Royal Museum of Central Africa Tervuren; and the University of California at Berkeley Human Evolution Research Center. We thank K. Brudvik for illustration and editorial assistance. We thank the following individuals for cooperation with comparative data: M. Brunet and C. V. Ward. We thank R. Meindl for statistical advice and assistance and P. L. Reno, M. A. Serrat, M. A. McCollum, M. Selby, and B. A. Rosenman for aid in data collection and exceptionally helpful discussions.	Almecija S, 2007, P ROY SOC B-BIOL SCI, V274, P2375, DOI 10.1098/rspb.2007.0750; ANDREWS P, 1986, COLD SPRING HARB SYM, V51, P419, DOI 10.1101/SQB.1986.051.01.050; Asfaw B, 1999, SCIENCE, V284, P629, DOI 10.1126/science.284.5414.629; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; CACCONE A, 1989, EVOLUTION, V43, P925, DOI 10.1111/j.1558-5646.1989.tb02540.x; Carroll S. B., 2001, DNA DIVERSITY MOL GE; CARTMILL M, 1977, AM J PHYS ANTHROPOL, V47, P249, DOI 10.1002/ajpa.1330470206; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Clarke RJ, 2002, S AFR J SCI, V98, P523; COOLIDGE H J, 1982, Primates, V23, P245, DOI 10.1007/BF02381164; DeSilva JM, 2009, P NATL ACAD SCI USA, V106, P6567, DOI 10.1073/pnas.0900270106; DeSilva JM., 2008, THESIS U MICHIGAN; Gregory William King, 1934, MANS PLACE ANTHROPOI; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Harrison T., 1991, P235; HORAI S, 1992, J MOL EVOL, V35, P32, DOI 10.1007/BF00160258; Huxley T., 1863, EVIDENCE MANS PLACE; JOHANSON DC, 1979, SCIENCE, V203, P321, DOI 10.1126/science.104384; JUNGERS WL, 1982, NATURE, V297, P676, DOI 10.1038/297676a0; Keith A, 1923, BRIT MED J, V1923, P545; Keith A, 1923, BRIT MED J, V1923, P499; Keith A, 1923, BMJ-BRIT MED J, V1923, P451, DOI 10.1136/bmj.1.3246.451; KEITH A, 1923, BRIT MED J, V1, P502; KEITH A, 1923, BRIT MED J, V1, P454; Kunimatsu Y, 2007, P NATL ACAD SCI USA, V104, P19220, DOI 10.1073/pnas.0706190104; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; LEMINOR JM, 1994, ACTA ANAT, V150, P227; LEWIS OJ, 1971, NATURE, V230, P577, DOI 10.1038/230577a0; Lovejoy CO, 2007, P ROY SOC B-BIOL SCI, V274, P2373, DOI 10.1098/rspb.2007.0855; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175827; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175832; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175831; Lovejoy CO, 1999, P NATL ACAD SCI USA, V96, P13247, DOI 10.1073/pnas.96.23.13247; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; Lovejoy CO, 2005, GAIT POSTURE, V21, P113, DOI 10.1016/j.gaitpost.2004.06.010; Lovejoy CO, 2002, AM J PHYS ANTHROPOL, V119, P97, DOI 10.1002/ajpa.10111; MCCOLLUM MA, J EXP ZOOL PART B, V312, DOI DOI 10.1002/JEZ.B.21316; McGrew William, 2004, CULTURED CHIMPANZEE; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Moya-Sola S, 2004, SCIENCE, V306, P1339, DOI 10.1126/science.1103094; Nakatsukasa M, 2003, J HUM EVOL, V45, P179, DOI 10.1016/S0047-2484(03)00092-7; Nakatsukasa M, 2007, PRIMATES, V48, P171, DOI 10.1007/s10329-007-0040-7; Nakatsukasa M, 2009, EVOL ANTHROPOL, V18, P103, DOI 10.1002/evan.20208; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Pilbeam D, 2004, J EXP ZOOL PART B, V302B, P241, DOI 10.1002/jez.b.22; PORTER AMW, 1995, INT J OSTEOARCHAEOL, V5, P203, DOI 10.1002/oa.1390050302; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; RAFFERTY KL, 1995, AM J PHYS ANTHROPOL, V97, P391, DOI 10.1002/ajpa.1330970406; Reno PL, 2008, J EXP ZOOL PART B, V310B, P240, DOI 10.1002/jez.b.21207; Reno PL, 2005, CURR ANTHROPOL, V46, P575, DOI 10.1086/431528; Reno PL, 2005, J HUM EVOL, V49, P279, DOI 10.1016/j.jhevol.2005.04.008; Richmond BG, 2001, YEARB PHYS ANTHROPOL, V44, P70, DOI 10.1002/ajpa.10019; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; SCHULTZ A. H., 1930, HUMAN BIOL, V2, P303; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Sonntag CF, 1923, P ZOOL SOC LOND, V1923, P323; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; STRAUS WL, 1949, Q REV BIOL, V24, P200, DOI 10.1086/397067; Suwa G, 2007, NATURE, V448, P921, DOI 10.1038/nature06113; Suwa G, 2009, SCIENCE, V326, P94, DOI 10.1126/science.1175824; Suwa G, 2009, SCIENCE, V326, DOI 10.1126/science.1175825; Thorpe SKS, 2009, P NATL ACAD SCI USA, V106, P12646, DOI 10.1073/pnas.0811537106; TUTTLE R, 1972, NATURE, V236, P33, DOI 10.1038/236033a0; TUTTLE RH, 1969, SCIENCE, V166, P953, DOI 10.1126/science.166.3908.953; Wagner GP, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-213; WARD C V, 1991, American Journal of Physical Anthropology, P180; WARD CV, 1993, AM J PHYS ANTHROPOL, V90, P77, DOI 10.1002/ajpa.1330900106; WASHBURN SL, 1968, STUDY HUMAN EVOLUTIO; WHITE TD, 1987, AM J PHYS ANTHROPOL, V72, P485, DOI 10.1002/ajpa.1330720409; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; WILSON AC, 1969, P NATL ACAD SCI USA, V63, P1088, DOI 10.1073/pnas.63.4.1088; Wood B, 2008, J ANAT, V212, P354, DOI 10.1111/j.1469-7580.2008.00871.x; Wrangham R, 2001, DEV PRIMATOL-PROG PR, P5; ZIHLMAN AL, 1978, NATURE, V275, P744, DOI 10.1038/275744a0; ZIHLMAN AL, 1978, FOLIA PRIMATOL, V29, P86, DOI 10.1159/000155830	78	193	200	2	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					100	106		10.1126/science.1175833	http://dx.doi.org/10.1126/science.1175833			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	501CA	19810199				2022-12-24	WOS:000270355600043
J	Ghaferi, AA; Birkmeyer, JD; Dimick, JB				Ghaferi, Amir A.; Birkmeyer, John D.; Dimick, Justin B.			Variation in Hospital Mortality Associated with Inpatient Surgery.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARE; OUTCOMES; QUALITY	Background: Hospital mortality that is associated with inpatient surgery varies widely. Reducing rates of postoperative complications, the current focus of payers and regulators, may be one approach to reducing mortality. However, effective management of complications once they have occurred may be equally important. Methods: We studied 84,730 patients who had undergone inpatient general and vascular surgery from 2005 through 2007, using data from the American College of Surgeons National Surgical Quality Improvement Program. We first ranked hospitals according to their risk-adjusted overall rate of death and divided them into five groups. For hospitals in each overall mortality quintile, we then assessed the incidence of overall and major complications and the rate of death among patients with major complications. Results: Rates of death varied widely across hospital quintiles, from 3.5% in very-low-mortality hospitals to 6.9% in very-high-mortality hospitals. Hospitals with either very high mortality or very low mortality had similar rates of overall complications (24.6% and 26.9%, respectively) and of major complications (18.2% and 16.2%, respectively). Rates of individual complications did not vary significantly across hospital mortality quintiles. In contrast, mortality in patients with major complications was almost twice as high in hospitals with very high overall mortality as in those with very low overall mortality (21.4% vs. 12.5%, P<0.001). Differences in rates of death among patients with major complications were also the primary determinant of variation in overall mortality with individual operations. Conclusions: In addition to efforts aimed at avoiding complications in the first place, reducing mortality associated with inpatient surgery will require greater attention to the timely recognition and management of complications once they occur. N Engl J Med 2009;361:1368-75.	[Ghaferi, Amir A.; Birkmeyer, John D.; Dimick, Justin B.] Univ Michigan, Dept Surg, Michigan Surg Collaborat Outcomes Res & Evaluat, Ann Arbor, MI 48104 USA	University of Michigan System; University of Michigan	Ghaferi, AA (corresponding author), Univ Michigan, Dept Surg, Michigan Surg Collaborat Outcomes Res & Evaluat, 211 N 4th Ave,Suite 201, Ann Arbor, MI 48104 USA.	aghaferi@umich.edu			National Cancer Institute [T32 CA009672, R01-CA098481, K05-CA115571-01]; Agency for Healthcare Research and Quality [K08-HS017765]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS017765] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K05CA115571, T32CA009672, R01CA098481] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by a training grant from the National Cancer Institute ( T32 CA009672, to Dr. Ghaferi), grants from the National Cancer Institute (R01-CA098481 and K05-CA115571-01, to Dr. Birkmeyer), and a career development award from the Agency for Healthcare Research and Quality (K08-HS017765, to Dr. Dimick).	AIKEN LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI [DOI 10.1001/JAMA.288.16.1987, 10.1001/jama.288.16.1987]; *AM COLL SURG NAT, ACS NSQIP DAT COLL O; *AM MED ASS, 2005, CPT 2006 CURR PROC T; Birkmeyer JD, 2004, SURGERY, V135, P569, DOI 10.1016/j.surg.2004.03.004; Carayon Pascale, 2005, Intensive Crit Care Nurs, V21, P284, DOI 10.1016/j.iccn.2004.12.003; Dellinger RP, 2008, CRIT CARE MED, V36, P1394; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Haynes Alex B, 2009, N Engl J Med, V360, P491, DOI 10.1056/NEJMsa0810119; HOUGHTON A, 1994, BRIT J SURG, V81, P653, DOI 10.1002/bjs.1800810508; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Pronovost PJ, 1999, JAMA-J AM MED ASSOC, V281, P1310, DOI 10.1001/jama.281.14.1310; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Pronovost PJ, 2004, CRIT CARE MED, V32, P1247, DOI 10.1097/01.CCM.0000128609.98470.8B; Sasichay-Akkadechanunt T, 2003, J NURS ADMIN, V33, P478, DOI 10.1097/00005110-200309000-00008; SILBER JH, 1992, MED CARE, V30, P615, DOI 10.1097/00005650-199207000-00004; Silber JH, 1997, MED CARE, V35, pOS77, DOI 10.1097/00005650-199710001-00011; SILBER JH, 1995, JAMA-J AM MED ASSOC, V274, P317, DOI 10.1001/jama.274.4.317; Zambon M, 2008, J CRIT CARE, V23, P455, DOI 10.1016/j.jcrc.2007.08.003	20	976	987	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2009	361	14					1368	1375		10.1056/NEJMsa0903048	http://dx.doi.org/10.1056/NEJMsa0903048			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500KZ	19797283	Bronze			2022-12-24	WOS:000270300000011
J	Yu, SR; Burkhardt, M; Nowak, M; Ries, J; Petrasek, Z; Scholpp, S; Schwille, P; Brand, M				Yu, Shuizi Rachel; Burkhardt, Markus; Nowak, Matthias; Ries, Jonas; Petrasek, Zdenek; Scholpp, Steffen; Schwille, Petra; Brand, Michael			Fgf8 morphogen gradient forms by a source-sink mechanism with freely diffusing molecules	NATURE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; EARLY XENOPUS EMBRYO; CROSS-CORRELATION; ZEBRAFISH; DIFFERENTIATION; ENDOCYTOSIS; TRANSPORT; DYNAMICS; PATTERN; RANGE	It is widely accepted that tissue differentiation and morphogenesis in multicellular organisms are regulated by tightly controlled concentration gradients of morphogens(1,2). How exactly these gradients are formed, however, remains unclear(3-12). Here we show that Fgf8 morphogen gradients in living zebrafish embryos are established andmaintained by two essential factors: fast, free diffusion of single molecules away from the source through extracellular space, and a sink function of the receiving cells, regulated by receptor-mediated endocytosis. Evidence is provided by directly examining single molecules of Fgf8 in living tissue by fluorescence correlation spectroscopy, quantifying their local mobility and concentration with high precision. By changing the degree of uptake of Fgf8 into its target cells, we are able to alter the shape of the Fgf8 gradient. Our results demonstrate that a freely diffusing morphogen can set up concentration gradients in a complex multicellular tissue by a simple source-sink mechanism.	[Yu, Shuizi Rachel; Burkhardt, Markus; Nowak, Matthias; Ries, Jonas; Petrasek, Zdenek; Scholpp, Steffen; Schwille, Petra; Brand, Michael] TUD, Ctr Biotechnol, D-01307 Dresden, Germany; [Yu, Shuizi Rachel; Burkhardt, Markus; Nowak, Matthias; Ries, Jonas; Petrasek, Zdenek; Schwille, Petra; Brand, Michael] TUD, Ctr Regenerat Therapies, D-01307 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Schwille, P (corresponding author), TUD, Ctr Biotechnol, Tatzberg 47-49, D-01307 Dresden, Germany.	petra.schwille@biotec.tu-dresden.de; michael.brand@biotec.tu-dresden.de	Ries, Jonas/Q-5157-2019; Scholpp, Steffen/E-4472-2018; Brand, Michael/A-5509-2010; Schwille, Petra/A-4983-2010; Scholpp, Steffen/H-2060-2013; , q/P-3251-2015; Ries, Jonas/P-3027-2014	Scholpp, Steffen/0000-0002-4903-9657; Brand, Michael/0000-0001-5711-6512; Scholpp, Steffen/0000-0002-4903-9657; , q/0000-0002-4930-1635; Ries, Jonas/0000-0002-6640-9250	HFSP network grant [050503-50]; EU [050503-52]	HFSP network grant; EU(European Commission)	We thank members of the Brand and Schwille laboratories for discussions; A. Picker and K. Heinze for help with initial FCS measurements; B. Lutz for discussions; A. Oates, C. Boekel, A. Picker and P. Scott for comments on the manuscript; M. Fischer and K. Sipple for fish care; and A. Machate and B. Borgonov for technical assistance. This work was supported by an HFSP network grant (050503-50) to M. Br. and P. S., and by the EU Endotrack grant (050503-52) to M.	AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Baeg GH, 2004, DEV BIOL, V276, P89, DOI 10.1016/j.ydbio.2004.08.023; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Brinkmeier M, 1999, ANAL CHEM, V71, P609, DOI 10.1021/ac980820i; Burkhardt M, 2006, OPT EXPRESS, V14, P5013, DOI 10.1364/OE.14.005013; CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0; Dertinger T, 2007, CHEMPHYSCHEM, V8, P433, DOI 10.1002/cphc.200600638; DESAI UR, 1993, ARCH BIOCHEM BIOPHYS, V306, P461, DOI 10.1006/abbi.1993.1538; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Goldfarb Mitchell, 1996, Cytokine and Growth Factor Reviews, V7, P311, DOI 10.1016/S1359-6101(96)00039-1; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Hou S, 2007, DEV CELL, V13, P226, DOI 10.1016/j.devcel.2007.07.001; Kerszberg M, 1998, J THEOR BIOL, V191, P103, DOI 10.1006/jtbi.1997.0575; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; McDowell N, 2001, INT J DEV BIOL, V45, P199; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Petrov EP, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258101; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; Reifers F, 1998, DEVELOPMENT, V125, P2381; Reifers F, 2000, DEVELOPMENT, V127, P225; Ries J, 2009, NAT METHODS, V6, P643, DOI [10.1038/NMETH.1355, 10.1038/nmeth.1355]; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Robinson MS, 1996, CELL, V84, P13, DOI 10.1016/S0092-8674(00)80988-5; Scholpp S, 2004, CURR BIOL, V14, P1834, DOI 10.1016/j.cub.2004.09.084; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0	32	275	277	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					533	U100		10.1038/nature08391	http://dx.doi.org/10.1038/nature08391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19741606				2022-12-24	WOS:000270082900042
J	Wyart, C; Del Bene, F; Warp, E; Scott, EK; Trauner, D; Baier, H; Isacoff, EY				Wyart, Claire; Del Bene, Filippo; Warp, Erica; Scott, Ethan K.; Trauner, Dirk; Baier, Herwig; Isacoff, Ehud Y.			Optogenetic dissection of a behavioural module in the vertebrate spinal cord	NATURE			English	Article							FLUID-CONTACTING NEURONS; IONOTROPIC GLUTAMATE-RECEPTOR; LARVAL ZEBRAFISH; IN-VIVO; GENETIC DISSECTION; LOCOMOTOR NETWORK; NEURAL CIRCUITS; CELLS; LIGHT; INTERNEURONS	Locomotion relies on neural networks called central pattern generators (CPGs) that generate periodic motor commands for rhythmic movements(1). In vertebrates, the excitatory synaptic drive for inducing the spinal CPG can originate from either supraspinal glutamatergic inputs or from within the spinal cord(2,3). Here we identify a spinal input to the CPG that drives spontaneous locomotion using a combination of intersectional gene expression and optogenetics(4) in zebrafish larvae. The photo-stimulation of one specific cell type was sufficient to induce a symmetrical tail beating sequence that mimics spontaneous slow forward swimming. This neuron is the Kolmer-Agduhr cell(5), which extends cilia into the central cerebrospinal-fluid-containing canal of the spinal cord and has an ipsilateral ascending axon that terminates in a series of consecutive segments(6). Genetically silencing Kolmer-Agduhr cells reduced the frequency of spontaneous free swimming, indicating that activity of Kolmer-Agduhr cells provides necessary tone for spontaneous forward swimming. Kolmer-Agduhr cells have been known for over 75 years, but their function has been mysterious. Our results reveal that during early development in zebrafish these cells provide a positive drive to the spinal CPG for spontaneous locomotion.	[Wyart, Claire; Warp, Erica; Isacoff, Ehud Y.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Wyart, Claire; Warp, Erica; Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Del Bene, Filippo; Scott, Ethan K.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94158 USA; [Trauner, Dirk] Univ Munich, Dept Chem, Munich, Germany; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of Munich; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	herwig.baier@ucsf.edu; ehud@berkeley.edu	del bene, filippo/D-1245-2010; Wyart, Claire/H-3783-2016; Wyart, Claire/AAB-4603-2020; isacoff, ehud/AAP-1459-2020	del bene, filippo/0000-0001-8551-2846; Wyart, Claire/0000-0002-1668-4975; Wyart, Claire/0000-0002-1668-4975; Scott, Ethan/0000-0003-3150-9216; Isacoff, Ehud Y./0000-0003-4775-9359	Marie Curie Outgoing International Fellowship [CNRS-UMR5020]; Human Frontier Science Program Long-term Postdoctoral Fellowship; National Institutes of Health Nanomedicine Development Center [5PN2EY018241]; Human Frontiers Science Program [RGP23-2005]; Lawrence Berkeley National Laboratory Directed Research and Development Program [R01 NS053358]; Sandler Opportunity Award; NATIONAL EYE INSTITUTE [PN2EY018241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053358, R01NS035549] Funding Source: NIH RePORTER	Marie Curie Outgoing International Fellowship(European Commission); Human Frontier Science Program Long-term Postdoctoral Fellowship(Human Frontier Science Program); National Institutes of Health Nanomedicine Development Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Lawrence Berkeley National Laboratory Directed Research and Development Program; Sandler Opportunity Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M.Volgraf for MAG-1 synthesis, K.Kawakami for the UAS: TeTxLC-CFP line, B.Appel for the Olig2-DsRed line, W.Staub for animal care, D.Li for help with screening BGUG larvae, B.Vigh, C.Girit, E.Brustein, P.Drapeau and S.Hugel for discussions, P.G.de Gennes and Noam Sobel for support and O.Wyart for aesthetic input.We are grateful to K.Best, P.Tavormina, H.Aaron, R.Ayer, B.Nowak and M.Ulbrich for advice on the design of the photostimulation setup.Support for the work was from the Marie Curie Outgoing International Fellowship (with the CNRS-UMR5020 'Neurosciences Sensorielles, Comportement Cognition' laboratory, Lyon, France) (C.W.), the Human Frontier Science Program Long-term Postdoctoral Fellowship (F.D.B.), the National Institutes of Health Nanomedicine Development Center for the Optical Control of Biological Function (5PN2EY018241) (E.Y.I., D.T.and H.B.), the Human Frontiers Science Program (RGP23-2005) (E.Y.I.and D.T.), the Lawrence Berkeley National Laboratory Directed Research and Development Program (E.Y.I.and D.T.), R01 NS053358 (H.B.) and a Sandler Opportunity Award (H.B.).	AGDUHR E, 1932, CYTOLOGY CELLULAR PA, V2, P535; ALFORD S, 1990, BRAIN RES, V506, P303, DOI 10.1016/0006-8993(90)91267-K; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Brustein E, 2005, J NEUROSCI, V25, P10607, DOI 10.1523/JNEUROSCI.2017-05.2005; Budick SA, 2000, J EXP BIOL, V203, P2565; DALE N, 1987, PROC R SOC SER B-BIO, V232, P193, DOI 10.1098/rspb.1987.0068; DOUGLAS JR, 1993, J NEUROSCI, V13, P990; Drapeau P, 1999, J NEUROSCI METH, V88, P1, DOI 10.1016/S0165-0270(99)00008-4; FENAUX F, 1991, EXP BRAIN RES, V86, P393; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Furusho M, 2006, DEV BIOL, V293, P348, DOI 10.1016/j.ydbio.2006.01.031; Gorostiza P, 2007, P NATL ACAD SCI USA, V104, P10865, DOI 10.1073/pnas.0701274104; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Higashijima S, 2004, J COMP NEUROL, V480, P1, DOI 10.1002/cne.20278; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Kiehn O, 2008, BRAIN RES REV, V57, P56, DOI 10.1016/j.brainresrev.2007.07.002; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Liao JC, 2008, J NEUROSCI, V28, P12982, DOI 10.1523/JNEUROSCI.3330-08.2008; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; Ritter DA, 2001, J NEUROSCI, V21, P8956, DOI 10.1523/JNEUROSCI.21-22-08956.2001; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Stoeckel ME, 2003, J COMP NEUROL, V457, P159, DOI 10.1002/cne.10565; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Vigh B, 1998, MICROSC RES TECHNIQ, V41, P57, DOI 10.1002/(SICI)1097-0029(19980401)41:1<57::AID-JEMT6>3.0.CO;2-R; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Xiao T, 2007, NAT NEUROSCI, V10, P1529, DOI 10.1038/nn2002	31	290	302	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					407	U105		10.1038/nature08323	http://dx.doi.org/10.1038/nature08323			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19759620	Green Accepted			2022-12-24	WOS:000269828100042
J	Kumar, A; Zarychanski, R; Pinto, R; Cook, DJ; Marshall, J; Lacroix, J; Stelfox, T; Bagshaw, S; Choong, K; Lamontagne, F; Turgeon, AF; Lapinsky, S; Ahern, SP; Smith, O; Siddiqui, F; Jouvet, P; Khwaja, K; McIntyre, L; Menon, K; Hutchison, J; Hornstein, D; Joffe, A; Lauzier, F; Singh, J; Karachi, T; Wiebe, K; Olafson, K; Ramsey, C; Sharma, S; Dodek, P; Meade, M; Hall, R; Fowler, RA				Kumar, Anand; Zarychanski, Ryan; Pinto, Ruxandra; Cook, Deborah J.; Marshall, John; Lacroix, Jacques; Stelfox, Tom; Bagshaw, Sean; Choong, Karen; Lamontagne, Francois; Turgeon, Alexis F.; Lapinsky, Stephen; Ahern, Stephane P.; Smith, Orla; Siddiqui, Faisal; Jouvet, Philippe; Khwaja, Kosar; McIntyre, Lauralyn; Menon, Kusum; Hutchison, Jamie; Hornstein, David; Joffe, Ari; Lauzier, Francois; Singh, Jeffrey; Karachi, Tim; Wiebe, Kim; Olafson, Kendiss; Ramsey, Clare; Sharma, Sat; Dodek, Peter; Meade, Maureen; Hall, Richard; Fowler, Robert A.		Canadian Critical Care Trials Grp	Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MORTALITY; EPIDEMIOLOGY	Context Between March and July 2009, the largest number of confirmed cases of 2009 influenza A(H1N1) infection occurred in North America. Objective To describe characteristics, treatment, and outcomes of critically ill patients in Canada with 2009 influenza A(H1N1) infection. Design, Setting, and Patients A prospective observational study of 168 critically ill patients with 2009 influenza A(H1N1) infection in 38 adult and pediatric intensive care units (ICUs) in Canada between April 16 and August 12, 2009. Main Outcome Measures The primary outcome measures were 28-day and 90-day mortality. Secondary outcomes included frequency and duration of mechanical ventilation and duration of ICU stay. Results Critical illness occurred in 215 patients with confirmed (n=162), probable (n=6), or suspected (n=47) community-acquired 2009 influenza A(H1N1) infection. Among the 168 patients with confirmed or probable 2009 influenza A(H1N1), the mean(SD) age was 32.3 (21.4) years; 113 were female (67.3%) and 50 were children (29.8%). Overall mortality among critically ill patients at 28 days was 14.3% (95% confidence interval, 9.5%-20.7%). There were 43 patients who were aboriginal Canadians (25.6%). The median time from symptom onset to hospital admission was 4 days (interquartile range [IQR], 2-7 days) and from hospitalization to ICU admission was 1 day (IQR, 0-2 days). Shock and nonpulmonary acute organ dysfunction was common (Sequential Organ Failure Assessment mean [SD] score of 6.8 [3.6] on day 1). Neuraminidase inhibitors were administered to 152 patients (90.5%). All patients were severely hypoxemic (mean [SD] ratio of PaO2 to fraction of inspired oxygen [FIO2] of 147 [128] mm Hg) at ICU admission. Mechanical ventilation was received by 136 patients (81.0%). The median duration of ventilation was 12 days (IQR, 6-20 days) and ICU stay was 12 days (IQR, 5-20 days). Lung rescue therapies included neuromuscular blockade (28% of patients), inhaled nitric oxide (13.7%), high-frequency oscillatory ventilation (11.9%), extracorporeal membrane oxygenation (4.2%), and prone positioning ventilation (3.0%). Overall mortality among critically ill patients at 90 days was 17.3%(95% confidence interval, 12.0%-24.0%; n=29). Conclusion Critical illness due to 2009 influenza A(H1N1) in Canada occurred rapidly after hospital admission, often in young adults, and was associated with severe hypoxemia, multisystem organ failure, a requirement for prolonged mechanical ventilation, and the frequent use of rescue therapies. JAMA. 2009;302(17):1872-1879	[Kumar, Anand; Siddiqui, Faisal; Wiebe, Kim; Olafson, Kendiss; Ramsey, Clare; Sharma, Sat] Hlth Sci Ctr, Sect Crit Care Med, Winnipeg, MB R3E 0Z3, Canada; [Kumar, Anand; Siddiqui, Faisal; Wiebe, Kim; Olafson, Kendiss; Ramsey, Clare; Sharma, Sat] St Boniface Gen Hosp, Winnipeg, MB R2H 2A6, Canada; [Zarychanski, Ryan] Cancercare Manitoba, Dept Med Oncol & Hematol, Winnipeg, MB, Canada; [Pinto, Ruxandra; Fowler, Robert A.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Cook, Deborah J.; Meade, Maureen] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Karachi, Tim] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Choong, Karen] McMaster Univ, McMaster Childrens Hosp, Hamilton, ON, Canada; [Marshall, John; Smith, Orla] St Michaels Hosp, Dept Crit Care Med, Toronto, ON M5B 1W8, Canada; [Lacroix, Jacques; Jouvet, Philippe] Univ Montreal, Dept Pediat, CHU St Justine, Montreal, PQ H3C 3J7, Canada; [Stelfox, Tom] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Stelfox, Tom] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Bagshaw, Sean; Joffe, Ari] Univ Alberta, Div Crit Care Med, Edmonton, AB, Canada; [Lamontagne, Francois] Univ Sherbrooke, Dept Med, Med Ctr, Sherbrooke, PQ J1K 2R1, Canada; [Turgeon, Alexis F.; Lauzier, Francois] Univ Laval, Hop Enfants Jesus, Ctr Rech CHA, Quebec City, PQ, Canada; [Lapinsky, Stephen] Univ Toronto, Mt Sinai Hosp, Intens Care Unit, Toronto, ON M5G 1X5, Canada; [Singh, Jeffrey] Univ Toronto, Univ Hlth Network, Toronto, ON M5G 1X5, Canada; [Ahern, Stephane P.] Univ Montreal, Dept Med, Hop Maison Neuve Rosemont, Montreal, PQ H3C 3J7, Canada; [Khwaja, Kosar] McGill Univ, Ctr Hlth, Trauma Serv, Montreal, PQ, Canada; [McIntyre, Lauralyn] Ottawa Hlth Res Inst, Clin Epidemiol Unit, Ottawa, ON, Canada; [Menon, Kusum] Childrens Hosp Eastern Ontario, Clin Res Unit, Ottawa, ON K1H 8L1, Canada; [Hutchison, Jamie] Hosp Sick Children, Dept Crit Care Med, Toronto, ON M5G 1X8, Canada; [Hornstein, David] SMBD Jewish Gen Hosp, Montreal, PQ, Canada; [Dodek, Peter] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Hall, Richard] Queen Elizabeth 2 Hlth Sci Ctr, Dept Anesthesia, Halifax, NS, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; CancerCare Manitoba Foundation; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Calgary; University of Calgary; University of Alberta; University of Sherbrooke; Laval University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Universite de Montreal; McGill University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of British Columbia; Queen Elizabeth II Health Sciences Centre	Kumar, A (corresponding author), Hlth Sci Ctr, Sect Crit Care Med, JJ 399,700 William Ave, Winnipeg, MB R3E 0Z3, Canada.	akumar61@yahoo.com	Griesdale, Donald/AAT-7762-2021; McIntyre, Lauralyn/AAR-7710-2021; Lauzier, Francois/B-9237-2015; Ferguson, Niall/D-7619-2019; Choong, Karen/ABB-7867-2021; Jouvet, Philippe A/H-3293-2018; Tuluc, Petronel/C-2527-2011; Zarychanski, Ryan/AAB-6369-2022; Lapinsky, Stephen/C-4624-2015	Griesdale, Donald/0000-0001-5985-8624; McIntyre, Lauralyn/0000-0001-7421-1407; Lauzier, Francois/0000-0002-6530-5513; Ferguson, Niall/0000-0002-6213-5264; Choong, Karen/0000-0002-4608-4508; Jouvet, Philippe A/0000-0001-5684-3398; Lapinsky, Stephen/0000-0002-6930-0306; Zarychanski, Ryan/0000-0001-9455-6138; Singh, Jeffrey/0000-0003-3499-574X; Friedrich, Jan/0000-0001-7248-2350; Stelfox, Henry/0000-0003-1231-1490	Public Health Agency of Canada; Ontario Ministry of Health and Longterm Care; Heart and Stroke Foundation Canada; Canadian Institutes of Health Research	Public Health Agency of Canada; Ontario Ministry of Health and Longterm Care(Ministry of Health and Long-Term Care, Ontario); Heart and Stroke Foundation Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The Public Health Agency of Canada, the Ontario Ministry of Health and Longterm Care, the Heart and Stroke Foundation Canada, and the Canadian Institutes of Health Research provided support for this article.	ABRAMOWITZ U, 1959, S AFR MED J, V32, P1155; Adhikari NKJ, 2007, BMJ-BRIT MED J, V334, P779, DOI 10.1136/bmj.39139.716794.55; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P171; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P173; [Anonymous], 1919, PUBLIC HLTH REP, V34, P2298; Beigi RH, 2007, OBSTET GYNECOL, V109, P1193, DOI 10.1097/01.AOG.0000262051.71925.ac; *CAN CRIT CAR TRIA, CAS REP FORM; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chan M., WORLD NOW START 2009; CHU C M, 1958, J Hyg Epidemiol Microbiol Immunol, V2, P1; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Crosby Alfred W., 1976, EPIDEMIC PEACE 1918; Cunha BA, 2004, INFECT DIS CLIN N AM, V18, P141, DOI 10.1016/S0891-5520(03)00095-3; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; *ED TEAM, 2009, EUROSURVEILLANCE, V14, P1; Fowler RA, 2003, JAMA-J AM MED ASSOC, V290, P367, DOI 10.1001/jama.290.3.367; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Goulenok C, 2004, CHEST, V125, P1441, DOI 10.1378/chest.125.4.1441; Graham-Cumming G, 1967, Med Serv J Can, V23, P115; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; MacMillan HL, 1996, CAN MED ASSOC J, V155, P1569; Markham N., 1986, THEM DAYS, V11, P4; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mcfee RB, 2007, DM-DIS MON, V53, P348, DOI 10.1016/j.disamonth.2007.05.006; Meade MO, 2009, AM J RESP CRIT CARE, V179; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; NAPOLITANO LM, 2009, MMWR-MORBID MORTAL W, V58, P1; *OSCAR TRIAL WEBS, HIGH FREQ OSC ARDS; Oxford JS, 2000, REV MED VIROL, V10, P119, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;119::AID-RMV272&gt;3.0.CO;2-O; Patterson KD., 1986, PANDEMIC INFLUENZA 1; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; *PUBL HLTH AG CAN, FLU WATCH AUG 16 23; *PUBL HLTH AG CAN, FLU WATCH JUL 5 2009; *PUBL HLTHA G CAN, CAS DEF NAT SURV H1N; Sakr Y, 2008, INTENS CARE MED, V34, P1999, DOI 10.1007/s00134-008-1243-0; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Valdez R, 1999, AM J PUBLIC HEALTH, V89, P1715, DOI 10.2105/AJPH.89.11.1715; WHO, INF; [No title captured]	46	999	1070	1	65	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 4	2009	302	17					1872	1879		10.1001/jama.2009.1496	http://dx.doi.org/10.1001/jama.2009.1496			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514DU	19822627	Bronze			2022-12-24	WOS:000271375300018
J	Ledesma, FC; El Khamisy, SF; Zuma, MC; Osborn, K; Caldecott, KW				Ledesma, Felipe Cortes; El Khamisy, Sherif F.; Zuma, Maria C.; Osborn, Kay; Caldecott, Keith W.			A human 5 '-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage	NATURE			English	Article							RECEPTOR-ASSOCIATED FACTORS; STRAND BREAK REPAIR; SPINOCEREBELLAR ATAXIA; COVALENT COMPLEXES; TTRAP; TDP1; PROTEIN; ENZYME; CD40	Topoisomerases regulate DNA topology and are fundamental to many aspects of chromosome metabolism(1,2). Their activity involves the transient cleavage of DNA, which, if it occurs near sites of endogenous DNA damage or in the presence of topoisomerase poisons, can result in abortive topoisomerase-induced DNA strand breaks(3-5). These breaks feature covalent linkage of the enzyme to the DNA termini by a 3'- or 5'-phosphotyrosyl bond and are implicated in hereditary human disease(6-8), chromosomal instability and cancer(4,9), and underlie the clinical efficacy of an important class of anti-tumour poisons(3,9,10). The importance of liberating DNA termini from trapped topoisomerase is illustrated by the progressive neurodegenerative disease observed in individuals containing a mutation in tyrosyl-DNA phosphodiesterase 1 (TDP1), an enzyme that cleaves 3'-phosphotyrosyl bonds(6-8). However, a complementary human enzyme that cleaves 5'-phosphotyrosyl bonds has not been reported, despite the effect of DNA double-strand breaks containing such termini on chromosome instability and cancer(6-8). Here we identify such an enzyme in human cells and show that this activity efficiently restores 5'-phosphate termini at DNA double-strand breaks in preparation for DNA ligation. This enzyme, TTRAP, is a member of the Mg2+/Mn2+-dependent family of phosphodiesterases. Cellular depletion of TTRAP results in increased susceptibility and sensitivity to topoisomerase-II-induced DNA double-strand breaks. TTRAP is, to our knowledge, the first human 5'-tyrosyl DNA phosphodiesterase to be identified, and we suggest that this enzyme is denoted tyrosyl DNA phosphodiesterase-2 (TDP2).	[Ledesma, Felipe Cortes; El Khamisy, Sherif F.; Zuma, Maria C.; Osborn, Kay; Caldecott, Keith W.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [El Khamisy, Sherif F.] Ain Shams Univ, Fac Pharm, Dept Biochem, Cairo 11566, Egypt	University of Sussex; Egyptian Knowledge Bank (EKB); Ain Shams University	Caldecott, KW (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Sci Pk Rd, Brighton BN1 9RQ, E Sussex, England.	fc55@sussex.ac.uk; k.w.caldecott@sussex.ac.uk	Ledesma, Felipe Cortés/F-4803-2014; Caldecott, Keith/S-4245-2019	Ledesma, Felipe Cortés/0000-0002-0440-6783; Osborn, Kay/0000-0003-0825-0322; , Sherif/0000-0003-2721-7763; Caldecott, Keith/0000-0003-4255-9016	MRC [G0600776]; BBSRC [BB/C516595/1]; CR-UK [C6563/A10192]; Wellcome Trust [085284]; Marie Curie [2007-2-1-IEF-221222]; EMBO [ALTF 956-2006]; Biotechnology and Biological Sciences Research Council [BB/C516595/1] Funding Source: researchfish; Medical Research Council [G0600776] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CR-UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Marie Curie(European Commission); EMBO(European Molecular Biology Organization (EMBO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the MRC (G0600776), the BBSRC (BB/C516595/1), and CR-UK (C6563/A10192). S. F. E. K. and F. C. L. were also funded by Fellowships from the Wellcome Trust ( S. F. E. K.; 085284), Marie Curie (FCL; 2007-2-1-IEF-221222) and EMBO ( FCL; ALTF 956-2006). We thank T. Wilson, H. Nash, M. Neale, J. Nitiss and E. Hoffmann for materials.	Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Connelly JC, 2004, MOL CELL, V13, P307, DOI 10.1016/S1097-2765(04)00056-5; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Esguerra CV, 2007, DEVELOPMENT, V134, P4381, DOI 10.1242/dev.000026; Hartsuiker E, 2009, MOL CELL, V33, P117, DOI 10.1016/j.molcel.2008.11.021; Katyal S, 2007, EMBO J, V26, P4720, DOI 10.1038/sj.emboj.7601869; Kingma PS, 1998, BBA-GENE STRUCT EXPR, V1400, P223, DOI 10.1016/S0167-4781(98)00138-9; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Liu CY, 2002, P NATL ACAD SCI USA, V99, P14970, DOI 10.1073/pnas.182557199; Mielke C, 2004, J BIOL CHEM, V279, P20559, DOI 10.1074/jbc.C400032200; Mielke C, 2007, DNA REPAIR, V6, P1757, DOI 10.1016/j.dnarep.2007.06.014; NITISS JL, 1992, CANCER RES, V52, P4467; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss KC, 2006, P NATL ACAD SCI USA, V103, P8953, DOI 10.1073/pnas.0603455103; Parsons JL, 2004, NUCLEIC ACIDS RES, V32, P3531, DOI 10.1093/nar/gkh676; Pei HP, 2003, ONCOGENE, V22, P2699, DOI 10.1038/sj.onc.1206374; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; Reynolds JJ, 2009, MOL CELL BIOL, V29, P1354, DOI 10.1128/MCB.01471-08; Rodrigues-Lima F, 2001, BIOCHEM BIOPH RES CO, V285, P1274, DOI 10.1006/bbrc.2001.5328; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Vance JR, 2002, P NATL ACAD SCI USA, V99, P13669, DOI 10.1073/pnas.202242599; Vance JR, 2001, MOL CELL BIOL, V21, P7191, DOI 10.1128/MCB.21.21.7191-7198.2001; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Xu GL, 2008, BIOCHEM BIOPH RES CO, V375, P395, DOI 10.1016/j.bbrc.2008.08.023; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534; Zucchelli S, 2009, CELL DEATH DIFFER, V16, P428, DOI 10.1038/cdd.2008.169	30	287	296	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					674	U125		10.1038/nature08444	http://dx.doi.org/10.1038/nature08444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19794497				2022-12-24	WOS:000270302600045
J	Bridgham, JT; Ortlund, EA; Thornton, JW				Bridgham, Jamie T.; Ortlund, Eric A.; Thornton, Joseph W.			An epistatic ratchet constrains the direction of glucocorticoid receptor evolution	NATURE			English	Article							DOLLOS LAW; IRREVERSIBLE EVOLUTION; REVERSIBILITY; SOFTWARE; PROTEINS	The extent to which evolution is reversible has long fascinated biologists(1-8). Most previous work on the reversibility of morphological and life-history evolution(9-13) has been indecisive, because of uncertainty and bias in the methods used to infer ancestral states for such characters(14,15). Further, despite theoretical work on the factors that could contribute to irreversibility(1,8,16), there is little empirical evidence on its causes, because sufficient understanding of the mechanistic basis for the evolution of new or ancestral phenotypes is seldom available(3,8,17). By studying the reversibility of evolutionary changes in protein structure and function, these limitations can be overcome. Here we show, using the evolution of hormone specificity in the vertebrate glucocorticoid receptor as a case-study, that the evolutionary path by which this protein acquired its new function soon became inaccessible to reverse exploration. Using ancestral gene reconstruction, protein engineering and X-ray crystallography, we demonstrate that five subsequent 'restrictive' mutations, which optimized the new specificity of the glucocorticoid receptor, also destabilized elements of the protein structure that were required to support the ancestral conformation. Unless these ratchet-like epistatic substitutions are restored to their ancestral states, reversing the key function-switching mutations yields a non-functional protein. Reversing the restrictive substitutions first, however, does nothing to enhance the ancestral function. Our findings indicate that even if selection for the ancestral function were imposed, direct reversal would be extremely unlikely, suggesting an important role for historical contingency in protein evolution.	[Bridgham, Jamie T.; Thornton, Joseph W.] Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA; [Thornton, Joseph W.] Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA; [Ortlund, Eric A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30332 USA	University of Oregon; Howard Hughes Medical Institute; University of Oregon; Emory University	Thornton, JW (corresponding author), Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA.	joet@uoregon.edu	Thornton, Joseph/GSN-4190-2022; Ortlund, Eric Anthony/P-3121-2019; Ortlund, Eric Anthony/F-4672-2014	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029	National Science Foundation [IOB-0546906]; National Institutes of Health [R01-GM081592, F32-GM074398]; Sloan Foundation Fellowship	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Foundation Fellowship(Alfred P. Sloan Foundation)	Supported by National Science Foundation IOB-0546906, National Institutes of Health R01-GM081592 and F32-GM074398, and a Sloan Foundation Fellowship to J. W. T. We thank M. Harms and members of the Thornton, Cresko and Phillips laboratories for comments.	Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BULL JJ, 1985, EVOLUTION, V39, P1149, DOI 10.2307/2408742; Chippindale PT, 2004, EVOLUTION, V58, P2809; Collin R, 2003, P ROY SOC B-BIOL SCI, V270, P2551, DOI 10.1098/rspb.2003.2517; Collin R, 2008, TRENDS ECOL EVOL, V23, P602, DOI 10.1016/j.tree.2008.06.013; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Dawkins R, 1994, BLIND WATCHMAKER; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Dennett Daniel C., 1995, DARWINS DANGEROUS ID; DOBZHANSKY TG, 1971, GENETICS EVOLUTIONAR, P428; Domes K, 2007, P NATL ACAD SCI USA, V104, P7139, DOI 10.1073/pnas.0700034104; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goldberg EE, 2008, EVOLUTION, V62, P2727, DOI 10.1111/j.1558-5646.2008.00505.x; GOULD S J, 1970, Journal of the History of Biology, V3, P189, DOI 10.1007/BF00137351; Kohlsdorf T, 2006, EVOLUTION, V60, P1896; LEWONTIN RC, 1966, BIOSCIENCE, V16, P25, DOI 10.2307/1293548; MACBETH N, 1980, SYST ZOOL, V29, P402, DOI 10.2307/2992345; MAJERUS MEN, 1998, MELANISM EVOLUTION A, P151; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller HJ, 1939, BIOL REV CAMB PHILOS, V14, P261, DOI 10.1111/j.1469-185X.1939.tb00934.x; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagel M, 2004, TRENDS ECOL EVOL, V19, P278, DOI 10.1016/j.tree.2004.03.020; Simpson GG., 1953, MAJOR FEATURES EVOLU, P310; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Teotonio H, 2001, EVOLUTION, V55, P653, DOI 10.1554/0014-3820(2001)055[0653:PRE]2.0.CO;2; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; WAGNER GP, 1982, J THEOR BIOL, V96, P337, DOI 10.1016/0022-5193(82)90114-X; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Whiting MF, 2003, NATURE, V421, P264, DOI 10.1038/nature01313; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; YANG ZH, 1995, GENETICS, V141, P1641; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Zufall RA, 2004, NATURE, V428, P847, DOI 10.1038/nature02489	35	284	288	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					515	U78		10.1038/nature08249	http://dx.doi.org/10.1038/nature08249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19779450	Green Accepted			2022-12-24	WOS:000270082900038
J	Haas, BJ; Kamoun, S; Zody, MC; Jiang, RHY; Handsaker, RE; Cano, LM; Grabherr, M; Kodira, CD; Raffaele, S; Torto-Alalibo, T; Bozkurt, TO; Ah-Fong, AMV; Alvarado, L; Anderson, VL; Armstrong, MR; Avrova, A; Baxter, L; Beynon, J; Boevink, PC; Bollmann, SR; Bos, JIB; Bulone, V; Cai, GH; Cakir, C; Carrington, JC; Chawner, M; Conti, L; Costanzo, S; Ewan, R; Fahlgren, N; Fischbach, MA; Fugelstad, J; Gilroy, EM; Gnerre, S; Green, PJ; Grenville-Briggs, LJ; Griffith, J; Grunwald, NJ; Horn, K; Horner, NR; Hu, CH; Huitema, E; Jeong, DH; Jones, AME; Jones, JDG; Jones, RW; Karlsson, EK; Kunjeti, SG; Lamour, K; Liu, ZY; Ma, LJ; MacLean, D; Chibucos, MC; McDonald, H; McWalters, J; Meijer, HJG; Morgan, W; Morris, PF; Munro, CA; O'Neill, K; Ospina-Giraldo, M; Pinzon, A; Pritchard, L; Ramsahoye, B; Ren, QH; Restrepo, S; Roy, S; Sadanandom, A; Savidor, A; Schornack, S; Schwartz, DC; Schumann, UD; Schwessinger, B; Seyer, L; Sharpe, T; Silvar, C; Song, J; Studholme, DJ; Sykes, S; Thines, M; van de Vondervoort, PJI; Phuntumart, V; Wawra, S; Weide, R; Win, J; Young, C; Zhou, SG; Fry, W; Meyers, BC; van West, P; Ristaino, J; Govers, F; Birch, PRJ; Whisson, SC; Judelson, HS; Nusbaum, C				Haas, Brian J.; Kamoun, Sophien; Zody, Michael C.; Jiang, Rays H. Y.; Handsaker, Robert E.; Cano, Liliana M.; Grabherr, Manfred; Kodira, Chinnappa D.; Raffaele, Sylvain; Torto-Alalibo, Trudy; Bozkurt, Tolga O.; Ah-Fong, Audrey M. V.; Alvarado, Lucia; Anderson, Vicky L.; Armstrong, Miles R.; Avrova, Anna; Baxter, Laura; Beynon, Jim; Boevink, Petra C.; Bollmann, Stephanie R.; Bos, Jorunn I. B.; Bulone, Vincent; Cai, Guohong; Cakir, Cahid; Carrington, James C.; Chawner, Megan; Conti, Lucio; Costanzo, Stefano; Ewan, Richard; Fahlgren, Noah; Fischbach, Michael A.; Fugelstad, Johanna; Gilroy, Eleanor M.; Gnerre, Sante; Green, Pamela J.; Grenville-Briggs, Laura J.; Griffith, John; Gruenwald, Niklaus J.; Horn, Karolyn; Horner, Neil R.; Hu, Chia-Hui; Huitema, Edgar; Jeong, Dong-Hoon; Jones, Alexandra M. E.; Jones, Jonathan D. G.; Jones, Richard W.; Karlsson, Elinor K.; Kunjeti, Sridhara G.; Lamour, Kurt; Liu, Zhenyu; Ma, LiJun; MacLean, Daniel; Chibucos, Marcus C.; McDonald, Hayes; McWalters, Jessica; Meijer, Harold J. G.; Morgan, William; Morris, Paul F.; Munro, Carol A.; O'Neill, Keith; Ospina-Giraldo, Manuel; Pinzon, Andres; Pritchard, Leighton; Ramsahoye, Bernard; Ren, Qinghu; Restrepo, Silvia; Roy, Sourav; Sadanandom, Ari; Savidor, Alon; Schornack, Sebastian; Schwartz, David C.; Schumann, Ulrike D.; Schwessinger, Ben; Seyer, Lauren; Sharpe, Ted; Silvar, Cristina; Song, Jing; Studholme, David J.; Sykes, Sean; Thines, Marco; van de Vondervoort, Peter J. I.; Phuntumart, Vipaporn; Wawra, Stephan; Weide, Rob; Win, Joe; Young, Carolyn; Zhou, Shiguo; Fry, William; Meyers, Blake C.; van West, Pieter; Ristaino, Jean; Govers, Francine; Birch, Paul R. J.; Whisson, Stephen C.; Judelson, Howard S.; Nusbaum, Chad			Genome sequence and analysis of the Irish potato famine pathogen Phytophthora infestans	NATURE			English	Article							EFFECTOR PROTEINS; RXLR EFFECTORS; CELL-DEATH; PLANT; AVIRULENCE; AVR3A; RESISTANCE; INFECTION; GENES	Phytophthora infestans is the most destructive pathogen of potato and a model organism for the oomycetes, a distinct lineage of fungus-like eukaryotes that are related to organisms such as brown algae and diatoms. As the agent of the Irish potato famine in the mid-nineteenth century, P. infestans has had a tremendous effect on human history, resulting in famine and population displacement(1). To this day, it affects world agriculture by causing the most destructive disease of potato, the fourth largest food crop and a critical alternative to the major cereal crops for feeding the world's population(1). Current annual worldwide potato crop losses due to late blight are conservatively estimated at $6.7 billion(2). Management of this devastating pathogen is challenged by its remarkable speed of adaptation to control strategies such as genetically resistant cultivars(3,4). Here we report the sequence of the P. infestans genome, which at similar to 240 megabases (Mb) is by far the largest and most complex genome sequenced so far in the chromalveolates. Its expansion results from a proliferation of repetitive DNA accounting for similar to 74% of the genome. Comparison with two other Phytophthora genomes showed rapid turnover and extensive expansion of specific families of secreted disease effector proteins, including many genes that are induced during infection or are predicted to have activities that alter host physiology. These fast-evolving effector genes are localized to highly dynamic and expanded regions of the P. infestans genome. This probably plays a crucial part in the rapid adaptability of the pathogen to host plants and underpins its evolutionary potential.	[Kamoun, Sophien; Cano, Liliana M.; Raffaele, Sylvain; Bozkurt, Tolga O.; Jones, Alexandra M. E.; Jones, Jonathan D. G.; MacLean, Daniel; Schornack, Sebastian; Schwessinger, Ben; Silvar, Cristina; Studholme, David J.; Thines, Marco; Win, Joe] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Haas, Brian J.; Zody, Michael C.; Handsaker, Robert E.; Grabherr, Manfred; Kodira, Chinnappa D.; Alvarado, Lucia; Gnerre, Sante; Karlsson, Elinor K.; Ma, LiJun; O'Neill, Keith; Sharpe, Ted; Sykes, Sean; Nusbaum, Chad] Broad Inst MIT & Harvard, Cambridge, MA 02141 USA; [Kamoun, Sophien; Torto-Alalibo, Trudy; Bos, Jorunn I. B.; Cakir, Cahid; Huitema, Edgar; Liu, Zhenyu; Song, Jing; Young, Carolyn] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Plant Pathol, Wooster, OH 44691 USA; [Zody, Michael C.] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75124 Uppsala, Sweden; [Jiang, Rays H. Y.; Meijer, Harold J. G.; van de Vondervoort, Peter J. I.; Weide, Rob; Govers, Francine] Univ Wageningen & Res Ctr, Phytopathol Lab, NL-6708 PB Wageningen, Netherlands; [Ah-Fong, Audrey M. V.; Roy, Sourav; Judelson, Howard S.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Anderson, Vicky L.; Grenville-Briggs, Laura J.; Horner, Neil R.; Schumann, Ulrike D.; Wawra, Stephan; van West, Pieter] Univ Aberdeen, Aberdeen Oomycete Lab, Coll Life Sci & Med, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Armstrong, Miles R.; Avrova, Anna; Boevink, Petra C.; Gilroy, Eleanor M.; Pritchard, Leighton; Whisson, Stephen C.] Scottish Crop Res Inst, Plant Pathol Programme, Dundee DD2 5DA, Scotland; [Baxter, Laura; Beynon, Jim] Univ Warwick, Warwick CV35 9EF, England; [Bollmann, Stephanie R.; Gruenwald, Niklaus J.] ARS, USDA, Hort Crops Res Lab, Corvallis, OR 97330 USA; [Bulone, Vincent; Fugelstad, Johanna] AlbaNova Univ Ctr, Sch Biotechnol, Royal Inst Technol KTH, SE-10691 Stockholm, Sweden; [Cai, Guohong; Fry, William] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14853 USA; [Carrington, James C.; Fahlgren, Noah] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Carrington, James C.; Fahlgren, Noah] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Chawner, Megan; Griffith, John; Horn, Karolyn; McWalters, Jessica; Ospina-Giraldo, Manuel; Seyer, Lauren] Lafayette Coll, Dept Biol, Easton, PA 18042 USA; [Conti, Lucio; Ewan, Richard; Sadanandom, Ari] Univ Glasgow, Plant Mol Sci Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Costanzo, Stefano] ARS, USDA, Dale Bumpers Natl Rice Res Ctr, Stuttgart, AR 72160 USA; [Fischbach, Michael A.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Green, Pamela J.; Jeong, Dong-Hoon; Meyers, Blake C.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA; [Hu, Chia-Hui; Ristaino, Jean] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [Jones, Richard W.] ARS, USDA, Beltsville, MD 20705 USA; [Kunjeti, Sridhara G.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19716 USA; [Lamour, Kurt] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37996 USA; [Chibucos, Marcus C.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [McDonald, Hayes] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Morgan, William] Coll Wooster, Dept Biol, Wooster, OH 44691 USA; [Morris, Paul F.; Phuntumart, Vipaporn] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; [Munro, Carol A.] Univ Aberdeen, Sch Med Sci, Coll Life Sci & Med, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Pinzon, Andres; Restrepo, Silvia] Univ Los Andes, Mycol & Phytopathol Lab, Bogota, Colombia; [Ramsahoye, Bernard] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Canc Res Ctr, Edinburgh EH4 2XU, Midlothian, Scotland; [Schwartz, David C.; Zhou, Shiguo] Univ Wisconsin, Dept Chem, Genet Lab, Ctr Biotechnol,Lab Mol & Computat Genom, Madison, WI 53706 USA; [Thines, Marco] Univ Hohenheim, Inst Bot 210, D-70593 Stuttgart, Germany; [Birch, Paul R. J.] Univ Dundee, SCRI, Coll Life Sci, Div Plant Sci, Dundee DD2 5DA, Scotland; [Ren, Qinghu] J Craig Venter Inst, Rockville, MD 20850 USA; [Savidor, Alon] Tel Aviv Univ, Dept Plant Sci, IL-69978 Tel Aviv, Israel	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University System of Ohio; Ohio State University; Uppsala University; Wageningen University & Research; University of California System; University of California Riverside; University of Aberdeen; James Hutton Institute; University of Warwick; United States Department of Agriculture (USDA); Royal Institute of Technology; Cornell University; Oregon State University; Oregon State University; Lafayette College; University of Glasgow; United States Department of Agriculture (USDA); Harvard University; Massachusetts General Hospital; University of Delaware; University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); University of Delaware; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University System of Maryland; University of Maryland Baltimore; Vanderbilt University; College of Wooster; University System of Ohio; Bowling Green State University; University of Aberdeen; Universidad de los Andes (Colombia); University of Edinburgh; University of Wisconsin System; University of Wisconsin Madison; University Hohenheim; James Hutton Institute; University of Dundee; J. Craig Venter Institute; Tel Aviv University	Kamoun, S (corresponding author), Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	sophien.kamoun@tsl.ac.uk; chad@broad.mit.edu	Silvar, Cristina/G-5141-2010; Ristaino, Jean Beagle/N-3616-2018; Bozkurt, Tolga Osman/AAA-8014-2019; Huitema, Edgar/G-3760-2011; Schornack, Sebastian/AAE-4897-2020; MacLean, Dan/C-7046-2013; Pritchard, Leighton/A-7331-2008; Grenville-Briggs, Laura J/C-3419-2014; Govers, Francine/A-5616-2009; Young, Carolyn Anne/Q-2963-2019; Studholme, David/H-6790-2019; Raffaele, Sylvain/F-7187-2012; Schwessinger, Benjamin/R-5869-2018; Liu, Zhenyu/O-2337-2018; Jones, Alexandra/B-5227-2009; Roy, Sourav/A-5330-2013; Thines, Marco/H-1685-2011; Kamoun, Sophien/B-3529-2009; Birch, Paul/F-7681-2012; Ma, Li-Jun/AAG-2359-2020; Restrepo, Silvia/G-1297-2010; Schumann, Ulrike D/F-3987-2011; Handsaker, Bob/AAX-9095-2021; Raffaele, Sylvain/K-6673-2019; Bos, Jorunn IB/E-4703-2011; Wawra, Stephan/D-2781-2013; Liu, Zhenyu/C-1369-2014; Meijer, Harold/S-3891-2019; Meyers, Blake/B-6535-2012; Grunwald, Niklaus` J/K-6041-2013; Liu, Zhenyu/C-9814-2012; Win, Joe/H-2557-2014; Baxter, laura/GWD-1304-2022; Boevink, Petra/AAO-6498-2021; Kunjeti, Sridhara/AFU-0653-2022; Song, Jing/F-7567-2014; Schornack, Sebastian/A-3650-2011; Cano, Liliana M/O-7041-2016; Meijer, Harold/G-5703-2012; Bulone, Vincent/D-7469-2013; Carrington, James C/A-4656-2012; Chibucos, Marcus/B-1506-2015; Conti, Lucio/M-7982-2013; Zhou, Shiguo/B-3832-2011; Bulone, Vincent/C-8492-2019; Meijer, HJG/AFN-5216-2022; Munro, Carol A/A-5175-2011; Cai, Guohong/N-1274-2013; Fahlgren, Noah/D-4404-2011; Grenville-Briggs, Laura/B-3386-2013; Bozkurt, Tolga O/C-9764-2014	Silvar, Cristina/0000-0002-1782-8045; Ristaino, Jean Beagle/0000-0002-9458-0514; Bozkurt, Tolga Osman/0000-0003-0507-6875; Huitema, Edgar/0000-0002-5766-0830; Schornack, Sebastian/0000-0002-7836-5881; MacLean, Dan/0000-0003-1032-0887; Pritchard, Leighton/0000-0002-8392-2822; Grenville-Briggs, Laura J/0000-0001-5910-3651; Govers, Francine/0000-0001-5311-929X; Young, Carolyn Anne/0000-0003-0406-8398; Studholme, David/0000-0002-3010-6637; Raffaele, Sylvain/0000-0002-2442-9632; Schwessinger, Benjamin/0000-0002-7194-2922; Liu, Zhenyu/0000-0002-8320-7845; Jones, Alexandra/0000-0003-2571-8708; Roy, Sourav/0000-0002-0359-994X; Kamoun, Sophien/0000-0002-0290-0315; Schumann, Ulrike D/0000-0002-2379-1226; Handsaker, Bob/0000-0002-3128-3547; Raffaele, Sylvain/0000-0002-2442-9632; Bos, Jorunn IB/0000-0003-3222-8643; Wawra, Stephan/0000-0001-8555-1618; Meijer, Harold/0000-0002-0883-219X; Meyers, Blake/0000-0003-3436-6097; Grunwald, Niklaus` J/0000-0003-1656-7602; Win, Joe/0000-0002-9851-2404; Boevink, Petra/0000-0002-7021-9097; Schornack, Sebastian/0000-0002-7836-5881; Cano, Liliana M/0000-0002-7996-4181; Carrington, James C/0000-0003-3572-129X; Chibucos, Marcus/0000-0001-9586-0780; Conti, Lucio/0000-0002-7837-4227; Zhou, Shiguo/0000-0001-7421-2506; Bulone, Vincent/0000-0003-2809-4160; Meijer, HJG/0000-0002-0883-219X; Cai, Guohong/0000-0002-7700-6019; Fahlgren, Noah/0000-0002-5597-4537; Bozkurt, Tolga O/0000-0003-0507-6875; Grabherr, Manfred/0000-0001-8792-6508; Birch, Paul/0000-0002-6559-3746; Morris, Paul/0000-0002-2989-041X; Pinzon, Andres/0000-0002-4133-810X; van West, Pieter/0000-0002-0767-6017; Morgan, William/0000-0001-7995-8067; Munro, Carol/0000-0003-0761-1755; Horner, Neil/0000-0002-0550-4537; Karlsson, Elinor/0000-0002-4343-3776; Restrepo, Silvia/0000-0001-9016-1040; Ma, Li-Jun/0000-0002-2733-3708; Sykes, Sean/0000-0001-8344-5176; Kunjeti, Sridhara/0000-0002-6326-2644; Fischbach, Michael/0000-0003-3079-8247	National Research Initiative of the USDA Cooperative State Research, Education and Extension Service [2004-35600-15024, 2006-35600-16623]; National Science Foundation [EF-0333274, EF-0523670]; Gatsby Charitable Foundation; Biotechnology and Biological Sciences Research Council [BB/E006795/1, BBS/B/07152, BB/E007120/1, BB/G015244/1, BB/C509123/1] Funding Source: researchfish; Medical Research Council [G0400284] Funding Source: researchfish; Natural Environment Research Council [NE/F012578/1] Funding Source: researchfish; BBSRC [BB/G015244/1, BB/E007120/1, BB/E006795/1] Funding Source: UKRI; MRC [G0400284] Funding Source: UKRI; NERC [NE/F012578/1] Funding Source: UKRI	National Research Initiative of the USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Science Foundation(National Science Foundation (NSF)); Gatsby Charitable Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Acknowledgements We thank L. Gaffney for help with figures and tables, E. Blanco and R. Guigo for training the GeneID gene prediction software, J. Crabtree for providing a Sybil (http://sybil.sf.net) software component used to render genome comparison illustrations, the Broad Institute Genome Sequencing Platform for sequence data generation, and C. Cuomo and D. Neafsey for comments on the manuscript. The project was supported by the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, grant numbers 2004-35600-15024 and 2006-35600-16623, and the National Science Foundation grants EF-0333274 and EF-0523670, and the Gatsby Charitable Foundation.	Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Enright AJ, 2003, NUCLEIC ACIDS RES, V31, P4632, DOI 10.1093/nar/gkg495; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Grenville-Briggs LJ, 2005, FUNGAL GENET BIOL, V42, P244, DOI 10.1016/j.fgb.2004.11.009; Haberer G, 2005, PLANT PHYSIOL, V139, P1612, DOI 10.1104/pp.105.068718; Haverkort AJ, 2008, POTATO RES, V51, P47, DOI 10.1007/s11540-008-9089-y; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Kamoun S, 1997, MOL PLANT MICROBE IN, V10, P13, DOI 10.1094/MPMI.1997.10.1.13; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Morgan W, 2007, CURR OPIN MICROBIOL, V10, P332, DOI 10.1016/j.mib.2007.04.005; Qutob D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005066; Reader J., 2009, POTATO HIST PROPITIO; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Yuan YN, 2002, GENOME RES, V12, P1345, DOI 10.1101/gr.185902	24	977	1150	15	427	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					393	398		10.1038/nature08358	http://dx.doi.org/10.1038/nature08358			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19741609	Green Published, hybrid			2022-12-24	WOS:000269828100039
J	Mallen, CD; Chesterton, LS; Hay, EM				Mallen, Christian David; Chesterton, Linda S.; Hay, Elaine M.			10-Minute Consultation Tennis elbow	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mallen, Christian David; Chesterton, Linda S.; Hay, Elaine M.] Keele Univ, Arthrit Res Campaign Natl Primary Care Ctr, Keele ST5 5BG, Staffs, England	Keele University	Mallen, CD (corresponding author), Keele Univ, Arthrit Res Campaign Natl Primary Care Ctr, Keele ST5 5BG, Staffs, England.	c.d.mallen@cphc.keele.ac.uk		Mallen, Christian/0000-0002-2677-1028	Arthritis Research UK Funding Source: Medline; Department of Health [PB-PG-0407-13189] Funding Source: Medline; National Institute for Health Research [PB-PG-0407-13189] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))			0	7	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 2	2009	339								b3180	10.1136/bmj.b3180	http://dx.doi.org/10.1136/bmj.b3180			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491CH	19726459				2022-12-24	WOS:000269554000013
J	Linnen, CR; Kingsley, EP; Jensen, JD; Hoekstra, HE				Linnen, Catherine R.; Kingsley, Evan P.; Jensen, Jeffrey D.; Hoekstra, Hopi E.			On the Origin and Spread of an Adaptive Allele in Deer Mice	SCIENCE			English	Article							STANDING GENETIC-VARIATION; MULTILOCUS GENOTYPE DATA; MOUSE AGOUTI LOCUS; POSITIVE SELECTION; COAT COLOR; PIGMENTATION; POLYMORPHISM; MUTATIONS; EVOLUTION; PEROMYSCUS	Adaptation is a central focus of biology, although it can be difficult to identify both the strength and agent of selection and the underlying molecular mechanisms causing change. We studied cryptically colored deer mice living on the Nebraska Sand Hills and show that their light coloration stems from a novel banding pattern on individual hairs produced by an increase in Agouti expression caused by a cis-acting mutation (or mutations), which either is or is closely linked to a single amino acid deletion in Agouti that appears to be under selection. Furthermore, our data suggest that this derived Agouti allele arose de novo after the formation of the Sand Hills. These findings reveal one means by which genetic, developmental, and evolutionary mechanisms can drive rapid adaptation under ecological pressure.	[Linnen, Catherine R.; Kingsley, Evan P.; Hoekstra, Hopi E.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Linnen, Catherine R.; Kingsley, Evan P.; Hoekstra, Hopi E.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Jensen, Jeffrey D.] Univ Calif Berkeley, Ctr Theoret Evolutionary Genom, Dept Integrat Biol, Berkeley, CA 94720 USA	Harvard University; Harvard University; University of California System; University of California Berkeley	Linnen, CR (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 26 Oxford St, Cambridge, MA 02138 USA.	clinnen@oeb.harvard.edu	Linnen, Catherine/F-2492-2011; Hoekstra, Hopi E/I-6690-2012; Jensen, Jeffrey/S-1084-2016	Hoekstra, Hopi E/0000-0003-1431-1769; Linnen, Catherine/0000-0001-5715-456X; Kingsley, Evan/0000-0002-4351-2300; Jensen, Jeffrey/0000-0002-4786-8064	NIH [Ruth Kirschstein National Research Service Award]; NSF [Biological Informatics Postdoctoral Fellowship]; Museum of Comparative Zoology at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM083073] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Museum of Comparative Zoology at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Crossland and M. Dewey for assistance with crosses; W. Dawson for his advice; M. Chin, B. Hehli, and K. Hogan for laboratory assistance; J. Chupasko, E. Kay, M. Manceau, and J. Weber for field assistance; J. Demboski and the Denver Museum of Nature and Science for logistical support; J. Losos and B. Payseur for comments; and G. Barsh for ongoing discussion about Agouti. C.R.L. was supported by a Ruth Kirschstein National Research Service Award from NIH; J.D.J. was supported by a NSF Biological Informatics Postdoctoral Fellowship. Laboratory and fieldwork was funded by NSF and the Museum of Comparative Zoology at Harvard University. P. maniculatus were collected under the Nebraska Game and Parks Commission Scientific and Educational Permit 901, and voucher specimens were deposited in the Mammal Department at the Museum of Comparative Zoology. Sequence data were deposited in GenBank (accession numbers GQ337976 to GQ337987 and GQ340804 to GQ340896).	AHLBRANDT TS, 1981, RECENT ANCIENT NONMA, P293; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; CLARKE B, 1962, HEREDITY, V17, P445, DOI 10.1038/hdy.1962.47; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; CREED ER, 1975, PROC R SOC SER B-BIO, V190, P135, DOI 10.1098/rspb.1975.0083; Dice L. R., 1941, Contributions from the Laboratory of Vertebrate Genetics University of Michigan, Vno. 15, P1; Dice Lee R., 1947, CONIR LAB VERTEBRATE BIOL UNIV MICHIGAN, V34, P1; DODSON KM, 1982, THESIS U S CAROLINA; Falush D, 2003, GENETICS, V164, P1567; Feder JL, 2003, P NATL ACAD SCI USA, V100, P10314, DOI 10.1073/pnas.1730757100; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hoekstra HE, 2004, EVOLUTION, V58, P1329; HORNER BE, 1980, J HERED, V71, P49, DOI 10.1093/oxfordjournals.jhered.a109310; JACKSON IJ, 1994, ANNU REV GENET, V28, P189, DOI 10.1146/annurev.ge.28.120194.001201; Jackson PJ, 2006, CHEM BIOL, V13, P1297, DOI 10.1016/j.chembiol.2006.10.006; Jensen JD, 2005, GENETICS, V170, P1401, DOI 10.1534/genetics.104.038224; Jensen JD, 2008, MOL BIOL EVOL, V25, P438, DOI 10.1093/molbev/msm273; Jensen JD, 2007, GENETICS, V176, P2371, DOI 10.1534/genetics.106.069450; Kim Y, 2002, GENETICS, V160, P765; Kingsley EP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006435; Laurie CC, 2007, PLOS GENET, V3, P1487, DOI 10.1371/journal.pgen.0030144; LEWIS DT, 1989, ATLAS SANDHILLS, P57; Loope D.B., 2000, GREAT PLAINS RES, V10, P5; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; McIntosh W. B., 1956, Contributions from the Laboratory of Vertebrate Biology of the University of Michigan, VNo. 73, P1; Meiklejohn CD, 2004, GENETICS, V168, P265, DOI 10.1534/genetics.103.025494; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; Miltenberger RJ, 2002, GENETICS, V160, P659; Mullen LM, 2008, EVOLUTION, V62, P1555, DOI 10.1111/j.1558-5646.2008.00425.x; Pritchard JK, 2000, GENETICS, V155, P945; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Przeworski M, 2003, GENETICS, V164, P1667; STEPHAN W, 1992, THEOR POPUL BIOL, V41, P237, DOI 10.1016/0040-5809(92)90045-U; Storz JF, 2007, PLOS GENET, V3, P448, DOI 10.1371/journal.pgen.0030045; Swinehart J.B., 1989, ATLAS SAND HILLS, P43; VRIELING H, 1994, P NATL ACAD SCI USA, V91, P5667, DOI 10.1073/pnas.91.12.5667; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698	39	181	189	0	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 28	2009	325	5944					1095	1098		10.1126/science.1175826	http://dx.doi.org/10.1126/science.1175826			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713521	Green Accepted			2022-12-24	WOS:000269382300032
J	Watts, JM; Dang, KK; Gorelick, RJ; Leonard, CW; Bess, JW; Swanstrom, R; Burch, CL; Weeks, KM				Watts, Joseph M.; Dang, Kristen K.; Gorelick, Robert J.; Leonard, Christopher W.; Bess, Julian W., Jr.; Swanstrom, Ronald; Burch, Christina L.; Weeks, Kevin M.			Architecture and secondary structure of an entire HIV-1 RNA genome	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SELECTIVE 2'-HYDROXYL ACYLATION; SINGLE NUCLEOTIDE RESOLUTION; PRIMER EXTENSION SHAPE; CONTEXT-FREE GRAMMARS; REVERSE TRANSCRIPTION; THERMODYNAMIC PARAMETERS; STRUCTURE PREDICTION; PROTEIN EXPRESSION; CODING REGIONS	Single-stranded RNA viruses encompass broad classes of infectious agents and cause the common cold, cancer, AIDS and other serious health threats. Viral replication is regulated at many levels, including the use of conserved genomic RNA structures. Most potential regulatory elements in viral RNA genomes are uncharacterized. Here we report the structure of an entire HIV-1 genome at single nucleotide resolution using SHAPE, a high-throughput RNA analysis technology. The genome encodes protein structure at two levels. In addition to the correspondence between RNA and protein primary sequences, a correlation exists between high levels of RNA structure and sequences that encode inter-domain loops in HIV proteins. This correlation suggests that RNA structure modulates ribosome elongation to promote native protein folding. Some simple genome elements previously shown to be important, including the ribosomal gag-pol frameshift stem-loop, are components of larger RNA motifs. We also identify organizational principles for unstructured RNA regions, including splice site acceptors and hypervariable regions. These results emphasize that the HIV-1 genome and, potentially, many coding RNAs are punctuated by previously unrecognized regulatory motifs and that extensive RNA structure constitutes an important component of the genetic code.	[Watts, Joseph M.; Leonard, Christopher W.; Weeks, Kevin M.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Dang, Kristen K.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Swanstrom, Ronald] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA; [Burch, Christina L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Gorelick, Robert J.; Bess, Julian W., Jr.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21702 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Weeks, KM (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	weeks@unc.edu		Dang, Kristen/0000-0002-7512-4476; Burch, Christina/0000-0001-7830-0124	US National Institutes of Health [AI068462]; National Cancer Institute [N01-CO-12400, HHSN261200800001E]; National Institutes of Health (NIH) [AI44667, T32 AI07419]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044667, R01AI044667, R56AI044667, R01AI068462, T32AI007419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064803] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the US National Institutes of Health (AI068462 to K. M. W.) and by the National Cancer Institute, under contracts N01-CO-12400 and HHSN261200800001E (to R. J. G. and J. W. B.). J. M. W. was supported as a Fellow of the UNC Lineberger Cancer Center and a National Institutes of Health (NIH) Kirschstein Postdoctoral Fellowship. R. S. and K. K. D. were supported by NIH grants AI44667 and T32 AI07419, respectively. We are indebted to D. Mathews and J. Low for assistance with the RNA structure program and genome secondary structure analysis, respectively. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations indicate endorsement by the US Government.	Abecasis AB, 2007, J VIROL, V81, P8543, DOI 10.1128/JVI.00463-07; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Badorrek CS, 2006, BIOCHEMISTRY-US, V45, P12664, DOI 10.1021/bi060521k; Badorrek CS, 2005, NAT CHEM BIOL, V1, P104, DOI 10.1038/nchembio712; Biswas P, 2004, J VIROL, V78, P2082, DOI 10.1128/JVI.78.4.2082-2087.2004; Buckman JS, 2003, J VIROL, V77, P1469, DOI 10.1128/JVI.77.2.1469-1480.2003; CANN AJ, 2005, PRINCIPLES MOL VIROL, pCH2; Chang TH, 2008, NUCLEIC ACIDS RES, V36, pW91, DOI 10.1093/nar/gkn258; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Cline AN, 2005, J MED PRIMATOL, V34, P303; Coffin J, 1997, RETROVIRUSES; Damgaard CK, 2004, J MOL BIOL, V336, P369, DOI 10.1016/j.jmb.2003.12.010; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Dowell RD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-71; Durbin R., 1998, BIOL SEQUENCE ANAL, DOI [10.1017/cbo9780511790492, DOI 10.1017/CBO9780511790492]; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Gherghe CM, 2008, J AM CHEM SOC, V130, P12244, DOI 10.1021/ja804541s; Giedroc DP, 2000, J MOL BIOL, V298, P167, DOI 10.1006/jmbi.2000.3668; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LEITNER T, 2005, HIV SEQUENCE COMPEND; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Means RE, 2001, J VIROL, V75, P3903, DOI 10.1128/JVI.75.8.3903-3915.2001; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; OLSEN HS, 1990, SCIENCE, V247, P845, DOI 10.1126/science.2406903; OTT DE, 1995, AIDS RES HUM RETROV, V11, P1003, DOI 10.1089/aid.1995.11.1003; Paillart JC, 2002, J BIOL CHEM, V277, P5995, DOI 10.1074/jbc.M108972200; Pedersen JS, 2004, NUCLEIC ACIDS RES, V32, P4925, DOI 10.1093/nar/gkh839; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; *R DEV CORE TEAM, 2008, R FDN STAT COMPUTING; STEIN BS, 1990, J BIOL CHEM, V265, P2640; Thomas JA, 2006, VIROLOGY, V353, P41, DOI 10.1016/j.virol.2006.05.014; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vasa SM, 2008, RNA, V14, P1979, DOI 10.1261/rna.1166808; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wilkinson KA, 2009, RNA, V15, P1314, DOI 10.1261/rna.1536209; WILSON W, 1988, CELL, V55, P1159, DOI 10.1016/0092-8674(88)90260-7; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425	52	581	601	0	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 6	2009	460	7256					711	U87		10.1038/nature08237	http://dx.doi.org/10.1038/nature08237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19661910	Green Accepted, Green Submitted			2022-12-24	WOS:000268670300032
J	Roberts, RB; Ser, JR; Kocher, TD				Roberts, Reade B.; Ser, Jennifer R.; Kocher, Thomas D.			Sexual Conflict Resolved by Invasion of a Novel Sex Determiner in Lake Malawi Cichlid Fishes	SCIENCE			English	Article							NEURAL CREST; CHROMOSOMES; EVOLUTION; COLORATION; SPECIATION; SELECTION	Sex determination mechanisms differ among animal species, but it is not clear how these differences evolve. New sex determiners may arise in response to sexual conflicts, which occur when traits benefit one sex but hinder the other. We identified the genetic basis for the orange-blotch ( OB) color pattern, a trait under sexually antagonistic selection in the cichlid fish of Lake Malawi, East Africa. The OB phenotype is due to a cis-regulatory mutation in the Pax7 gene. OB provides benefits of camouflage to females but disrupts the species-specific male color patterns used for mate recognition. We suggest that the resulting sexual conflict over the OB allele has been resolved by selection for a novel female sex determination locus that has invaded populations with an ancestral male sex determination system.	[Roberts, Reade B.; Ser, Jennifer R.; Kocher, Thomas D.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Kocher, TD (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	tdk@umd.edu	Kocher, Thomas D/B-3089-2013	Kocher, Thomas/0000-0002-7547-0133; Roberts, Reade/0000-0003-2551-3761	NIH [F32HD051383, R01HD058635]; NSF [DEB-0445212]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058635, F32HD051383] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank O. Seehausen for providing cichlid tissues from Lake Victoria, and S. Salzberg for assistance in aligning cichlid genome sequences to the Tetraodon genome. Supported by NIH fellowship F32HD051383 ( R. B. R.) and by NSF grant DEB-0445212 and NIH grant R01HD058635 ( T. D. K.). Sequences generated in this study are deposited in GenBank under accession numbers GQ403984 to GQ403986.	Allender CJ, 2003, P NATL ACAD SCI USA, V100, P14074, DOI 10.1073/pnas.2332665100; Arnqvist Goran, 2005, pUnpaginated; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Fisher RA, 1931, BIOL REV BIOL P CAMB, V6, P345, DOI 10.1111/j.1469-185X.1931.tb01030.x; HOLZBERG S, 1978, Z ZOOL SYST EVOL, V16, P171; Konings A., 2016, MALAWI CICHLIDS THEI; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lacosta AM, 2005, PIGM CELL RES, V18, P243, DOI 10.1111/j.1600-0749.2005.00238.x; Lande R, 2001, GENETICA, V112, P435, DOI 10.1023/A:1013379521338; Minchin JEN, 2008, DEV BIOL, V317, P508, DOI 10.1016/j.ydbio.2008.02.058; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; RICE WR, 1987, EVOLUTION, V41, P911, DOI 10.1111/j.1558-5646.1987.tb05864.x; Schaefer HM, 2006, P R SOC B, V273, P2427, DOI 10.1098/rspb.2006.3615; Streelman JT, 2003, MOL ECOL, V12, P2465, DOI 10.1046/j.1365-294X.2003.01920.x; van Doorn GS, 2007, NATURE, V449, P909, DOI 10.1038/nature06178; Van Oppen MJH, 1998, MOL ECOL, V7, P991, DOI 10.1046/j.1365-294x.1998.00417.x	16	237	243	4	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					998	1001		10.1126/science.1174705	http://dx.doi.org/10.1126/science.1174705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19797625	Green Accepted			2022-12-24	WOS:000271712300041
J	Klattenhoff, C; Xi, HL; Li, CJ; Lee, S; Xu, J; Khurana, JS; Zhang, F; Schultz, N; Koppetsch, BS; Nowosielska, A; Seitz, H; Zamore, PD; Weng, ZP; Theurkauf, WE				Klattenhoff, Carla; Xi, Hualin; Li, Chengjian; Lee, Soohyun; Xu, Jia; Khurana, Jaspreet S.; Zhang, Fan; Schultz, Nadine; Koppetsch, Birgit S.; Nowosielska, Anetta; Seitz, Herve; Zamore, Phillip D.; Weng, Zhiping; Theurkauf, William E.			The Drosophila HP1 Homolog Rhino Is Required for Transposon Silencing and piRNA Production by Dual-Strand Clusters	CELL			English	Article							EMBRYONIC AXIS SPECIFICATION; SELFISH GENETIC ELEMENTS; FLAMENCO GENE; DNA-DAMAGE; GERM-LINE; MELANOGASTER; HETEROCHROMATIN; GYPSY; PIWI; PROTEIN	Piwi-interacting RNAs (piRNAs) silence transposons and maintain genome integrity during germline development. In Drosophila, transposon-rich heterochromatic clusters encode piRNAs either on both genomic strands (dual-strand clusters) or predominantly one genomic strand (uni-strand clusters). Primary piRNAs derived from these clusters are proposed to drive a ping-pong amplification cycle catalyzed by proteins that localize to the perinuclear nuage. We show that the HP1 homolog Rhino is required for nuage organization, transposon silencing, and ping-pong amplification of piRNAs. rhi mutations virtually eliminate piRNAs from the dual-strand clusters and block production of putative precursor RNAs from both strands of the major 42AB dual-strand cluster, but not of transcripts or piRNAs from the uni-strand clusters. Furthermore, Rhino protein associates with the 42AB dual-strand cluster, but does not bind to uni-strand cluster 2 or flamenco. Rhino thus appears to promote transcription of dual-strand clusters, leading to production of piRNAs that drive the ping-pong amplification cycle.	[Li, Chengjian; Seitz, Herve; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Li, Chengjian; Seitz, Herve; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Klattenhoff, Carla; Khurana, Jaspreet S.; Zhang, Fan; Schultz, Nadine; Koppetsch, Birgit S.; Nowosielska, Anetta; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Klattenhoff, Carla; Khurana, Jaspreet S.; Zhang, Fan; Schultz, Nadine; Koppetsch, Birgit S.; Nowosielska, Anetta; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Cell Dynam, Worcester, MA 01605 USA; [Xi, Hualin; Lee, Soohyun; Xu, Jia; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Seitz, Herve] Univ Toulouse 3, Univ Toulouse, Lab Biol Mol Eucaryote, F-31000 Toulouse, France; [Seitz, Herve] CNRS, Lab Biol Mol Eucaryote, F-31000 Toulouse, France; [Xu, Jia] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Xi, Hualin; Lee, Soohyun] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Xi, Hualin] Pfizer Inc, Computat Sci Ctr Emphasis, Cambridge, MA 02139 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Boston University; Boston University; Pfizer	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu; zhiping.weng@umassmed.edu; william.theurkauf@umassmed.edu	Zamore, Phillip D/A-8941-2013; Xu, Jia/F-7750-2012; Seitz, Hervé/AAE-6487-2019	Seitz, Hervé/0000-0001-8172-5393; Zamore, Phillip/0000-0002-4505-9618; Theurkauf, William/0000-0001-7342-1912; Xu, Jia/0000-0003-3921-018X; Lee, Soohyun/0000-0002-3594-6213	Diabetes and Endocrinology research Center [DK032502]; National Institutes of Health [HD049116, GM62862, GM65236]; Pfizer; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062862, R01GM065236, R01GM062862] Funding Source: NIH RePORTER	Diabetes and Endocrinology research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Celeste Berg for rhi mutant stocks, Maria Zapp and Ellie Kittler in the UMass Deep Sequencing Core and Phyllis Spartick in the UMass Genomics core for expert assistance with small RNA sequencing and tiling array analyses, and members of the Zamore, Weng, and Theurkauf labs for critical discussions during the course of these studies. The Genomics Core was supported by the Diabetes and Endocrinology research Center grant DK032502. This work was supported in part by grants from the National Institutes of Health to W. E. T. (HD049116) and P. D. Z. (GM62862 and GM65236). H. X. was supported in part by Pfizer.	Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; BELMONT AS, 1989, CHROMOSOMA, V98, P129, DOI 10.1007/BF00291049; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; BOZZETTI MP, 1995, P NATL ACAD SCI USA, V92, P6067, DOI 10.1073/pnas.92.13.6067; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cha BJ, 2001, CELL, V106, P35, DOI 10.1016/S0092-8674(01)00419-6; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Girton JR, 2008, ADV GENET, V61, P1, DOI 10.1016/S0065-2660(07)00001-6; Gong WJ, 2005, PLOS GENET, V1, P589, DOI 10.1371/journal.pgen.0010067; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; HAWLEY RS, 1983, GENETICS, V104, P63; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Jang JK, 2003, J CELL SCI, V116, P3069, DOI 10.1242/jcs.00614; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; LIVAK KJ, 1990, GENETICS, V124, P303; LIVAK KJ, 1984, GENETICS, V107, P611; McKim KS, 1998, GENE DEV, V12, P2932, DOI 10.1101/gad.12.18.2932; Mevel-Ninio M, 2007, GENETICS, V175, P1615, DOI 10.1534/genetics.106.068106; Modesti M, 2001, CURR BIOL, V11, pR229, DOI 10.1016/S0960-9822(01)00112-9; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; PALUMBO G, 1994, GENETICS, V138, P1181; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; Pelisson A, 2007, MOL BIOL EVOL, V24, P498, DOI 10.1093/molbev/msl176; PRUDHOMME N, 1995, GENETICS, V139, P697; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; Soper SFC, 2008, DEV CELL, V15, P285, DOI 10.1016/j.devcel.2008.05.015; Takada S, 2003, CELL, V113, P87, DOI 10.1016/S0092-8674(03)00202-2; THEURKAUF WE, 1994, METHOD CELL BIOL, V44, P489, DOI 10.1016/S0091-679X(08)60928-0; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Vermaak D, 2005, PLOS GENET, V1, P96, DOI 10.1371/journal.pgen.0010009; Volpe AM, 2001, GENETICS, V159, P1117; Wang XQ, 2006, J CELL PHYSIOL, V208, P613, DOI 10.1002/jcp.20700	59	282	294	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1137	1149		10.1016/j.cell.2009.07.014	http://dx.doi.org/10.1016/j.cell.2009.07.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19732946	Green Accepted, Bronze			2022-12-24	WOS:000269923200014
J	Zhang, Y; Thiele, I; Weekes, D; Li, ZW; Jaroszewski, L; Ginalski, K; Deacon, AM; Wooley, J; Lesley, SA; Wilson, IA; Palsson, B; Osterman, A; Godzik, A				Zhang, Ying; Thiele, Ines; Weekes, Dana; Li, Zhanwen; Jaroszewski, Lukasz; Ginalski, Krzysztof; Deacon, Ashley M.; Wooley, John; Lesley, Scott A.; Wilson, Ian A.; Palsson, Bernhard; Osterman, Andrei; Godzik, Adam			Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima	SCIENCE			English	Article							EVOLUTION; RECONSTRUCTION; GENE; PATHWAYS; BIOSYNTHESIS; BIOCHEMISTRY; RESOLUTION; SEQUENCES; PROTEINS; DATABASE	Metabolic pathways have traditionally been described in terms of biochemical reactions and metabolites. With the use of structural genomics and systems biology, we generated a three-dimensional reconstruction of the central metabolic network of the bacterium Thermotoga maritima. The network encompassed 478 proteins, of which 120 were determined by experiment and 358 were modeled. Structural analysis revealed that proteins forming the network are dominated by a small number (only 182) of basic shapes (folds) performing diverse but mostly related functions. Most of these folds are already present in the essential core (similar to 30%) of the network, and its expansion by nonessential proteins is achieved with relatively few additional folds. Thus, integration of structural data with networks analysis generates insight into the function, mechanism, and evolution of biological networks.	[Zhang, Ying; Li, Zhanwen; Godzik, Adam] Burnham Inst Med Res, JCMM, La Jolla, CA 92037 USA; [Thiele, Ines; Palsson, Bernhard] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Weekes, Dana; Jaroszewski, Lukasz; Godzik, Adam] Burnham Inst Med Res, JCSG, La Jolla, CA 92037 USA; [Ginalski, Krzysztof] Warsaw Univ, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland; [Deacon, Ashley M.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, JCSG, Menlo Pk, CA 94025 USA; [Wooley, John; Godzik, Adam] Univ Calif San Diego, JCSG, La Jolla, CA 92093 USA; [Lesley, Scott A.] Novartis Res Fdn, Genom Inst, JCSG, San Diego, CA 92121 USA; [Wilson, Ian A.] Scripps Res Inst, JCSG, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; University of Warsaw; Interdisciplinary Centre for Mathematical & Computational Modelling; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California San Diego; Novartis; Scripps Research Institute	Godzik, A (corresponding author), Burnham Inst Med Res, JCMM, La Jolla, CA 92037 USA.	adam@burnham.org	Zhang, Ying/L-7614-2013; Thiele, Ines/A-7629-2014; Godzik, Adam/A-7279-2009; Zhang, Ying/ABA-6518-2021; Godzik, Adam/AAW-1467-2020	Zhang, Ying/0000-0001-8759-0194; Thiele, Ines/0000-0002-8071-7110; Godzik, Adam/0000-0002-2425-852X; Zhang, Ying/0000-0001-8759-0194; Godzik, Adam/0000-0002-2425-852X; Palsson, Bernhard/0000-0003-2357-6785	National Institute of General Medical Sciences (NIGMS); NIGMS [P20 GM076221, U54 GM074898]; Office of Science [DE-FG02-08ER64686]; U. S. Department of Energy; Betty Moore Foundation CAMERA project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074898, P20GM076221] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science(United States Department of Energy (DOE)); U. S. Department of Energy(United States Department of Energy (DOE)); Betty Moore Foundation CAMERA project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We specifically acknowledge the invaluable work of individual crystallographers at the JCSG and other Protein Structure Initiative (PSI) centers, as well as individual research groups, who have solved structures analyzed here, either directly or that we used as modeling templates. The full list of these proteins is provided in the supporting online material. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences (NIGMS). This work was supported by the NIH PSI grants P20 GM076221 (JCCM) and U54 GM074898 (JCSG) from the NIGMS; grant DE-FG02-08ER64686 from the Office of Science ( Biological and Environmental Research), U. S. Department of Energy; and the Gordon and Betty Moore Foundation CAMERA project.	Conners SB, 2006, FEMS MICROBIOL REV, V30, P872, DOI 10.1111/j.1574-6976.2006.00039.x; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Durot M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-85; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Holliday GL, 2007, NAT PROD REP, V24, P972, DOI 10.1039/b703107f; HOROWITZ NH, 1945, P NATL ACAD SCI USA, V31, P153, DOI 10.1073/pnas.31.6.153; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; Ideker T, 2003, TRENDS BIOTECHNOL, V21, P255, DOI 10.1016/S0167-7799(03)00115-X; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Joyce Andrew R, 2007, Prog Drug Res, V64, P267; Karp PD, 2001, SCIENCE, V293, P2040, DOI 10.1126/science.1064621; Koehn EM, 2009, NATURE, V458, P919, DOI 10.1038/nature07973; Koonin EV, 1996, TRENDS GENET, V12, P334, DOI 10.1016/0168-9525(96)20010-1; Kuhn P, 2002, PROTEINS, V49, P142, DOI 10.1002/prot.10202; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Matthews BW, 2007, NAT STRUCT MOL BIOL, V14, P459, DOI 10.1038/nsmb0607-459; Murzin AG, 2002, SCIENCE, V297, P61, DOI 10.1126/science.1073910; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pal C, 2006, NATURE, V440, P667, DOI 10.1038/nature04568; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rison SCG, 2002, CURR OPIN STRUC BIOL, V12, P374, DOI 10.1016/S0959-440X(02)00331-7; Schilling CH, 2000, BIOTECHNOL BIOENG, V71, P286, DOI 10.1002/1097-0290(2000)71:4<286::AID-BIT1018>3.0.CO;2-R; Senger RS, 2008, BIOTECHNOL BIOENG, V101, P1036, DOI 10.1002/bit.22010; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Yang C, 2008, J BACTERIOL, V190, P1773, DOI 10.1128/JB.01469-07; Yang ZR, 2003, J BIOL CHEM, V278, P8804, DOI 10.1074/jbc.M211892200; 2007, WORKSH SAN DIEG CA 9	31	130	134	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1544	1549		10.1126/science.1174671	http://dx.doi.org/10.1126/science.1174671			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762644	Green Accepted			2022-12-24	WOS:000269887900041
J	Monk, KR; Naylor, SG; Glenn, TD; Mercurio, S; Perlin, JR; Dominguez, C; Moens, CB; Talbot, WS				Monk, Kelly R.; Naylor, Stephen G.; Glenn, Thomas D.; Mercurio, Sara; Perlin, Julie R.; Dominguez, Claudia; Moens, Cecilia B.; Talbot, William S.			A G Protein-Coupled Receptor Is Essential for Schwann Cells to Initiate Myelination	SCIENCE			English	Article							ADHESION FAMILY; TRANSCRIPTION; ENSHEATHMENT; EXPRESSION; ZEBRAFISH; GENES; OCT-6; AXONS; ERBB2; SCIP	The myelin sheath allows axons to conduct action potentials rapidly in the vertebrate nervous system. Axonal signals activate expression of specific transcription factors, including Oct6 and Krox20, that initiate myelination in Schwann cells. Elevation of cyclic adenosine monophosphate ( cAMP) can mimic axonal contact in vitro, but the mechanisms that regulate cAMP levels in vivo are unknown. Using mutational analysis in zebrafish, we found that the G protein-coupled receptor Gpr126 is required autonomously in Schwann cells for myelination. In gpr126 mutants, Schwann cells failed to express oct6 and krox20 and were arrested at the promyelinating stage. Elevation of cAMP in gpr126 mutants, but not krox20 mutants, could restore myelination. We propose that Gpr126 drives the differentiation of promyelinating Schwann cells by elevating cAMP levels, thereby triggering Oct6 expression and myelination.	[Monk, Kelly R.; Naylor, Stephen G.; Glenn, Thomas D.; Mercurio, Sara; Perlin, Julie R.; Dominguez, Claudia; Talbot, William S.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Moens, Cecilia B.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA; [Moens, Cecilia B.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Stanford University; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Fred Hutchinson Cancer Center	Talbot, WS (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	william.talbot@stanford.edu	mercurio, sara/ABH-2793-2021; Moens, Cecilia/AAN-1536-2020	mercurio, sara/0000-0003-3469-8323; , William/0000-0002-2048-7472; Moens, Cecilia/0000-0002-1099-0728	NIH [HG002995, R01 NS050223]; National Multiple Sclerosis Society [FG 1719-A-1]; Telethon Italy fellowship [GFP03011]; Stanford Gabilan fellowship; Muscular Dystrophy Association [92233]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050223, R56NS050223] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Telethon Italy fellowship(Fondazione Telethon); Stanford Gabilan fellowship; Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Talbot laboratory for helpful discussions and suggestions, T. Reyes and C. Hill for fish facility support, J. Perrino and J. Buchanan for electron microscopy advice, and E. Wolf-Saxon and T. Donn for identifying the krox20<SUP>fh227</SUP> mutation with the support of NIH grant HG002995 ( C. B. M.). This work was also supported by National Multiple Sclerosis Society postdoctoral award FG 1719-A-1 ( K. R. M.), a Stanford NIH training grant ( T. D. G.), Telethon Italy fellowship GFP03011 ( S. M.), a Stanford Gabilan fellowship ( J. R. P.), and NIH grant R01 NS050223 and Muscular Dystrophy Association grant 92233 ( W. S. T.). The GenBank accession number for zebrafish gpr126 is GQ202546.	Bermingham JR, 1996, GENE DEV, V10, P1751, DOI 10.1101/gad.10.14.1751; Bjarnadottir TK, 2004, GENOMICS, V84, P23, DOI 10.1016/j.ygeno.2003.12.004; Chen S, 2006, J NEUROSCI, V26, P3079, DOI 10.1523/JNEUROSCI.3785-05.2006; Fredriksson R, 2003, BIOCHEM BIOPH RES CO, V301, P725, DOI 10.1016/S0006-291X(03)00026-3; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507; JESSEN KR, 1991, ANN NY ACAD SCI, V633, P78; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Levavasseur F, 1998, MECH DEVELOP, V74, P89, DOI 10.1016/S0925-4773(98)00067-7; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Moens Cecilia B., 2008, Briefings in Functional Genomics & Proteomics, V7, P454, DOI 10.1093/bfgp/eln046; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; Moriguchi T, 2004, GENES CELLS, V9, P549, DOI 10.1111/j.1356-9597.2004.00743.x; Pogoda HM, 2006, DEV BIOL, V298, P118, DOI 10.1016/j.ydbio.2006.06.021; SCHERER SS, 1994, J NEUROSCI, V14, P1930; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Stehlik C, 2004, FEBS LETT, V569, P149, DOI 10.1016/j.febslet.2004.05.038; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Zorick TS, 1999, DEVELOPMENT, V126, P1397	22	237	246	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1402	1405		10.1126/science.1173474	http://dx.doi.org/10.1126/science.1173474			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745155	Green Accepted			2022-12-24	WOS:000269699100041
J	Drinnenberg, IA; Weinberg, DE; Xie, KT; Mower, JP; Wolfe, KH; Fink, GR; Bartel, DP				Drinnenberg, Ines A.; Weinberg, David E.; Xie, Kathleen T.; Mower, Jeffrey P.; Wolfe, Kenneth H.; Fink, Gerald R.; Bartel, David P.			RNAi in Budding Yeast	SCIENCE			English	Article							RESOLUTION; EVOLUTION; RIBONUCLEASE; INITIATION; ELEMENTS	RNA interference (RNAi), a gene-silencing pathway triggered by double-stranded RNA, is conserved in diverse eukaryotic species but has been lost in the model budding yeast Saccharomyces cerevisiae. Here, we show that RNAi is present in other budding yeast species, including Saccharomyces castellii and Candida albicans. These species use noncanonical Dicer proteins to generate small interfering RNAs, which mostly correspond to transposable elements and Y' subtelomeric repeats. In S. castellii, RNAi mutants are viable but have excess Y' messenger RNA levels. In S. cerevisiae, introducing Dicer and Argonaute of S. castellii restores RNAi, and the reconstituted pathway silences endogenous retrotransposons. These results identify a previously unknown class of Dicer proteins, bring the tool of RNAi to the study of budding yeasts, and bring the tools of budding yeast to the study of RNAi.	[Drinnenberg, Ines A.; Weinberg, David E.; Xie, Kathleen T.; Fink, Gerald R.; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Drinnenberg, Ines A.; Weinberg, David E.; Xie, Kathleen T.; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Weinberg, David E.; Xie, Kathleen T.; Fink, Gerald R.; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Mower, Jeffrey P.; Wolfe, Kenneth H.] Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Trinity College Dublin	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu	Mower, Jeff/B-7875-2008; Mower, Jeff/P-5893-2019	Mower, Jeff/0000-0002-1501-5809; Mower, Jeff/0000-0002-1501-5809; Xie, Kathleen/0000-0002-3178-8959; Wolfe, Kenneth/0000-0003-4992-4979	Science Foundation Ireland; Irish Research Council for Science, Engineering, and Technology; NIH [GM040266, GM0305010, GM067031]; NSF graduate research fellowship; Boehringer-Ingelheim Fonds predoctoral fellowship; Howard Hughes Medical Institute;  [GSE17872]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031, R01GM040266] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science, Engineering, and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF graduate research fellowship(National Science Foundation (NSF)); Boehringer-Ingelheim Fonds predoctoral fellowship(Boehringer Ingelheim); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Hochwagen, G. Ruby, and H. Guo for helpful discussions; V. Agarwal for protein homology modeling; D. Garfinkel for Ty1-VLP antiserum and other reagents; M. Cohn and A. Regev for yeast strains; W. Johnston and the Whitehead Genome Technology Core for high-throughput sequencing; and S. P bo for academic advising. Supported by Science Foundation Ireland and the Irish Research Council for Science, Engineering, and Technology ( K. H. W.), NIH grants GM040266 ( G. R. F.), GM0305010 ( G. R. F.), and GM067031 ( D. P. B.), an NSF graduate research fellowship ( D. E. W.), and a Boehringer-Ingelheim Fonds predoctoral fellowship ( I. A. D.). D. P. B. is an Investigator of the Howard Hughes Medical Institute. The Gene Expression Omnibus accession number for all the mRNA-Seq and small-RNA cloning data is GSE17872.	Astromskas E, 2007, YEAST, V24, P499, DOI 10.1002/yea.1488; Axelson-Fisk M, 2006, TOP CURR GENET, V15, P1, DOI 10.1007/4735_111; Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Berretta J, 2008, GENE DEV, V22, P615, DOI 10.1101/gad.458008; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; GARFINKEL DJ, 1988, GENETICS, V120, P95; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Hall TMT, 2005, STRUCTURE, V13, P1403, DOI 10.1016/j.str.2005.08.005; Hedtke SM, 2006, SYST BIOL, V55, P522, DOI 10.1080/10635150600697358; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; KAWAKAMI K, 1993, GENETICS, V135, P309; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; Lamontagne B, 2001, Curr Issues Mol Biol, V3, P71; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Laurie JD, 2008, CURR GENET, V53, P49, DOI 10.1007/s00294-007-0165-7; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; LOUIS EJ, 1992, GENETICS, V131, P559; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nakayashiki H, 2006, J MOL EVOL, V63, P127, DOI 10.1007/s00239-005-0257-2; Scannell DR, 2007, P NATL ACAD SCI USA, V104, P8397, DOI 10.1073/pnas.0608218104; Sigova A, 2004, GENE DEV, V18, P2359, DOI 10.1101/gad.1218004; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Wickner RB, 1996, MICROBIOL REV, V60, P250, DOI 10.1128/MMBR.60.1.250-265.1996; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	35	364	387	6	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					544	550		10.1126/science.1176945	http://dx.doi.org/10.1126/science.1176945			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19745116	Green Submitted, Green Accepted			2022-12-24	WOS:000271019400033
J	Lieberman-Aiden, E; van Berkum, NL; Williams, L; Imakaev, M; Ragoczy, T; Telling, A; Amit, I; Lajoie, BR; Sabo, PJ; Dorschner, MO; Sandstrom, R; Bernstein, B; Bender, MA; Groudine, M; Gnirke, A; Stamatoyannopoulos, J; Mirny, LA; Lander, ES; Dekker, J				Lieberman-Aiden, Erez; van Berkum, Nynke L.; Williams, Louise; Imakaev, Maxim; Ragoczy, Tobias; Telling, Agnes; Amit, Ido; Lajoie, Bryan R.; Sabo, Peter J.; Dorschner, Michael O.; Sandstrom, Richard; Bernstein, Bradley; Bender, M. A.; Groudine, Mark; Gnirke, Andreas; Stamatoyannopoulos, John; Mirny, Leonid A.; Lander, Eric S.; Dekker, Job			Comprehensive Mapping of Long-Range Interactions Reveals Folding Principles of the Human Genome	SCIENCE			English	Article							GENE-REGULATION; IN-VIVO; CHROMOSOME CONFORMATION; NUCLEAR-ORGANIZATION; CHROMATIN ENVIRONMENT; INTERPHASE NUCLEUS; DNA; PROTEIN; CELLS; ARCHITECTURE	We describe Hi-C, a method that probes the three-dimensional architecture of whole genomes by coupling proximity-based ligation with massively parallel sequencing. We constructed spatial proximity maps of the human genome with Hi-C at a resolution of 1 megabase. These maps confirm the presence of chromosome territories and the spatial proximity of small, gene-rich chromosomes. We identified an additional level of genome organization that is characterized by the spatial segregation of open and closed chromatin to form two genome-wide compartments. At the megabase scale, the chromatin conformation is consistent with a fractal globule, a knot-free, polymer conformation that enables maximally dense packing while preserving the ability to easily fold and unfold any genomic locus. The fractal globule is distinct from the more commonly used globular equilibrium model. Our results demonstrate the power of Hi-C to map the dynamic conformations of whole genomes.	[Lieberman-Aiden, Erez; Williams, Louise; Amit, Ido; Bernstein, Bradley; Gnirke, Andreas; Lander, Eric S.] Broad Inst Harvard, Cambridge, MA 02139 USA; [Lieberman-Aiden, Erez; Imakaev, Maxim; Mirny, Leonid A.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Lieberman-Aiden, Erez] Harvard Univ, Dept Math, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Lieberman-Aiden, Erez] Harvard Univ, Dept Appl Math, Cambridge, MA 02138 USA; [van Berkum, Nynke L.; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [van Berkum, Nynke L.; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Ragoczy, Tobias; Telling, Agnes; Groudine, Mark] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Ragoczy, Tobias; Telling, Agnes; Groudine, Mark] Univ Washington, Sch Med, Dept Radiat Oncol, Seattle, WA 98195 USA; [Sabo, Peter J.; Dorschner, Michael O.; Sandstrom, Richard; Stamatoyannopoulos, John] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Bernstein, Bradley] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Bender, M. A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Mirny, Leonid A.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Lieberman-Aiden, E (corresponding author), Broad Inst Harvard, Cambridge, MA 02139 USA.	lander@broadinstitute.org; job.dekker@umassmed.edu	Mirny, Leonid/ABE-8083-2020; Aiden, Erez Lieberman/A-2908-2010	Mirny, Leonid/0000-0002-0785-5410; Sandstrom, Richard/0000-0002-3356-1547	Fannie and John Hertz Foundation; National Defense Science and Engineering; NSF; National Space Biomedical Research Institute; National Human Genome Research Institute (NHGRI) [T32 HG002295]; American Society of Hematology; National Heart, Lung, and Blood Institute [R01HL06544]; National Institute of Diabetes and Digestive and Kidney Diseases [R37DK44746]; NIH [U54HG004592]; NHGRI [HG003143]; Keck Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592, R01HG003143, T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044746] Funding Source: NIH RePORTER	Fannie and John Hertz Foundation; National Defense Science and Engineering; NSF(National Science Foundation (NSF)); National Space Biomedical Research Institute; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); American Society of Hematology; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Keck Foundation(W.M. Keck Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a Fannie and John Hertz Foundation graduate fellowship, a National Defense Science and Engineering graduate fellowship, an NSF graduate fellowship, the National Space Biomedical Research Institute, and grant no. T32 HG002295 from the National Human Genome Research Institute (NHGRI) (E. L.); a fellowship from the American Society of Hematology (T. R.); award no. R01HL06544 from the National Heart, Lung, and Blood Institute and R37DK44746 from the National Institute of Diabetes and Digestive and Kidney Diseases (M. G.); NIH grant U54HG004592 (J. S.); i2b2 (Informatics for Integrating Biology and the Bedside), the NIH-supported Center for Biomedical Computing at Brigham and Women's Hospital (L. A. M.), grant no. HG003143 from the NHGRI, and a Keck Foundation distinguished young scholar award (J. D.). We thank J. Goldy, K. Lee, S. Vong, and M. Weaver for assistance with DNaseI experiments; A. Kosmrlj for discussions and code; A. P. Aiden, X. R. Bao, M. Brenner, D. Galas, W. Gosper, A. Jaffer, A. Melnikov, A. Miele, G. Giannoukos, C. Nusbaum, A. J. M. Walhout, L. Wood, and K. Zeldovich for discussions; and L. Gaffney and B. Wong for help with visualization. We also acknowledge the ENCODE chromatin group at Broad Institute and Massachusetts General Hospital. Hi-C sequence data has been deposited at the GEO database (www. ncbi. nlm. nih. gov/geo/), accession no. GSE18199. Expression data are also available at GEO, accession no. GSE18350. Chromatin immunoprecipitation sequence (ChIP-Seq) data and DNAseI sensitivity data are available at the University of California Santa Cruz (UCSC) browser (http://genome. ucsc. edu/). Additional visualizations are available at http://hic. umassmed. edu. A provisional patent on the Hi-C method (no. 61/100,151) is under review.	Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; De Gennes PG., 1979, SCALING CONCEPTS POL; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Dekker J, 2008, J BIOL CHEM, V283, P34532, DOI 10.1074/jbc.M806479200; Dernburg AF, 1996, CELL, V85, P745, DOI 10.1016/S0092-8674(00)81240-4; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; GROSBERG A, 1993, EUROPHYS LETT, V23, P373, DOI 10.1209/0295-5075/23/5/012; GROSBERG AY, 1988, J PHYS-PARIS, V49, P2095, DOI 10.1051/jphys:0198800490120209500; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Kolesov G, 2007, NUCLEIC ACIDS RES, V35, pW425, DOI 10.1093/nar/gkm312; Kosak ST, 2004, GENE DEV, V18, P1371, DOI 10.1101/gad.1209304; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Munkel C, 1998, PHYS REV E, V57, P5888, DOI 10.1103/PhysRevE.57.5888; Naumann S, 2001, LEUKEMIA RES, V25, P313, DOI 10.1016/S0145-2126(00)00125-9; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sexton T, 2007, NAT STRUCT MOL BIOL, V14, P1049, DOI 10.1038/nsmb1324; Shopland LS, 2006, J CELL BIOL, V174, P27, DOI 10.1083/jcb.200603083; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Tanabe H, 2002, MUTAT RES-FUND MOL M, V504, P37, DOI 10.1016/S0027-5107(02)00077-5; Vasilyev OA, 2003, THEOR MATH PHYS+, V134, P142, DOI 10.1023/A:1022267802220; YOKOTA H, 1995, J CELL BIOL, V130, P1239, DOI 10.1083/jcb.130.6.1239; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	36	4565	4716	34	779	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					289	293		10.1126/science.1181369	http://dx.doi.org/10.1126/science.1181369			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815776	Green Submitted, Green Accepted			2022-12-24	WOS:000270599500043
J	Thomas, DL; Thio, CL; Martin, MP; Qi, Y; Ge, D; O'hUigin, C; Kidd, J; Kidd, K; Khakoo, SI; Alexander, G; Goedert, JJ; Kirk, GD; Donfield, SM; Rosen, HR; Tobler, LH; Busch, MP; McHutchison, JG; Goldstein, DB; Carrington, M				Thomas, David L.; Thio, Chloe L.; Martin, Maureen P.; Qi, Ying; Ge, Dongliang; O'hUigin, Colm; Kidd, Judith; Kidd, Kenneth; Khakoo, Salim I.; Alexander, Graeme; Goedert, James J.; Kirk, Gregory D.; Donfield, Sharyne M.; Rosen, Hugo R.; Tobler, Leslie H.; Busch, Michael P.; McHutchison, John G.; Goldstein, David B.; Carrington, Mary			Genetic variation in IL28B and spontaneous clearance of hepatitis C virus	NATURE			English	Article							NATURAL-HISTORY; INFECTION; ALPHA-2A; HOST	Hepatitis C virus (HCV) infection is the most common bloodborne infection in the United States, with estimates of 4 million HCV-infected individuals in the United States and 170 million worldwide(1). Most (70-80%) HCV infections persist and about 30% of individuals with persistent infection develop chronic liver disease, including cirrhosis and hepatocellular carcinoma(2). Epidemiological, viral and host factors have been associated with the differences in HCV clearance or persistence, and studies have demonstrated that a strong host immune response against HCV favours viral clearance(3,4). Thus, variation in genes involved in the immune response may contribute to the ability to clear the virus. In a recent genome-wide association study, a single nucleotide polymorphism (rs12979860) 3 kilobases upstream of the IL28B gene, which encodes the type III interferon IFN-lambda 3, was shown to associate strongly with more than a twofold difference in response to HCV drug treatment(5). To determine the potential effect of rs12979860 variation on outcome to HCV infection in a natural history setting, we genotyped this variant in HCV cohorts comprised of individuals who spontaneously cleared the virus (n = 388) or had persistent infection (n = 620). We show that the C/C genotype strongly enhances resolution of HCV infection among individuals of both European and African ancestry. To our knowledge, this is the strongest and most significant genetic effect associated with natural clearance of HCV, and these results implicate a primary role for IL28B in resolution of HCV infection.	[Martin, Maureen P.; Qi, Ying; O'hUigin, Colm; Carrington, Mary] NCI Frederick, SAIC Frederick Inc, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21702 USA; [Thomas, David L.; Thio, Chloe L.] Johns Hopkins Univ, Div Infect Dis, Baltimore, MD 21205 USA; [Martin, Maureen P.; Qi, Ying; O'hUigin, Colm; Carrington, Mary] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA 02114 USA; [Martin, Maureen P.; Qi, Ying; O'hUigin, Colm; Carrington, Mary] Harvard Univ, Boston, MA 02114 USA; [Ge, Dongliang; Goldstein, David B.] Duke Univ, Inst Genome Sci & Policy, Ctr Human Genome Variat, Durham, NC 27708 USA; [Kidd, Judith; Kidd, Kenneth] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Alexander, Graeme] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Khakoo, Salim I.] Univ London Imperial Coll Sci Technol & Med, Div Med, London W2 1NY, England; [Goedert, James J.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; [Kirk, Gregory D.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Donfield, Sharyne M.] Rho Inc, Chapel Hill, NC 27517 USA; [Rosen, Hugo R.] Univ Colorado, Hlth Sci Ctr, Div Gastroenterol & Hepatol, Aurora, CO 80045 USA; [Tobler, Leslie H.] Blood Syst Res Inst, San Francisco, CA 94118 USA; [Busch, Michael P.] Duke Univ, Duke Clin Res Inst, Durham, NC 27705 USA; [McHutchison, John G.] Duke Univ, Sch Med, Div Gastroenterol, Durham, NC 27705 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Johns Hopkins University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Duke University; Yale University; University of Cambridge; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Rho; University of Colorado System; University of Colorado Anschutz Medical Campus; Vitalant; Vitalant Research Institute; Duke University; Duke University	Carrington, M (corresponding author), NCI Frederick, SAIC Frederick Inc, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21702 USA.	carringm@mail.nih.gov	Goldstein, David/AAY-8125-2020; Ge, Dongliang/A-2073-2010	Ge, David/0000-0002-9732-8170; Khakoo, Salim/0000-0002-4057-9091	National Cancer Institute; National Institutes of Health [HHSN261200800001E, R01DA013324, R01DA004334, R01HL076902, R01DK60590, R01HD41224]; Wellcome Trust Senior Clinical Fellow; NATIONAL CANCER INSTITUTE [ZIABC010791, ZICBC011237, ZIACP010214] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Senior Clinical Fellow(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract number HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. This Research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. This research was supported by NIH grants R01DA013324 ( D. L. T.), R01DA004334 ( G. D. K.), R01HL076902 ( M. P. B.), R01DK60590 ( H. R. R.) and R01HD41224 ( S. M. D.). S. I. K. is a Wellcome Trust Senior Clinical Fellow.	[Anonymous], 1998, MMWR Recomm Rep, V47, P1; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Dellgren C, 2009, GENES IMMUN, V10, P125, DOI 10.1038/gene.2008.87; Donnelly RP, 2004, J LEUKOCYTE BIOL, V76, P314, DOI 10.1189/jlb.0204117; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; GOEDERT JJ, 1989, NEW ENGL J MED, V321, P1141, DOI 10.1056/NEJM198910263211701; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; HILGARTNER MW, 1993, AM J PEDIAT HEMATOL, V15, P208; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lindsay KL, 2001, HEPATOLOGY, V34, P395, DOI 10.1053/jhep.2001.26371; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Osier MV, 2002, AM J PHYS ANTHROPOL, V119, P77, DOI 10.1002/ajpa.10094; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Thio CL, 2008, CLIN LIVER DIS, V12, P713, DOI 10.1016/j.cld.2008.03.002; Thio CL, 2000, HEPATOLOGY, V31, P819, DOI 10.1053/he.2000.4316; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311; Vlahov D, 1991, NIDA Res Monogr, V109, P75; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301	24	1675	1772	0	78	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					798	U52		10.1038/nature08463	http://dx.doi.org/10.1038/nature08463			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19759533	Green Accepted			2022-12-24	WOS:000270547500037
J	Mets, DG; Meyer, BJ				Mets, David G.; Meyer, Barbara J.			Condensins Regulate Meiotic DNA Break Distribution, thus Crossover Frequency, by Controlling Chromosome Structure	CELL			English	Article							DOUBLE-STRAND BREAKS; YEAST SACCHAROMYCES-CEREVISIAE; RECOMBINATION HOT-SPOT; CROSSING-OVER; C-ELEGANS; CAENORHABDITIS-ELEGANS; SYNAPTONEMAL COMPLEX; INITIATION SITE; MEIOSIS; PROTEIN	Meiotic crossover (CO) recombination facilitates evolution and accurate chromosome segregation. CO distribution is tightly regulated: homolog pairs receive at least one CO, CO spacing is nonrandom, and COs occur preferentially in short genomic intervals called hotspots. We show that CO number and distribution are controlled on a chromosome-wide basis at the level of DNA double-strand break (DSB) formation by a condensin complex composed of subunits from two known condensins: the C. elegans dosage compensation complex and mitotic condensin II. Disruption of any subunit of the CO-controlling condensin dominantly changes DSB distribution, and thereby COs, and extends meiotic chromosome axes. These phenotypes are cosuppressed by disruption of a chromosome axis element. Our data implicate higher-order chromosome structure in the regulation of CO recombination, provide a model for the rapid evolution of CO hotspots, and show that reshuffling of interchangeable molecular parts can create independent machines with similar architectures but distinct biological functions.	[Mets, David G.; Meyer, Barbara J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Mets, David G.; Meyer, Barbara J.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Meyer, BJ (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	bjmeyer@berkeley.edu		Meyer, Barbara/0000-0002-6530-4588	Howard HughesMedical Institute [T32GM07127, T32GM07232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007127, T32GM007232, R01GM030702] Funding Source: NIH RePORTER	Howard HughesMedical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	thank S. Uzawa for microscopy advice, A. Gartner for RAD-51 antibody, A. Dernburg for HTP-3 antibody, S. Ruzen for computing facilities, J. Gunther for figure design, and T. Cline, A. Severson, C. Tsai, S. Uzawa, and A. Wood for discussions. D. G. M. was funded by training grants T32GM07127 and T32GM07232. B.J.M. is an investigator of the Howard HughesMedical Institute.	Alpi A, 2003, CHROMOSOMA, V112, P6, DOI 10.1007/s00412-003-0237-5; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Chan RC, 2004, J CELL BIOL, V167, P613, DOI 10.1083/jcb.200408061; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Coop G, 2007, PLOS GENET, V3, P377, DOI 10.1371/journal.pgen.0030035; Couteau F, 2004, CURR BIOL, V14, P585, DOI 10.1016/j.cub.2004.03.033; Csankovszki G, 2009, CURR BIOL, V19, P9, DOI 10.1016/j.cub.2008.12.006; DEMASSY B, 1995, EMBO J, V14, P4589, DOI 10.1002/j.1460-2075.1995.tb00138.x; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Goodyer W, 2008, DEV CELL, V14, P263, DOI 10.1016/j.devcel.2007.11.016; Greenawalt DM, 2006, GENOME RES, V16, P208, DOI 10.1101/gr.4641706; Grey C, 2009, PLOS BIOL, V7, P327, DOI 10.1371/journal.pbio.1000035; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Jones G.H., 1984, Symposia of the Society for Experimental Biology, P293; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kauppi L, 2007, P NATL ACAD SCI USA, V104, P13396, DOI 10.1073/pnas.0701965104; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Maloisel L, 1998, GENE DEV, V12, P1381, DOI 10.1101/gad.12.9.1381; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Martin JS, 2005, MOL CELL BIOL, V25, P3127, DOI 10.1128/MCB.25.8.3127-3139.2005; Meyer BJ., 2005, WORMBOOK, P1, DOI [10.1895/wormbook.1.8.1, DOI 10.1895/WORMBOOK.1.8.1]; Moens PB, 2002, J CELL SCI, V115, P1611; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; Novak I, 2008, J CELL BIOL, V180, P83, DOI 10.1083/jcb.200706136; OGAWA T, 1993, SCIENCE, V58, P567; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Sturtevant AH, 1913, J EXP ZOOL, V14, P43, DOI 10.1002/jez.1400140104; Tsai CJ, 2008, GENE DEV, V22, P194, DOI 10.1101/gad.1618508; VILLENEUVE AM, 1994, GENETICS, V136, P887; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; XU LH, 1995, EMBO J, V14, P5115, DOI 10.1002/j.1460-2075.1995.tb00194.x; Yauk CL, 2003, EMBO J, V22, P1389, DOI 10.1093/emboj/cdg136; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	46	170	177	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					73	86		10.1016/j.cell.2009.07.035	http://dx.doi.org/10.1016/j.cell.2009.07.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19781752	Green Accepted, Bronze			2022-12-24	WOS:000270388600017
J	Hu, WQ; Sweet, TJ; Chamnongpol, S; Baker, KE; Coller, J				Hu, Wenqian; Sweet, Thomas J.; Chamnongpol, Sangpen; Baker, Kristian E.; Coller, Jeff			Co-translational mRNA decay in Saccharomyces cerevisiae	NATURE			English	Article							P-BODY FORMATION; CELLS; DEGRADATION; PATHWAYS; TURNOVER; BODIES	The rates of RNA decay and transcription determine the steady-state levels of allmessenger RNA and both can be subject to regulation. Although the details of transcriptional regulation are becoming increasingly understood, the mechanism(s) controlling mRNA decay remain unclear. In yeast, a major pathway of mRNA decay begins with deadenylation followed by decapping and 5'-3' exonuclease digestion. Importantly, it is hypothesized that ribosomes must be removed from mRNA before transcripts are destroyed. Contrary to this prediction, here we show that decay takes place while mRNAs are associated with actively translating ribosomes. The data indicate that dissociation of ribosomes from mRNA is not a prerequisite for decay and we suggest that the 5'-3' polarity of mRNA degradation has evolved to ensure that the last translocating ribosome can complete translation.	[Hu, Wenqian; Sweet, Thomas J.; Baker, Kristian E.; Coller, Jeff] Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; [Chamnongpol, Sangpen] Affymetrix Inc, Cleveland, OH 44128 USA	Case Western Reserve University; Affymetrix	Coller, J (corresponding author), Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA.	jmc71@case.edu	Hu, Wenqian/H-6094-2019	Hu, Wenqian/0000-0003-3577-3604; Coller, Jeff/0000-0001-5662-8110	American Heart Association; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080465] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Maroney and T. Nilsen for sharing unpublished data about the poly( A) tailing assay. We also thank T. Nilsen for his insight, suggestions and evaluation of the manuscript. We also thank R. Parker, A. van Hoof and M. Wickens for reagents and advice. Funding was provided by the American Heart Association and the National Institutes of Health.	Amrani N, 2008, NATURE, V453, P1276, DOI 10.1038/nature06974; BEELMAN CA, 1994, J BIOL CHEM, V269, P9687; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; He F, 2001, MOL CELL BIOL, V21, P1515, DOI 10.1128/MCB.21.5.1515-1530.2001; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Inada T, 2002, RNA, V8, P948, DOI 10.1017/S1355838202026018; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Mangus DA, 1999, METHODS, V17, P28, DOI 10.1006/meth.1998.0704; Moore MJ, 2000, METHOD ENZYMOL, V317, P109; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; SMITH DW, 1971, SCIENCE, V971, P577; Stevens A, 2001, METHOD ENZYMOL, V342, P251, DOI 10.1016/S0076-6879(01)42549-3; Sweet TJ, 2007, RNA, V13, P493, DOI 10.1261/rna.355807; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599	23	224	226	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					225	U96		10.1038/nature08265	http://dx.doi.org/10.1038/nature08265			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19701183	Green Accepted			2022-12-24	WOS:000269654600036
J	Calarco, JA; Superina, S; O'Hanlon, D; Gabut, M; Raj, B; Pan, Q; Skalska, U; Clarke, L; Gelinas, D; van der Kooy, D; Zhen, M; Ciruna, B; Blencowe, BJ				Calarco, John A.; Superina, Simone; O'Hanlon, Dave; Gabut, Mathieu; Raj, Bushra; Pan, Qun; Skalska, Ursula; Clarke, Laura; Gelinas, Danielle; van der Kooy, Derek; Zhen, Mei; Ciruna, Brian; Blencowe, Benjamin J.			Regulation of Vertebrate Nervous System Alternative Splicing and Development by an SR-Related Protein	CELL			English	Article							TRACT-BINDING-PROTEIN; STEM-CELLS; SWITCH; INSIGHTS; FAMILY; SHAPE; NOVA; CODE; PTB	Alternative splicing is a key process underlying the evolution of increased proteomic and functional complexity and is especially prevalent in the mammalian nervous system. However, the factors and mechanisms governing nervous system-specific alternative splicing are not well understood. Through a genome-wide computational and expression profiling strategy, we have identified a tissue- and verte-brate-restricted Ser/Arg (SR) repeat splicing factor, the neural-specific SR-related protein of 100 kDa (nSR100). We show that nSR100 regulates an extensive network of brain-specific alternative exons enriched in genes that function in neural cell differentiation. nSR100 acts by increasing the levels of the neural/brain-enriched polypyrimidine tract binding protein and by interacting with its target transcripts. Disruption of nSR100 prevents neural cell differentiation in cell culture and in the developing zebrafish. Our results thus reveal a critical neural-specific alternative splicing regulator, the evolution of which has contributed to increased complexity in the vertebrate nervous system.	[Calarco, John A.; O'Hanlon, Dave; Gabut, Mathieu; Raj, Bushra; Pan, Qun; Skalska, Ursula; van der Kooy, Derek; Blencowe, Benjamin J.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Calarco, John A.; Superina, Simone; Raj, Bushra; Clarke, Laura; van der Kooy, Derek; Zhen, Mei; Ciruna, Brian; Blencowe, Benjamin J.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Superina, Simone; Gelinas, Danielle; Ciruna, Brian] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Zhen, Mei] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Blencowe, Benjamin J.] Kings Coll London, Ctr Bioinformat, London WC2R 2LS, England	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of London; King's College London	Blencowe, BJ (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Banting & Best Dept Med Res, 160 Coll St, Toronto, ON M5S 3E1, Canada.	b.blencowe@utoronto.ca	GABUT, Mathieu/M-7624-2017; Zhen, Mei/A-4967-2012	GABUT, Mathieu/0000-0001-7343-5361; Zhen, Mei/0000-0003-0086-9622; Raj, Bushra/0000-0002-5833-0251	Canada Research Chairs Program; Terry Fox Foundation [018165]; Canadian Institutes of Health Research [MOP-14609]; Ontario Research Fund; Ontario Genomics Institute	Canada Research Chairs Program(Canada Research Chairs); Terry Fox Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Ontario Genomics Institute	We are grateful to Leo Lee, Yoseph Barash, Valentina Slobodeniuc, and Xinyi Tang for assistance. We thank many colleagues for providing reagents ( Supplemental Data) and to Donny Licatalosi and Robert Darnell for sharing unpublished information and for critical reading of the manuscript. Jim Ingles, Christos Ouzounis, Duncan Odom, Nuno Barbosa-Morais, Arneet Saltzman, Joanna Ip, Jonathan Ellis, and Cori Hanson are also thanked for helpful comments on the manuscript. This work was supported in part by the Canada Research Chairs Program and a grant from the Terry Fox Foundation (# 018165) to B. C. Research funding to B. J. B. was provided by a Canadian Institutes of Health Research operating grant (MOP-14609), the Ontario Research Fund, and a grant from Genome Canada through the Ontario Genomics Institute. M. Z. is the recipient of an EJLB scholarship and J.A.C is the recipient of an Alexander Graham Bell Canada graduate scholarship.	Ashiya M, 1997, RNA, V3, P996; Barbosa-Morais NL, 2006, GENOME RES, V16, P66, DOI 10.1101/gr.3936206; Behrends U, 2003, INT J CANCER, V106, P244, DOI 10.1002/ijc.11208; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Fagnani M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r108; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hanamura A, 1998, RNA, V4, P430; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Matusek T, 2008, J NEUROSCI, V28, P13310, DOI 10.1523/JNEUROSCI.2727-08.2008; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Shen HH, 2004, MOL CELL, V13, P367, DOI 10.1016/S1097-2765(04)00025-5; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; ZAHLER AM, 1993, SCIENCE, V260, P219, DOI 10.1126/science.8385799; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	36	142	148	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					898	910		10.1016/j.cell.2009.06.012	http://dx.doi.org/10.1016/j.cell.2009.06.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737518	Bronze			2022-12-24	WOS:000269564600016
J	Fukuoka, S; Saka, N; Koga, H; Ono, K; Shimizu, T; Ebana, K; Hayashi, N; Takahashi, A; Hirochika, H; Okuno, K; Yano, M				Fukuoka, Shuichi; Saka, Norikuni; Koga, Hironori; Ono, Kazuko; Shimizu, Takehiko; Ebana, Kaworu; Hayashi, Nagao; Takahashi, Akira; Hirochika, Hirohiko; Okuno, Kazutoshi; Yano, Masahiro			Loss of Function of a Proline-Containing Protein Confers Durable Disease Resistance in Rice	SCIENCE			English	Article							FIELD-RESISTANCE; GENE; TRANSPORTER; PATHOGENS; DOMAINS; BINDING; BLAST; WHEAT	Blast disease is a devastating fungal disease of rice, one of the world's staple foods. Race-specific resistance to blast disease has usually not been durable. Here, we report the cloning of a previously unknown type of gene that confers non-race-specific resistance and its successful use in breeding. Pi21 encodes a proline-rich protein that includes a putative heavy metal-binding domain and putative protein-protein interaction motifs. Wild-type Pi21 appears to slow the plant's defense responses, which may support optimization of defense mechanisms. Deletions in its proline-rich motif inhibit this slowing. Pi21 is separable from a closely linked gene conferring poor flavor. The resistant pi21 allele, which is found in some strains of japonica rice, could improve blast resistance of rice worldwide.	[Fukuoka, Shuichi; Ono, Kazuko; Ebana, Kaworu; Yano, Masahiro] Natl Inst Agrobiol Sci, QTL Genom Res Ctr, Tsukuba, Ibaraki 3058602, Japan; [Saka, Norikuni] Aichi Agr Res Ctr, Mountainous Region Agr Res Inst, Aichi 4412513, Japan; [Koga, Hironori] Ishikawa Prefectural Univ, Nonoichi, Ishikawa 9218836, Japan; [Shimizu, Takehiko] Inst Soc Technoinnovat Agr Forestry & Fisheries, Tsukuba, Ibaraki 3050854, Japan; [Hayashi, Nagao; Takahashi, Akira] Natl Inst Agrobiol Sci, Div Plant Sci, Tsukuba, Ibaraki 3058602, Japan; [Hirochika, Hirohiko] Natl Inst Agrobiol Sci, Div Genome & Biodivers Res, Tsukuba, Ibaraki 3058602, Japan; [Okuno, Kazutoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	National Institute of Agrobiological Sciences - Japan; Ishikawa Prefecture University; National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan; University of Tsukuba	Fukuoka, S (corresponding author), Natl Inst Agrobiol Sci, QTL Genom Res Ctr, Kannondai 2-1-2, Tsukuba, Ibaraki 3058602, Japan.	fukusan@affrc.go.jp	Hayashi, Nagao/AAE-8295-2020; Yano, Masahiro/AAC-5441-2019; Okuno, Kazutoshi/AAQ-9507-2021	Yano, Masahiro/0000-0003-1510-4622	Ministry of Agriculture, Forestry and Fisheries of Japan [MP1103b, MP1132, QT4004, GB1004, QTL2002, RGB1101]	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by grants from the Ministry of Agriculture, Forestry and Fisheries of Japan (MP1103b, MP1132, QT4004, GB1004, QTL2002, and RGB1101).	Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Brown JKM, 2002, CURR OPIN PLANT BIOL, V5, P339, DOI 10.1016/S1369-5266(02)00270-4; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; EZUKA A, 1972, Review of Plant Protection Research, V5, P1; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Fukuoka S, 2001, THEOR APPL GENET, V103, P185, DOI 10.1007/s001220100611; JOHNSON R, 1984, ANNU REV PHYTOPATHOL, V22, P309, DOI 10.1146/annurev.py.22.090184.001521; JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384a0; Koga H, 2004, PHYSIOL MOL PLANT P, V64, P67, DOI 10.1016/j.pmpp.2004.07.002; Kojima Y, 2005, BREEDING SCI, V55, P431, DOI 10.1270/jsbbs.55.431; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Liu GS, 2007, J CELL SCI, V120, P596, DOI 10.1242/jcs.001362; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; PARLEVLIET JE, 1979, ANNU REV PHYTOPATHOL, V17, P203, DOI 10.1146/annurev.py.17.090179.001223; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Saka N, 2006, PLANT PROD SCI, V9, P3, DOI 10.1626/pps.9.3; Shi JS, 1996, P NATL ACAD SCI USA, V93, P6014, DOI 10.1073/pnas.93.12.6014; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372	19	411	500	9	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					998	1001		10.1126/science.1175550	http://dx.doi.org/10.1126/science.1175550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19696351				2022-12-24	WOS:000269242800047
J	Mayr, C; Bartel, DP				Mayr, Christine; Bartel, David P.			Widespread Shortening of 3 ' UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells	CELL			English	Article							MESSENGER-RNA POLYADENYLATION; 3' UNTRANSLATED REGIONS; BINDING PROTEIN; TRANSGENIC MICE; POSTTRANSCRIPTIONAL REGULATION; MICRORNA TARGETS; GENE-EXPRESSION; SITE SELECTION; RICH ELEMENTS; CYCLIN D2	In cancer cells, genetic alterations can activate proto-oncogenes, thereby contributing to tumorigenesis. However, the protein products of oncogenes are sometimes overexpressed without alteration of the proto-oncogene. Helping to explain this phenomenon, we found that when compared to similarly proliferating nontransformed cell lines, cancer cell lines often expressed substantial amounts of mRNA isoforms with shorter 30 untranslated regions (UTRs). These shorter isoforms usually resulted from alternative cleavage and polyadenylation (APA). The APA had functional consequences, with the shorter mRNA isoforms exhibiting increased stability and typically producing ten-fold more protein, in part through the loss of microRNA-mediated repression. Moreover, expression of the shorter mRNA isoform of the proto-oncogene IGF2BP1/IMP-1 led to far more oncogenic transformation than did expression of the full-length, annotated mRNA. The high incidence of APA in cancer cells, with consequent loss of 3'UTR repressive elements, suggests a pervasive role for APA in oncogene activation without genetic alteration.	[Mayr, Christine; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Mayr, Christine; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Mayr, Christine; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Mayr, C (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	mayrc@mskcc.org; dbartel@wi.mit.edu			Deutsche Forschungsgemeinschaft; National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Calvin Jan (C.J.) and Andrew Grimson (A.G.) for very helpful advice throughout the project; Wendy Johnston for preparing the small RNA libraries for the cell lines; Gina Lafkas for help with the soft-agar assay; A. G. and Rosaria Chang for analyzing the Solexa reads; and Olivia Rissland, A. G., C.J., and Alena Shkumatava for helpful comments on the manuscript. Supported by grants from the Deutsche Forschungsgemeinschaft (C.M.) and the National Institutes of Health (D.B.). D.B. is a Howard Hughes Medical Institute Investigator.	Amrani N, 2008, NATURE, V453, P1276, DOI 10.1038/nature06974; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; COLEMAN MS, 1974, NATURE, V248, P407, DOI 10.1038/248407a0; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; DERYNCK R, 1995, CURR OPIN CELL BIOL, V7, P843, DOI 10.1016/0955-0674(95)80068-9; Doyle GAR, 1998, NUCLEIC ACIDS RES, V26, P5036, DOI 10.1093/nar/26.22.5036; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Evron E, 2001, CANCER RES, V61, P2782; Fedele M, 2002, ONCOGENE, V21, P3190, DOI 10.1038/sj.onc.1205428; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; HAUSER H, 1978, EXP CELL RES, V111, P175, DOI 10.1016/0014-4827(78)90247-1; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; LEBWOHL DE, 1994, ONCOGENE, V9, P1925; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LUKAS J, 1995, ONCOGENE, V10, P2125; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; Martincic K, 1998, P NATL ACAD SCI USA, V95, P11095, DOI 10.1073/pnas.95.19.11095; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Miyamoto S, 1996, BIOCHEM J, V315, P791, DOI 10.1042/bj3150791; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Primrose Sandy, 2006, PRINCIPLES GENE MANI; PROUDFOOT N, 1991, CELL, V64, P671, DOI 10.1016/0092-8674(91)90495-K; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; RUTHER U, 1987, NATURE, V325, P412, DOI 10.1038/325412a0; SAMBROOK J, 2006, SEPARATION RNA ACCOR; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wiestner A, 2007, BLOOD, V109, P4599, DOI 10.1182/blood-2006-08-039859; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	54	1081	1105	5	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 21	2009	138	4					673	684		10.1016/j.cell.2009.06.016	http://dx.doi.org/10.1016/j.cell.2009.06.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703394	Green Submitted, Bronze, Green Accepted			2022-12-24	WOS:000269156100010
J	Wang, Y; Zhang, H; Chen, YP; Sun, YM; Yang, F; Yu, WH; Liang, J; Sun, LY; Yang, XH; Shi, L; Li, RF; Li, YY; Zhang, Y; Li, Q; Yi, X; Shang, YF				Wang, Yan; Zhang, Hua; Chen, Yupeng; Sun, Yimin; Yang, Fen; Yu, Wenhua; Liang, Jing; Sun, Luyang; Yang, Xiaohan; Shi, Lei; Li, Ruifang; Li, Yanyan; Zhang, Yu; Li, Qian; Yi, Xia; Shang, Yongfeng			LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer	CELL			English	Article							RECEPTOR-REGULATED TRANSCRIPTION; HISTONE LYSINE DEMETHYLASES; TGF-BETA; ENDOMETRIAL CARCINOGENESIS; MESENCHYMAL TRANSITIONS; MOLECULAR-MECHANISMS; MI-2/NURD COMPLEX; GENE-REGULATION; EMERGING ROLES; ESTROGEN	Lysine-specific demethylase 1 (LSD1) exerts pathway-specific activity in animal development and has been linked to several high-risk cancers. Here, we report that LSD1 is an integral component of the Mi-2/nucleosome remodeling and deacetylase (NuRD) complex. Transcriptional target analysis revealed that the LSD1/NuRD complexes regulate several cellular signaling pathways including TGF beta 1 signaling pathway that are critically involved in cell proliferation, survival, and epithelial-to-mesenchymal transition. We demonstrated that LSD1 inhibits the invasion of breast cancer cells in vitro and suppresses breast cancer metastatic potential in vivo. We found that LSD1 is downregulated in breast carcinomas and that its level of expression is negatively correlated with that of TGFb1. Our data provide a molecular basis for the interplay of histone demethylation and deacetylation in chromatin remodeling. By enlisting LSD1, the NuRD complex expands its chromatin remodeling capacity to include ATPase, histone deacetylase, and histone demethylase.	[Wang, Yan; Zhang, Hua; Chen, Yupeng; Sun, Yimin; Yang, Fen; Yu, Wenhua; Liang, Jing; Sun, Luyang; Yang, Xiaohan; Shi, Lei; Li, Ruifang; Li, Yanyan; Zhang, Yu; Li, Qian; Yi, Xia; Shang, Yongfeng] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100191, Peoples R China	Peking University	Shang, YF (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100191, Peoples R China.	yshang@hsc.pku.edu.cn	Chen, Yupeng/T-5275-2019	Chen, Yupeng/0000-0001-8887-9547; Li, Qian/0000-0003-0359-5604	National Natural Science Foundation of China [30830032, 30621002, 30470912]; Ministry of Science and Technology of China [2006AA02Z466, 2005CB522404, 2007CB914503]; NATIONAL INSTITUTE ON AGING [Z01AG000650] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Joanne Balmer Green (Penn State University) for editorial assistance. This work was supported by grants (30830032, 30621002 and 30470912, to Y.S.) from the National Natural Science Foundation of China and grants (863 Program: 2006AA02Z466 and 973 Program: 2005CB522404 and 2007CB914503, to Y.S.) from the Ministry of Science and Technology of China.	Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Cheng XD, 2007, MUTAT RES-FUND MOL M, V618, P102, DOI 10.1016/j.mrfmmm.2006.05.041; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Di Stefano L, 2007, CURR BIOL, V17, P808, DOI 10.1016/j.cub.2007.03.068; Dumont N, 2003, CANCER CELL, V3, P531, DOI 10.1016/S1535-6108(03)00135-1; Forneris F, 2008, TRENDS BIOCHEM SCI, V33, P181, DOI 10.1016/j.tibs.2008.01.003; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mukherjee Shibaji, 2005, Journal of Bioinformatics and Computational Biology, V3, P491, DOI 10.1142/S0219720005001077; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Sasai N, 2008, CELL, V133, P878, DOI 10.1016/j.cell.2008.03.035; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shang YF, 2006, NAT REV CANCER, V6, P360, DOI 10.1038/nrc1879; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; WELCH DR, 1990, P NATL ACAD SCI USA, V87, P7678, DOI 10.1073/pnas.87.19.7678; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Yamazaki K, 2006, BIOCHEM BIOPH RES CO, V346, P802, DOI 10.1016/j.bbrc.2006.05.178; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Ye Zhaohui, 2008, V430, P243, DOI 10.1007/978-1-59745-182-6_17; Yin N, 2004, CANCER RES, V64, P5870, DOI 10.1158/0008-5472.CAN-04-0655; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zhang Y, 2007, EMBO J, V26, P2645, DOI 10.1038/sj.emboj.7601710	44	498	543	9	95	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					660	672		10.1016/j.cell.2009.05.050	http://dx.doi.org/10.1016/j.cell.2009.05.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703393	Bronze			2022-12-24	WOS:000269156100009
J	Kadokura, H; Beckwith, J				Kadokura, Hiroshi; Beckwith, Jon			Detecting Folding Intermediates of a Protein as It Passes through the Bacterial Translocation Channel	CELL			English	Article							DISULFIDE BOND FORMATION; SIGNAL RECOGNITION PARTICLE; ESCHERICHIA-COLI; IN-VIVO; ALKALINE-PHOSPHATASE; NONCONSECUTIVE DISULFIDE; MEMBRANE; DSBA; ISOMERASE; OXIDOREDUCTASES	Most bacterial exported proteins cross the cytoplasmic membrane as unfolded polypeptides. However, little is known about how they fold during or after this process due to the difficulty in detecting folding intermediates. Here we identify cotranslational and posttranslational folding intermediates of a periplasmic protein in which the protein and DsbA, a periplasmic disulfide bond-forming enzyme, are covalently linked by a disulfide bond. The cotranslational mixed-disulfide intermediate is, upon further chain elongation, resolved, releasing the oxidized polypeptide, thus allowing us to follow the folding process. This analysis reveals that two cysteines that are joined to form a structural disulfide can play different roles during the folding reaction and that the mode of translocation ( cotranslational verse posttranslational) can affect the folding process of a protein in the periplasm. The latter finding leads us to propose that the activity of the ribosome ( translation) can modulate protein folding even in an extracytosolic compartment.	[Kadokura, Hiroshi; Beckwith, Jon] Harvard Univ, Dept Microbiol & Mol Genet, Sch Med, Boston, MA 02115 USA; [Kadokura, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan	Harvard University; Harvard Medical School; Nara Institute of Science & Technology	Kadokura, H (corresponding author), Harvard Univ, Dept Microbiol & Mol Genet, Sch Med, 200 Longwood Ave, Boston, MA 02115 USA.	hkadokura@bs.naist.jp; jbeckwith@hms.harvard.edu	Kadokura, Hiroshi/AAE-1645-2019	Kadokura, Hiroshi/0000-0001-7308-7141	NIH [GM41883]; MEXT of Japan [21580092]; JSPS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041883] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of J. B.'s laboratory, especially Markus Eser, and SeungHyun Cho for discussions. H. K. thanks Kenji Kohno, in whose laboratory part of this work was done. J. B. is an American Cancer Society Professor. This work was supported by NIH grant GM41883 ( to J. B.) and in part by an international research fellowship from the Global COE program in NAIST from MEXT of Japan and Grant-in-Aid for Scientific Research ( C) ( 21580092) from JSPS ( to H. K.).	AKIYAMA Y, 1993, J BIOL CHEM, V268, P8146; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Berkmen M, 2005, J BIOL CHEM, V280, P11387, DOI 10.1074/jbc.M411774200; BRADSHAW RA, 1981, P NATL ACAD SCI-BIOL, V78, P3473, DOI 10.1073/pnas.78.6.3473; Cho SH, 2007, EMBO J, V26, P3509, DOI 10.1038/sj.emboj.7601799; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P3576, DOI 10.1021/bi00011a012; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; Duguay AR, 2004, BBA-MOL CELL RES, V1694, P121, DOI 10.1016/j.bbamcr.2004.04.012; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; ENNIS HL, 1972, ANTIMICROB AGENTS CH, V1, P197, DOI 10.1128/AAC.1.3.197; Evans MS, 2008, J MOL BIOL, V383, P683, DOI 10.1016/j.jmb.2008.07.035; Fedorov AN, 1997, J BIOL CHEM, V272, P32715, DOI 10.1074/jbc.272.52.32715; Frech C, 1996, EMBO J, V15, P392, DOI 10.1002/j.1460-2075.1996.tb00369.x; Harms N, 2001, J BIOL CHEM, V276, P18804, DOI 10.1074/jbc.M011194200; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; ITO K, 1981, CELL, V24, P707, DOI 10.1016/0092-8674(81)90097-0; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; JOSEFSSON LG, 1981, CELL, V25, P151, DOI 10.1016/0092-8674(81)90239-7; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KAMITANI S, 1992, EMBO J, V11, P57, DOI 10.1002/j.1460-2075.1992.tb05027.x; LIU G, 1988, J BIOL CHEM, V263, P14790; MATSUYAMA S, 1992, BIOCHIM BIOPHYS ACTA, V1122, P77, DOI 10.1016/0167-4838(92)90130-6; Messens J, 2007, J BIOL CHEM, V282, P31302, DOI 10.1074/jbc.M705236200; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Rutkowska A, 2008, J BIOL CHEM, V283, P4124, DOI 10.1074/jbc.M708294200; Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797; Sone M, 1997, J BIOL CHEM, V272, P10349; Sone M, 1997, J BIOL CHEM, V272, P6174, DOI 10.1074/jbc.272.10.6174; Tian P, 2009, J BIOL CHEM, V284, P11396, DOI 10.1074/jbc.M900375200; Ureta AR, 2007, J BACTERIOL, V189, P446, DOI 10.1128/JB.01103-06; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752	39	81	86	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 18	2009	138	6					1164	1173		10.1016/j.cell.2009.07.030	http://dx.doi.org/10.1016/j.cell.2009.07.030			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766568	Green Accepted, Bronze			2022-12-24	WOS:000269923200016
J	Sommer, MOA; Dantas, G; Church, GM				Sommer, Morten O. A.; Dantas, Gautam; Church, George M.			Functional Characterization of the Antibiotic Resistance Reservoir in the Human Microflora	SCIENCE			English	Article							BETA-LACTAMASE NOMENCLATURE; MOLECULAR-MECHANISMS; GUT MICROBIOME; GENE-TRANSFER; BACTERIA; DIVERSITY; DISEASE	To understand the process by which antibiotic resistance genes are acquired by human pathogens, we functionally characterized the resistance reservoir in the microbial flora of healthy individuals. Most of the resistance genes we identified using culture-independent sampling have not been previously identified and are evolutionarily distant from known resistance genes. By contrast, nearly half of the resistance genes we identified in cultured aerobic gut isolates (a small subset of the gut microbiome) are identical to resistance genes harbored by major pathogens. The immense diversity of resistance genes in the human microbiome could contribute to future emergence of antibiotic resistance in human pathogens.	[Sommer, Morten O. A.; Dantas, Gautam; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Sommer, MOA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	sommer@genetics.med.harvard.edu; dantas@wustl.edu		Dantas, Gautam/0000-0003-0455-8370; Sommer, Morten Otto Alexander/0000-0003-4005-5674; church, george/0000-0001-6232-9969	National Human Genome Research Institute Centers of Excellence in Genomic Science; Personal Genome Project; Bill and Melinda Gates Foundation; Harvard Biophysics Program; Hartmann Foundation; Det Kongelige Danske Videnskabernes Selskab; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003170] Funding Source: NIH RePORTER	National Human Genome Research Institute Centers of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Personal Genome Project; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Harvard Biophysics Program; Hartmann Foundation; Det Kongelige Danske Videnskabernes Selskab; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge J. Davies, J. Aach, and M. Strong for helpful discussions regarding this manuscript; and the expert assistance of G. Jacoby and K. Bush for beta-lactamase enzyme family nomenclature, L. Kraal and G. Rockwell for sequence manipulations and similarity computations, and S. Caliri, A. Ellison, and T. Ellison for microbial culturing and DNA processing. We acknowledge National Human Genome Research Institute Centers of Excellence in Genomic Science, Personal Genome Project, Bill and Melinda Gates Foundation, Harvard Biophysics Program, Hartmann Foundation, and Det Kongelige Danske Videnskabernes Selskab for funding. GenBank accession numbers GQ342978 to GQ343187 are listed in Table 1 and tables S3, S4, and S7. M.O.A.S. and G.M.C. advise many companies, listed in (24); none is working within fields related to the subject of the manuscript.	Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Florez AB, 2006, APPL ENVIRON MICROB, V72, P7377, DOI 10.1128/AEM.00486-06; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; *CDC, 2006, CTR DIS CONTR PREV A; *CDC, 2008, CTR DIS CONTR PREV H, V18; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; Jacoby GA, 2006, ANTIMICROB AGENTS CH, V50, P1123, DOI 10.1128/AAC.50.4.1123-1129.2006; Jacoby GA, 2005, J CLIN MICROBIOL, V43, P6220, DOI 10.1128/JCM.43.12.6220.2005; Jacoby GA, 2009, AMINO ACID SEQUENCES; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Marshall B., 2009, MICROBE WASH 600, V4, P231, DOI [DOI 10.1128/MICROBE.4.231.1, 10.1128/microbe.4.231.1]; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ready D, 2004, ANTIMICROB AGENTS CH, V48, P2883, DOI 10.1128/AAC.48.8.2883-2887.2004; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Shoemaker NB, 2001, APPL ENVIRON MICROB, V67, P561, DOI 10.1128/AEM.67.2.561-568.2001; Sjolund M, 2003, ANN INTERN MED, V139, P483, DOI 10.7326/0003-4819-139-6-200309160-00011; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Young VB, 2004, J CLIN MICROBIOL, V42, P1203, DOI 10.1128/JCM.42.3.1203-1206.2004	32	569	597	6	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 28	2009	325	5944					1128	1131		10.1126/science.1176950	http://dx.doi.org/10.1126/science.1176950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713526	Green Accepted			2022-12-24	WOS:000269382300041
J	Wu, G; Park, MY; Conway, SR; Wang, JW; Weigel, D; Poethig, RS				Wu, Gang; Park, Mee Yeon; Conway, Susan R.; Wang, Jia-Wei; Weigel, Detlef; Poethig, R. Scott			The Sequential Action of miR156 and miR172 Regulates Developmental Timing in Arabidopsis	CELL			English	Article							EPIDERMAL-CELL IDENTITY; BOX GENE SPL3; PHASE-CHANGE; MICRORNA ACTIVITY; SHOOT DEVELOPMENT; TARGET GENES; THALIANA; MAIZE; GLOSSY15; ELEGANS	The transition from the juvenile to the adult phase of shoot development in plants is accompanied by changes in vegetative morphology and an increase in reproductive potential. Here, we describe the regulatory mechanism of this transition. We show that miR156 is necessary and sufficient for the expression of the juvenile phase, and regulates the timing of the juvenile-to-adult transition by coordinating the expression of several pathways that control different aspects of this process. miR156 acts by repressing the expression of functionally distinct SPL transcription factors. miR172 acts downstream of miR156 to promote adult epidermal identity. miR156 regulates the expression of miR172 via SPL9 which, redundantly with SPL10, directly promotes the transcription of miR172b. Thus, like the larval-to-adult transition in Caenorhabditis elegans, the juvenile-to-adult transition in Arabidopsis is mediated by sequentially operating miRNAs. miR156 and miR172 are positively regulated by the transcription factors they target, suggesting that negative feedback loops contribute to the stability of the juvenile and adult phases.	[Wu, Gang; Park, Mee Yeon; Conway, Susan R.; Poethig, R. Scott] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Wang, Jia-Wei; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	University of Pennsylvania; Max Planck Society	Poethig, RS (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	spoethig@sas.upenn.edu	Poethig, R. Scott/J-7009-2015; Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021	Poethig, R. Scott/0000-0001-6592-5862; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Wang, Jia-Wei/0000-0003-3885-6296	NIH [R01 GM051893]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM051893, R01GM051893] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to members of the Poethig laboratory for comments on this manuscript and helpful discussions throughout the course of these experiments. We are also grateful to Milo Aukerman for supplying seeds of toe1 toe2. This research was supported by a grant from NIH (R01 GM051893).	Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chuck G, 2005, CURR OPIN PLANT BIOL, V8, P67, DOI 10.1016/j.pbi.2004.11.002; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Daxinger L, 2008, TRENDS PLANT SCI, V13, P4, DOI 10.1016/j.tplants.2007.10.007; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; EVANS MMS, 1994, DEVELOPMENT, V120, P1971; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gould S. J., 1977, ONTOGENY PHYLOGENY; Guo AY, 2008, GENE, V418, P1, DOI 10.1016/j.gene.2008.03.016; Hackett W. P., 1997, Biotechnology of ornamental plants., P73; Hackett W. P., 1985, Horticultural Reviews, V7, P109, DOI 10.1002/9781118060735.ch3; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kerstetter RA, 1998, ANNU REV CELL DEV BI, V14, P373, DOI 10.1146/annurev.cellbio.14.1.373; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; LLOYD AM, 1994, SCIENCE, V266, P436, DOI 10.1126/science.7939683; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; MOOSE SP, 1994, PLANT CELL, V6, P1343, DOI 10.1105/tpc.6.10.1343; Moss EG, 2007, CURR BIOL, V17, pR425, DOI 10.1016/j.cub.2007.03.043; Parcy F, 2005, INT J DEV BIOL, V49, P585, DOI 10.1387/ijdb.041930fp; Poethig RS, 2003, SCIENCE, V301, P334, DOI 10.1126/science.1085328; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rougvie AE, 2005, DEVELOPMENT, V132, P3787, DOI 10.1242/dev.01972; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Smith MR, 2009, P NATL ACAD SCI USA, V106, P5424, DOI 10.1073/pnas.0812729106; Telfer A, 1997, DEVELOPMENT, V124, P645; Tsukaya H, 2000, PLANTA, V210, P536, DOI 10.1007/s004250050042; Usami T, 2009, DEVELOPMENT, V136, P955, DOI 10.1242/dev.028613; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; William DA, 2004, P NATL ACAD SCI USA, V101, P1775, DOI 10.1073/pnas.0307842100; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Zhao L, 2007, PLANT J, V51, P840, DOI 10.1111/j.1365-313X.2007.03181.x; ZIMMERMAN RH, 1985, ENCY PLANT PHYSL, V11, P79	47	1069	1182	34	313	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					750	759		10.1016/j.cell.2009.06.031	http://dx.doi.org/10.1016/j.cell.2009.06.031			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703400	Green Accepted, Bronze			2022-12-24	WOS:000269156100016
J	Brun, R; Blum, J; Chappuis, F; Burri, C				Brun, Reto; Blum, Johannes; Chappuis, Francois; Burri, Christian			Human African trypanosomiasis	LANCET			English	Article							GAMBIENSE SLEEPING SICKNESS; CARD-AGGLUTINATION-TEST; OF-THE-CONGO; CATT/TRYPANOSOMA-BRUCEI-GAMBIENSE; INTRATHECAL IMMUNE-RESPONSE; NERVOUS-SYSTEM INVOLVEMENT; POLYMERASE-CHAIN-REACTION; CEREBROSPINAL-FLUID; LATE-STAGE; COTE-DIVOIRE	Human African trypanosomiasis (sleeping sickness) occurs in sub-Saharan Africa. It is caused by the protozoan parasite Trypanosoma brucei, transmitted by tsetse flies. Almost all cases are due to Trypanosoma brucei gambiense, which is indigenous to west and central Africa. Prevalence is strongly dependent on control measures, which are often neglected during periods of political instability, thus leading to resurgence. With fewer than 12000 cases of this disabling and fatal disease reported per year, trypanosomiasis belongs to the most neglected tropical diseases. The clinical presentation is complex, and diagnosis and treatment difficult. The available drugs are old, complicated to administer, and can cause severe adverse reactions. New diagnostic methods and safe and effective drugs are urgently needed. Vector control, to reduce the number of flies in existing foci, needs to be organised on a pan-African basis. WHO has stated that if national control programmes, international organisations, research institutes, and philanthropic partners engage in concerted action, elimination of this disease might even be possible.	[Brun, Reto; Blum, Johannes; Burri, Christian] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Chappuis, Francois] Univ Geneva, Univ Hosp Geneva, CH-1211 Geneva 4, Switzerland; Med Sans Frontieres, Geneva, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Geneva; Doctors Without Borders	Brun, R (corresponding author), Swiss Trop Inst, CH-4002 Basel, Switzerland.	reto.brun@unibas.ch		Burri, Christian/0000-0001-5418-1984				Abel PM, 2004, TROP MED INT HEALTH, V9, P141, DOI 10.1046/j.1365-3156.2003.01152.x; *AFR UN, 2002, AHP DFID SPEC WORKSH; Agranoff D, 2005, TRENDS PARASITOL, V21, P154, DOI 10.1016/j.pt.2005.02.003; Ancelle T, 1997, Med Trop (Mars), V57, P245; [Anonymous], MANSONS TROPICAL DIS; [Anonymous], 1998, CONTR SURV AFR TRYP; Ayed Z, 1997, AM J TROP MED HYG, V57, P1; Balasegaram M, 2006, B WORLD HEALTH ORGAN, V84, P783, DOI 10.2471/BLT.06.031955; Balasegaram M, 2006, B WORLD HEALTH ORGAN, V84, P777, DOI 10.2471/BLT.05.028399; Barrett MP, 2007, BRIT J PHARMACOL, V152, P1155, DOI 10.1038/sj.bjp.0707354; Barrett MP, 2006, LANCET, V367, P1377, DOI 10.1016/S0140-6736(06)68591-7; Barrett MP, 1999, LANCET, V353, P1113, DOI 10.1016/S0140-6736(98)00416-4; BAYER AG, 2004, BAYER SUSTAINABLE DE; Bedat-Millet AL, 2000, REV NEUROL, V156, P505; Bisoffi Z, 2005, EMERG INFECT DIS, V11, P1745, DOI 10.3201/eid1111.050649; Bisser S, 2002, J NEUROL SCI, V193, P127, DOI 10.1016/S0022-510X(01)00655-4; Bisser S, 2007, J INFECT DIS, V195, P322, DOI 10.1086/510534; Blum J, 2006, ACTA TROP, V97, P55, DOI 10.1016/j.actatropica.2005.08.001; Blum J, 2005, T ROY SOC TROP MED H, V99, P795, DOI 10.1016/j.trstmh.2005.04.010; Blum J, 2001, TROP MED INT HEALTH, V6, P390, DOI 10.1046/j.1365-3156.2001.00710.x; Blum JA, 2008, LANCET INFECT DIS, V8, P631, DOI 10.1016/S1473-3099(08)70230-5; Blum JA, 2007, TROP MED INT HEALTH, V12, P1422, DOI 10.1111/j.1365-3156.2007.01948.x; Blum JA, 2007, ACTA TROP, V104, P16, DOI 10.1016/j.actatropica.2007.07.004; BRONNER U, 1991, T ROY SOC TROP MED H, V85, P608, DOI 10.1016/0035-9203(91)90364-5; Bronner U., 1994, THESIS KAROLINSKA I; Brun R, 2006, CURR OPIN INFECT DIS, V19, P415, DOI 10.1097/01.qco.0000244045.93016.b1; Buguet A, 2001, Med Trop (Mars), V61, P328; Burri C, 2003, PARASITOL RES, V90, pS49, DOI 10.1007/s00436-002-0766-5; Chappuis F, 2005, CLIN INFECT DIS, V41, P748, DOI 10.1086/432576; Chappuis F, 2005, CLIN MICROBIOL REV, V18, P133, DOI 10.1128/CMR.18.1.133-146.2005; Chappuis F, 2004, AM J TROP MED HYG, V71, P313, DOI 10.4269/ajtmh.2004.71.313; Chappuis F, 2002, TROP MED INT HEALTH, V7, P942, DOI 10.1046/j.1365-3156.2002.00956.x; CHAPPUIS F, 2004, DEV SANTE, V171, P41; Chappuis F, 2007, CLIN INFECT DIS, V45, P1443, DOI 10.1086/522983; Checchi F, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000064; Checchi F, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-16; Courtioux B, 2005, J CLIN MICROBIOL, V43, P4789, DOI 10.1128/JCM.43.9.4789-4795.2005; de Raadt P, 1968, East Afr Med J, V45, P128; Deborggraeve S, 2006, J CLIN MICROBIOL, V44, P2884, DOI 10.1128/JCM.02594-05; Deborggraeve S, 2008, DIAGN MICR INFEC DIS, V61, P428, DOI 10.1016/j.diagmicrobio.2008.03.006; *DNDI, 2008, DNDI NEWSL; Dorlo TPC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000225; Doua F, 1996, AM J TROP MED HYG, V55, P586, DOI 10.4269/ajtmh.1996.55.586; DUGGAN AJ, 1966, J TROP MED HYG, V69, P124; DUKES P, 1992, ACTA TROP, V51, P123, DOI 10.1016/0001-706X(92)90054-2; Ekwanzala M, 1996, LANCET, V348, P1427, DOI 10.1016/S0140-6736(96)06088-6; Enyaru JCK, 2006, ANN NY ACAD SCI, V1081, P311, DOI 10.1196/annals.1373.041; Ezzedine K, 2007, J TRAVEL MED, V14, P192, DOI 10.1111/j.1708-8305.2007.00114.x; Fevre EM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-96; Fevre EM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000333; GREENWOOD BM, 1973, LANCET, V2, P525; Gustafsson LL, 1987, HDB DRUGS TROPICAL P, P160; Hutchinson OC, 2004, TRENDS PARASITOL, V20, P519, DOI 10.1016/j.pt.2004.08.007; Iborra C, 1999, CLIN INFECT DIS, V28, P679, DOI 10.1086/517213; Inojosa WO, 2006, BMJ-BRIT MED J, V332, P1479, DOI 10.1136/bmj.38859.531354.7C; *INT FED PHARM MAN, HLTH PARTN DEV WORLD; Iten M, 1997, ANTIMICROB AGENTS CH, V41, P1922, DOI 10.1128/AAC.41.9.1922; Jamonneau V, 2004, ANN TROP MED PARASIT, V98, P329, DOI 10.1179/000349804225003406; Jamonneau V, 2003, TROP MED INT HEALTH, V8, P589, DOI 10.1046/j.1365-3156.2003.01079.x; Jamonneau V, 2002, TROP MED INT HEALTH, V7, P610, DOI 10.1046/j.1365-3156.2002.00905.x; Jamonneau V, 2000, ANN TROP MED PARASIT, V94, P831, DOI 10.1080/00034980020028004; Jamonneau V, 2000, ACTA TROP, V76, P175, DOI 10.1016/S0001-706X(00)00095-4; Jansson R, 2008, ANTIMICROB AGENTS CH, V52, P2842, DOI 10.1128/AAC.00050-08; Jelinek T, 2002, EMERG INFECT DIS, V8, P634, DOI 10.3201/eid0806.010432; Jordan A. M., 1993, P333; Joshi PP, 2005, AM J TROP MED HYG, V73, P491, DOI 10.4269/ajtmh.2005.73.491; Kabasa JD, 2007, TRENDS PARASITOL, V23, P191, DOI 10.1016/j.pt.2007.03.006; Kennedy PGE, 2008, T ROY SOC TROP MED H, V102, P306, DOI 10.1016/j.trstmh.2007.11.011; Kennedy PGE, 2006, J NEUROL, V253, P411, DOI 10.1007/s00415-006-0093-3; KOTEN JW, 1969, T ROY SOC TROP MED H, V63, P485, DOI 10.1016/0035-9203(69)90036-4; Lejon V, 2005, TROP MED INT HEALTH, V10, P395, DOI 10.1111/j.1365-3156.2005.01403.x; Lejon V, 1999, AM J TROP MED HYG, V60, P94, DOI 10.4269/ajtmh.1999.60.94; Lejon V, 2003, LANCET INFECT DIS, V3, P804, DOI 10.1016/S1473-3099(03)00834-X; Lejon V, 2003, J NEUROIMMUNOL, V144, P132, DOI 10.1016/j.jneuroim.2003.08.033; Lejon V, 2003, EUR J NEUROL, V10, P711, DOI 10.1046/j.1468-1331.2003.00660.x; Lejon V, 2003, J INFECT DIS, V187, P1475, DOI 10.1086/374645; Lejon V, 2002, TROP MED INT HEALTH, V7, P685, DOI 10.1046/j.1365-3156.2002.00917.x; Lejon V, 1998, ACTA TROP, V69, P151, DOI 10.1016/S0001-706X(97)00137-X; Louis F J, 2005, Med Trop (Mars), V65, P251; LUMSDEN WHR, 1979, T ROY SOC TROP MED H, V73, P312, DOI 10.1016/0035-9203(79)90092-0; Lundkvist GB, 2004, PHYSIOLOGY, V19, P198, DOI 10.1152/physiol.00006.2004; Lutumba P, 2006, TROP MED INT HEALTH, V11, P470, DOI 10.1111/j.1365-3156.2006.01591.x; Lutumba P, 2005, EMERG INFECT DIS, V11, P1382; Lutumba P, 2005, TROP MED INT HEALTH, V10, P347, DOI 10.1111/j.1365-3156.2005.01391.x; Lutumba P, 2007, EMERG INFECT DIS, V13, P1484, DOI 10.3201/eid1310.060358; MacLean L, 2004, INFECT IMMUN, V72, P7040, DOI 10.1128/IAI.72.12.7040-7044.2004; Macleod ET, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000239; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; Marcello L, 2007, GENOME RES, V17, P1344, DOI 10.1101/gr.6421207; Marcello L, 2007, J EUKARYOT MICROBIOL, V54, P14, DOI 10.1111/j.1550-7408.2006.00227.x; Masocha W, 2007, PHYSIOL BEHAV, V92, P110, DOI 10.1016/j.physbeh.2007.05.045; Maudlin I, 2006, ANN TROP MED PARASIT, V100, P679, DOI 10.1179/136485906X112211; *MED SANS FRONT, 2007, CLIN GUID; Mendonca Melo M, 2002, Ned Tijdschr Geneeskd, V146, P2552; Moore A, 2001, TROP MED INT HEALTH, V6, P342, DOI 10.1046/j.1365-3156.2001.00714.x; Moore AC, 2002, NEW ENGL J MED, V346, P2069, DOI 10.1056/NEJMcpc010056; Moore DAJ, 2002, EMERG INFECT DIS, V8, P74, DOI 10.3201/eid0801.010130; Na-Bangchang K, 2004, EUR J CLIN PHARMACOL, V60, P269, DOI 10.1007/s00228-004-0759-7; Njiokou F, 2006, INFECT GENET EVOL, V6, P147, DOI 10.1016/j.meegid.2005.04.003; Njiru ZK, 2008, INT J PARASITOL, V38, P589, DOI 10.1016/j.ijpara.2007.09.006; NOIREAU F, 1991, B WORLD HEALTH ORGAN, V69, P607; NOIREAU F, 1988, T ROY SOC TROP MED H, V82, P237, DOI 10.1016/0035-9203(88)90430-0; Odiit M, 2005, TROP MED INT HEALTH, V10, P840, DOI 10.1111/j.1365-3156.2005.01470.x; Odiit M, 1997, E AFR MED J, V74, P792; Oscherwitz SL, 2003, J TRAVEL MED, V10, P141, DOI 10.2310/7060.2003.31743; Papadopoulos MC, 2004, LANCET, V363, P1358, DOI 10.1016/S0140-6736(04)16046-7; PAQUET C, 1995, B SOC PATHOL EXOT, V88, P38; Penchenier L, 2003, ACTA TROP, V85, P31, DOI 10.1016/S0001-706X(02)00232-2; PEPIN J, 1992, T ROY SOC TROP MED H, V86, P254, DOI 10.1016/0035-9203(92)90298-Q; Picozzi K, 2005, BMJ-BRIT MED J, V331, P1238, DOI 10.1136/bmj.331.7527.1238; Pohlig G, 2008, 57 M AM SOC TROP MED; POHLIG G, 2005, 28 M INT SCI COUNC T; Priotto G, 2008, BMJ-BRIT MED J, V336, P679; Priotto G, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010039; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Reincke M, 1998, ANN NY ACAD SCI, V840, P809, DOI 10.1111/j.1749-6632.1998.tb09619.x; Ripamonti D, 2002, CLIN INFECT DIS, V34, pE18, DOI 10.1086/338157; Robays J, 2004, TROP MED INT HEALTH, V9, P869, DOI 10.1111/j.1365-3156.2004.01266.x; Robays J, 2004, TROP MED INT HEALTH, V9, P542, DOI 10.1111/j.1365-3156.2004.01240.x; Ruiz JA, 2002, B WORLD HEALTH ORGAN, V80, P738; Schmid C, 2005, J INFECT DIS, V191, P1922, DOI 10.1086/429929; SEIXAS J, 2004, THESIS U NOVA LISBOA; Shiflett AM, 2007, J EUKARYOT MICROBIOL, V54, P18, DOI 10.1111/j.1550-7408.2006.00228.x; Simarro P P, 2003, Med Trop (Mars), V63, P231; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Simarro PP, 1999, TROP MED INT HEALTH, V4, P858, DOI 10.1046/j.1365-3156.1999.00494.x; Simo G, 2006, VET PARASITOL, V139, P57, DOI 10.1016/j.vetpar.2006.02.026; Smith DH, 1998, BRIT MED BULL, V54, P341, DOI 10.1093/oxfordjournals.bmb.a011692; SPENCER HC, 1975, ANN INTERN MED, V82, P633, DOI 10.7326/0003-4819-82-5-633; Stanghellini A, 2001, TROP MED INT HEALTH, V6, P330, DOI 10.1046/j.1365-3156.2001.00724.x; Stevens B, 2004, NEURON GLIA BIOL, V1, P23, DOI 10.1017/s1740925x04000055; Steverding D, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-3; Steverding Dietmar, 2006, Kinetoplastid Biol Dis, V5, P1, DOI 10.1186/1475-9292-5-1; Stijemans B, 2007, VET PARASITOL, V148, P3, DOI 10.1016/j.vetpar.2007.05.005; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Taylor JE, 2006, TRENDS GENET, V22, P614, DOI 10.1016/j.tig.2006.08.003; Torr SJ, 2007, MED VET ENTOMOL, V21, P53, DOI 10.1111/j.1365-2915.2006.00657.x; Truc P, 1998, T ROY SOC TROP MED H, V92, P537, DOI 10.1016/S0035-9203(98)90904-X; Truc P, 1999, B WORLD HEALTH ORGAN, V77, P745; Truc P, 2002, B WORLD HEALTH ORGAN, V80, P882; Truc P, 1998, T ROY SOC TROP MED H, V92, P288, DOI 10.1016/S0035-9203(98)91014-8; Van Nieuwenhove S, 2001, TROP MED INT HEALTH, V6, P335, DOI 10.1046/j.1365-3156.2001.00731.x; Vanhamme L, 2004, INT J PARASITOL, V34, P887, DOI 10.1016/j.ijpara.2004.04.008; Vanhollebeke B, 2006, NEW ENGL J MED, V355, P2752, DOI 10.1056/NEJMoa063265; VANMEIRVENNE N, 1999, PROGR HUMAN AFRICAN, P235; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123; Welburn SC, 2006, TRENDS PARASITOL, V22, P123, DOI 10.1016/j.pt.2006.01.011; Welburn SC, 2001, LANCET, V358, P2017, DOI 10.1016/S0140-6736(01)07096-9; *WHO, 1986, WHO TECH REP SER, V739; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P71; Woo P. T. K., 1970, Acta trop., V27, P384; World Health Organization, 2002, WHO PROGR EL SLEEP S; 2008, ARZNEIMITTELKOMPENDI	153	550	559	8	228	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2010	375	9709					148	159		10.1016/S0140-6736(09)60829-1	http://dx.doi.org/10.1016/S0140-6736(09)60829-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544NM	19833383				2022-12-24	WOS:000273664500032
J	Selman, C; Tullet, JMA; Wieser, D; Irvine, E; Lingard, SJ; Choudhury, AI; Claret, M; Al-Qassab, H; Carmignac, D; Ramadani, F; Woods, A; Robinson, ICA; Schuster, E; Batterham, RL; Kozma, SC; Thomas, G; Carling, D; Okkenhaug, K; Thornton, JM; Partridge, L; Gems, D; Withers, DJ				Selman, Colin; Tullet, Jennifer M. A.; Wieser, Daniela; Irvine, Elaine; Lingard, Steven J.; Choudhury, Agharul I.; Claret, Marc; Al-Qassab, Hind; Carmignac, Danielle; Ramadani, Faruk; Woods, Angela; Robinson, Iain C. A.; Schuster, Eugene; Batterham, Rachel L.; Kozma, Sara C.; Thomas, George; Carling, David; Okkenhaug, Klaus; Thornton, Janet M.; Partridge, Linda; Gems, David; Withers, Dominic J.			Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span	SCIENCE			English	Article							DIET-INDUCED OBESITY; CAENORHABDITIS-ELEGANS; INSULIN SENSITIVITY; C-ELEGANS; MICE; GROWTH; AMPK; AGE; RESTRICTION; LONGEVITY	Caloric restriction (CR) protects against aging and disease, but the mechanisms by which this affects mammalian life span are unclear. We show in mice that deletion of ribosomal S6 protein kinase 1 (S6K1), a component of the nutrient-responsive mTOR (mammalian target of rapamycin) signaling pathway, led to increased life span and resistance to age-related pathologies, such as bone, immune, and motor dysfunction and loss of insulin sensitivity. Deletion of S6K1 induced gene expression patterns similar to those seen in CR or with pharmacological activation of adenosine monophosphate (AMP)-activated protein kinase (AMPK), a conserved regulator of the metabolic response to CR. Our results demonstrate that S6K1 influences healthy mammalian life span and suggest that therapeutic manipulation of S6K1 and AMPK might mimic CR and could provide broad protection against diseases of aging.	[Selman, Colin; Irvine, Elaine; Lingard, Steven J.; Choudhury, Agharul I.; Claret, Marc; Al-Qassab, Hind; Batterham, Rachel L.; Withers, Dominic J.] UCL, Dept Med, Ctr Diabet & Endocrinol, Inst Healthy Ageing, London WC1E 6JJ, England; [Tullet, Jennifer M. A.; Partridge, Linda; Gems, David] UCL, Dept Genet Evolut & Environm, Inst Healthy Ageing, London WC1E 6BT, England; [Wieser, Daniela; Schuster, Eugene; Thornton, Janet M.] European Bioinformat Inst, Cambridge CB10 1SD, England; [Carmignac, Danielle; Robinson, Iain C. A.] Natl Inst Med Res, MRC, Div Mol Neuroendocrinol, London NW7 1AA, England; [Ramadani, Faruk; Okkenhaug, Klaus] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England; [Woods, Angela; Carling, David] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Cellular Stress Grp, London W12 0NN, England; [Kozma, Sara C.; Thomas, George] Univ Cincinnati, Genome Res Inst, Dept Canc & Cell Biol, Cincinnati, OH 45237 USA; [Withers, Dominic J.] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Metab Signaling Grp, London W12 0NN, England	University of London; University College London; University of London; University College London; European Molecular Biology Laboratory (EMBL); MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Imperial College London; University System of Ohio; University of Cincinnati; Imperial College London	Withers, DJ (corresponding author), UCL, Dept Med, Ctr Diabet & Endocrinol, Inst Healthy Ageing, London WC1E 6JJ, England.	d.withers@ucl.ac.uk	Ramadani, Faruk/HHM-9664-2022; Okkenhaug, Klaus/D-5149-2012; Okkenhaug, Klaus/H-3154-2019; Partridge, Linda/A-5501-2010; Partridge, Linda/E-7342-2015; Carling, David/F-1943-2014; Withers, Dominic J/D-7671-2014; Thomas, George/K-9235-2014	Ramadani, Faruk/0000-0001-8228-4868; Okkenhaug, Klaus/0000-0002-9432-4051; Okkenhaug, Klaus/0000-0002-9432-4051; Carling, David/0000-0002-2316-1830; Withers, Dominic J/0000-0002-8009-7521; Thomas, George/0000-0003-3518-8149; Batterham, Rachel/0000-0002-5477-8585; Partridge, Linda/0000-0001-9615-0094; Selman, Colin/0000-0002-8727-0593; Irvine, Elaine/0000-0001-5508-8140; Claret, Marc/0000-0001-7766-9296; Tullet, Jennifer/0000-0002-2037-526X; Thornton, Janet/0000-0003-0824-4096; Schuster, Eugene/0000-0001-5076-2810; Gems, David/0000-0002-6653-4676	Wellcome Trust Functional Genomics; Wellcome Trust Strategic Award; Medical Research Council, Research into Aging; Biological and Biotechnology Research Council; BBSRC [BBS/E/B/0000C236] Funding Source: UKRI; MRC [MC_U120097114, G108/551, G0800339, MC_U117531708] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C236, BBS/E/B/0000M979] Funding Source: researchfish; Medical Research Council [MC_U120097114, G108/551, MC_U117531708, G0800339, MC_U120027537, G0700729B] Funding Source: researchfish	Wellcome Trust Functional Genomics(Wellcome Trust); Wellcome Trust Strategic Award(Wellcome Trust); Medical Research Council, Research into Aging(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biological and Biotechnology Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by a Wellcome Trust Functional Genomics award to J. M. T., L. P., D. G., and D. J. W.; a Wellcome Trust Strategic Award to J. M. T., L. P., D. G., and D. J. W.; and grants from the Medical Research Council, Research into Aging, and the Biological and Biotechnology Research Council to D. J. W.	Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Anisimov VN, 2008, CELL CYCLE, V7, P2769, DOI 10.4161/cc.7.17.6625; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Bartke A, 2008, AGING CELL, V7, P285, DOI 10.1111/j.1474-9726.2008.00387.x; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chang GR, 2009, J PHARMACOL SCI, V109, P496, DOI 10.1254/jphs.08215FP; Curtis R, 2006, AGING CELL, V5, P119, DOI 10.1111/j.1474-9726.2006.00205.x; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gulati P, 2007, BIOCHEM SOC T, V35, P236, DOI 10.1042/BST0350236; Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Masternak MM, 2009, J GERONTOL A-BIOL, V64, P516, DOI 10.1093/gerona/glp024; Mieulet V, 2007, AM J PHYSIOL-CELL PH, V293, pC712, DOI 10.1152/ajpcell.00499.2006; Miller RA, 2001, J GERONTOL A-BIOL, V56, pB180, DOI 10.1093/gerona/56.4.B180; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Picard F, 2005, INT J OBESITY, V29, pS36, DOI 10.1038/sj.ijo.0802912; Piper MDW, 2008, J INTERN MED, V263, P179, DOI 10.1111/j.1365-2796.2007.01906.x; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	28	800	848	2	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					140	144		10.1126/science.1177221	http://dx.doi.org/10.1126/science.1177221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797661	Green Accepted			2022-12-24	WOS:000270355600055
J	Hattori, D; Chen, Y; Matthews, BJ; Salwinski, L; Sabatti, C; Grueber, WB; Zipursky, SL				Hattori, Daisuke; Chen, Yi; Matthews, Benjamin J.; Salwinski, Lukasz; Sabatti, Chiara; Grueber, Wesley B.; Zipursky, S. Lawrence			Robust discrimination between self and non-self neurites requires thousands of Dscam1 isoforms	NATURE			English	Article							DROSOPHILA MUSHROOM BODIES; SENSORY NEURONS; AXON GUIDANCE; MOLECULAR DIVERSITY; STRUCTURAL BASIS; SPECIFICITY; BINDING; MORPHOGENESIS; ORGANIZATION; RECOGNITION	Down Syndrome cell adhesion molecule (Dscam) genes encode neuronal cell recognition proteins of the immunoglobulin superfamily(1,2). In Drosophila, Dscam1 generates 19,008 different ectodomains by alternative splicing of three exon clusters, each encoding half or a complete variable immunoglobulin domain(3). Identical isoforms bind to each other, but rarely to isoforms differing at any one of the variable immunoglobulin domains(4,5). Binding between isoforms on opposing membranes promotes repulsion(6). Isoform diversity provides the molecular basis for neurite self-avoidance(6-11). Self-avoidance refers to the tendency of branches from the same neuron (self-branches) to selectively avoid one another(12). To ensure that repulsion is restricted to self-branches, different neurons express different sets of isoforms in a biased stochastic fashion(7,13). Genetic studies demonstrated that Dscam1 diversity has a profound role in wiring the fly brain(11). Here we show how many isoforms are required to provide an identification system that prevents non-self branches from inappropriately recognizing each other. Using homologous recombination, we generated mutant animals encoding 12, 24, 576 and 1,152 potential isoforms. Mutant animals with deletions encoding 4,752 and 14,256 isoforms(14) were also analysed. Branching phenotypes were assessed in three classes of neurons. Branching patterns improved as the potential number of isoforms increased, and this was independent of the identity of the isoforms. Although branching defects in animals with 1,152 potential isoforms remained substantial, animals with 4,752 isoforms were indistinguishable from wild-type controls. Mathematical modelling studies were consistent with the experimental results that thousands of isoforms are necessary to ensure acquisition of unique Dscam1 identities in many neurons. We conclude that thousands of isoforms are essential to provide neurons with a robust discrimination mechanism to distinguish between self and non-self during self-avoidance.	[Hattori, Daisuke; Chen, Yi; Zipursky, S. Lawrence] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Matthews, Benjamin J.] Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, New York, NY 10032 USA; [Salwinski, Lukasz] Univ Calif Los Angeles, Inst Mol Biol, Howard Hughes Med Inst, DOE Inst Genom & Prote, Los Angeles, CA 90095 USA; [Sabatti, Chiara] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Grueber, Wesley B.] Columbia Univ, Med Ctr, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Grueber, Wesley B.] Columbia Univ, Med Ctr, Dept Neurosci, New York, NY 10032 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Columbia University; Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Columbia University; Columbia University	Zipursky, SL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	lzipursky@mednet.ucla.edu		Matthews, Benjamin/0000-0002-8697-699X; Grueber, Wesley/0000-0001-6751-256X; Zipursky, Stephen/0000-0001-5630-7181; Salwinski, Lukasz/0000-0003-4522-1969	NIH; NRSA; NIH/NINDS; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS060341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006485] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank T. Lee and B. Dickson for fly stocks, B. Dickson and E. Demir for advice on homologous recombination procedures, S. Miura for staining of embryos, and N. Nocera and other members of the Zipursky laboratory for help in screening homologous recombinants. We thank D. Eisenberg for helpful discussion on mathematical modelling. We thank R. Axel, A. Nern, W. Wojtowicz and other members of the Zipursky and Grueber laboratories for discussion and comments on the manuscript. This work was supported by a grant from the NIH ( S.L.Z.), and NRSA from NIH/NINDS (B.J.M.). W. B. G. is a Searle Scholar, McKnight Scholar and Klingenstein Fellow. S. L. Z. is an investigator of the Howard Hughes Medical Institute.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Brites D, 2008, MOL BIOL EVOL, V25, P1429, DOI 10.1093/molbev/msn087; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Graveley BR, 2004, RNA, V10, P1499, DOI 10.1261/rna.7105504; Grillenzoni N, 1998, DEVELOPMENT, V125, P3563; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; KRAMER AP, 1985, J NEUROSCI, V5, P768; Lee T, 1999, DEVELOPMENT, V126, P4065; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Sawaya MR, 2008, CELL, V134, P1007, DOI 10.1016/j.cell.2008.07.042; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schmucker D, 2009, GENE DEV, V23, P147, DOI 10.1101/gad.1752909; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652	26	114	114	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					644	U87		10.1038/nature08431	http://dx.doi.org/10.1038/nature08431			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19794492	Green Accepted			2022-12-24	WOS:000270302600039
J	Reich, D; Thangaraj, K; Patterson, N; Price, AL; Singh, L				Reich, David; Thangaraj, Kumarasamy; Patterson, Nick; Price, Alkes L.; Singh, Lalji			Reconstructing Indian population history	NATURE			English	Article							Y-CHROMOSOME; GENETIC AFFINITIES; MITOCHONDRIAL; INFERENCE; GENOTYPE; CASTE; HAPLOTYPE; PATTERNS; ORIGINS	India has been underrepresented in genome-wide surveys of human variation. We analyse 25 diverse groups in India to provide strong evidence for two ancient populations, genetically divergent, that are ancestral to most Indians today. One, the 'Ancestral North Indians' ( ANI), is genetically close to Middle Easterners, Central Asians, and Europeans, whereas the other, the 'Ancestral South Indians' (ASI), is as distinct from ANI and East Asians as they are from each other. By introducing methods that can estimate ancestry without accurate ancestral populations, we show that ANI ancestry ranges from 39-71% in most Indian groups, and is higher in traditionally upper caste and Indo-European speakers. Groups with only ASI ancestry may no longer exist in mainland India. However, the indigenous Andaman Islanders are unique in being ASI-related groups without ANI ancestry. Allele frequency differences between groups in India are larger than in Europe, reflecting strong founder effects whose signatures have been maintained for thousands of years owing to endogamy. We therefore predict that there will be an excess of recessive diseases in India, which should be possible to screen and map genetically.	[Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Reich, David; Patterson, Nick; Price, Alkes L.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Thangaraj, Kumarasamy; Singh, Lalji] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Reich, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	reich@genetics.med.harvard.edu; lalji@ccmb.res.in	Thangaraj, Kumarasamy/G-5596-2010	Thangaraj, Kumarasamy/0000-0002-0075-0106	NIH [HG004168]; Burroughs Wellcome Career Development Award; Council of Scientific and Industrial Research of the Government of India; UKIERI Major Award [RG-4772]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004168, R01HG006399] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Development Award(Burroughs Wellcome Fund); Council of Scientific and Industrial Research of the Government of India(Council of Scientific & Industrial Research (CSIR) - India); UKIERI Major Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the volunteers from throughout India who donated DNA; A. G. Reddy, A. Shah and R. Tamang for generating the Y chromosome and mtDNA data; J. Neubauer for sample preparation; and A. Tandon for data curation. We thank B. N. Sarkar and A. G. Roy for helping with group census size estimates, and D. Falush, J. Novembre, A. Ruiz-Linares and S. Watkins for comments on the manuscript. D. R., N. P. and A. L. P. were supported by NIH grant HG004168, and D. R. was supported by a Burroughs Wellcome Career Development Award in the Biomedical Sciences. K. T. and L. S. were supported by grants from the Council of Scientific and Industrial Research of the Government of India, and K. T. was supported by a UKIERI Major Award (RG-4772).	Abbi A, 2009, LANG SCI, V31, P791, DOI 10.1016/j.langsci.2008.02.002; Baird SJE, 2006, HEREDITY, V97, P81, DOI 10.1038/sj.hdy.6800850; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Barik SS, 2008, AM J PHYS ANTHROPOL, V136, P19, DOI 10.1002/ajpa.20773; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Bhasin MK., 2001, GENETICS CASTES TRIB; Boivin N, 2007, VERTEBR PALEOBIOL PA, P341, DOI 10.1007/1-4020-5562-5_15; Brahmachari SK, 2008, J GENET, V87, P3; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chikhi L, 2001, GENETICS, V158, P1347; Cordaux R, 2003, EUR J HUM GENET, V11, P253, DOI 10.1038/sj.ejhg.5200949; Das B M, 1986, Anthropol Anz, V44, P239; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Dirks Nicholas, 2001, CASTES MIND COLONIAL; DRONAMRA.KR, 1964, COLD SPRING HARB SYM, V29, P81, DOI 10.1101/SQB.1964.029.01.013; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; HALDANE JBS, 1964, PERSPECT BIOL MED, V7, P343; Hellenthal G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000078; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Karve IK, 1968, HINDU SOC INTERPRETA; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; KUNSCH HR, 1989, ANN STAT, V17, P1217, DOI 10.1214/aos/1176347265; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lohmueller KE, 2009, GENETICS, V182, P217, DOI 10.1534/genetics.108.099275; Majumdar D.N., 1960, RACE ELEMENTS BENGAL; MALLORY J.P., 2006, OXFORD INTRO PROTO I; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Palanichamy MG, 2006, SCIENCE, V311, DOI 10.1126/science.1120176; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pemberton TJ, 2008, ANN HUM GENET, V72, P535, DOI 10.1111/j.1469-1809.2008.00457.x; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2006, PLOS GENET, V2, P2052, DOI 10.1371/journal.pgen.0020215; ROYCHOUDHURY AK, 1985, HUM HERED, V35, P201, DOI 10.1159/000153545; SINGH KS, 1993, PEOPLE INDIA NATL SE, V3; SINGH KS, 1994, PEOPLE INDIA NATL SE, V3; Southworth F.C., 2005, LINGUISTIC ARCHAEOLO; Thangaraj K, 1999, ELECTROPHORESIS, V20, P1743, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1743::AID-ELPS1743>3.0.CO;2-V; Thangaraj K, 2003, CURR BIOL, V13, P86, DOI 10.1016/S0960-9822(02)01336-2; Thangaraj K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-151; Thanseem I, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-42; THORBURN D, 1977, SCAND J STAT, V4, P113; Watkins WS, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-86; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Zerjal T, 2007, HUM GENET, V121, P137, DOI 10.1007/s00439-006-0282-2	52	1008	1018	7	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					489	U50		10.1038/nature08365	http://dx.doi.org/10.1038/nature08365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	497SP	19779445	Green Accepted			2022-12-24	WOS:000270082900032
J	Halabi, N; Rivoire, O; Leibler, S; Ranganathan, R				Halabi, Najeeb; Rivoire, Olivier; Leibler, Stanislas; Ranganathan, Rama			Protein Sectors: Evolutionary Units of Three-Dimensional Structure	CELL			English	Article							AMINO-ACID SUBSTITUTIONS; SUBSTRATE-SPECIFICITY; CORRELATED MUTATIONS; ALLOSTERIC COMMUNICATION; SIGNAL-TRANSDUCTION; SERINE PROTEASES; PEPTIDE RECOGNITION; CONTACT PREDICTION; SEQUENCE ALIGNMENT; ENZYME CATALYSIS	Proteins display a hierarchy of structural features at primary, secondary, tertiary, and higher-order levels, an organization that guides our current understanding of their biological properties and evolutionary origins. Here, we reveal a structural organization distinct from this traditional hierarchy by statistical analysis of correlated evolution between amino acids. Applied to the S1A serine proteases, the analysis indicates a decomposition of the protein into three quasi-independent groups of correlated amino acids that we term "protein sectors.'' Each sector is physically connected in the tertiary structure, has a distinct functional role, and constitutes an independent mode of sequence divergence in the protein family. Functionally relevant sectors are evident in other protein families as well, suggesting that they may be general features of proteins. We propose that sectors represent a structural organization of proteins that reflects their evolutionary histories.	[Halabi, Najeeb; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Halabi, Najeeb; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Rivoire, Olivier; Leibler, Stanislas] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10065 USA; [Rivoire, Olivier; Leibler, Stanislas] Rockefeller Univ, Lab Living Matter, New York, NY 10065 USA; [Leibler, Stanislas] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA; [Leibler, Stanislas] Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Rockefeller University; Rockefeller University; Institute for Advanced Study - USA; Institute for Advanced Study - USA	Ranganathan, R (corresponding author), Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu	Halabi, Najeeb/AAX-8250-2020	Halabi, Najeeb/0000-0002-9345-6132	Robert A. Welch foundation; UT Southwestern Medical Center; NATIONAL EYE INSTITUTE [R01EY018720] Funding Source: NIH RePORTER	Robert A. Welch foundation(The Welch Foundation); UT Southwestern Medical Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank members of the Ranganathan and Leibler laboratories for discussion and critical review of the manuscript, L. Hedstrom for materials and protocols, and A. Poole and W. Russ for the SH domain alignments. This study was supported by the Robert A. Welch foundation (R.R.) and the Green Center for Systems Biology at UT Southwestern Medical Center. O.R. is a fellow of the Human Frontier Science Program.	Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Baird TT, 2006, PROTEIN SCI, V15, P1229, DOI 10.1110/ps.062179006; Bell JK, 2003, NAT STRUCT BIOL, V10, P527, DOI 10.1038/nsb944; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Bittar ER, 2003, BRAZ J MED BIOL RES, V36, P1621, DOI 10.1590/S0100-879X2003001200003; Bodi A, 2001, EUR J BIOCHEM, V268, P6238, DOI 10.1046/j.0014-2956.2001.02578.x; Bouchaud J.P., 2000, THEORY FINANCIAL RIS; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; Brumano MHN, 2000, ARCH BIOCHEM BIOPHYS, V382, P57; Buck MJ, 2005, MOL BIOL EVOL, V22, P1627, DOI 10.1093/molbev/msi157; Bush-Pelc LA, 2007, J BIOL CHEM, V282, P27165, DOI 10.1074/jbc.M703202200; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; CHOTHIA C, 1982, J MOL BIOL, V160, P309, DOI 10.1016/0022-2836(82)90178-4; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CRAIK CS, 1985, SCIENCE, V228, P291, DOI 10.1126/science.3838593; DARROCH JN, 1972, ANN MATH STAT, V43, P1470, DOI 10.1214/aoms/1177692379; Datta D, 2008, J MOL BIOL, V381, P1157, DOI 10.1016/j.jmb.2008.06.040; DOOLITTLE RF, 1996, COMPUTER METHODS MAC, V266; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Ferguson AD, 2007, P NATL ACAD SCI USA, V104, P513, DOI 10.1073/pnas.0609887104; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Guinto ER, 1999, P NATL ACAD SCI USA, V96, P1852, DOI 10.1073/pnas.96.5.1852; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Hamilton N, 2004, PROTEINS, V56, P679, DOI 10.1002/prot.20160; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; HEDSTROM L, 1994, BIOCHEMISTRY-US, V33, P8757, DOI 10.1021/bi00195a017; Hedstrom L, 1996, BIOL CHEM, V377, P465; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Huntington JA, 2003, STRUCTURE, V11, P469, DOI 10.1016/S0969-2126(03)00049-2; John DM, 2000, PROTEIN SCI, V9, P1416, DOI 10.1110/ps.9.7.1416; Kam CM, 2000, BBA-PROTEIN STRUCT M, V1477, P307, DOI 10.1016/S0167-4838(99)00282-4; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Kullback S., 1997, INFORM THEORY STAT; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Lapedes A. S., 1999, STAT MOL BIOL GENETI, P236; Larson SM, 2000, J MOL BIOL, V303, P433, DOI 10.1006/jmbi.2000.4146; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Lee WS, 2004, J BIOCHEM, V135, P93, DOI 10.1093/jb/mvh011; LESK AM, 1982, J MOL BIOL, V160, P325, DOI 10.1016/0022-2836(82)90179-6; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Martinez JC, 1999, NAT STRUCT BIOL, V6, P1010; MCGRATH ME, 1992, BIOCHEMISTRY-US, V31, P3059, DOI 10.1021/bi00127a005; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Naganathan AN, 2008, BIOCHEMISTRY-US, V47, P6752, DOI 10.1021/bi800336x; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Olmea O, 1997, FOLD DES, V2, pS25, DOI 10.1016/S1359-0278(97)00060-6; Olsson AY, 2004, GENOMICS, V84, P147, DOI 10.1016/j.ygeno.2004.01.009; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; Ortiz AR, 1999, PROTEINS, P177; Ota N, 2005, J MOL BIOL, V351, P345, DOI 10.1016/j.jmb.2005.05.043; Pasternak A, 1999, PROTEIN SCI, V8, P253; PERONA JJ, 1995, BIOCHEMISTRY-US, V34, P1489, DOI 10.1021/bi00005a004; PERONA JJ, 1993, SCIENCE, V261, P620, DOI 10.1126/science.8342029; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Plerou V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066126; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Riddle DS, 1999, NAT STRUCT BIOL, V6, P1016; Rugles SW, 2004, J BIOL CHEM, V279, P30751, DOI 10.1074/jbc.M400949200; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Sadovsky E, 2007, P NATL ACAD SCI USA, V104, P19813, DOI 10.1073/pnas.0708120104; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Thomas DJ, 1996, PROTEIN ENG, V9, P941, DOI 10.1093/protein/9.11.941; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thornton JM, 1999, J MOL BIOL, V293, P333, DOI 10.1006/jmbi.1999.3054; Wang ECW, 1997, PROTEIN ENG, V10, P405, DOI 10.1093/protein/10.4.405; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; WIGNER EP, 1967, SIAM REV, V9, P1, DOI 10.1137/1009001; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8; ZVELEBIL MJ, 1987, J MOL BIOL, V195, P957, DOI 10.1016/0022-2836(87)90501-8	87	484	493	2	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					774	786		10.1016/j.cell.2009.07.038	http://dx.doi.org/10.1016/j.cell.2009.07.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703402	Green Accepted, Bronze			2022-12-24	WOS:000269156100018
J	Bartholomaus, I; Kawakami, N; Odoardi, F; Schlager, C; Miljkovic, D; Ellwart, JW; Klinkert, WEF; Flugel-Koch, C; Issekutz, TB; Wekerle, H; Flugel, A				Bartholomaeus, Ingo; Kawakami, Naoto; Odoardi, Francesca; Schlaeger, Christian; Miljkovic, Djordje; Ellwart, Joachim W.; Klinkert, Wolfgang E. F.; Fluegel-Koch, Cassandra; Issekutz, Thomas B.; Wekerle, Hartmut; Fluegel, Alexander			Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions	NATURE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; GERMLINE TRANSMISSION; DENDRITIC CELLS; CHOROID-PLEXUS; ANTIGEN; PROTEIN; LYMPHOCYTES; BRAIN; EXTRAVASATION	The tissues of the central nervous system are effectively shielded from the blood circulation by specialized vessels that are impermeable not only to cells, but also to most macromolecules circulating in the blood. Despite this seemingly absolute seclusion, central nervous system tissues are subject to immune surveillance and are vulnerable to autoimmune attacks(1). Using intravital two-photon imaging in a Lewis rat model of experimental autoimmune encephalomyelitis, here we present in real-time the interactive processes between effector T cells and cerebral structures from their first arrival to manifest autoimmune disease. We observed that incoming effector T cells successively scanned three planes. The T cells got arrested to leptomeningeal vessels and immediately monitored the luminal surface, crawling preferentially against the blood flow. After diapedesis, the cells continued their scan on the abluminal vascular surface and the underlying leptomeningeal (pial) membrane. There, the T cells encountered phagocytes that effectively present antigens, foreign as well as myelin proteins. These contacts stimulated the effector T cells to produce pro-inflammatory mediators, and provided a trigger to tissue invasion and the formation of inflammatory infiltrations.	[Bartholomaeus, Ingo; Kawakami, Naoto; Odoardi, Francesca; Schlaeger, Christian; Miljkovic, Djordje; Klinkert, Wolfgang E. F.; Wekerle, Hartmut; Fluegel, Alexander] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Odoardi, Francesca; Schlaeger, Christian; Fluegel, Alexander] Inst Multiple Sclerosis Res, Dept Neuroimmunol, Gemeinnutzige Hertie Stiftung, D-37073 Gottingen, Germany; [Odoardi, Francesca; Schlaeger, Christian; Fluegel, Alexander] Univ Med Ctr Gottingen, D-37073 Gottingen, Germany; [Odoardi, Francesca; Fluegel, Alexander] Univ Munich, Inst Immunol, D-80336 Munich, Germany; [Ellwart, Joachim W.] Helmholtz Ctr, Inst Expt Hematol, D-81377 Munich, Germany; [Fluegel-Koch, Cassandra] Univ Erlangen Nurnberg, Inst Anat 2, D-91054 Erlangen, Germany; [Issekutz, Thomas B.] Dalhousie Univ, Dept Pediat, Div Immunol, Halifax, NS B3K 6R8, Canada	Max Planck Society; University of Gottingen; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Erlangen Nuremberg; Dalhousie University	Flugel, A (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	hwekerle@neuro.mpg.de; Fluegel@med.uni-goettingen.de	Miljković, Đorđe/F-1378-2015	Miljković, Đorđe/0000-0002-5613-9306; Issekutz, Thomas/0000-0001-5486-9463; Kawakami, Naoto/0000-0001-7693-3489	Deutsche Forschungsgemeinschaft [SFB455 A8, SFB571 C6]; Hertie foundation [1.01.1/04/010]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hertie foundation	We thank S. Kosin, I. Haarmann, C. Federle, T. H. Ngugen and K. Nispel for technical assistance. We thank M. Krumbholz for help in statistical analysis, M. Hubener for support in 3D analysis software, and K. Dornmair, E. Meinl and E. Lutjen-Drecoll for critical comments on the paper. We are grateful to V. Staiger for providing software and R. Schorner for help with the artwork. This work was supported by the Deutsche Forschungsgemeinschaft (SFB455 project A8 and SFB571 project C6) and the Hertie foundation (Hertie no. 1.01.1/04/010).	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Becher B, 2006, J MOL MED, V84, P532, DOI 10.1007/s00109-006-0065-1; Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007; BENNUN A, 1981, EUR J IMMUNOL, V11, P195, DOI 10.1002/eji.1830110307; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Eylar E H, 1974, Methods Enzymol, V32, P323; Flugel A, 1999, NAT MED, V5, P843, DOI 10.1038/10567; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; HICKEY WF, 1992, J NEUROPATH EXP NEUR, V51, P246, DOI 10.1097/00005072-199205000-00002; HINRICHS DJ, 1987, J EXP MED, V166, P1906, DOI 10.1084/jem.166.6.1906; ISSEKUTZ TB, 1993, AM J PATHOL, V143, P1286; Kawakami N, 2005, J IMMUNOL, V175, P69, DOI 10.4049/jimmunol.175.1.69; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; Kawakami N, 2004, J EXP MED, V199, P185, DOI 10.1084/jem.20031064; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; KUCHROO VK, 1992, J IMMUNOL, V148, P3776; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Matyszak MK, 1996, NEUROSCIENCE, V74, P599, DOI 10.1016/0306-4522(96)00160-1; McMenamin PG, 2003, CELL TISSUE RES, V313, P259, DOI 10.1007/s00441-003-0779-0; Odoardi F, 2007, P NATL ACAD SCI USA, V104, P18625, DOI 10.1073/pnas.0705033104; Odoardi F, 2007, P NATL ACAD SCI USA, V104, P920, DOI 10.1073/pnas.0608383104; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; TAMATANI T, 1991, EUR J IMMUNOL, V21, P627, DOI 10.1002/eji.1830210314; TRAUGOTT U, 1979, Journal of the Neurological Sciences, V42, P331, DOI 10.1016/0022-510X(79)90166-7; TSUCHIDA M, 1994, IMMUNOLOGY, V81, P420; Vajkoczy P, 2001, J CLIN INVEST, V108, P557; Walther M, 2001, J NEUROIMMUNOL, V117, P30, DOI 10.1016/S0165-5728(01)00302-2; WEKERLE H, 1986, TRENDS NEUROSCI, V9, P271, DOI 10.1016/0166-2236(86)90077-9; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	36	468	476	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					94	U104		10.1038/nature08478	http://dx.doi.org/10.1038/nature08478			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19829296				2022-12-24	WOS:000271419200039
J	Garcia-Garcia, L; Valdespino-Gomez, JL; Lazcano-Ponce, E; Jimenez-Corona, A; Higuera-Iglesias, A; Cruz-Hervert, P; Cano-Arellano, B; Garcia-Anaya, A; Ferreira-Guerrero, E; Baez-Saldana, R; Ferreyra-Reyes, L; Ponce-de-Leon-Rosales, S; Alpuche-Aranda, C; Rodriguez-Lopez, MH; Perez-Padilla, R; Hernandez-Avila, M				Garcia-Garcia, Lourdes; Luis Valdespino-Gomez, Jose; Lazcano-Ponce, Eduardo; Jimenez-Corona, Aida; Higuera-Iglesias, Anjarath; Cruz-Hervert, Pablo; Cano-Arellano, Bulmaro; Garcia-Anaya, Antonio; Ferreira-Guerrero, Elizabeth; Baez-Saldana, Renata; Ferreyra-Reyes, Leticia; Ponce-de-Leon-Rosales, Samuel; Alpuche-Aranda, Celia; Henry Rodriguez-Lopez, Mario; Perez-Padilla, Rogelio; Hernandez-Avila, Mauricio			Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; A H1N1 VIRUS; ANTIGENIC MATCH; WORKING ADULTS; CHILDREN; IMMUNOGENICITY; INFECTION; EVOLUTION; HEALTHY; CARE	Objective To evaluate the association of 2008-9 seasonal trivalent inactivated vaccine with cases of influenza A/H1N1 during the epidemic in Mexico. Design Frequency matched case-control study. Setting Specialty hospital in Mexico City, March to May 2009. Participants 60 patients with laboratory confirmed influenza A/H1N1 and 180 controls with other diseases ( not influenza-like illness or pneumonia) living in Mexico City or the State of Mexico and matched for age and socioeconomic status. Main outcome measures Odds ratio and effectiveness of trivalent inactivated vaccine against influenza A/H1N1. Results Cases were more likely than controls to be admitted to hospital, undergo invasive mechanical ventilation, and die. Controls were more likely than cases to have chronic conditions that conferred a higher risk of influenza related complications. In the multivariate model, influenza A/H1N1 was independently associated with trivalent inactivated vaccine ( odds ratio 0.27, 95% confidence interval 0.11 to 0.66) and underlying conditions (0.15, 0.08 to 0.30). Vaccine effectiveness was 73% ( 95% confidence interval 34% to 89%). None of the eight vaccinated cases died. Conclusions Preliminary evidence suggests some protection from the 2008-9 trivalent inactivated vaccine against pandemic influenza A/H1N1 2009, particularly severe forms of the disease, diagnosed in a specialty hospital during the influenza epidemic in Mexico City.	[Luis Valdespino-Gomez, Jose; Ponce-de-Leon-Rosales, Samuel] Labs Biol React Mexico BIRMEX, Mexico City 03100, DF, Mexico; [Garcia-Garcia, Lourdes; Lazcano-Ponce, Eduardo; Jimenez-Corona, Aida; Cruz-Hervert, Pablo; Cano-Arellano, Bulmaro; Garcia-Anaya, Antonio; Ferreira-Guerrero, Elizabeth; Baez-Saldana, Renata; Ferreyra-Reyes, Leticia; Henry Rodriguez-Lopez, Mario] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Higuera-Iglesias, Anjarath; Perez-Padilla, Rogelio] INER, Mexico City, DF, Mexico; [Alpuche-Aranda, Celia] InDRE, Mexico City, DF, Mexico; [Hernandez-Avila, Mauricio] Subsecretariat Hlth Prevent & Promot, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica	Valdespino-Gomez, JL (corresponding author), Labs Biol React Mexico BIRMEX, Amores 1240, Mexico City 03100, DF, Mexico.	jvaldespinog@birmex.gob.mx	Mamelund, Svenn-Erik/Q-3158-2019; Cruz-Hervert, Luis Pablo/AEI-4595-2022; García, Maria de Lourdes/I-2724-2019; Mamelund, Svenn-Erik/G-4495-2016	Mamelund, Svenn-Erik/0000-0002-3980-3818; Cruz-Hervert, Luis Pablo/0000-0002-6094-958X; García, Maria de Lourdes/0000-0001-5262-1157; Mamelund, Svenn-Erik/0000-0002-3980-3818	Mexican Ministry of Health	Mexican Ministry of Health	This study was supported by the Mexican Ministry of Health. The funding source did not influence or participate in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; in writing the manuscript; or in the decision to submit the article for publication. The researchers were independent of the funder. Competing interests: JLV-G and SPdeLR are employed by Laboratorios de Biologicos y Reactivos de Mexico (BIRMEX).	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P185; [Anonymous], MMWR MORB MORTAL WKL; Barraza-Llorens M, 2002, HEALTH AFFAIR, V21, P47, DOI 10.1377/hlthaff.21.3.47; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Carrillo-Rodriguez JG, 2000, SALUD PUBLICA MEXICO, V42, P201; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gobierno Federal, MAN VAC 2008 2009; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Herrera GA, 2007, VACCINE, V25, P154, DOI 10.1016/j.vaccine.2006.05.129; Leyva-Flores R, 2001, HEALTH POLICY, V57, P15, DOI 10.1016/S0168-8510(00)00136-6; MOGABGAB WJ, 1970, J AMER MED ASSOC, V211, P1672, DOI 10.1001/jama.211.10.1672; *NAT CTR BIOT INF, 2009, GENBANK SEQ 2009 H1N; Nichol KL, 1999, JAMA-J AM MED ASSOC, V282, P137, DOI 10.1001/jama.282.2.137; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; ORENSTEIN WA, 1988, EPIDEMIOL REV, V10, P212, DOI 10.1093/oxfordjournals.epirev.a036023; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Ritzwoller DP, 2005, PEDIATRICS, V116, P153, DOI 10.1542/peds.2005-0049; Shuler CM, 2007, PEDIATRICS, V119, pE587, DOI 10.1542/peds.2006-1878; Tumpey TM, 2004, P NATL ACAD SCI USA, V101, P3166, DOI 10.1073/pnas.0308391100; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2009, SWIN FLU ILLN US MEX; *WHO, 2009, INFL A H1N1 UPD 58; World Health Organization, WHO REC PAND H1N1 20; World Health Organization, 2009, VACC NEW INFL A H1N1; World Health Organization, 2009, CDC PROT REALT RTPCR; 2009, MMWR MORB MORTAL WKL, V58, P521; 2009, MMWR MORB MORTAL WKL, V58, P585	28	127	132	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2009	339								b3928	10.1136/bmj.b3928	http://dx.doi.org/10.1136/bmj.b3928			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505TF	19808768	Green Published, hybrid			2022-12-24	WOS:000270719100006
J	Norden, C; Young, S; Link, BA; Harris, WA				Norden, Caren; Young, Stephen; Link, Brian A.; Harris, William A.			Actomyosin Is the Main Driver of Interkinetic Nuclear Migration in the Retina	CELL			English	Article							NEUROEPITHELIAL CELLS; IN-VIVO; DIVISION; BINDING; PHOSPHORYLATION; NEUROGENESIS; ZEBRAFISH; MOVEMENT; DYNAMICS; MOTILITY	Progenitor cell nuclei in the rapidly expanding epithelium of the embryonic vertebrate central nervous system undergo a process called interkinetic nuclear migration (IKNM). Movements of IKNM are generally believed to involve smooth migration of nuclei from apical to basal and back during the G1 and G2 phases of the cell cycle, respectively. Yet, this has not been formally demonstrated, nor have the molecular mechanisms that drive IKNM been identified. Using time-lapse confocal microscopy to observe nuclear movements in zebrafish retinal neuroepithelial cells, we show that, except for brief apical nuclear translocations preceding mitosis, IKNM is stochastic rather than smooth and directed. We also show that IKNM is driven largely by actomyosin-dependent forces as it still occurs when the microtubule cytoskeleton is compromised but is blocked when MyosinII activity is inhibited.	[Norden, Caren; Young, Stephen; Harris, William A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Link, Brian A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	University of Cambridge; Medical College of Wisconsin	Harris, WA (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England.	harris@mole.bio.cam.ac.uk	Norden, Caren/I-3918-2014	Norden, Caren/0000-0001-8835-1451	European Molecular Biology Organization; Human Frontier Science Program; Wellcome Trust; NATIONAL EYE INSTITUTE [R01EY014167] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank J. C. Bulinski, N. Galjart, V. Lecaudey, C. J. Wilkinson, W. M. Bements, and H. Hosoya for sharing constructs and morpholinos. J. Skepper and A. Sossick are thanked for help with electron and confocal microscopy, and A. McNabb and G. Stooke- Vaughan for help with fish maintenance and cloning. We are grateful to J. Sanes for discussing the manuscript. S. Y. would like to thank G. B. Blanchard and A. J. Kabla for advice on data analysis, and R. J. Adams for encouraging him to pursue the collaboration. C. N. was supported by the European Molecular Biology Organization and a Human Frontier Science Program long- term fellowship. S. Y. is a member of the Wellcome Trust PhD program in developmental biology. B. A. L. is supported by the National Institutes of Health. This work was supported by a Wellcome Trust Programme Grant to W. A. H. C. N. designed and performed the experiments, measured all trajectories, made all figures and wrote the manuscript. S. Y. designed and implemented the trajectory analysis, prepared graphs and contributed to the manuscript. B. L. made and supplied constructs, helped designing experiments, and contributed to figures and the manuscript. W. A. H conceived the study, helped in designing experiments, and wrote the manuscript together with C. N.	Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; BRESNICK AR, 1995, BIOCHEMISTRY-US, V34, P12576, DOI 10.1021/bi00039a012; Bulinski JC, 1999, CELL STRUCT FUNCT, V24, P313; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Carlier MF, 1998, CURR OPIN CELL BIOL, V10, P45, DOI 10.1016/S0955-0674(98)80085-9; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; CRAMER LP, 1995, J CELL BIOL, V131, P179, DOI 10.1083/jcb.131.1.179; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; GOLDMAN RD, 1971, J CELL BIOL, V51, P752, DOI 10.1083/jcb.51.3.752; Huet S, 2006, BIOPHYS J, V91, P3542, DOI 10.1529/biophysj.105.080622; Iwasaki T, 2001, CELL STRUCT FUNCT, V26, P677, DOI 10.1247/csf.26.677; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kusch J, 2003, TRENDS CELL BIOL, V13, P562, DOI 10.1016/j.tcb.2003.09.008; Miyata T, 2008, DEV GROWTH DIFFER, V50, pS105, DOI 10.1111/j.1440-169x.2007.00980.x; Murciano A, 2002, MOL CELL NEUROSCI, V21, P285, DOI 10.1006/mcne.2002.1174; Nowakowski R.S., 2005, DEV NEUROBIOL, P21; Owens DF, 1998, J NEUROSCI, V18, P5374, DOI 10.1523/JNEUROSCI.18-14-05374.1998; Pearson RA, 2005, J NEUROSCI, V25, P10803, DOI 10.1523/JNEUROSCI.2312-05.2005; Poggi L, 2005, J CELL BIOL, V171, P991, DOI 10.1083/jcb.200509098; R Development Core Team, 2009, R FDN STAT COMP; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Stepanova T, 2003, J NEUROSCI, V23, P2655; TAKEMURA R, 1992, J CELL SCI, V103, P953; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Vaughan PS, 2001, J BIOL CHEM, V276, P26171, DOI 10.1074/jbc.M102649200; WEBSTER W, 1978, AM J ANAT, V152, P209, DOI 10.1002/aja.1001520204; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026	31	182	182	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1195	1208		10.1016/j.cell.2009.06.032	http://dx.doi.org/10.1016/j.cell.2009.06.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766571	hybrid, Green Published			2022-12-24	WOS:000269923200019
J	Silva, J; Nichols, J; Theunissen, TW; Guo, G; van Oosten, AL; Barrandon, O; Wray, J; Yamanaka, S; Chambers, I; Smith, A				Silva, Jose; Nichols, Jennifer; Theunissen, Thorold W.; Guo, Ge; van Oosten, Anouk L.; Barrandon, Ornella; Wray, Jason; Yamanaka, Shinya; Chambers, Ian; Smith, Austin			Nanog Is the Gateway to the Pluripotent Ground State	CELL			English	Article							EMBRYONIC STEM-CELLS; X-INACTIVATION; TRANSCRIPTIONAL NETWORK; REGULATORY CIRCUITRY; MOUSE EPIBLAST; SOMATIC-CELLS; TERATOCARCINOMA; DIFFERENTIATION; ESTABLISHMENT; FIBROBLASTS	Pluripotency is generated naturally during mammalian development through formation of the epiblast, founder tissue of the embryo proper. Pluripotency can be recreated by somatic cell reprogramming. Here we present evidence that the homeodomain protein Nanog mediates acquisition of both embryonic and induced pluripotency. Production of pluripotent hybrids by cell fusion is promoted by and dependent on Nanog. In transcription factor-induced molecular reprogramming, Nanog is initially dispensable but becomes essential for dedifferentiated intermediates to transit to ground state pluripotency. In the embryo, Nanog specifically demarcates the nascent epiblast, coincident with the domain of X chromosome reprogramming. Without Nanog, pluripotency does not develop, and the inner cell mass is trapped in a pre-pluripotent, indeterminate state that is ultimately nonviable. These findings suggest that Nanog choreographs synthesis of the naive epiblast ground state in the embryo and that this function is recapitulated in the culmination of somatic cell reprogramming.	[Silva, Jose; Nichols, Jennifer; Theunissen, Thorold W.; Guo, Ge; van Oosten, Anouk L.; Barrandon, Ornella; Wray, Jason; Smith, Austin] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Silva, Jose; Theunissen, Thorold W.; Guo, Ge; van Oosten, Anouk L.; Barrandon, Ornella; Wray, Jason; Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England; [Nichols, Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QR, England; [Yamanaka, Shinya] Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto 6068507, Japan; [Chambers, Ian] Univ Edinburgh, Sch Biol Sci, Inst Stem Cell Res, MRC,Ctr Regenerat Med, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Cambridge; University of Cambridge; University of Cambridge; Kyoto University; University of Edinburgh	Silva, J (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QR, England.	jcs64@cscr.cam.ac.uk; austin.smith@cscr.cam.ac.uk	Silva, Jose C R/X-5140-2019; Chambers, Ian/H-5416-2011; Silva, Jose/G-1920-2014	Silva, Jose C R/0000-0001-5487-1117; Chambers, Ian/0000-0003-2605-1597; Silva, Jose/0000-0001-5487-1117; Smith, Austin/0000-0002-3029-4682; Theunissen, Thorold/0000-0001-6943-7858; Nichols, Jennifer/0000-0002-8650-1388	The Wellcome Trust; Biotechnology and Biological Sciences Research Council; Medical Research Council; EC Framework 7; Medical Research Council [G0700711B, G0300723B, G0700665, G9806702] Funding Source: researchfish; MRC [G9806702, G0700665] Funding Source: UKRI	The Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EC Framework 7(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Sameera Patel for genotyping, Rachel Walker for flow cytometry, Peter Humphreys for imaging, Bill Mansfield for chimera generation, and Sam Jameson and staff for mouse husbandry. This research was supported by The Wellcome Trust, the Biotechnology and Biological Sciences Research Council, the Medical Research Council, and the EC Framework 7 project Euro-SyStem. A.S. is a Medical Research Council Professor.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GARDNER RL, 1988, J CELL SCI, P11; GARDNER RL, 1983, INT REV EXP PATHOL, V24, P63; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Lavial F, 2007, DEVELOPMENT, V134, P3549, DOI 10.1242/dev.006569; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MILLER RA, 1976, CELL, V9, P45, DOI 10.1016/0092-8674(76)90051-9; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Navarro P, 2009, FEBS LETT, V583, P1721, DOI 10.1016/j.febslet.2009.03.043; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2001, DEVELOPMENT, V128, P2333; NICHOLS J, 1984, J EMBRYOL EXP MORPH, V80, P225; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; Selwood L, 2006, BIOESSAYS, V28, P128, DOI 10.1002/bies.20360; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; TAKAGI N, 1983, CELL, V34, P1053, DOI 10.1016/0092-8674(83)90563-9; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	58	727	796	4	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					722	737		10.1016/j.cell.2009.07.039	http://dx.doi.org/10.1016/j.cell.2009.07.039			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703398	hybrid, Green Published, Green Submitted			2022-12-24	WOS:000269156100014
J	Goodson, JL; Schrock, SE; Klatt, JD; Kabelik, D; Kingsbury, MA				Goodson, James L.; Schrock, Sara E.; Klatt, James D.; Kabelik, David; Kingsbury, Marcy A.			Mesotocin and Nonapeptide Receptors Promote Estrildid Flocking Behavior	SCIENCE			English	Article							SOCIAL RECOGNITION; OXYTOCIN RELEASE; NEURAL CIRCUITRY; MEDIAL AMYGDALA; VASOPRESSIN; FEMALE; BRAIN; VASOTOCIN	Proximate neural mechanisms that influence preferences for groups of a given size are almost wholly unknown. In the highly gregarious zebra finch (Estrildidae: Taeniopygia guttata), blockade of nonapeptide receptors by an oxytocin (OT) antagonist significantly reduced time spent with large groups and familiar social partners independent of time spent in social contact. Opposing effects were produced by central infusions of mesotocin (MT, avian homolog of OT). Most drug effects appeared to be female-specific. Across five estrildid finch species, species-typical group size correlates with nonapeptide receptor distributions in the lateral septum, and sociality in female zebra finches was reduced by OT antagonist infusions into the septum but not a control area. We propose that titration of sociality by MT represents a phylogenetically deep framework for the evolution of OT's female-specific roles in pair bonding and maternal functions.	[Goodson, James L.; Schrock, Sara E.; Klatt, James D.; Kabelik, David; Kingsbury, Marcy A.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Goodson, JL (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	jlgoodso@indiana.edu	Kabelik, David/O-9932-2019		NIH [MH062656]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062656] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funded by NIH MH062656 (study section on Biobehavioral Regulation, Learning, and Ethology) to J.L.G.	Acher R, 1995, ADV EXP MED BIOL, V395, P615; Baeyens DA, 2006, COMP BIOCHEM PHYS B, V143, P12, DOI 10.1016/j.cbpb.2005.09.012; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Bosch OJ, 2005, J NEUROSCI, V25, P6807, DOI 10.1523/JNEUROSCI.1342-05.2005; Carter CS, 2008, PROG BRAIN RES, V170, P331, DOI 10.1016/S0079-6123(08)00427-5; Choleris E, 2007, P NATL ACAD SCI USA, V104, P4670, DOI 10.1073/pnas.0700670104; Cushing BS, 2000, HORM BEHAV, V37, P49, DOI 10.1006/hbeh.1999.1558; DEVRIES GJ, 1983, BRAIN RES, V273, P307, DOI 10.1016/0006-8993(83)90855-7; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Goodson JL, 2006, P NATL ACAD SCI USA, V103, P17013, DOI 10.1073/pnas.0606278103; Goodson JL, 2006, HORM BEHAV, V50, P223, DOI 10.1016/j.yhbeh.2006.03.005; Goodson JL, 2008, PROG BRAIN RES, V170, P3, DOI 10.1016/S0079-6123(08)00401-9; Goodson JL, 2004, HORM BEHAV, V45, P136, DOI 10.1016/j.yhbeh.2003.08.006; Goodson JL, 2000, NATURE, V403, P769, DOI 10.1038/35001581; Goodwin, 1982, ESTRILDID FINCHES WO; INSEL TR, 1995, BEHAV NEUROSCI, V109, P782, DOI 10.1037/0735-7044.109.4.782; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Krause J, 2002, LIVING GROUPS; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Leng G, 2008, CURR OPIN PHARMACOL, V8, P731, DOI 10.1016/j.coph.2008.07.001; Leung CH, 2009, J COMP NEUROL, V513, P197, DOI 10.1002/cne.21947; Lim MM, 2006, HORM BEHAV, V50, P506, DOI 10.1016/j.yhbeh.2006.06.028; Ross HE, 2009, J NEUROSCI, V29, P1312, DOI 10.1523/JNEUROSCI.5039-08.2009; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Skead D.M., 1975, Ostrich (), VNo. 11, P1; Thompson RR, 2004, BEHAV NEUROSCI, V118, P620, DOI 10.1037/0735-7044.118.3.620; Veenema AH, 2008, PROG BRAIN RES, V170, P261, DOI 10.1016/S0079-6123(08)00422-6; Zann RA., 1996, ZEBRA FINCH SYNTHESI	29	172	173	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					862	866		10.1126/science.1174929	http://dx.doi.org/10.1126/science.1174929			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AK	19679811	Green Accepted			2022-12-24	WOS:000269242400043
J	Alby, K; Schaefer, D; Bennett, RJ				Alby, Kevin; Schaefer, Dana; Bennett, Richard J.			Homothallic and heterothallic mating in the opportunistic pathogen Candida albicans	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; CRYPTOCOCCUS-NEOFORMANS; SEXUAL REPRODUCTION; GENE-EXPRESSION; BAR1 GENE; PHEROMONE; PROTEIN; YEAST; IDENTIFICATION; INFECTIONS	Candida albicans is the most common fungal pathogen in humans, causing both debilitating mucosal infections and potentially life-threatening systemic infections(1,2). Until recently, C. albicans was thought to be strictly asexual, existing only as an obligate diploid. A cryptic mating cycle has since been uncovered in which diploid a and alpha cells undergo efficient cell and nuclear fusion, resulting in tetraploid a/alpha mating products(3-6). Whereas mating between a and alpha cells has been established (heterothallism), we report here two pathways for same-sex mating (homothallism) in C. albicans. First, unisexual populations of a cells were found to undergo autocrine pheromone signalling and same-sex mating in the absence of the Bar1 protease. In both C. albicans and Saccharomyces cerevisiae, Bar1 is produced by a cells and inactivates mating pheromone alpha, typically secreted by alpha cells(7-10). C. albicans Delta bar1 a cells were shown to secrete both a and alpha mating pheromones; alpha-pheromone activated self-mating in these cells in a process dependent on Ste2, the receptor for alpha-pheromone. In addition, pheromone production by alpha cells was found to promote same-sex mating between wild-type a cells. These results establish that homothallic mating can occur in C. albicans, revealing the potential for genetic exchange even within unisexual populations of the organism. Furthermore, Bar1 protease has an unexpected but pivotal role in determining whether sexual reproduction can potentially be homothallic or is exclusively heterothallic. These findings also have implications for the mode of sexual reproduction in related species that propagate unisexually, and indicate a role for specialized sexual cycles in the survival and adaptation of pathogenic fungi.	[Alby, Kevin; Schaefer, Dana; Bennett, Richard J.] Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA	Brown University	Bennett, RJ (corresponding author), Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA.	Richard_Bennett@brown.edu		Bennett, Richard/0000-0001-7563-484X	Burroughs Wellcome Fund; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F31DE019752] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors would like to thank D. MacCallum and the Aberdeen Fungal Group for strains, and J. Laney, T. Serio, R. Sherwood and M. Tessmer for discussions and critical reading of the manuscript. We also thank D. Koveal and S. Gilman for assistance during the preliminary stages of this work. R. J. B. holds an Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund. K. A. was supported by a training grant for Graduate Assistance in Areas of National Need.	Alby K, 2009, MOL BIOL CELL, V20, P3178, DOI 10.1091/mbc.E09-01-0040; Bennett RJ, 2006, MOL MICROBIOL, V62, P100, DOI 10.1111/j.1365-2958.2006.05367.x; Bennett RJ, 2005, MOL MICROBIOL, V55, P1046, DOI 10.1111/j.1365-2958.2005.04466.x; Bennett RJ, 2003, MOL CELL BIOL, V23, P8189, DOI 10.1128/MCB.23.22.8189-8201.2003; Bui T, 2008, EUKARYOT CELL, V7, P1771, DOI 10.1128/EC.00097-08; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Guthrie C, 1991, GUIDE YEAST GENETICS; HALL M, 1993, EARLY DAYS YEAST GEN; HICKS JB, 1976, NATURE, V260, P246, DOI 10.1038/260246a0; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; Hull CM, 1999, SCIENCE, V285, P1271, DOI 10.1126/science.285.5431.1271; JACKSON CL, 1990, MOL CELL BIOL, V10, P2202, DOI 10.1128/MCB.10.5.2202; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; Lin XR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000283; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; Lockhart SR, 2003, EUKARYOT CELL, V2, P49, DOI 10.1128/EC.2.1.49-61.2003; Lockhart SR, 2002, GENETICS, V162, P737; MACKAY VL, 1988, P NATL ACAD SCI USA, V85, P55, DOI 10.1073/pnas.85.1.55; Magee BB, 2000, SCIENCE, V289, P310, DOI 10.1126/science.289.5477.310; MANNEY TR, 1983, J BACTERIOL, V155, P291, DOI 10.1128/JB.155.1.291-301.1983; Miller MG, 2002, CELL, V110, P293, DOI 10.1016/S0092-8674(02)00837-1; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Odds FC, 2007, EUKARYOT CELL, V6, P1041, DOI 10.1128/EC.00041-07; Panwar SL, 2003, EUKARYOT CELL, V2, P1350, DOI 10.1128/EC.2.6.1350-1360.2003; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Samaranayake LP, 2002, ORAL DIS, V8, P151, DOI 10.1034/j.1601-0825.8.s2.6.x; Schaefer D, 2007, EUKARYOT CELL, V6, P907, DOI 10.1128/EC.00090-07; SEGALL JE, 1993, P NATL ACAD SCI USA, V90, P8332, DOI 10.1073/pnas.90.18.8332; Sherwood RK, 2008, EUKARYOT CELL, V7, P1460, DOI 10.1128/EC.00138-08; Smulian AG, 2001, GENETICS, V157, P991; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	34	148	155	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 13	2009	460	7257					890	U127		10.1038/nature08252	http://dx.doi.org/10.1038/nature08252			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	483CB	19675652	Green Accepted			2022-12-24	WOS:000268938300038
J	Angelo, G; Van Gilst, MR				Angelo, Giana; Van Gilst, Marc R.			Starvation Protects Germline Stem Cells and Extends Reproductive Longevity in C-elegans	SCIENCE			English	Article							LIFE-SPAN EXTENSION; CAENORHABDITIS-ELEGANS; EMBRYONIC DIAPAUSE; RECEPTOR NHR-49; DROSOPHILA; RESTRICTION; GENETICS; HYPOXIA; DEATH	The study of starvation-resistant biological programs has elucidated numerous mechanisms influencing aging. Here we present the discovery and characterization of starvation-induced adult reproductive diapause (ARD) in Caenorhabditis elegans. ARD differs from the C. elegans dauer diapause in that it enables sexually mature adults to delay reproductive onset 15-fold and extend total adult life span at least threefold. The effectiveness of ARD requires apoptotic death of the entire germ line, except for a small population of protected germline stem cells (GSCs). When feeding is resumed, surviving GSCs regenerate a new germ line capable of offspring production near the level of nonstarved animals. The starvation-sensing nuclear receptor NHR-49 is required for ARD entry and recovery. Our findings establish mechanisms for preserving stem cell potency and reproductive potential during prolonged starvation.	[Angelo, Giana; Van Gilst, Marc R.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Van Gilst, MR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	vangilst@fhcrc.org			NIH [GM080895-02, RDK079273A]; American Diabetes Association Junior Investigator Award [1-07-JF-72]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080895] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Junior Investigator Award(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Priess and B. Edgar for critical reading of the manuscript; J. Kimble and L. Jones for helpful suggestions; the Priess lab for materials and equipment; and the Van Gilst, Priess, and Roth laboratories for helpful discussions and feedback. G. A. is funded by a Ruth Kirchstein postdoctoral fellowship from NIH (GM080895-02). This work was also funded by an American Diabetes Association Junior Investigator Award ( ADA 1-07-JF-72)and by a grant from NIH (RDK079273A).	Aballay A, 2001, P NATL ACAD SCI USA, V98, P2735, DOI 10.1073/pnas.041613098; Chen JJ, 2004, J NEMATOL, V36, P107; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Cypser JR, 2006, EXP GERONTOL, V41, P935, DOI 10.1016/j.exger.2006.09.004; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hsu HJ, 2008, DEV BIOL, V313, P700, DOI 10.1016/j.ydbio.2007.11.006; HUANG HFS, 1979, BIOL REPROD, V21, P891, DOI 10.1095/biolreprod21.4.891; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Lopes FL, 2004, REPRODUCTION, V128, P669, DOI 10.1530/rep.1.00444; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Miller DL, 2009, CURR BIOL, V19, P1233, DOI 10.1016/j.cub.2009.05.066; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Renfree MB, 2000, ANNU REV PHYSIOL, V62, P353, DOI 10.1146/annurev.physiol.62.1.353; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Riddle DL, 1997, C ELEGANS, P739; Salinas LS, 2006, CELL DEATH DIFFER, V13, P2129, DOI 10.1038/sj.cdd.4401976; Selesniemi K, 2008, AGING CELL, V7, P622, DOI 10.1111/j.1474-9726.2008.00409.x; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Tavaluc RT, 2007, CELL CYCLE, V6, P2554, DOI 10.4161/cc.6.20.4911; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011	27	185	192	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					954	958		10.1126/science.1178343	http://dx.doi.org/10.1126/science.1178343			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19713489				2022-12-24	WOS:000271712300027
J	Moore, DL; Blackmore, MG; Hu, Y; Kaestner, KH; Bixby, JL; Lemmon, VP; Goldberg, JL				Moore, Darcie L.; Blackmore, Murray G.; Hu, Ying; Kaestner, Klaus H.; Bixby, John L.; Lemmon, Vance P.; Goldberg, Jeffrey L.			KLF Family Members Regulate Intrinsic Axon Regeneration Ability	SCIENCE			English	Article							KRUPPEL-LIKE FACTOR; CENTRAL-NERVOUS-SYSTEM; IN-VIVO; TRANSCRIPTION FACTORS; DEVELOPMENTAL LOSS; SPINAL-CORD; CELLS; PATHWAY; GROWTH; GENE	Neurons in the central nervous system (CNS) lose their ability to regenerate early in development, but the underlying mechanisms are unknown. By screening genes developmentally regulated in retinal ganglion cells (RGCs), we identified Kruppel-like factor-4 (KLF4) as a transcriptional repressor of axon growth in RGCs and other CNS neurons. RGCs lacking KLF4 showed increased axon growth both in vitro and after optic nerve injury in vivo. Related KLF family members suppressed or enhanced axon growth to differing extents, and several growth-suppressive KLFs were up-regulated postnatally, whereas growth-enhancing KLFs were down-regulated. Thus, coordinated activities of different KLFs regulate the regenerative capacity of CNS neurons.	[Moore, Darcie L.; Hu, Ying; Goldberg, Jeffrey L.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Moore, Darcie L.; Bixby, John L.; Lemmon, Vance P.; Goldberg, Jeffrey L.] Univ Miami, Miller Sch Med, Neurosci Program, Miami, FL 33136 USA; [Blackmore, Murray G.; Bixby, John L.; Lemmon, Vance P.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Kaestner, Klaus H.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA	Bascom Palmer Eye Institute; University of Miami; University of Miami; University of Miami; University of Pennsylvania	Goldberg, JL (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	jgoldberg@med.miami.edu	Lemmon, Vance/A-2565-2008; Ying, Hu/F-3581-2010; Lemmon, Vance/A-7410-2010	Lemmon, Vance/0000-0003-3550-7576; Bixby, John/0000-0003-1633-5318; Goldberg, Jeffrey/0000-0002-1390-7360; Moore, Darcie/0000-0002-0854-7655	National Eye Institute (NEI) [EY016790, EY014801]; National Institute of Neurological Disorders and Stroke (NINDS) [NS061348, T32 NS07492, T32 NS007459]; Glaucoma Foundation; Seigal Foundation; C. H. Neilsen Foundation; Ralph Wilson Medical Research Foundation; W. G. Ross Foundation; Buoniconti Fund to Cure Paralysis; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R03EY016790, P30EY014801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061348, T32NS007459, T32NS007492, R01NS059866] Funding Source: NIH RePORTER	National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Glaucoma Foundation; Seigal Foundation; C. H. Neilsen Foundation; Ralph Wilson Medical Research Foundation; W. G. Ross Foundation; Buoniconti Fund to Cure Paralysis; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by a National Eye Institute (NEI) R03 grant (EY016790, J. L. G.) and subsequently by a National Institute of Neurological Disorders and Stroke (NINDS) R01 grant (NS061348, J. L. G.) and critical funding from The Glaucoma Foundation and the Seigal Foundation (J. L. G.), the C. H. Neilsen Foundation (V. P. L. and J. L. G.), the Ralph Wilson Medical Research Foundation and the W. G. Ross Foundation (V. P. L.), The Buoniconti Fund to Cure Paralysis (V. P. L. and J. L. B.), an NEI P30 grant (EY014801), and an unrestricted grant from Research to Prevent Blindness to the University of Miami. D. L. M. is a Lois Pope LIFE Fellow, with support from NINDS training grants T32 NS07492 and T32 NS007459. We are indebted for generous gifts of FLAG-tagged KLF4 (C. Liu, University of Texas), mCherry (R. Tsien, University of California, San Diego), and KLF2 constructs (J. Lingrel, University of Cincinnati). We are grateful to W. Feuer (University of Miami) for statistical contributions and to R. Corredor (University of Miami) for optimizing RGC electroporation. We thank the following lab members and collaborators for their meaningful contributions: Ne. Patel, Ni. Patel, J. Gallardo, N. Sharifai, E. Walford, M. Velarde, A. Sloan, M. Benny, A. Oliva, Y. Shi, E. Hernandez, G. Lambert, and G. Gaidosh. The authors declare they have no conflicts of interest.	Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Blackmore M, 2006, J NEUROBIOL, V66, P348, DOI 10.1002/neu.20224; Bouslama-Oueghlani L, 2003, J NEUROSCI, V23, P8318; BREGMAN BS, 1989, J COMP NEUROL, V282, P355, DOI 10.1002/cne.902820304; Buchser WJ, 2006, BIOTECHNIQUES, V41, P619, DOI 10.2144/000112279; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Cayrou C, 2002, ENDOCRINOLOGY, V143, P2242, DOI 10.1210/en.143.6.2242; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; CHEN DF, 1995, P NATL ACAD SCI USA, V92, P7287, DOI 10.1073/pnas.92.16.7287; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; Dai X, 2004, CURR OPIN GENET DEV, V14, P485, DOI 10.1016/j.gde.2004.07.002; Dang DT, 2002, NUCLEIC ACIDS RES, V30, P2736, DOI 10.1093/nar/gkf400; Dusart I, 1997, J NEUROSCI, V17, P3710; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Ghaleb AM, 2007, ONCOGENE, V26, P2365, DOI 10.1038/sj.onc.1210022; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Hagos EG, 2009, ONCOGENE, V28, P1197, DOI 10.1038/onc.2008.465; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Katz JP, 2002, DEVELOPMENT, V129, P2619; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; LI D, 1995, EUR J NEUROSCI, V7, P1164, DOI 10.1111/j.1460-9568.1995.tb01106.x; Nicholls J, 1996, TRENDS NEUROSCI, V19, P229, DOI 10.1016/0166-2236(96)10021-7; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Veldman MB, 2007, DEV BIOL, V312, P596, DOI 10.1016/j.ydbio.2007.09.019; Wang JT, 2007, J NEUROSCI, V27, P8593, DOI 10.1523/JNEUROSCI.4488-06.2007; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006; Zhao R, 2008, J CELL BIOCHEM, V105, P949, DOI 10.1002/jcb.21871; Zhu SS, 2009, BRAIN RES, V1250, P49, DOI 10.1016/j.brainres.2008.11.013	39	496	508	3	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					298	301		10.1126/science.1175737	http://dx.doi.org/10.1126/science.1175737			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815778	Green Accepted			2022-12-24	WOS:000270599500045
J	Triplett, JW; Owens, MT; Yamada, J; Lemke, G; Cang, JH; Stryker, MP; Feldheim, DA				Triplett, Jason W.; Owens, Melinda T.; Yamada, Jena; Lemke, Greg; Cang, Jianhua; Stryker, Michael P.; Feldheim, David A.			Retinal Input Instructs Alignment of Visual Topographic Maps	CELL			English	Article							EPHRIN-AS; SUPERIOR COLLICULUS; MICE LACKING; FUNCTIONAL MAPS; GANGLION-CELL; WAVES; PROJECTIONS; REFINEMENT; MECHANISMS; SEGREGATION	Sensory information is represented in the brain in the form of topographic maps, in which neighboring neurons respond to adjacent external stimuli. In the visual system, the superior colliculus receives topographic projections from the retina and primary visual cortex (V1) that are aligned. Alignment may be achieved through the use of a gradient of shared axon guidance molecules, or through a retinal-matching mechanism in which axons that monitor identical regions of visual space align. To distinguish between these possibilities, we take advantage of genetically engineered mice that we show have a duplicated functional retinocollicular map but only a single map in V1. Anatomical tracing revealed that the corticocollicular projection bifurcates to align with the duplicated retinocollicular map in a manner dependent on the normal pattern of spontaneous activity during development. These data suggest a general model in which convergent maps use coincident activity patterns to achieve alignment.	[Triplett, Jason W.; Yamada, Jena; Feldheim, David A.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Owens, Melinda T.; Stryker, Michael P.] Univ Calif San Francisco, Dept Physiol, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Lemke, Greg] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Cang, Jianhua] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	University of California System; University of California Santa Cruz; University of California System; University of California San Francisco; Salk Institute; Northwestern University	Feldheim, DA (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	feldheim@biology.ucsc.edu		Owens, Melinda/0000-0001-8286-5419; Stryker, Michael/0000-0003-1546-5831	NIH [R01-EY014689, R01-EY02874, R01-EY018621, R01-NS031249]; NIH National Research Service Award Postdoctoral Fellowship [F32-EY18531]; NIH Training Program for the Visual Sciences [T32-EY007120]; NATIONAL EYE INSTITUTE [R01EY014689, R01EY018621, R01EY002874, F32EY018531, T32EY007120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS031249] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Training Program for the Visual Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the NIH (R01-EY014689 to D. A. F., R01-EY02874 to M. P. S., R01-EY018621 to J.C., R01-NS031249 to G. L.). J.W.T. was supported by an NIH National Research Service Award Postdoctoral Fellowship (F32-EY18531). M.T.O was supported by an NIH Training Program for the Visual Sciences (T32-EY007120). We thank Bin Chen, Yi Zuo, and members of the Feldheim and Stryker labs for discussion and critical reading of the manuscript.	Bansal A, 2000, J NEUROSCI, V20, P7672; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Brown NL, 2001, DEVELOPMENT, V128, P2497; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Cang JH, 2005, NEURON, V48, P577, DOI 10.1016/j.neuron.2005.10.026; Cang JH, 2008, J NEUROSCI, V28, P11015, DOI 10.1523/JNEUROSCI.2478-08.2008; Cang JH, 2008, NEURON, V57, P511, DOI 10.1016/j.neuron.2007.12.025; Chandrasekaran AR, 2007, J NEUROSCI, V27, P1746, DOI 10.1523/JNEUROSCI.4383-06.2007; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; Del Cano GG, 2002, J COMP NEUROL, V446, P166, DOI 10.1002/cne.10179; Demas J, 2006, NEURON, V50, P247, DOI 10.1016/j.neuron.2006.03.033; DRAGER UC, 1976, J NEUROPHYSIOL, V39, P91, DOI 10.1152/jn.1976.39.1.91; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Firth SI, 2005, CELL CALCIUM, V37, P425, DOI 10.1016/j.ceca.2005.01.010; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gallarda BW, 2008, SCIENCE, V320, P233, DOI 10.1126/science.1153758; Hebb D. O., 1949, ORG BEHAV NEUROPHYSI; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Khachab MY, 1999, DEV BRAIN RES, V114, P179, DOI 10.1016/S0165-3806(99)00020-6; KING AJ, 1988, NATURE, V332, P73, DOI 10.1038/332073a0; KNUDSEN EI, 1991, SCIENCE, V253, P85, DOI 10.1126/science.2063209; Lemke G, 2005, ANNU REV CELL DEV BI, V21, P551, DOI 10.1146/annurev.cellbio.20.022403.093702; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Pak W, 2004, CELL, V119, P567, DOI 10.1016/j.cell.2004.10.026; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Pittman AJ, 2008, DEVELOPMENT, V135, P2865, DOI 10.1242/dev.025049; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; SCHILLER PH, 1974, J NEUROPHYSIOL, V37, P181, DOI 10.1152/jn.1974.37.1.181; Singer JH, 2001, J NEUROSCI, V21, P8514, DOI 10.1523/JNEUROSCI.21-21-08514.2001; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Sun C, 2008, P NATL ACAD SCI USA, V105, P13638, DOI 10.1073/pnas.0807178105; Syed MM, 2004, J PHYSIOL-LONDON, V560, P533, DOI 10.1113/jphysiol.2004.066597; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Xu W, 1999, J NEUROSCI, V19, P9298	49	81	82	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					175	185		10.1016/j.cell.2009.08.028	http://dx.doi.org/10.1016/j.cell.2009.08.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804762	Green Accepted, Bronze			2022-12-24	WOS:000270388600025
J	Rajakulendran, T; Sahmi, M; Lefrancois, M; Sicheri, F; Therrien, M				Rajakulendran, Thanashan; Sahmi, Malha; Lefrancois, Martin; Sicheri, Frank; Therrien, Marc			A dimerization-dependent mechanism drives RAF catalytic activation	NATURE			English	Article							B-RAF; SIGNALING PATHWAY; ONCOGENIC BRAF; HUMAN CANCER; KINASE; PROTEIN; HETERODIMERIZATION; DOMAIN; INHIBITORS; DROSOPHILA	The ERK (extracellular signal-regulated kinase) pathway is an evolutionarily conserved signal transduction module that controls cellular growth, differentiation and survival(1). Activation of receptor tyrosine kinases (RTKs) by the binding of growth factors initiates GTP loading of RAS, which triggers the initial steps in the activation of the ERK pathway by modulating RAF family kinase function. Once activated, RAF participates in a sequential cascade of phosphorylation events that activate MEK, and in turn ERK. Unbridled signalling through the ERK pathway caused by activating mutations in RTKs, RAS or RAF has been linked to several human cancers(2). Of note, one member of the RAF family, BRAF, is the most frequently mutated oncogene in the kinase superfamily(3). Not surprisingly, there has been a colossal effort to understand the underlying regulation of this family of kinases. In particular, the process by which the RAF kinase domain becomes activated towards its substrate MEK remains of topical interest. Here, using Drosophila Schneider S2 cells, we demonstrate that RAF catalytic function is regulated in response to a specific mode of dimerization of its kinase domain, which we term the side-to-side dimer. Moreover, we find that the RAF-related pseudo-kinase KSR ( kinase suppressor of Ras) also participates in forming side-to-side heterodimers with RAF and can thereby trigger RAF activation. This mechanism provides an elegant explanation for the longstanding conundrumabout RAF catalytic activation, and also provides an explanation for the capacity of KSR, despite lacking catalytic function, to directly mediate RAF activation. We also show that RAF side-to-side dimer formation is essential for aberrant signalling by oncogenic BRAF mutants, and identify an oncogenic mutation that acts specifically by promoting side-to-side dimerization. Together, our data identify the side-to-side dimer interface of RAF as a potential therapeutic target for intervention in BRAF-dependent tumorigenesis.	[Rajakulendran, Thanashan; Sicheri, Frank] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Rajakulendran, Thanashan; Sicheri, Frank] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Sahmi, Malha; Lefrancois, Martin; Therrien, Marc] Univ Montreal, Inst Res Immunol & Canc, Lab Intracellular Signaling, Montreal, PQ H3C 3J7, Canada; [Therrien, Marc] Univ Montreal, Dept Pathol & Biol Cellular, Montreal, PQ H3C 3J7, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Universite de Montreal; Universite de Montreal	Sicheri, F (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	sicheri@lunenfeld.ca; marc.therrien@umontreal.ca	Sicheri, Frank/F-8856-2013		Canadian Institutes for Health Research [MOP-36399]; Canadian Cancer Society [018046]; Research Fellow of The Terry Fox Foundation [019684]; National Cancer Institute of Canada Scientist award; Canada Research Chair	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Research Fellow of The Terry Fox Foundation; National Cancer Institute of Canada Scientist award; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	We thank members of the F. S. and M. T. laboratories for advice and discussions. We are also grateful to R. Lambert and IRIC genomic platform for conducting qPCR reactions. This work was supported by grants from the Canadian Institutes for Health Research to F. S. (MOP-36399) and from the Canadian Cancer Society to M. T. ( Award 018046). T. R. is a Research Fellow of The Terry Fox Foundation ( Award 019684). F. S. is a recipient of a National Cancer Institute of Canada Scientist award, and M. T. is a Canada Research Chair ( Tier II) in Intracellular Signaling.	Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Douziech M, 2006, GENE DEV, V20, P807, DOI 10.1101/gad.1390406; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Halilovic E, 2008, CURR OPIN PHARMACOL, V8, P419, DOI 10.1016/j.coph.2008.06.014; Hansen JD, 2008, BIOORG MED CHEM LETT, V18, P4692, DOI 10.1016/j.bmcl.2008.07.002; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Ritt DA, 2007, CURR BIOL, V17, P179, DOI 10.1016/j.cub.2006.11.061; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roignant JY, 2006, GENE DEV, V20, P795, DOI 10.1101/gad.1390506; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	25	328	335	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					542	U114		10.1038/nature08314	http://dx.doi.org/10.1038/nature08314			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19727074				2022-12-24	WOS:000270082900044
J	Melbourne, BA; Hastings, A				Melbourne, Brett A.; Hastings, Alan			Highly Variable Spread Rates in Replicated Biological Invasions: Fundamental Limits to Predictability	SCIENCE			English	Article							CHAOTIC DYNAMICS; VARIABILITY; DISPERSAL; ECOLOGY; MODELS	Although mean rates of spread for invasive species have been intensively studied, variance in spread rates has been neglected. Variance in spread rates can be driven exogenously by environmental variability or endogenously by demographic or genetic stochasticity in reproduction, survival, and dispersal. Endogenous variability is likely to be important in spread but has not been studied empirically. We show that endogenously generated variance in spread rates is remarkably high between replicated invasions of the flour beetle Tribolium castaneum in laboratory microcosms. The observed variation between replicate invasions cannot be explained by demographic stochasticity alone, which indicates inherent limitations to predictability in even the simplest ecological settings.	[Melbourne, Brett A.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Hastings, Alan] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of Colorado System; University of Colorado Boulder; University of California System; University of California Davis	Melbourne, BA (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	brett.melbourne@colorado.edu	Hastings, Alan/O-6864-2019	Hastings, Alan/0000-0002-0717-8026; MELBOURNE, BRETT/0000-0002-8843-4131	National Science Foundation [DEB 0516150]; NSF Biological Invasions Integrative Graduate Education and Research Traineeship (IGERT) [DGE 0114432]	National Science Foundation(National Science Foundation (NSF)); NSF Biological Invasions Integrative Graduate Education and Research Traineeship (IGERT)(National Science Foundation (NSF))	We thank M. Gibson, D. Hodgkiss, C. Koenig, T. McCabe, D. Paulus, D. Smith, N. Tcheou, R. Villalobos, and M. Wu for assistance. This study was funded by National Science Foundation grant DEB 0516150 to A. H. and B. A. M. and by NSF Biological Invasions Integrative Graduate Education and Research Traineeship (IGERT) DGE 0114432.	ANDOW DA, 1990, LANDSCAPE ECOL, V4, P177, DOI 10.1007/BF00132860; Carpenter SR, 2002, ECOLOGY, V83, P2069, DOI 10.2307/3072038; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; CLARK JS, 1979, ECOLOGY, V84, P2003; Costantino R. F., 1991, POPULATION DYNAMICS; Costantino RF, 1997, SCIENCE, V275, P389, DOI 10.1126/science.275.5298.389; Dennis B, 2001, ECOL MONOGR, V71, P277, DOI 10.1890/0012-9615(2001)071[0277:ECACDI]2.0.CO;2; Gibson GJ, 2006, STAT COMPUT, V16, P391, DOI 10.1007/s11222-006-0019-z; Gibson GJ, 1999, P ROY SOC B-BIOL SCI, V266, P1743, DOI 10.1098/rspb.1999.0841; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hengeveld R., 1989, Dynamics of biological invasions., P116; Henson SM, 2001, SCIENCE, V294, P602, DOI 10.1126/science.1063358; Kleczkowski A, 1996, P ROY SOC B-BIOL SCI, V263, P777, DOI 10.1098/rspb.1996.0116; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Lewis MA, 2000, J MATH BIOL, V41, P430, DOI 10.1007/s002850000022; Lewis MA, 2000, J MATH BIOL, V41, P387, DOI 10.1007/s002850000050; LEWIS MA, 1993, THEOR POPUL BIOL, V43, P141, DOI 10.1006/tpbi.1993.1007; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; MOLLISON D, 1991, MATH BIOSCI, V107, P255, DOI 10.1016/0025-5564(91)90009-8; National Invasive Species Council, 2008, 2008 2012 NAT INV SP; NAYLOR AF, 1961, ECOLOGY, V42, P231, DOI 10.2307/1932074; Otten W, 2003, ECOLOGY, V84, P3232, DOI 10.1890/02-0564; PARK T, 1948, ECOL MONOGR, V18, P265, DOI 10.2307/1948641; SHIGESADA N, 1995, AM NAT, V146, P229, DOI 10.1086/285796; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; VANDENBOSCH F, 1992, J BIOGEOGR, V19, P135, DOI 10.2307/2845500; Weinberger HF, 2002, J MATH BIOL, V45, P183, DOI 10.1007/s002850200145; Wikle CK, 2003, ECOLOGY, V84, P1382, DOI 10.1890/0012-9658(2003)084[1382:HBMFPT]2.0.CO;2	30	119	120	3	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1536	1539		10.1126/science.1176138	http://dx.doi.org/10.1126/science.1176138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762641				2022-12-24	WOS:000269887900038
J	Turner, SL; Ray, A				Turner, Stephanie Lynn; Ray, Anandasankar			Modification of CO2 avoidance behaviour in Drosophila by inhibitory odorants	NATURE			English	Article							CARBON-DIOXIDE; RECEPTORS; BANANA; ETHYLENE; ANTENNA; FLIGHT; AROMA; LIFE	The fruitfly Drosophila melanogaster exhibits a robust and innate olfactory-based avoidance behaviour to CO2, a component of odour emitted from stressed flies(1). Specialized neurons in the antenna and a dedicated neuronal circuit in the higher olfactory system mediate CO2 detection and avoidance(1,2). However, fruitflies need to overcome this avoidance response in some environments that contain CO2 such as ripening fruits and fermenting yeast, which are essential food sources. Very little is known about the molecular and neuronal basis of this unique, context-dependent modification of innate olfactory avoidance behaviour. Here we identify a new class of odorants present in food that directly inhibit CO2-sensitive neurons in the antenna. Using an in vivo expression system we establish that the odorants act on the Gr21a/Gr63a CO2 receptor(3). The presence of these odorants significantly and specifically reduces CO2-mediated avoidance behaviour, as well as avoidance mediated by 'Drosophila stress odour'. We propose a model in which behavioural avoidance to CO2 is directly influenced by inhibitory interactions of the novel odours with CO2 receptors. Furthermore, we observe differences in the temporal dynamics of inhibition: the effect of one of these odorants lasts several minutes beyond the initial exposure. Notably, animals that have been briefly pre-exposed to this odorant do not respond to the CO2 avoidance cue even after the odorant is no longer present. We also show that related odorants are effective inhibitors of the CO2 response in Culex mosquitoes that transmit West Nile fever and filariasis. Our findings have broader implications in highlighting the important role of inhibitory odorants in olfactory coding, and in their potential to disrupt CO2-mediated host-seeking behaviour in disease-carrying insects like mosquitoes.	[Ray, Anandasankar] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Turner, Stephanie Lynn] Univ Calif Riverside, Cellular Mol & Dev Biol Program, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Ray, A (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	anand.ray@ucr.edu	Chen, Stephanie/G-3888-2010	Ray, Anandasankar/0000-0003-4133-2581				Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Carde RT, 1996, CIBA F SYMP, V200, P54; CARDE RT, 1996, CIBA F SYMP, V200, P66; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Cooperband MF, 2006, MED VET ENTOMOL, V20, P11, DOI 10.1111/j.1365-2915.2006.00613.x; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; GALLIARD T, 1977, J SCI FOOD AGR, V28, P863, DOI 10.1002/jsfa.2740280915; Golding JB, 1998, POSTHARVEST BIOL TEC, V14, P87, DOI 10.1016/S0925-5214(98)00032-5; Golding JB, 1999, J AGR FOOD CHEM, V47, P1646, DOI 10.1021/jf980906c; Guerenstein PG, 2008, ANNU REV ENTOMOL, V53, P161, DOI 10.1146/annurev.ento.53.103106.093402; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Hughes P. S., 2001, BEER QUALITY SAFETY, P40; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Katz DB, 2008, J NEUROSCI, V28, P11802, DOI 10.1523/JNEUROSCI.3613-08.2008; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; MARTINEAU B, 1995, AM J ENOL VITICULT, V46, P385; Mayr D, 2003, INT J MASS SPECTROM, V223, P743, DOI 10.1016/S1387-3806(02)00967-3; NYKANEN L, 1991, VOLATILE COMPOUNDS F, P548; ROBERTSON HM, 2009, J INSECT SCI, V19, P1; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	29	136	145	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 10	2009	461	7261					277	U159		10.1038/nature08295	http://dx.doi.org/10.1038/nature08295			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19710651				2022-12-24	WOS:000269654600047
J	Kawamura, T; Suzuki, J; Wang, YV; Menendez, S; Morera, LB; Raya, A; Wahl, GM; Belmonte, JCI				Kawamura, Teruhisa; Suzuki, Jotaro; Wang, Yunyuan V.; Menendez, Sergio; Batlle Morera, Laura; Raya, Angel; Wahl, Geoffrey M.; Izpisua Belmonte, Juan Carlos			Linking the p53 tumour suppressor pathway to somatic cell reprogramming	NATURE			English	Article							PLURIPOTENT STEM-CELLS; EXPRESSION CLONING; HUMAN FIBROBLASTS; C-MYC; GENERATION; MOUSE; INDUCTION; DIFFERENTIATION; EFFICIENCY; OCT4	Reprogramming somatic cells to induced pluripotent stem (iPS) cells has been accomplished by expressing pluripotency factors and oncogenes(1-8), but the low frequency and tendency to induce malignant transformation(9) compromise the clinical utility of this powerful approach. We address both issues by investigating the mechanisms limiting reprogramming efficiency in somatic cells. Here we show that reprogramming factors can activate the p53 (also known as Trp53 in mice, TP53 in humans) pathway. Reducing signalling to p53 by expressing a mutated version of one of its negative regulators, by deleting or knocking down p53 or its target gene, p21 (also known as Cdkn1a), or by antagonizing reprogramming-induced apoptosis in mouse fibroblasts increases reprogramming efficiency. Notably, decreasing p53 protein levels enabled fibroblasts to give rise to iPS cells capable of generating germline-transmitting chimaeric mice using only Oct4 ( also known as Pou5f1) and Sox2. Furthermore, silencing of p53 significantly increased the reprogramming efficiency of human somatic cells. These results provide insights into reprogramming mechanisms and suggest new routes to more efficient reprogramming while minimizing the use of oncogenes.	[Kawamura, Teruhisa; Suzuki, Jotaro; Wang, Yunyuan V.; Wahl, Geoffrey M.; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Kawamura, Teruhisa] Kyoto Univ, Career Path Promot Unit Young Life Scientists, Kyoto 6068501, Japan; [Wang, Yunyuan V.] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan; [Menendez, Sergio; Batlle Morera, Laura; Raya, Angel; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Raya, Angel] ICREA, Barcelona 08010, Spain; [Raya, Angel] Networking Ctr Biomed Res Bioengn Biomat & Nanome, Barcelona 08003, Spain	Salk Institute; Kyoto University; Astellas Pharmaceuticals; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; ICREA	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wahl@salk.edu; belmonte@salk.edu	Raya, Angel/E-6205-2010	Raya, Angel/0000-0003-2189-9775; BATLLE MORERA, LAURA/0000-0002-6924-9002; Menendez, Sergio/0000-0002-7929-8641	Astellas Pharma Inc; Japan Society for the Promotion of Science; NIH [5 R01 CA061449, CA100845]; Leila Y. Mathers Charitable Foundation and Fundacion Cellex; ICREA Funding Source: Custom; NATIONAL CANCER INSTITUTE [R01CA061449, R01CA100845] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL088293] Funding Source: NIH RePORTER	Astellas Pharma Inc(Astellas Pharmaceuticals); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leila Y. Mathers Charitable Foundation and Fundacion Cellex; ICREA(ICREA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to the CMRB Histology & Bioimaging and Cell culture Platforms for assistance, S. Boue for microarray analysis, S. Kim for help with maintenance of mouse colonies, Y. Richaud for technical assistance, M. Nagao for preparation of mouse neural stem cells, K. Brennand and F. Gage for preparation of human neural stem cells, I. Verma and A. Consiglio for advice and help with lentiviral transduction, Y. Dayn for chimaeric mouse production, and all members of the Gene Expression Laboratory and CMRB for discussions and M. Serrano for sharing unpublished results. J. S. was partially supported by Astellas Pharma Inc. T. K. was partially supported by Japan Society for the Promotion of Science. Work in the laboratory of G. M. W. was supported by NIH grants ( 5 R01 CA061449 and CA100845). Work in the laboratory of J. C. I. B. was supported by grants from the NIH, Tercel, Marato, G. Harold and Leila Y. Mathers Charitable Foundation and Fundacion Cellex.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Cleveland JL, 2004, CANCER CELL, V6, P309, DOI 10.1016/j.ccr.2004.09.020; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; HUPPI K, 1994, ONCOGENE, V9, P3017; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; MIYASHITA T, 1995, CELL, V80, P293; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; SHERLEY JL, 1991, J BIOL CHEM, V266, P24815; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang YYV, 2009, CANCER CELL, V16, P33, DOI 10.1016/j.ccr.2009.05.008; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	38	836	905	0	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1140	U107		10.1038/nature08311	http://dx.doi.org/10.1038/nature08311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19668186	Green Accepted			2022-12-24	WOS:000269314000041
J	Heo, I; Joo, C; Kim, YK; Ha, M; Yoon, MJ; Cho, J; Yeom, KH; Han, J; Kim, VN				Heo, Inha; Joo, Chirlmin; Kim, Young-Kook; Ha, Minju; Yoon, Mi-Jeong; Cho, Jun; Yeom, Kyu-Hyeon; Han, Jinju; Kim, V. Narry			TUT4 in Concert with Lin28 Suppresses MicroRNA Biogenesis through Pre-MicroRNA Uridylation	CELL			English	Article							EMBRYONIC STEM-CELLS; RNA-INTERFERENCE; POLY(A) POLYMERASE; NUCLEAR EXPORT; POSTTRANSCRIPTIONAL REGULATION; BINDING PROTEIN; LET-7 MICRORNA; MESSENGER-RNA; LIN-28; IDENTIFICATION	As key regulators in cellular functions, microRNAs (miRNAs) themselves need to be tightly controlled. Lin28, a pluripotency factor, was reported to downregulate let-7 miRNA by inducing uridylation of let-7 precursor (pre-let-7). But the enzyme responsible for the uridylation remained unknown. Here we identify a noncanonical poly (A) polymerase, TUTase4 (TUT4), as the uridylyl transferase for pre-let-7. Lin28 recruits TUT4 to pre-let-7 by recognizing a tetra-nucleotide sequence motif (GGAG) in the terminal loop. TUT4 in turn adds an oligouridine tail to the pre-let-7, which blocks Dicer processing. Other miRNAs with the same sequence motif (miR-107, -143, and -200c) are regulated through the same mechanism. Knockdown of TUT4 and Lin28 reduces the level of stem cell markers, suggesting that they are required for stem cell maintenance. This study uncovers the role of TUT4 and Lin28 as specific suppressors of miRNA biogenesis, which has implications for stem cell research and cancer biology.	[Heo, Inha; Joo, Chirlmin; Kim, Young-Kook; Ha, Minju; Yoon, Mi-Jeong; Cho, Jun; Yeom, Kyu-Hyeon; Han, Jinju; Kim, V. Narry] Seoul Natl Univ, Creat Res Ctr, Seoul 151742, South Korea; [Heo, Inha; Joo, Chirlmin; Kim, Young-Kook] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, VN (corresponding author), Seoul Natl Univ, Creat Res Ctr, Seoul 151742, South Korea.	narrykim@snu.ac.kr	Han, Jinju/D-9091-2017; Joo, Chirlmin/B-9294-2008; Kim, Young-Kook/AAE-8306-2020; Ha, Minju/G-3559-2017	Joo, Chirlmin/0000-0003-2803-0335; Kim, Young-Kook/0000-0001-6434-2235; Ha, Minju/0000-0003-2328-415X; Kim, Young Kook/0000-0002-6037-8449; HAN, Jinju/0000-0003-1844-2301	National Research Foundation of Korea [20090063603]; Ministry of Education, Science and Technology of Korea	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We are grateful to the members of our laboratory, particularly Hyeshik Chang for helpful discussion and Ahyoung Cho and Je-Keun Rhee for technical help. We also thank Yong Joon Huh and Dr. Dong-Wook Kim for the gift of mES cells (R1) and their advice on stem cell culture; Kyung Hoon Kim and Dr. Se Won Seo for their advice on protein purification; and Drs. Guhung Jung and Seung Hwan Hong for the gift of cell lines. This work was supported by the Creative Research Initiatives Program (20090063603) through the National Research Foundation of Korea (NRF) and the BK21 Research Fellowships (I. H., C.J., Y.-K.K., J.C., K.-H.Y., and J.H.) from the Ministry of Education, Science and Technology of Korea.	Amarasinghe GK, 2000, J MOL BIOL, V301, P491, DOI 10.1006/jmbi.2000.3979; Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Kwak JE, 2007, RNA, V13, P860, DOI 10.1261/rna.514007; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; MENEELY PM, 1979, GENETICS, V92, P99; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; Nakanishi T, 2006, DEV BIOL, V289, P115, DOI 10.1016/j.ydbio.2005.10.017; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Pappalardo L, 1998, J MOL BIOL, V282, P801, DOI 10.1006/jmbi.1998.2046; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Stevenson AL, 2006, YEAST, V23, P991, DOI 10.1002/yea.1408; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tomecki R, 2004, NUCLEIC ACIDS RES, V32, P6001, DOI 10.1093/nar/gkh923; Trippe R, 2003, EUR J BIOCHEM, V270, P971, DOI 10.1046/j.1432-1033.2003.03466.x; Trippe R, 2006, RNA, V12, P1494, DOI 10.1261/rna.87706; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang SW, 2000, MOL CELL BIOL, V20, P3234, DOI 10.1128/MCB.20.9.3234-3244.2000; Wang X., 2008, J VIS EXP, V17; Wickens M, 2008, SCIENCE, V319, P1344, DOI 10.1126/science.1154946; Wilusz CJ, 2008, GENE DEV, V22, P1, DOI 10.1101/gad.1634508; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	65	592	620	2	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					696	708		10.1016/j.cell.2009.08.002	http://dx.doi.org/10.1016/j.cell.2009.08.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703396	Bronze			2022-12-24	WOS:000269156100012
J	Rossato, JI; Bevilaqua, LRM; Izquierdo, I; Medina, JH; Cammarota, M				Rossato, Janine I.; Bevilaqua, Lia R. M.; Izquierdo, Ivan; Medina, Jorge H.; Cammarota, Martin			Dopamine Controls Persistence of Long-Term Memory Storage	SCIENCE			English	Article							VENTRAL TEGMENTAL AREA; HIPPOCAMPAL SLICES; CA1 REGION; NEURONS; RECEPTORS; RAT; LTP; POTENTIATION; INFORMATION; ACTIVATION	The paradigmatic feature of long-term memory (LTM) is its persistence. However, little is known about the mechanisms that make some LTMs last longer than others. In rats, a long-lasting fear LTM vanished rapidly when the D1 dopamine receptor antagonist SCH23390 was injected into the dorsal hippocampus 12 hours, but not immediately or 9 hours, after the fearful experience. Conversely, intrahippocampal application of the D1 agonist SK38393 at the same critical post-training time converted a rapidly decaying fear LTM into a persistent one. This effect was mediated by brain-derived neurotrophic factor and regulated by the ventral tegmental area (VTA). Thus, the persistence of LTM depends on activation of VTA/hippocampus dopaminergic connections and can be specifically modulated by manipulating this system at definite post-learning time points.	[Rossato, Janine I.; Bevilaqua, Lia R. M.; Izquierdo, Ivan; Medina, Jorge H.; Cammarota, Martin] Pontificia Univ Catolica Rio Grande do Sul, Inst Cerebro, Ctr Memoria, Porto Alegre, RS, Brazil; [Medina, Jorge H.; Cammarota, Martin] Univ Buenos Aires, Inst Biol Celular & Neurociencias Prof Dr Eduardo, Buenos Aires, DF, Argentina; [Medina, Jorge H.] Univ Buenos Aires, Dept Fisiol, Buenos Aires, DF, Argentina	Pontificia Universidade Catolica Do Rio Grande Do Sul; University of Buenos Aires; University of Buenos Aires	Cammarota, M (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Inst Cerebro, Ctr Memoria, Porto Alegre, RS, Brazil.	mcammaro@terra.com.br	Cammarota, Martin/AAC-7478-2021; Rossato, Janine/E-9543-2014; Rossato, Janine Inez/AHD-3513-2022	Cammarota, Martin/0000-0001-9741-5074; Rossato, Janine Inez/0000-0002-7980-5842; Izquierdo, Ivan/0000-0002-7208-0869; Bevilaqua, Lia/0000-0001-8537-1289	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazil); Consejo Nacional de Investigaciones Cientificas y Tecnicas; Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT)	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazil) and the Consejo Nacional de Investigaciones Cientificas y Tecnicas and Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina).	Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Carr DB, 2008, NEURON, V59, P353, DOI 10.1016/j.neuron.2008.07.025; CARTER DA, 1977, NEUROSCIENCE, V2, P569, DOI 10.1016/0306-4522(77)90052-5; CHERGUI K, 1993, EUR J NEUROSCI, V5, P137, DOI 10.1111/j.1460-9568.1993.tb00479.x; Dahan L, 2007, NEUROPSYCHOPHARMACOL, V32, P1232, DOI 10.1038/sj.npp.1301251; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; FREY U, 1990, BRAIN RES, V522, P69, DOI 10.1016/0006-8993(90)91578-5; Gifkins A, 2002, BEHAV NEUROSCI, V116, P785, DOI 10.1037//0735-7044.116.5.785; Huang YY, 2006, LEARN MEMORY, V13, P298, DOI 10.1101/lm.166906; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; IZQUIERDO I, 2006, TRENDS NEUROSCI, V69, P356; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; JOH TH, 1978, P NATL ACAD SCI USA, V75, P4744, DOI 10.1073/pnas.75.10.4744; Kuppers E, 2001, NEUROREPORT, V12, P1175; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Mereu G, 1997, NEUROSCIENCE, V77, P1029, DOI 10.1016/S0306-4522(96)00474-5; Navakkode S, 2007, NEUROPHARMACOLOGY, V52, P1547, DOI 10.1016/j.neuropharm.2007.02.010; O'Carroll CM, 2006, LEARN MEMORY, V13, P760, DOI 10.1101/lm.321006; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	24	309	317	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					1017	1020		10.1126/science.1172545	http://dx.doi.org/10.1126/science.1172545			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19696353				2022-12-24	WOS:000269242800052
J	Yauch, RL; Dijkgraaf, GJP; Alicke, B; Januario, T; Ahn, CP; Holcomb, T; Pujara, K; Stinson, J; Callahan, CA; Tang, T; Bazan, JF; Kan, Z; Seshagiri, S; Hann, CL; Gould, SE; Low, JA; Rudin, CM; de Sauvage, FJ				Yauch, Robert L.; Dijkgraaf, Gerrit J. P.; Alicke, Bruno; Januario, Thomas; Ahn, Christina P.; Holcomb, Thomas; Pujara, Kanan; Stinson, Jeremy; Callahan, Christopher A.; Tang, Tracy; Bazan, J. Fernando; Kan, Zhengyan; Seshagiri, Somasekar; Hann, Christine L.; Gould, Stephen E.; Low, Jennifer A.; Rudin, Charles M.; de Sauvage, Frederic J.			Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma	SCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; CYCLOPAMINE; CANCER	The Hedgehog (Hh) signaling pathway is inappropriately activated in certain human cancers, including medulloblastoma, an aggressive brain tumor. GDC-0449, a drug that inhibits Hh signaling by targeting the serpentine receptor Smoothened (SMO), has produced promising anti-tumor responses in early clinical studies of cancers driven by mutations in this pathway. To evaluate the mechanism of resistance in a medulloblastoma patient who had relapsed after an initial response to GDC-0449, we determined the mutational status of Hh signaling genes in the tumor after disease progression. We identified an amino acid substitution at a conserved aspartic acid residue of SMO that had no effect on Hh signaling but disrupted the ability of GDC-0449 to bind SMO and suppress this pathway. A mutation altering the same amino acid also arose in a GDC-0449-resistant mouse model of medulloblastoma. These findings show that acquired mutations in a serpentine receptor with features of a G protein-coupled receptor can serve as a mechanism of drug resistance in human cancer.	[Yauch, Robert L.; Dijkgraaf, Gerrit J. P.; Alicke, Bruno; Januario, Thomas; Ahn, Christina P.; Holcomb, Thomas; Pujara, Kanan; Stinson, Jeremy; Callahan, Christopher A.; Tang, Tracy; Bazan, J. Fernando; Kan, Zhengyan; Seshagiri, Somasekar; Gould, Stephen E.; Low, Jennifer A.; de Sauvage, Frederic J.] Genentech Inc, San Francisco, CA 94080 USA; [Hann, Christine L.; Rudin, Charles M.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Roche Holding; Genentech; Johns Hopkins University; Johns Hopkins Medicine	de Sauvage, FJ (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	sauvage@gene.com	Bazan, J. Fernando/B-4562-2010; Rudin, Charles/R-2530-2019; de Sauvage, Frederic/ABE-8400-2020	Rudin, Charles/0000-0001-5204-3465; de Sauvage, Frederic/0000-0002-5275-2584; Seshagiri, Somasekar/0000-0003-4272-6443	Genentech [GDC-0449]; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Fu, H. Tian, Z. Zhang, K. Toy, Z. Modrusan, L. Li, S. Scales, and T. Wu for their contributions to this manuscript. Patient-informed consent was obtained for the research performed in this study. C. M. R. received research funding from Genentech for a GDC-0449 phase I trial and received a BioOncology Grant Program Award from Genentech. All authors, except C. M. R. and C. L. H., are employees of Genentech. F. J. S. holds patents related to hedgehog signaling.	Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Dellovade T, 2006, ANNU REV NEUROSCI, V29, P539, DOI 10.1146/annurev.neuro.29.051605.112858; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Goudet C., 2004, DRUG DISCOV TODAY TH, V1, P125, DOI DOI 10.1016/J.DDSTR.2004.08.017; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Molckovsky A, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-20; Polkinghorn WR, 2007, NAT CLIN PRACT ONCOL, V4, P295, DOI 10.1038/ncponc0794; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; VONHOFF DD, 2009, NEW ENGL J MED, V164, P1164; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	16	666	710	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					572	574		10.1126/science.1179386	http://dx.doi.org/10.1126/science.1179386			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19726788	Green Accepted			2022-12-24	WOS:000271019400041
J	D'Agostino, RB				D'Agostino, Ralph B., Sr.			The Delayed-Start Study Design	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE		Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	Boston University	D'Agostino, RB (corresponding author), Boston Univ, Dept Math & Stat, 111 Cummington St, Boston, MA 02215 USA.	ralph@bu.edu						D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Leber P, 1997, ALZ DIS ASSOC DIS, V11, pS10; Mallinckrodt C H, 2001, J Biopharm Stat, V11, P9, DOI 10.1081/BIP-100104194; Mani RB, 2004, STAT MED, V23, P305, DOI 10.1002/sim.1718; Olanow CW, 2009, NEW ENGL J MED, V361, P1268, DOI 10.1056/NEJMoa0809335; Siderowf A, 2004, ARCH NEUROL-CHICAGO, V61, P561	6	82	82	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2009	361	13					1304	1306		10.1056/NEJMsm0904209	http://dx.doi.org/10.1056/NEJMsm0904209			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497RN	19776413				2022-12-24	WOS:000270078700014
J	Snijder, B; Sacher, R; Ramo, P; Damm, EM; Liberali, P; Pelkmans, L				Snijder, Berend; Sacher, Raphael; Raemoe, Pauli; Damm, Eva-Maria; Liberali, Prisca; Pelkmans, Lucas			Population context determines cell-to-cell variability in endocytosis and virus infection	NATURE			English	Article							STOCHASTIC GENE-EXPRESSION; MEDIATED ENDOCYTOSIS; GM1 GANGLIOSIDE; SINGLE-CELL; SYSTEMS; ENTRY; KINASES	Single-cell heterogeneity in cell populations arises from a combination of intrinsic and extrinsic factors(1-3). This heterogeneity has been measured for gene transcription, phosphorylation, cell morphology and drug perturbations, and used to explain various aspects of cellular physiology(4-6). In all cases, however, the causes of heterogeneity were not studied. Here we analyse, for the first time, the heterogeneous patterns of related cellular activities, namely virus infection, endocytosis and membrane lipid composition in adherent human cells. We reveal correlations with specific cellular states that are defined by the population context of a cell, and we derive probabilistic models that can explain and predict most cellular heterogeneity of these activities, solely on the basis of each cell's population context. We find that accounting for population-determined heterogeneity is essential for interpreting differences between the activity levels of cell populations. Finally, we reveal that synergy between two molecular components, focal adhesion kinase and the sphingolipid GM1, enhances the population-determined pattern of simian virus 40 (SV40) infection. Our findings provide an explanation for the origin of heterogeneity patterns of cellular activities in adherent cell populations.	[Snijder, Berend; Sacher, Raphael; Raemoe, Pauli; Damm, Eva-Maria; Liberali, Prisca; Pelkmans, Lucas] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Snijder, Berend; Sacher, Raphael] Zurich PhD Program Mol Life Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Pelkmans, L (corresponding author), Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Mol Syst Biol, Wolfgang Pauli Str 16, CH-8093 Zurich, Switzerland.	pelkmans@imsb.biol.ethz.ch	Snijder, Berend/M-2998-2017; Snijder, Berend/O-9206-2019	Snijder, Berend/0000-0003-3386-6583; Pelkmans, Lucas/0000-0002-6754-9730; Liberali, Prisca/0000-0003-0695-6081	European Molecular Biology Organisation; Human Frontiers Science Program; Oncosuisse; Federation of European Biochemical Societies; ETH Zurich; SystemsX.ch; Swiss National Science Foundation; European Union	European Molecular Biology Organisation; Human Frontiers Science Program(Human Frontier Science Program); Oncosuisse; Federation of European Biochemical Societies; ETH Zurich(ETH Zurich); SystemsX.ch; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission)	We acknowledge H. Verheije and L. Burleigh for providing images of MHV and dengue virus infection, G. Jurisic for providing primary cells and help with experiments, and all members of the laboratory for comments on the manuscript. P. R. is supported by the European Molecular Biology Organisation and the Human Frontiers Science Program, E.- M. D. by Oncosuisse and P. L. by the Federation of European Biochemical Societies. L. P. is supported by the ETH Zurich, SystemsX.ch, the Swiss National Science Foundation and the European Union.	Ben-Jacob E, 1998, ANNU REV MICROBIOL, V52, P779, DOI 10.1146/annurev.micro.52.1.779; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CASTOR LN, 1970, J CELL PHYSIOL, V75, P57, DOI 10.1002/jcp.1040750107; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; EAGLE H, 1967, NATURE, V213, P1102, DOI 10.1038/2131102a0; Eifart P, 2007, J VIROL, V81, P10758, DOI 10.1128/JVI.00725-07; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; HOLMGREN J, 1973, INFECT IMMUN, V8, P208, DOI 10.1128/IAI.8.2.208-214.1973; Iwabuchi K, 2000, J BIOL CHEM, V275, P15174, DOI 10.1074/jbc.275.20.15174; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Liberali P, 2008, ANNU REV CELL DEV BI, V24, P501, DOI 10.1146/annurev.cellbio.041008.145637; Lopez S, 2004, TRENDS MICROBIOL, V12, P271, DOI 10.1016/j.tim.2004.04.003; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Neu U, 2008, P NATL ACAD SCI USA, V105, P5219, DOI 10.1073/pnas.0710301105; Neumann AK, 2008, J CELL SCI, V121, P634, DOI 10.1242/jcs.022418; Newman JRS, 2006, NATURE, V444, P561, DOI 10.1038/nature05407; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Pelkmans L, 2005, BBA-MOL CELL RES, V1746, P295, DOI 10.1016/j.bbamcr.2005.06.009; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Sacher R, 2008, CURR OPIN CELL BIOL, V20, P483, DOI 10.1016/j.ceb.2008.06.002; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509	29	296	299	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					520	523		10.1038/nature08282	http://dx.doi.org/10.1038/nature08282			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19710653				2022-12-24	WOS:000270082900039
J	Richardson, JM; Colloms, SD; Finnegan, DJ; Walkinshaw, MD				Richardson, Julia M.; Colloms, Sean D.; Finnegan, David J.; Walkinshaw, Malcolm D.			Molecular Architecture of the Mos1 Paired-End Complex: The Structural Basis of DNA Transposition in a Eukaryote	CELL			English	Article							V(D)J RECOMBINATION; SYNAPTIC COMPLEX; TRANSPOSABLE ELEMENTS; MARINER TRANSPOSASE; TN5 TRANSPOSITION; CRYSTAL-STRUCTURE; TC3 TRANSPOSASE; BINDING DOMAIN; ACTIVE-SITE; C-ELEGANS	A key step in cut-and-paste DNA transposition is the pairing of transposon ends before the element is excised and inserted at a new site in its host genome. Crystallographic analyses of the paired-end complex (PEC) formed from precleaved transposon ends and the transposase of the eukaryotic element Mos1 reveals two parallel ends bound to a dimeric enzyme. The complex has a trans arrangement, with each transposon end recognized by the DNA binding region of one transposase monomer and by the active site of the other monomer. Two additional DNA duplexes in the crystal indicate likely binding sites for flanking DNA. Biochemical data provide support for a model of the target capture complex and identify Arg186 to be critical for target binding. Mixing experiments indicate that a transposase dimer initiates first-strand cleavage and suggest a pathway for PEC formation.	[Richardson, Julia M.; Finnegan, David J.; Walkinshaw, Malcolm D.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Colloms, Sean D.] Xermit, Glasgow G12 0NF, Lanark, Scotland	University of Edinburgh	Richardson, JM (corresponding author), Univ Edinburgh, Sch Biol Sci, Kings Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.	jrichard@staffmail.ed.ac.uk	walkinshaw, malcolm/AAB-7497-2019; Richardson, Julia/D-1808-2013	Richardson, Julia/0000-0002-1547-3009; walkinshaw, malcolm/0000-0001-5955-9325; Colloms, Sean/0000-0003-2369-8168	Wellcome Trust; Medical Research Council; MRC [G0301082] Funding Source: UKRI; Medical Research Council [G0301082] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Wellcome Trust and the Medical Research Council. X-ray data were collected at the ESRF (beam-lines BM14 and ID231), and we thank Martin Walsh for his expert assistance. We are grateful to Marshall Stark, Jean Beggs, and Adrian Bird for their insightful comments on the manuscript.	Ason B, 2002, J BIOL CHEM, V277, P11284, DOI 10.1074/jbc.M111119200; Auge-Gouillou C, 2005, MOL CELL BIOL, V25, P2861, DOI 10.1128/MCB.25.7.2861-2870.2005; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Cordaux R, 2006, P NATL ACAD SCI USA, V103, P8101, DOI 10.1073/pnas.0601161103; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Dawson A, 2003, MOL CELL, V11, P225, DOI 10.1016/S1097-2765(02)00798-0; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Grundy GJ, 2007, P NATL ACAD SCI USA, V104, P3078, DOI 10.1073/pnas.0611293104; Guimond N, 2003, MOL GENET GENOMICS, V268, P779, DOI 10.1007/s00438-002-0800-4; Ivics Z, 2006, CURR GENE THER, V6, P593, DOI 10.2174/156652306778520647; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; Lipkow K, 2004, MOL CELL BIOL, V24, P8301, DOI 10.1128/MCB.24.18.8301-8311.2004; Lohe AR, 1996, MOL BIOL EVOL, V13, P549, DOI 10.1093/oxfordjournals.molbev.a025615; Lovell S, 2002, NAT STRUCT BIOL, V9, P278, DOI 10.1038/nsb778; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Mouw KW, 2008, MOL CELL, V30, P145, DOI 10.1016/j.molcel.2008.02.023; Naumann TA, 2000, P NATL ACAD SCI USA, V97, P8944, DOI 10.1073/pnas.160107997; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Rice PA, 2001, NAT STRUCT BIOL, V8, P302, DOI 10.1038/86166; Richardson JM, 2006, EMBO J, V25, P1324, DOI 10.1038/sj.emboj.7601018; Richardson JM, 2004, ACTA CRYSTALLOGR D, V60, P962, DOI 10.1107/S0907444904003798; Richardson JM, 2007, ACTA CRYSTALLOGR F, V63, P434, DOI 10.1107/S1744309107019045; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Robinson AS, 2004, INSECT BIOCHEM MOLEC, V34, P113, DOI 10.1016/j.ibmb.2003.10.004; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; Savilahti H, 1996, CELL, V85, P271, DOI 10.1016/S0092-8674(00)81103-4; Shevchenko Y, 2002, NUCLEIC ACIDS RES, V30, P2469, DOI 10.1093/nar/30.11.2469; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Swanson PC, 2001, MOL CELL BIOL, V21, P449, DOI 10.1128/MCB.21.2.449-458.2001; VANLUENEN HGAM, 1994, CELL, V79, P293, DOI 10.1016/0092-8674(94)90198-8; vanPouderoyen G, 1997, EMBO J, V16, P6044, DOI 10.1093/emboj/16.19.6044; Watkins S, 2004, NUCLEIC ACIDS RES, V32, P4306, DOI 10.1093/nar/gkh770; Xu HE, 1999, GENE DEV, V13, P1263, DOI 10.1101/gad.13.10.1263; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157	38	101	103	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1096	1108		10.1016/j.cell.2009.07.012	http://dx.doi.org/10.1016/j.cell.2009.07.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766564	Green Accepted, Bronze			2022-12-24	WOS:000269923200011
J	Sharon, I; Alperovitch, A; Rohwer, F; Haynes, M; Glaser, F; Atamna-Ismaeel, N; Pinter, RY; Partensky, F; Koonin, EV; Wolf, YI; Nelson, N; Beja, O				Sharon, Itai; Alperovitch, Ariella; Rohwer, Forest; Haynes, Matthew; Glaser, Fabian; Atamna-Ismaeel, Nof; Pinter, Ron Y.; Partensky, Frederic; Koonin, Eugene V.; Wolf, Yuri I.; Nelson, Nathan; Beja, Oded			Photosystem I gene cassettes are present in marine virus genomes	NATURE			English	Article							CYANOBACTERIUM SYNECHOCYSTIS SP; PHOTOSYNTHESIS GENES; TARGETED INACTIVATION; ELECTRON FLOW; PROCHLOROCOCCUS; ORGANIZATION; PROKARYOTE	Cyanobacteria of the Synechococcus and Prochlorococcus genera are important contributors to photosynthetic productivity in the open oceans(1-3). Recently, core photosystem II (PSII) genes were identified in cyanophages and proposed to function in photosynthesis and in increasing viral fitness by supplementing the host production of these proteins(4-7). Here we show evidence for the presence of photosystem I (PSI) genes in the genomes of viruses that infect these marine cyanobacteria, using pre-existing meta-genomic data from the global ocean sampling expedition(8) as well as from viral biomes(9). The seven cyanobacterial core PSI genes identified in this study, psaA, B, C, D, E, K and a unique J and F fusion, form a cluster in cyanophage genomes, suggestive of selection for a distinct function in the virus life cycle. The existence of this PSI cluster was confirmed with overlapping and long polymerase chain reaction on environmental DNA from the Northern Line Islands. Potentially, the seven proteins encoded by the viral genes are sufficient to form an intact monomeric PSI complex. Projection of viral predicted peptides on the cyanobacterial PSI crystal structure(10) suggested that the viral-PSI components might provide a unique way of funnelling reducing power from respiratory and other electron transfer chains to the PSI.	[Sharon, Itai; Alperovitch, Ariella; Atamna-Ismaeel, Nof; Beja, Oded] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel; [Sharon, Itai; Pinter, Ron Y.] Technion Israel Inst Technol, Fac Comp Sci, IL-32000 Haifa, Israel; [Glaser, Fabian] Technion Israel Inst Technol, Bioinformat Knowledge Unit, Lorry I Lokey Interdisciplinary Ctr Life Sci & En, IL-32000 Haifa, Israel; [Rohwer, Forest; Haynes, Matthew] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Rohwer, Forest] San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA; [Partensky, Frederic] CNRS, F-29682 Roscoff, France; [Partensky, Frederic] UPMC, Biol Stn, UMR 7144, F-29682 Roscoff, France; [Koonin, Eugene V.; Wolf, Yuri I.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; [Nelson, Nathan] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, Daniella Rich Inst Struct Biol, IL-69978 Tel Aviv, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; California State University System; San Diego State University; California State University System; San Diego State University; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Tel Aviv University	Beja, O (corresponding author), Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel.	beja@tx.technion.ac.il	Sharon, Itai/M-4472-2019; Rohwer, Forest/AAC-5315-2019; Partensky, Frédéric/B-9194-2018; Partensky, Frédéric/AAH-1170-2021	Sharon, Itai/0000-0003-0705-2316; Partensky, Frédéric/0000-0003-1274-4050; Partensky, Frédéric/0000-0003-1274-4050; Rohwer, Forest/0000-0003-1548-5429; Nelson, Nathan/0000-0003-3588-7265; Wolf, Yuri/0000-0002-0247-8708	Israel Science Foundation [1203/06, 356/06]; Henry Taub Award for Academic Excellence; Technion V. P. R. Fund-Henri Gutwirth Promotion of Research Fund	Israel Science Foundation(Israel Science Foundation); Henry Taub Award for Academic Excellence; Technion V. P. R. Fund-Henri Gutwirth Promotion of Research Fund	We would like to thank M. Rosenberg for technical support, D. Rusch, J. Zehr and S. Bench for sharing genomic data, D. Lindell and R. Sorek for encouragement and discussions, and U. Pick for the comments on cyclic photosynthesis. This work was supported in part by grants 1203/06 ( O. B.) and 356/06 ( N. N.) from the Israel Science Foundation, by the Henry Taub Award for Academic Excellence, and by the Technion V. P. R. Fund-Henri Gutwirth Promotion of Research Fund ( O. B.).	Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; BOEKEMA EJ, 1987, FEBS LETT, V217, P283, DOI 10.1016/0014-5793(87)80679-8; Brown Nat F., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020042; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hippler M, 1997, BIOCHEMISTRY-US, V36, P6343, DOI 10.1021/bi970082c; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kerfeld CA, 1998, ANNU REV PLANT PHYS, V49, P397, DOI 10.1146/annurev.arplant.49.1.397; Kouril R, 2005, PHOTOCH PHOTOBIO SCI, V4, P1091, DOI 10.1039/b505519a; LI WKW, 1993, MAR ECOL PROG SER, V102, P79, DOI 10.3354/meps102079; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Liu HB, 1997, AQUAT MICROB ECOL, V12, P39, DOI 10.3354/ame012039; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Merchant S, 2005, PLANT CELL, V17, P648, DOI 10.1105/tpc.105.030676; Millard A, 2004, P NATL ACAD SCI USA, V101, P11007, DOI 10.1073/pnas.0401478101; Naithani S, 2000, PHOTOSYNTH RES, V63, P225, DOI 10.1023/A:1006463932538; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Partensky F, 1997, PHOTOSYNTH RES, V51, P209, DOI 10.1023/A:1005807408161; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sharon I, 2007, ISME J, V1, P492, DOI 10.1038/ismej.2007.67; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; XU Q, 1995, J BIOL CHEM, V270, P16243, DOI 10.1074/jbc.270.27.16243	30	145	158	1	70	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					258	262		10.1038/nature08284	http://dx.doi.org/10.1038/nature08284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19710652	Green Accepted			2022-12-24	WOS:000269654600043
J	Wang, ZB; Zang, CZ; Cui, KR; Schones, DE; Barski, A; Peng, WQ; Zhao, KJ				Wang, Zhibin; Zang, Chongzhi; Cui, Kairong; Schones, Dustin E.; Barski, Artem; Peng, Weiqun; Zhao, Keji			Genome-wide Mapping of HATs and HDACs Reveals Distinct Functions in Active and Inactive Genes	CELL			English	Article							HISTONE DEACETYLASE; CHROMATIN SIGNATURES; CODING REGIONS; COMPLEX; YEAST; ACETYLATION; METHYLATION; ACETYLTRANSFERASE; TRANSCRIPTION; NUCLEOSOMES	Histone acetyltransferases (HATs) and deacetylases (HDACs) function antagonistically to control histone acetylation. As acetylation is a histone mark for active transcription, HATs have been associated with active and HDACs with inactive genes. We describe here genome-wide mapping of HATs and HDACs binding on chromatin and find that both are found at active genes with acetylated histones. Our data provide evidence that HATs and HDACs are both targeted to transcribed regions of active genes by phosphorylated RNA Pol II. Furthermore, the majority of HDACs in the human genome function to reset chromatin by removing acetylation at active genes. Inactive genes that are primed by MLL-mediated histone H3K4 methylation are subject to a dynamic cycle of acetylation and deacetylation by transient HAT/HDAC binding, preventing Pol II from binding to these genes but poising them for future activation. Silent genes without any H3K4 methylation signal show no evidence of being bound by HDACs.	[Wang, Zhibin; Cui, Kairong; Schones, Dustin E.; Barski, Artem; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Zang, Chongzhi; Peng, Weiqun] George Washington Univ, Dept Phys, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); George Washington University	Zhao, KJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov	Zang, Chongzhi/D-1445-2011; /AAI-2516-2019	Zang, Chongzhi/0000-0003-4812-3627; Barski, Artem/0000-0002-1861-5316; Peng, Weiqun/0000-0001-5521-9091	George Washington University; Division of Intramural Research Program of the National Heart, Lung, and Blood Institute, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006030, ZICHL006018, ZIAHL005801] Funding Source: NIH RePORTER	George Washington University; Division of Intramural Research Program of the National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The mRNA profiles were analyzed on Affymetrix gene chips by the National Heart, Lung, and Blood Institute (NHLBI) Genomics Core Facility. D. E. S. was supported by the Lenfant Biomedical Fellowship of the NHLBI. C.Z. and W. P. were partially supported by the University Facilitating Fund of the George Washington University. The research was supported by the Division of Intramural Research Program of the National Heart, Lung, and Blood Institute, National Institutes of Health.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Martin DGE, 2006, MOL CELL BIOL, V26, P3018, DOI 10.1128/MCB.26.8.3018-3028.2006; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Rea S, 2007, ONCOGENE, V26, P5385, DOI 10.1038/sj.onc.1210607; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xie JX, 1999, EMBO J, V18, P6448, DOI 10.1093/emboj/18.22.6448; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	54	963	992	1	114	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					1019	1031		10.1016/j.cell.2009.06.049	http://dx.doi.org/10.1016/j.cell.2009.06.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19698979	Bronze, Green Accepted			2022-12-24	WOS:000269564600025
J	Ward, BB; Devol, AH; Rich, JJ; Chang, BX; Bulow, SE; Naik, H; Pratihary, A; Jayakumar, A				Ward, B. B.; Devol, A. H.; Rich, J. J.; Chang, B. X.; Bulow, S. E.; Naik, Hema; Pratihary, Anil; Jayakumar, A.			Denitrification as the dominant nitrogen loss process in the Arabian Sea	NATURE			English	Article							ANAEROBIC AMMONIUM OXIDATION; WATER COLUMN; ANAMMOX; BACTERIA; OXIDE; N-2; NIRS	Primary production in over half of the world's oceans is limited by fixed nitrogen availability. The main loss term from the fixed nitrogen inventory is the production of dinitrogen gas (N-2) by heterotrophic denitrification or the more recently discovered autotrophic process, anaerobic ammonia oxidation (anammox). Oceanic oxygen minimum zones (OMZ) are responsible for about 35% of oceanic N-2 production and up to half of that occurs in the Arabian Sea(1). Although denitrification was long thought to be the only loss term, it has recently been argued that anammox alone is responsible for fixed nitrogen loss in the OMZs(2-4). Here we measure denitrification and anammox rates and quantify the abundance of denitrifying and anammox bacteria in the OMZ regions of the Eastern Tropical South Pacific and the Arabian Sea. We find that denitrification rather than anammox dominates the N-2 loss term in the Arabian Sea, the largest and most intense OMZ in the world ocean. In seven of eight experiments in the Arabian Sea denitrification is responsible for 87-99% of the total N-2 production. The dominance of denitrification is reproducible using two independent isotope incubation methods. In contrast, anammox is dominant in the Eastern Tropical South Pacific OMZ, as detected using one of the isotope incubation methods, as previously reported(3,5). The abundance of denitrifying bacteria always exceeded that of anammox bacteria by up to 7- and 19-fold in the Eastern Tropical South Pacific and Arabian Sea, respectively. Geographic and temporal variability in carbon supply may be responsible for the different contributions of denitrification and anammox in these two OMZs. The large contribution of denitrification to N-2 loss in the Arabian Sea indicates the global significance of denitrification to the oceanic nitrogen budget.	[Ward, B. B.; Bulow, S. E.; Jayakumar, A.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Devol, A. H.; Chang, B. X.] Univ Washington, Dept Oceanog, Seattle, WA 98195 USA; [Rich, J. J.] Brown Univ, Ctr Environm Studies, Providence, RI 02912 USA; [Naik, Hema; Pratihary, Anil] Natl Inst Oceanog, Panaji 403004, Goa, India	Princeton University; University of Washington; University of Washington Seattle; Brown University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO)	Ward, BB (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	bbw@princeton.edu	黄, 宝同/E-6579-2010; Newell, Silvia E/M-4336-2014; Jayakumar, Amal/AAM-1748-2020	Newell, Silvia E/0000-0002-0684-3100; Jayakumar, Amal/0000-0002-3568-1403	NSF	NSF(National Science Foundation (NSF))	W. Naqvi helped make it possible to schedule the RV Roger Revelle to work in the Arabian Sea in 2007. We thank the master and crews of the RV Knorr and RV Roger Revelle, and J. Moffett who was chief scientist on the Knorr. This work was supported by NSF grants to B. B. W., A. H. D. and A. J.	Braker G, 1998, APPL ENVIRON MICROB, V64, P3769; CASTROGONZALEZ M, 2005, ENVIRON MICROBIOL, DOI DOI 10.1111/J.1462-2920; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; Dalsgaard T, 2003, NATURE, V422, P606, DOI 10.1038/nature01526; Dalsgaard T, 2005, RES MICROBIOL, V156, P457, DOI 10.1016/j.resmic.2005.01.011; Devol AH, 2006, DEEP-SEA RES PT I, V53, P1533, DOI 10.1016/j.dsr.2006.07.005; Ducklow HW, 2001, DEEP-SEA RES PT II, V48, P1303, DOI 10.1016/S0967-0645(00)00140-5; Emerson S, 1999, MAR CHEM, V64, P337, DOI 10.1016/S0304-4203(98)00090-5; Farias L, 2009, LIMNOL OCEANOGR, V54, P132, DOI 10.4319/lo.2009.54.1.0132; Hamersley MR, 2007, LIMNOL OCEANOGR, V52, P923, DOI 10.4319/lo.2007.52.3.0923; Jayakumar A, 2009, MICROB ECOL, V58, P350, DOI 10.1007/s00248-009-9487-y; JAYAKUMAR A, GEOPHYS MON IN PRESS; Jayakumar DA, 2004, AQUAT MICROB ECOL, V34, P69, DOI 10.3354/ame034069; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Nicholls JC, 2007, LIMNOL OCEANOGR, V52, P156, DOI 10.4319/lo.2007.52.1.0156; NIELSEN LP, 1992, FEMS MICROBIOL ECOL, V86, P357, DOI 10.1016/0378-1097(92)90800-4; Schmid M, 2003, SYST APPL MICROBIOL, V26, P529, DOI 10.1078/072320203770865837; Schmid MC, 2007, ENVIRON MICROBIOL, V9, P1476, DOI 10.1111/j.1462-2920.2007.01266.x; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Thamdrup B, 2006, LIMNOL OCEANOGR, V51, P2145, DOI 10.4319/lo.2006.51.5.2145; Ward BB, 2005, AQUAT MICROB ECOL, V38, P295, DOI 10.3354/ame038295; Ward BB, 2008, DEEP-SEA RES PT I, V55, P1672, DOI 10.1016/j.dsr.2008.07.005; Woebken D, 2008, ENVIRON MICROBIOL, V10, P3106, DOI 10.1111/j.1462-2920.2008.01640.x; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	27	360	386	7	314	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					78	U77		10.1038/nature08276	http://dx.doi.org/10.1038/nature08276			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19727197				2022-12-24	WOS:000269478800033
J	Hu, JJ; Shibata, Y; Zhu, PP; Voss, C; Rismanchi, N; Prinz, WA; Rapoport, TA; Blackstone, C				Hu, Junjie; Shibata, Yoko; Zhu, Peng-Peng; Voss, Christiane; Rismanchi, Neggy; Prinz, William A.; Rapoport, Tom A.; Blackstone, Craig			A Class of Dynamin-like GTPases Involved in the Generation of the Tubular ER Network	CELL			English	Article							HEREDITARY SPASTIC PARAPLEGIA; ENDOPLASMIC-RETICULUM; MITOCHONDRIAL FUSION; MEMBRANE-PROTEINS; BINDING PARTNERS; GOLGI-APPARATUS; LIVING CELLS; ATLASTIN; GENE; YEAST	The endoplasmic reticulum ( ER) consists of tubules that are shaped by the reticulons and DP1/Yop1p, but how the tubules form an interconnected network is unknown. Here, we show that mammalian atlastins, which are dynamin-like, integral membrane GTPases, interact with the tubule-shaping proteins. The atlastins localize to the tubular ER and are required for proper network formation in vivo and in vitro. Depletion of the atlastins or overexpression of dominant-negative forms inhibits tubule interconnections. The Sey1p GTPase in S. cerevisiae is likely a functional ortholog of the atlastins; it shares the same signature motifs and membrane topology and interacts genetically and physically with the tubule-shaping proteins. Cells simultaneously lacking Sey1p and a tubule-shaping protein have ER morphology defects. These results indicate that formation of the tubular ER network depends on conserved dynamin-like GTPases. Since atlastin-1 mutations cause a common form of hereditary spastic paraplegia, we suggest ER-shaping defects as a neuropathogenic mechanism.	[Hu, Junjie; Shibata, Yoko; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Howard Hughes Med Inst, Boston, MA 02115 USA; [Zhu, Peng-Peng; Rismanchi, Neggy; Blackstone, Craig] NINDS, Cellular Neurol Unit, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; [Voss, Christiane; Prinz, William A.] NIDDKD, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu	Hu, Junjie/F-9713-2013		American Heart Association; Intramural Research Programs of the NINDS; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Howard Hughes Medical Institute investigator; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002992, ZIANS002992] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Intramural Research Programs of the NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute investigator(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Jaffe ( National Institute of Neurological Disorders and Stroke; NINDS) for MALDI-TOF analysis, F. Yang ( National Institute of Child Health and Human Development) for providing Xenopus eggs, L. Dreier and G. Voeltz for advice, and P. Carvalho for generating some yeast deletion strains. We thank S. Schulman, A. Palazzo, and D. Pellman for critical reading of the manuscript. Y. S. was supported by the American Heart Association, and C. B. and W. A. P. by the Intramural Research Programs of the NINDS and National Institute of Diabetes and Digestive and Kidney Diseases, respectively, National Institutes of Health. T. A. R. is a Howard Hughes Medical Institute investigator.	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Beetz C, 2008, BRAIN, V131, P1078, DOI 10.1093/brain/awn026; Brands A, 2002, PLANT PHYSIOL, V130, P1121, DOI 10.1104/pp.007716; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; Du YR, 2004, J CELL SCI, V117, P2871, DOI 10.1242/jcs.01286; Evans K, 2006, P NATL ACAD SCI USA, V103, P10666, DOI 10.1073/pnas.0510863103; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; LEE C, 1988, CELL, V54, P37, DOI 10.1016/0092-8674(88)90177-8; Mannan AU, 2006, NEUROGENETICS, V7, P93, DOI 10.1007/s10048-006-0034-4; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Namekawa M, 2007, MOL CELL NEUROSCI, V35, P1, DOI 10.1016/j.mcn.2007.01.012; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Sanderson CM, 2006, HUM MOL GENET, V15, P307, DOI 10.1093/hmg/ddi447; SCHIEFELBEIN JW, 1990, PLANT CELL, V2, P235, DOI 10.1105/tpc.2.3.235; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wang HY, 1997, GENE DEV, V11, P799, DOI 10.1101/gad.11.6.799; Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758; Zheng HQ, 2004, PLANT J, V37, P398, DOI 10.1046/j.1365-313X.2003.01969.x; Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200; Zhu PP, 2006, HUM MOL GENET, V15, P1343, DOI 10.1093/hmg/ddl054; Zuchner S, 2006, AM J HUM GENET, V79, P365, DOI 10.1086/505361	42	386	415	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					549	561		10.1016/j.cell.2009.05.025	http://dx.doi.org/10.1016/j.cell.2009.05.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665976	Green Accepted, Bronze			2022-12-24	WOS:000268771900019
J	Eroglu, C; Allen, NJ; Susman, MW; O'Rourke, NA; Park, CY; Ozkan, E; Chakraborty, C; Mulinyawe, SB; Annis, DS; Huberman, AD; Green, EM; Lawler, J; Dolmetsch, R; Garcia, KC; Smith, SJ; Luo, ZD; Rosenthal, A; Mosher, DF; Barres, BA				Eroglu, Cagla; Allen, Nicola J.; Susman, Michael W.; O'Rourke, Nancy A.; Park, Chan Young; Oezkan, Engin; Chakraborty, Chandrani; Mulinyawe, Sara B.; Annis, Douglas S.; Huberman, Andrew D.; Green, Eric M.; Lawler, Jack; Dolmetsch, Ricardo; Garcia, K. Christopher; Smith, Stephen J.; Luo, Z. David; Rosenthal, Arnon; Mosher, Deane F.; Barres, Ben A.			Gabapentin Receptor alpha 2 delta-1 Is a Neuronal Thrombospondin Receptor Responsible for Excitatory CNS Synaptogenesis	CELL			English	Article							CALCIUM-CHANNEL; ALPHA(2)DELTA SUBUNIT; NERVOUS-SYSTEM; RAT; GLUTAMATE; SYNAPSES; DOMAINS; BINDING; TARGET; BRAIN	Synapses are asymmetric cellular adhesions that are critical for nervous system development and function, but the mechanisms that induce their formation are not well understood. We have previously identified thrombospondin as an astrocyte-secreted protein that promotes central nervous system (CNS) synaptogenesis. Here, we identify the neuronal thrombospondin receptor involved in CNS synapse formation as alpha 2 delta-1, the receptor for the anti-epileptic and analgesic drug gabapentin. We show that the VWF-A domain of alpha 2 delta-1 interacts with the epidermal growth factor-like repeats common to all thrombospondins. alpha 2 delta-1 overexpression increases synaptogenesis in vitro and in vivo and is required postsynaptically for thrombospondin-and astrocyte-induced synapse formation in vitro. Gabapentin antagonizes thrombospondin binding to alpha 2 delta-1 and powerfully inhibits excitatory synapse formation in vitro and in vivo. These findings identify alpha 2 delta-1 as a receptor involved in excitatory synapse formation and suggest that gabapentin may function therapeutically by blocking new synapse formation.	[Eroglu, Cagla] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Eroglu, Cagla; Allen, Nicola J.; Susman, Michael W.; Park, Chan Young; Chakraborty, Chandrani; Mulinyawe, Sara B.; Huberman, Andrew D.; Green, Eric M.; Dolmetsch, Ricardo; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [O'Rourke, Nancy A.; Oezkan, Engin; Garcia, K. Christopher; Smith, Stephen J.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Biol Struct, Stanford, CA 94305 USA; [Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Med Sci Ctr, Dept Med, Madison, WI 53706 USA; [Luo, Z. David] Univ Calif Irvine, Med Ctr, Dept Anesthesiol & Perioperat Care, Orange, CA 92868 USA; [Luo, Z. David] Univ Calif Irvine, Med Ctr, Dept Pharmacol, Orange, CA 92868 USA; [Lawler, Jack] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Rosenthal, Arnon] MazoRx Inc, Redwood City, CA 94061 USA	Duke University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Irvine; University of California System; University of California Irvine; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Eroglu, C (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	c.eroglu@cellbio.duke.edu	Park, Chan Young/F-5696-2010; Eroglu, Cagla/P-5315-2014; Tuluc, Petronel/C-2527-2011; Lawler, Jack/AAJ-1379-2020	Park, Chan Young/0000-0002-5183-3665; Eroglu, Cagla/0000-0002-7204-0218; Ozkan, Engin/0000-0002-0263-6729; Smith, Stephen/0000-0002-2290-8701; Green, Eric/0000-0001-7874-9482	National Institute of Drug Addiction [DA15043]; National Heart, Lung and Blood Institute [HL49081]; National Institute of Neurological Disorders and Stroke; National Institute of Dental and Craniofacial Research [NS40135, DE14545]; Human Frontiers Scientific Program long-term fellowships; Helen Hay Whitney postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE014545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015043, R01DA015043] Funding Source: NIH RePORTER	National Institute of Drug Addiction; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Human Frontiers Scientific Program long-term fellowships; Helen Hay Whitney postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Maria L. Fabian, Navid Nouri, and Mark Duquette for excellent technical assistance, and Beth Stevens, Junryo Watanabe, and Alissa Winzeler for critical reading of the manuscript. This work was supported by grants from the National Institute of Drug Addiction (DA15043 to B. A. B.), the National Heart, Lung and Blood Institute (HL49081 to J.L.), and the National Institute of Neurological Disorders and Stroke and National Institute of Dental and Craniofacial Research (NS40135 and DE14545 to Z.D.L.). C. E. and N.J.A. were supported by the Human Frontiers Scientific Program long-term fellowships and A. D. H by the Helen Hay Whitney postdoctoral fellowship. Arnon Rosenthal is founder and president of MazoRx Inc.	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Annis DS, 2007, J BIOL CHEM, V282, P27067, DOI 10.1074/jbc.M703804200; Annis DS, 2006, J THROMB HAEMOST, V4, P459, DOI 10.1111/j.1538-7836.2006.01723.x; ARBER S, 1995, J CELL BIOL, V131, P1083, DOI 10.1083/jcb.131.4.1083; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; BORK P, 1991, BIOCHEM J, V279, P908, DOI 10.1042/bj2790908; Bornstein P, 2004, INT J BIOCHEM CELL B, V36, P1115, DOI 10.1016/j.biocel.2004.01.012; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cole RL, 2005, J COMP NEUROL, V491, P246, DOI 10.1002/cne.20693; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Dickman DK, 2008, J NEUROSCI, V28, P31, DOI 10.1523/JNEUROSCI.4498-07.2008; Dooley DJ, 2007, TRENDS PHARMACOL SCI, V28, P75, DOI 10.1016/j.tips.2006.12.006; Eroglu Cagla, 2008, P683, DOI 10.1007/978-0-387-77232-5_23; Erzurumlu RS, 2006, ANAT REC PART A, V288A, P121, DOI 10.1002/ar.a.20285; Field MJ, 2006, P NATL ACAD SCI USA, V103, P17537, DOI 10.1073/pnas.0409066103; Fox MA, 2006, J NEUROCHEM, V97, P1215, DOI 10.1111/j.1471-4159.2006.03834.x; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Garcia K, 2007, J PHYSL, V586, P727; Gee NS, 1996, J BIOL CHEM, V271, P5768, DOI 10.1074/jbc.271.10.5768; Gurnett CA, 1996, NEURON, V16, P431, DOI 10.1016/S0896-6273(00)80061-6; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Klugbauer N, 2003, J BIOENERG BIOMEMBR, V35, P639, DOI 10.1023/B:JOBB.0000008028.41056.58; Kurshan PT, 2009, NAT NEUROSCI, V12, P1415, DOI 10.1038/nn.2417; Li CY, 2006, PAIN, V125, P20, DOI 10.1016/j.pain.2006.04.022; Li CY, 2004, J NEUROSCI, V24, P8494, DOI 10.1523/JNEUROSCI.2982-04.2004; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Lin TN, 2003, STROKE, V34, P177, DOI 10.1161/01.STR.0000047100.84604.BA; Liu L, 2000, EXP BRAIN RES, V131, P64, DOI 10.1007/s002219900273; Lohmann C, 2008, NEURON, V59, P253, DOI 10.1016/j.neuron.2008.05.025; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Nakamura K, 2005, J COMP NEUROL, V492, P263, DOI 10.1002/cne.20705; Pluskota E, 2005, BLOOD, V106, P3970, DOI 10.1182/blood-2005-03-1292; Prince D A, 1999, Adv Neurol, V79, P665; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; SUMANCHAUHAN N, 1993, EUR J PHARM-MOLEC PH, V244, P293, DOI 10.1016/0922-4106(93)90155-3; Traa BS, 2008, PEDIATR RES, V64, P81, DOI 10.1203/PDR.0b013e318174e70e; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Valder CR, 2003, J NEUROCHEM, V87, P560, DOI 10.1046/j.1471-4159.2003.02016.x; Wang H, 2002, NEUROSCIENCE, V114, P529, DOI 10.1016/S0306-4522(02)00341-X; Wang MH, 1999, BIOCHEM J, V342, P313, DOI 10.1042/0264-6021:3420313; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wierenga CJ, 2008, NAT NEUROSCI, V11, P1044, DOI 10.1038/nn.2180; Wilkins JA, 1996, J BIOL CHEM, V271, P3046, DOI 10.1074/jbc.271.6.3046; Wycisk KA, 2006, INVEST OPHTH VIS SCI, V47, P3523, DOI 10.1167/iovs.06-0271	48	574	589	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					380	392		10.1016/j.cell.2009.09.025	http://dx.doi.org/10.1016/j.cell.2009.09.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19818485	Bronze, Green Accepted			2022-12-24	WOS:000270857500020
J	Shah, SP; Morin, RD; Khattra, J; Prentice, L; Pugh, T; Burleigh, A; Delaney, A; Gelmon, K; Guliany, R; Senz, J; Steidl, C; Holt, RA; Jones, S; Sun, M; Leung, G; Moore, R; Severson, T; Taylor, GA; Teschendorff, AE; Tse, K; Turashvili, G; Varhol, R; Warren, RL; Watson, P; Zhao, YJ; Caldas, C; Huntsman, D; Hirst, M; Marra, MA; Aparicio, S				Shah, Sohrab P.; Morin, Ryan D.; Khattra, Jaswinder; Prentice, Leah; Pugh, Trevor; Burleigh, Angela; Delaney, Allen; Gelmon, Karen; Guliany, Ryan; Senz, Janine; Steidl, Christian; Holt, Robert A.; Jones, Steven; Sun, Mark; Leung, Gillian; Moore, Richard; Severson, Tesa; Taylor, Greg A.; Teschendorff, Andrew E.; Tse, Kane; Turashvili, Gulisa; Varhol, Richard; Warren, Rene L.; Watson, Peter; Zhao, Yongjun; Caldas, Carlos; Huntsman, David; Hirst, Martin; Marra, Marco A.; Aparicio, Samuel			Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution	NATURE			English	Article							GENOME; IDENTIFICATION	Recent advances in next generation sequencing(1-4) have made it possible to precisely characterize all somatic coding mutations that occur during the development and progression of individual cancers. Here we used these approaches to sequence the genomes (>43-fold coverage) and transcriptomes of an oestrogen-receptor-apositive metastatic lobular breast cancer at depth. We found 32 somatic non-synonymous coding mutations present in the metastasis, and measured the frequency of these somatic mutations in DNA from the primary tumour of the same patient, which arose 9 years earlier. Five of the 32 mutations (in ABCB11, HAUS3, SLC24A4, SNX4 and PALB2) were prevalent in the DNA of the primary tumour removed at diagnosis 9 years earlier, six ( in KIF1C, USP28, MYH8, MORC1, KIAA1468 and RNASEH2A) were present at lower frequencies (1-13%), 19 were not detected in the primary tumour, and two were undetermined. The combined analysis of genome and transcriptome data revealed two new RNA-editing events that recode the amino acid sequence of SRP9 and COG3. Taken together, our data show that single nucleotide mutational heterogeneity can be a property of low or intermediate grade primary breast cancers and that significant evolution can occur with disease progression.	[Morin, Ryan D.; Pugh, Trevor; Delaney, Allen; Holt, Robert A.; Jones, Steven; Moore, Richard; Severson, Tesa; Taylor, Greg A.; Varhol, Richard; Warren, Rene L.; Zhao, Yongjun; Hirst, Martin; Marra, Marco A.] British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Shah, Sohrab P.; Senz, Janine; Steidl, Christian; Huntsman, David; Aparicio, Samuel] British Columbia Canc Agcy, Ctr Translat & Appl Genom, Vancouver, BC V5Z 1L3, Canada; [Steidl, Christian; Huntsman, David; Aparicio, Samuel] Univ British Columbia, Dept Pathol, Vancouver, BC V6T 2B5, Canada; [Teschendorff, Andrew E.; Caldas, Carlos] Li Ka Shing Ctr, Cambridge Res Inst, Canc Res UK, Cambridge CB2 0RE, England; [Watson, Peter] BC Canc Agcy, Deeley Res Ctr, Victoria, BC V8R 6V5, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; British Columbia Cancer Agency	Marra, MA (corresponding author), British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	mmarra@bcgsc.ca; saparicio@bccrc.ca	Holt, Robert A/C-3303-2009; Caldas, Carlos/U-7250-2019; Huntsman, David/ABE-6082-2020; Pugh, Trevor/Y-2535-2019; Hirst, Martin/B-7684-2016; Turashvili, Gulisa/A-6056-2008; Marra, Marco A/B-5987-2008; Caldas, Carlos/A-7543-2008; Morin, Ryan/AAE-7824-2019; Jones, Steven J/C-3621-2009; Warren, Rene/R-7681-2016	Holt, Robert A/0000-0002-7259-1247; Caldas, Carlos/0000-0003-3547-1489; Pugh, Trevor/0000-0002-8073-5888; Marra, Marco A/0000-0001-7146-7175; Morin, Ryan/0000-0003-2932-7800; Jones, Steven J/0000-0003-3394-2208; Warren, Rene/0000-0002-9890-2293; Aparicio, Samuel/0000-0002-0487-9599; Turashvili, Gulisa/0000-0001-6125-5865; Watson, Peter/0000-0002-1642-0638	Michael Smith Foundation for Health Research; Vanier scholar (CIHR); NSERC; Canada Foundation for Innovation; BC Cancer Foundation	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Vanier scholar (CIHR)(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); BC Cancer Foundation	We thank C. Eaves and M. Pollak for comments on earlier versions of the manuscript. We thank and acknowledge the patients of the BC Cancer Agency for donations of tumour tissues to the TTR-BREAST tumour banking program. S. A. is supported by a Canada Research Chair in Molecular Oncology, S. P. S., J. K., L. P., A. B. and T. P. are supported by Michael Smith Foundation for Health Research awards. R. D. M. is a Vanier scholar (CIHR). A. B. is also supported by an NSERC award, and L. P. by a CIHR award. We are grateful for platform support from CIHR, Genome Canada, Genome BC, Canada Foundation for Innovation and the Michael Smith Foundation for Health Research. The work was funded by the BC Cancer Foundation and the CBCF BC/Yukon chapter.	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Maas Stefan, 2006, RNA Biol, V3, P1; Meireles M, 2009, J CELL BIOL, V184, P777, DOI 10.1083/jcb.200811102; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pauklin S, 2009, J EXP MED, V206, P99, DOI 10.1084/jem.20080521; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	19	851	894	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					809	U67		10.1038/nature08489	http://dx.doi.org/10.1038/nature08489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19812674	hybrid			2022-12-24	WOS:000270547500039
J	Zippo, A; Serafini, R; Rocchigiani, M; Pennacchini, S; Krepelova, A; Oliviero, S				Zippo, Alessio; Serafini, Riccardo; Rocchigiani, Marina; Pennacchini, Susanna; Krepelova, Anna; Oliviero, Salvatore			Histone Crosstalk between H3S10ph and H4K16ac Generates a Histone Code that Mediates Transcription Elongation	CELL			English	Article							RNA-POLYMERASE-II; BROMODOMAIN PROTEIN BRD4; P-TEFB; DEPENDENT TRANSCRIPTION; H3; PHOSPHORYLATION; ACETYLATION; ACTIVATION; DROSOPHILA; PROMOTER	The phosphorylation of the serine 10 at histone H3 has been shown to be important for transcriptional activation. Here, we report the molecular mechanism through which H3S10ph triggers transcript elongation of the FOSL1 gene. Serum stimulation induces the PIM1 kinase to phosphorylate the preacetylated histone H3 at the FOSL1 enhancer. The adaptor protein 14-3-3 binds the phosphorylated nucleosome and recruits the histone acetyltransferase MOF, which triggers the acetylation of histone H4 at lysine 16 (H4K16ac). This histone crosstalk generates the nucleosomal recognition code composed of H3K9acS10ph/H4K16ac determining a nucleosome platform for the bromodomain protein BRD4 binding. The recruitment of the positive transcription elongation factor b (P-TEFb) via BRD4 induces the release of the promoter-proximal paused RNA polymerase II and the increase of its processivity. Thus, the single phosphorylation H3S10ph at the FOSL1 enhancer triggers a cascade of events which activate transcriptional elongation.	[Zippo, Alessio; Serafini, Riccardo; Rocchigiani, Marina; Pennacchini, Susanna; Krepelova, Anna; Oliviero, Salvatore] Univ Siena, Dipartimento Biol Mol, I-53100 Siena, Italy	University of Siena	Oliviero, S (corresponding author), Univ Siena, Dipartimento Biol Mol, Via Fiorentina 1, I-53100 Siena, Italy.	oliviero@unisi.it	oliviero, salvatore/R-6657-2019	oliviero, salvatore/0000-0002-3405-765X; zippo, Alessio/0000-0002-3686-6151; Krepelova, Anna/0000-0002-2775-1336	Associazione Italiana Ricerca sul cancro (AIRC); Fondazione Monte dei Paschi di Siena, and Istituto Toscano Tumori	Associazione Italiana Ricerca sul cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Monte dei Paschi di Siena, and Istituto Toscano Tumori	This work was supported by Associazione Italiana Ricerca sul cancro (AIRC), Fondazione Monte dei Paschi di Siena, and Istituto Toscano Tumori ( ITT). We are in indebted to Isabel Delany, Marco Bianchi, Alessandra Agresti, and Enzo Scarlato for helpful suggestions and critical reading of the manuscript.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Agresti A, 2005, MOL CELL, V18, P109, DOI 10.1016/j.molcel.2005.03.005; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Cai WL, 2008, DEVELOPMENT, V135, P2917, DOI 10.1242/dev.024927; Calestagne-Morelli A, 2006, BIOCHEM CELL BIOL, V84, P518, DOI 10.1139/O06-067; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cirillo LA, 2004, METHOD ENZYMOL, V375, P131; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Ferrai C, 2007, J BIOL CHEM, V282, P12537, DOI 10.1074/jbc.M700867200; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Ivaldi MS, 2007, GENE DEV, V21, P2818, DOI 10.1101/gad.1604007; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Lee DK, 2001, J BIOL CHEM, V276, P9978, DOI 10.1074/jbc.M002285200; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rea S, 2007, ONCOGENE, V26, P5385, DOI 10.1038/sj.onc.1210607; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Simone C, 2002, ONCOGENE, V21, P4137, DOI 10.1038/sj.onc.1205493; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; Walter W, 2008, MOL CELL BIOL, V28, P2840, DOI 10.1128/MCB.01457-07; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Winter S, 2008, EMBO J, V27, P88, DOI 10.1038/sj.emboj.7601954; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	50	297	304	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1122	1136		10.1016/j.cell.2009.07.031	http://dx.doi.org/10.1016/j.cell.2009.07.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766566	Bronze			2022-12-24	WOS:000269923200013
J	Gogolla, N; Caroni, P; Luthi, A; Herry, C				Gogolla, Nadine; Caroni, Pico; Luethi, Andreas; Herry, Cyril			Perineuronal Nets Protect Fear Memories from Erasure	SCIENCE			English	Article							CHONDROITIN-SULFATE PROTEOGLYCANS; CONDITIONED FEAR; DEVELOPMENTAL DISSOCIATION; AMYGDALA DEPOTENTIATION; BASOLATERAL AMYGDALA; EXTRACELLULAR-MATRIX; EXTINGUISHED FEAR; VISUAL-CORTEX; EXTINCTION; PLASTICITY	In adult animals, fear conditioning induces a permanent memory that is resilient to erasure by extinction. In contrast, during early postnatal development, extinction of conditioned fear leads to memory erasure, suggesting that fear memories are actively protected in adults. We show here that this protection is conferred by extracellular matrix chondroitin sulfate proteoglycans (CSPGs) in the amygdala. The organization of CSPGs into perineuronal nets (PNNs) coincided with the developmental switch in fear memory resilience. In adults, degradation of PNNs by chondroitinase ABC specifically rendered subsequently acquired fear memories susceptible to erasure. This result indicates that intact PNNs mediate the formation of erasure-resistant fear memories and identifies a molecular mechanism closing a postnatal critical period during which traumatic memories can be erased by extinction.	[Gogolla, Nadine; Caroni, Pico; Luethi, Andreas; Herry, Cyril] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Luthi, A (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	andreas.luthi@fmi.ch; cyril.herry@inserm.fr	Herry, Cyril/AAP-9902-2020	Herry, Cyril/0000-0003-2973-0843	Austrian Science Fund (FWF); Swiss National Science Foundation; Novartis Research Foundation	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Research Foundation	This work was supported by the Austrian Science Fund (FWF), Swiss National Science Foundation, and Novartis Research Foundation. We thank G. Cassasus for electrophysiological characterization of ChABC-injected animals and K. Scheffler for help with programming. We thank R. F. Westbrook and all members of the Luthi lab for discussions and critical comments on the manuscript. The manuscript was prepared by N.G., P.C., A.L., and C.H. The authors declare that they have no competing financial interest.	Anglada-Figueroa D, 2005, J NEUROSCI, V25, P9680, DOI 10.1523/JNEUROSCI.2600-05.2005; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Bouwmeester H, 2002, J COMP NEUROL, V450, P241, DOI 10.1002/cne.10321; Bruckner G, 1998, EXP BRAIN RES, V121, P300, DOI 10.1007/s002210050463; Bukalo O, 2001, NEUROSCIENCE, V104, P359, DOI 10.1016/S0306-4522(01)00082-3; Cunningham MG, 2002, J COMP NEUROL, V453, P116, DOI 10.1002/cne.10376; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Harris JA, 2000, J EXP PSYCHOL-ANIM B, V26, P174, DOI 10.1037//0097-7403.26.2.174; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Kim JH, 2008, J NEUROSCI, V28, P1282, DOI 10.1523/JNEUROSCI.4736-07.2008; Kim JH, 2007, BEHAV NEUROSCI, V121, P131, DOI 10.1037/0735-7044.121.1.131; Kim JH, 2007, NEUROBIOL LEARN MEM, V88, P48, DOI 10.1016/j.nlm.2007.03.004; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lin CH, 2003, MOL PHARMACOL, V63, P44, DOI 10.1124/mol.63.1.44; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; Rodriguez BI, 1999, BEHAV RES THER, V37, P845, DOI 10.1016/S0005-7967(98)00106-5; Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732	28	478	490	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1258	1261		10.1126/science.1174146	http://dx.doi.org/10.1126/science.1174146			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	490RY	19729657				2022-12-24	WOS:000269523200041
J	Magurran, AE				Magurran, Anne E.			Threats to Freshwater Fish	SCIENCE			English	Editorial Material							EXTINCTION RISK; CICHLID FISH; ZOOGONETICUS; DIVERSITY		Univ St Andrews, Scottish Oceans Inst, Sch Biol, St Andrews KY16 8LB, Fife, Scotland	University of St Andrews	Magurran, AE (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sch Biol, St Andrews KY16 8LB, Fife, Scotland.	aem1@st-andrews.ac.uk	Magurran, Anne E/D-7463-2013	Magurran, Anne/0000-0002-0036-2795				Bailey NW, 2007, HEREDITY, V98, P360, DOI 10.1038/sj.hdy.6800947; Chu C, 2005, DIVERS DISTRIB, V11, P299, DOI 10.1111/j.1366-9516.2005.00153.x; De La Vega-Salazar MY, 2003, ENVIRON BIOL FISH, V68, P14, DOI 10.1023/A:1026040727808; De La Vega-Salazar MY, 2003, BIODIVERS CONSERV, V12, P2043, DOI 10.1023/A:1024155731112; Duncan JR, 2001, BIOL CONSERV, V102, P97, DOI 10.1016/S0006-3207(01)00077-5; Fagan WE, 2005, ECOLOGY, V86, P34, DOI 10.1890/04-0491; GASTON KJ, 1990, J FISH BIOL, V37, P97, DOI 10.1111/j.1095-8649.1990.tb05025.x; Gislason D, 1999, CAN J FISH AQUAT SCI, V56, P2229, DOI 10.1139/cjfas-56-12-2229; HORN MH, 1972, FISH B-NOAA, V70, P1295; Jelks HL, 2008, FISHERIES, V33, P372, DOI 10.1577/1548-8446-33.8.372; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; MAITLAND PS, 1995, BIOL CONSERV, V72, P259, DOI 10.1016/0006-3207(94)00088-8; Nelson JS, 1984, FISHES WORLD; Rabinowitz D., 1981, BIOL ASPECTS RARE PL, P205, DOI DOI 10.1177/004728702237415; Reynolds JD, 2005, CAN J FISH AQUAT SCI, V62, P854, DOI 10.1139/F05-066; Richter BD, 1997, CONSERV BIOL, V11, P1081, DOI 10.1046/j.1523-1739.1997.96236.x; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Van Oppen MJH, 1997, P ROY SOC B-BIOL SCI, V264, P1803, DOI 10.1098/rspb.1997.0248; Verzijden MN, 2007, BIOL LETTERS, V3, P134, DOI 10.1098/rsbl.2006.0601	20	48	51	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1215	1216		10.1126/science.1177215	http://dx.doi.org/10.1126/science.1177215			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729647				2022-12-24	WOS:000269523200027
J	Schafer, ZT; Grassian, AR; Song, LL; Jiang, ZY; Gerhart-Hines, Z; Irie, HY; Gao, SZ; Puigserver, P; Brugge, JS				Schafer, Zachary T.; Grassian, Alexandra R.; Song, Loling; Jiang, Zhenyang; Gerhart-Hines, Zachary; Irie, Hanna Y.; Gao, Sizhen; Puigserver, Pere; Brugge, Joan S.			Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment	NATURE			English	Article							BREAST-CANCER; DUCTAL MORPHOGENESIS; EXTRACELLULAR-MATRIX; EPITHELIAL ACINI; CELL-GROWTH; APOPTOSIS; ANOIKIS; MECHANISMS; AUTOPHAGY; CULTURES	Normal epithelial cells require matrix attachment for survival, and the ability of tumour cells to survive outside their natural extracellular matrix (ECM) niches is dependent on acquisition of anchorage independence(1). Although apoptosis is the most rapid mechanism for eliminating cells lacking appropriate ECM attachment(2), recent reports suggest that non-apoptotic death processes prevent survival when apoptosis is inhibited in matrix-deprived cells(3,4). Here we demonstrate that detachment of mammary epithelial cells from ECM causes an ATP deficiency owing to the loss of glucose transport. Overexpression of ERBB2 rescues the ATP deficiency by restoring glucose uptake through stabilization of EGFR and phosphatidylinositol-3-OH kinase (PI(3) K) activation, and this rescue is dependent on glucose-stimulated flux through the antioxidant-generating pentose phosphate pathway. Notably, we found that the ATP deficiency could be rescued by antioxidant treatment without rescue of glucose uptake. This rescue was found to be dependent on stimulation of fatty acid oxidation, which is inhibited by detachment-induced reactive oxygen species (ROS). The significance of these findings was supported by evidence of an increase in ROS in matrix-deprived cells in the luminal space of mammary acini, and the discovery that antioxidants facilitate the survival of these cells and enhance anchorage-independent colony formation. These results show both the importance of matrix attachment in regulating metabolic activity and an unanticipated mechanism for cell survival in altered matrix environments by antioxidant restoration of ATP generation.	[Schafer, Zachary T.; Grassian, Alexandra R.; Song, Loling; Jiang, Zhenyang; Irie, Hanna Y.; Gao, Sizhen; Puigserver, Pere; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Gerhart-Hines, Zachary; Puigserver, Pere] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Gerhart-Hines, Zachary] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Johns Hopkins University	Brugge, JS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	joan_brugge@hms.harvard.edu			National Cancer Institute; National Institutes of Health (NIH); NCI; National Science Graduate Research Fellowship; NATIONAL CANCER INSTITUTE [K25CA100290, R01CA105134] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Graduate Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Overholtzer, G. Mouneimne, M. Mazzone and C. Leung for critical reading of the manuscript and/or experimental assistance. We thank A. Mailleux, A. Kaanta, V. Schafer, A. Zhou, K. Simpson, and the members of the Brugge laboratory for experimental assistance, comments, and/or discussion. This work was supported by a grant from the National Cancer Institute (J. S. B.) and a grant from the National Institutes of Health (NIH) (P. P.). Z. T. S. is the recipient of a Ruth L. Kirschstein National Research Service Award (NRSA) for Postdoctoral Fellows from the National Cancer Institute; L. S. an NCI Mentored Quantitative Research Development Award (K25); A. R. G. a National Science Graduate Research Fellowship; and H. Y. I. an NCI K08 Award.	Bennett BD, 1996, J BIOL CHEM, V271, P3647; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Boada J, 2000, FEBS LETT, V480, P261, DOI 10.1016/S0014-5793(00)01950-5; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Chen EI, 2007, CANCER RES, V67, P1472, DOI 10.1158/0008-5472.CAN-06-3137; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Humphreys RC, 1996, DEVELOPMENT, V122, P4013; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Lawenda BD, 2008, JNCI-J NATL CANCER I, V100, P773, DOI 10.1093/jnci/djn148; Li AE, 1999, CIRC RES, V85, P304, DOI 10.1161/01.RES.85.4.304; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Narayanan BA, 2006, CURR CANCER DRUG TAR, V6, P711, DOI 10.2174/156800906779010218; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Schafer ZT, 2006, CANCER RES, V66, P2210, DOI 10.1158/0008-5472.CAN-05-3923; Sebastia J, 2003, CYTOM PART A, V51A, P16, DOI 10.1002/cyto.a.10003; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Vishwasrao HD, 2005, J BIOL CHEM, V280, P25119, DOI 10.1074/jbc.M502475200	34	731	743	8	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					109	U118		10.1038/nature08268	http://dx.doi.org/10.1038/nature08268			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19693011	Green Accepted			2022-12-24	WOS:000269478800040
J	Pan, F; Yu, H; Dang, EV; Barbi, J; Pan, XY; Grosso, JF; Jinasena, D; Sharma, SM; McCadden, EM; Getnet, D; Drake, CG; Liu, JO; Ostrowski, MC; Pardoll, DM				Pan, Fan; Yu, Hong; Dang, Eric V.; Barbi, Joseph; Pan, Xiaoyu; Grosso, Joseph F.; Jinasena, Dinili; Sharma, Sudarshana M.; McCadden, Erin M.; Getnet, Derese; Drake, Charles G.; Liu, Jun O.; Ostrowski, Michael C.; Pardoll, Drew M.			Eos Mediates Foxp3-Dependent Gene Silencing in CD4(+) Regulatory T Cells	SCIENCE			English	Article							INTESTINAL INFLAMMATION; IN-VIVO; FOXP3; DEMETHYLATION; TRANSCRIPTION; COREPRESSORS; IKAROS	CD4(+) regulatory T cells (T-regs) maintain immunological self-tolerance and immune homeostasis by suppressing aberrant or excessive immune responses. The core genetic program of T-regs and their ability to suppress pathologic immune responses depends on the transcription factor Foxp3. Despite progress in understanding mechanisms of Foxp3-dependent gene activation, the molecular mechanism of Foxp3-dependent gene repression remains largely unknown. We identified Eos, a zinc-finger transcription factor of the Ikaros family, as a critical mediator of Foxp3-dependent gene silencing in T-regs. Eos interacts directly with Foxp3 and induces chromatin modifications that result in gene silencing in T-regs. Silencing of Eos in T-regs abrogates their ability to suppress immune responses and endows them with partial effector function, thus demonstrating the critical role that Eos plays in T-reg programming.	[Pan, Fan; Yu, Hong; Dang, Eric V.; Barbi, Joseph; Pan, Xiaoyu; Grosso, Joseph F.; Jinasena, Dinili; McCadden, Erin M.; Getnet, Derese; Drake, Charles G.; Pardoll, Drew M.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Immunol & Hematopoiesis Div, Baltimore, MD 21231 USA; [Sharma, Sudarshana M.; Ostrowski, Michael C.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Sharma, Sudarshana M.; Ostrowski, Michael C.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Johns Hopkins University	Pardoll, DM (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Immunol & Hematopoiesis Div, Baltimore, MD 21231 USA.	dpardol1@jhmi.edu	Getnet, Derese/C-5421-2012; Sharma, Sudarshana Mangalore/AAI-2475-2019; Ostrowski, Michael/H-3108-2011	Ostrowski, Michael/0000-0003-2948-6297; Dang, Eric/0000-0002-2389-6167; Sharma, Sudarshana/0000-0002-9745-0061	NIH; Melanoma Research Alliance; Janey Fund; Seraph Foundation; NATIONAL CANCER INSTITUTE [P01CA097189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089830, R01AI058156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044719] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Janey Fund; Seraph Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Rudensky, Y. Shi, M. Crossley, S. Smale, A. Friedman, H. Levisky, C. V. Dang, J. D. Powell, and S. L. Topalian for reagents and helpful suggestions. We are grateful to G. Zhou, K. J. Rhee, and members of the Pardoll laboratory for helpful discussions. The array data sets are deposited at Gene Expression Omnibus (accession number GSE17166). This work was supported by grants from NIH and the Melanoma Research Alliance, the Janey Fund and Seraph Foundation, and gifts from Bill and Betty Topecer and Dorothy Needle.	Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Heo K, 2007, J BIOL CHEM, V282, P15476, DOI 10.1074/jbc.M610270200; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Koipally J, 2002, J BIOL CHEM, V277, P27697, DOI 10.1074/jbc.M201694200; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Murayama A, 2006, EMBO J, V25, P1081, DOI 10.1038/sj.emboj.7601012; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pan F, 2007, NATURE, V445, P433, DOI 10.1038/nature05476; Perdomo J, 2002, EUR J BIOCHEM, V269, P5885, DOI 10.1046/j.1432-1033.2002.03313.x; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sojka DK, 2004, J IMMUNOL, V172, P6136, DOI 10.4049/jimmunol.172.10.6136; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	24	234	244	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 28	2009	325	5944					1142	1146		10.1126/science.1176077	http://dx.doi.org/10.1126/science.1176077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19696312	Green Accepted			2022-12-24	WOS:000269382300045
J	Kang, JE; Lim, MM; Bateman, RJ; Lee, JJ; Smyth, LP; Cirrito, JR; Fujiki, N; Nishino, S; Holtzman, DM				Kang, Jae-Eun; Lim, Miranda M.; Bateman, Randall J.; Lee, James J.; Smyth, Liam P.; Cirrito, John R.; Fujiki, Nobuhiro; Nishino, Seiji; Holtzman, David M.			Amyloid-beta Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle	SCIENCE			English	Article							NEUROBIOLOGY; DROSOPHILA; PLAQUES; SYSTEMS; NEURONS; MICE	Amyloid-beta (A beta) accumulation in the brain extracellular space is a hallmark of Alzheimer's disease. The factors regulating this process are only partly understood. A beta aggregation is a concentration-dependent process that is likely responsive to changes in brain interstitial fluid (ISF) levels of A beta. Using in vivo microdialysis in mice, we found that the amount of ISF A beta correlated with wakefulness. The amount of ISF A beta also significantly increased during acute sleep deprivation and during orexin infusion, but decreased with infusion of a dual orexin receptor antagonist. Chronic sleep restriction significantly increased, and a dual orexin receptor antagonist decreased, A beta plaque formation in amyloid precursor protein transgenic mice. Thus, the sleep-wake cycle and orexin may play a role in the pathogenesis of Alzheimer's disease.	[Kang, Jae-Eun; Lim, Miranda M.; Bateman, Randall J.; Lee, James J.; Smyth, Liam P.; Cirrito, John R.; Holtzman, David M.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Bateman, Randall J.; Cirrito, John R.; Holtzman, David M.] Washington Univ, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Bateman, Randall J.; Holtzman, David M.] Washington Univ, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Fujiki, Nobuhiro; Nishino, Seiji] Stanford Univ, Sleep & Circadian Neurobiol Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Holtzman, David M.] Washington Univ, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Stanford University; Washington University (WUSTL)	Holtzman, DM (corresponding author), Washington Univ, Dept Neurol, St Louis, MO 63110 USA.	holtzman@neuro.wustl.edu		Bateman, Randall/0000-0002-7729-1702	NIH [AG025824, AG030946, NS065667, AG029524, MH072525]; Neuroscience Blueprint Center Core [P30 NS057105]; Cure Alzheimer's Fund; Alzheimer's Association Zenith Award; Eli Lilly; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105, R01NS065667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025824, K01AG029524, P50AG005681, K23AG030946] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neuroscience Blueprint Center Core; Cure Alzheimer's Fund; Alzheimer's Association Zenith Award(Alzheimer's Association); Eli Lilly(Eli Lilly); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. D. Herzog and G. M. Freeman Jr. for assistance and P. J. Shaw for discussion. This work was supported by NIH grants AG025824, AG030946, NS065667, AG029524, and MH072525; Neuroscience Blueprint Center Core Grant P30 NS057105; Cure Alzheimer's Fund; Alzheimer's Association Zenith Award; and Eli Lilly.	Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Gagnon JF, 2008, CURR PHARM DESIGN, V14, P3430, DOI 10.2174/138161208786549353; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kang JE, 2007, P NATL ACAD SCI USA, V104, P10673, DOI 10.1073/pnas.0700148104; Kilduff TS, 2008, J NEUROSCI, V28, P11814, DOI 10.1523/JNEUROSCI.3768-08.2008; Peyron C, 1998, J NEUROSCI, V18, P9996; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Yan P, 2009, J NEUROSCI, V29, P10706, DOI 10.1523/JNEUROSCI.2637-09.2009; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x	14	913	979	10	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					1005	1007		10.1126/science.1180962	http://dx.doi.org/10.1126/science.1180962			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19779148	Green Accepted			2022-12-24	WOS:000271712300043
J	Walker, LM; Phogat, SK; Chan-Hui, PY; Wagner, D; Phung, P; Goss, JL; Wrin, T; Simek, MD; Fling, S; Mitcham, JL; Lehrman, JK; Priddy, FH; Olsen, OA; Frey, SM; Hammond, PW; Kaminsky, S; Zamb, T; Moyle, M; Koff, WC; Poignard, P; Burton, DR				Walker, Laura M.; Phogat, Sanjay K.; Chan-Hui, Po-Ying; Wagner, Denise; Phung, Pham; Goss, Julie L.; Wrin, Terri; Simek, Melissa D.; Fling, Steven; Mitcham, Jennifer L.; Lehrman, Jennifer K.; Priddy, Frances H.; Olsen, Ole A.; Frey, Steven M.; Hammond, Phillip W.; Kaminsky, Stephen; Zamb, Timothy; Moyle, Matthew; Koff, Wayne C.; Poignard, Pascal; Burton, Dennis R.		Protocol G Principal Investigators	Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target	SCIENCE			English	Article							SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS; MONOCLONAL-ANTIBODIES; PASSIVE TRANSFER; V2 DOMAIN; GP120; ENVELOPE; PROTECTION; MACAQUES; EPITOPE; DESIGN	Broadly neutralizing antibodies (bNAbs), which develop over time in some HIV-1-infected individuals, define critical epitopes for HIV vaccine design. Using a systematic approach, we have examined neutralization breadth in the sera of about 1800 HIV-1-infected individuals, primarily infected with non-clade B viruses, and have selected donors for monoclonal antibody (mAb) generation. We then used a high-throughput neutralization screen of antibody-containing culture supernatants from about 30,000 activated memory B cells from a clade A-infected African donor to isolate two potent mAbs that target a broadly neutralizing epitope. This epitope is preferentially expressed on trimeric Envelope protein and spans conserved regions of variable loops of the gp120 subunit. The results provide a framework for the design of new vaccine candidates for the elicitation of bNAb responses.	[Phogat, Sanjay K.; Wagner, Denise; Kaminsky, Stephen; Zamb, Timothy] Int AIDS Vaccine Initiat, AIDS Vaccine Design & Dev Lab, New York, NY 11220 USA; [Walker, Laura M.; Fling, Steven; Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Walker, Laura M.; Fling, Steven; Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Chan-Hui, Po-Ying; Mitcham, Jennifer L.; Olsen, Ole A.; Frey, Steven M.; Hammond, Phillip W.; Moyle, Matthew] Theraclone Sci, Seattle, WA 98104 USA; [Phung, Pham; Goss, Julie L.; Wrin, Terri] Monogram Biosci Inc, San Francisco, CA 94080 USA; [Simek, Melissa D.; Lehrman, Jennifer K.; Priddy, Frances H.; Koff, Wayne C.] Int AIDS Vaccine Initiat, New York, NY 10038 USA; [Burton, Dennis R.] Massachusetts Gen Hosp, MIT, Ragon Inst, Boston, MA 02114 USA; [Burton, Dennis R.] Harvard Univ, Boston, MA 02114 USA	International AIDS Vaccine Initiative; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; International AIDS Vaccine Initiative; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Phogat, SK (corresponding author), Int AIDS Vaccine Initiat, AIDS Vaccine Design & Dev Lab, New York, NY 11220 USA.	SPhogat@iavi.org; burton@scripps.edu	poignard, pascal/N-6678-2013; Kaminsky, Stephen/J-5141-2016; poignard, pascal/AAB-4613-2020	Kaminsky, Stephen/0000-0003-1869-834X; Poignard, Pascal/0000-0002-0021-7192; DeHovitz, Jack/0000-0001-7307-0614	International AIDS Vaccine Initiative (IAVI); U. S. Agency for International Development (USAID); National Institute of Allergy and Infectious Diseases; NIH [AI33292]; MRC [MC_U950097145] Funding Source: UKRI; Medical Research Council [MC_U950097145] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033292, R37AI033292] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative (IAVI); U. S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Aguilar-Sino for technical assistance at The Scripps Research Institute; C. Ward, W. Cieplak, and M. Branum for technical assistance at Theraclone Sciences; R. Pejchal for assistance in structural modeling; S. M. Eagol and C. Williams for assistance with figures; E. Anton from Monogram R & D and the Monogram Clinical Reference Laboratory staff; all the study participants and research staff at each of the Protocol G clinical centers; and Protocol G project team members for all of the support that they have provided for this study (individuals and affiliations are listed in the supporting online material text as notes). We also thank A. Pinter for supplying the antibodies 10/76b and c108 g, W. Olson and J. Moore for providing the KNH1144 SOSIP trimer, and R. Wyatt for providing the YU2gp140foldon trimer. This work was supported by the International AIDS Vaccine Initiative (IAVI) through the contributions of a number of government and private donors who are listed on the Web site www. iavi. org, as well as IAVI's Innovation Fund (which is cofunded by the Bill & Melinda Gates Foundation); the U. S. Agency for International Development (USAID); and the National Institute of Allergy and Infectious Diseases, NIH, AI33292 (D. R. B.). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the U. S. government. The authors declare competing financial interests. Protocol G Principal Investigators: G. Miiro, J. Serwanga, A. Pozniak, D. McPhee, O. Manigart, L. Mwananyanda, E. Karita, A. Inwoley, W. Jaoko, J. DeHovitz, L. G. Bekker, P. Pitisuttithum, R. Paris, and S. Allen.	Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Darbha R, 2004, BIOCHEMISTRY-US, V43, P1410, DOI 10.1021/bi035323x; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Honnen WJ, 2007, J VIROL, V81, P1424, DOI 10.1128/JVI.02054-06; ICHIYOSHI Y, 1994, J EXP MED, V180, P885, DOI 10.1084/jem.180.3.885; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Mascola JR, 2002, VACCINE, V20, P1922, DOI 10.1016/S0264-410X(02)00068-3; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pantophlet R, 2009, J VIROL, V83, P1649, DOI 10.1128/JVI.02046-08; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Phogat S, 2007, CURR PHARM DESIGN, V13, P213, DOI 10.2174/138161207779313632; Pinter A, 2005, J VIROL, V79, P6909, DOI 10.1128/JVI.79.11.6909-6917.2005; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622	23	1344	1438	2	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					285	289		10.1126/science.1178746	http://dx.doi.org/10.1126/science.1178746			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19729618	Green Accepted			2022-12-24	WOS:000270599500042
J	van Heijst, JWJ; Gerlach, C; Swart, E; Sie, D; Nunes-Alves, C; Kerkhoven, RM; Arens, R; Correia-Neves, M; Schepers, K; Schumacher, TNM				van Heijst, Jeroen W. J.; Gerlach, Carmen; Swart, Erwin; Sie, Daoud; Nunes-Alves, Claudio; Kerkhoven, Ron M.; Arens, Ramon; Correia-Neves, Margarida; Schepers, Koen; Schumacher, Ton N. M.			Recruitment of Antigen-Specific CD8(+) T Cells in Response to Infection Is Markedly Efficient	SCIENCE			English	Article							REPERTOIRE; AFFINITY; BINDING; MAGNITUDE	The magnitude of antigen-specific CD8(+) T cell responses is not fixed but correlates with the severity of infection. Although by definition T cell response size is the product of both the capacity to recruit naive T cells (clonal selection) and their subsequent proliferation (clonal expansion), it remains undefined how these two factors regulate antigen-specific T cell responses. We determined the relative contribution of recruitment and expansion by labeling naive T cells with unique genetic tags and transferring them into mice. Under disparate infection conditions with different pathogens and doses, recruitment of antigen-specific T cells was near constant and close to complete. Thus, naive T cell recruitment is highly efficient, and the magnitude of antigen-specific CD8(+) T cell responses is primarily controlled by clonal expansion.	[van Heijst, Jeroen W. J.; Gerlach, Carmen; Swart, Erwin; Arens, Ramon; Schepers, Koen; Schumacher, Ton N. M.] Netherlands Canc Inst, Dept Immunol, NL-1066 CX Amsterdam, Netherlands; [Sie, Daoud; Kerkhoven, Ron M.] Netherlands Canc Inst, Cent Microarray Facil, NL-066 CX Amsterdam, Netherlands; [Nunes-Alves, Claudio; Correia-Neves, Margarida] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, P-4710057 Braga, Portugal	Netherlands Cancer Institute; Netherlands Cancer Institute; Universidade do Minho	Schumacher, TNM (corresponding author), Netherlands Canc Inst, Dept Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	t.schumacher@nki.nl	Correia-Neves, Margarida/AAH-4636-2020; Schepers, Koen/H-7108-2013; Arens, Ramon/V-4010-2018; Correia-Neves, Margarida/C-9122-2009; Schumacher, Ton/Y-2432-2019	Correia-Neves, Margarida/0000-0002-2202-5431; Schepers, Koen/0000-0003-2442-242X; Arens, Ramon/0000-0001-5058-4110; Correia-Neves, Margarida/0000-0002-2202-5431; Schumacher, Ton/0000-0003-0517-8804; Sie, Daoud/0000-0001-6762-2582; Nunes-Alves, Claudio/0000-0001-9639-0477; Gerlach, Carmen/0000-0001-7889-2393				Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Beltman JB, 2007, J EXP MED, V204, P771, DOI 10.1084/jem.20061278; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Correia-Neves M, 2001, IMMUNITY, V14, P21, DOI 10.1016/S1074-7613(01)00086-3; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Schepers K, 2008, J EXP MED, V205, P2309, DOI 10.1084/jem.20072462; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	15	108	110	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1265	1269		10.1126/science.1175455	http://dx.doi.org/10.1126/science.1175455			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729659				2022-12-24	WOS:000269523200043
J	Gupta, PB; Onder, TT; Jiang, GZ; Tao, K; Kuperwasser, C; Weinberg, RA; Lander, ES				Gupta, Piyush B.; Onder, Tamer T.; Jiang, Guozhi; Tao, Kai; Kuperwasser, Charlotte; Weinberg, Robert A.; Lander, Eric S.			Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening	CELL			English	Article							BREAST-CANCER; MESENCHYMAL TRANSITION; RESISTANCE; METASTASIS; LINES; RADIORESISTANCE; TRANSFORMATION; HETEROGENEITY; CHEMOTHERAPY; SENSITIVITY	Screens for agents that specifically kill epithelial cancer stem cells (CSCs) have not been possible due to the rarity of these cells within tumor cell populations and their relative instability in culture. We describe here an approach to screening for agents with epithelial CSC-specific toxicity. We implemented this method in a chemical screen and discovered compounds showing selective toxicity for breast CSCs. One compound, salinomycin, reduces the proportion of CSCs by > 100-fold relative to paclitaxel, a commonly used breast cancer chemotherapeutic drug. Treatment of mice with salinomycin inhibits mammary tumor growth in vivo and induces increased epithelial differentiation of tumor cells. In addition, global gene expression analyses show that salinomycin treatment results in the loss of expression of breast CSC genes previously identified by analyses of breast tissues isolated directly from patients. This study demonstrates the ability to identify agents with specific toxicity for epithelial CSCs.	[Gupta, Piyush B.; Onder, Tamer T.; Jiang, Guozhi; Weinberg, Robert A.; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Onder, Tamer T.; Weinberg, Robert A.; Lander, Eric S.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Gupta, Piyush B.; Jiang, Guozhi; Lander, Eric S.] MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA; [Tao, Kai; Kuperwasser, Charlotte] Tufts Univ, Sch Med, Dept Anat & Cell Biol, Boston, MA 02111 USA; [Tao, Kai; Kuperwasser, Charlotte] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Weinberg, Robert A.] MIT, Ludwig Ctr Mol Oncol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Tufts University; Tufts Medical Center; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Gupta, PB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	piyush@broadinstitute.org; weinberg@wi.mit.edu; lander@broadinstitute.org	Onder, Tamer T/H-3330-2013; Onder, Tamer/O-3669-2019	Onder, Tamer T/0000-0002-2372-9158; Onder, Tamer/0000-0002-2372-9158	National Cancer Institute; Initiative for Chemical Genetics; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH089663] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Initiative for Chemical Genetics; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the National Cancer Institute and the Initiative for Chemical Genetics, who provided support for this publication, and the Chemical Biology Platform of the Broad Institute of Harvard and the Massachusetts Institute of Technology (MIT) for their assistance in this work. We also wish to thank David Root and the RNAi Platform of the Broad Institute as well as the Breast Cancer Research Foundation for their support. We are grateful to Stephanie Norton, Nicola Tolliday, and Paul Clemons for assistance with chemical screening experiments and analysis. We thank Ina Klebba for assistance with animal experiments, Annette Shepard-Barry in the Histology-Special Procedures Lab at Tufts Medical Center for histological and immunohistochemical staining, Tugba Bagci Onder for help with initial drug resistance characterization, and Supriya Gupta in the Genetic Analysis Platform at the Broad Institute for assistance with gene expression microarray data collection. We thank Li Li in the Department of Chemistry Instrumentation Facility at MIT for fourier-transform mass spectrometry analysis and Dr. Sagi Shapira for helpful criticism of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Croker AK, 2008, J CELL MOL MED, V12, P374, DOI 10.1111/j.1582-4934.2007.00211.x; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; R Development Core Team, 2007, R LANG ENV STAT COMP; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh SK, 2003, CANCER RES, V63, P5821; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	33	1819	1963	5	370	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 21	2009	138	4					645	659		10.1016/j.cell.2009.06.034	http://dx.doi.org/10.1016/j.cell.2009.06.034			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19682730	Green Submitted, Green Accepted, Bronze, Green Published			2022-12-24	WOS:000269156100008
J	Hattori, Y; Nagai, K; Furukawa, S; Song, XJ; Kawano, R; Sakakibara, H; Wu, JZ; Matsumoto, T; Yoshimura, A; Kitano, H; Matsuoka, M; Mori, H; Ashikari, M				Hattori, Yoko; Nagai, Keisuke; Furukawa, Shizuka; Song, Xian-Jun; Kawano, Ritsuko; Sakakibara, Hitoshi; Wu, Jianzhong; Matsumoto, Takashi; Yoshimura, Atsushi; Kitano, Hidemi; Matsuoka, Makoto; Mori, Hitoshi; Ashikari, Motoyuki			The ethylene response factors SNORKEL1 and SNORKEL2 allow rice to adapt to deep water	NATURE			English	Article							SUBMERGENCE TOLERANCE; INTERNODE ELONGATION; GROWTH-RESPONSE; FLOATING RICE; ABSCISIC-ACID; GRAIN WIDTH; MAJOR QTL; GIBBERELLIN; GENE; AGROBACTERIUM	Living organisms must acquire new biological functions to adapt to changing and hostile environments. Deepwater rice has evolved and adapted to flooding by acquiring the ability to significantly elongate its internodes, which have hollow structures and function as snorkels to allow gas exchange with the atmosphere, and thus prevent drowning(1-3). Many physiological studies have shown that the phytohormones ethylene, gibberellin and abscisic acid are involved in this response(4-8), but the gene(s) responsible for this trait has not been identified. Here we show the molecular mechanism of deepwater response through the identification of the genes SNORKEL1 and SNORKEL2, which trigger deepwater response by encoding ethylene response factors involved in ethylene signalling. Under deepwater conditions, ethylene accumulates in the plant and induces expression of these two genes. The products of SNORKEL1 and SNORKEL2 then trigger remarkable internode elongation via gibberellin. We also demonstrate that the introduction of three quantitative trait loci from deepwater rice into non-deepwater rice enabled the latter to become deepwater rice. This discovery will contribute to rice breeding in lowland areas that are frequently flooded during the rainy season.	[Hattori, Yoko; Nagai, Keisuke; Furukawa, Shizuka; Song, Xian-Jun; Kitano, Hidemi; Matsuoka, Makoto; Ashikari, Motoyuki] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Mori, Hitoshi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Kawano, Ritsuko; Yoshimura, Atsushi] Kyushu Univ, Sch Agr, Fukuoka 8128581, Japan; [Sakakibara, Hitoshi] RIKEN, Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Wu, Jianzhong; Matsumoto, Takashi] Natl Inst Agrobiol Resources, Tsukuba, Ibaraki 3058602, Japan	Nagoya University; Nagoya University; Kyushu University; RIKEN; National Institute of Agrobiological Sciences - Japan	Ashikari, M (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	ashi@agr.nagoya-u.ac.jp	Sakakibara, Hitoshi/A-6040-2010; Wu, Jian/AAU-5221-2020; Matsumura, Ritsuko/AAS-7122-2020; Hattori, Yoko/AAG-7622-2020; Wu, Jian/AAU-5221-2020	Sakakibara, Hitoshi/0000-0001-5449-6492; Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507; Nagai, Keisuke/0000-0001-9273-5562	Ministry of Agriculture, Forestry, and Fisheries of Japan [QT-2003, QT-4002]; Japan Society for the Promotion of Science (Y. H.); National Bioresource Project, MEXT, Japan; International Rice Research Institute, Philippines	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Japan Society for the Promotion of Science (Y. H.)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Bioresource Project, MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Rice Research Institute, Philippines	We thank I. Aichi for helping to produce the transgenic lines and M. Ito for helping to map the genes. We also thank P. Chaiyawat for the opportunity to photograph the deepwater rice specimen and M. Kojima for technical assistance with the hormone analysis. This work was supported by a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan ( Integrated Research Project for Plants, Insects, and Animals using Genome Technology, QT-2003 and QT-4002) and a research fellowship from the Japan Society for the Promotion of Science (Y. H.). The wild rice lines used in this study were obtained from the National Institute of Genetics supported by the National Bioresource Project, MEXT, Japan and the International Rice Research Institute, Philippines.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Ashikari M, 2006, TRENDS PLANT SCI, V11, P344, DOI 10.1016/j.tplants.2006.05.008; AZUMA T, 1995, J PLANT PHYSIOL, V146, P323, DOI 10.1016/S0176-1617(11)82062-6; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Catling D., 1992, RICE DEEPWATER, V1st edition; Cheng CY, 2002, GENES GENET SYST, V77, P323, DOI 10.1266/ggs.77.323; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fukao T, 2008, P NATL ACAD SCI USA, V105, P16814, DOI 10.1073/pnas.0807821105; Fukao T, 2006, PLANT CELL, V18, P2021, DOI 10.1105/tpc.106.043000; Hattori Y, 2008, BREEDING SCI, V58, P39, DOI 10.1270/jsbbs.58.39; Hattori Y, 2007, BREEDING SCI, V57, P305, DOI 10.1270/jsbbs.57.305; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirano K, 2008, PLANT CELL PHYSIOL, V49, P1429, DOI 10.1093/pcp/pcn123; HOFFMANNBENNING S, 1992, PLANT PHYSIOL, V99, P1156, DOI 10.1104/pp.99.3.1156; HOOD EE, 1986, J BACTERIOL, V168, P1291, DOI 10.1128/jb.168.3.1291-1301.1986; HOOLEY R, 1994, PLANT MOL BIOL, V26, P1529, DOI 10.1007/BF00016489; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; JACKSON MB, 1985, ANNU REV PLANT PHYS, V36, P145, DOI 10.1146/annurev.pp.36.060185.001045; Kaneko M, 2003, PLANT J, V35, P104, DOI 10.1046/j.1365-313X.2003.01780.x; Kawano R, 2008, BREEDING SCI, V58, P47, DOI 10.1270/jsbbs.58.47; Kende H, 1998, PLANT PHYSIOL, V118, P1105, DOI 10.1104/pp.118.4.1105; Mao CZ, 2006, PLANT MOL BIOL, V61, P141, DOI 10.1007/s11103-005-6184-1; METRAUX JP, 1983, PLANT PHYSIOL, V72, P441, DOI 10.1104/pp.72.2.441; MORISHIMA H., 1962, Indian Journal of Genetics, V22, P1; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nemoto K, 2004, THEOR APPL GENET, V109, P42, DOI 10.1007/s00122-004-1600-5; RASKIN I, 1984, PLANT PHYSIOL, V76, P947, DOI 10.1104/pp.76.4.947; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Vaughan DA, 2008, PLANT SCI, V174, P394, DOI 10.1016/j.plantsci.2008.01.016; VERGARA B S, 1976, P301; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920	34	587	640	14	272	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					1026	U116		10.1038/nature08258	http://dx.doi.org/10.1038/nature08258			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19693083				2022-12-24	WOS:000269085500037
J	Ye, X; Wang, YS; Cahill, H; Yu, MZ; Badea, TC; Smallwood, PM; Peachey, NS; Nathans, J				Ye, Xin; Wang, Yanshu; Cahill, Hugh; Yu, Minzhong; Badea, Tudor C.; Smallwood, Philip M.; Peachey, Neal S.; Nathans, Jeremy			Norrin, Frizzled-4, and Lrp5 Signaling in Endothelial Cells Controls a Genetic Program for Retinal Vascularization	CELL			English	Article							FAMILIAL EXUDATIVE VITREORETINOPATHY; VENOUS INSUFFICIENCY; REDUNDANT ROLES; DISEASE MICE; ANGIOGENESIS; MUTATIONS; MOUSE; VASCULATURE; MODEL; SOX17	Disorders of vascular structure and function play a central role in a wide variety of CNS diseases. Mutations in the Frizzled-4 (Fz4) receptor, Lrp5 coreceptor, or Norrin ligand cause retinal hypovascularization, but the mechanisms by which Norrin/Fz4/Lrp signaling controls vascular development have not been defined. Using mouse genetic and cell culture models, we show that loss of Fz4 signaling in endothelial cells causes defective vascular growth, which leads to chronic but reversible silencing of retinal neurons. Loss of Fz4 in all endothelial cells disrupts the blood brain barrier in the cerebellum, whereas excessive Fz4 signaling disrupts embryonic angiogenesis. Sox17, a transcription factor that is upregulated by Norrin/Fz4/Lrp signaling, plays a central role in inducing the angiogenic program controlled by Norrin/Fz4/Lrp. These experiments establish a cellular basis for retinal hypovascularization diseases due to insufficient Frizzled signaling, and they suggest a broader role for Frizzled signaling in vascular growth, remodeling, maintenance, and disease.	[Ye, Xin; Wang, Yanshu; Badea, Tudor C.; Smallwood, Philip M.; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Cahill, Hugh; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Wang, Yanshu; Badea, Tudor C.; Smallwood, Philip M.; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Yu, Minzhong; Peachey, Neal S.] Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA; [Peachey, Neal S.] Cleveland VA Med Ctr, Res Serv, Cleveland, OH 44106 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Nathans, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	jnathans@jhmi.edu	Badea, Tudor Constantin/B-1654-2018; Peachey, Neal/G-5533-2010	Badea, Tudor Constantin/0000-0003-3086-6713; Peachey, Neal/0000-0002-4419-7226; Nathans, Jeremy/0000-0001-8106-5460	National Eye Institute; Howard Hughes Medical Institute; Foundation Fighting Blindness; Veterans Administration; NATIONAL EYE INSTITUTE [R01EY018637] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Foundation Fighting Blindness(European Commission); Veterans Administration(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Elke Stein, Shin Kang, and Dwight Bergles for helpful discussions; Chip Hawkins and the JHMI transgenic core for blastocyst injection; Lawrence Chan, Milan Jamrich, Eric Swindell, Ralf Adams, and Masashi Yanagisawa for mouse lines; Se-Jin Lee for the mouse ES cell genomic library; Huimin Yu for the Norrin-expressing 293 cell line; Corrinne Lobe for the Z/AP plasmid; Tom Rotolo for the Z/AP targeting vector; William Guggino for the use of his fluorescent microscope; Hongjun Song for advice on producing the lentivirus; Linda Orzolek, Ira Maine, Haiping Hao, and Connie Talbot for microarray support; Yifeng Zhang and Markus Meister for advice on microelectrode array recording; and David Ginty, Stewart Hendry, Se-Jin Lee, Amir Rattner, and Randy Reed for helpful comments on the manuscript. This work was supported by the National Eye Institute, the Howard Hughes Medical Institute, the Foundation Fighting Blindness, and the Veterans Administration.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Ai MR, 2005, AM J HUM GENET, V77, P741, DOI 10.1086/497706; Alm A., 1992, ADLERS PHYSL EYE, P198; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Barker TH, 2005, AM J PATHOL, V166, P923, DOI 10.1016/S0002-9440(10)62312-7; BERGER W, 2001, METABOLIC MOL BASES, P5977; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Girard JP, 1996, J BIOL CHEM, V271, P4511; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hayashi Shigemi, 2002, Gene Expression Patterns, V2, P93, DOI 10.1016/S0925-4773(02)00292-7; Hsieh M, 2005, BIOL REPROD, V73, P1135, DOI 10.1095/biolreprod.105.042739; Iwakabe H, 1997, NEUROPHARMACOLOGY, V36, P135, DOI 10.1016/S0028-3908(96)00167-0; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Jiao XD, 2004, AM J HUM GENET, V75, P878, DOI 10.1086/425080; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kondo H, 2007, OPHTHALMIC GENET, V28, P220, DOI 10.1080/13816810701663543; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Luhmann UFO, 2005, INVEST OPHTH VIS SCI, V46, P3372, DOI 10.1167/iovs.05-0174; Luhmann UFO, 2005, GENESIS, V42, P253, DOI 10.1002/gene.20141; Luhmann UFO, 2008, EUR J NEUROSCI, V27, P2619, DOI 10.1111/j.1460-9568.2008.06237.x; Matsubara T, 2000, CURR EYE RES, V20, P1, DOI 10.1076/0271-3683(200001)20:1;1-H;FT001; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; McCall MA, 2008, J PHYSIOL-LONDON, V586, P4385, DOI 10.1113/jphysiol.2008.159327; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Michaelides M, 2004, BRIT J OPHTHALMOL, V88, P1475, DOI 10.1136/bjo.2004.042556; Ohlmann A, 2005, J NEUROSCI, V25, P1701, DOI 10.1523/JNEUROSCI.4756-04.2005; Ohlmann AV, 2004, INVEST OPHTH VIS SCI, V45, P2384, DOI 10.1167/iovs.03-1214; Pendeville H, 2008, DEV BIOL, V317, P405, DOI 10.1016/j.ydbio.2008.01.028; Qin MH, 2005, HUM MUTAT, V26, P104, DOI 10.1002/humu.20191; Rehm HL, 1997, HUM MUTAT, V9, P402; Rehm HL, 2002, J NEUROSCI, V22, P4286, DOI 10.1523/JNEUROSCI.22-11-04286.2002; Richter M, 1998, INVEST OPHTH VIS SCI, V39, P2450; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Sakamoto Y, 2007, BIOCHEM BIOPH RES CO, V360, P539, DOI 10.1016/j.bbrc.2007.06.093; Shastry BS, 1997, ARCH OPHTHALMOL-CHIC, V115, P651, DOI 10.1001/archopht.1997.01100150653015; Smallwood PM, 2007, J BIOL CHEM, V282, P4057, DOI 10.1074/jbc.M609618200; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Su XJ, 2003, MOL VIS, V9, P171; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; Wang YS, 2001, J NEUROSCI, V21, P4761, DOI 10.1523/JNEUROSCI.21-13-04761.2001; Xia CH, 2008, HUM MOL GENET, V17, P1605, DOI 10.1093/hmg/ddn047; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8	48	294	304	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					285	298		10.1016/j.cell.2009.07.047	http://dx.doi.org/10.1016/j.cell.2009.07.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837032	Green Accepted, Bronze			2022-12-24	WOS:000270857500013
J	Dermitzakis, ET; Clark, AG				Dermitzakis, Emmanouil T.; Clark, Andrew G.			Life After GWA Studies	SCIENCE			English	Editorial Material							LOCI; HEIGHT		[Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	University of Geneva; Cornell University	Dermitzakis, ET (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	emmanouil.dermitzakis@unige.ch; ac347@cornell.edu	Dermitzakis, Emmanouil/B-7687-2013	Clark, Andrew/0000-0001-7159-8511	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084706] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG003229-05, R01 HG003229] Funding Source: Medline; NHLBI NIH HHS [U01 HL084706, U01 HL084706-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Dermitzakis ET, 2008, NAT GENET, V40, P492, DOI 10.1038/ng0508-492; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Macdonald SJ, 2005, GENETICS, V171, P1741, DOI 10.1534/genetics.105.045344; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	9	27	30	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					239	240		10.1126/science.1182009	http://dx.doi.org/10.1126/science.1182009			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	504EX	19815762	Green Accepted			2022-12-24	WOS:000270599500026
J	Zhang, EE; Liu, AC; Hirota, T; Miraglia, LJ; Welch, G; Pongsawakul, PY; Liu, XZ; Atwood, A; Huss, JW; Janes, J; Su, AI; Hogenesch, JB; Kay, SA				Zhang, Eric E.; Liu, Andrew C.; Hirota, Tsuyoshi; Miraglia, Loren J.; Welch, Genevieve; Pongsawakul, Pagkapol Y.; Liu, Xianzhong; Atwood, Ann; Huss, Jon W., III; Janes, Jeff; Su, Andrew I.; Hogenesch, John B.; Kay, Steve A.			A Genome-wide RNAi Screen for Modifiers of the Circadian Clock in Human Cells	CELL			English	Article							GENE-EXPRESSION; RESPONSE ELEMENT; REVEALS; TRANSCRIPTION; MOUSE; IDENTIFICATION; CRYPTOCHROME; COMPONENT; MUTATION; FBXL3	Two decades of research identified more than a dozen clock genes and defined a biochemical feedback mechanism of circadian oscillator function. To identify additional clock genes and modifiers, we conducted a genome-wide small interfering RNA screen in a human cellular clock model. Knockdown of nearly 1000 genes reduced rhythm amplitude. Potent effects on period length or increased amplitude were less frequent; we found hundreds of these and confirmed them in secondary screens. Characterization of a subset of these genes demonstrated a dosage-dependent effect on oscillator function. Protein interaction network analysis showed that dozens of gene products directly or indirectly associate with known clock components. Pathway analysis revealed these genes are overrepresented for components of insulin and hedgehog signaling, the cell cycle, and the folate metabolism. Coupled with data showing many of these pathways are clock regulated, we conclude the clock is interconnected with many aspects of cellular function.	[Hogenesch, John B.] Univ Penn, Sch Med, Penn Genome Frontiers Inst, Inst Translat Med & Therapeut,Dept Pharmacol, Philadelphia, PA 19104 USA; [Zhang, Eric E.; Liu, Andrew C.; Hirota, Tsuyoshi; Miraglia, Loren J.; Welch, Genevieve; Liu, Xianzhong; Huss, Jon W., III; Janes, Jeff; Su, Andrew I.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Zhang, Eric E.; Hirota, Tsuyoshi; Pongsawakul, Pagkapol Y.; Atwood, Ann; Kay, Steve A.] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA; [Liu, Andrew C.] Univ Memphis, Dept Biol, Memphis, TN 38152 USA	University of Pennsylvania; Pennsylvania Medicine; Novartis; University of California System; University of California San Diego; University of Memphis	Hogenesch, JB (corresponding author), Univ Penn, Sch Med, Penn Genome Frontiers Inst, Inst Translat Med & Therapeut,Dept Pharmacol, Philadelphia, PA 19104 USA.	hogenesc@mail.med.upenn.edu; skay@ucsd.edu	Kay, Steve A/F-6025-2011; Pongsawakul, Pagkapol Y./GSD-2959-2022; Liu, Andrew C/B-3548-2009; Hirota, Tsuyoshi/D-8158-2015	Kay, Steve A/0000-0002-0402-2878; Liu, Andrew C/0000-0003-1927-0900; Hirota, Tsuyoshi/0000-0003-4876-3608; Zhang, Eric/0000-0002-4472-7493; Su, Andrew I./0000-0002-9859-4104	National Institutes of Health [MH51573, GM74868]; Pennsylvania Commonwealth Health Research Formula Funds; National Institute of Neurological Disease and Stroke [1R01NS054794]; National Institute of Mental Health [P50 MH074924-01]; University of Memphis startup fund; National Science Foundation [IOS-0920417]; NIGMS [1R01GM083924]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074868, R01GM083924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051573, P50MH074924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Commonwealth Health Research Formula Funds; National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); University of Memphis startup fund; National Science Foundation(National Science Foundation (NSF)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Buu Tu for technical support in the screens, Jia Zhang and Tony Orth for help with Qiagen siRNA libraries, Chunlei Wu and Ghislain Bonamy for help with BioGPS, and Richard Glynne and Peter Schultz for their institutional support and encouragement. We also thank Jose Pruneda-Paz, Elizabeth Hamilton, Dmitri A. Nusinow, Michael Hughes, Julie Baggs, and Jason DeBruyne for critically reading the manuscript. This work is supported by National Institutes of Health grants to S. A. K. (MH51573 and GM74868). J.B.H. is supported by the Pennsylvania Commonwealth Health Research Formula Funds, the National Institute of Neurological Disease and Stroke (1R01NS054794), and the National Institute of Mental Health (P50 MH074924-01, awarded to Joseph S. Takahashi, Northwestern University). A. C. L. is supported by The University of Memphis startup fund and the National Science Foundation (IOS-0920417). S. A. K. is a founder of ReSet Therapeutics and is a member of its Scientific Advisory Board. BioGPS development is supported by NIGMS (1R01GM083924 to A. I. S.). This is manuscript number 090513 of the Genomics Institute of the Novartis Research Foundation.	Andre E, 1998, EMBO J, V17, P3867, DOI 10.1093/emboj/17.14.3867; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Etchegaray JP, 2009, MOL CELL BIOL, V29, P3853, DOI 10.1128/MCB.00338-09; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; FLORENES VA, 1994, J NATL CANCER I, V86, P1297, DOI 10.1093/jnci/86.17.1297; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Hirota T, 2008, P NATL ACAD SCI USA, V105, P20746, DOI 10.1073/pnas.0811410106; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Liu AC, 2007, NAT CHEM BIOL, V3, P630, DOI 10.1038/nchembio.2007.37; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Maier B, 2009, GENE DEV, V23, P708, DOI 10.1101/gad.512209; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Mullenders J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004798; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takahashi JS, 2004, J BIOL RHYTHM, V19, P339, DOI 10.1177/0748730404269151; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Ukai-Tadenuma M, 2008, NAT CELL BIOL, V10, P1154, DOI 10.1038/ncb1775; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453	43	303	312	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					199	210		10.1016/j.cell.2009.08.031	http://dx.doi.org/10.1016/j.cell.2009.08.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19765810	Green Accepted, Bronze			2022-12-24	WOS:000270388600027
J	Lee, G; Papapetrou, EP; Kim, H; Chambers, SM; Tomishima, MJ; Fasano, CA; Ganat, YM; Menon, J; Shimizu, F; Viale, A; Tabar, V; Sadelain, M; Studer, L				Lee, Gabsang; Papapetrou, Eirini P.; Kim, Hyesoo; Chambers, Stuart M.; Tomishima, Mark J.; Fasano, Christopher A.; Ganat, Yosif M.; Menon, Jayanthi; Shimizu, Fumiko; Viale, Agnes; Tabar, Viviane; Sadelain, Michel; Studer, Lorenz			Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs	NATURE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN ES; MESSENGER-RNA; DIFFERENTIATION; EXPRESSION; DISEASE; INHIBITION; INDUCTION; DEFECTS	The isolation of human induced pluripotent stem cells (iPSCs)(1-3) offers a new strategy for modelling human disease. Recent studies have reported the derivation and differentiation of disease-specific human iPSCs(4-7). However, a key challenge in the field is the demonstration of disease-related phenotypes and the ability to model pathogenesis and treatment of disease in iPSCs. Familial dysautonomia (FD) is a rare but fatal peripheral neuropathy, caused by a point mutation in the IKBKAP(8) gene involved in transcriptional elongation(9). The disease is characterized by the depletion of autonomic and sensory neurons. The specificity to the peripheral nervous system and the mechanism of neuron loss in FD are poorly understood owing to the lack of an appropriate model system. Here we report the derivation of patient-specific FD-iPSCs and the directed differentiation into cells of all three germ layers including peripheral neurons. Gene expression analysis in purified FD-iPSC-derived lineages demonstrates tissue-specific mis-splicing of IKBKAP in vitro. Patient-specific neural crest precursors express particularly low levels of normal IKBKAP transcript, suggesting a mechanism for disease specificity. FD pathogenesis is further characterized by transcriptome analysis and cell-based assays revealing marked defects in neurogenic differentiation and migration behaviour. Furthermore, we use FD-iPSCs for validating the potency of candidate drugs in reversing aberrant splicing and ameliorating neuronal differentiation and migration. Our study illustrates the promise of iPSC technology for gaining new insights into human disease pathogenesis and treatment.	[Papapetrou, Eirini P.; Tomishima, Mark J.; Tabar, Viviane; Sadelain, Michel; Studer, Lorenz] Sloan Kettering Inst, Ctr Cell Engn, New York, NY 10065 USA; [Lee, Gabsang; Kim, Hyesoo; Chambers, Stuart M.; Tomishima, Mark J.; Fasano, Christopher A.; Ganat, Yosif M.; Studer, Lorenz] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Tomishima, Mark J.] Sloan Kettering Inst, SKI Stem Cell Res Facil, New York, NY 10065 USA; [Menon, Jayanthi; Shimizu, Fumiko; Tabar, Viviane; Studer, Lorenz] Sloan Kettering Inst, Dept Neurosurg, New York, NY 10065 USA; [Viale, Agnes] Sloan Kettering Inst, Genom Core Facil, New York, NY 10065 USA; [Ganat, Yosif M.] Weill Cornell Grad Sch, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Studer, L (corresponding author), Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	studerl@mskcc.org	Pillay, Nischalan/F-9536-2012; Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987; Lee, Gabsang/0000-0002-5052-5927	Starr Foundation; NYSTEM; New York Stem Cell Foundation (NYCSF); Druckenmiller fellowships; Starr Scholar fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052671] Funding Source: NIH RePORTER	Starr Foundation; NYSTEM; New York Stem Cell Foundation (NYCSF); Druckenmiller fellowships; Starr Scholar fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Hendrikx, M. Leversha and C. Zhao for technical help. The work was supported by grants from the Starr Foundation and NYSTEM, by the New York Stem Cell Foundation (NYCSF, Druckenmiller fellowships to G. L. and C. A. F.) and by the Starr Scholar fellowship to S. M. C.	Anderson SL, 2003, BIOCHEM BIOPH RES CO, V310, P627, DOI 10.1016/j.bbrc.2003.09.019; Anderson SL, 2003, BIOCHEM BIOPH RES CO, V306, P303, DOI 10.1016/S0006-291X(03)00971-9; Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Axelrod FB, 2005, EXPERT OPIN PHARMACO, V6, P561, DOI 10.1517/14656566.6.4.561; Axelrod FB, 2002, J PEDIATR-US, V141, P518, DOI 10.1067/mpd.2002.127088; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Iwashita T, 2003, SCIENCE, V301, P972, DOI 10.1126/science.1085649; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Lee GS, 2008, MOL CELLS, V25, P487; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lu SJ, 2007, NAT METHODS, V4, P501, DOI 10.1038/nmeth1041; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Placantonakis DG, 2009, STEM CELLS, V27, P521, DOI 10.1634/stemcells.2008-0884; Rodriguez Luis G., 2004, V294, P23; Slaugenhaupt SA, 2004, HUM MOL GENET, V13, P429, DOI 10.1093/hmg/ddh046; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sommer L, 1995, NEURON, V15, P1245, DOI 10.1016/0896-6273(95)90005-5; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	30	641	712	2	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					402	U100		10.1038/nature08320	http://dx.doi.org/10.1038/nature08320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19693009	Green Accepted			2022-12-24	WOS:000269828100041
J	Alle, H; Roth, A; Geiger, JRP				Alle, Henrik; Roth, Arnd; Geiger, Joerg R. P.			Energy-Efficient Action Potentials in Hippocampal Mossy Fibers	SCIENCE			English	Article							CHANNELS; BOUTONS; SIGNALS; BUDGET; MATTER; BRAIN	Action potentials in nonmyelinated axons are considered to contribute substantially to activity-dependent brain metabolism. Here we show that fast Na(+) current decay and delayed K(+) current onset during action potentials in nonmyelinated mossy fibers of the rat hippocampus minimize the overlap of their respective ion fluxes. This results in total Na(+) influx and associated energy demand per action potential of only 1.3 times the theoretical minimum, in contrast to the factor of 4 used in previous energy budget calculations for neural activity. Analysis of ionic conductance parameters revealed that the properties of Na(+) and K(+) channels are matched to make axonal action potentials energy-efficient, minimizing their contribution to activity-dependent metabolism.	[Alle, Henrik; Geiger, Joerg R. P.] Max Planck Inst Brain Res, Independent Hertie Res Grp, D-60528 Frankfurt, Germany; [Roth, Arnd] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	Max Planck Society; University of London; University College London	Alle, H (corresponding author), Max Planck Inst Brain Res, Independent Hertie Res Grp, D-60528 Frankfurt, Germany.	henrik.alle@charite.de		Roth, Arnd/0000-0003-0325-4287	Max Planck Society; Hertie Foundation; Deutsche Forschungsgemeinschaft [AL 1193/2-1]; Engineering and Physical Sciences Research Council; Engineering and Physical Sciences Research Council [EP/C010841/1] Funding Source: researchfish	Max Planck Society(Max Planck SocietyFoundation CELLEX); Hertie Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank A. Lampert and C. Schmidt- Hieber for discussion on sodium conductances and M. H usser for comments on the manuscript. This work was supported by the Max Planck Society, the Hertie Foundation, the Deutsche Forschungsgemeinschaft ( AL 1193/2-1), and the Engineering and Physical Sciences Research Council.	Acsady L, 1998, J NEUROSCI, V18, P3386; Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Faisal AA, 2007, PLOS COMPUT BIOL, V3, P783, DOI 10.1371/journal.pcbi.0030079; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; HODGKIN A, 1975, PHILOS T ROY SOC B, V270, P297, DOI 10.1098/rstb.1975.0010; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Mangia S, 2009, J CEREBR BLOOD F MET, V29, P441, DOI 10.1038/jcbfm.2008.134; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Nawroth JC, 2007, J NEUROSCI, V27, P9790, DOI 10.1523/JNEUROSCI.1415-07.2007; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Ritchie J M, 1973, Prog Biophys Mol Biol, V26, P147; Wang SSH, 2008, J NEUROSCI, V28, P4047, DOI 10.1523/JNEUROSCI.5559-05.2008; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008	23	273	276	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 11	2009	325	5946					1405	1408		10.1126/science.1174331	http://dx.doi.org/10.1126/science.1174331			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745156				2022-12-24	WOS:000269699100042
J	Lange, J; Skaletsky, H; van Daalen, SKM; Embry, SL; Korver, CM; Brown, LG; Oates, RD; Silber, S; Repping, S; Page, DC				Lange, Julian; Skaletsky, Helen; van Daalen, Saskia K. M.; Embry, Stephanie L.; Korver, Cindy M.; Brown, Laura G.; Oates, Robert D.; Silber, Sherman; Repping, Sjoerd; Page, David C.			Isodicentric Y Chromosomes and Sex Disorders as Byproducts of Homologous Recombination that Maintains Palindromes	CELL			English	Article							NATURALLY-OCCURRING DELETIONS; TESTIS-DETERMINING GENE; ROBERTSONIAN TRANSLOCATIONS; MATERNAL AGE; INTRACHROMOSOMAL RECOMBINATION; FUNCTIONAL CENTROMERES; DICENTRIC CHROMOSOMES; TURNER-SYNDROME; SERTOLI-CELLS; X-CHROMOSOMES	Massive palindromes in the human Y chromosome harbor mirror-image gene pairs essential for spermatogenesis. During evolution, these gene pairs have been maintained by intrapalindrome, arm-to-arm recombination. The mechanism of intrapalindrome recombination and risk of harmful effects are unknown. We report 51 patients with isodicentric Y (idicY) chromosomes formed by homologous crossing over between opposing arms of palindromes on sister chromatids. These ectopic recombination events occur at nearly all Y-linked palindromes. Based on our findings, we propose that intrapalindrome sequence identity is maintained via noncrossover pathways of homologous recombination. DNA double-strand breaks that initiate these pathways can be alternatively resolved by crossing over between sister chromatids to form idicY chromosomes, with clinical consequences ranging from spermatogenic failure to sex reversal and Turner syndrome. Our observations imply that crossover and noncrossover pathways are active in nearly all Y-linked palindromes, exposing an Achilles' heel in the mechanism that preserves palindrome-borne genes.	[Lange, Julian; Skaletsky, Helen; Brown, Laura G.; Page, David C.] MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; [Lange, Julian; Skaletsky, Helen; Brown, Laura G.; Page, David C.] MIT, Dept Biol, Cambridge, MA 02142 USA; [van Daalen, Saskia K. M.; Korver, Cindy M.; Repping, Sjoerd] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynecol, Ctr Reprod Med, NL-1012 WX Amsterdam, Netherlands; [Embry, Stephanie L.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Oates, Robert D.] Boston Univ, Dept Urol, Med Ctr, Boston, MA 02118 USA; [Silber, Sherman] St Lukes Hosp, Infertil Ctr St Louis, St Louis, MO 63107 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Amsterdam; Academic Medical Center Amsterdam; Duke University; Boston University; Saint Luke's Hospital - Missouri	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dcpage@wi.mit.edu		Repping, Sjoerd/0000-0002-6959-149X; Oates, Robert/0000-0003-2330-6697	National Institutes of Health; Howard Hughes Medical Institute; Netherlands Organization for Scientific Research; Academic Medical Center of the University of Amsterdam; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000257] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Academic Medical Center of the University of Amsterdam; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Institutes of Health, the Howard Hughes Medical Institute, the Netherlands Organization for Scientific Research, and the Academic Medical Center of the University of Amsterdam. J. L. received a Boehringer Ingelheim fellowship.	BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Blanco P, 2000, J MED GENET, V37, P752, DOI 10.1136/jmg.37.10.752; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; BURGOYNE PS, 1988, DEVELOPMENT, V102, P443; CAMARGO M, 1984, HUM GENET, V67, P37, DOI 10.1007/BF00270556; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; DANIEL A, 1976, J MED GENET, V13, P381, DOI 10.1136/jmg.13.5.381; Darlington CD, 1939, J GENET, V37, P341, DOI 10.1007/BF02982733; EARNSHAW WC, 1985, CHROMOSOMA, V92, P290, DOI 10.1007/BF00329812; Guillon H, 2005, MOL CELL, V20, P563, DOI 10.1016/j.molcel.2005.09.021; HAIR JB, 1953, HEREDITY S, V6, P215; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HASSOLD T, 1988, AM J HUM GENET, V42, P534; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; HASSOLD T, 1980, ANN HUM GENET, V44, P29, DOI 10.1111/j.1469-1809.1980.tb00943.x; HSU LYF, 1994, AM J MED GENET, V53, P108, DOI 10.1002/ajmg.1320530204; HSU TC, 1975, CYTOGENET CELL GENET, V15, P41, DOI 10.1159/000130497; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; Hurles ME, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r55; Jacobs P, 1997, ANN HUM GENET, V61, P471, DOI 10.1017/S0003480097006507; JACOBS PA, 1966, NATURE, V210, P352, DOI 10.1038/210352a0; JAGER RJ, 1990, NATURE, V348, P452, DOI 10.1038/348452a0; Jobling MA, 1998, CURR BIOL, V8, P1391, DOI 10.1016/S0960-9822(98)00020-7; JOHN B, 1975, CHROMOSOMA, V52, P123, DOI 10.1007/BF00326262; Kamp C, 2000, HUM MOL GENET, V9, P2563, DOI 10.1093/hmg/9.17.2563; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kirsch S, 2005, GENOME RES, V15, P195, DOI 10.1101/gr.3302705; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOSHLAND D, 1987, CELL, V48, P801, DOI 10.1016/0092-8674(87)90077-8; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lange J, 2008, NUCLEIC ACIDS RES, V36, pD809, DOI 10.1093/nar/gkm849; MOHANDAS TK, 1992, AM J HUM GENET, V51, P526; NIEBUHR E, 1972, HUMANGENETIK, V15, P96, DOI 10.1007/BF00273440; Page SL, 1998, CHROMOSOME RES, V6, P115, DOI 10.1023/A:1009286929145; PAGE SL, 1995, HUM MOL GENET, V4, P289, DOI 10.1093/hmg/4.2.289; PALMER SJ, 1991, DEVELOPMENT, V112, P265; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Sullivan BA, 1998, NAT GENET, V20, P227, DOI 10.1038/3024; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; THERMAN E, 1986, HUM GENET, V72, P191, DOI 10.1007/BF00291876; THERMAN E, 1974, AM J HUM GENET, V26, P83; Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170; Uematsu A, 2002, AM J MED GENET, V111, P134, DOI 10.1002/ajmg.10506; VERGNAUD G, 1986, AM J HUM GENET, V38, P109; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769; WANDALL A, 1989, HUM GENET, V82, P137, DOI 10.1007/BF00284046; WARBURTON D, 1980, LANCET, V1, P167	56	163	172	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					855	869		10.1016/j.cell.2009.07.042	http://dx.doi.org/10.1016/j.cell.2009.07.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737515	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000269564600013
J	Yadav, VK; Oury, F; Suda, N; Liu, ZW; Gao, XB; Confavreux, C; Klemenhagen, KC; Tanaka, KF; Gingrich, JA; Guo, XE; Tecott, LH; Mann, JJ; Hen, R; Horvath, TL; Karsenty, G				Yadav, Vijay K.; Oury, Franck; Suda, Nina; Liu, Zhong-Wu; Gao, Xiao-Bing; Confavreux, Cyrille; Klemenhagen, Kristen C.; Tanaka, Kenji F.; Gingrich, Jay A.; Guo, X. Edward; Tecott, Laurence H.; Mann, J. John; Hen, Rene; Horvath, Tamas L.; Karsenty, Gerard			A Serotonin-Dependent Mechanism Explains the Leptin Regulation of Bone Mass, Appetite, and Energy Expenditure	CELL			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; BODY-WEIGHT; FOOD-INTAKE; GLUCOSE-HOMEOSTASIS; 5-HT1A RECEPTOR; ARCUATE NUCLEUS; MICE LACKING; NEURONS; ACTIVATION; OBESITY	Leptin inhibition of bone mass accrual requires the integrity of specific hypothalamic neurons but not expression of its receptor on these neurons. The same is true for its regulation of appetite and energy expenditure. This suggests that leptin acts elsewhere in the brain to achieve these three functions. We show here that brainstem-derived serotonin (BDS) favors bone mass accrual following its binding to Htr2c receptors on ventromedial hypothalamic neurons and appetite via Htr1a and 2b receptors on arcuate neurons. Leptin inhibits these functions and increases energy expenditure because it reduces serotonin synthesis and firing of serotonergic neurons. Accordingly, while abrogating BDS synthesis corrects the bone, appetite and energy expenditure phenotypes caused by leptin deficiency, inactivation of the leptin receptor in serotonergic neurons recapitulates them fully. This study modifies the map of leptin signaling in the brain and identifies a molecular basis for the common regulation of bone and energy metabolisms. For a video summary of this article, see the PaperFlick file with the Supplemental Data available online.	[Yadav, Vijay K.; Oury, Franck; Suda, Nina; Confavreux, Cyrille; Karsenty, Gerard] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Liu, Zhong-Wu; Gao, Xiao-Bing; Horvath, Tamas L.] Yale Univ, Comparat Med Sect, Sch Med, New Haven, CT 06510 USA; [Klemenhagen, Kristen C.; Tanaka, Kenji F.; Hen, Rene] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Tanaka, Kenji F.] Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan; [Gingrich, Jay A.] Columbia Univ, Dept Psychiat Dev Psychobiol, New York, NY 10032 USA; [Guo, X. Edward] Columbia Univ, Dept Biomed Engn, Bone Bioengn Lab, New York, NY 10027 USA; [Tecott, Laurence H.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Mann, J. John] Columbia Univ, Dept Psychiat, New York, NY 10032 USA	Columbia University; Yale University; Columbia University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Columbia University; Columbia University; University of California System; University of California San Francisco; Columbia University	Karsenty, G (corresponding author), Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA.	gk2172@columbia.edu	Bruix, Marta/H-4161-2011; Liu, Zhong-Wu/C-2794-2011; Martinez-del-Pozo, Alvaro/L-8556-2014; Gao, Xiao-Bing/C-3121-2011; yadav, VIJAY k/Q-2540-2016	Bruix, Marta/0000-0002-0096-3558; Martinez-del-Pozo, Alvaro/0000-0003-0043-5939; Gao, Xiao-Bing/0000-0002-2035-4936; yadav, VIJAY k/0000-0003-2345-2846; Tanaka, Kenji/0000-0003-2511-0057; OURY, FRANCK/0000-0003-0562-9900	NIH; IBMS; HFSP; FRM; foundation Bettencourt Schueller; Philippe foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058883, R01DK067936] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IBMS; HFSP(Human Frontier Science Program); FRM(Fondation pour la Recherche Medicale); foundation Bettencourt Schueller; Philippe foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH (G. K.), a Gideon and Sevgi Rodan fellowship from IBMS (V. K. Y.), HFSP (F. O.), FRM (F. O.), foundation Bettencourt Schueller (F. O. and C. C.), and the Philippe foundation (F. O. and C. C.). G. K. is the founder of Escoublac.	ASTONJONES G, 1991, J NEUROSCI, V11, P760; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Elmquist JK, 2000, FRONT HORM RES, V26, P21; EYRE DR, 1988, BIOCHEM J, V252, P495, DOI 10.1042/bj2520495; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GILBERT F, 1988, PSYCHONEUROENDOCRINO, V13, P471, DOI 10.1016/0306-4530(88)90032-7; HEATH MJS, 1995, CURR BIOL, V5, P997, DOI 10.1016/S0960-9822(95)00199-0; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Klemenhagen KC, 2006, NEUROPSYCHOPHARMACOL, V31, P101, DOI 10.1038/sj.npp.1300774; Lam DD, 2008, ENDOCRINOLOGY, V149, P1323, DOI 10.1210/en.2007-1321; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Liu RJ, 2002, J NEUROSCI, V22, P9453; MANN JJ, 1992, ARCH GEN PSYCHIAT, V49, P442; NEILL JC, 1988, EUR J PHARMACOL, V151, P329, DOI 10.1016/0014-2999(88)90818-7; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Oury F, 2006, SCIENCE, V313, P1408, DOI 10.1126/science.1130042; Pasqualetti M, 1998, ANN NY ACAD SCI, V861, P245, DOI 10.1111/j.1749-6632.1998.tb10202.x; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Pogoda P, 2006, J BONE MINER RES, V21, P1591, DOI 10.1359/JBMR.060709; Rao Y, 2007, J CLIN INVEST, V117, P4022, DOI 10.1172/JCI32829; Richards JB, 2007, ARCH INTERN MED, V167, P188, DOI 10.1001/archinte.167.2.188; Shi Y, 2008, P NATL ACAD SCI USA, V105, P20529, DOI 10.1073/pnas.0808701106; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Vickers SP, 1999, PSYCHOPHARMACOLOGY, V143, P309, DOI 10.1007/s002130050952; Waddington SN, 2007, CURR OPIN MOL THER, V9, P432; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Warden SJ, 2005, ENDOCRINOLOGY, V146, P685, DOI 10.1210/en.2004-1259; Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	48	462	486	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					976	989		10.1016/j.cell.2009.06.051	http://dx.doi.org/10.1016/j.cell.2009.06.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737523	Bronze, Green Accepted			2022-12-24	WOS:000269564600022
J	Marion, RM; Strati, K; Li, H; Murga, M; Blanco, R; Ortega, S; Fernandez-Capetillo, O; Serrano, M; Blasco, MA				Marion, Rosa M.; Strati, Katerina; Li, Han; Murga, Matilde; Blanco, Raquel; Ortega, Sagrario; Fernandez-Capetillo, Oscar; Serrano, Manuel; Blasco, Maria A.			A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity	NATURE			English	Article							PLURIPOTENT STEM-CELLS; MOUSE; FIBROBLASTS; ATM; P53; SENESCENCE; GENERATION; TELOMERES; ABSENCE; MICE	The reprogramming of differentiated cells to pluripotent cells (induced pluripotent stem (iPS) cells) is known to be an inefficient process. We recently reported that cells with short telomeres cannot be reprogrammed to iPS cells despite their normal proliferation rates(1,2), probably reflecting the existence of 'reprogramming barriers' that abort the reprogramming of cells with uncapped telomeres. Here we show that p53 (also known as Trp53 in mice and TP53 in humans) is critically involved in preventing the reprogramming of cells carrying various types of DNA damage, including short telomeres, DNA repair deficiencies, or exogenously inflicted DNA damage. Reprogramming in the presence of pre-existing, but tolerated, DNA damage is aborted by the activation of a DNA damage response and p53-dependent apoptosis. Abrogation of p53 allows efficient reprogramming in the face of DNA damage and the generation of iPS cells carrying persistent DNA damage and chromosomal aberrations. These observations indicate that during reprogramming cells increase their intolerance to different types of DNA damage and that p53 is critical in preventing the generation of human and mouse pluripotent cells from suboptimal parental cells.	[Marion, Rosa M.; Strati, Katerina; Blanco, Raquel; Blasco, Maria A.] Spanish Natl Canc Res Ctr CNIO, Telomeres & Telomerase Grp, E-28029 Madrid, Spain; [Li, Han; Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, E-28029 Madrid, Spain; [Murga, Matilde; Fernandez-Capetillo, Oscar] Spanish Natl Canc Res Ctr CNIO, Genet Instabil Grp, Mol Oncol Program, E-28029 Madrid, Spain; [Ortega, Sagrario] Spanish Natl Canc Res Ctr CNIO, Biotechnol Program, Transgen Mice Unit, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Blasco, MA (corresponding author), Spanish Natl Canc Res Ctr CNIO, Telomeres & Telomerase Grp, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	mblasco@cnio.es	Strati, Katerina/GSN-2131-2022; Marión, Rosa/AAE-8657-2020; Marión, Rosa/L-1488-2015; Blasco, Maria A./M-1694-2014; Serrano, Manuel/H-2634-2015; Fernandez-Capetillo, Oscar/H-3508-2015; Murga, Matilde/B-3499-2018	Strati, Katerina/0000-0002-2332-787X; Marión, Rosa/0000-0002-0374-3884; Marión, Rosa/0000-0002-0374-3884; Blasco, Maria A./0000-0002-4211-233X; Serrano, Manuel/0000-0001-7177-9312; Fernandez-Capetillo, Oscar/0000-0002-2690-6885; 	Spanish Association Against Cancer (AECC); MICINN (CONSOLIDER); Regional Government of Madrid; European Union; European Research Council (ERC); AECC; Korber European Research Award	Spanish Association Against Cancer (AECC); MICINN (CONSOLIDER)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Madrid; European Union(European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); AECC; Korber European Research Award	We thank R. Serrano for mouse colony management, and M. Canamero and the Comparative Pathology Unit at the CNIO for teratoma analysis. K. S. is recipient of a contract from the Spanish Association Against Cancer (AECC). Work in the laboratory of M. A. B. is funded by grants from the MICINN (CONSOLIDER), the Regional Government of Madrid, the European Union, the European Research Council (ERC), the AECC, and the Korber European Research Award.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Davy P, 2009, CELL STEM CELL, V4, P95, DOI 10.1016/j.stem.2009.01.004; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Samper E, 2000, EMBO REP, V1, P244, DOI 10.1093/embo-reports/kvd051; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	29	785	824	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1149	U119		10.1038/nature08287	http://dx.doi.org/10.1038/nature08287			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19668189	Green Accepted			2022-12-24	WOS:000269314000043
J	Kerschensteiner, D; Morgan, JL; Parker, ED; Lewis, RM; Wong, ROL				Kerschensteiner, Daniel; Morgan, Josh L.; Parker, Edward D.; Lewis, Renate M.; Wong, Rachel O. L.			Neurotransmission selectively regulates synapse formation in parallel circuits in vivo	NATURE			English	Article							RETINAL GANGLION-CELLS; BIPOLAR CELLS; MOUSE RETINA; MAMMALIAN RETINA; RIBBON SYNAPSES; COMPETITION; EXPRESSION	Activity is thought to guide the patterning of synaptic connections in the developing nervous system. Specifically, differences in the activity of converging inputs are thought to cause the elimination of synapses from less active inputs and increase connectivity with more active inputs(1,2). Here we present findings that challenge the generality of this notion and offer a new view of the role of activity in synapse development. To imbalance neurotransmission from different sets of inputs in vivo, we generated transgenic mice in which ON but not OFF types of bipolar cells in the retina express tetanus toxin ( TeNT). During development, retinal ganglion cells (RGCs) select between ON and OFF bipolar cell inputs ( ON or OFF RGCs) or establish a similar number of synapses with both on separate dendritic arborizations (ON-OFF RGCs). In TeNT retinas, ON RGCs correctly selected the silenced ON bipolar cell inputs over the transmitting OFF bipolar cells, but were connected with them through fewer synapses at maturity. Time-lapse imaging revealed that this was caused by a reduced rate of synapse formation rather than an increase in synapse elimination. Similarly, TeNT-expressing ON bipolar cell axons generated fewer presynaptic active zones. The remaining active zones often recruited multiple, instead of single, synaptic ribbons. ON-OFF RGCs in TeNT mice maintained convergence of ON and OFF bipolar cells inputs and had fewer synapses on their ON arbor without changes to OFF arbor synapses. Our results reveal an unexpected and remarkably selective role for activity in circuit development in vivo, regulating synapse formation but not elimination, affecting synapse number but not dendritic or axonal patterning, and mediating independently the refinement of connections from parallel (ON and OFF) processing streams even where they converge onto the same postsynaptic cell.	[Kerschensteiner, Daniel; Morgan, Josh L.; Lewis, Renate M.; Wong, Rachel O. L.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Kerschensteiner, Daniel; Morgan, Josh L.; Wong, Rachel O. L.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Parker, Edward D.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA	Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kerschensteiner, D (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	KerschensteinerD@vision.wustl.edu; wongr2@u.washington.edu			National Institutes of Health [EY10699, T32 EY07031]; McDonnell Foundation at Washington University; National Eye Institute [EY01730]; Deutsche Forschungsgemeinschaft [1466/1-1]; NATIONAL EYE INSTITUTE [P30EY001730, T32EY007031, R01EY010699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Foundation at Washington University; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to J. Sanes and R. W. Burgess for TeNT-CFP, S. Naganishi for the mGluR6 promoter fragment, A. M. Craig for PSD95-CFP and R. Y. Tsien for tdTomato. We thank F. Soto, L. Godinho, A. Lewis, F. Dunn and T. Misgeld for comments on the manuscript. This work was supported by the National Institutes of Health ( R. O. L. W., EY10699, J. L. M. T32 EY07031), the McDonnell Foundation at Washington University ( R. O. L. W.), National Eye Institute core grant ( E. D. P., EY01730) and the Deutsche Forschungsgemeinschaft ( D. K., KE 1466/1-1).	Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Coombs JL, 2007, J COMP NEUROL, V503, P803, DOI 10.1002/cne.21429; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Harms KJ, 2005, J COMP NEUROL, V490, P72, DOI 10.1002/cne.20635; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; Johnson J, 2003, J NEUROSCI, V23, P518, DOI 10.1523/JNEUROSCI.23-02-00518.2003; Kasthuri N, 2003, NATURE, V424, P426, DOI 10.1038/nature01836; Kerschensteiner D, 2008, J NEUROSCI, V28, P2342, DOI 10.1523/JNEUROSCI.4784-07.2008; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MASLIM J, 1986, J COMP NEUROL, V254, P382, DOI 10.1002/cne.902540310; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Morgan JL, 2006, NAT NEUROSCI, V9, P85, DOI 10.1038/nn1615; Morgan JL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-8; NELSON R, 1978, J NEUROPHYSIOL, V41, P472, DOI 10.1152/jn.1978.41.2.472; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Regus-Leidig H, 2009, J COMP NEUROL, V512, P814, DOI 10.1002/cne.21915; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Ueda Y, 1997, J NEUROSCI, V17, P3014; Wang GY, 2001, J NEUROSCI, V21, P4310, DOI 10.1523/JNEUROSCI.21-12-04310.2001; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wong R. O. L., 2002, FUNDAMENTAL NEUROSCI, P533; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4	28	134	134	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 20	2009	460	7258					1016	U103		10.1038/nature08236	http://dx.doi.org/10.1038/nature08236			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19693082	Green Accepted			2022-12-24	WOS:000269085500035
J	Cadieu, E; Neff, MW; Quignon, P; Walsh, K; Chase, K; Parker, HG; VonHoldt, BM; Rhue, A; Boyko, A; Byers, A; Wong, A; Mosher, DS; Elkahloun, AG; Spady, TC; Andre, C; Lark, KG; Cargill, M; Bustamante, CD; Wayne, RK; Ostrander, EA				Cadieu, Edouard; Neff, Mark W.; Quignon, Pascale; Walsh, Kari; Chase, Kevin; Parker, Heidi G.; VonHoldt, Bridgett M.; Rhue, Alison; Boyko, Adam; Byers, Alexandra; Wong, Aaron; Mosher, Dana S.; Elkahloun, Abdel G.; Spady, Tyrone C.; Andre, Catherine; Lark, K. Gordon; Cargill, Michelle; Bustamante, Carlos D.; Wayne, Robert K.; Ostrander, Elaine A.			Coat Variation in the Domestic Dog Is Governed by Variants in Three Genes	SCIENCE			English	Article							MAJOR DETERMINANT; HAIR FOLLICLE; MUTATIONS; GENOME; FGF5; MULTIPLE; SEQUENCE; CATENIN; TRAITS; CYCLE	Coat color and type are essential characteristics of domestic dog breeds. Although the genetic basis of coat color has been well characterized, relatively little is known about the genes influencing coat growth pattern, length, and curl. We performed genome-wide association studies of more than 1000 dogs from 80 domestic breeds to identify genes associated with canine fur phenotypes. Taking advantage of both inter- and intrabreed variability, we identified distinct mutations in three genes, RSPO2, FGF5, and KRT71 (encoding R-spondin-2, fibroblast growth factor-5, and keratin-71, respectively), that together account for most coat phenotypes in purebred dogs in the United States. Thus, an array of varied and seemingly complex phenotypes can be reduced to the combinatorial effects of only a few genes.	[Cadieu, Edouard; Quignon, Pascale; Parker, Heidi G.; Byers, Alexandra; Mosher, Dana S.; Elkahloun, Abdel G.; Spady, Tyrone C.; Ostrander, Elaine A.] NHGRI, NIH, Bethesda, MD 20892 USA; [Neff, Mark W.; Walsh, Kari; Rhue, Alison; Wong, Aaron] Univ Calif Davis, Vet Genet Lab, Davis, CA 95616 USA; [Chase, Kevin; Lark, K. Gordon] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [VonHoldt, Bridgett M.; Wayne, Robert K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Boyko, Adam; Bustamante, Carlos D.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Cargill, Michelle] Affymetrix Corp, Santa Clara, CA 95051 USA; [Andre, Catherine] Univ Rennes 1, CNRS, Fac Med, UMR 6061, Rennes, France	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California Davis; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; Cornell University; Affymetrix; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Ostrander, EA (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	eostrand@mail.nih.gov	Fiumefreddo, Andrea/T-2977-2019	Bustamante, Carlos D./0000-0002-4187-7920; Ostrander, Elaine/0000-0001-6075-9738; Wong, Aaron/0000-0002-7294-0646; Parker, Heidi G./0000-0002-9707-6380	NSF [0733033, 516310]; NIH [1RO1GM83606, GM063056]; Nestle Purina company; AKC Canine Health Foundation; University of California-Davis Veterinary Genetics Laboratory; Intramural Program of the National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200325, ZICHG200365, T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063056, R01GM083606] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nestle Purina company(Nestle SA); AKC Canine Health Foundation; University of California-Davis Veterinary Genetics Laboratory; Intramural Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge support from NSF grants 0733033 ( R. K. W.) and 516310 ( C. D. B.), NIH grants 1RO1GM83606 ( C. D. B.) and GM063056 ( K. G. L. and K. C.), the Nestle Purina company, the AKC Canine Health Foundation, the University of California-Davis Veterinary Genetics Laboratory, and the Intramural Program of the National Human Genome Research Institute. We thank L. Warren and S. Stafford for providing pictures. Finally, we thank the many dog owners who generously provided us with samples from their pets.	American Kennel Club, 1998, COMPL DOG BOOK, V19th; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; ASH EC, 1927, DOGS THEIR HIST DEV; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Drogemuller C, 2007, ANIM GENET, V38, P218, DOI 10.1111/j.1365-2052.2007.01590.x; Drogemuller C, 2008, SCIENCE, V321, P1462, DOI 10.1126/science.1162525; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Housley DJE, 2006, ANIM GENET, V37, P309, DOI 10.1111/j.1365-2052.2006.01448.x; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Langbein L, 2005, INT REV CYTOL, V243, P1, DOI 10.1016/S0074-7696(05)43001-6; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Martin J, 2004, TRENDS BIOCHEM SCI, V29, P455, DOI 10.1016/j.tibs.2004.07.004; Meuten D.J., 2020, TUMORS DOMESTIC ANIM; Mou C, 2008, HUM MUTAT, V29, P1405, DOI 10.1002/humu.20795; Runkel F, 2006, MAMM GENOME, V17, P1172, DOI 10.1007/s00335-006-0084-9; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Stockard Charles Rupert, 1941, GENETIC ENDOCRINE BA; Sundberg JP, 1997, VET PATHOL, V34, P171, DOI 10.1177/030098589703400301; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Wayne RK, 2007, TRENDS GENET, V23, P557, DOI 10.1016/j.tig.2007.08.013; Wong AK, 2009, ANIM GENET, V40, P569, DOI 10.1111/j.1365-2052.2009.01875.x	25	225	236	6	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					150	153		10.1126/science.1177808	http://dx.doi.org/10.1126/science.1177808			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19713490	Green Accepted			2022-12-24	WOS:000270355600058
J	Kleine, H; Luscher, B				Kleine, Henning; Luescher, Bernhard			Learning How to Read ADP-Ribosylation	CELL			English	Editorial Material							POLY(ADP-RIBOSE); CHROMATIN; ACTIVATION; PROTEINS; PROTEOME	ADP-ribosylation is a posttranslational modification that is emerging as a broadly used mechanism to regulate the functions of proteins and their interactions. Recent findings by three groups (Ahel et al., 2009; Gottschalk et al., 2009; Timinszky et al., 2009) establish that proteins with macrodomains bind poly-ADP-ribose to mediate the cellular response to DNA damage.	[Kleine, Henning; Luescher, Bernhard] Rhein Westfal TH Aachen, Sch Med, Inst Biochem & Mol Biol, D-52074 Aachen, Germany	RWTH Aachen University	Luscher, B (corresponding author), Rhein Westfal TH Aachen, Sch Med, Inst Biochem & Mol Biol, Pauwelsstr 30, D-52074 Aachen, Germany.	luescher@rwth-aachen.de	Luscher, Bernhard/A-7330-2011	Luscher, Bernhard/0000-0002-9622-8709; Kleine, Henning/0000-0003-2559-6608				Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Dania N, 2009, P NATL ACAD SCI USA, V106, P4243, DOI 10.1073/pnas.0900066106; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664	10	37	38	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					17	19		10.1016/j.cell.2009.09.018	http://dx.doi.org/10.1016/j.cell.2009.09.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804746	Bronze			2022-12-24	WOS:000270388600008
J	Medlock, J; Galvani, AP				Medlock, Jan; Galvani, Alison P.			Optimizing Influenza Vaccine Distribution	SCIENCE			English	Article							PANDEMIC INFLUENZA; UNITED-STATES; DISEASE; TIME; AGE; INFECTIONS; COMMUNITY; HOUSEHOLD; MORTALITY; FAMILIES	The criteria to assess public health policies are fundamental to policy optimization. Using a model parametrized with survey-based contact data and mortality data from influenza pandemics, we determined optimal vaccine allocation for five outcome measures: deaths, infections, years of life lost, contingent valuation, and economic costs. We find that optimal vaccination is achieved by prioritization of schoolchildren and adults aged 30 to 39 years. Schoolchildren are most responsible for transmission, and their parents serve as bridges to the rest of the population. Our results indicate that consideration of age-specific transmission dynamics is paramount to the optimal allocation of influenza vaccines. We also found that previous and new recommendations from the U. S. Centers for Disease Control and Prevention both for the novel swine-origin influenza and, particularly, for seasonal influenza, are suboptimal for all outcome measures.	[Medlock, Jan; Galvani, Alison P.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Medlock, Jan] Clemson Univ, Dept Math Sci, Clemson, SC 29634 USA	Yale University; Clemson University	Medlock, J (corresponding author), Yale Univ, Sch Med, 60 Coll St, New Haven, CT 06520 USA.	medlock@clemson.edu			NSF [SBE-0624117]; Notsew Orm Sands Foundation	NSF(National Science Foundation (NSF)); Notsew Orm Sands Foundation	A. G. and J. M. were funded by NSF grant SBE-0624117 and the Notsew Orm Sands Foundation. We thank two anonymous reviewers for their helpful comments and A. Hofmann for editorial support.	ANDERSON R M, 1991; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Centers for Disease Control and Prevention, PREV CONTR INFL REC; Centers for Disease Control and Prevention, 2007, 2007 NAT HLTH INT SU; Couzin J, 2004, SCIENCE, V306, P960; CROPPER ML, 1994, J RISK UNCERTAINTY, V8, P243, DOI 10.1007/BF01064044; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; Emanuel EJ, 2006, SCIENCE, V312, P854, DOI 10.1126/science.1125347; Enserink M, 2004, SCIENCE, V306, P385, DOI 10.1126/science.306.5695.385; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Galvani AP, 2006, SCIENCE, V313, P758; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; Haddix A, 1996, PREVENTION EFFECTIVE; House T, 2009, EPIDEMIOL INFECT, V137, P654, DOI 10.1017/S0950268808001416; JENNINGS LC, 1978, J HYG-CAMBRIDGE, V81, P67, DOI 10.1017/S0022172400053778; Lipsitch M, 2005, SCIENCE, V307, P41; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; LONGINI IM, 1978, MATH BIOSCI, V38, P141, DOI 10.1016/0025-5564(78)90023-8; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Luk J, 2001, CLIN INFECT DIS, V33, P1375, DOI 10.1086/322662; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; MONTO AS, 1969, B WORLD HEALTH ORGAN, V41, P537; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Patel R, 2005, J THEOR BIOL, V234, P201, DOI 10.1016/j.jtbi.2004.11.032; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; REINBERG S, HEALTHDAY; SERFLING RE, 1967, AM J EPIDEMIOL, V86, P433, DOI 10.1093/oxfordjournals.aje.a120753; TABER LH, 1981, J HYG-CAMBRIDGE, V86, P303, DOI 10.1017/S0022172400069059; *US CDCP, NOV H1N1 VACC REC	37	269	271	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1705	1708		10.1126/science.1175570	http://dx.doi.org/10.1126/science.1175570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19696313				2022-12-24	WOS:000270131800050
J	Elliott, MR; Chekeni, FB; Trampont, PC; Lazarowski, ER; Kadl, A; Walk, SF; Park, D; Woodson, RI; Ostankovich, M; Sharma, P; Lysiak, JJ; Harden, TK; Leitinger, N; Ravichandran, KS				Elliott, Michael R.; Chekeni, Faraaz B.; Trampont, Paul C.; Lazarowski, Eduardo R.; Kadl, Alexandra; Walk, Scott F.; Park, Daeho; Woodson, Robin I.; Ostankovich, Marina; Sharma, Poonam; Lysiak, Jeffrey J.; Harden, T. Kendall; Leitinger, Norbert; Ravichandran, Kodi S.			Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance	NATURE			English	Article							EXTRACELLULAR NUCLEOTIDES; RECEPTOR SUBTYPES; EPITHELIAL-CELLS; INFLAMMATION; CHEMOTAXIS; ENGULFMENT; ELEGANS; THYMUS; DEATH; UTP	Phagocytic removal of apoptotic cells occurs efficiently in vivo such that even in tissues with significant apoptosis, very few apoptotic cells are detectable(1). This is thought to be due to the release of 'find-me' signals by apoptotic cells that recruit motile phagocytes such as monocytes, macrophages and dendritic cells, leading to the prompt clearance of the dying cells(2). However, the identity and in vivo relevance of such find-me signals are not well understood. Here, through several lines of evidence, we identify extracellular nucleotides as a critical apoptotic cell find-me signal. We demonstrate the caspase-dependent release of ATP and UTP (in equimolar quantities) during the early stages of apoptosis by primary thymocytes and cell lines. Purified nucleotides at these concentrations were sufficient to induce monocyte recruitment comparable to that of apoptotic cell supernatants. Enzymatic removal of ATP and UTP (by apyrase or the expression of ectopic CD39) abrogated the ability of apoptotic cell supernatants to recruit monocytes in vitro and in vivo. We then identified the ATP/UTP receptor P2Y(2) as a critical sensor of nucleotides released by apoptotic cells using RNA interference-mediated depletion studies in monocytes, and macrophages from P2Y(2)-null mice(3). The relevance of nucleotides in apoptotic cell clearance in vivo was revealed by two approaches. First, in a murine air-pouch model, apoptotic cell supernatants induced a threefold greater recruitment of monocytes and macrophages than supernatants from healthy cells did; this recruitment was abolished by depletion of nucleotides and was significantly decreased in P2Y(2)(-/-) ( also known as P2ry(2)(-/-)) mice. Second, clearance of apoptotic thymocytes was significantly impaired by either depletion of nucleotides or interference with P2Y receptor function ( by pharmacological inhibition or in P2Y(2)(-/-) mice). These results identify nucleotides as a critical find-me cue released by apoptotic cells to promote P2Y(2)-dependent recruitment of phagocytes, and provide evidence for a clear relationship between a find-me signal and efficient corpse clearance in vivo.	[Elliott, Michael R.; Chekeni, Faraaz B.; Trampont, Paul C.; Walk, Scott F.; Park, Daeho; Ravichandran, Kodi S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Elliott, Michael R.; Trampont, Paul C.; Walk, Scott F.; Park, Daeho; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Chekeni, Faraaz B.; Leitinger, Norbert] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Kadl, Alexandra; Ostankovich, Marina; Sharma, Poonam; Leitinger, Norbert] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Woodson, Robin I.; Lysiak, Jeffrey J.] Univ Virginia, Dept Urol, Charlottesville, VA 22908 USA; [Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Lazarowski, Eduardo R.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; [Harden, T. Kendall] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Ravichandran, KS (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.	ravi@virginia.edu	Kadl, Alexandra/AAV-3395-2021	Ostankovitch, Marina/0000-0001-8467-6486; Trampont, Paul/0000-0002-3643-8472; Ravichandran, Kodi/0000-0001-9049-1410; Elliott, Michael/0000-0002-0642-482X	National Institutes of Health; American Cancer Society; University of Virginia Farrow Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267, R01GM064709, R01GM069998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); University of Virginia Farrow Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Rock, C. Borowski and members of the Ravichandran laboratory for helpful suggestions; I. Juncadella for lung epithelial cells; K. Lauber and S. Wesselborg for providing MCF-7/caspase-3 cells; and R. Tacke for assistance with primary monocyte experiments. This work was supported by Public Health Service grants from the National Institutes of Health ( to K. S. R. and N. L.), the American Cancer Society ( to M. R. E.) and the University of Virginia Farrow Fellowship ( to M. R. E.).	Bournazou I, 2009, J CLIN INVEST, V119, P20, DOI 10.1172/JCI36226; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Homolya L, 1999, J BIOL CHEM, V274, P26454, DOI 10.1074/jbc.274.37.26454; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Idzko M, 2004, J CELL PHYSIOL, V201, P286, DOI 10.1002/jcp.20070; Kadl A, 2009, ARTHRITIS RHEUM-US, V60, P1362, DOI 10.1002/art.24448; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; la Sala A, 2003, J LEUKOCYTE BIOL, V73, P339, DOI 10.1189/jlb.0802418; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lazarowski ER, 1999, BRIT J PHARMACOL, V127, P1272, DOI 10.1038/sj.bjp.0702654; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Lazarowski ER, 1997, J BIOL CHEM, V272, P24348, DOI 10.1074/jbc.272.39.24348; Lysiak JJ, 2000, BIOL REPROD, V63, P1465, DOI 10.1095/biolreprod63.5.1465; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Monks J, 2008, BIOL REPROD, V78, P586, DOI 10.1095/biolreprod.107.065045; Moore DJ, 2001, BBA-GENE STRUCT EXPR, V1521, P107, DOI 10.1016/S0167-4781(01)00291-3; Myrtek D, 2007, PURINERG SIGNAL, V3, P5, DOI 10.1007/s11302-006-9032-0; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Truman LA, 2008, BLOOD, V112, P5026, DOI 10.1182/blood-2008-06-162404	30	1021	1059	7	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					282	U165		10.1038/nature08296	http://dx.doi.org/10.1038/nature08296			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19741708	Green Accepted, Green Submitted			2022-12-24	WOS:000269654600048
J	Wang, X; Kruithof-de Julio, M; Economides, KD; Walker, D; Yu, HL; Halili, MV; Hu, YP; Price, SM; Abate-Shen, C; Shen, MM				Wang, Xi; Kruithof-de Julio, Marianna; Economides, Kyriakos D.; Walker, David; Yu, Hailong; Halili, M. Vivienne; Hu, Ya-Ping; Price, Sandy M.; Abate-Shen, Cory; Shen, Michael M.			A luminal epithelial stem cell that is a cell of origin for prostate cancer	NATURE			English	Article							ANDROGEN-INDUCED REGENERATION; BASAL-CELLS; RECOMBINASE ACTIVITY; TUMOR INITIATION; MOUSE PROSTATE; HOMEOBOX GENE; MUTANT MICE; IN-VIVO; NKX3.1; EXPRESSION	In epithelial tissues, the lineage relationship between normal progenitor cells and cell type(s) of origin for cancer has been poorly understood. Here we show that a known regulator of prostate epithelial differentiation, the homeobox gene Nkx3-1, marks a stem cell population that functions during prostate regeneration. Genetic lineage-marking demonstrates that rare luminal cells that express Nkx3-1 in the absence of testicular androgens (castration-resistant Nkx3-1-expressing cells, CARNs) are bipotential and can self-renew in vivo, and single-cell transplantation assays show that CARNs can reconstitute prostate ducts in renal grafts. Functional assays of Nkx3-1 mutant mice in serial prostate regeneration suggest that Nkx3-1 is required for stem cell maintenance. Furthermore, targeted deletion of the Pten tumour suppressor gene in CARNs results in rapid carcinoma formation after androgen-mediated regeneration. These observations indicate that CARNs represent a new luminal stem cell population that is an efficient target for oncogenic transformation in prostate cancer.	[Wang, Xi; Kruithof-de Julio, Marianna; Shen, Michael M.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Wang, Xi; Kruithof-de Julio, Marianna; Shen, Michael M.] Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; [Abate-Shen, Cory] Columbia Univ Coll Phys & Surg, Dept Urol, New York, NY 10032 USA; [Abate-Shen, Cory] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Wang, Xi; Economides, Kyriakos D.; Walker, David; Yu, Hailong; Halili, M. Vivienne; Hu, Ya-Ping; Price, Sandy M.; Abate-Shen, Cory; Shen, Michael M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Wang, Xi; Walker, David; Yu, Hailong; Halili, M. Vivienne; Hu, Ya-Ping; Price, Sandy M.; Shen, Michael M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Piscataway, NJ 08854 USA; [Economides, Kyriakos D.; Abate-Shen, Cory] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Piscataway, NJ 08854 USA	Columbia University; Columbia University; Columbia University; Columbia University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Shen, MM (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA.	mshen@columbia.edu	yu, hailong/F-7716-2011; Abate-Shen, Cory/O-2520-2014; Thomson, Axel/A-7893-2013; Shen, Michael M/C-7546-2009	Abate-Shen, Cory/0000-0002-5021-0570; Shen, Michael M/0000-0002-4042-1657; Kruithof-de Julio, Marianna/0000-0002-6085-7706; Walker, David/0000-0002-8783-0562	NIH; DOD Prostate Cancer Research Program; NCI Mouse Models of Human Cancer Consortium; NATIONAL CANCER INSTITUTE [U01CA084294, P01CA154293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076602] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD Prostate Cancer Research Program; NCI Mouse Models of Human Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Kim for her initial observations on Nkx3-1 expression in the regressed prostate, and C. Cordon-Cardo, E. Gelmann, C. Mendelsohn and B. Reizis for comments on the manuscript. Weare also grateful to C. Bieberich, M. Capecchi, P. Chambon and F. Costantini for providing mice and reagents. This work was supported by grants from the NIH (C.A.-S. and M. M. S.), DOD Prostate Cancer Research Program ( K. D. E., C. A.-S. and M. M. S.), and the NCI Mouse Models of Human Cancer Consortium.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Abate-Shen C, 2008, DIFFERENTIATION, V76, P717, DOI 10.1111/j.1432-0436.2008.00292.x; Abdulkadir SA, 2002, MOL CELL BIOL, V22, P1495, DOI 10.1128/MCB.22.5.1495-1503.2002; Banach-Petrosky W, 2007, CANCER RES, V67, P9089, DOI 10.1158/0008-5472.CAN-07-2887; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; BICKENBACH JR, 1987, J INVEST DERMATOL, V88, P42, DOI 10.1111/1523-1747.ep12464857; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Chen H, 2005, DEV DYNAM, V234, P961, DOI 10.1002/dvdy.20596; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; CUNHA GR, 1984, STAIN TECHNOL, V59, P7, DOI 10.3109/10520298409113823; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; EVANS GS, 1987, PROSTATE, V11, P339, DOI 10.1002/pros.2990110406; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Gao H, 2006, CANCER RES, V66, P7929, DOI 10.1158/0008-5472.CAN-06-1637; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Grisanzio C, 2008, J CELL BIOCHEM, V103, P1354, DOI 10.1002/jcb.21555; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Humphrey PA, 2007, J CLIN PATHOL, V60, P35, DOI 10.1136/jcp.2005.036442; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Isaacs JT, 1985, BENIGN PROSTATIC HYP, P85; Kasper S, 2008, J CELL PHYSIOL, V216, P332, DOI 10.1002/jcp.21489; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim MJ, 2002, CANCER RES, V62, P2999; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Lawson DA, 2007, J CLIN INVEST, V117, P2044, DOI 10.1172/JCI32810; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; Nagy A., 2003, MANIPULATING MOUSE E; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Ouyang X, 2005, CANCER RES, V65, P6773, DOI 10.1158/0008-5472.CAN-05-1948; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Sciavolino PJ, 1997, DEV DYNAM, V209, P127, DOI 10.1002/(SICI)1097-0177(199705)209:1<127::AID-AJA12>3.0.CO;2-Z; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; SUGIMURA Y, 1986, BIOL REPROD, V34, P973, DOI 10.1095/biolreprod34.5.973; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Weaver M, 2008, SCIENCE, V321, P1496, DOI 10.1126/science.1158712; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015	50	515	533	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 24	2009	461	7263					495	U61		10.1038/nature08361	http://dx.doi.org/10.1038/nature08361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19741607	Green Accepted			2022-12-24	WOS:000270082900033
J	Liu, ZF; Gandhi, CS; Rees, DC				Liu, Zhenfeng; Gandhi, Chris S.; Rees, Douglas C.			Structure of a tetrameric MscL in an expanded intermediate state	NATURE			English	Article							MECHANOSENSITIVE ION-CHANNEL; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; GATING MECHANISM; PROGRAM; MODELS; MAPS	The ability of cells to sense and respond to mechanical force underlies diverse processes such as touch and hearing in animals, gravitropism in plants, and bacterial osmoregulation(1,2). In bacteria, mechanosensation is mediated by the mechanosensitive channels of large (MscL), small (MscS), potassium-dependent (MscK) and mini (MscM) conductances. These channels act as 'emergency relief valves' protecting bacteria from lysis upon acute osmotic down-shock(3). Among them, MscL has been intensively studied since the original identification and characterization 15 years ago(4). MscL is reversibly and directly gated by changes in membrane tension. In the open state, MscL forms a non-selective 3 nS conductance channel which gates at tensions close to the lytic limit of the bacterial membrane. An earlier crystal structure at 3.5 angstrom resolution of a pentameric MscL from Mycobacterium tuberculosis represents a closed-state or non-conducting conformation(5,6). MscL has a complex gating behaviour; it exhibits several intermediates between the closed and open states, including one putative non-conductive expanded state and at least three sub-conducting states(7). Although our understanding of the closed(5,6) and open(8-10) states of MscL has been increasing, little is known about the structures of the intermediate states despite their importance in elucidating the complete gating process of MscL. Here we present the crystal structure of a carboxy-terminal truncation mutant (Delta 95-120) of MscL from Staphylococcus aureus (SaMscL(C Delta 26)) at 3.8 angstrom resolution. Notably, SaMscL(C Delta 26) forms a tetrameric channel with both transmembrane helices tilted away from the membrane normal at angles close to that inferred for the open state(9), probably corresponding to a non-conductive but partially expanded intermediate state.	[Liu, Zhenfeng; Gandhi, Chris S.; Rees, Douglas C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Liu, Zhenfeng; Rees, Douglas C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Rees, DC (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	dcrees@caltech.edu		liu, zhen feng/0000-0001-5502-9474	Howard Hughes Medical Institute; National Institutes of Health [GM084211]; Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084211] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Shih for early cloning work, T. Walton for biochemical analysis, A. Lee for initial efforts on the MscL project, J. Choe for expression and purification protocols, O. Lewinson for manuscript reading, Y. Poon and J. Lai for treating MJF465 with lDE3 and the osmotic down-shock assay protocol, J. Kaiser for suggestions on structure refinement, R. Phillips, E. Haswell and P. Pal for discussions, P. Blount for the MJF465 strain, and the staff at SSRL, the Advanced Light Source (ALS) and the Advanced Photon Source (APS) for technical support with crystal screening and data collection. We would like to acknowledge the Gordon and Betty Moore Foundation for support of the Molecular Observatory at Caltech. Operations at SSRL, ALS and APS are supported by the US Department of Energy and NIH. This work was supported in part by grants from the Howard Hughes Medical Institute and the National Institutes of Health (GM084211). C. S. G. was supported in part by postdoctoral fellowships from the National Institutes of Health and the Beckman Foundation. D. C. R. is an Investigator in the Howard Hughes Medical Institute.	Ajouz B, 1998, J BIOL CHEM, V273, P26670, DOI 10.1074/jbc.273.41.26670; Ajouz B, 2000, J BIOL CHEM, V275, P1015, DOI 10.1074/jbc.275.2.1015; Anishkin A, 2009, J BIOL CHEM, V284, P19153, DOI 10.1074/jbc.R109.009357; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beckstein O, 2004, PHYS BIOL, V1, P42, DOI 10.1088/1478-3967/1/1/005; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Booth IR, 2007, NAT REV MICROBIOL, V5, P431, DOI 10.1038/nrmicro1659; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cogdell RJ, 1997, PROG BIOPHYS MOL BIO, V68, P1, DOI 10.1016/S0079-6107(97)00010-2; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; DeLano WL, 2002, PYMOL USERS MANUAL; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HASE CC, 1995, J BIOL CHEM, V270, P18329, DOI 10.1074/jbc.270.31.18329; Hase CC, 1997, J MEMBRANE BIOL, V157, P17, DOI 10.1007/s002329900212; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Iscla I, 2008, BIOPHYS J, V95, P2283, DOI 10.1529/biophysj.107.127423; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Lusty CJ, 1999, J APPL CRYSTALLOGR, V32, P106, DOI 10.1107/S002188989801053X; Maurer JA, 2000, J BIOL CHEM, V275, P22238, DOI 10.1074/jbc.M003056200; Moe PC, 1998, MOL MICROBIOL, V28, P583, DOI 10.1046/j.1365-2958.1998.00821.x; Niegowski D, 2007, CELL MOL LIFE SCI, V64, P2564, DOI 10.1007/s00018-007-7174-z; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Spencer RH, 2002, ANNU REV BIOPH BIOM, V31, P207, DOI 10.1146/annurev.biophys.31.082901.134329; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; Strop P, 2003, ADV PROTEIN CHEM, V63, P177; Sukharev S, 2001, BIOPHYS J, V81, P917, DOI 10.1016/S0006-3495(01)75751-7; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; SUKHAREV SI, 1993, BIOPHYS J, V65, P177, DOI 10.1016/S0006-3495(93)81044-0; Sukharev SI, 1999, J GEN PHYSIOL, V113, P525, DOI 10.1085/jgp.113.4.525; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; SUKHAREV SI, 2004, SCI STKE, P1; Tsai IJ, 2005, EUR BIOPHYS J BIOPHY, V34, P403, DOI 10.1007/s00249-005-0476-x; van den Bogaart G, 2007, BIOPHYS J, V92, P1233, DOI 10.1529/biophysj.106.088708; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Yoshimura K, 2008, P NATL ACAD SCI USA, V105, P4033, DOI 10.1073/pnas.0709436105	46	96	100	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					120	U132		10.1038/nature08277	http://dx.doi.org/10.1038/nature08277			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19701184	Green Accepted			2022-12-24	WOS:000269478800042
J	Krashes, MJ; DasGupta, S; Vreede, A; White, B; Armstrong, JD; Waddell, S				Krashes, Michael J.; DasGupta, Shamik; Vreede, Andrew; White, Benjamin; Armstrong, J. Douglas; Waddell, Scott			A Neural Circuit Mechanism Integrating Motivational State with Memory Expression in Drosophila	CELL			English	Article							RAT HIPPOCAMPAL SLICE; NEUROPEPTIDE Y-LIKE; LONG-TERM-MEMORY; FEEDING-BEHAVIOR; MUSHROOM BODIES; PRESYNAPTIC INHIBITION; SYNAPTIC-TRANSMISSION; DOPAMINERGIC-NEURONS; TARGETED EXPRESSION; LOCOMOTOR-ACTIVITY	Behavioral expression of food-associated memory in fruit flies is constrained by satiety and promoted by hunger, suggesting an influence of motivational state. Here, we identify a neural mechanism that integrates the internal state of hunger and appetitive memory. We show that stimulation of neurons that express neuropeptide F(dNPF), an ortholog of mammalian NPY, mimics food deprivation and promotes memory performance in satiated flies. Robust appetitive memory performance requires the dNPF receptor in six dopaminergic neurons that innervate a distinct region of the mushroom bodies. Blocking these dopaminergic neurons releases memory performance in satiated flies, whereas stimulation suppresses memory performance in hungry flies. Therefore, dNPF and dopamine provide a motivational switch in the mushroom body that controls the output of appetitive memory.	[Krashes, Michael J.; DasGupta, Shamik; Waddell, Scott] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Vreede, Andrew; White, Benjamin] NIMH, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Armstrong, J. Douglas] Univ Edinburgh, Sch Informat, Inst Adapt & Neural Computat, Edinburgh EH1 2QL, Midlothian, Scotland; [Krashes, Michael J.] Harvard Univ, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Boston, MA 02215 USA	University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Edinburgh; Harvard University; Harvard Medical School	Waddell, S (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	scott.waddell@umassmed.edu	Krashes, Michael/P-7677-2019	DasGupta, Shamik/0000-0001-5566-7548; Waddell, Scott/0000-0003-4503-6229; Armstrong, Douglas/0000-0002-5397-3864; DasGupta, Shamik/0000-0001-5803-8982	National Institutes of Health [MH09883, MH081982]; National Research Service Award [DA024499]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH009883, R01MH081982, R01MH069883, ZIAMH002800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA024499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Andre Fiala, Paul Garrity, Julie Simpson, Ping Shen, Tim Tully, and Troy Zars for flies. We also thank Geraldine Wright, Hans Hoffman, Tzumin Lee, and Stanley Heinze for their input. This work was supported by National Institutes of Health grants MH09883 and MH081982 to S. W. and National Research Service Award DA024499 to M. J. K.	Abizaid A, 2008, REGUL PEPTIDES, V149, P3, DOI 10.1016/j.regpep.2007.10.006; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; [Anonymous], 1956, LEARNING INSTINCT AN; Arquier N, 2008, CELL METAB, V7, P333, DOI 10.1016/j.cmet.2008.02.003; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bewick GA, 2005, FASEB J, V19, P1680, DOI 10.1096/fj.04-3434fje; Bindra D, 1959, MOTIVATION SYSTEMATI; Blum K, 1996, J ROY SOC MED, V89, P396, DOI 10.1177/014107689608900711; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; Browning KN, 2003, J PHYSIOL-LONDON, V549, P775, DOI 10.1113/jphysiol.2003.042036; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; CLARK JT, 1985, ENDOCRINOLOGY, V117, P2435, DOI 10.1210/endo-117-6-2435; COLMERS WF, 1991, BRIT J PHARMACOL, V102, P41, DOI 10.1111/j.1476-5381.1991.tb12129.x; COLMERS WF, 1988, J NEUROSCI, V8, P3827; Dethier V. G., 1976, HUNGRY FLY PHYSL STU; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Figlewicz DP, 2009, AM J PHYSIOL-REG I, V296, pR9, DOI 10.1152/ajpregu.90725.2008; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Garczynski SF, 2002, PEPTIDES, V23, P773, DOI 10.1016/S0196-9781(01)00647-7; GELPERIN A, 1967, SCIENCE, V157, P208, DOI 10.1126/science.157.3785.208; GELPERIN A, 1971, Z VERGL PHYSIOL, V72, P17, DOI 10.1007/BF00299201; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HINDE RA, 1966, ANIMAL BEHAVIOUR SYN; HUBER F, 1967, INVERTEBRATE NERVOUS, P333; Hull C.L., 1951, ESSENTIALS BEHAV; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kalra SP, 1997, NEURON, V19, P227, DOI 10.1016/S0896-6273(00)80934-4; Keene AC, 2006, CURR BIOL, V16, P1524, DOI 10.1016/j.cub.2006.06.022; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; KENNEDY JS, 1987, PERSPECTIVES CHEMORE; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KLAPSTEIN GJ, 1993, HIPPOCAMPUS, V3, P103, DOI 10.1002/hipo.450030111; Kohyama-Koganeya A, 2008, P NATL ACAD SCI USA, V105, P15328, DOI 10.1073/pnas.0807833105; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Levin BE, 2006, DIABETES, V55, pS122, DOI 10.2337/db06-S016; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; LORENZ KZ, 1950, SYM SOC EXP BIOL, V4, P221; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Martin JR, 1998, LEARN MEMORY, V5, P179; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Meunier N, 2007, J EXP BIOL, V210, P1424, DOI 10.1242/jeb.02755; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Peabody NC, 2009, J NEUROSCI, V29, P3343, DOI 10.1523/JNEUROSCI.4241-08.2009; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Qian J, 1997, J NEUROSCI, V17, P8169; Redrobe JP, 2004, J MOL NEUROSCI, V22, P159, DOI 10.1385/JMN:22:3:159; Rhim H, 1997, J NEUROSCI, V17, P2980; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Roeder KD, 1955, SCI MON, V80, P362; SAHU A, 1988, PEPTIDES, V9, P83, DOI 10.1016/0196-9781(88)90013-7; SANACORA G, 1990, ENDOCRINOLOGY, V127, P730, DOI 10.1210/endo-127-2-730; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Seugnet L, 2008, CURR BIOL, V18, P1110, DOI 10.1016/j.cub.2008.07.028; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; Sun QQ, 2003, J NEUROSCI, V23, P9639; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; TATEMOTO K, 1982, NATURE, V296, P659, DOI 10.1038/296659a0; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; Toates F., 1986, MOTIVATIONAL SYSTEMS; Tolman E.C., 1932, PURPOSIVE BEHAV ANIM; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; van Swinderen B, 2007, SCIENCE, V315, P1590, DOI 10.1126/science.1137931; Watts Alan G., 2003, HDB BRAIN THEORY NEU, P680; Weintraub D, 2008, ANN NEUROL, V64, pS93, DOI 10.1002/ana.21454; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Zhang K, 2007, SCIENCE, V316, P1901, DOI 10.1126/science.1137357	82	375	387	3	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					416	427		10.1016/j.cell.2009.08.035	http://dx.doi.org/10.1016/j.cell.2009.08.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837040	Bronze, Green Submitted, Green Accepted, Green Published			2022-12-24	WOS:000270857500023
J	Byrne, S; Dundas, CM; Kennedy, MR; Mellon, MT; McEwen, AS; Cull, SC; Daubar, IJ; Shean, DE; Seelos, KD; Murchie, SL; Cantor, BA; Arvidson, RE; Edgett, KS; Reufer, A; Thomas, N; Harrison, TN; Posiolova, LV; Seelos, FP				Byrne, Shane; Dundas, Colin M.; Kennedy, Megan R.; Mellon, Michael T.; McEwen, Alfred S.; Cull, Selby C.; Daubar, Ingrid J.; Shean, David E.; Seelos, Kimberly D.; Murchie, Scott L.; Cantor, Bruce A.; Arvidson, Raymond E.; Edgett, Kenneth S.; Reufer, Andreas; Thomas, Nicolas; Harrison, Tanya N.; Posiolova, Liliya V.; Seelos, Frank P.			Distribution of Mid-Latitude Ground Ice on Mars from New Impact Craters	SCIENCE			English	Article							NEAR-SURFACE; STABILITY; DYNAMICS; HYDROGEN; BEHAVIOR; ODYSSEY; WATER; DUST; H2O	New impact craters at five sites in the martian mid-latitudes excavated material from depths of decimeters that has a brightness and color indicative of water ice. Near-infrared spectra of the largest example confirm this composition, and repeated imaging showed fading over several months, as expected for sublimating ice. Thermal models of one site show that millimeters of sublimation occurred during this fading period, indicating clean ice rather than ice in soil pores. Our derived ice-table depths are consistent with models using higher long-term average atmospheric water vapor content than present values. Craters at most of these sites may have excavated completely through this clean ice, probing the ice table to previously unsampled depths of meters and revealing substantial heterogeneity in the vertical distribution of the ice itself.	[Byrne, Shane; Dundas, Colin M.; McEwen, Alfred S.; Daubar, Ingrid J.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Kennedy, Megan R.; Shean, David E.; Cantor, Bruce A.; Edgett, Kenneth S.; Harrison, Tanya N.; Posiolova, Liliya V.] Malin Space Sci Syst, San Diego, CA 92191 USA; [Mellon, Michael T.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Cull, Selby C.; Arvidson, Raymond E.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Seelos, Kimberly D.; Murchie, Scott L.; Seelos, Frank P.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Reufer, Andreas; Thomas, Nicolas] Univ Bern, Inst Phys, Bern, Switzerland	University of Arizona; University of Colorado System; University of Colorado Boulder; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Bern	Byrne, S (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	shane@lpl.arizona.edu	Byrne, Shane/B-8104-2012; Mellon, Michael/C-3456-2016; Seelos, Frank/C-7875-2016; Seelos, Kimberly D/F-4647-2015; Murchie, Scott L/E-8030-2015; Daubar, Ingrid/N-1408-2013; Harrison, Tanya N./AAH-4918-2020; Thomas, Nicolas/G-4693-2015	Seelos, Frank/0000-0001-9721-941X; Seelos, Kimberly D/0000-0001-7236-0580; Murchie, Scott L/0000-0002-1616-8751; Edgett, Kenneth/0000-0001-7197-5751; Dundas, Colin/0000-0003-2343-7224; Shean, David/0000-0003-3840-3860; Daubar, Ingrid/0000-0001-9790-2972; Thomas, Nicolas/0000-0002-0146-0071	NASA Mars Reconnaissance Orbiter (MRO) project	NASA Mars Reconnaissance Orbiter (MRO) project	Funding for this work was provided by the NASA Mars Reconnaissance Orbiter (MRO) project. We thank the CTX, HiRISE, CRISM, and MRO-operations teams for the (time-critical) acquisition of these data and three reviewers for their helpful comments.	Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Cantor BA, 2007, ICARUS, V186, P60, DOI 10.1016/j.icarus.2006.08.019; Chamberlain MA, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002801; Diez B, 2008, ICARUS, V196, P409, DOI 10.1016/j.icarus.2008.02.006; Feldman WC, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002160; FELDMAN WC, 1993, J GEOPHYS RES-PLANET, V98, P20855, DOI 10.1029/93JE02325; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; FISCHER EM, 1993, ICARUS, V102, P185, DOI 10.1006/icar.1993.1043; Fisher DA, 2005, ICARUS, V179, P387, DOI 10.1016/j.icarus.2005.07.024; Fouchet T, 2007, ICARUS, V190, P32, DOI 10.1016/j.icarus.2007.03.003; Holt JW, 2008, SCIENCE, V322, P1235, DOI 10.1126/science.1164246; KIEFFER HH, 1990, J GEOPHYS RES-SOLID, V95, P1481, DOI 10.1029/JB095iB02p01481; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Malin MC, 2006, SCIENCE, V314, P1573, DOI 10.1126/science.1135156; Malin MC, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002808; MCEWEN AS, 2007, J GEOPHYS RES-PLANET, V112, DOI DOI 10.1029/2005JE002605; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Mellon MT, 2004, ICARUS, V169, P324, DOI 10.1016/j.icarus.2003.10.022; MELLON MT, 1993, J GEOPHYS RES-PLANET, V98, P3345, DOI 10.1029/92JE02355; MELLON MT, 2009, LUNAR PLANET SCI C, V40, P1904; Miller RD, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001873; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; MOORE HJ, 1979, J GEOPHYS RES, V84, P8365, DOI 10.1029/JB084iB14p08365; Murchie S, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002682; Mustard JF, 2001, NATURE, V412, P411, DOI 10.1038/35086515; PAIGE DA, 1992, NATURE, V356, P43, DOI 10.1038/356043a0; Plaut JJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036379; Rempel AW, 2004, J FLUID MECH, V498, P227, DOI 10.1017/S0022112003006761; Schorghofer N, 2007, NATURE, V449, P192, DOI 10.1038/nature06082; Smith MD, 2004, ICARUS, V167, P148, DOI 10.1016/j.icarus.2003.09.010; Smith PH, 2009, SCIENCE, V325, P58, DOI 10.1126/science.1172339; SQUYRES SW, 1986, SCIENCE, V231, P249, DOI 10.1126/science.231.4735.249	32	227	229	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1674	1676		10.1126/science.1175307	http://dx.doi.org/10.1126/science.1175307			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779195				2022-12-24	WOS:000270131800041
J	Tsukahara, S; Kobayashi, A; Kawabe, A; Mathieu, O; Miura, A; Kakutani, T				Tsukahara, Sayuri; Kobayashi, Akie; Kawabe, Akira; Mathieu, Olivier; Miura, Asuka; Kakutani, Tetsuji			Bursts of retrotransposition reproduced in Arabidopsis	NATURE			English	Article							NON-CG METHYLATION; DNA METHYLATION; DIVERSITY; THALIANA; GENOME; TRANSPOSONS; MUTATION; ELEMENTS	Retrotransposons, which proliferate by reverse transcription of RNA intermediates, comprise a major portion of plant genomes(1,2). Plants often change the genome size and organization during evolution by rapid proliferation and deletion of long terminal repeat (LTR) retrotransposons(3,4). Precise transposon sequences throughout the Arabidopsis thaliana genome and the trans-acting mutations affecting epigenetic states make it an ideal model organism with which to study transposon dynamics(5-9). Here we report the mobilization of various families of endogenous A. thaliana LTR retrotransposons identified through genetic and genomic approaches with high-resolution genomic tiling arrays and mutants in the chromatin-remodelling gene DDM1 (DECREASE IN DNA METHYLATION1)(10,11). Using multiple lines of self-pollinated ddm1 mutant, we detected an increase in copy number, and verified this for various retrotransposons in a gypsy family (ATGP3) and copia families (ATCOPIA13, ATCOPIA21, ATCOPIA93), and also for a DNA transposon of a Mutator family, VANDAL21. A burst of retrotransposition occurred stochastically and independently for each element, suggesting an additional autocatalytic process. Furthermore, comparison of the identified LTR retrotransposons in related Arabidopsis species revealed that a lineage-specific burst of retrotransposition of these elements did indeed occur in natural Arabidopsis populations. The recent burst of retrotransposition in natural population is targeted to centromeric repeats, which is presumably less harmful than insertion into genes. The ddm1-induced retrotransposon proliferations and genome rearrangements mimic the transposon-mediated genome dynamics during evolution and provide experimental systems with which to investigate the controlling molecular factors directly.	[Tsukahara, Sayuri; Kobayashi, Akie; Kawabe, Akira; Miura, Asuka; Kakutani, Tetsuji] Natl Inst Genet, Dept Integrated Genet, Mishima, Shizuoka 4118540, Japan; [Tsukahara, Sayuri; Kakutani, Tetsuji] Grad Univ Adv Studies, Sch Life Sci, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Mathieu, Olivier] Univ Geneva, Dept Plant Biol, CH-1211 Geneva 4, Switzerland; [Mathieu, Olivier] Univ Clermont Ferrand 2, CNRS, INSERMU, GReD,UMR 6247,U931, F-63177 Clermont Ferrand, France	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; University of Geneva; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	Kakutani, T (corresponding author), Natl Inst Genet, Dept Integrated Genet, Yata 1111, Mishima, Shizuoka 4118540, Japan.	tkakutan@lab.nig.ac.jp	Kawabe, Akira/W-7485-2019; Mathieu, Olivier/AAV-6593-2021	Kawabe, Akira/0000-0001-5770-412X; Mathieu, Olivier/0000-0001-5302-1102	Takeda Science Foundation	Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank A. Terui for technical assistance, M. Nakamura for plant materials, M. Morita and M. Tasaka for genetic marker information, H. Tsukaya for advice on the wvs phenotypes, and E. Richards for critical comments on the manuscript. This study was supported by the Takeda Science Foundation and a Grant-in-Aid for Scientific Research.	Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Havecker ER, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-225; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Kakutani T, 1997, PLANT J, V12, P1447, DOI 10.1046/j.1365-313x.1997.12061447.x; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Kankel MW, 2003, GENETICS, V163, P1109; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Kawabe A, 2007, J MOL EVOL, V64, P237, DOI 10.1007/s00239-006-0097-8; Kaya H, 2001, CELL, V104, P131, DOI 10.1016/S0092-8674(01)00197-0; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Le QH, 2000, P NATL ACAD SCI USA, V97, P7376, DOI 10.1073/pnas.97.13.7376; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; LUCAS H, 1995, EMBO J, V14, P2364, DOI 10.1002/j.1460-2075.1995.tb07231.x; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Peterson-Burch BD, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r78; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Steimer A, 2000, PLANT CELL, V12, P1165, DOI 10.1105/tpc.12.7.1165; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vitte C, 2006, P NATL ACAD SCI USA, V103, P17638, DOI 10.1073/pnas.0605618103; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Yu ZH, 2000, GENETICS, V156, P2019	29	255	262	1	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					423	U125		10.1038/nature08351	http://dx.doi.org/10.1038/nature08351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19734880				2022-12-24	WOS:000269828100046
J	Zhao, XY; Li, W; Lv, Z; Liu, L; Tong, M; Hai, T; Hao, J; Guo, CL; Ma, QW; Wang, L; Zeng, FY; Zhou, Q				Zhao, Xiao-yang; Li, Wei; Lv, Zhuo; Liu, Lei; Tong, Man; Hai, Tang; Hao, Jie; Guo, Chang-long; Ma, Qing-wen; Wang, Liu; Zeng, Fanyi; Zhou, Qi			iPS cells produce viable mice through tetraploid complementation	NATURE			English	Article							PLURIPOTENT STEM-CELLS; FIBROBLASTS; GENERATION; INDUCTION; ABSENCE	Since the initial description of induced pluripotent stem (iPS) cells created by forced expression of four transcription factors in mouse fibroblasts, the technique has been used to generate embryonic stem (ES)-cell-like pluripotent cells from a variety of cell types in other species, including primates and rat(1-6). It has become a popular means to reprogram somatic genomes into an embryonic-like pluripotent state, and a preferred alternative to somatic-cell nuclear transfer and somatic-cell fusion with ES cells(7,8). However, iPS cell reprogramming remains slow and inefficient. Notably, no live animals have been produced by the most stringent tetraploid complementation assay, indicative of a failure to create fully pluripotent cells. Here we report the generation of several iPS cell lines that are capable of generating viable, fertile live-born progeny by tetraploid complementation. These iPS cells maintain a pluripotent potential that is very close to ES cells generated from in vivo or nuclear transfer embryos. We demonstrate the practicality of using iPS cells as useful tools for the characterization of cellular reprogramming and developmental potency, and confirm that iPS cells can attain true pluripotency that is similar to that of ES cells.	[Zhao, Xiao-yang; Li, Wei; Lv, Zhuo; Liu, Lei; Tong, Man; Hai, Tang; Hao, Jie; Guo, Chang-long; Ma, Qing-wen; Wang, Liu; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Zhao, Xiao-yang; Li, Wei; Lv, Zhuo; Tong, Man; Hao, Jie; Guo, Chang-long] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China; [Ma, Qing-wen; Zeng, Fanyi] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Shanghai Inst Med Genet, Shanghai 200040, Peoples R China; [Zeng, Fanyi] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhou, Q (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China.	fzeng@sjtu.edu.cn; qzhou@ioz.ac.cn	Lu, Zhuo/D-4517-2014	ZHAO, Xiao-Yang/0000-0003-2544-8293; , Haitang/0000-0002-3192-0753	China National Basic Research Program [2006CB701500, 2007CB947800, 2007CB947700]; National Science Foundation of China [30525040];  [30871379/C0607]	China National Basic Research Program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This study was supported in part by grants from the China National Basic Research Program 2006CB701500 (to Q. Z.), 2007CB947800 (to F. Z.), 2007CB947700 (to L. W.) and grants from the National Science Foundation of China 30525040 (to Q. Z.) and 30871379/C0607 (to F. Z.).	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Cheng J, 2004, GENESIS, V39, P100, DOI 10.1002/gene.20031; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; LOVE JM, 1990, NUCLEIC ACIDS RES, V18, P4123, DOI 10.1093/nar/18.14.4123; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; NAGY A, 1990, DEVELOPMENT, V110, P815; NAGY T, 2003, MANIPULATING MOUSE E; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zhou Q, 2001, BIOL REPROD, V65, P412, DOI 10.1093/biolreprod/65.2.412	35	574	686	11	269	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					86	U88		10.1038/nature08267	http://dx.doi.org/10.1038/nature08267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19672241				2022-12-24	WOS:000269478800035
J	Aimanianda, V; Bayry, J; Bozza, S; Kniemeyer, O; Perruccio, K; Elluru, SR; Clavaud, C; Paris, S; Brakhage, AA; Kaveri, SV; Romani, L; Latge, JP				Aimanianda, Vishukumar; Bayry, Jagadeesh; Bozza, Silvia; Kniemeyer, Olaf; Perruccio, Katia; Elluru, Sri Ramulu; Clavaud, Cecile; Paris, Sophie; Brakhage, Axel A.; Kaveri, Srini V.; Romani, Luigina; Latge, Jean-Paul			Surface hydrophobin prevents immune recognition of airborne fungal spores	NATURE			English	Article							ASPERGILLUS-FUMIGATUS; CELL-WALL; ALVEOLAR MACROPHAGES; CLADOSPORIUM; RESPONSES; PROTEINS; ANTIGENS	The air we breathe is filled with thousands of fungal spores (conidia) per cubic metre, which in certain composting environments can easily exceed 10 9 per cubic metre. They originate from more than a hundred fungal species belonging mainly to the genera Cladosporium, Penicillium, Alternaria and Aspergillus(1-4). Although these conidia contain many antigens and allergens(5-7), it is not known why airborne fungal microflora do not activate the host innate immune cells continuously and do not induce detrimental inflammatory responses following their inhalation. Here we show that the surface layer on the dormant conidia masks their recognition by the immune system and hence prevents immune response. To explore this, we used several fungal members of the airborne microflora, including the human opportunistic fungal pathogen Aspergillus fumigatus, in in vitro assays with dendritic cells and alveolar macrophages and in in vivo murine experiments. In A. fumigatus, this surface 'rodlet layer' is composed of hydrophobic RodA protein covalently bound to the conidial cell wall through glycosylphosphatidylinositol-remnants. RodA extracted from conidia of A. fumigatus was immunologically inert and did not induce dendritic cell or alveolar macrophage maturation and activation, and failed to activate helper T-cell immune responses in vivo. The removal of this surface 'rodlet/hydrophobin layer' either chemically (using hydrofluoric acid), genetically (Delta rodA mutant) or biologically (germination) resulted in conidial morphotypes inducing immune activation. All these observations show that the hydrophobic rodlet layer on the conidial cell surface immunologically silences airborne moulds.	[Aimanianda, Vishukumar; Clavaud, Cecile; Paris, Sophie; Latge, Jean-Paul] Inst Pasteur, Unite Aspergillus, F-75015 Paris, France; [Bayry, Jagadeesh; Elluru, Sri Ramulu; Kaveri, Srini V.] Univ Paris 06, INSERM, UMR S 872, U872, F-75006 Paris, France; [Bayry, Jagadeesh; Elluru, Sri Ramulu; Kaveri, Srini V.] Univ Paris 06, Ctr Rech Cordeliers, UMR S 872, F-75006 Paris, France; [Bayry, Jagadeesh; Elluru, Sri Ramulu; Kaveri, Srini V.] Univ Paris 05, UMR S 872, F-75006 Paris, France; [Bozza, Silvia; Romani, Luigina] Univ Perugia, Dept Expt Med & Biochem Sci, I-06122 Perugia, Italy; [Perruccio, Katia] Univ Perugia, Dept Clin & Expt Med, I-06122 Perugia, Italy; [Kniemeyer, Olaf; Brakhage, Axel A.] Leibniz Inst Nat Prod Res & Infect Biol HKI, Dept Mol & Appl Microbiol, D-07745 Jena, Germany; [Kniemeyer, Olaf; Brakhage, Axel A.] Univ Jena, D-07745 Jena, Germany	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Perugia; University of Perugia; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Latge, JP (corresponding author), Inst Pasteur, Unite Aspergillus, F-75015 Paris, France.	jplatge@pasteur.fr	Kniemeyer, Olaf/K-1253-2013; Aimanianda, Vishukumar/E-9204-2011; Latge, Jean Paul/C-9846-2014; Romani, Luigina/O-9987-2018; Perruccio, Katia/ABF-8021-2020; Elluru, Sri Ramulu/B-1097-2009; Bayry, Jagadeesh/A-6589-2011	Kniemeyer, Olaf/0000-0002-9493-6402; Aimanianda, Vishukumar/0000-0001-5813-7497; Elluru, Sri Ramulu/0000-0001-9188-710X; Bayry, Jagadeesh/0000-0003-0498-9808; Romani, Luigina/0000-0002-1356-525X; Kaveri, Srini/0000-0002-0837-4053	Deutsche Forschungsgemeinschaft (DFG); EU-STREP [LSHB-CT-2004-511952, MANASP LSGBH37899]; INSERM; CNRS; Universities Paris 5 and 6	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EU-STREP(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universities Paris 5 and 6	We thank J. Vani, Y. Repesse and C. Galeotti for help with dendritic cell experiments; and R. Winkler, S. Behnken and M. Potsch for help with the MALDI-TOF/TOF analysis. The research of O. K. and A. A. B. was supported by the Deutsche Forschungsgemeinschaft (DFG) Priority Programme 1160, and the EU-STREP Fungwall LSHB-CT-2004-511952 and MANASP LSGBH37899 were also awarded to J.-P. L., A. A. B. and L. R. J. B and S. V. K are supported by INSERM, CNRS and Universities Paris 5 and 6.	Bayry J, 2007, J IMMUNOL, V178, P4184, DOI 10.4049/jimmunol.178.7.4184; Bernard M, 2001, MED MYCOL, V39, P9, DOI 10.1080/mmy.39.1.9.17; Boualem K, 2008, RES MICROBIOL, V159, P110, DOI 10.1016/j.resmic.2007.10.004; Bozza S, 2003, BLOOD, V102, P3807, DOI 10.1182/blood-2003-03-0748; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Braedel S, 2004, BRIT J HAEMATOL, V125, P392, DOI 10.1111/j.1365-2141.2004.04922.x; Codina R, 2008, J INVEST ALLERG CLIN, V18, P156; Dague E, 2008, LANGMUIR, V24, P2955, DOI 10.1021/la703741y; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Dubourdeau M, 2006, J IMMUNOL, V177, P3994, DOI 10.4049/jimmunol.177.6.3994; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; Glaser AG, 2009, ALLERGY, V64, P1144, DOI 10.1111/j.1398-9995.2009.02029.x; de Ana SG, 2006, J INVEST ALLERG CLIN, V16, P357; Graham LM, 2006, J IMMUNOL METHODS, V314, P164, DOI 10.1016/j.jim.2006.05.013; Hektor HJ, 2005, CURR OPIN BIOTECH, V16, P434, DOI 10.1016/j.copbio.2005.05.004; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Kasprzyk I, 2008, ANN AGR ENV MED, V15, P1; Kniemeyer O, 2006, CURR GENET, V49, P178, DOI 10.1007/s00294-005-0047-9; Lamarre C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-417; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; LATGE JP, 1988, CAN J MICROBIOL, V34, P1325, DOI 10.1139/m88-232; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lee T, 2006, ATMOS ENVIRON, V40, P2902, DOI 10.1016/j.atmosenv.2006.01.011; Philippe B, 2003, INFECT IMMUN, V71, P3034, DOI 10.1128/IAI.71.6.3034-3042.2003; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Sarfati J, 2006, DIAGN MICR INFEC DIS, V55, P279, DOI 10.1016/j.diagmicrobio.2006.02.002; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; THAU N, 1994, INFECT IMMUN, V62, P4380, DOI 10.1128/IAI.62.10.4380-4388.1994	30	539	557	1	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1117	+		10.1038/nature08264	http://dx.doi.org/10.1038/nature08264			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19713928				2022-12-24	WOS:000269314000036
J	Kitano, J; Ross, JA; Mori, S; Kume, M; Jones, FC; Chan, YF; Absher, DM; Grimwood, J; Schmutz, J; Myers, RM; Kingsley, DM; Peichel, CL				Kitano, Jun; Ross, Joseph A.; Mori, Seiichi; Kume, Manabu; Jones, Felicity C.; Chan, Yingguang F.; Absher, Devin M.; Grimwood, Jane; Schmutz, Jeremy; Myers, Richard M.; Kingsley, David M.; Peichel, Catherine L.			A role for a neo-sex chromosome in stickleback speciation	NATURE			English	Article							REPRODUCTIVE ISOLATION; CICHLID FISH; THREESPINE STICKLEBACKS; SEGREGATION DISTORTION; SYMPATRIC SPECIATION; Y-CHROMOSOME; EVOLUTION; DROSOPHILA; SELECTION; GASTEROSTEUS	Sexual antagonism, or conflict between the sexes, has been proposed as a driving force in both sex-chromosome turnover and speciation. Although closely related species often have different sex-chromosome systems, it is unknown whether sex-chromosome turnover contributes to the evolution of reproductive isolation between species. Here we show that a newly evolved sex chromosome contains genes that contribute to speciation in threespine stickleback fish (Gasterosteus aculeatus). We first identified a neo-sex chromosome system found only in one member of a sympatric species pair in Japan. We then performed genetic linkage mapping of male-specific traits important for reproductive isolation between the Japanese species pair. The neo-X chromosome contains loci for male courtship display traits that contribute to behavioural isolation, whereas the ancestral X chromosome contains loci for both behavioural isolation and hybrid male sterility. Our work not only provides strong evidence for a large X-effect on reproductive isolation in a vertebrate system, but also provides direct evidence that a young neo-X chromosome contributes to reproductive isolation between closely related species. Our data indicate that sex-chromosome turnover might have a greater role in speciation than was previously appreciated.	[Kitano, Jun; Ross, Joseph A.; Peichel, Catherine L.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Ross, Joseph A.] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Mori, Seiichi] Gifu Keizai Univ, Biol Lab, Gifu 5038550, Japan; [Kume, Manabu] Publ Works Res Inst, Aqua Restorat Res Ctr, Gifu 5016021, Japan; [Jones, Felicity C.; Chan, Yingguang F.; Kingsley, David M.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Jones, Felicity C.; Chan, Yingguang F.; Kingsley, David M.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Absher, Devin M.; Grimwood, Jane; Schmutz, Jeremy; Myers, Richard M.] Stanford Univ, Dept Genet, Stanford, CA 94304 USA; [Absher, Devin M.; Grimwood, Jane; Schmutz, Jeremy; Myers, Richard M.] Stanford Univ, Stanford Human Genome Ctr, Stanford, CA 94304 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; PWRI: Public Works Research Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Peichel, CL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1100 Fairview Ave N, Seattle, WA 98109 USA.	cpeichel@fhcrc.org	Grimwood, Jane/ABD-5737-2021; Chan, Yingguang Frank/ABG-9852-2020; Chan, Yingguang/A-7654-2011; Kume, Manabu/AAI-7926-2020; Jones, Felicity C/AAY-3523-2021; Schmutz, Jeremy/N-3173-2013; Ross, Joseph/D-1574-2012; Kume, Manabu/Y-5237-2018	Chan, Yingguang Frank/0000-0001-6292-9681; Chan, Yingguang/0000-0001-6292-9681; Kume, Manabu/0000-0001-7287-029X; Jones, Felicity C/0000-0002-5027-1031; Schmutz, Jeremy/0000-0001-8062-9172; Kume, Manabu/0000-0001-7287-029X; Ross, Joseph/0000-0001-6553-2591	Uehara Memorial Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Water and People Project of Research Institute for Humanity and Nature; Akkeshi Town Grants-in-Aid for Scientific Research in the Lake Akkeshi-Bekanbeushi Wetland; Burroughs Wellcome Fund Career Award in the Biomedical Sciences; National Institutes of Health [T32 GM07270, R01 GM071854, P50 HG02568]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071854, T32GM007270] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Water and People Project of Research Institute for Humanity and Nature; Akkeshi Town Grants-in-Aid for Scientific Research in the Lake Akkeshi-Bekanbeushi Wetland; Burroughs Wellcome Fund Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Nishitani, J. Kitajima, M. Nishida, S. Takeyama, T. Andoh, T. Kuwahara, C. Torii, Akkeshi Fisheries Cooperative Association, Akkeshi Waterfowl Center, S. Brady, A. Southwick, all members of the Peichel laboratory, and many field assistants for technical help and discussion. We thank J. Boughman, T. Bradshaw, H. Malik, J. McKinnon, N. Phadnis and D. Schluter for comments on the manuscript. We also thank the Broad Institute for the public release of an initial stickleback genome assembly. This research was supported by the Uehara Memorial Foundation ( J. K.), a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and Water and People Project of Research Institute for Humanity and Nature ( S. M.), Akkeshi Town Grants-in-Aid for Scientific Research in the Lake Akkeshi-Bekanbeushi Wetland ( M. K.), a Burroughs Wellcome Fund Career Award in the Biomedical Sciences ( C. L. P.), and National Institutes of Health grants T32 GM07270 ( J. A. R.), R01 GM071854 ( C. L. P.) and P50 HG02568 ( R. M. M., D. M. K. and C. L. P.).	Arnqvist Goran, 2005, pUnpaginated; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; CHARLESWORTH D, 1980, GENET RES, V35, P205, DOI 10.1017/S0016672300014051; Ezaz T, 2006, CURR BIOL, V16, pR736, DOI 10.1016/j.cub.2006.08.021; Foster Susan A., 1994, P381; Gavrilets S, 2004, FITNESS LANDSCAPES O; Higuchi M, 1996, ENVIRON BIOL FISH, V47, P1, DOI 10.1007/BF00002375; Kingsley David M., 2007, P41; Kitano J, 2007, COPEIA, P336, DOI 10.1643/0045-8511(2007)7[336:SDITEM]2.0.CO;2; Kitano J, 2007, BIOL J LINN SOC, V91, P671, DOI 10.1111/j.1095-8312.2007.00824.x; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kyoichi S, 2004, GENETICS, V166, P789, DOI 10.1534/genetics.166.2.789; Lande R, 2001, GENETICA, V112, P435, DOI 10.1023/A:1013379521338; Mank JE, 2006, BIOL J LINN SOC, V87, P83, DOI 10.1111/j.1095-8312.2006.00558.x; Orr HA, 2001, GENETICS, V158, P1089; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Presgraves DC, 2008, TRENDS GENET, V24, P336, DOI 10.1016/j.tig.2008.04.007; Qvarnstrom A, 2009, HEREDITY, V102, P4, DOI 10.1038/hdy.2008.93; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; RICE WR, 1987, GENETICS, V116, P161; RICE WR, 1987, EVOLUTION, V41, P911, DOI 10.1111/j.1558-5646.1987.tb05864.x; Ross JA, 2008, GENETICS, V179, P2173, DOI 10.1534/genetics.108.088559; Ross JA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000391; Seehausen O, 1999, ECOL LETT, V2, P367; Tanaka K, 2007, GENETICS, V177, P2075, DOI 10.1534/genetics.107.075598; Tao Y, 2001, P NATL ACAD SCI USA, V98, P13183, DOI 10.1073/pnas.231478798; van Doorn GS, 2007, NATURE, V449, P909, DOI 10.1038/nature06178; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; van Ooijen JW, 2002, MAPQTL 4 0 SOFTWARE; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL; Wootton R. J., 1984, FUNCTIONAL BIOL STIC; Woram RA, 2003, GENOME RES, V13, P272, DOI 10.1101/gr.578503; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534	35	255	265	6	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1079	1083		10.1038/nature08441	http://dx.doi.org/10.1038/nature08441			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19783981	Green Accepted			2022-12-24	WOS:000270987600035
J	Adameyko, I; Lallemend, F; Aquino, JB; Pereira, JA; Topilko, P; Muller, T; Fritz, N; Beljajeva, A; Mochii, M; Liste, I; Usoskin, D; Suter, U; Birchmeier, C; Ernfors, P				Adameyko, Igor; Lallemend, Francois; Aquino, Jorge B.; Pereira, Jorge A.; Topilko, Piotr; Mueller, Thomas; Fritz, Nicolas; Beljajeva, Anna; Mochii, Makoto; Liste, Isabel; Usoskin, Dmitry; Suter, Ueli; Birchmeier, Carmen; Ernfors, Patrik			Schwann Cell Precursors from Nerve Innervation Are a Cellular Origin of Melanocytes in Skin	CELL			English	Article							NEURAL CREST CELLS; LINEAGE SEGREGATION; GROWTH-FACTOR; MOUSE EMBRYO; GLIAL-CELLS; EXPRESSION; MIGRATION; DIFFERENTIATION; MELANOBLASTS; SYSTEM	Current opinion holds that pigment cells, melanocytes, are derived from neural crest cells produced at the dorsal neural tube and that migrate under the epidermis to populate all parts of the skin. Here, we identify growing nerves projecting throughout the body as a stem/progenitor niche containing Schwann cell precursors (SCPs) from which large numbers of skin melanocytes originate. SCPs arise as a result of lack of neuronal specification by Hmx1 homeobox gene function in the neural crest ventral migratory pathway. Schwann cell and melanocyte development share signaling molecules with both the glial and melanocyte cell fates intimately linked to nerve contact and regulated in an opposing manner by Neuregulin and soluble signals including insulin-like growth factor and platelet-derived growth factor. These results reveal SCPs as a cellular origin of melanocytes, and have broad implications on the molecular mechanisms regulating skin pigmentation during development, in health and pigmentation disorders.	[Adameyko, Igor; Lallemend, Francois; Aquino, Jorge B.; Fritz, Nicolas; Liste, Isabel; Usoskin, Dmitry; Ernfors, Patrik] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Unit, S-17177 Stockholm, Sweden; [Aquino, Jorge B.] Austral Univ, Sch Med, Liver Unit, Buenos Aires, DF, Argentina; [Pereira, Jorge A.; Suter, Ueli] ETH, Dept Biol, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Topilko, Piotr] Ecole Normale Super, Inserm 784, Lab Genet Mol Dev, F-75230 Paris 05, France; [Mueller, Thomas; Birchmeier, Carmen] Max Delbruck Ctr Mol Med, Dept Neurosci, D-13125 Berlin, Germany; [Beljajeva, Anna] Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Mochii, Makoto] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Akoh, Hyogo 6781297, Japan	Karolinska Institutet; Austral University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Karolinska Institutet; University of Hyogo	Ernfors, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Unit, S-17177 Stockholm, Sweden.	patrik.ernfors@ki.se	Fritz, Nicolas/N-1030-2013; Suter, Ueli/A-1624-2010; Fritz, Nicolas/P-1290-2019	Fritz, Nicolas/0000-0002-9722-7425; Fritz, Nicolas/0000-0002-9722-7425; Liste, Isabel/0000-0002-3294-9558; Ernfors, Patrik/0000-0002-1140-3986; Muller, Thomas/0000-0001-8096-1853; Adameyko, Igor/0000-0001-5471-0356; Aquino, Jorge B/0000-0002-3818-5181	Swedish Research Council [K2007-77PK-20285-01-6]; Swedish Foundation for Strategic Research; Linne grants; Swedish Cancer Foundation; Swedish Child Cancer Foundation; Swedish Brain Foundation; Bertil Hallsten Research Foundation; EU [FP7 MOLPARK, Marie Curie MEIF-CT-2006-039237]; ERC [232675]; Knut and Alice Wallenberg Foundation; Swiss National Science Foundation; National Center for Competence in Research Neural Plasticity and Repair	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Linne grants; Swedish Cancer Foundation; Swedish Child Cancer Foundation; Swedish Brain Foundation; Bertil Hallsten Research Foundation; EU(European Commission); ERC(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center for Competence in Research Neural Plasticity and Repair	We thank Michael Wegner, Vince Hearing, and Yoshio Wakamatsu for the generous gifts of antibodies directed against Sox10, Dct and MEBL-1, respectively. This work was supported by the Swedish Research Council, the Swedish Foundation for Strategic Research, Linne grants (CEDB and DBRM grants), the Swedish Cancer Foundation, Swedish Child Cancer Foundation, the Swedish Brain Foundation, Bertil Hallsten Research Foundation, EU FP7 MOLPARK collaborative project, and ERC advanced grant (232675) to P. E., and Knut and Alice Wallenberg Foundation (CLICK Imaging Facility). I. A. was supported by the Swedish Research Council. F. L. was supported by the Swedish Medical Research Council (K2007-77PK-20285-01-6) and the European Union (Marie Curie MEIF-CT-2006-039237). U.S. was supported by the Swiss National Science Foundation and the National Center for Competence in Research Neural Plasticity and Repair.	Aoki Y, 2003, DEV BIOL, V259, P19, DOI 10.1016/S0012-1606(03)00161-1; DORRIS F, 1939, J EXP ZOOL, V86, P315; Dorris F, 1938, ROUX ARCH DEV BIOL, V138, P323, DOI 10.1007/BF00573807; Dorsky RI, 2000, GENE DEV, V14, P158; Dunn KJ, 2000, P NATL ACAD SCI USA, V97, P10050, DOI 10.1073/pnas.97.18.10050; Dupin E, 2003, P NATL ACAD SCI USA, V100, P5229, DOI 10.1073/pnas.0831229100; Dushane GP, 1935, J EXP ZOOL, V72, P1, DOI 10.1002/jez.1400720102; ERICKSON CA, 1993, PIGM CELL RES, V6, P336, DOI 10.1111/j.1600-0749.1993.tb00611.x; Fetsch JF, 2000, AM J SURG PATHOL, V24, P331, DOI 10.1097/00000478-200003000-00001; FOX MH, 1949, PHYSIOL ZOOL, V22, P1; Gambardella L, 2000, MECH DEVELOP, V96, P215, DOI 10.1016/S0925-4773(00)00398-1; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Honore SM, 2003, DEV BIOL, V260, P79, DOI 10.1016/S0012-1606(03)00247-1; HUSZAR D, 1991, DEVELOPMENT, V113, P653; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Jeffery WR, 2004, NATURE, V431, P696, DOI 10.1038/nature02975; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jin EJ, 2001, DEV BIOL, V233, P22, DOI 10.1006/dbio.2001.0222; JOHNSTON MC, 1966, ANAT RECORD, V156, P143, DOI 10.1002/ar.1091560204; Le Douarin N, 1973, Dev Biol, V30, P217, DOI 10.1016/0012-1606(73)90061-4; LEMKE GE, 1984, J NEUROSCI, V4, P75; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Marmigere F, 2006, NAT NEUROSCI, V9, P180, DOI 10.1038/nn1631; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; Meier C, 1999, J NEUROSCI, V19, P3847; MINTZ B, 1967, P NATL ACAD SCI USA, V58, P344, DOI 10.1073/pnas.58.1.344; Montelius A, 2007, DIFFERENTIATION, V75, P404, DOI 10.1111/j.1432-0436.2006.00154.x; Nakagawa S, 1998, DEVELOPMENT, V125, P2963; RAWLES ME, 1947, PHYSIOL ZOOL, V20, P248, DOI 10.1086/physzool.20.3.30151958; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; RIS HANS, 1941, PHYSIOL ZOOL, V14, P48; Rizvi TA, 2002, J NEUROSCI, V22, P9831; SERBEDZIJA GN, 1990, DEVELOPMENT, V108, P605; SERBEDZIJA GN, 1989, DEVELOPMENT, V106, P809; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; STEWART HJS, 1993, EUR J NEUROSCI, V5, P1136, DOI 10.1111/j.1460-9568.1993.tb00968.x; Thomas AJ, 2008, PIGM CELL MELANOMA R, V21, P598, DOI 10.1111/j.1755-148X.2008.00506.x; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Twitty VC, 1936, J EXP ZOOL, V74, P239, DOI 10.1002/jez.1400740206; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Weinreb I, 2007, J CUTAN PATHOL, V34, P52, DOI 10.1111/j.1600-0560.2007.00733.x; WESTON JA, 1963, DEV BIOL, V6, P279, DOI 10.1016/0012-1606(63)90016-2; Wilkie AL, 2002, DEVELOPMENT, V129, P3349; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199	48	349	357	2	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					366	379		10.1016/j.cell.2009.07.049	http://dx.doi.org/10.1016/j.cell.2009.07.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837037	Bronze			2022-12-24	WOS:000270857500019
J	Lamia, KA; Sachdeva, UM; DiTacchio, L; Williams, EC; Alvarez, JG; Egan, DF; Vasquez, DS; Juguilon, H; Panda, S; Shaw, RJ; Thompson, CB; Evans, RM				Lamia, Katja A.; Sachdeva, Uma M.; DiTacchio, Luciano; Williams, Elliot C.; Alvarez, Jacqueline G.; Egan, Daniel F.; Vasquez, Debbie S.; Juguilon, Henry; Panda, Satchidananda; Shaw, Reuben J.; Thompson, Craig B.; Evans, Ronald M.			AMPK Regulates the Circadian Clock by Cryptochrome Phosphorylation and Degradation	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; LIVER; OSCILLATORS; BMAL1; FORM	Circadian clocks coordinate behavioral and physiological processes with daily light-dark cycles by driving rhythmic transcription of thousands of genes. Whereas the master clock in the brain is set by light, pacemakers in peripheral organs, such as the liver, are reset by food availability, although the setting, or "entrainment," mechanisms remain mysterious. Studying mouse fibroblasts, we demonstrated that the nutrient-responsive adenosine monophosphate-activated protein kinase (AMPK) phosphorylates and destabilizes the clock component cryptochrome 1 (CRY1). In mouse livers, AMPK activity and nuclear localization were rhythmic and inversely correlated with CRY1 nuclear protein abundance. Stimulation of AMPK destabilized cryptochromes and altered circadian rhythms, and mice in which the AMPK pathway was genetically disrupted showed alterations in peripheral clocks. Thus, phosphorylation by AMPK enables cryptochrome to transduce nutrient signals to circadian clocks in mammalian peripheral organs.	[Sachdeva, Uma M.; Thompson, Craig B.] Univ Penn, Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Lamia, Katja A.; Williams, Elliot C.; Alvarez, Jacqueline G.; Juguilon, Henry; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [DiTacchio, Luciano; Panda, Satchidananda] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; [Alvarez, Jacqueline G.; Juguilon, Henry; Shaw, Reuben J.; Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Egan, Daniel F.; Vasquez, Debbie S.; Shaw, Reuben J.] Salk Inst Biol Studies, Mol & Cellular Biol Lab, La Jolla, CA 92037 USA	University of Pennsylvania; Pennsylvania Medicine; Salk Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute; Salk Institute	Thompson, CB (corresponding author), Univ Penn, Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	craig@mail.med.upenn.edu; evans@salk.edu	Panda, Satchidananda/J-6891-2012; Evans, Ronald/AAF-4001-2019; DiTacchio, Luciano/D-6341-2011; Williams, Elliot/CAH-1352-2022	Evans, Ronald/0000-0002-9986-5965; DiTacchio, Luciano/0000-0001-9570-7348; Williams, Elliot/0000-0001-7839-3658	NIH [DK057978, DK062434, CA104838, DK080425, EY016807, T32-HL07439-27]; Life Sciences Research Foundation; NATIONAL CANCER INSTITUTE [P01CA104838, P30CA014195] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016807] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434, R01DK080425, R37DK057978] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Sciences Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Asara and the Beth Israel Deaconess Medical Center Mass Spectrometry facility for phosphopeptide detection; A. Sancar for mouse strains; C. Weitz and S. Reppert for clock gene expression plasmids; and M. Downes and R. Yu for critical reading of the manuscript. Supported by NIH grants DK057978 and DK062434 (R. M. E.), CA104838 (C. B. T.), DK080425 (R. J. S.), EY016807 (S. P.), and T32-HL07439-27 (U. M. S.) and by the Pew Charitable Trust (S. P.). K. A. L. is a Merck fellow of the Life Sciences Research Foundation. Several of the authors (K. A. L., U. M. S., L. D., S. P., R. J. S., C. B. T., and R. M. E.) have filed preliminary patent applications related to this work.	Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; DAVIES SP, 1992, EUR J BIOCHEM, V203, P615, DOI 10.1111/j.1432-1033.1992.tb16591.x; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Gatfield D, 2007, SCIENCE, V316, P1135, DOI 10.1126/science.1144165; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Suzuki A, 2007, MOL CELL BIOL, V27, P4317, DOI 10.1128/MCB.02222-06; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Villena JA, 2004, DIABETES, V53, P2242, DOI 10.2337/diabetes.53.9.2242; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Witters LA, 2006, TRENDS BIOCHEM SCI, V31, P13, DOI 10.1016/j.tibs.2005.11.009; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yang X, 2007, COLD SPRING HARB SYM, V72, P387, DOI 10.1101/sqb.2007.72.058; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050	28	589	623	5	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					437	440		10.1126/science.1172156	http://dx.doi.org/10.1126/science.1172156			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19833968	Green Accepted			2022-12-24	WOS:000270818600056
J	Ozsolak, F; Platt, AR; Jones, DR; Reifenberger, JG; Sass, LE; McInerney, P; Thompson, JF; Bowers, J; Jarosz, M; Milos, PM				Ozsolak, Fatih; Platt, Adam R.; Jones, Dan R.; Reifenberger, Jeffrey G.; Sass, Lauryn E.; McInerney, Peter; Thompson, John F.; Bowers, Jayson; Jarosz, Mirna; Milos, Patrice M.			Direct RNA sequencing	NATURE			English	Article							2ND-STRAND CDNA SYNTHESIS; DNA; TRANSCRIPTOME; POLYADENYLATION; EXPRESSION; SNORNA	Our understanding of human biology and disease is ultimately dependent on a complete understanding of the genome and its functions. The recent application of microarray and sequencing technologies to transcriptomics has changed the simplistic view of transcriptomes to a more complicated view of genome-wide transcription where a large fraction of transcripts emanates from unannotated parts of genomes(1-7), and underlined our limited knowledge of the dynamic state of transcription. Most of this broad body of knowledge was obtained indirectly because current transcriptome analysis methods typically require RNA to be converted to complementary DNA ( cDNA) before measurements, even though the cDNA synthesis step introduces multiple biases and artefacts that interfere with both the proper characterization and quantification of transcripts(8-18). Furthermore, cDNA synthesis is not particularly suitable for the analysis of short, degraded and/or small quantity RNA samples. Here we report direct single molecule RNA sequencing without prior conversion of RNA to cDNA. We applied this technology to sequence femtomole quantities of poly(A)(+) Saccharomyces cerevisiae RNA using a surface coated with poly(dT) oligonucleotides to capture the RNAs at their natural poly(A) tails and initiate sequencing by synthesis. We observed transcript 3' end heterogeneity and polyadenylated small nucleolar RNAs. This study provides a path to high-throughput and low-cost direct RNA sequencing and achieving the ultimate goal of a comprehensive and bias-free understanding of transcriptomes.	[Ozsolak, Fatih; Platt, Adam R.; Jones, Dan R.; Reifenberger, Jeffrey G.; Sass, Lauryn E.; McInerney, Peter; Thompson, John F.; Bowers, Jayson; Jarosz, Mirna; Milos, Patrice M.] Helicos BioSci Corp, Cambridge, MA 02139 USA		Ozsolak, F (corresponding author), Helicos BioSci Corp, 1 Kendall Sq, Cambridge, MA 02139 USA.	fatihozsolak@gmail.com; pmilos@helicosbio.com		Thompson, John/0000-0001-8568-3311; Jones, Daniel/0000-0001-8108-0169	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005230] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG005230] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Grzechnik P, 2008, MOL CELL, V32, P247, DOI 10.1016/j.molcel.2008.10.003; GUBLER U, 1987, METHOD ENZYMOL, V152, P330; GUBLER U, 1987, METHOD ENZYMOL, V152, P325; Haddad F, 2006, AM J PHYSIOL-HEART C, V290, pH2351, DOI 10.1152/ajpheart.01111.2005; Haddad F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-21; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; KARKAS JD, 1972, P NATL ACAD SCI USA, V69, P398, DOI 10.1073/pnas.69.2.398; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Lipson D, 2009, NAT BIOTECHNOL, V27, P652, DOI 10.1038/nbt.1551; Mader RM, 2001, J LAB CLIN MED, V137, P422, DOI 10.1067/mlc.2001.115452; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; QianWu J, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-1-r3, 10.1186/gb-2008-9-5-220]; ROBERTS JD, 1989, MOL CELL BIOL, V9, P469, DOI 10.1128/MCB.9.2.469; Roy SW, 2008, BIOESSAYS, V30, P601, DOI 10.1002/bies.20749; Roy SW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-208; RUTTIMANN C, 1985, EUR J BIOCHEM, V149, P41, DOI 10.1111/j.1432-1033.1985.tb08890.x; Slomovic S, 2006, NUCLEIC ACIDS RES, V34, P2966, DOI 10.1093/nar/gkl357; SPIEGELMAN S, 1970, NATURE, V227, P1029, DOI 10.1038/2271029a0; STENESH J, 1968, BIOCHIM BIOPHYS ACTA, V161, P442, DOI 10.1016/0005-2787(68)90121-4; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; VARADARAJ K, 1994, GENE, V140, P1, DOI 10.1016/0378-1119(94)90723-4; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002	30	289	329	9	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					814	U73		10.1038/nature08390	http://dx.doi.org/10.1038/nature08390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19776739				2022-12-24	WOS:000270547500040
J	Nishida, Y; Arakawa, S; Fujitani, K; Yamaguchi, H; Mizuta, T; Kanaseki, T; Komatsu, M; Otsu, K; Tsujimoto, Y; Shimizu, S				Nishida, Yuya; Arakawa, Satoko; Fujitani, Kenji; Yamaguchi, Hirofumi; Mizuta, Takeshi; Kanaseki, Toku; Komatsu, Masaaki; Otsu, Kinya; Tsujimoto, Yoshihide; Shimizu, Shigeomi			Discovery of Atg5/Atg7-independent alternative macroautophagy	NATURE			English	Article							AUTOPHAGOSOME FORMATION; STARVATION; PROTEIN; DEGRADATION; ENDOSOMES; BECLIN-1; DISEASE; LC3	Macroautophagy is a process that leads to the bulk degradation of subcellular constituents by producing autophagosomes/autolysosomes(1-3). It is believed that Atg5 (ref. 4) and Atg7 (ref. 5) are essential genes for mammalian macroautophagy. Here we show, however, that mouse cells lacking Atg5 or Atg7 can still form autophagosomes/autolysosomes and perform autophagy-mediated protein degradation when subjected to certain stressors. Although lipidation of the microtubule-associated protein light chain 3 (LC3, also known as Map1lc3a) to form LC3-II is generally considered to be a good indicator of macroautophagy(6), it did not occur during the Atg5/Atg7-independent alternative process of macroautophagy. We also found that this alternative process of macroautophagy was regulated by several autophagic proteins, including Unc-51-like kinase 1 (Ulk1) and beclin 1. Unlike conventional macroautophagy, autophagosomes seemed to be generated in aRab9-dependent manner by the fusion of isolation membranes with vesicles derived from the trans-Golgi and late endosomes. In vivo, Atg5-independent alternative macroautophagy was detected in several embryonic tissues. It also had a function in clearing mitochondria during erythroid maturation. These results indicate that mammalian macroautophagy can occur through at least two different pathways: an Atg5/Atg7-dependent conventional pathway and an Atg5/Atg7-independent alternative pathway.	[Nishida, Yuya; Arakawa, Satoko; Fujitani, Kenji; Yamaguchi, Hirofumi; Mizuta, Takeshi; Kanaseki, Toku; Shimizu, Shigeomi] Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Cell Biol, Bunkyo Ku, Tokyo 1138510, Japan; [Otsu, Kinya] Osaka Univ, Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Nishida, Yuya; Tsujimoto, Yoshihide] Osaka Univ, Sch Med, Dept Med Genet, Suita, Osaka 5650871, Japan; [Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan	Tokyo Medical & Dental University (TMDU); Osaka University; Osaka University; Tokyo Metropolitan Institute of Medical Science	Shimizu, S (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Cell Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	shimizu.pcb@mri.tmd.ac.jp	Komatsu, Masaaki/B-8321-2011; Yamaguchi, Hirofumi/ABC-4940-2020; Arakawa, Satoko/AAM-9638-2020	Komatsu, Masaaki/0000-0001-7672-7722; Arakawa, Satoko/0000-0002-4375-1643	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Creative Scientific Research; Japanese Ministry of Education, Science, Sports and Culture; Japanese Ministry of Health, Labor and Welfare; Japan Science and Technology Corporation; Uehara Memorial Foundation; Sagawa Foundation for Promotion of Cancer Research; YASUDA Medical Foundation; Astellas foundation for research on metabolic disorders; Foundation for Promotion of Cancer Research	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Creative Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); Uehara Memorial Foundation(Uehara Memorial Foundation); Sagawa Foundation for Promotion of Cancer Research; YASUDA Medical Foundation; Astellas foundation for research on metabolic disorders; Foundation for Promotion of Cancer Research	We thank M. Narita and A. R. J. Young for critical reading of the manuscript; N. Mizushima for providing Atg5<SUP>+/-</SUP> mice and the expression plasmid of GFP-LC3; T. Yoshimori for the human beclin 1 expression plasmid; and T. Kitamura for providing Plat-E cells. This study was supported in part by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), a grant for Creative Scientific Research, a grant for the 21st Century COE Program from the Japanese Ministry of Education, Science, Sports and Culture, a grant for Comprehensive Research on Aging and Health from the Japanese Ministry of Health, Labor and Welfare, and a grant for Solution-Oriented Research for Science and Technology (SORST) from the Japan Science and Technology Corporation. This study was also supported by grants from the Uehara Memorial Foundation, the Sagawa Foundation for Promotion of Cancer Research, the YASUDA Medical Foundation, the Astellas foundation for research on metabolic disorders, and the Foundation for Promotion of Cancer Research.	Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Fader CM, 2006, AUTOPHAGY, V2, P122, DOI 10.4161/auto.2.2.2350; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; Matsui M, 2006, BIOCHEM BIOPH RES CO, V339, P485, DOI 10.1016/j.bbrc.2005.11.044; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; OgierDenis E, 1996, J BIOL CHEM, V271, P28593, DOI 10.1074/jbc.271.45.28593; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Rosenbluth JM, 2009, AUTOPHAGY, V5, P114, DOI 10.4161/auto.5.1.7294; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	28	819	843	4	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					654	U99		10.1038/nature08455	http://dx.doi.org/10.1038/nature08455			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19794493				2022-12-24	WOS:000270302600041
J	Ge, DL; Fellay, J; Thompson, AJ; Simon, JS; Shianna, KV; Urban, TJ; Heinzen, EL; Qiu, P; Bertelsen, AH; Muir, AJ; Sulkowski, M; McHutchison, JG; Goldstein, DB				Ge, Dongliang; Fellay, Jacques; Thompson, Alexander J.; Simon, Jason S.; Shianna, Kevin V.; Urban, Thomas J.; Heinzen, Erin L.; Qiu, Ping; Bertelsen, Arthur H.; Muir, Andrew J.; Sulkowski, Mark; McHutchison, John G.; Goldstein, David B.			Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance	NATURE			English	Article							PEGINTERFERON ALPHA-2B; RIBAVIRIN	Chronic infection with hepatitis C virus (HCV) affects 170 million people worldwide and is the leading cause of cirrhosis in North America(1). Although the recommended treatment for chronic infection involves a 48-week course of peginterferon-alpha-2b (PegIFN-alpha-2b) or-alpha-2a (PegIFN-alpha-2a) combined with ribavirin (RBV), it is well known that many patients will not be cured by treatment, and that patients of European ancestry have a significantly higher probability of being cured than patients of African ancestry. In addition to limited efficacy, treatment is often poorly tolerated because of side effects that prevent some patients from completing therapy. For these reasons, identification of the determinants of response to treatment is a high priority. Here we report that a genetic polymorphism near the IL28B gene, encoding interferon-lambda-3 (IFN-lambda-3), is associated with an approximately twofold change in response to treatment, both among patients of European ancestry (P = 1.06 x 10(-25)) and African-Americans (P = 2.06 x 10(-3)). Because the genotype leading to better response is in substantially greater frequency in European than African populations, this genetic polymorphism also explains approximately half of the difference in response rates between African-Americans and patients of European ancestry.	[Ge, Dongliang; Fellay, Jacques; Shianna, Kevin V.; Urban, Thomas J.; Heinzen, Erin L.; Goldstein, David B.] Duke Univ, Ctr Human Genome Variat, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Thompson, Alexander J.; Muir, Andrew J.; McHutchison, John G.] Duke Univ, Duke Clin Res Inst, Durham, NC 27705 USA; [Thompson, Alexander J.; Muir, Andrew J.; McHutchison, John G.] Duke Univ, Div Gastroenterol, Sch Med, Durham, NC 27705 USA; [Simon, Jason S.; Qiu, Ping; Bertelsen, Arthur H.] Schering Plough Res Inst, Kenilworth, NJ 07033 USA; [Sulkowski, Mark] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Duke University; Duke University; Duke University; Merck & Company; Schering-Plough Research Institute; Johns Hopkins University	Goldstein, DB (corresponding author), Duke Univ, Ctr Human Genome Variat, Inst Genome Sci & Policy, Durham, NC 27708 USA.	d.goldstein@duke.edu	Goldstein, David/AAY-8125-2020; Ge, Dongliang/A-2073-2010; Fellay, Jacques/A-6681-2009	Fellay, Jacques/0000-0002-8240-939X; Ge, David/0000-0002-9732-8170	National Health and Medical Research Council of Australia; Gastroenterological Society of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Gastroenterological Society of Australia	We are indebted to the IDEAL principal investigators, the study coordinators, nurses and patients involved in the study. We also recognize E. Gustafson, P. Savino, D. Devlin, S. Noviello, M. Geffner, J. Albrecht and A. C. Need for their contributions to the study. This study was funded by Schering-Plough Research Institute, Kenilworth, New Jersey. A. J. T. received funding support from the National Health and Medical Research Council of Australia and the Gastroenterological Society of Australia.	BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Liu CH, 2008, CLIN INFECT DIS, V47, P1260, DOI 10.1086/592579; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Muir AJ, 2004, NEW ENGL J MED, V350, P2265, DOI 10.1056/NEJMoa032502; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shiffman ML, 2004, GASTROENTEROLOGY, V126, P1015, DOI 10.1053/j.gastro.2004.01.014; SHIFFMAN ML, 2009, J HEPATOL S1, V50; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; *WHO, 2009, HEP; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Yan KK, 2008, WORLD J GASTROENTERO, V14, P3416, DOI 10.3748/wjg.14.3416	19	2822	3005	0	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					399	401		10.1038/nature08309	http://dx.doi.org/10.1038/nature08309			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19684573				2022-12-24	WOS:000269828100040
J	Lauchle, JO; Kim, D; Le, DT; Akagi, K; Crone, M; Krisman, K; Warner, K; Bonifas, JM; Li, Q; Coakley, KM; Diaz-Flores, E; Gorman, M; Przybranowski, S; Tran, M; Kogan, SC; Roose, JP; Copeland, NG; Jenkins, NA; Parada, L; Wolff, L; Sebolt-Leopold, J; Shannon, K				Lauchle, Jennifer O.; Kim, Doris; Le, Doan T.; Akagi, Keiko; Crone, Michael; Krisman, Kimberly; Warner, Kegan; Bonifas, Jeannette M.; Li, Qing; Coakley, Kristen M.; Diaz-Flores, Ernesto; Gorman, Matthew; Przybranowski, Sally; Tran, Mary; Kogan, Scott C.; Roose, Jeroen P.; Copeland, Neal G.; Jenkins, Nancy A.; Parada, Luis; Wolff, Linda; Sebolt-Leopold, Judith; Shannon, Kevin			Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MALIGNANT MYELOID DISORDERS; BCR-ABL; HEMATOPOIETIC-CELLS; KINASE INHIBITORS; TYROSINE KINASE; BLAST CRISIS; BONE-MARROW; CHILDREN; PATHWAY	The cascade comprising Raf, mitogen-activated protein kinase kinase (MEK) and extracellular signal-regulated kinase (ERK) is a therapeutic target in human cancers with deregulated Ras signalling, which includes tumours that have inactivated the Nf1 tumour suppressor(1,2). Nf1 encodes neurofibromin, a GTPase-activating protein that terminates Ras signalling by stimulating hydrolysis of Ras-GTP. We compared the effects of inhibitors of MEK in a myeloproliferative disorder (MPD) initiated by inactivating Nf1 in mouse bone marrow and in acute myeloid leukaemias (AMLs) in which cooperating mutations were induced by retroviral insertional mutagenesis. Here we show that MEK inhibitors are ineffective in MPD, but induce objective regression of many Nf1-deficient AMLs. Drug resistance developed because of outgrowth of AML clones that were present before treatment. We cloned clone-specific retroviral integrations to identify candidate resistance genes including Rasgrp1, Rasgrp4 and Mapk14, which encodes p38 alpha. Functional analysis implicated increased RasGRP1 levels and reduced p38 kinase activity in resistance to MEK inhibitors. This approach represents a robust strategy for identifying genes and pathways that modulate how primary cancer cells respond to targeted therapeutics and for probing mechanisms of de novo and acquired resistance.	[Lauchle, Jennifer O.; Kim, Doris; Le, Doan T.; Crone, Michael; Krisman, Kimberly; Warner, Kegan; Bonifas, Jeannette M.; Diaz-Flores, Ernesto; Gorman, Matthew; Tran, Mary; Shannon, Kevin] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Li, Qing] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Coakley, Kristen M.; Roose, Jeroen P.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Kogan, Scott C.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Akagi, Keiko] NCI, Mouse Canc Genet Program, Frederick, MD 21702 USA; [Przybranowski, Sally; Sebolt-Leopold, Judith] Pfizer Global Res & Dev, Ann Arbor, MI 48105 USA; [Copeland, Neal G.; Jenkins, Nancy A.] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Parada, Luis] Univ Texas SW, Dallas, TX 75235 USA; [Wolff, Linda] NCI, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pfizer; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Shannon, K (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	shannonk@peds.ucsf.edu		Kogan, Scott/0000-0002-2395-8479; Roose, Jeroen/0000-0003-4746-2811	National Institutes of Health [U01 CA84221, R37 CA72614, T32 CA09043, T32 HD044331, K08 CA119105]; Leukemia and Lymphoma Society [LLS 7019-04]; US Army Neurofibromatosis Research Program [DAMD 17-02-1-0638]; Ronald McDonald House Charities of Southern California/Couples Against Leukemia; Jeffrey and Karen Peterson Family Foundation; Frank A. Campini Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD044331] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA072614, K08CA119105, U01CA084221, T32CA128583, T32CA009043] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); US Army Neurofibromatosis Research Program; Ronald McDonald House Charities of Southern California/Couples Against Leukemia; Jeffrey and Karen Peterson Family Foundation; Frank A. Campini Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to B. Braun, J. Downing, S. Lowe and C. Sawyers for discussion and advice throughout the project. We are thankful for C. Hartzell for studies on RasGRP protein expression. This work was supported by National Institutes of Health grants U01 CA84221, R37 CA72614, T32 CA09043, T32 HD044331 and K08 CA119105, by a Specialized Center of Research award from the Leukemia and Lymphoma Society (LLS 7019-04), by the US Army Neurofibromatosis Research Program (Project DAMD 17-02-1-0638), by the Ronald McDonald House Charities of Southern California/Couples Against Leukemia, by the Jeffrey and Karen Peterson Family Foundation and by the Frank A. Campini Foundation. S. C. K. is a Scholar of the Leukemia and Lymphoma Society of America. J. P. R. is a Kimmel Foundation Scholar. The Intramural Research Program of the National Cancer Institute's Center for Cancer Research supports research in the laboratory of L. W. at the National Institutes of Health.	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bollag G, 1996, NAT GENET, V12, P144, DOI 10.1038/ng0296-144; Brown AP, 2007, CANCER CHEMOTH PHARM, V59, P671, DOI 10.1007/s00280-006-0323-5; Choi S, 2007, BLOOD, V110, P632, DOI 10.1182/blood-2007-01-067785; Curtiss NP, 2005, GENOMICS, V85, P600, DOI 10.1016/j.ygeno.2005.01.013; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Lauchle JO, 2006, PEDIATR BLOOD CANCER, V46, P579, DOI 10.1002/pbc.20644; Le DT, 2004, BLOOD, V103, P4243, DOI 10.1182/blood-2003-08-2650; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Parmar S, 2004, J BIOL CHEM, V279, P25345, DOI 10.1074/jbc.M400590200; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; SHANNON KM, 1994, NEW ENGL J MED, V330, P597, DOI 10.1056/NEJM199403033300903; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Side L, 1997, NEW ENGL J MED, V336, P1713, DOI 10.1056/NEJM199706123362404; Stone JC, 2006, BIOCHEM SOC T, V34, P858, DOI 10.1042/BST0340858; Van Etten RA, 2004, CANCER CELL, V6, P547, DOI 10.1016/j.ccr.2004.12.004; Wolff L, 2003, J VIROL, V77, P4965, DOI 10.1128/JVI.77.8.4965-4971.2003	25	105	106	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					411	U110		10.1038/nature08279	http://dx.doi.org/10.1038/nature08279			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19727076	Green Accepted			2022-12-24	WOS:000269828100043
J	Guerrier, S; Coutinho-Budd, J; Sassa, T; Gresset, A; Jordan, NV; Chen, K; Jin, WL; Frost, A; Polleux, F				Guerrier, Sabrice; Coutinho-Budd, Jaeda; Sassa, Takayuki; Gresset, Aurelie; Jordan, Nicole Vincent; Chen, Keng; Jin, Wei-Lin; Frost, Adam; Polleux, Franck			The F-BAR Domain of srGAP2 Induces Membrane Protrusions Required for Neuronal Migration and Morphogenesis	CELL			English	Article							GTPASE-ACTIVATING PROTEINS; RHO-GTPASES; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; PYRAMIDAL NEURONS; STRUCTURAL BASIS; CELL-MIGRATION; FILOPODIA; IRSP53; FAMILY	During brain development, proper neuronal migration and morphogenesis is critical for the establishment of functional neural circuits. Here we report that srGAP2 negatively regulates neuronal migration and induces neurite outgrowth and branching through the ability of its F-BAR domain to induce filopodia-like membrane protrusions resembling those induced by I-BAR domains in vivo and in vitro. Previous work has suggested that in nonneuronal cells filopodia dynamics decrease the rate of cell migration and the persistence of leading edge protrusions. srGAP2 knockdown reduces leading process branching and increases the rate of neuronal migration in vivo. Overexpression of srGAP2 or its F-BAR domain has the opposite effects, increasing leading process branching and decreasing migration. These results suggest that F-BAR domains are functionally diverse and highlight the functional importance of proteins directly regulating membrane deformation for proper neuronal migration and morphogenesis.	[Guerrier, Sabrice; Gresset, Aurelie; Jordan, Nicole Vincent; Polleux, Franck] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Guerrier, Sabrice; Sassa, Takayuki; Polleux, Franck] Univ N Carolina, Neurosci Res Ctr, Chapel Hill, NC 27599 USA; [Coutinho-Budd, Jaeda] Univ N Carolina, Neurobiol Curriculum, Chapel Hill, NC 27599 USA; [Chen, Keng; Jin, Wei-Lin] Shanghai Jiao Tong Univ, Inst Neurosci, Shanghai 200240, Peoples R China; [Frost, Adam] Yale Univ, Dept Mol Biophys & Biochem, Interdept Neurosci Program, New Haven, CT 06510 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Shanghai Jiao Tong University; Yale University	Polleux, F (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA.	polleux@med.unc.edu	SASSA, Takayuki/B-2519-2012; , UNC Neuroscience Microscopy Core/AAE-8305-2022; Jin, Wei-Lin/A-8355-2013; Polleux, Franck/H-9948-2014	SASSA, Takayuki/0000-0003-3145-9829; Jin, Wei-Lin/0000-0001-8011-2405; Frost, Adam/0000-0003-2231-2577; Polleux, Franck/0000-0003-4313-0481	Epilepsy Foundation; National Institutes of Health (NIH) Medical Scientist Training Program [TG 5T32GM07205]; NIH Predoctoral Fellowship [5F31NS052969-03]; North Carolina Developmental Biology Training [T32 HD046369]; National Institute of Neurological Disorders and Stroke Institutional Center; Neuroscience Research [P30 NS45892-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD046369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, R01NS067557, F31NS052969] Funding Source: NIH RePORTER	Epilepsy Foundation; National Institutes of Health (NIH) Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina Developmental Biology Training; National Institute of Neurological Disorders and Stroke Institutional Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Neuroscience Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Predoctoral Research Training Fellowship from the Epilepsy Foundation (A. F.) and a National Institutes of Health (NIH) Medical Scientist Training Program award (TG 5T32GM07205 to A. F.), an NIH Predoctoral Fellowship (5F31NS052969-03 to S. G.), University of North Carolina Developmental Biology Training Grant (T32 HD046369 to J. C. B.), a Pew Scholar Award in Biomedical Sciences (F. P.), and the National Institute of Neurological Disorders and Stroke Institutional Center Core Grant to Support Neuroscience Research (P30 NS45892-01).	Aspenstrom P, 2006, TRENDS BIOCHEM SCI, V31, P670, DOI 10.1016/j.tibs.2006.10.001; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bacon C, 2009, J COMP NEUROL, V513, P224, DOI 10.1002/cne.21955; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Burnette DT, 2007, NAT CELL BIOL, V9, P1360, DOI 10.1038/ncb1655; Causeret F, 2009, CEREB CORTEX, V19, P861, DOI 10.1093/cercor/bhn133; Chitu V, 2005, MOL BIOL CELL, V16, P2947, DOI 10.1091/mbc.e04-10-0914; de Rouvroit CL, 2001, MECH DEVELOP, V105, P47, DOI 10.1016/S0925-4773(01)00396-3; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Eberth A, 2009, BIOCHEM J, V417, P371, DOI 10.1042/BJ20081535; Endris V, 2002, P NATL ACAD SCI USA, V99, P11754, DOI 10.1073/pnas.162241099; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; Goh KL, 2002, CURR BIOL, V12, P565, DOI 10.1016/S0960-9822(02)00725-X; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Gupta A, 2003, NAT NEUROSCI, V6, P1284, DOI 10.1038/nn1151; GUPTON SL, 2007, SCI STKE, pRE5, DOI DOI 10.1126/STKE.4002007RE5; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Konno D, 2005, J BIOL CHEM, V280, P5082, DOI 10.1074/jbc.M408251200; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Li XF, 2006, J BIOL CHEM, V281, P28430, DOI 10.1074/jbc.M604135200; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Linkermann A, 2009, BBA-PROTEINS PROTEOM, V1794, P168, DOI 10.1016/j.bbapap.2008.10.013; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Mattar P, 2004, DEV BIOL, V273, P373, DOI 10.1016/j.ydbio.2004.06.013; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Millard TH, 2007, J CELL SCI, V120, P1663, DOI 10.1242/jcs.001776; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; POLLEUX F, 2002, SCI STKE, pPL9; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saarikangas J, 2008, J CELL SCI, V121, P1444, DOI 10.1242/jcs.027466; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; She BR, 2002, EXP CELL RES, V273, P34, DOI 10.1006/excr.2001.5435; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Shutes A, 2006, METHOD ENZYMOL, V407, P9, DOI 10.1016/S0076-6879(05)07002-3; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Suetsugu S, 2006, J BIOL CHEM, V281, P35347, DOI 10.1074/jbc.M606814200; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Yao Q, 2008, CELL MOL NEUROBIOL, V28, P205, DOI 10.1007/s10571-007-9187-4; Yohe ME, 2007, J BIOL CHEM, V282, P13813, DOI 10.1074/jbc.M700185200; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005	67	230	239	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					990	1004		10.1016/j.cell.2009.06.047	http://dx.doi.org/10.1016/j.cell.2009.06.047			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737524	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000269564600023
J	Hui, EF; Johnson, CP; Yao, J; Dunning, FM; Chapman, ER				Hui, Enfu; Johnson, Colin P.; Yao, Jun; Dunning, F. Mark; Chapman, Edwin R.			Synaptotagmin-Mediated Bending of the Target Membrane Is a Critical Step in Ca2+-Regulated Fusion	CELL			English	Article							NEUROTRANSMITTER RELEASE; BAR DOMAIN; C2B DOMAIN; PENETRATION ACTIVITY; SNARE COMPLEX; CA2+; SIMULATION; BINDING; PORE; PHOSPHOLIPIDS	Decades ago it was proposed that exocytosis involves invagination of the target membrane, resulting in a highly localized site of contact between the bilayers destined to fuse. The vesicle protein synaptotagmin-I (syt) bends membranes in response to Ca2+, but whether this drives localized invagination of the target membrane to accelerate fusion has not been determined. Previous studies relied on reconstituted vesicles that were already highly curved and used mutations in syt that were not selective for membrane-bending activity. Here, we directly address this question by utilizing vesicles with different degrees of curvature. A tubulation-defective syt mutant was able to promote fusion between highly curved SNARE-bearing liposomes but exhibited a marked loss of activity when the membranes were relatively flat. Moreover, bending of flat membranes by adding an N-BAR domain rescued the function of the tubulation-deficient syt mutant. Hence, syt-mediated membrane bending is a critical step in membrane fusion.	[Hui, Enfu; Johnson, Colin P.; Yao, Jun; Dunning, F. Mark; Chapman, Edwin R.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Hui, Enfu; Johnson, Colin P.; Yao, Jun; Dunning, F. Mark; Chapman, Edwin R.] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; [Hui, Enfu; Chapman, Edwin R.] Univ Wisconsin, Biophys Training Program, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1300 Univ Ave,SMI 129, Madison, WI 53706 USA.	chapman@physiology.wisc.edu	Hui, Enfu/C-2806-2012	Yao, Jun/0000-0002-4916-3412; Chapman, Edwin/0000-0001-9787-8140; Johnson, Colin/0000-0002-6783-2835	US Institutes of Health [MH 61876]; American Heart Association [0440168N]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER	US Institutes of Health; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J.D. Gaffaney and Z. Wang for providing materials and technical suggestions for experiments in Figure 3, R. Massey and M. Stowell for assistance and suggestions regarding tubulation assays, and D. McCaslin for ITC training. We also thank M. Jackson, J. Audhya, J. Weisshaar, and members of the Chapman lab for helpful discussions and critical comments. This study was supported by grants from the US Institutes of Health (MH 61876) and the American Heart Association (0440168N) to E. R. C. E. H. was supported by an American Heart Association predoctoral fellowship. E.R.C. is an Investigator of the Howard Hughes Medical Institute.	Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Ayton GS, 2007, BIOPHYS J, V92, P3595, DOI 10.1529/biophysj.106.101709; Bai JH, 2002, P NATL ACAD SCI USA, V99, P1665, DOI 10.1073/pnas.032541099; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Bhalla A, 2005, MOL BIOL CELL, V16, P4755, DOI 10.1091/mbc.E05-04-0277; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Casal E, 2006, BIOCHEMISTRY-US, V45, P12917, DOI 10.1021/bi060717k; Chanturiya A, 2002, BIOPHYS J, V82, P3072, DOI 10.1016/S0006-3495(02)75648-8; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Craxton M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-43; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Gaffaney JD, 2008, J BIOL CHEM, V283, P31763, DOI 10.1074/jbc.M803355200; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; HEIMBURG T, 1994, BIOCHEMISTRY-US, V33, P9477, DOI 10.1021/bi00198a013; Kozlov MM, 2002, TRAFFIC, V3, P256, DOI 10.1034/j.1600-0854.2002.030403.x; LIU YC, 1991, NEURON, V6, P411, DOI 10.1016/0896-6273(91)90249-Y; Lynch KL, 2008, MOL BIOL CELL, V19, P5093, DOI 10.1091/mbc.E08-03-0235; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Mahal LK, 2002, J CELL BIOL, V158, P273, DOI 10.1083/jcb.200203135; Marrink SJ, 2003, J AM CHEM SOC, V125, P15233, DOI 10.1021/ja0352092; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; MONCK JR, 1994, NEURON, V12, P707, DOI 10.1016/0896-6273(94)90325-5; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Steenbergen R, 2006, BBA-MOL CELL BIOL L, V1761, P313, DOI 10.1016/j.bbalip.2006.03.005; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wu Y, 2003, P NATL ACAD SCI USA, V100, P2082, DOI 10.1073/pnas.0435872100	37	209	210	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 21	2009	138	4					709	721		10.1016/j.cell.2009.05.049	http://dx.doi.org/10.1016/j.cell.2009.05.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703397	Bronze, Green Accepted			2022-12-24	WOS:000269156100013
J	Roy, R; Kozlov, AG; Lohman, TM; Ha, T				Roy, Rahul; Kozlov, Alexander G.; Lohman, Timothy M.; Ha, Taekjip			SSB protein diffusion on single-stranded DNA stimulates RecA filament formation	NATURE			English	Article							ESCHERICHIA-COLI; BINDING-PROTEIN; HOMOLOGOUS RECOMBINATION; GENETIC-RECOMBINATION; MOLECULE FRET; COMPLEXES; REPAIR; MECHANISM; SSDNA; MODES	Single-stranded DNA generated in the cell during DNA metabolism is stabilized and protected by binding of ssDNA-binding (SSB) proteins. Escherichia coli SSB, a representative homotetrameric SSB, binds to ssDNA by wrapping the DNA using its four subunits. However, such a tightly wrapped, high-affinity protein-DNA complex still needs to be removed or repositioned quickly for unhindered action of other proteins. Here we show, using single-molecule two- and three-colour fluorescence resonance energy transfer, that tetrameric SSB can spontaneously migrate along ssDNA. Diffusional migration of SSB helps in the local displacement of SSB by an elongating RecA filament. SSB diffusion also melts short DNA hairpins transiently and stimulates RecA filament elongation on DNA with secondary structure. This observation of diffusional movement of a protein on ssDNA introduces a new model for how an SSB protein can be redistributed, while remaining tightly bound to ssDNA during recombination and repair processes.	[Roy, Rahul; Ha, Taekjip] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Roy, Rahul; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Roy, Rahul; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Kozlov, Alexander G.; Lohman, Timothy M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Washington University (WUSTL); Howard Hughes Medical Institute	Ha, T (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.	tjha@illinois.edu	Ha, Taekjip/B-9506-2009; Roy, Rahul/Y-5878-2019; Roy, Rahul/D-5329-2009	Ha, Taekjip/0000-0003-2195-6258; Roy, Rahul/0000-0003-3329-8803; Roy, Rahul/0000-0003-3329-8803	National Institutes of Health; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367, R01GM030498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Joo, S. A. McKinney, I. Rasnik, S. Hohng and S. Myong for experimental help and discussion; C. Murphy, M. Nahas and K. Raghunathan for discussion; T. Ho and A. Niedziela- Majka for help with DNA and protein preparation, respectively; and R. Porter for the SSB expression plasmid. T. H. is an employee of the Howard Hughes Medical Institute. These studies were supported by grants from the National Institutes of Health and the National Science Foundation.	Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; BUJALOWSKI W, 1987, J MOL BIOL, V195, P897, DOI 10.1016/0022-2836(87)90493-1; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; CLENDENNING JB, 1994, BIOPHYS CHEM, V52, P227, DOI 10.1016/0301-4622(94)00036-J; Eggington JM, 2006, BIOCHEMISTRY-US, V45, P14490, DOI 10.1021/bi061178m; ENNIS DG, 1987, GENETICS, V115, P11; GLASSBERG J, 1979, J BACTERIOL, V140, P14, DOI 10.1128/JB.140.1.14-19.1979; GLIKIN GC, 1983, NATURE, V303, P770, DOI 10.1038/303770a0; GOLUB EI, 1983, P NATL ACAD SCI-BIOL, V80, P1401, DOI 10.1073/pnas.80.5.1401; GRIFFITH JD, 1984, COLD SPRING HARB SYM, V49, P553, DOI 10.1101/SQB.1984.049.01.062; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Hohng S, 2004, BIOPHYS J, V87, P1328, DOI 10.1529/biophysj.104.043935; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P11611, DOI 10.1021/bi020361m; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Kuznetsov SV, 2006, J MOL BIOL, V359, P55, DOI 10.1016/j.jmb.2006.02.070; Lecointe F, 2007, EMBO J, V26, P4239, DOI 10.1038/sj.emboj.7601848; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; MUNIYAPPA K, 1984, P NATL ACAD SCI-BIOL, V81, P2757, DOI 10.1073/pnas.81.9.2757; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; ROMER R, 1984, BIOCHEMISTRY-US, V23, P6132; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Sun WL, 1998, J MOL BIOL, V276, P689, DOI 10.1006/jmbi.1997.1471; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875	41	200	202	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1092	1097		10.1038/nature08442	http://dx.doi.org/10.1038/nature08442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19820696	Green Accepted			2022-12-24	WOS:000270987600037
J	Sereno, PC; Tan, L; Brusatte, SL; Kriegstein, HJ; Zhao, XJ; Cloward, K				Sereno, Paul C.; Tan, Lin; Brusatte, Stephen L.; Kriegstein, Henry J.; Zhao, Xijin; Cloward, Karen			Tyrannosaurid Skeletal Design First Evolved at Small Body Size	SCIENCE			English	Article							THEROPOD DINOSAURS; CRANIAL ANATOMY; NORTH-AMERICA; MECHANICS; POSITION; ENGLAND; LENGTH; CHINA	Nearly all of the large-bodied predators (>2.5 tons) on northern continents during the Late Cretaceous were tyrannosaurid dinosaurs. We show that their most conspicuous functional specializations-a proportionately large skull, incisiform premaxillary teeth, expanded jaw-closing musculature, diminutive forelimbs, and hindlimbs with cursorial proportions-were present in a new, small-bodied, basal tyrannosauroid from Lower Cretaceous rocks in northeastern China. These specializations, which were later scaled up in Late Cretaceous tyrannosaurids with body masses approaching 100 times greater, drove the most dominant radiation of macropredators of the Mesozoic.	[Sereno, Paul C.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Tan, Lin] Bur Land & Resources, Long Hao Inst Geol & Paleontol, Hohhot 010010, Peoples R China; [Brusatte, Stephen L.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Zhao, Xijin] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [Cloward, Karen] Western Paleontol Labs, Lehi, UT 84043 USA	University of Chicago; American Museum of Natural History (AMNH); Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Sereno, PC (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	dinosaur@uchicago.edu	Brusatte, Stephen/O-9663-2014	Brusatte, Stephen/0000-0001-7525-7319	Whitten-Newman Foundation; National Geographic Society	Whitten-Newman Foundation; National Geographic Society(National Geographic Society)	For final drafts of all figures, we thank C. Abraczinskas. For preparation of fossil material, we thank personnel of the Western Paleontological Laboratories and the Fossil Lab at the University of Chicago. For assistance with computed tomography imaging, we thank C. Straus and C. Wietholt; for preparation of paleohistologic sections, we thank E. Lamm and D. Varricchio. For examination of fossil material in their care, we thank X. Xu, M. Norell, and S. Hutt. Supported by the Whitten-Newman Foundation and the National Geographic Society (to P. C. S.). This is Publication 3 of the Chinese-American Dinosaur Expeditions.	Benson RBJ, 2008, J VERTEBR PALEONTOL, V28, P732, DOI 10.1671/0272-4634(2008)28[732:NIOSAT]2.0.CO;2; Brochu C., 2002, J VERTEBRATE PALEO S, V7, P1, DOI DOI 10.1671/0272-4634(2002)022[0001:ARAOPA]2.0.CO;2; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Franzosa J.W., 2004, THESIS U TEXAS AUSTI; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; Hopson J.A., 1979, P39; Hurum JH, 2003, ACTA PALAEONTOL POL, V48, P161; Hutt S, 2001, CRETACEOUS RES, V22, P227, DOI 10.1006/cres.2001.0252; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; Li DQ, 2010, P ROY SOC B-BIOL SCI, V277, P183, DOI 10.1098/rspb.2009.0249; Matthew WD, 1923, AM MUS NOVIT, V89, P1, DOI [10.5281/zenodo.4715537, DOI 10.5281/ZENODO.4715537]; Middleton KM, 2000, ZOOL J LINN SOC-LOND, V128, P149; Rauhut O, 2008, J VERTEBR PALEONTOL, V28, p130A; Rauhut OWM, 2003, PALAEONTOLOGY, V46, P903, DOI 10.1111/1475-4983.00325; Rayfield EJ, 2005, ZOOL J LINN SOC-LOND, V144, P309, DOI 10.1111/j.1096-3642.2005.00176.x; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; SERENO PC, 2005, PHYLOINFORMATICS, V8, P1, DOI DOI 10.5281/ZENODO.59797; Smith A. G., 1994, ATLAS MESOZOIC CENOZ, P1; Snively E, 2006, ACTA PALAEONTOL POL, V51, P435; Stokstad E, 2004, SCIENCE, V306, P211; Therrien F, 2007, J VERTEBR PALEONTOL, V27, P108, DOI 10.1671/0272-4634(2007)27[108:MTIBTY]2.0.CO;2; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855; Zelenitsky DK, 2009, P ROY SOC B-BIOL SCI, V276, P667, DOI 10.1098/rspb.2008.1075	27	70	76	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					418	422		10.1126/science.1177428	http://dx.doi.org/10.1126/science.1177428			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19762599				2022-12-24	WOS:000270818600051
J	Machacek, M; Hodgson, L; Welch, C; Elliott, H; Pertz, O; Nalbant, P; Abell, A; Johnson, GL; Hahn, KM; Danuser, G				Machacek, Matthias; Hodgson, Louis; Welch, Christopher; Elliott, Hunter; Pertz, Olivier; Nalbant, Perihan; Abell, Amy; Johnson, Gary L.; Hahn, Klaus M.; Danuser, Gaudenz			Coordination of Rho GTPase activities during cell protrusion	NATURE			English	Article							MIGRATING CELLS; LIVING CELLS; RAC; ACTIVATION; DYNAMICS; ACTIN; MEMBRANE; ADHESION; POLARITY	The GTPases Rac1, RhoA and Cdc42 act together to control cytoskeleton dynamics(1-3). Recent biosensor studies have shown that all three GTPases are activated at the front of migrating cells(4-7), and biochemical evidence suggests that they may regulate one another: Cdc42 can activate Rac1 (ref. 8), and Rac1 and RhoA are mutually inhibitory(9-12). However, their spatiotemporal coordination, at the seconds and single-micrometre dimensions typical of individual protrusion events, remains unknown. Here we examine GTPase coordination in mouse embryonic fibroblasts both through simultaneous visualization of two GTPase biosensors and using a 'computational multiplexing' approach capable of defining the relationships between multiple protein activities visualized in separate experiments. We found that RhoA is activated at the cell edge synchronous with edge advancement, whereas Cdc42 and Rac1 are activated 2 mm behind the edge with a delay of 40s. This indicates that Rac1 and RhoA operate antagonistically through spatial separation and precise timing, and that RhoA has a role in the initial events of protrusion, whereas Rac1 and Cdc42 activate pathways implicated in reinforcement and stabilization of newly expanded protrusions.	[Hodgson, Louis; Welch, Christopher; Abell, Amy; Johnson, Gary L.; Hahn, Klaus M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Hodgson, Louis; Welch, Christopher; Abell, Amy; Johnson, Gary L.; Hahn, Klaus M.] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA; [Hodgson, Louis; Welch, Christopher; Abell, Amy; Johnson, Gary L.; Hahn, Klaus M.] Univ N Carolina, Dept Med Chem, Chapel Hill, NC 27599 USA; [Machacek, Matthias; Elliott, Hunter; Pertz, Olivier; Danuser, Gaudenz] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Nalbant, Perihan] Univ Duisburg Essen, Ctr Med Biotechnol, Dept Mol Cell Biol, D-45117 Essen, Germany	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Scripps Research Institute; University of Duisburg Essen	Hahn, KM (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	khahn@med.unc.edu; gdanuser@scripps.edu		pertz, olivier/0000-0001-8579-4919; Hodgson, Louis/0000-0001-9188-7580; Danuser, Gaudenz/0000-0001-8583-2014; Hahn, Klaus/0000-0002-1970-7562	Swiss National Science Foundation; Novartis Foundation; Ciba-Geigy Jubilee Foundation; NIGMS [U54 GM064346];  [NIH T32 GM008719];  [NIH F30 HL094020];  [NIH R01 GM57464];  [NIH R01 GM71868]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL094020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030324, R01GM057464, T32GM008719, U54GM064346, R01GM071868] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); Ciba-Geigy Jubilee Foundation; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge funding from the Swiss National Science Foundation and the Novartis Foundation, formerly the Ciba-Geigy Jubilee Foundation (M. M.), NIH T32 GM008719 and NIH F30 HL094020 (C. W.), NIH R01 GM57464 (K. M. H.), NIH R01 GM71868 (G. D.), and the Cell Migration Consortium, grant U54 GM064346 from NIGMS (G. D. and K. M. H.).	Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Hodgson L, 2006, METHOD ENZYMOL, V406, P140, DOI 10.1016/S0076-6879(06)06012-5; HODGSON L, CURR PROTOC IN PRESS; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Marguet D, 2006, EMBO J, V25, P3446, DOI 10.1038/sj.emboj.7601204; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792	28	653	663	4	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					99	103		10.1038/nature08242	http://dx.doi.org/10.1038/nature08242			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19693013	Green Accepted, Green Submitted			2022-12-24	WOS:000269478800038
J	Wang, JW; Czech, B; Weigel, D				Wang, Jia-Wei; Czech, Benjamin; Weigel, Detlef			miR156-Regulated SPL Transcription Factors Define an Endogenous Flowering Pathway in Arabidopsis thaliana	CELL			English	Article							FLORAL MERISTEM IDENTITY; MADS DOMAIN PROTEIN; BOX GENE SPL3; LOCUS-T; DNA-BINDING; TIME GENES; SBP-DOMAIN; INTEGRATOR FT; LEAFY; SIGNALS	The FT gene integrates several external and endogenous cues controlling flowering, including information on day length. A complex of the mobile FT protein and the bZIP transcription factor FD in turn has a central role in activating genes that execute the switch from vegetative to reproductive development. Here we reveal that microRNA156-targeted SQUAMOSA PROMOTER BINDING PROTEIN-LIKE (SPL) genes not only act downstream of FT/FD, but also define a separate endogenous flowering pathway. High levels of miR156 in young plants prevent precocious flowering. A subsequent day length-independent decline in miR156 abundance provides a permissive environment for flowering and is paralleled by a rise in SPL levels. At the shoot apex, FT/FD and SPLs converge on an overlapping set of targets, with SPLs directly activating flower-promoting MADS box genes, providing a molecular substrate for both the redundant activities and the feed-forward action of the miR156/SPL and FT/FD modules in flowering control.	[Wang, Jia-Wei; Czech, Benjamin; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	Max Planck Society	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	weigel@weigelworld.org	Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022; Czech, Benjamin/AAJ-8592-2020; Weigel, Detlef/AAR-3312-2021	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Czech, Benjamin/0000-0001-8471-0007; Wang, Jia-Wei/0000-0003-3885-6296	EMBO Long-Term Fellowship [ALTF 274-2006]; European Community FP6 IP SIROCCO [LSHG-CT-2006-037900];  [DFG-SFB 446 grant]	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); European Community FP6 IP SIROCCO(European Commission); 	We thank the European Arabidopsis Stock Centre for seeds; Eunyoung Chae, Yasushi Kobayashi, Francois Parcy, Patrice Salome, Markus Schmid, the members of Weigelworld Team MiRNA, and Gang Wu and Scott Poethig for discussion; and Ayako Yamaguchi and Doris Wagner for the exchange of unpublished information. This work was supported by an EMBO Long-Term Fellowship to J.-W.W. (ALTF 274-2006), by a DFG-SFB 446 grant, and by European Community FP6 IP SIROCCO (contract LSHG-CT-2006-037900).	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Birkenbihl RP, 2005, J MOL BIOL, V352, P585, DOI 10.1016/j.jmb.2005.07.013; Blazquez MA, 1998, PLANT CELL, V10, P791, DOI 10.1105/tpc.10.5.791; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Borner R, 2000, PLANT J, V24, P591, DOI 10.1046/j.1365-313x.2000.00906.x; BOWMAN JL, 1993, DEVELOPMENT, V119, P721; Cardon G, 1999, GENE, V237, P91, DOI 10.1016/S0378-1119(99)00308-X; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Eriksson S, 2006, PLANT CELL, V18, P2172, DOI 10.1105/tpc.106.042317; Ferrandiz C, 2000, SCIENCE, V289, P436, DOI 10.1126/science.289.5478.436; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Hempel FD, 1997, DEVELOPMENT, V124, P3845; Hepworth SR, 2002, EMBO J, V21, P4327, DOI 10.1093/emboj/cdf432; Hisamatsu T, 2008, J EXP BOT, V59, P3821, DOI 10.1093/jxb/ern232; HUALA E, 1992, PLANT CELL, V4, P901, DOI 10.1105/tpc.4.8.901; Izawa T, 2007, J EXP BOT, V58, P3091, DOI 10.1093/jxb/erm159; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/s004380050046; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Kropat J, 2005, P NATL ACAD SCI USA, V102, P18730, DOI 10.1073/pnas.0507693102; LANGRIDGE J, 1957, NATURE, V180, P36, DOI 10.1038/180036a0; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lee J, 2008, PLANT J, V55, P832, DOI 10.1111/j.1365-313X.2008.03552.x; Li CX, 2008, PLANT J, V55, P543, DOI 10.1111/j.1365-313X.2008.03526.x; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Liang XW, 2008, BIOCHEMISTRY-US, V47, P3645, DOI 10.1021/bi701431y; Liljegren SJ, 1999, PLANT CELL, V11, P1007, DOI 10.1105/tpc.11.6.1007; Liu C, 2008, DEVELOPMENT, V135, P1481, DOI 10.1242/dev.020255; Liu C, 2007, DEVELOPMENT, V134, P1901, DOI 10.1242/dev.003103; LLOYD AM, 1994, SCIENCE, V266, P436, DOI 10.1126/science.7939683; Lohmann JU, 2002, DEV CELL, V2, P135, DOI 10.1016/S1534-5807(02)00122-3; Long J, 2000, DEV BIOL, V218, P341, DOI 10.1006/dbio.1999.9572; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Melzer S, 2008, NAT GENET, V40, P1489, DOI 10.1038/ng.253; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2005, PLANT PHYSIOL, V137, P149, DOI 10.1104/pp.104.052811; Michaels SD, 2003, PLANT J, V33, P867, DOI 10.1046/j.1365-313X.2003.01671.x; Moss EG, 2007, CURR BIOL, V17, pR425, DOI 10.1016/j.cub.2007.03.043; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; Parcy F, 2002, DEVELOPMENT, V129, P2519; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Ratcliffe OJ, 1999, DEVELOPMENT, V126, P1109; Reeves PH, 2001, PLANT PHYSIOL, V126, P1085, DOI 10.1104/pp.126.3.1085; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; RuizGarcia L, 1997, PLANT CELL, V9, P1921, DOI 10.1105/tpc.9.11.1921; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; SCHULTZ EA, 1991, PLANT CELL, V3, P771, DOI 10.1105/tpc.3.8.771; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Shimada S, 2009, PLANT J, V58, P668, DOI 10.1111/j.1365-313X.2009.03806.x; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Teper-Bamnolker P, 2005, PLANT CELL, V17, P2661, DOI 10.1105/tpc.105.035766; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Yamaguchi A, 2005, PLANT CELL PHYSIOL, V46, P1175, DOI 10.1093/pcp/pci151; Yang ZF, 2008, GENE, V407, P1, DOI 10.1016/j.gene.2007.02.034; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Yu H, 2002, P NATL ACAD SCI USA, V99, P16336, DOI 10.1073/pnas.212624599	80	937	1037	30	353	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					738	749		10.1016/j.cell.2009.06.014	http://dx.doi.org/10.1016/j.cell.2009.06.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703399	Bronze			2022-12-24	WOS:000269156100015
J	Itoh, Y; Shinya, K; Kiso, M; Watanabe, T; Sakoda, Y; Hatta, M; Muramoto, Y; Tamura, D; Sakai-Tagawa, Y; Noda, T; Sakabe, S; Imai, M; Hatta, Y; Watanabe, S; Li, CJ; Yamada, S; Fujii, K; Murakami, S; Imai, H; Kakugawa, S; Ito, M; Takano, R; Iwatsuki-Horimoto, K; Shimojima, M; Horimoto, T; Goto, H; Takahashi, K; Makino, A; Ishigaki, H; Nakayama, M; Okamatsu, M; Takahashi, K; Warshauer, D; Shult, PA; Saito, R; Suzuki, H; Furuta, Y; Yamashita, M; Mitamura, K; Nakano, K; Nakamura, M; Brockman-Schneider, R; Mitamura, H; Yamazaki, M; Sugaya, N; Suresh, M; Ozawa, M; Neumann, G; Gern, J; Kida, H; Ogasawara, K; Kawaoka, Y				Itoh, Yasushi; Shinya, Kyoko; Kiso, Maki; Watanabe, Tokiko; Sakoda, Yoshihiro; Hatta, Masato; Muramoto, Yukiko; Tamura, Daisuke; Sakai-Tagawa, Yuko; Noda, Takeshi; Sakabe, Saori; Imai, Masaki; Hatta, Yasuko; Watanabe, Shinji; Li, Chengjun; Yamada, Shinya; Fujii, Ken; Murakami, Shin; Imai, Hirotaka; Kakugawa, Satoshi; Ito, Mutsumi; Takano, Ryo; Iwatsuki-Horimoto, Kiyoko; Shimojima, Masayuki; Horimoto, Taisuke; Goto, Hideo; Takahashi, Kei; Makino, Akiko; Ishigaki, Hirohito; Nakayama, Misako; Okamatsu, Masatoshi; Takahashi, Kazuo; Warshauer, David; Shult, Peter A.; Saito, Reiko; Suzuki, Hiroshi; Furuta, Yousuke; Yamashita, Makoto; Mitamura, Keiko; Nakano, Kunio; Nakamura, Morio; Brockman-Schneider, Rebecca; Mitamura, Hiroshi; Yamazaki, Masahiko; Sugaya, Norio; Suresh, M.; Ozawa, Makoto; Neumann, Gabriele; Gern, James; Kida, Hiroshi; Ogasawara, Kazumasa; Kawaoka, Yoshihiro			In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses	NATURE			English	Article							RESISTANT INFLUENZA; A VIRUSES; CELLS; INFECTION; TRANSMISSION; MODEL	Influenza A viruses cause recurrent outbreaks at local or global scale with potentially severe consequences for human health and the global economy. Recently, a new strain of influenza A virus was detected that causes disease in and transmits among humans, probably owing to little or no pre-existing immunity to the new strain. On 11 June 2009 the World Health Organization declared that the infections caused by the new strain had reached pandemic proportion. Characterized as an influenza A virus of the H1N1 subtype, the genomic segments of the new strain were most closely related to swine viruses(1). Most human infections with swine-origin H1N1 influenza viruses (S-OIVs) seem to be mild; however, a substantial number of hospitalized individuals do not have underlying health issues, attesting to the pathogenic potential of S-OIVs. To achieve a better assessment of the risk posed by the new virus, we characterized one of the first US S-OIV isolates, A/California/04/09 ( H1N1; hereafter referred to as CA04), as well as several other S-OIV isolates, in vitro and in vivo. In mice and ferrets, CA04 and other S- OIV isolates tested replicate more efficiently than a currently circulating human H1N1 virus. In addition, CA04 replicates efficiently in non-human primates, causes more severe pathological lesions in the lungs of infected mice, ferrets and non-human primates than a currently circulating human H1N1 virus, and transmits among ferrets. In specific-pathogen-free miniature pigs, CA04 replicates without clinical symptoms. The assessment of human sera from different age groups suggests that infection with human H1N1 viruses antigenically closely related to viruses circulating in 1918 confers neutralizing antibody activity to CA04. Finally, we show that CA04 is sensitive to approved and experimental antiviral drugs, suggesting that these compounds could function as a first line of defence against the recently declared S- OIV pandemic.	[Itoh, Yasushi; Makino, Akiko; Kawaoka, Yoshihiro] Kobe Univ, Dept Microbiol & Infect Dis, Kobe, Hyogo 6500017, Japan; [Itoh, Yasushi; Ishigaki, Hirohito; Nakayama, Misako; Ogasawara, Kazumasa] Shiga Univ Med Sci, Dept Pathol, Shiga 5202192, Japan; [Kiso, Maki; Tamura, Daisuke; Sakai-Tagawa, Yuko; Sakabe, Saori; Yamada, Shinya; Murakami, Shin; Imai, Hirotaka; Kakugawa, Satoshi; Ito, Mutsumi; Takano, Ryo; Iwatsuki-Horimoto, Kiyoko; Shimojima, Masayuki; Horimoto, Taisuke; Goto, Hideo; Takahashi, Kei; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan; [Watanabe, Tokiko; Hatta, Masato; Imai, Masaki; Hatta, Yasuko; Watanabe, Shinji; Li, Chengjun; Suresh, M.; Ozawa, Makoto; Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53711 USA; [Sakoda, Yoshihiro; Okamatsu, Masatoshi; Kida, Hiroshi] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Sapporo, Hokkaido 0600818, Japan; [Muramoto, Yukiko; Fujii, Ken; Kawaoka, Yoshihiro] ERATO Infect Induced Host Responses Project, Kawaguchi, Saitama 3320012, Japan; [Noda, Takeshi; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens, Tokyo 1088639, Japan; [Takahashi, Kazuo] Osaka Prefectural Inst Publ Hlth, Dept Infect Dis, Osaka 5370025, Japan; [Warshauer, David; Shult, Peter A.] Wisconsin State Lab Hyg, Madison, WI 53706 USA; [Saito, Reiko; Suzuki, Hiroshi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Publ Hlth, Niigata 9518510, Japan; [Furuta, Yousuke] Toyama Chem Co Ltd, Toyama 9308508, Japan; [Yamashita, Makoto] Daiichi Sankyo Co Ltd, Tokyo 1408710, Japan; [Mitamura, Keiko; Nakano, Kunio; Nakamura, Morio] Eiju Gen Hosp, Tokyo 1108654, Japan; [Brockman-Schneider, Rebecca; Gern, James] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53792 USA; [Mitamura, Hiroshi] Mitamura Clin, Dept Internal Med, Shizuoka 4130103, Japan; [Yamazaki, Masahiko] Childrens Clin, Dept Pediat, Kanagawa 2280023, Japan; [Sugaya, Norio] Keiyu Hosp, Kanagawa 2200012, Japan; [Kawaoka, Yoshihiro] Hokkaido Univ, Creat Res Initiat, Sapporo, Hokkaido 0600818, Japan	Kobe University; Shiga University of Medical Science; University of Tokyo; University of Wisconsin System; University of Wisconsin Madison; Hokkaido University; Japan Science & Technology Agency (JST); University of Tokyo; Osaka Prefectural Institute of Public Health; Niigata University; Daiichi Sankyo Company Limited; University of Wisconsin System; University of Wisconsin Madison; Hokkaido University	Kawaoka, Y (corresponding author), Kobe Univ, Dept Microbiol & Infect Dis, Kobe, Hyogo 6500017, Japan.	kawaokay@svm.vetmed.wisc.edu	Kida, Hiroshi/F-7244-2012; Li, Chengjun/GWM-7661-2022; Ishigaki, Hirohito/AAO-7458-2020; Ozawa, Makoto/AFM-4137-2022; Okamatsu, Masatoshi/F-9124-2012; Sakoda, Yoshihiro/A-5183-2012	Ishigaki, Hirohito/0000-0002-5249-8598; Ozawa, Makoto/0000-0002-7731-5321; Nakayama, Misako/0000-0001-8611-0662; Itoh, Yasushi/0000-0001-7462-2193; Suresh, Marulasiddappa/0000-0003-1794-3358	Centers for Disease Control (CDC) [A/California/04/09, A/Netherlands/603/09]; National Institute of Allergy and Infectious Diseases Public Health Service; NIAID [HHSN266200700010C]; Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health and by ERATO ( Japan Science and Technology Agency); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069274, U19AI070503] Funding Source: NIH RePORTER	Centers for Disease Control (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Allergy and Infectious Diseases Public Health Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)United States Public Health Service); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and by ERATO ( Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Centers for Disease Control (CDC) for A/California/04/09 virus and R. Fouchier for A/Netherlands/603/09 virus. We thank K. Wells for editing the manuscript, and M. McGregor, R. Moritz, A. Hanson, H. Ishida, H. Tsuchiya, R. Torii, N. Yamamoto, K. Soda, N. Nomura and H. Yoshida for technical assistance. We also thank T. Umemura, Y. Sunden and T. Tanaka for pathological analyses of virus-infected pigs. This work was supported by National Institute of Allergy and Infectious Diseases Public Health Service research grants, by an NIAID-funded Center for Research on Influenza Pathogenesis ( CRIP, HHSN266200700010C), by Grant- in-Aid for Specially Promoted Research, by a contract research fund for the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology, and by grants-in-aid from the Ministry of Health and by ERATO ( Japan Science and Technology Agency).	Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayden FG, 2000, NEW ENGL J MED, V343, P1282, DOI 10.1056/NEJM200011023431801; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; KAWAOKA Y, 1988, P NATL ACAD SCI USA, V85, P324, DOI 10.1073/pnas.85.2.324; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; Neumann G, 2005, J VIROL, V79, P10300, DOI 10.1128/JVI.79.16.10300-10307.2005; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691; Yamashita M, 2009, ANTIMICROB AGENTS CH, V53, P186, DOI 10.1128/AAC.00333-08	21	856	902	1	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 20	2009	460	7258					1021	U110		10.1038/nature08260	http://dx.doi.org/10.1038/nature08260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484YC	19672242	Green Accepted, Bronze			2022-12-24	WOS:000269085500036
J	Chaudhry, A; Rudra, D; Treuting, P; Samstein, RM; Liang, YQ; Kas, A; Rudensky, AY				Chaudhry, Ashutosh; Rudra, Dipayan; Treuting, Piper; Samstein, Robert M.; Liang, Yuqiong; Kas, Arnold; Rudensky, Alexander Y.			CD4(+) Regulatory T Cells Control T(H)17 Responses in a Stat3-Dependent Manner	SCIENCE			English	Article							ROR-GAMMA; TGF-BETA; DIFFERENTIATION; INFLAMMATION; IL-23; FOXP3; HOMEOSTASIS; INDUCTION; PATHWAYS; PROGRAMS	Distinct classes of protective immunity are guided by activation of STAT transcription factor family members in response to environmental cues. CD4(+) regulatory T cells (T-regs) suppress excessive immune responses, and their deficiency results in a lethal, multi-organ autoimmune syndrome characterized by T helper 1 (T(H)1) and T helper 2 (T(H)2) CD4(+) T cell-dominated lesions. Here we show that pathogenic T(H)17 responses in mice are also restrained by T-regs. This suppression was lost upon T-reg-specific ablation of Stat3, a transcription factor critical for T(H)17 differentiation, and resulted in the development of a fatal intestinal inflammation. These findings suggest that T-regs adapt to their environment by engaging distinct effector response-specific suppression modalities upon activation of STAT proteins that direct the corresponding class of the immune response.	[Chaudhry, Ashutosh; Rudra, Dipayan; Samstein, Robert M.; Liang, Yuqiong; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Chaudhry, Ashutosh; Rudra, Dipayan; Samstein, Robert M.; Liang, Yuqiong; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Chaudhry, Ashutosh; Rudra, Dipayan; Kas, Arnold; Rudensky, Alexander Y.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Treuting, Piper] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.	rudenska@mskcc.org	Rudra, Dipayan/AAZ-5426-2020; Treuting, Piper M./AAB-2721-2019; Rudra, Dipayan/B-6660-2012	Rudra, Dipayan/0000-0002-9667-5891; Treuting, Piper M./0000-0002-1812-1519; Chaudhry, Ashutosh/0000-0003-3379-5236; Samstein, Robert/0000-0001-6860-2401	NIH [AI-061816, AI-034206]; Cancer Research Institute; Arthritis Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034206, R29AI034206, R01AI061816, R37AI034206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Arthritis Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Forbush, T. Chu, L. Karpik, and A. Bravo for assistance with the mouse colony management; S. Akira for Stat3fl/fl mice; and J. Renauld for antibody to IL-22. This work was supported by NIH grants AI-061816 and AI-034206. A. C. is supported by the Cancer Research Institute, and D. R. is supported by the Arthritis Foundation. A. Y. R. is an investigator with the Howard Hughes Medical Institute. Gene expression microarray data have been deposited in the NCBI Gene Expression Omnibus repository with the accession code GSE17962.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Maloy KJ, 2008, MUCOSAL IMMUNOL, V1, P339, DOI 10.1038/mi.2008.28; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Yadav M, 2008, J IMMUNOL, V180, P2772, DOI 10.4049/jimmunol.180.5.2772; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	26	732	759	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 13	2009	326	5955					986	991		10.1126/science.1172702	http://dx.doi.org/10.1126/science.1172702			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19797626	Green Accepted			2022-12-24	WOS:000271712300038
J	Ishikawa, H; Ma, Z; Barber, GN				Ishikawa, Hiroki; Ma, Zhe; Barber, Glen N.			STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity	NATURE			English	Article							HEPATITIS-C VIRUS; RIG-I; ADAPTER PROTEIN; CYTOPLASMIC DNA; CYTOSOLIC DNA; KAPPA-B; RECOGNITION; RNA; INFLAMMASOME; ACTIVATION	The innate immune system is critical for the early detection of invading pathogens and for initiating cellular host defence countermeasures, which include the production of type I interferon (IFN) 1-3. However, little is known about how the innate immune system is galvanized to respond to DNA-based microbes. Here we show that STING (stimulator of interferon genes) is critical for the induction of IFN by non-CpG intracellular DNA species produced by various DNA pathogens after infection(4). Murine embryonic fibroblasts, as well as antigen presenting cells such as macrophages and dendritic cells (exposed to intracellular B-form DNA, the DNA virus herpes simplex virus 1 (HSV-1) or bacteria Listeria monocytogenes), were found to require STING to initiate effective IFN production. Accordingly, Sting-knockout mice were susceptible to lethal infection after exposure to HSV-1. The importance of STING in facilitating DNA-mediated innate immune responses was further evident because cytotoxic T-cell responses induced by plasmid DNA vaccination were reduced in Sting-deficient animals. In the presence of intracellular DNA, STING relocalized with TANK-binding kinase 1 (TBK1) from the endoplasmic reticulum to perinuclear vesicles containing the exocystcomponent Sec5 (also known as EXOC2). Collectively, our studies indicate that STING is essential for host defence against DNA pathogens such as HSV-1 and facilitates the adjuvant activity of DNA-based vaccines.	[Barber, Glen N.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami; University of Miami	Barber, GN (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.	gbarber@med.miami.edu	Li, Chia Cheng/D-9906-2015; Ma, Zhe/N-9467-2017	Ma, Zhe/0000-0002-7222-2556	NIH [AI079336]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079336, R56AI079336] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Yewdell for VV-OVA, B. Jacobs for VVDE3L, K. Frueh for HCMV, M. Kobayashi for baculovirus, H. Horiuchi for the Sec5 antibody, Y. C. Weh for Tbk1-knockout MEFs, and S. Nagata, T. Maniatis, J. Hiscott and N. Reich for plasmid constructs. This work was supported by NIH grant AI079336.	ABLASSER A, 2009, NATURE          0716, DOI DOI 10.1038/NI.1779; Bauer S, 2008, IMMUNOBIOLOGY, V213, P315, DOI 10.1016/j.imbio.2007.10.010; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Mavinakere MS, 2006, J VIROL, V80, P6771, DOI 10.1128/JVI.00492-06; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Spiczka KS, 2008, J CELL SCI, V121, P2880, DOI 10.1242/jcs.031641; Spies B, 2003, J IMMUNOL, V171, P5908, DOI 10.4049/jimmunol.171.11.5908; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	30	1575	1651	14	278	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					788	U40		10.1038/nature08476	http://dx.doi.org/10.1038/nature08476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19776740	Green Accepted			2022-12-24	WOS:000270547500035
J	de Boer, M; van Deurzen, CHM; van Dijck, JAAM; Borm, GF; van Diest, PJ; Adang, EMM; Nortier, JWR; Rutgers, EJT; Seynaeve, C; Menke-Pluymers, MBE; Bult, P; Tjan-Heijnen, VCG				de Boer, Maaike; van Deurzen, Carolien H. M.; van Dijck, Jos A. A. M.; Borm, George F.; van Diest, Paul J.; Adang, Eddy M. M.; Nortier, Johan W. R.; Rutgers, Emiel J. T.; Seynaeve, Caroline; Menke-Pluymers, Marian B. E.; Bult, Peter; Tjan-Heijnen, Vivianne C. G.			Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	31st San Antonio Breast Cancer Symposium	DEC 10-14, 2008	San Antonio, TX				LYMPH-NODE MICROMETASTASES; PROGNOSTIC-SIGNIFICANCE; GUIDELINE TREATMENT; METASTASES; SURVIVAL; BIOPSY; NUMBER; WOMEN	Background The association of isolated tumor cells and micrometastases in regional lymph nodes with the clinical outcome of breast cancer is unclear. Methods We identified all patients in the Netherlands who underwent a sentinel-node biopsy for breast cancer before 2006 and had breast cancer with favorable primary-tumor characteristics and isolated tumor cells or micrometastases in the regional lymph nodes. Patients with node-negative disease were randomly selected from the years 2000 and 2001. The primary end point was disease-free survival. Results We identified 856 patients with node-negative disease who had not received systemic adjuvant therapy ( the node-negative, no-adjuvant-therapy cohort), 856 patients with isolated tumor cells or micrometastases who had not received systemic adjuvant therapy ( the node-positive, no-adjuvant-therapy cohort), and 995 patients with isolated tumor cells or micrometastases who had received such treatment ( the node-positive, adjuvant-therapy cohort). The median follow-up was 5.1 years. The adjusted hazard ratio for disease events among patients with isolated tumor cells who did not receive systemic therapy, as compared with women with node-negative disease, was 1.50 (95% confidence interval [CI], 1.15 to 1.94); among patients with micrometastases, the adjusted hazard ratio was 1.56 ( 95% CI, 1.15 to 2.13). Among patients with isolated tumor cells or micrometastases, the adjusted hazard ratio was 0.57 ( 95% CI, 0.45 to 0.73) in the node-positive, adjuvant-therapy cohort, as compared with the node-positive, no-adjuvant-therapy cohort. Conclusions Isolated tumor cells or micrometastases in regional lymph nodes were associated with a reduced 5-year rate of disease-free survival among women with favorable early-stage breast cancer who did not receive adjuvant therapy. In patients with isolated tumor cells or micrometastases who received adjuvant therapy, disease-free survival was improved.	[Tjan-Heijnen, Vivianne C. G.] Maastricht Univ, Med Ctr, Dept Internal Med, Div Med Oncol, NL-6202 AZ Maastricht, Netherlands; [de Boer, Maaike; van Dijck, Jos A. A. M.] Radboud Univ Nijmegen, Med Ctr, Comprehens Canc Ctr E, NL-6525 ED Nijmegen, Netherlands; [van Dijck, Jos A. A. M.; Borm, George F.; Adang, Eddy M. M.] Radboud Univ Nijmegen, Med Ctr, Div Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands; [Bult, Peter] Radboud Univ Nijmegen, Med Ctr, Div Pathol, NL-6525 ED Nijmegen, Netherlands; [van Deurzen, Carolien H. M.; van Diest, Paul J.] Univ Med Ctr Utrecht, Div Pathol, Utrecht, Netherlands; [Nortier, Johan W. R.] Leiden Univ, Med Ctr, Div Med Oncol, Leiden, Netherlands; [Rutgers, Emiel J. T.] Netherlands Canc Inst, Div Surg, Amsterdam, Netherlands; [Seynaeve, Caroline] Dr Daniel Den Hoed Canc Ctr, Erasmus Med Ctr, Div Med Oncol, NL-3008 AE Rotterdam, Netherlands; [Menke-Pluymers, Marian B. E.] Dr Daniel Den Hoed Canc Ctr, Erasmus Med Ctr, Div Surg, NL-3008 AE Rotterdam, Netherlands	Maastricht University; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Tjan-Heijnen, VCG (corresponding author), Maastricht Univ, Med Ctr, Dept Internal Med, Div Med Oncol, POB 5800, NL-6202 AZ Maastricht, Netherlands.	vcg.tjan.heijnen@mumc.nl	Bult, Peter/L-4236-2015; Rutgers, Emiel J T/C-5934-2015; Adang, E.M.M./L-4169-2015; van Dijck, Jos/A-1676-2016	Bult, Peter/0000-0001-6427-9889; 				Bleiweiss IJ, 2006, J CLIN ONCOL, V24, P2013, DOI 10.1200/JCO.2005.04.7076; Bolster MJ, 2006, ANN SURG ONCOL, V13, P1466, DOI 10.1245/s10434-006-9084-y; Chen SL, 2007, ANN SURG ONCOL, V14, P3378, DOI 10.1245/s10434-007-9513-6; Colleoni M, 2005, J CLIN ONCOL, V23, P1379, DOI 10.1200/JCO.2005.07.094; Cote RJ, 1999, LANCET, V354, P896, DOI 10.1016/S0140-6736(98)11104-2; Cox CE, 2008, J AM COLL SURGEONS, V206, P261, DOI 10.1016/j.jamcollsurg.2007.08.024; Cserni G, 2003, EUR J CANCER, V39, P1654, DOI 10.1016/S0959-8049(03)00203-X; Cummings MC, 2002, AM J SURG PATHOL, V26, P1286, DOI 10.1097/00000478-200210000-00005; DEMASCAREL I, 1992, BRIT J CANCER, V66, P523, DOI 10.1038/bjc.1992.306; *DUTCH I HEALTHC I, 2002, TREATM BREAST CANC G; Ernst-Kruis M R, 2003, Ned Tijdschr Geneeskd, V147, P1126; Fan YG, 2005, ANN SURG ONCOL, V12, P705, DOI 10.1245/ASO.2005.08.020; FISHER B, 1983, CANCER-AM CANCER SOC, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3; Gobardhan PD, 2009, ANN ONCOL, V20, P41, DOI 10.1093/annonc/mdn535; Grabau D, 2007, APMIS, V115, P828, DOI 10.1111/j.1600-0463.2007.apm_442.x; GREEN EL, 2002, AJCC CANC STAGING MA; Kuijt GP, 2005, EJSO, V31, P500, DOI 10.1016/j.ejso.2005.01.001; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Maibenco DC, 2006, CANCER, V107, P1234, DOI 10.1002/cncr.22112; Millis RR, 2002, BRIT J CANCER, V86, P396, DOI 10.1038/sj.bjc.6600070; Rutgers E J Th, 2002, Ned Tijdschr Geneeskd, V146, P2144; SAS Institute, 1999, SAS STAT US GUID VER; Sobin, 2009, UICC TNM CLASSIFICAT; Struikmans H, 2008, Ned Tijdschr Geneeskd, V152, P2507; Tan LK, 2008, J CLIN ONCOL, V26, P1803, DOI 10.1200/JCO.2007.12.6425; Truong PT, 2008, EUR J CANCER, V44, P1670, DOI 10.1016/j.ejca.2008.05.011; van der Heiden-vander Loo M, 2006, EJSO-EUR J SURG ONC, V32, P710, DOI 10.1016/j.ejso.2006.04.001; van Deurzen CHM, 2009, AM J SURG PATHOL, V33, P106, DOI 10.1097/PAS.0b013e31817eec40	28	372	375	1	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2009	361	7					653	663		10.1056/NEJMoa0904832	http://dx.doi.org/10.1056/NEJMoa0904832			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	482JX	19675329	Green Published			2022-12-24	WOS:000268884100005
J	Zhao, Y; Sfeir, AJ; Zou, Y; Buseman, CM; Chow, TT; Shay, JW; Wright, WE				Zhao, Yong; Sfeir, Agnel J.; Zou, Ying; Buseman, Christen M.; Chow, Tracy T.; Shay, Jerry W.; Wright, Woodring E.			Telomere Extension Occurs at Most Chromosome Ends and Is Uncoupled from Fill-In in Human Cancer Cells	CELL			English	Article							DNA-POLYMERASE-ALPHA; MAMMALIAN TELOMERES; LENGTH REGULATION; C-STRAND; G TAILS; REPLICATION; CYCLE; MECHANISM; FIBROBLASTS; MAINTENANCE	Telomeres are thought to be maintained by the preferential recruitment of telomerase to the shortest telomeres. The extension of the G-rich telomeric strand by telomerase is also believed to be coordinated with the complementary synthesis of the C strand by the conventional replication machinery. However, we show that under telomere length-maintenance conditions in cancer cells, human telomerase extends most chromosome ends during each S phase and is not preferentially recruited to the shortest telomeres. Telomerase rapidly extends the G-rich strand following telomere replication but fill-in of the C strand is delayed into late S phase. This late C-strand fill-in is not executed by conventional Okazaki fragment synthesis but by a mechanism using a series of small incremental steps. These findings highlight differences between telomerase actions during steady state versus nonequilibrium conditions and reveal steps in the human telomere maintenance pathway that may provide additional targets for the development of anti-telomerase therapeutics.	[Zhao, Yong; Sfeir, Agnel J.; Zou, Ying; Buseman, Christen M.; Chow, Tracy T.; Shay, Jerry W.; Wright, Woodring E.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Wright, WE (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	woodring.wright@utsouthwestern.edu	Shay, Jerry W/F-7878-2011	Zou, Ying/0000-0003-2787-1917; Zhao, Yong/0000-0001-5068-2212	National Institutes of Health [AG01228, P50 CA70907, CA12729701]; American Federation for Aging Research [NNJ05HD36G]; Department of Defense Breast Cancer Program; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG001228, R37AG001228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging Research; Department of Defense Breast Cancer Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants AG01228, P50 CA70907, and CA12729701 from the National Institutes of Health, NASA NNJ05HD36G, fellowship support from the American Federation for Aging Research ( AFAR) to Y.Z., and the Department of Defense Breast Cancer Program to C. B. and T. C. We thank Angela Diehl for help in preparing Figure 1.	Adams AK, 1996, MOL CELL BIOL, V16, P4614; Bailey SM, 2004, CYTOGENET GENOME RES, V107, P14, DOI 10.1159/000079565; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Bryan TM, 1998, EXP CELL RES, V239, P370, DOI 10.1006/excr.1997.3907; Chai WH, 2006, MOL CELL, V21, P427, DOI 10.1016/j.molcel.2005.12.004; Chakhparonian M, 2003, TRENDS GENET, V19, P439, DOI 10.1016/S0168-9525(03)00135-5; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Dionne I, 1998, NUCLEIC ACIDS RES, V26, P5365, DOI 10.1093/nar/26.23.5365; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Herbert BS, 2005, ONCOGENE, V24, P5262, DOI 10.1038/sj.onc.1208760; Jady BE, 2006, MOL BIOL CELL, V17, P944, DOI 10.1091/mbc.E05-09-0904; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Marcand S, 1999, EMBO J, V18, P3509, DOI 10.1093/emboj/18.12.3509; Martin AD, 2000, MOL CELL BIOL, V20, P786, DOI 10.1128/MCB.20.3.786-796.2000; MCCARROLL RM, 1988, CELL, V54, P505, DOI 10.1016/0092-8674(88)90072-4; Nakamura M, 2005, MOL CELL BIOL, V25, P11073, DOI 10.1128/MCB.25.24.11073-11088.2005; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Price CM, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1216; PRICE CM, 1994, J EUKARYOT MICROBIOL, V41, P267, DOI 10.1111/j.1550-7408.1994.tb01507.x; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Sfeir AJ, 2005, MOL CELL, V18, P131, DOI 10.1016/j.molcel.2005.02.035; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Steinert S, 2000, BIOCHEM BIOPH RES CO, V273, P1095, DOI 10.1006/bbrc.2000.3080; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; TENHAGEN KG, 1990, MOL CELL BIOL, V10, P6348, DOI 10.1128/MCB.10.12.6348; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Wright WE, 1999, EXP CELL RES, V251, P492, DOI 10.1006/excr.1999.4602; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; Zhao Y, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1063; Zhu LX, 1998, P NATL ACAD SCI USA, V95, P8648, DOI 10.1073/pnas.95.15.8648; Zou Y, 2004, P NATL ACAD SCI USA, V101, P12928, DOI 10.1073/pnas.0404106101	45	165	174	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 7	2009	138	3					463	475		10.1016/j.cell.2009.05.026	http://dx.doi.org/10.1016/j.cell.2009.05.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480XZ	19665970	Bronze, Green Accepted			2022-12-24	WOS:000268771900012
J	Conrad, DF; Pinto, D; Redon, R; Feuk, L; Gokcumen, O; Zhang, YJ; Aerts, J; Andrews, TD; Barnes, C; Campbell, P; Fitzgerald, T; Hu, M; Ihm, CH; Kristiansson, K; MacArthur, DG; MacDonald, JR; Onyiah, I; Pang, AWC; Robson, S; Stirrups, K; Valsesia, A; Walter, K; Wei, J; Tyler-Smith, C; Carter, NP; Lee, C; Scherer, SW; Hurles, ME				Conrad, Donald F.; Pinto, Dalila; Redon, Richard; Feuk, Lars; Gokcumen, Omer; Zhang, Yujun; Aerts, Jan; Andrews, T. Daniel; Barnes, Chris; Campbell, Peter; Fitzgerald, Tomas; Hu, Min; Ihm, Chun Hwa; Kristiansson, Kati; MacArthur, Daniel G.; MacDonald, Jeffrey R.; Onyiah, Ifejinelo; Pang, Andy Wing Chun; Robson, Sam; Stirrups, Kathy; Valsesia, Armand; Walter, Klaudia; Wei, John; Tyler-Smith, Chris; Carter, Nigel P.; Lee, Charles; Scherer, Stephen W.; Hurles, Matthew E.		Wellcome Trust Case Control	Origins and functional impact of copy number variation in the human genome	NATURE			English	Article							RECOMBINATION HOT-SPOTS; STRUCTURAL VARIATION; POSITIVE SELECTION; DELETION POLYMORPHISM; WIDE ASSOCIATION; GENE; REARRANGEMENTS; INSTABILITY; NUCLEOTIDE; EXPRESSION	Structural variations of DNA greater than 1 kilobase in size account for most bases that vary among human genomes, but are still relatively under-ascertained. Here we use tiling oligonucleotide microarrays, comprising 42 million probes, to generate a comprehensive map of 11,700 copy number variations (CNVs) greater than 443 base pairs, of which most (8,599) have been validated independently. For 4,978 of these CNVs, we generated reference genotypes from 450 individuals of European, African or East Asian ancestry. The predominant mutational mechanisms differ among CNV size classes. Retrotransposition has duplicated and inserted some coding and non-coding DNA segments randomly around the genome. Furthermore, by correlation with known trait-associated single nucleotide polymorphisms (SNPs), we identified 30 loci with CNVs that are candidates for influencing disease susceptibility. Despite this, having assessed the completeness of our map and the patterns of linkage disequilibrium between CNVs and SNPs, we conclude that, for complex traits, the heritability void left by genome-wide association studies will not be accounted for by common CNVs.	[Conrad, Donald F.; Redon, Richard; Zhang, Yujun; Aerts, Jan; Andrews, T. Daniel; Barnes, Chris; Campbell, Peter; Fitzgerald, Tomas; Hu, Min; Kristiansson, Kati; MacArthur, Daniel G.; Onyiah, Ifejinelo; Robson, Sam; Stirrups, Kathy; Valsesia, Armand; Walter, Klaudia; Tyler-Smith, Chris; Carter, Nigel P.; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Pinto, Dalila; Feuk, Lars; MacDonald, Jeffrey R.; Pang, Andy Wing Chun; Wei, John; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, MaRS Ctr, Toronto, ON M5G 1L7, Canada; [Pinto, Dalila; Feuk, Lars; MacDonald, Jeffrey R.; Pang, Andy Wing Chun; Wei, John; Scherer, Stephen W.] Hosp Sick Children, Program Genet & Genom, MaRS Ctr, Toronto, ON M5G 1L7, Canada; [Redon, Richard] INSERM, UMR915, Inst Thorax, F-44035 Nantes, France; [Feuk, Lars] Uppsala Univ, Rudbeck Lab, Uppsala Dept Genet & Pathol, S-75185 Uppsala, Sweden; [Gokcumen, Omer; Ihm, Chun Hwa; Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Gokcumen, Omer; Ihm, Chun Hwa; Lee, Charles] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	Wellcome Trust Sanger Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Uppsala University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Toronto	Hurles, ME (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	steve@genet.sickkids.on.ca; meh@sanger.ac.uk	Pinto, Dalila/C-4218-2016; Valsesia, Armand/F-1724-2010; Redon, Richard/F-3303-2014; Andrews, Dan/ABG-4815-2020; Prescott, Natalie J/F-6490-2011; Scherer, Stephen W./B-3785-2013; Aerts, Jan/AAQ-6949-2020; MacDonald, Jeffrey Robert/GLU-2255-2022; MacArthur, Daniel/E-3275-2010; Gokcumen, Omer/J-6984-2013	Pinto, Dalila/0000-0002-8769-0846; Redon, Richard/0000-0001-7751-2280; Prescott, Natalie J/0000-0002-5901-7371; Scherer, Stephen W./0000-0002-8326-1999; Aerts, Jan/0000-0002-6416-2717; Gokcumen, Omer/0000-0003-4371-679X; Andrews, Dan/0000-0003-3922-6376; Fitzgerald, Tomas/0000-0002-2370-8496; Walter, Klaudia/0000-0003-4448-0301; Kristiansson, Kati/0000-0003-4688-107X; Barnes, Chris/0000-0002-9459-1395; Valsesia, Armand/0000-0003-0746-9664; MacDonald, Jeffrey/0000-0001-5058-2393; MacArthur, Daniel/0000-0002-5771-2290	Wellcome Trust [077006/Z/05/Z]; Canada Foundation of Innovation and Ontario Innovation Trust; Canadian Institutes of Health Research (CIHR); Genome Canada/Ontario Genomics Institute; McLaughlin Centre for Molecular Medicine; Ontario Ministry of Research and Innovation; Hospital for Sick Children Foundation; Department of Pathology at Brigham and Women's Hospital; National Institutes of Health (NIH) [HG004221, GM081533]; Academy of Finland; Royal Netherlands Academy of Arts and Sciences [TMF/DA/5801]; Netherlands Organization for Scientific Research [825.06.031]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG004221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081533] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Canada Foundation of Innovation and Ontario Innovation Trust; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada/Ontario Genomics Institute(Genome Canada); McLaughlin Centre for Molecular Medicine; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Hospital for Sick Children Foundation; Department of Pathology at Brigham and Women's Hospital; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Royal Netherlands Academy of Arts and Sciences; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank A. Boyko, J. J. Emerson, J. Pickrell, S. Kudaravalli, J. Pritchard, T. Down, S. McCarroll, J. Collins, C. Beazley, M. Dermitzakis, P. Eis, T. Richmond, M. Hogan, D. Bailey, S. Giles, G. Speight, N. Sparkes, D. Peiffer, C. Chen, K. Li, P. Oeth, D. Stetson and D. Church for advice, sharing data, sharing software and technical assistance. We are grateful for the efforts and support of our colleagues at NimbleGen, Agilent, Illumina, Applied Biosystems and Sequenom. We thank J. Barrett for comments on an earlier version of the manuscript. The Centre for Applied Genomics at the Hospital for Sick Children and Wellcome Trust Sanger Institute are acknowledged for database, technical assistance and bioinformatics support. This research was supported by the Wellcome Trust (grant no. 077006/Z/05/Z; to M. E. H., N. P. C., C. T.-S.), Canada Foundation of Innovation and Ontario Innovation Trust (to S. W. S.), Canadian Institutes of Health Research (CIHR) (to S. W. S.), Genome Canada/Ontario Genomics Institute (to S. W. S.), the McLaughlin Centre for Molecular Medicine (to S. W. S.), Ontario Ministry of Research and Innovation (to S. W. S.), the Hospital for Sick Children Foundation (to S. W. S.), the Department of Pathology at Brigham and Women's Hospital (to C. L.) and the National Institutes of Health (NIH) (grants HG004221 and GM081533; to C. L.). K. K. is supported by the Academy of Finland. D. P. is supported by fellowships from the Royal Netherlands Academy of Arts and Sciences (TMF/DA/5801) and the Netherlands Organization for Scientific Research (Rubicon 825.06.031). S. W. S. holds the GlaxoSmithKline Pathfinder Chair in Genetics and Genomics at the University of Toronto and the Hospital for Sick Children.	Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Buchanan JA, 2008, GENET MED, V10, P639, DOI [10.1097/GIM.0b013e318183f848, 10.1097GIM.0b013e318183f848]; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Down TA, 2005, NUCLEIC ACIDS RES, V33, P1445, DOI 10.1093/nar/gki282; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GONDO Y, 1993, P NATL ACAD SCI USA, V90, P297, DOI 10.1073/pnas.90.1.297; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Hurles ME, 2008, TRENDS GENET, V24, P238, DOI 10.1016/j.tig.2008.03.001; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jeffreys A, 1999, ELECTROPHORESIS, V20, P1665, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1665::AID-ELPS1665>3.0.CO;2-L; Jeffreys AJ, 2004, PHILOS T ROY SOC B, V359, P141, DOI 10.1098/rstb.2003.1372; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kim PM, 2007, P NATL ACAD SCI USA, V104, P20274, DOI 10.1073/pnas.0710183104; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lee C, 2007, NAT GENET, V39, pS48, DOI 10.1038/ng2092; Levy S, 2008, NATURE, V456, P49, DOI 10.1038/456049a; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Nielsen R, 2009, GENOME RES, V19, P838, DOI 10.1101/gr.088336.108; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pique-Regi R, 2008, BIOINFORMATICS, V24, P309, DOI 10.1093/bioinformatics/btm601; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Silva AM, 2010, AM J HUM BIOL, V22, P76, DOI 10.1002/ajhb.20956; Smith EE, 2009, GENOME RES, V19, P850, DOI 10.1101/gr.085647.108; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang LL, 2002, AM J HUM GENET, V71, P165, DOI 10.1086/341234; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006	50	1295	1350	3	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					704	712		10.1038/nature08516	http://dx.doi.org/10.1038/nature08516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	19812545	Green Accepted			2022-12-24	WOS:000276205000035
J	Saito, K; Inagaki, S; Mituyama, T; Kawamura, Y; Ono, Y; Sakota, E; Kotani, H; Asai, K; Siomi, H; Siomi, MC				Saito, Kuniaki; Inagaki, Sachi; Mituyama, Toutai; Kawamura, Yoshinori; Ono, Yukiteru; Sakota, Eri; Kotani, Hazuki; Asai, Kiyoshi; Siomi, Haruhiko; Siomi, Mikiko C.			A regulatory circuit for piwi by the large Maf gene traffic jam in Drosophila	NATURE			English	Article							GERMLINE STEM-CELLS; RNA PATHWAY; PIRNA; MECHANISMS; MUTATIONS; DIVISION; ENCODES; GONAD; RISC	PIWI-interacting RNAs (piRNAs) silence retrotransposons in Drosophila germ lines by associating with the PIWI proteins Argonaute 3 (AGO3), Aubergine (Aub) and Piwi(1,2). piRNAs in Drosophila are produced from intergenic repetitive genes and piRNA clusters by two systems: the primary processing pathway and the amplification loop(1-7). The amplification loop occurs in a Dicer-independent, PIWI-Slicer-dependent manner(3,4,8). However, primary piRNA processing remains elusive. Here we analysed piRNA processing in a Drosophila ovarian somatic cell line where Piwi, but not Aub or AGO3, is expressed; thus, only the primary piRNAs exist. In addition to flamenco, a Piwi-specific piRNA cluster(3), traffic jam (tj)(9), a large Maf gene, was determined as a new piRNA cluster. piRNAs arising from tj correspond to the untranslated regions of tj messenger RNA and are sense-oriented. piRNA loading on to Piwi may occur in the cytoplasm. zucchini(10), a gene encoding a putative cytoplasmic nuclease, is required for tj-derived piRNA production. In tj and piwi mutant ovaries, somatic cells fail to intermingle with germ cells and Fasciclin III is overexpressed. Loss of tj abolishes Piwi expression in gonadal somatic cells. Thus, in gonadal somatic cells, tj gives rise simultaneously to two different molecules: the TJ protein, which activates Piwi expression, and piRNAs, which define the Piwi targets for silencing.	[Saito, Kuniaki; Inagaki, Sachi; Kawamura, Yoshinori; Kotani, Hazuki; Siomi, Haruhiko; Siomi, Mikiko C.] Keio Univ, Sch Med, Tokyo 1608582, Japan; [Mituyama, Toutai; Asai, Kiyoshi] Natl Inst Adv Ind Sci & Technol, CBRC, Tokyo 1350064, Japan; [Kawamura, Yoshinori] Univ Tokushima, Inst Hlth Biosci, Tokushima 7708503, Japan; [Ono, Yukiteru] Informat & Math Sci Lab Inc, Dept Life Sci, Tokushima 1120012, Japan; [Sakota, Eri] JBIC, Tokyo 1358073, Japan; [Asai, Kiyoshi] Univ Tokyo, Grad Sch Frontier Sci, Chiba 2778583, Japan; [Siomi, Mikiko C.] CREST, JST, Kawaguchi, Saitama 3320012, Japan	Keio University; National Institute of Advanced Industrial Science & Technology (AIST); Tokushima University; University of Tokyo; Japan Science & Technology Agency (JST)	Siomi, H (corresponding author), Keio Univ, Sch Med, Tokyo 1608582, Japan.	awa403@sc.itc.keio.ac.jp; siomim@sc.itc.keio.ac.jp	Asai, Kiyoshi/AAT-8344-2020; Saito, Kuniaki/A-6967-2015; Siomi, Haruhiko/A-7020-2015; Inagaki, Sachi/P-8036-2019; Mituyama, Toutai/A-5610-2017	Asai, Kiyoshi/0000-0003-0909-4982; Saito, Kuniaki/0000-0001-8233-9283; Siomi, Haruhiko/0000-0001-8690-3822; Inagaki, Sachi/0000-0002-2365-9938; Mituyama, Toutai/0000-0002-1110-6375	MEXT; NEDO ( New Energy and Industrial Technology Development Organization); CREST; Grants-in-Aid for Scientific Research [19061001] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NEDO ( New Energy and Industrial Technology Development Organization)(New Energy and Industrial Technology Development Organization (NEDO)); CREST(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Niki, D. Godt, H. Lin, E. Matunis, S. Kobayashi, Y. Kitadate, Y. Kageyama and H. Sano for providing reagents. We also thank Bloomington and Kyoto Drosophila Stock Center for the supply of Drosophila strains. We thank K. Yamada, E. Hattori, K. M. Nishida and T. N. Okada for technical assistance; S. Takahashi and K. Kataoka for discussions and suggestions; and other members of the Siomi laboratory for discussions and comments on the manuscript. We also thank K. Greer and D. McGowan for encouragement. This work was supported by MEXT grants to H. S. and NEDO ( New Energy and Industrial Technology Development Organization) grants to M. C. S., T. M. and K. A. M. C. S. is supported by CREST from JST. M. C. S. is Associate Professor of Global COE for Human Metabolomics Systems Biology by MEXT.	Arama E, 2000, ONCOGENE, V19, P3706, DOI 10.1038/sj.onc.1203706; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Kataoka K, 2007, J BIOCHEM, V141, P775, DOI 10.1093/jb/mvm105; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kitadate Y, 2007, DEV CELL, V13, P151, DOI 10.1016/j.devcel.2007.05.001; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Lin HF, 1997, DEVELOPMENT, V124, P2463; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mituyama T, 2009, NUCLEIC ACIDS RES, V37, pD89, DOI 10.1093/nar/gkn805; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Niki Y, 2006, P NATL ACAD SCI USA, V103, P16325, DOI 10.1073/pnas.0607435103; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263	30	318	334	3	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1296	U135		10.1038/nature08501	http://dx.doi.org/10.1038/nature08501			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19812547				2022-12-24	WOS:000271190800052
J	Vogtle, FN; Wortelkamp, S; Zahedi, RP; Becker, D; Leidhold, C; Gevaert, K; Kellermann, J; Voos, W; Sickmann, A; Pfanner, N; Meisinger, C				Voegtle, F. -Nora; Wortelkamp, Stefanie; Zahedi, Rene P.; Becker, Dorothea; Leidhold, Claudia; Gevaert, Kris; Kellermann, Josef; Voos, Wolfgang; Sickmann, Albert; Pfanner, Nikolaus; Meisinger, Chris			Global Analysis of the Mitochondrial N-Proteome Identifies a Processing Peptidase Critical for Protein Stability	CELL			English	Article							AMINOPEPTIDASE-P; END RULE; PREDICTION; COMPLEX; INHIBITOR; MECHANISM; CLEAVAGE; IMPORT	Many mitochondrial proteins are synthesized with N-terminal presequences that are removed by specific peptidases. The N-termini of the mature proteins and thus peptidase cleavage sites have only been determined for a small fraction of mitochondrial proteins and yielded a controversial situation for the cleavage site specificity of the major mitochondrial processing peptidase (MPP). We report a global analysis of the N-proteome of yeast mitochondria, revealing the N-termini of 615 different proteins. Significantly more proteins than predicted contained cleavable presequences. We identified the intermediate cleaving peptidase Icp55, which removes an amino acid from a characteristic set of MPP-generated N-termini, solving the controversial situation of MPP specificity and suggesting that Icp55 converts instable intermediates into stable proteins. Our results suggest that Icp55 is critical for stabilization of the mitochondrial proteome and illustrate how the N-proteome can serve as rich source for a systematic analysis of mitochondrial protein targeting, cleavage and turnover.	[Wortelkamp, Stefanie; Zahedi, Rene P.; Sickmann, Albert] ISAS, Inst Analyt Sci, D-44139 Dortmund, Germany; [Voegtle, F. -Nora; Becker, Dorothea; Leidhold, Claudia; Voos, Wolfgang; Pfanner, Nikolaus; Meisinger, Chris] Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Voegtle, F. -Nora] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Becker, Dorothea; Voos, Wolfgang] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany; [Gevaert, Kris] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Kellermann, Josef] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Sickmann, Albert] Ruhr Univ Bochum, MPC, D-44801 Bochum, Germany; [Pfanner, Nikolaus; Meisinger, Chris] Univ Freiburg, Ctr Biol Signalling Studies Bioss, D-79104 Freiburg, Germany	Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); University of Freiburg; University of Freiburg; University of Bonn; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Max Planck Society; Ruhr University Bochum; University of Freiburg	Sickmann, A (corresponding author), ISAS, Inst Analyt Sci, D-44139 Dortmund, Germany.	albert.sickmann@isas.de; nikolaus.pfanner@biochemie.uni-freiburg.de	Gevaert, Kris/D-6489-2017; Meisinger, Chris/J-1110-2014; Sickmann, Albert/A-1010-2011; Gevaert, Kris/AAE-4212-2019; Zahedi, René/A-9148-2012; Vögtle, F.-Nora/T-4290-2017; Zahedi, Rene/HGU-5710-2022; Pfanner, Nikolaus/AAV-7878-2021; Gevaert, Kris/H-3637-2013	Gevaert, Kris/0000-0002-4237-0283; Meisinger, Chris/0000-0002-8326-3548; Sickmann, Albert/0000-0002-2388-5265; Gevaert, Kris/0000-0002-4237-0283; Zahedi, René/0000-0002-4960-5460; Vögtle, F.-Nora/0000-0002-5062-3287; Gevaert, Kris/0000-0002-4237-0283	Deutsche Forschungsgemeinschaft; Sonderforschungsbereich 746; Excellence Initiative of the German Federal and State Governments [EXC 294]; Gottfried Wilhelm Leibniz Program; Trinational Research Training Group [GRK 1478]; Ministerium fur Innovation; Wissenschaft, Forschung und Technologie des Landes Nordrhein-Westfalen; Bundesministerium fur Bildung und Forschung; Fonds der Chemischen Industrie; Fund for Scientific Research-Flanders (Belgium); Ghent University; Inter University Attraction Poles [IUAP06]; European Union Interaction Proteome (6<SUP>th</SUP> Framework Program)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich 746(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; Gottfried Wilhelm Leibniz Program; Trinational Research Training Group; Ministerium fur Innovation; Wissenschaft, Forschung und Technologie des Landes Nordrhein-Westfalen; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Fund for Scientific Research-Flanders (Belgium)(FWO); Ghent University(Ghent University); Inter University Attraction Poles(Belgian Federal Science Policy Office); European Union Interaction Proteome (6<SUP>th</SUP> Framework Program)(European Commission)	We thank Drs. M. Yaffe, T. Lithgow, J. Rassow, and P. Rehling for strains and antisera; Dr. N. Wiedemann for discussion; and C. Prinz and B. Schonfisch for expert technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 746, Excellence Initiative of the German Federal and State Governments (EXC 294), Gottfried Wilhelm Leibniz Program, Trinational Research Training Group (GRK 1478, fellowship to F. N. V.), the Ministerium fur Innovation, Wissenschaft, Forschung und Technologie des Landes Nordrhein-Westfalen, the Bundesministerium fur Bildung und Forschung, the Fonds der Chemischen Industrie, the Fund for Scientific Research-Flanders (Belgium), the Concerted Research Actions from Ghent University, the Inter University Attraction Poles (IUAP06) and the European Union Interaction Proteome (6<SUP>th</SUP> Framework Program).	Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; BRANDA SS, 1995, J BIOL CHEM, V270, P27366, DOI 10.1074/jbc.270.45.27366; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Emanuelsson O, 2001, METHOD CELL BIOL, V65, P175, DOI 10.1016/S0091-679X(01)65011-8; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Ersahin C, 2005, ARCH BIOCHEM BIOPHYS, V435, P303, DOI 10.1016/j.abb.2004.12.023; Esser K, 2002, J MOL BIOL, V323, P835, DOI 10.1016/S0022-2836(02)01000-8; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gevaert K, 2003, NAT BIOTECHNOL, V21, P566, DOI 10.1038/nbt810; Graham SC, 2004, ACTA CRYSTALLOGR D, V60, P1770, DOI 10.1107/S0907444904018724; Habib SJ, 2007, METHOD CELL BIOL, V80, P761, DOI 10.1016/S0091-679X(06)80035-X; Meinnel T, 2006, BIOL CHEM, V387, P839, DOI 10.1515/BC.2006.107; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Prokisch H, 2006, NUCLEIC ACIDS RES, V34, pD705, DOI 10.1093/nar/gkj127; Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Schneider G, 1998, PROTEINS, V30, P49, DOI 10.1002/(SICI)1097-0134(19980101)30:1<49::AID-PROT5>3.3.CO;2-P; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2008, NAT STRUCT MOL BIOL, V15, P1238, DOI 10.1038/nsmb1208-1238; Wilce MCJ, 1998, P NATL ACAD SCI USA, V95, P3472, DOI 10.1073/pnas.95.7.3472; WITTE C, 1988, EMBO J, V7, P1439, DOI 10.1002/j.1460-2075.1988.tb02961.x; Wolfrum S, 2001, BRIT J PHARMACOL, V134, P370, DOI 10.1038/sj.bjp.0704236	29	336	345	3	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					428	439		10.1016/j.cell.2009.07.045	http://dx.doi.org/10.1016/j.cell.2009.07.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19837041	Bronze			2022-12-24	WOS:000270857500024
J	Margueron, R; Justin, N; Ohno, K; Sharpe, ML; Son, J; Drury, WJ; Voigt, P; Martin, SR; Taylor, WR; De Marco, V; Pirrotta, V; Reinberg, D; Gamblin, SJ				Margueron, Raphael; Justin, Neil; Ohno, Katsuhito; Sharpe, Miriam L.; Son, Jinsook; Drury, William J., III; Voigt, Philipp; Martin, Stephen R.; Taylor, William R.; De Marco, Valeria; Pirrotta, Vincenzo; Reinberg, Danny; Gamblin, Steven J.			Role of the polycomb protein EED in the propagation of repressive histone marks	NATURE			English	Article							METHYLTRANSFERASE ACTIVITY; STRUCTURAL BASIS; DROSOPHILA; RECOGNITION; H3; TRIMETHYLATION; ESC; METHYLATION; COMPLEXES; CHROMATIN	Polycomb group proteins have an essential role in the epigenetic maintenance of repressive chromatin states. The gene-silencing activity of the Polycomb repressive complex 2 (PRC2) depends on its ability to trimethylate lysine 27 of histone H3 (H3K27) by the catalytic SET domain of the EZH2 subunit, and at least two other subunits of the complex: SUZ12 and EED. Here we show that the carboxy-terminal domain of EED specifically binds to histone tails carrying trimethyl-lysine residues associated with repressive chromatin marks, and that this leads to the allosteric activation of the methyltransferase activity of PRC2. Mutations in EED that prevent it from recognizing repressive trimethyl-lysine marks abolish the activation of PRC2 in vitro and, in Drosophila, reduce global methylation and disrupt development. These findings suggest a model for the propagation of the H3K27me3 mark that accounts for the maintenance of repressive chromatin domains and for the transmission of a histone modification from mother to daughter cells.	[Ohno, Katsuhito; Pirrotta, Vincenzo] Rutgers State Univ, Dept Mol Biol & Biochem, Nelson Labs, Piscataway, NJ 08854 USA; [Margueron, Raphael; Son, Jinsook; Drury, William J., III; Voigt, Philipp; Reinberg, Danny] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Margueron, Raphael; Son, Jinsook; Drury, William J., III; Voigt, Philipp; Reinberg, Danny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Justin, Neil; Sharpe, Miriam L.; Martin, Stephen R.; Taylor, William R.; De Marco, Valeria; Gamblin, Steven J.] MRC Natl Inst Med Res, London NW7 1AA, England	Rutgers State University New Brunswick; Howard Hughes Medical Institute; New York University; New York University; MRC National Institute for Medical Research	Pirrotta, V (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Nelson Labs, 604 Allison Rd, Piscataway, NJ 08854 USA.	pirrotta@biology.rutgers.edu; reinbd01@med.nyu.edu; sgambli@nimr.mrc.ac.uk	Margueron, Raphael F/B-9996-2015; Justin, Neil/E-1774-2011	Margueron, Raphael F/0000-0002-9093-7977; Sharpe, Miriam/0000-0002-8936-1595; Gamblin, Steve/0000-0001-5331-639X; Voigt, Philipp/0000-0003-4366-0490; Reinberg, Danny/0000-0003-4288-2016	Deutsche Akademie der Naturforscher Leopoldina [LPDS 2009-5]; NIH [GM064844, GM37120]; HHMI; MRC; Division of Life Sciences of Rutgers University; Medical Research Council [MC_U117584222] Funding Source: researchfish; MRC [MC_U117584222] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064844, R37GM037120, R01GM037120] Funding Source: NIH RePORTER	Deutsche Akademie der Naturforscher Leopoldina; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Division of Life Sciences of Rutgers University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. McCabe for technical assistance, K. Basler for fly stocks and the pUASTattB plasmid, T. Jenuwein for antibodies and J. Muller for Drosophila PRC2 baculovirus. We thank J. Millar and A. Gould for suggestions and discussions, D. Allis for insightful discussions on histone specificity, P. Walker for technical assistance, and J. Brock for assistance with figures. This work was supported by the following grants: Fellowship from the Deutsche Akademie der Naturforscher Leopoldina (LPDS 2009-5) to P. V., NIH grants GM064844 and GM37120 and HHMI to D. R. Work in the S. J. G. laboratory is funded by the MRC. Work in the V. P. laboratory was supported by the Division of Life Sciences of Rutgers University.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Han ZF, 2007, STRUCTURE, V15, P1306, DOI 10.1016/j.str.2007.08.007; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurzhals RL, 2008, DEV BIOL, V313, P293, DOI 10.1016/j.ydbio.2007.10.025; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nekrasov M, 2005, EMBO REP, V6, P348, DOI 10.1038/sj.embor.7400376; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; Ohno K, 2008, MECH DEVELOP, V125, P527, DOI 10.1016/j.mod.2008.01.002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Schiefner A, 2004, J BIOL CHEM, V279, P5588, DOI 10.1074/jbc.M309771200; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; STRUHL G, 1982, CELL, V31, P285, DOI 10.1016/0092-8674(82)90428-7; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tie F, 2007, MOL CELL BIOL, V27, P2014, DOI 10.1128/MCB.01822-06; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4	40	809	822	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					762	U11		10.1038/nature08398	http://dx.doi.org/10.1038/nature08398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19767730	Green Accepted			2022-12-24	WOS:000270547500029
J	Merlin, C; Gegear, RJ; Reppert, SM				Merlin, Christine; Gegear, Robert J.; Reppert, Steven M.			Antennal Circadian Clocks Coordinate Sun Compass Orientation in Migratory Monarch Butterflies	SCIENCE			English	Article							POLARIZED SKYLIGHT; DROSOPHILA BRAIN; NEURONS; RHYTHMS; INSECT; MODEL	During their fall migration, Eastern North American monarch butterflies (Danaus plexippus) use a time-compensated Sun compass to aid navigation to their overwintering grounds in central Mexico. It has been assumed that the circadian clock that provides time compensation resides in the brain, although this assumption has never been examined directly. Here, we show that the antennae are necessary for proper time-compensated Sun compass orientation in migratory monarch butterflies, that antennal clocks exist in monarchs, and that they likely provide the primary timing mechanism for Sun compass orientation. These unexpected findings pose a novel function for the antennae and open a new line of investigation into clock-compass connections that may extend widely to other insects that use this orientation mechanism.	[Merlin, Christine; Gegear, Robert J.; Reppert, Steven M.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	Steven.Reppert@umassmed.edu		Gegear, Robert/0000-0001-9886-1324	NIH [R01 GM086794]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086794] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Foley and A. Casselman for assistance; F. Gagnon, C. Cullar, and O. Taylor for supplying monarch butterflies; and D. Weaver, Q. Yuan, and members of the Reppert laboratory for their inputs and comments. Supported by NIH grant R01 GM086794.	Brower Lincoln P., 1995, Journal of the Lepidopterists' Society, V49, P304; Calvert William H., 2001, Journal of the Lepidopterists' Society, V55, P162; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Froy O, 2003, SCIENCE, V300, P1303, DOI 10.1126/science.1084874; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Heinze S, 2007, SCIENCE, V315, P995, DOI 10.1126/science.1135531; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Merlin C, 2006, INSECT MOL BIOL, V15, P137, DOI 10.1111/j.1365-2583.2006.00617.x; Merlin C, 2007, J BIOL RHYTHM, V22, P502, DOI 10.1177/0748730407307737; Mouritsen H, 2002, P NATL ACAD SCI USA, V99, P10162, DOI 10.1073/pnas.152137299; Perez SM, 1997, NATURE, V387, P29, DOI 10.1038/387029a0; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Reppert SM, 2006, CELL, V124, P233, DOI 10.1016/j.cell.2006.01.009; Reppert SM, 2004, CURR BIOL, V14, P155, DOI 10.1016/j.cub.2003.12.034; Saifullah ASM, 2009, J BIOL RHYTHM, V24, P144, DOI 10.1177/0748730408331166; Sakura M, 2008, J NEUROPHYSIOL, V99, P667, DOI 10.1152/jn.00784.2007; Sane SP, 2007, SCIENCE, V315, P863, DOI 10.1126/science.1133598; Sauman I, 2005, NEURON, V46, P457, DOI 10.1016/j.neuron.2005.03.014; Schuckel J, 2007, CELL TISSUE RES, V330, P271, DOI 10.1007/s00441-007-0471-x; Stalleicken J, 2005, J EXP BIOL, V208, P2399, DOI 10.1242/jeb.01613; Tanoue S, 2004, CURR BIOL, V14, P638, DOI 10.1016/j.cub.2004.04.009; TRUMAN JW, 1970, SCIENCE, V167, P1624, DOI 10.1126/science.167.3925.1624; Urquhart FA., 1960, MONARCH BUTTERFLY; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zhu HS, 2008, PLOS BIOL, V6, P138, DOI 10.1371/journal.pbio.0060004; Zhu HS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-14; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	29	117	126	1	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1700	1704		10.1126/science.1176221	http://dx.doi.org/10.1126/science.1176221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779201	Green Submitted, Green Accepted			2022-12-24	WOS:000270131800049
J	Hubert, C; Loy, A; Nickel, M; Arnosti, C; Baranyi, C; Bruchert, V; Ferdelman, T; Finster, K; Christensen, FM; de Rezende, JR; Vandieken, V; Jorgensen, BB				Hubert, Casey; Loy, Alexander; Nickel, Maren; Arnosti, Carol; Baranyi, Christian; Bruechert, Volker; Ferdelman, Timothy; Finster, Kai; Christensen, Flemming Monsted; de Rezende, Julia Rosa; Vandieken, Verona; Jorgensen, Bo Barker			A Constant Flux of Diverse Thermophilic Bacteria into the Cold Arctic Seabed	SCIENCE			English	Article							SULFATE-REDUCING BACTERIA; SP NOV.; MICROBIAL DIVERSITY; GEN. NOV.; TEMPERATURE; REDUCTION; SEDIMENTS; BIOSPHERE; SVALBARD	Microorganisms have been repeatedly discovered in environments that do not support their metabolic activity. Identifying and quantifying these misplaced organisms can reveal dispersal mechanisms that shape natural microbial diversity. Using endospore germination experiments, we estimated a stable supply of thermophilic bacteria into permanently cold Arctic marine sediment at a rate exceeding 10(8) spores per square meter per year. These metabolically and phylogenetically diverse Firmicutes show no detectable activity at cold in situ temperatures but rapidly mineralize organic matter by hydrolysis, fermentation, and sulfate reduction upon induction at 50 degrees C. The closest relatives to these bacteria come from warm subsurface petroleum reservoir and ocean crust ecosystems, suggesting that seabed fluid flow from these environments is delivering thermophiles to the cold ocean. These transport pathways may broadly influence microbial community composition in the marine environment.	[Hubert, Casey; Nickel, Maren; Bruechert, Volker; Ferdelman, Timothy; de Rezende, Julia Rosa; Vandieken, Verona; Jorgensen, Bo Barker] Max Planck Inst Marine Microbiol, Biogeochem Grp, D-28359 Bremen, Germany; [Loy, Alexander; Baranyi, Christian] Univ Vienna, Dept Microbial Ecol, A-1090 Vienna, Austria; [Arnosti, Carol] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27599 USA; [Finster, Kai; Christensen, Flemming Monsted] Aarhus Univ, Dept Biol Sci, Microbiol Sect, DK-8000 Aarhus C, Denmark; [Christensen, Flemming Monsted; de Rezende, Julia Rosa; Jorgensen, Bo Barker] Aarhus Univ, Dept Biol Sci, Ctr Geomicrobiol, DK-8000 Aarhus C, Denmark	Max Planck Society; University of Vienna; University of North Carolina; University of North Carolina Chapel Hill; Aarhus University; Aarhus University	Hubert, C (corresponding author), Max Planck Inst Marine Microbiol, Biogeochem Grp, Celsiusstr 1, D-28359 Bremen, Germany.	chubert@mpi-bremen.de	Ferdelman, Timothy G/A-3758-2013; baranyi, christian/AAZ-3471-2020; de Rezende, Julia/G-3670-2012; Loy, Alexander/A-8182-2008; Jorgensen, Bo B/C-2214-2013; Finster, Kai W/I-7475-2013	Ferdelman, Timothy G/0000-0002-9701-3793; baranyi, christian/0000-0003-3118-2145; de Rezende, Julia/0000-0001-7750-4344; Loy, Alexander/0000-0001-8923-5882; Jorgensen, Bo B/0000-0001-9398-8027; Finster, Kai W/0000-0002-9132-5542; Hubert, Casey/0000-0002-8691-8116; Bruchert, Volker/0000-0002-8956-3840	Natural Sciences and Engineering Research Council of Canada; Austrian Science Fund [P20185-B17]; U.S. National Science Foundation [OCE-0323975, OCE-0848703]; Max Planck Society; Austrian Science Fund (FWF) [P 20185] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Austrian Science Fund(Austrian Science Fund (FWF)); U.S. National Science Foundation(National Science Foundation (NSF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank S. Henningsen, J. Mortensen, K. Barker, and A. Steen for assistance aboard R/V Farm and the Alfred Wegener Institute for kindly providing laboratory space in Ny Alesund, Svalbard ( project KOP56; RIS ID: 3298). We are grateful to K. Imhoff, M. Meyer, and A. Schipper for technical assistance and to A. Judd, M. Holtappels, N. Finke, and W. Bach for valuable discussions. This work was supported by the Natural Sciences and Engineering Research Council of Canada ( C. H.), the Austrian Science Fund (P20185-B17; A. L.), the U.S. National Science Foundation (OCE-0323975 and OCE-0848703; C. A.), and the Max Planck Society. Nucleotide sequences have been deposited in the European Molecular Biology Laboratory database under accession numbers FN396615 to FN396795.	Alain K, 2002, INT J SYST EVOL MICR, V52, P1621, DOI 10.1099/00207713-52-5-1621; Arnosti C, 2006, GEOMICROBIOL J, V23, P551, DOI 10.1080/01490450600897336; Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; BARTHOLO.JW, 1966, J BACTERIOL, V92, P635, DOI 10.1128/JB.92.3.635-638.1966; Cowen JP, 2004, RES MICROBIOL, V155, P497, DOI 10.1016/j.resmic.2004.03.008; Damm E, 2005, CONT SHELF RES, V25, P1453, DOI 10.1016/j.csr.2005.03.003; Detmers J, 2001, APPL ENVIRON MICROB, V67, P888, DOI 10.1128/AEM.67.2.888-894.2001; Egorova AA, 1938, CR ACAD SCI URSS, V19, P649; Finke N, 2008, ISME J, V2, P815, DOI [10.1038/ismej.2008.20, 10.1038/ISMEJ.2008.20]; Head IM, 2003, NATURE, V426, P344, DOI 10.1038/nature02134; Huber JA, 2006, ENVIRON MICROBIOL, V8, P88, DOI 10.1111/j.1462-2920.2005.00872.x; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hutnak M, 2008, NAT GEOSCI, V1, P611, DOI 10.1038/ngeo264; ISAKSEN MF, 1994, FEMS MICROBIOL ECOL, V14, P1; Judd A., 2007, SEABED FLUID FLOW IM, DOI 10.1017/CBO9780511535918; Knoblauch C, 1999, ENVIRON MICROBIOL, V1, P457, DOI 10.1046/j.1462-2920.1999.00061.x; Lee YJ, 2005, EXTREMOPHILES, V9, P375, DOI 10.1007/s00792-005-0453-4; MCBEE RH, 1956, J BACTERIOL, V71, P182, DOI 10.1128/JB.71.2.182-185.1956; Parkes RJ, 2007, ORG GEOCHEM, V38, P845, DOI 10.1016/j.orggeochem.2006.12.011; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Ravenschlag K, 2001, APPL ENVIRON MICROB, V67, P387, DOI 10.1128/AEM.67.1.387-395.2001; Sagemann J, 1998, GEOMICROBIOL J, V15, P85, DOI 10.1080/01490459809378067; Sahm K, 1999, ENVIRON MICROBIOL, V1, P65, DOI 10.1046/j.1462-2920.1999.00007.x; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; STETTER KO, 1993, NATURE, V365, P743, DOI 10.1038/365743a0; Vandieken V, 2006, INT J SYST EVOL MICR, V56, P687, DOI 10.1099/ijs.0.64058-0	27	145	150	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1541	1544		10.1126/science.1174012	http://dx.doi.org/10.1126/science.1174012			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762643	Green Published			2022-12-24	WOS:000269887900040
J	Volkow, ND; Wang, GJ; Kollins, SH; Wigal, TL; Newcorn, JH; Telang, F; Fowler, JS; Zhu, W; Logan, J; Ma, YM; Pradhan, K; Wong, C; Swanson, JM				Volkow, Nora D.; Wang, Gene-Jack; Kollins, Scott H.; Wigal, Tim L.; Newcorn, Jeffrey H.; Telang, Frank; Fowler, Joanna S.; Zhu, Wei; Logan, Jean; Ma, Yeming; Pradhan, Kith; Wong, Christopher; Swanson, James M.			Evaluating Dopamine Reward Pathway in ADHD Clinical Implications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; NUCLEUS-ACCUMBENS; COCAINE BINDING; BRAIN DOPAMINE; CHILDREN; REINFORCEMENT; PET; AVAILABILITY; ADOLESCENTS	Context Attention-deficit/hyperactivity disorder (ADHD)-characterized by symptoms of inattention and hyperactivity-impulsivity-is the most prevalent childhood psychiatric disorder that frequently persists into adulthood, and there is increasing evidence of reward-motivation deficits in this disorder. Objective To evaluate biological bases that might underlie a reward/motivation deficit by imaging key components of the brain dopamine reward pathway (mesoaccumbens). Design, Setting, and Participants We used positron emission tomography to measure dopamine synaptic markers (transporters and D-2/D-3 receptors) in 53 nonmedicated adults with ADHD and 44 healthy controls between 2001-2009 at Brookhaven National Laboratory. Main Outcome Measures We measured specific binding of positron emission tomographic radioligands for dopamine transporters (DAT) using [C-11] cocaine and for D-2/D-3 receptors using [C-11]raclopride, quantified as binding potential (distribution volume ratio -1). Results For both ligands, statistical parametric mapping showed that specific binding was lower in ADHD than in controls (threshold for significance set at P < .005) in regions of the dopamine reward pathway in the left side of the brain. Region-of-interest analyses corroborated these findings. The mean (95% confidence interval [CI] of mean difference) for DAT in the nucleus accumbens for controls was 0.71 vs 0.63 for those with ADHD (95% CI, 0.03-0.13, P=.004) and in the midbrain for controls was 0.16 vs 0.09 for those with ADHD ( 95% CI, 0.03-0.12; P <=. 001); for D-2/D-3 receptors, the mean accumbens for controls was 2.85 vs 2.68 for those with ADHD( 95% CI, 0.06-0.30, P=.004); and in the midbrain, it was for controls 0.28 vs 0.18 for those with ADHD ( 95% CI, 0.02-0.17, P=.01). The analysis also corroborated differences in the left caudate: the mean DAT for controls was 0.66 vs 0.53 for those with ADHD ( 95% CI, 0.04-0.22; P=. 003) and the mean D-2/D-3 for controls was 2.80 vs 2.47 for those with ADHD ( 95% CI, 0.10-0.56; P=.005) and differences in D-2/D-3 in the hypothalamic region, with controls having a mean of 0.12 vs 0.05 for those with ADHD (95% CI, 0.02-0.12; P=.004). Ratings of attention correlated with D-2/D-3 in the accumbens (r=0.35; 95% CI, 0.15-0.52; P=.001), midbrain (r=0.35; 95% CI, 0.14-0.52; P=.001), caudate (r=0.32; 95% CI, 0.11-0.50; P=.003), and hypothalamic (r=0.31; CI, 0.10-0.49; P=.003) regions and with DAT in the midbrain (r=0.37; 95% CI, 0.16-0.53; P <= .001). Conclusion A reduction in dopamine synaptic markers associated with symptoms of inattention was shown in the dopamine reward pathway of participants with ADHD. JAMA. 2009;302(10):1084-1091 www.jama.com	[Volkow, Nora D.] Natl Inst Drug Abuse, Bethesda, MD 20892 USA; [Volkow, Nora D.; Telang, Frank; Ma, Yeming] NIAAA, Lab Neuroimaging, Bethesda, MD USA; [Wang, Gene-Jack; Fowler, Joanna S.; Logan, Jean; Pradhan, Kith; Wong, Christopher] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA; [Wang, Gene-Jack; Fowler, Joanna S.; Logan, Jean; Pradhan, Kith; Wong, Christopher] Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA; [Wang, Gene-Jack; Newcorn, Jeffrey H.; Fowler, Joanna S.] Mt Sinai Med Ctr, Dept Psychiat, New York, NY 10029 USA; [Kollins, Scott H.] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA; [Wigal, Tim L.; Swanson, James M.] Univ Calif Irvine, Child Dev Ctr, Irvine, CA USA; [Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory; Icahn School of Medicine at Mount Sinai; Duke University; University of California System; University of California Irvine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Volkow, ND (corresponding author), Natl Inst Drug Abuse, 6001 Execut Blvd,Room 5274,MSC 9581, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov	Kollins, Scott H/G-2965-2012; Kollins, Scott/AAD-6291-2020	Kollins, Scott/0000-0001-6847-6935; Newcorn, Jeffrey/0000-0001-8993-9337; Logan, Jean/0000-0002-6993-9994	Brookhaven National Laboratory (BNL); Intramural Research Program of the National Institutes of Health (NIH) [MH66961-02]; Department of Energy; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA023464] Funding Source: NIH RePORTER	Brookhaven National Laboratory (BNL); Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was carried out at Brookhaven National Laboratory (BNL) and was supported in part by grant MH66961-02 from the Intramural Research Program of the National Institutes of Health (NIH), the National Institute of Mental Health and infrastructure support from the Department of Energy.	Agranat-Meged A, 2008, AM J MED GENET B, V147B, P1547, DOI 10.1002/ajmg.b.30842; Barkley R. A, 2014, ATTENTION DEFICIT HY; Barkley Russell A, 2004, J Psychiatr Pract, V10, P39, DOI 10.1097/00131746-200401000-00005; Booth JR, 2005, J CHILD PSYCHOL PSYC, V46, P94, DOI 10.1111/j.1469-7610.2004.00337.x; Braun JM, 2006, ENVIRON HEALTH PERSP, V114, P1904, DOI 10.1289/ehp.9478; Castellanos FX, 2001, ARCH GEN PSYCHIAT, V58, P289, DOI 10.1001/archpsyc.58.3.289; Castellanos FX, 1996, ARCH GEN PSYCHIAT, V53, P607; Conners CK, 1998, J CLIN PSYCHIAT, V59, P24; Cortese S, 2006, SLEEP, V29, P504; Cortese S, 2008, MED HYPOTHESES, V71, P770, DOI 10.1016/j.mehy.2008.06.017; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Dopheide JA, 2009, PHARMACOTHERAPY, V29, P656, DOI 10.1592/phco.29.6.656; Elkins IJ, 2007, ARCH GEN PSYCHIAT, V64, P1145, DOI 10.1001/archpsyc.64.10.1145; Ernst M, 1999, AM J PSYCHIAT, V156, P1209; Filipek PA, 1997, NEUROLOGY, V48, P589, DOI 10.1212/WNL.48.3.589; FOWLER JS, 1989, SYNAPSE, V4, P371, DOI 10.1002/syn.890040412; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; GATLEY SJ, 1995, SYNAPSE, V20, P137, DOI 10.1002/syn.890200207; Gjedde A, 2005, INT REV NEUROBIOL, V63, P1, DOI 10.1016/S0074-7742(05)63001-2; Gurevich EV, 1999, NEUROPSYCHOPHARMACOL, V20, P60, DOI 10.1016/S0893-133X(98)00066-9; Guy W., 2000, HDB PSYCHIAT MEASURE, V1st; HAENLEIN M, 1987, J AM ACAD CHILD PSY, V26, P356, DOI 10.1097/00004583-198705000-00014; Johansen EB, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-7; Jucaite A, 2005, BIOL PSYCHIAT, V57, P229, DOI 10.1016/j.biopsych.2004.11.009; King JA, 1998, BIOL PSYCHIAT, V44, P72, DOI 10.1016/S0006-3223(97)00507-6; Kollins SH, 1997, PSYCHOL REC, V47, P25, DOI 10.1007/BF03395211; Kupfer DJ, 2000, J AM ACAD CHILD PSY, V39, P182, DOI 10.1097/00004583-200002000-00018; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Lopez-Larson M, 2009, J CHILD ADOL PSYCHOP, V19, P31, DOI 10.1089/cap.2008.041; Lou HC, 2004, DEV MED CHILD NEUROL, V46, P179; Luman M, 2005, CLIN PSYCHOL REV, V25, P183, DOI 10.1016/j.cpr.2004.11.001; Neto PR, 2002, ANN NY ACAD SCI, V965, P434; Plichta MM, 2009, BIOL PSYCHIAT, V65, P7, DOI 10.1016/j.biopsych.2008.07.008; Qiu AQ, 2009, AM J PSYCHIAT, V166, P74, DOI 10.1176/appi.ajp.2008.08030426; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; Sonuga-Barke EJS, 2003, NEUROSCI BIOBEHAV R, V27, P593, DOI 10.1016/j.neubiorev.2003.08.005; Sparrow E., 1999, ADULT ADHD RATING SC; Spencer TJ, 2007, BIOL PSYCHIAT, V62, P1059, DOI 10.1016/j.biopsych.2006.12.008; Strohle A, 2008, NEUROIMAGE, V39, P966, DOI 10.1016/j.neuroimage.2007.09.044; Swanson J, 2001, CLIN NEUROSCI RES, V1, P207, DOI 10.1016/S1566-2772(01)00007-X; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; Tripp G, 2008, J CHILD PSYCHOL PSYC, V49, P691, DOI 10.1111/j.1469-7610.2007.01851.x; Vaidya CJ, 2005, AM J PSYCHIAT, V162, P1605, DOI 10.1176/appi.ajp.162.9.1605; van Dyck CH, 2002, AM J PSYCHIAT, V159, P309, DOI 10.1176/appi.ajp.159.2.309; VOLKOW ND, 1995, J NUCL MED, V36, P1289; VOLKOW ND, 1993, J NUCL MED, V34, P609; Volkow ND, 2004, AM J PSYCHIAT, V161, P1173, DOI 10.1176/appi.ajp.161.7.1173; Volkow ND, 2007, ARCH GEN PSYCHIAT, V64, P932, DOI 10.1001/archpsyc.64.8.932; Volkow ND, 2007, NEUROIMAGE, V34, P1182, DOI 10.1016/j.neuroimage.2006.10.014; Waring ME, 2008, PEDIATRICS, V122, pE1, DOI 10.1542/peds.2007-1955; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Young DJ, 2009, CHILD PSYCHIAT HUM D, V40, P543, DOI 10.1007/s10578-009-0143-z; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9	57	394	398	6	84	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 9	2009	302	10					1084	1091		10.1001/jama.2009.1308	http://dx.doi.org/10.1001/jama.2009.1308			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491XH	19738093	Bronze, Green Accepted			2022-12-24	WOS:000269616200026
J	Oliver, KM; Degnan, PH; Hunter, MS; Moran, NA				Oliver, Kerry M.; Degnan, Patrick H.; Hunter, Martha S.; Moran, Nancy A.			Bacteriophages Encode Factors Required for Protection in a Symbiotic Mutualism	SCIENCE			English	Article							DEFENSIVE SYMBIONTS; ENDOSYMBIONT; APHIDS; RESISTANCE; EVOLUTION; BACTERIA; GENOME	Bacteriophages are known to carry key virulence factors for pathogenic bacteria, but their roles in symbiotic bacteria are less well understood. The heritable symbiont Hamiltonella defensa protects the aphid Acyrthosiphon pisum from attack by the parasitoid Aphidius ervi by killing developing wasp larvae. In a controlled genetic background, we show that a toxin-encoding bacteriophage is required to produce the protective phenotype. Phage loss occurs repeatedly in laboratory-held H. defensa-infected aphid clonal lines, resulting in increased susceptibility to parasitism in each instance. Our results show that these mobile genetic elements can endow a bacterial symbiont with benefits that extend to the animal host. Thus, phages vector ecologically important traits, such as defense against parasitoids, within and among symbiont and animal host lineages.	[Oliver, Kerry M.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Degnan, Patrick H.; Moran, Nancy A.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Hunter, Martha S.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	University System of Georgia; University of Georgia; University of Arizona; University of Arizona	Oliver, KM (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	kmoliver@uga.edu	oliver, kerry/H-4498-2017; Hunter, Martha/B-7307-2012; Hunter, Martha/AAF-5288-2020; Moran, Nancy A/G-1591-2010	oliver, kerry/0000-0002-2835-4017; Hunter, Martha/0000-0002-6342-675X; Hunter, Martha/0000-0002-6342-675X; 	National Research Initiative of the U.S. Department of Agriculture Cooperative Research, Education, and Extension Service [2006-35302-17307]; NSF [0313737]; NIH [1K 12 GM00708];  [NSF 0654435]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	National Research Initiative of the U.S. Department of Agriculture Cooperative Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the National Research Initiative of the U.S. Department of Agriculture Cooperative Research, Education, and Extension Service, grant 2006-35302-17307 to K.M.O. and M.S.H., and NSF grant 0313737 to N.A.M. K.M.O. also received support from NIH training grant 1K 12 GM00708, and P.H.D. was supported by an NSF Integrative Graduate Education and Research Traineeship fellowship in comparative genomics (NSF 0654435).	Bordenstein SR, 2005, NAT REV MICROBIOL, V3, P688, DOI 10.1038/nrmicro1233; Clark AJ, 2007, J BACTERIOL, V189, P2949, DOI 10.1128/JB.00913-06; Degnan PH, 2008, APPL ENVIRON MICROB, V74, P6782, DOI 10.1128/AEM.01285-08; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Haynes S, 2003, APPL ENVIRON MICROB, V69, P7216, DOI 10.1128/AEM.69.12.7216-7223.2003; Masui S, 2000, J MOL EVOL, V51, P491, DOI 10.1007/s002390010112; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; OBRIEN AD, 1984, SCIENCE, V226, P694, DOI 10.1126/science.6387911; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Oliver KM, 2008, P R SOC B, V275, P293, DOI 10.1098/rspb.2007.1192; Oliver KM, 2006, P ROY SOC B-BIOL SCI, V273, P1273, DOI 10.1098/rspb.2005.3436; Oliver KM, 2009, MYCOL SER, V27, P129; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Simon JC, 2003, P ROY SOC B-BIOL SCI, V270, P1703, DOI 10.1098/rspb.2003.2430; van der Wilk F, 1999, VIROLOGY, V262, P104, DOI 10.1006/viro.1999.9902; Vorburger C, 2009, EVOLUTION, V63, P1439, DOI 10.1111/j.1558-5646.2009.00660.x; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910	21	325	342	0	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 21	2009	325	5943					992	994		10.1126/science.1174463	http://dx.doi.org/10.1126/science.1174463			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AN	19696350	Green Accepted			2022-12-24	WOS:000269242800045
J	White, TD; Asfaw, B; Beyene, Y; Haile-Selassie, Y; Lovejoy, CO; Suwa, G; WoldeGabriel, G				White, Tim D.; Asfaw, Berhane; Beyene, Yonas; Haile-Selassie, Yohannes; Lovejoy, C. Owen; Suwa, Gen; WoldeGabriel, Giday			Ardipithecus ramidus and the Paleobiology of Early Hominids	SCIENCE			English	Article							EARLY PLIOCENE HOMINIDS; AUSTRALOPITHECUS-AFARENSIS; FOSSIL RECORD; MIDDLE AWASH; NATURAL-HISTORY; UPPER MIOCENE; HUMAN GAIT; ETHIOPIA; EVOLUTION; ORIGINS	Hominid fossils predating the emergence of Australopithecus have been sparse and fragmentary. The evolution of our lineage after the last common ancestor we shared with chimpanzees has therefore remained unclear. Ardipithecus ramidus, recovered in ecologically and temporally resolved contexts in Ethiopia's Afar Rift, now illuminates earlier hominid paleobiology and aspects of extant African ape evolution. More than 110 specimens recovered from 4.4-million-year-old sediments include a partial skeleton with much of the skull, hands, feet, limbs, and pelvis. This hominid combined arboreal palmigrade clambering and careful climbing with a form of terrestrial bipedality more primitive than that of Australopithecus. Ar. ramidus had a reduced canine/premolar complex and a little-derived cranial morphology and consumed a predominantly C-3 plant-based diet (plants using the C-3 photosynthetic pathway). Its ecological habitat appears to have been largely woodland-focused. Ar. ramidus lacks any characters typical of suspension, vertical climbing, or knuckle-walking. Ar. ramidus indicates that despite the genetic similarities of living humans and chimpanzees, the ancestor we last shared probably differed substantially from any extant African ape. Hominids and extant African apes have each become highly specialized through very different evolutionary pathways. This evidence also illuminates the origins of orthogrady, bipedality, ecology, diet, and social behavior in earliest Hominidae and helps to define the basal hominid adaptation, thereby accentuating the derived nature of Australopithecus.	[White, Tim D.] Univ Calif Berkeley, Human Evolut Res Ctr, Berkeley, CA 94720 USA; [White, Tim D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Asfaw, Berhane] Rift Valley Res Serv, Addis Ababa, Ethiopia; [Beyene, Yonas] Minist Youth Sports & Culture, Dept Anthropol & Archaeol, Author Res & Conservat Cultural Heritage, Addis Ababa, Ethiopia; [Haile-Selassie, Yohannes] Cleveland Museum Nat Hist, Dept Phys Anthropol, Cleveland, OH 44106 USA; [Lovejoy, C. Owen] Kent State Univ, Sch Biomed Sci, Dept Anthropol, Kent, OH 44240 USA; [Suwa, Gen] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Cleveland Museum of Natural History; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of Tokyo	White, TD (corresponding author), Univ Calif Berkeley, Human Evolut Res Ctr, 3101 Valley Life Sci Bldg, Berkeley, CA 94720 USA.	timwhite@berkeley.edu	, owen/N-7301-2019	, owen/0000-0003-0053-4523	NSF [8210897, 9318698, 9512534, 9632389, 9729060, 9727519, 9910344, 0321893]; Institute of Geophysics and Planetary Physics of the University of California at Los Alamos National Laboratory (LANL); Japan Society for the Promotion of Science	NSF(National Science Foundation (NSF)); Institute of Geophysics and Planetary Physics of the University of California at Los Alamos National Laboratory (LANL)(United States Department of Energy (DOE)Los Alamos National Laboratory); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	For funding, we thank NSF (this material is based on work supported by grants 8210897, 9318698, 9512534, 9632389, 9729060, 9727519, 9910344, and 0321893 HOMINID-RHOI), the Institute of Geophysics and Planetary Physics of the University of California at Los Alamos National Laboratory (LANL), and the Japan Society for the Promotion of Science. D. Clark and C. Howell inspired this effort and conducted laboratory and field research. We thank the coauthors of the companion papers (22-30), with special thanks to the ARA-VP-6/500 and -7/2 excavation teams, including A. Amzaye, the Alisera Afar Clan, Lu Baka, A. Bears, D. Brill, J. M. Carretero, S. Cornero, D. DeGusta, A. Defleur, A. Dessie, G. Fule, A. Getty, H. Gilbert, E. Gulec, G. Kadir, B. Latimer, D. Pennington, A. Sevim, S. Simpson, D. Trachewsky, and S. Yoseph. G. Curtis, J. DeHeinzelin, and G. Heiken provided field geological support. D. Helgren, D. DeGusta, L. Hlusko, and H. Gilbert provided insightful suggestions and advice. We thank H. Gilbert, K. Brudvik, L. Bach, D. Paul, B. Daniels, and D. Brill for illustrations; G. Richards and A. Mleczko for imaging; the Ministry of Tourism and Culture, the Authority for Research and Conservation of the Cultural Heritage, and the National Museum of Ethiopia for permissions and facilitation; and the Afar Regional Government, the Afar people of the Middle Awash, and many other field workers who contributed directly to the research efforts and results.	Allard P, 2001, NEUROPSYCHOBIOLOGY, V44, P70, DOI 10.1159/000054918; Begun DR, 2005, ANTHROPOL SCI, V113, P53, DOI 10.1537/ase.04S008; BEHRENSMEYER AK, 1982, PALEOBIOLOGY, V8, P211, DOI 10.1017/S0094837300006941; Britten RJ, 2002, P NATL ACAD SCI USA, V99, P13633, DOI 10.1073/pnas.172510699; Brunet M, 2005, NATURE, V434, P752, DOI 10.1038/nature03392; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Darwin G., 1871, P423; De Bonis Louis, 1994, Evolutionary Anthropology, V3, P75, DOI 10.1002/evan.1360030303; Elango N, 2006, P NATL ACAD SCI USA, V103, P1370, DOI 10.1073/pnas.0510716103; Elton S, 2008, J ANAT, V212, P377, DOI 10.1111/j.1469-7580.2008.00872.x; Fedorov AV, 2006, SCIENCE, V312, P1485, DOI 10.1126/science.1122666; Gee Henry, 1999, DEEP TIME CLADISTICS; GILBERT H, 2008, HOMOERECTUS PLEISTOC; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Haile-Selassie Y, 2004, SCIENCE, V303, P1503, DOI 10.1126/science.1092978; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Haile-Selassie Yohannes, 2009, P159; HILL A, 1987, YEARB PHYS ANTHROPOL, V31, P49; Hlusko LJ, 2004, AM J PHYS ANTHROPOL, V124, P223, DOI 10.1002/ajpa.10353; Huxley T., 1863, EVIDENCE MANS PLACE; HUXLEY TH, 1860, WESTMINSTER REV, V73, P541; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P373, DOI 10.1002/ajpa.1330570402; KAPPELMAN J, 1995, NATURE, V376, P558, DOI 10.1038/376558b0; Kidwell SM, 1996, ANNU REV EARTH PL SC, V24, P433, DOI 10.1146/annurev.earth.24.1.433; Kimbel WH, 2006, J HUM EVOL, V51, P134, DOI 10.1016/j.jhevol.2006.02.003; Latimer B., 1991, P169; LEAKEY MD, 1976, NATURE, V262, P460, DOI 10.1038/262460a0; LEAKEY MG, LOTHAGAM DAWN HUMANI; Louchart A, 2009, SCIENCE, V326, DOI 10.1126/science.1175823; Lovejoy CO, 2007, GAIT POSTURE, V25, P325, DOI 10.1016/j.gaitpost.2006.05.001; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175834; Lovejoy CO, 2009, SCIENCE, V326, P100, DOI 10.1126/science.1175833; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175827; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175832; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175831; Lovejoy CO, 1999, P NATL ACAD SCI USA, V96, P13247, DOI 10.1073/pnas.96.23.13247; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; Lovejoy CO, 2005, GAIT POSTURE, V21, P113, DOI 10.1016/j.gaitpost.2004.06.010; Lovejoy CO, 2002, AM J PHYS ANTHROPOL, V119, P97, DOI 10.1002/ajpa.10111; MCCOLLUM MA, J EXP ZOOL PART B, V312, DOI DOI 10.1002/JEZ.B.21316; Moore Jim, 1996, P275, DOI 10.1017/CBO9780511752414.022; Palfy J, 2007, EARTH PLANET SC LETT, V258, P160, DOI 10.1016/j.epsl.2007.03.029; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Pik R, 2003, EARTH PLANET SC LETT, V215, P73, DOI 10.1016/S0012-821X(03)00457-6; Pilbeam D, 2004, CR PALEVOL, V3, P305, DOI 10.1016/j.crpv.2004.01.006; Pulquerio MJF, 2007, TRENDS ECOL EVOL, V22, P180, DOI 10.1016/j.tree.2006.11.013; Renne PR, 1999, GEOL SOC AM BULL, V111, P869, DOI 10.1130/0016-7606(1999)111<0869:COTMPS>2.3.CO;2; Reno PL, 2003, P NATL ACAD SCI USA, V100, P9404, DOI 10.1073/pnas.1133180100; SARICH VM, 1967, P NATL ACAD SCI USA, V58, P142, DOI 10.1073/pnas.58.1.142; Semaw S, 2005, NATURE, V433, P301, DOI 10.1038/nature03177; Senut B, 2004, CR PALEVOL, V3, P265, DOI 10.1016/j.crpv.2003.12.005; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Strait DS, 2004, J HUM EVOL, V47, P399, DOI 10.1016/j.jhevol.2004.08.008; Suwa G, 2007, NATURE, V448, P921, DOI 10.1038/nature06113; Suwa G, 2009, SCIENCE, V326, P94, DOI 10.1126/science.1175824; Suwa G, 2009, SCIENCE, V326, DOI 10.1126/science.1175825; TRINKAUS E, 1990, AM J PHYS ANTHROPOL, V83, P1, DOI 10.1002/ajpa.1330830102; Ward C, 1999, EVOL ANTHROPOL, V7, P197, DOI 10.1002/(SICI)1520-6505(1999)7:6<197::AID-EVAN4>3.0.CO;2-T; Wesselman H.B., 2009, ARDIPITHECUS KADDABA; Western D, 2009, SCIENCE, V324, P1061, DOI 10.1126/science.1171155; White TD, 2006, NATURE, V440, P883, DOI 10.1038/nature04629; WHITE TD, 1995, NATURE, V375, P88, DOI 10.1038/375088a0; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; WHITE TD, PRIMATE FOSSIL RECOR, P407; WHITE TD, 2009, PALEOBIOLOGICAL REVO, P121; White TD, 2009, SCIENCE, V326, P87, DOI 10.1126/science.1175822; WOLDEGABRIEL G, 1994, NATURE, V371, P330, DOI 10.1038/371330a0; WoldeGabriel G, 2009, SCIENCE, V326, DOI 10.1126/science.1175817; Wood B, 2002, NATURE, V418, P133, DOI 10.1038/418133a; Wrangham R, 2001, DEV PRIMATOL-PROG PR, P5	76	406	422	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					75	86		10.1126/science.1175802	http://dx.doi.org/10.1126/science.1175802			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	501CA	19810190				2022-12-24	WOS:000270355600040
J	Huang, SMA; Mishina, YM; Liu, SM; Cheung, A; Stegmeier, F; Michaud, GA; Charlat, O; Wiellette, E; Zhang, Y; Wiessner, S; Hild, M; Shi, XY; Wilson, CJ; Mickanin, C; Myer, V; Fazal, A; Tomlinson, R; Serluca, F; Shao, WL; Cheng, H; Shultz, M; Rau, C; Schirle, M; Schlegl, J; Ghidelli, S; Fawell, S; Lu, C; Curtis, D; Kirschner, MW; Lengauer, C; Finan, PM; Tallarico, JA; Bouwmeester, T; Porter, JA; Bauer, A; Cong, F				Huang, Shih-Min A.; Mishina, Yuji M.; Liu, Shanming; Cheung, Atwood; Stegmeier, Frank; Michaud, Gregory A.; Charlat, Olga; Wiellette, Elizabeth; Zhang, Yue; Wiessner, Stephanie; Hild, Marc; Shi, Xiaoying; Wilson, Christopher J.; Mickanin, Craig; Myer, Vic; Fazal, Aleem; Tomlinson, Ronald; Serluca, Fabrizio; Shao, Wenlin; Cheng, Hong; Shultz, Michael; Rau, Christina; Schirle, Markus; Schlegl, Judith; Ghidelli, Sonja; Fawell, Stephen; Lu, Chris; Curtis, Daniel; Kirschner, Marc W.; Lengauer, Christoph; Finan, Peter M.; Tallarico, John A.; Bouwmeester, Tewis; Porter, Jeffery A.; Bauer, Andreas; Cong, Feng			Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling	NATURE			English	Article							BETA-CATENIN; COLORECTAL TUMORS; UBIQUITIN LIGASE; REGENERATION; PATHWAY; CANCER; APC; MUTATIONS; TELOMERES; COMPLEX	The stability of the Wnt pathway transcription factor beta-catenin is tightly regulated by the multi-subunit destruction complex. Deregulated Wnt pathway activity has been implicated in many cancers, making this pathway an attractive target for anticancer therapies. However, the development of targeted Wnt pathway inhibitors has been hampered by the limited number of pathway components that are amenable to small molecule inhibition. Here, we used a chemical genetic screen to identify a small molecule, XAV939, which selectively inhibits beta-catenin-mediated transcription. XAV939 stimulates beta-catenin degradation by stabilizing axin, the concentration-limiting component of the destruction complex. Using a quantitative chemical proteomic approach, we discovered that XAV939 stabilizes axin by inhibiting the poly-ADP-ribosylating enzymes tankyrase 1 and tankyrase 2. Both tankyrase isoforms interact with a highly conserved domain of axin and stimulate its degradation through the ubiquitin-proteasome pathway. Thus, our study provides new mechanistic insights into the regulation of axin protein homeostasis and presents new avenues for targeted Wnt pathway therapies.	[Huang, Shih-Min A.; Mishina, Yuji M.; Liu, Shanming; Cheung, Atwood; Stegmeier, Frank; Michaud, Gregory A.; Charlat, Olga; Wiellette, Elizabeth; Zhang, Yue; Wiessner, Stephanie; Hild, Marc; Shi, Xiaoying; Wilson, Christopher J.; Mickanin, Craig; Myer, Vic; Fazal, Aleem; Tomlinson, Ronald; Serluca, Fabrizio; Shao, Wenlin; Cheng, Hong; Shultz, Michael; Fawell, Stephen; Lu, Chris; Curtis, Daniel; Lengauer, Christoph; Finan, Peter M.; Tallarico, John A.; Porter, Jeffery A.; Cong, Feng] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Rau, Christina; Schirle, Markus; Schlegl, Judith; Ghidelli, Sonja; Bouwmeester, Tewis; Bauer, Andreas] Cellzome AG, D-69117 Heidelberg, Germany; [Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Novartis; GlaxoSmithKline; Cellzome GmbH; Harvard University; Harvard Medical School	Cong, F (corresponding author), Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	feng.cong@novartis.com		Wilson, Christopher/0000-0002-9146-522X				Bantscheff M, 2008, MOL CELL PROTEOMICS, V7, P1702, DOI 10.1074/mcp.M800029-MCP200; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Chang Anne B, 2005, Cough, V1, P7; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002639; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Dynek JN, 2004, SCIENCE, V304, P97, DOI 10.1126/science.1094754; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; Hsiao SJ, 2006, MOL CELL BIOL, V26, P2044, DOI 10.1128/MCB.26.6.2044-2054.2006; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Kishida M, 1999, ONCOGENE, V18, P979, DOI 10.1038/sj.onc.1202388; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; MIYAKI M, 1994, CANCER RES, V54, P3011; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Sbodio JI, 2002, BIOCHEM J, V361, P451, DOI 10.1042/0264-6021:3610451; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yeh TYJ, 2006, BIOCHEM J, V399, P415, DOI 10.1042/BJ20060713	29	1481	1593	5	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					614	620		10.1038/nature08356	http://dx.doi.org/10.1038/nature08356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19759537				2022-12-24	WOS:000270302600032
J	Holt, LJ; Tuch, BB; Villen, J; Johnson, AD; Gygi, SP; Morgan, DO				Holt, Liam J.; Tuch, Brian B.; Villen, Judit; Johnson, Alexander D.; Gygi, Steven P.; Morgan, David O.			Global Analysis of Cdk1 Substrate Phosphorylation Sites Provides Insights into Evolution	SCIENCE			English	Article							CYCLIN-DEPENDENT KINASE; YEAST; MECHANISM; TARGETS; DOMAINS	To explore the mechanisms and evolution of cell-cycle control, we analyzed the position and conservation of large numbers of phosphorylation sites for the cyclin-dependent kinase Cdk1 in the budding yeast Saccharomyces cerevisiae. We combined specific chemical inhibition of Cdk1 with quantitative mass spectrometry to identify the positions of 547 phosphorylation sites on 308 Cdk1 substrates in vivo. Comparisons of these substrates with orthologs throughout the ascomycete lineage revealed that the position of most phosphorylation sites is not conserved in evolution; instead, clusters of sites shift position in rapidly evolving disordered regions. We propose that the regulation of protein function by phosphorylation often depends on simple nonspecific mechanisms that disrupt or enhance protein-protein interactions. The gain or loss of phosphorylation sites in rapidly evolving regions could facilitate the evolution of kinase-signaling circuits.	[Villen, Judit; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Holt, Liam J.; Morgan, David O.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Holt, Liam J.; Morgan, David O.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Tuch, Brian B.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA	Harvard University; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gygi, SP (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	steven_gygi@hms.harvard.edu; david.morgan@ucsf.edu		Villen, Judit/0000-0002-1005-1739; Holt, Liam/0000-0002-4002-0861; Morgan, David/0000-0001-8753-4416	NIH [GM50684, HG3456, GM037049]; NSF; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037049, R01GM069901] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Feldman, R. Fletterick, M. Jacobson, H. Li, M. Matyskiela, P. O'Farrell, M. Sullivan, and S. Naylor for helpful comments; A. K. Dunker, E. Garner, C. Oldfield, K. Shimizu, and T. Ishida for disorder prediction algorithms; the Broad Institute, Sanger Center, Genolevures, and the Joint Genome Institute for genome sequence data; and O. Jensen, C. Zhang, and K. Shokat for reagents. This work was supported by grants from NIH (GM50684 to D. O. M., HG3456 to S. P. G., and GM037049 to A. D. J.) and fellowships from NSF (to L. J. H. and B. B. T.).	Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; CARROLL SB, 2005, DNA DIVERSITY MOL GE; Drury LS, 2009, CURR BIOL, V19, P530, DOI 10.1016/j.cub.2009.02.034; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Holt LJ, 2007, MOL CELL, V25, P689, DOI 10.1016/j.molcel.2007.02.012; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Kakiuchi K, 2007, BIOCHEMISTRY-US, V46, P7781, DOI 10.1021/bi700501t; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Moses AM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r23; Moses AM, 2007, P NATL ACAD SCI USA, V104, P17713, DOI 10.1073/pnas.0700997104; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Serber Z, 2007, CELL, V128, P441, DOI 10.1016/j.cell.2007.01.018; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7	20	643	2391	3	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1682	1686		10.1126/science.1172867	http://dx.doi.org/10.1126/science.1172867			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779198	Green Accepted			2022-12-24	WOS:000270131800044
J	Johnston, CA; Hirono, K; Prehoda, KE; Doe, CQ				Johnston, Christopher A.; Hirono, Keiko; Prehoda, Kenneth E.; Doe, Chris Q.			Identification of an Aurora-A/Pins(LINKER)/Dlg Spindle Orientation Pathway using Induced Cell Polarity in S2 Cells	CELL			English	Article							DROSOPHILA AURORA-A; NEURAL STEM-CELLS; G-ALPHA-I; CORTICAL POLARITY; SELF-RENEWAL; CAENORHABDITIS-ELEGANS; ASYMMETRIC DIVISIONS; TUMOR-SUPPRESSOR; PROTEIN COMPLEX; NEUROBLASTS	Asymmetric cell division is intensely studied because it can generate cellular diversity as well as maintain stem cell populations. Asymmetric cell division requires mitotic spindle alignment with intrinsic or extrinsic polarity cues, but mechanistic detail of this process is lacking. Here, we develop a method to construct cortical polarity in a normally unpolarized cell line and use this method to characterize Partner of Inscuteable ( Pins; LGN/AGS3 in mammals) -dependent spindle orientation. We identify a previously unrecognized evolutionarily conserved Pins domain ( Pins LINKER) that requires Aurora-A phosphorylation to recruit Discs large (Dlg; PSD-95/hDlg in mammals) and promote partial spindle orientation. The well-characterized Pins TPR domain has no function alone, but placing the Pins TPR in cis to the Pins LINKER gives dynein-dependent precise spindle orientation. This "induced cortical polarity'' assay is suitable for rapid identification of the proteins, domains, and amino acids regulating spindle orientation or cell polarity.	[Johnston, Christopher A.; Hirono, Keiko; Prehoda, Kenneth E.; Doe, Chris Q.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Johnston, Christopher A.; Hirono, Keiko; Doe, Chris Q.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Johnston, Christopher A.; Hirono, Keiko; Doe, Chris Q.] Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA	University of Oregon; University of Oregon; Howard Hughes Medical Institute; University of Oregon	Prehoda, KE (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	prehoda@uoregon.edu; cdoe@uoregon.edu		Prehoda, Ken/0000-0003-4214-6158	Damon Runyon postdoctoral fellowship; National Institutes of Health [GM068032]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087457, R01GM068032] Funding Source: NIH RePORTER	Damon Runyon postdoctoral fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Cabernard for Figure 6M; T. Gillies for Figures 6N and 6K; S. Liu, R. Vale, K. Siller, S. Spencer, T. Kaufman, J. Raff, J. Knoblich, and the Bloomington Stock Center for providing fly, DNA, and antibody reagents; B. Wee for technical assistance; and B. Bowerman, C. Cabernard, S. O'Rourke, S. Rogers, and S. Atwood for comments. This work was funded by a Damon Runyon postdoctoral fellowship ( C. A. J.), the National Institutes of Health GM068032 ( K. E. P.), and the Howard Hughes Medical Institute ( C. Q. D.).	Bai JM, 2001, DEVELOPMENT, V128, P591; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Couwenbergs C, 2007, J CELL BIOL, V179, P15, DOI 10.1083/jcb.200707085; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Knoblich JA, 1999, CURR BIOL, V9, P155, DOI 10.1016/S0960-9822(99)80070-0; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lorson MA, 2000, J CELL BIOL, V148, P73, DOI 10.1083/jcb.148.1.73; Megraw TL, 1999, DEVELOPMENT, V126, P2829; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Nguyen-Ngoc T, 2007, NAT CELL BIOL, V9, P1294, DOI 10.1038/ncb1649; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siller KH, 2008, DEV BIOL, V319, P1, DOI 10.1016/j.ydbio.2008.03.018; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174	40	164	165	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 18	2009	138	6					1150	1163		10.1016/j.cell.2009.07.041	http://dx.doi.org/10.1016/j.cell.2009.07.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766567	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000269923200015
J	Maida, Y; Yasukawa, M; Furuuchi, M; Lassmann, T; Possemato, R; Okamoto, N; Kasim, V; Hayashizaki, Y; Hahn, WC; Masutomi, K				Maida, Yoshiko; Yasukawa, Mami; Furuuchi, Miho; Lassmann, Timo; Possemato, Richard; Okamoto, Naoko; Kasim, Vivi; Hayashizaki, Yoshihide; Hahn, William C.; Masutomi, Kenkichi			An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA	NATURE			English	Article							SMALL INTERFERING RNAS; CARTILAGE-HAIR-HYPOPLASIA; HEPATITIS-C VIRUS; HUMAN TELOMERASE; CATALYTIC SUBUNIT; HUMAN-CELLS; GENETIC ELEMENTS; MARROW FAILURE; IMMORTAL CELLS; MOUSE OOCYTES	Constitutive expression of telomerase in human cells prevents the onset of senescence and crisis by maintaining telomere homeostasis. However, accumulating evidence suggests that the human telomerase reverse transcriptase catalytic subunit ( TERT) contributes to cell physiology independently of its ability to elongate telomeres. Here we show that TERT interacts with the RNA component of mitochondrial RNA processing endoribonuclease (RMRP), a gene that is mutated in the inherited pleiotropic syndrome cartilage-hair hypoplasia. Human TERT and RMRP form a distinct ribonucleoprotein complex that has RNA-dependent RNA polymerase (RdRP) activity and produces double- stranded RNAs that can be processed into small interfering RNA in a Dicer ( also known as DICER1)-dependent manner. These observations identify a mammalian RdRP composed of TERT in complex with RMRP.	[Possemato, Richard; Hahn, William C.] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Possemato, Richard; Hahn, William C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Possemato, Richard; Hahn, William C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hahn, William C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Masutomi, Kenkichi] Japan Sci & Technol Agcy, PREST, Kawaguchi, Saitama 3320012, Japan; [Maida, Yoshiko; Yasukawa, Mami; Furuuchi, Miho; Okamoto, Naoko; Kasim, Vivi; Masutomi, Kenkichi] Natl Canc Ctr, Canc Stem Cell Project, Chuo Ku, Tokyo 1040045, Japan; [Lassmann, Timo; Hayashizaki, Yoshihide] RIKEN, Yokohama Inst, RIKEN Om Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Japan Science & Technology Agency (JST); National Cancer Center - Japan; RIKEN	Hahn, WC (corresponding author), Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	william_hahn@dfci.harvard.edu; kmasutom@ncc.go.jp	Hayashizaki, Yoshihide/N-6590-2015; Lassmann, Timo/HCH-4313-2022; Lassmann, Timo/A-8271-2008	Lassmann, Timo/0000-0002-0138-2691; Lassmann, Timo/0000-0002-0138-2691; Kasim, Vivi/0000-0001-9182-8230; Possemato, Richard/0000-0002-2401-0030	NIA NIH HHS [R01 AG023145-05, R01 AG23145, R01 AG023145] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG023145] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Almeida R, 2005, TRENDS CELL BIOL, V15, P251, DOI 10.1016/j.tcb.2005.03.006; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Ford LP, 2001, J BIOL CHEM, V276, P32198, DOI 10.1074/jbc.M104469200; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Guggenheim R, 2006, BONE MARROW TRANSPL, V38, P751, DOI 10.1038/sj.bmt.1705520; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lee J, 2008, ONCOGENE, V27, P3754, DOI 10.1038/sj.onc.1211037; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Liu JM, 2006, BLOOD, V107, P4583, DOI 10.1182/blood-2005-12-4831; Lue NF, 2005, P NATL ACAD SCI USA, V102, P9778, DOI 10.1073/pnas.0502252102; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Moriarty TJ, 2002, MOL CELL BIOL, V22, P1253, DOI 10.1128/MCB.22.4.1253-1265.2002; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nishikura K, 2001, CELL, V107, P415, DOI 10.1016/S0092-8674(01)00581-5; Pascale E, 2004, CANCER RES, V64, P7702, DOI 10.1158/0008-5472.CAN-04-1711; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; SEMLER BL, 2002, MOL BIOL PICORNAVIRU, P255; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Won J, 2004, P NATL ACAD SCI USA, V101, P11328, DOI 10.1073/pnas.0401801101; Yamashita T, 1998, J BIOL CHEM, V273, P15479, DOI 10.1074/jbc.273.25.15479; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141	49	284	293	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					230	U104		10.1038/nature08283	http://dx.doi.org/10.1038/nature08283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19701182	Green Accepted, Bronze			2022-12-24	WOS:000269654600037
J	Utikal, J; Polo, JM; Stadtfeld, M; Maherali, N; Kulalert, W; Walsh, RM; Khalil, A; Rheinwald, JG; Hochedlinger, K				Utikal, Jochen; Polo, Jose M.; Stadtfeld, Matthias; Maherali, Nimet; Kulalert, Warakorn; Walsh, Ryan M.; Khalil, Adam; Rheinwald, James G.; Hochedlinger, Konrad			Immortalization eliminates a roadblock during cellular reprogramming into iPS cells	NATURE			English	Article							PLURIPOTENT STEM-CELLS; TUMOR SUPPRESSION; INK4A LOCUS; LIFE-SPAN; FIBROBLASTS; EFFICIENCY; SYSTEM; GENERATION; PROMOTER; LIMITS	The overexpression of defined transcription factors in somatic cells results in their reprogramming into induced pluripotent stem (iPS) cells(1-3). The extremely low efficiency and slow kinetics of in vitro reprogramming suggest that further rare events are required to generate iPS cells. The nature and identity of these events, however, remain elusive. We noticed that the reprogramming potential of primary murine fibroblasts into iPS cells decreases after serial passaging and the concomitant onset of senescence. Consistent with the notion that loss of replicative potential provides a barrier for reprogramming, here we show that cells with low endogenous p19(Arf) (encoded by the Ink4a/Arf locus, also known as Cdkn2a locus) protein levels and immortal fibroblasts deficient in components of the Arf-Trp53 pathway yield iPS cell colonies with up to threefold faster kinetics and at a significantly higher efficiency than wild-type cells, endowing almost every somatic cell with the potential to form iPS cells. Notably, the acute genetic ablation of Trp53 (also known as p53) in cellular sub-populations that normally fail to reprogram rescues their ability to produce iPS cells. Our results show that the acquisition of immortality is a crucial and rate-limiting step towards the establishment of a pluripotent state in somatic cells and underscore the similarities between induced pluripotency and tumorigenesis.	[Utikal, Jochen; Polo, Jose M.; Stadtfeld, Matthias; Maherali, Nimet; Kulalert, Warakorn; Walsh, Ryan M.; Khalil, Adam; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Utikal, Jochen; Polo, Jose M.; Stadtfeld, Matthias; Maherali, Nimet; Kulalert, Warakorn; Walsh, Ryan M.; Khalil, Adam; Hochedlinger, Konrad] Harvard Stem Cell Inst, Ctr Regenerat Med, Boston, MA 02114 USA; [Utikal, Jochen; Polo, Jose M.; Stadtfeld, Matthias; Maherali, Nimet; Kulalert, Warakorn; Walsh, Ryan M.; Khalil, Adam; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Utikal, Jochen] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, D-68135 Mannheim, Germany; [Maherali, Nimet] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Rheinwald, James G.] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Rheinwald, James G.] Harvard Skin Dis Res Ctr, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Ruprecht Karls University Heidelberg; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 185 Cambridge St, Boston, MA 02114 USA.	khochedlinger@helix.mgh.harvard.edu		Stadtfeld, Matthias/0000-0002-5852-9906; Polo, Jose M/0000-0002-2531-778X; Utikal, Jochen/0000-0001-5316-0241	Mildred Scheel Foundation; ECOR fellowship; Schering Foundation; NIH Skin Disease Research Center Grant; Natural Sciences and Engineering Council of Canada; NIH Director's Innovator Award; Harvard Stem Cell Institute; Kimmel Foundation and the V Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	Mildred Scheel Foundation(Deutsche Krebshilfe); ECOR fellowship; Schering Foundation; NIH Skin Disease Research Center Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH Director's Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Kimmel Foundation and the V Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Roussel and C. Sherr for providing us with Arf-GFP cells, D. C. Bennett and E. Sviderskaya for sharing Melan A cells, and A. Ventura and T. Jacks for tail biopsies of conditional Trp53-mutant mice. We also thank A. Tzatsos and N. Bardeesy for suggestions, for critical reading of the manuscript and for providing Ink4a/Arf2/2 MEFs. We are grateful to P. Follett for blastocyst injections and L. Prickett and K. Folz-Donahue for assistance with FACS. J. U. was supported by a postdoctoral fellowship from the Mildred Scheel Foundation, J. M. P. by an ECOR fellowship, and M. S. by a fellowship from the Schering Foundation. J. G. R. was supported by an NIH Skin Disease Research Center Grant. N. M. was supported by a graduated scholarship from the Natural Sciences and Engineering Council of Canada. Support to K. H. came from the NIH Director's Innovator Award, the Harvard Stem Cell Institute, the Kimmel Foundation and the V Foundation.	BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; EMINLI S, NATURE GENE IN PRESS; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zindy F, 2003, P NATL ACAD SCI USA, V100, P15930, DOI 10.1073/pnas.2536808100	29	651	703	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1145	U112		10.1038/nature08285	http://dx.doi.org/10.1038/nature08285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19668190	Green Accepted			2022-12-24	WOS:000269314000042
J	Bormuth, V; Varga, V; Howard, J; Schaffer, E				Bormuth, Volker; Varga, Vladimir; Howard, Jonathon; Schaeffer, Erik			Protein Friction Limits Diffusive and Directed Movements of Kinesin Motors on Microtubules	SCIENCE			English	Article							DEPENDENT MANNER; MOLECULAR MOTORS; FORCE; MICROSPHERES; SPINDLE; ENDS	Friction limits the operation of macroscopic engines and is critical to the performance of micromechanical devices. We report measurements of friction in a biological nanomachine. Using optical tweezers, we characterized the frictional drag force of individual kinesin-8 motor proteins interacting with their microtubule tracks. At low speeds and with no energy source, the frictional drag was related to the diffusion coefficient by the Einstein relation. At higher speeds, the frictional drag force increased nonlinearly, consistent with the motor jumping 8 nanometers between adjacent tubulin dimers along the microtubule, and was asymmetric, reflecting the structural polarity of the microtubule. We argue that these frictional forces arise from breaking bonds between the motor domains and the microtubule, and they limit the speed and efficiency of kinesin.	[Bormuth, Volker; Varga, Vladimir; Howard, Jonathon] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Schaeffer, Erik] Tech Univ Dresden, Nanomech Grp, Biotechnol Ctr, D-01307 Dresden, Germany	Max Planck Society; Technische Universitat Dresden	Howard, J (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	Howard@mpi-cbg.de; Erik.Schaeffer@biotec.tu-dresden.de	Schäffer, Erik/A-4664-2010; Howard, Jonathon/D-4229-2011	Schäffer, Erik/0000-0001-7876-085X; Howard, Jonathon/0000-0003-0086-1196; Varga, Vladimir/0000-0002-0384-1281	Deutsche Forschungsgemeinschaft (E. Noether Program); Max Planck Society; Technische Universitat Dresden; Boehringer Ingelheim Fonds	Deutsche Forschungsgemeinschaft (E. Noether Program)(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Technische Universitat Dresden; Boehringer Ingelheim Fonds(Boehringer Ingelheim)	The work was supported by the Deutsche Forschungsgemeinschaft (E. Noether Program), the Max Planck Society, and the Technische Universitat Dresden. V.B. had a fellowship from the Boehringer Ingelheim Fonds.	Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Bormuth V, 2008, OPT EXPRESS, V16, P13831, DOI 10.1364/OE.16.013831; BRENNER B, 1982, P NATL ACAD SCI-BIOL, V79, P7288, DOI 10.1073/pnas.79.23.7288; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Charvin G, 2002, SINGLE MOL, V3, P43, DOI 10.1002/1438-5171(200204)3:1<43::AID-SIMO43>3.3.CO;2-J; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Fisher ME, 1999, P NATL ACAD SCI USA, V96, P6597, DOI 10.1073/pnas.96.12.6597; Furuta K, 2008, CURR BIOL, V18, P152, DOI 10.1016/j.cub.2007.12.056; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Howard J, 2001, MOTOR PROTEINS CYTOS; Howard J, 2009, ANNU REV BIOPHYS, V38, P217, DOI 10.1146/annurcv.biophys.050708.133732; Kapitein LC, 2008, CURR BIOL, V18, P1713, DOI 10.1016/j.cub.2008.09.046; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Parmeggiani A, 1999, PHYS REV E, V60, P2127, DOI 10.1103/PhysRevE.60.2127; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Schaffer E, 2007, LANGMUIR, V23, P3654, DOI 10.1021/la0622368; Suda H, 2001, LANGMUIR, V17, P6045, DOI 10.1021/la0106384; SVOBODA K, 1994, P NATL ACAD SCI USA, V91, P11782, DOI 10.1073/pnas.91.25.11782; TAWADA K, 1991, J THEOR BIOL, V150, P193, DOI 10.1016/S0022-5193(05)80331-5; Thomas N, 2001, P ROY SOC B-BIOL SCI, V268, P2113, DOI 10.1098/rspb.2001.1764; Tolic-Norrelykke SF, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2356852; Uemura S, 2003, NAT STRUCT BIOL, V10, P308, DOI 10.1038/nsb911; Urbakh M, 2004, NATURE, V430, P525, DOI 10.1038/nature02750; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Westermann S, 2006, NATURE, V440, P565, DOI 10.1038/nature04409; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018	34	161	162	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					870	873		10.1126/science.1174923	http://dx.doi.org/10.1126/science.1174923			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AK	19679813				2022-12-24	WOS:000269242400045
J	He, Y; Jones, CR; Fujiki, N; Xu, Y; Guo, B; Holder, JL; Rossner, MJ; Nishino, S; Fu, YH				He, Ying; Jones, Christopher R.; Fujiki, Nobuhiro; Xu, Ying; Guo, Bin; Holder, Jimmy L., Jr.; Rossner, Moritz J.; Nishino, Seiji; Fu, Ying-Hui			The Transcriptional Repressor DEC2 Regulates Sleep Length in Mammals	SCIENCE			English	Article							PHASE SYNDROME; MOLECULAR CLOCK; MUSHROOM BODIES; MUTANT MICE; DROSOPHILA; EXPRESSION; MUTATION; CONSEQUENCES; NEUROBIOLOGY; DEPRIVATION	Sleep deprivation can impair human health and performance. Habitual total sleep time and homeostatic sleep response to sleep deprivation are quantitative traits in humans. Genetic loci for these traits have been identified in model organisms, but none of these potential animal models have a corresponding human genotype and phenotype. We have identified a mutation in a transcriptional repressor (hDEC2-P385R) that is associated with a human short sleep phenotype. Activity profiles and sleep recordings of transgenic mice carrying this mutation showed increased vigilance time and less sleep time than control mice in a zeitgeber time- and sleep deprivation-dependent manner. These mice represent a model of human sleep homeostasis that provides an opportunity to probe the effect of sleep on human physical and mental health.	[He, Ying; Xu, Ying; Holder, Jimmy L., Jr.; Fu, Ying-Hui] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Jones, Christopher R.] Univ Utah, Dept Neurol, Salt Lake City, UT 84132 USA; [Fujiki, Nobuhiro; Nishino, Seiji] Stanford Univ, Sleep & Circadian Neurobiol Lab, Palo Alto, CA 94304 USA; [Guo, Bin] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Rossner, Moritz J.] Max Planck Inst Expt Med, D-37075 Gottingen, Germany	University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; Stanford University; University of California System; University of California Berkeley; Max Planck Society	Fu, YH (corresponding author), Univ Calif San Francisco, Dept Neurol, Mission Bay,1550 4th St, San Francisco, CA 94158 USA.	ying-hui.fu@ucsf.edu	Xu, Ying/A-3009-2013; Holder, J. Lloyd/AFT-0389-2022; He, Ying/B-3952-2010; Xu, Ying/AAF-3081-2019	Xu, Ying/0000-0002-6689-7768; He, Ying/0000-0002-2052-8350; Xu, Ying/0000-0002-6689-7768; Rossner, Moritz/0000-0002-0667-3420	NIH [HL059596]; Conte Center [MH074924]; Sandler Neurogenetics fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conte Center; Sandler Neurogenetics fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grant HL059596, Conte Center grant (MH074924), and by the Sandler Neurogenetics fund.	Akiskal HS, 2005, J AFFECT DISORDERS, V85, P3, DOI 10.1016/j.jad.2004.12.001; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Franken P, 2006, P NATL ACAD SCI USA, V103, P7118, DOI 10.1073/pnas.0602006103; Fuller PM, 2006, J BIOL RHYTHM, V21, P482, DOI 10.1177/0748730406294627; Hamaguchi H, 2004, BIOCHEM J, V382, P43, DOI 10.1042/BJ20031760; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Jones CR, 1999, NAT MED, V5, P1062, DOI 10.1038/12502; Kadener S, 2007, GENE DEV, V21, P1675, DOI 10.1101/gad.1552607; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Kondo J, 2006, INT J MOL MED, V17, P1053; Lim C, 2007, CURR BIOL, V17, P1082, DOI 10.1016/j.cub.2007.05.039; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Noshiro M, 2005, J BIOL RHYTHM, V20, P404, DOI 10.1177/0748730405280195; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Rossner MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002762; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; YANG MY, 1995, NEURON, V15, P45; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	23	199	207	4	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 14	2009	325	5942					866	870		10.1126/science.1174443	http://dx.doi.org/10.1126/science.1174443			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AK	19679812	Green Accepted			2022-12-24	WOS:000269242400044
J	Jay, M; Marmot, MG				Jay, M.; Marmot, M. G.			Health and climate change	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jay, M.] House Lords, London SW1A 0PW, England; [Marmot, M. G.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of London; University College London	Jay, M (corresponding author), House Lords, London SW1A 0PW, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G0100222, G8802774, G19/35] Funding Source: Medline; Medical Research Council [G0100222, G19/35, G8802774] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], CLIMATE CHANGE HUMAN; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Costello A, 2009, LANCET, V373, P1693, DOI 10.1016/S0140-6736(09)60929-6; *GROUP 8 LEAD, 2009, RESP LEAD SUST FUT; Intergovernmental Panel on Climate Change, 4 IPCC; McMichael AJ, 2008, BRIT MED J, V336, P191, DOI 10.1136/bmj.39392.473727.AD; *OPT POP TRUST, 2009, POP GROWTH CLIM CHAN; Stern Nicholas, 2006, STERN REV EC CLIMATE	8	12	13	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2009	339								b3669	10.1136/bmj.b3669	http://dx.doi.org/10.1136/bmj.b3669			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	496RR	19762077				2022-12-24	WOS:000269994600011
J	Jay, M; Marmot, MG				Jay, M.; Marmot, M. G.			Health and climate change	LANCET			English	Editorial Material									[Marmot, M. G.] UCL, Int Inst Soc & Hlth, London WC1E 6BT, England; [Jay, M.] Merlin, London, England	University of London; University College London	Marmot, MG (corresponding author), UCL, Int Inst Soc & Hlth, London WC1E 6BT, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G0100222, G8802774, G19/35] Funding Source: Medline; Medical Research Council [G0100222, G19/35, G8802774] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Costello A, 2009, LANCET, V373, P1693, DOI 10.1016/S0140-6736(09)60929-6; Intergovernmental Panel on Climate Change, 2007, CLIM CHANG 2007 SYNT; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; McMichael AJ, 2008, BRIT MED J, V336, P191, DOI 10.1136/bmj.39392.473727.AD; *OPT POP TRUST, 2009, POP GROWTH CLIM CHAN; Stern Nicholas, 2007, EC CLIMATE CHANGE; *WHO, SEA LEV RIS; [No title captured]	8	12	13	2	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2009	374	9694					961	962		10.1016/S0140-6736(09)61603-2	http://dx.doi.org/10.1016/S0140-6736(09)61603-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	498PK	19762077				2022-12-24	WOS:000270154100010
